archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,5.508e-06,1.7184,1.5009,1,1
1,GO BLEB ASSEMBLY,2.7578e-07,1.6202,1.4129,1,1
1,GO MEMBRANE RAFT ASSEMBLY,2.5774e-06,1.4257,1.574,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,1.349e-05,1.3467,1.1412,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,3.17e-07,1.2317,1.0873,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,8.4155e-08,1.1934,1.1896,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,2.4515e-08,1.1682,1.1164,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,2.9957e-08,1.1619,1.1056,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,7.013e-05,1.1571,1.0862,1,1
1,GO NEUTROPHIL HOMEOSTASIS,2.1831e-07,1.0953,1.0242,1,1
1,GO RESPONSE TO INTERFERON ALPHA,3.3202e-07,1.076,1.1515,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,1.725e-07,1.0692,1.0512,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.2971e-07,1.054,1.0019,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,4.6623e-06,1.0476,0.9885,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,9.389e-05,1.0416,0.80787,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,1.9873e-07,1.0286,1.0401,1,1
1,GO HYALURONAN CATABOLIC PROCESS,6.93e-08,1.0272,1.0615,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,4.4878e-05,1.0145,0.89651,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,2.3975e-07,0.99651,0.87839,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,6.2786e-05,0.99375,0.8563,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.4039e-05,0.9908,0.87926,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,2.2879e-07,0.98973,0.84912,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,4.2876e-06,0.98827,0.87997,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,3.6414e-07,0.9695,0.95482,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,5.0683e-06,0.94575,0.95524,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,3.8423e-08,0.93272,0.93407,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,3.17e-07,0.93268,0.99762,1,1
1,GO BONE TRABECULA FORMATION,1.4039e-05,0.92917,0.88071,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,2.9301e-06,0.92892,0.84687,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,6.4994e-06,0.92141,0.86984,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,2.8496e-08,0.92007,0.9877,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.0311e-06,0.91684,0.86337,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00011241,0.91524,0.72381,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,2.0784e-06,0.90936,0.89304,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,3.9926e-07,0.90577,0.97577,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,8.628e-07,0.90321,0.81079,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,4.6623e-06,0.89158,1.0644,1,1
1,GO HEMIDESMOSOME ASSEMBLY,1.3441e-06,0.88821,1.2473,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,7.2756e-08,0.88753,0.92083,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,3.479e-08,0.87035,0.95484,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,3.6414e-07,0.86993,0.83986,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,1.2366e-07,0.8622,0.84804,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,7.2111e-07,0.86061,0.73218,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,4.2424e-08,0.85508,0.86684,1,1
1,GO MEMBRANE RAFT ORGANIZATION,2.4692e-06,0.85217,0.93814,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.0033e-05,0.83667,0.7734,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,5.6999e-08,0.83422,0.84731,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.1702e-06,0.83326,0.72633,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.5813e-07,0.83235,0.72335,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.2879e-07,0.83091,0.83929,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.6322e-07,0.82762,0.77824,1,1
1,GO CD40 SIGNALING PATHWAY,3.8131e-07,0.82693,0.76047,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.1237e-07,0.82175,0.79057,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,6.6003e-08,0.81999,0.79183,1,1
1,GO RESPONSE TO INTERFERON BETA,2.3654e-06,0.81918,0.96086,1,1
1,GO HIPPO SIGNALING,1.0311e-06,0.81736,0.66293,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,6.5896e-07,0.81364,0.88591,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,1.5201e-05,0.80448,0.81594,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,3.4772e-07,0.80446,0.68239,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,5.0194e-07,0.80137,0.70362,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,3.9926e-07,0.79819,0.77418,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,2.5308e-05,0.79748,0.71523,1,1
1,GO ZYMOGEN INHIBITION,3.3202e-07,0.79652,0.81438,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,7.5427e-07,0.79611,0.70191,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.725e-07,0.79161,0.77508,1,1
1,GO PLASMINOGEN ACTIVATION,5.2139e-05,0.79105,0.63467,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,3.1904e-06,0.7774,0.68572,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.0207e-07,0.77482,0.71761,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,8.6584e-06,0.77167,0.65882,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,9.7275e-08,0.76737,0.76016,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,1.8958e-07,0.76567,0.76789,1,1
1,GO ENDODERM FORMATION,4.6826e-08,0.76452,0.83948,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,2.7578e-07,0.75871,0.87318,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,3.7791e-06,0.7582,0.71576,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,1.104e-05,0.75427,0.68002,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,1.7118e-05,0.75255,0.63701,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.00079435,0.74994,0.54448,1,1
1,GO CYTIDINE TO URIDINE EDITING,0.00014935,0.74461,0.67938,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,1.2971e-07,0.74323,0.70837,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,6.0198e-07,0.74315,0.72966,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,1.1267e-06,0.73634,0.69929,1,1
1,GO EPIBOLY,8.8325e-08,0.73565,0.80908,1,1
1,GO LATERAL MESODERM DEVELOPMENT,4.8612e-06,0.73191,0.6384,1,1
1,GO GAP JUNCTION ASSEMBLY,1.0311e-06,0.73129,0.67255,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,5.986e-08,0.72952,0.70342,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,9.2696e-08,0.72741,0.6954,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,3.6228e-06,0.72536,0.74745,1,1
1,GO CELLULAR RESPONSE TO X RAY,1.9263e-05,0.72155,0.59077,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00038934,0.72057,0.54763,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,5.1671e-08,0.71959,0.70783,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,7.0571e-06,0.71559,0.71371,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,5.2139e-05,0.71338,0.67383,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,9.4334e-07,0.71211,0.68399,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.6003e-08,0.71003,0.73512,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,2.4346e-05,0.70774,0.63065,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,2.0784e-06,0.70343,0.74778,1,1
1,GO LEUKOCYTE AGGREGATION,0.00011241,0.69722,0.60339,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,6.93e-08,0.69716,0.69103,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.6729e-06,0.69356,0.62259,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.00017186,0.69309,0.56826,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,6.0198e-07,0.69195,0.63481,1,1
1,GO NOTOCHORD DEVELOPMENT,2.5122e-07,0.68927,0.78584,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,1.4039e-05,0.68836,0.6141,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,2.7343e-05,0.68761,0.55695,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,3.8131e-07,0.68664,0.84649,1,1
1,GO SALIVARY GLAND DEVELOPMENT,3.17e-07,0.68638,0.67602,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,5.986e-08,0.68278,0.66825,1,1
1,GO VASCULOGENESIS,2.8496e-08,0.68204,0.65965,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,9.4334e-07,0.67953,0.73999,1,1
1,GO FIBRINOLYSIS,1.0779e-06,0.67892,0.81607,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,4.5813e-07,0.67742,0.59491,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,3.3287e-06,0.67604,0.57416,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,2.3975e-07,0.67448,0.73294,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,4.1617e-05,0.67352,0.63404,1,1
1,GO BIOLOGICAL PHASE,0.00020448,0.67212,0.61919,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,9.8628e-07,0.67077,0.80045,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,3.4728e-06,0.66881,0.80018,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,5.2837e-06,0.66835,0.62614,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00021909,0.664,0.50011,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.4728e-06,0.66109,0.51158,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,9.4334e-07,0.6609,0.61441,1,1
1,GO RESPONSE TO INTERLEUKIN 18,0.0073363,0.66078,0.60706,1,1
1,GO T CELL EXTRAVASATION,7.0571e-06,0.66048,0.67233,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,1.3441e-06,0.65821,0.59943,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,5.9841e-06,0.65686,0.55414,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,1.3441e-06,0.65443,0.66436,1,1
1,GO REGULATION OF PINOCYTOSIS,4.8379e-05,0.65266,0.63654,1,1
1,GO SKIN MORPHOGENESIS,8.3127e-06,0.65191,0.80368,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,3.1888e-05,0.65072,0.62192,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,5.2837e-06,0.64875,0.6295,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.1267e-06,0.6482,0.70463,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00065623,0.64802,0.50733,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,9.3916e-06,0.64565,0.56948,1,1
1,GO APOPTOTIC CELL CLEARANCE,8.8325e-08,0.64512,0.73573,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,4.2876e-06,0.64479,0.57037,1,1
1,GO MUCUS SECRETION,0.0011199,0.64318,0.51538,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,5.2139e-05,0.64162,0.56673,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.5774e-06,0.64007,0.62719,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,7.889e-07,0.6392,0.60534,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,2.5308e-05,0.63898,0.55847,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,2.8077e-06,0.63626,0.74231,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.4963e-07,0.62926,0.67969,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,3.8423e-08,0.62907,0.62618,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,3.7791e-06,0.62864,0.55245,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,9.0221e-07,0.62737,0.74372,1,1
1,GO ENDODERM DEVELOPMENT,6.2859e-08,0.62469,0.69376,1,1
1,GO CELLULAR RESPONSE TO IRON ION,1.8084e-07,0.62306,0.63603,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,3.8131e-07,0.62179,0.63472,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.0375e-08,0.62011,0.63901,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,1.1776e-06,0.61767,0.65141,1,1
1,GO DNA DEAMINATION,5.7413e-06,0.61555,0.62226,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,6.7728e-06,0.61406,0.59624,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,2.3654e-06,0.61151,0.545,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,6.2786e-05,0.60729,0.43524,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,2.4692e-06,0.60628,0.71537,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.6455e-05,0.60417,0.56309,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,2.1702e-06,0.60305,0.66544,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,1.1267e-06,0.60224,0.66415,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,5.0194e-07,0.60223,0.62889,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.725e-07,0.60211,0.65678,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.9873e-07,0.60033,0.61925,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,6.7728e-06,0.60027,0.59159,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,2.2879e-07,0.59871,0.51871,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0037331,0.59725,0.37797,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.6729e-06,0.59693,0.67702,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,4.1617e-05,0.59676,0.56317,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,1.4044e-06,0.59621,0.50964,1,1
1,GO LIVER REGENERATION,2.2167e-08,0.59611,0.62435,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00027832,0.59606,0.41536,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,1.0311e-06,0.59451,0.54487,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,5.508e-06,0.59393,0.69408,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0038387,0.59369,0.68239,1,1
1,GO REGULATION OF FIBRINOLYSIS,2.0033e-05,0.59308,0.60813,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,2.3418e-05,0.59277,0.51755,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.00011241,0.59186,0.49079,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,6.2985e-07,0.59159,0.66751,1,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.0073363,0.59057,0.48591,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,5.0683e-06,0.58951,0.60123,1,1
1,GO ELASTIC FIBER ASSEMBLY,4.8379e-05,0.58863,0.77004,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,3.4728e-06,0.58625,0.51544,1,1
1,GO RESPONSE TO X RAY,2.8496e-08,0.58533,0.6381,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,7.2754e-05,0.58363,0.46339,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,2.9301e-06,0.58286,0.52773,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.4963e-07,0.58243,0.59464,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,1.906e-06,0.58178,0.49143,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00022676,0.58103,0.49147,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,1.0604e-05,0.58028,0.54071,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,1.8084e-07,0.57919,0.61678,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,1.2971e-07,0.57918,0.63349,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,1.4039e-05,0.57865,0.5865,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,4.7955e-07,0.57823,0.54135,1,1
1,GO RESPONSE TO TYPE I INTERFERON,2.3418e-05,0.57683,0.64307,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,2.6902e-06,0.57606,0.64345,1,1
1,GO AORTIC VALVE DEVELOPMENT,1.4674e-06,0.57598,0.57178,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,3.7791e-06,0.57578,0.67583,1,1
1,GO AMYLOID BETA CLEARANCE,5.2533e-07,0.57467,0.502,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,1.104e-05,0.57423,0.60146,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,2.1663e-05,0.57321,0.53206,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,7.0571e-06,0.57217,0.59984,1,1
1,GO ENTRY INTO HOST,2.2879e-07,0.57198,0.59714,1,1
1,GO HEME METABOLIC PROCESS,2.0784e-06,0.57183,0.51518,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.6015e-06,0.57079,0.49733,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00016023,0.57034,0.45126,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,3.9418e-06,0.56938,0.5261,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,1.0604e-05,0.56519,0.46787,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,3.0576e-06,0.56309,0.74151,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.7343e-05,0.56139,0.45568,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.4772e-07,0.56103,0.59418,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,1.104e-05,0.5601,0.53101,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,2.0033e-05,0.55988,0.47954,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,1.2308e-06,0.55959,0.51596,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,7.889e-07,0.55853,0.56302,1,1
1,GO TOLERANCE INDUCTION,0.00011241,0.55805,0.50511,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.019739,0.55727,0.38238,1,1
1,GO CELLULAR RESPONSE TO DSRNA,1.0207e-07,0.557,0.58626,1,1
1,GO PIGMENT GRANULE MATURATION,0.00014935,0.55681,0.4344,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,5.0683e-06,0.5539,0.53795,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.00013917,0.5528,0.60879,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,5.2533e-07,0.55218,0.50396,1,1
1,GO TYPE 2 IMMUNE RESPONSE,5.508e-06,0.5506,0.56334,1,1
1,GO CYTOLYSIS,3.6228e-06,0.54962,0.48231,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,6.0198e-07,0.5484,0.59362,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.4963e-07,0.54697,0.53793,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0007696,0.54679,0.43161,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0025083,0.5456,0.39081,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0001165,0.54443,0.48453,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,3.7791e-06,0.54439,0.47906,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,4.4712e-06,0.54234,0.58473,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.00065623,0.54189,0.43228,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.4044e-06,0.54152,0.51795,1,1
1,GO INTERLEUKIN 1 PRODUCTION,4.1112e-06,0.53987,0.49721,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.4609e-05,0.53898,0.40458,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,9.3916e-06,0.53874,0.49543,1,1
1,GO COLLAGEN CATABOLIC PROCESS,5.4977e-07,0.53677,0.59561,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,1.2454e-05,0.53459,0.55137,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,4.1802e-07,0.53434,0.49367,1,1
1,GO ZYMOGEN ACTIVATION,1.1964e-05,0.53383,0.54373,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.8131e-07,0.5333,0.58501,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,7.889e-07,0.53276,0.58372,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,7.3528e-06,0.53275,0.49209,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.0207e-07,0.53268,0.56439,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.00013433,0.53213,0.48009,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,9.0179e-06,0.53206,0.65343,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,5.8301e-05,0.5317,0.42431,1,1
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0046564,0.53123,0.35871,1,1
1,GO VAGINA DEVELOPMENT,1.5331e-06,0.53062,0.60296,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,6.2985e-07,0.53034,0.52662,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,7.2111e-07,0.52885,0.50215,1,1
1,GO RESPONSE TO INTERFERON GAMMA,2.0784e-06,0.52776,0.528,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,3.5759e-05,0.52653,0.46011,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.5691e-07,0.52641,0.60119,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00090094,0.52614,0.55853,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,1.4268e-07,0.52534,0.48066,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.2454e-05,0.52479,0.53952,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,6.2859e-08,0.52372,0.53622,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.31e-08,0.52304,0.51984,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.6729e-06,0.52287,0.45135,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,5.0194e-07,0.52137,0.50984,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,6.5149e-05,0.52076,0.45961,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00041602,0.51955,0.4455,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0019282,0.51884,0.38198,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,5.4977e-07,0.51825,0.46919,1,1
1,GO VIRAL GENOME REPLICATION,6.8936e-07,0.51779,0.47932,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.3202e-07,0.51749,0.47658,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,3.3287e-06,0.51692,0.53205,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,4.0073e-05,0.51528,0.50871,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.349e-05,0.51489,0.44234,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,2.1663e-05,0.51455,0.53631,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,1.4674e-06,0.51362,0.47492,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,1.725e-07,0.51143,0.54693,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,3.4421e-05,0.51102,0.50668,1,1
1,GO PULMONARY VALVE DEVELOPMENT,8.1192e-05,0.51006,0.51078,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,4.5813e-07,0.50975,0.75055,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,6.7596e-05,0.50867,0.44217,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,2.8077e-06,0.50831,0.45265,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,3.0576e-06,0.5083,0.53335,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,5.6999e-08,0.50793,0.52023,1,1
1,GO T CELL MEDIATED IMMUNITY,1.6729e-06,0.50765,0.49809,1,1
1,GO ENAMEL MINERALIZATION,6.7596e-05,0.5076,0.50329,1,1
1,GO OSTEOBLAST DEVELOPMENT,6.7596e-05,0.50516,0.46095,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0001165,0.50438,0.478,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,3.8583e-05,0.50344,0.39677,1,1
1,GO RESPONSE TO HYPEROXIA,1.0184e-05,0.50157,0.52224,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,1.2308e-06,0.50143,0.48073,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.00028792,0.50101,0.4917,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,2.9301e-06,0.50099,0.58244,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,9.0221e-07,0.5007,0.6274,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,7.8282e-05,0.4997,0.50542,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,4.7955e-07,0.49959,0.51994,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,2.2658e-06,0.49926,0.49037,1,1
1,GO PEPTIDE CROSS LINKING,5.4121e-05,0.49844,0.5217,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,2.9532e-05,0.4983,0.52124,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,1.5331e-06,0.49778,0.54084,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,9.3916e-06,0.4976,0.43014,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,2.6322e-07,0.49739,0.56731,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00041602,0.49693,0.47921,1,1
1,GO LYMPHANGIOGENESIS,2.5122e-07,0.49659,0.52339,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00030804,0.49644,0.42953,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.001191,0.49603,0.42872,1,1
1,GO STORE OPERATED CALCIUM ENTRY,6.4994e-06,0.49539,0.4176,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.001662,0.49509,0.40113,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0010528,0.49409,0.40842,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,1.8251e-06,0.49401,0.46549,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,7.013e-05,0.49286,0.36739,1,1
1,GO GLAND MORPHOGENESIS,2.6902e-06,0.49221,0.47366,1,1
1,GO DETECTION OF BIOTIC STIMULUS,2.1702e-06,0.49201,0.50412,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00084609,0.49094,0.46949,1,1
1,GO FOREGUT MORPHOGENESIS,7.0571e-06,0.49031,0.50204,1,1
1,GO FIBROBLAST ACTIVATION,0.00012512,0.48989,0.42295,1,1
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0029794,0.48779,0.41499,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,9.8628e-07,0.48769,0.52434,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.011326,0.48596,0.40804,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00072223,0.48586,0.37189,1,1
1,GO PINOCYTOSIS,2.7578e-07,0.48579,0.61965,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,5.4272e-08,0.48568,0.50204,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,2.5308e-05,0.48508,0.39866,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00074557,0.48507,0.52123,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,5.2533e-07,0.48502,0.46893,1,1
1,GO PROTEIN OXIDATION,0.00031859,0.48447,0.47647,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,6.4994e-06,0.48286,0.47391,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.1493e-05,0.4825,0.39885,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,1.2962e-05,0.48197,0.52592,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.6603e-06,0.48118,0.48768,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,1.5201e-05,0.48084,0.4311,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00055855,0.48059,0.37338,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.007729,0.48008,0.26905,1,1
1,GO RESPONSE TO ANGIOTENSIN,9.4334e-07,0.47974,0.46273,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,5.7413e-06,0.47935,0.48012,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,2.1702e-06,0.47868,0.48843,1,1
1,GO VIRAL RNA GENOME REPLICATION,5.6999e-08,0.47778,0.47308,1,1
1,GO REGULATION OF TRANSPOSITION,1.5816e-05,0.47764,0.5152,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,3.1904e-06,0.47736,0.43811,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,3.3132e-05,0.47718,0.45458,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,3.9926e-07,0.4766,0.40141,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00013433,0.47632,0.39817,1,1
1,GO NIK NF KAPPAB SIGNALING,1.1788e-07,0.4751,0.44192,1,1
1,GO CYTOKINE METABOLIC PROCESS,1.7474e-06,0.47403,0.41172,1,1
1,GO BLOOD VESSEL REMODELING,4.8379e-05,0.47379,0.42356,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,5.2533e-07,0.47301,0.51739,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,4.4878e-05,0.47298,0.41503,1,1
1,GO HYALURONAN METABOLIC PROCESS,2.5122e-07,0.47297,0.50941,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,4.1802e-07,0.47221,0.49903,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.2524e-05,0.47181,0.44653,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.0184e-05,0.47136,0.49741,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,4.1112e-06,0.4713,0.48348,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,3.3287e-06,0.47005,0.50663,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00079435,0.46966,0.45714,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,2.9301e-06,0.46884,0.53929,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,2.1663e-05,0.46861,0.41337,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,1.1964e-05,0.46829,0.43867,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,3.8131e-07,0.46814,0.51002,1,1
1,GO REGULATION OF MYOBLAST FUSION,4.6597e-05,0.46731,0.53485,1,1
1,GO DEFENSE RESPONSE TO VIRUS,5.2837e-06,0.46678,0.43157,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,2.2524e-05,0.46674,0.45194,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.3763e-07,0.46666,0.51311,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.6729e-06,0.4665,0.42559,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,1.6455e-05,0.46564,0.59884,1,1
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.0019282,0.46498,0.59317,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,9.0551e-05,0.46484,0.39138,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,8.628e-07,0.46434,0.47518,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,1.0779e-06,0.46341,0.46979,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0018173,0.46336,0.38856,1,1
1,GO RESPONSE TO INTERLEUKIN 12,3.0264e-07,0.4632,0.44406,1,1
1,GO BONE GROWTH,1.1267e-06,0.4616,0.5596,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,3.7791e-06,0.46152,0.41941,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,6.0198e-07,0.46152,0.47516,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,4.6826e-08,0.46133,0.4494,1,1
1,GO MACROPHAGE PROLIFERATION,0.00057693,0.46034,0.46996,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00018427,0.46009,0.42487,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0060989,0.45999,0.32449,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,9.3916e-06,0.45962,0.41041,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,5.2837e-06,0.45935,0.44055,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,7.013e-05,0.45863,0.39536,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00034072,0.45763,0.41108,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,5.0683e-06,0.45696,0.45277,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.7791e-06,0.45695,0.41965,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,9.8628e-07,0.4567,0.40206,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,4.8612e-06,0.45662,0.41288,1,1
1,GO REPLICATIVE SENESCENCE,0.00036427,0.4566,0.45109,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,1.5201e-05,0.45603,0.53236,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0013457,0.45586,0.43816,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,7.0571e-06,0.45585,0.45832,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,7.5427e-07,0.45481,0.41386,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,5.508e-06,0.45459,0.41183,1,1
1,GO ANIMAL ORGAN REGENERATION,9.7275e-08,0.45455,0.51689,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.4268e-07,0.45439,0.40297,1,1
1,GO PROTEASOME ASSEMBLY,0.00017186,0.45437,0.31453,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.3132e-05,0.45359,0.69859,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,7.6603e-06,0.45257,0.49676,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.3605e-07,0.4525,0.51194,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.5896e-07,0.45234,0.48177,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.0018173,0.45175,0.36868,1,1
1,GO TRABECULA FORMATION,0.00011241,0.4515,0.48904,1,1
1,GO MRNA TRANSCRIPTION,2.7343e-05,0.45148,0.37433,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.014486,0.45146,0.28393,1,1
1,GO MUSCLE CELL FATE COMMITMENT,3.1888e-05,0.45136,0.45821,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,2.7343e-05,0.45131,0.35745,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00052342,0.45123,0.32221,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.0311e-06,0.45052,0.41222,1,1
1,GO RESPONSE TO SALT STRESS,3.0264e-07,0.45042,0.41909,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.001191,0.45035,0.36474,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,1.3441e-06,0.45007,0.39798,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,3.17e-07,0.44967,0.52049,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,7.5427e-07,0.44963,0.42391,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,3.0264e-07,0.44781,0.42852,1,1
1,GO TONGUE MORPHOGENESIS,0.01282,0.44763,0.31539,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.3132e-05,0.44759,0.40291,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,3.9926e-07,0.44684,0.4321,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00018427,0.44657,0.4854,1,1
1,GO HAIR FOLLICLE MATURATION,0.00087311,0.44653,0.36396,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.1663e-05,0.44636,0.36603,1,1
1,GO MATURATION OF LSU RRNA,0.00013917,0.4463,0.38091,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00027832,0.44597,0.36682,1,1
1,GO RESPONSE TO PROGESTERONE,0.0060989,0.44549,0.29835,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.4977e-07,0.44516,0.43554,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,2.6902e-06,0.44463,0.51177,1,1
1,GO ETHANOL OXIDATION,0.013798,0.44459,0.38118,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,6.8936e-07,0.44452,0.39721,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.0576e-06,0.44436,0.4461,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,2.7343e-05,0.44397,0.53568,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,4.1112e-06,0.44386,0.39086,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.8301e-05,0.44368,0.32778,1,1
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.00013433,0.44332,0.39958,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,6.5896e-07,0.4425,0.41131,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,5.9841e-06,0.44232,0.47999,1,1
1,GO PROTEIN ACTIVATION CASCADE,1.1493e-05,0.44166,0.37722,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00081984,0.44133,0.33266,1,1
1,GO EMBRYO IMPLANTATION,3.0264e-07,0.44132,0.53216,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.00065623,0.44109,0.40692,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,1.7474e-06,0.44108,0.54439,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,7.6603e-06,0.43997,0.47511,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,2.1663e-05,0.43992,0.49914,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.00090094,0.43989,0.46246,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,9.8628e-07,0.43934,0.45692,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,1.349e-05,0.43912,0.41624,1,1
1,GO REGULATION OF HIPPO SIGNALING,5.4121e-05,0.43903,0.40661,1,1
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.023205,0.43896,0.27247,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,4.6597e-05,0.4387,0.35116,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00074557,0.43804,0.54122,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,9.0551e-05,0.43779,0.6396,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.0017641,0.43741,0.31401,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00057693,0.4374,0.51477,1,1
1,GO VIRAL TRANSLATION,5.2837e-06,0.4367,0.41455,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,3.4421e-05,0.43643,0.41067,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,3.9418e-06,0.43604,0.45408,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00067758,0.43512,0.32015,1,1
1,GO DISTAL TUBULE DEVELOPMENT,0.012203,0.43499,0.34738,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.3127e-06,0.43469,0.41498,1,1
1,GO INTERLEUKIN 2 PRODUCTION,5.4977e-07,0.43407,0.45457,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,5.508e-06,0.43402,0.48004,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,2.2524e-05,0.434,0.4691,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,6.2786e-05,0.4337,0.39049,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,6.7596e-05,0.43294,0.35645,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,2.3418e-05,0.43243,0.31654,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,7.2754e-05,0.43216,0.3845,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.00057693,0.43181,0.35482,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,4.4878e-05,0.43171,0.37885,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0050528,0.43133,0.26081,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00084609,0.43072,0.46835,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.9263e-05,0.43051,0.47308,1,1
1,GO FOCAL ADHESION ASSEMBLY,3.3287e-06,0.4299,0.43249,1,1
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0039469,0.42942,0.28778,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,2.1702e-06,0.42879,0.41876,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.5331e-06,0.42869,0.59202,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,9.0551e-05,0.42777,0.38098,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.0034322,0.42732,0.3936,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0011549,0.42653,0.3326,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,6.2367e-06,0.42639,0.38131,1,1
1,GO FIBROBLAST MIGRATION,4.1802e-07,0.42632,0.44796,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.00059588,0.4263,0.49259,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,1.4963e-07,0.42609,0.45895,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,4.6623e-06,0.42585,0.46272,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,6.2985e-07,0.4255,0.41943,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,1.2862e-06,0.4253,0.43484,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,5.7413e-06,0.42502,0.39932,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,1.2971e-07,0.42501,0.39221,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,4.4712e-06,0.42487,0.37314,1,1
1,GO I KAPPAB PHOSPHORYLATION,5.0683e-06,0.42378,0.34683,1,1
1,GO RECEPTOR CATABOLIC PROCESS,4.8612e-06,0.42329,0.42185,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,5.753e-07,0.42324,0.39979,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,1.1776e-06,0.42312,0.46262,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,3.8583e-05,0.42129,0.34644,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00047456,0.42118,0.48173,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.4211,0.40813,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,4.4878e-05,0.42104,0.36792,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,4.1617e-05,0.42058,0.38039,1,1
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00010462,0.42,0.42627,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.2308e-06,0.41965,0.3758,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00063551,0.41955,0.30059,1,1
1,GO VIRAL LIFE CYCLE,1.6452e-07,0.41928,0.43742,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,6.2985e-07,0.41881,0.36738,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,2.2658e-06,0.4188,0.40225,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00034072,0.41814,0.35916,1,1
1,GO TOOTH MINERALIZATION,0.00031859,0.41799,0.35106,1,1
1,GO VASCULAR TRANSPORT,0.0062634,0.41798,0.49423,1,1
1,GO IMMATURE T CELL PROLIFERATION,6.4994e-06,0.41788,0.47812,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,3.7791e-06,0.41779,0.44856,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,3.9418e-06,0.41743,0.36297,1,1
1,GO MULTI ORGANISM LOCALIZATION,6.6003e-08,0.41721,0.41753,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,8.7323e-05,0.41665,0.42495,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,1.2454e-05,0.41629,0.42609,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00016595,0.41575,0.34953,1,1
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.00029782,0.41551,0.33804,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.001986,0.41542,0.33184,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00013433,0.41503,0.39286,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,2.0833e-05,0.41442,0.39404,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,2.7343e-05,0.41398,0.4873,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,4.4712e-06,0.41343,0.40083,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,2.0829e-07,0.4132,0.41919,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,1.349e-05,0.4132,0.35796,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,9.2696e-08,0.41314,0.40922,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00074557,0.41258,0.35594,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0057817,0.41251,0.32307,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.0023671,0.4121,0.41985,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,4.4712e-06,0.41181,0.41574,1,1
1,GO LENS FIBER CELL DEVELOPMENT,7.8282e-05,0.41124,0.46027,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.5201e-05,0.41118,0.49195,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00095906,0.41106,0.31698,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0014299,0.41106,0.31566,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,8.2505e-07,0.41099,0.41056,1,1
1,GO PLATELET AGGREGATION,6.8936e-07,0.41073,0.39543,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00012074,0.41069,0.39557,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00025131,0.41067,0.40932,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0013872,0.4106,0.37924,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,1.7474e-06,0.41033,0.41669,1,1
1,GO COPPER ION HOMEOSTASIS,5.7413e-06,0.40959,0.49461,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00055855,0.40881,0.32476,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00031859,0.40821,0.38782,1,1
1,GO REGULATION OF MRNA BINDING,2.9532e-05,0.40814,0.35834,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,7.3528e-06,0.40805,0.43756,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,2.1663e-05,0.40762,0.31474,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,6.7728e-06,0.40742,0.46673,1,1
1,GO INTERACTION WITH SYMBIONT,6.4994e-06,0.40735,0.35046,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,1.5201e-05,0.40725,0.60288,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,3.8583e-05,0.40714,0.40231,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0045306,0.4063,0.42698,1,1
1,GO RIBOSOME ASSEMBLY,0.00095906,0.40605,0.30983,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.8251e-06,0.40562,0.42348,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0038387,0.40561,0.29002,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,5.2837e-06,0.4053,0.48023,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,6.8936e-07,0.40499,0.37879,1,1
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0064317,0.40495,0.45903,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.00013917,0.40493,0.41342,1,1
1,GO POSITIVE REGULATION OF CELL SIZE,0.03245,0.40476,0.24325,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.019283,0.40455,0.25412,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,2.2524e-05,0.40431,0.35948,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00013917,0.40385,0.41031,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.3916e-06,0.40363,0.36413,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00038934,0.40356,0.3555,1,1
1,GO INTERLEUKIN 8 PRODUCTION,4.6623e-06,0.40344,0.40128,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,4.6597e-05,0.40231,0.48349,1,1
1,GO CELL SUBSTRATE ADHESION,3.3202e-07,0.40222,0.43433,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,4.8379e-05,0.40197,0.42985,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.00038934,0.40041,0.48014,1,1
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.0030654,0.40023,0.29137,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00095906,0.40023,0.40711,1,1
1,GO REGULATION OF STEROL TRANSPORT,3.3287e-06,0.40018,0.3528,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,9.7801e-06,0.3998,0.47496,1,1
1,GO INTERFERON BETA PRODUCTION,2.4346e-05,0.39934,0.33089,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,5.0226e-05,0.39932,0.40259,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,4.7955e-07,0.39927,0.38815,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.00026003,0.399,0.37255,1,1
1,GO GENITALIA MORPHOGENESIS,0.0014299,0.39898,0.34403,1,1
1,GO CERAMIDE CATABOLIC PROCESS,0.00014418,0.39898,0.36353,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,7.8282e-05,0.39853,0.40436,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00057693,0.3984,0.32299,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,5.2533e-07,0.39777,0.42665,1,1
1,GO SPROUTING ANGIOGENESIS,1.0311e-06,0.39741,0.39064,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.1904e-06,0.39685,0.35255,1,1
1,GO NEURAL CREST CELL MIGRATION,0.0025083,0.39675,0.27672,1,1
1,GO PRIMARY MIRNA PROCESSING,3.7145e-05,0.39624,0.39607,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,3.4728e-06,0.39609,0.39301,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.018398,0.39607,0.35906,1,1
1,GO TYPE I INTERFERON PRODUCTION,7.0571e-06,0.39558,0.34487,1,1
1,GO GALACTOSE METABOLIC PROCESS,0.00049035,0.39556,0.32527,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,1.7474e-06,0.39547,0.498,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,5.7413e-06,0.39516,0.44722,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.00023468,0.39484,0.5331,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0019282,0.39441,0.33315,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.0036303,0.39434,0.48562,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,8.3127e-06,0.39367,0.44573,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.00049035,0.39326,0.33356,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.015574,0.39287,0.2673,1,1
1,GO CHONDROCYTE DEVELOPMENT,2.6307e-05,0.3927,0.42333,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,8.7323e-05,0.39213,0.36006,1,1
1,GO MYOBLAST DIFFERENTIATION,1.2308e-06,0.39197,0.37714,1,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.015574,0.39159,0.23633,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00027832,0.39137,0.33663,1,1
1,GO OSTEOCLAST DEVELOPMENT,1.4674e-06,0.39084,0.4321,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.0571e-06,0.39081,0.37292,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,2.0033e-05,0.39063,0.44451,1,1
1,GO CARNITINE METABOLIC PROCESS,9.389e-05,0.39055,0.37277,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,7.3528e-06,0.39052,0.42323,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,1.2962e-05,0.39002,0.36923,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.013798,0.39,0.35536,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00022676,0.38999,0.41384,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1702e-06,0.38909,0.37049,1,1
1,GO URETER DEVELOPMENT,0.00041602,0.38905,0.36045,1,1
1,GO INTERACTION WITH HOST,4.3763e-07,0.38851,0.43804,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,1.3441e-06,0.38821,0.42304,1,1
1,GO ERBB2 SIGNALING PATHWAY,3.4728e-06,0.38782,0.35095,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0028957,0.38744,0.36176,1,1
1,GO T CELL APOPTOTIC PROCESS,9.8628e-07,0.38743,0.37698,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00040247,0.38656,0.30366,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,6.2859e-08,0.38616,0.39678,1,1
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0007696,0.3861,0.3116,1,1
1,GO RESPONSE TO ESTROGEN,2.8891e-07,0.38605,0.40701,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.0033e-05,0.38539,0.34552,1,1
1,GO REGULATION OF GASTRULATION,4.5813e-07,0.38483,0.39684,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00040247,0.38479,0.40096,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,3.6228e-06,0.3847,0.35572,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.00012074,0.38339,0.31385,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0026572,0.38332,0.32862,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0021062,0.38304,0.28445,1,1
1,GO PHAGOCYTOSIS RECOGNITION,0.00016595,0.38198,0.52221,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,7.9801e-06,0.38186,0.34631,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00027832,0.3813,0.37827,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1.1493e-05,0.38043,0.33234,1,1
1,GO PLATELET DEGRANULATION,9.3916e-06,0.37956,0.43397,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00030804,0.37929,0.31592,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.011326,0.37908,0.24689,1,1
1,GO MEMBRANE INVAGINATION,1.1267e-06,0.37863,0.37241,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,1.1267e-06,0.3785,0.47687,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00087311,0.37847,0.40253,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,0.00013917,0.37812,0.34601,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,6.7728e-06,0.37795,0.3289,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,9.7801e-06,0.37792,0.48888,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,8.3127e-06,0.3776,0.31717,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.9301e-06,0.37758,0.44774,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,8.628e-07,0.37732,0.38043,1,1
1,GO MUSCLE FILAMENT SLIDING,2.1702e-06,0.37727,0.38353,1,1
1,GO REGULATION OF PHAGOCYTOSIS,3.0264e-07,0.37716,0.40933,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,1.1776e-06,0.37663,0.41177,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,0.00017186,0.37643,0.33811,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0001547,0.37627,0.3262,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.6729e-06,0.37625,0.35319,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,8.1192e-05,0.37601,0.28929,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.00026903,0.37583,0.35501,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,4.7955e-07,0.37582,0.52909,1,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.00026003,0.37515,0.31233,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.009256,0.37506,0.29688,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.00057693,0.37462,0.34686,1,1
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.00049035,0.37432,0.47491,1,1
1,GO T CELL CYTOKINE PRODUCTION,3.0576e-06,0.37391,0.43388,1,1
1,GO REGULATION OF LIPASE ACTIVITY,7.6603e-06,0.37269,0.29335,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,8.7323e-05,0.37205,0.29455,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,1.6015e-06,0.37192,0.40919,1,1
1,GO FIBROBLAST PROLIFERATION,2.0833e-05,0.37164,0.35526,1,1
1,GO REGULATION OF PROTEIN IMPORT,8.6584e-06,0.37155,0.3762,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,1.104e-05,0.37147,0.34969,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.00011241,0.37114,0.2928,1,1
1,GO MITRAL VALVE DEVELOPMENT,0.0039469,0.37088,0.43334,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00021909,0.37076,0.46051,1,1
1,GO MEMBRANE DISASSEMBLY,0.00017186,0.37042,0.30777,1,1
1,GO INTERLEUKIN 17 PRODUCTION,4.6623e-06,0.37025,0.45312,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0022332,0.36963,0.44343,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,2.1663e-05,0.36911,0.30242,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,5.2139e-05,0.36901,0.29275,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0013457,0.3688,0.25294,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0020453,0.36879,0.28683,1,1
1,GO CHEMOKINE PRODUCTION,0.00084609,0.36857,0.28433,1,1
1,GO RIG I SIGNALING PATHWAY,8.4205e-05,0.36825,0.35611,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.0017641,0.3679,0.3187,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00095906,0.36769,0.27998,1,1
1,GO CHONDROCYTE DIFFERENTIATION,2.3654e-06,0.36766,0.34635,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,9.389e-05,0.36731,0.30709,1,1
1,GO KERATINOCYTE MIGRATION,2.6307e-05,0.3672,0.36761,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.00034072,0.3671,0.36236,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.001872,0.36695,0.29009,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00095906,0.36639,0.28986,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,7.9801e-06,0.36626,0.3458,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00036427,0.36623,0.29937,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,4.0073e-05,0.36599,0.32294,1,1
1,GO GLIAL CELL ACTIVATION,0.00036427,0.36566,0.33333,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0083534,0.36563,0.38078,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0032441,0.36536,0.30037,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.00042998,0.36517,0.28183,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0012662,0.36504,0.33149,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.1192e-05,0.36502,0.44186,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,3.0689e-05,0.36479,0.31308,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00044439,0.36451,0.30988,1,1
1,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.012203,0.36361,0.32982,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,1.6729e-06,0.36359,0.36797,1,1
1,GO TRANSLATIONAL INITIATION,0.00030804,0.36348,0.29944,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,2.9301e-06,0.36298,0.40298,1,1
1,GO MESODERM MORPHOGENESIS,2.0829e-07,0.36274,0.38813,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,6.2786e-05,0.36267,0.30401,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.9841e-06,0.36256,0.33475,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00045924,0.36245,0.36964,1,1
1,GO LYMPH VESSEL DEVELOPMENT,9.0551e-05,0.3623,0.41288,1,1
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00021909,0.36224,0.3815,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00050664,0.36221,0.305,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0015653,0.36207,0.27075,1,1
1,GO PROSTANOID METABOLIC PROCESS,4.3218e-05,0.36201,0.38651,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,3.7145e-05,0.36163,0.34897,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.013798,0.36073,0.34667,1,1
1,GO MUSCLE CELL MIGRATION,0.0032441,0.36066,0.26953,1,1
1,GO VASCULATURE DEVELOPMENT,1.0311e-06,0.36033,0.33505,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,3.8131e-07,0.36015,0.34958,1,1
1,GO RESPONSE TO CORTICOSTEROID,8.4205e-05,0.36013,0.2709,1,1
1,GO GASTRULATION,1.4268e-07,0.35998,0.39661,1,1
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00019079,0.35981,0.31965,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.1888e-05,0.3595,0.33992,1,1
1,GO RETINAL METABOLIC PROCESS,0.010245,0.35945,0.31067,1,1
1,GO RESPONSE TO VIRUS,3.0576e-06,0.3591,0.37023,1,1
1,GO MATURATION OF 5 8S RRNA,0.00067758,0.35875,0.26412,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,0.0001165,0.35868,0.29248,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.0033e-05,0.35847,0.2988,1,1
1,GO FOREBRAIN MORPHOGENESIS,0.036164,0.35829,0.18538,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,2.1663e-05,0.35821,0.28555,1,1
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.010506,0.35819,0.24596,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.2962e-05,0.35757,0.39017,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00065623,0.35754,0.31708,1,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0097392,0.35747,0.29219,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,7.9801e-06,0.35743,0.37553,1,1
1,GO HYPOTONIC RESPONSE,0.00022676,0.35712,0.32167,1,1
1,GO WOUND HEALING,3.3287e-06,0.35685,0.34761,1,1
1,GO SERTOLI CELL DIFFERENTIATION,0.00040247,0.35657,0.31584,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,1.7118e-05,0.35633,0.33618,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.00030804,0.35629,0.30948,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,2.3654e-06,0.35555,0.38151,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.6452e-07,0.35527,0.39832,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,3.7791e-06,0.35527,0.37698,1,1
1,GO REGULATION OF PROTEIN MATURATION,1.0311e-06,0.35515,0.37907,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,0.00074557,0.35474,0.33669,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,1.0604e-05,0.35434,0.39998,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,3.8583e-05,0.35427,0.33478,1,1
1,GO ENDOTHELIAL CELL MIGRATION,2.8077e-06,0.35421,0.36021,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.7118e-05,0.35415,0.34044,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00013433,0.35402,0.2949,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,8.6584e-06,0.35398,0.35815,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,9.0179e-06,0.35377,0.37693,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.4712e-06,0.35336,0.37131,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,9.2696e-08,0.35322,0.37305,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,5.7413e-06,0.35291,0.33919,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,2.5774e-06,0.35283,0.34003,1,1
1,GO CHONDROCYTE PROLIFERATION,0.00067758,0.35273,0.47315,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.9418e-06,0.35213,0.41541,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0013872,0.35078,0.24248,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,3.7145e-05,0.35072,0.33176,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00010845,0.35045,0.33658,1,1
1,GO B CELL MEDIATED IMMUNITY,9.0179e-06,0.35039,0.32256,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.9904e-06,0.35015,0.34875,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,4.3218e-05,0.34992,0.28461,1,1
1,GO ERAD PATHWAY,1.5816e-05,0.34991,0.2649,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,0.00013433,0.34985,0.53882,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.8418e-05,0.34969,0.27193,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00037661,0.34967,0.3816,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.00034072,0.34936,0.41664,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,7.2754e-05,0.34888,0.4205,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,2.9532e-05,0.34883,0.37954,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.2139e-05,0.34844,0.38134,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,6.4994e-06,0.34652,0.35534,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00055855,0.34579,0.314,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,2.4692e-06,0.34515,0.38039,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00081984,0.34498,0.2687,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0049174,0.34434,0.24962,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0006154,0.34418,0.3643,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0024367,0.34378,0.32105,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.001191,0.34376,0.31282,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,1.5201e-05,0.34369,0.30267,1,1
1,GO TISSUE MIGRATION,5.9841e-06,0.34364,0.33071,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0067808,0.3431,0.28886,1,1
1,GO VIRAL GENE EXPRESSION,5.0226e-05,0.34305,0.33472,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,7.5427e-07,0.34289,0.33847,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.8077e-06,0.34281,0.38271,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00013917,0.34245,0.25611,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.00031859,0.34226,0.36283,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00012074,0.34205,0.45551,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,2.0033e-05,0.34183,0.34739,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,2.6307e-05,0.34159,0.31082,1,1
1,GO TRACHEA DEVELOPMENT,0.00087311,0.34132,0.30734,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00010092,0.34126,0.33201,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,5.0226e-05,0.3411,0.37569,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,4.4878e-05,0.34108,0.35422,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.8077e-06,0.34067,0.34491,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,6.5896e-07,0.34036,0.43025,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00037661,0.34028,0.42126,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0021689,0.33988,0.36928,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,4.6597e-05,0.33981,0.31344,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,5.2139e-05,0.3398,0.3566,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00044439,0.3396,0.34908,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.0033e-05,0.33957,0.40821,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,6.4994e-06,0.33933,0.33087,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00026903,0.33911,0.3873,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00087311,0.33898,0.3122,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.0022992,0.33887,0.32333,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00030804,0.33869,0.31819,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0006154,0.33851,0.45396,1,1
1,GO NATURAL KILLER CELL ACTIVATION,1.0311e-06,0.33817,0.34937,1,1
1,GO DECIDUALIZATION,0.0012662,0.33798,0.41675,1,1
1,GO L GLUTAMATE IMPORT,0.0039469,0.33789,0.28867,1,1
1,GO CARTILAGE DEVELOPMENT,4.2876e-06,0.33751,0.31029,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,5.508e-06,0.33746,0.29246,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,3.1904e-06,0.33729,0.39959,1,1
1,GO PROTEIN HYDROXYLATION,0.007729,0.33717,0.36629,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.00031859,0.33694,0.56942,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.00028792,0.33692,0.26,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00038934,0.33691,0.31374,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,6.5149e-05,0.33688,0.34884,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00023468,0.33684,0.33748,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,1.8958e-07,0.33631,0.3641,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.00047456,0.33612,0.27297,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.7343e-05,0.33554,0.36556,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,7.0571e-06,0.3351,0.31242,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,8.4205e-05,0.3345,0.24353,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,7.3528e-06,0.33443,0.4164,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00013433,0.33435,0.32518,1,1
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.023205,0.3342,0.1934,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,3.0689e-05,0.33416,0.28992,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,3.4421e-05,0.3341,0.27906,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.00067758,0.33395,0.21679,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,5.2837e-06,0.33393,0.3391,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.349e-05,0.33372,0.46564,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,5.2837e-06,0.33369,0.33207,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,5.2533e-07,0.33348,0.4048,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.00016023,0.33311,0.43196,1,1
1,GO CELL MATRIX ADHESION,3.3287e-06,0.33299,0.36709,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,7.013e-05,0.33296,0.35892,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,9.389e-05,0.33279,0.37146,1,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.0083534,0.3324,0.25428,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,3.8131e-07,0.33206,0.34353,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00032948,0.33181,0.33723,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,1.906e-06,0.33124,0.32594,1,1
1,GO GLOMERULUS DEVELOPMENT,2.7343e-05,0.33113,0.41455,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,5.0683e-06,0.33076,0.32029,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00084609,0.33076,0.24147,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00084609,0.33051,0.29838,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00010845,0.33042,0.262,1,1
1,GO RESPONSE TO WOUNDING,2.3654e-06,0.33042,0.30397,1,1
1,GO RESPONSE TO MANGANESE ION,1.5201e-05,0.3302,0.31716,1,1
1,GO PROTEIN TARGETING TO VACUOLE,7.8282e-05,0.33016,0.26638,1,1
1,GO TISSUE REGENERATION,1.7806e-05,0.32996,0.3383,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.3654e-06,0.32971,0.31148,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,8.1192e-05,0.32953,0.29167,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,3.4728e-06,0.3294,0.40405,1,1
1,GO NADPH REGENERATION,0.00036427,0.32921,0.30185,1,1
1,GO REGULATION OF BMP SIGNALING PATHWAY,3.3132e-05,0.32891,0.30439,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,6.2367e-06,0.32887,0.33631,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0028957,0.32879,0.31063,1,1
1,GO AMYLOID FIBRIL FORMATION,0.022165,0.32847,0.26309,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0017123,0.32836,0.36234,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00079435,0.32824,0.25527,1,1
1,GO REGENERATION,1.2971e-07,0.32782,0.33217,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0017641,0.32774,0.22786,1,1
1,GO MACROPHAGE MIGRATION,1.1267e-06,0.3277,0.38329,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0025817,0.32766,0.33896,1,1
1,GO REGULATION OF HEART GROWTH,6.7728e-06,0.32763,0.29731,1,1
1,GO MACROPHAGE DIFFERENTIATION,8.6584e-06,0.32739,0.37734,1,1
1,GO MUSCLE CELL PROLIFERATION,6.2985e-07,0.32726,0.3483,1,1
1,GO PIGMENT ACCUMULATION,0.00028792,0.32724,0.30868,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.00025131,0.32704,0.2921,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00018427,0.327,0.32984,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,1.4044e-06,0.32652,0.35994,1,1
1,GO PEPTIDE CATABOLIC PROCESS,7.547e-05,0.32645,0.26176,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,9.0551e-05,0.3263,0.29501,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.00035231,0.3263,0.36867,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00019079,0.32555,0.36693,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00038934,0.32549,0.35457,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,6.4994e-06,0.32525,0.32283,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00019079,0.32491,0.29078,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.3528e-06,0.32487,0.29303,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0025817,0.32434,0.26089,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,8.2505e-07,0.32407,0.29046,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,9.0221e-07,0.324,0.3143,1,1
1,GO MATURATION OF SSU RRNA,0.0006154,0.32345,0.29832,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00010845,0.3227,0.28532,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.00022676,0.32251,0.30849,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.017549,0.32249,0.19299,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.6307e-05,0.32243,0.40398,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00035231,0.32241,0.29484,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00016595,0.32237,0.31355,1,1
1,GO RESPONSE TO INTERLEUKIN 1,1.0311e-06,0.32236,0.36946,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.2876e-06,0.32235,0.30915,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,4.6623e-06,0.32205,0.35115,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,5.9841e-06,0.322,0.35441,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.0014299,0.32189,0.27618,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.5331e-06,0.32185,0.33129,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,0.00013433,0.32172,0.22954,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0025817,0.32141,0.23581,1,1
1,GO NECROTIC CELL DEATH,4.0073e-05,0.32109,0.40332,1,1
1,GO CYTOKINETIC PROCESS,2.6902e-06,0.32024,0.32384,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,8.1192e-05,0.31984,0.27394,1,1
1,GO KERATINOCYTE PROLIFERATION,0.0039469,0.31971,0.36279,1,1
1,GO SYNCYTIUM FORMATION,1.0184e-05,0.31957,0.3487,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00016595,0.31928,0.26441,1,1
1,GO ASTROCYTE ACTIVATION,9.0551e-05,0.31904,0.35246,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,4.3763e-07,0.31874,0.3538,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.9904e-06,0.31858,0.35186,1,1
1,GO HISTONE PHOSPHORYLATION,3.9926e-07,0.31819,0.31884,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.00025131,0.31814,0.34164,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,2.5308e-05,0.31805,0.39551,1,1
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00036427,0.31799,0.32963,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,7.5427e-07,0.31778,0.3424,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.4609e-05,0.31755,0.3962,1,1
1,GO VIRAL RELEASE FROM HOST CELL,7.2754e-05,0.31754,0.2805,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.00090094,0.31733,0.27638,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0015653,0.3172,0.23568,1,1
1,GO SNRNA PROCESSING,0.001986,0.31672,0.5482,1,1
1,GO REGULATION OF CELL KILLING,0.00095906,0.3167,0.23408,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,3.5759e-05,0.31668,0.30788,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,7.889e-07,0.31659,0.35953,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.8379e-05,0.31656,0.34451,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0001165,0.31639,0.2824,1,1
1,GO ETHER BIOSYNTHETIC PROCESS,0.0050528,0.31628,0.34057,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00044439,0.31617,0.30669,1,1
1,GO REGULATION OF ORGAN GROWTH,2.0829e-07,0.31608,0.34289,1,1
1,GO PROTEIN DEGLYCOSYLATION,0.00021167,0.31509,0.30841,1,1
1,GO RENAL FILTRATION,0.0050528,0.31496,0.37967,1,1
1,GO IRON ION HOMEOSTASIS,4.6623e-06,0.3149,0.27564,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.2756e-08,0.3146,0.32672,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,3.0689e-05,0.31442,0.26702,1,1
1,GO INNATE IMMUNE RESPONSE,8.6584e-06,0.31441,0.28882,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0062634,0.31427,0.45453,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0097392,0.31416,0.23587,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00010845,0.314,0.27587,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0001547,0.31363,0.28863,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00095906,0.31356,0.40301,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,7.8282e-05,0.31341,0.30256,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00019753,0.31318,0.30409,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00031859,0.31284,0.29268,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00018427,0.31264,0.35992,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0010206,0.31251,0.23892,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00052342,0.31232,0.29881,1,1
1,GO LIPOPROTEIN LOCALIZATION,0.0001547,0.31231,0.39588,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,2.0033e-05,0.31221,0.26598,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,4.0073e-05,0.31209,0.35194,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00010845,0.31172,0.28948,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.001191,0.31156,0.20843,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,3.3132e-05,0.31143,0.38887,1,1
1,GO VESICLE CARGO LOADING,0.00012512,0.31075,0.28125,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,6.0504e-05,0.31036,0.30161,1,1
1,GO OSTEOBLAST DIFFERENTIATION,1.6015e-06,0.31013,0.32627,1,1
1,GO ALPHA BETA T CELL ACTIVATION,0.00011241,0.31,0.24847,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00024286,0.30971,0.34122,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,5.0226e-05,0.30967,0.28641,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.6603e-06,0.30918,0.30546,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.104e-05,0.30911,0.28582,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,7.9801e-06,0.30905,0.41325,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,6.5149e-05,0.30894,0.41687,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.00026903,0.30892,0.2929,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,1.7806e-05,0.30885,0.37349,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.7474e-06,0.30865,0.35557,1,1
1,GO MACROPHAGE CHEMOTAXIS,1.9263e-05,0.30858,0.35615,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,2.7578e-07,0.30854,0.33426,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.00065623,0.30823,0.2854,1,1
1,GO RESPONSE TO PROTOZOAN,0.00017186,0.30772,0.31899,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,2.9301e-06,0.30765,0.28173,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.00065623,0.30728,0.41601,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00072223,0.30639,0.2643,1,1
1,GO NEURAL TUBE PATTERNING,0.00092958,0.30636,0.25352,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0017123,0.3054,0.32425,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,8.7323e-05,0.30525,0.25046,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,7.3528e-06,0.30464,0.2858,1,1
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.00025131,0.30439,0.2987,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.00018427,0.304,0.22811,1,1
1,GO MESENCHYME MORPHOGENESIS,0.0011549,0.30372,0.33791,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.3441e-06,0.30344,0.23737,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,3.5759e-05,0.30279,0.30688,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0014738,0.30263,0.29383,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,2.1702e-06,0.30251,0.44319,1,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.0054795,0.30223,0.22642,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,1.7118e-05,0.3022,0.27805,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,9.389e-05,0.30201,0.29465,1,1
1,GO PIGMENT METABOLIC PROCESS,1.6455e-05,0.30198,0.26703,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00049035,0.30195,0.28375,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00016595,0.30194,0.31737,1,1
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0087944,0.30191,0.35138,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,1.6015e-06,0.30179,0.28198,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,2.1702e-06,0.30171,0.37943,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.00025131,0.30164,0.27413,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00012964,0.3015,0.28746,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.020205,0.30131,0.22145,1,1
1,GO SELECTIVE AUTOPHAGY,1.6729e-06,0.30121,0.29974,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,4.3218e-05,0.30117,0.29474,1,1
1,GO PLASMA MEMBRANE TUBULATION,6.4994e-06,0.30096,0.34669,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,7.9801e-06,0.30055,0.32719,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.349e-05,0.30038,0.27366,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,1.906e-06,0.30032,0.33949,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0010859,0.30023,0.26164,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0075304,0.29989,0.22155,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.03245,0.2998,0.27523,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,1.1493e-05,0.29941,0.31055,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010845,0.29918,0.28576,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,2.0033e-05,0.29899,0.23336,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0017123,0.29871,0.30857,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,5.7413e-06,0.29853,0.26885,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,7.8282e-05,0.29845,0.38103,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0021689,0.29829,0.23479,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.024288,0.29828,0.31289,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0013457,0.29826,0.25989,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00011241,0.29798,0.20307,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,2.7343e-05,0.29795,0.31879,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,7.0571e-06,0.29783,0.29025,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0023671,0.29761,0.30454,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,6.5149e-05,0.29726,0.28649,1,1
1,GO PODOSOME ASSEMBLY,7.2754e-05,0.2969,0.37578,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,5.7413e-06,0.2969,0.36236,1,1
1,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.0007696,0.29653,0.38364,1,1
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00057693,0.29649,0.29969,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00019753,0.29605,0.30434,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.2308e-06,0.296,0.28361,1,1
1,GO TRABECULA MORPHOGENESIS,0.00013917,0.29589,0.31048,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,1.7474e-06,0.29555,0.30055,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,1.5816e-05,0.29552,0.35078,1,1
1,GO TRANSPOSITION,0.001662,0.29552,0.28455,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.5759e-05,0.29543,0.27013,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.014841,0.29542,0.23032,1,1
1,GO RESPONSE TO CYTOKINE,4.2876e-06,0.29539,0.31178,1,1
1,GO RESPONSE TO RETINOIC ACID,2.5308e-05,0.29505,0.2842,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00047456,0.29502,0.2337,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,1.8251e-06,0.29489,0.25889,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0014299,0.29486,0.27412,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,2.1702e-06,0.2947,0.31701,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0019282,0.29469,0.34333,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00017796,0.29444,0.35979,1,1
1,GO TONGUE DEVELOPMENT,0.00055855,0.29437,0.37263,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00098941,0.29414,0.25104,1,1
1,GO CYTOKINE PRODUCTION,9.0179e-06,0.2941,0.27399,1,1
1,GO REGULATION OF CELL AGING,1.9873e-07,0.29407,0.33221,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.001191,0.29401,0.22511,1,1
1,GO SPERM EGG RECOGNITION,1.349e-05,0.29394,0.25495,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,3.5759e-05,0.29377,0.25879,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.0073e-05,0.29373,0.24818,1,1
1,GO POSITIVE CHEMOTAXIS,0.0012662,0.29362,0.25041,1,1
1,GO SNRNA METABOLIC PROCESS,0.00059588,0.29348,0.43984,1,1
1,GO TRACHEA MORPHOGENESIS,0.00026003,0.29325,0.2967,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,3.3132e-05,0.29324,0.31984,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0029794,0.29308,0.19773,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00024286,0.29295,0.33106,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0037331,0.29266,0.25563,1,1
1,GO RESPONSE TO DSRNA,3.4728e-06,0.29261,0.35998,1,1
1,GO COAGULATION,3.7791e-06,0.29223,0.3057,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00040247,0.29219,0.24676,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,7.9801e-06,0.29206,0.29555,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0041716,0.29199,0.22628,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00022676,0.29186,0.29323,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,6.5149e-05,0.29172,0.25076,1,1
1,GO GONADOTROPIN SECRETION,0.019739,0.29148,0.23541,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.8077e-06,0.29105,0.31887,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.018836,0.29093,0.24037,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,1.9904e-06,0.2906,0.23951,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,1.2862e-06,0.29037,0.30295,1,1
1,GO RESPONSE TO UV B,0.036164,0.29036,0.2277,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.00035231,0.29032,0.27157,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00023468,0.29,0.25329,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0042883,0.28967,0.28732,1,1
1,GO NCRNA PROCESSING,0.00012964,0.28872,0.24901,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00021167,0.2886,0.26168,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00025131,0.28853,0.26949,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,8.4205e-05,0.28779,0.31816,1,1
1,GO MYOBLAST FUSION,6.5149e-05,0.28771,0.35071,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,2.4346e-05,0.28766,0.27792,1,1
1,GO T CELL CHEMOTAXIS,6.5149e-05,0.28754,0.24611,1,1
1,GO REGULATION OF RNA BINDING,1.104e-05,0.28722,0.28958,1,1
1,GO RESPONSE TO BACTERIUM,1.8521e-05,0.2872,0.26653,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,3.0576e-06,0.28709,0.26919,1,1
1,GO SYMBIOTIC PROCESS,1.5691e-07,0.28705,0.28733,1,1
1,GO LIPID IMPORT INTO CELL,0.0067808,0.28695,0.23656,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,3.0264e-07,0.28687,0.27271,1,1
1,GO STEROL TRANSPORT,0.0001547,0.28642,0.22613,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,7.547e-05,0.28628,0.3471,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.7323e-05,0.28627,0.28864,1,1
1,GO ARTERY DEVELOPMENT,0.00042998,0.28608,0.30981,1,1
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.023741,0.28599,0.18652,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.0016129,0.28595,0.27698,1,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.012203,0.28592,0.23012,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00014935,0.28584,0.25273,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,3.1888e-05,0.28583,0.2813,1,1
1,GO CELL CELL RECOGNITION,1.2308e-06,0.28569,0.28905,1,1
1,GO ASTROCYTE DEVELOPMENT,2.2524e-05,0.28566,0.34615,1,1
1,GO BONE MORPHOGENESIS,4.0073e-05,0.2853,0.30585,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.014841,0.2853,0.19944,1,1
1,GO CELLULAR RESPONSE TO VIRUS,0.00027832,0.28499,0.27219,1,1
1,GO MACROPHAGE APOPTOTIC PROCESS,0.0007696,0.28445,0.37107,1,1
1,GO PLACENTA DEVELOPMENT,9.7346e-05,0.28417,0.24456,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,2.5308e-05,0.28405,0.29741,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.00067758,0.28405,0.20614,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,2.6902e-06,0.28401,0.26802,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.28384,0.34917,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,8.3127e-06,0.2838,0.27605,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.4039e-05,0.28378,0.25396,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0059384,0.28353,0.20022,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,3.9418e-06,0.28344,0.23832,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00044439,0.28341,0.24429,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.00020448,0.28297,0.3166,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,1.7118e-05,0.28291,0.28086,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00045924,0.28272,0.22747,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.0013872,0.28271,0.27102,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,2.0784e-06,0.28244,0.26693,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,6.7728e-06,0.28234,0.29194,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00020448,0.28227,0.40919,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,1.6455e-05,0.28227,0.29371,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,7.2754e-05,0.28222,0.23035,1,1
1,GO RNA 5 END PROCESSING,0.001191,0.28201,0.24118,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.0073363,0.2819,0.20986,1,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0045306,0.2815,0.4372,1,1
1,GO HISTONE H4 DEACETYLATION,0.0029794,0.28093,0.27769,1,1
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.00067758,0.28063,0.33651,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.28061,0.367,1,1
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.042857,0.28057,0.1818,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.019283,0.28044,0.23299,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,9.7346e-05,0.28031,0.21748,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00059588,0.28015,0.24508,1,1
1,GO REGULATION OF GENE SILENCING,1.906e-06,0.28012,0.25829,1,1
1,GO RESPONSE TO IONIZING RADIATION,1.5331e-06,0.2792,0.29396,1,1
1,GO CHOLESTEROL EFFLUX,4.6597e-05,0.27905,0.27208,1,1
1,GO TISSUE REMODELING,0.00020448,0.27882,0.26781,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,3.7145e-05,0.27862,0.31563,1,1
1,GO NUCLEOSIDE SALVAGE,0.0019282,0.27852,0.40917,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.7596e-05,0.27852,0.45626,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.0576e-06,0.27834,0.30938,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,1.0184e-05,0.27826,0.22138,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,7.547e-05,0.27737,0.2725,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0028141,0.27715,0.1955,1,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.018836,0.27707,0.22399,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.024288,0.27702,0.20516,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,2.4346e-05,0.27695,0.28518,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.023741,0.27687,0.22191,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00081984,0.2768,0.20867,1,1
1,GO MESENCHYME DEVELOPMENT,1.7118e-05,0.27658,0.25865,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.019283,0.27642,0.21389,1,1
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.013139,0.27636,0.20499,1,1
1,GO RESPONSE TO OXYGEN RADICAL,7.547e-05,0.27635,0.21509,1,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.01282,0.27612,0.24158,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,1.8521e-05,0.27595,0.2436,1,1
1,GO ERK1 AND ERK2 CASCADE,4.1112e-06,0.27594,0.2625,1,1
1,GO RRNA METABOLIC PROCESS,0.00054072,0.27593,0.24076,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.00084609,0.27574,0.28123,1,1
1,GO TRNA 5 LEADER REMOVAL,0.00036427,0.27553,0.29987,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.7343e-05,0.27534,0.27607,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00019079,0.27517,0.25607,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,9.7801e-06,0.27511,0.23816,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,6.2786e-05,0.27492,0.2892,1,1
1,GO CELLULAR RESPONSE TO LIPID,4.1617e-05,0.27488,0.21772,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.01282,0.27483,0.46088,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,8.6584e-06,0.27461,0.26384,1,1
1,GO T CELL MIGRATION,0.00014935,0.27459,0.27706,1,1
1,GO CELL REDOX HOMEOSTASIS,4.8379e-05,0.27437,0.27323,1,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.024288,0.27378,0.22604,1,1
1,GO ACUTE PHASE RESPONSE,0.0034322,0.27373,0.27708,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,2.6902e-06,0.2732,0.24281,1,1
1,GO FACE DEVELOPMENT,3.7145e-05,0.27319,0.29234,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,4.3218e-05,0.27309,0.33784,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.1267e-06,0.27301,0.25721,1,1
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.027803,0.27274,0.24614,1,1
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00059588,0.27266,0.3078,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0069616,0.27212,0.28256,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,2.4346e-05,0.27192,0.26024,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00013433,0.27188,0.21454,1,1
1,GO MESODERM DEVELOPMENT,4.1112e-06,0.27184,0.2408,1,1
1,GO DNA LIGATION,0.00011241,0.27181,0.30211,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.0013054,0.27174,0.27647,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.00017186,0.27149,0.22086,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0001165,0.27146,0.21707,1,1
1,GO COMPLEMENT ACTIVATION,7.0571e-06,0.27136,0.29459,1,1
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.0032441,0.27135,0.26312,1,1
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,2.3418e-05,0.27127,0.31394,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0083534,0.27115,0.23253,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,6.8936e-07,0.27113,0.27984,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.0604e-05,0.27041,0.3078,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00028792,0.27038,0.27467,1,1
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.027803,0.27019,0.21006,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00012964,0.27019,0.23496,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0012662,0.27018,0.30552,1,1
1,GO DETECTION OF OTHER ORGANISM,0.0012662,0.27011,0.32779,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0011549,0.27009,0.28314,1,1
1,GO TUBE MORPHOGENESIS,1.349e-05,0.26996,0.24183,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00018427,0.26994,0.28228,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.00074557,0.26975,0.21137,1,1
1,GO RIBOSOME BIOGENESIS,0.00041602,0.26974,0.2562,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00013917,0.26973,0.29802,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.001228,0.26924,0.25561,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.0013054,0.26909,0.30565,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00027832,0.26873,0.29176,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0034322,0.26864,0.25376,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0011199,0.26858,0.23295,1,1
1,GO PHAGOCYTOSIS,6.8936e-07,0.26827,0.33898,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.0833e-05,0.26815,0.26917,1,1
1,GO NCRNA 3 END PROCESSING,0.018398,0.26797,0.34733,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0032441,0.26796,0.28997,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,7.6603e-06,0.26748,0.26385,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,3.4772e-07,0.26747,0.27359,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.0031536,0.26747,0.24447,1,1
1,GO SEQUESTERING OF METAL ION,0.001191,0.26745,0.24946,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.007729,0.2673,0.19503,1,1
1,GO RESPONSE TO TUMOR CELL,0.011612,0.2672,0.21902,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.3441e-06,0.26716,0.27067,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00038934,0.2671,0.2179,1,1
1,GO RESPONSE TO REDOX STATE,0.012203,0.2669,0.22639,1,1
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.016339,0.26674,0.2591,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00079435,0.26622,0.22936,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,2.4346e-05,0.2662,0.28044,1,1
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0071468,0.26593,0.33779,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.5816e-05,0.2657,0.27122,1,1
1,GO MIDGUT DEVELOPMENT,0.043763,0.26564,0.20965,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,4.4878e-05,0.26542,0.22717,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0016129,0.2653,0.35709,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0026572,0.26523,0.30048,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,3.17e-07,0.26522,0.27484,1,1
1,GO RNA CATABOLIC PROCESS,2.0784e-06,0.26513,0.25257,1,1
1,GO NCRNA METABOLIC PROCESS,0.00026903,0.26492,0.21954,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00067758,0.26473,0.28537,1,1
1,GO REGULATION OF PROTEOLYSIS,1.4609e-05,0.26473,0.20941,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.00027832,0.2647,0.20119,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0042883,0.26457,0.23402,1,1
1,GO CELL AGING,4.8612e-06,0.26455,0.22253,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.00098941,0.26451,0.43728,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,0.0028957,0.26448,0.28119,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0027346,0.2644,0.22926,1,1
1,GO VIRION ASSEMBLY,6.0504e-05,0.26433,0.21113,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0066042,0.26425,0.20845,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,2.1702e-06,0.2642,0.26294,1,1
1,GO TOXIN TRANSPORT,0.0029794,0.26416,0.17846,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00050664,0.26416,0.28707,1,1
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.027188,0.26392,0.18094,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,9.389e-05,0.26377,0.26546,1,1
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.015203,0.26359,0.20967,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.00040247,0.26345,0.24733,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00055855,0.26343,0.23979,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,9.7801e-06,0.26321,0.38129,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0057817,0.26317,0.26312,1,1
1,GO PROTEIN KINASE B SIGNALING,4.4712e-06,0.26305,0.23763,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.001228,0.26304,0.18421,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,2.0833e-05,0.26289,0.21133,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,8.6584e-06,0.26241,0.24509,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,3.3132e-05,0.2621,0.25039,1,1
1,GO HEART VALVE DEVELOPMENT,0.00016023,0.26197,0.31117,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00069957,0.26187,0.22488,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.00011241,0.26154,0.23751,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,6.7728e-06,0.26154,0.28503,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.00026003,0.26143,0.24139,1,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0018173,0.26131,0.34176,1,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.018398,0.26096,0.14652,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.00041602,0.2609,0.23322,1,1
1,GO AUTOPHAGOSOME MATURATION,8.4205e-05,0.26078,0.25791,1,1
1,GO FATTY ACID BETA OXIDATION,0.00028792,0.26068,0.24757,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,9.7801e-06,0.26068,0.22634,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,2.2658e-06,0.26056,0.33255,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0051916,0.26052,0.2117,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.0042883,0.2604,0.21414,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,5.8301e-05,0.25998,0.23987,1,1
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0062634,0.25973,0.21081,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,7.547e-05,0.25962,0.20759,1,1
1,GO RESPONSE TO TESTOSTERONE,2.1663e-05,0.25954,0.28266,1,1
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0059384,0.25944,0.22938,1,1
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.0021062,0.25933,0.24494,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00028792,0.2593,0.27413,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.00045924,0.25927,0.23846,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,6.4994e-06,0.25923,0.3464,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,4.8612e-06,0.25921,0.26233,1,1
1,GO ETHANOL METABOLIC PROCESS,0.0059384,0.25921,0.279,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.0001165,0.25908,0.23883,1,1
1,GO RNA DESTABILIZATION,3.0689e-05,0.25884,0.2522,1,1
1,GO T CELL PROLIFERATION,0.00032948,0.25878,0.21627,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00027832,0.25858,0.24164,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,2.0033e-05,0.25824,0.22355,1,1
1,GO IMMUNE EFFECTOR PROCESS,7.0571e-06,0.25819,0.28504,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,6.0504e-05,0.25806,0.26873,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.3654e-06,0.25792,0.31376,1,1
1,GO RESPONSE TO VITAMIN A,0.014138,0.25784,0.19917,1,1
1,GO PROTEIN FOLDING,8.4205e-05,0.25772,0.2204,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.9301e-06,0.2576,0.28521,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.0031536,0.25748,0.25602,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.7343e-05,0.25738,0.31123,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.0001547,0.25732,0.2487,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00049035,0.25727,0.25089,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,1.5816e-05,0.25722,0.2565,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.2754e-05,0.25674,0.33627,1,1
1,GO TRNA 5 END PROCESSING,0.00029782,0.25637,0.27623,1,1
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00074557,0.25617,0.31142,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00017796,0.25562,0.22705,1,1
1,GO STRESS FIBER ASSEMBLY,0.0007696,0.25553,0.23735,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00095906,0.25546,0.1819,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.01282,0.25533,0.18868,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,1.2308e-06,0.25531,0.24738,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00010092,0.25529,0.27071,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.2547,0.29806,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00029782,0.25459,0.19909,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,1.104e-05,0.2544,0.25618,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,3.0689e-05,0.25431,0.2312,1,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.02068,0.25355,0.19067,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,5.508e-06,0.25329,0.27255,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,7.9801e-06,0.25303,0.254,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,6.0198e-07,0.25298,0.24698,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,7.013e-05,0.25279,0.24207,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,6.2786e-05,0.25276,0.28574,1,1
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.01282,0.25264,0.27943,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00026003,0.25262,0.20319,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.0689e-05,0.25242,0.21137,1,1
1,GO LYMPHOCYTE MIGRATION,9.0551e-05,0.25196,0.22897,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00063551,0.25158,0.26698,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,2.4692e-06,0.25132,0.2362,1,1
1,GO INFLAMMATORY RESPONSE,6.7596e-05,0.25125,0.24954,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.00018427,0.25096,0.25556,1,1
1,GO FIBROBLAST APOPTOTIC PROCESS,0.017137,0.25051,0.23408,1,1
1,GO LIPID OXIDATION,0.0015189,0.2504,0.19167,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00047456,0.25035,0.24009,1,1
1,GO OSTEOCLAST DIFFERENTIATION,1.9904e-06,0.25017,0.24218,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.0028957,0.25013,0.21101,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0019282,0.24999,0.30159,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,5.8301e-05,0.2499,0.29269,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,2.0833e-05,0.24952,0.21807,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0029794,0.24942,0.21488,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.5816e-05,0.24918,0.29605,1,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0028957,0.24892,0.2482,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.010245,0.24891,0.28982,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00017186,0.24818,0.21648,1,1
1,GO RRNA TRANSCRIPTION,0.0019282,0.24808,0.19882,1,1
1,GO NUCLEUS LOCALIZATION,0.0073363,0.24791,0.16321,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,2.8418e-05,0.24744,0.21394,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,9.389e-05,0.24708,0.23038,1,1
1,GO SEQUESTERING OF TRIGLYCERIDE,0.0028957,0.24704,0.33249,1,1
1,GO GTP METABOLIC PROCESS,0.00052342,0.24681,0.28293,1,1
1,GO T CELL ACTIVATION,3.7145e-05,0.24678,0.2242,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,1.6455e-05,0.24651,0.25956,1,1
1,GO AMELOGENESIS,0.009256,0.24648,0.24992,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,4.8612e-06,0.24637,0.24519,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00016023,0.24627,0.20578,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.00057693,0.24626,0.17812,1,1
1,GO CARDIOLIPIN METABOLIC PROCESS,0.036948,0.24609,0.12711,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,7.6603e-06,0.24599,0.29026,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,8.4205e-05,0.24585,0.22292,1,1
1,GO P38MAPK CASCADE,2.4346e-05,0.24581,0.33779,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.023205,0.24469,0.17117,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00013433,0.24461,0.22382,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0042883,0.24436,0.3828,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,1.1493e-05,0.24432,0.24978,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,7.3528e-06,0.24408,0.21467,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00028792,0.244,0.27341,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00042998,0.24347,0.22118,1,1
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.046579,0.24318,0.16755,1,1
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0013872,0.24315,0.21731,1,1
1,GO AORTA DEVELOPMENT,0.0033369,0.24311,0.29162,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0042883,0.24301,0.34396,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00021167,0.24275,0.20022,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,3.1888e-05,0.24259,0.21215,1,1
1,GO REGULATION OF IMMUNE RESPONSE,1.0184e-05,0.24247,0.2257,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.023205,0.24242,0.15661,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,3.6228e-06,0.24234,0.24713,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0006154,0.24227,0.22492,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00027832,0.24223,0.23301,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.00014935,0.24204,0.26179,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0013054,0.24196,0.18179,1,1
1,GO RRNA MODIFICATION,0.012203,0.24195,0.1653,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,1.349e-05,0.24185,0.28526,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00055855,0.24174,0.19226,1,1
1,GO REGULATION OF MITOPHAGY,0.019739,0.24166,0.19067,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0069616,0.24149,0.15923,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00054072,0.24144,0.1851,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,1.4039e-05,0.24117,0.2362,1,1
1,GO NADP METABOLIC PROCESS,0.037747,0.24105,0.16528,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,2.4346e-05,0.24064,0.21189,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00049035,0.24034,0.27216,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.4044e-06,0.24034,0.22714,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00022676,0.24023,0.2237,1,1
1,GO PEPTIDE METABOLIC PROCESS,8.6584e-06,0.24018,0.20283,1,1
1,GO OSSIFICATION,5.0226e-05,0.24013,0.23337,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00057693,0.24008,0.22153,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.0015653,0.24005,0.22822,1,1
1,GO PLATELET ACTIVATION,6.7596e-05,0.23998,0.24849,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.00012074,0.23988,0.21572,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.4421e-05,0.23948,0.36188,1,1
1,GO REGULATION OF CELL ADHESION,0.00045924,0.23935,0.20896,1,1
1,GO DEFENSE RESPONSE,2.8418e-05,0.2391,0.23251,1,1
1,GO MITOTIC CELL CYCLE ARREST,0.0099891,0.23909,0.19715,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0034322,0.23905,0.18963,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0028141,0.23891,0.20424,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.014138,0.23889,0.25244,1,1
1,GO MEMBRANE BIOGENESIS,0.011047,0.23859,0.21032,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.0007696,0.23846,0.19006,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.2524e-05,0.23845,0.3011,1,1
1,GO EPITHELIAL CELL PROLIFERATION,0.00026903,0.23821,0.21377,1,1
1,GO CELLULAR DEFENSE RESPONSE,0.0017641,0.23782,0.28637,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00032948,0.2378,0.18826,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0017123,0.23778,0.25366,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00025131,0.23778,0.33391,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0062634,0.23754,0.2021,1,1
1,GO ANIMAL ORGAN FORMATION,0.00095906,0.23742,0.21853,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,1.2454e-05,0.23739,0.21833,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00041602,0.23711,0.2014,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.8521e-05,0.23703,0.27174,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00063551,0.23651,0.23134,1,1
1,GO HEAD MORPHOGENESIS,0.00072223,0.23645,0.26753,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.00072223,0.23614,0.22916,1,1
1,GO MYOTUBE DIFFERENTIATION,0.0066042,0.23595,0.16044,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00054072,0.23585,0.25146,1,1
1,GO ORGAN GROWTH,5.0226e-05,0.23549,0.24024,1,1
1,GO DNA DEALKYLATION,0.0011199,0.23537,0.224,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0020453,0.23516,0.21539,1,1
1,GO HYPEROSMOTIC RESPONSE,0.00092958,0.23488,0.24565,1,1
1,GO HISTONE H2B UBIQUITINATION,0.007729,0.23483,0.1696,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00013433,0.23444,0.20871,1,1
1,GO LIPID STORAGE,0.00032948,0.23358,0.23996,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,5.8301e-05,0.23317,0.20343,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,9.8628e-07,0.2331,0.27221,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,8.1192e-05,0.23293,0.26472,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00036427,0.23282,0.23798,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.1964e-05,0.23268,0.35232,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0007696,0.23266,0.27671,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,1.1964e-05,0.23235,0.24826,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.547e-05,0.23229,0.24429,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.014486,0.23228,0.2219,1,1
1,GO LEUKOCYTE PROLIFERATION,0.0011549,0.23221,0.18435,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,9.3916e-06,0.23214,0.21486,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0010859,0.23208,0.25865,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0059384,0.23172,0.17069,1,1
1,GO MYELOID CELL HOMEOSTASIS,2.9301e-06,0.23169,0.23265,1,1
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.018836,0.23134,0.15806,1,1
1,GO CELLULAR EXTRAVASATION,9.7346e-05,0.23119,0.22768,1,1
1,GO CELLULAR OXIDANT DETOXIFICATION,0.0019282,0.23117,0.18135,1,1
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00034072,0.23093,0.26455,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00012512,0.23091,0.19516,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,3.1888e-05,0.23062,0.23412,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.00029782,0.23044,0.20567,1,1
1,GO TRNA METHYLATION,0.0012662,0.23037,0.18249,1,1
1,GO REGULATION OF PROTON TRANSPORT,0.0024367,0.23037,0.21071,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0029794,0.23004,0.30007,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0013054,0.23001,0.23649,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,1.6729e-06,0.22991,0.2337,1,1
1,GO REGULATION OF HEMOPOIESIS,4.1112e-06,0.22985,0.22174,1,1
1,GO STEROL IMPORT,0.00029782,0.22965,0.4251,1,1
1,GO RNA 3 END PROCESSING,0.00069957,0.22924,0.17783,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,2.3654e-06,0.22913,0.20771,1,1
1,GO DE NOVO PROTEIN FOLDING,0.0085714,0.22912,0.15997,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.0019282,0.22889,0.2447,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,7.2754e-05,0.22864,0.25798,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,1.4044e-06,0.22854,0.23009,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0013457,0.22842,0.19926,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.001986,0.22801,0.19141,1,1
1,GO CERAMIDE TRANSPORT,0.0075304,0.22783,0.2135,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0030654,0.22732,0.19223,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00019753,0.22728,0.23402,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,8.4205e-05,0.22711,0.22781,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,3.7145e-05,0.22703,0.26137,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,2.1663e-05,0.22691,0.22672,1,1
1,GO AGING,2.1663e-05,0.22677,0.19722,1,1
1,GO POSITIVE REGULATION OF CELL KILLING,0.014138,0.22677,0.16809,1,1
1,GO MITOPHAGY,0.0010206,0.22669,0.22377,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,2.1663e-05,0.22657,0.24154,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00041602,0.22647,0.22662,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,2.4346e-05,0.22606,0.22339,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00012964,0.226,0.24294,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00014418,0.22585,0.21157,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00014418,0.22555,0.35716,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,2.9532e-05,0.2255,0.23577,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,7.5427e-07,0.2252,0.20175,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00035231,0.22519,0.27492,1,1
1,GO REGULATION OF BODY FLUID LEVELS,8.7323e-05,0.22516,0.20614,1,1
1,GO KINETOCHORE ASSEMBLY,0.033894,0.22504,0.17756,1,1
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0021689,0.22479,0.29095,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.7596e-05,0.22465,0.18459,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.0014299,0.22433,0.17241,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,2.3418e-05,0.22415,0.21293,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0026572,0.22404,0.19728,1,1
1,GO RESPONSE TO GONADOTROPIN,0.0032441,0.2238,0.28977,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00042998,0.22367,0.22375,1,1
1,GO PERICARDIUM DEVELOPMENT,0.0013054,0.2236,0.2806,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,1.9263e-05,0.22333,0.28046,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0069616,0.2233,0.20609,1,1
1,GO CELL KILLING,0.0023671,0.22321,0.16413,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0056288,0.22304,0.22693,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.00090094,0.22304,0.19288,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00026903,0.22294,0.23449,1,1
1,GO PLATELET MORPHOGENESIS,0.00041602,0.22279,0.22896,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0017123,0.22265,0.21737,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0007696,0.22254,0.23043,1,1
1,GO LEUKOCYTE HOMEOSTASIS,9.389e-05,0.22209,0.20622,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,4.1112e-06,0.22209,0.24222,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00019753,0.22208,0.32803,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.011326,0.22193,0.1673,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.001191,0.22185,0.21192,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0025083,0.22171,0.2781,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,2.4692e-06,0.22127,0.21364,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.0045306,0.22116,0.19011,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00012074,0.22115,0.22921,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,2.6307e-05,0.22078,0.19256,1,1
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.020205,0.22062,0.15277,1,1
1,GO REGULATION OF URINE VOLUME,9.389e-05,0.22054,0.25475,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.001662,0.22028,0.17466,1,1
1,GO REPLACEMENT OSSIFICATION,0.0014299,0.22015,0.32086,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.6597e-05,0.21995,0.21261,1,1
1,GO OVULATION,0.031059,0.21987,0.22934,1,1
1,GO BODY FLUID SECRETION,0.00036427,0.21983,0.20859,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00031859,0.21961,0.23222,1,1
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00038934,0.21958,0.20983,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,1.4609e-05,0.21957,0.2041,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.001986,0.21939,0.19961,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.031059,0.21936,0.15708,1,1
1,GO TISSUE MORPHOGENESIS,3.0689e-05,0.21928,0.197,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0050528,0.21909,0.19272,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.5816e-05,0.21904,0.2348,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,1.5201e-05,0.21884,0.22275,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.011904,0.2188,0.17683,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.00024286,0.21859,0.20796,1,1
1,GO INTERFERON GAMMA PRODUCTION,5.2139e-05,0.21747,0.26436,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.004408,0.21699,0.16796,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0017123,0.2169,0.18389,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0014299,0.21687,0.21787,1,1
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.042857,0.21642,0.16515,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,2.8418e-05,0.21603,0.20201,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00026903,0.216,0.19705,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,1.0604e-05,0.216,0.18088,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.001228,0.21583,0.18594,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.0010528,0.21566,0.22342,1,1
1,GO PORE COMPLEX ASSEMBLY,0.0050528,0.21566,0.17833,1,1
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0062634,0.21546,0.20174,1,1
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.00098941,0.21528,0.23103,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,7.0571e-06,0.21526,0.19502,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,1.4674e-06,0.21471,0.20647,1,1
1,GO REGULATION OF CELL ACTIVATION,5.4121e-05,0.21463,0.20738,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0071468,0.21454,0.28688,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00027832,0.21444,0.22214,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0038387,0.2141,0.15056,1,1
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.02268,0.21399,0.24884,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0011199,0.21397,0.24272,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00092958,0.21394,0.23137,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0032441,0.21379,0.21339,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0033369,0.21359,0.13852,1,1
1,GO BONE DEVELOPMENT,3.5759e-05,0.21353,0.24032,1,1
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.022165,0.21345,0.2021,1,1
1,GO SPINDLE LOCALIZATION,3.3287e-06,0.21337,0.2116,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,0.00012512,0.21324,0.20425,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.00084609,0.21322,0.20908,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0017641,0.21315,0.19176,1,1
1,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.042857,0.21291,0.12547,1,1
1,GO TRNA MODIFICATION,0.0036303,0.21222,0.14837,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0079323,0.21153,0.26754,1,1
1,GO RNA MODIFICATION,0.00069957,0.21144,0.16051,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00016023,0.21143,0.19185,1,1
1,GO CELL ACTIVATION,1.4039e-05,0.21138,0.23614,1,1
1,GO REGULATION OF DEFENSE RESPONSE,8.4205e-05,0.21122,0.20466,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,2.2658e-06,0.21113,0.24401,1,1
1,GO RESPONSE TO LIPID,0.00032948,0.21105,0.17802,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0015189,0.21091,0.18545,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,2.4346e-05,0.21087,0.23069,1,1
1,GO MITOTIC CYTOKINESIS,0.00014418,0.21071,0.22298,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0081404,0.21035,0.25722,1,1
1,GO LYMPHOCYTE ACTIVATION,2.8418e-05,0.21024,0.20422,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.7806e-05,0.21022,0.21866,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,2.6307e-05,0.20992,0.18093,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.0083534,0.20978,0.17206,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,0.00025131,0.20959,0.19766,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00013917,0.20958,0.19798,1,1
1,GO RRNA METHYLATION,0.018398,0.20936,0.13963,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0040578,0.20936,0.18476,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0067808,0.20905,0.18836,1,1
1,GO REGULATION OF T CELL ACTIVATION,0.00017796,0.20885,0.19896,1,1
1,GO TRNA PROCESSING,0.0025083,0.20879,0.14846,1,1
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.0085714,0.20848,0.21244,1,1
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.019739,0.20847,0.24045,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.0024367,0.20847,0.16859,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,6.7728e-06,0.20827,0.2102,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.001228,0.20827,0.19278,1,1
1,GO MYELOID CELL DIFFERENTIATION,4.2876e-06,0.20806,0.19327,1,1
1,GO RESPONSE TO ISCHEMIA,0.00079435,0.20766,0.19136,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,4.4712e-06,0.20749,0.23372,1,1
1,GO CAMP METABOLIC PROCESS,0.02843,0.20744,0.21666,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,1.104e-05,0.20742,0.25151,1,1
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0071468,0.20731,0.2454,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.0020453,0.20702,0.17657,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,5.0226e-05,0.20697,0.27355,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00038934,0.20654,0.18097,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,1.7118e-05,0.20651,0.22746,1,1
1,GO LEUKOCYTE MIGRATION,0.0016129,0.20628,0.19458,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0073363,0.20604,0.1813,1,1
1,GO GLIAL CELL APOPTOTIC PROCESS,0.0090226,0.20574,0.2971,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.012508,0.20567,0.16538,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.00353,0.20564,0.17078,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00013917,0.20545,0.19083,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00042998,0.2054,0.22312,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0037331,0.2054,0.22591,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.0028957,0.20534,0.22461,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0022992,0.20503,0.20466,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,8.3127e-06,0.20499,0.2006,1,1
1,GO RUFFLE ORGANIZATION,0.001986,0.20481,0.1557,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00041602,0.2047,0.1791,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00034072,0.20436,0.16897,1,1
1,GO RESPONSE TO KETONE,0.0038387,0.20427,0.15619,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,1.8251e-06,0.20376,0.23503,1,1
1,GO CELLULAR RESPONSE TO ATP,0.0007696,0.20366,0.19658,1,1
1,GO MIDBODY ABSCISSION,0.0094949,0.2034,0.20782,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,1.9263e-05,0.20319,0.21673,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,6.5149e-05,0.20293,0.15689,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00037661,0.20272,0.17302,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.20259,0.25004,1,1
1,GO REGULATION OF LIPID STORAGE,0.00069957,0.2024,0.23966,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0060989,0.20239,0.23577,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.009256,0.20209,0.19572,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0007696,0.20208,0.18926,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.00026903,0.20205,0.17786,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0017641,0.20204,0.18437,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00013917,0.20189,0.1684,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,4.6623e-06,0.20184,0.19624,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001228,0.20164,0.16341,1,1
1,GO SECRETION BY TISSUE,0.029068,0.20161,0.14299,1,1
1,GO HEART GROWTH,0.00057693,0.20136,0.1967,1,1
1,GO TRNA METABOLIC PROCESS,0.0030654,0.20095,0.14574,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,1.0311e-06,0.20085,0.1923,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.010245,0.2008,0.22092,1,1
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0032441,0.20054,0.20109,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.906e-06,0.20027,0.18125,1,1
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.011326,0.20021,0.16208,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00032948,0.20009,0.19356,1,1
1,GO NEUROINFLAMMATORY RESPONSE,0.025414,0.19991,0.2154,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,9.7346e-05,0.19988,0.17125,1,1
1,GO PROTEIN PROCESSING,0.00023468,0.19977,0.20209,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00069957,0.19966,0.20027,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00090094,0.19931,0.23381,1,1
1,GO CARNITINE SHUTTLE,0.042857,0.19902,0.15634,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00065623,0.19887,0.16878,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,5.2533e-07,0.19884,0.16616,1,1
1,GO NUCLEAR EXPORT,8.3127e-06,0.19868,0.20204,1,1
1,GO TUBE DEVELOPMENT,0.00010462,0.19846,0.19742,1,1
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.02268,0.19825,0.20528,1,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.013139,0.19799,0.13373,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0026572,0.19748,0.20278,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.013798,0.1974,0.15479,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,6.2786e-05,0.19708,0.18961,1,1
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.033894,0.19694,0.091015,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.010245,0.19672,0.19274,1,1
1,GO NEURAL TUBE FORMATION,0.001986,0.19646,0.20077,1,1
1,GO HEART TRABECULA MORPHOGENESIS,0.0053338,0.19631,0.20348,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,9.7801e-06,0.19627,0.22044,1,1
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.0026572,0.19597,0.22768,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,3.1888e-05,0.1959,0.17572,1,1
1,GO VESICLE TARGETING,0.00049035,0.19585,0.19756,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.011326,0.1958,0.20103,1,1
1,GO STEM CELL DIFFERENTIATION,2.2524e-05,0.19562,0.20305,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.031748,0.19555,0.15749,1,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.0087944,0.19538,0.1661,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,0.00014418,0.19521,0.16457,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,6.7728e-06,0.19489,0.18352,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,4.4878e-05,0.19428,0.2027,1,1
1,GO TRANSLATIONAL ELONGATION,0.007729,0.19408,0.16328,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.010773,0.19402,0.12874,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,1.5816e-05,0.19354,0.19428,1,1
1,GO ALDITOL METABOLIC PROCESS,0.0013872,0.19338,0.20366,1,1
1,GO TRANSLATIONAL TERMINATION,0.0029794,0.19295,0.19824,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.00019753,0.19255,0.17619,1,1
1,GO RESPONSE TO GAMMA RADIATION,6.7596e-05,0.19175,0.23926,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00034072,0.19172,0.29373,1,1
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.044685,0.19165,0.16492,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,2.0033e-05,0.19162,0.19654,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,9.0551e-05,0.1916,0.23249,1,1
1,GO RESPONSE TO UV,2.9532e-05,0.19128,0.19393,1,1
1,GO PROTEIN TARGETING,0.00034072,0.19024,0.16372,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,9.389e-05,0.19012,0.16057,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.00032948,0.19008,0.2029,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,6.7596e-05,0.19004,0.18236,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00025131,0.19004,0.19606,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00035231,0.19003,0.16092,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.00074557,0.19001,0.18505,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,4.4878e-05,0.18989,0.1941,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.001228,0.18987,0.16965,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00010092,0.18966,0.19574,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00067758,0.18957,0.16348,1,1
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0006154,0.18945,0.14596,1,1
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.013139,0.1894,0.17167,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.004408,0.18937,0.14175,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,6.0504e-05,0.18895,0.20022,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00024286,0.1889,0.20944,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.00067758,0.18864,0.15066,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0029794,0.18839,0.13876,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,1.1964e-05,0.18834,0.16972,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0025083,0.18806,0.18791,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,0.00041602,0.18757,0.19532,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00098941,0.18753,0.1846,1,1
1,GO GLIAL CELL MIGRATION,0.017549,0.18746,0.1878,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.00019079,0.18744,0.17768,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,3.6414e-07,0.18718,0.1792,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,2.0033e-05,0.18716,0.15696,1,1
1,GO RESPONSE TO GROWTH FACTOR,8.7323e-05,0.18714,0.178,1,1
1,GO HISTONE DEACETYLATION,0.00052342,0.18712,0.1312,1,1
1,GO ORGANELLE INHERITANCE,0.0013054,0.18635,0.17319,1,1
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.031748,0.18628,0.1327,1,1
1,GO CELLULAR RESPONSE TO UV,0.00025131,0.18588,0.18047,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0013054,0.18588,0.22103,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,3.1904e-06,0.18517,0.1544,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,6.5149e-05,0.18497,0.18282,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.0054795,0.18468,0.26426,1,1
1,GO BIOLOGICAL ADHESION,0.0054795,0.18456,0.13772,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,5.2139e-05,0.18445,0.15923,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.00054072,0.18442,0.16693,1,1
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.023205,0.18388,0.16966,1,1
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.033894,0.18372,0.19789,1,1
1,GO RNA METHYLATION,0.0024367,0.18327,0.15141,1,1
1,GO REGULATION OF AMYLOID BETA FORMATION,0.026586,0.18289,0.16963,1,1
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0073363,0.18289,0.15852,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00045924,0.18284,0.15845,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,7.2754e-05,0.18279,0.17373,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.00092958,0.18265,0.1753,1,1
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.024846,0.18262,0.13464,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.001986,0.18255,0.16681,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,3.6228e-06,0.18255,0.184,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0039469,0.18224,0.12844,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.011326,0.18222,0.1246,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.04854,0.182,0.15516,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,4.0073e-05,0.18161,0.1616,1,1
1,GO RESPONSE TO INTERLEUKIN 4,0.001986,0.18153,0.16156,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00021167,0.18152,0.16634,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0013872,0.18143,0.14652,1,1
1,GO CHYLOMICRON ASSEMBLY,0.038561,0.18109,0.1737,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.029719,0.1806,0.21274,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.007729,0.18033,0.20721,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.00055855,0.18021,0.17218,1,1
1,GO CARDIAC CHAMBER DEVELOPMENT,0.0049174,0.18001,0.16127,1,1
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.033894,0.17995,0.23596,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.031059,0.17981,0.12261,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,4.3763e-07,0.17974,0.17823,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00027832,0.17948,0.15484,1,1
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.036164,0.17914,0.1784,1,1
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.0081404,0.17905,0.11172,1,1
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0040578,0.17899,0.15288,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.00041602,0.1787,0.16371,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.00069957,0.17842,0.17965,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.00017796,0.17811,0.1754,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00020448,0.17808,0.15762,1,1
1,GO XENOBIOTIC TRANSPORT,0.0022332,0.17807,0.23296,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,9.0179e-06,0.17749,0.1777,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.00030804,0.17717,0.17856,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.0017641,0.17712,0.18556,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00090094,0.17681,0.20695,1,1
1,GO SULFUR COMPOUND TRANSPORT,0.00024286,0.17648,0.16499,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00016023,0.17599,0.16591,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0067808,0.17584,0.13437,1,1
1,GO TRNA TRANSPORT,0.0097392,0.17573,0.14978,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00023468,0.17564,0.19278,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,3.4728e-06,0.17557,0.16743,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,0.00013917,0.17476,0.2001,1,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0047853,0.17469,0.16813,1,1
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0099891,0.17462,0.17046,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0036303,0.17454,0.14473,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.0053338,0.17437,0.13567,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.00087311,0.17435,0.16124,1,1
1,GO GOLGI VESICLE TRANSPORT,2.3418e-05,0.17426,0.16258,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.0011549,0.17419,0.1829,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.0028957,0.17392,0.14811,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.0021062,0.17384,0.1709,1,1
1,GO CENTRIOLE ASSEMBLY,0.007729,0.17344,0.12327,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0040578,0.17324,0.12996,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00049035,0.17309,0.17282,1,1
1,GO MITOCHONDRIAL TRANSLATION,0.0075304,0.17296,0.15636,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,2.6902e-06,0.17273,0.16172,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.013139,0.17266,0.17177,1,1
1,GO REGULATION OF MAPK CASCADE,8.4205e-05,0.17259,0.16851,1,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0013872,0.17233,0.18664,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,0.0018173,0.17231,0.16897,1,1
1,GO RESPONSE TO CHEMOKINE,0.016339,0.17226,0.18439,1,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.021165,0.1722,0.13754,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0075304,0.17211,0.17531,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,1.906e-06,0.17186,0.16152,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0021062,0.17184,0.15173,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00069957,0.17181,0.17894,1,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.04854,0.1717,0.19297,1,1
1,GO LYSOSOMAL TRANSPORT,0.00057693,0.17139,0.16816,1,1
1,GO TRANSLESION SYNTHESIS,0.00034072,0.17119,0.17023,1,1
1,GO POSITIVE REGULATION OF CELL DIVISION,0.030383,0.17116,0.13323,1,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.0033369,0.17095,0.16982,1,1
1,GO REGULATION OF RESPONSE TO STRESS,2.6307e-05,0.17084,0.16534,1,1
1,GO COENZYME A METABOLIC PROCESS,0.013139,0.17074,0.15407,1,1
1,GO LEUKOCYTE DIFFERENTIATION,0.00014418,0.17039,0.17214,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0017641,0.17018,0.14282,1,1
1,GO REGULATION OF NUCLEAR DIVISION,2.7343e-05,0.17003,0.14911,1,1
1,GO RESPONSE TO MINERALOCORTICOID,0.0056288,0.1699,0.2433,1,1
1,GO BLASTOCYST GROWTH,0.0025083,0.16955,0.24007,1,1
1,GO REGULATION OF CATABOLIC PROCESS,7.889e-07,0.1695,0.1623,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0001547,0.16919,0.13964,1,1
1,GO REGULATION OF CELL SHAPE,0.0030654,0.16902,0.18732,1,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.041093,0.16883,0.10593,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.001228,0.16866,0.24956,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0053338,0.16863,0.19901,1,1
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0038387,0.16858,0.19841,1,1
1,GO MUSCLE ORGAN MORPHOGENESIS,0.047551,0.16848,0.13367,1,1
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0075304,0.16841,0.12716,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0039469,0.16818,0.14856,1,1
1,GO DENDRITIC CELL CHEMOTAXIS,0.036164,0.16812,0.20338,1,1
1,GO IMPORT INTO NUCLEUS,0.00028792,0.16798,0.13799,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.0016129,0.16756,0.18402,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,3.7791e-06,0.16748,0.15617,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.00353,0.16744,0.17834,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.026586,0.16734,0.1768,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0011199,0.16726,0.13087,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00026003,0.16683,0.18679,1,1
1,GO RESPONSE TO BMP,0.021165,0.16642,0.13928,1,1
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.016339,0.16632,0.13615,1,1
1,GO AMYLOID BETA METABOLIC PROCESS,0.016339,0.16626,0.15872,1,1
1,GO LAMELLIPODIUM ORGANIZATION,0.00052342,0.1659,0.21976,1,1
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.041093,0.16577,0.13426,1,1
1,GO REGULATION OF OSSIFICATION,0.00025131,0.16574,0.23308,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0019282,0.16567,0.1888,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,6.5149e-05,0.16563,0.14963,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0021689,0.16556,0.13085,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,9.7346e-05,0.16554,0.13758,1,1
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.0083534,0.16545,0.13942,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.011612,0.16518,0.17322,1,1
1,GO PROTEIN KINASE A SIGNALING,0.00020448,0.16514,0.20909,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00034072,0.16511,0.20207,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.004408,0.16504,0.17076,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,0.00055855,0.16459,0.14039,1,1
1,GO LAMELLIPODIUM ASSEMBLY,0.00067758,0.16451,0.21238,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.2876e-06,0.16447,0.16909,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00018427,0.16445,0.18211,1,1
1,GO REGULATION OF MYELINATION,0.011612,0.16445,0.14145,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.011326,0.16437,0.17336,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0026572,0.16378,0.12129,1,1
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.027188,0.16357,0.21513,1,1
1,GO RESPONSE TO PH,0.025994,0.16335,0.17198,1,1
1,GO RESPONSE TO ANTIBIOTIC,0.0016129,0.16316,0.19236,1,1
1,GO RNA DECAPPING,0.00041602,0.16313,0.19151,1,1
1,GO POSITIVE REGULATION OF BINDING,0.00016595,0.16287,0.15988,1,1
1,GO REGULATION OF MUSCLE ADAPTATION,0.044685,0.16286,0.099072,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,6.4994e-06,0.16278,0.14523,1,1
1,GO HEART MORPHOGENESIS,0.0034322,0.16235,0.16245,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.02843,0.16233,0.11369,1,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.00081984,0.16213,0.15755,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00041602,0.16211,0.20325,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00074557,0.16209,0.15972,1,1
1,GO VACUOLE ORGANIZATION,0.00030804,0.16206,0.14107,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0025083,0.16198,0.148,1,1
1,GO RRNA 3 END PROCESSING,0.0036303,0.16195,0.1766,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,8.1192e-05,0.16169,0.18276,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0047853,0.16141,0.18005,1,1
1,GO RECEPTOR RECYCLING,0.016339,0.16122,0.11988,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.030383,0.16117,0.13923,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0020453,0.16108,0.12252,1,1
1,GO PROTEIN POLYUBIQUITINATION,2.2524e-05,0.161,0.1564,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.02268,0.161,0.14363,1,1
1,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.014841,0.16093,0.17832,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.017549,0.16073,0.14857,1,1
1,GO MUSCLE ADAPTATION,0.013465,0.1606,0.11489,1,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.0027346,0.16042,0.19923,1,1
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0051916,0.16023,0.098224,1,1
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.013139,0.16022,0.13386,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0014738,0.16001,0.20788,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,4.1617e-05,0.15981,0.16332,1,1
1,GO PLASMA MEMBRANE ORGANIZATION,0.009256,0.15957,0.14197,1,1
1,GO PROTEOLYSIS,1.7806e-05,0.15947,0.14516,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0081404,0.15933,0.19789,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,4.8379e-05,0.15925,0.19057,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.013465,0.15898,0.17564,1,1
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0087944,0.15839,0.16827,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0031536,0.15826,0.13885,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00036427,0.15794,0.20364,1,1
1,GO POSTREPLICATION REPAIR,0.00026903,0.15789,0.14927,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.010245,0.15752,0.15917,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00057693,0.15742,0.2235,1,1
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00353,0.15736,0.14973,1,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,0.00011241,0.15708,0.19563,1,1
1,GO CELL CELL SIGNALING BY WNT,0.0010528,0.15697,0.14163,1,1
1,GO PROTEIN IMPORT,0.0001165,0.15671,0.15442,1,1
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0054795,0.15665,0.19456,1,1
1,GO MAINTENANCE OF LOCATION,9.0551e-05,0.156,0.16337,1,1
1,GO MITOCHONDRIAL GENE EXPRESSION,0.011612,0.15594,0.14298,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0006154,0.1558,0.15242,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00044439,0.15577,0.14245,1,1
1,GO LYMPHOCYTE COSTIMULATION,0.0069616,0.15512,0.14122,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.00098941,0.15497,0.15627,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.041967,0.15493,0.1302,1,1
1,GO PROTEIN CATABOLIC PROCESS,3.1904e-06,0.15492,0.14536,1,1
1,GO RESPONSE TO HEAT,0.00034072,0.15478,0.17555,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.033894,0.15425,0.1424,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.0034322,0.15422,0.1491,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.00028792,0.15417,0.16766,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.00041602,0.15401,0.18536,1,1
1,GO PROTEIN STABILIZATION,6.5149e-05,0.15372,0.15513,1,1
1,GO CENTRIOLE CENTRIOLE COHESION,0.0039469,0.15345,0.19305,1,1
1,GO RESPONSE TO DRUG,0.0094949,0.15335,0.11519,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,3.5759e-05,0.15332,0.18274,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,1.2962e-05,0.15305,0.18414,1,1
1,GO CELL MOTILITY,0.0040578,0.15291,0.12094,1,1
1,GO MUSCLE ORGAN DEVELOPMENT,0.00059588,0.1528,0.14423,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0042883,0.15267,0.1551,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0064317,0.15266,0.10873,1,1
1,GO TELOMERE ORGANIZATION,0.0011549,0.15251,0.12291,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,3.5759e-05,0.1523,0.13415,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,7.3528e-06,0.15189,0.15562,1,1
1,GO REGULATION OF CELL DEATH,7.547e-05,0.15169,0.14259,1,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.030383,0.15166,0.10566,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.001228,0.15159,0.11503,1,1
1,GO B CELL ACTIVATION,0.001228,0.15151,0.14117,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00031859,0.15137,0.13575,1,1
1,GO REGULATION OF BINDING,0.00018427,0.15112,0.14291,1,1
1,GO RESPONSE TO NUTRIENT,0.023741,0.15094,0.13752,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00019753,0.15091,0.1491,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,2.0833e-05,0.15067,0.16434,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.010773,0.15056,0.1985,1,1
1,GO LACTATION,0.0083534,0.15046,0.1752,1,1
1,GO REGULATION OF ERAD PATHWAY,0.00057693,0.1504,0.14562,1,1
1,GO RESPONSE TO LEPTIN,0.02166,0.15038,0.18643,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0012662,0.15034,0.16853,1,1
1,GO GOLGI VESICLE BUDDING,0.0026572,0.14979,0.1623,1,1
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.0047853,0.14958,0.12363,1,1
1,GO HEART DEVELOPMENT,0.00026003,0.14936,0.16167,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0099891,0.14936,0.12219,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.0019282,0.14929,0.20351,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0042883,0.14927,0.12862,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00052342,0.14921,0.13892,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00057693,0.14897,0.13662,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,2.7343e-05,0.14888,0.15111,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00014935,0.14842,0.19145,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.00081984,0.14805,0.18477,1,1
1,GO REGULATION OF PROTEIN BINDING,0.00024286,0.14769,0.15781,1,1
1,GO DNA BIOSYNTHETIC PROCESS,1.4674e-06,0.14764,0.16582,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.0023671,0.1476,0.11515,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00017186,0.14706,0.12228,1,1
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0079323,0.14699,0.11904,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0053338,0.14694,0.14833,1,1
1,GO POSITIVE REGULATION OF DNA BINDING,0.020205,0.14691,0.12296,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0040578,0.14631,0.18715,1,1
1,GO REGULATION OF MAP KINASE ACTIVITY,0.00055855,0.14608,0.13845,1,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.02843,0.14584,0.09765,1,1
1,GO CHROMOSOME LOCALIZATION,0.022165,0.14565,0.11807,1,1
1,GO AEROBIC RESPIRATION,0.038561,0.14559,0.094552,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.00012074,0.14545,0.12204,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,0.00052342,0.1454,0.12297,1,1
1,GO MITOTIC RECOMBINATION,0.018836,0.14529,0.16391,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.0013457,0.14472,0.13601,1,1
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0045306,0.14472,0.16678,1,1
1,GO NUCLEAR TRANSPORT,5.4121e-05,0.14458,0.14747,1,1
1,GO REGULATION OF CELL DIVISION,0.0075304,0.14453,0.10529,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00010092,0.14448,0.14527,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.00026003,0.14447,0.14938,1,1
1,GO REGULATION OF DNA BINDING,0.018836,0.14437,0.089188,1,1
1,GO RNA LOCALIZATION,0.00035231,0.14429,0.17298,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.00021167,0.14391,0.12443,1,1
1,GO VACUOLAR ACIDIFICATION,0.0060989,0.14387,0.15795,1,1
1,GO REGULATION OF SENSORY PERCEPTION,0.010773,0.14368,0.15257,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.011612,0.14339,0.14595,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.00023468,0.14318,0.12769,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.031059,0.14317,0.14727,1,1
1,GO POSITIVE REGULATION OF URINE VOLUME,0.012508,0.14311,0.23337,1,1
1,GO RNA PROCESSING,0.00030804,0.14295,0.14859,1,1
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0039469,0.14253,0.10982,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00035231,0.14245,0.18739,1,1
1,GO COPII COATED VESICLE BUDDING,0.0051916,0.14234,0.16085,1,1
1,GO RNA CAPPING,0.001662,0.14165,0.14068,1,1
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.013798,0.14134,0.11431,1,1
1,GO PROTEIN NEDDYLATION,0.0046564,0.14116,0.16595,1,1
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.027803,0.14074,0.16823,1,1
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.00090094,0.1406,0.12916,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,6.2786e-05,0.14057,0.13341,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00011241,0.14043,0.13928,1,1
1,GO CYTOKINESIS,0.00084609,0.13949,0.12969,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00029782,0.13896,0.16921,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.6307e-05,0.13892,0.15048,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00018427,0.13874,0.16295,1,1
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0064317,0.13807,0.12252,1,1
1,GO ENDOSOME ORGANIZATION,0.00047456,0.13765,0.15976,1,1
1,GO SPINDLE ORGANIZATION,0.00059588,0.13731,0.13477,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0075304,0.13726,0.12022,1,1
1,GO APOPTOTIC PROCESS,7.547e-05,0.13719,0.13407,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00012964,0.13711,0.14077,1,1
1,GO REGULATION OF ENDOCYTOSIS,0.0059384,0.13709,0.11533,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.0032441,0.13703,0.17041,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0066042,0.13702,0.18703,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.00023468,0.13645,0.16829,1,1
1,GO NUCLEUS ORGANIZATION,0.0031536,0.13624,0.11874,1,1
1,GO GENE SILENCING,9.389e-05,0.13576,0.13397,1,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.01282,0.13522,0.1106,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00021167,0.13508,0.13112,1,1
1,GO FAT CELL DIFFERENTIATION,0.0034322,0.13495,0.1279,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0039469,0.13485,0.10686,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.0085714,0.13419,0.092766,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00021909,0.13395,0.15154,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0071468,0.13392,0.19536,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.015953,0.13331,0.19639,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00031859,0.13267,0.14978,1,1
1,GO OXALATE TRANSPORT,0.044685,0.13224,0.096043,1,1
1,GO VIRAL BUDDING,0.0046564,0.13218,0.13868,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.004408,0.13215,0.14936,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0013872,0.13127,0.13589,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00055855,0.13116,0.13708,1,1
1,GO ANIMAL ORGAN MORPHOGENESIS,0.0051916,0.13114,0.11846,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00067758,0.13107,0.17764,1,1
1,GO CHROMOSOME CONDENSATION,0.0027346,0.13093,0.13786,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.00353,0.1305,0.12038,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0016129,0.12993,0.13255,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0097392,0.1297,0.096545,1,1
1,GO CELL DIVISION,0.00027832,0.12918,0.12456,1,1
1,GO G2 DNA DAMAGE CHECKPOINT,0.013139,0.1291,0.11961,1,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0020453,0.12889,0.14908,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.00036427,0.12876,0.13773,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,4.0073e-05,0.1286,0.14635,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.00014935,0.12824,0.13755,1,1
1,GO MRNA METABOLIC PROCESS,7.547e-05,0.12795,0.14857,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0024367,0.12782,0.11782,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0014299,0.12768,0.19351,1,1
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0064317,0.12767,0.15354,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.0017641,0.12762,0.11201,1,1
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.023741,0.12753,0.10933,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00063551,0.12744,0.12114,1,1
1,GO REGULATION OF DNA REPAIR,0.0075304,0.1273,0.097303,1,1
1,GO LIPID CATABOLIC PROCESS,0.004408,0.12669,0.095345,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00024286,0.12654,0.11295,1,1
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00038934,0.12649,0.14089,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,0.0019282,0.12643,0.11157,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.0019282,0.12626,0.13215,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00059588,0.12616,0.10988,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00081984,0.12615,0.11659,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.03939,0.1261,0.16067,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,7.0571e-06,0.12604,0.12122,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00050664,0.12601,0.12139,1,1
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.035393,0.12563,0.097927,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00017186,0.12559,0.21519,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.004408,0.12541,0.11332,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.011326,0.12507,0.097991,1,1
1,GO CELLULAR RESPIRATION,0.02268,0.12505,0.10078,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00069957,0.12468,0.12999,1,1
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.004408,0.12466,0.1094,1,1
1,GO MEMBRANE ORGANIZATION,0.0027346,0.12443,0.10151,1,1
1,GO MITOTIC CELL CYCLE,0.00016023,0.1243,0.12277,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,3.3132e-05,0.12394,0.12685,1,1
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00353,0.12356,0.1176,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00049035,0.12336,0.12878,1,1
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.02068,0.12309,0.15501,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.016339,0.12303,0.098804,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.00065623,0.12286,0.14005,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.0030654,0.12269,0.1348,1,1
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.009256,0.12254,0.089169,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00023468,0.12208,0.10341,1,1
1,GO ACTIN FILAMENT ORGANIZATION,0.033166,0.12171,0.099949,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,4.8379e-05,0.12119,0.13265,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00045924,0.12117,0.1705,1,1
1,GO CELLULAR SENESCENCE,0.0027346,0.12096,0.12477,1,1
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.02843,0.12043,0.088165,1,1
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.031748,0.12038,0.076634,1,1
1,GO BLASTOCYST FORMATION,0.015953,0.12014,0.12905,1,1
1,GO ENDOCYTOSIS,0.00095906,0.11991,0.13217,1,1
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.0018173,0.11989,0.1627,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.00012964,0.11974,0.11378,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.00353,0.1197,0.11694,1,1
1,GO FLUID TRANSPORT,0.0046564,0.11895,0.15022,1,1
1,GO REGULATION OF DNA REPLICATION,0.0013054,0.11843,0.11621,1,1
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.027803,0.11822,0.096605,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.6174e-05,0.11802,0.13885,1,1
1,GO CHROMOSOME SEPARATION,0.0071468,0.11668,0.13798,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.018836,0.11649,0.090456,1,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0013872,0.1163,0.11478,1,1
1,GO GOLGI ORGANIZATION,0.0046564,0.11613,0.11633,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00017796,0.11605,0.13622,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.001986,0.11582,0.12664,1,1
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0047853,0.11574,0.12475,1,1
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0062634,0.11558,0.094557,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.018836,0.11523,0.094847,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.0011199,0.11502,0.13863,1,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00084609,0.11494,0.1192,1,1
1,GO RESPONSE TO HORMONE,0.001228,0.11492,0.12158,1,1
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0024367,0.11489,0.12106,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.010506,0.11482,0.11863,1,1
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.015574,0.11446,0.080023,1,1
1,GO REGULATION OF AUTOPHAGY,5.8301e-05,0.11411,0.13587,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0013457,0.11376,0.11618,1,1
1,GO ORGANELLE FISSION,0.0014738,0.11369,0.098494,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00012512,0.11368,0.12567,1,1
1,GO REGULATION OF ATP METABOLIC PROCESS,0.021165,0.11367,0.093388,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.0053338,0.11364,0.086034,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.031059,0.11323,0.12129,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.00072223,0.11293,0.11902,1,1
1,GO RNA SURVEILLANCE,0.0030654,0.11283,0.16482,1,1
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.0001547,0.11267,0.11329,1,1
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.023205,0.11234,0.081032,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.0026572,0.11233,0.10475,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00038934,0.11221,0.11171,1,1
1,GO MACROAUTOPHAGY,5.6174e-05,0.11204,0.13267,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0021062,0.11193,0.098696,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0047853,0.11169,0.09179,1,1
1,GO FEMALE GAMETE GENERATION,0.0025083,0.11153,0.099842,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0024367,0.11144,0.11354,1,1
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.02166,0.1111,0.10296,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00067758,0.11092,0.12495,1,1
1,GO METAPHASE PLATE CONGRESSION,0.015203,0.11086,0.11512,1,1
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.017969,0.10967,0.090435,1,1
1,GO MRNA TRANSPORT,0.00072223,0.10949,0.1556,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,1.8521e-05,0.10925,0.12536,1,1
1,GO ORGANELLE DISASSEMBLY,0.00074557,0.10897,0.11714,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0006154,0.10845,0.10094,1,1
1,GO CYTOSKELETON ORGANIZATION,0.02843,0.10832,0.073862,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00054072,0.1082,0.1135,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,2.2524e-05,0.10751,0.11314,1,1
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.01282,0.10742,0.098388,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0067808,0.10647,0.1066,1,1
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.044685,0.10621,0.14105,1,1
1,GO SULFATE TRANSPORT,0.0031536,0.10612,0.11352,1,1
1,GO CARDIOCYTE DIFFERENTIATION,0.0036303,0.10576,0.1797,1,1
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.030383,0.10568,0.073984,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0062634,0.10564,0.16601,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.0006154,0.10542,0.1258,1,1
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.001662,0.10406,0.12773,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.0083534,0.10385,0.097964,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0083534,0.1038,0.12848,1,1
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.024288,0.10367,0.14078,1,1
1,GO CELL CYCLE PROCESS,0.00030804,0.10353,0.10072,1,1
1,GO MRNA CLEAVAGE,0.010245,0.10301,0.095414,1,1
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.027188,0.10203,0.075965,1,1
1,GO NEGATIVE REGULATION OF BINDING,0.0051916,0.10135,0.11124,1,1
1,GO DNA INTEGRITY CHECKPOINT,0.030383,0.10104,0.086549,1,1
1,GO REGULATION OF CELL CYCLE,0.00042998,0.10084,0.088985,1,1
1,GO CELLULAR RESPONSE TO DRUG,0.035393,0.099759,0.10347,1,1
1,GO PROTEIN TETRAMERIZATION,0.0083534,0.099286,0.10184,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0028957,0.098743,0.095974,1,1
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.042857,0.098423,0.11141,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0062634,0.096813,0.18237,1,1
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.036948,0.09675,0.091883,1,1
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0010528,0.09651,0.10507,1,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0083534,0.096042,0.09663,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0006154,0.095805,0.076897,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0027346,0.095001,0.088013,1,1
1,GO MACROMOLECULE DEACYLATION,0.018398,0.094987,0.074363,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0064317,0.094858,0.12223,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.00045924,0.094263,0.087248,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0018173,0.093935,0.10508,1,1
1,GO MRNA 3 END PROCESSING,0.022165,0.093093,0.098174,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.011612,0.092858,0.080535,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0030654,0.092091,0.12969,1,1
1,GO MULTI ORGANISM PROCESS,0.0047853,0.092018,0.068931,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.018398,0.091715,0.088866,1,1
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.016734,0.09145,0.11259,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0066042,0.091401,0.14546,1,1
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.012203,0.091334,0.078173,1,1
1,GO CELL CYCLE,0.00050664,0.09073,0.08412,1,1
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0028141,0.090629,0.10261,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.017969,0.090262,0.08705,1,1
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0051916,0.089693,0.093786,1,1
1,GO IRON ION TRANSPORT,0.0081404,0.08938,0.094071,1,1
1,GO REGULATION OF CYTOKINESIS,0.037747,0.089267,0.074076,1,1
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.01282,0.088978,0.08993,1,1
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.029719,0.088833,0.068501,1,1
1,GO REGULATION OF CENTROSOME CYCLE,0.0085714,0.08844,0.11339,1,1
1,GO RESPONSE TO ACID CHEMICAL,0.046579,0.088233,0.11721,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00035231,0.087704,0.092213,1,1
1,GO MUSCLE CELL DIFFERENTIATION,0.03245,0.087516,0.10749,1,1
1,GO ACTIN FILAMENT BASED PROCESS,0.014138,0.087492,0.10299,1,1
1,GO SPINDLE ASSEMBLY,0.0049174,0.086935,0.097064,1,1
1,GO DNA METABOLIC PROCESS,0.00034072,0.086822,0.094615,1,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0033369,0.086683,0.12624,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.00031859,0.085656,0.088966,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0037331,0.085483,0.098986,1,1
1,GO NEGATIVE REGULATION OF TRANSPORT,0.0099891,0.085441,0.087363,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.019739,0.085254,0.077934,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00044439,0.084405,0.10058,1,1
1,GO POSITIVE REGULATION OF SIGNALING,0.011326,0.084129,0.076112,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00034072,0.083888,0.10582,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0046564,0.083293,0.065301,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00025131,0.083088,0.093344,1,1
1,GO RESPONSE TO RADIATION,0.007729,0.081098,0.069949,1,1
1,GO CELL CYCLE CHECKPOINT,0.0047853,0.079292,0.088715,1,1
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.024846,0.077082,0.072086,1,1
1,GO ELECTRON TRANSPORT CHAIN,0.037747,0.076105,0.083723,1,1
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0028957,0.075382,0.13985,1,1
1,GO PEPTIDYL SERINE MODIFICATION,0.029719,0.074445,0.065094,1,1
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.041093,0.074211,0.082131,1,1
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.038561,0.073357,0.086039,1,1
1,GO DNA CATABOLIC PROCESS,0.012203,0.073105,0.069313,1,1
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.015574,0.07194,0.088852,1,1
1,GO CHROMOSOME SEGREGATION,0.022165,0.071793,0.087507,1,1
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0066042,0.071599,0.094573,1,1
1,GO T CELL LINEAGE COMMITMENT,0.043763,0.071521,0.10918,1,1
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0099891,0.071049,0.066936,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.023741,0.070728,0.11404,1,1
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.030383,0.07063,0.078195,1,1
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.011326,0.068697,0.055381,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.035393,0.065358,0.059211,1,1
1,GO DNA REPAIR,0.0071468,0.06391,0.07903,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.01282,0.063461,0.09106,1,1
1,GO INTRACELLULAR TRANSPORT,0.0038387,0.063372,0.067539,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.03245,0.061943,0.046634,1,1
1,GO MITOCHONDRION ORGANIZATION,0.010245,0.061687,0.066657,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.014486,0.06149,0.052455,1,1
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.019739,0.060453,0.060427,1,1
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.020205,0.059805,0.067687,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.0046564,0.058212,0.1191,1,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.023741,0.050345,0.072492,1,1
1,GO DNA REPLICATION,0.047551,0.049182,0.062098,1,1
1,GO ORGANELLE ASSEMBLY,0.013798,0.040663,0.062271,1,1
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00013433,0.47855,0.55458,1,0
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00087311,0.46949,0.47329,1,0
1,GO GERMINAL CENTER FORMATION,0.00052342,0.42882,0.40147,1,0
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0018173,0.39749,0.33233,1,0
1,GO INTERLEUKIN 13 PRODUCTION,0.00032948,0.39432,0.46301,1,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0007696,0.38781,0.32837,1,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0028141,0.37579,0.34321,1,0
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.001872,0.37538,0.35648,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.019739,0.37202,0.36261,1,0
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00054072,0.37077,0.38401,1,0
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00010092,0.36765,0.45558,1,0
1,GO REGULATION OF COAGULATION,2.5308e-05,0.3648,0.41743,1,0
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0012662,0.3636,0.36672,1,0
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.033166,0.34999,0.29114,1,0
1,GO ARGININE METABOLIC PROCESS,0.00057693,0.34214,0.35295,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0083534,0.33431,0.4336,1,0
1,GO MONONUCLEAR CELL MIGRATION,0.00021167,0.33034,0.3116,1,0
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.001191,0.32245,0.28884,1,0
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0079323,0.31575,0.30824,1,0
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0049174,0.3156,0.50054,1,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.033894,0.31059,0.3728,1,0
1,GO EOSINOPHIL MIGRATION,0.0039469,0.31021,0.35672,1,0
1,GO PSEUDOURIDINE SYNTHESIS,0.014486,0.30845,0.19956,1,0
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,5.2139e-05,0.30716,0.33814,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00045924,0.30154,0.36232,1,0
1,GO HEPARIN METABOLIC PROCESS,0.0029794,0.29926,0.37078,1,0
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0018173,0.29765,0.37465,1,0
1,GO PROSTATE GLAND DEVELOPMENT,0.00010462,0.2967,0.45796,1,0
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.047551,0.29351,0.34456,1,0
1,GO LEFT RIGHT AXIS SPECIFICATION,0.027188,0.29121,0.30367,1,0
1,GO COPPER ION TRANSPORT,0.00012512,0.28722,0.2998,1,0
1,GO REGULATION OF WOUND HEALING,0.00012964,0.28669,0.3103,1,0
1,GO BEHAVIORAL RESPONSE TO PAIN,0.0045306,0.28287,0.26955,1,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0029794,0.27928,0.34203,1,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.019739,0.27863,0.22413,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,5.6174e-05,0.27514,0.27334,1,0
1,GO RESPONSE TO THYROID HORMONE,0.00022676,0.27496,0.31539,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0099891,0.27338,0.28357,1,0
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,8.4205e-05,0.2694,0.26503,1,0
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0032441,0.26933,0.35257,1,0
1,GO ACTIN FILAMENT SEVERING,0.02166,0.26758,0.23447,1,0
1,GO FOAM CELL DIFFERENTIATION,0.0013872,0.26715,0.24968,1,0
1,GO EOSINOPHIL CHEMOTAXIS,0.031748,0.26561,0.33384,1,0
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00013917,0.2653,0.34483,1,0
1,GO POSITIVE REGULATION OF COAGULATION,0.0047853,0.26264,0.27563,1,0
1,GO MONOCYTE CHEMOTAXIS,0.00050664,0.2614,0.32362,1,0
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0015653,0.26043,0.25278,1,0
1,GO PENTOSE METABOLIC PROCESS,0.0067808,0.25889,0.19578,1,0
1,GO HEPATOCYTE DIFFERENTIATION,0.036948,0.25513,0.28711,1,0
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00014418,0.2536,0.2135,1,0
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0026572,0.25359,0.22083,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.04854,0.25306,0.1463,1,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.014841,0.25259,0.22491,1,0
1,GO REGULATION OF RESPONSE TO WOUNDING,0.00010092,0.25227,0.26807,1,0
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0024367,0.24844,0.32417,1,0
1,GO AMINO SUGAR CATABOLIC PROCESS,0.00049035,0.24798,0.22422,1,0
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0022332,0.24784,0.25064,1,0
1,GO LIVER MORPHOGENESIS,0.042857,0.2462,0.17809,1,0
1,GO HOMOTYPIC CELL CELL ADHESION,0.00013433,0.24342,0.29105,1,0
1,GO REGULATION OF ANOIKIS,0.023741,0.24272,0.23697,1,0
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.016734,0.24008,0.33692,1,0
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0025817,0.23997,0.23458,1,0
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0021062,0.23848,0.35418,1,0
1,GO MYOBLAST MIGRATION,0.011047,0.23699,0.38271,1,0
1,GO AXIS ELONGATION,0.0060989,0.23616,0.28763,1,0
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,8.1192e-05,0.2357,0.24914,1,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0030654,0.22944,0.18803,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.019739,0.22837,0.23931,1,0
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00079435,0.22678,0.25143,1,0
1,GO SUPEROXIDE ANION GENERATION,0.0028141,0.22601,0.26864,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0069616,0.22344,0.20549,1,0
1,GO GRANULOCYTE MIGRATION,0.00016023,0.22343,0.27789,1,0
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.00084609,0.21325,0.17644,1,0
1,GO GLUTATHIONE METABOLIC PROCESS,0.0021062,0.21206,0.21644,1,0
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.009256,0.21202,0.2458,1,0
1,GO AMINE CATABOLIC PROCESS,0.0010528,0.21166,0.31193,1,0
1,GO FATTY ACID HOMEOSTASIS,0.04854,0.21042,0.15725,1,0
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.007729,0.20665,0.14549,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00017796,0.20658,0.20582,1,0
1,GO HORMONE BIOSYNTHETIC PROCESS,0.0013054,0.20481,0.20942,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0011549,0.20466,0.19094,1,0
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0022992,0.20026,0.22245,1,0
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.04854,0.19793,0.15776,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,7.2754e-05,0.19742,0.20919,1,0
1,GO REGULATION OF PLATELET ACTIVATION,0.036164,0.19693,0.1654,1,0
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.043763,0.19646,0.21767,1,0
1,GO IMMUNOGLOBULIN SECRETION,0.0045306,0.19485,0.26715,1,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.043763,0.19424,0.13872,1,0
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.027803,0.19335,0.16387,1,0
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.018836,0.19309,0.13349,1,0
1,GO GRANULOCYTE CHEMOTAXIS,0.0027346,0.19272,0.24457,1,0
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.017137,0.19034,0.14352,1,0
1,GO REGULATION OF CELL CELL ADHESION,0.0015653,0.18834,0.16286,1,0
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.0069616,0.18825,0.21009,1,0
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,1.5201e-05,0.18675,0.23211,1,0
1,GO RETINOL METABOLIC PROCESS,0.0046564,0.18663,0.19112,1,0
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.013139,0.18647,0.22754,1,0
1,GO PROTEIN DEMANNOSYLATION,0.017549,0.18607,0.17096,1,0
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.012508,0.18485,0.14158,1,0
1,GO REGULATION OF BONE DEVELOPMENT,0.0011199,0.18423,0.25301,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION,0.004408,0.18259,0.15375,1,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.017549,0.1822,0.27747,1,0
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.035393,0.18029,0.17197,1,0
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.00052342,0.18029,0.19057,1,0
1,GO RESPONSE TO INTERLEUKIN 6,0.046579,0.18024,0.11719,1,0
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,6.7596e-05,0.18004,0.22469,1,0
1,GO ISOPRENOID METABOLIC PROCESS,0.025994,0.1794,0.1342,1,0
1,GO NEPHRON TUBULE FORMATION,0.044685,0.17874,0.21533,1,0
1,GO RESPONSE TO IRON ION,0.02068,0.17827,0.14099,1,0
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0015653,0.17438,0.22316,1,0
1,GO T CELL DIFFERENTIATION,0.0019282,0.17422,0.14327,1,0
1,GO RESPONSE TO INTERLEUKIN 15,0.0032441,0.17135,0.28078,1,0
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00029782,0.1709,0.20945,1,0
1,GO MYELOID LEUKOCYTE MIGRATION,0.010773,0.17045,0.19114,1,0
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.8379e-05,0.17043,0.18236,1,0
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.023205,0.17037,0.37242,1,0
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.011047,0.16907,0.17037,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.02843,0.16833,0.16576,1,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.036948,0.16789,0.16982,1,0
1,GO DRUG METABOLIC PROCESS,0.037747,0.16779,0.10207,1,0
1,GO PROTEIN DENEDDYLATION,0.0094949,0.16628,0.16,1,0
1,GO REGULATION OF B CELL ACTIVATION,0.011326,0.16617,0.12793,1,0
1,GO REGULATION OF ERBB SIGNALING PATHWAY,9.0551e-05,0.16495,0.29061,1,0
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00041602,0.16465,0.17424,1,0
1,GO PROTEIN MATURATION,0.00021167,0.16448,0.14976,1,0
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0010206,0.16216,0.15184,1,0
1,GO ERBB SIGNALING PATHWAY,0.00014935,0.16211,0.23362,1,0
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.007729,0.16176,0.16112,1,0
1,GO BONE REMODELING,0.0019282,0.16144,0.19205,1,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00036427,0.16102,0.18465,1,0
1,GO MAMMARY GLAND DEVELOPMENT,0.0060989,0.16021,0.16434,1,0
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.030383,0.16001,0.12336,1,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00059588,0.15904,0.20454,1,0
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.035393,0.15882,0.14408,1,0
1,GO AMINO ACID ACTIVATION,0.040234,0.15854,0.13588,1,0
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.020205,0.15843,0.1462,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.019739,0.15799,0.21007,1,0
1,GO DETOXIFICATION,0.012508,0.15753,0.13844,1,0
1,GO INTEGRIN ACTIVATION,0.016339,0.15641,0.16743,1,0
1,GO PROTEIN N LINKED GLYCOSYLATION,0.0039469,0.15557,0.13341,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.025414,0.15399,0.16173,1,0
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.015953,0.15383,0.18499,1,0
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00019753,0.15321,0.19715,1,0
1,GO FATTY ACID METABOLIC PROCESS,0.0022332,0.15297,0.1245,1,0
1,GO AMYLOID BETA FORMATION,0.024846,0.15269,0.15724,1,0
1,GO LYMPHOCYTE DIFFERENTIATION,0.00045924,0.15239,0.15061,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.035393,0.15186,0.17889,1,0
1,GO CELL CHEMOTAXIS,0.0022992,0.15136,0.1954,1,0
1,GO REGULATION OF LIPID TRANSPORT,0.0011199,0.14923,0.14402,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0069616,0.14901,0.13005,1,0
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0067808,0.1481,0.16238,1,0
1,GO NEUTROPHIL MIGRATION,0.0034322,0.14773,0.23039,1,0
1,GO DIOL BIOSYNTHETIC PROCESS,0.033894,0.14711,0.11073,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.011047,0.14478,0.21527,1,0
1,GO REGULATION OF CHEMOTAXIS,0.0027346,0.14433,0.14168,1,0
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00045924,0.14322,0.11889,1,0
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00011241,0.14054,0.1881,1,0
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0014738,0.13975,0.12927,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.011047,0.13972,0.13337,1,0
1,GO ERYTHROCYTE MATURATION,0.013139,0.13963,0.2323,1,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.025414,0.13824,0.12081,1,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,0.0025817,0.13545,0.10837,1,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.047551,0.13373,0.15281,1,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.024846,0.13354,0.094981,1,0
1,GO MATURE B CELL DIFFERENTIATION,0.019739,0.13056,0.19201,1,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.013465,0.12847,0.14565,1,0
1,GO ENDOCRINE PROCESS,0.013139,0.12835,0.13944,1,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0050528,0.12793,0.10855,1,0
1,GO GOLGI TO ENDOSOME TRANSPORT,0.0094949,0.12728,0.16319,1,0
1,GO EXOCYTOSIS,0.001872,0.12645,0.13272,1,0
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00038934,0.12622,0.33618,1,0
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0069616,0.12591,0.11571,1,0
1,GO LIPID HOMEOSTASIS,0.019283,0.12411,0.072072,1,0
1,GO LIPID MODIFICATION,0.010506,0.12396,0.097748,1,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0069616,0.12097,0.13225,1,0
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.023205,0.12036,0.099644,1,0
1,GO TRANSITION METAL ION TRANSPORT,0.0021689,0.11946,0.086016,1,0
1,GO HUMORAL IMMUNE RESPONSE,0.011326,0.1193,0.11957,1,0
1,GO OXIDATION REDUCTION PROCESS,0.0094949,0.11854,0.090852,1,0
1,GO REGULATION OF PROTEIN STABILITY,0.0007696,0.11752,0.11114,1,0
1,GO AMINE METABOLIC PROCESS,0.025414,0.11325,0.091552,1,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.02166,0.113,0.12155,1,0
1,GO NUCLEOTIDE EXCISION REPAIR,0.00050664,0.11239,0.12939,1,0
1,GO RESPONSE TO PEPTIDE,0.001872,0.1123,0.10325,1,0
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0036303,0.11225,0.088971,1,0
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.011047,0.11076,0.12479,1,0
1,GO LIPID LOCALIZATION,0.03245,0.10962,0.067193,1,0
1,GO ESTROGEN METABOLIC PROCESS,0.027188,0.10866,0.15418,1,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.02166,0.10866,0.11088,1,0
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.041093,0.10752,0.12974,1,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.013798,0.1066,0.092276,1,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,0.0060989,0.10616,0.12615,1,0
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.011612,0.10573,0.19856,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE,0.0021689,0.10516,0.093556,1,0
1,GO RNA POLYADENYLATION,0.0053338,0.10277,0.12901,1,0
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0060989,0.10265,0.094539,1,0
1,GO ALCOHOL METABOLIC PROCESS,0.03245,0.10242,0.069999,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.043763,0.10234,0.091844,1,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.016339,0.10138,0.086063,1,0
1,GO PEROXISOME ORGANIZATION,0.0028141,0.10105,0.16727,1,0
1,GO CELLULAR LIPID METABOLIC PROCESS,0.029068,0.098918,0.058927,1,0
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.035393,0.098655,0.073372,1,0
1,GO RESPONSE TO PEPTIDE HORMONE,0.0059384,0.098274,0.084721,1,0
1,GO PEROXISOMAL TRANSPORT,0.0038387,0.098213,0.17439,1,0
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.013139,0.098032,0.095114,1,0
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.044685,0.097952,0.10779,1,0
1,GO HORMONE METABOLIC PROCESS,0.0046564,0.097909,0.12187,1,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0069616,0.09764,0.17296,1,0
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.025414,0.096574,0.12723,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.014486,0.095704,0.13597,1,0
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.015574,0.094728,0.066686,1,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.03245,0.092574,0.15188,1,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.011326,0.092243,0.08285,1,0
1,GO PROTEIN AUTOPHOSPHORYLATION,0.037747,0.092106,0.080387,1,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.017969,0.090966,0.068593,1,0
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0018173,0.090496,0.10563,1,0
1,GO BONE RESORPTION,0.038561,0.08991,0.10845,1,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.037747,0.089193,0.13759,1,0
1,GO EPITHELIUM DEVELOPMENT,0.014138,0.088153,0.10909,1,0
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.043763,0.088046,0.051168,1,0
1,GO VESICLE ORGANIZATION,0.019739,0.087253,0.087883,1,0
1,GO ACTIVATION OF MAPK ACTIVITY,0.017549,0.087098,0.083251,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.023741,0.0869,0.067298,1,0
1,GO LIPID METABOLIC PROCESS,0.017137,0.08625,0.06188,1,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.024846,0.085725,0.05016,1,0
1,GO FATTY ACID TRANSPORT,0.047551,0.085055,0.075323,1,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.016734,0.084413,0.11562,1,0
1,GO DNA GEOMETRIC CHANGE,0.025414,0.08162,0.11952,1,0
1,GO MIRNA METABOLIC PROCESS,0.02268,0.081499,0.10802,1,0
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.037747,0.079624,0.056011,1,0
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.042857,0.079178,0.075305,1,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.031059,0.07915,0.055924,1,0
1,GO CARBOHYDRATE METABOLIC PROCESS,0.0087944,0.078528,0.068798,1,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.038561,0.078243,0.048605,1,0
1,GO JNK CASCADE,0.03939,0.075757,0.066911,1,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.033894,0.075629,0.1194,1,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.040234,0.075502,0.14497,1,0
1,GO BIOMINERALIZATION,0.035393,0.072403,0.15546,1,0
1,GO REGULATION OF TUBE SIZE,0.016339,0.072113,0.12947,1,0
1,GO NCRNA TRANSCRIPTION,0.043763,0.071543,0.080709,1,0
1,GO ATP METABOLIC PROCESS,0.034637,0.071083,0.073221,1,0
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.026586,0.069578,0.055286,1,0
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.021165,0.069561,0.2359,1,0
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00098941,0.069134,0.095136,1,0
1,GO GLAND DEVELOPMENT,0.037747,0.064331,0.096809,1,0
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.04854,0.06396,0.072132,1,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.043763,0.061481,0.31576,1,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.043763,0.061034,0.11223,1,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.03245,0.052866,0.074848,1,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0059384,-0.047688,-0.10895,1,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.02068,-0.059122,-0.087931,1,0
1,GO STEROL BIOSYNTHETIC PROCESS,0.03939,-0.060481,-0.17024,1,0
1,GO ORGANIC ACID TRANSPORT,0.0087944,-0.064267,-0.093501,1,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.037747,-0.06894,-0.10858,1,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,0.042857,-0.075721,-0.0912,1,0
1,GO TRANSMEMBRANE TRANSPORT,0.009256,-0.082732,-0.075373,1,0
1,GO REGULATION OF ANION TRANSPORT,0.018398,-0.083661,-0.11354,1,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.04854,-0.084312,-0.10203,1,0
1,GO SENSORY PERCEPTION OF SMELL,0.017969,-0.084331,-0.084143,1,0
1,GO CARBOHYDRATE HOMEOSTASIS,0.012203,-0.094651,-0.10376,1,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,0.0023671,-0.097125,-0.11229,1,0
1,GO REGULATION OF HORMONE LEVELS,0.0094949,-0.097622,-0.11342,1,0
1,GO PEPTIDE SECRETION,0.0020453,-0.099981,-0.10971,1,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.024846,-0.10172,-0.10244,1,0
1,GO FEAR RESPONSE,0.0045306,-0.1021,-0.1576,1,0
1,GO POSITIVE REGULATION OF SECRETION,0.0031536,-0.10334,-0.10807,1,0
1,GO DETECTION OF STIMULUS,0.00036427,-0.10348,-0.11094,1,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0069616,-0.10466,-0.14834,1,0
1,GO CALCIUM ION IMPORT,0.024846,-0.10647,-0.10922,1,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.036948,-0.10949,-0.13165,1,0
1,GO REGULATION OF ACTIN NUCLEATION,0.013465,-0.11063,-0.16551,1,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.009256,-0.1126,-0.1516,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.0010528,-0.11262,-0.15319,1,0
1,GO OLIGODENDROCYTE DEVELOPMENT,0.007729,-0.11769,-0.20309,1,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0053338,-0.11797,-0.18493,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,0.0050528,-0.11797,-0.10212,1,0
1,GO CELL MATURATION,0.0023671,-0.11967,-0.11494,1,0
1,GO REGULATION OF PEPTIDE SECRETION,0.0064317,-0.11992,-0.10079,1,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0034322,-0.12199,-0.11257,1,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.03245,-0.12249,-0.10999,1,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.036948,-0.12298,-0.092248,1,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.031748,-0.12387,-0.13456,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00072223,-0.12508,-0.17338,1,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0023671,-0.12518,-0.25852,1,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,0.015574,-0.12666,-0.091402,1,0
1,GO HYPOTHALAMUS DEVELOPMENT,0.046579,-0.12992,-0.1508,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00014418,-0.13024,-0.14711,1,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0060989,-0.13101,-0.15757,1,0
1,GO GLUTAMATE METABOLIC PROCESS,0.034637,-0.13405,-0.11249,1,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.024846,-0.13559,-0.11414,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0020453,-0.13645,-0.17227,1,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.034637,-0.13723,-0.23342,1,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,0.015203,-0.13828,-0.19495,1,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.046579,-0.13846,-0.22976,1,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.021165,-0.13911,-0.1298,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0069616,-0.14107,-0.18212,1,0
1,GO LIPID DROPLET ORGANIZATION,0.0079323,-0.14519,-0.16957,1,0
1,GO SENSORY PERCEPTION OF TASTE,0.0064317,-0.14698,-0.17156,1,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0064317,-0.14739,-0.20232,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.04854,-0.14863,-0.2205,1,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.011047,-0.14885,-0.19079,1,0
1,GO REGULATION OF SECRETION,3.8583e-05,-0.15007,-0.1487,1,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00041602,-0.15052,-0.16827,1,0
1,GO DETERMINATION OF ADULT LIFESPAN,0.043763,-0.1522,-0.14245,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.010773,-0.15722,-0.38062,1,0
1,GO REGULATION OF RESPIRATORY BURST,0.035393,-0.15911,-0.20044,1,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.02268,-0.15917,-0.11534,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,8.7323e-05,-0.16089,-0.17279,1,0
1,GO REGULATION OF ION TRANSPORT,6.0504e-05,-0.16317,-0.16375,1,0
1,GO MITOTIC SISTER CHROMATID COHESION,0.034637,-0.16341,-0.13181,1,0
1,GO CHLORIDE TRANSPORT,0.0011549,-0.16599,-0.13288,1,0
1,GO HISTONE H4 ACETYLATION,0.00067758,-0.1661,-0.15104,1,0
1,GO REGULATION OF ICOSANOID SECRETION,0.04854,-0.16616,-0.13097,1,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.045624,-0.16881,-0.20774,1,0
1,GO HISTONE H4 K16 ACETYLATION,0.00065623,-0.16885,-0.23492,1,0
1,GO REGULATION OF BLOOD CIRCULATION,0.0016129,-0.16908,-0.14614,1,0
1,GO DIGESTIVE SYSTEM PROCESS,0.026586,-0.17127,-0.13286,1,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0036303,-0.17235,-0.16981,1,0
1,GO ACID SECRETION,0.00074557,-0.17314,-0.1879,1,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.031748,-0.17379,-0.15387,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00040247,-0.17502,-0.14985,1,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.036948,-0.17747,-0.16659,1,0
1,GO PHAGOSOME ACIDIFICATION,0.0090226,-0.18138,-0.16383,1,0
1,GO NEUTRAL AMINO ACID TRANSPORT,0.02068,-0.18152,-0.15486,1,0
1,GO OXIDATIVE DEMETHYLATION,0.0017641,-0.18339,-0.15016,1,0
1,GO POLYOL TRANSPORT,0.042857,-0.18473,-0.15507,1,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.011326,-0.1902,-0.13267,1,0
1,GO DIGESTION,0.0060989,-0.19258,-0.16309,1,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.029068,-0.19258,-0.24526,1,0
1,GO RESPONSE TO INTERLEUKIN 2,0.0040578,-0.19289,-0.23364,1,0
1,GO REGULATION OF HORMONE SECRETION,1.1493e-05,-0.19387,-0.22636,1,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.007729,-0.19481,-0.24589,1,0
1,GO RESPONSE TO PAIN,0.01282,-0.1954,-0.19157,1,0
1,GO HISTONE H3 K9 DEMETHYLATION,0.013798,-0.19631,-0.19255,1,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0014738,-0.20226,-0.21083,1,0
1,GO HAIR CELL DIFFERENTIATION,0.023741,-0.20357,-0.21429,1,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.012203,-0.20367,-0.17888,1,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0026572,-0.20964,-0.18082,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0022992,-0.21069,-0.22783,1,0
1,GO LIPID TRANSLOCATION,0.0064317,-0.2115,-0.18774,1,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00095906,-0.21249,-0.22699,1,0
1,GO HORMONE TRANSPORT,3.1904e-06,-0.21296,-0.24434,1,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00072223,-0.21569,-0.24947,1,0
1,GO SODIUM ION HOMEOSTASIS,0.0011549,-0.21594,-0.25205,1,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.019283,-0.2167,-0.19266,1,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.0053338,-0.2194,-0.19581,1,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,7.3528e-06,-0.22292,-0.25914,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,2.9532e-05,-0.22632,-0.22727,1,0
1,GO KETONE BODY METABOLIC PROCESS,0.0087944,-0.22803,-0.28357,1,0
1,GO REPRODUCTIVE BEHAVIOR,0.00020448,-0.22816,-0.24181,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,0.00023468,-0.22905,-0.22193,1,0
1,GO BILE ACID METABOLIC PROCESS,0.015953,-0.2389,-0.17155,1,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,0.0028957,-0.24172,-0.18131,1,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.014138,-0.24218,-0.19846,1,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.029068,-0.24295,-0.19056,1,0
1,GO SHORT TERM MEMORY,0.0059384,-0.24447,-0.32036,1,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.0020453,-0.24481,-0.22115,1,0
1,GO FEEDING BEHAVIOR,1.725e-07,-0.25467,-0.27886,1,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.001662,-0.25512,-0.25083,1,0
1,GO REGULATION OF ACTION POTENTIAL,0.0073363,-0.25755,-0.19174,1,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,5.4121e-05,-0.25913,-0.25887,1,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0075304,-0.25972,-0.22979,1,0
1,GO GENETIC IMPRINTING,0.0054795,-0.26005,-0.17627,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,0.00021909,-0.26075,-0.23465,1,0
1,GO CELL FATE SPECIFICATION,0.0015653,-0.26287,-0.30223,1,0
1,GO ENERGY HOMEOSTASIS,0.0047853,-0.26479,-0.2379,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,2.5774e-06,-0.26497,-0.23131,1,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.0073363,-0.26678,-0.20337,1,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.00010845,-0.26735,-0.22491,1,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.011612,-0.26854,-0.2151,1,0
1,GO GLYCINE TRANSPORT,0.013465,-0.27644,-0.29237,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.011326,-0.27864,-0.27617,1,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.0022332,-0.2795,-0.30326,1,0
1,GO SIGNAL RELEASE,2.8891e-07,-0.28052,-0.26865,1,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0017641,-0.28276,-0.25139,1,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0025817,-0.28303,-0.23771,1,0
1,GO PEPTIDE HORMONE SECRETION,6.8936e-07,-0.28632,-0.3008,1,0
1,GO ACROSOME ASSEMBLY,0.0006154,-0.28782,-0.23972,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,1.2308e-06,-0.28974,-0.287,1,0
1,GO REGULATION OF INSULIN SECRETION,9.0179e-06,-0.28997,-0.27193,1,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.001662,-0.29809,-0.24515,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,5.9841e-06,-0.29984,-0.29135,1,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0001547,-0.30046,-0.33547,1,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.0022332,-0.30529,-0.30704,1,0
1,GO INSEMINATION,0.03245,-0.30648,-0.1839,1,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.0059384,-0.30791,-0.29913,1,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.011904,-0.30929,-0.26756,1,0
1,GO INSULIN SECRETION,2.9301e-06,-0.3103,-0.29351,1,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.9801e-06,-0.31077,-0.29618,1,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,1.4039e-05,-0.31234,-0.36619,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0037331,-0.31297,-0.30454,1,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,6.7728e-06,-0.31473,-0.33195,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00055855,-0.3166,-0.28252,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.015203,-0.317,-0.22344,1,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,7.6603e-06,-0.31707,-0.32246,1,0
1,GO MITOCHONDRION DISTRIBUTION,0.00065623,-0.32165,-0.30577,1,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.02068,-0.32343,-0.24445,1,0
1,GO DENDRITIC TRANSPORT,0.0032441,-0.3289,-0.29694,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,6.7728e-06,-0.32932,-0.34972,1,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00079435,-0.3396,-0.34178,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00017186,-0.3474,-0.33738,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.011047,-0.34974,-0.41562,1,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0029794,-0.35248,-0.27713,1,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,1.6455e-05,-0.35324,-0.34623,1,0
1,GO N GLYCAN PROCESSING,0.00032948,-0.35547,-0.3392,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.00072223,-0.36004,-0.28171,1,0
1,GO LIPID DROPLET FORMATION,0.0036303,-0.36562,-0.36143,1,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0051916,-0.36716,-0.23543,1,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,3.4728e-06,-0.36907,-0.35359,1,0
1,GO RESPONSE TO DIETARY EXCESS,0.00016595,-0.37244,-0.39033,1,0
1,GO AROMATIC AMINO ACID TRANSPORT,0.00040247,-0.37346,-0.35746,1,0
1,GO RESPONSE TO INSECTICIDE,0.00042998,-0.37667,-0.34672,1,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.016734,-0.38083,-0.28053,1,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.010506,-0.38945,-0.32376,1,0
1,GO OPTIC NERVE DEVELOPMENT,0.00065623,-0.39006,-0.37108,1,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0017123,-0.39232,-0.28504,1,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,2.6902e-06,-0.39727,-0.44757,1,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00023468,-0.4085,-0.54173,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0097392,-0.42712,-0.3063,1,0
1,GO SYNAPTIC VESICLE LOCALIZATION,4.1112e-06,-0.42777,-0.45465,1,0
1,GO RESPONSE TO L GLUTAMATE,0.00090094,-0.43447,-0.45488,1,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00021167,-0.43542,-0.35079,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,2.3654e-06,-0.44394,-0.4386,1,0
1,GO SUCKLING BEHAVIOR,0.00032948,-0.44493,-0.4125,1,0
1,GO EXOCYTIC PROCESS,1.6452e-07,-0.45225,-0.44155,1,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,2.1663e-05,-0.45869,-0.45635,1,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0027346,-0.46606,-0.37116,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,3.5759e-05,-0.46707,-0.42901,1,0
1,GO REGULATION OF CELL PROJECTION SIZE,1.8251e-06,-0.47781,-0.50862,1,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.044685,-0.48016,-0.30397,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,9.3916e-06,-0.48194,-0.64797,1,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00072223,-0.50684,-0.45366,1,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.041093,-0.50881,-0.2771,1,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00055855,-0.53871,-0.48615,1,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00030804,-0.55403,-0.38951,1,0
1,GO REGULATION OF NEURON MATURATION,0.00084609,-0.55486,-0.48021,1,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0017123,-0.56332,-0.44996,1,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,8.1192e-05,-0.57347,-0.4111,1,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,2.7578e-07,-0.57427,-0.54838,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00019079,-0.592,-0.4968,1,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,8.6584e-06,-0.60295,-0.57,1,0
1,GO DOPAMINE METABOLIC PROCESS,1.4963e-07,-0.63318,-0.60186,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00036427,-0.63525,-0.44047,1,0
1,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.0013054,-0.64208,-0.48285,1,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,2.7578e-07,-0.67351,-0.77451,1,0
1,GO CATECHOLAMINE METABOLIC PROCESS,1.725e-07,-0.68065,-0.58594,1,0
1,GO RESPONSE TO LITHIUM ION,7.3528e-06,-0.68229,-0.58147,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,4.8612e-06,-0.69069,-0.7266,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.00010092,-0.69926,-0.58851,1,0
1,GO RESPONSE TO HISTAMINE,3.6414e-07,-0.71108,-0.73935,1,0
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0021689,-0.73268,-0.49192,1,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,0.0073363,-0.73735,-0.5769,1,0
1,GO INNERVATION,3.3287e-06,-0.76895,-0.63911,1,0
1,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.0779e-06,-0.77378,-0.77697,1,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.0067808,-0.78379,-0.52936,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,1.6729e-06,-0.85528,-0.83469,1,0
1,GO SYNAPTIC VESICLE MATURATION,6.7728e-06,-0.85695,-0.82752,1,0
1,GO NEURON FATE SPECIFICATION,1.8251e-06,-0.86658,-0.90746,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,2.2879e-07,-0.88784,-0.77983,1,0
1,GO SYNAPTIC VESICLE PRIMING,5.4977e-07,-0.89151,-0.83599,1,0
1,GO DOPAMINE TRANSPORT,9.2696e-08,-0.97561,-0.84422,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,8.0176e-08,-0.97572,-0.91941,1,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,1.1776e-06,-0.98507,-0.8102,1,0
1,GO CATECHOLAMINE SECRETION,1.071e-07,-1.0262,-0.86284,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,7.889e-07,-1.0372,-0.99694,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,1.6729e-06,-1.0401,-0.89494,1,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,3.6228e-06,-1.0488,-0.84844,1,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,6.7728e-06,-1.2119,-1.0874,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.12908,0.51852,0.24513,0,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.054842,0.35151,0.21391,0,1
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.059411,0.35149,0.1571,0,1
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.56075,0.33949,0.27661,0,1
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.26471,0.31559,0.14399,0,1
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.17374,0.30882,0.18071,0,1
1,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.053746,0.3074,0.19363,0,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.11434,0.30312,0.18385,0,1
1,GO TRNA CATABOLIC PROCESS,0.050569,0.29439,0.24047,0,1
1,GO MICROVILLUS ASSEMBLY,0.092194,0.28076,0.15827,0,1
1,GO L SERINE METABOLIC PROCESS,0.12473,0.2806,0.1349,0,1
1,GO MYOBLAST PROLIFERATION,0.05161,0.27701,0.15435,0,1
1,GO NUCLEAR MIGRATION,0.082489,0.26748,0.11709,0,1
1,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.11039,0.26736,0.14461,0,1
1,GO VITAMIN D METABOLIC PROCESS,0.072231,0.2603,0.19797,0,1
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.082489,0.25355,0.14922,0,1
1,GO REGULATION OF MESODERM DEVELOPMENT,0.084046,0.24949,0.20547,0,1
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.059411,0.24785,0.20259,0,1
1,GO BARBED END ACTIN FILAMENT CAPPING,0.10465,0.24563,0.14462,0,1
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.25001,0.24278,0.13751,0,1
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.25729,0.24167,0.1989,0,1
1,GO OXYGEN TRANSPORT,0.53742,0.24068,0.096853,0,1
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.12473,0.23509,0.23721,0,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.3746,0.23138,0.11854,0,1
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.061812,0.2296,0.27888,0,1
1,GO LYSINE METABOLIC PROCESS,0.092194,0.22542,0.18973,0,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.26098,0.22048,0.072053,0,1
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.080955,0.21464,0.12231,0,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.068167,0.21355,0.22664,0,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.052669,0.2118,0.10649,0,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.12473,0.20439,0.18288,0,1
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.2,0.19851,0.090143,0,1
1,GO VIRAL LATENCY,0.22905,0.1978,0.073748,0,1
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.11235,0.1976,0.14538,0,1
1,GO RESPONSE TO CADMIUM ION,0.21579,0.19549,0.10191,0,1
1,GO UV PROTECTION,0.12689,0.1928,0.15033,0,1
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.077957,0.19072,0.11122,0,1
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.15015,0.18478,0.13062,0,1
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.27227,0.18415,0.14868,0,1
1,GO DNA DEMETHYLATION,0.05824,0.1819,0.13333,0,1
1,GO GAS TRANSPORT,0.188,0.17923,0.17438,0,1
1,GO PRO B CELL DIFFERENTIATION,0.47588,0.17409,0.10216,0,1
1,GO KINETOCHORE ORGANIZATION,0.077957,0.17277,0.12498,0,1
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.54321,0.17246,0.04649,0,1
1,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.17374,0.17196,0.087857,0,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.085627,0.17176,0.09057,0,1
1,GO ENDOTHELIUM DEVELOPMENT,0.079444,0.17126,0.088565,0,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.070855,0.16762,0.14872,0,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.16559,0.16744,0.13781,0,1
1,GO FOLIC ACID METABOLIC PROCESS,0.15517,0.16684,0.078583,0,1
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.39858,0.16512,0.092566,0,1
1,GO PEPTIDYL ARGININE N METHYLATION,0.13355,0.16317,0.10367,0,1
1,GO ARTERY MORPHOGENESIS,0.066855,0.16224,0.22778,0,1
1,GO PROTEIN REFOLDING,0.14526,0.16111,0.11844,0,1
1,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.33812,0.15908,0.083874,0,1
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.073629,0.15882,0.14051,0,1
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.12908,0.15799,0.11677,0,1
1,GO HEART TRABECULA FORMATION,0.12689,0.15692,0.22296,0,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.14048,0.15329,0.05491,0,1
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.059411,0.15303,0.099453,0,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.27999,0.15187,0.11263,0,1
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.12049,0.15129,0.078812,0,1
1,GO CENTROSOME SEPARATION,0.057089,0.15102,0.11608,0,1
1,GO MUSCLE HYPERTROPHY,0.2839,0.15062,0.061737,0,1
1,GO MAINTENANCE OF CELL NUMBER,0.072231,0.14971,0.12327,0,1
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.050569,0.14938,0.10615,0,1
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.064293,0.14643,0.13486,0,1
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.16032,0.14512,0.13476,0,1
1,GO EXTRACELLULAR TRANSPORT,0.085627,0.14495,0.12282,0,1
1,GO PEPTIDYL ARGININE METHYLATION,0.097379,0.14385,0.095438,0,1
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.20937,0.14245,0.081289,0,1
1,GO NCRNA CATABOLIC PROCESS,0.073629,0.14238,0.1243,0,1
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.1028,0.14174,0.064351,0,1
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.084046,0.14169,0.097343,0,1
1,GO INOSITOL METABOLIC PROCESS,0.22568,0.13978,0.067235,0,1
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.066855,0.13892,0.06831,0,1
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.065563,0.13724,0.1307,0,1
1,GO RESPONSE TO VITAMIN D,0.63978,0.13635,0.03293,0,1
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.077957,0.13591,0.1681,0,1
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.1313,0.1358,0.093226,0,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.17374,0.13571,0.1059,0,1
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.18508,0.13559,0.1339,0,1
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.27227,0.13462,0.066419,0,1
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.23589,0.1345,0.054147,0,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.053746,0.13316,0.12767,0,1
1,GO HISTONE H3 DEACETYLATION,0.057089,0.13305,0.1063,0,1
1,GO RESPONSE TO NITRIC OXIDE,0.22568,0.13258,0.071,0,1
1,GO MACROPHAGE ACTIVATION,0.059411,0.13154,0.13661,0,1
1,GO TAXIS,0.092194,0.13153,0.053951,0,1
1,GO ACTIVATED T CELL PROLIFERATION,0.059411,0.12918,0.11014,0,1
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.14285,0.12875,0.10467,0,1
1,GO ATP TRANSPORT,0.14769,0.12863,0.065538,0,1
1,GO RESPONSE TO INTERLEUKIN 7,0.072231,0.12855,0.16179,0,1
1,GO SPHINGOMYELIN METABOLIC PROCESS,0.16032,0.12799,0.076922,0,1
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.24288,0.12724,0.058523,0,1
1,GO RETROGRADE AXONAL TRANSPORT,0.64605,0.12599,-0.012119,0,1
1,GO MITOTIC DNA REPLICATION CHECKPOINT,0.12689,0.12569,0.092677,0,1
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.10465,0.12518,0.094179,0,1
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.054842,0.12405,0.12152,0,1
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.15773,0.12339,0.076271,0,1
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.14769,0.12288,0.084158,0,1
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.077957,0.12069,0.096579,0,1
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.16294,0.11949,0.091074,0,1
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.14285,0.11858,0.088009,0,1
1,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.24288,0.11794,0.073892,0,1
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.050569,0.11711,0.081355,0,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.049546,0.11071,0.11691,0,1
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.15015,0.10926,0.1051,0,1
1,GO ACETYL COA METABOLIC PROCESS,0.21579,0.10604,0.04543,0,1
1,GO OVULATION CYCLE PROCESS,0.20937,0.10602,0.075277,0,1
1,GO PYRUVATE METABOLIC PROCESS,0.25729,0.10582,0.050143,0,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.15264,0.10534,0.09093,0,1
1,GO HISTONE ARGININE METHYLATION,0.36064,0.10344,0.046564,0,1
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.22905,0.1028,0.093844,0,1
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.39371,0.10173,0.043001,0,1
1,GO LYTIC VACUOLE ORGANIZATION,0.2839,0.10115,0.035867,0,1
1,GO CENTROSOME DUPLICATION,0.0695,0.1011,0.087891,0,1
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.099158,0.096116,0.064858,0,1
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.079444,0.095923,0.070428,0,1
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.15264,0.095914,0.09496,0,1
1,GO NUCLEOTIDE PHOSPHORYLATION,0.15773,0.094913,0.056289,0,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.12259,0.094172,0.091139,0,1
1,GO NEGATIVE REGULATION OF DNA BINDING,0.15517,0.094099,0.06176,0,1
1,GO REGULATION OF T CELL MIGRATION,0.24643,0.092845,0.077609,0,1
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.12473,0.092311,0.1262,0,1
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.11235,0.092034,0.085522,0,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.072231,0.090336,0.13863,0,1
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.20621,0.090074,0.11618,0,1
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.059411,0.088705,0.099605,0,1
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.066855,0.088269,0.073587,0,1
1,GO PROTEIN SUMOYLATION,0.084046,0.086251,0.073148,0,1
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.088862,0.085245,0.088425,0,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.15015,0.084807,0.042067,0,1
1,GO MIDBRAIN DEVELOPMENT,0.10845,0.083122,0.091928,0,1
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.080955,0.081904,0.10736,0,1
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.16294,0.081311,0.12269,0,1
1,GO OXIDATIVE PHOSPHORYLATION,0.13583,0.080171,0.079355,0,1
1,GO PROTEIN LOCALIZATION TO CILIUM,0.36991,0.079112,0.067296,0,1
1,GO P BODY ASSEMBLY,0.61497,0.078396,0.027278,0,1
1,GO HISTONE EXCHANGE,0.26471,0.075341,0.06564,0,1
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.16828,0.073737,0.076579,0,1
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.23937,0.072909,0.059752,0,1
1,GO REGULATION OF GTPASE ACTIVITY,0.092194,0.07231,0.059265,0,1
1,GO SARCOMERE ORGANIZATION,0.59664,0.072142,0.063372,0,1
1,GO FERTILIZATION,0.097379,0.070817,0.052542,0,1
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.21579,0.069838,0.073305,0,1
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.19095,0.068097,0.052897,0,1
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.47588,0.066591,0.033126,0,1
1,GO REGULATION OF CELL FATE SPECIFICATION,0.30815,0.066205,0.13406,0,1
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.40843,0.066099,0.027172,0,1
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.20937,0.065009,0.042182,0,1
1,GO RESPONSE TO LEAD ION,0.13355,0.064649,0.098267,0,1
1,GO REGULATION OF HELICASE ACTIVITY,0.38888,0.063124,0.076538,0,1
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.087232,0.061187,0.072739,0,1
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.066855,0.06072,0.066375,0,1
1,GO MISMATCH REPAIR,0.32077,0.057231,0.04407,0,1
1,GO MEIOTIC CELL CYCLE PROCESS,0.12049,0.054783,0.066177,0,1
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.061812,0.048267,0.096421,0,1
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.080955,0.04814,0.055307,0,1
1,GO POSITIVE REGULATION OF CELL CYCLE,0.12259,0.047104,0.040346,0,1
1,GO DNA RECOMBINATION,0.049546,0.043564,0.081338,0,1
1,GO DNA METHYLATION OR DEMETHYLATION,0.29586,0.041616,0.047673,0,1
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.50896,0.04134,0.017015,0,1
1,GO REGULATION OF DEPHOSPHORYLATION,0.76281,0.041337,-0.0024251,0,1
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.14285,0.040112,0.039657,0,1
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.39858,0.039608,0.047583,0,1
1,GO DNA MODIFICATION,0.05824,0.039047,0.067755,0,1
1,GO DNA METHYLATION,0.61497,0.028977,0.008546,0,1
1,GO MEIOTIC CELL CYCLE,0.43367,0.02819,0.038378,0,1
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.00027832,0.52319,0.59709,0,0
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.00067758,0.43658,0.58281,0,0
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,8.1192e-05,0.43236,0.58916,0,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.014138,0.41556,0.47269,0,0
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.0039469,0.40721,0.31257,0,0
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00087311,0.40024,0.30491,0,0
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.0016129,0.38098,0.44887,0,0
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0045306,0.38003,0.34412,0,0
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,9.0551e-05,0.3658,0.2936,0,0
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,7.547e-05,0.35638,0.40028,0,0
1,GO CELL CELL JUNCTION MAINTENANCE,0.0047853,0.3562,0.29745,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0032441,0.3507,0.3001,0,0
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0020453,0.35017,0.31618,0,0
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0073363,0.34493,0.35824,0,0
1,GO PROSTATIC BUD FORMATION,0.0006154,0.33585,0.48138,0,0
1,GO ASYMMETRIC CELL DIVISION,0.00034072,0.32482,0.28407,0,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.014841,0.3196,0.41723,0,0
1,GO INTERLEUKIN 5 PRODUCTION,0.012508,0.31412,0.27244,0,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.12908,0.30385,0.32568,0,0
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.015953,0.30136,0.41823,0,0
1,GO CYCLOOXYGENASE PATHWAY,0.11434,0.29727,0.25942,0,0
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0047853,0.29144,0.36004,0,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0015189,0.29058,0.26699,0,0
1,GO LUNG MORPHOGENESIS,0.00042998,0.29041,0.32643,0,0
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0021689,0.28499,0.32445,0,0
1,GO MINERALOCORTICOID METABOLIC PROCESS,0.04854,0.2817,0.27476,0,0
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.022165,0.28042,0.24626,0,0
1,GO EPOXYGENASE P450 PATHWAY,0.010773,0.27946,0.22839,0,0
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.023205,0.27304,0.32487,0,0
1,GO INTRACELLULAR MRNA LOCALIZATION,3.4421e-05,0.27126,0.36892,0,0
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.020205,0.26693,0.24718,0,0
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0057817,0.26597,0.26183,0,0
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.011047,0.26088,0.20969,0,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.00010462,0.25949,0.43593,0,0
1,GO METANEPHROS DEVELOPMENT,3.3132e-05,0.25939,0.26281,0,0
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.2,0.24979,0.17087,0,0
1,GO PROSTATE GLAND MORPHOGENESIS,0.031748,0.2483,0.36871,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.060602,0.2406,0.25313,0,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00025131,0.2387,0.33778,0,0
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0019282,0.23758,0.20325,0,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.042857,0.23632,0.18957,0,0
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.079444,0.23384,0.14037,0,0
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.052669,0.23326,0.19571,0,0
1,GO GLYCINE METABOLIC PROCESS,0.05161,0.23202,0.17426,0,0
1,GO INTERLEUKIN 4 PRODUCTION,0.0021689,0.23194,0.19406,0,0
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0017641,0.2312,0.19034,0,0
1,GO CELL JUNCTION DISASSEMBLY,0.0034322,0.23111,0.23586,0,0
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.0030654,0.22757,0.19869,0,0
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.00010462,0.22718,0.2525,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,9.389e-05,0.22457,0.26724,0,0
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.073629,0.22203,0.10621,0,0
1,GO HINDLIMB MORPHOGENESIS,0.02068,0.22184,0.22142,0,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,0.082489,0.21815,0.20869,0,0
1,GO REGULATION OF VASCULOGENESIS,0.024288,0.2178,0.27745,0,0
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0097392,0.21555,0.24567,0,0
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.00057693,0.21539,0.26003,0,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.22905,0.21439,0.12838,0,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.059411,0.21298,0.31199,0,0
1,GO REGULATION OF BONE MINERALIZATION,0.0040578,0.21161,0.24851,0,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.041093,0.21101,0.25528,0,0
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0024367,0.20979,0.21822,0,0
1,GO LAMELLIPODIUM MORPHOGENESIS,0.42855,0.20847,0.10891,0,0
1,GO REGULATION OF BIOMINERALIZATION,0.00072223,0.2034,0.26383,0,0
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.001986,0.2032,0.28738,0,0
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.084046,0.20239,0.12298,0,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.43367,0.20211,0.10337,0,0
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.027803,0.20173,0.2066,0,0
1,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.065563,0.2003,0.30757,0,0
1,GO BODY MORPHOGENESIS,0.0033369,0.19999,0.18658,0,0
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.035393,0.19912,0.1502,0,0
1,GO NEGATIVE T CELL SELECTION,0.075049,0.19886,0.16188,0,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.34702,0.19806,0.096662,0,0
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00063551,0.19779,0.20405,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0027346,0.19579,0.22081,0,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.2839,0.19544,0.18022,0,0
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.00030804,0.19408,0.21396,0,0
1,GO REGULATION OF FATTY ACID OXIDATION,0.10096,0.19166,0.1053,0,0
1,GO COLLECTING DUCT DEVELOPMENT,0.061812,0.19065,0.14402,0,0
1,GO HEART VALVE FORMATION,0.20309,0.18984,0.18179,0,0
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.050569,0.18975,0.15282,0,0
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.12259,0.1866,0.16404,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.22568,0.18505,0.2483,0,0
1,GO DENDRITIC CELL MIGRATION,0.32077,0.18442,0.11193,0,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.10845,0.18382,0.088074,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.009256,0.18381,0.19625,0,0
1,GO PROTEIN AUTOPROCESSING,0.10654,0.18314,0.10146,0,0
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0057817,0.18278,0.13569,0,0
1,GO ANION HOMEOSTASIS,0.0079323,0.18146,0.15085,0,0
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.12908,0.18128,0.15958,0,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.075049,0.18126,0.1238,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.085627,0.18125,0.3202,0,0
1,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.065563,0.17916,0.18698,0,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.38888,0.17727,0.097565,0,0
1,GO EPITHELIAL CELL DEVELOPMENT,0.0046564,0.17726,0.15774,0,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.30402,0.17648,0.090326,0,0
1,GO MESENCHYMAL CELL PROLIFERATION,0.1028,0.17636,0.1756,0,0
1,GO T CELL DIFFERENTIATION IN THYMUS,0.00014418,0.17575,0.185,0,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.038561,0.17561,0.17266,0,0
1,GO BILE ACID AND BILE SALT TRANSPORT,0.052669,0.17554,0.11629,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.076492,0.17539,0.17678,0,0
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.019283,0.17437,0.1448,0,0
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.17099,0.17398,0.12401,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,0.084046,0.17334,0.21648,0,0
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0019282,0.17314,0.29718,0,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.33812,0.1728,0.10504,0,0
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.16559,0.17144,0.1063,0,0
1,GO REGULATION OF CELLULAR RESPIRATION,0.076492,0.17109,0.11733,0,0
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.05824,0.17059,0.17433,0,0
1,GO RESPONSE TO UV C,0.0075304,0.17038,0.20641,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.02268,0.17033,0.13997,0,0
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.014486,0.16862,0.23073,0,0
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.21579,0.16839,0.095981,0,0
1,GO VACUOLAR TRANSPORT,0.0012662,0.1682,0.14035,0,0
1,GO INACTIVATION OF MAPK ACTIVITY,0.043763,0.16747,0.22211,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.29184,0.16732,0.2317,0,0
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.13583,0.16694,0.14788,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.068167,0.16573,0.19582,0,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.36064,0.16403,0.060289,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.033166,0.16347,0.1506,0,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.082489,0.16259,0.13798,0,0
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00098941,0.16223,0.20482,0,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.2,0.1622,0.073408,0,0
1,GO ETHER METABOLIC PROCESS,0.049546,0.1593,0.15714,0,0
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.063042,0.15894,0.24674,0,0
1,GO REGULATION OF GTP BINDING,0.13355,0.15858,0.1503,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.50337,0.15844,0.063769,0,0
1,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.58456,0.15828,0.045592,0,0
1,GO TRICARBOXYLIC ACID CYCLE,0.20621,0.15798,0.052561,0,0
1,GO NEUROBLAST DIVISION,0.23589,0.15779,0.12247,0,0
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.012508,0.15712,0.23929,0,0
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.29586,0.15701,0.21639,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.064293,0.15612,0.14099,0,0
1,GO DENDRITIC SPINE MAINTENANCE,0.040234,0.15602,0.18668,0,0
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0011549,0.156,0.15295,0,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.049546,0.15579,0.16194,0,0
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0085714,0.15544,0.14571,0,0
1,GO RENAL VESICLE DEVELOPMENT,0.25363,0.15457,0.10873,0,0
1,GO OUTFLOW TRACT MORPHOGENESIS,0.001872,0.15302,0.28042,0,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.007729,0.15302,0.15348,0,0
1,GO ACTIN FILAMENT NETWORK FORMATION,0.73628,0.1528,-0.014942,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.15015,0.15179,0.12175,0,0
1,GO STEM CELL DIVISION,0.082489,0.15108,0.17158,0,0
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.22905,0.151,0.13864,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00019753,0.15048,0.23452,0,0
1,GO INTERMEMBRANE LIPID TRANSFER,0.0027346,0.15047,0.15595,0,0
1,GO LATERAL VENTRICLE DEVELOPMENT,0.10845,0.15036,0.16085,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.038561,0.15027,0.19261,0,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.20309,0.15019,0.17505,0,0
1,GO RESPONSE TO VITAMIN,0.036948,0.14949,0.16878,0,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.05824,0.1479,0.10101,0,0
1,GO NUCLEOTIDE SALVAGE,0.24643,0.14775,0.19971,0,0
1,GO MALE GENITALIA DEVELOPMENT,0.29184,0.14772,0.05004,0,0
1,GO REGULATION OF GONAD DEVELOPMENT,0.54903,0.14709,0.005719,0,0
1,GO TUBE FORMATION,0.0071468,0.147,0.15003,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.11235,0.14665,0.21195,0,0
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0069616,0.1451,0.17432,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.095625,0.14507,0.14272,0,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.59664,0.1448,0.080716,0,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,0.25363,0.14383,0.10617,0,0
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.11636,0.1435,0.12336,0,0
1,GO CORPUS CALLOSUM DEVELOPMENT,0.088862,0.14349,0.13821,0,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.070855,0.14319,0.064786,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.8303,0.14273,-0.0048016,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.16294,0.14268,0.1258,0,0
1,GO EPITHELIAL TUBE FORMATION,0.023741,0.14213,0.13709,0,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.59059,0.14211,0.078013,0,0
1,GO STEROL HOMEOSTASIS,0.055956,0.1415,0.082803,0,0
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0097392,0.14105,0.21879,0,0
1,GO REGULATION OF HAIR CYCLE,0.072231,0.14064,0.21238,0,0
1,GO CELL PROLIFERATION IN HINDBRAIN,0.02166,0.14055,0.1838,0,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.32077,0.14048,0.081656,0,0
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.010245,0.13955,0.15817,0,0
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.0085714,0.13892,0.14136,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.32938,0.13885,0.10118,0,0
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.11235,0.13876,0.11992,0,0
1,GO POSITIVE REGULATION OF WOUND HEALING,0.060602,0.13831,0.19938,0,0
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0025817,0.13779,0.21276,0,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.20309,0.13725,0.064349,0,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.14526,0.1372,0.12376,0,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.20937,0.13695,0.083566,0,0
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.2839,0.13688,0.089277,0,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.71006,0.13668,0.016722,0,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.12473,0.13667,0.11104,0,0
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.00041602,0.13666,0.12392,0,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.24288,0.13591,0.042726,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.12049,0.13524,0.14247,0,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.077957,0.13467,0.1131,0,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.19095,0.13463,0.091416,0,0
1,GO GENITALIA DEVELOPMENT,0.0094949,0.1344,0.11426,0,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.017137,0.13436,0.27215,0,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.092194,0.13395,0.15587,0,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.13355,0.13274,0.08458,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.082489,0.1327,0.12174,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.068167,0.13238,0.13933,0,0
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.092194,0.13225,0.11941,0,0
1,GO MANGANESE ION TRANSPORT,0.099158,0.132,0.12715,0,0
1,GO ACTIVATION OF JNKK ACTIVITY,0.1028,0.13189,0.10211,0,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.11434,0.13162,0.22761,0,0
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.18508,0.13128,0.096384,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0024367,0.12995,0.13906,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.19095,0.12965,0.10678,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.32077,0.12957,0.14604,0,0
1,GO LIPID DIGESTION,0.33373,0.12938,0.037878,0,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0099891,0.12908,0.12939,0,0
1,GO EMBRYONIC MORPHOGENESIS,0.0010206,0.12904,0.13878,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.19095,0.12852,0.11784,0,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.49227,0.12835,0.051051,0,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.26847,0.12801,0.079064,0,0
1,GO ANOIKIS,0.16294,0.12786,0.11931,0,0
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.053746,0.1273,0.10162,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.35153,0.12726,0.048122,0,0
1,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.059411,0.12725,0.13289,0,0
1,GO CELL PROLIFERATION IN FOREBRAIN,0.41341,0.12702,0.040158,0,0
1,GO SKIN DEVELOPMENT,0.059411,0.12676,0.17111,0,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0087944,0.12666,0.19571,0,0
1,GO TERPENOID METABOLIC PROCESS,0.0695,0.12653,0.12853,0,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.21256,0.12632,0.12175,0,0
1,GO REGULATION OF TISSUE REMODELING,0.061812,0.12632,0.081792,0,0
1,GO INTERLEUKIN 6 PRODUCTION,0.11841,0.12623,0.10503,0,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.54321,0.12575,0.0454,0,0
1,GO GLYCOSIDE METABOLIC PROCESS,0.43883,0.12568,0.071585,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.064293,0.12548,0.19331,0,0
1,GO RESPONSE TO PROSTAGLANDIN E,0.079444,0.12529,0.098866,0,0
1,GO REVERSE CHOLESTEROL TRANSPORT,0.26098,0.12519,0.07704,0,0
1,GO INTRACELLULAR STEROL TRANSPORT,0.19393,0.12487,0.11193,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.066855,0.12468,0.12184,0,0
1,GO ENGULFMENT OF APOPTOTIC CELL,0.12473,0.12443,0.089701,0,0
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.082489,0.12402,0.21579,0,0
1,GO PIRNA METABOLIC PROCESS,0.38408,0.12242,0.134,0,0
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.064293,0.12176,0.11156,0,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.16828,0.12166,0.058738,0,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.024846,0.12151,0.10387,0,0
1,GO PROTEIN KINASE C SIGNALING,0.32077,0.12144,0.043941,0,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.030383,0.12141,0.15674,0,0
1,GO CELLULAR RESPONSE TO KETONE,0.073629,0.12124,0.09965,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16032,0.12098,0.19075,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.46512,0.12093,0.039931,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0053338,0.12085,0.18101,0,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.007729,0.12057,0.16699,0,0
1,GO REGULATION OF HISTONE DEACETYLATION,0.061812,0.12055,0.10692,0,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.16032,0.12055,0.058756,0,0
1,GO RESPONSE TO ESTRADIOL,0.019283,0.12009,0.12109,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.44924,0.11917,0.12615,0,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.61497,0.11864,0.033535,0,0
1,GO AORTA MORPHOGENESIS,0.4978,0.11834,0.15967,0,0
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.20309,0.11784,0.076869,0,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.17934,0.11669,0.097427,0,0
1,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.52025,0.11668,-0.14507,0,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.049546,0.11647,0.11536,0,0
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.075049,0.11632,0.091392,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.12689,0.11596,0.092086,0,0
1,GO NEURON PROJECTION REGENERATION,0.10654,0.11578,0.08534,0,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,0.14526,0.11529,0.11285,0,0
1,GO SPHINGOID METABOLIC PROCESS,0.10654,0.11507,0.066982,0,0
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.14526,0.11487,0.16268,0,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.0085714,0.11468,0.17988,0,0
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.21256,0.11426,0.13055,0,0
1,GO UBIQUINONE METABOLIC PROCESS,0.2,0.1142,0.059234,0,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.018398,0.11411,0.28258,0,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.65234,0.11386,0.004905,0,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.40349,0.11376,0.013626,0,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.036948,0.11354,0.10852,0,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.077957,0.11315,0.10764,0,0
1,GO RNA INTERFERENCE,0.46512,0.11313,0.047271,0,0
1,GO POSITIVE REGULATION OF OSSIFICATION,0.011904,0.11186,0.19251,0,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.061812,0.11154,0.14307,0,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.088862,0.11149,0.055876,0,0
1,GO CELL CELL ADHESION,0.11039,0.11135,0.068589,0,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,0.1313,0.11111,0.12452,0,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.19393,0.11109,0.050922,0,0
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.22905,0.11101,0.077659,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.099158,0.11088,0.13304,0,0
1,GO MUSCLE FIBER DEVELOPMENT,0.13355,0.11048,0.068602,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.22568,0.11029,0.059516,0,0
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.055956,0.11018,0.065263,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.13355,0.11002,0.060761,0,0
1,GO CELLULAR PIGMENTATION,0.04854,0.10983,0.08577,0,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.1028,0.10981,0.11148,0,0
1,GO RESPONSE TO HYDROPEROXIDE,0.4978,0.10974,0.1154,0,0
1,GO LEUKOCYTE CHEMOTAXIS,0.049546,0.10957,0.14125,0,0
1,GO PHOSPHOLIPID EFFLUX,0.28785,0.10956,0.1816,0,0
1,GO DEFINITIVE HEMOPOIESIS,0.19695,0.10935,0.089966,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.05824,0.1093,0.091277,0,0
1,GO INTRACELLULAR LIPID TRANSPORT,0.050569,0.10921,0.13309,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.36991,0.10889,0.072655,0,0
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.27611,0.1087,0.081154,0,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.22235,0.1083,0.1671,0,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.061812,0.1082,0.12039,0,0
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.40349,0.10812,0.053651,0,0
1,GO L PHENYLALANINE METABOLIC PROCESS,0.40349,0.10809,0.032357,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.32938,0.10794,0.051129,0,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.079444,0.10777,0.094039,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.30815,0.10767,0.026157,0,0
1,GO REGULATION OF MAST CELL ACTIVATION,0.19695,0.10746,0.10101,0,0
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.05824,0.1074,0.13026,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.057089,0.10739,0.13876,0,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.084046,0.1071,0.082793,0,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.29992,0.10708,0.067262,0,0
1,GO MONOSACCHARIDE CATABOLIC PROCESS,0.25363,0.10705,0.049309,0,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.21579,0.10704,0.12923,0,0
1,GO KERATINOCYTE DIFFERENTIATION,0.12473,0.10696,0.15493,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.56666,0.10694,0.029354,0,0
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0030654,0.10678,0.10589,0,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.39371,0.10676,0.058583,0,0
1,GO RESPONSE TO STEROL,0.093897,0.10639,0.11093,0,0
1,GO ER NUCLEUS SIGNALING PATHWAY,0.39371,0.10603,0.037236,0,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.12908,0.10589,0.10825,0,0
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0695,0.10564,0.056087,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.080955,0.10553,0.10153,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.033894,0.10536,0.21569,0,0
1,GO ODONTOGENESIS,0.0034322,0.10518,0.23103,0,0
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.1313,0.10505,0.087972,0,0
1,GO LEFT RIGHT PATTERN FORMATION,0.0695,0.10503,0.18779,0,0
1,GO NAD METABOLIC PROCESS,0.26847,0.1047,0.096295,0,0
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.10465,0.10468,0.082747,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.10096,0.10463,0.072577,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.41842,0.10419,0.06888,0,0
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.12259,0.10415,0.11286,0,0
1,GO GLIAL CELL DEVELOPMENT,0.11039,0.10411,0.062324,0,0
1,GO OVULATION CYCLE,0.018398,0.10379,0.14746,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.26098,0.10379,0.14209,0,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.82348,0.10298,-0.012544,0,0
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0695,0.10237,0.15498,0,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,0.054842,0.10225,0.095761,0,0
1,GO B CELL DIFFERENTIATION,0.053746,0.1017,0.099358,0,0
1,GO REGULATION OF TELOMERASE ACTIVITY,0.054842,0.10153,0.093355,0,0
1,GO THIOESTER METABOLIC PROCESS,0.10845,0.10143,0.071512,0,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.14048,0.10073,0.12697,0,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.029719,0.10063,0.087048,0,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,0.24288,0.1006,0.12002,0,0
1,GO STEROID ESTERIFICATION,0.12473,0.10046,0.14593,0,0
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00014418,0.099937,0.13449,0,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.0079323,0.099608,0.13682,0,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.26098,0.099449,0.087533,0,0
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.004408,0.098904,0.19827,0,0
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.39858,0.098648,0.043697,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.11636,0.098508,0.090675,0,0
1,GO APPENDAGE DEVELOPMENT,0.18219,0.098468,0.098413,0,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.023741,0.098393,0.13198,0,0
1,GO POSITIVE REGULATION OF MYELINATION,0.14769,0.097841,0.11907,0,0
1,GO COCHLEA MORPHOGENESIS,0.78289,0.097431,-0.027526,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.55487,0.097396,0.052923,0,0
1,GO NEPHRON DEVELOPMENT,0.010773,0.097375,0.18502,0,0
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.57857,0.096932,0.090184,0,0
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.097379,0.096653,0.075055,0,0
1,GO CRISTAE FORMATION,0.11235,0.096536,0.138,0,0
1,GO ATRIAL SEPTUM DEVELOPMENT,0.50896,0.096458,0.060268,0,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.027803,0.095801,0.088413,0,0
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.47049,0.095471,0.077401,0,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.090515,0.095356,0.078223,0,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.27227,0.095288,0.12371,0,0
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.15264,0.095138,0.060614,0,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.11636,0.094865,0.090946,0,0
1,GO ADHERENS JUNCTION ASSEMBLY,0.23589,0.094765,0.089585,0,0
1,GO ACTIVATION OF GTPASE ACTIVITY,0.095625,0.094598,0.081825,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.27999,0.094108,0.057916,0,0
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.22905,0.093846,0.053214,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.059411,0.093588,0.098996,0,0
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.33373,0.093484,0.046891,0,0
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.10096,0.093473,0.052545,0,0
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.18508,0.092629,0.12756,0,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,0.58456,0.092194,0.032941,0,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.19695,0.092133,0.089332,0,0
1,GO INTESTINAL LIPID ABSORPTION,0.18508,0.092128,0.092879,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.56075,0.092087,0.064426,0,0
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.15517,0.091727,0.046691,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.2839,0.091651,0.05208,0,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.05161,0.0916,0.094081,0,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.27227,0.091529,0.026913,0,0
1,GO REGULATION OF B CELL DIFFERENTIATION,0.85768,0.091295,0.028119,0,0
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.13583,0.09109,0.14025,0,0
1,GO CELLULAR RESPONSE TO PH,0.27999,0.09083,0.071733,0,0
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0017641,0.090791,0.11587,0,0
1,GO NEGATIVE REGULATION OF GROWTH,0.025994,0.090637,0.079313,0,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.20621,0.090581,0.17346,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.42855,0.090556,0.08744,0,0
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.58456,0.090535,0.14367,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.05161,0.090494,0.08378,0,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.22568,0.090187,0.11877,0,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.12689,0.090139,0.06477,0,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.22235,0.090136,0.063425,0,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.072231,0.090014,0.12287,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.073629,0.089551,0.098062,0,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.015953,0.089295,0.094337,0,0
1,GO RESPONSE TO ALCOHOL,0.37932,0.089243,0.036981,0,0
1,GO B CELL PROLIFERATION,0.50896,0.088547,0.017531,0,0
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.34702,0.088502,0.11922,0,0
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.34256,0.088477,0.032058,0,0
1,GO MYELIN MAINTENANCE,0.50896,0.088396,0.064599,0,0
1,GO RNA STABILIZATION,0.075049,0.088289,0.092828,0,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.11434,0.088189,0.067591,0,0
1,GO OOCYTE MATURATION,0.29184,0.088046,0.043066,0,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.12259,0.087945,0.068664,0,0
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.03939,0.087804,0.10545,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.40843,0.087698,0.025322,0,0
1,GO CELL CYCLE ARREST,0.0062634,0.087257,0.078992,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.22905,0.086625,0.074532,0,0
1,GO MUSCLE ATROPHY,0.25001,0.086402,0.13436,0,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.057089,0.086336,0.11282,0,0
1,GO B CELL APOPTOTIC PROCESS,0.64605,0.086093,0.010272,0,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.26098,0.085987,0.071986,0,0
1,GO INTERLEUKIN 12 PRODUCTION,0.12908,0.085532,0.10112,0,0
1,GO MALE SEX DIFFERENTIATION,0.036948,0.0849,0.11101,0,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.49227,0.084856,0.015339,0,0
1,GO REGULATION OF RUFFLE ASSEMBLY,0.17653,0.084514,0.067097,0,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.099158,0.084331,0.099312,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.27999,0.084186,0.10917,0,0
1,GO STEROL METABOLIC PROCESS,0.26847,0.084099,0.026502,0,0
1,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.95466,0.083729,-0.03184,0,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.27227,0.083694,0.068511,0,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.11235,0.083544,0.13632,0,0
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.059411,0.083497,0.1342,0,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.58456,0.083468,0.048272,0,0
1,GO POLYOL BIOSYNTHETIC PROCESS,0.0695,0.083423,0.068998,0,0
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.12049,0.083418,0.098505,0,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.4598,0.083294,0.065245,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.17099,0.082895,0.069441,0,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.41842,0.082734,0.058726,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.090515,0.082518,0.065792,0,0
1,GO RNA EXPORT FROM NUCLEUS,0.025414,0.082505,0.099336,0,0
1,GO GOLGI RIBBON FORMATION,0.17653,0.082104,0.11963,0,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.50337,0.082011,0.052454,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.15773,0.081955,0.073743,0,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.40843,0.081901,0.036524,0,0
1,GO OSTEOBLAST PROLIFERATION,0.12473,0.081862,0.1824,0,0
1,GO LYMPHOCYTE HOMEOSTASIS,0.30815,0.081529,0.031207,0,0
1,GO KETONE CATABOLIC PROCESS,0.29992,0.08124,0.12773,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.18508,0.081199,0.094618,0,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.59059,0.08096,0.037763,0,0
1,GO RESPONSE TO WATER,0.5726,0.080941,0.073112,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.27999,0.080817,0.071492,0,0
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.042857,0.080795,0.074153,0,0
1,GO NEGATIVE REGULATION OF SECRETION,0.061812,0.080785,0.076314,0,0
1,GO CALCINEURIN MEDIATED SIGNALING,0.11235,0.080698,0.079166,0,0
1,GO RESPONSE TO ATP,0.031748,0.080477,0.098945,0,0
1,GO STEROID METABOLIC PROCESS,0.14048,0.080366,0.03721,0,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.67776,0.080078,0.0098386,0,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.05161,0.08001,0.071971,0,0
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.093897,0.07984,0.10494,0,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.89215,0.079714,-0.088275,0,0
1,GO LACTATE METABOLIC PROCESS,0.15015,0.079638,0.089705,0,0
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.055956,0.079586,0.12463,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.69061,0.079166,-0.0098249,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.15264,0.07911,0.10185,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.40349,0.078721,0.074405,0,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.23245,0.078466,0.083159,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.088862,0.078375,0.11806,0,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.27999,0.07802,0.12559,0,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.11235,0.077925,0.0657,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.17374,0.077882,0.099682,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.57857,0.077695,0.011906,0,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.99651,0.077571,-0.038959,0,0
1,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.42347,0.077536,0.054533,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.36064,0.077396,0.062642,0,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.055956,0.07722,0.05398,0,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.29184,0.076827,0.035678,0,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,0.26098,0.07679,0.032564,0,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.16294,0.076717,0.08166,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.49227,0.076624,0.026517,0,0
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.90599,0.076619,-0.011208,0,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.36064,0.076511,0.060225,0,0
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.92682,0.076434,0.078873,0,0
1,GO TUMOR NECROSIS FACTOR SECRETION,0.29586,0.076232,0.10858,0,0
1,GO SULFATION,0.19695,0.076201,0.1424,0,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.40843,0.076024,0.18506,0,0
1,GO NEURAL CREST FORMATION,1,0.075967,0.028289,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.059411,0.075747,0.07447,0,0
1,GO RESPONSE TO MUSCLE INACTIVITY,0.14769,0.075588,0.13244,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.19695,0.0755,0.064946,0,0
1,GO STEM CELL PROLIFERATION,0.59059,0.075386,0.0052359,0,0
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.12908,0.075222,0.070092,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.052669,0.075149,0.1892,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.16559,0.075131,0.10029,0,0
1,GO PHOSPHOLIPID HOMEOSTASIS,0.21579,0.074686,0.12967,0,0
1,GO BLASTODERM SEGMENTATION,0.29184,0.074614,0.14358,0,0
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.059411,0.074607,0.061885,0,0
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.001986,0.07455,0.091324,0,0
1,GO PROTEIN K11 LINKED UBIQUITINATION,0.11434,0.074344,0.08595,0,0
1,GO GROWTH,0.034637,0.074265,0.065317,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.26847,0.0741,0.078338,0,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.099158,0.073716,0.050607,0,0
1,GO EMBRYONIC HEMOPOIESIS,0.96163,0.073653,-0.0067416,0,0
1,GO RRNA CATABOLIC PROCESS,0.50337,0.073622,0.041535,0,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.39371,0.073401,0.061003,0,0
1,GO ADHESION OF SYMBIONT TO HOST,0.1028,0.073317,0.21212,0,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.040234,0.073237,0.078011,0,0
1,GO LOCOMOTOR RHYTHM,0.38888,0.07317,0.079327,0,0
1,GO RESPIRATORY BURST,0.46512,0.072495,0.030644,0,0
1,GO NOTCH RECEPTOR PROCESSING,0.23937,0.072483,0.1361,0,0
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.04854,0.072454,0.080875,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.18219,0.072351,0.083828,0,0
1,GO HEXOSE CATABOLIC PROCESS,0.3746,0.07222,0.03216,0,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.22235,0.072214,0.14374,0,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.072231,0.072131,0.047035,0,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.34256,0.071956,0.096622,0,0
1,GO PEPTIDYL HISTIDINE MODIFICATION,0.17934,0.071894,0.092514,0,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.20309,0.071716,0.087305,0,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.26471,0.071313,0.082468,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.36526,0.071277,0.15541,0,0
1,GO NEUTROPHIL CHEMOTAXIS,0.077957,0.070917,0.17854,0,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.053746,0.07084,0.089334,0,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.21905,0.070765,0.11208,0,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.097379,0.07074,0.080416,0,0
1,GO EMBRYO DEVELOPMENT,0.015953,0.070658,0.088129,0,0
1,GO CYTOKINE SECRETION,0.32506,0.070564,0.061338,0,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.71658,0.070555,0.081421,0,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.066855,0.070462,0.11424,0,0
1,GO MYELOID CELL DEVELOPMENT,0.19393,0.069954,0.069643,0,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.1028,0.069828,0.048078,0,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.91987,0.069811,-0.013908,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.96163,0.069775,-0.030423,0,0
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.10845,0.06976,0.052742,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.24643,0.069678,0.14793,0,0
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.30402,0.06956,0.13761,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.15517,0.069523,0.071865,0,0
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.72969,0.069501,-0.002996,0,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.053746,0.069099,0.14885,0,0
1,GO NEGATIVE CHEMOTAXIS,0.13583,0.068751,0.12632,0,0
1,GO SEQUESTERING OF CALCIUM ION,0.20309,0.068582,0.061577,0,0
1,GO RUFFLE ASSEMBLY,0.10465,0.068166,0.085894,0,0
1,GO RESPONSE TO PROSTAGLANDIN,0.13583,0.067957,0.15714,0,0
1,GO CELL PROJECTION ASSEMBLY,0.1028,0.067938,0.059116,0,0
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.023205,0.067846,0.12261,0,0
1,GO APPENDAGE MORPHOGENESIS,0.36064,0.067816,0.070141,0,0
1,GO MRNA EXPORT FROM NUCLEUS,0.073629,0.067562,0.073399,0,0
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.87144,0.067532,0.0014144,0,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,0.52025,0.067391,0.048109,0,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,0.18508,0.067372,0.067585,0,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.24643,0.067345,0.095796,0,0
1,GO HISTONE H3 K27 METHYLATION,0.33812,0.067274,0.047425,0,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.24643,0.067239,0.073509,0,0
1,GO URONIC ACID METABOLIC PROCESS,0.31232,0.066944,0.029162,0,0
1,GO REGULATION OF HISTONE UBIQUITINATION,0.055956,0.06676,0.10977,0,0
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.4598,0.06673,0.042404,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.31653,0.066711,0.053545,0,0
1,GO RESPONSE TO TOXIC SUBSTANCE,0.42347,0.066572,0.029481,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.11841,0.066535,0.067795,0,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.37932,0.066365,0.011623,0,0
1,GO NADH METABOLIC PROCESS,0.27227,0.066191,0.082794,0,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.31232,0.066086,0.067142,0,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.89907,0.065854,-0.018393,0,0
1,GO PLASMA MEMBRANE FUSION,0.17374,0.065842,0.13824,0,0
1,GO SNRNA TRANSCRIPTION,0.0067808,0.065664,0.093449,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.11636,0.065657,0.092568,0,0
1,GO RECEPTOR INTERNALIZATION,0.12473,0.065623,0.069289,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.050569,0.065535,0.070285,0,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.17099,0.065479,0.051917,0,0
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.4978,0.065436,0.024584,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.35153,0.065368,0.056139,0,0
1,GO SMOOTH MUSCLE CONTRACTION,0.34702,0.065002,0.052403,0,0
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.77618,0.064615,0.011473,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.34702,0.064383,0.069567,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.41341,0.064298,0.03406,0,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.35153,0.064231,0.047297,0,0
1,GO THYROID GLAND DEVELOPMENT,0.47049,0.063999,0.072594,0,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.24643,0.063819,0.046435,0,0
1,GO GLYCEROLIPID METABOLIC PROCESS,0.076492,0.063351,0.041462,0,0
1,GO POSITIVE REGULATION OF NEURON DEATH,0.32077,0.063324,0.041733,0,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.38888,0.063322,0.10874,0,0
1,GO TISSUE HOMEOSTASIS,0.10465,0.062816,0.056265,0,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.76948,0.062545,-0.019612,0,0
1,GO RESPIRATORY SYSTEM PROCESS,0.69061,0.062509,0.020597,0,0
1,GO APICAL JUNCTION ASSEMBLY,0.20937,0.062473,0.10785,0,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.19695,0.06236,0.071765,0,0
1,GO MODIFIED AMINO ACID TRANSPORT,0.053746,0.062293,0.11765,0,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.77618,0.062245,0.0023675,0,0
1,GO RESPONSE TO CORTICOSTERONE,0.11235,0.061384,0.20629,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.60272,0.061298,0.042358,0,0
1,GO BONE CELL DEVELOPMENT,0.47049,0.061201,0.047885,0,0
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.13355,0.061138,0.054122,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.43367,0.061072,0.037175,0,0
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.054842,0.060966,0.07818,0,0
1,GO RESPONSE TO AMYLOID BETA,0.34256,0.060803,0.11296,0,0
1,GO REPRODUCTION,0.029719,0.06079,0.055817,0,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.4545,0.060584,0.1036,0,0
1,GO POSITIVE REGULATION OF DNA REPAIR,0.15264,0.060476,0.05628,0,0
1,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.28785,0.060002,0.10827,0,0
1,GO MEMBRANE FUSION,0.26098,0.059833,0.035347,0,0
1,GO PANCREATIC JUICE SECRETION,0.72969,0.05948,0.039147,0,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.15773,0.059461,0.07885,0,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.20937,0.059378,0.030983,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.32506,0.05929,0.10919,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,0.33812,0.058957,0.042571,0,0
1,GO REGULATION OF TELOMERE CAPPING,0.71006,0.058786,0.0088064,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.34702,0.058765,0.069687,0,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.60883,0.058736,0.099786,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.16559,0.058616,0.068188,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.082489,0.05853,0.11853,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.11039,0.058469,0.048998,0,0
1,GO INCLUSION BODY ASSEMBLY,0.66501,0.058464,-0.097322,0,0
1,GO PROTEIN AUTOUBIQUITINATION,0.34702,0.058319,0.029106,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.30815,0.058283,0.053853,0,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0014738,0.05801,0.087935,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.40843,0.057866,0.079099,0,0
1,GO REGULATION OF PROTEIN TARGETING,0.32077,0.057624,0.037778,0,0
1,GO EPIDERMIS DEVELOPMENT,0.25001,0.057582,0.11978,0,0
1,GO ENSHEATHMENT OF NEURONS,0.20937,0.057383,0.049684,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.71006,0.057363,0.019302,0,0
1,GO MICROVILLUS ORGANIZATION,0.41341,0.057264,-0.10114,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.088862,0.056938,0.043536,0,0
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.50896,0.056114,0.14186,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.25363,0.056009,0.061231,0,0
1,GO MUSCLE SYSTEM PROCESS,0.22568,0.055954,0.048029,0,0
1,GO DNA REPLICATION INITIATION,0.36526,0.055904,0.031784,0,0
1,GO POLYOL METABOLIC PROCESS,0.0695,0.05581,0.053129,0,0
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.19393,0.055701,0.052308,0,0
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0017641,0.055678,0.069428,0,0
1,GO EXECUTION PHASE OF APOPTOSIS,0.0695,0.055558,0.05809,0,0
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.076492,0.055361,0.071751,0,0
1,GO AMMONIUM TRANSPORT,0.059411,0.055347,0.1655,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.53167,0.055172,0.057071,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.050569,0.055151,0.053682,0,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.98953,0.055141,-0.021058,0,0
1,GO SPECIFICATION OF SYMMETRY,0.068167,0.055086,0.067615,0,0
1,GO POSITIVE REGULATION OF JNK CASCADE,0.17099,0.055038,0.047551,0,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.27999,0.054821,0.048965,0,0
1,GO CHLORIDE ION HOMEOSTASIS,0.4978,0.054489,0.039101,0,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.1313,0.054374,0.058209,0,0
1,GO MITOTIC CHROMOSOME CONDENSATION,0.91987,0.054236,0.010746,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.44924,0.054103,0.098152,0,0
1,GO DNA CONFORMATION CHANGE,0.16032,0.053859,0.054513,0,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.15015,0.053713,0.057612,0,0
1,GO REGULATION OF CELL SIZE,0.29184,0.053632,0.030636,0,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.31653,0.053629,0.040508,0,0
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.39371,0.05351,0.034448,0,0
1,GO ERYTHROCYTE DEVELOPMENT,0.090515,0.053448,0.10682,0,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.10465,0.053363,0.12038,0,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.50896,0.053159,0.072749,0,0
1,GO MICROTUBULE ANCHORING,0.48131,0.053065,0.03419,0,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.11841,0.053025,0.11395,0,0
1,GO MUSCLE TISSUE DEVELOPMENT,0.16559,0.052983,0.079773,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,0.15517,0.052901,0.079285,0,0
1,GO T HELPER CELL LINEAGE COMMITMENT,0.088862,0.052815,0.12157,0,0
1,GO GOLGI LOCALIZATION,0.9686,0.052534,0.0023713,0,0
1,GO HOMEOSTATIC PROCESS,0.18219,0.052336,0.025792,0,0
1,GO RESPONSE TO MECHANICAL STIMULUS,0.22568,0.052079,0.079703,0,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.91987,0.051821,0.013205,0,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.32506,0.051594,0.082465,0,0
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.42855,0.051288,0.027564,0,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,0.16828,0.051219,0.059665,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.80312,0.051212,-0.011,0,0
1,GO DNA REPLICATION CHECKPOINT,0.56666,0.051173,0.027467,0,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.39858,0.051093,0.072101,0,0
1,GO REGULATION OF PROTEIN DEACETYLATION,0.74288,0.05094,0.0062787,0,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.88523,0.05051,-0.0018625,0,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.084046,0.050509,0.059315,0,0
1,GO RESPONSE TO INSULIN,0.2,0.05024,0.02772,0,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.19393,0.050224,0.051613,0,0
1,GO AMP METABOLIC PROCESS,0.36064,0.049977,0.14997,0,0
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.29184,0.049963,0.095788,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.61497,0.049928,0.017027,0,0
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.17374,0.049915,0.082341,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.64605,0.049882,0.040752,0,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.38888,0.049654,0.019071,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.65234,0.049636,0.024977,0,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,0.27999,0.049466,0.038317,0,0
1,GO SKIN EPIDERMIS DEVELOPMENT,0.23589,0.049224,0.15923,0,0
1,GO RESPONSE TO ACTIVITY,0.27227,0.048946,0.034714,0,0
1,GO ICOSANOID METABOLIC PROCESS,0.22568,0.048926,0.074619,0,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.59664,0.048905,0.029001,0,0
1,GO REGULATION OF B CELL PROLIFERATION,0.74288,0.04885,-0.0062404,0,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.33373,0.048783,0.071047,0,0
1,GO RESPONSE TO STEROL DEPLETION,0.89215,0.048757,-0.052064,0,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.43883,0.048339,0.044287,0,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.11235,0.047968,0.035459,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.47588,0.047909,0.026854,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.80312,0.047893,-0.0084869,0,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.25729,0.047863,0.10735,0,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.15773,0.047789,0.038643,0,0
1,GO PURINE NUCLEOTIDE TRANSPORT,0.54903,0.047686,0.021903,0,0
1,GO PROTEIN DESTABILIZATION,0.70355,0.047535,0.012495,0,0
1,GO VITAMIN METABOLIC PROCESS,0.11636,0.047375,0.069031,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.26098,0.047302,0.045157,0,0
1,GO MRNA PROCESSING,0.33812,0.047,0.037377,0,0
1,GO RESPONSE TO COPPER ION,0.75615,0.04697,0.041769,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.48678,0.046833,-0.1748,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.52594,0.046496,0.011217,0,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.079444,0.046495,0.051482,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.69061,0.046457,0.012421,0,0
1,GO SECRETION,0.061812,0.045892,0.059321,0,0
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.20309,0.045881,0.13829,0,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.26098,0.045873,0.06584,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.60272,0.045846,0.022964,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.38888,0.045747,0.059836,0,0
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.86455,0.045621,0.0010332,0,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.55487,0.045615,0.033241,0,0
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.19095,0.045524,0.070334,0,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.55487,0.045376,0.062571,0,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.83713,0.045368,0.031561,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.14769,0.04529,0.035578,0,0
1,GO TRANSFERRIN TRANSPORT,0.50337,0.045175,0.016969,0,0
1,GO REGULATION OF GROWTH,0.061812,0.045143,0.053457,0,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.31653,0.044665,0.048255,0,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.44402,0.04459,0.018215,0,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.87833,0.044565,-0.031435,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.61497,0.04452,-0.0030979,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.4598,0.044428,0.086841,0,0
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.82348,0.044402,0.0028601,0,0
1,GO RESPONSE TO ZINC ION,0.46512,0.044298,0.044683,0,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.43883,0.044005,0.042218,0,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.21256,0.043801,0.046242,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.50896,0.043794,-0.075073,0,0
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.049546,0.043743,0.09423,0,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.17653,0.043689,0.12639,0,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.49227,0.043536,0.037242,0,0
1,GO RESPONSE TO AXON INJURY,0.74288,0.043292,0.00079299,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION,0.22568,0.043292,0.082639,0,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,0.5726,0.04322,0.076528,0,0
1,GO BRONCHUS DEVELOPMENT,0.70355,0.043216,0.034853,0,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.31232,0.043172,0.02214,0,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.32938,0.043059,0.036895,0,0
1,GO CELLULAR ION HOMEOSTASIS,0.30815,0.042912,0.02975,0,0
1,GO ONE CARBON METABOLIC PROCESS,0.38888,0.042884,0.043942,0,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.43883,0.042792,0.027837,0,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.34256,0.042276,0.027431,0,0
1,GO METHIONINE METABOLIC PROCESS,0.72313,0.042082,-0.02501,0,0
1,GO RESPONSE TO NITROGEN COMPOUND,0.070855,0.042053,0.055653,0,0
1,GO PROTEIN O LINKED GLYCOSYLATION,0.89907,0.041933,-0.031235,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.36526,0.041797,0.10808,0,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.91293,0.041691,-0.010636,0,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.15264,0.041673,0.079665,0,0
1,GO MITOCHONDRIAL TRANSPORT,0.16559,0.041663,0.038214,0,0
1,GO BASE EXCISION REPAIR,0.12259,0.041643,0.08145,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION,0.14769,0.041521,0.037564,0,0
1,GO NAD BIOSYNTHETIC PROCESS,0.72313,0.041251,0.050228,0,0
1,GO REGULATION OF EXCRETION,0.78289,0.04108,-0.028927,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.60883,0.041054,0.019537,0,0
1,GO PHOTOPERIODISM,0.43367,0.041053,0.01525,0,0
1,GO PROTEIN POLYMERIZATION,0.188,0.040933,0.03949,0,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,0.20937,0.040889,0.075361,0,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.29184,0.040858,0.02584,0,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.49227,0.040126,0.046742,0,0
1,GO RECOMBINATIONAL REPAIR,0.65234,0.040048,0.041696,0,0
1,GO REGULATION OF GLUCONEOGENESIS,0.39371,0.039916,0.015964,0,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.20621,0.039851,0.17571,0,0
1,GO RNA SPLICING,0.26471,0.039613,0.037995,0,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.82348,0.039598,-0.00096838,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.47049,0.039579,-0.067806,0,0
1,GO CELL VOLUME HOMEOSTASIS,0.22568,0.039497,0.049795,0,0
1,GO REGULATION OF BLOOD PRESSURE,0.63978,0.039394,0.030408,0,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.3746,0.039386,0.068261,0,0
1,GO ENDOSOMAL TRANSPORT,0.052669,0.03914,0.063962,0,0
1,GO FEMALE GENITALIA DEVELOPMENT,0.32506,0.039129,0.085216,0,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.13814,0.039004,0.082723,0,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.20937,0.038841,0.043309,0,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.17653,0.038709,0.041179,0,0
1,GO DISACCHARIDE METABOLIC PROCESS,0.31232,0.038616,0.083256,0,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.47049,0.038523,0.035708,0,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.29992,0.038392,0.07147,0,0
1,GO METAL ION HOMEOSTASIS,0.38408,0.038153,0.025152,0,0
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.087232,0.038113,0.052625,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.04854,0.038077,0.067733,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.94073,0.037951,-0.026134,0,0
1,GO MICROTUBULE NUCLEATION,0.39858,0.037931,0.051218,0,0
1,GO PROSTAGLANDIN SECRETION,0.18219,0.03793,0.10034,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.84397,0.037783,0.024227,0,0
1,GO REGULATION OF ODONTOGENESIS,0.54321,0.037754,0.06549,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,0.26471,0.037741,0.073144,0,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.11636,0.037457,0.057609,0,0
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.21905,0.037345,0.042178,0,0
1,GO CERAMIDE METABOLIC PROCESS,0.27999,0.037319,0.010001,0,0
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.32506,0.037173,0.08957,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.10465,0.036927,0.10387,0,0
1,GO ORGAN INDUCTION,0.11434,0.036747,0.11749,0,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.76281,0.036639,0.02524,0,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.87833,0.036608,0.020318,0,0
1,GO AUTOPHAGIC CELL DEATH,0.32938,0.036252,0.099409,0,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.41341,0.03624,0.080074,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.69707,0.036134,0.02321,0,0
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.56666,0.036023,0.032833,0,0
1,GO HISTONE H3 ACETYLATION,0.50896,0.035782,0.021002,0,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.84397,0.035777,-0.00012577,0,0
1,GO GLUCOSE CATABOLIC PROCESS,0.55487,0.035388,0.043845,0,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.98255,0.035241,-0.0073004,0,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.34256,0.035019,0.028879,0,0
1,GO SISTER CHROMATID SEGREGATION,0.1313,0.034871,0.061101,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.24643,0.034781,0.081761,0,0
1,GO ONE CARBON COMPOUND TRANSPORT,0.61497,0.034774,0.066331,0,0
1,GO POSITIVE REGULATION OF GROWTH,0.21905,0.034583,0.041774,0,0
1,GO CELL GROWTH,0.44402,0.034571,0.031026,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.90599,0.034492,0.00026877,0,0
1,GO BONE MATURATION,0.42347,0.034455,0.02131,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.49227,0.034361,0.036619,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.74288,0.034221,-0.040134,0,0
1,GO DIOL METABOLIC PROCESS,0.59059,0.034214,0.019992,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.58456,0.033958,-0.14167,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.48678,0.033836,0.050777,0,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.30402,0.033684,0.035728,0,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,0.32506,0.033621,0.050875,0,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.59664,0.033577,0.032641,0,0
1,GO MOLTING CYCLE,0.19095,0.033546,0.15975,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,0.34702,0.033316,0.050694,0,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.15773,0.033088,0.1234,0,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.87833,0.033073,-0.034241,0,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.4545,0.032916,0.011631,0,0
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.17099,0.032885,0.035098,0,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.80312,0.032646,0.021824,0,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.98255,0.032618,-0.020067,0,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.63354,0.032568,0.031444,0,0
1,GO ENDOCRINE HORMONE SECRETION,0.67776,0.032526,0.026552,0,0
1,GO MUSCLE CELL DEVELOPMENT,0.26471,0.032445,0.076511,0,0
1,GO REGULATION OF PLATELET AGGREGATION,0.65866,0.032442,-0.058374,0,0
1,GO REGULATION OF JUN KINASE ACTIVITY,0.43367,0.03221,0.042794,0,0
1,GO CELLULAR RESPONSE TO FATTY ACID,0.46512,0.032148,0.069096,0,0
1,GO SEX DIFFERENTIATION,0.50337,0.031838,0.024929,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.47588,0.03173,0.1302,0,0
1,GO CHOLESTEROL STORAGE,0.41341,0.03159,0.091564,0,0
1,GO PROSTAGLANDIN TRANSPORT,0.92682,0.031303,-0.012343,0,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.18508,0.031221,0.029594,0,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.60883,0.031218,0.016391,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.71006,0.030893,-0.03293,0,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,0.75615,0.030886,-0.0095813,0,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.89215,0.030814,-0.0079321,0,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,0.71658,0.030342,0.0065204,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.87144,0.030149,-0.019464,0,0
1,GO HISTONE UBIQUITINATION,0.4978,0.030082,0.033109,0,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.50337,0.02983,0.034233,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.34256,0.029807,0.064561,0,0
1,GO TRANSCYTOSIS,0.32506,0.02937,0.088208,0,0
1,GO HISTONE H3 K4 TRIMETHYLATION,0.78289,0.029327,0.024813,0,0
1,GO SINGLE FERTILIZATION,0.50337,0.029053,0.019695,0,0
1,GO APICAL PROTEIN LOCALIZATION,0.58456,0.028983,-0.080796,0,0
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.91987,0.028968,0.0041603,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,0.78962,0.02888,-0.0041332,0,0
1,GO ION HOMEOSTASIS,0.49227,0.028603,0.019283,0,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.65866,0.028417,0.016145,0,0
1,GO DEVELOPMENTAL GROWTH,0.52025,0.028303,0.021607,0,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.93377,0.028272,-0.012745,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.93377,0.028112,-0.016819,0,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.94769,0.028088,0.026925,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.47588,0.028081,0.049772,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.25001,0.027988,0.07679,0,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.76281,0.027909,0.065501,0,0
1,GO ESTROUS CYCLE,0.47588,0.027641,0.075043,0,0
1,GO CYTOPLASM ORGANIZATION,0.56075,0.027598,0.067253,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.63354,0.027413,0.028754,0,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.93377,0.027338,-0.012599,0,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.35607,0.027211,0.050839,0,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.59664,0.02713,0.01653,0,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.58456,0.026947,0.0049196,0,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.94769,0.026854,-0.035023,0,0
1,GO RESPONSE TO CAMP,0.21579,0.026708,0.10681,0,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.15517,0.026704,0.097668,0,0
1,GO CELLULAR RESPONSE TO ALCOHOL,0.4545,0.026671,0.052279,0,0
1,GO IMP METABOLIC PROCESS,0.69707,0.026646,0.032645,0,0
1,GO PIGMENT CELL DIFFERENTIATION,0.63978,0.026561,0.050833,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.36064,0.026299,0.084226,0,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.63978,0.026086,0.0053337,0,0
1,GO RETINA HOMEOSTASIS,0.99651,0.026073,-0.017771,0,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.25729,0.02593,0.10826,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.53742,0.025521,0.033297,0,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.57857,0.025494,0.039035,0,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.14285,0.025185,0.16831,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.76281,0.025082,0.0015494,0,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.63978,0.024966,0.022139,0,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,0.69707,0.024771,0.014365,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.36991,0.024764,0.078473,0,0
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.2839,0.024566,0.081989,0,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.40349,0.024349,0.024048,0,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,0.91293,0.02427,-0.0003888,0,0
1,GO TEMPERATURE HOMEOSTASIS,0.48678,0.024265,0.022404,0,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.69707,0.023952,-0.05767,0,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.84397,0.023943,0.0016805,0,0
1,GO ACTIN NUCLEATION,0.74288,0.023871,-0.022561,0,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.39858,0.023812,0.037834,0,0
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.36526,0.023783,0.12993,0,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.32938,0.02357,0.024242,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.62113,0.023215,-0.02581,0,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.37932,0.023156,0.075095,0,0
1,GO RESPONSE TO ACIDIC PH,0.58456,0.023099,0.028593,0,0
1,GO REGULATION OF HISTONE MODIFICATION,0.89215,0.022779,0.0079184,0,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.28785,0.022717,0.046453,0,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.89907,0.022694,0.0068375,0,0
1,GO LIPID BIOSYNTHETIC PROCESS,0.42855,0.022432,-0.00023338,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.82348,0.02218,-0.060428,0,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.40843,0.02217,0.02622,0,0
1,GO REGULATION OF CHROMOSOME ORGANIZATION,0.4545,0.022111,0.02542,0,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.60883,0.021587,-0.084415,0,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,0.5726,0.021281,-0.044458,0,0
1,GO MITOCHONDRIAL FISSION,0.71658,0.021278,0.01637,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.38888,0.021136,0.02693,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.72969,0.020979,0.023566,0,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.47049,0.02088,0.019038,0,0
1,GO MICROTUBULE SEVERING,0.52025,0.020716,-0.043739,0,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.77618,0.019888,0.012835,0,0
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.84397,0.01988,0.0099295,0,0
1,GO PROTEIN HOMOOLIGOMERIZATION,0.62732,0.019845,0.017303,0,0
1,GO FUCOSE METABOLIC PROCESS,0.94073,0.019839,-0.019509,0,0
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.68418,0.019774,0.033062,0,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.60272,0.019596,0.0056256,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.5726,0.01945,0.022578,0,0
1,GO REGULATION OF CELL DIFFERENTIATION,0.2839,0.01914,0.033711,0,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.76948,0.019111,-0.0338,0,0
1,GO MIDDLE EAR MORPHOGENESIS,0.7495,0.019082,0.072199,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.76281,0.019051,0.016872,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.9686,0.01895,0.0096451,0,0
1,GO HISTONE MONOUBIQUITINATION,0.59664,0.018931,0.017441,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.39371,0.018444,0.031074,0,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.34256,0.018414,0.031906,0,0
1,GO HISTONE H2A UBIQUITINATION,0.76948,0.018368,0.013883,0,0
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.55487,0.017976,0.0090037,0,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.71658,0.017964,0.074141,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.33373,0.01762,0.066089,0,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.9686,0.017549,0.021191,0,0
1,GO CELLULAR HOMEOSTASIS,0.25001,0.017506,0.031624,0,0
1,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.76281,0.017327,-0.10028,0,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.65866,0.016864,0.021683,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.65866,0.016751,0.0037759,0,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.7495,0.016669,0.054768,0,0
1,GO VITAMIN TRANSPORT,0.94073,0.016634,-0.0079963,0,0
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.62113,0.016629,0.032867,0,0
1,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.96163,0.016278,-0.022685,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.76281,0.016271,0.034256,0,0
1,GO ANIMAL ORGAN MATURATION,0.56666,0.016183,0.041139,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.5726,0.016082,0.026524,0,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.8303,0.015978,-0.028264,0,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.89907,0.015719,0.013804,0,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.20937,0.01566,0.28102,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.83713,0.015654,0.0062361,0,0
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.061812,0.015565,0.11507,0,0
1,GO NUCLEOTIDE TRANSPORT,0.5726,0.015554,0.0070389,0,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.30402,0.015403,0.091687,0,0
1,GO LIPID PHOSPHORYLATION,0.83713,0.014905,0.0015557,0,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.27999,0.014805,0.032455,0,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.64605,0.014732,0.041415,0,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.77618,0.014569,0.022713,0,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.44402,0.014363,0.080834,0,0
1,GO REGULATION OF CELLULAR LOCALIZATION,0.5726,0.01424,0.015378,0,0
1,GO TOR SIGNALING,0.98953,0.013798,0.0093264,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.51459,0.013723,0.025666,0,0
1,GO GLYCOSYLATION,0.89215,0.013578,-0.040138,0,0
1,GO POSITIVE REGULATION OF CELL GROWTH,0.62732,0.013063,0.021687,0,0
1,GO POSITIVE REGULATION OF TRANSPORT,0.38408,0.012855,0.024335,0,0
1,GO CHROMOSOME ORGANIZATION,0.52025,0.012811,0.025771,0,0
1,GO ENDOCYTIC RECYCLING,0.188,0.012798,0.053393,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,0.4598,0.012479,0.025475,0,0
1,GO MUSCLE CONTRACTION,0.42855,0.012253,0.037029,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.72313,0.012216,-0.0076308,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.67776,0.012116,0.04845,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.44402,0.01199,0.042299,0,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.71658,0.011855,0.041619,0,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.96163,0.011725,-0.02538,0,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.59664,0.011621,0.010325,0,0
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.60883,0.011417,0.029859,0,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.84397,0.011416,0.0049488,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.93377,0.011349,-0.0019056,0,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.32938,0.01128,0.22417,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.63354,0.011256,0.037605,0,0
1,GO DIVALENT METAL ION EXPORT,0.77618,0.011072,0.016629,0,0
1,GO REGULATION OF CHLORIDE TRANSPORT,0.98255,0.010898,0.0054547,0,0
1,GO ACYLGLYCEROL HOMEOSTASIS,0.85082,0.010853,-0.032166,0,0
1,GO REGULATION OF MUSCLE CONTRACTION,0.60272,0.010834,0.020848,0,0
1,GO INTERSTRAND CROSS LINK REPAIR,0.54903,0.010795,0.015601,0,0
1,GO STRIATED MUSCLE ADAPTATION,0.78289,0.010629,0.0023499,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.90599,0.010615,0.021742,0,0
1,GO GLUCOSE IMPORT,0.74288,0.010433,-0.025585,0,0
1,GO ETHANOL CATABOLIC PROCESS,0.70355,0.010425,0.12088,0,0
1,GO RESPONSE TO LIGHT STIMULUS,0.86455,0.01034,-0.0022365,0,0
1,GO ENERGY RESERVE METABOLIC PROCESS,0.8303,0.010201,0.0023268,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,0.84397,0.010089,0.015697,0,0
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.81668,0.009984,-0.012724,0,0
1,GO REGULATION OF PROTEIN SUMOYLATION,0.37932,0.0099176,0.082953,0,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.99651,0.0097933,0.045432,0,0
1,GO DNA DEPENDENT DNA REPLICATION,0.58456,0.0097865,0.021628,0,0
1,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.40843,0.0095535,-0.065946,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.91987,0.0093522,-0.01669,0,0
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.43883,0.0091093,0.10628,0,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.94073,0.0089795,-0.0075017,0,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.65234,0.0089665,0.0598,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.4545,0.008734,0.078381,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.84397,0.0086856,-0.010073,0,0
1,GO HISTONE H3 K9 TRIMETHYLATION,1,0.0085235,-0.0044787,0,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.40843,0.0084504,0.062125,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.72969,0.0082964,0.021157,0,0
1,GO HISTONE H3 K9 ACETYLATION,0.62113,0.0082186,0.046187,0,0
1,GO MYELIN ASSEMBLY,0.63354,0.0081881,0.04435,0,0
1,GO ORGANELLE MEMBRANE FUSION,0.93377,0.0080999,-0.0099218,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.72969,0.0080861,0.014392,0,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,0.65234,0.0079758,-0.006342,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,0.34702,0.0077344,0.045651,0,0
1,GO ARACHIDONIC ACID SECRETION,0.55487,0.0076162,-0.086074,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.82348,0.0075917,0.027768,0,0
1,GO SINGLE STRAND BREAK REPAIR,0.91987,0.0074265,0.016605,0,0
1,GO ADAPTIVE THERMOGENESIS,0.67776,0.0071635,0.018896,0,0
1,GO PHOSPHOLIPID TRANSPORT,0.88523,0.0071449,-0.0080248,0,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.43367,0.0070358,0.0539,0,0
1,GO REGULATION OF VASCULAR PERMEABILITY,0.82348,0.0069352,-0.012349,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.58456,0.0067392,-0.03233,0,0
1,GO STEROID BIOSYNTHETIC PROCESS,0.74288,0.0063959,-0.045494,0,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.63978,0.0061886,0.025628,0,0
1,GO PEPTIDYL LYSINE MODIFICATION,0.53167,0.0061204,-0.02464,0,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.99651,0.0058693,-0.021761,0,0
1,GO HETEROTYPIC CELL CELL ADHESION,0.55487,0.00576,0.038261,0,0
1,GO STRESS GRANULE ASSEMBLY,0.53167,0.0056795,-0.033215,0,0
1,GO VASODILATION,0.64605,0.0056344,-0.075409,0,0
1,GO CELL RECOGNITION,0.65234,0.0055472,-0.024348,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.89907,0.0054449,-0.0036565,0,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.59664,0.0052723,0.040939,0,0
1,GO B CELL HOMEOSTASIS,0.84397,0.0051746,-0.0036586,0,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.82348,0.0049806,-0.039934,0,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.57857,0.0048643,-0.028484,0,0
1,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.92682,0.0047889,0.03043,0,0
1,GO NODAL SIGNALING PATHWAY,0.89215,0.0046767,0.0033979,0,0
1,GO RESPONSE TO GROWTH HORMONE,0.44924,0.004669,0.067619,0,0
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.59664,0.0045312,0.057971,0,0
1,GO LYMPH NODE DEVELOPMENT,0.74288,0.0045066,0.082447,0,0
1,GO CHROMATIN DISASSEMBLY,0.67776,0.0044687,0.0031935,0,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.60272,0.0044527,0.041943,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.93377,0.0041688,-0.0087053,0,0
1,GO MRNA METHYLATION,0.91987,0.004158,0.0020584,0,0
1,GO NON MOTILE CILIUM ASSEMBLY,0.87144,0.003638,-0.0053702,0,0
1,GO CONVERGENT EXTENSION,0.90599,0.0034441,0.0040514,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.90599,0.0033734,-0.027105,0,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.89907,0.0032863,-0.0039892,0,0
1,GO CELLULAR RESPONSE TO VITAMIN D,0.77618,0.0031101,-0.025484,0,0
1,GO PHOSPHATE ION TRANSPORT,0.69061,0.0030329,-0.014254,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,0.9686,0.0030296,0.04658,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.89907,0.0027275,-0.0025344,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.83713,0.0027099,0.019677,0,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.54321,0.0025383,-0.033242,0,0
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.4545,0.0018691,0.062166,0,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.39371,0.0016786,-0.062047,0,0
1,GO MAGNESIUM ION HOMEOSTASIS,0.64605,0.0014784,0.057116,0,0
1,GO GLIOGENESIS,0.53742,0.0013621,0.020945,0,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.96163,0.0011646,-0.0053437,0,0
1,GO PATTERN SPECIFICATION PROCESS,0.50896,0.0011501,-0.054655,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.82348,0.0010432,0.0091545,0,0
1,GO DEPHOSPHORYLATION,0.52025,0.00079431,-0.02428,0,0
1,GO EYE MORPHOGENESIS,0.98255,0.00071635,0.003655,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.85082,0.00070773,-0.016179,0,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.72969,0.00023964,0.071511,0,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.75615,-0.00011307,-0.015906,0,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.7495,-0.00021799,0.021686,0,0
1,GO REGULATION OF CELLULAR PH,0.87833,-0.00030724,-0.003566,0,0
1,GO SEXUAL REPRODUCTION,0.63978,-0.00087517,0.010789,0,0
1,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.97557,-0.001125,0.035164,0,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.29992,-0.0014047,0.061072,0,0
1,GO CHEMICAL HOMEOSTASIS,0.67137,-0.001426,-0.018272,0,0
1,GO CARBOHYDRATE TRANSPORT,0.96163,-0.0015082,-0.016243,0,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.50896,-0.0016425,0.06792,0,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.78289,-0.0018598,0.005255,0,0
1,GO REGULATION OF ENDOCRINE PROCESS,0.59664,-0.0021235,0.027583,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.65866,-0.0021606,0.04615,0,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.91987,-0.0022372,0.04389,0,0
1,GO REPLICATION FORK PROCESSING,0.70355,-0.0022801,0.06041,0,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.85082,-0.0022908,0.0089568,0,0
1,GO TELOMERIC LOOP DISASSEMBLY,0.75615,-0.0023184,-0.034862,0,0
1,GO CAMERA TYPE EYE DEVELOPMENT,0.57857,-0.0023462,0.03447,0,0
1,GO DEVELOPMENTAL PIGMENTATION,0.57857,-0.0024347,-0.031225,0,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.89215,-0.0025827,-0.021355,0,0
1,GO METHYLATION,0.79636,-0.0031648,-0.0057988,0,0
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.95466,-0.0032073,0.13672,0,0
1,GO EPITHELIAL CELL CELL ADHESION,0.59059,-0.004139,0.13676,0,0
1,GO RESPONSE TO GLUCAGON,0.91987,-0.0042423,-0.0088162,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.86455,-0.0044906,0.003008,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,0.64605,-0.0046899,0.04535,0,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.95466,-0.0052017,-0.0098625,0,0
1,GO TONIC SMOOTH MUSCLE CONTRACTION,0.74288,-0.0052914,0.1295,0,0
1,GO MESODERMAL CELL FATE COMMITMENT,0.85768,-0.005424,-0.056891,0,0
1,GO REGIONALIZATION,0.47049,-0.0054885,-0.067665,0,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.97557,-0.0057069,0.031281,0,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.55487,-0.0058327,0.041121,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.92682,-0.0058562,0.0062935,0,0
1,GO RENAL SODIUM EXCRETION,0.46512,-0.0063661,-0.050905,0,0
1,GO LIPOPROTEIN METABOLIC PROCESS,0.54903,-0.0063736,-0.043212,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.90599,-0.0064268,-0.0242,0,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.91293,-0.0065413,0.032825,0,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.98255,-0.0065943,-0.052238,0,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.57857,-0.0067809,0.038693,0,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.99651,-0.0070428,0.0018205,0,0
1,GO GLIAL CELL DIFFERENTIATION,0.97557,-0.0073423,-0.0078941,0,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.98953,-0.0074861,-0.024791,0,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.88523,-0.0074902,-0.024426,0,0
1,GO REGULATION OF RNA SPLICING,0.76281,-0.0076035,-0.023809,0,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.72969,-0.0078124,-0.012708,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.63978,-0.0080142,-0.025327,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.89215,-0.008195,-0.0056454,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.76281,-0.0082448,-0.046035,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,0.69061,-0.0082558,0.052692,0,0
1,GO ACTIN FILAMENT BASED MOVEMENT,0.94769,-0.0083239,0.0082647,0,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,0.72313,-0.0084116,-0.019641,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.81668,-0.0084773,-0.0078706,0,0
1,GO PRENYLATION,0.67137,-0.0085747,-0.048637,0,0
1,GO O GLYCAN PROCESSING,0.69061,-0.0093573,-0.069511,0,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.89907,-0.0094784,0.0072892,0,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.84397,-0.0095472,-0.0089428,0,0
1,GO SENSORY ORGAN MORPHOGENESIS,0.87144,-0.0095609,-0.013954,0,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.68418,-0.010135,-0.049237,0,0
1,GO REGULATION OF AXON GUIDANCE,0.92682,-0.010275,-0.014684,0,0
1,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.91987,-0.010309,-0.028055,0,0
1,GO MICROTUBULE BASED PROCESS,0.75615,-0.010395,-0.016341,0,0
1,GO PROSTATE GLAND GROWTH,0.50896,-0.010952,0.24843,0,0
1,GO MEMBRANE HYPERPOLARIZATION,0.83713,-0.010959,-0.015993,0,0
1,GO COVALENT CHROMATIN MODIFICATION,0.47588,-0.011003,-0.017496,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.59059,-0.011143,-0.064029,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.91987,-0.011174,-0.021003,0,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.63354,-0.011315,-0.04682,0,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.51459,-0.011467,-0.070032,0,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.79636,-0.011534,-0.02868,0,0
1,GO RESPONSE TO FATTY ACID,0.72969,-0.011587,0.048265,0,0
1,GO NEUROBLAST PROLIFERATION,0.36991,-0.011722,-0.10266,0,0
1,GO REGULATION OF PEPTIDE TRANSPORT,0.56075,-0.011867,-0.022267,0,0
1,GO REGULATION OF MRNA PROCESSING,0.73628,-0.012012,-0.022427,0,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.32506,-0.012103,-0.055447,0,0
1,GO REGULATION OF MRNA POLYADENYLATION,0.91293,-0.012534,0.019702,0,0
1,GO HISTAMINE TRANSPORT,0.68418,-0.012581,-0.074401,0,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,0.84397,-0.012645,-0.0004154,0,0
1,GO RENAL TUBULE DEVELOPMENT,0.36991,-0.012776,0.10139,0,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,0.49227,-0.012883,0.077914,0,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.87144,-0.012954,-0.045928,0,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.43367,-0.013291,-0.057393,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.63978,-0.013465,-0.014661,0,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.85768,-0.013892,-0.012216,0,0
1,GO BICARBONATE TRANSPORT,0.67137,-0.014092,0.025118,0,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,0.47588,-0.014259,-0.055656,0,0
1,GO REGULATION OF STEM CELL DIVISION,0.92682,-0.014293,-0.015098,0,0
1,GO NEPHRON MORPHOGENESIS,0.48678,-0.014495,0.050943,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.61497,-0.014502,-0.0072148,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.95466,-0.014518,0.0028885,0,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.81668,-0.014805,0.020721,0,0
1,GO MYOTUBE CELL DEVELOPMENT,0.70355,-0.01482,-0.065178,0,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.4978,-0.015192,-0.040708,0,0
1,GO REGULATION OF FATTY ACID TRANSPORT,0.99651,-0.015509,0.0041156,0,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.95466,-0.015588,0.0079907,0,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.86455,-0.015699,0.014548,0,0
1,GO REGULATION OF LYASE ACTIVITY,0.98255,-0.015778,0.0028833,0,0
1,GO GMP METABOLIC PROCESS,0.75615,-0.015894,-0.030818,0,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.60883,-0.016173,0.078967,0,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.56666,-0.016311,-0.019036,0,0
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.74288,-0.016389,0.059037,0,0
1,GO CELLULAR RESPONSE TO STEROL,0.29184,-0.016397,-0.078495,0,0
1,GO SENSORY SYSTEM DEVELOPMENT,0.67137,-0.016411,0.013638,0,0
1,GO ADULT HEART DEVELOPMENT,0.54321,-0.016447,-0.072369,0,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.49227,-0.016683,-0.031669,0,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.94769,-0.016949,-0.018,0,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.65866,-0.016974,-0.031964,0,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.95466,-0.016975,0.00021596,0,0
1,GO CARBOHYDRATE PHOSPHORYLATION,0.80312,-0.017624,0.019326,0,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,0.37932,-0.017814,-0.052736,0,0
1,GO QUINONE METABOLIC PROCESS,0.82348,-0.017886,0.023044,0,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.79636,-0.017891,-0.013177,0,0
1,GO RENAL ABSORPTION,0.78289,-0.018212,0.036035,0,0
1,GO PROTEIN DEPHOSPHORYLATION,0.8303,-0.018215,-0.00855,0,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.41341,-0.018372,-0.10196,0,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,0.22568,-0.018479,-0.099624,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.57857,-0.018488,-0.084231,0,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.59059,-0.018789,0.045465,0,0
1,GO PLASMA MEMBRANE REPAIR,0.78962,-0.018946,-0.061884,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.62732,-0.018984,0.026359,0,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.33812,-0.019194,0.10804,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.24643,-0.019365,-0.11675,0,0
1,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.94073,-0.019552,0.052041,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.87833,-0.019647,0.022563,0,0
1,GO OOGENESIS,0.43883,-0.019655,-0.030234,0,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.65866,-0.019665,-0.032589,0,0
1,GO PROTEIN TRIMERIZATION,0.93377,-0.019825,-0.0016031,0,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.67137,-0.020034,0.027043,0,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,0.58456,-0.02013,-0.019657,0,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.66501,-0.020166,-0.021392,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.7495,-0.0203,-0.0063504,0,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.66501,-0.020925,-0.010471,0,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,1,-0.02117,0.025216,0,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.4545,-0.021758,-0.069229,0,0
1,GO ORGANELLE FUSION,0.65234,-0.022544,-0.017753,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.67776,-0.022634,0.3071,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.56075,-0.022692,-0.055144,0,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.52025,-0.022777,-0.070196,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.41842,-0.023069,-0.044282,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.97557,-0.023111,0.01941,0,0
1,GO HISTONE DEUBIQUITINATION,0.95466,-0.023466,0.011609,0,0
1,GO CARDIAC CHAMBER FORMATION,0.76281,-0.023488,-0.094013,0,0
1,GO ACTIN MEDIATED CELL CONTRACTION,0.60883,-0.023837,0.036382,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.92682,-0.024104,0.0080342,0,0
1,GO EXIT FROM MITOSIS,0.88523,-0.024208,0.011768,0,0
1,GO GAMETE GENERATION,0.78289,-0.024278,0.009377,0,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.70355,-0.024606,-0.029024,0,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.20937,-0.025207,-0.14394,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.99651,-0.025231,-0.0069984,0,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,0.85082,-0.025283,0.0077484,0,0
1,GO DRUG CATABOLIC PROCESS,0.87833,-0.025323,-0.012522,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.77618,-0.025347,0.010156,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.71006,-0.025424,-0.030374,0,0
1,GO PIGMENTATION,0.63354,-0.025498,-0.0058805,0,0
1,GO LYSOSOME LOCALIZATION,0.55487,-0.025524,-0.021404,0,0
1,GO AXON EXTENSION,0.68418,-0.025526,-0.021544,0,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.70355,-0.025554,-0.0022573,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.72969,-0.025713,-0.052982,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.69061,-0.025724,-0.024544,0,0
1,GO RHYTHMIC PROCESS,0.16294,-0.025781,-0.044873,0,0
1,GO REGULATION OF BONE REMODELING,0.99651,-0.025975,-0.0087756,0,0
1,GO REGULATION OF METAL ION TRANSPORT,0.52025,-0.026049,-0.01591,0,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.80312,-0.02615,0.023319,0,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.40843,-0.026303,-0.051459,0,0
1,GO SKELETAL MUSCLE CONTRACTION,0.65866,-0.026448,-0.035801,0,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.43883,-0.026531,-0.032614,0,0
1,GO NUCLEOSOME ORGANIZATION,0.44924,-0.02654,-0.031128,0,0
1,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.66501,-0.026693,-0.06661,0,0
1,GO HOMOLOGOUS RECOMBINATION,0.90599,-0.027129,0.038293,0,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.25729,-0.027276,-0.10682,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,0.94073,-0.02777,0.021581,0,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,0.050569,-0.027947,-0.10582,0,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.61497,-0.028245,0.24614,0,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.52025,-0.028324,-0.028462,0,0
1,GO BONE MINERALIZATION,0.37932,-0.028439,0.10769,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.86455,-0.028642,-0.088786,0,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.47049,-0.028654,-0.043835,0,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.70355,-0.028757,-0.011202,0,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.56075,-0.02884,-0.023161,0,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.85768,-0.028846,0.010146,0,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.43883,-0.028854,-0.065218,0,0
1,GO REGULATION OF CELL MORPHOGENESIS,0.48131,-0.028957,-0.039598,0,0
1,GO PROTEIN NITROSYLATION,0.64605,-0.02903,-0.049964,0,0
1,GO GLUCOSE METABOLIC PROCESS,0.63354,-0.029312,-0.025877,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.60272,-0.0297,-0.002955,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,0.79636,-0.029849,-0.026918,0,0
1,GO MALE GAMETE GENERATION,0.63354,-0.02985,-0.006035,0,0
1,GO KERATINOCYTE DEVELOPMENT,0.95466,-0.029892,-0.013544,0,0
1,GO TELOMERE CAPPING,0.67776,-0.030002,-0.011354,0,0
1,GO MULTICELLULAR ORGANISM GROWTH,0.16559,-0.030069,-0.045562,0,0
1,GO HISTAMINE SECRETION,0.92682,-0.030177,-0.0090466,0,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.20621,-0.030278,-0.07234,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.48678,-0.030441,0.05168,0,0
1,GO CYTOSOLIC TRANSPORT,0.98255,-0.030586,0.016359,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.76281,-0.030614,0.044155,0,0
1,GO THYMIC T CELL SELECTION,0.63978,-0.030702,0.00038608,0,0
1,GO SECONDARY METABOLIC PROCESS,0.79636,-0.030768,0.021181,0,0
1,GO POST ANAL TAIL MORPHOGENESIS,0.33373,-0.030836,-0.088401,0,0
1,GO GRANULOCYTE DIFFERENTIATION,0.4978,-0.030863,-0.047892,0,0
1,GO REGULATION OF PH,0.96163,-0.030914,-0.0073616,0,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.18508,-0.031327,-0.06567,0,0
1,GO ZINC ION TRANSPORT,0.87144,-0.031351,0.018469,0,0
1,GO STEROID CATABOLIC PROCESS,0.89907,-0.031524,0.0050125,0,0
1,GO AMINO ACID IMPORT,0.78289,-0.031533,-0.0082187,0,0
1,GO EPIDERMAL CELL DIFFERENTIATION,0.69707,-0.031724,0.073651,0,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.22905,-0.031744,-0.1207,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,0.61497,-0.031857,-0.027223,0,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.58456,-0.031894,-0.043483,0,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.49227,-0.031895,-0.025412,0,0
1,GO ORGANELLE LOCALIZATION,0.26471,-0.032192,-0.02458,0,0
1,GO CHEMOSENSORY BEHAVIOR,0.38888,-0.032526,-0.11211,0,0
1,GO GLIAL CELL PROLIFERATION,0.50896,-0.032607,0.061622,0,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.88523,-0.032671,-0.032288,0,0
1,GO REGULATION OF TOR SIGNALING,0.29184,-0.032812,-0.028322,0,0
1,GO ANION TRANSPORT,0.076492,-0.032926,-0.05701,0,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,0.63354,-0.033141,-0.016463,0,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.59664,-0.03321,0.028548,0,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.12049,-0.033326,-0.074044,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.77618,-0.033521,0.02527,0,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.60272,-0.033614,-0.017232,0,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.44402,-0.034003,0.067492,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.48131,-0.034277,-0.065277,0,0
1,GO ORGANIC ANION TRANSPORT,0.093897,-0.034407,-0.062165,0,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.26098,-0.034513,-0.10888,0,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.22235,-0.034648,-0.11763,0,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.11434,-0.034656,-0.067729,0,0
1,GO SEGMENTATION,0.57857,-0.034833,-0.015533,0,0
1,GO METANEPHROS MORPHOGENESIS,0.71658,-0.035022,-0.049004,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.59059,-0.035028,-0.013874,0,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.23589,-0.035255,-0.027221,0,0
1,GO HISTONE H2A ACETYLATION,0.78289,-0.035451,-0.014591,0,0
1,GO RESPONSE TO METAL ION,0.5726,-0.035558,-0.021347,0,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.95466,-0.036047,0.043593,0,0
1,GO PIGMENT GRANULE LOCALIZATION,0.33812,-0.036086,-0.061743,0,0
1,GO RESPONSE TO ETHANOL,0.19393,-0.036173,-0.056965,0,0
1,GO HETEROCHROMATIN ORGANIZATION,0.84397,-0.036289,-0.006972,0,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.78962,-0.036354,-0.001991,0,0
1,GO INORGANIC ANION TRANSPORT,0.2,-0.03659,-0.041546,0,0
1,GO ESTROGEN BIOSYNTHETIC PROCESS,0.87833,-0.036699,-0.0083822,0,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.23937,-0.036863,-0.066113,0,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.84397,-0.037016,-0.0077861,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.87833,-0.037109,0.0068697,0,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.46512,-0.037109,-0.045823,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.26847,-0.037118,-0.085896,0,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.41341,-0.037136,-0.041492,0,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,0.19095,-0.037234,-0.07669,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.67776,-0.03803,-0.0060217,0,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.31653,-0.038404,-0.040836,0,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.36526,-0.038418,-0.05321,0,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.93377,-0.038638,0.023488,0,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,0.99651,-0.038751,0.012508,0,0
1,GO HEART INDUCTION,0.88523,-0.038887,0.031607,0,0
1,GO MITOCHONDRION MORPHOGENESIS,0.41341,-0.039001,-0.020165,0,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.15264,-0.03907,-0.070523,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.22568,-0.039092,-0.058555,0,0
1,GO HISTONE H3 K14 ACETYLATION,0.62113,-0.039276,-0.038959,0,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.82348,-0.039474,-0.012883,0,0
1,GO CELL JUNCTION ASSEMBLY,0.99651,-0.039572,0.0021018,0,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.34702,-0.039617,-0.0959,0,0
1,GO NEURON DEATH,0.30815,-0.039695,-0.02595,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.87833,-0.039735,-0.01909,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.29586,-0.039825,-0.19246,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.54321,-0.040006,-0.031256,0,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.33373,-0.040496,-0.092313,0,0
1,GO RESPONSE TO SALT,0.99651,-0.041014,-0.036106,0,0
1,GO MITOCHONDRIAL FUSION,0.86455,-0.041036,-0.0068175,0,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.67137,-0.041295,-0.024589,0,0
1,GO LINOLEIC ACID METABOLIC PROCESS,0.35607,-0.041848,-0.13957,0,0
1,GO PEPTIDYL LYSINE ACETYLATION,0.029068,-0.041878,-0.066827,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.46512,-0.04211,-0.050468,0,0
1,GO CELLULAR RESPONSE TO CAMP,0.18219,-0.042146,-0.047554,0,0
1,GO MANNOSYLATION,0.26471,-0.042241,-0.062593,0,0
1,GO EMBRYONIC BODY MORPHOGENESIS,0.7495,-0.042381,-0.031334,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.69707,-0.042398,-0.15314,0,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.075049,-0.042527,-0.093473,0,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.26098,-0.042552,-0.091563,0,0
1,GO RESPONSE TO STARVATION,0.5726,-0.042619,-0.029083,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.53167,-0.042799,-0.11636,0,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.25363,-0.042871,-0.068107,0,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.42347,-0.042884,-0.054714,0,0
1,GO FEMALE SEX DIFFERENTIATION,0.42347,-0.042917,-0.033147,0,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.60272,-0.043139,-0.016971,0,0
1,GO CARDIAC CELL DEVELOPMENT,0.9686,-0.043184,0.023284,0,0
1,GO PRE MIRNA PROCESSING,0.79636,-0.043613,-0.021258,0,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,0.67776,-0.043655,0.025308,0,0
1,GO ANATOMICAL STRUCTURE REGRESSION,0.47588,-0.043771,-0.13076,0,0
1,GO WHITE FAT CELL DIFFERENTIATION,0.80312,-0.043987,-0.0096192,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.77618,-0.044036,0.029159,0,0
1,GO INTERLEUKIN 10 PRODUCTION,0.72313,-0.044076,0.0075215,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.36991,-0.044364,-0.059724,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.56666,-0.044581,-0.039195,0,0
1,GO CELLULAR RESPONSE TO STARVATION,0.40349,-0.044629,-0.035836,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.89215,-0.044831,-0.00048238,0,0
1,GO OOCYTE DIFFERENTIATION,0.13355,-0.044948,-0.063194,0,0
1,GO CELLULAR RESPONSE TO ALKALOID,0.13355,-0.045065,-0.087169,0,0
1,GO T CELL SELECTION,0.68418,-0.045103,-0.0010551,0,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.39371,-0.045175,-0.063707,0,0
1,GO MESONEPHROS DEVELOPMENT,0.64605,-0.04523,0.061302,0,0
1,GO SENSORY ORGAN DEVELOPMENT,0.63354,-0.045422,-0.033519,0,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.25729,-0.045484,-0.083423,0,0
1,GO DNA PACKAGING,0.74288,-0.045514,-0.012471,0,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.67776,-0.045606,0.10073,0,0
1,GO RESPONSE TO CALCIUM ION,0.30402,-0.045817,-0.056448,0,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.052669,-0.045836,-0.086155,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.85768,-0.045914,-0.018788,0,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.36991,-0.045983,-0.1205,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.47049,-0.046037,-0.03718,0,0
1,GO MALE MEIOSIS I,0.63354,-0.046327,-0.040681,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.93377,-0.046427,-0.012154,0,0
1,GO MYOFIBRIL ASSEMBLY,0.85768,-0.046525,0.052316,0,0
1,GO GLUTAMINE METABOLIC PROCESS,0.5726,-0.046627,-0.073276,0,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.064293,-0.046685,-0.11895,0,0
1,GO RESPONSE TO CARBOHYDRATE,0.34256,-0.046738,-0.026252,0,0
1,GO BLASTOCYST DEVELOPMENT,0.31232,-0.046791,-0.028685,0,0
1,GO CHROMATIN ORGANIZATION,0.22235,-0.047137,-0.030117,0,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.32938,-0.047197,-0.11284,0,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.77618,-0.047361,-0.01244,0,0
1,GO REGULATION OF OOGENESIS,0.33373,-0.047537,-0.032238,0,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,0.84397,-0.047763,-0.014445,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,0.9686,-0.047852,0.0026056,0,0
1,GO WATER TRANSPORT,0.23245,-0.048059,-0.05741,0,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.20937,-0.048074,-0.078475,0,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.36991,-0.048077,-0.075542,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.48678,-0.04836,-0.046017,0,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.99651,-0.048826,0.032422,0,0
1,GO CRANIAL NERVE MORPHOGENESIS,0.40349,-0.048828,-0.050904,0,0
1,GO CELL MORPHOGENESIS,0.26098,-0.048829,-0.049025,0,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.4978,-0.048919,-0.038896,0,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.95466,-0.049118,0.016239,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.3746,-0.049378,-0.026879,0,0
1,GO REGULATION OF NEURON MIGRATION,0.4545,-0.049932,-0.074052,0,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.97557,-0.050187,0.023097,0,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.31653,-0.050317,-0.093442,0,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.38888,-0.050464,-0.074294,0,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.36064,-0.050688,-0.10021,0,0
1,GO CELL CYCLE DNA REPLICATION,0.43883,-0.051257,-0.050372,0,0
1,GO MRNA MODIFICATION,0.89215,-0.051616,-0.0070753,0,0
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.98255,-0.05169,0.03287,0,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.31232,-0.051929,-0.11365,0,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.73628,-0.051947,-0.013182,0,0
1,GO SNORNA 3 END PROCESSING,0.62113,-0.052057,-0.075546,0,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.41341,-0.052086,-0.02896,0,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.23589,-0.052189,-0.08093,0,0
1,GO ECTODERM DEVELOPMENT,0.71006,-0.052218,0.032758,0,0
1,GO REGULATION OF FEEDING BEHAVIOR,0.35607,-0.052237,-0.076508,0,0
1,GO PROTEIN O LINKED MANNOSYLATION,0.49227,-0.05228,-0.047775,0,0
1,GO RENAL SYSTEM PROCESS,0.65234,-0.052337,-0.01586,0,0
1,GO LOCALIZATION WITHIN MEMBRANE,0.38888,-0.052592,-0.047696,0,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.67137,-0.052843,0.16046,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.56666,-0.05301,-0.036764,0,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.85768,-0.053055,0.02078,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.87144,-0.053097,-0.032326,0,0
1,GO DEMETHYLATION,0.47588,-0.05315,-0.01224,0,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.56075,-0.053226,-0.017216,0,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.42855,-0.053341,-0.016298,0,0
1,GO SPHINGOLIPID METABOLIC PROCESS,0.092194,-0.053575,-0.071692,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.3746,-0.054076,-0.040548,0,0
1,GO T CELL HOMEOSTASIS,0.188,-0.054375,-0.060509,0,0
1,GO CILIUM ORGANIZATION,0.5726,-0.054493,-0.0061974,0,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.10845,-0.054634,-0.13614,0,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.40843,-0.055028,-0.11447,0,0
1,GO REGULATION OF GLUCOSE IMPORT,0.12259,-0.05517,-0.086181,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.18219,-0.055394,-0.082817,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.22905,-0.055473,-0.033826,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.59664,-0.055537,-0.052149,0,0
1,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.51459,-0.05556,-0.10117,0,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.2839,-0.055949,-0.059885,0,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,0.054842,-0.056239,-0.085263,0,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.21579,-0.056354,-0.049169,0,0
1,GO FRUCTOSE METABOLIC PROCESS,0.42855,-0.056419,-0.13658,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.53167,-0.05658,-0.065048,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.76281,-0.056677,-0.0062467,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.94769,-0.056677,0.014478,0,0
1,GO MEMBRANE DOCKING,0.36526,-0.056914,-0.027294,0,0
1,GO HISTONE H3 K36 METHYLATION,0.34702,-0.056918,-0.073993,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.85768,-0.056922,-0.00079132,0,0
1,GO MAST CELL ACTIVATION,0.14526,-0.056964,-0.11099,0,0
1,GO RESPONSE TO MONOSACCHARIDE,0.19393,-0.057341,-0.037818,0,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.26847,-0.057404,-0.034606,0,0
1,GO MICROTUBULE BASED TRANSPORT,0.37932,-0.057694,-0.026045,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,0.1028,-0.058347,-0.11047,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.2839,-0.058476,-0.063539,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.11235,-0.05852,-0.063547,0,0
1,GO POST EMBRYONIC DEVELOPMENT,0.63978,-0.05871,-0.017844,0,0
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.50337,-0.058892,-0.013005,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.22568,-0.059299,-0.063659,0,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.11841,-0.059451,-0.090493,0,0
1,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.69061,-0.059626,-0.039756,0,0
1,GO SPLEEN DEVELOPMENT,0.91293,-0.059628,0.031937,0,0
1,GO RESPONSE TO INACTIVITY,0.50896,-0.059873,-0.059132,0,0
1,GO REGULATION OF CYCLASE ACTIVITY,0.28785,-0.059929,-0.050347,0,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.097379,-0.060109,-0.071579,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.89215,-0.060469,0.0074477,0,0
1,GO DNA STRAND ELONGATION,0.24643,-0.060593,-0.07672,0,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.61497,-0.060598,0.096039,0,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.67137,-0.060646,0.0091042,0,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,0.18508,-0.060823,-0.066832,0,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.087232,-0.060884,-0.13838,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.084046,-0.060893,-0.091568,0,0
1,GO REGULATION OF TRANSPORT,0.060602,-0.060984,-0.051879,0,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.53167,-0.061041,-0.13111,0,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.94073,-0.061478,0.014425,0,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.73628,-0.062545,-0.038302,0,0
1,GO REGULATION OF FERTILIZATION,0.28785,-0.062559,-0.07597,0,0
1,GO CELL PROJECTION ORGANIZATION,0.020205,-0.062765,-0.082673,0,0
1,GO REGULATION OF CELL CYCLE ARREST,0.16559,-0.062923,-0.04678,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.40843,-0.063364,-0.061225,0,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.73628,-0.063669,-0.020257,0,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.16828,-0.063896,-0.038787,0,0
1,GO ACTIN CROSSLINK FORMATION,0.47588,-0.064066,-0.11573,0,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.42347,-0.064241,-0.071305,0,0
1,GO MITOTIC DNA REPLICATION,0.56666,-0.064269,-0.036738,0,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.65866,-0.064434,-0.04006,0,0
1,GO CIRCULATORY SYSTEM PROCESS,0.21256,-0.064554,-0.044804,0,0
1,GO CARTILAGE MORPHOGENESIS,0.4545,-0.065409,-0.1057,0,0
1,GO CELLULAR COMPONENT MAINTENANCE,0.19695,-0.065431,-0.081163,0,0
1,GO FUCOSYLATION,0.19095,-0.065618,-0.087788,0,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.52025,-0.065788,-0.038204,0,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.54903,-0.065858,-0.049635,0,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.31653,-0.065882,-0.043718,0,0
1,GO ADIPOSE TISSUE DEVELOPMENT,0.060602,-0.06604,-0.13951,0,0
1,GO PHAGOSOME MATURATION,0.7495,-0.066357,-0.020845,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.31653,-0.066734,-0.10935,0,0
1,GO SPERM MOTILITY,0.075049,-0.066903,-0.071708,0,0
1,GO ALCOHOL CATABOLIC PROCESS,0.24288,-0.067066,-0.019835,0,0
1,GO CELL FATE COMMITMENT,0.11434,-0.067066,-0.10671,0,0
1,GO RESPONSE TO COLD,0.26471,-0.067173,-0.098212,0,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.59059,-0.067203,-0.01011,0,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.21905,-0.067302,-0.17176,0,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.41341,-0.06743,-0.12618,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.11841,-0.067892,-0.094833,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.58456,-0.067966,-0.0043257,0,0
1,GO REGULATION OF DNA METHYLATION,0.64605,-0.068081,-0.031009,0,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,0.1313,-0.068178,-0.1363,0,0
1,GO GANGLIOSIDE METABOLIC PROCESS,0.095625,-0.06819,-0.10346,0,0
1,GO BROWN FAT CELL DIFFERENTIATION,0.68418,-0.068242,-0.027854,0,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.42347,-0.068519,-0.072761,0,0
1,GO EMBRYONIC PATTERN SPECIFICATION,0.20309,-0.068889,-0.12184,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.12473,-0.068985,-0.055022,0,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.19695,-0.069402,-0.13609,0,0
1,GO POSITIVE T CELL SELECTION,0.53167,-0.069519,0.013697,0,0
1,GO VESICLE LOCALIZATION,0.053746,-0.069603,-0.055507,0,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.4598,-0.06969,-0.069581,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,0.93377,-0.069791,0.0011679,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.5726,-0.069828,-0.011097,0,0
1,GO DRINKING BEHAVIOR,0.16828,-0.069884,-0.12103,0,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.35607,-0.069898,-0.071259,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.54321,-0.069959,-0.042011,0,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.15773,-0.070071,-0.079179,0,0
1,GO REGULATION OF CELL DEVELOPMENT,0.035393,-0.070154,-0.09552,0,0
1,GO PENILE ERECTION,0.24643,-0.070211,-0.10188,0,0
1,GO MICROTUBULE BASED MOVEMENT,0.18219,-0.070907,-0.048884,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.25001,-0.070974,-0.11373,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.075049,-0.07109,-0.064285,0,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.015953,-0.071158,-0.11757,0,0
1,GO CALCIUM MEDIATED SIGNALING,0.11039,-0.071283,-0.051299,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.15773,-0.071711,-0.059282,0,0
1,GO ALANINE TRANSPORT,0.25001,-0.071805,-0.10624,0,0
1,GO NUCLEOSOME ASSEMBLY,0.28785,-0.071962,-0.059296,0,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.031748,-0.07219,-0.085327,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.88523,-0.072491,-0.030668,0,0
1,GO CGMP MEDIATED SIGNALING,0.31232,-0.072635,-0.065649,0,0
1,GO ANION TRANSMEMBRANE TRANSPORT,0.11841,-0.073135,-0.059037,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.50896,-0.07351,-0.059997,0,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.65234,-0.073783,-0.026381,0,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.93377,-0.073956,0.044422,0,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.027803,-0.074115,-0.15209,0,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.14526,-0.07419,-0.11887,0,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.064293,-0.074292,-0.18096,0,0
1,GO DIET INDUCED THERMOGENESIS,0.087232,-0.074351,-0.13579,0,0
1,GO EAR MORPHOGENESIS,0.24288,-0.074781,-0.069607,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.92682,-0.074906,0.020708,0,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.77618,-0.074911,-0.052598,0,0
1,GO CELLULAR ANION HOMEOSTASIS,0.39371,-0.074958,-0.048337,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.40843,-0.074991,-0.035463,0,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.085627,-0.075189,-0.084045,0,0
1,GO SISTER CHROMATID COHESION,0.27611,-0.075287,-0.054448,0,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.24643,-0.075334,-0.14732,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.12259,-0.075751,-0.090905,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.94073,-0.075979,0.0089758,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.54321,-0.076182,-0.0041338,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.86455,-0.076207,0.013675,0,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.95466,-0.076521,0.0050173,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.31653,-0.076737,-0.1218,0,0
1,GO PARTURITION,0.4978,-0.076936,-0.079011,0,0
1,GO NOTCH SIGNALING PATHWAY,0.22568,-0.076954,-0.057144,0,0
1,GO LIPID EXPORT FROM CELL,0.53167,-0.07733,-0.042378,0,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.073629,-0.077348,-0.096988,0,0
1,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.50896,-0.077796,-0.056095,0,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.21256,-0.077827,-0.058551,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.67137,-0.07788,0.047322,0,0
1,GO MOTOR NEURON AXON GUIDANCE,0.11434,-0.077897,-0.087203,0,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,0.42855,-0.078055,-0.041499,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.093897,-0.078471,-0.086879,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.44402,-0.078721,-0.054009,0,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.043763,-0.07904,-0.073797,0,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.25001,-0.079109,-0.071078,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.90599,-0.079618,0.000551,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.23245,-0.079805,-0.08028,0,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.16294,-0.079828,-0.064302,0,0
1,GO ER OVERLOAD RESPONSE,0.67137,-0.080222,-0.028515,0,0
1,GO PROTEIN ACETYLATION,0.0054795,-0.080392,-0.078937,0,0
1,GO FORELIMB MORPHOGENESIS,0.49227,-0.080419,-0.045987,0,0
1,GO REGULATION OF PROTEIN ACETYLATION,0.024288,-0.080509,-0.088908,0,0
1,GO ANATOMICAL STRUCTURE MATURATION,0.05161,-0.080524,-0.074824,0,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.073629,-0.080688,-0.116,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.064293,-0.08087,-0.08894,0,0
1,GO POLYOL CATABOLIC PROCESS,0.12049,-0.080871,-0.09924,0,0
1,GO CARDIAC VENTRICLE FORMATION,0.29184,-0.081009,-0.24801,0,0
1,GO GERM CELL DEVELOPMENT,0.0695,-0.08184,-0.053831,0,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.0695,-0.081929,-0.070588,0,0
1,GO AXO DENDRITIC TRANSPORT,0.045624,-0.082022,-0.14424,0,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.085627,-0.082039,-0.15409,0,0
1,GO COBALAMIN METABOLIC PROCESS,0.090515,-0.082387,-0.12491,0,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.053746,-0.082757,-0.059988,0,0
1,GO PH REDUCTION,0.049546,-0.082842,-0.086453,0,0
1,GO CIRCADIAN RHYTHM,0.0047853,-0.082936,-0.098521,0,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,0.077957,-0.082987,-0.062283,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.57857,-0.083126,-0.014038,0,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.32506,-0.083158,-0.022612,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.60272,-0.083484,-0.013622,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.41842,-0.083493,-0.096451,0,0
1,GO L AMINO ACID TRANSPORT,0.32938,-0.083583,-0.059744,0,0
1,GO RESPONSE TO MUSCLE STRETCH,0.97557,-0.083613,0.046217,0,0
1,GO BRAIN MORPHOGENESIS,0.18219,-0.083676,-0.097521,0,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.099158,-0.084012,-0.09118,0,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.085627,-0.084054,-0.061473,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.11434,-0.084179,-0.12371,0,0
1,GO MITOCHONDRIAL TRNA PROCESSING,0.84397,-0.084349,-0.0016556,0,0
1,GO HEAD DEVELOPMENT,0.0083534,-0.084411,-0.12989,0,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.10465,-0.084763,-0.068571,0,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.42347,-0.084859,-0.12822,0,0
1,GO TRANSPORT ALONG MICROTUBULE,0.2839,-0.08529,-0.055468,0,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.063042,-0.085488,-0.12529,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.54321,-0.086054,-0.010864,0,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.21579,-0.086511,-0.077806,0,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,0.15015,-0.086591,-0.061589,0,0
1,GO REGULATION OF CILIUM BEAT FREQUENCY,0.60272,-0.086837,-0.037323,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.05824,-0.086851,-0.097175,0,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.034637,-0.087069,-0.11088,0,0
1,GO MAST CELL MEDIATED IMMUNITY,0.15015,-0.087325,-0.098143,0,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.087232,-0.088025,-0.11698,0,0
1,GO SPERM CAPACITATION,0.34702,-0.088133,-0.051565,0,0
1,GO CELLULAR RESPONSE TO NUTRIENT,0.47588,-0.088535,-0.028238,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.22905,-0.088551,-0.10809,0,0
1,GO MAGNESIUM ION TRANSPORT,0.1313,-0.089072,-0.093262,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.29992,-0.089143,-0.1146,0,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.076492,-0.089979,-0.13409,0,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.25363,-0.090493,-0.067733,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.30402,-0.090726,-0.083068,0,0
1,GO ADAPTATION OF SIGNALING PATHWAY,0.22905,-0.090784,-0.097865,0,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.34702,-0.091562,-0.11221,0,0
1,GO HISTONE H3 K9 MODIFICATION,0.10096,-0.091879,-0.093614,0,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.14526,-0.091923,-0.049224,0,0
1,GO GASTRIC ACID SECRETION,0.54903,-0.092486,-0.040357,0,0
1,GO ZINC ION HOMEOSTASIS,0.72313,-0.092717,-0.037893,0,0
1,GO SOMITOGENESIS,0.057089,-0.092774,-0.073282,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.60272,-0.09281,-0.040035,0,0
1,GO HORMONE CATABOLIC PROCESS,0.67137,-0.0929,-0.038001,0,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.15015,-0.092996,-0.081435,0,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.56666,-0.093163,-0.027293,0,0
1,GO REGULATION OF TORC1 SIGNALING,0.0090226,-0.093432,-0.12047,0,0
1,GO KIDNEY MORPHOGENESIS,0.74288,-0.093772,-0.0082075,0,0
1,GO EXPLORATION BEHAVIOR,0.11841,-0.094317,-0.17247,0,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.47588,-0.094537,-0.05572,0,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,0.10654,-0.094679,-0.17905,0,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.27611,-0.095186,-0.040529,0,0
1,GO PROTEIN DEMETHYLATION,0.093897,-0.095266,-0.12679,0,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.16559,-0.095364,-0.12831,0,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.48131,-0.095541,-0.040945,0,0
1,GO ANTEROGRADE AXONAL TRANSPORT,0.037747,-0.095739,-0.16778,0,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.34256,-0.095894,-0.034908,0,0
1,GO SNORNA METABOLIC PROCESS,0.56075,-0.095969,-0.069839,0,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.14526,-0.096039,-0.08869,0,0
1,GO STEROID HORMONE SECRETION,0.19695,-0.096382,-0.11448,0,0
1,GO CHROMATIN REMODELING,0.17099,-0.096453,-0.064189,0,0
1,GO ADULT FEEDING BEHAVIOR,0.027803,-0.096581,-0.17934,0,0
1,GO NEURON APOPTOTIC PROCESS,0.015574,-0.096625,-0.084106,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00079435,-0.096685,-0.10359,0,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.61497,-0.096731,-0.033416,0,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.077957,-0.097157,-0.096046,0,0
1,GO LONG TERM MEMORY,0.27999,-0.097207,-0.072886,0,0
1,GO CELL JUNCTION ORGANIZATION,0.10465,-0.097272,-0.069188,0,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.53742,-0.097427,-0.077707,0,0
1,GO EXCRETION,0.24643,-0.097436,-0.048022,0,0
1,GO CILIUM MOVEMENT,0.14526,-0.098263,-0.056062,0,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.29184,-0.098307,-0.09125,0,0
1,GO REGULATION OF CILIUM ASSEMBLY,0.092194,-0.098489,-0.084443,0,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.019283,-0.098603,-0.1774,0,0
1,GO DORSAL VENTRAL PATTERN FORMATION,0.05824,-0.098635,-0.13216,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.14769,-0.098735,-0.099106,0,0
1,GO PSEUDOPODIUM ORGANIZATION,0.78962,-0.098764,-0.020183,0,0
1,GO HEART FORMATION,0.14285,-0.098894,-0.11892,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.047551,-0.099401,-0.1105,0,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.25729,-0.099608,-0.079278,0,0
1,GO SOMITE DEVELOPMENT,0.017549,-0.099749,-0.10764,0,0
1,GO RECEPTOR CLUSTERING,0.027188,-0.099931,-0.156,0,0
1,GO MULTICELLULAR ORGANISM AGING,0.05161,-0.10013,-0.10526,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.060602,-0.10023,-0.096107,0,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.075049,-0.1003,-0.076967,0,0
1,GO CHROMATIN SILENCING,0.12908,-0.10055,-0.047009,0,0
1,GO DOSAGE COMPENSATION,0.34702,-0.10058,-0.030011,0,0
1,GO PROTEIN ACYLATION,0.00029782,-0.10067,-0.10478,0,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,0.075049,-0.10116,-0.08186,0,0
1,GO MATING,0.017969,-0.10132,-0.09974,0,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.39371,-0.10136,-0.052058,0,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.053746,-0.10152,-0.12367,0,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.17374,-0.102,-0.056798,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.05161,-0.10246,-0.05738,0,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.63354,-0.10264,-0.019657,0,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.024288,-0.10286,-0.087629,0,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.043763,-0.10368,-0.13579,0,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.025994,-0.10376,-0.089233,0,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.33373,-0.10394,-0.082836,0,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.58456,-0.10401,-0.069719,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.27611,-0.10403,-0.045418,0,0
1,GO CORNIFICATION,0.62113,-0.10419,0.00094599,0,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.29586,-0.10438,-0.11018,0,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.079444,-0.1049,-0.080905,0,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.27999,-0.10508,-0.085596,0,0
1,GO RESPONSE TO FUNGUS,0.097379,-0.10566,-0.1107,0,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.064293,-0.10619,-0.047763,0,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.53742,-0.10671,-0.022048,0,0
1,GO UTERUS DEVELOPMENT,0.10845,-0.1068,-0.15821,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.86455,-0.10692,-0.055028,0,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0097392,-0.10745,-0.10653,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.77618,-0.10764,0.00074886,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.068167,-0.10765,-0.10956,0,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0046564,-0.10791,-0.13828,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.093897,-0.10799,-0.10184,0,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.17653,-0.10847,-0.1052,0,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.3746,-0.10848,-0.052941,0,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.15015,-0.10849,-0.082656,0,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,0.33812,-0.10913,-0.072534,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.3746,-0.10914,-0.058926,0,0
1,GO METAL ION TRANSPORT,0.0015653,-0.10961,-0.10757,0,0
1,GO G0 TO G1 TRANSITION,0.188,-0.10986,-0.05441,0,0
1,GO AXIS SPECIFICATION,0.14769,-0.11015,-0.099656,0,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.012203,-0.11019,-0.12376,0,0
1,GO TORC1 SIGNALING,0.068167,-0.11076,-0.065832,0,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.29184,-0.11094,-0.083418,0,0
1,GO FATTY ACYL COA METABOLIC PROCESS,0.25363,-0.11099,-0.08684,0,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0069616,-0.11132,-0.11835,0,0
1,GO LUNG ALVEOLUS DEVELOPMENT,0.31232,-0.11141,-0.07751,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.092194,-0.11162,-0.17582,0,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.41842,-0.11223,-0.077615,0,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,0.009256,-0.11281,-0.095471,0,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.17374,-0.11318,-0.10155,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.9686,-0.11327,0.057145,0,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0022332,-0.11336,-0.13681,0,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.15773,-0.11404,-0.091281,0,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.05824,-0.11439,-0.11855,0,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.4598,-0.11458,-0.088247,0,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.04854,-0.11467,-0.10516,0,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.23937,-0.11516,-0.13505,0,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.0015653,-0.11519,-0.11821,0,0
1,GO MEMBRANE REPOLARIZATION,0.099158,-0.11565,-0.11818,0,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.014486,-0.11586,-0.079328,0,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.05161,-0.11621,-0.10936,0,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.4545,-0.11638,-0.012864,0,0
1,GO VASCULAR WOUND HEALING,0.34702,-0.11661,-0.12321,0,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.21905,-0.1171,-0.086263,0,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.025414,-0.11724,-0.13605,0,0
1,GO SPERMATID DIFFERENTIATION,0.092194,-0.11763,-0.068729,0,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.32506,-0.1177,-0.071907,0,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.047551,-0.11773,-0.14924,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.30815,-0.11776,-0.074917,0,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.097379,-0.11795,-0.2315,0,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.60272,-0.11812,-0.13195,0,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.007729,-0.11827,-0.12848,0,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,0.89907,-0.11947,0.006438,0,0
1,GO RHYTHMIC BEHAVIOR,0.055956,-0.11962,-0.1332,0,0
1,GO DENDRITE SELF AVOIDANCE,0.49227,-0.11965,-0.03216,0,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.32506,-0.11968,-0.079103,0,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.10096,-0.12019,-0.10696,0,0
1,GO POSITIVE REGULATION OF RNA SPLICING,0.0062634,-0.12019,-0.1157,0,0
1,GO CELL CELL SIGNALING,0.0017641,-0.1202,-0.10296,0,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.11841,-0.1203,-0.063914,0,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.17374,-0.1206,-0.084955,0,0
1,GO REGULATION OF RESPONSE TO FOOD,0.01282,-0.12087,-0.15683,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,0.75615,-0.12089,-0.0030187,0,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.019283,-0.12139,-0.14514,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.043763,-0.12188,-0.11089,0,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.010506,-0.12195,-0.11076,0,0
1,GO MATING BEHAVIOR,0.080955,-0.1228,-0.11263,0,0
1,GO NEURON PROJECTION GUIDANCE,0.035393,-0.12295,-0.14813,0,0
1,GO MECHANORECEPTOR DIFFERENTIATION,0.038561,-0.12302,-0.15491,0,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0010859,-0.1232,-0.16207,0,0
1,GO WATER HOMEOSTASIS,0.12908,-0.12331,-0.080501,0,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0060989,-0.12337,-0.1169,0,0
1,GO REGULATION OF SISTER CHROMATID COHESION,0.05161,-0.12361,-0.10406,0,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.11039,-0.12375,-0.10717,0,0
1,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.97557,-0.1238,0.084564,0,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.092194,-0.12382,-0.081806,0,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.28785,-0.12386,-0.11337,0,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.16828,-0.12406,-0.09491,0,0
1,GO FACIAL NERVE MORPHOGENESIS,0.42855,-0.12434,-0.031516,0,0
1,GO ION TRANSPORT,0.00054072,-0.12438,-0.11063,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.24288,-0.12467,-0.10663,0,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.016339,-0.1248,-0.13663,0,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.061812,-0.12493,-0.15178,0,0
1,GO DEVELOPMENTAL INDUCTION,0.13355,-0.12513,-0.10491,0,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.027188,-0.12513,-0.15857,0,0
1,GO BASIC AMINO ACID TRANSPORT,0.082489,-0.126,-0.17404,0,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.11841,-0.12609,-0.11589,0,0
1,GO KERATINIZATION,0.43883,-0.12627,-0.032139,0,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00095906,-0.12676,-0.14993,0,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.0083534,-0.12783,-0.15779,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0024367,-0.12791,-0.13514,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.035393,-0.12823,-0.15535,0,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.39858,-0.12849,-0.082637,0,0
1,GO HISTONE METHYLATION,0.019739,-0.1288,-0.10999,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.22905,-0.1307,-0.075353,0,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,0.1313,-0.13073,-0.17718,0,0
1,GO REGULATION OF CILIUM MOVEMENT,0.0057817,-0.13077,-0.1351,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,0.11636,-0.13082,-0.10862,0,0
1,GO REGULATION OF GLIOGENESIS,0.072231,-0.13097,-0.088005,0,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.12473,-0.13115,-0.089993,0,0
1,GO COLLATERAL SPROUTING,0.084046,-0.13119,-0.11517,0,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.050569,-0.1318,-0.21118,0,0
1,GO RESPONSE TO ETHER,0.188,-0.13189,-0.1226,0,0
1,GO REGULATION OF CARDIAC CONDUCTION,0.022165,-0.1326,-0.11899,0,0
1,GO PHOTOTRANSDUCTION,0.00028792,-0.1327,-0.16521,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.082489,-0.13289,-0.098471,0,0
1,GO PEPTIDYL LYSINE METHYLATION,0.073629,-0.133,-0.10455,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.073629,-0.13308,-0.10218,0,0
1,GO DEVELOPMENTAL CELL GROWTH,0.0040578,-0.13315,-0.14394,0,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,0.029719,-0.13363,-0.12353,0,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.012508,-0.13375,-0.12392,0,0
1,GO RENAL WATER HOMEOSTASIS,0.10654,-0.13451,-0.081744,0,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,0.35607,-0.13472,-0.070363,0,0
1,GO INNER EAR MORPHOGENESIS,0.10845,-0.13515,-0.11884,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.19095,-0.13522,-0.10032,0,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.22568,-0.1362,-0.088704,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.17374,-0.13622,-0.10955,0,0
1,GO NEUROGENESIS,0.0016129,-0.13646,-0.14252,0,0
1,GO FEVER GENERATION,0.31653,-0.13648,0.00010399,0,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,0.080955,-0.13672,-0.097187,0,0
1,GO RESPONSE TO AMINE,0.034637,-0.13686,-0.14695,0,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.011612,-0.13696,-0.18867,0,0
1,GO THYMUS DEVELOPMENT,0.20621,-0.13733,-0.076035,0,0
1,GO AXONAL TRANSPORT,0.013139,-0.13755,-0.18656,0,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0028141,-0.13761,-0.15567,0,0
1,GO PROTEIN MANNOSYLATION,0.10096,-0.13797,-0.084578,0,0
1,GO SECRETORY GRANULE ORGANIZATION,0.016339,-0.13803,-0.13001,0,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.072231,-0.13849,-0.096277,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.1313,-0.13852,-0.15787,0,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.059411,-0.13861,-0.10324,0,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.11235,-0.14026,-0.11405,0,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.00353,-0.14034,-0.1408,0,0
1,GO MICROTUBULE POLYMERIZATION,0.0042883,-0.14064,-0.15246,0,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.33812,-0.14086,-0.056322,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.98953,-0.1414,0.10248,0,0
1,GO HINDBRAIN MORPHOGENESIS,0.0030654,-0.14161,-0.16425,0,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.052669,-0.14279,-0.087929,0,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.11434,-0.14388,-0.088602,0,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.014138,-0.14407,-0.14845,0,0
1,GO REGULATION OF SYSTEM PROCESS,0.00074557,-0.14496,-0.13207,0,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00038934,-0.14547,-0.13882,0,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.27999,-0.1456,-0.086783,0,0
1,GO ION TRANSMEMBRANE TRANSPORT,0.00031859,-0.14569,-0.12992,0,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.15264,-0.14628,-0.075314,0,0
1,GO V D J RECOMBINATION,0.29586,-0.14638,-0.059817,0,0
1,GO NEURON PROJECTION ORGANIZATION,0.0079323,-0.14649,-0.17679,0,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.10654,-0.1472,-0.084693,0,0
1,GO FOREBRAIN CELL MIGRATION,0.013465,-0.14783,-0.18879,0,0
1,GO CELL PART MORPHOGENESIS,0.00047456,-0.14804,-0.18723,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.53167,-0.14804,-0.04572,0,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,0.00045924,-0.14856,-0.21584,0,0
1,GO REGULATION OF COLLATERAL SPROUTING,0.088862,-0.14858,-0.14791,0,0
1,GO CELL FATE DETERMINATION,0.038561,-0.14878,-0.1918,0,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.13583,-0.14883,-0.099871,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.50337,-0.14897,-0.027834,0,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.37932,-0.14905,-0.095574,0,0
1,GO HISTONE H3 K9 METHYLATION,0.015574,-0.15012,-0.13603,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.041967,-0.15031,-0.091093,0,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,0.014486,-0.15065,-0.15341,0,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.097379,-0.1507,-0.078266,0,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.15517,-0.15072,-0.075985,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00065623,-0.15123,-0.19428,0,0
1,GO SNARE COMPLEX ASSEMBLY,0.32938,-0.15149,-0.053491,0,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.093897,-0.15151,-0.078321,0,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,0.47049,-0.15169,-0.072147,0,0
1,GO SENSORY PERCEPTION,0.00013433,-0.15191,-0.13562,0,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.011326,-0.15193,-0.12955,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.061812,-0.15229,-0.14806,0,0
1,GO REGULATION OF HISTONE METHYLATION,0.03245,-0.15287,-0.1077,0,0
1,GO GAMMA DELTA T CELL ACTIVATION,0.48678,-0.15301,-0.075657,0,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.030383,-0.15336,-0.1759,0,0
1,GO CATION TRANSPORT,9.0551e-05,-0.15391,-0.14131,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.91293,-0.15394,0.18905,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.19695,-0.15495,-0.10817,0,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,0.00074557,-0.15502,-0.16599,0,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.35607,-0.15523,-0.059814,0,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.073629,-0.1554,-0.16844,0,0
1,GO REGULATION OF APPETITE,0.00074557,-0.15555,-0.16978,0,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.188,-0.15605,-0.097157,0,0
1,GO HISTONE H2A MONOUBIQUITINATION,0.15773,-0.15633,-0.090659,0,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.013465,-0.15648,-0.12251,0,0
1,GO FOREBRAIN DEVELOPMENT,0.0006154,-0.15704,-0.17901,0,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0014299,-0.15779,-0.19366,0,0
1,GO RESPONSE TO EPINEPHRINE,0.21256,-0.15785,-0.14168,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.19095,-0.15819,-0.13245,0,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.84397,-0.15821,0.0021654,0,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.072231,-0.1585,-0.15652,0,0
1,GO SODIUM ION TRANSPORT,0.00049035,-0.15864,-0.16222,0,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.12259,-0.15881,-0.060081,0,0
1,GO TELENCEPHALON DEVELOPMENT,0.0011199,-0.15892,-0.1689,0,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.077957,-0.15991,-0.11827,0,0
1,GO REGULATION OF ACROSOME REACTION,0.17934,-0.16064,-0.1295,0,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.00095906,-0.16073,-0.14234,0,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0025083,-0.16108,-0.23962,0,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.17099,-0.16119,-0.12554,0,0
1,GO PHAGOLYSOSOME ASSEMBLY,0.12259,-0.16153,-0.14126,0,0
1,GO PROTEIN METHYLATION,0.010506,-0.16261,-0.11807,0,0
1,GO INTRACILIARY TRANSPORT,0.25001,-0.16272,-0.076328,0,0
1,GO COPULATION,0.097379,-0.16357,-0.12473,0,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0059384,-0.16393,-0.20144,0,0
1,GO MELANOCYTE DIFFERENTIATION,0.15015,-0.16397,-0.10899,0,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.10845,-0.16399,-0.11622,0,0
1,GO CATION TRANSMEMBRANE TRANSPORT,0.00018427,-0.16409,-0.14442,0,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.031748,-0.16453,-0.20804,0,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.014138,-0.16486,-0.184,0,0
1,GO PROTEIN DEPOLYMERIZATION,0.0011199,-0.16551,-0.19734,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00047456,-0.1667,-0.13817,0,0
1,GO CEREBRAL CORTEX CELL MIGRATION,0.050569,-0.16673,-0.19637,0,0
1,GO NEURON REMODELING,0.89907,-0.16691,0.014911,0,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.11636,-0.16733,-0.080671,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.59664,-0.16757,-0.001958,0,0
1,GO EATING BEHAVIOR,0.0022332,-0.16882,-0.15667,0,0
1,GO COCHLEA DEVELOPMENT,0.0067808,-0.16888,-0.22891,0,0
1,GO NUCLEAR BODY ORGANIZATION,0.018398,-0.16935,-0.21607,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.30402,-0.16954,-0.078514,0,0
1,GO AXON DEVELOPMENT,0.0038387,-0.16958,-0.17539,0,0
1,GO RESPONSE TO POTASSIUM ION,0.027803,-0.16962,-0.26194,0,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.030383,-0.16962,-0.17567,0,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.0094949,-0.16998,-0.22641,0,0
1,GO INTESTINAL ABSORPTION,0.065563,-0.16999,-0.15259,0,0
1,GO GDP METABOLIC PROCESS,0.079444,-0.17052,-0.20981,0,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00017186,-0.17063,-0.14593,0,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.046579,-0.17071,-0.16264,0,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.0066042,-0.17077,-0.17809,0,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.31232,-0.1708,-0.081252,0,0
1,GO REGULATION OF CIRCADIAN RHYTHM,0.00012964,-0.17096,-0.17151,0,0
1,GO DETECTION OF LIGHT STIMULUS,1.5201e-05,-0.17101,-0.20078,0,0
1,GO HEART PROCESS,0.001191,-0.1712,-0.15392,0,0
1,GO REGULATION OF AXONOGENESIS,0.001228,-0.17133,-0.18332,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.036948,-0.17156,-0.19582,0,0
1,GO DORSAL AORTA DEVELOPMENT,0.20309,-0.17178,-0.10494,0,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.188,-0.17218,-0.059347,0,0
1,GO RESPONSE TO AMINO ACID STARVATION,0.0059384,-0.17306,-0.13847,0,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.029068,-0.17309,-0.13377,0,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0023671,-0.17339,-0.19218,0,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00054072,-0.17341,-0.18144,0,0
1,GO HISTONE H3 K4 METHYLATION,0.031748,-0.1741,-0.17834,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0010206,-0.17465,-0.19203,0,0
1,GO CELL AGGREGATION,0.40843,-0.17482,-0.043873,0,0
1,GO POSITIVE REGULATION OF HEART RATE,0.39858,-0.17488,-0.045296,0,0
1,GO REGULATION OF NEURON DIFFERENTIATION,0.00044439,-0.17532,-0.1898,0,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.05161,-0.17589,-0.20588,0,0
1,GO MAINTENANCE OF CELL POLARITY,0.0079323,-0.17608,-0.16461,0,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.010773,-0.17704,-0.17538,0,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.024846,-0.17706,-0.16326,0,0
1,GO VESICLE DOCKING,0.00049035,-0.17778,-0.18084,0,0
1,GO REGULATION OF BEHAVIOR,0.00353,-0.17809,-0.16839,0,0
1,GO REGULATION OF SODIUM ION TRANSPORT,0.011047,-0.17817,-0.15319,0,0
1,GO STRIATED MUSCLE CONTRACTION,0.0056288,-0.17838,-0.14052,0,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00019079,-0.17845,-0.18921,0,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0039469,-0.17873,-0.13998,0,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.033894,-0.17936,-0.17475,0,0
1,GO MEMBRANE FISSION,0.0040578,-0.17975,-0.24154,0,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.095625,-0.18034,-0.19001,0,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.041967,-0.1806,-0.22047,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0021062,-0.1811,-0.20849,0,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.041093,-0.18123,-0.14111,0,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0016129,-0.18186,-0.18645,0,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0019282,-0.18192,-0.19686,0,0
1,GO CARDIAC MUSCLE CONTRACTION,0.02068,-0.1822,-0.11995,0,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0062634,-0.18222,-0.31811,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.26471,-0.18258,-0.14325,0,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,0.05824,-0.18308,-0.13084,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.15264,-0.18348,-0.15089,0,0
1,GO EAR DEVELOPMENT,0.030383,-0.18412,-0.14805,0,0
1,GO POSITIVE REGULATION OF CELL MATURATION,0.36064,-0.18436,-0.096441,0,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.38408,-0.18438,-0.079484,0,0
1,GO RESPONSE TO FORSKOLIN,0.16828,-0.18464,-0.14449,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.14048,-0.18474,-0.012324,0,0
1,GO DEVELOPMENTAL MATURATION,0.00010462,-0.18481,-0.18294,0,0
1,GO SPERM AXONEME ASSEMBLY,0.10845,-0.18489,-0.12393,0,0
1,GO TOXIN METABOLIC PROCESS,0.11636,-0.18491,-0.16252,0,0
1,GO CARDIOBLAST PROLIFERATION,0.053746,-0.18513,-0.31187,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.05824,-0.18524,-0.18217,0,0
1,GO SLEEP,0.0017641,-0.18585,-0.17507,0,0
1,GO DENDRITIC SPINE DEVELOPMENT,0.010506,-0.18603,-0.16059,0,0
1,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.088862,-0.18694,-0.20786,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.42347,-0.18696,-0.10243,0,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00098941,-0.18738,-0.18588,0,0
1,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.00035231,-0.18738,-0.24052,0,0
1,GO IMPORT INTO CELL,0.0040578,-0.1881,-0.13749,0,0
1,GO LONG TERM SYNAPTIC POTENTIATION,0.0079323,-0.18847,-0.1644,0,0
1,GO REGULATION OF CHROMATIN BINDING,0.011612,-0.18873,-0.17581,0,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.013798,-0.18957,-0.2129,0,0
1,GO NEURON DEVELOPMENT,0.00018427,-0.18983,-0.18698,0,0
1,GO RESPONSE TO CAFFEINE,0.17099,-0.19011,-0.1043,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00072223,-0.19061,-0.22595,0,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,0.017137,-0.19204,-0.17331,0,0
1,GO NERVOUS SYSTEM PROCESS,1.5331e-06,-0.19211,-0.19309,0,0
1,GO SECONDARY PALATE DEVELOPMENT,0.018836,-0.19282,-0.16932,0,0
1,GO RESPONSE TO ALKALOID,7.3528e-06,-0.19348,-0.2091,0,0
1,GO NEURON DIFFERENTIATION,0.00011241,-0.19386,-0.18914,0,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0075304,-0.19403,-0.20219,0,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00014935,-0.19555,-0.17234,0,0
1,GO STRIATUM DEVELOPMENT,0.001191,-0.19617,-0.26527,0,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0020453,-0.19675,-0.23024,0,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.16828,-0.19696,-0.12968,0,0
1,GO NEUROMUSCULAR PROCESS,0.00020448,-0.19696,-0.2066,0,0
1,GO POSTSYNAPSE ORGANIZATION,0.00042998,-0.19794,-0.22709,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.0081404,-0.19798,-0.23041,0,0
1,GO DETECTION OF VISIBLE LIGHT,7.2754e-05,-0.1987,-0.1889,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.014138,-0.1988,-0.17317,0,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0017641,-0.19916,-0.17046,0,0
1,GO SPINAL CORD DEVELOPMENT,0.001191,-0.20009,-0.23352,0,0
1,GO RESPONSE TO AMPHETAMINE,0.00069957,-0.20037,-0.26445,0,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.52025,-0.20159,-0.035516,0,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00018427,-0.2027,-0.19856,0,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.00063551,-0.20407,-0.25677,0,0
1,GO PALLIUM DEVELOPMENT,0.0021062,-0.20428,-0.18776,0,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,5.0226e-05,-0.20447,-0.19802,0,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.087232,-0.20514,-0.18282,0,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.024846,-0.2052,-0.22233,0,0
1,GO ORGANIC CATION TRANSPORT,0.00014935,-0.20551,-0.23982,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0013457,-0.20596,-0.22565,0,0
1,GO MESODERMAL CELL FATE SPECIFICATION,0.14526,-0.20692,-0.21669,0,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,5.6174e-05,-0.20694,-0.22937,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.17653,-0.20716,-0.11403,0,0
1,GO NEURON PROJECTION EXTENSION,0.0023671,-0.20769,-0.17501,0,0
1,GO PROTEIN POLYGLUTAMYLATION,0.00044439,-0.20791,-0.25942,0,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00037661,-0.20835,-0.18521,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.029068,-0.20849,-0.19217,0,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.044685,-0.20977,-0.21806,0,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,6.5149e-05,-0.2101,-0.18966,0,0
1,GO PRESYNAPSE ORGANIZATION,0.001662,-0.21027,-0.25418,0,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.004408,-0.21182,-0.20445,0,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.001986,-0.21268,-0.21331,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0051916,-0.2138,-0.21394,0,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00021909,-0.21394,-0.22377,0,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.20937,-0.21464,-0.14712,0,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0083534,-0.21519,-0.19565,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0023671,-0.21623,-0.20947,0,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,9.7346e-05,-0.21633,-0.26886,0,0
1,GO RESPONSE TO FOOD,6.2786e-05,-0.21685,-0.19497,0,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0036303,-0.21693,-0.24892,0,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,3.1888e-05,-0.21705,-0.20959,0,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,7.8282e-05,-0.21787,-0.20128,0,0
1,GO CEREBRAL CORTEX DEVELOPMENT,0.012203,-0.21945,-0.16643,0,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0075304,-0.21965,-0.21892,0,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0015189,-0.21973,-0.19647,0,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0015189,-0.21988,-0.20264,0,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,0.068167,-0.22149,-0.12375,0,0
1,GO REGULATION OF CELL MATURATION,0.0050528,-0.22172,-0.19846,0,0
1,GO VISUAL BEHAVIOR,0.00012512,-0.22191,-0.20002,0,0
1,GO COGNITION,3.1888e-05,-0.22251,-0.20829,0,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,5.2139e-05,-0.22292,-0.22963,0,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.015574,-0.22301,-0.25446,0,0
1,GO ACROSOME REACTION,0.0085714,-0.22302,-0.16377,0,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.28785,-0.22322,-0.079165,0,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00018427,-0.22328,-0.31649,0,0
1,GO ADHERENS JUNCTION ORGANIZATION,0.0056288,-0.22367,-0.2223,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0057817,-0.22455,-0.24758,0,0
1,GO FILOPODIUM ASSEMBLY,0.009256,-0.22496,-0.18834,0,0
1,GO CLATHRIN COAT ASSEMBLY,0.015953,-0.22503,-0.22439,0,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00044439,-0.22523,-0.16763,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.17374,-0.22581,-0.12605,0,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0071468,-0.22632,-0.14732,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00353,-0.22656,-0.14359,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0016129,-0.22733,-0.19763,0,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00010462,-0.22735,-0.26896,0,0
1,GO MICROTUBULE BUNDLE FORMATION,0.010506,-0.22815,-0.13835,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.10654,-0.22934,-0.15261,0,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,0.00092958,-0.22945,-0.24997,0,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0032441,-0.2298,-0.16121,0,0
1,GO REGULATION OF MICROTUBULE BINDING,0.00014935,-0.2308,-0.25999,0,0
1,GO RESPONSE TO CATECHOLAMINE,5.0226e-05,-0.23128,-0.21257,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.033166,-0.23141,-0.17884,0,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.013798,-0.23156,-0.21051,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.064293,-0.23175,-0.16791,0,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.0027346,-0.23206,-0.15759,0,0
1,GO MEMORY,5.8301e-05,-0.23357,-0.2095,0,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.038561,-0.23387,-0.30096,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.0022992,-0.23414,-0.2392,0,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.041093,-0.23467,-0.15478,0,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.37932,-0.23486,-0.079674,0,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,1.1267e-06,-0.23566,-0.22598,0,0
1,GO EMBRYONIC AXIS SPECIFICATION,0.0019282,-0.23587,-0.25157,0,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0094949,-0.23607,-0.28894,0,0
1,GO CRANIAL NERVE DEVELOPMENT,0.0019282,-0.23756,-0.24088,0,0
1,GO BEHAVIOR,1.6015e-06,-0.23774,-0.23389,0,0
1,GO LONG TERM SYNAPTIC DEPRESSION,0.00014935,-0.23833,-0.31024,0,0
1,GO RESPONSE TO HYDROXYUREA,0.0090226,-0.23848,-0.19989,0,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.22235,-0.2394,-0.090355,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.0064317,-0.23963,-0.22665,0,0
1,GO SEX DETERMINATION,0.018836,-0.24037,-0.18506,0,0
1,GO LIMBIC SYSTEM DEVELOPMENT,0.00087311,-0.2435,-0.24177,0,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00059588,-0.24438,-0.1798,0,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.017137,-0.24501,-0.22002,0,0
1,GO HIPPOCAMPUS DEVELOPMENT,0.00045924,-0.24531,-0.26896,0,0
1,GO EPITHELIAL CELL MORPHOGENESIS,0.40349,-0.24534,-0.075859,0,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.0011199,-0.24542,-0.2267,0,0
1,GO TUBULIN DEACETYLATION,0.010506,-0.24588,-0.25841,0,0
1,GO REGULATION OF FLAGELLATED SPERM MOTILITY,4.3218e-05,-0.24648,-0.21257,0,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.5816e-05,-0.24696,-0.22421,0,0
1,GO HEAT GENERATION,0.15264,-0.24747,-0.13513,0,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,0.00098941,-0.24832,-0.20563,0,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,6.7728e-06,-0.24972,-0.2284,0,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00059588,-0.25075,-0.24868,0,0
1,GO CARDIAC CONDUCTION,0.00021909,-0.25079,-0.2507,0,0
1,GO PANCREAS DEVELOPMENT,0.004408,-0.25112,-0.19693,0,0
1,GO HEART FIELD SPECIFICATION,0.14048,-0.25182,-0.17666,0,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0062634,-0.25348,-0.24668,0,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.0067808,-0.25402,-0.31646,0,0
1,GO DETECTION OF ABIOTIC STIMULUS,2.8891e-07,-0.25422,-0.27673,0,0
1,GO MICROTUBULE DEPOLYMERIZATION,3.4421e-05,-0.25483,-0.34172,0,0
1,GO FOREBRAIN REGIONALIZATION,0.00095906,-0.25496,-0.31716,0,0
1,GO RESPONSE TO DOPAMINE,3.6228e-06,-0.25522,-0.24172,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,3.3132e-05,-0.25555,-0.30201,0,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00023468,-0.25661,-0.28742,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.034637,-0.25673,-0.17575,0,0
1,GO REGULATION OF HEART RATE,0.00055855,-0.25768,-0.2275,0,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00026903,-0.25787,-0.26308,0,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.097379,-0.25809,-0.21569,0,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.095625,-0.25824,-0.18291,0,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0020453,-0.25824,-0.20997,0,0
1,GO CHROMATIN SILENCING AT TELOMERE,2.8418e-05,-0.25832,-0.24474,0,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.00087311,-0.25932,-0.29029,0,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0026572,-0.26008,-0.26695,0,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.00054072,-0.26042,-0.3051,0,0
1,GO AMINO ACID TRANSPORT,1.2454e-05,-0.26044,-0.23429,0,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.063042,-0.26044,-0.14921,0,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,0.017969,-0.26077,-0.20764,0,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,1.7118e-05,-0.26132,-0.28991,0,0
1,GO CAMP BIOSYNTHETIC PROCESS,0.0038387,-0.26581,-0.26899,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0075304,-0.26772,-0.22545,0,0
1,GO AXONEME ASSEMBLY,0.036948,-0.26925,-0.16311,0,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.00017186,-0.26984,-0.24979,0,0
1,GO RESPONSE TO LIGHT INTENSITY,0.00010845,-0.27176,-0.33082,0,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.0015189,-0.27176,-0.26704,0,0
1,GO IMMATURE B CELL DIFFERENTIATION,0.027803,-0.27203,-0.16637,0,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.014138,-0.27258,-0.33075,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.0036303,-0.27272,-0.20814,0,0
1,GO ACTIN FILAMENT BASED TRANSPORT,0.04854,-0.27299,-0.18057,0,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00014935,-0.2733,-0.36208,0,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,3.7145e-05,-0.27462,-0.32275,0,0
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.030383,-0.27639,-0.3531,0,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.064293,-0.27689,-0.27196,0,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,2.2524e-05,-0.27798,-0.2674,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.033166,-0.27859,-0.27392,0,0
1,GO FOREBRAIN GENERATION OF NEURONS,0.00031859,-0.27989,-0.32567,0,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,1.1493e-05,-0.28118,-0.31402,0,0
1,GO DETECTION OF MECHANICAL STIMULUS,2.8418e-05,-0.28245,-0.29648,0,0
1,GO DENDRITIC SPINE MORPHOGENESIS,0.0019282,-0.28261,-0.27632,0,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,6.7596e-05,-0.28276,-0.26487,0,0
1,GO LIPOXYGENASE PATHWAY,0.033166,-0.28313,-0.25181,0,0
1,GO SENSORY PERCEPTION OF PAIN,3.0576e-06,-0.2845,-0.25554,0,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.00014418,-0.28486,-0.35368,0,0
1,GO RELAXATION OF MUSCLE,0.017549,-0.28495,-0.19984,0,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.013798,-0.28526,-0.18513,0,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0017123,-0.28765,-0.29757,0,0
1,GO CELL JUNCTION MAINTENANCE,0.0085714,-0.28811,-0.24497,0,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0031536,-0.28811,-0.24646,0,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0013872,-0.28945,-0.31933,0,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,9.0221e-07,-0.2901,-0.27297,0,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0028957,-0.29031,-0.26799,0,0
1,GO SYNAPSE ORGANIZATION,4.8379e-05,-0.29118,-0.2744,0,0
1,GO NEURON PROJECTION ARBORIZATION,0.0085714,-0.29145,-0.20999,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015653,-0.2928,-0.3179,0,0
1,GO HISTONE H4 K5 ACETYLATION,9.7346e-05,-0.29457,-0.27925,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.12259,-0.29589,-0.19524,0,0
1,GO HINDBRAIN DEVELOPMENT,7.6603e-06,-0.29671,-0.2796,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.053746,-0.29712,-0.20814,0,0
1,GO DENDRITE MORPHOGENESIS,6.0504e-05,-0.29767,-0.28516,0,0
1,GO RESPONSE TO NICOTINE,0.0015189,-0.2979,-0.24438,0,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.04854,-0.29832,-0.20213,0,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00037661,-0.29836,-0.33325,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.035393,-0.29844,-0.44101,0,0
1,GO CELL MIGRATION IN HINDBRAIN,0.00019079,-0.29885,-0.38279,0,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,4.0073e-05,-0.29887,-0.29831,0,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.037747,-0.29933,-0.23857,0,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0029794,-0.29998,-0.2612,0,0
1,GO NERVE DEVELOPMENT,9.389e-05,-0.30094,-0.29098,0,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,9.7801e-06,-0.30096,-0.36836,0,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00034072,-0.303,-0.29475,0,0
1,GO POTASSIUM ION HOMEOSTASIS,0.001986,-0.30379,-0.22797,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.7806e-05,-0.30427,-0.2833,0,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,0.00013917,-0.30615,-0.25575,0,0
1,GO DENDRITE DEVELOPMENT,3.5759e-05,-0.30649,-0.26934,0,0
1,GO SKELETAL MUSCLE ADAPTATION,0.013465,-0.30721,-0.2044,0,0
1,GO SOMATIC STEM CELL DIVISION,0.43367,-0.308,-0.091122,0,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.011612,-0.30827,-0.26001,0,0
1,GO PROTEIN PALMITOYLATION,2.1702e-06,-0.3094,-0.31599,0,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.001191,-0.31046,-0.36209,0,0
1,GO RESPONSE TO MAGNESIUM ION,0.00353,-0.31211,-0.29406,0,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,4.4712e-06,-0.31241,-0.32267,0,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.00013433,-0.31322,-0.25645,0,0
1,GO NOREPINEPHRINE SECRETION,0.00017796,-0.31395,-0.29508,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.001872,-0.31486,-0.23635,0,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0057817,-0.3161,-0.29429,0,0
1,GO ACIDIC AMINO ACID TRANSPORT,1.5816e-05,-0.31615,-0.28972,0,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,2.1831e-07,-0.31759,-0.32494,0,0
1,GO NEURON CELLULAR HOMEOSTASIS,0.00079435,-0.31843,-0.31942,0,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0013054,-0.31857,-0.31559,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0011199,-0.3187,-0.28771,0,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0001547,-0.31903,-0.309,0,0
1,GO POSITIVE REGULATION OF CILIUM MOVEMENT,1.8521e-05,-0.31955,-0.29098,0,0
1,GO ADRENAL GLAND DEVELOPMENT,0.00016595,-0.32048,-0.34704,0,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,1.104e-05,-0.32062,-0.29527,0,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,3.4728e-06,-0.3212,-0.32465,0,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0011199,-0.32124,-0.33889,0,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.012203,-0.32282,-0.29404,0,0
1,GO ACTION POTENTIAL,1.4039e-05,-0.32453,-0.31952,0,0
1,GO ASSOCIATIVE LEARNING,3.4421e-05,-0.32529,-0.26414,0,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0033369,-0.32553,-0.26675,0,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0001165,-0.32646,-0.2938,0,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.0013872,-0.32699,-0.30974,0,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,4.1617e-05,-0.32726,-0.27332,0,0
1,GO FAT CELL PROLIFERATION,0.00092958,-0.32759,-0.33829,0,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0087944,-0.32948,-0.22734,0,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.033166,-0.32951,-0.19051,0,0
1,GO SYNAPTIC VESICLE RECYCLING,3.7791e-06,-0.32967,-0.35435,0,0
1,GO SYNAPTIC VESICLE TRANSPORT,1.6455e-05,-0.33029,-0.33875,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0022332,-0.33055,-0.27774,0,0
1,GO DICARBOXYLIC ACID TRANSPORT,1.349e-05,-0.33069,-0.24707,0,0
1,GO OTIC VESICLE MORPHOGENESIS,0.15015,-0.33144,-0.27934,0,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,1.8521e-05,-0.33144,-0.37618,0,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,2.4346e-05,-0.33257,-0.32319,0,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,1.7474e-06,-0.33419,-0.38169,0,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,6.4994e-06,-0.33472,-0.33533,0,0
1,GO PITUITARY GLAND DEVELOPMENT,8.1192e-05,-0.33561,-0.39731,0,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,1.4039e-05,-0.33621,-0.31332,0,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0021062,-0.33752,-0.22641,0,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0057817,-0.33924,-0.22468,0,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0071468,-0.33985,-0.32526,0,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.00047456,-0.3403,-0.29467,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,4.8379e-05,-0.34081,-0.36783,0,0
1,GO REGULATION OF MEMBRANE POTENTIAL,3.6414e-07,-0.34233,-0.33906,0,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,2.5308e-05,-0.34264,-0.39705,0,0
1,GO MITOCHONDRION LOCALIZATION,0.00059588,-0.34275,-0.26695,0,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.04854,-0.34298,-0.24134,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.04854,-0.34382,-0.18396,0,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0010206,-0.34488,-0.28774,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.001228,-0.34622,-0.33225,0,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,5.9841e-06,-0.34713,-0.39179,0,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.0085714,-0.3472,-0.24987,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0083534,-0.34736,-0.29459,0,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0013872,-0.34781,-0.33078,0,0
1,GO LEARNING,6.2367e-06,-0.34827,-0.311,0,0
1,GO NEURON MIGRATION,5.8301e-05,-0.34908,-0.34179,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.04854,-0.34925,-0.27695,0,0
1,GO SEGMENT SPECIFICATION,0.00024286,-0.35193,-0.44501,0,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,7.547e-05,-0.3536,-0.39104,0,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.017137,-0.35613,-0.33759,0,0
1,GO METENCEPHALON DEVELOPMENT,6.5896e-07,-0.35615,-0.37689,0,0
1,GO REGULATION OF EXOCYTOSIS,6.5896e-07,-0.35666,-0.32215,0,0
1,GO NEURAL RETINA DEVELOPMENT,1.7806e-05,-0.35859,-0.40908,0,0
1,GO RESPONSE TO LEUCINE,0.0081404,-0.35924,-0.34088,0,0
1,GO MEMBRANE DEPOLARIZATION,4.0073e-05,-0.3596,-0.30365,0,0
1,GO LOCOMOTORY BEHAVIOR,1.0207e-07,-0.36024,-0.39737,0,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0041716,-0.36031,-0.31871,0,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,0.060602,-0.36125,-0.2284,0,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.011326,-0.36236,-0.25576,0,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,7.9801e-06,-0.36275,-0.44363,0,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00022676,-0.36544,-0.32334,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,7.0571e-06,-0.36563,-0.40406,0,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.2454e-05,-0.36704,-0.38679,0,0
1,GO SYNAPTIC SIGNALING,6.8936e-07,-0.3675,-0.33074,0,0
1,GO POTASSIUM ION TRANSPORT,2.2879e-07,-0.36758,-0.34299,0,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00087311,-0.3732,-0.51219,0,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.00019079,-0.37346,-0.37308,0,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,1.8251e-06,-0.37423,-0.34575,0,0
1,GO MALE SEX DETERMINATION,0.021165,-0.37695,-0.26779,0,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00050664,-0.3772,-0.33152,0,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00012074,-0.37799,-0.38659,0,0
1,GO WALKING BEHAVIOR,2.0033e-05,-0.37866,-0.36476,0,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.00067758,-0.37943,-0.33077,0,0
1,GO NOREPINEPHRINE TRANSPORT,0.00019079,-0.38079,-0.3106,0,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,1.3441e-06,-0.38235,-0.37983,0,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.5201e-05,-0.3841,-0.44977,0,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00063551,-0.38474,-0.3302,0,0
1,GO RESPONSE TO ACETYLCHOLINE,0.00032948,-0.38529,-0.33204,0,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00026903,-0.38823,-0.34683,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,1.5201e-05,-0.38882,-0.37773,0,0
1,GO POSTSYNAPSE ASSEMBLY,0.0020453,-0.3896,-0.40637,0,0
1,GO REGULATION OF TUBULIN DEACETYLATION,0.00067758,-0.39162,-0.44077,0,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0066042,-0.39576,-0.29404,0,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,2.0033e-05,-0.39669,-0.35414,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00034072,-0.39817,-0.34173,0,0
1,GO MRNA SPLICE SITE SELECTION,1.5201e-05,-0.39984,-0.36815,0,0
1,GO GLIAL CELL FATE COMMITMENT,0.0015653,-0.39988,-0.50952,0,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,3.1904e-06,-0.40043,-0.38782,0,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00042998,-0.40157,-0.44765,0,0
1,GO RESPONSE TO COCAINE,1.5691e-07,-0.40183,-0.44614,0,0
1,GO NEUROTRANSMITTER REUPTAKE,4.1112e-06,-0.40183,-0.40261,0,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0006154,-0.4049,-0.38452,0,0
1,GO NEURON RECOGNITION,1.4039e-05,-0.40569,-0.44644,0,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,4.1112e-06,-0.40674,-0.36857,0,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,1.4268e-07,-0.40682,-0.38878,0,0
1,GO SECRETORY GRANULE LOCALIZATION,0.00024286,-0.41139,-0.59317,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.79636,-0.41216,0.061913,0,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,6.7728e-06,-0.41244,-0.44056,0,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.00025131,-0.4137,-0.34935,0,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.00067758,-0.41501,-0.36714,0,0
1,GO LUNG EPITHELIUM DEVELOPMENT,0.020205,-0.41545,-0.24202,0,0
1,GO RELAXATION OF CARDIAC MUSCLE,0.0049174,-0.41594,-0.36698,0,0
1,GO RETROGRADE TRANS SYNAPTIC SIGNALING,7.8282e-05,-0.41906,-0.55562,0,0
1,GO PRESYNAPTIC ENDOCYTOSIS,3.0576e-06,-0.41998,-0.39135,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.5331e-06,-0.42301,-0.40686,0,0
1,GO REGULATION OF HEAT GENERATION,0.015953,-0.4238,-0.31765,0,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.017137,-0.42502,-0.36486,0,0
1,GO REGULATION OF AMINO ACID TRANSPORT,2.5122e-07,-0.42545,-0.44145,0,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0014299,-0.42584,-0.37092,0,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,2.6307e-05,-0.4263,-0.41521,0,0
1,GO ADULT LOCOMOTORY BEHAVIOR,4.9191e-08,-0.4272,-0.45676,0,0
1,GO SYNAPSE ASSEMBLY,1.6015e-06,-0.42938,-0.42414,0,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,6.8936e-07,-0.43133,-0.44275,0,0
1,GO PARENTAL BEHAVIOR,0.00020448,-0.43186,-0.39798,0,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,2.1663e-05,-0.43205,-0.50871,0,0
1,GO TRANSMISSION OF NERVE IMPULSE,5.2533e-07,-0.43317,-0.4643,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.050569,-0.43332,-0.25224,0,0
1,GO SEROTONIN TRANSPORT,2.1831e-07,-0.43436,-0.58001,0,0
1,GO ADULT BEHAVIOR,3.6563e-08,-0.43592,-0.50759,0,0
1,GO DIENCEPHALON DEVELOPMENT,1.0604e-05,-0.43668,-0.36463,0,0
1,GO OTIC VESICLE DEVELOPMENT,0.057089,-0.43677,-0.24226,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,9.389e-05,-0.43724,-0.42603,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,8.7323e-05,-0.44488,-0.38641,0,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.2862e-06,-0.44555,-0.41116,0,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00011241,-0.44581,-0.50964,0,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,2.0833e-05,-0.45042,-0.52153,0,0
1,GO NEURON MATURATION,5.2837e-06,-0.45356,-0.43091,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,5.0683e-06,-0.45367,-0.40434,0,0
1,GO ENDOCARDIUM DEVELOPMENT,0.0695,-0.45783,-0.23081,0,0
1,GO LIMB BUD FORMATION,0.22235,-0.46012,-0.16276,0,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,5.4272e-08,-0.46269,-0.54371,0,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.0207e-07,-0.46281,-0.44451,0,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,5.4121e-05,-0.46289,-0.43763,0,0
1,GO PYRAMIDAL NEURON DIFFERENTIATION,0.019283,-0.4665,-0.44787,0,0
1,GO MEGAKARYOCYTE DEVELOPMENT,0.00057693,-0.46746,-0.38436,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,5.6174e-05,-0.46947,-0.46808,0,0
1,GO NEUROTRANSMITTER UPTAKE,6.4994e-06,-0.47043,-0.38323,0,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.00036427,-0.477,-0.40535,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.00019079,-0.47711,-0.39609,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,1.6729e-06,-0.47716,-0.4941,0,0
1,GO SUBPALLIUM DEVELOPMENT,5.2139e-05,-0.47814,-0.43461,0,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.00065623,-0.48095,-0.32073,0,0
1,GO AXONAL FASCICULATION,0.001191,-0.48472,-0.46814,0,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,1.104e-05,-0.48527,-0.54599,0,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,4.4878e-05,-0.48581,-0.41638,0,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,3.0264e-07,-0.48934,-0.49617,0,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0038387,-0.49498,-0.50842,0,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,8.6584e-06,-0.49535,-0.45978,0,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,6.2985e-07,-0.49949,-0.50382,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,4.2876e-06,-0.50169,-0.42875,0,0
1,GO CATECHOLAMINE UPTAKE,1.1493e-05,-0.50302,-0.4399,0,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.2,-0.50354,-0.20063,0,0
1,GO CEREBELLAR CORTEX FORMATION,3.9926e-07,-0.5063,-0.52608,0,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,6.2859e-08,-0.50635,-0.49741,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,2.8077e-06,-0.50796,-0.54827,0,0
1,GO NEURON FATE COMMITMENT,2.6902e-06,-0.50975,-0.64711,0,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,1.6455e-05,-0.5109,-0.36296,0,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0085714,-0.51113,-0.46464,0,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00054072,-0.51333,-0.42654,0,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.041093,-0.51574,-0.25513,0,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,9.8628e-07,-0.51629,-0.4672,0,0
1,GO EPITHELIAL CELL MATURATION,2.3418e-05,-0.51645,-0.49395,0,0
1,GO CGMP METABOLIC PROCESS,1.4674e-06,-0.51939,-0.54224,0,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00067758,-0.51969,-0.42581,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,1.2862e-06,-0.52704,-0.56323,0,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,1.6729e-06,-0.52774,-0.53412,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,9.3916e-06,-0.53045,-0.48635,0,0
1,GO NEURAL NUCLEUS DEVELOPMENT,1.3441e-06,-0.53337,-0.46478,0,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,7.5427e-07,-0.53377,-0.57045,0,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,1.5201e-05,-0.53483,-0.5575,0,0
1,GO GROOMING BEHAVIOR,2.9301e-06,-0.53668,-0.47006,0,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00014418,-0.54045,-0.4434,0,0
1,GO REGULATION OF VESICLE FUSION,9.0551e-05,-0.54171,-0.45695,0,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.017969,-0.54359,-0.33639,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,1.4963e-07,-0.54818,-0.52911,0,0
1,GO GLUTAMATE SECRETION,2.2658e-06,-0.5485,-0.47971,0,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,3.3202e-07,-0.55192,-0.54546,0,0
1,GO ADENOHYPOPHYSIS DEVELOPMENT,6.0504e-05,-0.55287,-0.61416,0,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,2.5122e-07,-0.55375,-0.53635,0,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,1.104e-05,-0.55515,-0.48655,0,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00017186,-0.55907,-0.46098,0,0
1,GO REFLEX,0.00010462,-0.56442,-0.51893,0,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,4.8612e-06,-0.56795,-0.56727,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS,6.2985e-07,-0.56965,-0.60051,0,0
1,GO LUNG CELL DIFFERENTIATION,0.0045306,-0.57447,-0.4186,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,3.1904e-06,-0.57546,-0.56974,0,0
1,GO MAST CELL MIGRATION,0.00055855,-0.58071,-0.46882,0,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,1.0207e-07,-0.58284,-0.62252,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,5.9841e-06,-0.58404,-0.59955,0,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,2.0033e-05,-0.58472,-0.57017,0,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,1.104e-05,-0.58525,-0.62544,0,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,1.7806e-05,-0.58637,-0.58837,0,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,3.6414e-07,-0.58639,-0.58879,0,0
1,GO DETECTION OF CALCIUM ION,1.2454e-05,-0.58999,-0.55061,0,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,7.2111e-07,-0.59011,-0.53436,0,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,1.4963e-07,-0.59617,-0.56439,0,0
1,GO SYNAPTIC MEMBRANE ADHESION,0.0001165,-0.59644,-0.50978,0,0
1,GO SPINAL CORD PATTERNING,2.4346e-05,-0.59801,-0.55025,0,0
1,GO SIALYLATION,1.0311e-06,-0.6012,-0.57693,0,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,0.00052342,-0.60694,-0.59471,0,0
1,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,4.1617e-05,-0.60857,-0.48991,0,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,3.7791e-06,-0.60931,-0.53938,0,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,2.2658e-06,-0.61227,-0.68688,0,0
1,GO GROWTH HORMONE SECRETION,3.8131e-07,-0.61447,-0.57924,0,0
1,GO NEUROTRANSMITTER TRANSPORT,2.3975e-07,-0.61572,-0.58543,0,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,1.4609e-05,-0.61995,-0.61915,0,0
1,GO REGULATION OF SYNAPSE MATURATION,8.4205e-05,-0.62295,-0.58908,0,0
1,GO REGULATION OF GLUTAMATE SECRETION,6.8936e-07,-0.62414,-0.58199,0,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,5.0194e-07,-0.62708,-0.64379,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,1.2366e-07,-0.6331,-0.65215,0,0
1,GO NEURONAL ACTION POTENTIAL,2.0829e-07,-0.63542,-0.66671,0,0
1,GO DENTATE GYRUS DEVELOPMENT,0.00050664,-0.63696,-0.53389,0,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,6.0198e-07,-0.65651,-0.62372,0,0
1,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,1.6729e-06,-0.6579,-0.69032,0,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,3.7791e-06,-0.66067,-0.52279,0,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.20309,-0.66317,-0.3269,0,0
1,GO STARTLE RESPONSE,9.8628e-07,-0.66452,-0.55928,0,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,3.8131e-07,-0.66615,-0.61138,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,4.8379e-05,-0.66821,-0.71054,0,0
1,GO NEUROTRANSMITTER SECRETION,3.9926e-07,-0.67206,-0.63694,0,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,2.8891e-07,-0.69269,-0.67158,0,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,1.8084e-07,-0.7019,-0.68691,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,1.725e-07,-0.70374,-0.61103,0,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,4.1802e-07,-0.70621,-0.67119,0,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,6.5896e-07,-0.71008,-0.67468,0,0
1,GO THALAMUS DEVELOPMENT,1.9263e-05,-0.72111,-0.58447,0,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,6.93e-08,-0.72267,-0.68145,0,0
1,GO DENSE CORE GRANULE TRANSPORT,4.2876e-06,-0.7241,-0.94087,0,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,5.508e-06,-0.72507,-0.66077,0,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,3.7145e-05,-0.72507,-0.66917,0,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,2.8891e-07,-0.73801,-0.69229,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,9.7275e-08,-0.74019,-0.77244,0,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,5.508e-06,-0.74799,-0.62655,0,0
1,GO NEURON CELL CELL ADHESION,8.2505e-07,-0.74952,-0.92074,0,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,8.628e-07,-0.76166,-0.68228,0,0
1,GO SYNAPTIC VESICLE DOCKING,7.5427e-07,-0.76187,-0.75504,0,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,1.5816e-05,-0.76701,-0.6741,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,9.7275e-08,-0.76739,-0.76479,0,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,3.9926e-07,-0.76874,-0.74413,0,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,4.4712e-06,-0.77358,-0.70814,0,0
1,GO AMINE TRANSPORT,8.0176e-08,-0.77655,-0.67146,0,0
1,GO MONOAMINE TRANSPORT,8.4155e-08,-0.78163,-0.70645,0,0
1,GO RESPONSE TO AUDITORY STIMULUS,3.6228e-06,-0.78722,-0.64707,0,0
1,GO SEROTONIN SECRETION,1.8251e-06,-0.79114,-0.63194,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,1.6729e-06,-0.80254,-0.75186,0,0
1,GO SEROTONIN METABOLIC PROCESS,2.8077e-06,-0.80773,-0.6816,0,0
1,GO SYNAPSE MATURATION,7.3528e-06,-0.81147,-0.75657,0,0
1,GO PROTEIN LOCALIZATION TO AXON,5.2533e-07,-0.81572,-0.96159,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,1.2962e-05,-0.81891,-0.81364,0,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,4.2876e-06,-0.8321,-0.76004,0,0
1,GO EPITHELIAL CELL FATE COMMITMENT,0.00052342,-0.8366,-0.67764,0,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,4.4712e-06,-0.8381,-0.71324,0,0
1,GO VOCALIZATION BEHAVIOR,1.1776e-06,-0.86899,-0.85993,0,0
1,GO DENDRITE EXTENSION,7.2756e-08,-0.88462,-0.80029,0,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,7.2756e-08,-0.89905,-0.86263,0,0
1,GO RETINA LAYER FORMATION,6.4994e-06,-0.91788,-0.68728,0,0
1,GO PREPULSE INHIBITION,3.0264e-07,-0.92547,-0.83144,0,0
1,GO NEURONAL ION CHANNEL CLUSTERING,8.3127e-06,-0.93,-0.79369,0,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,2.9532e-05,-0.94595,-0.80486,0,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,5.4272e-08,-0.97087,-0.91106,0,0
1,GO REGULATION OF DENDRITE EXTENSION,9.7275e-08,-0.97206,-0.88928,0,0
1,GO SYNAPTIC VESICLE CLUSTERING,1.4674e-06,-0.99067,-0.89963,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,5.986e-08,-1.0108,-1.0535,0,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,7.2111e-07,-1.0573,-0.86353,0,0
1,GO GANGLION DEVELOPMENT,1.5691e-07,-1.0795,-0.95242,0,0
1,GO GABAERGIC NEURON DIFFERENTIATION,2.2658e-06,-1.0796,-0.95271,0,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,1.8958e-07,-1.0969,-1.0478,0,0
1,GO NOSE DEVELOPMENT,3.9418e-06,-1.1182,-0.84574,0,0
1,GO MECHANOSENSORY BEHAVIOR,4.7955e-07,-1.1346,-1.0423,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,3.9926e-07,-1.1642,-1.0797,0,0
1,GO REGULATION OF DOPAMINE SECRETION,1.1788e-07,-1.1705,-1.0443,0,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,2.7578e-07,-1.4043,-1.2392,0,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,4.3763e-07,-1.5934,-1.4408,0,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,1.4674e-06,-1.6108,-1.5999,0,0
2,GO ETHER BIOSYNTHETIC PROCESS,2.3975e-07,1.2188,0.98077,1,1
2,GO ETHANOL OXIDATION,6.8936e-07,1.0574,0.91957,1,1
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00025131,0.96721,0.71972,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,3.6414e-07,0.82551,0.76751,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00049035,0.82084,0.6559,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.7791e-06,0.80051,0.61412,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00024286,0.79234,0.65233,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.4963e-07,0.77703,0.7163,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00012074,0.75668,0.61402,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.0001547,0.7414,0.61311,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00067758,0.73434,0.48717,1,1
2,GO RESPONSE TO INTERLEUKIN 18,8.4205e-05,0.71907,0.69033,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,9.7801e-06,0.70935,0.70201,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,0.00021909,0.69788,0.51912,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.2876e-06,0.68144,0.51662,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,3.8131e-07,0.68021,0.52836,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,3.3202e-07,0.67989,0.64115,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,2.0833e-05,0.67581,0.59002,1,1
2,GO BIOLOGICAL PHASE,5.8301e-05,0.67252,0.64455,1,1
2,GO MUCUS SECRETION,0.00041602,0.66447,0.62258,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,0.00014418,0.66081,0.48671,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00012512,0.65356,0.55602,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0032441,0.64671,0.46843,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00079435,0.63924,0.56895,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0067808,0.63783,0.41816,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,8.1192e-05,0.62672,0.54969,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00026903,0.62238,0.47929,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,7.9801e-06,0.61743,0.54446,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00079435,0.6163,0.43915,1,1
2,GO MYOBLAST MIGRATION,0.012203,0.61214,0.48969,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.9904e-06,0.61141,0.58141,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0006154,0.60615,0.39289,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,2.8077e-06,0.59842,0.53565,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,7.013e-05,0.59822,0.57271,1,1
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0050528,0.59403,0.40774,1,1
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,3.4421e-05,0.59241,0.56255,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,0.001662,0.5892,0.41026,1,1
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0037331,0.58809,0.38473,1,1
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0014738,0.58398,0.48389,1,1
2,GO PROSTATE GLAND GROWTH,2.6902e-06,0.58277,0.66094,1,1
2,GO PROSTANOID METABOLIC PROCESS,1.2454e-05,0.57692,0.50387,1,1
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0036303,0.57617,0.5243,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00072223,0.5746,0.41042,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.8612e-06,0.5727,0.41492,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,8.3127e-06,0.57002,0.51339,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00054072,0.56861,0.49296,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,5.0226e-05,0.56849,0.50487,1,1
2,GO HAIR FOLLICLE MATURATION,5.0226e-05,0.56535,0.46299,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,4.8379e-05,0.56446,0.5591,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,7.547e-05,0.56443,0.52748,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,6.0504e-05,0.5639,0.50941,1,1
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00029782,0.55977,0.55728,1,1
2,GO ETHER METABOLIC PROCESS,2.2658e-06,0.55969,0.52151,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00041602,0.55842,0.38525,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.00057693,0.54504,0.45648,1,1
2,GO LYSINE METABOLIC PROCESS,0.00027832,0.54427,0.50937,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.5331e-06,0.53953,0.52941,1,1
2,GO OTIC VESICLE DEVELOPMENT,0.00035231,0.53863,0.44538,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,5.2533e-07,0.5381,0.50383,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,1.1493e-05,0.53748,0.58244,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00035231,0.53501,0.54111,1,1
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0014299,0.53424,0.37862,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.0085714,0.53404,0.37151,1,1
2,GO RETINAL METABOLIC PROCESS,0.011612,0.52399,0.33519,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.5201e-05,0.52013,0.45297,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,8.1192e-05,0.50824,0.40378,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00040247,0.50678,0.4586,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0023671,0.50474,0.3476,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00045924,0.50334,0.43411,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,1.0184e-05,0.50221,0.42961,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00012964,0.50121,0.46953,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,2.8418e-05,0.50099,0.40463,1,1
2,GO REGULATION OF GASTRIC ACID SECRETION,0.00013433,0.49905,0.45815,1,1
2,GO HEPATOCYTE DIFFERENTIATION,0.0034322,0.49763,0.40906,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0014299,0.49496,0.35548,1,1
2,GO CYCLOOXYGENASE PATHWAY,0.0073363,0.49416,0.4227,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00037661,0.49345,0.43814,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0010206,0.48643,0.35473,1,1
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00034072,0.48059,0.47727,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.4692e-06,0.47901,0.43059,1,1
2,GO ACTIN FILAMENT SEVERING,0.03939,0.47803,0.31778,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.00011241,0.47764,0.43602,1,1
2,GO OXYGEN TRANSPORT,0.0097392,0.47714,0.44234,1,1
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,6.7728e-06,0.47699,0.47013,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,5.2139e-05,0.4752,0.43857,1,1
2,GO ETHANOL METABOLIC PROCESS,3.9418e-06,0.47423,0.53454,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0094949,0.47382,0.31455,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.7806e-05,0.47187,0.42891,1,1
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.043763,0.47024,0.31162,1,1
2,GO RESPONSE TO INTERFERON BETA,0.014841,0.46842,0.33406,1,1
2,GO MUSCLE ATROPHY,0.0056288,0.46832,0.35363,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00074557,0.46758,0.36777,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,2.8077e-06,0.46665,0.46345,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.017969,0.46374,0.33599,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0039469,0.46115,0.3362,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00010092,0.45356,0.32321,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,5.0683e-06,0.45162,0.44542,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0025083,0.45013,0.35679,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,5.2139e-05,0.44985,0.38143,1,1
2,GO NEPHRON TUBULE FORMATION,0.0051916,0.44818,0.29165,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,1.8521e-05,0.44531,0.36481,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.2139e-05,0.44416,0.39268,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,3.4421e-05,0.44402,0.44861,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00038934,0.4434,0.31054,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00079435,0.44175,0.41148,1,1
2,GO OTIC VESICLE MORPHOGENESIS,0.00065623,0.43886,0.40518,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0012662,0.43534,0.28381,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.00065623,0.43487,0.32608,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0037331,0.43454,0.36136,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.021165,0.4339,0.38552,1,1
2,GO DENDRITIC CELL MIGRATION,0.00023468,0.43328,0.35887,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0013054,0.43308,0.34556,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0014738,0.43185,0.41882,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.43045,0.34009,1,1
2,GO HEME METABOLIC PROCESS,0.0001165,0.43026,0.36397,1,1
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.0042883,0.42078,0.35767,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0099891,0.41912,0.31179,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.03245,0.41769,0.28844,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00081984,0.41675,0.40011,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,8.7323e-05,0.41199,0.35263,1,1
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,7.6603e-06,0.41126,0.34496,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.00095906,0.40983,0.34481,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00067758,0.40915,0.3631,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.013798,0.40864,0.36164,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0013872,0.40716,0.36921,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.036948,0.40538,0.21569,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00059588,0.40313,0.31314,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00024286,0.40309,0.35282,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0021689,0.40206,0.36819,1,1
2,GO PIGMENT GRANULE MATURATION,0.0064317,0.40113,0.28935,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,5.8301e-05,0.39563,0.37481,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0007696,0.39535,0.36431,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00084609,0.39496,0.37627,1,1
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.012508,0.39302,0.25517,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,1.4609e-05,0.39275,0.36363,1,1
2,GO NEURAL CREST FORMATION,0.001986,0.39274,0.31258,1,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00010462,0.39259,0.33245,1,1
2,GO PORE COMPLEX ASSEMBLY,1.5331e-06,0.39017,0.3861,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00012512,0.39002,0.30019,1,1
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0036303,0.38886,0.24956,1,1
2,GO NEUTROPHIL HOMEOSTASIS,0.0056288,0.38851,0.34701,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.0021062,0.38673,0.39568,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00024286,0.38641,0.33182,1,1
2,GO CYSTEINE METABOLIC PROCESS,0.00052342,0.38428,0.45613,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0071468,0.3838,0.34373,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,3.6228e-06,0.38376,0.3767,1,1
2,GO GAS TRANSPORT,0.0027346,0.38344,0.3948,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00047456,0.38307,0.29409,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00034072,0.38284,0.29717,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.0085714,0.38202,0.30739,1,1
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.010506,0.38191,0.27894,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.00013917,0.37995,0.34824,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,5.2139e-05,0.3795,0.44891,1,1
2,GO FATTY ACID HOMEOSTASIS,0.0060989,0.37871,0.24295,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.0059384,0.37771,0.34512,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0022992,0.3771,0.31748,1,1
2,GO LIMB BUD FORMATION,0.004408,0.37637,0.45708,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,3.6228e-06,0.37556,0.3522,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,7.9801e-06,0.37499,0.34095,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00081984,0.37398,0.26276,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.00020448,0.3725,0.44521,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00019753,0.37234,0.31057,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,1.6015e-06,0.37228,0.38208,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00059588,0.37187,0.25297,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,0.001986,0.37038,0.27804,1,1
2,GO VESICLE CARGO LOADING,7.6603e-06,0.36955,0.32422,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.00079435,0.36948,0.30425,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00017186,0.36863,0.3066,1,1
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.011612,0.36735,0.27613,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,8.1192e-05,0.36734,0.34248,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,3.4421e-05,0.36571,0.30276,1,1
2,GO ACETYL COA METABOLIC PROCESS,0.00050664,0.36557,0.26279,1,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.042857,0.36536,0.1533,1,1
2,GO POSITIVE REGULATION OF CELL MATURATION,0.015574,0.36517,0.32126,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0015189,0.36464,0.39153,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0025083,0.3632,0.3316,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0099891,0.36188,0.30721,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0007696,0.36136,0.28495,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.00013433,0.36053,0.30139,1,1
2,GO PENTOSE METABOLIC PROCESS,9.389e-05,0.36036,0.36299,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,2.5308e-05,0.35899,0.36324,1,1
2,GO ERYTHROCYTE MATURATION,0.0032441,0.35683,0.33047,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00055855,0.3557,0.30435,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,5.4121e-05,0.35549,0.35851,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0011199,0.35417,0.25943,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.044685,0.35396,0.22261,1,1
2,GO I KAPPAB PHOSPHORYLATION,0.0040578,0.35337,0.21368,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,4.4878e-05,0.35275,0.36296,1,1
2,GO INTERLEUKIN 13 PRODUCTION,0.00079435,0.35091,0.3868,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0013872,0.35069,0.28011,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0006154,0.35048,0.29794,1,1
2,GO TYPE 2 IMMUNE RESPONSE,0.00037661,0.34998,0.27938,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,3.7791e-06,0.3499,0.32381,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,6.5149e-05,0.34977,0.29849,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,4.8379e-05,0.34956,0.49294,1,1
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0011199,0.34881,0.38049,1,1
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.020205,0.34859,0.23365,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00029782,0.34843,0.37059,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0001165,0.34839,0.33558,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,8.7323e-05,0.34835,0.24901,1,1
2,GO PROTEIN DEMANNOSYLATION,0.0015653,0.34824,0.25943,1,1
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00042998,0.34749,0.40917,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.00017796,0.34744,0.30255,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.016734,0.34708,0.26331,1,1
2,GO GLYCINE METABOLIC PROCESS,0.0010859,0.34597,0.28162,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.017969,0.34567,0.21733,1,1
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.020205,0.34249,0.23351,1,1
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0028957,0.34167,0.22797,1,1
2,GO PRE MIRNA PROCESSING,0.0024367,0.34144,0.21951,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.015953,0.34087,0.33089,1,1
2,GO REGULATION OF PROTEIN IMPORT,0.0001165,0.33992,0.29113,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0022992,0.33906,0.28396,1,1
2,GO REGULATION OF DNA METHYLATION,0.00049035,0.3388,0.242,1,1
2,GO NEUROBLAST DIVISION,0.00072223,0.33846,0.37127,1,1
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.017969,0.33702,0.30073,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00057693,0.33599,0.28252,1,1
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.038561,0.3359,0.18055,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0019282,0.33542,0.26919,1,1
2,GO NOTOCHORD DEVELOPMENT,0.00017186,0.3353,0.50849,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.021165,0.33524,0.21581,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.027803,0.3351,0.19838,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.00011241,0.33447,0.3165,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0033369,0.3344,0.33026,1,1
2,GO RNA DECAPPING,1.1493e-05,0.33388,0.25129,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00035231,0.3336,0.25115,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,1.6455e-05,0.33295,0.37286,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.00353,0.33197,0.20721,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.001662,0.33102,0.3149,1,1
2,GO ERBB2 SIGNALING PATHWAY,0.00074557,0.33092,0.25496,1,1
2,GO TONGUE MORPHOGENESIS,0.019283,0.33071,0.29047,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.001228,0.33066,0.33854,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,2.5308e-05,0.33032,0.35008,1,1
2,GO RETINOL METABOLIC PROCESS,8.1192e-05,0.33001,0.34236,1,1
2,GO FIBROBLAST ACTIVATION,0.00032948,0.32998,0.33966,1,1
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0018173,0.32972,0.32863,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.001662,0.32941,0.2276,1,1
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00031859,0.32938,0.3004,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,0.0087944,0.32827,0.20394,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00084609,0.32825,0.27999,1,1
2,GO MICROVILLUS ASSEMBLY,0.010506,0.32748,0.307,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0062634,0.3265,0.22607,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0067808,0.32616,0.21725,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.017969,0.32523,0.24907,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00063551,0.32312,0.24574,1,1
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0057817,0.32299,0.26181,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,9.7801e-06,0.32178,0.32829,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.0011199,0.32154,0.29743,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0010528,0.32145,0.2392,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0036303,0.32106,0.27455,1,1
2,GO FOREGUT MORPHOGENESIS,0.001228,0.32032,0.36484,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0073363,0.3201,0.28901,1,1
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.0066042,0.3199,0.31447,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00022676,0.31757,0.28225,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,2.4692e-06,0.31751,0.26071,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,4.3218e-05,0.31731,0.30741,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.024288,0.31666,0.21477,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0012662,0.31647,0.25098,1,1
2,GO REGULATION OF TELOMERASE ACTIVITY,6.2985e-07,0.31647,0.29308,1,1
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0053338,0.31633,0.24956,1,1
2,GO RESPONSE TO NITROSATIVE STRESS,0.014486,0.31618,0.27754,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0013054,0.31594,0.27754,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011241,0.31574,0.2736,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00013917,0.31551,0.29973,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0034322,0.31543,0.26202,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00021909,0.31514,0.27835,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.012203,0.31502,0.22058,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,2.6902e-06,0.31497,0.33393,1,1
2,GO PHAGOCYTOSIS RECOGNITION,0.0075304,0.31489,0.24774,1,1
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0081404,0.31474,0.29061,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00050664,0.3143,0.2573,1,1
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.02268,0.31397,0.26268,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.011326,0.31389,0.23893,1,1
2,GO RESPONSE TO ANGIOTENSIN,0.00017186,0.3137,0.29961,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00027832,0.31301,0.28947,1,1
2,GO CARNITINE SHUTTLE,4.4878e-05,0.31298,0.32458,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0069616,0.31284,0.29225,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0022992,0.31212,0.25508,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0073363,0.31211,0.22347,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.001228,0.31164,0.26226,1,1
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,3.6228e-06,0.3115,0.30406,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.0604e-05,0.31107,0.26557,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0040578,0.31092,0.30449,1,1
2,GO HISTONE SERINE PHOSPHORYLATION,0.00087311,0.31004,0.25051,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00050664,0.30986,0.21472,1,1
2,GO REGULATION OF LIPASE ACTIVITY,1.6455e-05,0.3096,0.24778,1,1
2,GO AMP METABOLIC PROCESS,0.0083534,0.30824,0.24605,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.015953,0.30823,0.22793,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0013872,0.30794,0.20978,1,1
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0025817,0.30789,0.24625,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00017186,0.3076,0.27318,1,1
2,GO OVULATION,7.547e-05,0.30732,0.34627,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.00055855,0.30703,0.26567,1,1
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0097392,0.30686,0.26815,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,0.0028957,0.30673,0.22582,1,1
2,GO DNA LIGATION,0.0013872,0.30662,0.22916,1,1
2,GO THYMOCYTE APOPTOTIC PROCESS,0.0087944,0.30646,0.24362,1,1
2,GO MONOCYTE CHEMOTAXIS,0.00059588,0.30575,0.26266,1,1
2,GO MONONUCLEAR CELL MIGRATION,5.4121e-05,0.3057,0.27806,1,1
2,GO INTERLEUKIN 2 PRODUCTION,5.8301e-05,0.30565,0.2589,1,1
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00072223,0.30557,0.27088,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.014138,0.305,0.3023,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.019283,0.30472,0.30503,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0010528,0.30438,0.22548,1,1
2,GO CHONDROCYTE PROLIFERATION,0.0016129,0.30433,0.37661,1,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.0087944,0.30363,0.18653,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0090226,0.30346,0.27204,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0010859,0.30308,0.29313,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0010528,0.30198,0.25207,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00016595,0.29938,0.32981,1,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00072223,0.29931,0.23673,1,1
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0020453,0.2993,0.2478,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0020453,0.2992,0.25235,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,2.3418e-05,0.29884,0.2868,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,0.00010092,0.29871,0.25627,1,1
2,GO RESPONSE TO GONADOTROPIN,0.0030654,0.29827,0.2272,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0064317,0.29801,0.21124,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.00040247,0.29755,0.24907,1,1
2,GO RESPONSE TO TUMOR CELL,0.001228,0.29688,0.2561,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00012512,0.29589,0.29569,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0001165,0.29584,0.32224,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0028141,0.29582,0.18248,1,1
2,GO NUCLEAR PORE ORGANIZATION,5.9841e-06,0.29577,0.36087,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0010859,0.29556,0.20829,1,1
2,GO ENTRY INTO HOST,0.0021689,0.29495,0.21752,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00010092,0.29466,0.24138,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0012662,0.29446,0.24354,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,7.2111e-07,0.29425,0.2659,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0046564,0.2937,0.26234,1,1
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00022676,0.29315,0.29834,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0010206,0.29304,0.23921,1,1
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0097392,0.29273,0.26839,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00032948,0.29162,0.30054,1,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,7.013e-05,0.29107,0.24873,1,1
2,GO HISTONE H4 DEACETYLATION,4.4878e-05,0.29103,0.3279,1,1
2,GO ZYMOGEN INHIBITION,0.010245,0.29042,0.24546,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0032441,0.29041,0.22435,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0001547,0.29001,0.29361,1,1
2,GO PODOSOME ASSEMBLY,0.0022332,0.28995,0.25805,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.0034322,0.28871,0.23378,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0038387,0.28853,0.27612,1,1
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0010859,0.28853,0.22523,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00022676,0.28845,0.29004,1,1
2,GO MRNA MODIFICATION,0.001191,0.28832,0.21786,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00017796,0.28826,0.26875,1,1
2,GO GASTRIC ACID SECRETION,0.0024367,0.28823,0.22976,1,1
2,GO RIG I SIGNALING PATHWAY,9.389e-05,0.2881,0.25117,1,1
2,GO VIRAL TRANSLATION,0.00029782,0.2879,0.3207,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.023741,0.28738,0.34516,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00027832,0.28729,0.27398,1,1
2,GO PEPTIDE CROSS LINKING,0.0021689,0.28685,0.26412,1,1
2,GO FRUCTOSE METABOLIC PROCESS,0.020205,0.28525,0.3749,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0060989,0.28503,0.23448,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00018427,0.28472,0.21719,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.00032948,0.28463,0.2552,1,1
2,GO TELOMERASE RNA LOCALIZATION,0.001872,0.28431,0.27043,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,3.1888e-05,0.28428,0.28014,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.00012074,0.28381,0.26318,1,1
2,GO BLASTODERM SEGMENTATION,0.027803,0.28377,0.28331,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0054795,0.28375,0.24407,1,1
2,GO DETOXIFICATION,0.00023468,0.28367,0.25648,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.037747,0.28284,0.2367,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0001547,0.28128,0.25224,1,1
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00065623,0.28103,0.19887,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0037331,0.28095,0.2198,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00016023,0.28011,0.24105,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.00050664,0.27965,0.2655,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00023468,0.27964,0.36523,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.001228,0.27896,0.4369,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00031859,0.27855,0.2719,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00054072,0.27659,0.25955,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0017641,0.27646,0.20075,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,2.0033e-05,0.27471,0.25233,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,4.3218e-05,0.27462,0.37623,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0013457,0.27447,0.17784,1,1
2,GO PROSTATE GLAND DEVELOPMENT,0.0059384,0.27414,0.33267,1,1
2,GO REGULATION OF CELL KILLING,0.0036303,0.27402,0.19491,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.001872,0.27392,0.26244,1,1
2,GO ARACHIDONIC ACID SECRETION,0.00029782,0.27323,0.27101,1,1
2,GO HIPPO SIGNALING,0.0017123,0.27315,0.33362,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.029719,0.27292,0.33387,1,1
2,GO CHROMATIN DISASSEMBLY,0.0033369,0.27261,0.19177,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.00052342,0.2726,0.39055,1,1
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.0038387,0.27242,0.24319,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0015189,0.27208,0.20134,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00072223,0.27153,0.26824,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0036303,0.27045,0.252,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0013457,0.26947,0.21333,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.0032441,0.26892,0.23371,1,1
2,GO MIRNA METABOLIC PROCESS,2.7343e-05,0.26846,0.21557,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,7.013e-05,0.2683,0.23074,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,8.1192e-05,0.26805,0.24199,1,1
2,GO L PHENYLALANINE METABOLIC PROCESS,0.0017641,0.26734,0.28463,1,1
2,GO GTP METABOLIC PROCESS,0.0021689,0.26711,0.27004,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.00047456,0.26689,0.19917,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00031859,0.26667,0.23997,1,1
2,GO VIRAL GENE EXPRESSION,0.0013872,0.26609,0.24196,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00049035,0.2655,0.24123,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.009256,0.26545,0.19744,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.046579,0.26516,0.14257,1,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0017123,0.26478,0.19242,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.0064317,0.26433,0.24907,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0019282,0.26309,0.20352,1,1
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.026586,0.263,0.21919,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.0020453,0.26282,0.18821,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0057817,0.26253,0.26756,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.017549,0.26251,0.14963,1,1
2,GO RESPONSE TO CADMIUM ION,0.04854,0.26217,0.18851,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.004408,0.26155,0.19522,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.001986,0.26104,0.19359,1,1
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0040578,0.26074,0.30895,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.00092958,0.26067,0.25007,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.017969,0.25969,0.15241,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.00017186,0.25959,0.22385,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00035231,0.25894,0.24524,1,1
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0067808,0.25804,0.21197,1,1
2,GO T CELL CHEMOTAXIS,0.00018427,0.25766,0.2468,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0016129,0.25764,0.2328,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0024367,0.25744,0.20189,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.029719,0.25735,0.17793,1,1
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.04854,0.25722,0.18507,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00069957,0.2569,0.2449,1,1
2,GO MATURATION OF SSU RRNA,0.00084609,0.25673,0.29059,1,1
2,GO AMINE CATABOLIC PROCESS,0.0036303,0.25667,0.29734,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.00081984,0.25639,0.41676,1,1
2,GO CELL REDOX HOMEOSTASIS,0.00019079,0.25586,0.23492,1,1
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.021165,0.25578,0.2371,1,1
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0047853,0.25545,0.30462,1,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0014738,0.25496,0.20245,1,1
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.010773,0.25458,0.16782,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.7118e-05,0.2542,0.27672,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0021689,0.2539,0.28436,1,1
2,GO HYPEROSMOTIC RESPONSE,0.0015653,0.25339,0.25632,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.011047,0.2531,0.31198,1,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0040578,0.25298,0.25278,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0013457,0.25295,0.22878,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,4.8379e-05,0.25284,0.22507,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0041716,0.25283,0.28006,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,0.0013054,0.25253,0.19678,1,1
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0062634,0.25197,0.248,1,1
2,GO HISTONE H3 K9 ACETYLATION,7.2754e-05,0.25194,0.23856,1,1
2,GO NUCLEAR MIGRATION,0.015203,0.25191,0.17003,1,1
2,GO LAMELLIPODIUM ORGANIZATION,0.00014418,0.25118,0.24104,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.0024367,0.25058,0.24338,1,1
2,GO OSTEOBLAST DEVELOPMENT,0.0007696,0.25012,0.29923,1,1
2,GO TRNA METHYLATION,0.00032948,0.25004,0.22206,1,1
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0010206,0.24986,0.17177,1,1
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.044685,0.24969,0.14031,1,1
2,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.016734,0.24912,0.22943,1,1
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00026003,0.24904,0.27761,1,1
2,GO MITOCHONDRIAL TRANSLATION,0.00063551,0.24882,0.23474,1,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0049174,0.2486,0.2264,1,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0049174,0.24796,0.25013,1,1
2,GO L SERINE METABOLIC PROCESS,0.010245,0.24727,0.27613,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00065623,0.24712,0.21993,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00038934,0.24674,0.24009,1,1
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00029782,0.24587,0.23021,1,1
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0034322,0.2458,0.24629,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0027346,0.24537,0.16134,1,1
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.011612,0.24511,0.23128,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0006154,0.24507,0.18006,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,3.7145e-05,0.24489,0.30063,1,1
2,GO AMINO ACID ACTIVATION,0.00012512,0.2448,0.28844,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.038561,0.24479,0.19904,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.001191,0.2446,0.23915,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,4.1617e-05,0.24431,0.21518,1,1
2,GO PIGMENT ACCUMULATION,0.0018173,0.24311,0.23967,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.014138,0.24257,0.14992,1,1
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0020453,0.2422,0.17979,1,1
2,GO ALDITOL METABOLIC PROCESS,0.00042998,0.24196,0.29156,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0033369,0.24189,0.25778,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.001986,0.24169,0.24642,1,1
2,GO SECRETION BY TISSUE,0.00084609,0.24153,0.26552,1,1
2,GO RESPONSE TO X RAY,0.00021167,0.24149,0.32623,1,1
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.02166,0.24111,0.23275,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0010859,0.24071,0.20213,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0013054,0.24067,0.22835,1,1
2,GO RESPIRATORY BURST,0.0071468,0.24015,0.208,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00030804,0.2401,0.23034,1,1
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.019739,0.23977,0.25071,1,1
2,GO RESPONSE TO SALT STRESS,0.015203,0.23956,0.21946,1,1
2,GO LIPID OXIDATION,0.0021062,0.23939,0.17205,1,1
2,GO BONE GROWTH,0.029068,0.23881,0.1969,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.0037331,0.23853,0.16552,1,1
2,GO RNA DESTABILIZATION,0.0024367,0.2384,0.17203,1,1
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.024846,0.2383,0.23175,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.025994,0.23823,0.18665,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.00065623,0.23789,0.20556,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0025817,0.23788,0.2218,1,1
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,8.4205e-05,0.2378,0.21736,1,1
2,GO PROTEASOME ASSEMBLY,0.0045306,0.23755,0.17653,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00092958,0.23742,0.22919,1,1
2,GO LAMELLIPODIUM ASSEMBLY,0.00072223,0.23741,0.19308,1,1
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0036303,0.23737,0.20855,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0033369,0.23721,0.1863,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,7.547e-05,0.23686,0.22712,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0013457,0.23666,0.23242,1,1
2,GO PIGMENT METABOLIC PROCESS,0.00079435,0.23664,0.21849,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00031859,0.23639,0.23097,1,1
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00032948,0.23636,0.18846,1,1
2,GO MITOCHONDRIAL GENE EXPRESSION,0.00069957,0.23604,0.23027,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.010245,0.23464,0.22901,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0069616,0.23437,0.19769,1,1
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.0042883,0.23412,0.21176,1,1
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0069616,0.23371,0.21872,1,1
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.014841,0.23354,0.15149,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0057817,0.23337,0.23912,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.010773,0.23317,0.23857,1,1
2,GO PLATELET MORPHOGENESIS,0.00035231,0.23317,0.22927,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.0045306,0.23289,0.16763,1,1
2,GO APOPTOTIC CELL CLEARANCE,0.0016129,0.23281,0.16276,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0014738,0.23278,0.1853,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.017969,0.232,0.23813,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00087311,0.23158,0.14143,1,1
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.023205,0.23139,0.1733,1,1
2,GO NIK NF KAPPAB SIGNALING,0.00069957,0.23138,0.18493,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.0021062,0.23137,0.2324,1,1
2,GO BLASTOCYST FORMATION,0.00018427,0.23087,0.21374,1,1
2,GO RESPONSE TO MANGANESE ION,0.0032441,0.23076,0.21233,1,1
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0027346,0.23076,0.21381,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0006154,0.23059,0.22253,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.23008,0.16171,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,4.4878e-05,0.22963,0.18907,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0022332,0.22962,0.29499,1,1
2,GO MALE GENITALIA DEVELOPMENT,0.0021062,0.22959,0.2365,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00012074,0.22931,0.24113,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0073363,0.22907,0.20161,1,1
2,GO GOLGI LOCALIZATION,0.013798,0.22894,0.17862,1,1
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0030654,0.22886,0.28273,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.00014418,0.22856,0.19017,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0010528,0.22811,0.15312,1,1
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.029068,0.22789,0.2342,1,1
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,6.7728e-06,0.2271,0.20914,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00028792,0.22699,0.22064,1,1
2,GO RESPONSE TO INTERLEUKIN 1,0.00047456,0.22602,0.17607,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0051916,0.22589,0.25335,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0028957,0.22506,0.15516,1,1
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.0051916,0.22504,0.19169,1,1
2,GO LIVER REGENERATION,0.009256,0.22487,0.17921,1,1
2,GO MATURATION OF 5 8S RRNA,0.0013872,0.22463,0.26926,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0028141,0.22434,0.18227,1,1
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0059384,0.22408,0.14845,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0025817,0.22397,0.23425,1,1
2,GO FATTY ACID BETA OXIDATION,0.0097392,0.22386,0.13625,1,1
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0022992,0.22377,0.25427,1,1
2,GO ARGININE METABOLIC PROCESS,0.042857,0.22346,0.19524,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.001191,0.22342,0.23147,1,1
2,GO TRANSLATIONAL TERMINATION,0.001662,0.22313,0.21854,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00353,0.22311,0.19444,1,1
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.047551,0.22297,0.12548,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.001986,0.22295,0.22217,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.001228,0.22269,0.1664,1,1
2,GO NUCLEUS LOCALIZATION,0.0022992,0.22255,0.17072,1,1
2,GO INTESTINAL ABSORPTION,0.0087944,0.22167,0.19457,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.1888e-05,0.22099,0.21191,1,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0021062,0.22023,0.22781,1,1
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,6.7596e-05,0.22022,0.21071,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.026586,0.21991,0.22807,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0073363,0.21941,0.17182,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0014299,0.21924,0.20608,1,1
2,GO RIBOSOME BIOGENESIS,0.00027832,0.21919,0.25342,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0013872,0.21916,0.1558,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00034072,0.21914,0.23942,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0001165,0.21882,0.18182,1,1
2,GO ICOSANOID METABOLIC PROCESS,0.001986,0.21868,0.18629,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,6.2786e-05,0.21847,0.19701,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,7.547e-05,0.21796,0.18325,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.00057693,0.2177,0.19629,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.017137,0.21665,0.1399,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00054072,0.21655,0.15534,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0013457,0.21629,0.18669,1,1
2,GO AMINO SUGAR CATABOLIC PROCESS,0.02843,0.21616,0.17568,1,1
2,GO T CELL APOPTOTIC PROCESS,0.00042998,0.21578,0.23293,1,1
2,GO IRON ION HOMEOSTASIS,0.00353,0.21575,0.16266,1,1
2,GO KERATAN SULFATE METABOLIC PROCESS,0.042857,0.21563,0.1387,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00047456,0.21534,0.22068,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0054795,0.21529,0.23026,1,1
2,GO MAINTENANCE OF CELL NUMBER,0.00028792,0.21523,0.20008,1,1
2,GO REGULATION OF GENE SILENCING,5.0683e-06,0.21484,0.20369,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0045306,0.21476,0.17825,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0020453,0.2146,0.23118,1,1
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0024367,0.21452,0.16188,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.017969,0.21442,0.17791,1,1
2,GO AMYLOID BETA CLEARANCE,0.0053338,0.21354,0.19606,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00035231,0.2133,0.22123,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.015953,0.21288,0.16625,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0087944,0.2128,0.19349,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.010245,0.21234,0.19501,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.0017641,0.21185,0.19463,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00038934,0.21182,0.21758,1,1
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0062634,0.21164,0.15797,1,1
2,GO B CELL APOPTOTIC PROCESS,0.012203,0.21164,0.14712,1,1
2,GO INTERACTION WITH HOST,0.0015653,0.21138,0.17433,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00059588,0.21126,0.22841,1,1
2,GO MULTI ORGANISM LOCALIZATION,0.00011241,0.21104,0.18282,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0028957,0.21095,0.16386,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00017186,0.21095,0.22245,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00035231,0.21028,0.20847,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.0025817,0.2102,0.1538,1,1
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.035393,0.21012,0.17625,1,1
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0073363,0.20983,0.34947,1,1
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.001986,0.20965,0.18519,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,5.0226e-05,0.2095,0.19498,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.00024286,0.20924,0.16592,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00012074,0.20924,0.19773,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.011047,0.20914,0.15851,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.00353,0.20899,0.1704,1,1
2,GO REGULATION OF NECROTIC CELL DEATH,0.010773,0.20837,0.21633,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0059384,0.20828,0.15751,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.031059,0.20813,0.13046,1,1
2,GO REGULATION OF B CELL PROLIFERATION,0.0034322,0.20778,0.16856,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.0064317,0.20764,0.17278,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0075304,0.20759,0.20384,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00013433,0.20735,0.26378,1,1
2,GO RNA POLYADENYLATION,0.00090094,0.20729,0.15255,1,1
2,GO THIOESTER METABOLIC PROCESS,0.0017123,0.20708,0.19953,1,1
2,GO CYTOPLASM ORGANIZATION,0.014138,0.20701,0.22853,1,1
2,GO RNA STABILIZATION,0.0010859,0.20696,0.15655,1,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.017549,0.20675,0.17263,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0040578,0.20642,0.15938,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00041602,0.20632,0.23578,1,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.043763,0.20628,0.15932,1,1
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0050528,0.20625,0.15868,1,1
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.025994,0.20513,0.18979,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00011241,0.20513,0.18637,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00098941,0.20481,0.21861,1,1
2,GO NCRNA PROCESSING,0.00041602,0.20423,0.2166,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0013872,0.20411,0.18274,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,9.7801e-06,0.20398,0.25326,1,1
2,GO CORNIFICATION,0.0054795,0.20373,0.26068,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00063551,0.20371,0.1765,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.00079435,0.2034,0.26889,1,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0030654,0.20338,0.21657,1,1
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0099891,0.20327,0.15712,1,1
2,GO HISTONE DEUBIQUITINATION,7.547e-05,0.2029,0.18267,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00353,0.20256,0.21796,1,1
2,GO CYTOPLASMIC TRANSLATION,0.027803,0.20244,0.1905,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0021062,0.20239,0.17034,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00021167,0.20213,0.2128,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0010859,0.20199,0.18167,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0006154,0.2018,0.18869,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0099891,0.20159,0.14887,1,1
2,GO COPII COATED VESICLE CARGO LOADING,0.0038387,0.20083,0.15725,1,1
2,GO RESPONSE TO ESTROGEN,0.0087944,0.20081,0.17641,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.031748,0.20068,0.16199,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0051916,0.20066,0.225,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,0.0028957,0.20054,0.14857,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0023671,0.20051,0.12722,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.02166,0.20016,0.1438,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.0038387,0.2001,0.20733,1,1
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.025994,0.20005,0.18769,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,9.0551e-05,0.20004,0.17681,1,1
2,GO REGULATION OF CELLULAR RESPIRATION,0.025414,0.19993,0.16782,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00029782,0.19988,0.18905,1,1
2,GO INTERACTION WITH SYMBIONT,0.00013917,0.19985,0.21832,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0039469,0.19936,0.23072,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.010506,0.19913,0.15499,1,1
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0015189,0.19911,0.25399,1,1
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,9.0551e-05,0.19886,0.19566,1,1
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.02268,0.19854,0.17481,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00013917,0.19847,0.1919,1,1
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0085714,0.19833,0.20911,1,1
2,GO MICROVILLUS ORGANIZATION,0.018398,0.19815,0.28573,1,1
2,GO RNA METHYLATION,0.00092958,0.19798,0.16294,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0094949,0.19781,0.19501,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00017186,0.1976,0.2146,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0028957,0.19753,0.16624,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0014299,0.19602,0.1642,1,1
2,GO POLYOL BIOSYNTHETIC PROCESS,0.0075304,0.19591,0.12552,1,1
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.024288,0.19573,0.21444,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.0047853,0.1957,0.14912,1,1
2,GO LEFT RIGHT PATTERN FORMATION,0.0085714,0.19557,0.23464,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0031536,0.19524,0.19626,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.016339,0.19508,0.18222,1,1
2,GO RRNA METABOLIC PROCESS,0.00055855,0.1949,0.22801,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,5.2139e-05,0.19463,0.21572,1,1
2,GO AEROBIC RESPIRATION,0.00067758,0.19461,0.20015,1,1
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.041967,0.19459,0.11585,1,1
2,GO PRIMARY MIRNA PROCESSING,0.0011549,0.19456,0.20914,1,1
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.011047,0.19441,0.16738,1,1
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.019283,0.19425,0.13959,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0013054,0.19389,0.16848,1,1
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.017137,0.19358,0.19846,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.016734,0.19333,0.15527,1,1
2,GO GENITALIA MORPHOGENESIS,0.033894,0.19304,0.18236,1,1
2,GO ORGANIC ACID CATABOLIC PROCESS,0.00081984,0.19263,0.15868,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0053338,0.1925,0.15136,1,1
2,GO CHYLOMICRON ASSEMBLY,0.010245,0.19239,0.13701,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,0.0054795,0.19231,0.21851,1,1
2,GO AXIS ELONGATION,0.0057817,0.19211,0.29493,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0019282,0.19199,0.16639,1,1
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.030383,0.19172,0.21302,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00021909,0.19153,0.23874,1,1
2,GO NEGATIVE T CELL SELECTION,0.0097392,0.19146,0.10581,1,1
2,GO TRNA TRANSPORT,1.2962e-05,0.19136,0.24443,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.0022992,0.19126,0.18958,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00017186,0.19105,0.1935,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0013872,0.19076,0.15061,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.02166,0.19062,0.1709,1,1
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.0020453,0.19051,0.18013,1,1
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.018836,0.19027,0.12598,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,1.1964e-05,0.19023,0.1697,1,1
2,GO TRNA METABOLIC PROCESS,0.00024286,0.19017,0.18626,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0064317,0.19007,0.16536,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.004408,0.18971,0.13579,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.013798,0.18928,0.1723,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.0046564,0.18915,0.16219,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.00026903,0.18909,0.24946,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,1.8251e-06,0.18902,0.20438,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00057693,0.18899,0.15748,1,1
2,GO THYMUS DEVELOPMENT,0.0037331,0.18875,0.16836,1,1
2,GO NCRNA METABOLIC PROCESS,0.00055855,0.18855,0.19249,1,1
2,GO TOXIN TRANSPORT,0.0057817,0.1885,0.1456,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0051916,0.18804,0.21643,1,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0022332,0.18785,0.18755,1,1
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.104e-05,0.18701,0.20664,1,1
2,GO TRANSLATIONAL INITIATION,0.030383,0.18694,0.17979,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0025817,0.18598,0.19064,1,1
2,GO FATTY ACID CATABOLIC PROCESS,0.016734,0.18597,0.12578,1,1
2,GO RNA INTERFERENCE,0.0079323,0.18581,0.17857,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0012662,0.18571,0.18463,1,1
2,GO PIGMENT GRANULE ORGANIZATION,8.7323e-05,0.18527,0.22708,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0069616,0.18433,0.11737,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0069616,0.18345,0.13427,1,1
2,GO PINOCYTOSIS,0.014841,0.18316,0.12439,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.0006154,0.18295,0.19425,1,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.0022332,0.18237,0.14422,1,1
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00012964,0.18213,0.16658,1,1
2,GO TERPENOID METABOLIC PROCESS,0.014138,0.18173,0.16093,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0045306,0.18087,0.15133,1,1
2,GO TRICARBOXYLIC ACID CYCLE,0.0022332,0.18054,0.22706,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.0015653,0.18012,0.16492,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.03245,0.18005,0.25633,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,7.547e-05,0.17989,0.2359,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.011047,0.17951,0.15129,1,1
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.023741,0.17946,0.15152,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.001228,0.17842,0.16056,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.030383,0.17838,0.13751,1,1
2,GO FATTY ACID TRANSPORT,0.00047456,0.17825,0.15179,1,1
2,GO RNA MODIFICATION,0.00044439,0.17762,0.15747,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0024367,0.17744,0.16598,1,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.023205,0.17733,0.16175,1,1
2,GO SYMBIOTIC PROCESS,0.00024286,0.17731,0.1543,1,1
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.041093,0.17726,0.15127,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00095906,0.17713,0.16939,1,1
2,GO LIPID MODIFICATION,0.0021689,0.17696,0.12455,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0034322,0.17693,0.1522,1,1
2,GO NATURAL KILLER CELL PROLIFERATION,0.024288,0.17676,0.2034,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00017796,0.17655,0.1617,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,1.0604e-05,0.17621,0.15951,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00044439,0.17616,0.15531,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00026003,0.17577,0.17065,1,1
2,GO TRANSLATIONAL ELONGATION,0.0083534,0.17542,0.1696,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00023468,0.17535,0.20304,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.0028957,0.17527,0.15919,1,1
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.020205,0.17464,0.13701,1,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0057817,0.17464,0.21213,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0094949,0.17437,0.15959,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0011549,0.17327,0.20141,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0042883,0.17306,0.17563,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0021689,0.17303,0.13629,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.014486,0.17283,0.1539,1,1
2,GO ANIMAL ORGAN REGENERATION,0.027188,0.17246,0.12398,1,1
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0037331,0.17227,0.19047,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.026586,0.17219,0.12706,1,1
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.017549,0.17208,0.16465,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.00050664,0.17196,0.17433,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.025414,0.17191,0.10941,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0015653,0.1718,0.17091,1,1
2,GO INTERFERON GAMMA PRODUCTION,0.001662,0.17143,0.14687,1,1
2,GO MYOBLAST DIFFERENTIATION,0.009256,0.17078,0.18835,1,1
2,GO HISTONE H2B UBIQUITINATION,0.007729,0.17077,0.14854,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.015574,0.17074,0.15454,1,1
2,GO TRNA PROCESSING,0.00049035,0.17067,0.17675,1,1
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.046579,0.17014,0.12077,1,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00054072,0.17004,0.17289,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0006154,0.16995,0.19681,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.00042998,0.1698,0.17626,1,1
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0025083,0.16922,0.21776,1,1
2,GO APICAL JUNCTION ASSEMBLY,0.023205,0.16919,0.17737,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.01282,0.16889,0.11203,1,1
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.0046564,0.16874,0.16218,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.00038934,0.1686,0.16018,1,1
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.0027346,0.16813,0.18006,1,1
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.025414,0.16808,0.2129,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00074557,0.16787,0.13555,1,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.03939,0.16748,0.16595,1,1
2,GO CELL CELL JUNCTION ORGANIZATION,0.041967,0.16729,0.11507,1,1
2,GO B CELL PROLIFERATION,0.0047853,0.16701,0.14361,1,1
2,GO MRNA METHYLATION,0.043763,0.16696,0.13958,1,1
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.001228,0.16684,0.19329,1,1
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.025414,0.16674,0.14619,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.011904,0.1666,0.17072,1,1
2,GO VIRAL LIFE CYCLE,0.0036303,0.16567,0.15337,1,1
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0053338,0.16558,0.16805,1,1
2,GO HISTONE H3 K14 ACETYLATION,0.0001165,0.16544,0.16381,1,1
2,GO SCHWANN CELL DIFFERENTIATION,0.018836,0.16524,0.13202,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0022332,0.16519,0.13686,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0057817,0.16474,0.13628,1,1
2,GO LIPID HOMEOSTASIS,0.0066042,0.16454,0.13305,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.0024367,0.1636,0.14178,1,1
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0014738,0.16358,0.14047,1,1
2,GO PEPTIDE METABOLIC PROCESS,0.0010528,0.16319,0.1454,1,1
2,GO PHOTOPERIODISM,0.037747,0.163,0.10871,1,1
2,GO RNA CATABOLIC PROCESS,0.00065623,0.16236,0.15626,1,1
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.044685,0.16235,0.15542,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0036303,0.16221,0.11467,1,1
2,GO MRNA TRANSCRIPTION,0.0054795,0.1621,0.15992,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0011199,0.16207,0.18441,1,1
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.023205,0.16192,0.14178,1,1
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.035393,0.16185,0.15526,1,1
2,GO INTERLEUKIN 17 PRODUCTION,0.0083534,0.16154,0.13889,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.00045924,0.16152,0.1328,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.017969,0.1614,0.10898,1,1
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0064317,0.16078,0.11643,1,1
2,GO STEROL BIOSYNTHETIC PROCESS,0.013139,0.16041,0.17544,1,1
2,GO ERBB SIGNALING PATHWAY,0.0025083,0.16019,0.13469,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.023205,0.16015,0.15877,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00050664,0.15975,0.16706,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,0.0039469,0.15965,0.13605,1,1
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.001662,0.15962,0.17465,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.014841,0.1596,0.14453,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.035393,0.15896,0.12123,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0020453,0.15803,0.2254,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0099891,0.15693,0.16133,1,1
2,GO POLYAMINE METABOLIC PROCESS,0.018836,0.15685,0.13907,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,0.0032441,0.15641,0.15467,1,1
2,GO VIRAL RNA GENOME REPLICATION,0.037747,0.15628,0.13703,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0071468,0.15591,0.12945,1,1
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00026003,0.15589,0.16989,1,1
2,GO P BODY ASSEMBLY,0.0021062,0.15574,0.13824,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00092958,0.15548,0.15424,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.0099891,0.15546,0.11883,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.00016023,0.15532,0.16415,1,1
2,GO NUCLEOBASE METABOLIC PROCESS,0.0010206,0.15521,0.19759,1,1
2,GO REGULATION OF DEFENSE RESPONSE,0.0037331,0.1552,0.11424,1,1
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.0020453,0.1547,0.12485,1,1
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0087944,0.15451,0.1445,1,1
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0038387,0.15392,0.11986,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.018836,0.15387,0.12064,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0007696,0.15353,0.18701,1,1
2,GO ELECTRON TRANSPORT CHAIN,0.0075304,0.15341,0.1267,1,1
2,GO REGULATION OF HAIR CYCLE,0.015203,0.15329,0.21629,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00016023,0.15322,0.17951,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0012662,0.15321,0.26055,1,1
2,GO VESICLE TARGETING,0.0027346,0.15303,0.13314,1,1
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0064317,0.15296,0.14558,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00055855,0.15295,0.14861,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00019753,0.15285,0.13176,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.014138,0.1527,0.15803,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00054072,0.15264,0.1465,1,1
2,GO PHAGOCYTOSIS,0.0053338,0.15245,0.14532,1,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0023671,0.15244,0.16936,1,1
2,GO DIGESTION,0.010245,0.15226,0.12736,1,1
2,GO CELLULAR RESPONSE TO VIRUS,0.01282,0.15211,0.13598,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,8.1192e-05,0.15147,0.14497,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.2454e-05,0.15134,0.17892,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0099891,0.15133,0.228,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00025131,0.15068,0.1261,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0019282,0.15066,0.16843,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00026903,0.15027,0.16241,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00029782,0.15017,0.14509,1,1
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0011549,0.14967,0.1426,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0028957,0.14932,0.15495,1,1
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.029719,0.14929,0.20822,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0025083,0.1487,0.13906,1,1
2,GO PROGRAMMED NECROTIC CELL DEATH,0.024846,0.14852,0.15197,1,1
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.014138,0.14815,0.12236,1,1
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0069616,0.14791,0.18175,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.00055855,0.14791,0.14492,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.015203,0.14779,0.12728,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00065623,0.14779,0.13653,1,1
2,GO GOLGI VESICLE BUDDING,0.001191,0.1476,0.12614,1,1
2,GO PROTEIN IMPORT,0.0019282,0.14747,0.13069,1,1
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.019283,0.14734,0.19193,1,1
2,GO TRANSEPITHELIAL TRANSPORT,0.0099891,0.14711,0.16459,1,1
2,GO REGULATION OF ACTION POTENTIAL,0.035393,0.14703,0.12533,1,1
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.009256,0.14702,0.13791,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.030383,0.147,0.13639,1,1
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,4.0073e-05,0.14657,0.1437,1,1
2,GO RECEPTOR CATABOLIC PROCESS,0.023205,0.14637,0.15217,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0064317,0.14602,0.12032,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0013872,0.14542,0.16642,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.041967,0.14542,0.10338,1,1
2,GO IMPORT INTO NUCLEUS,0.02166,0.14532,0.11211,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.013465,0.1451,0.10265,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0039469,0.1451,0.16692,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.029068,0.14507,0.1199,1,1
2,GO GMP METABOLIC PROCESS,0.029068,0.14505,0.14564,1,1
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.041967,0.14461,0.16146,1,1
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.00045924,0.14451,0.14198,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0097392,0.14404,0.10802,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0027346,0.14395,0.22552,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0053338,0.1438,0.17457,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.010506,0.14334,0.10937,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.013139,0.14308,0.11518,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.023741,0.14298,0.20433,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.004408,0.1428,0.16105,1,1
2,GO GOLGI RIBBON FORMATION,0.018398,0.14271,0.13842,1,1
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.01282,0.14237,0.09459,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00065623,0.14228,0.12581,1,1
2,GO SIGNAL PEPTIDE PROCESSING,0.024846,0.14192,0.18904,1,1
2,GO OXIDATION REDUCTION PROCESS,0.0017641,0.14183,0.12411,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.016339,0.14159,0.09467,1,1
2,GO HEXOSE CATABOLIC PROCESS,0.0079323,0.1415,0.17319,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00045924,0.14128,0.12944,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.012508,0.14123,0.11833,1,1
2,GO RESPONSE TO GAMMA RADIATION,0.001228,0.14088,0.18212,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.02843,0.14062,0.16459,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00034072,0.14024,0.1391,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.010245,0.14011,0.14857,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.011047,0.14009,0.1295,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0021062,0.14006,0.1955,1,1
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00045924,0.14001,0.18454,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.0017641,0.13993,0.1523,1,1
2,GO POLYOL METABOLIC PROCESS,0.00022676,0.13931,0.16091,1,1
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0060989,0.13914,0.11523,1,1
2,GO TISSUE HOMEOSTASIS,0.010506,0.13892,0.095562,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,7.8282e-05,0.13869,0.13004,1,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0024367,0.13867,0.13598,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,5.8301e-05,0.13846,0.13368,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0090226,0.13832,0.11569,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,3.1888e-05,0.13781,0.14227,1,1
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0017123,0.13778,0.12931,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,7.8282e-05,0.1376,0.15382,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0034322,0.13759,0.1665,1,1
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.00028792,0.13758,0.17884,1,1
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.018398,0.13753,0.087825,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.013465,0.13733,0.1162,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0027346,0.13732,0.13605,1,1
2,GO COPII COATED VESICLE BUDDING,0.0010859,0.13715,0.12497,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.014486,0.13686,0.14357,1,1
2,GO RESPONSE TO ACTIVITY,0.02843,0.13685,0.096477,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0059384,0.13645,0.15131,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.00025131,0.13617,0.13029,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.020205,0.13609,0.13976,1,1
2,GO BASE EXCISION REPAIR,0.0038387,0.13528,0.12574,1,1
2,GO NUCLEAR EXPORT,9.7346e-05,0.13523,0.16091,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.01282,0.13487,0.12132,1,1
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.019283,0.13353,0.10579,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00029782,0.13335,0.15018,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.013798,0.13291,0.12961,1,1
2,GO TELOMERE ORGANIZATION,0.00038934,0.13287,0.13776,1,1
2,GO LIPID METABOLIC PROCESS,0.0011199,0.13283,0.11064,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.0025817,0.13282,0.11717,1,1
2,GO DNA GEOMETRIC CHANGE,0.00014418,0.13213,0.15335,1,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00049035,0.13205,0.12337,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.034637,0.13135,0.13753,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.2754e-05,0.13118,0.13638,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.0010859,0.13044,0.11862,1,1
2,GO CELL CELL RECOGNITION,0.016734,0.13043,0.10222,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00052342,0.13042,0.15987,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0054795,0.12974,0.12503,1,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.0036303,0.12951,0.12591,1,1
2,GO STEROID BIOSYNTHETIC PROCESS,0.0053338,0.12924,0.12441,1,1
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0090226,0.12856,0.12848,1,1
2,GO MRNA CLEAVAGE,2.2524e-05,0.12849,0.1658,1,1
2,GO BODY FLUID SECRETION,0.00090094,0.12831,0.15203,1,1
2,GO MRNA 3 END PROCESSING,0.00045924,0.12808,0.14323,1,1
2,GO HISTONE PHOSPHORYLATION,0.0090226,0.12784,0.10778,1,1
2,GO OXIDATIVE DEMETHYLATION,0.020205,0.12765,0.092979,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0090226,0.12752,0.13045,1,1
2,GO GOLGI VESICLE TRANSPORT,0.0015189,0.12696,0.098636,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.0022332,0.12681,0.13721,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.042857,0.1268,0.083463,1,1
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.046579,0.12674,0.081802,1,1
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.001872,0.12617,0.12099,1,1
2,GO STEROL IMPORT,0.01282,0.12604,0.17471,1,1
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.019283,0.12555,0.088981,1,1
2,GO LIPID CATABOLIC PROCESS,0.011904,0.1254,0.099419,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,9.7346e-05,0.12488,0.11788,1,1
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.019739,0.12444,0.084239,1,1
2,GO HISTONE H3 DEACETYLATION,0.019283,0.12442,0.11692,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.0015189,0.12418,0.16255,1,1
2,GO RNA PROCESSING,0.00016595,0.12406,0.15172,1,1
2,GO GENE SILENCING,1.4609e-05,0.12385,0.13436,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.041967,0.12359,0.091026,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.015574,0.1223,0.1206,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0026572,0.12217,0.14542,1,1
2,GO MRNA METABOLIC PROCESS,0.00017796,0.12179,0.13519,1,1
2,GO PROTEIN SUMOYLATION,0.00012074,0.12162,0.12794,1,1
2,GO STRESS GRANULE ASSEMBLY,0.012203,0.12125,0.11656,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.016339,0.1207,0.11852,1,1
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.0069616,0.1204,0.10391,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.00021909,0.12029,0.1183,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0053338,0.12013,0.14305,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.029068,0.11945,0.11822,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0017123,0.11902,0.14885,1,1
2,GO OXIDATIVE PHOSPHORYLATION,0.041967,0.11893,0.11637,1,1
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.027803,0.11866,0.083935,1,1
2,GO REGULATION OF MYELINATION,0.038561,0.11862,0.10344,1,1
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.033166,0.11851,0.10815,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0028957,0.11847,0.10615,1,1
2,GO PROTEIN NEDDYLATION,0.029719,0.1179,0.10556,1,1
2,GO RESPONSE TO STEROID HORMONE,0.047551,0.11788,0.095905,1,1
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00022676,0.11771,0.13518,1,1
2,GO ACTIN NUCLEATION,0.018836,0.11733,0.11748,1,1
2,GO REGULATION OF ORGAN GROWTH,0.044685,0.11715,0.1211,1,1
2,GO NON RECOMBINATIONAL REPAIR,0.0094949,0.11703,0.1006,1,1
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0037331,0.11662,0.091428,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00084609,0.11653,0.15272,1,1
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0033369,0.11639,0.10396,1,1
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.0032441,0.11633,0.097154,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0033369,0.1161,0.10579,1,1
2,GO DNA BIOSYNTHETIC PROCESS,0.00035231,0.11606,0.10502,1,1
2,GO RESPONSE TO ALCOHOL,0.030383,0.11596,0.089355,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00042998,0.11559,0.13664,1,1
2,GO PEROXISOMAL TRANSPORT,0.0062634,0.11531,0.13382,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0022992,0.11526,0.12147,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.02268,0.11509,0.16863,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0083534,0.11383,0.10364,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.033894,0.11371,0.11804,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.033166,0.11368,0.091151,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0046564,0.11353,0.16041,1,1
2,GO ACTIVATION OF GTPASE ACTIVITY,0.02268,0.11326,0.098049,1,1
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.017969,0.11311,0.078825,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.015203,0.11295,0.095117,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.046579,0.11292,0.15119,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00047456,0.11254,0.13846,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.033166,0.11249,0.11698,1,1
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.013139,0.11244,0.092192,1,1
2,GO REGULATION OF MRNA 3 END PROCESSING,0.015203,0.11232,0.11,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.0053338,0.11221,0.11821,1,1
2,GO NUCLEAR TRANSPORT,0.0018173,0.11205,0.11881,1,1
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.027803,0.11186,0.085733,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.033894,0.11167,0.081114,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0018173,0.11141,0.12801,1,1
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.02843,0.11116,0.10349,1,1
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.011047,0.11097,0.083466,1,1
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.031748,0.11092,0.13206,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0026572,0.11053,0.13885,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.010506,0.11016,0.10935,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0067808,0.11001,0.12022,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.035393,0.10958,0.078272,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00020448,0.10956,0.14177,1,1
2,GO PEROXISOME ORGANIZATION,0.0079323,0.10944,0.11875,1,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0024367,0.1094,0.11329,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.00084609,0.10883,0.11147,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0087944,0.10781,0.10084,1,1
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0029794,0.10774,0.082699,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.013139,0.1067,0.087767,1,1
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.042857,0.10645,0.11624,1,1
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.035393,0.10585,0.09222,1,1
2,GO RESPONSE TO SALT,0.025414,0.10581,0.16652,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.031748,0.10467,0.10111,1,1
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.036164,0.10462,0.10478,1,1
2,GO MRNA TRANSPORT,0.00098941,0.10385,0.13743,1,1
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.023741,0.1036,0.13061,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.0079323,0.10355,0.24638,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.004408,0.10246,0.096349,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,6.2786e-05,0.10215,0.13018,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0014738,0.10198,0.11941,1,1
2,GO MRNA PROCESSING,0.00098941,0.10175,0.10927,1,1
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0022332,0.10162,0.13468,1,1
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.02068,0.1014,0.0759,1,1
2,GO RNA 3 END PROCESSING,0.0057817,0.099327,0.11797,1,1
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00057693,0.099124,0.098164,1,1
2,GO VESICLE BUDDING FROM MEMBRANE,0.023741,0.098839,0.081716,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.036164,0.098715,0.07261,1,1
2,GO RNA LOCALIZATION,0.00018427,0.098195,0.15138,1,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.0025817,0.097503,0.12772,1,1
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.045624,0.097182,0.075032,1,1
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.018398,0.096798,0.066552,1,1
2,GO REGULATION OF CATABOLIC PROCESS,0.0045306,0.096121,0.075563,1,1
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0099891,0.09543,0.095039,1,1
2,GO DNA METHYLATION,0.009256,0.09471,0.090647,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.007729,0.094352,0.098635,1,1
2,GO STEM CELL DIFFERENTIATION,0.010506,0.094058,0.12132,1,1
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.03939,0.093606,0.13947,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00026903,0.093346,0.10056,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0059384,0.093334,0.12289,1,1
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0037331,0.092719,0.099204,1,1
2,GO EPIDERMAL CELL DIFFERENTIATION,0.016734,0.090882,0.17315,1,1
2,GO DNA CONFORMATION CHANGE,0.0094949,0.090581,0.083715,1,1
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.033166,0.09009,0.05905,1,1
2,GO RESPONSE TO UV,0.0054795,0.089115,0.12713,1,1
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0017123,0.089078,0.099938,1,1
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.029068,0.088773,0.086824,1,1
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0081404,0.088757,0.10054,1,1
2,GO RNA SPLICING,0.0020453,0.088566,0.107,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0001165,0.088133,0.11976,1,1
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00074557,0.0881,0.11853,1,1
2,GO GLUCOSE METABOLIC PROCESS,0.025414,0.087595,0.056385,1,1
2,GO PROTEIN POLYUBIQUITINATION,0.021165,0.087472,0.072275,1,1
2,GO CARBOHYDRATE METABOLIC PROCESS,0.0064317,0.08741,0.077006,1,1
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.001986,0.087387,0.081898,1,1
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.024288,0.087296,0.15212,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.017549,0.08723,0.086512,1,1
2,GO CHROMATIN REMODELING,0.0028141,0.08717,0.097614,1,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.024288,0.086722,0.099406,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.013465,0.084988,0.07816,1,1
2,GO MACROMOLECULE CATABOLIC PROCESS,0.0051916,0.084422,0.074039,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.043763,0.083876,0.064938,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.011904,0.083078,0.08958,1,1
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.001872,0.082814,0.090291,1,1
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.031059,0.080511,0.077587,1,1
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.014841,0.080462,0.056878,1,1
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00092958,0.080457,0.097065,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.015203,0.080293,0.083498,1,1
2,GO HISTONE H3 ACETYLATION,0.0027346,0.079136,0.091673,1,1
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.033166,0.078754,0.15685,1,1
2,GO CELLULAR RESPONSE TO UV,0.0069616,0.078364,0.11375,1,1
2,GO PROTEIN CATABOLIC PROCESS,0.036948,0.077488,0.050192,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.024288,0.077301,0.066165,1,1
2,GO DOUBLE STRAND BREAK REPAIR,0.0094949,0.077022,0.090903,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.024288,0.07674,0.09339,1,1
2,GO CELLULAR COMPONENT DISASSEMBLY,0.047551,0.075331,0.056464,1,1
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.018836,0.073754,0.10395,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.02166,0.073512,0.070546,1,1
2,GO ALCOHOL CATABOLIC PROCESS,0.026586,0.073346,0.13253,1,1
2,GO HISTONE DEACETYLATION,0.0099891,0.073149,0.086896,1,1
2,GO MACROAUTOPHAGY,0.017137,0.0718,0.058488,1,1
2,GO RESPONSE TO RADIATION,0.026586,0.070833,0.063464,1,1
2,GO REGULATION OF DNA METABOLIC PROCESS,0.0051916,0.068134,0.076837,1,1
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.025994,0.067604,0.060824,1,1
2,GO REGULATION OF GTPASE ACTIVITY,0.046579,0.066185,0.065842,1,1
2,GO DNA INTEGRITY CHECKPOINT,0.023741,0.065549,0.083447,1,1
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.02268,0.063877,0.05164,1,1
2,GO DNA METABOLIC PROCESS,0.004408,0.0637,0.06765,1,1
2,GO DNA MODIFICATION,0.015203,0.06315,0.059423,1,1
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.011326,0.06093,0.084026,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.044685,0.059932,0.075487,1,1
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.044685,0.059404,0.068066,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0056288,0.058792,0.05732,1,1
2,GO DNA REPAIR,0.010506,0.056856,0.066843,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.025414,0.054148,0.046814,1,1
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.017137,0.053453,0.051302,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.04854,0.051571,0.065494,1,1
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.014486,0.048574,0.065694,1,1
2,GO CHROMOSOME ORGANIZATION,0.033894,0.03304,0.055595,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0038387,1.138,0.85188,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00353,0.96422,0.68716,1,0
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0028957,0.8366,0.52159,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00353,0.70604,0.44328,1,0
2,GO NEGATIVE REGULATION OF CELL KILLING,0.0025083,0.63952,0.43062,1,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.0019282,0.41489,0.4172,1,0
2,GO TOLERANCE INDUCTION,0.0081404,0.39066,0.29059,1,0
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.01282,0.38181,0.34354,1,0
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00095906,0.36619,0.34868,1,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.018836,0.35986,0.33488,1,0
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.015203,0.35094,0.22572,1,0
2,GO T CELL MEDIATED IMMUNITY,0.00047456,0.34696,0.27333,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0099891,0.33904,0.22043,1,0
2,GO MATURE B CELL DIFFERENTIATION,0.0024367,0.33597,0.23208,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0083534,0.33389,0.21814,1,0
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00013917,0.31908,0.42465,1,0
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0059384,0.31716,0.23558,1,0
2,GO GERMINAL CENTER FORMATION,0.047551,0.31157,0.1849,1,0
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0014738,0.30768,0.32743,1,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.035393,0.29898,0.22937,1,0
2,GO URETER DEVELOPMENT,0.017137,0.29587,0.27349,1,0
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.29527,0.28158,1,0
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0038387,0.29291,0.19189,1,0
2,GO MATURATION OF LSU RRNA,0.0025083,0.29137,0.3167,1,0
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.033894,0.29084,0.31826,1,0
2,GO REGULATION OF TOLERANCE INDUCTION,0.044685,0.28763,0.17223,1,0
2,GO NADPH REGENERATION,0.0017641,0.28635,0.26696,1,0
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.02268,0.28104,0.37924,1,0
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0037331,0.2768,0.36624,1,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.02166,0.27533,0.19504,1,0
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.027803,0.27488,0.28056,1,0
2,GO RESPONSE TO INTERFERON GAMMA,0.0081404,0.26871,0.20036,1,0
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.018398,0.26687,0.20717,1,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0087944,0.2652,0.21549,1,0
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.001191,0.26443,0.29381,1,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0019282,0.26382,0.2562,1,0
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0083534,0.26208,0.22252,1,0
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00041602,0.26031,0.22615,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0013054,0.26006,0.18805,1,0
2,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.019739,0.26004,0.24362,1,0
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.007729,0.2573,0.15246,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0011549,0.25712,0.20929,1,0
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.04854,0.25663,0.21703,1,0
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.00069957,0.255,0.2861,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0046564,0.25488,0.20254,1,0
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0028957,0.25469,0.27699,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0067808,0.25369,0.22767,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0034322,0.25361,0.27097,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0047853,0.25176,0.16018,1,0
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.001986,0.25005,0.2615,1,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.03245,0.24865,0.26531,1,0
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0037331,0.24227,0.3657,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.046579,0.24218,0.16041,1,0
2,GO NADP METABOLIC PROCESS,0.0040578,0.24197,0.21318,1,0
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.00049035,0.24142,0.25504,1,0
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00084609,0.24081,0.28566,1,0
2,GO ADAPTIVE IMMUNE RESPONSE,0.00079435,0.24069,0.18663,1,0
2,GO RESPONSE TO PROTOZOAN,0.029719,0.24025,0.1423,1,0
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.014841,0.23949,0.29946,1,0
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00041602,0.23939,0.21465,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0031536,0.23774,0.16335,1,0
2,GO POSITIVE REGULATION OF COAGULATION,0.0037331,0.23681,0.25739,1,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.033894,0.23465,0.19223,1,0
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0083534,0.23382,0.19717,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0033369,0.23332,0.25122,1,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.00084609,0.23136,0.20754,1,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.023741,0.2311,0.23819,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.001986,0.23108,0.20533,1,0
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0029794,0.22867,0.16082,1,0
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00054072,0.22693,0.18568,1,0
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.036164,0.22639,0.15966,1,0
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.031059,0.22358,0.213,1,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0024367,0.22328,0.16015,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.022165,0.22068,0.17369,1,0
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.001986,0.21951,0.22876,1,0
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.010245,0.21766,0.12813,1,0
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0042883,0.21627,0.18511,1,0
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.016339,0.21488,0.18081,1,0
2,GO RESPONSE TO INTERLEUKIN 15,0.0013457,0.21402,0.19559,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0013054,0.21353,0.17504,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0014299,0.21348,0.16489,1,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.031059,0.21126,0.19432,1,0
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0031536,0.21046,0.1433,1,0
2,GO RRNA TRANSCRIPTION,0.00045924,0.21026,0.2361,1,0
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.036948,0.21016,0.12121,1,0
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00059588,0.21,0.20423,1,0
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0013457,0.2097,0.23096,1,0
2,GO LEUKOCYTE PROLIFERATION,0.00081984,0.20964,0.16127,1,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0025817,0.20756,0.17138,1,0
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0079323,0.20737,0.13116,1,0
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.029068,0.20715,0.23126,1,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.047551,0.20663,0.1471,1,0
2,GO POSITIVE REGULATION OF WOUND HEALING,0.045624,0.20643,0.17967,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0010206,0.20549,0.16386,1,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.037747,0.2052,0.14902,1,0
2,GO RRNA MODIFICATION,0.0064317,0.20453,0.20358,1,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.031748,0.20364,0.16144,1,0
2,GO COPPER ION TRANSPORT,0.009256,0.2032,0.1839,1,0
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0024367,0.20161,0.18814,1,0
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.031748,0.20084,0.13299,1,0
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.015203,0.20034,0.11934,1,0
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.03939,0.19964,0.14,1,0
2,GO TRACHEA DEVELOPMENT,0.036164,0.19939,0.18053,1,0
2,GO RIBOSOME ASSEMBLY,0.0046564,0.199,0.23715,1,0
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.030383,0.19871,0.14288,1,0
2,GO B CELL MEDIATED IMMUNITY,0.0059384,0.19809,0.14249,1,0
2,GO CELLULAR KETONE METABOLIC PROCESS,0.0030654,0.1979,0.13998,1,0
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0019282,0.19743,0.15948,1,0
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.015574,0.19701,0.14489,1,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.0021062,0.19675,0.16849,1,0
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.0064317,0.19616,0.20011,1,0
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0049174,0.196,0.18078,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0029794,0.19218,0.16155,1,0
2,GO SERTOLI CELL DEVELOPMENT,0.024846,0.19142,0.24298,1,0
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0015653,0.191,0.15022,1,0
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.023741,0.18962,0.18593,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0071468,0.18946,0.13467,1,0
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0087944,0.1893,0.17194,1,0
2,GO T CELL PROLIFERATION,0.0013054,0.1891,0.16658,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.041093,0.18769,0.11979,1,0
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.045624,0.18763,0.15208,1,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0030654,0.18731,0.17513,1,0
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.001662,0.18686,0.20618,1,0
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.025994,0.1818,0.11009,1,0
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.035393,0.18155,0.17467,1,0
2,GO NECROTIC CELL DEATH,0.020205,0.18127,0.16414,1,0
2,GO INTERLEUKIN 1 PRODUCTION,0.0069616,0.18054,0.22126,1,0
2,GO RNA 5 END PROCESSING,0.00353,0.18042,0.19983,1,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.046579,0.18021,0.16375,1,0
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0090226,0.17921,0.19403,1,0
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.016734,0.17875,0.21327,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0053338,0.17656,0.13126,1,0
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0013872,0.17632,0.31742,1,0
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0039469,0.17582,0.12905,1,0
2,GO STEROL HOMEOSTASIS,0.011047,0.17565,0.15574,1,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.019739,0.17461,0.12015,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0090226,0.17438,0.13526,1,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.047551,0.1743,0.13988,1,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0042883,0.17424,0.14521,1,0
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.0059384,0.17209,0.13113,1,0
2,GO TRNA MODIFICATION,0.0010528,0.17206,0.17241,1,0
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.029719,0.17203,0.12588,1,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.03939,0.17135,0.20164,1,0
2,GO CHRONIC INFLAMMATORY RESPONSE,0.040234,0.17131,0.1715,1,0
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0094949,0.16996,0.16746,1,0
2,GO STEROL METABOLIC PROCESS,0.011612,0.16977,0.11677,1,0
2,GO MACROPHAGE CHEMOTAXIS,0.014841,0.16833,0.16284,1,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.01282,0.16756,0.17904,1,0
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0085714,0.16502,0.17276,1,0
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.03939,0.16403,0.11607,1,0
2,GO GRANULOCYTE CHEMOTAXIS,0.030383,0.16397,0.099348,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.014486,0.16376,0.14946,1,0
2,GO REGULATION OF PHAGOCYTOSIS,0.012203,0.1637,0.1256,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0042883,0.16351,0.16534,1,0
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.011904,0.16298,0.11383,1,0
2,GO CYTOKINE PRODUCTION,0.0064317,0.16274,0.1265,1,0
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.021165,0.1624,0.14384,1,0
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.00092958,0.16212,0.13204,1,0
2,GO CYTOKINE METABOLIC PROCESS,0.0047853,0.16174,0.13514,1,0
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0029794,0.16138,0.13888,1,0
2,GO POSITIVE CHEMOTAXIS,0.02068,0.16138,0.13575,1,0
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.014138,0.16136,0.10153,1,0
2,GO T CELL CYTOKINE PRODUCTION,0.0028141,0.16123,0.16319,1,0
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.010506,0.16111,0.10097,1,0
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.023741,0.16092,0.10399,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0051916,0.16065,0.11368,1,0
2,GO CD40 SIGNALING PATHWAY,0.023205,0.1606,0.1248,1,0
2,GO RESPONSE TO BACTERIUM,0.013798,0.16045,0.1005,1,0
2,GO POSITIVE REGULATION OF CELL ADHESION,0.018398,0.16042,0.12306,1,0
2,GO INNATE IMMUNE RESPONSE,0.0066042,0.16021,0.13071,1,0
2,GO REGULATION OF IMMUNE RESPONSE,0.0028141,0.15981,0.12407,1,0
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.011326,0.15945,0.14807,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0029794,0.15939,0.13956,1,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.040234,0.15938,0.10529,1,0
2,GO T CELL DIFFERENTIATION,0.0038387,0.15926,0.13341,1,0
2,GO REGULATION OF CELL CELL ADHESION,0.014138,0.1585,0.12078,1,0
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0017641,0.15845,0.25468,1,0
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.010773,0.1578,0.10157,1,0
2,GO PROTEIN KINASE B SIGNALING,0.024846,0.15722,0.099977,1,0
2,GO CHEMOKINE PRODUCTION,0.0060989,0.15687,0.19117,1,0
2,GO REGULATION OF CELL ACTIVATION,0.0036303,0.15647,0.1229,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.02843,0.1554,0.11709,1,0
2,GO LYMPHOCYTE CHEMOTAXIS,0.027188,0.15363,0.12555,1,0
2,GO REGULATION OF VIRAL LIFE CYCLE,0.047551,0.15299,0.15692,1,0
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.038561,0.15277,0.2914,1,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.038561,0.15271,0.13388,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.013139,0.15199,0.095955,1,0
2,GO RESPONSE TO CYTOKINE,0.010245,0.15167,0.11094,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0059384,0.15083,0.17458,1,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.037747,0.15073,0.2,1,0
2,GO T CELL ACTIVATION,0.0071468,0.15054,0.12592,1,0
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0029794,0.15024,0.15125,1,0
2,GO INTERFERON BETA PRODUCTION,0.027803,0.15021,0.14766,1,0
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.023741,0.14998,0.10987,1,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.00095906,0.14965,0.18134,1,0
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0094949,0.14907,0.11794,1,0
2,GO TRNA 5 LEADER REMOVAL,0.0037331,0.14896,0.18576,1,0
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.016734,0.14825,0.22555,1,0
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.0017641,0.14824,0.14279,1,0
2,GO B CELL DIFFERENTIATION,0.0083534,0.14779,0.11728,1,0
2,GO REGULATION OF T CELL ACTIVATION,0.0067808,0.14699,0.12821,1,0
2,GO LEUKOCYTE CELL CELL ADHESION,0.00353,0.1469,0.14386,1,0
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.041967,0.14637,0.30564,1,0
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0071468,0.14637,0.11556,1,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.031059,0.14634,0.1214,1,0
2,GO LYMPHOCYTE DIFFERENTIATION,0.0022992,0.14556,0.12527,1,0
2,GO ACTIVATION OF IMMUNE RESPONSE,0.0014299,0.14556,0.13322,1,0
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.023741,0.14512,0.11237,1,0
2,GO CELL KILLING,0.010245,0.14501,0.12763,1,0
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0062634,0.14475,0.14604,1,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.016734,0.1447,0.19623,1,0
2,GO RESPONSE TO BIOTIC STIMULUS,0.011904,0.14415,0.10279,1,0
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.038561,0.14392,0.11589,1,0
2,GO ALPHA BETA T CELL DIFFERENTIATION,0.0060989,0.14273,0.16905,1,0
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.034637,0.14212,0.12967,1,0
2,GO IMMUNE EFFECTOR PROCESS,0.0066042,0.14144,0.12496,1,0
2,GO STRESS FIBER ASSEMBLY,0.04854,0.1413,0.1257,1,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.013465,0.14105,0.18162,1,0
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.033166,0.14087,0.19502,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0031536,0.14025,0.183,1,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0062634,0.14016,0.12479,1,0
2,GO TRNA WOBBLE BASE MODIFICATION,0.015574,0.13976,0.11239,1,0
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.009256,0.13947,0.11403,1,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.014138,0.13922,0.1544,1,0
2,GO TRNA 5 END PROCESSING,0.011326,0.13873,0.15724,1,0
2,GO INTERFERON ALPHA PRODUCTION,0.027188,0.1384,0.18867,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0075304,0.13836,0.10637,1,0
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.02268,0.13821,0.12472,1,0
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.020205,0.13768,0.1028,1,0
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.016734,0.1369,0.14322,1,0
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0036303,0.13685,0.11346,1,0
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.023205,0.13679,0.11631,1,0
2,GO REGULATION OF HEMOPOIESIS,0.007729,0.13664,0.11952,1,0
2,GO REGULATION OF B CELL ACTIVATION,0.015953,0.13589,0.10866,1,0
2,GO AMIDE BIOSYNTHETIC PROCESS,0.00049035,0.13545,0.15649,1,0
2,GO ERK1 AND ERK2 CASCADE,0.019739,0.13512,0.11902,1,0
2,GO ALPHA BETA T CELL ACTIVATION,0.001986,0.13488,0.16073,1,0
2,GO MACROPHAGE MIGRATION,0.025994,0.1348,0.13815,1,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.027188,0.13476,0.15834,1,0
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0001547,0.13381,0.17833,1,0
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.010245,0.13342,0.11188,1,0
2,GO LYMPHOCYTE ACTIVATION,0.010773,0.13245,0.10337,1,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.0060989,0.13199,0.16888,1,0
2,GO CELL ACTIVATION,0.013465,0.13196,0.098859,1,0
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.010245,0.13166,0.14685,1,0
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.04854,0.13121,0.097599,1,0
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.041967,0.13121,0.16611,1,0
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.017137,0.13073,0.1163,1,0
2,GO MAMMARY GLAND MORPHOGENESIS,0.015203,0.13047,0.25445,1,0
2,GO DEFENSE RESPONSE,0.021165,0.12953,0.082723,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.047551,0.12911,0.13171,1,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.011612,0.12821,0.09855,1,0
2,GO REGULATION OF CELL ADHESION,0.035393,0.12796,0.10496,1,0
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.018398,0.12784,0.17315,1,0
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.037747,0.1276,0.11031,1,0
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0085714,0.12758,0.1446,1,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.012508,0.12586,0.16701,1,0
2,GO MYELOID CELL HOMEOSTASIS,0.0075304,0.12576,0.1236,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.026586,0.12342,0.11507,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.018836,0.12338,0.18031,1,0
2,GO SPROUTING ANGIOGENESIS,0.014138,0.12281,0.14236,1,0
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.047551,0.12157,0.097572,1,0
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.038561,0.1209,0.10299,1,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.044685,0.12059,0.087742,1,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.014486,0.1204,0.15337,1,0
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.013465,0.1201,0.10696,1,0
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.033894,0.1196,0.069089,1,0
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.004408,0.11894,0.17245,1,0
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0099891,0.11889,0.15156,1,0
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.014486,0.11797,0.090136,1,0
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.02068,0.11795,0.1316,1,0
2,GO FOCAL ADHESION ASSEMBLY,0.044685,0.11749,0.15245,1,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0026572,0.11731,0.11132,1,0
2,GO KERATINOCYTE DIFFERENTIATION,0.011047,0.11693,0.21399,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.025994,0.11658,0.10127,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.037747,0.11605,0.10562,1,0
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.017137,0.11562,0.16704,1,0
2,GO PYRUVATE METABOLIC PROCESS,0.047551,0.11417,0.086022,1,0
2,GO EPIDERMIS DEVELOPMENT,0.021165,0.11342,0.16004,1,0
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.041967,0.11319,0.066742,1,0
2,GO LEUKOCYTE DIFFERENTIATION,0.0099891,0.11272,0.098411,1,0
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0049174,0.11225,0.094239,1,0
2,GO REGULATION OF T CELL DIFFERENTIATION,0.013798,0.1109,0.1266,1,0
2,GO ERYTHROCYTE HOMEOSTASIS,0.012508,0.11064,0.11214,1,0
2,GO CELLULAR RESPIRATION,0.0090226,0.11016,0.14416,1,0
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.001986,0.10989,0.11985,1,0
2,GO HUMORAL IMMUNE RESPONSE,0.021165,0.10956,0.070156,1,0
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.020205,0.10936,0.088882,1,0
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.031059,0.10864,0.088391,1,0
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.025414,0.10792,0.091682,1,0
2,GO REGULATION OF ATP METABOLIC PROCESS,0.016339,0.10697,0.087305,1,0
2,GO VIRAL RELEASE FROM HOST CELL,0.017969,0.10491,0.12078,1,0
2,GO CELLULAR RESPONSE TO DRUG,0.012203,0.10453,0.11572,1,0
2,GO KERATINIZATION,0.043763,0.10427,0.17057,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.046579,0.1041,0.10784,1,0
2,GO NEGATIVE REGULATION OF CELL DEATH,0.017137,0.10317,0.081932,1,0
2,GO PEPTIDYL TYROSINE MODIFICATION,0.011326,0.10223,0.12461,1,0
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.012508,0.10205,0.18478,1,0
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0039469,0.10171,0.10602,1,0
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.036164,0.10158,0.11777,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.041967,0.10013,0.12686,1,0
2,GO REGULATION OF RESPONSE TO STRESS,0.016734,0.099552,0.073165,1,0
2,GO CELLULAR RESPONSE TO LIPID,0.017549,0.098976,0.096403,1,0
2,GO IMMUNE SYSTEM DEVELOPMENT,0.018398,0.097919,0.08746,1,0
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.033894,0.097259,0.11515,1,0
2,GO MRNA EXPORT FROM NUCLEUS,0.00037661,0.097151,0.15034,1,0
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.007729,0.09698,0.14849,1,0
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.017969,0.096777,0.11998,1,0
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.04854,0.096747,0.14137,1,0
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.014138,0.096221,0.11691,1,0
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.03245,0.09567,0.095013,1,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.019283,0.094969,0.095211,1,0
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.03245,0.094176,0.085156,1,0
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.013139,0.092965,0.11187,1,0
2,GO RESPONSE TO HEAT,0.023205,0.092209,0.096968,1,0
2,GO SNRNA PROCESSING,0.015953,0.091876,0.089899,1,0
2,GO SKIN DEVELOPMENT,0.037747,0.091574,0.15729,1,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.011904,0.091509,0.11392,1,0
2,GO REGULATION OF CELL SHAPE,0.040234,0.091423,0.1247,1,0
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.031748,0.090444,0.1863,1,0
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.029068,0.089912,0.078888,1,0
2,GO CELL AGING,0.029719,0.089427,0.077403,1,0
2,GO RNA CAPPING,0.011326,0.089316,0.09395,1,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.018836,0.088762,0.10341,1,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.045624,0.088661,0.13228,1,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.0020453,0.087903,0.080348,1,0
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.013465,0.087811,0.079473,1,0
2,GO CELLULAR RESPONSE TO HEAT,0.027803,0.087546,0.10435,1,0
2,GO NUCLEOTIDE EXCISION REPAIR,0.007729,0.087517,0.074423,1,0
2,GO B CELL ACTIVATION,0.0071468,0.087369,0.096825,1,0
2,GO PLACENTA DEVELOPMENT,0.047551,0.08683,0.11298,1,0
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.023741,0.086541,0.12529,1,0
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.037747,0.086203,0.081786,1,0
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.022165,0.085765,0.10052,1,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0062634,0.085721,0.14359,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.011047,0.085512,0.11567,1,0
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0027346,0.085276,0.13248,1,0
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.04854,0.084751,0.10662,1,0
2,GO STEROID METABOLIC PROCESS,0.0094949,0.08392,0.10543,1,0
2,GO ENDOCRINE PROCESS,0.036948,0.083704,0.099355,1,0
2,GO RRNA METHYLATION,0.031059,0.081485,0.15902,1,0
2,GO ERAD PATHWAY,0.012508,0.081021,0.10279,1,0
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.033894,0.080907,0.14041,1,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.040234,0.080415,0.094849,1,0
2,GO NCRNA TRANSCRIPTION,0.01282,0.080268,0.092715,1,0
2,GO APOPTOTIC SIGNALING PATHWAY,0.044685,0.080223,0.064321,1,0
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.018398,0.080161,0.17197,1,0
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.019739,0.080129,0.14325,1,0
2,GO SELECTIVE AUTOPHAGY,0.017137,0.079739,0.094735,1,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.016734,0.077577,0.087139,1,0
2,GO TISSUE MIGRATION,0.034637,0.07691,0.12267,1,0
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.047551,0.076601,0.11128,1,0
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.04854,0.075743,0.09271,1,0
2,GO MYELOID CELL DIFFERENTIATION,0.031748,0.075335,0.085187,1,0
2,GO SNRNA METABOLIC PROCESS,0.0053338,0.07527,0.09641,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.020205,0.075099,0.085013,1,0
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.034637,0.074611,0.10856,1,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.074162,0.089584,1,0
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.015953,0.074118,0.083679,1,0
2,GO MITOCHONDRIAL TRANSPORT,0.011047,0.072808,0.090779,1,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.042857,0.071806,0.089381,1,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.029068,0.071761,0.097148,1,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0064317,0.071385,0.10616,1,0
2,GO REGULATION OF PROTEIN STABILITY,0.017969,0.06935,0.068076,1,0
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.043763,0.068468,0.10681,1,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.04854,0.066692,0.060075,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.037747,0.063522,0.070517,1,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0085714,0.063147,0.064397,1,0
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.017137,0.062306,0.080172,1,0
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.043763,0.062204,0.059861,1,0
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.034637,0.061746,0.08234,1,0
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.035393,0.061512,0.08402,1,0
2,GO CHROMOSOME CONDENSATION,0.047551,0.061065,0.077465,1,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.042857,0.060539,0.090977,1,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.01282,0.059742,0.066338,1,0
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.02268,0.058892,0.11355,1,0
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.042857,0.057639,0.060944,1,0
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.029068,0.045261,0.11508,1,0
2,GO METHYLATION,0.0064317,0.04502,0.071068,1,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.046579,0.034587,0.061009,1,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.041093,0.032896,0.044536,1,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.010773,-0.055575,-0.078245,1,0
2,GO PEPTIDE SECRETION,0.033166,-0.062393,-0.088797,1,0
2,GO FEAR RESPONSE,0.042857,-0.062561,-0.12621,1,0
2,GO SENSORY PERCEPTION OF SMELL,0.044685,-0.080246,-0.075703,1,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.031748,-0.084532,-0.081316,1,0
2,GO POSITIVE REGULATION OF SECRETION,0.0071468,-0.085082,-0.10242,1,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.03939,-0.085362,-0.08028,1,0
2,GO REGULATION OF SECRETION,0.02068,-0.088713,-0.0923,1,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.014486,-0.090757,-0.11501,1,0
2,GO ENERGY HOMEOSTASIS,0.041967,-0.096654,-0.15343,1,0
2,GO RESPONSE TO MECHANICAL STIMULUS,0.046579,-0.099978,-0.10098,1,0
2,GO REGULATION OF BLOOD CIRCULATION,0.02268,-0.10223,-0.10572,1,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.0023671,-0.104,-0.14276,1,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.03245,-0.10569,-0.1523,1,0
2,GO CHLORIDE TRANSPORT,0.031748,-0.1081,-0.098541,1,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0094949,-0.11008,-0.11269,1,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.041967,-0.11254,-0.12601,1,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.036948,-0.11428,-0.093852,1,0
2,GO FEEDING BEHAVIOR,0.033894,-0.11713,-0.098931,1,0
2,GO CELL MATURATION,0.0067808,-0.11822,-0.11562,1,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.027188,-0.11822,-0.095743,1,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0040578,-0.11977,-0.13897,1,0
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.024288,-0.12008,-0.17897,1,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.036948,-0.12448,-0.12108,1,0
2,GO REGULATION OF ION TRANSPORT,0.0087944,-0.12549,-0.10957,1,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.04854,-0.12554,-0.14773,1,0
2,GO PHAGOSOME MATURATION,0.02068,-0.12601,-0.13216,1,0
2,GO REGULATION OF HORMONE SECRETION,0.0028141,-0.12856,-0.13032,1,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0083534,-0.13822,-0.15085,1,0
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.02843,-0.14133,-0.096811,1,0
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.033894,-0.14309,-0.15081,1,0
2,GO HORMONE TRANSPORT,0.0033369,-0.14561,-0.1338,1,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.011612,-0.14724,-0.14223,1,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.035393,-0.1493,-0.14091,1,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.030383,-0.15016,-0.13885,1,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00065623,-0.15063,-0.17227,1,0
2,GO REPRODUCTIVE BEHAVIOR,0.0023671,-0.1508,-0.20795,1,0
2,GO CELLULAR RESPONSE TO PH,0.031748,-0.15159,-0.12339,1,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0030654,-0.15462,-0.15878,1,0
2,GO REGULATION OF DNA BINDING,0.017137,-0.15475,-0.11958,1,0
2,GO RESPONSE TO CALCIUM ION,0.0053338,-0.15485,-0.148,1,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0083534,-0.15529,-0.097714,1,0
2,GO REGULATION OF INSULIN SECRETION,0.0066042,-0.15835,-0.13039,1,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.0026572,-0.15857,-0.16968,1,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.012203,-0.16064,-0.20274,1,0
2,GO PROTEIN HETEROOLIGOMERIZATION,0.0017123,-0.16124,-0.1522,1,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.041093,-0.16269,-0.12979,1,0
2,GO SUCKLING BEHAVIOR,0.014841,-0.16275,-0.23342,1,0
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.016734,-0.16358,-0.1648,1,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0023671,-0.16698,-0.17207,1,0
2,GO ACROSOME ASSEMBLY,0.0051916,-0.17449,-0.20243,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.04854,-0.17581,-0.176,1,0
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.0075304,-0.17893,-0.26668,1,0
2,GO ANDROGEN METABOLIC PROCESS,0.040234,-0.17912,-0.071323,1,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0006154,-0.17982,-0.16591,1,0
2,GO INSULIN SECRETION,0.0066042,-0.17994,-0.14029,1,0
2,GO DENDRITE SELF AVOIDANCE,0.021165,-0.18006,-0.21701,1,0
2,GO CAMP METABOLIC PROCESS,0.038561,-0.1818,-0.17325,1,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.010506,-0.18225,-0.18591,1,0
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.02843,-0.18747,-0.22547,1,0
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0090226,-0.1915,-0.15378,1,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.00074557,-0.19168,-0.15348,1,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00037661,-0.19293,-0.1986,1,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00087311,-0.19823,-0.26404,1,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0010206,-0.19835,-0.18128,1,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0014738,-0.19929,-0.22693,1,0
2,GO PEPTIDE HORMONE SECRETION,0.00045924,-0.20159,-0.17852,1,0
2,GO REGULATION OF FERTILIZATION,0.0015653,-0.2019,-0.1974,1,0
2,GO RESPONSE TO FUNGUS,0.0037331,-0.20389,-0.14599,1,0
2,GO SIGNAL RELEASE,0.00012074,-0.20499,-0.16978,1,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0024367,-0.20554,-0.21439,1,0
2,GO DENDRITIC TRANSPORT,0.025414,-0.21053,-0.20565,1,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.00079435,-0.21056,-0.22187,1,0
2,GO CALCIUM ION IMPORT,0.00021909,-0.21137,-0.20977,1,0
2,GO RESPONSE TO PH,0.023205,-0.21215,-0.14171,1,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.031059,-0.21246,-0.14597,1,0
2,GO DEFENSE RESPONSE TO FUNGUS,0.00016023,-0.21445,-0.21678,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.045624,-0.21626,-0.23385,1,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.00023468,-0.23711,-0.21995,1,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,6.2786e-05,-0.2467,-0.22982,1,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.001662,-0.25748,-0.3272,1,0
2,GO AMMONIUM ION METABOLIC PROCESS,0.0057817,-0.26182,-0.27576,1,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.031748,-0.26628,-0.22889,1,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0011199,-0.2678,-0.24778,1,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.0024367,-0.26922,-0.23852,1,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0099891,-0.27012,-0.21728,1,0
2,GO AMINE BIOSYNTHETIC PROCESS,0.0062634,-0.27163,-0.19677,1,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.00022676,-0.27186,-0.31015,1,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.009256,-0.27352,-0.30867,1,0
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.001986,-0.27644,-0.33458,1,0
2,GO ALANINE TRANSPORT,0.014486,-0.28426,-0.19128,1,0
2,GO MEMBRANE BIOGENESIS,0.0067808,-0.28516,-0.21802,1,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.0013457,-0.28732,-0.23763,1,0
2,GO HORMONE CATABOLIC PROCESS,0.026586,-0.29056,-0.18762,1,0
2,GO OPTIC NERVE DEVELOPMENT,0.00353,-0.29833,-0.31267,1,0
2,GO TOXIN METABOLIC PROCESS,0.041093,-0.3095,-0.2175,1,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.023205,-0.31189,-0.23159,1,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,8.1192e-05,-0.31378,-0.29285,1,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,6.5149e-05,-0.32139,-0.28044,1,0
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.001191,-0.32514,-0.32941,1,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.0033369,-0.32549,-0.25505,1,0
2,GO EXOCYTIC PROCESS,6.5149e-05,-0.32779,-0.27868,1,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00034072,-0.33215,-0.35432,1,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,3.9418e-06,-0.3328,-0.33353,1,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0064317,-0.33964,-0.32578,1,0
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0011199,-0.34695,-0.2692,1,0
2,GO DORSAL AORTA DEVELOPMENT,2.0033e-05,-0.35222,-0.38177,1,0
2,GO RESPONSE TO DIETARY EXCESS,0.00041602,-0.36072,-0.38641,1,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.00021909,-0.3711,-0.3776,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0030654,-0.39009,-0.35103,1,0
2,GO INCLUSION BODY ASSEMBLY,0.00037661,-0.40517,-0.35682,1,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,3.4421e-05,-0.41294,-0.37964,1,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0075304,-0.41315,-0.32271,1,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,9.389e-05,-0.41611,-0.32533,1,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,4.3218e-05,-0.41759,-0.40071,1,0
2,GO SYNAPTIC VESICLE LOCALIZATION,9.7346e-05,-0.4335,-0.3702,1,0
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.0021062,-0.43651,-0.33772,1,0
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0007696,-0.43936,-0.49714,1,0
2,GO CATECHOLAMINE METABOLIC PROCESS,3.6228e-06,-0.44661,-0.44857,1,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00072223,-0.45579,-0.44077,1,0
2,GO CARDIOBLAST PROLIFERATION,0.0041716,-0.45976,-0.48552,1,0
2,GO RESPONSE TO HISTAMINE,0.00042998,-0.46764,-0.52218,1,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0019282,-0.47184,-0.3142,1,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0057817,-0.4742,-0.38282,1,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0020453,-0.47903,-0.36518,1,0
2,GO RESPONSE TO LITHIUM ION,0.0013872,-0.48226,-0.3472,1,0
2,GO DOPAMINE METABOLIC PROCESS,4.8612e-06,-0.493,-0.45643,1,0
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0020453,-0.49519,-0.44063,1,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0056288,-0.50641,-0.4666,1,0
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,9.0179e-06,-0.51127,-0.4967,1,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.00047456,-0.5209,-0.55834,1,0
2,GO PLASMA MEMBRANE REPAIR,5.6174e-05,-0.5512,-0.59354,1,0
2,GO NEURON FATE SPECIFICATION,0.00084609,-0.55274,-0.43307,1,0
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00045924,-0.55607,-0.41556,1,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,1.2454e-05,-0.55775,-0.47568,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,6.2786e-05,-0.57945,-0.49844,1,0
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00019753,-0.59447,-0.57583,1,0
2,GO RESPONSE TO INSECTICIDE,1.3441e-06,-0.64942,-0.58409,1,0
2,GO SYNAPTIC VESICLE PRIMING,6.7596e-05,-0.68553,-0.56218,1,0
2,GO INNERVATION,1.2862e-06,-0.69684,-0.70258,1,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,6.7728e-06,-0.70171,-0.64283,1,0
2,GO SYNAPTIC VESICLE MATURATION,8.3127e-06,-0.70729,-0.76326,1,0
2,GO DOPAMINE TRANSPORT,3.5759e-05,-0.72243,-0.57568,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,6.7596e-05,-0.76375,-0.65106,1,0
2,GO CATECHOLAMINE SECRETION,5.4121e-05,-0.77421,-0.58309,1,0
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00038934,-0.82534,-0.63904,1,0
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,7.8282e-05,-0.92275,-0.71216,1,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,6.8936e-07,-0.94969,-0.82317,1,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,8.2505e-07,-1.3246,-1.3117,1,0
2,GO RESPONSE TO INTERFERON ALPHA,0.063042,0.54113,0.22231,0,1
2,GO REGULATION OF HIPPO SIGNALING,0.052669,0.46175,0.2215,0,1
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.080955,0.38487,0.22266,0,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.29184,0.33582,0.14403,0,1
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.2839,0.3324,0.09428,0,1
2,GO RESPONSE TO HYDROPEROXIDE,0.065563,0.32846,0.2261,0,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.057089,0.32157,0.14601,0,1
2,GO REGULATION OF GLOMERULAR FILTRATION,0.099158,0.31969,0.23045,0,1
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.088862,0.2992,0.19098,0,1
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.22235,0.2954,0.1369,0,1
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.087232,0.29077,0.33096,0,1
2,GO REGULATION OF GTP BINDING,0.050569,0.28956,0.18015,0,1
2,GO EPIBOLY,0.053746,0.28775,0.16702,0,1
2,GO IMP METABOLIC PROCESS,0.060602,0.28529,0.25349,0,1
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.077957,0.27839,0.26011,0,1
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.093897,0.2779,0.20106,0,1
2,GO LIPID DROPLET FORMATION,0.24643,0.27697,0.1663,0,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.15015,0.27108,0.12299,0,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.054842,0.27104,0.13684,0,1
2,GO LATERAL MESODERM DEVELOPMENT,0.58456,0.26822,0.079068,0,1
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.12689,0.26768,0.17934,0,1
2,GO MUSCLE CELL FATE COMMITMENT,0.095625,0.26686,0.2174,0,1
2,GO REPLICATIVE SENESCENCE,0.16294,0.26561,0.1168,0,1
2,GO NUCLEOTIDE SALVAGE,0.27227,0.25074,0.12218,0,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.050569,0.247,0.2102,0,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.073629,0.24623,0.18956,0,1
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.064293,0.24328,0.25429,0,1
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.092194,0.24267,0.13945,0,1
2,GO HYALURONAN CATABOLIC PROCESS,0.32938,0.24062,0.099074,0,1
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.092194,0.2398,0.19845,0,1
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.26471,0.23828,0.060823,0,1
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.13355,0.23608,0.15843,0,1
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.32077,0.23439,0.087182,0,1
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.16828,0.2329,0.082452,0,1
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.22905,0.23287,0.17104,0,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.068167,0.22679,0.19783,0,1
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.13583,0.22586,0.14651,0,1
2,GO REGULATION OF GASTRULATION,0.085627,0.22362,0.11002,0,1
2,GO MAGNESIUM ION HOMEOSTASIS,0.064293,0.21305,0.24165,0,1
2,GO B CELL HOMEOSTASIS,0.05161,0.21235,0.1073,0,1
2,GO TROPHOBLAST CELL MIGRATION,0.068167,0.20951,0.1586,0,1
2,GO REGULATION OF NEURON MATURATION,0.12259,0.20895,0.17081,0,1
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.10096,0.20819,0.13771,0,1
2,GO ENDODERMAL CELL FATE COMMITMENT,0.25363,0.20678,0.074198,0,1
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.080955,0.20477,0.14161,0,1
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.073629,0.2029,0.16161,0,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.29184,0.20147,0.08261,0,1
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.0695,0.19812,0.13539,0,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.12049,0.19584,0.11147,0,1
2,GO RESPONSE TO LIGHT INTENSITY,0.20621,0.19564,0.11576,0,1
2,GO SEQUESTERING OF METAL ION,0.063042,0.1939,0.17141,0,1
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.19393,0.19236,0.041747,0,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.070855,0.19227,0.17953,0,1
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.39371,0.19101,0.049554,0,1
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.11434,0.19048,0.095229,0,1
2,GO PARAXIAL MESODERM DEVELOPMENT,0.60883,0.19032,0.082736,0,1
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.1313,0.18883,0.28085,0,1
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.088862,0.18848,0.1969,0,1
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.052669,0.18756,0.18764,0,1
2,GO GRANULOCYTE MIGRATION,0.057089,0.18658,0.089707,0,1
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.066855,0.18597,0.12651,0,1
2,GO PIGMENT CELL DIFFERENTIATION,0.080955,0.18587,0.089522,0,1
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.50896,0.18519,0.083008,0,1
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.16559,0.18416,0.10967,0,1
2,GO ENAMEL MINERALIZATION,0.05161,0.18393,0.28276,0,1
2,GO HETEROTYPIC CELL CELL ADHESION,0.084046,0.18345,0.12892,0,1
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.22235,0.18056,0.087653,0,1
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.084046,0.18006,0.10998,0,1
2,GO GLYCOLIPID CATABOLIC PROCESS,0.31232,0.17875,0.052113,0,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.052669,0.17825,0.12082,0,1
2,GO EMBRYO IMPLANTATION,0.068167,0.17722,0.12447,0,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.073629,0.17551,0.11475,0,1
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.05824,0.17372,0.095999,0,1
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.26847,0.17367,0.080919,0,1
2,GO RESPONSE TO CORTICOSTEROID,0.052669,0.17206,0.11945,0,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.8303,0.17173,-0.021904,0,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.060602,0.1715,0.16258,0,1
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.16032,0.16865,0.19145,0,1
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.37932,0.16802,0.058955,0,1
2,GO PROTEIN AUTOPROCESSING,0.15015,0.16767,0.11861,0,1
2,GO EPITHELIAL CELL FATE COMMITMENT,0.53167,0.16765,0.038435,0,1
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.19695,0.16755,0.05786,0,1
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.13814,0.16669,0.10982,0,1
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.11235,0.16663,0.09743,0,1
2,GO RESPONSE TO DEXAMETHASONE,0.060602,0.16635,0.14814,0,1
2,GO KERATINOCYTE PROLIFERATION,0.049546,0.16557,0.26095,0,1
2,GO PENILE ERECTION,0.22568,0.16534,0.065227,0,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.2,0.16435,0.069143,0,1
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.059411,0.16298,0.10188,0,1
2,GO CELL CELL JUNCTION ASSEMBLY,0.066855,0.16285,0.099333,0,1
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.12689,0.16184,0.15446,0,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.05161,0.16181,0.16158,0,1
2,GO DEVELOPMENTAL PIGMENTATION,0.11235,0.16095,0.072407,0,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.05161,0.16072,0.13974,0,1
2,GO NAD METABOLIC PROCESS,0.11235,0.16039,0.12541,0,1
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.31232,0.16014,0.08255,0,1
2,GO MALE SEX DETERMINATION,0.088862,0.15768,0.14581,0,1
2,GO DIOL BIOSYNTHETIC PROCESS,0.188,0.15724,0.065485,0,1
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.065563,0.15653,0.15437,0,1
2,GO GOLGI TO VACUOLE TRANSPORT,0.27611,0.15487,0.073976,0,1
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.10845,0.15396,0.089352,0,1
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.079444,0.15288,0.14247,0,1
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.50896,0.15115,0.040151,0,1
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.14769,0.15085,0.11782,0,1
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.068167,0.14909,0.15697,0,1
2,GO INTRACELLULAR MRNA LOCALIZATION,0.27999,0.14869,0.12168,0,1
2,GO REGULATION OF URINE VOLUME,0.057089,0.14863,0.14911,0,1
2,GO REGULATION OF B CELL DIFFERENTIATION,0.12908,0.1472,0.13816,0,1
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.56075,0.14566,0.033947,0,1
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.057089,0.14532,0.14845,0,1
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.3746,0.14401,0.058861,0,1
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.077957,0.1439,0.13831,0,1
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.30402,0.14372,0.078414,0,1
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.064293,0.1431,0.1027,0,1
2,GO REGULATION OF PROTEIN SUMOYLATION,0.050569,0.14237,0.11908,0,1
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.070855,0.14156,0.093252,0,1
2,GO SUPEROXIDE METABOLIC PROCESS,0.072231,0.14087,0.10585,0,1
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.25001,0.14053,0.050568,0,1
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.080955,0.13988,0.14825,0,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.05824,0.13917,0.10256,0,1
2,GO MALE SEX DIFFERENTIATION,0.050569,0.13817,0.12307,0,1
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.060602,0.13814,0.093329,0,1
2,GO RESPONSE TO IRON ION,0.050569,0.13805,0.14981,0,1
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.20309,0.13741,0.078497,0,1
2,GO REGULATION OF STEROL TRANSPORT,0.11841,0.1366,0.10535,0,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0695,0.13642,0.10682,0,1
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.063042,0.1361,0.11484,0,1
2,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.092194,0.13604,0.16583,0,1
2,GO ACTIVATION OF JNKK ACTIVITY,0.1028,0.13577,0.11402,0,1
2,GO HISTONE MONOUBIQUITINATION,0.15264,0.13517,0.079626,0,1
2,GO LYMPHOCYTE COSTIMULATION,0.10845,0.13515,0.076141,0,1
2,GO FEVER GENERATION,0.050569,0.13509,0.1561,0,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.055956,0.13462,0.096665,0,1
2,GO PANCREATIC JUICE SECRETION,0.19095,0.13455,0.11508,0,1
2,GO RESPONSE TO TESTOSTERONE,0.16559,0.13454,0.095674,0,1
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.24288,0.13346,0.086675,0,1
2,GO GASTRULATION,0.24288,0.1316,0.091063,0,1
2,GO INTERMEMBRANE LIPID TRANSFER,0.060602,0.13151,0.08933,0,1
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.090515,0.13029,0.098373,0,1
2,GO IMMATURE T CELL PROLIFERATION,0.12259,0.12925,0.14068,0,1
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.36064,0.12918,0.05576,0,1
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.063042,0.12901,0.11476,0,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.23245,0.12822,0.08049,0,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.15015,0.12816,0.088549,0,1
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.055956,0.12774,0.11468,0,1
2,GO RRNA 3 END PROCESSING,0.088862,0.12745,0.11038,0,1
2,GO RESPONSE TO KETONE,0.050569,0.12686,0.092858,0,1
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.066855,0.12677,0.11821,0,1
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.16828,0.12622,0.053136,0,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.22568,0.12586,0.078873,0,1
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.064293,0.12579,0.11107,0,1
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.063042,0.12517,0.10421,0,1
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.12049,0.12507,0.069283,0,1
2,GO TELOMERIC LOOP DISASSEMBLY,0.057089,0.12506,0.12334,0,1
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.2839,0.12441,0.10232,0,1
2,GO REGULATION OF SPINDLE ORGANIZATION,0.17934,0.1229,0.065533,0,1
2,GO RUFFLE ORGANIZATION,0.092194,0.12238,0.072639,0,1
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.39858,0.12175,0.063185,0,1
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.18219,0.12165,0.078352,0,1
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.30402,0.11961,0.15989,0,1
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.097379,0.11906,0.12386,0,1
2,GO CARNITINE METABOLIC PROCESS,0.29992,0.11888,0.049815,0,1
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.55487,0.11824,0.0074321,0,1
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.079444,0.11779,0.10406,0,1
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.26847,0.11758,0.04733,0,1
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.4598,0.11721,0.019327,0,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.26471,0.11709,0.052568,0,1
2,GO HISTONE UBIQUITINATION,0.088862,0.11564,0.066123,0,1
2,GO EXIT FROM MITOSIS,0.088862,0.11516,0.064135,0,1
2,GO REGULATION OF CELL MATURATION,0.088862,0.11449,0.12117,0,1
2,GO BILE ACID METABOLIC PROCESS,0.057089,0.11361,0.15449,0,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.32506,0.11341,0.043418,0,1
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.22568,0.11314,0.10885,0,1
2,GO REGULATION OF ACTIN NUCLEATION,0.12689,0.11137,0.13614,0,1
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.054842,0.11128,0.087777,0,1
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.42347,0.11091,0.082201,0,1
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.075049,0.11039,0.088663,0,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.060602,0.10815,0.12756,0,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.059411,0.10776,0.12099,0,1
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.11636,0.10775,0.076252,0,1
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0695,0.10759,0.099446,0,1
2,GO RESPONSE TO INACTIVITY,0.30815,0.10681,0.068087,0,1
2,GO CELLULAR RESPONSE TO KETONE,0.11235,0.10677,0.082631,0,1
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.088862,0.10676,0.10972,0,1
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.088862,0.10546,0.076086,0,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.21256,0.1053,0.033189,0,1
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.092194,0.10451,0.096344,0,1
2,GO HAIR CELL DIFFERENTIATION,0.22568,0.10399,0.075128,0,1
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.41842,0.10154,0.044147,0,1
2,GO PROTEIN MONOUBIQUITINATION,0.077957,0.098914,0.06319,0,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.072231,0.098218,0.070119,0,1
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.71006,0.096537,0.024914,0,1
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.087232,0.096435,0.062645,0,1
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.34256,0.096344,0.096742,0,1
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.51459,0.096297,0.072128,0,1
2,GO REGULATION OF DNA REPAIR,0.079444,0.095058,0.057662,0,1
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.05161,0.094905,0.10417,0,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.060602,0.094182,0.08205,0,1
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.082489,0.09414,0.063575,0,1
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.20937,0.092703,0.11412,0,1
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.1313,0.091865,0.058301,0,1
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.47049,0.090757,0.051336,0,1
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.14526,0.090379,0.049426,0,1
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.20309,0.090209,0.06768,0,1
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.23937,0.090124,0.069741,0,1
2,GO ORGANELLE INHERITANCE,0.057089,0.089061,0.063955,0,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.084046,0.088338,0.08885,0,1
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.25729,0.087746,0.04585,0,1
2,GO NEURAL TUBE DEVELOPMENT,0.29184,0.086613,0.092549,0,1
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.05824,0.082925,0.065111,0,1
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.05161,0.081166,0.12635,0,1
2,GO HISTONE H2A UBIQUITINATION,0.4598,0.081142,0.040003,0,1
2,GO GENITALIA DEVELOPMENT,0.12049,0.080401,0.070371,0,1
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.32077,0.07987,0.044413,0,1
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.099158,0.079117,0.09513,0,1
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.079444,0.078719,0.064374,0,1
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.12689,0.078591,0.068206,0,1
2,GO RETROGRADE AXONAL TRANSPORT,0.20621,0.078274,0.094806,0,1
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.13583,0.078207,0.030329,0,1
2,GO SEQUESTERING OF CALCIUM ION,0.31232,0.076715,0.050178,0,1
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.32938,0.076357,0.041056,0,1
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.095625,0.07619,0.049325,0,1
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.39858,0.075778,0.10638,0,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.080955,0.075706,0.11539,0,1
2,GO CELLULAR PIGMENTATION,0.085627,0.075329,0.091981,0,1
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.11841,0.075183,0.055451,0,1
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.19095,0.073008,0.056941,0,1
2,GO RESPONSE TO INSULIN,0.070855,0.072547,0.042346,0,1
2,GO PROTEIN N LINKED GLYCOSYLATION,0.21579,0.071987,0.04243,0,1
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.29992,0.07025,0.073023,0,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.5726,0.070004,0.026147,0,1
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.27999,0.068606,0.10096,0,1
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.10654,0.068472,0.073738,0,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.62113,0.06794,0.014666,0,1
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.14285,0.067801,0.059931,0,1
2,GO NADH METABOLIC PROCESS,0.34702,0.067056,0.068801,0,1
2,GO LIPID PHOSPHORYLATION,0.10096,0.066729,0.055988,0,1
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.11039,0.066311,0.04756,0,1
2,GO POLYOL CATABOLIC PROCESS,0.20621,0.065999,0.04707,0,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.53167,0.065404,0.030318,0,1
2,GO REGULATION OF SPINDLE ASSEMBLY,0.11636,0.064357,0.1064,0,1
2,GO GLYCOSYLATION,0.35607,0.063382,0.0022593,0,1
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.05824,0.063191,0.11528,0,1
2,GO CELLULAR RESPONSE TO RADIATION,0.052669,0.062614,0.086433,0,1
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.18219,0.062219,0.065854,0,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.055956,0.059895,0.080027,0,1
2,GO SPINDLE ASSEMBLY,0.21256,0.059852,0.03875,0,1
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.052669,0.059572,0.058881,0,1
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.12689,0.059295,0.050526,0,1
2,GO RETINA HOMEOSTASIS,0.22905,0.055983,0.073195,0,1
2,GO VITAMIN METABOLIC PROCESS,0.12259,0.055938,0.078718,0,1
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.076492,0.054714,0.073762,0,1
2,GO AUTOPHAGY OF MITOCHONDRION,0.22905,0.053994,0.03087,0,1
2,GO RESPONSE TO LIGHT STIMULUS,0.097379,0.052565,0.04853,0,1
2,GO MACROMOLECULE DEACYLATION,0.12473,0.051139,0.044017,0,1
2,GO HISTONE H3 K9 MODIFICATION,0.25363,0.049598,0.053925,0,1
2,GO REGULATION OF RNA SPLICING,0.11434,0.049129,0.064477,0,1
2,GO REGULATION OF ATPASE ACTIVITY,0.13355,0.046244,0.054773,0,1
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.19095,0.043626,0.042786,0,1
2,GO MYOFIBRIL ASSEMBLY,0.27611,0.043396,0.044495,0,1
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.11434,0.040316,0.070428,0,1
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.25363,0.039238,0.037812,0,1
2,GO REGULATION OF MRNA PROCESSING,0.24288,0.037671,0.045098,0,1
2,GO INTRACELLULAR TRANSPORT,0.11039,0.036052,0.036249,0,1
2,GO REGULATION OF CELL CYCLE PROCESS,0.075049,0.035549,0.056404,0,1
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.15264,0.035014,0.059982,0,1
2,GO PROTEIN INSERTION INTO MEMBRANE,0.72969,0.034552,0.0085737,0,1
2,GO COVALENT CHROMATIN MODIFICATION,0.13355,0.033243,0.039948,0,1
2,GO PEPTIDYL LYSINE MODIFICATION,0.077957,0.028043,0.041344,0,1
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.19393,0.027589,0.04921,0,1
2,GO CHROMATIN ORGANIZATION,0.23589,0.023718,0.03341,0,1
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.16294,0.39154,0.28594,0,0
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.0057817,0.3878,0.26355,0,0
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.082489,0.37762,0.26315,0,0
2,GO BLEB ASSEMBLY,0.093897,0.35148,0.21631,0,0
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.56666,0.31933,0.038372,0,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.050569,0.31374,0.16713,0,0
2,GO RENAL VESICLE DEVELOPMENT,0.0069616,0.30486,0.24256,0,0
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.13583,0.28361,0.17335,0,0
2,GO RESPONSE TO TYPE I INTERFERON,0.082489,0.27709,0.15385,0,0
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.13814,0.27522,0.11734,0,0
2,GO MEMBRANE RAFT ASSEMBLY,0.44402,0.27411,0.019861,0,0
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.04854,0.2695,0.16692,0,0
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.057089,0.26803,0.14163,0,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.19095,0.26562,0.11913,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.063042,0.26146,0.21245,0,0
2,GO LEYDIG CELL DIFFERENTIATION,0.93377,0.25142,-0.059376,0,0
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.017549,0.24908,0.15923,0,0
2,GO ZYMOGEN ACTIVATION,0.088862,0.246,0.19494,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.05161,0.24393,0.10771,0,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.38408,0.23773,0.10749,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0056288,0.23319,0.23287,0,0
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.4978,0.23175,0.033712,0,0
2,GO HEART VALVE FORMATION,0.18219,0.22788,0.16582,0,0
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.050569,0.22646,0.16166,0,0
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.05161,0.22623,0.21643,0,0
2,GO GAP JUNCTION ASSEMBLY,0.31232,0.2231,0.085722,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.11636,0.22162,0.15686,0,0
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.057089,0.21735,0.17258,0,0
2,GO STEM CELL DIVISION,0.0024367,0.21697,0.2289,0,0
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.25729,0.21603,0.12694,0,0
2,GO LIPID IMPORT INTO CELL,0.061812,0.2143,0.14245,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.055956,0.21293,0.157,0,0
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.11841,0.21248,0.19384,0,0
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.10465,0.21225,0.13291,0,0
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0695,0.21084,0.10684,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.20621,0.2098,0.14021,0,0
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0695,0.20974,0.13068,0,0
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.054842,0.20936,0.16877,0,0
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.010506,0.20862,0.17098,0,0
2,GO DETECTION OF OTHER ORGANISM,0.12908,0.20762,0.083082,0,0
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.10465,0.20713,0.18127,0,0
2,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.12049,0.20656,0.15656,0,0
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.055956,0.20611,0.19914,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.061812,0.20547,0.1102,0,0
2,GO ASYMMETRIC CELL DIVISION,0.017549,0.20512,0.17735,0,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.073629,0.20446,0.19594,0,0
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.050569,0.2029,0.10848,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.18219,0.20133,0.14194,0,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.0075304,0.20095,0.25875,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.41842,0.20094,0.067461,0,0
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.077957,0.19846,0.17008,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.17099,0.19838,0.077583,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.12689,0.19668,0.11638,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.19095,0.19591,0.096522,0,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.20937,0.19587,0.11256,0,0
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.049546,0.19565,0.13607,0,0
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.27999,0.19559,0.17439,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.10845,0.19376,0.14501,0,0
2,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.054842,0.19195,0.23784,0,0
2,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.23245,0.19122,0.070318,0,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.087232,0.19109,0.11793,0,0
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.036948,0.18975,0.13877,0,0
2,GO CYTIDINE TO URIDINE EDITING,0.099158,0.18903,0.26021,0,0
2,GO VASCULOGENESIS,0.055956,0.18889,0.14778,0,0
2,GO ELASTIC FIBER ASSEMBLY,0.077957,0.1882,0.22282,0,0
2,GO EPOXYGENASE P450 PATHWAY,0.05161,0.18786,0.17388,0,0
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.001662,0.18718,0.18496,0,0
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0071468,0.18672,0.17147,0,0
2,GO PROTEIN ACTIVATION CASCADE,0.072231,0.18518,0.19348,0,0
2,GO MINERALOCORTICOID METABOLIC PROCESS,0.29184,0.18435,0.078925,0,0
2,GO REGULATION OF FATTY ACID OXIDATION,0.064293,0.18338,0.12435,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.052669,0.18337,0.15964,0,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.63978,0.18262,0.0021483,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.12473,0.18182,0.11063,0,0
2,GO HISTAMINE TRANSPORT,0.16032,0.1811,0.11397,0,0
2,GO CELL AGGREGATION,0.018398,0.1811,0.17618,0,0
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.079444,0.17995,0.14984,0,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.20937,0.17896,0.11266,0,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.073629,0.17874,0.13278,0,0
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.059411,0.17867,0.14436,0,0
2,GO VIRAL GENOME REPLICATION,0.065563,0.17838,0.13495,0,0
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0029794,0.17721,0.16503,0,0
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00081984,0.17614,0.17901,0,0
2,GO RENAL TUBULE DEVELOPMENT,0.072231,0.17611,0.13289,0,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.10465,0.17281,0.22753,0,0
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.059411,0.17272,0.11077,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0014738,0.17259,0.17271,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.087232,0.17181,0.11405,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.049546,0.17176,0.11927,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.10845,0.17084,0.16805,0,0
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.052669,0.17062,0.11496,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.15264,0.17048,0.13938,0,0
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.088862,0.17039,0.15067,0,0
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.21579,0.17028,0.45232,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.055956,0.17002,0.3346,0,0
2,GO METANEPHROS DEVELOPMENT,0.043763,0.16974,0.14965,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.11636,0.1694,0.15093,0,0
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.070855,0.16931,0.14962,0,0
2,GO ENDODERM DEVELOPMENT,0.26847,0.16863,0.10656,0,0
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.11434,0.16861,0.098807,0,0
2,GO EMBRYONIC HEMOPOIESIS,0.13583,0.16853,0.10269,0,0
2,GO PRO B CELL DIFFERENTIATION,0.13814,0.16811,0.17448,0,0
2,GO LIPOXYGENASE PATHWAY,0.16559,0.16772,0.15902,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.44402,0.16763,0.035114,0,0
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.1313,0.16705,0.12838,0,0
2,GO FOREBRAIN MORPHOGENESIS,0.17374,0.16695,0.11023,0,0
2,GO DENDRITIC CELL DIFFERENTIATION,0.32938,0.16689,0.043929,0,0
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20621,0.16687,0.1257,0,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.092194,0.16684,0.13711,0,0
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.068167,0.16637,0.09031,0,0
2,GO CERAMIDE TRANSPORT,0.17374,0.16584,0.13205,0,0
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.050569,0.16568,0.15236,0,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.23245,0.16551,0.11312,0,0
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.068167,0.16503,0.077257,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.014138,0.16502,0.47093,0,0
2,GO SKIN MORPHOGENESIS,0.42347,0.16451,0.072708,0,0
2,GO NAD BIOSYNTHETIC PROCESS,0.37932,0.16397,0.084627,0,0
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.055956,0.16396,0.17549,0,0
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.053746,0.16377,0.10305,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.61497,0.16366,0.018161,0,0
2,GO BRONCHUS DEVELOPMENT,0.23245,0.16304,0.12625,0,0
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.073629,0.16297,0.091833,0,0
2,GO CYTOLYSIS,0.17099,0.16233,0.12004,0,0
2,GO HYPOTONIC RESPONSE,0.11039,0.162,0.1295,0,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.21905,0.16119,0.14073,0,0
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.0050528,0.16108,0.23242,0,0
2,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.22235,0.1605,0.14003,0,0
2,GO DEFENSE RESPONSE TO VIRUS,0.053746,0.15992,0.12457,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.48131,0.15964,0.012996,0,0
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.15264,0.15934,0.10203,0,0
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.046579,0.15901,0.17462,0,0
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.11434,0.15829,0.13917,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.29992,0.15824,0.081431,0,0
2,GO COPPER ION HOMEOSTASIS,0.14526,0.15823,0.058481,0,0
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.12473,0.15818,0.063564,0,0
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.022165,0.15811,0.16841,0,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.54903,0.15754,0.01227,0,0
2,GO EMBRYONIC BRAIN DEVELOPMENT,0.063042,0.15644,0.1737,0,0
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.092194,0.1561,0.11948,0,0
2,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.31232,0.15558,0.20794,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.11235,0.15541,0.12413,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.26471,0.15469,0.071473,0,0
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.099158,0.1544,0.14888,0,0
2,GO REGULATION OF PLATELET ACTIVATION,0.16559,0.15364,0.10391,0,0
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.21905,0.15361,0.068908,0,0
2,GO TRACHEA MORPHOGENESIS,0.16828,0.15286,0.084797,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.11636,0.15262,0.11212,0,0
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.58456,0.15238,0.010018,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.33373,0.15205,0.1027,0,0
2,GO PLATELET ACTIVATION,0.050569,0.15154,0.089358,0,0
2,GO MACROPHAGE APOPTOTIC PROCESS,0.084046,0.15148,0.12569,0,0
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.093897,0.15144,0.12422,0,0
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.53167,0.15089,0.039508,0,0
2,GO VIRAL LATENCY,0.30815,0.15043,0.075981,0,0
2,GO RESPONSE TO VIRUS,0.059411,0.15,0.099898,0,0
2,GO MEMBRANE RAFT ORGANIZATION,0.4598,0.14994,0.047045,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.19695,0.1499,0.13802,0,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.27611,0.14969,0.089586,0,0
2,GO COCHLEA MORPHOGENESIS,0.023741,0.14914,0.15472,0,0
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.1028,0.14911,0.12537,0,0
2,GO HISTAMINE SECRETION,0.092194,0.14889,0.15752,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.26098,0.14801,0.072995,0,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.079444,0.14797,0.08087,0,0
2,GO RESPONSE TO THYROID HORMONE,0.064293,0.14797,0.16201,0,0
2,GO ANION HOMEOSTASIS,0.049546,0.14786,0.13483,0,0
2,GO COBALAMIN METABOLIC PROCESS,0.11636,0.14752,0.086772,0,0
2,GO MULTI ORGANISM CELLULAR PROCESS,0.19095,0.14704,0.093555,0,0
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.099158,0.14695,0.075805,0,0
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.061812,0.14632,0.18406,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.22568,0.14624,0.10786,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.080955,0.14554,0.1267,0,0
2,GO REGULATION OF EXIT FROM MITOSIS,0.11434,0.14549,0.08678,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.40349,0.14509,0.055244,0,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.26847,0.14406,0.053756,0,0
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.12259,0.14405,0.095081,0,0
2,GO CELLULAR RESPONSE TO DSRNA,0.093897,0.14396,0.089456,0,0
2,GO POSITIVE REGULATION OF CELL AGING,0.0695,0.14388,0.12377,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0073363,0.1434,0.12064,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.10845,0.14315,0.095776,0,0
2,GO RESPONSE TO COPPER ION,0.25363,0.14301,0.13107,0,0
2,GO INNER EAR MORPHOGENESIS,0.055956,0.1429,0.11297,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.060602,0.14229,0.1496,0,0
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.13814,0.14202,0.14797,0,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.079444,0.14194,0.12858,0,0
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.14769,0.14187,0.068057,0,0
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.085627,0.14173,0.11721,0,0
2,GO MACROPHAGE PROLIFERATION,0.32077,0.14173,0.087752,0,0
2,GO GONADOTROPIN SECRETION,0.33373,0.1416,0.07184,0,0
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.21256,0.14155,0.17677,0,0
2,GO SOMATIC STEM CELL DIVISION,0.33373,0.14148,0.1415,0,0
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.065563,0.1414,0.1243,0,0
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.10654,0.14132,0.095675,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.22905,0.14099,0.10207,0,0
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.021165,0.14081,0.13514,0,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.050569,0.14071,0.10297,0,0
2,GO REGULATION OF ANOIKIS,0.15773,0.14065,0.1159,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.13583,0.14016,0.089871,0,0
2,GO V D J RECOMBINATION,0.10654,0.13993,0.14102,0,0
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.090515,0.13993,0.090351,0,0
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.10096,0.13961,0.092271,0,0
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.25001,0.1396,0.075345,0,0
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.72969,0.13933,-0.008866,0,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.34702,0.13923,0.077272,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.099158,0.13848,0.10269,0,0
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.092194,0.13818,0.10126,0,0
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.064293,0.13815,0.089921,0,0
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.11841,0.13786,0.1347,0,0
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.36991,0.13785,0.10663,0,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.17653,0.13774,0.13468,0,0
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.27227,0.13761,0.036422,0,0
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.10654,0.1376,0.098199,0,0
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.13814,0.13738,0.12182,0,0
2,GO HEMIDESMOSOME ASSEMBLY,0.070855,0.13729,0.32097,0,0
2,GO RESPONSE TO UV C,0.075049,0.13699,0.1781,0,0
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.079444,0.13675,0.1534,0,0
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.14769,0.13653,0.031313,0,0
2,GO LEUKOCYTE HOMEOSTASIS,0.1313,0.13639,0.063869,0,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.31653,0.1363,0.12241,0,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.28785,0.13615,0.070826,0,0
2,GO PROGESTERONE METABOLIC PROCESS,0.28785,0.13587,0.14681,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.11235,0.13587,0.10433,0,0
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.057089,0.13573,0.10493,0,0
2,GO DIOL METABOLIC PROCESS,0.17934,0.13564,0.089759,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.12908,0.1355,0.061498,0,0
2,GO PLASMA MEMBRANE FUSION,0.27999,0.13487,0.063169,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.079444,0.13486,0.09668,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.61497,0.13482,0.0336,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.25001,0.13426,0.085579,0,0
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.084046,0.13404,0.10988,0,0
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.23589,0.13391,0.11047,0,0
2,GO MUSCLE CELL MIGRATION,0.070855,0.13384,0.13158,0,0
2,GO RESPONSE TO UV B,0.43883,0.13376,0.09136,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.53742,0.13374,0.075356,0,0
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.11434,0.13364,0.080248,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.1028,0.13318,0.12515,0,0
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.13355,0.13276,0.065381,0,0
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.050569,0.13238,0.13667,0,0
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.059411,0.13209,0.09131,0,0
2,GO MYOBLAST FUSION,0.24288,0.13208,0.052877,0,0
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.26098,0.13206,0.12818,0,0
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.40843,0.13206,0.039793,0,0
2,GO ACTIN CROSSLINK FORMATION,0.27999,0.13198,0.049633,0,0
2,GO MITOCHONDRIAL RNA PROCESSING,0.050569,0.13139,0.13625,0,0
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.53742,0.13123,0.083537,0,0
2,GO COAGULATION,0.12049,0.13102,0.067262,0,0
2,GO STORE OPERATED CALCIUM ENTRY,0.12049,0.13099,0.12141,0,0
2,GO GDP METABOLIC PROCESS,0.33812,0.13079,0.078605,0,0
2,GO PROTEIN HYDROXYLATION,0.18508,0.13071,0.074944,0,0
2,GO FIBROBLAST PROLIFERATION,0.21256,0.13067,0.090643,0,0
2,GO REGULATION OF COAGULATION,0.54903,0.1304,0.040398,0,0
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.14526,0.13037,0.063631,0,0
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.11434,0.13015,0.10944,0,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.62732,0.13006,0.0037658,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.085627,0.12976,0.18558,0,0
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.11841,0.12957,0.1228,0,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.38888,0.12944,0.067557,0,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.21579,0.12935,0.052737,0,0
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.1313,0.12919,0.079426,0,0
2,GO POSITIVE REGULATION OF URINE VOLUME,0.25363,0.12877,0.15628,0,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.1028,0.12868,0.080478,0,0
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.29586,0.12856,0.075636,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.16828,0.12843,0.08257,0,0
2,GO LEUKOCYTE AGGREGATION,0.27227,0.12819,0.11164,0,0
2,GO INFLAMMATORY RESPONSE,0.085627,0.12814,0.061529,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.085627,0.12767,0.10489,0,0
2,GO FILOPODIUM ASSEMBLY,0.51459,0.12761,0.023456,0,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.4545,0.12746,0.023906,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.33373,0.12736,0.05348,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.10654,0.1268,0.1099,0,0
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.13583,0.12666,0.11127,0,0
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.20621,0.12664,0.21301,0,0
2,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.188,0.12639,0.090517,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.12473,0.12631,0.082532,0,0
2,GO NEGATIVE REGULATION OF CELL SIZE,0.079444,0.12625,0.10138,0,0
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.13583,0.12586,0.1188,0,0
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.090515,0.12583,0.13983,0,0
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.12473,0.12577,0.11613,0,0
2,GO POSITIVE REGULATION OF CELL SIZE,0.16828,0.12538,0.13284,0,0
2,GO REGULATION OF PROTEOLYSIS,0.0695,0.12535,0.07339,0,0
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.060602,0.12528,0.3753,0,0
2,GO MYELIN ASSEMBLY,0.38408,0.12493,0.079493,0,0
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.17099,0.12488,0.061163,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.64605,0.12462,0.021644,0,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.54321,0.12457,0.052761,0,0
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.084046,0.1245,0.15396,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.095625,0.12422,0.087534,0,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.11841,0.12402,0.11408,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.21256,0.12287,0.1068,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.40843,0.12287,0.041964,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.48131,0.12276,0.087928,0,0
2,GO RESPONSE TO VITAMIN A,0.092194,0.12268,0.15362,0,0
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.066855,0.12262,0.091816,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.42855,0.12241,0.14488,0,0
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.12689,0.1224,0.082685,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.25001,0.12218,0.084396,0,0
2,GO LYMPHANGIOGENESIS,0.14526,0.12207,0.10848,0,0
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.61497,0.12177,0.031894,0,0
2,GO EPITHELIAL CELL MORPHOGENESIS,0.15773,0.12124,0.16123,0,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.029068,0.12124,0.11861,0,0
2,GO MAST CELL ACTIVATION,0.14285,0.12117,0.10219,0,0
2,GO INTERLEUKIN 4 PRODUCTION,0.050569,0.12115,0.1093,0,0
2,GO CHOLESTEROL STORAGE,0.10654,0.12112,0.1439,0,0
2,GO ADHESION OF SYMBIONT TO HOST,0.2,0.12095,0.1175,0,0
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.21579,0.12041,0.040357,0,0
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.057089,0.12041,0.12085,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.22568,0.1204,0.097014,0,0
2,GO RESPONSE TO MUSCLE ACTIVITY,0.024288,0.12038,0.18032,0,0
2,GO RESPONSE TO FATTY ACID,0.079444,0.12023,0.10232,0,0
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.033894,0.12019,0.15197,0,0
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.33812,0.11995,0.033225,0,0
2,GO REGULATION OF RUFFLE ASSEMBLY,0.073629,0.1199,0.099555,0,0
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.14769,0.11968,0.06432,0,0
2,GO RENAL ABSORPTION,0.20621,0.11918,0.15836,0,0
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.60272,0.11917,0.028142,0,0
2,GO KERATINOCYTE MIGRATION,0.080955,0.11906,0.11853,0,0
2,GO CELLULAR RESPONSE TO ZINC ION,0.4545,0.11878,0.21283,0,0
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.23937,0.11867,0.17945,0,0
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.072231,0.11849,0.10903,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.14048,0.11846,0.096823,0,0
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.21579,0.11808,0.056079,0,0
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.22905,0.11799,0.12028,0,0
2,GO NEPHRON DEVELOPMENT,0.088862,0.1177,0.11667,0,0
2,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.30815,0.11751,0.067843,0,0
2,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.14526,0.1168,0.15146,0,0
2,GO NEPHRIC DUCT MORPHOGENESIS,0.12473,0.11669,0.31063,0,0
2,GO UV PROTECTION,0.13355,0.11661,0.11273,0,0
2,GO BEHAVIORAL RESPONSE TO PAIN,0.25363,0.11655,0.1283,0,0
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.30402,0.11647,0.081891,0,0
2,GO PLASMINOGEN ACTIVATION,0.16828,0.11645,0.12835,0,0
2,GO REGULATION OF LIPID TRANSPORT,0.060602,0.1164,0.08925,0,0
2,GO TONGUE DEVELOPMENT,0.19095,0.11632,0.11962,0,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.188,0.11623,0.11115,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.099158,0.1162,0.30427,0,0
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.093897,0.11597,0.16274,0,0
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.21579,0.11505,0.095892,0,0
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.13583,0.11501,0.063598,0,0
2,GO PLATELET AGGREGATION,0.092194,0.1149,0.11076,0,0
2,GO MYELOID LEUKOCYTE MIGRATION,0.073629,0.1149,0.073663,0,0
2,GO NEPHRON MORPHOGENESIS,0.16294,0.11469,0.07751,0,0
2,GO REGULATION OF WOUND HEALING,0.25001,0.11457,0.074979,0,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.9686,0.11446,-0.0006603,0,0
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.62113,0.11428,-0.0079114,0,0
2,GO WOUND HEALING,0.12259,0.1142,0.081568,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.30815,0.11409,0.047113,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.20621,0.11406,0.073129,0,0
2,GO LIPID LOCALIZATION,0.05824,0.11397,0.069322,0,0
2,GO ENDODERM FORMATION,0.44924,0.11395,0.07845,0,0
2,GO EAR MORPHOGENESIS,0.017969,0.11382,0.13164,0,0
2,GO AUTOPHAGY OF NUCLEUS,0.17374,0.11324,0.069741,0,0
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.12689,0.11318,0.13556,0,0
2,GO FATTY ACYL COA METABOLIC PROCESS,0.025994,0.11296,0.17457,0,0
2,GO AMYLOID BETA METABOLIC PROCESS,0.22905,0.11272,0.052374,0,0
2,GO PROTEIN PROCESSING,0.32938,0.11263,0.048001,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.11434,0.11249,0.084839,0,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.40843,0.11248,0.097408,0,0
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.27227,0.11221,0.088019,0,0
2,GO ACUTE INFLAMMATORY RESPONSE,0.19695,0.11214,0.057077,0,0
2,GO REGULATION OF FIBRINOLYSIS,0.15264,0.11211,0.099759,0,0
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.47588,0.11205,0.030682,0,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.057089,0.11197,0.08541,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.053746,0.11196,0.11981,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.059411,0.11195,0.15856,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.26847,0.11175,0.089364,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.03939,0.11133,0.11888,0,0
2,GO OLIGOPEPTIDE TRANSPORT,0.17653,0.11127,0.1901,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.076492,0.11116,0.10593,0,0
2,GO ZINC ION HOMEOSTASIS,0.13814,0.11109,0.20186,0,0
2,GO POSITIVE REGULATION OF HEART GROWTH,0.077957,0.11106,0.11157,0,0
2,GO RNA EXPORT FROM NUCLEUS,0.0001165,0.11068,0.16892,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.43367,0.11053,0.026849,0,0
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.54321,0.11039,0.055093,0,0
2,GO RESPONSE TO LEPTIN,0.2839,0.11018,0.063978,0,0
2,GO RESPONSE TO HYPEROXIA,0.61497,0.11014,0.017471,0,0
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.052669,0.11011,0.095652,0,0
2,GO REGULATION OF LIPID LOCALIZATION,0.054842,0.10998,0.084576,0,0
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.05161,0.10988,0.07732,0,0
2,GO CELL CHEMOTAXIS,0.066855,0.10986,0.087616,0,0
2,GO VITAMIN D METABOLIC PROCESS,0.61497,0.10984,0.016772,0,0
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.38408,0.10959,0.077868,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.23245,0.1094,0.062074,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.52594,0.10933,0.029219,0,0
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.40349,0.10928,0.079367,0,0
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0045306,0.10927,0.12488,0,0
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.29586,0.10926,0.13615,0,0
2,GO SPHINGOID METABOLIC PROCESS,0.12689,0.10921,0.11144,0,0
2,GO REGULATION OF MYOBLAST FUSION,0.25363,0.10909,0.062985,0,0
2,GO SPLEEN DEVELOPMENT,0.079444,0.10899,0.11865,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.25001,0.10878,0.099767,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.67776,0.10842,0.033637,0,0
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.89907,0.10817,-0.027581,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.21579,0.10801,0.099652,0,0
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.43367,0.1079,0.04157,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.30402,0.10781,0.1409,0,0
2,GO BODY MORPHOGENESIS,0.94073,0.10764,-0.017362,0,0
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.75615,0.10733,0.017307,0,0
2,GO LYMPH VESSEL DEVELOPMENT,0.23937,0.10715,0.15126,0,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.14526,0.10711,0.082571,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.40843,0.10707,0.1772,0,0
2,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.76281,0.10697,0.020478,0,0
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.15773,0.10673,0.08894,0,0
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.13355,0.10663,0.089021,0,0
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.18508,0.10652,0.038049,0,0
2,GO GALACTOSE METABOLIC PROCESS,0.52594,0.10649,0.029711,0,0
2,GO PEPTIDYL ARGININE METHYLATION,0.1313,0.10648,0.095011,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.26098,0.10637,0.14889,0,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.099158,0.10627,0.10818,0,0
2,GO RESPONSE TO LIPID,0.0695,0.1062,0.072828,0,0
2,GO NEURAL CREST CELL MIGRATION,0.32506,0.10617,0.0677,0,0
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.059411,0.10605,0.094489,0,0
2,GO REGULATION OF BODY FLUID LEVELS,0.10654,0.10573,0.061124,0,0
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.059411,0.1055,0.1336,0,0
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.075049,0.10544,0.17634,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.22235,0.10485,0.083723,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.15264,0.10456,0.18017,0,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.054842,0.10455,0.10282,0,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.18508,0.10447,0.1401,0,0
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.38408,0.10443,0.089899,0,0
2,GO REGULATION OF CALCIUM ION IMPORT,0.47049,0.10405,0.025789,0,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.34702,0.10402,0.090579,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.087232,0.1039,0.12863,0,0
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00024286,0.1037,0.11292,0,0
2,GO RESPONSE TO OXYGEN LEVELS,0.061812,0.10352,0.06748,0,0
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.41341,0.10341,0.029649,0,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.14769,0.10338,0.17649,0,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.18219,0.10315,0.090404,0,0
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.14769,0.10305,0.055041,0,0
2,GO CELLULAR RESPONSE TO X RAY,0.11235,0.10298,0.17594,0,0
2,GO MUSCLE FILAMENT SLIDING,0.38408,0.10294,0.057297,0,0
2,GO CELLULAR DEFENSE RESPONSE,0.21579,0.10288,0.023808,0,0
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.20937,0.10286,0.061079,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.22905,0.10279,0.086979,0,0
2,GO CYTOKINETIC PROCESS,0.11636,0.10261,0.10373,0,0
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.67137,0.1026,0.027999,0,0
2,GO RESPONSE TO RETINOIC ACID,0.17099,0.10255,0.1089,0,0
2,GO ACUTE PHASE RESPONSE,0.10654,0.10216,0.082293,0,0
2,GO T CELL MIGRATION,0.37932,0.10216,0.052318,0,0
2,GO LEUKOCYTE CHEMOTAXIS,0.054842,0.10188,0.079892,0,0
2,GO FIBRINOLYSIS,0.93377,0.10186,-0.018493,0,0
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.23937,0.10173,0.13546,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.26471,0.1017,0.086367,0,0
2,GO MEMBRANE INVAGINATION,0.12259,0.10167,0.076923,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.27999,0.10138,0.082795,0,0
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.02843,0.10107,0.10756,0,0
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014486,0.10103,0.090429,0,0
2,GO RESPONSE TO DSRNA,0.082489,0.10092,0.076593,0,0
2,GO PEPTIDYL HISTIDINE MODIFICATION,0.20937,0.10088,0.10962,0,0
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.22568,0.10084,0.042231,0,0
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.59664,0.10081,0.052241,0,0
2,GO ALPHA BETA T CELL PROLIFERATION,0.11841,0.10057,0.080837,0,0
2,GO REGENERATION,0.11434,0.1002,0.081626,0,0
2,GO ACTIN MEDIATED CELL CONTRACTION,0.018398,0.10015,0.12694,0,0
2,GO HYALURONAN METABOLIC PROCESS,0.4545,0.10003,-0.070845,0,0
2,GO INTERLEUKIN 12 PRODUCTION,0.099158,0.099976,0.099231,0,0
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.23589,0.09988,0.076684,0,0
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.13583,0.099757,0.070787,0,0
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.15264,0.099755,0.09644,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.10845,0.099611,0.15451,0,0
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.34256,0.099506,0.078523,0,0
2,GO RESPONSE TO NUTRIENT,0.42347,0.099491,0.040713,0,0
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.066855,0.099294,0.056174,0,0
2,GO LIVER MORPHOGENESIS,0.20937,0.099285,0.069364,0,0
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.049546,0.099204,0.075117,0,0
2,GO MESODERMAL CELL DIFFERENTIATION,0.10465,0.099192,0.14364,0,0
2,GO MUSCLE ADAPTATION,0.53167,0.09915,0.036455,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.56666,0.099032,0.030653,0,0
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.087232,0.098624,0.15229,0,0
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0046564,0.098112,0.12286,0,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.23245,0.097973,0.092468,0,0
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.37932,0.097927,0.063185,0,0
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.32506,0.097921,0.10248,0,0
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.42855,0.097736,0.0099991,0,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.94073,0.097726,-0.026272,0,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.29992,0.097471,0.041019,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.1028,0.097279,0.11535,0,0
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.063042,0.097247,0.075757,0,0
2,GO ACTIN FILAMENT BASED TRANSPORT,0.26471,0.097242,0.090795,0,0
2,GO NEGATIVE REGULATION OF SECRETION,0.025414,0.096758,0.084518,0,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.15517,0.096737,0.071417,0,0
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.065563,0.096697,0.16723,0,0
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.12473,0.096681,0.084971,0,0
2,GO BONE MORPHOGENESIS,0.068167,0.09644,0.12503,0,0
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.072231,0.096436,0.084495,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.060602,0.096202,0.15998,0,0
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.16032,0.096189,0.063134,0,0
2,GO LIPID STORAGE,0.11039,0.096141,0.07665,0,0
2,GO TISSUE REGENERATION,0.063042,0.095834,0.11722,0,0
2,GO PHOSPHOLIPID HOMEOSTASIS,0.22568,0.095769,0.10472,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.13583,0.095613,0.10298,0,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.56075,0.095587,0.015111,0,0
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.24288,0.095559,0.056253,0,0
2,GO POSITIVE REGULATION OF MYELINATION,0.15015,0.095451,0.086097,0,0
2,GO METHIONINE METABOLIC PROCESS,0.58456,0.095339,0.0018157,0,0
2,GO MANGANESE ION TRANSPORT,0.30815,0.094835,0.063081,0,0
2,GO REGULATION OF STEM CELL DIVISION,0.39371,0.094815,0.097405,0,0
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.063042,0.094804,0.063511,0,0
2,GO PROTEOLYSIS,0.064293,0.09465,0.054824,0,0
2,GO MITOCHONDRIAL TRNA PROCESSING,0.13814,0.094647,0.10892,0,0
2,GO CELLULAR RESPONSE TO FATTY ACID,0.61497,0.094526,0.032514,0,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.68418,0.094423,0.019796,0,0
2,GO DRUG CATABOLIC PROCESS,0.33373,0.094332,0.050661,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.20621,0.094244,0.10102,0,0
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.090515,0.094207,0.066378,0,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.11434,0.094117,0.11679,0,0
2,GO COENZYME A METABOLIC PROCESS,0.13583,0.094107,0.087217,0,0
2,GO RENAL FILTRATION,0.63354,0.094037,0.00096906,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.1313,0.094024,0.096368,0,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.42855,0.093847,0.090528,0,0
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.16294,0.093667,0.073057,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.97557,0.093433,-0.054127,0,0
2,GO RESPONSE TO DRUG,0.11636,0.093337,0.064976,0,0
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.5726,0.093292,0.012496,0,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.31653,0.093155,0.062193,0,0
2,GO OSTEOBLAST PROLIFERATION,0.188,0.093068,0.10656,0,0
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.061812,0.092713,0.099242,0,0
2,GO GLUCOSE CATABOLIC PROCESS,0.16294,0.092678,0.11635,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.21905,0.092669,0.094173,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.21256,0.09258,0.092422,0,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.1028,0.092521,0.15063,0,0
2,GO DNA REPLICATION INITIATION,0.23589,0.092476,0.071566,0,0
2,GO MESONEPHROS DEVELOPMENT,0.29586,0.092384,0.075402,0,0
2,GO MUSCLE CELL PROLIFERATION,0.17653,0.092315,0.080449,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.59059,0.092213,0.08617,0,0
2,GO ER NUCLEUS SIGNALING PATHWAY,0.18508,0.092175,0.084447,0,0
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.036948,0.092147,0.084753,0,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.20937,0.092023,0.057879,0,0
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.22235,0.091694,0.080191,0,0
2,GO NEUTROPHIL MIGRATION,0.17099,0.091633,0.032042,0,0
2,GO ACTIN FILAMENT BASED PROCESS,0.05161,0.091497,0.07557,0,0
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.15517,0.091431,0.12159,0,0
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.24643,0.091392,0.096258,0,0
2,GO BLOOD VESSEL MORPHOGENESIS,0.32938,0.091315,0.066117,0,0
2,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.05824,0.091289,0.27887,0,0
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.14048,0.091261,0.11753,0,0
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.12689,0.091074,0.047437,0,0
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.39371,0.091067,0.087993,0,0
2,GO PROTEIN NITROSYLATION,0.43367,0.091042,0.079073,0,0
2,GO REGULATION OF BONE MINERALIZATION,0.42347,0.090986,0.045114,0,0
2,GO MOLTING CYCLE,0.11636,0.090904,0.12444,0,0
2,GO RESPONSE TO PROGESTERONE,0.25729,0.090795,0.10099,0,0
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.41842,0.090617,0.070806,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.26847,0.090611,0.08548,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.22568,0.090496,0.046941,0,0
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.072231,0.090359,0.10641,0,0
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.072231,0.090322,0.11147,0,0
2,GO GLOMERULUS DEVELOPMENT,0.11235,0.090139,0.1677,0,0
2,GO CELLULAR RESPONSE TO COPPER ION,0.25001,0.090106,0.21318,0,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.13583,0.089697,0.09415,0,0
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.1313,0.089421,0.12692,0,0
2,GO ASTROCYTE DEVELOPMENT,0.41842,0.089405,0.056937,0,0
2,GO PROTEIN MATURATION,0.13814,0.089251,0.054372,0,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.063042,0.089166,0.06544,0,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.036948,0.088925,0.086146,0,0
2,GO PEPTIDYL ARGININE N METHYLATION,0.19695,0.08886,0.11773,0,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.37932,0.088799,0.072739,0,0
2,GO MACROPHAGE ACTIVATION,0.075049,0.088741,0.058071,0,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.31232,0.088665,0.091196,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.35607,0.088611,0.064784,0,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.12049,0.088419,0.087538,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.9686,0.088383,-0.024385,0,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.16828,0.088368,0.055699,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.98255,0.088299,-0.014168,0,0
2,GO RESPONSE TO PEPTIDOGLYCAN,0.075049,0.088034,0.0786,0,0
2,GO CELL CELL ADHESION,0.20937,0.08758,0.048905,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.11636,0.087563,0.069361,0,0
2,GO AORTA MORPHOGENESIS,0.64605,0.087484,0.03621,0,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.27227,0.087448,0.10435,0,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.59059,0.08732,-0.01058,0,0
2,GO REGULATION OF MACROPHAGE MIGRATION,0.080955,0.087273,0.1248,0,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.064293,0.087165,0.065531,0,0
2,GO PERICARDIUM DEVELOPMENT,0.18508,0.087023,0.12926,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.14048,0.08695,0.091156,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.12049,0.0869,0.042364,0,0
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.17099,0.086829,0.052305,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.22905,0.086725,0.068068,0,0
2,GO RESPONSE TO ETHANOL,0.16828,0.086561,0.066735,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.38408,0.086494,0.034244,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.23937,0.086227,0.046253,0,0
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.81668,0.086178,0.0042539,0,0
2,GO ANOIKIS,0.26847,0.0861,0.072002,0,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.37932,0.086034,0.060725,0,0
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.64605,0.085809,0.036181,0,0
2,GO SYNCYTIUM FORMATION,0.21579,0.085778,0.057868,0,0
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.13814,0.085723,0.11213,0,0
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.29586,0.085383,0.032481,0,0
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.43883,0.085063,0.058101,0,0
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.12689,0.084897,0.06924,0,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.95466,0.084825,-0.0078341,0,0
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.18508,0.084715,0.078109,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.44402,0.084673,0.040067,0,0
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.35153,0.084302,0.046332,0,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.21905,0.084164,0.054765,0,0
2,GO REGULATION OF LIPID STORAGE,0.16828,0.084122,0.058116,0,0
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.21256,0.084095,0.069034,0,0
2,GO CELLULAR RESPONSE TO IRON ION,0.16559,0.084042,0.16198,0,0
2,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.20621,0.084034,0.1635,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION,0.2,0.084018,0.082088,0,0
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.12473,0.083965,0.12297,0,0
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.15264,0.083882,0.096195,0,0
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.082489,0.083856,0.081404,0,0
2,GO ACTIVATION OF MAPKK ACTIVITY,0.48131,0.083842,0.035298,0,0
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.35607,0.083764,0.052465,0,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.30402,0.083734,0.031997,0,0
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.52594,0.083659,0.031965,0,0
2,GO POSTREPLICATION REPAIR,0.14526,0.083645,0.044703,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0695,0.083536,0.12491,0,0
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.050569,0.083464,0.052446,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.11841,0.083459,0.09335,0,0
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.89215,0.083423,0.01096,0,0
2,GO DETECTION OF BIOTIC STIMULUS,0.17653,0.083265,0.087848,0,0
2,GO PIGMENTATION,0.24288,0.083208,0.048605,0,0
2,GO MYOBLAST PROLIFERATION,0.43883,0.083189,0.042293,0,0
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.80989,0.082922,-0.050793,0,0
2,GO CRISTAE FORMATION,0.063042,0.082908,0.13426,0,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0695,0.082895,0.13943,0,0
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.16294,0.082884,0.067025,0,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.27999,0.082817,0.063307,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.12473,0.082697,0.089399,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.44924,0.082646,0.070745,0,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.12049,0.08263,0.059723,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.18508,0.082554,0.074205,0,0
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.11039,0.082511,0.093174,0,0
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.32938,0.082092,0.04531,0,0
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.052669,0.08195,0.073113,0,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.5726,0.081927,0.047205,0,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.27611,0.081828,0.098635,0,0
2,GO IMMATURE B CELL DIFFERENTIATION,0.39858,0.081808,0.086525,0,0
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.31232,0.081742,0.043632,0,0
2,GO MYOTUBE DIFFERENTIATION,0.36526,0.08157,0.037138,0,0
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.26847,0.081418,0.11727,0,0
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0695,0.081236,0.065082,0,0
2,GO CELLULAR RESPONSE TO STEROL,0.072231,0.081171,0.12902,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.11841,0.081074,0.063127,0,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.50337,0.08066,0.044958,0,0
2,GO TRANSLESION SYNTHESIS,0.23245,0.080556,0.03765,0,0
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.11235,0.080543,0.065889,0,0
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.90599,0.080215,-0.011087,0,0
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.18508,0.080097,0.052439,0,0
2,GO REGULATION OF CELL DEATH,0.066855,0.080025,0.064078,0,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.72969,0.079749,0.067673,0,0
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.054842,0.079717,0.066517,0,0
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.060602,0.07959,0.070055,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.095625,0.079399,0.1268,0,0
2,GO HOMOTYPIC CELL CELL ADHESION,0.082489,0.079372,0.14946,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.12689,0.079212,0.065304,0,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.87144,0.079179,-0.002172,0,0
2,GO REGULATION OF RESPONSE TO WOUNDING,0.25363,0.079126,0.071764,0,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.012508,0.078993,0.14714,0,0
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.31653,0.07899,0.048058,0,0
2,GO SMOOTH MUSCLE CELL MIGRATION,0.29184,0.078989,0.059958,0,0
2,GO MESODERMAL CELL FATE COMMITMENT,0.60883,0.078934,0.060271,0,0
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.099158,0.078786,0.11244,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.19095,0.078723,0.12738,0,0
2,GO DEFENSE RESPONSE TO BACTERIUM,0.054842,0.078703,0.072775,0,0
2,GO MAST CELL MEDIATED IMMUNITY,0.28785,0.078598,0.08807,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.10096,0.077965,0.086054,0,0
2,GO STEROID ESTERIFICATION,0.16032,0.077939,0.087396,0,0
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.05824,0.077561,0.070672,0,0
2,GO VASCULATURE DEVELOPMENT,0.21579,0.07744,0.072908,0,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.44924,0.077381,0.023105,0,0
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.33373,0.077273,0.038413,0,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.99651,0.077114,-0.049793,0,0
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.12473,0.07689,0.040457,0,0
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.58456,0.076884,0.057007,0,0
2,GO EPITHELIAL TUBE FORMATION,0.052669,0.076783,0.11943,0,0
2,GO RESPONSE TO HORMONE,0.16294,0.076735,0.044275,0,0
2,GO RENAL SYSTEM PROCESS,0.25001,0.076609,0.048952,0,0
2,GO REGULATION OF BLOOD PRESSURE,0.24288,0.076378,0.034462,0,0
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.23589,0.076336,0.092755,0,0
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.097379,0.076232,0.080975,0,0
2,GO RESPONSE TO ESTRADIOL,0.33812,0.076073,0.039108,0,0
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.11235,0.076035,0.043356,0,0
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.10096,0.075956,0.085506,0,0
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.20309,0.075847,0.075634,0,0
2,GO XENOBIOTIC TRANSPORT,0.53167,0.075706,0.072644,0,0
2,GO TISSUE REMODELING,0.78962,0.075662,0.0031628,0,0
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.17934,0.075632,0.061281,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.41341,0.075529,0.0081552,0,0
2,GO LEUKOCYTE MIGRATION,0.13355,0.075468,0.058185,0,0
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.4545,0.075327,0.041534,0,0
2,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.53167,0.075269,-0.11028,0,0
2,GO HISTONE ARGININE METHYLATION,0.22905,0.075256,0.063656,0,0
2,GO ORGAN GROWTH,0.097379,0.075231,0.11457,0,0
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.072231,0.075185,0.061397,0,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.26471,0.07503,0.024294,0,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.99651,0.074887,-0.031894,0,0
2,GO KIDNEY MORPHOGENESIS,0.14769,0.074182,0.074984,0,0
2,GO TRNA CATABOLIC PROCESS,0.50337,0.073786,0.077552,0,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.11434,0.073768,0.063863,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.037747,0.073641,0.090477,0,0
2,GO T CELL DIFFERENTIATION IN THYMUS,0.21905,0.073635,0.052971,0,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.29586,0.073398,0.052743,0,0
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.11636,0.073265,0.057768,0,0
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.33812,0.073247,0.051448,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.48131,0.073198,0.083978,0,0
2,GO RECEPTOR METABOLIC PROCESS,0.23937,0.073142,0.047939,0,0
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.88523,0.073125,-0.044063,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.055956,0.072966,0.12744,0,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.29184,0.07291,0.036466,0,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.12259,0.072879,0.064063,0,0
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.53742,0.072807,0.0020666,0,0
2,GO ADHERENS JUNCTION ORGANIZATION,0.37932,0.072784,0.034731,0,0
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.14285,0.072782,0.096903,0,0
2,GO MACROPHAGE DIFFERENTIATION,0.29992,0.072697,0.038802,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.21256,0.072562,0.041164,0,0
2,GO REGULATION OF WATER LOSS VIA SKIN,0.36991,0.072556,0.10527,0,0
2,GO DNA STRAND ELONGATION,0.30815,0.072537,0.046847,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.46512,0.072331,0.058579,0,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.18219,0.07219,0.051368,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.03245,0.072105,0.1759,0,0
2,GO ENDOSOME ORGANIZATION,0.14285,0.072082,0.067592,0,0
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.11235,0.072074,0.058623,0,0
2,GO RUFFLE ASSEMBLY,0.19695,0.072029,0.057157,0,0
2,GO REGULATION OF PROTEIN MATURATION,0.10465,0.071932,0.11124,0,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.35153,0.07191,0.043249,0,0
2,GO URONIC ACID METABOLIC PROCESS,0.18508,0.071851,0.09253,0,0
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.30815,0.071737,0.12124,0,0
2,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.78962,0.071665,0.0070213,0,0
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.12259,0.071568,0.095413,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.092194,0.071566,0.073684,0,0
2,GO REGULATION OF CELL AGING,0.33373,0.071439,0.039404,0,0
2,GO IMMUNOGLOBULIN PRODUCTION,0.079444,0.071435,0.063845,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.15517,0.071369,0.10321,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.27611,0.071197,0.044131,0,0
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.22905,0.071195,0.061893,0,0
2,GO PHOSPHOLIPID TRANSPORT,0.39371,0.071167,0.02047,0,0
2,GO REGULATION OF GLUCONEOGENESIS,0.05161,0.071089,0.068492,0,0
2,GO RESPONSE TO PROSTAGLANDIN,0.29184,0.071089,0.07567,0,0
2,GO AUTOPHAGOSOME MATURATION,0.188,0.070855,0.059502,0,0
2,GO GLIAL CELL ACTIVATION,0.22235,0.070847,0.054778,0,0
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.48678,0.070742,0.056992,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.67137,0.070719,0.017186,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.36526,0.070674,0.072818,0,0
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.25363,0.070657,0.061644,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.27999,0.070647,0.053058,0,0
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.32938,0.070572,0.045885,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.87144,0.07057,0.0030165,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.061812,0.070512,0.13806,0,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.17934,0.070509,0.049555,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.24288,0.0705,0.087909,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.17374,0.070333,0.08018,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.30815,0.070287,0.037393,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.4545,0.070059,0.01594,0,0
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.20937,0.069902,0.11581,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.34702,0.069837,0.026482,0,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.12908,0.069697,0.088339,0,0
2,GO REGULATION OF FEEDING BEHAVIOR,0.080955,0.069672,0.13257,0,0
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.063042,0.069657,0.20039,0,0
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.38888,0.069472,0.055228,0,0
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.87144,0.069295,-0.00035789,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.95466,0.06929,-0.030714,0,0
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.27227,0.069046,0.060352,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.12689,0.068975,0.084159,0,0
2,GO REGULATION OF HYDROLASE ACTIVITY,0.055956,0.068934,0.062965,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.2,0.068798,0.18985,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.98953,0.068728,-0.025439,0,0
2,GO MESODERM DEVELOPMENT,0.23937,0.068722,0.069906,0,0
2,GO BICARBONATE TRANSPORT,0.32077,0.068715,0.066466,0,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.27611,0.06863,0.066392,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.52594,0.06857,0.017132,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.69061,0.068507,0.041163,0,0
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.15773,0.068483,0.063138,0,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.44924,0.068389,0.074364,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.7495,0.068361,0.04339,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.26098,0.068196,0.029662,0,0
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.015203,0.068177,0.080644,0,0
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.47588,0.068109,0.015972,0,0
2,GO PEPTIDE CATABOLIC PROCESS,0.26847,0.067985,0.063865,0,0
2,GO REGULATION OF ERAD PATHWAY,0.055956,0.067916,0.075182,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.072231,0.067854,0.094771,0,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.42855,0.067826,0.053204,0,0
2,GO RESPONSE TO INTERLEUKIN 4,0.057089,0.067719,0.083894,0,0
2,GO AMMONIUM TRANSPORT,0.47049,0.067664,0.050254,0,0
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.19695,0.06755,0.032662,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.26098,0.067498,0.072428,0,0
2,GO DNA DEPENDENT DNA REPLICATION,0.070855,0.06747,0.078884,0,0
2,GO TRANSCYTOSIS,0.17653,0.067317,0.071398,0,0
2,GO SUPEROXIDE ANION GENERATION,0.25001,0.067255,0.09332,0,0
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.16559,0.067186,0.22309,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.98953,0.067092,-0.016826,0,0
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.4598,0.067088,0.043355,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.7495,0.067043,0.058175,0,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.14285,0.066977,0.097502,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.53742,0.066972,0.02261,0,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.42347,0.066892,0.044659,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.73628,0.066832,-0.0098556,0,0
2,GO RNA SURVEILLANCE,0.12473,0.066628,0.097117,0,0
2,GO RESPONSE TO WOUNDING,0.29184,0.066617,0.052858,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.69707,0.066378,-0.010361,0,0
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.19695,0.066124,0.059684,0,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.32938,0.066063,0.058131,0,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.33373,0.065958,0.051236,0,0
2,GO EXOCYTOSIS,0.22905,0.065642,0.033676,0,0
2,GO CELLULAR EXTRAVASATION,0.14769,0.065606,0.062092,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.10845,0.065279,0.10475,0,0
2,GO DETERMINATION OF ADULT LIFESPAN,0.11039,0.065114,0.12516,0,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.25363,0.065055,0.027797,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.78289,0.065043,-0.015947,0,0
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.079444,0.065017,0.069519,0,0
2,GO HORMONE METABOLIC PROCESS,0.1313,0.064958,0.084313,0,0
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.89215,0.064939,-0.035654,0,0
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.76948,0.064931,-0.018214,0,0
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.19095,0.064915,0.14503,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.17099,0.064642,0.095309,0,0
2,GO NCRNA CATABOLIC PROCESS,0.066855,0.06463,0.10967,0,0
2,GO MITOTIC CYTOKINETIC PROCESS,0.42347,0.064588,0.058606,0,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.070855,0.064521,0.077683,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.16294,0.064399,0.041157,0,0
2,GO ER OVERLOAD RESPONSE,0.51459,0.06436,0.058558,0,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.13583,0.063934,0.065174,0,0
2,GO REGULATION OF RECEPTOR RECYCLING,0.55487,0.063907,0.040183,0,0
2,GO DENTATE GYRUS DEVELOPMENT,0.53167,0.063833,0.049612,0,0
2,GO POSITIVE REGULATION OF CELL DEATH,0.188,0.063792,0.052637,0,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.48131,0.063774,0.017469,0,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.18508,0.063767,0.085786,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.23245,0.063755,0.059672,0,0
2,GO NEURAL TUBE FORMATION,0.11039,0.063658,0.11713,0,0
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.4978,0.063578,-0.099994,0,0
2,GO COLLAGEN CATABOLIC PROCESS,0.43883,0.063562,0.02257,0,0
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.25363,0.063539,0.10307,0,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.12049,0.063486,0.15647,0,0
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.88523,0.063472,-0.014339,0,0
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.65234,0.063441,0.010904,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.59664,0.063388,0.027366,0,0
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.095625,0.063363,0.095752,0,0
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.20621,0.063312,0.089835,0,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.76948,0.063301,0.057677,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.15264,0.063284,0.042523,0,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.38888,0.06321,0.013181,0,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.16032,0.063126,0.069114,0,0
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.32938,0.063053,0.056422,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.47049,0.062748,0.078003,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.18219,0.062608,0.099802,0,0
2,GO VIRION ASSEMBLY,0.30402,0.062566,0.03971,0,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.1028,0.062462,0.053973,0,0
2,GO CELL MATRIX ADHESION,0.30815,0.062385,0.068191,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.23937,0.062231,0.079162,0,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.17374,0.06218,0.10736,0,0
2,GO NEGATIVE REGULATION OF TRANSPORT,0.17653,0.062154,0.037275,0,0
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.12689,0.062107,0.11944,0,0
2,GO EOSINOPHIL MIGRATION,0.53167,0.062024,0.030003,0,0
2,GO APOPTOTIC PROCESS,0.11235,0.062024,0.045331,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.33373,0.061993,0.09053,0,0
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.25001,0.061992,0.059602,0,0
2,GO HOMEOSTATIC PROCESS,0.14285,0.06184,0.026156,0,0
2,GO AUTOPHAGOSOME ORGANIZATION,0.15015,0.061766,0.057686,0,0
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.63978,0.061722,0.030241,0,0
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.1313,0.061657,0.083221,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.1313,0.061642,0.060189,0,0
2,GO LYMPHOCYTE HOMEOSTASIS,0.59664,0.061632,0.0073668,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.12259,0.061523,0.19262,0,0
2,GO MAINTENANCE OF LOCATION,0.20309,0.06152,0.041113,0,0
2,GO MUSCLE HYPERTROPHY,0.52025,0.061505,0.048203,0,0
2,GO DE NOVO PROTEIN FOLDING,0.70355,0.061453,0.014449,0,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.26098,0.061358,0.051267,0,0
2,GO PROTEIN DESTABILIZATION,0.13583,0.061293,0.066914,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.095625,0.061175,0.11034,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.17374,0.061073,0.11841,0,0
2,GO PROTEIN STABILIZATION,0.15517,0.06103,0.052538,0,0
2,GO RESPONSE TO CHEMOKINE,0.14526,0.060975,0.049648,0,0
2,GO MITOTIC SISTER CHROMATID COHESION,0.18508,0.060872,0.10956,0,0
2,GO FEMALE GAMETE GENERATION,0.10465,0.060855,0.045256,0,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.27611,0.060831,0.077906,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.14769,0.060777,0.12163,0,0
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.70355,0.060566,-0.00091479,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.13355,0.060353,0.075027,0,0
2,GO MAINTENANCE OF LOCATION IN CELL,0.22235,0.060332,0.04458,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.67776,0.060304,0.0094515,0,0
2,GO CHOLESTEROL EFFLUX,0.18219,0.06026,0.074667,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.13814,0.060158,0.085756,0,0
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.042857,0.060125,0.1171,0,0
2,GO PROTEIN KINASE A SIGNALING,0.13814,0.059906,0.058759,0,0
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.11841,0.0599,0.084224,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.60272,0.059866,0.014885,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.75615,0.059804,0.03003,0,0
2,GO CERAMIDE METABOLIC PROCESS,0.17374,0.059721,0.032726,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.15015,0.059703,0.060585,0,0
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.47049,0.059545,0.024318,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.39858,0.059469,0.035602,0,0
2,GO LIPID DIGESTION,0.81668,0.059464,0.02361,0,0
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.025414,0.059455,0.10878,0,0
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.25729,0.05942,0.14124,0,0
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.1028,0.059347,0.041993,0,0
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.097379,0.059264,0.050593,0,0
2,GO BIOLOGICAL ADHESION,0.26471,0.059241,0.043815,0,0
2,GO SPERM EGG RECOGNITION,0.1313,0.059211,0.062231,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.17099,0.059151,0.055058,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.14769,0.059121,0.047274,0,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.080955,0.059078,0.046692,0,0
2,GO EPITHELIAL CELL DEVELOPMENT,0.51459,0.05905,0.053807,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.72969,0.058997,0.029669,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.54903,0.05892,0.066151,0,0
2,GO ETHANOL CATABOLIC PROCESS,0.10654,0.058886,0.22075,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.38888,0.058769,0.023079,0,0
2,GO PROTEIN POLYMERIZATION,0.22568,0.05864,0.030805,0,0
2,GO THYROID GLAND DEVELOPMENT,0.64605,0.058613,0.01634,0,0
2,GO RESPONSE TO NITRIC OXIDE,0.67137,0.058537,0.011682,0,0
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.23937,0.058502,0.0282,0,0
2,GO TELOMERE CAPPING,0.11039,0.058457,0.057419,0,0
2,GO CENTRIOLE ASSEMBLY,0.36991,0.05839,0.050098,0,0
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.53742,0.058315,0.12352,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.12259,0.058285,0.090305,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.79636,0.058264,-0.012582,0,0
2,GO NODAL SIGNALING PATHWAY,0.27999,0.058251,0.052669,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.51459,0.05823,0.033042,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.36064,0.058189,0.04263,0,0
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.021165,0.058186,0.084135,0,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.35153,0.058115,0.056884,0,0
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.13583,0.057925,0.13194,0,0
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.12689,0.057862,0.050336,0,0
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.60272,0.057685,0.040924,0,0
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.44402,0.057612,0.052166,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.91293,0.05738,-0.0030978,0,0
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.072231,0.057372,0.042179,0,0
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.16559,0.057364,0.078912,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.66501,0.057312,-0.018015,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.14285,0.057261,0.092605,0,0
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.27999,0.057258,0.020029,0,0
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.16032,0.057201,0.039392,0,0
2,GO CELLULAR SENESCENCE,0.44924,0.057061,0.032098,0,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.94769,0.056992,0.011154,0,0
2,GO BLASTOCYST GROWTH,0.12049,0.056992,0.070176,0,0
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.063042,0.056932,0.082073,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.57857,0.05693,0.071173,0,0
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.26471,0.056924,0.045021,0,0
2,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.4545,0.056898,0.092314,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.087232,0.05687,0.044303,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.13355,0.056524,0.037642,0,0
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.11235,0.056502,0.084675,0,0
2,GO INTERLEUKIN 5 PRODUCTION,0.22905,0.056353,0.1366,0,0
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.16559,0.056087,0.13162,0,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.35607,0.055956,0.12611,0,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.42347,0.05584,0.048543,0,0
2,GO FOAM CELL DIFFERENTIATION,0.32506,0.055815,0.064432,0,0
2,GO FOLIC ACID METABOLIC PROCESS,0.18508,0.055791,0.14098,0,0
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.8303,0.055743,0.071818,0,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.36526,0.05567,0.060907,0,0
2,GO BONE REMODELING,0.67776,0.055495,0.0018481,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.27999,0.055451,0.034104,0,0
2,GO GAMMA DELTA T CELL ACTIVATION,0.33812,0.055397,0.10871,0,0
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.36064,0.055328,0.073663,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.3746,0.055305,0.10122,0,0
2,GO COLLAGEN METABOLIC PROCESS,0.40843,0.055285,0.024037,0,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.67137,0.055266,0.011387,0,0
2,GO CELL SUBSTRATE ADHESION,0.26098,0.055121,0.074961,0,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.5726,0.054957,0.0029024,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.35153,0.054829,0.046507,0,0
2,GO STEROL TRANSPORT,0.36064,0.054801,0.057541,0,0
2,GO MEMBRANE DISASSEMBLY,0.56075,0.054697,0.026081,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.40349,0.054672,0.069374,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.093897,0.054671,0.11261,0,0
2,GO AGING,0.24643,0.054642,0.041461,0,0
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.073629,0.054566,0.046402,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.62113,0.054495,0.080096,0,0
2,GO RESPONSE TO VITAMIN,0.40349,0.054491,0.052149,0,0
2,GO REGULATION OF AMYLOID BETA FORMATION,0.44402,0.054363,0.045512,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.42855,0.054257,0.031819,0,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.29586,0.054233,0.051363,0,0
2,GO LACTATION,0.061812,0.054089,0.10072,0,0
2,GO ACYLGLYCEROL HOMEOSTASIS,0.23937,0.054042,0.081445,0,0
2,GO SEX DIFFERENTIATION,0.49227,0.053991,0.026913,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.16559,0.053981,0.065246,0,0
2,GO DISTAL TUBULE DEVELOPMENT,0.29586,0.05398,0.15941,0,0
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.27611,0.053965,0.040676,0,0
2,GO ARTERY MORPHOGENESIS,0.23589,0.053948,0.08456,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.080955,0.053932,0.089151,0,0
2,GO RESPONSE TO ISCHEMIA,0.16828,0.053809,0.06112,0,0
2,GO SMOOTH MUSCLE CONTRACTION,0.72969,0.053687,-0.015973,0,0
2,GO MAMMARY GLAND DEVELOPMENT,0.16828,0.053519,0.088209,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.27999,0.053497,0.045256,0,0
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.99651,0.053398,-0.00069992,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.77618,0.053311,0.039,0,0
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.25729,0.053275,0.052918,0,0
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.14048,0.053218,0.047171,0,0
2,GO NEUTROPHIL CHEMOTAXIS,0.12049,0.053161,0.033873,0,0
2,GO SPHINGOLIPID METABOLIC PROCESS,0.36991,0.05315,0.013936,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.28785,0.052902,0.037388,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.31232,0.052645,0.068914,0,0
2,GO CERAMIDE CATABOLIC PROCESS,0.69707,0.052616,0.017502,0,0
2,GO BONE DEVELOPMENT,0.42347,0.052598,0.052045,0,0
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.9686,0.052474,-0.022629,0,0
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.5726,0.052461,-0.0025141,0,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.14526,0.052445,0.039609,0,0
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.15773,0.052414,0.13329,0,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.22905,0.052412,0.05365,0,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.17653,0.052285,0.070454,0,0
2,GO CYTOKINE SECRETION,0.2839,0.052253,0.045762,0,0
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.26098,0.05217,0.080184,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.60883,0.052093,0.033458,0,0
2,GO CRANIAL NERVE MORPHOGENESIS,0.83713,0.052062,0.00071116,0,0
2,GO CHROMOSOME SEPARATION,0.064293,0.052028,0.066195,0,0
2,GO NCRNA 3 END PROCESSING,0.27999,0.051993,0.049113,0,0
2,GO TUBE FORMATION,0.052669,0.051947,0.11581,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.43367,0.051915,0.027256,0,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.92682,0.051803,-0.0077261,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.84397,0.051702,-0.0041795,0,0
2,GO SEGMENTATION,0.20309,0.05169,0.056251,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.76281,0.051655,0.013767,0,0
2,GO RESPONSE TO ABIOTIC STIMULUS,0.21579,0.051421,0.034838,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.35607,0.051345,0.051473,0,0
2,GO EOSINOPHIL CHEMOTAXIS,0.65866,0.051232,0.01177,0,0
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.85768,0.051175,-0.0061845,0,0
2,GO REGULATION OF PROTEIN BINDING,0.33812,0.051084,0.037003,0,0
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.22235,0.050999,0.06295,0,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.32938,0.050946,0.055806,0,0
2,GO REGULATION OF HEAT GENERATION,0.69707,0.050858,0.018577,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.25363,0.050834,0.21206,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.96163,0.050764,-0.037167,0,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.39371,0.050672,0.051543,0,0
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.39371,0.050646,0.041394,0,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.84397,0.050566,-0.035629,0,0
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.15264,0.050409,0.080732,0,0
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.63978,0.050179,-0.001188,0,0
2,GO RESPONSE TO MINERALOCORTICOID,0.48678,0.049972,0.034318,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.34256,0.049815,0.083913,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.38408,0.049664,0.033353,0,0
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.61497,0.049588,0.1048,0,0
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.29586,0.049531,0.039461,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.85082,0.0494,0.0089154,0,0
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.18508,0.049323,0.055498,0,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.57857,0.04929,0.03603,0,0
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.19695,0.049276,0.11657,0,0
2,GO COMPLEMENT ACTIVATION,0.25363,0.049225,0.055402,0,0
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.48678,0.048945,0.050184,0,0
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.86455,0.048812,-0.020336,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.70355,0.04875,-0.003524,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.63354,0.04863,0.011377,0,0
2,GO REGULATORY T CELL DIFFERENTIATION,0.26098,0.048504,0.085795,0,0
2,GO REPLACEMENT OSSIFICATION,0.32506,0.048461,0.12281,0,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.072231,0.048251,0.097913,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.088862,0.048177,0.049392,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.25729,0.048158,0.11566,0,0
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.84397,0.048118,0.0097135,0,0
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.20309,0.048074,0.045711,0,0
2,GO REGULATION OF MITOTIC CELL CYCLE,0.14526,0.048039,0.050601,0,0
2,GO DNA DEAMINATION,0.3746,0.048018,0.075219,0,0
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.073629,0.047949,0.063547,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.12049,0.047907,0.057357,0,0
2,GO SISTER CHROMATID COHESION,0.37932,0.047877,0.064265,0,0
2,GO CARTILAGE MORPHOGENESIS,0.85768,0.047535,0.0067048,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.78962,0.04753,-0.0015796,0,0
2,GO RENAL SODIUM EXCRETION,0.48131,0.047487,0.072455,0,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.27611,0.047483,0.11032,0,0
2,GO G0 TO G1 TRANSITION,0.47588,0.047383,0.045866,0,0
2,GO RECOMBINATIONAL REPAIR,0.32506,0.047318,0.060457,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.37932,0.047132,0.049471,0,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.85768,0.047027,0.0034197,0,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.32938,0.046968,0.057114,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.063042,0.046927,0.057468,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.42855,0.046872,0.12127,0,0
2,GO RECEPTOR INTERNALIZATION,0.29992,0.046865,0.048028,0,0
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.11636,0.046819,0.063289,0,0
2,GO REGULATION OF PHOSPHORYLATION,0.29184,0.046771,0.029323,0,0
2,GO AUTOPHAGIC CELL DEATH,0.82348,0.046658,0.0027666,0,0
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.013465,0.046629,0.059808,0,0
2,GO MITOTIC CYTOKINESIS,0.30815,0.046613,0.067228,0,0
2,GO EPITHELIUM DEVELOPMENT,0.42347,0.046485,0.050241,0,0
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.21579,0.046463,0.049333,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.0695,0.046419,0.099192,0,0
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.11235,0.046332,0.053318,0,0
2,GO RESPONSE TO AMINE,0.72969,0.046229,0.010764,0,0
2,GO LUNG MORPHOGENESIS,0.1313,0.046194,0.19256,0,0
2,GO GLIAL CELL APOPTOTIC PROCESS,0.72969,0.046183,0.031357,0,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.33812,0.046154,0.052627,0,0
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.043763,0.045971,0.15646,0,0
2,GO CORPUS CALLOSUM DEVELOPMENT,0.89907,0.045845,-0.016325,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.7495,0.045814,0.010805,0,0
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.65234,0.045804,0.034302,0,0
2,GO PROTEIN AUTOUBIQUITINATION,0.16828,0.045799,0.03886,0,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.60272,0.045751,0.0099525,0,0
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.24643,0.045723,0.033676,0,0
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.82348,0.045637,0.020347,0,0
2,GO REGULATION OF PROTEIN ACETYLATION,0.11636,0.045625,0.0581,0,0
2,GO MITOTIC CELL CYCLE,0.11235,0.045536,0.05095,0,0
2,GO PROTEIN TARGETING,0.15517,0.045481,0.064985,0,0
2,GO PROSTATIC BUD FORMATION,0.72969,0.04529,0.032502,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.56075,0.045257,0.018639,0,0
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.060602,0.045243,0.070766,0,0
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.29184,0.045223,0.072978,0,0
2,GO GLIAL CELL DEVELOPMENT,0.76281,0.04497,0.0047427,0,0
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.22568,0.044901,0.030597,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.87833,0.044883,0.011785,0,0
2,GO INTERLEUKIN 6 PRODUCTION,0.25001,0.044826,0.055048,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.47588,0.044822,-0.087458,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.47049,0.044746,0.022234,0,0
2,GO DECIDUALIZATION,0.83713,0.044745,-0.010069,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.69707,0.044698,0.0093733,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.24643,0.044696,0.071539,0,0
2,GO QUINONE METABOLIC PROCESS,0.44924,0.044673,0.06904,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.89215,0.044629,-0.0095757,0,0
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.14048,0.044477,0.043083,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.83713,0.044178,-0.00079444,0,0
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.25729,0.044033,0.053022,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.27611,0.043973,0.053388,0,0
2,GO PROTEIN HETEROTETRAMERIZATION,0.58456,0.043855,0.027109,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.36526,0.043854,0.021532,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.20937,0.043799,0.048456,0,0
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.56666,0.043746,0.066707,0,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.1313,0.04351,0.035579,0,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.39371,0.04347,0.030976,0,0
2,GO MICROTUBULE NUCLEATION,0.79636,0.043375,-0.029253,0,0
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.60883,0.043335,0.054661,0,0
2,GO REGULATION OF AUTOPHAGY,0.12049,0.043328,0.038046,0,0
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.17099,0.043279,0.061053,0,0
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,1,0.043253,-0.05713,0,0
2,GO LIPID EXPORT FROM CELL,0.2839,0.043223,0.050833,0,0
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.31232,0.043194,0.025754,0,0
2,GO HINDLIMB MORPHOGENESIS,0.17934,0.043168,0.098308,0,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.20309,0.043095,0.064295,0,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.4978,0.043091,0.014743,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.092194,0.042995,0.058439,0,0
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.17653,0.042892,0.12975,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.4598,0.042892,0.06622,0,0
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.28785,0.042805,0.019618,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.92682,0.042794,0.0022004,0,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.48678,0.042786,0.025058,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.50337,0.042741,0.022365,0,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.44924,0.04269,0.02059,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.53167,0.042618,0.029094,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.15264,0.042403,0.11119,0,0
2,GO PRENYLATION,0.33373,0.042256,0.076529,0,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.59664,0.042106,0.028992,0,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.32077,0.041973,0.037874,0,0
2,GO DNA RECOMBINATION,0.073629,0.041972,0.063612,0,0
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.7495,0.041947,0.0011604,0,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.21905,0.041944,0.085095,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.55487,0.041857,0.02113,0,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.34702,0.04181,0.032928,0,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.72313,0.041801,0.014719,0,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.40843,0.04157,0.020369,0,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.40843,0.041394,0.033425,0,0
2,GO MULTIVESICULAR BODY ORGANIZATION,0.39371,0.041308,0.059175,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.67137,0.041209,0.020544,0,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.18508,0.041175,0.095371,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.11636,0.041174,0.21743,0,0
2,GO FACE DEVELOPMENT,0.72313,0.040916,0.039901,0,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.38408,0.040885,0.073523,0,0
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.1313,0.040883,0.0633,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.65234,0.040842,0.014004,0,0
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.85768,0.040832,-0.0087024,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.63978,0.040784,0.026218,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.67776,0.040758,-0.0047225,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.72969,0.040714,0.043791,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.40843,0.040672,0.025004,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.86455,0.040574,-0.023526,0,0
2,GO PIGMENT GRANULE LOCALIZATION,0.52594,0.040529,0.04381,0,0
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.85768,0.04052,0.021853,0,0
2,GO RESPONSE TO ZINC ION,0.32938,0.04037,0.10388,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.10845,0.04019,0.081764,0,0
2,GO REGULATION OF CENTROSOME CYCLE,0.80989,0.040132,0.03321,0,0
2,GO REGULATION OF CHROMATIN BINDING,0.54903,0.039991,0.045055,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.31653,0.039908,0.044427,0,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.73628,0.039736,-0.005372,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.72969,0.039659,0.021379,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.30402,0.039517,0.051608,0,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.23589,0.039502,0.038332,0,0
2,GO CELLULAR RESPONSE TO ATP,0.52025,0.0395,-0.055219,0,0
2,GO REGULATION OF CHLORIDE TRANSPORT,0.54903,0.039445,0.038314,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.58456,0.039428,0.01829,0,0
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.61497,0.039356,0.018642,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.21579,0.039281,0.032189,0,0
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.30815,0.039262,0.033494,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.80989,0.039216,0.028084,0,0
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.29992,0.039193,0.026193,0,0
2,GO ATP METABOLIC PROCESS,0.060602,0.039159,0.071659,0,0
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.16294,0.039028,0.031862,0,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.090515,0.038997,0.068984,0,0
2,GO ESTROGEN METABOLIC PROCESS,0.35607,0.03892,0.11798,0,0
2,GO SARCOMERE ORGANIZATION,0.59059,0.038797,0.034242,0,0
2,GO SNRNA TRANSCRIPTION,0.014841,0.038684,0.074131,0,0
2,GO REGULATION OF GLIAL CELL MIGRATION,0.93377,0.03867,-0.01905,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.8303,0.038662,0.0060126,0,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.37932,0.038637,0.029254,0,0
2,GO ENDOTHELIAL CELL MIGRATION,0.21256,0.038631,0.073191,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.98953,0.038607,-0.013592,0,0
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.7495,0.038597,-0.016891,0,0
2,GO MITOTIC NUCLEAR DIVISION,0.16294,0.038524,0.052742,0,0
2,GO EPITHELIAL CELL PROLIFERATION,0.48131,0.038449,0.044117,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.36064,0.038378,0.055452,0,0
2,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.74288,0.038324,0.062177,0,0
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.24643,0.03826,0.031995,0,0
2,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.4598,0.038212,0.053896,0,0
2,GO PROTEIN HOMOTETRAMERIZATION,0.44402,0.038091,0.025581,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.68418,0.038058,0.056383,0,0
2,GO VAGINA DEVELOPMENT,0.78962,0.037925,-0.047127,0,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.7495,0.037623,-0.02575,0,0
2,GO PROTEIN TARGETING TO MEMBRANE,0.4598,0.037597,0.052169,0,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.46512,0.037582,0.039643,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.93377,0.037574,-0.010417,0,0
2,GO RECEPTOR RECYCLING,0.70355,0.037371,0.013687,0,0
2,GO CARDIOBLAST DIFFERENTIATION,0.87144,0.037353,0.026408,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.60272,0.037353,0.028599,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.38408,0.037328,0.10176,0,0
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.42855,0.037287,0.023202,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.71006,0.037185,0.054928,0,0
2,GO SECRETION,0.5726,0.037036,0.0020986,0,0
2,GO REGULATION OF MAPK CASCADE,0.25001,0.036943,0.039906,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.70355,0.036921,0.013616,0,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.71006,0.03677,0.013583,0,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.29184,0.036694,0.065826,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.80989,0.036635,0.061339,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.56075,0.036622,0.0085201,0,0
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.97557,0.036604,-0.042554,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.59664,0.036566,0.028603,0,0
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.32938,0.036552,0.056788,0,0
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.5726,0.036531,0.013194,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.69707,0.036392,0.056279,0,0
2,GO AXONAL FASCICULATION,0.82348,0.036389,0.0024468,0,0
2,GO PROTEIN TRIMERIZATION,0.35607,0.036297,0.069392,0,0
2,GO O GLYCAN PROCESSING,0.46512,0.03606,0.0082653,0,0
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.69061,0.035962,0.015121,0,0
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.25729,0.03594,0.12133,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.46512,0.035904,0.025741,0,0
2,GO INTRACELLULAR LIPID TRANSPORT,0.10465,0.035804,0.11171,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE,0.53742,0.035662,0.015703,0,0
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.61497,0.035503,0.025501,0,0
2,GO REGULATION OF ENDOCYTOSIS,0.91987,0.035488,0.0059609,0,0
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.35607,0.035477,0.020796,0,0
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.63978,0.035456,0.027149,0,0
2,GO FLUID TRANSPORT,0.73628,0.035326,0.010579,0,0
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.42347,0.035276,0.11124,0,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.53742,0.035207,0.015664,0,0
2,GO P38MAPK CASCADE,0.71006,0.035144,0.006867,0,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.4545,0.035083,0.038645,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.46512,0.035031,0.019268,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.9686,0.034904,-0.02223,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.97557,0.03487,-0.003393,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.46512,0.034825,0.028811,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.29586,0.034589,0.044475,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.18508,0.034566,0.076017,0,0
2,GO BONE MINERALIZATION,0.76281,0.034529,-0.027994,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.37932,0.034336,0.046111,0,0
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.14526,0.034313,0.054407,0,0
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.21905,0.034257,0.039903,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.068167,0.03413,0.046116,0,0
2,GO REGULATION OF NUCLEAR DIVISION,0.32077,0.033934,0.037139,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.14048,0.033852,0.10169,0,0
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.041967,0.033803,0.069917,0,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.44402,0.033725,0.041712,0,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.94073,0.033663,0.0021918,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.83713,0.033583,-0.031972,0,0
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.29184,0.033551,0.04952,0,0
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.43883,0.033417,0.039235,0,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.40349,0.033339,0.020056,0,0
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.76948,0.03327,0.0068478,0,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.90599,0.033141,-0.021652,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.1028,0.033129,0.038402,0,0
2,GO EMBRYO DEVELOPMENT,0.48131,0.032976,0.037728,0,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.98953,0.032932,0.002905,0,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.55487,0.03287,0.014214,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.69061,0.032807,0.006582,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.57857,0.032781,-0.05103,0,0
2,GO REGULATION OF RNA BINDING,0.53742,0.032718,0.041695,0,0
2,GO HEAD MORPHOGENESIS,0.99651,0.032695,-0.0077516,0,0
2,GO BLASTOCYST DEVELOPMENT,0.20309,0.032582,0.039575,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,1,0.032516,-0.015681,0,0
2,GO GLYCOSIDE METABOLIC PROCESS,0.63978,0.032462,0.10884,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.25363,0.032462,0.030518,0,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.75615,0.032445,-0.0043502,0,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.65234,0.03244,0.0039803,0,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.36991,0.032262,0.052637,0,0
2,GO ATP TRANSPORT,0.91293,0.032258,-0.007011,0,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.2,0.032057,0.039871,0,0
2,GO APPENDAGE DEVELOPMENT,0.18508,0.03204,0.086136,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.42347,0.032008,0.065739,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.47588,0.031521,0.024743,0,0
2,GO PLATELET DEGRANULATION,0.78962,0.031469,-0.0028543,0,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.52025,0.031418,0.027699,0,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.48678,0.031389,0.051235,0,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.31653,0.03131,0.032266,0,0
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.27999,0.031305,0.048618,0,0
2,GO DNA METHYLATION OR DEMETHYLATION,0.19695,0.031297,0.039334,0,0
2,GO REGULATION OF CENTROSOME DUPLICATION,0.73628,0.031236,0.036241,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.48131,0.031182,0.030152,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.53167,0.031,0.0099123,0,0
2,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.14285,0.030974,0.23046,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.90599,0.03097,0.0046589,0,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.74288,0.030965,-0.012795,0,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.61497,0.030908,0.0071251,0,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.82348,0.030891,-0.0083575,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.62732,0.030771,0.013266,0,0
2,GO WHITE FAT CELL DIFFERENTIATION,0.90599,0.030763,0.0064894,0,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.7495,0.030692,0.033281,0,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.59664,0.030609,0.016718,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.31232,0.030586,0.070966,0,0
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.76948,0.03054,0.0027782,0,0
2,GO INTESTINAL LIPID ABSORPTION,0.78289,0.030472,0.02464,0,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.32506,0.030433,0.047082,0,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.4545,0.03036,0.056778,0,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.42347,0.030289,0.03224,0,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.31653,0.030101,0.073736,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.83713,0.029998,0.018595,0,0
2,GO RESPONSE TO STEROL,0.29586,0.029937,0.078741,0,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.91987,0.029902,-0.01766,0,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.65866,0.029873,0.03232,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.79636,0.029833,0.010621,0,0
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.71658,0.029788,0.037452,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.14285,0.029697,0.039902,0,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.2839,0.029653,0.040152,0,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.065563,0.029589,0.046567,0,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.36526,0.029547,0.043763,0,0
2,GO TUBE MORPHOGENESIS,0.36526,0.02949,0.059156,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.25001,0.029489,0.064294,0,0
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.56075,0.029395,0.045257,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.21905,0.029375,0.037604,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.80989,0.029323,-0.034324,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.26847,0.029292,0.065104,0,0
2,GO HETEROCHROMATIN ORGANIZATION,0.4978,0.029202,0.020868,0,0
2,GO MITOCHONDRION ORGANIZATION,0.063042,0.0292,0.055407,0,0
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.20621,0.028946,0.088579,0,0
2,GO LYMPHOCYTE MIGRATION,0.72313,0.028894,0.018142,0,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.59664,0.028797,0.016951,0,0
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.70355,0.028782,0.0064481,0,0
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.54903,0.028766,0.021342,0,0
2,GO CALCINEURIN MEDIATED SIGNALING,0.33373,0.028672,0.050185,0,0
2,GO TRANSITION METAL ION TRANSPORT,0.56666,0.028641,0.0071574,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.22235,0.028598,0.046478,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.29992,0.02859,0.091538,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.47049,0.028517,0.020525,0,0
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.42347,0.028448,0.027729,0,0
2,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.188,0.028386,0.10489,0,0
2,GO REGULATION OF T CELL MIGRATION,0.44402,0.028174,0.036356,0,0
2,GO JNK CASCADE,0.29992,0.028047,0.036871,0,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.35153,0.028027,0.05416,0,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.42855,0.028019,0.03263,0,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.14526,0.028001,0.064574,0,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.43367,0.027942,0.070998,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.21256,0.027936,0.076261,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.47588,0.027911,0.033602,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.36526,0.027829,0.037581,0,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.58456,0.027781,0.015785,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.43883,0.027726,0.077576,0,0
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.42347,0.027708,0.053747,0,0
2,GO HISTONE H2A ACETYLATION,0.75615,0.027704,0.0088158,0,0
2,GO RESPONSE TO PEPTIDE,0.38408,0.027684,0.022862,0,0
2,GO REGULATION OF INTEGRIN ACTIVATION,0.77618,0.027672,0.015587,0,0
2,GO CELL CYCLE PROCESS,0.088862,0.027517,0.046,0,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.61497,0.027361,0.010952,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.58456,0.027307,0.0058109,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.54321,0.027137,-0.044071,0,0
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.69061,0.027113,0.022769,0,0
2,GO ENDOCYTOSIS,0.4545,0.027025,0.016522,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.36991,0.026877,0.041981,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.97557,0.026853,0.0075853,0,0
2,GO VACUOLE ORGANIZATION,0.64605,0.026761,0.0044229,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.42347,0.026648,0.0098656,0,0
2,GO CHROMATIN SILENCING,0.31232,0.026638,0.06477,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.78962,0.026614,0.0031865,0,0
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.72969,0.026485,0.0078607,0,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.49227,0.026358,0.030857,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.85768,0.026332,-0.0065069,0,0
2,GO RESPONSE TO VITAMIN D,0.90599,0.026294,-0.037903,0,0
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.75615,0.026243,-0.021933,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.80312,0.026175,0.0025297,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.60883,0.025945,0.050321,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.66501,0.025811,0.021853,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.25363,0.025784,0.032654,0,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.52025,0.025618,0.0015567,0,0
2,GO FERTILIZATION,0.7495,0.025285,0.00047148,0,0
2,GO ORGANELLE DISASSEMBLY,0.46512,0.025228,0.017058,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.29586,0.025151,0.076327,0,0
2,GO SINGLE FERTILIZATION,0.69061,0.025042,-0.024283,0,0
2,GO TRABECULA FORMATION,0.48131,0.025003,0.050973,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.49227,0.024976,0.056146,0,0
2,GO NEURON REMODELING,0.89907,0.024973,-0.030406,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.47588,0.024924,0.014087,0,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.4978,0.024857,-0.061763,0,0
2,GO REGULATION OF HISTONE MODIFICATION,0.42855,0.024784,0.025493,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.33373,0.024767,0.02688,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.88523,0.024756,0.014385,0,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.78962,0.02452,0.034119,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.51459,0.024496,0.026824,0,0
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.93377,0.024331,0.010955,0,0
2,GO REGULATION OF CELL CYCLE,0.35607,0.024321,0.030757,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.67776,0.024296,0.0129,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.65866,0.024258,0.038721,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.53742,0.024154,0.042654,0,0
2,GO MIDGUT DEVELOPMENT,0.80989,0.024043,0.071845,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.54903,0.024034,0.015968,0,0
2,GO METANEPHROS MORPHOGENESIS,0.78289,0.024021,0.0078214,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.39858,0.024006,0.023334,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.63978,0.023907,0.0080017,0,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.69061,0.023824,0.033469,0,0
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.98953,0.023721,0.0029453,0,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.98953,0.023712,-0.0083586,0,0
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.89907,0.023672,-0.0031214,0,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.82348,0.023668,-0.0022776,0,0
2,GO REGULATION OF DNA REPLICATION,0.65234,0.023625,0.03358,0,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.8303,0.023547,-0.016275,0,0
2,GO CELL PROLIFERATION IN FOREBRAIN,0.80989,0.023451,0.028645,0,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.87833,0.02345,-0.014675,0,0
2,GO RESPONSE TO ATP,0.9686,0.023282,-0.015126,0,0
2,GO REGULATION OF JUN KINASE ACTIVITY,0.33373,0.022965,0.055703,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.71006,0.022929,0.0014662,0,0
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.21256,0.02283,0.056155,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.77618,0.022795,0.0054464,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.23937,0.02277,0.031305,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.87144,0.02271,0.0025128,0,0
2,GO TUMOR NECROSIS FACTOR SECRETION,0.50337,0.022646,0.04877,0,0
2,GO CELL CYCLE,0.15264,0.022449,0.035142,0,0
2,GO NUCLEOSOME ORGANIZATION,0.80312,0.022427,0.024905,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.41341,0.022287,0.025259,0,0
2,GO VACUOLAR ACIDIFICATION,0.94769,0.022273,-0.015556,0,0
2,GO REGULATION OF HEART GROWTH,0.62113,0.022233,0.024104,0,0
2,GO SISTER CHROMATID SEGREGATION,0.19393,0.0222,0.063441,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.43883,0.022176,0.041355,0,0
2,GO MATING BEHAVIOR,0.99651,0.022062,-0.009965,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.7495,0.02204,0.012448,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.69061,0.021801,0.013839,0,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.7495,0.021682,-0.0027375,0,0
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.15264,0.021488,0.037039,0,0
2,GO DENDRITIC SPINE MAINTENANCE,0.94073,0.021359,-0.013155,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.36064,0.021256,0.035434,0,0
2,GO ACTIVATION OF MAPK ACTIVITY,0.85082,0.021009,-0.0070816,0,0
2,GO UTERUS DEVELOPMENT,0.64605,0.020986,-0.059039,0,0
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.48678,0.020916,0.046324,0,0
2,GO SEX DETERMINATION,0.72313,0.020867,-0.0014263,0,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.8303,0.020862,0.010301,0,0
2,GO GOLGI ORGANIZATION,0.43883,0.02072,0.027036,0,0
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.94769,0.020712,-0.03594,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.67776,0.020673,0.0090346,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.91987,0.02064,-0.014575,0,0
2,GO MITOCHONDRIAL FUSION,0.59059,0.020533,0.017529,0,0
2,GO DRINKING BEHAVIOR,0.85082,0.020339,-0.0051647,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.77618,0.020329,0.030799,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.57857,0.020293,0.0042949,0,0
2,GO DNA PACKAGING,0.73628,0.020284,0.018157,0,0
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.91987,0.020225,-0.025808,0,0
2,GO FAT CELL DIFFERENTIATION,0.8303,0.020208,0.015048,0,0
2,GO CYTOSOLIC TRANSPORT,0.64605,0.020185,0.013705,0,0
2,GO SPECIFICATION OF SYMMETRY,0.4978,0.020146,0.025093,0,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.80989,0.020108,-0.0063958,0,0
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.63354,0.020032,0.035783,0,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.53742,0.020018,0.026049,0,0
2,GO PHOSPHOLIPID EFFLUX,0.5726,0.019895,0.058125,0,0
2,GO LIPID DROPLET ORGANIZATION,0.50896,0.01982,0.05302,0,0
2,GO NEGATIVE CHEMOTAXIS,0.75615,0.019443,-0.059141,0,0
2,GO TUBE DEVELOPMENT,0.71006,0.019328,0.035888,0,0
2,GO BLOOD VESSEL REMODELING,0.48678,0.019247,0.01552,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.60883,0.019238,-0.044648,0,0
2,GO CGMP MEDIATED SIGNALING,0.88523,0.019229,-0.026413,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.48678,0.018993,0.046698,0,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.73628,0.018971,0.070063,0,0
2,GO PROTEIN TETRAMERIZATION,0.67776,0.018952,0.012088,0,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.36526,0.018916,-0.059513,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.59059,0.018874,0.039145,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.60272,0.018789,0.010702,0,0
2,GO REGULATION OF MRNA BINDING,0.36526,0.018765,0.067555,0,0
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.66501,0.018742,0.075501,0,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.63354,0.018599,0.013832,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.60883,0.018535,0.0055299,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.8303,0.018479,0.012257,0,0
2,GO REGULATION OF METAL ION TRANSPORT,1,0.018415,-0.0056358,0,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.8303,0.018393,-0.0083662,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.50896,0.018105,0.036055,0,0
2,GO REGULATION OF CELL CYCLE ARREST,0.79636,0.018054,0.018746,0,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.40349,0.01798,0.033161,0,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.99651,0.017869,-0.00038742,0,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.15015,0.017842,0.10863,0,0
2,GO OOCYTE DIFFERENTIATION,0.7495,0.017722,0.0099445,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.74288,0.017697,0.018622,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.48131,0.017621,0.013141,0,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.60272,0.017522,0.013426,0,0
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.90599,0.017475,-0.025743,0,0
2,GO LIPID TRANSLOCATION,0.85768,0.017406,-0.026045,0,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.50896,0.017366,0.030647,0,0
2,GO POSITIVE REGULATION OF TRANSPORT,0.98953,0.017365,-0.011546,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.86455,0.017239,-0.017393,0,0
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.14526,0.017052,0.083043,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.65866,0.016672,-0.034107,0,0
2,GO RESPONSE TO MUSCLE INACTIVITY,0.98255,0.016616,0.0031485,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.42855,0.016576,0.037121,0,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.20937,0.016546,0.027842,0,0
2,GO PROTEIN REFOLDING,0.89907,0.016486,0.0016649,0,0
2,GO L GLUTAMATE IMPORT,0.87833,0.016469,-0.01442,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.78289,0.016337,0.0038758,0,0
2,GO REGULATION OF PLATELET AGGREGATION,0.41341,0.016285,-0.087819,0,0
2,GO RESPONSE TO ETHER,0.25729,0.016208,0.072016,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.89907,0.016105,0.074946,0,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.65234,0.016101,0.083137,0,0
2,GO MUSCLE SYSTEM PROCESS,0.97557,0.016034,-0.0089498,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.56075,0.015993,0.07165,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.36064,0.015979,0.072749,0,0
2,GO MITRAL VALVE DEVELOPMENT,0.29586,0.015937,0.25288,0,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.89907,0.015922,-0.020164,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.9686,0.015533,-0.027975,0,0
2,GO REGULATION OF MRNA POLYADENYLATION,0.93377,0.015515,0.0033865,0,0
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.27999,0.015412,0.14544,0,0
2,GO APPENDAGE MORPHOGENESIS,0.59059,0.015397,0.060253,0,0
2,GO REPLICATION FORK PROCESSING,0.52594,0.015266,0.054076,0,0
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.32077,0.01517,0.087686,0,0
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.14526,0.0151,0.056854,0,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.69707,0.015062,0.049906,0,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.64605,0.014858,0.013312,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.44402,0.014455,0.053455,0,0
2,GO NEURAL TUBE PATTERNING,0.60883,0.014338,-0.016108,0,0
2,GO EATING BEHAVIOR,0.53167,0.01433,0.024148,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.27999,0.014258,0.051218,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.9686,0.014153,-0.0083412,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.91987,0.014062,0.047162,0,0
2,GO DNA REPLICATION CHECKPOINT,0.31653,0.013991,0.086732,0,0
2,GO BRAIN MORPHOGENESIS,0.78962,0.013964,-0.035771,0,0
2,GO MEMBRANE ORGANIZATION,0.95466,0.013837,-0.0053667,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.38888,0.013815,0.036363,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.48678,0.013812,0.010328,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.75615,0.013802,0.055013,0,0
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.73628,0.01373,0.022867,0,0
2,GO CELL MOTILITY,0.74288,0.013634,0.011931,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.72969,0.013625,0.0045963,0,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.65234,0.013461,-0.04808,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.67776,0.013443,0.0065223,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.86455,0.013359,0.0072627,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.46512,0.013255,0.041123,0,0
2,GO RESPONSE TO LEAD ION,0.67137,0.013088,0.039547,0,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.63354,0.012902,0.016399,0,0
2,GO POSITIVE REGULATION OF SIGNALING,0.94073,0.0129,-0.0099678,0,0
2,GO ARTERY DEVELOPMENT,0.69061,0.012857,0.050188,0,0
2,GO PHOTOTRANSDUCTION,0.59059,0.012838,0.11626,0,0
2,GO SPINDLE ORGANIZATION,0.78289,0.012775,0.012031,0,0
2,GO MITOTIC DNA REPLICATION CHECKPOINT,0.80312,0.012655,0.069119,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.85082,0.012635,-0.025164,0,0
2,GO PROTEIN ACYLATION,0.60272,0.012622,-0.0069486,0,0
2,GO MYELOID CELL DEVELOPMENT,0.50896,0.012618,0.040322,0,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.47049,0.012544,0.098085,0,0
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.78962,0.012481,0.0093054,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.96163,0.012399,0.026879,0,0
2,GO NATURAL KILLER CELL ACTIVATION,0.61497,0.012312,0.029205,0,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.56075,0.012283,0.027255,0,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.41341,0.012271,0.046036,0,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.67137,0.012162,0.019518,0,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.68418,0.012041,0.0070634,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.5726,0.012039,0.040014,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.91987,0.012015,-0.013353,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.72969,0.011852,0.015393,0,0
2,GO CELLULAR RESPONSE TO STARVATION,0.78289,0.011822,-0.022931,0,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.72969,0.01182,0.057109,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.57857,0.011807,0.023794,0,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.50337,0.011793,0.043602,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.61497,0.01175,0.027737,0,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.80312,0.01175,0.009354,0,0
2,GO T CELL HOMEOSTASIS,0.53167,0.011627,-0.058445,0,0
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.57857,0.011501,0.020879,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.94073,0.01144,-0.0038807,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.4978,0.011111,0.021609,0,0
2,GO ORGANELLE ASSEMBLY,0.80312,0.011049,-0.0078397,0,0
2,GO CHEMICAL HOMEOSTASIS,0.86455,0.011002,-0.004875,0,0
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.75615,0.01098,0.024542,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.97557,0.010968,0.037476,0,0
2,GO SULFATE TRANSPORT,0.55487,0.010757,0.050956,0,0
2,GO MUSCLE CONTRACTION,0.74288,0.010675,-0.022861,0,0
2,GO RESPONSE TO L GLUTAMATE,0.67776,0.01036,0.045009,0,0
2,GO MISMATCH REPAIR,0.7495,0.010326,0.015596,0,0
2,GO REGULATION OF TOR SIGNALING,0.61497,0.010233,-0.021166,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.71658,0.010171,0.021268,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.32506,0.010076,0.13771,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.89215,0.010036,-0.0097549,0,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.44924,0.010004,0.056128,0,0
2,GO MESODERM MORPHOGENESIS,0.41341,0.0098992,0.063608,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.52594,0.0098922,0.064383,0,0
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.87833,0.0098736,-0.016701,0,0
2,GO ADAPTATION OF SIGNALING PATHWAY,0.70355,0.0098523,-0.025832,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.74288,0.0098396,0.009699,0,0
2,GO CELL CYCLE CHECKPOINT,0.22235,0.0098329,0.055913,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.66501,0.0096986,0.050184,0,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.40349,0.009694,0.077622,0,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.82348,0.0096727,-0.012382,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.39858,0.0096105,0.028944,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.77618,0.0095893,0.035763,0,0
2,GO CELL DIVISION,0.36526,0.0095324,0.045682,0,0
2,GO GLAND DEVELOPMENT,0.92682,0.0095112,0.018506,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.85768,0.0094649,0.0017085,0,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.33812,0.0094588,0.058016,0,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.91987,0.009406,-0.010454,0,0
2,GO CHROMOSOME SEGREGATION,0.39371,0.0092842,0.038284,0,0
2,GO HEAT GENERATION,0.68418,0.0092815,0.022541,0,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.69707,0.00926,0.07722,0,0
2,GO OSTEOCLAST DEVELOPMENT,0.73628,0.0092581,-0.053737,0,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.72313,0.0091907,-0.019616,0,0
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.89215,0.0091848,-0.006986,0,0
2,GO MAGNESIUM ION TRANSPORT,0.63978,0.00906,-0.067355,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.59059,0.0089028,0.053729,0,0
2,GO POSITIVE REGULATION OF NEURON DEATH,0.91293,0.0088526,0.0067403,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.75615,0.0088429,-0.0090987,0,0
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.4978,0.00876,0.040308,0,0
2,GO REGULATION OF TISSUE REMODELING,0.80989,0.0086779,0.0023625,0,0
2,GO MITOCHONDRIAL FISSION,0.36991,0.008547,-0.059483,0,0
2,GO EXECUTION PHASE OF APOPTOSIS,0.79636,0.0084836,-0.013987,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.88523,0.0084633,0.0050016,0,0
2,GO ENDOSOMAL TRANSPORT,0.59059,0.0082531,0.02519,0,0
2,GO PROTEIN OXIDATION,0.69707,0.0082262,0.051567,0,0
2,GO WATER TRANSPORT,0.95466,0.0077279,-0.028291,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.77618,0.0077134,0.023652,0,0
2,GO INOSITOL METABOLIC PROCESS,0.80989,0.0077052,-0.022306,0,0
2,GO CELL CYCLE DNA REPLICATION,0.5726,0.0075946,0.034854,0,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.53742,0.0075504,0.039163,0,0
2,GO NUCLEUS ORGANIZATION,0.5726,0.0074728,0.011678,0,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.4598,0.0074041,0.034769,0,0
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.74288,0.0073751,0.021727,0,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.75615,0.0072565,0.010879,0,0
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.71658,0.0071937,-0.030661,0,0
2,GO REGULATION OF AXON GUIDANCE,0.76948,0.0071827,-0.053506,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.79636,0.0071708,0.015467,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.52594,0.0071061,0.0050166,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.90599,0.0069861,-0.004411,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.85082,0.0069724,0.0062615,0,0
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.68418,0.0069102,-0.031353,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.84397,0.0067318,-0.0030574,0,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.92682,0.0067243,0.0044902,0,0
2,GO CYTOSKELETON ORGANIZATION,0.63978,0.0066741,0.014277,0,0
2,GO PROTEIN ACETYLATION,0.52594,0.006589,0.024734,0,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.76948,0.0064927,0.034092,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.89215,0.0064517,-0.015807,0,0
2,GO OVULATION CYCLE PROCESS,0.80989,0.0063019,-0.021438,0,0
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.56075,0.0061494,0.024294,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.66501,0.006082,0.031611,0,0
2,GO NEGATIVE REGULATION OF ANOIKIS,0.89907,0.006076,-0.032917,0,0
2,GO BONE RESORPTION,0.85768,0.0060643,-0.010131,0,0
2,GO SODIUM ION HOMEOSTASIS,0.94769,0.0057869,-0.015416,0,0
2,GO KETONE CATABOLIC PROCESS,0.84397,0.005628,0.022782,0,0
2,GO PH REDUCTION,0.93377,0.005601,-0.0081931,0,0
2,GO PROTEIN DENEDDYLATION,0.78962,0.0055024,0.0072892,0,0
2,GO WALKING BEHAVIOR,0.4598,0.0054161,-0.054516,0,0
2,GO DEPHOSPHORYLATION,0.87833,0.0053724,-0.0066831,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.71006,0.0053297,-0.030461,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.91987,0.0051927,0.010535,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.82348,0.0051331,-0.0021245,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.77618,0.0051145,0.0090304,0,0
2,GO HISTONE EXCHANGE,0.83713,0.0049908,0.012825,0,0
2,GO REGULATION OF CELLULAR PH,0.90599,0.0049615,-0.017841,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.95466,0.0049114,-0.0043188,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.76281,0.0049073,0.034467,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.84397,0.0048482,-0.028904,0,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.5726,0.004383,0.017424,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.94073,0.0043415,0.0062301,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.8303,0.0042569,-0.024802,0,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.61497,0.0042378,-0.08825,0,0
2,GO IRON ION TRANSPORT,0.78962,0.0041465,0.0021447,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.91293,0.0041299,0.0027496,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.33373,0.00398,0.10037,0,0
2,GO PEPTIDYL THREONINE MODIFICATION,0.52594,0.0037629,0.028498,0,0
2,GO CELLULAR HOMEOSTASIS,0.74288,0.0037499,0.0051812,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.87833,0.0037383,-0.024991,0,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.84397,0.0037307,0.052826,0,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.78289,0.0031905,-0.013152,0,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.58456,0.003086,0.053702,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.97557,0.0029426,-0.0051277,0,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.56075,0.0027484,0.036652,0,0
2,GO REGULATION OF MUSCLE ADAPTATION,0.63978,0.0024382,-0.031982,0,0
2,GO REPRODUCTION,0.72313,0.0021527,-0.013962,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.94073,0.0019425,-0.0018992,0,0
2,GO SENSORY PERCEPTION,0.65234,0.0018956,-0.016888,0,0
2,GO MATING,0.36526,0.0018918,-0.054081,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.82348,0.0018274,0.0095585,0,0
2,GO VIRAL BUDDING,0.97557,0.0016543,0.016957,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.30815,0.0016021,0.062639,0,0
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.99651,0.001597,0.0014926,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.87833,0.0015336,0.0040787,0,0
2,GO REGULATION OF PROTEIN DEACETYLATION,0.56075,0.0014938,-0.038684,0,0
2,GO VESICLE ORGANIZATION,0.68418,0.0013084,0.0062369,0,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.98953,0.0011613,0.0043153,0,0
2,GO PROSTAGLANDIN TRANSPORT,0.82348,0.00116,-0.0097459,0,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.89215,0.0011231,0.042199,0,0
2,GO EAR DEVELOPMENT,0.77618,0.0010406,0.013661,0,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.99651,0.00086165,-0.0038053,0,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.74288,0.00077932,-0.027932,0,0
2,GO GLIAL CELL PROLIFERATION,0.52594,0.00075536,0.036686,0,0
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1,0.00058687,0.001803,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.93377,0.00056386,0.10696,0,0
2,GO REGULATION OF PH,0.76281,0.00039771,-0.030528,0,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.90599,0.00036424,0.021547,0,0
2,GO T HELPER CELL LINEAGE COMMITMENT,0.52025,0.00033945,0.066979,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.67776,0.0003183,0.045074,0,0
2,GO EMBRYONIC MORPHOGENESIS,0.75615,0.00026735,0.03115,0,0
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.82348,0.00025621,-0.0098244,0,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.49227,0.00018928,0.040537,0,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.79636,0.00014742,0.017455,0,0
2,GO TAXIS,0.72313,6.2914e-05,-0.024804,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.95466,1.8455e-05,0.0122,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.87833,-0.00012537,0.0068972,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.70355,-0.00016878,-0.037091,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.37932,-0.00029308,0.052587,0,0
2,GO CARTILAGE DEVELOPMENT,0.9686,-0.00029828,0.0093014,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.98953,-0.00039405,0.021472,0,0
2,GO RESPONSE TO ACID CHEMICAL,0.76281,-0.00056072,0.0034267,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.72313,-0.00059637,-0.050412,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.43367,-0.00059704,-0.040982,0,0
2,GO REGULATION OF CHEMOTAXIS,0.88523,-0.00068344,-0.0020245,0,0
2,GO IMMUNOGLOBULIN SECRETION,0.8303,-0.00077609,-0.052762,0,0
2,GO POSITIVE REGULATION OF BINDING,0.91987,-0.00089924,0.0026498,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.72313,-0.00097177,-0.018705,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.56666,-0.0010306,-0.057381,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.87833,-0.0010726,0.0030977,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.8303,-0.0010925,0.00047146,0,0
2,GO FORELIMB MORPHOGENESIS,0.87833,-0.0011968,-0.031024,0,0
2,GO GLAND MORPHOGENESIS,0.36991,-0.0012119,0.11897,0,0
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.89907,-0.0013098,-0.0018572,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.38888,-0.0013866,0.022974,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.69707,-0.0014435,0.064384,0,0
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.94073,-0.0014555,-0.014599,0,0
2,GO ION HOMEOSTASIS,0.94769,-0.0014913,-0.0059473,0,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.97557,-0.0015183,-0.0027313,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.88523,-0.001591,0.0283,0,0
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.87833,-0.0016381,0.0038563,0,0
2,GO TOR SIGNALING,0.51459,-0.0016716,-0.021523,0,0
2,GO STRIATED MUSCLE CONTRACTION,0.76281,-0.0016826,-0.013681,0,0
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.57857,-0.0017304,0.037301,0,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.98255,-0.0020826,0.0044694,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.91293,-0.0021085,-0.023585,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.79636,-0.0021736,0.036788,0,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.54321,-0.0021904,0.033113,0,0
2,GO AMINE METABOLIC PROCESS,0.67137,-0.0022021,0.020501,0,0
2,GO REGULATION OF BIOMINERALIZATION,0.65866,-0.0022196,0.022488,0,0
2,GO CELL CELL SIGNALING BY WNT,0.91293,-0.0022395,0.018842,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.98255,-0.0024613,-0.0048535,0,0
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.67137,-0.0024702,0.080555,0,0
2,GO ADAPTIVE THERMOGENESIS,0.54903,-0.0024934,-0.03146,0,0
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.25729,-0.0025068,0.04698,0,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.32506,-0.0026135,-0.035664,0,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.69707,-0.0027167,0.016843,0,0
2,GO POSITIVE REGULATION OF JNK CASCADE,0.72313,-0.0027333,0.018203,0,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.96163,-0.0027628,0.007237,0,0
2,GO RRNA CATABOLIC PROCESS,0.94073,-0.0027738,-0.021793,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.59664,-0.0028348,-0.02644,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.94073,-0.0028998,-0.0017574,0,0
2,GO AMYLOID BETA FORMATION,0.51459,-0.0029539,0.035364,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.97557,-0.002971,-0.00084455,0,0
2,GO BIOMINERALIZATION,0.80989,-0.0029999,-0.014685,0,0
2,GO WATER HOMEOSTASIS,0.73628,-0.0031569,-0.029147,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.80312,-0.0032039,0.02597,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.67137,-0.0032594,-0.028665,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.60272,-0.0033201,0.048687,0,0
2,GO ENSHEATHMENT OF NEURONS,0.73628,-0.0033464,-0.026519,0,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.33812,-0.0033693,-0.058144,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.53167,-0.0035456,0.052798,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.92682,-0.0037123,0.00080376,0,0
2,GO RESPONSE TO GLUCAGON,0.59664,-0.0037547,-0.027582,0,0
2,GO VASODILATION,0.75615,-0.0038696,-0.062143,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.65866,-0.0039272,-0.041717,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.85768,-0.0039392,-0.014985,0,0
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.71006,-0.0039408,0.040754,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.79636,-0.0039936,0.013037,0,0
2,GO MANNOSYLATION,0.88523,-0.0042661,0.0064654,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.8303,-0.0043896,0.0090485,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.96163,-0.0044958,-0.048995,0,0
2,GO CELL CYCLE ARREST,0.44924,-0.0046931,0.029086,0,0
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.72313,-0.0048028,-0.033319,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.71658,-0.0048601,0.01158,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.52025,-0.0048895,-0.058711,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.46512,-0.0051292,0.088929,0,0
2,GO OXALATE TRANSPORT,0.76281,-0.0052229,-0.018883,0,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.83713,-0.0052623,-0.016513,0,0
2,GO ONE CARBON METABOLIC PROCESS,0.89907,-0.0054368,0.0028789,0,0
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.85082,-0.0054609,0.016751,0,0
2,GO GROWTH,0.5726,-0.0055105,-0.016685,0,0
2,GO SPINDLE LOCALIZATION,0.98255,-0.0055741,-0.0070161,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.91293,-0.0058966,0.015035,0,0
2,GO SECONDARY METABOLIC PROCESS,0.74288,-0.0059259,-2.0443e-05,0,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.76948,-0.0059273,-0.0076739,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.71658,-0.0060155,0.046057,0,0
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.33812,-0.0060251,-0.068516,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.88523,-0.0060664,-0.0074116,0,0
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.59059,-0.0061222,0.034564,0,0
2,GO OVULATION CYCLE,0.85082,-0.0061384,-0.02061,0,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.58456,-0.0065534,-0.07631,0,0
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.44402,-0.0065608,-0.026814,0,0
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.38408,-0.0065622,0.087586,0,0
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.84397,-0.0065923,0.016348,0,0
2,GO LEUKOCYTE TETHERING OR ROLLING,0.87833,-0.0067291,-0.010366,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.88523,-0.0068799,0.010563,0,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.89907,-0.006896,0.0053878,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.58456,-0.0070655,0.040279,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.89907,-0.0070769,0.0079739,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.98953,-0.0071707,-0.0013146,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.81668,-0.0071842,-0.012407,0,0
2,GO LACTATE METABOLIC PROCESS,0.63354,-0.0072825,0.037983,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.63978,-0.0073265,-0.036832,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.5726,-0.007482,-0.029554,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.27999,-0.0076264,-0.11404,0,0
2,GO BROWN FAT CELL DIFFERENTIATION,0.92682,-0.0076962,-0.01278,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.87144,-0.0077009,-0.011609,0,0
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.53167,-0.0078082,0.051855,0,0
2,GO NOTCH SIGNALING PATHWAY,0.38408,-0.0078258,-0.046534,0,0
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76948,-0.0078298,0.010051,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.96163,-0.0078352,-0.00023404,0,0
2,GO BONE TRABECULA FORMATION,0.57857,-0.0080774,0.09708,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.98255,-0.0081972,0.028712,0,0
2,GO MEMBRANE FUSION,0.42855,-0.0085795,-0.041218,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.78289,-0.0086888,-0.005884,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.91987,-0.008701,0.0071416,0,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.71658,-0.0088635,-0.026352,0,0
2,GO AXIS SPECIFICATION,0.98953,-0.009185,1.2987e-05,0,0
2,GO CELLULAR RESPONSE TO CAMP,0.77618,-0.0093159,-0.017755,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.43367,-0.0093751,-0.11005,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.98255,-0.0093771,0.009943,0,0
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.84397,-0.0094787,0.0093582,0,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.42855,-0.0095387,-0.054569,0,0
2,GO POSITIVE REGULATION OF RNA SPLICING,0.69707,-0.0095574,-0.035775,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.42855,-0.0098818,0.054415,0,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.96163,-0.0099162,-0.0044856,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.79636,-0.010054,-0.019376,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.89907,-0.010102,-0.03043,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.89907,-0.010147,-0.0043319,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.59664,-0.010295,-0.021603,0,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.84397,-0.010349,0.0039356,0,0
2,GO VACUOLAR TRANSPORT,0.88523,-0.010383,0.0044945,0,0
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.81668,-0.010426,0.036238,0,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.91293,-0.010513,-0.017921,0,0
2,GO RESPONSE TO MONOSACCHARIDE,0.58456,-0.01057,-0.024469,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.97557,-0.010601,0.0074659,0,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.70355,-0.010632,-0.040248,0,0
2,GO DNA REPLICATION,0.7495,-0.010667,0.040908,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.91293,-0.010719,-0.0032229,0,0
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.27611,-0.010776,-0.048037,0,0
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.70355,-0.010863,0.017354,0,0
2,GO SOMITOGENESIS,0.98953,-0.010913,0.0086586,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.69061,-0.010932,-0.030905,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.36064,-0.010969,-0.034786,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.80312,-0.011023,-0.015826,0,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.56666,-0.011113,-0.027263,0,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.87144,-0.011281,-0.0051471,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.60883,-0.011285,-0.031787,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.88523,-0.011296,0.0051333,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.59059,-0.011298,-0.033658,0,0
2,GO CELLULAR ION HOMEOSTASIS,0.89907,-0.011358,-0.0093428,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.8303,-0.011383,-0.022394,0,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.91987,-0.011455,0.015282,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.75615,-0.011487,-0.024704,0,0
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.94769,-0.011568,-0.006151,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.65234,-0.011633,0.026623,0,0
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.73628,-0.011654,-0.014688,0,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.47049,-0.011714,-0.036674,0,0
2,GO DNA DEALKYLATION,0.64605,-0.011793,0.032167,0,0
2,GO EXCRETION,0.82348,-0.011851,0.008984,0,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.96163,-0.011859,0.00021095,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.84397,-0.01189,0.008715,0,0
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.54903,-0.011947,-0.050972,0,0
2,GO MUSCLE CELL DIFFERENTIATION,0.96163,-0.012099,0.010214,0,0
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.76948,-0.012111,-0.017649,0,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.96163,-0.012247,0.020975,0,0
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.77618,-0.012366,0.021347,0,0
2,GO REGULATION OF BONE REMODELING,0.82348,-0.012425,-0.042416,0,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.78962,-0.012555,-0.023784,0,0
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.72313,-0.012921,-0.016024,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.76948,-0.012923,-0.02426,0,0
2,GO HISTONE H3 K9 DEMETHYLATION,0.65234,-0.013032,-0.025508,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.59059,-0.013042,-0.049284,0,0
2,GO REGULATION OF RECEPTOR BINDING,0.87833,-0.013235,0.028008,0,0
2,GO MIDBODY ABSCISSION,0.9686,-0.013379,0.036093,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.89215,-0.01347,0.014831,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.95466,-0.013559,0.0061666,0,0
2,GO CELL JUNCTION ASSEMBLY,0.70355,-0.013663,-0.016974,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.39371,-0.013666,-0.03591,0,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.58456,-0.013689,-0.026542,0,0
2,GO METAL ION HOMEOSTASIS,0.86455,-0.013714,-0.0040677,0,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.9686,-0.013829,0.028536,0,0
2,GO RESPONSE TO LEUCINE,0.63978,-0.013848,-0.057766,0,0
2,GO REGULATION OF ODONTOGENESIS,0.94769,-0.013859,-0.021025,0,0
2,GO ORGANELLE FISSION,0.80989,-0.013953,0.00059308,0,0
2,GO ASTROCYTE DIFFERENTIATION,0.98255,-0.014185,0.002911,0,0
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.78962,-0.014215,0.011186,0,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.59059,-0.014293,-0.069135,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.98953,-0.014308,0.091397,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.44402,-0.014545,0.16305,0,0
2,GO OOGENESIS,0.63978,-0.01462,-0.036198,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.98953,-0.014844,0.00022346,0,0
2,GO METAPHASE PLATE CONGRESSION,0.7495,-0.0149,0.029571,0,0
2,GO CENTROSOME DUPLICATION,0.52025,-0.015034,-0.0093029,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.78962,-0.015331,-0.030094,0,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.87833,-0.015427,-0.043867,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.86455,-0.015443,0.015143,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.67776,-0.015606,0.0016209,0,0
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.82348,-0.015717,-0.0019405,0,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.36064,-0.015822,-0.028301,0,0
2,GO RESPONSE TO STARVATION,0.76948,-0.015825,-0.021181,0,0
2,GO FUCOSE METABOLIC PROCESS,0.4978,-0.015903,0.046013,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.86455,-0.015928,-0.0080455,0,0
2,GO TEMPERATURE HOMEOSTASIS,0.51459,-0.015996,-0.03295,0,0
2,GO VESICLE LOCALIZATION,0.83713,-0.016024,-0.018983,0,0
2,GO MULTI ORGANISM PROCESS,0.43367,-0.016092,-0.027922,0,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.20309,-0.016125,-0.055509,0,0
2,GO AMELOGENESIS,0.17099,-0.016261,0.16302,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.67137,-0.016512,9.9475e-05,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.5726,-0.016694,-0.015029,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.68418,-0.017019,-0.010342,0,0
2,GO INTEGRIN ACTIVATION,0.87833,-0.017089,-0.0030735,0,0
2,GO ORGANELLE FUSION,0.62732,-0.017171,-0.026173,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.63354,-0.017183,0.03977,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.98953,-0.017205,-0.019084,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.85768,-0.017257,-0.0096711,0,0
2,GO T CELL SELECTION,0.87144,-0.017361,0.0047008,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.98953,-0.017592,0.020635,0,0
2,GO CIRCULATORY SYSTEM PROCESS,0.26847,-0.017631,-0.047189,0,0
2,GO APICAL PROTEIN LOCALIZATION,0.4545,-0.017693,-0.12573,0,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.89215,-0.017717,0.0047196,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.72313,-0.017801,-0.051456,0,0
2,GO LYSOSOME LOCALIZATION,0.97557,-0.018245,-0.0037694,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.75615,-0.018273,-0.014383,0,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.36526,-0.018484,-0.047006,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.64605,-0.018594,0.024563,0,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.76281,-0.01881,-0.098425,0,0
2,GO HEART GROWTH,1,-0.01894,0.01549,0,0
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.76281,-0.019128,-0.018297,0,0
2,GO MICROTUBULE ANCHORING,0.47588,-0.019147,-0.035487,0,0
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,1,-0.019162,0.032099,0,0
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1,-0.019299,-0.00031802,0,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.65866,-0.019308,0.056119,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.71658,-0.01932,-0.012586,0,0
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.5726,-0.01936,-0.042953,0,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.17653,-0.019374,-0.084506,0,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.85082,-0.019467,-0.023315,0,0
2,GO TISSUE MORPHOGENESIS,0.71658,-0.019739,0.03387,0,0
2,GO OSSIFICATION,0.66501,-0.019761,-0.015105,0,0
2,GO SHORT TERM MEMORY,0.77618,-0.019992,0.020355,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.77618,-0.020032,-0.0093307,0,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.42347,-0.020034,-0.0493,0,0
2,GO REGULATION OF TRANSPORT,0.21579,-0.020034,-0.044335,0,0
2,GO RESPONSE TO FOOD,0.18219,-0.020137,-0.065747,0,0
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.60272,-0.020255,0.032877,0,0
2,GO HEART DEVELOPMENT,0.96163,-0.020326,0.011576,0,0
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.74288,-0.020533,-0.025706,0,0
2,GO REGULATION OF CELL DIVISION,0.81668,-0.020543,0.0028317,0,0
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.88523,-0.020632,0.0080921,0,0
2,GO SOMITE DEVELOPMENT,0.24643,-0.021163,-0.03564,0,0
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.63354,-0.021189,-0.044895,0,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.16294,-0.021193,-0.060615,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.39858,-0.021416,-0.070684,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.69707,-0.021563,0.038531,0,0
2,GO HISTONE H3 K36 METHYLATION,0.76281,-0.021667,0.041624,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.50337,-0.021679,0.069387,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.85768,-0.021683,-0.0040034,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.85082,-0.021896,0.030312,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.95466,-0.022045,-0.014615,0,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.89907,-0.0221,0.012742,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.80312,-0.022194,-0.014232,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.26098,-0.022207,-0.071443,0,0
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.56666,-0.022296,0.00097749,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.4545,-0.022392,-0.025868,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.49227,-0.022409,-0.049302,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.71658,-0.022526,-0.061517,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.40843,-0.022631,-0.031686,0,0
2,GO KINETOCHORE ASSEMBLY,0.63354,-0.022648,-0.024484,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.9686,-0.022757,0.012039,0,0
2,GO REGULATION OF BINDING,0.62113,-0.022959,-0.014841,0,0
2,GO DETECTION OF STIMULUS,0.55487,-0.0231,-0.016357,0,0
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.80312,-0.023271,-0.016593,0,0
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.34702,-0.023286,-0.046481,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.42855,-0.023339,-0.046163,0,0
2,GO MITOPHAGY,0.86455,-0.023514,-0.0090201,0,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.94073,-0.02364,-0.014966,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.37932,-0.0239,-0.0738,0,0
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.66501,-0.023993,-0.085396,0,0
2,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.81668,-0.024007,0.006539,0,0
2,GO GAMETE GENERATION,0.28785,-0.024278,-0.037436,0,0
2,GO SEXUAL REPRODUCTION,0.26847,-0.024443,-0.03858,0,0
2,GO PROTEIN FOLDING,0.94073,-0.024472,0.0025148,0,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.93377,-0.024573,-0.020054,0,0
2,GO GLIAL CELL MIGRATION,0.76948,-0.024752,-0.025941,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.91987,-0.025332,0.013851,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.52594,-0.025364,-0.025083,0,0
2,GO CELL VOLUME HOMEOSTASIS,0.8303,-0.02539,-0.0075711,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.84397,-0.025424,0.016235,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.97557,-0.025741,-0.016785,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.92682,-0.02576,0.01655,0,0
2,GO PEPTIDYL SERINE MODIFICATION,0.41842,-0.025802,-0.020666,0,0
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.46512,-0.026013,-0.026384,0,0
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.59664,-0.026051,-0.048228,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.72969,-0.026141,-0.013437,0,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.87833,-0.02615,0.0052452,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.74288,-0.026299,-0.0089633,0,0
2,GO CALCIUM MEDIATED SIGNALING,0.33812,-0.026483,-0.037923,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.39371,-0.026505,-0.056251,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.71658,-0.026529,-0.0034536,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.36526,-0.026618,0.049572,0,0
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.62113,-0.026708,0.056237,0,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.9686,-0.026846,0.0022645,0,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.38888,-0.026921,-0.033704,0,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.91987,-0.026986,-0.0020084,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.95466,-0.026993,0.0027768,0,0
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.36526,-0.027009,-0.15265,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.91987,-0.027315,0.01477,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.72969,-0.027356,-0.013964,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.58456,-0.027524,-0.00014057,0,0
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.95466,-0.027679,0.010391,0,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.31232,-0.027695,-0.045453,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.42855,-0.027783,-0.02595,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.76948,-0.027953,-0.02756,0,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.53167,-0.028121,-0.089281,0,0
2,GO ORGANIC ANION TRANSPORT,0.87144,-0.028141,-0.0037958,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.85082,-0.028252,0.017435,0,0
2,GO HISTONE H3 K9 METHYLATION,0.85082,-0.028265,0.0062881,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.58456,-0.028513,-0.020902,0,0
2,GO SNORNA METABOLIC PROCESS,0.86455,-0.02859,-0.015164,0,0
2,GO GLUCOSE IMPORT,0.13814,-0.02869,-0.070984,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.32938,-0.0287,0.099575,0,0
2,GO MIDBRAIN DEVELOPMENT,0.92682,-0.028785,0.046084,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.36991,-0.028859,-0.038214,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.41341,-0.028914,-0.050075,0,0
2,GO REGULATION OF CELL SIZE,0.14048,-0.02905,-0.07173,0,0
2,GO HEART TRABECULA FORMATION,0.56075,-0.029148,-0.070081,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.24643,-0.029197,0.043572,0,0
2,GO OOCYTE MATURATION,0.54321,-0.029201,-0.049253,0,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.26098,-0.029376,-0.053581,0,0
2,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.58456,-0.029458,-0.020593,0,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.50896,-0.029691,-0.07775,0,0
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.4978,-0.029884,0.13171,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.38408,-0.029942,-0.026644,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.63978,-0.029948,-0.010646,0,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.53742,-0.030015,-0.0065412,0,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.65234,-0.030076,-0.024977,0,0
2,GO MALE GAMETE GENERATION,0.26847,-0.030132,-0.039988,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.22905,-0.030148,-0.14243,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.64605,-0.03028,-0.011078,0,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.62113,-0.030451,-0.024901,0,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.15773,-0.030462,-0.064731,0,0
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.74288,-0.030539,-0.0412,0,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.87833,-0.030543,-0.0088713,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.61497,-0.030586,-0.013107,0,0
2,GO AORTIC VALVE DEVELOPMENT,0.95466,-0.030716,0.032102,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.23245,-0.030805,-0.027262,0,0
2,GO INORGANIC ANION TRANSPORT,0.35153,-0.030947,-0.031482,0,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.2839,-0.031143,-0.063615,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.95466,-0.031616,-0.01396,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.46512,-0.031751,-0.047314,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.69707,-0.032064,-0.027486,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.7495,-0.032305,-0.045568,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.52594,-0.032955,-0.10194,0,0
2,GO ANION TRANSPORT,0.66501,-0.033115,-0.01571,0,0
2,GO RENAL WATER HOMEOSTASIS,0.4978,-0.03376,-0.038089,0,0
2,GO ACID SECRETION,0.63978,-0.033773,-0.014139,0,0
2,GO AORTA DEVELOPMENT,0.62732,-0.033787,-0.0197,0,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.27999,-0.033875,-0.052183,0,0
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.26098,-0.033978,-0.040893,0,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.61497,-0.03421,-0.028086,0,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.2839,-0.034363,-0.069568,0,0
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.10845,-0.034452,-0.076053,0,0
2,GO ENDOCYTIC RECYCLING,0.53742,-0.034465,-0.025211,0,0
2,GO REGULATION OF PROTEIN TARGETING,0.87144,-0.034617,-0.0012699,0,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.76281,-0.034838,0.058907,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.80989,-0.035077,0.0064644,0,0
2,GO VASCULAR WOUND HEALING,0.68418,-0.03512,-0.047522,0,0
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.35607,-0.035191,-0.068666,0,0
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.85768,-0.035198,-0.12188,0,0
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.86455,-0.035362,-0.011997,0,0
2,GO REGULATION OF GROWTH,0.29184,-0.035374,-0.034842,0,0
2,GO FUCOSYLATION,1,-0.035418,-0.0056255,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.9686,-0.035452,0.034349,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.23937,-0.035528,-0.055804,0,0
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.81668,-0.035558,-0.00021331,0,0
2,GO RESPONSE TO PAIN,0.51459,-0.035642,-0.072615,0,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.69061,-0.035756,0.032522,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.36064,-0.035853,-0.077823,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.38408,-0.035927,-0.11027,0,0
2,GO RESPONSE TO PROSTAGLANDIN E,0.90599,-0.035976,0.013261,0,0
2,GO CYTOKINESIS,0.60883,-0.036034,-0.010199,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.41842,-0.03607,-0.041351,0,0
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.5726,-0.036082,-0.022996,0,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.46512,-0.036477,-0.026513,0,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.27227,-0.036518,-0.059104,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.79636,-0.036618,0.093057,0,0
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.33373,-0.036764,-0.08679,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.54321,-0.036963,-0.047315,0,0
2,GO CELL JUNCTION ORGANIZATION,0.17934,-0.037074,-0.062279,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.30402,-0.037264,-0.062774,0,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.46512,-0.037369,-0.091547,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.98953,-0.037387,0.01358,0,0
2,GO CELL PROJECTION ASSEMBLY,0.33373,-0.037516,-0.022587,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.62113,-0.037564,-0.014106,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.78289,-0.037755,0.032919,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.61497,-0.037975,-0.032724,0,0
2,GO REGULATION OF PINOCYTOSIS,0.63354,-0.038108,0.044776,0,0
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.3746,-0.038253,-0.046474,0,0
2,GO PROTEIN METHYLATION,0.27611,-0.038343,-0.0080718,0,0
2,GO DEVELOPMENTAL GROWTH,0.30402,-0.038458,-0.033293,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.59664,-0.038478,-0.053823,0,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.13583,-0.038544,-0.04613,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.8303,-0.038612,0.0083334,0,0
2,GO REGULATION OF CYTOKINESIS,0.53742,-0.038623,-0.020439,0,0
2,GO PHOSPHATE ION TRANSPORT,0.31232,-0.03872,-0.047115,0,0
2,GO POSITIVE T CELL SELECTION,0.7495,-0.038726,-9.7204e-06,0,0
2,GO VASCULAR TRANSPORT,0.92682,-0.038771,-0.010297,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.31653,-0.038901,-0.063993,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.73628,-0.039334,-0.011981,0,0
2,GO POSITIVE REGULATION OF GROWTH,0.052669,-0.039828,-0.060784,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.47049,-0.039905,-0.042693,0,0
2,GO MULTICELLULAR ORGANISM AGING,0.087232,-0.040181,-0.060754,0,0
2,GO REGULATION OF EXCRETION,0.72313,-0.040283,0.06041,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.9686,-0.040353,0.014672,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.22568,-0.040423,-0.084093,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.93377,-0.040449,-0.0032401,0,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.71658,-0.040471,-0.013124,0,0
2,GO HISTONE METHYLATION,0.48131,-0.040562,-0.0028625,0,0
2,GO MEIOTIC CELL CYCLE,0.095625,-0.040567,-0.041578,0,0
2,GO ZINC ION TRANSPORT,0.76281,-0.04059,0.019141,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.40843,-0.040909,-0.064698,0,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.11235,-0.041019,-0.053328,0,0
2,GO DNA CATABOLIC PROCESS,0.39858,-0.041351,-0.035638,0,0
2,GO LIPOPROTEIN METABOLIC PROCESS,0.47588,-0.041353,-0.040267,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.59059,-0.041376,-0.052631,0,0
2,GO CHROMOSOME LOCALIZATION,0.38408,-0.041405,-0.015596,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.44924,-0.041419,-0.044605,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.66501,-0.041442,-0.064975,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.94769,-0.041505,-0.0027582,0,0
2,GO REGULATION OF TUBE SIZE,0.13355,-0.041671,-0.07919,0,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.8303,-0.041691,-0.0098863,0,0
2,GO PROSTAGLANDIN SECRETION,0.91293,-0.041734,0.0039218,0,0
2,GO REGULATION OF GONAD DEVELOPMENT,0.93377,-0.042096,-0.037719,0,0
2,GO CENTROSOME SEPARATION,0.54903,-0.042115,-0.016338,0,0
2,GO RESPONSE TO INTERLEUKIN 6,0.23245,-0.042278,-0.078595,0,0
2,GO REGULATION OF OSSIFICATION,0.94073,-0.042528,0.024121,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.72969,-0.042759,-0.032082,0,0
2,GO RETINOIC ACID METABOLIC PROCESS,0.43367,-0.042777,-0.065802,0,0
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.52594,-0.042794,0.034217,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.48678,-0.042899,-0.041009,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.18508,-0.042901,-0.03755,0,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.23245,-0.043006,-0.074609,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.85768,-0.043017,0.02078,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.44924,-0.043113,-0.039185,0,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.21905,-0.043124,-0.038631,0,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.21579,-0.043126,-0.066544,0,0
2,GO REGULATION OF CELL FATE COMMITMENT,0.91293,-0.043553,0.061676,0,0
2,GO MESODERMAL CELL FATE SPECIFICATION,0.44402,-0.04377,-0.062866,0,0
2,GO ASTROCYTE ACTIVATION,0.63978,-0.043899,-0.030368,0,0
2,GO VITAMIN TRANSPORT,0.64605,-0.043911,-0.008399,0,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.9686,-0.043957,0.037473,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.89215,-0.044064,0.031097,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.079444,-0.044238,-0.048435,0,0
2,GO T CELL EXTRAVASATION,0.64605,-0.044242,-0.075127,0,0
2,GO NUCLEOTIDE TRANSPORT,0.21256,-0.044327,-0.076097,0,0
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.43883,-0.044329,-0.011793,0,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.40843,-0.044442,-0.066447,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.36526,-0.044455,-0.019908,0,0
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.22568,-0.044473,-0.043817,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.31232,-0.044665,-0.10835,0,0
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.51459,-0.044861,-0.073885,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.21579,-0.044977,-0.036125,0,0
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.69707,-0.045278,0.064034,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.4545,-0.045397,-0.020003,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.48131,-0.045435,-0.095853,0,0
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.33373,-0.045543,-0.043934,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.72969,-0.0456,-0.051668,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.25729,-0.045638,-0.049157,0,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.42855,-0.045924,-0.055066,0,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.22235,-0.045987,-0.065267,0,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.80989,-0.046029,0.035084,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.78289,-0.046144,0.015188,0,0
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.85768,-0.046435,-0.019542,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.35607,-0.046786,-0.038609,0,0
2,GO SULFATION,0.5726,-0.046986,0.018196,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.25363,-0.047016,-0.043905,0,0
2,GO TRABECULA MORPHOGENESIS,0.95466,-0.047126,0.022908,0,0
2,GO DRUG METABOLIC PROCESS,0.78962,-0.047336,0.015121,0,0
2,GO NEUROINFLAMMATORY RESPONSE,0.59664,-0.047347,-0.029478,0,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.20621,-0.047515,-0.060449,0,0
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.31232,-0.047807,-0.14525,0,0
2,GO NEURON DEATH,0.042857,-0.048111,-0.063209,0,0
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.31653,-0.04812,-0.093822,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.74288,-0.048221,-0.031974,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.55487,-0.048293,-0.06501,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.38408,-0.048366,-0.019921,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.46512,-0.048599,-0.032635,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.23937,-0.048606,-0.046691,0,0
2,GO ORGANIC ACID TRANSPORT,0.4598,-0.04865,-0.017585,0,0
2,GO REGULATION OF GLUCOSE IMPORT,0.065563,-0.048836,-0.096684,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.72969,-0.048882,-0.020977,0,0
2,GO REGULATION OF VASCULOGENESIS,0.37932,-0.048933,-0.097995,0,0
2,GO ONE CARBON COMPOUND TRANSPORT,0.72313,-0.049393,0.046123,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.41341,-0.049428,-0.055265,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.98953,-0.049444,0.064661,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.72969,-0.049484,-0.0012847,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.47588,-0.04952,-0.049253,0,0
2,GO HISTONE H4 ACETYLATION,0.39371,-0.049613,-0.020019,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.26847,-0.049927,-0.069337,0,0
2,GO ORGANELLE LOCALIZATION,0.22568,-0.050186,-0.029873,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.51459,-0.050322,-0.043136,0,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.11434,-0.050329,-0.070378,0,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.014486,-0.050377,-0.07353,0,0
2,GO EYE MORPHOGENESIS,0.71658,-0.050436,-0.010371,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.60272,-0.050598,-0.043531,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.17099,-0.050746,-0.046507,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.39371,-0.050782,-0.088637,0,0
2,GO RHYTHMIC PROCESS,0.26471,-0.050802,-0.032595,0,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.15015,-0.050831,-0.1095,0,0
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.2,-0.051029,-0.14215,0,0
2,GO MICROTUBULE BASED PROCESS,0.022165,-0.051252,-0.064916,0,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.11434,-0.051253,-0.15515,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.99651,-0.051278,-0.0074236,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.22568,-0.051408,-0.03978,0,0
2,GO BONE CELL DEVELOPMENT,0.60883,-0.051431,-0.017881,0,0
2,GO NEURON APOPTOTIC PROCESS,0.090515,-0.051539,-0.054554,0,0
2,GO CARBOHYDRATE PHOSPHORYLATION,0.65234,-0.051598,-0.02741,0,0
2,GO HEART MORPHOGENESIS,0.82348,-0.051725,0.0082847,0,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.86455,-0.052147,-0.012337,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.71006,-0.052262,-0.029372,0,0
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.72313,-0.052279,-0.032658,0,0
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.25363,-0.052366,-0.068526,0,0
2,GO GENETIC IMPRINTING,0.47588,-0.052394,-0.042353,0,0
2,GO MESENCHYME DEVELOPMENT,0.68418,-0.052527,0.0084847,0,0
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.26098,-0.052602,-0.07102,0,0
2,GO CIRCADIAN RHYTHM,0.019283,-0.052637,-0.064605,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.063042,-0.052647,-0.18424,0,0
2,GO RESPONSE TO GROWTH FACTOR,0.67776,-0.052956,-0.000308,0,0
2,GO RESPONSE TO GROWTH HORMONE,0.84397,-0.05297,0.017507,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.19393,-0.05302,-0.067996,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.95466,-0.053109,0.064628,0,0
2,GO REGULATION OF MITOPHAGY,0.21256,-0.053177,-0.060991,0,0
2,GO RESPONSE TO REDOX STATE,0.98953,-0.053199,-0.017689,0,0
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.85768,-0.053201,0.067541,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.82348,-0.053277,-0.010364,0,0
2,GO ATP BIOSYNTHETIC PROCESS,0.56666,-0.053301,-0.052062,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.087232,-0.053536,-0.081352,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.22905,-0.054231,-0.084796,0,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.47049,-0.054518,-0.013404,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.53742,-0.05466,-0.016985,0,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.49227,-0.054766,-0.045024,0,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.12473,-0.054853,-0.14175,0,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.30815,-0.054965,-0.13053,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.32506,-0.05523,-0.077225,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.33373,-0.055265,-0.087901,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.82348,-0.055324,0.026021,0,0
2,GO INTERSTRAND CROSS LINK REPAIR,0.18508,-0.05535,-0.031325,0,0
2,GO HEART TRABECULA MORPHOGENESIS,0.49227,-0.055629,-0.028897,0,0
2,GO INTRACELLULAR STEROL TRANSPORT,0.85082,-0.055773,0.04983,0,0
2,GO RHYTHMIC BEHAVIOR,0.28785,-0.055791,-0.058893,0,0
2,GO DEFINITIVE HEMOPOIESIS,0.40349,-0.055891,-0.048092,0,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.095625,-0.05593,-0.050506,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.20937,-0.056098,-0.084387,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.41341,-0.056256,-0.004091,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.32938,-0.056319,-0.064915,0,0
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.87833,-0.056386,-0.04041,0,0
2,GO THYMIC T CELL SELECTION,0.35153,-0.056415,-0.034688,0,0
2,GO REGULATION OF BEHAVIOR,0.34256,-0.056445,-0.048972,0,0
2,GO PROTEIN TARGETING TO LYSOSOME,0.44924,-0.056445,-0.059471,0,0
2,GO MATERNAL PLACENTA DEVELOPMENT,0.98953,-0.056627,-0.0020032,0,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.54903,-0.056738,-0.014405,0,0
2,GO CELL JUNCTION DISASSEMBLY,0.72969,-0.056738,-0.026157,0,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.77618,-0.056997,0.039936,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.33373,-0.057029,-0.064355,0,0
2,GO AROMATIC AMINO ACID TRANSPORT,0.68418,-0.057132,-0.024346,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.99651,-0.057243,0.0056578,0,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.093897,-0.057306,-0.063062,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.26847,-0.057378,-0.025327,0,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.087232,-0.057401,-0.085223,0,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.11235,-0.057844,-0.058791,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.19095,-0.058063,-0.11712,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.31232,-0.058116,-0.083821,0,0
2,GO CARBOHYDRATE TRANSPORT,0.13583,-0.058121,-0.070379,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.89215,-0.058394,0.0092809,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.57857,-0.058668,0.00423,0,0
2,GO RESPONSE TO METAL ION,0.26847,-0.058676,-0.049653,0,0
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.20937,-0.058759,-0.067843,0,0
2,GO CELL FATE COMMITMENT,0.15773,-0.058795,-0.05904,0,0
2,GO REGULATION OF VASOCONSTRICTION,0.090515,-0.058893,-0.10655,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.81668,-0.05919,-0.00083678,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.32938,-0.059263,-0.073786,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.18508,-0.059266,-0.097543,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.59059,-0.059657,-0.041606,0,0
2,GO RESPONSE TO AMPHETAMINE,0.51459,-0.059932,-0.034617,0,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.99651,-0.060124,0.0029968,0,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.15517,-0.060165,-0.075885,0,0
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.69707,-0.060185,0.033631,0,0
2,GO RESPIRATORY SYSTEM PROCESS,0.32506,-0.06033,-0.068785,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.4978,-0.060357,-0.024197,0,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.50896,-0.060604,-0.033191,0,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.56075,-0.060615,-0.044859,0,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.25001,-0.060697,-0.055959,0,0
2,GO GLIOGENESIS,0.20937,-0.060827,-0.058978,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.13583,-0.060883,-0.097349,0,0
2,GO REGULATION OF RESPONSE TO FOOD,0.11235,-0.060924,-0.11574,0,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.049546,-0.061049,-0.088915,0,0
2,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.23245,-0.061064,-0.047249,0,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.073629,-0.06125,-0.013978,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.89215,-0.061412,0.055096,0,0
2,GO CHEMOSENSORY BEHAVIOR,0.12908,-0.061435,-0.10799,0,0
2,GO SEGMENT SPECIFICATION,0.36526,-0.061625,-0.091425,0,0
2,GO LYSOSOMAL TRANSPORT,0.7495,-0.061674,-0.014669,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.29184,-0.061806,-0.036513,0,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.76281,-0.061857,-0.045413,0,0
2,GO REGULATION OF HORMONE LEVELS,0.188,-0.061874,-0.060799,0,0
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.064293,-0.061962,-0.079133,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.89215,-0.062097,0.014146,0,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.37932,-0.062197,-0.025281,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.50896,-0.062227,-0.040126,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.16559,-0.062234,-0.059356,0,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,0.53167,-0.062237,-0.032079,0,0
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.4598,-0.062635,-0.023972,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.73628,-0.062895,0.064902,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.69707,-0.062914,-0.012719,0,0
2,GO SPERM MOTILITY,0.0071468,-0.063174,-0.12621,0,0
2,GO HISTONE H3 K27 METHYLATION,0.34256,-0.0632,-0.038491,0,0
2,GO SLEEP,0.69061,-0.063328,0.005272,0,0
2,GO REGULATION OF PEPTIDE SECRETION,0.13355,-0.063335,-0.067574,0,0
2,GO MEMBRANE REPOLARIZATION,0.1313,-0.063438,-0.10407,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.031748,-0.063511,-0.059013,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.60272,-0.063727,-0.019814,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.36991,-0.063827,-0.069585,0,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.60272,-0.063839,-0.05088,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,1,-0.063886,0.016312,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.29586,-0.063894,-0.040709,0,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.16294,-0.063912,-0.10677,0,0
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.75615,-0.063948,-0.02357,0,0
2,GO DEMETHYLATION,0.43367,-0.064005,-0.01497,0,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23589,-0.064231,-0.060601,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.2839,-0.064239,-0.10486,0,0
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.88523,-0.064419,-0.036031,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.81668,-0.064456,-0.016517,0,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.11434,-0.064583,-0.11656,0,0
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.2839,-0.064641,-0.045622,0,0
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.075049,-0.065407,-0.064969,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.62732,-0.065427,-0.0078982,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.1028,-0.065429,-0.055874,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.21579,-0.065554,-0.070829,0,0
2,GO CELL GROWTH,0.045624,-0.065897,-0.072663,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.29586,-0.066348,-0.040096,0,0
2,GO ION TRANSPORT,0.099158,-0.066432,-0.057574,0,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.015953,-0.066456,-0.10693,0,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.50337,-0.066576,-0.023972,0,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.13814,-0.066579,-0.094896,0,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.015203,-0.0666,-0.10497,0,0
2,GO SNORNA 3 END PROCESSING,0.48131,-0.0667,-0.061327,0,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.19095,-0.066803,-0.051865,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.58456,-0.066982,-0.029499,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.40349,-0.067076,-0.042411,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.11636,-0.067122,-0.059899,0,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.21579,-0.067209,-0.10196,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.25363,-0.067372,-0.086467,0,0
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.27227,-0.067376,-0.063143,0,0
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.037747,-0.067655,-0.11884,0,0
2,GO RESPONSE TO COLD,0.05824,-0.067722,-0.17604,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.97557,-0.068004,0.0038735,0,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.70355,-0.068197,0.0039817,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.33373,-0.068277,-0.032062,0,0
2,GO NEURON PROJECTION ORGANIZATION,0.0695,-0.06839,-0.10995,0,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.79636,-0.068403,0.0023372,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.29992,-0.068459,-0.03458,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.80989,-0.069164,-0.012833,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.24288,-0.069299,-0.046934,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.33812,-0.069373,-0.033491,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.7495,-0.069818,0.07963,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.55487,-0.070029,-0.039567,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.15015,-0.070104,-0.1102,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.024846,-0.070236,-0.067997,0,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.13355,-0.070246,-0.098535,0,0
2,GO STEROID HORMONE SECRETION,0.98953,-0.070397,-0.023594,0,0
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.19095,-0.070428,-0.071238,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.20621,-0.070565,-0.079939,0,0
2,GO HEART VALVE DEVELOPMENT,0.58456,-0.070739,-0.029514,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.1313,-0.070935,-0.073739,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.79636,-0.071229,0.02707,0,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.17099,-0.07136,-0.097154,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.32938,-0.071396,-0.055229,0,0
2,GO DIET INDUCED THERMOGENESIS,0.12908,-0.071429,-0.13198,0,0
2,GO RECEPTOR CLUSTERING,0.21579,-0.071505,-0.10225,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.50896,-0.071639,-0.010929,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.99651,-0.071646,0.042389,0,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.011612,-0.071705,-0.13161,0,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.39371,-0.071749,-0.038725,0,0
2,GO ODONTOGENESIS,0.97557,-0.071949,0.022468,0,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.24643,-0.072084,-0.11824,0,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.19695,-0.072111,-0.070293,0,0
2,GO PANCREAS DEVELOPMENT,0.47049,-0.072176,-0.0357,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.12689,-0.072244,-0.073364,0,0
2,GO CELL JUNCTION MAINTENANCE,0.40843,-0.072356,-0.042054,0,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.44924,-0.072378,-0.012235,0,0
2,GO RESPONSE TO FORSKOLIN,0.35153,-0.072381,-0.13813,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.80989,-0.072472,0.041786,0,0
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.12908,-0.072766,-0.11958,0,0
2,GO REGULATION OF ANION TRANSPORT,0.11434,-0.072769,-0.088328,0,0
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.035393,-0.072864,-0.11203,0,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.39858,-0.07289,-0.019567,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.0067808,-0.073036,-0.11756,0,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.26471,-0.073121,-0.09997,0,0
2,GO PROTEIN DEMETHYLATION,0.76281,-0.073123,-0.0082881,0,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.9686,-0.073175,0.0022449,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.57857,-0.073347,-0.005607,0,0
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.44402,-0.073465,-0.057385,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.56075,-0.073562,-0.010615,0,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.001662,-0.073666,-0.13373,0,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.4545,-0.073666,-0.05009,0,0
2,GO BONE TRABECULA MORPHOGENESIS,0.98255,-0.073864,0.054342,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.72969,-0.073952,0.0042436,0,0
2,GO T CELL LINEAGE COMMITMENT,0.76948,-0.074005,0.015368,0,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.87144,-0.074126,0.0068299,0,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.49227,-0.074484,-0.016629,0,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.12049,-0.074542,-0.069182,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.40349,-0.07458,-0.04181,0,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.54321,-0.07459,-0.024109,0,0
2,GO ECTODERM DEVELOPMENT,0.12259,-0.074657,-0.051655,0,0
2,GO PROTEIN MANNOSYLATION,0.28785,-0.074832,-0.066359,0,0
2,GO RESPONSE TO HYDROXYUREA,0.91293,-0.075051,0.026236,0,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.31232,-0.075392,-0.055371,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.27227,-0.075503,-0.054488,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.87833,-0.075606,-0.0086654,0,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.36064,-0.075694,-0.11124,0,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.080955,-0.076127,-0.087841,0,0
2,GO CELL RECOGNITION,0.068167,-0.076332,-0.079491,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.21256,-0.076383,-0.05364,0,0
2,GO STEM CELL PROLIFERATION,0.71006,-0.076459,-0.010431,0,0
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.36991,-0.076593,-0.043299,0,0
2,GO REGULATION OF SPINDLE CHECKPOINT,0.67137,-0.077137,-0.0087186,0,0
2,GO BONE MATURATION,0.23245,-0.077311,-0.080771,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.27611,-0.077435,-0.058174,0,0
2,GO NUCLEOSOME ASSEMBLY,0.15264,-0.077522,-0.043279,0,0
2,GO GERM CELL DEVELOPMENT,0.0049174,-0.077626,-0.09572,0,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.56666,-0.077686,-0.0051062,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,0.89907,-0.077937,0.022457,0,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.29184,-0.078094,-0.1796,0,0
2,GO HISTONE H3 K4 METHYLATION,0.78962,-0.078417,0.019897,0,0
2,GO HINDBRAIN MORPHOGENESIS,0.019283,-0.078538,-0.12392,0,0
2,GO RESPONSE TO BMP,0.25363,-0.078794,-0.033804,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.30402,-0.079454,-0.040451,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.05824,-0.079628,-0.098131,0,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,0.82348,-0.079878,0.028623,0,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.15773,-0.080014,-0.059344,0,0
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.23245,-0.080084,-0.10693,0,0
2,GO METAL ION TRANSPORT,0.015953,-0.080093,-0.088956,0,0
2,GO MICROTUBULE POLYMERIZATION,0.12049,-0.080307,-0.10055,0,0
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.52025,-0.080309,-0.055825,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.52594,-0.08032,-0.03684,0,0
2,GO CELLULAR ANION HOMEOSTASIS,0.50337,-0.08037,-0.021891,0,0
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.14285,-0.080522,-0.09474,0,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.097379,-0.080884,-0.11402,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.4598,-0.08095,-0.04505,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.50896,-0.081153,-0.040243,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.16294,-0.081179,-0.061797,0,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.58456,-0.081193,-0.03291,0,0
2,GO DENDRITIC SPINE DEVELOPMENT,0.10465,-0.081427,-0.081287,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.5726,-0.081803,-0.050244,0,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.28785,-0.082087,-0.066249,0,0
2,GO AXON EXTENSION,0.01282,-0.08211,-0.15953,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.17934,-0.082134,-0.057602,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.15773,-0.082405,0.05873,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.35607,-0.082541,-0.06777,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.088862,-0.082657,-0.1399,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.10845,-0.082762,-0.052332,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.25363,-0.083035,-0.061169,0,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.8303,-0.083239,-0.012646,0,0
2,GO DENDRITIC SPINE MORPHOGENESIS,0.12689,-0.083294,-0.10674,0,0
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.4598,-0.083486,-0.052829,0,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.48678,-0.083504,-0.025853,0,0
2,GO REGULATION OF RESPIRATORY BURST,0.50896,-0.08362,-0.059529,0,0
2,GO TRANSFERRIN TRANSPORT,0.063042,-0.083863,-0.11041,0,0
2,GO AMINO ACID IMPORT,0.63354,-0.083922,0.018102,0,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.10465,-0.084116,-0.079904,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.4545,-0.084333,-0.068777,0,0
2,GO DOSAGE COMPENSATION,0.31232,-0.084426,0.0052337,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.71658,-0.084473,-0.029654,0,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.013465,-0.085073,-0.077396,0,0
2,GO LIMBIC SYSTEM DEVELOPMENT,0.054842,-0.085285,-0.078652,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.56666,-0.085701,-0.0020953,0,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0032441,-0.085741,-0.12898,0,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.16294,-0.085779,-0.049638,0,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.099158,-0.085879,-0.094679,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.30815,-0.086002,-0.046272,0,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.097379,-0.086113,-0.090619,0,0
2,GO HEPARIN METABOLIC PROCESS,0.76281,-0.086115,0.0031747,0,0
2,GO HEART PROCESS,0.046579,-0.086201,-0.089287,0,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.24288,-0.08625,-0.12657,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,0.78962,-0.08632,-0.04243,0,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.31653,-0.086833,-0.039914,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.81668,-0.087032,0.036815,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.036948,-0.08713,-0.10318,0,0
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.15264,-0.08734,-0.057935,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.4598,-0.087612,-0.041122,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.63978,-0.087694,-0.043043,0,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.090515,-0.088046,-0.13276,0,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.02166,-0.088061,-0.085515,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.75615,-0.088121,0.017645,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.50896,-0.088139,-0.027352,0,0
2,GO AXO DENDRITIC TRANSPORT,0.016734,-0.08822,-0.10836,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.068167,-0.088323,-0.10719,0,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.099158,-0.08841,-0.072969,0,0
2,GO CELL PROLIFERATION IN HINDBRAIN,0.29992,-0.088442,-0.080892,0,0
2,GO DNA DEMETHYLATION,0.10845,-0.088479,-0.074689,0,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.19095,-0.088728,-0.078426,0,0
2,GO MICROTUBULE BASED MOVEMENT,0.0011549,-0.088785,-0.10941,0,0
2,GO RESPONSE TO CAMP,0.095625,-0.089059,-0.087935,0,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.60272,-0.089122,-0.074893,0,0
2,GO NEURON PROJECTION GUIDANCE,0.015203,-0.089162,-0.15271,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.61497,-0.089206,-0.01618,0,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.36526,-0.089357,-0.053387,0,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.41341,-0.089375,-0.11296,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.4598,-0.089807,-0.090348,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0060989,-0.08995,-0.10948,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.21256,-0.090005,-0.041903,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.15517,-0.090186,-0.15367,0,0
2,GO AXON DEVELOPMENT,0.0071468,-0.090403,-0.15315,0,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.20309,-0.090673,-0.13826,0,0
2,GO REGULATION OF EXOSOMAL SECRETION,0.51459,-0.090806,-0.045232,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.045624,-0.090954,-0.18368,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.18508,-0.09121,-0.11886,0,0
2,GO ENDOTHELIUM DEVELOPMENT,0.17934,-0.091221,-0.079817,0,0
2,GO MITOCHONDRION LOCALIZATION,0.02843,-0.091259,-0.12136,0,0
2,GO REGULATION OF GLIOGENESIS,0.18508,-0.091735,-0.072454,0,0
2,GO REGIONALIZATION,0.087232,-0.091947,-0.07666,0,0
2,GO CATION TRANSPORT,0.015203,-0.092023,-0.089465,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.25363,-0.09205,-0.065236,0,0
2,GO NUCLEOSIDE SALVAGE,0.78962,-0.09228,-0.019331,0,0
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.33373,-0.092517,-0.053062,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.02268,-0.09254,-0.10872,0,0
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.43883,-0.092559,-0.10846,0,0
2,GO ANIMAL ORGAN MATURATION,0.23245,-0.092597,-0.054761,0,0
2,GO POLYOL TRANSPORT,0.4598,-0.092676,-0.021326,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.30815,-0.09275,-0.040577,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.25001,-0.092841,-0.066566,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.76281,-0.092926,-0.016774,0,0
2,GO REGULATION OF HEART RATE,0.17934,-0.093261,-0.073595,0,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.48678,-0.093276,-0.065741,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.72313,-0.093469,0.0021383,0,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.15517,-0.093766,-0.12039,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.21905,-0.093794,-0.083748,0,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0069616,-0.093862,-0.11782,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.22235,-0.093991,-0.060278,0,0
2,GO CILIUM MOVEMENT,0.0041716,-0.094022,-0.12914,0,0
2,GO N GLYCAN PROCESSING,0.066855,-0.094133,-0.19033,0,0
2,GO MUSCLE ORGAN MORPHOGENESIS,0.40843,-0.094189,-0.028715,0,0
2,GO L AMINO ACID TRANSPORT,0.11636,-0.094203,-0.050848,0,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.084046,-0.094471,-0.10586,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.30402,-0.094654,-0.15534,0,0
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.060602,-0.094911,-0.10163,0,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.075049,-0.095183,-0.10684,0,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.51459,-0.095377,-0.035019,0,0
2,GO CELL PROJECTION ORGANIZATION,0.0075304,-0.095528,-0.1012,0,0
2,GO STEROID CATABOLIC PROCESS,0.14769,-0.095932,-0.096242,0,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0099891,-0.096128,-0.10281,0,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.12049,-0.09646,-0.11419,0,0
2,GO MITOTIC RECOMBINATION,0.49227,-0.096936,-0.021279,0,0
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.030383,-0.097112,-0.078806,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.10465,-0.09724,-0.125,0,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.31653,-0.097338,-0.18139,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.023205,-0.097567,-0.10192,0,0
2,GO RESPONSE TO NICOTINE,0.30815,-0.097801,-0.073712,0,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.037747,-0.098227,-0.13525,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.36064,-0.09829,-0.023491,0,0
2,GO REGULATION OF SYSTEM PROCESS,0.0040578,-0.098446,-0.11473,0,0
2,GO ENDOCRINE HORMONE SECRETION,0.20621,-0.098657,-0.067353,0,0
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.5726,-0.098933,0.153,0,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.012203,-0.099207,-0.1286,0,0
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.18219,-0.099341,-0.088766,0,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.30402,-0.09937,-0.049236,0,0
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.12473,-0.099545,-0.10934,0,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.11636,-0.099561,-0.070567,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.73628,-0.099578,-0.064133,0,0
2,GO REGULATION OF CYCLASE ACTIVITY,0.16559,-0.099636,-0.098829,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.20937,-0.099731,-0.11087,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.030383,-0.099758,-0.10895,0,0
2,GO REGULATION OF CELL DEVELOPMENT,0.0067808,-0.099974,-0.10964,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.48131,-0.10012,-0.10864,0,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.41842,-0.10023,-0.12573,0,0
2,GO LYTIC VACUOLE ORGANIZATION,0.14526,-0.10024,-0.081395,0,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.029068,-0.10046,-0.091212,0,0
2,GO CELL MORPHOGENESIS,0.065563,-0.10053,-0.082466,0,0
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.088862,-0.10074,-0.06938,0,0
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.41842,-0.10086,-0.065862,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.48131,-0.10099,-0.012107,0,0
2,GO SPERMATID DIFFERENTIATION,0.009256,-0.10126,-0.096652,0,0
2,GO TRANSPORT ALONG MICROTUBULE,0.0025817,-0.10147,-0.1004,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.67137,-0.10154,-0.066936,0,0
2,GO MICROTUBULE BASED TRANSPORT,0.001986,-0.10171,-0.10579,0,0
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,1,-0.10188,0.05218,0,0
2,GO ADULT FEEDING BEHAVIOR,0.11434,-0.10199,-0.096285,0,0
2,GO OSTEOCLAST DIFFERENTIATION,0.53742,-0.10212,-0.01945,0,0
2,GO RESPONSE TO EPINEPHRINE,0.69061,-0.10213,-0.021762,0,0
2,GO TORC1 SIGNALING,0.02068,-0.1023,-0.083363,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.32077,-0.10245,-0.10431,0,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.02843,-0.10265,-0.16494,0,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.42855,-0.10284,-0.036568,0,0
2,GO FEMALE SEX DIFFERENTIATION,0.13583,-0.10289,-0.066505,0,0
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.53167,-0.10293,-0.055704,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.30402,-0.10309,-0.039559,0,0
2,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.41842,-0.10322,-0.093205,0,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.23245,-0.10323,-0.1142,0,0
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.16032,-0.1034,-0.067653,0,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.12473,-0.10349,-0.081884,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.14048,-0.10367,-0.086065,0,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.27227,-0.104,-0.068824,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.72313,-0.10421,-0.026541,0,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.027188,-0.10437,-0.086604,0,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.026586,-0.10452,-0.10419,0,0
2,GO ORGANIC CATION TRANSPORT,0.42347,-0.1046,-0.047827,0,0
2,GO PATTERN SPECIFICATION PROCESS,0.031748,-0.10465,-0.09525,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.23937,-0.10473,-0.11168,0,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.024846,-0.10513,-0.099811,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.11841,-0.10537,-0.079774,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.072231,-0.10537,-0.17324,0,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.087232,-0.10545,-0.094851,0,0
2,GO RESPONSE TO CORTICOSTERONE,0.37932,-0.10547,-0.10631,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.76281,-0.10568,0.038714,0,0
2,GO TOOTH MINERALIZATION,0.90599,-0.10569,0.067913,0,0
2,GO CONVERGENT EXTENSION,0.87833,-0.10573,0.02668,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.20621,-0.10595,-0.044676,0,0
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.47049,-0.10597,-0.033148,0,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.10465,-0.10619,-0.086287,0,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0020453,-0.10625,-0.16321,0,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.066855,-0.1063,-0.11892,0,0
2,GO RELAXATION OF MUSCLE,0.28785,-0.10667,-0.084047,0,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.059411,-0.10712,-0.11061,0,0
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.011326,-0.10759,-0.12913,0,0
2,GO REGULATION OF LYASE ACTIVITY,0.22235,-0.1076,-0.086417,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.4545,-0.10785,-0.061927,0,0
2,GO ORGAN INDUCTION,0.12049,-0.10798,-0.12241,0,0
2,GO CELL FATE SPECIFICATION,0.22235,-0.10805,-0.083766,0,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.12049,-0.10837,-0.064474,0,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0075304,-0.10842,-0.10558,0,0
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.1028,-0.10871,-0.19712,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.034637,-0.10884,-0.15788,0,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.17099,-0.10893,-0.086647,0,0
2,GO ESTROGEN BIOSYNTHETIC PROCESS,0.54321,-0.10941,0.051535,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.16828,-0.11005,-0.12855,0,0
2,GO BASIC AMINO ACID TRANSPORT,0.29586,-0.11013,-0.036117,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.10654,-0.11043,-0.12801,0,0
2,GO REGULATION OF ICOSANOID SECRETION,0.1028,-0.11048,-0.10618,0,0
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.019739,-0.1105,-0.12531,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.025994,-0.1107,-0.1761,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.51459,-0.11075,-0.042363,0,0
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.050569,-0.11076,-0.12312,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0017123,-0.1108,-0.1633,0,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.018398,-0.11087,-0.17341,0,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.024288,-0.11144,-0.088272,0,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.016734,-0.11176,-0.11239,0,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.41341,-0.11203,-0.035811,0,0
2,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.4978,-0.11204,-0.016094,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.71006,-0.11216,-0.062843,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.20309,-0.1124,-0.082332,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.48678,-0.11288,-0.034736,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.18508,-0.11304,-0.076532,0,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.0090226,-0.11309,-0.1,0,0
2,GO ACTIVATED T CELL PROLIFERATION,0.5726,-0.11313,-0.0065659,0,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.05824,-0.11321,-0.15226,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.31653,-0.11336,-0.081342,0,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0029794,-0.11341,-0.15675,0,0
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.038561,-0.11345,-0.10901,0,0
2,GO IMPORT INTO CELL,0.042857,-0.11405,-0.10311,0,0
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.011612,-0.11465,-0.17034,0,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.19695,-0.11481,-0.087168,0,0
2,GO RESPONSE TO MAGNESIUM ION,0.75615,-0.11493,-0.024123,0,0
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.42347,-0.11517,-0.033985,0,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.17374,-0.11519,-0.065427,0,0
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.36991,-0.11536,-0.082397,0,0
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.15773,-0.11539,-0.064974,0,0
2,GO ACTION POTENTIAL,0.060602,-0.1155,-0.10784,0,0
2,GO CELL CELL SIGNALING,0.0018173,-0.11591,-0.10968,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.25363,-0.11617,-0.056325,0,0
2,GO STRIATED MUSCLE ADAPTATION,0.32506,-0.11617,-0.071486,0,0
2,GO RESPONSE TO ALKALOID,0.0028957,-0.11633,-0.15109,0,0
2,GO SPERM CAPACITATION,0.054842,-0.11638,-0.12947,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.061812,-0.11674,-0.077513,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.085627,-0.11692,-0.12063,0,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.013465,-0.11736,-0.10042,0,0
2,GO REGULATION OF AXONOGENESIS,0.0013054,-0.11737,-0.19695,0,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.11636,-0.11739,-0.14344,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.44402,-0.11777,-0.047844,0,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.027188,-0.11827,-0.14011,0,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.0018173,-0.1183,-0.22776,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.12473,-0.11864,-0.077517,0,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.13814,-0.1191,-0.20047,0,0
2,GO KINETOCHORE ORGANIZATION,0.24288,-0.1196,-0.062911,0,0
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.25001,-0.11962,-0.037633,0,0
2,GO ANIMAL ORGAN FORMATION,0.24643,-0.11995,-0.046849,0,0
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.063042,-0.11999,-0.13983,0,0
2,GO CILIUM ORGANIZATION,0.0017123,-0.12008,-0.11921,0,0
2,GO DETECTION OF VISIBLE LIGHT,0.017549,-0.12014,-0.0085071,0,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.15517,-0.12043,-0.093358,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.024288,-0.12062,-0.13558,0,0
2,GO CRANIAL NERVE DEVELOPMENT,0.020205,-0.12068,-0.15033,0,0
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.62732,-0.12086,-0.028047,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.18508,-0.12135,-0.09244,0,0
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.23245,-0.12154,-0.053399,0,0
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.24643,-0.12155,-0.032938,0,0
2,GO MEMBRANE DOCKING,0.001228,-0.12196,-0.10505,0,0
2,GO NEUROGENESIS,0.0014738,-0.12269,-0.12542,0,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.095625,-0.12338,-0.18995,0,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0028141,-0.12363,-0.14604,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.015953,-0.12381,-0.13768,0,0
2,GO FIBROBLAST MIGRATION,0.41842,-0.12387,-0.01757,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.67137,-0.12403,-0.035,0,0
2,GO NEUROBLAST PROLIFERATION,0.03245,-0.12431,-0.14259,0,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.43367,-0.12442,-0.073922,0,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.022165,-0.12446,-0.11748,0,0
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.2839,-0.12475,-0.11974,0,0
2,GO MITOTIC DNA REPLICATION,0.049546,-0.12486,-0.10157,0,0
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.1313,-0.12502,-0.11919,0,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.010773,-0.12562,-0.12681,0,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.21905,-0.12567,-0.080485,0,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.14526,-0.126,-0.13703,0,0
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.23937,-0.12607,-0.082686,0,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.0036303,-0.12617,-0.13951,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.188,-0.12642,-0.083421,0,0
2,GO VISUAL BEHAVIOR,0.25001,-0.12713,-0.076983,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.046579,-0.12716,-0.12553,0,0
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.05824,-0.12734,-0.090576,0,0
2,GO CELL PART MORPHOGENESIS,0.0007696,-0.12743,-0.16279,0,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0025817,-0.12765,-0.12346,0,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.009256,-0.12785,-0.12117,0,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.047551,-0.12838,-0.095889,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.095625,-0.12863,-0.10272,0,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.053746,-0.12872,-0.15065,0,0
2,GO HIPPOCAMPUS DEVELOPMENT,0.0695,-0.12889,-0.087897,0,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0011549,-0.12904,-0.14394,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.15264,-0.12904,-0.073056,0,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.42855,-0.12924,-0.071783,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.16032,-0.12938,-0.11749,0,0
2,GO EXTRACELLULAR TRANSPORT,0.095625,-0.12951,-0.12535,0,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.090515,-0.13017,-0.075954,0,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0057817,-0.13102,-0.14918,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.2,-0.13111,-0.17212,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.37932,-0.13185,-0.081329,0,0
2,GO PIRNA METABOLIC PROCESS,0.044685,-0.13253,-0.18969,0,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.29184,-0.13263,-0.044778,0,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.18508,-0.13273,-0.063127,0,0
2,GO DEVELOPMENTAL CELL GROWTH,0.00057693,-0.13303,-0.16903,0,0
2,GO NERVOUS SYSTEM PROCESS,0.0057817,-0.1338,-0.10528,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.35153,-0.13443,-0.083634,0,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.50896,-0.13464,-0.066784,0,0
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.073629,-0.13477,-0.10075,0,0
2,GO REVERSE CHOLESTEROL TRANSPORT,0.32077,-0.13509,-0.060756,0,0
2,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.055956,-0.13532,-0.10442,0,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0016129,-0.13543,-0.16682,0,0
2,GO REGULATION OF NEURON DIFFERENTIATION,0.00050664,-0.13561,-0.16453,0,0
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.060602,-0.13562,-0.23041,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.17934,-0.13566,-0.082839,0,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.095625,-0.13572,-0.10661,0,0
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.4978,-0.13583,-0.013967,0,0
2,GO MESENCHYME MORPHOGENESIS,0.27227,-0.13621,-0.04142,0,0
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.72969,-0.13645,-0.023551,0,0
2,GO REGULATION OF CELL FATE SPECIFICATION,0.71658,-0.13659,0.019399,0,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00081984,-0.13677,-0.17393,0,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.19095,-0.13748,-0.058047,0,0
2,GO ANATOMICAL STRUCTURE REGRESSION,0.016734,-0.13783,-0.31307,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.31653,-0.13793,-0.05097,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.12259,-0.13824,-0.11649,0,0
2,GO AXONAL TRANSPORT,0.0085714,-0.13841,-0.13215,0,0
2,GO PHAGOSOME ACIDIFICATION,0.068167,-0.13845,-0.11882,0,0
2,GO DENDRITE MORPHOGENESIS,0.0016129,-0.13885,-0.17899,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.11039,-0.13891,-0.060742,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.15015,-0.13897,-0.11496,0,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0019282,-0.13902,-0.12211,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.088862,-0.13902,-0.13056,0,0
2,GO MRNA SPLICE SITE SELECTION,0.14769,-0.13913,-0.1072,0,0
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.092194,-0.1393,-0.076793,0,0
2,GO CELLULAR RESPONSE TO NUTRIENT,0.055956,-0.1394,-0.14777,0,0
2,GO LOCOMOTOR RHYTHM,0.22568,-0.13949,-0.085562,0,0
2,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.10654,-0.13965,-0.19386,0,0
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.5726,-0.13966,0.012214,0,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.077957,-0.14051,-0.10708,0,0
2,GO NEURON DEVELOPMENT,0.00052342,-0.14058,-0.15873,0,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.017549,-0.14079,-0.1273,0,0
2,GO REGULATION OF TRANSPOSITION,0.94073,-0.14101,-0.035037,0,0
2,GO REGULATION OF APPETITE,0.034637,-0.14129,-0.10958,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.17374,-0.14137,-0.11384,0,0
2,GO COCHLEA DEVELOPMENT,0.024288,-0.14188,-0.13103,0,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.27999,-0.14221,-0.046313,0,0
2,GO HEAD DEVELOPMENT,0.0028957,-0.1424,-0.11874,0,0
2,GO SODIUM ION TRANSPORT,0.0032441,-0.14244,-0.13786,0,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00098941,-0.14278,-0.11432,0,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0097392,-0.14281,-0.25729,0,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0032441,-0.14309,-0.14919,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.001872,-0.1432,-0.1353,0,0
2,GO NEURON DIFFERENTIATION,0.00047456,-0.14352,-0.15109,0,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.044685,-0.14359,-0.14032,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.4545,-0.14418,-0.048201,0,0
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0050528,-0.14442,-0.1548,0,0
2,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.076492,-0.14445,-0.14835,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0051916,-0.14452,-0.15605,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.013798,-0.14468,-0.17854,0,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.00063551,-0.14502,-0.13949,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.32938,-0.14541,-0.045377,0,0
2,GO MITOCHONDRION DISTRIBUTION,0.085627,-0.14547,-0.15961,0,0
2,GO DEVELOPMENTAL INDUCTION,0.04854,-0.14564,-0.16164,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.11841,-0.14568,-0.14823,0,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.32506,-0.14591,-0.10264,0,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.48678,-0.14609,-0.0063551,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.1313,-0.14613,-0.16932,0,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.019739,-0.14668,-0.1028,0,0
2,GO PARTURITION,0.12259,-0.14688,-0.1508,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.59059,-0.14714,-0.068868,0,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.001228,-0.14715,-0.224,0,0
2,GO RESPONSE TO AXON INJURY,0.034637,-0.1472,-0.12804,0,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.20621,-0.14732,-0.11173,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.079444,-0.14748,-0.12168,0,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.061812,-0.14797,-0.13079,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.30815,-0.14801,-0.041878,0,0
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.077957,-0.14865,-0.16494,0,0
2,GO ADULT HEART DEVELOPMENT,0.11039,-0.14922,-0.12612,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00010462,-0.15014,-0.1726,0,0
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.93377,-0.15029,0.035227,0,0
2,GO TRANSPOSITION,0.19095,-0.15048,-0.12826,0,0
2,GO NEUROTRANSMITTER REUPTAKE,0.059411,-0.15056,-0.16974,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0060989,-0.15074,-0.14546,0,0
2,GO NEURAL RETINA DEVELOPMENT,0.0062634,-0.15076,-0.18356,0,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.11841,-0.15218,-0.09414,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.29184,-0.15229,-0.053789,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.079444,-0.15233,-0.11913,0,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00044439,-0.15257,-0.20677,0,0
2,GO LYMPH NODE DEVELOPMENT,0.0027346,-0.15363,-0.2055,0,0
2,GO REGULATION OF CARDIAC CONDUCTION,0.0038387,-0.15385,-0.15896,0,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.11636,-0.15404,-0.1528,0,0
2,GO COLLATERAL SPROUTING,0.027188,-0.15496,-0.18408,0,0
2,GO POSTSYNAPSE ORGANIZATION,0.0038387,-0.15542,-0.17316,0,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.0062634,-0.15569,-0.096481,0,0
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.10096,-0.15576,-0.17193,0,0
2,GO ESTROUS CYCLE,0.24643,-0.15718,-0.099037,0,0
2,GO POSITIVE THYMIC T CELL SELECTION,0.023205,-0.15738,-0.13104,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.23245,-0.15787,-0.11544,0,0
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.025994,-0.1585,-0.12969,0,0
2,GO SENSORY PERCEPTION OF PAIN,0.00353,-0.15857,-0.16196,0,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.013798,-0.15888,-0.15902,0,0
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.0016129,-0.15933,-0.16154,0,0
2,GO AMYLOID FIBRIL FORMATION,0.082489,-0.16004,-0.15912,0,0
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.034637,-0.16016,-0.13244,0,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.14285,-0.16033,-0.098759,0,0
2,GO NEURON PROJECTION REGENERATION,0.04854,-0.16035,-0.12272,0,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.027803,-0.16067,-0.12286,0,0
2,GO CARDIAC CONDUCTION,0.01282,-0.16117,-0.15155,0,0
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.0015189,-0.16153,-0.19814,0,0
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.036164,-0.16169,-0.18281,0,0
2,GO RESPONSE TO INTERLEUKIN 2,0.18508,-0.16231,-0.067551,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.060602,-0.16271,-0.1142,0,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.17374,-0.16292,-0.11459,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.52025,-0.1631,-0.035196,0,0
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.11235,-0.1635,-0.17497,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.21256,-0.16382,-0.094304,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.10465,-0.16414,-0.096025,0,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.66501,-0.16478,-0.02275,0,0
2,GO RESPONSE TO POTASSIUM ION,0.041967,-0.16481,-0.17361,0,0
2,GO RESPONSE TO WATER,0.62113,-0.16512,-0.032047,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.10096,-0.16536,-0.18354,0,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.017969,-0.16588,-0.22832,0,0
2,GO HINDBRAIN DEVELOPMENT,0.00012964,-0.16636,-0.19848,0,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.51459,-0.16756,-0.0099698,0,0
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0053338,-0.168,-0.14838,0,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.011047,-0.16814,-0.17292,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.13814,-0.16831,-0.12968,0,0
2,GO MAINTENANCE OF CELL POLARITY,0.0049174,-0.16946,-0.25552,0,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.25001,-0.17009,-0.091077,0,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.15264,-0.17013,-0.16543,0,0
2,GO IRON COORDINATION ENTITY TRANSPORT,0.14048,-0.17063,-0.12202,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0045306,-0.17069,-0.18542,0,0
2,GO RESPONSE TO ACIDIC PH,0.23937,-0.17072,-0.068509,0,0
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.16559,-0.17136,-0.23761,0,0
2,GO LONG TERM MEMORY,0.015574,-0.17206,-0.15929,0,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.05824,-0.17249,-0.2604,0,0
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.0064317,-0.17263,-0.20861,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.27999,-0.17354,-0.098364,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.29184,-0.17428,-0.037531,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.057089,-0.17434,-0.12944,0,0
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.02068,-0.17582,-0.20035,0,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.092194,-0.17759,-0.24386,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.077957,-0.17792,-0.1111,0,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0695,-0.17866,-0.18624,0,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.13355,-0.17884,-0.13873,0,0
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.049546,-0.17935,-0.24481,0,0
2,GO PALLIUM DEVELOPMENT,0.0012662,-0.17991,-0.14982,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.099158,-0.18005,-0.1472,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.13355,-0.18018,-0.18614,0,0
2,GO NEUROMUSCULAR PROCESS,0.0075304,-0.1808,-0.14975,0,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20309,-0.18088,-0.10667,0,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.11636,-0.18103,-0.11612,0,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.0027346,-0.18109,-0.15826,0,0
2,GO FEMALE GENITALIA DEVELOPMENT,0.16828,-0.18178,-0.082065,0,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.055956,-0.18189,-0.13368,0,0
2,GO DENDRITE DEVELOPMENT,0.00074557,-0.18222,-0.17873,0,0
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.13355,-0.18245,-0.12033,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.188,-0.18247,-0.20972,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.047551,-0.18306,-0.18781,0,0
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.21256,-0.18364,-0.10485,0,0
2,GO REGULATION OF NEURON MIGRATION,0.014841,-0.18404,-0.19345,0,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.0099891,-0.18411,-0.16927,0,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.24288,-0.18434,-0.16383,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.39858,-0.18474,-0.021356,0,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0695,-0.18493,-0.25813,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.087232,-0.18582,-0.13971,0,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.0025083,-0.18613,-0.1903,0,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0033369,-0.18623,-0.14935,0,0
2,GO PROTEIN KINASE C SIGNALING,0.0064317,-0.18628,-0.21498,0,0
2,GO AMINO ACID TRANSPORT,0.00098941,-0.1863,-0.19181,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.031059,-0.18633,-0.13876,0,0
2,GO SEROTONIN TRANSPORT,0.052669,-0.18672,-0.15653,0,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0007696,-0.18694,-0.19989,0,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00020448,-0.18717,-0.1579,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.36064,-0.18745,-0.10274,0,0
2,GO GLYCINE TRANSPORT,0.17934,-0.18777,-0.1055,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.1313,-0.18835,-0.10397,0,0
2,GO NEUROTRANSMITTER UPTAKE,0.16828,-0.18843,-0.12204,0,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.17374,-0.18869,-0.065057,0,0
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.035393,-0.18877,-0.13545,0,0
2,GO CARDIAC CELL FATE COMMITMENT,0.25001,-0.18891,-0.1918,0,0
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.010506,-0.19095,-0.22819,0,0
2,GO RESPONSE TO CAFFEINE,0.42347,-0.19098,-0.040653,0,0
2,GO DEVELOPMENTAL MATURATION,8.1192e-05,-0.19179,-0.18135,0,0
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0011199,-0.19204,-0.17957,0,0
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.03245,-0.19231,-0.17406,0,0
2,GO RESPONSE TO AMINO ACID STARVATION,0.001191,-0.19298,-0.2005,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0010859,-0.19314,-0.20653,0,0
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.066855,-0.19373,-0.1132,0,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00045924,-0.19383,-0.18392,0,0
2,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.041967,-0.19387,-0.14763,0,0
2,GO CARDIAC VENTRICLE FORMATION,0.10845,-0.19469,-0.27994,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0094949,-0.19529,-0.18911,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.023205,-0.19584,-0.28975,0,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0022992,-0.19601,-0.26976,0,0
2,GO FAT CELL PROLIFERATION,0.027188,-0.197,-0.18016,0,0
2,GO BEHAVIOR,5.0226e-05,-0.19727,-0.18304,0,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0695,-0.19736,-0.13162,0,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00050664,-0.19737,-0.20649,0,0
2,GO SKELETAL MUSCLE CONTRACTION,0.018836,-0.1975,-0.14701,0,0
2,GO COGNITION,0.00013917,-0.19805,-0.19697,0,0
2,GO SPINAL CORD DEVELOPMENT,0.001191,-0.1981,-0.18808,0,0
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0016129,-0.19819,-0.19221,0,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.0046564,-0.19978,-0.14732,0,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.21256,-0.19981,-0.081556,0,0
2,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.16032,-0.20007,-0.12623,0,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.0045306,-0.20074,-0.16755,0,0
2,GO STRIATUM DEVELOPMENT,0.0069616,-0.20081,-0.23813,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.0099891,-0.20082,-0.1651,0,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0001547,-0.20083,-0.21197,0,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.033894,-0.20092,-0.21033,0,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0059384,-0.20111,-0.1339,0,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.37932,-0.20125,-0.097044,0,0
2,GO MEMORY,5.8301e-05,-0.20125,-0.2259,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.11636,-0.20132,-0.1543,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.20621,-0.20216,-0.090998,0,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.0021062,-0.20234,-0.25539,0,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.23937,-0.20318,-0.19951,0,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0022992,-0.20403,-0.15169,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0039469,-0.20411,-0.23054,0,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.043763,-0.20414,-0.23725,0,0
2,GO CEREBRAL CORTEX DEVELOPMENT,0.0018173,-0.2043,-0.15583,0,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.14769,-0.20464,-0.19872,0,0
2,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.15517,-0.20486,-0.16489,0,0
2,GO SYNAPSE ORGANIZATION,0.001191,-0.20513,-0.19479,0,0
2,GO CAMP BIOSYNTHETIC PROCESS,0.0029794,-0.20549,-0.28145,0,0
2,GO REGULATION OF MICROTUBULE BINDING,0.00019079,-0.20582,-0.27432,0,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0046564,-0.20588,-0.29512,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.39371,-0.2063,-0.075492,0,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,7.547e-05,-0.20693,-0.22894,0,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.0064317,-0.2075,-0.20056,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.029068,-0.20975,-0.26026,0,0
2,GO REGULATION OF CILIUM MOVEMENT,2.6307e-05,-0.2099,-0.20293,0,0
2,GO FOREBRAIN DEVELOPMENT,0.00024286,-0.20996,-0.16718,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.05161,-0.21006,-0.18794,0,0
2,GO REGULATION OF OOGENESIS,0.00081984,-0.21013,-0.1946,0,0
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.018836,-0.21069,-0.22139,0,0
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.024288,-0.2111,-0.18921,0,0
2,GO TELENCEPHALON DEVELOPMENT,0.00023468,-0.21206,-0.1721,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.023741,-0.21261,-0.21123,0,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.0001547,-0.21312,-0.25368,0,0
2,GO METENCEPHALON DEVELOPMENT,0.00012074,-0.21327,-0.22203,0,0
2,GO PULMONARY VALVE DEVELOPMENT,0.19393,-0.21455,-0.15355,0,0
2,GO NEURON PROJECTION EXTENSION,9.7346e-05,-0.21487,-0.22502,0,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0015653,-0.21561,-0.2136,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.26471,-0.21725,-0.091142,0,0
2,GO DIVALENT METAL ION EXPORT,0.017137,-0.21757,-0.20318,0,0
2,GO SECONDARY PALATE DEVELOPMENT,0.0090226,-0.2176,-0.22318,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.0033369,-0.21902,-0.22971,0,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.010245,-0.2195,-0.17283,0,0
2,GO COPULATION,0.065563,-0.2195,-0.12403,0,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.095625,-0.21992,-0.17932,0,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,3.1888e-05,-0.22034,-0.22296,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.011326,-0.22129,-0.18969,0,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,0.001191,-0.22222,-0.19739,0,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.15015,-0.22231,-0.20103,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.10654,-0.22275,-0.1224,0,0
2,GO FACIAL NERVE MORPHOGENESIS,0.03939,-0.22369,-0.29967,0,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00037661,-0.22444,-0.22699,0,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0046564,-0.22523,-0.29187,0,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.085627,-0.22589,-0.11232,0,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.033166,-0.22603,-0.20853,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.03939,-0.22788,-0.24771,0,0
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.049546,-0.22808,-0.20625,0,0
2,GO MYELIN MAINTENANCE,0.029068,-0.22874,-0.20169,0,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00012074,-0.23028,-0.22111,0,0
2,GO REGULATION OF EXOCYTOSIS,0.0071468,-0.2305,-0.18465,0,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.045624,-0.23087,-0.17644,0,0
2,GO CGMP METABOLIC PROCESS,0.045624,-0.23291,-0.20903,0,0
2,GO EPITHELIAL CELL MATURATION,0.0085714,-0.2347,-0.26325,0,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.036948,-0.23482,-0.15327,0,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.076492,-0.23486,-0.167,0,0
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.00092958,-0.23537,-0.23076,0,0
2,GO INSEMINATION,0.052669,-0.23544,-0.19735,0,0
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.012203,-0.23558,-0.26128,0,0
2,GO MALE MEIOSIS I,0.00047456,-0.23568,-0.30661,0,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.001662,-0.23585,-0.22547,0,0
2,GO VESICLE DOCKING,0.00032948,-0.23716,-0.22693,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.23937,-0.23722,-0.099567,0,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0025817,-0.23733,-0.32751,0,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0006154,-0.23832,-0.16553,0,0
2,GO ASSOCIATIVE LEARNING,0.0014738,-0.23927,-0.20993,0,0
2,GO VITAMIN CATABOLIC PROCESS,0.025994,-0.24011,-0.23319,0,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.40349,-0.24025,-0.074586,0,0
2,GO MICROTUBULE SEVERING,0.023205,-0.24075,-0.18688,0,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.0097392,-0.24089,-0.18148,0,0
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.097379,-0.2423,-0.16936,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.2,-0.24277,-0.085125,0,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.019283,-0.24333,-0.20231,0,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00023468,-0.2434,-0.2281,0,0
2,GO SEROTONIN SECRETION,0.054842,-0.24417,-0.19844,0,0
2,GO CELL FATE DETERMINATION,0.016339,-0.24432,-0.17805,0,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0007696,-0.24627,-0.27139,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.011047,-0.24633,-0.32227,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00072223,-0.24779,-0.25411,0,0
2,GO RESPONSE TO MUSCLE STRETCH,0.011326,-0.24853,-0.27218,0,0
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,-0.24873,-0.22131,0,0
2,GO SYNAPSE ASSEMBLY,0.00028792,-0.24913,-0.23467,0,0
2,GO REGULATION OF MEMBRANE POTENTIAL,5.6174e-05,-0.24929,-0.23828,0,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00087311,-0.25066,-0.19984,0,0
2,GO ACROSOME REACTION,0.00034072,-0.25085,-0.22925,0,0
2,GO MICROTUBULE DEPOLYMERIZATION,0.00010092,-0.25131,-0.29239,0,0
2,GO LEARNING,0.00065623,-0.25137,-0.23618,0,0
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0040578,-0.25177,-0.18548,0,0
2,GO SECRETORY GRANULE ORGANIZATION,0.00024286,-0.25222,-0.24678,0,0
2,GO SIALYLATION,0.02843,-0.25261,-0.2102,0,0
2,GO INNER DYNEIN ARM ASSEMBLY,0.0050528,-0.25304,-0.33587,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.30402,-0.25338,-0.11827,0,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.023741,-0.25381,-0.23691,0,0
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.021165,-0.25403,-0.19439,0,0
2,GO PULMONARY VALVE MORPHOGENESIS,0.088862,-0.2547,-0.19483,0,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.1028,-0.2548,-0.13637,0,0
2,GO RESPONSE TO AMYLOID BETA,0.0049174,-0.25483,-0.17216,0,0
2,GO RESPONSE TO COCAINE,0.00069957,-0.25761,-0.23012,0,0
2,GO THALAMUS DEVELOPMENT,0.012203,-0.25771,-0.23578,0,0
2,GO FOREBRAIN CELL MIGRATION,0.00042998,-0.25831,-0.22002,0,0
2,GO CARDIAC CHAMBER FORMATION,0.16294,-0.25868,-0.2115,0,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00031859,-0.2593,-0.23481,0,0
2,GO MICROTUBULE BUNDLE FORMATION,1.2454e-05,-0.26023,-0.27713,0,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,3.3132e-05,-0.26191,-0.28373,0,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,2.4346e-05,-0.26317,-0.26987,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.037747,-0.26323,-0.16705,0,0
2,GO MEMBRANE FISSION,0.0028957,-0.26481,-0.25935,0,0
2,GO RESPONSE TO CATECHOLAMINE,1.7806e-05,-0.26511,-0.25978,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.009256,-0.26573,-0.3094,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,9.389e-05,-0.2658,-0.28206,0,0
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,5.2139e-05,-0.26617,-0.24721,0,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.0094949,-0.2669,-0.30182,0,0
2,GO CELL MIGRATION IN HINDBRAIN,0.0032441,-0.26722,-0.31052,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.00055855,-0.26744,-0.26926,0,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.0784e-06,-0.26834,-0.26998,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.56666,-0.26881,0.011367,0,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.004408,-0.26914,-0.23244,0,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.044685,-0.27008,-0.20895,0,0
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.011047,-0.27069,-0.34342,0,0
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0039469,-0.27158,-0.26802,0,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.02068,-0.27243,-0.30108,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0062634,-0.27246,-0.28057,0,0
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.03245,-0.27422,-0.25295,0,0
2,GO PYRAMIDAL NEURON DIFFERENTIATION,0.011612,-0.27433,-0.29277,0,0
2,GO INTRACILIARY TRANSPORT,0.0013054,-0.27466,-0.23595,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.049546,-0.27534,-0.18113,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.099158,-0.27536,-0.094569,0,0
2,GO NERVE DEVELOPMENT,2.8418e-05,-0.27625,-0.28724,0,0
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.14526,-0.27672,-0.16164,0,0
2,GO MEMBRANE DEPOLARIZATION,7.547e-05,-0.27841,-0.30182,0,0
2,GO PROTEIN PALMITOYLATION,0.00074557,-0.27874,-0.22261,0,0
2,GO POTASSIUM ION TRANSPORT,9.0551e-05,-0.27874,-0.22649,0,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.00028792,-0.27923,-0.32231,0,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0010859,-0.28015,-0.23914,0,0
2,GO REGULATION OF ACROSOME REACTION,0.0039469,-0.28107,-0.27225,0,0
2,GO NEURON CELLULAR HOMEOSTASIS,0.0026572,-0.28163,-0.31205,0,0
2,GO RETINA LAYER FORMATION,0.0038387,-0.28213,-0.2967,0,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0030654,-0.28232,-0.2738,0,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0013054,-0.28309,-0.30464,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0056288,-0.28343,-0.23293,0,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,1.6455e-05,-0.28349,-0.32418,0,0
2,GO SKELETAL MUSCLE ADAPTATION,0.027188,-0.2861,-0.20521,0,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,2.8418e-05,-0.28626,-0.32466,0,0
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0036303,-0.28726,-0.22272,0,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.10465,-0.28726,-0.11925,0,0
2,GO REGULATION OF SYNAPTIC PLASTICITY,6.2786e-05,-0.28806,-0.29603,0,0
2,GO NEURON RECOGNITION,0.00025131,-0.29167,-0.32172,0,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.0066042,-0.29207,-0.23654,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.019283,-0.29231,-0.2116,0,0
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.00092958,-0.29337,-0.25233,0,0
2,GO SYNAPTIC SIGNALING,1.349e-05,-0.29393,-0.27318,0,0
2,GO RESPONSE TO DOPAMINE,2.0784e-06,-0.29538,-0.28501,0,0
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.011047,-0.29623,-0.26894,0,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00026003,-0.29653,-0.25121,0,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.00047456,-0.29791,-0.22352,0,0
2,GO RESPONSE TO ACETYLCHOLINE,0.0071468,-0.29835,-0.26746,0,0
2,GO POSITIVE REGULATION OF AXONOGENESIS,4.8379e-05,-0.29943,-0.28855,0,0
2,GO NOTCH RECEPTOR PROCESSING,0.0085714,-0.30207,-0.28486,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.14048,-0.30236,-0.18742,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.085627,-0.3027,-0.18191,0,0
2,GO NEURON PROJECTION ARBORIZATION,8.4205e-05,-0.30274,-0.34189,0,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.17934,-0.30401,-0.32927,0,0
2,GO ADULT LOCOMOTORY BEHAVIOR,1.9263e-05,-0.30462,-0.28124,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0016129,-0.3054,-0.3088,0,0
2,GO REGULATION OF TUBULIN DEACETYLATION,0.018836,-0.30616,-0.23974,0,0
2,GO KERATINOCYTE DEVELOPMENT,0.14285,-0.30645,-0.18095,0,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.0040578,-0.30719,-0.22644,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.004408,-0.30724,-0.21713,0,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.00016595,-0.30761,-0.33353,0,0
2,GO NEURON MATURATION,0.0013872,-0.30768,-0.23605,0,0
2,GO LONG TERM SYNAPTIC DEPRESSION,0.00014935,-0.30829,-0.303,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.023205,-0.3085,-0.24635,0,0
2,GO SECRETORY GRANULE LOCALIZATION,0.0057817,-0.30858,-0.3296,0,0
2,GO LOCOMOTORY BEHAVIOR,7.9801e-06,-0.30916,-0.27576,0,0
2,GO NOREPINEPHRINE TRANSPORT,0.001191,-0.3096,-0.25154,0,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0012662,-0.31016,-0.24519,0,0
2,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.011047,-0.31029,-0.40552,0,0
2,GO PRESYNAPSE ORGANIZATION,0.00022676,-0.31055,-0.29473,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0041716,-0.31092,-0.29813,0,0
2,GO TUBULIN DEACETYLATION,0.0056288,-0.31111,-0.23405,0,0
2,GO DIENCEPHALON DEVELOPMENT,5.8301e-05,-0.31156,-0.29536,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.32506,-0.31157,-0.12432,0,0
2,GO NEURAL NUCLEUS DEVELOPMENT,3.1888e-05,-0.31288,-0.33587,0,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.013139,-0.31491,-0.25885,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,5.7413e-06,-0.31537,-0.29574,0,0
2,GO PROTEIN POLYGLUTAMYLATION,9.0551e-05,-0.31768,-0.27997,0,0
2,GO GROOMING BEHAVIOR,0.0011199,-0.31825,-0.29764,0,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.031748,-0.31881,-0.22796,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0028141,-0.31932,-0.273,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,5.2837e-06,-0.32164,-0.34556,0,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.019739,-0.32165,-0.22635,0,0
2,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.12689,-0.32264,-0.27234,0,0
2,GO MAST CELL MIGRATION,0.25363,-0.32279,-0.11083,0,0
2,GO REGULATION OF CILIUM BEAT FREQUENCY,9.7801e-06,-0.32295,-0.31446,0,0
2,GO NEURON MIGRATION,8.1192e-05,-0.32354,-0.2878,0,0
2,GO NOREPINEPHRINE SECRETION,0.00055855,-0.32373,-0.3068,0,0
2,GO REGULATION OF AMINO ACID TRANSPORT,0.00010462,-0.32373,-0.30426,0,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00020448,-0.32505,-0.32347,0,0
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0079323,-0.32674,-0.33154,0,0
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00016595,-0.32774,-0.3059,0,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.001228,-0.32889,-0.25414,0,0
2,GO DORSAL VENTRAL PATTERN FORMATION,0.00032948,-0.32902,-0.27937,0,0
2,GO REFLEX,0.0062634,-0.33049,-0.33856,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00087311,-0.33136,-0.36021,0,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00014418,-0.33256,-0.33006,0,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.088862,-0.33395,-0.17094,0,0
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00353,-0.334,-0.34468,0,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.0059384,-0.33413,-0.21619,0,0
2,GO SYNAPTIC VESICLE TRANSPORT,2.0833e-05,-0.34114,-0.31289,0,0
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00011241,-0.34176,-0.32099,0,0
2,GO ACIDIC AMINO ACID TRANSPORT,2.0033e-05,-0.34653,-0.31578,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.073629,-0.34723,-0.18373,0,0
2,GO ADULT BEHAVIOR,5.7413e-06,-0.34936,-0.30585,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,6.2786e-05,-0.34987,-0.3304,0,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,6.0504e-05,-0.3543,-0.40923,0,0
2,GO SYNAPTIC VESICLE RECYCLING,9.7801e-06,-0.35485,-0.3546,0,0
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00079435,-0.35599,-0.32389,0,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00069957,-0.35672,-0.33649,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.349e-05,-0.35759,-0.39984,0,0
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00057693,-0.35917,-0.27599,0,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.00019753,-0.36027,-0.33874,0,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,3.4728e-06,-0.36368,-0.39828,0,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,6.2367e-06,-0.36445,-0.31262,0,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,1.1493e-05,-0.3655,-0.38361,0,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.00055855,-0.37017,-0.37113,0,0
2,GO TRANSMISSION OF NERVE IMPULSE,1.4039e-05,-0.37042,-0.36846,0,0
2,GO MOTILE CILIUM ASSEMBLY,0.0022992,-0.37045,-0.25323,0,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,6.4994e-06,-0.37119,-0.45625,0,0
2,GO CELL DIFFERENTIATION IN HINDBRAIN,2.9532e-05,-0.37203,-0.3619,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0073363,-0.37229,-0.26976,0,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,8.7323e-05,-0.37254,-0.43785,0,0
2,GO LUNG CELL DIFFERENTIATION,0.40843,-0.37364,-0.12833,0,0
2,GO CATECHOLAMINE UPTAKE,0.0017641,-0.3765,-0.29749,0,0
2,GO EXPLORATION BEHAVIOR,1.1493e-05,-0.37666,-0.44339,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.00052342,-0.37804,-0.40865,0,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00031859,-0.37851,-0.29406,0,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,4.4878e-05,-0.37901,-0.35527,0,0
2,GO NEUROTRANSMITTER TRANSPORT,0.00018427,-0.38009,-0.35303,0,0
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00028792,-0.38038,-0.32131,0,0
2,GO REGULATION OF VESICLE FUSION,0.018398,-0.38038,-0.26224,0,0
2,GO AXONEME ASSEMBLY,3.7145e-05,-0.38059,-0.34033,0,0
2,GO HEART INDUCTION,0.0047853,-0.3811,-0.51035,0,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,9.389e-05,-0.38303,-0.35509,0,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,3.5759e-05,-0.38486,-0.34848,0,0
2,GO CEREBELLAR CORTEX FORMATION,1.0184e-05,-0.38599,-0.3695,0,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0015653,-0.38614,-0.46382,0,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.00044439,-0.38707,-0.29461,0,0
2,GO SPERM AXONEME ASSEMBLY,0.0019282,-0.38751,-0.29654,0,0
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0045306,-0.39075,-0.34257,0,0
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0029794,-0.39131,-0.33692,0,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.1663e-05,-0.39358,-0.34316,0,0
2,GO NEURONAL ACTION POTENTIAL,0.00012964,-0.39375,-0.38255,0,0
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.066855,-0.39573,-0.23367,0,0
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00042998,-0.39646,-0.37475,0,0
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00016595,-0.39718,-0.35308,0,0
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.00012512,-0.39729,-0.28993,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.906e-06,-0.39738,-0.40355,0,0
2,GO ADRENAL GLAND DEVELOPMENT,4.4878e-05,-0.39755,-0.41232,0,0
2,GO HEART FORMATION,0.00019753,-0.39792,-0.37544,0,0
2,GO PRESYNAPTIC ENDOCYTOSIS,2.7343e-05,-0.40049,-0.35982,0,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.00032948,-0.40117,-0.39776,0,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.0001165,-0.4078,-0.41052,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.8583e-05,-0.41092,-0.35373,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00014935,-0.41146,-0.42288,0,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00030804,-0.41188,-0.48725,0,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0032441,-0.41686,-0.37001,0,0
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.00021167,-0.41761,-0.47672,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,1.9263e-05,-0.41802,-0.38864,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.0069616,-0.41804,-0.33531,0,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,1.104e-05,-0.41953,-0.42704,0,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00016595,-0.42106,-0.37432,0,0
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.00032948,-0.42147,-0.34325,0,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00029782,-0.42396,-0.32309,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0041716,-0.42401,-0.41182,0,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,8.3127e-06,-0.42864,-0.47246,0,0
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0001547,-0.43245,-0.46212,0,0
2,GO STARTLE RESPONSE,9.7346e-05,-0.43451,-0.41573,0,0
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.00036427,-0.43471,-0.52049,0,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,4.3218e-05,-0.4381,-0.36893,0,0
2,GO NEUROTRANSMITTER SECRETION,0.0001165,-0.43911,-0.39431,0,0
2,GO PITUITARY GLAND DEVELOPMENT,2.8418e-05,-0.44241,-0.40207,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.19393,-0.44887,-0.18028,0,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.00031859,-0.44954,-0.51172,0,0
2,GO NEURON FATE COMMITMENT,9.389e-05,-0.45099,-0.40042,0,0
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00019753,-0.45114,-0.39929,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,1.4609e-05,-0.45131,-0.40182,0,0
2,GO SPINAL CORD PATTERNING,0.00014418,-0.45579,-0.43606,0,0
2,GO GLIAL CELL FATE COMMITMENT,0.0069616,-0.45634,-0.38429,0,0
2,GO OLFACTORY LOBE DEVELOPMENT,2.0833e-05,-0.46481,-0.42169,0,0
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.5759e-05,-0.46495,-0.48686,0,0
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.024846,-0.46498,-0.296,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,5.2837e-06,-0.47011,-0.50826,0,0
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00059588,-0.4731,-0.62579,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,1.4609e-05,-0.47385,-0.48456,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,3.1904e-06,-0.47613,-0.44787,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,2.0033e-05,-0.47806,-0.59416,0,0
2,GO DETECTION OF CALCIUM ION,2.1663e-05,-0.47921,-0.4581,0,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00027832,-0.48431,-0.38024,0,0
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,1.1776e-06,-0.48566,-0.43682,0,0
2,GO TELENCEPHALON REGIONALIZATION,0.00090094,-0.48665,-0.43538,0,0
2,GO PROTEIN LOCALIZATION TO AXON,0.0042883,-0.49988,-0.51522,0,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,1.1493e-05,-0.50426,-0.45948,0,0
2,GO FOREBRAIN REGIONALIZATION,1.8521e-05,-0.50683,-0.44827,0,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0027346,-0.50924,-0.43193,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,1.3441e-06,-0.50969,-0.55469,0,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.00012964,-0.51217,-0.46023,0,0
2,GO RESPONSE TO AUDITORY STIMULUS,0.00040247,-0.51533,-0.43402,0,0
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0006154,-0.51565,-0.46508,0,0
2,GO SEROTONIN METABOLIC PROCESS,0.00012964,-0.51618,-0.48398,0,0
2,GO PARENTAL BEHAVIOR,2.2658e-06,-0.5173,-0.52335,0,0
2,GO DENSE CORE GRANULE TRANSPORT,2.8418e-05,-0.51826,-0.60454,0,0
2,GO GLUTAMATE SECRETION,7.9801e-06,-0.52196,-0.45489,0,0
2,GO ADENOHYPOPHYSIS DEVELOPMENT,0.001191,-0.52376,-0.48236,0,0
2,GO POSTSYNAPSE ASSEMBLY,4.0073e-05,-0.53093,-0.54051,0,0
2,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.02268,-0.53215,-0.42098,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,4.6623e-06,-0.53818,-0.44798,0,0
2,GO REGULATION OF SYNAPSE MATURATION,0.00032948,-0.53915,-0.44638,0,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00022676,-0.54078,-0.50822,0,0
2,GO NEURONAL ION CHANNEL CLUSTERING,0.00019079,-0.54665,-0.54081,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS,3.7791e-06,-0.54756,-0.51119,0,0
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00036427,-0.55378,-0.45042,0,0
2,GO AMINE TRANSPORT,1.0604e-05,-0.55393,-0.47415,0,0
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.7806e-05,-0.55845,-0.49749,0,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,1.8251e-06,-0.56376,-0.53302,0,0
2,GO SUBPALLIUM DEVELOPMENT,5.508e-06,-0.56698,-0.51447,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,7.9801e-06,-0.56854,-0.56987,0,0
2,GO REGULATION OF GLUTAMATE SECRETION,1.4039e-05,-0.5753,-0.49886,0,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,4.4712e-06,-0.57623,-0.63792,0,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,1.1964e-05,-0.57795,-0.48891,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,8.1192e-05,-0.58511,-0.56837,0,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.4039e-05,-0.58792,-0.49606,0,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,7.013e-05,-0.58816,-0.43887,0,0
2,GO PREPULSE INHIBITION,0.0017641,-0.59001,-0.48413,0,0
2,GO SYNAPTIC MEMBRANE ADHESION,4.6623e-06,-0.59578,-0.60314,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.4609e-05,-0.59663,-0.62733,0,0
2,GO HEART FIELD SPECIFICATION,8.4205e-05,-0.60151,-0.54288,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0010528,-0.61174,-0.5662,0,0
2,GO DENDRITE EXTENSION,2.6902e-06,-0.61273,-0.54732,0,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,1.349e-05,-0.61804,-0.51355,0,0
2,GO MONOAMINE TRANSPORT,1.1964e-05,-0.61853,-0.48974,0,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,3.0576e-06,-0.62233,-0.57237,0,0
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.2454e-05,-0.62242,-0.60131,0,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,1.2862e-06,-0.63003,-0.58564,0,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,2.8418e-05,-0.63175,-0.57593,0,0
2,GO REGULATION OF DENDRITE EXTENSION,1.4044e-06,-0.63491,-0.67112,0,0
2,GO GROWTH HORMONE SECRETION,3.17e-07,-0.64066,-0.60111,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,6.2786e-05,-0.64945,-0.57445,0,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.001986,-0.65138,-0.49689,0,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,7.889e-07,-0.65177,-0.63147,0,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,5.9841e-06,-0.67669,-0.59296,0,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,6.5896e-07,-0.67931,-0.65628,0,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00019753,-0.68225,-0.59851,0,0
2,GO NOSE DEVELOPMENT,0.00037661,-0.68387,-0.53349,0,0
2,GO SYNAPTIC VESICLE DOCKING,0.00081984,-0.68503,-0.54517,0,0
2,GO SYNAPSE MATURATION,2.9532e-05,-0.68558,-0.63869,0,0
2,GO NEURON CELL CELL ADHESION,7.6603e-06,-0.69428,-0.74771,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,1.7806e-05,-0.70774,-0.61998,0,0
2,GO MECHANOSENSORY BEHAVIOR,0.00065623,-0.71598,-0.62206,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,2.4692e-06,-0.71759,-0.69427,0,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00026903,-0.72004,-0.49951,0,0
2,GO GANGLION DEVELOPMENT,2.5774e-06,-0.72491,-0.75393,0,0
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,4.7955e-07,-0.73288,-0.7439,0,0
2,GO SYNAPTIC VESICLE CLUSTERING,0.0007696,-0.73672,-0.60238,0,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,2.9301e-06,-0.76196,-0.67725,0,0
2,GO VOCALIZATION BEHAVIOR,1.5816e-05,-0.77548,-0.68249,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,2.0784e-06,-0.80624,-0.81764,0,0
2,GO REGULATION OF DOPAMINE SECRETION,0.00021909,-0.81849,-0.65869,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0021062,-0.82314,-0.61269,0,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,4.3763e-07,-0.89906,-0.86905,0,0
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,1.7118e-05,-0.9647,-0.8053,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,2.4346e-05,-0.98847,-0.92485,0,0
2,GO GABAERGIC NEURON DIFFERENTIATION,5.9841e-06,-1.0785,-0.85681,0,0
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.00353,-1.1089,-0.88928,0,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,2.8418e-05,-1.2441,-0.96112,0,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,5.0683e-06,-1.4504,-1.1919,0,0
3,GO OXYGEN TRANSPORT,7.547e-05,0.81539,0.747,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.1888e-05,0.78882,0.71035,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.5816e-05,0.72334,0.66453,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.1964e-05,0.71028,0.61784,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,5.2139e-05,0.64875,0.55119,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,3.3287e-06,0.63001,0.61814,1,1
3,GO RESPONSE TO HISTAMINE,2.0833e-05,0.61441,0.63341,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,9.7801e-06,0.60828,0.57979,1,1
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,2.9532e-05,0.59411,0.58126,1,1
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,5.2139e-05,0.58202,0.58056,1,1
3,GO GAS TRANSPORT,0.00018427,0.57434,0.54092,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,5.2139e-05,0.56973,0.46119,1,1
3,GO RESPONSE TO L GLUTAMATE,1.7118e-05,0.5632,0.54731,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.00079435,0.55166,0.45742,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00045924,0.54979,0.4128,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,3.3287e-06,0.53768,0.54006,1,1
3,GO GLYCINE TRANSPORT,0.0013054,0.53755,0.45246,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,6.7728e-06,0.52581,0.51835,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,5.8301e-05,0.52235,0.52449,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,2.9532e-05,0.52075,0.4714,1,1
3,GO RIBOSOME ASSEMBLY,1.2454e-05,0.51965,0.52271,1,1
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.00057693,0.51373,0.47329,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00063551,0.51371,0.55799,1,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,5.0226e-05,0.51244,0.43381,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,5.2139e-05,0.50845,0.43768,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,1.5201e-05,0.50695,0.52578,1,1
3,GO UV PROTECTION,9.4334e-07,0.50261,0.49723,1,1
3,GO CYTOPLASMIC TRANSLATION,3.0689e-05,0.50222,0.49325,1,1
3,GO MATURATION OF LSU RRNA,4.1112e-06,0.502,0.52582,1,1
3,GO IMP METABOLIC PROCESS,6.7728e-06,0.49745,0.52991,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,7.6603e-06,0.49722,0.46517,1,1
3,GO SYNAPTIC VESICLE MATURATION,0.00032948,0.49002,0.46862,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,4.8612e-06,0.48957,0.52222,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,2.1663e-05,0.48707,0.4741,1,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0016129,0.48064,0.3453,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.00023468,0.4804,0.55075,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,4.3218e-05,0.47808,0.45036,1,1
3,GO PLASMA MEMBRANE REPAIR,1.7118e-05,0.47515,0.43057,1,1
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00022676,0.47195,0.35921,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,9.7801e-06,0.46923,0.41322,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.00055855,0.46866,0.47831,1,1
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0034322,0.46605,0.40317,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,1.7474e-06,0.46223,0.46803,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,5.9841e-06,0.4566,0.47396,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0010206,0.45403,0.33701,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,4.6623e-06,0.45177,0.42629,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00090094,0.44779,0.4969,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.00090094,0.44589,0.36452,1,1
3,GO MYOBLAST PROLIFERATION,2.2658e-06,0.44337,0.42829,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,2.8077e-06,0.4422,0.38801,1,1
3,GO GLYCINE METABOLIC PROCESS,0.0028141,0.43581,0.3201,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.0040578,0.43436,0.25227,1,1
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,3.7145e-05,0.43423,0.42594,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,2.8418e-05,0.43092,0.46841,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,7.9801e-06,0.4301,0.48694,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00010092,0.42967,0.42685,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.3132e-05,0.42733,0.37696,1,1
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.030383,0.42493,0.19913,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.00026003,0.42415,0.32079,1,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00055855,0.42385,0.41074,1,1
3,GO TRANSLATIONAL INITIATION,7.547e-05,0.41916,0.42211,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,3.1888e-05,0.41789,0.46439,1,1
3,GO SUCKLING BEHAVIOR,0.00026903,0.4172,0.33519,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00035231,0.41604,0.49831,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,5.0683e-06,0.41334,0.38134,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.9263e-05,0.40305,0.42321,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,2.5308e-05,0.40108,0.41323,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.010506,0.40104,0.28928,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.00012074,0.39933,0.39412,1,1
3,GO MATURATION OF SSU RRNA,6.2367e-06,0.39869,0.44019,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00042998,0.3971,0.41154,1,1
3,GO VIRAL TRANSLATION,7.2754e-05,0.3964,0.39111,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0001547,0.39577,0.46904,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,2.7343e-05,0.39541,0.37787,1,1
3,GO SNORNA METABOLIC PROCESS,0.00029782,0.39513,0.40738,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,0.00092958,0.39423,0.35709,1,1
3,GO TELOMERASE RNA LOCALIZATION,4.8612e-06,0.39353,0.45365,1,1
3,GO CRISTAE FORMATION,0.00054072,0.39055,0.29118,1,1
3,GO ADULT HEART DEVELOPMENT,0.00037661,0.38782,0.35746,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.0027346,0.38363,0.34733,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,4.3218e-05,0.38243,0.41963,1,1
3,GO SNORNA 3 END PROCESSING,5.2139e-05,0.38121,0.44397,1,1
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.011326,0.38101,0.26645,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.00050664,0.37775,0.38325,1,1
3,GO SHORT TERM MEMORY,0.00095906,0.37704,0.40963,1,1
3,GO L GLUTAMATE IMPORT,0.00029782,0.37583,0.3149,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00098941,0.37401,0.34407,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.00012964,0.3711,0.36059,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.00050664,0.37102,0.42067,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00037661,0.36981,0.37519,1,1
3,GO MATURATION OF 5 8S RRNA,3.8583e-05,0.36945,0.37424,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00019753,0.36444,0.35376,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00054072,0.36443,0.38469,1,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,1.5201e-05,0.36311,0.41577,1,1
3,GO ARGININE METABOLIC PROCESS,0.0046564,0.36281,0.30972,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,4.6597e-05,0.36187,0.34182,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00012964,0.36154,0.30061,1,1
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.00035231,0.36102,0.32193,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00010462,0.3597,0.34641,1,1
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.0010859,0.35691,0.32071,1,1
3,GO INNERVATION,0.0039469,0.35026,0.33228,1,1
3,GO NEUROBLAST DIVISION,0.011612,0.34975,0.28156,1,1
3,GO PEPTIDYL ARGININE N METHYLATION,3.6228e-06,0.34889,0.39181,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00042998,0.34806,0.28949,1,1
3,GO PENTOSE METABOLIC PROCESS,0.00014935,0.34481,0.31658,1,1
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0069616,0.34396,0.22937,1,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.00037661,0.34094,0.27564,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0007696,0.3396,0.27294,1,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,3.7145e-05,0.33157,0.30388,1,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.0015653,0.33131,0.30878,1,1
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0026572,0.32997,0.31892,1,1
3,GO MITOCHONDRIAL TRNA PROCESSING,0.013465,0.32818,0.24099,1,1
3,GO REGULATION OF MRNA BINDING,1.8521e-05,0.32602,0.39788,1,1
3,GO VIRAL GENE EXPRESSION,0.00084609,0.324,0.33686,1,1
3,GO TRNA MODIFICATION,1.7474e-06,0.32353,0.31884,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,9.0551e-05,0.3233,0.37047,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,8.3127e-06,0.32282,0.32446,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00059588,0.31962,0.31253,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00034072,0.31902,0.31313,1,1
3,GO PROTEIN TARGETING TO MEMBRANE,0.00038934,0.31485,0.30664,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00026003,0.31477,0.24803,1,1
3,GO GTP METABOLIC PROCESS,0.00067758,0.31441,0.28031,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.017969,0.31376,0.23899,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,9.389e-05,0.31309,0.25901,1,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.011326,0.31244,0.21095,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00050664,0.31142,0.28401,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00087311,0.30888,0.36835,1,1
3,GO RIBOSOME BIOGENESIS,1.5201e-05,0.30689,0.38255,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,3.0689e-05,0.30657,0.24294,1,1
3,GO NUCLEOBASE METABOLIC PROCESS,7.2754e-05,0.30498,0.28153,1,1
3,GO RRNA MODIFICATION,0.00019079,0.3047,0.35171,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,3.1888e-05,0.30322,0.37676,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.010506,0.30297,0.20661,1,1
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.0020453,0.30247,0.24302,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.018398,0.30166,0.21952,1,1
3,GO PEPTIDYL HISTIDINE MODIFICATION,9.7346e-05,0.30067,0.26078,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00079435,0.30007,0.18658,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,6.7596e-05,0.29759,0.34957,1,1
3,GO MRNA MODIFICATION,4.8379e-05,0.29207,0.30818,1,1
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.015574,0.29146,0.20846,1,1
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.00052342,0.29102,0.28985,1,1
3,GO TRNA PROCESSING,1.2962e-05,0.29098,0.2654,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,8.7323e-05,0.29082,0.30253,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.6584e-06,0.2905,0.29277,1,1
3,GO NAD METABOLIC PROCESS,0.0023671,0.28961,0.22695,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,6.5149e-05,0.28915,0.28619,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00028792,0.28897,0.30145,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,9.0179e-06,0.28815,0.27527,1,1
3,GO TRANSLATIONAL ELONGATION,1.1964e-05,0.28733,0.32113,1,1
3,GO SYNAPTIC VESICLE PRIMING,0.0028957,0.2873,0.30296,1,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.02166,0.28604,0.24007,1,1
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.0022992,0.28452,0.2835,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.029719,0.28363,0.18988,1,1
3,GO RRNA METABOLIC PROCESS,2.3418e-05,0.28323,0.34974,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,9.3916e-06,0.27902,0.3275,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00090094,0.27851,0.25073,1,1
3,GO RRNA METHYLATION,0.00026903,0.27841,0.29014,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00030804,0.27816,0.28971,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0016129,0.27614,0.26508,1,1
3,GO REGULATION OF RNA BINDING,1.1964e-05,0.27574,0.32944,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.00074557,0.27567,0.30316,1,1
3,GO HEART VALVE FORMATION,0.0046564,0.27408,0.30475,1,1
3,GO MITOCHONDRIAL TRANSLATION,9.7346e-05,0.27364,0.32059,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,7.013e-05,0.27345,0.32831,1,1
3,GO TRNA METHYLATION,3.5759e-05,0.27313,0.26945,1,1
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00030804,0.27291,0.23048,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.001662,0.27016,0.21343,1,1
3,GO AMINO ACID IMPORT,0.0012662,0.2701,0.22735,1,1
3,GO AORTA DEVELOPMENT,0.0085714,0.26865,0.15313,1,1
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0015189,0.26804,0.21471,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.0001165,0.26645,0.3032,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.0040578,0.26605,0.17922,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,7.2754e-05,0.26601,0.31884,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0085714,0.26571,0.18409,1,1
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.031748,0.26536,0.17453,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00072223,0.26487,0.30639,1,1
3,GO FOLIC ACID METABOLIC PROCESS,0.0023671,0.26395,0.24744,1,1
3,GO RNA SURVEILLANCE,0.00047456,0.26387,0.23038,1,1
3,GO HISTONE ARGININE METHYLATION,0.00026003,0.26385,0.24286,1,1
3,GO TRNA METABOLIC PROCESS,7.547e-05,0.2631,0.22931,1,1
3,GO RRNA TRANSCRIPTION,2.1663e-05,0.26243,0.2901,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0067808,0.26079,0.18637,1,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00026903,0.25989,0.18357,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.00029782,0.25896,0.22688,1,1
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.041093,0.25782,0.22084,1,1
3,GO BONE GROWTH,0.018398,0.25539,0.2292,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,8.4205e-05,0.25489,0.25305,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.00067758,0.25404,0.22668,1,1
3,GO HEME METABOLIC PROCESS,0.0087944,0.25225,0.22885,1,1
3,GO PEPTIDYL ARGININE METHYLATION,2.9532e-05,0.25169,0.27082,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.009256,0.25137,0.19355,1,1
3,GO RNA 5 END PROCESSING,0.0012662,0.25107,0.26658,1,1
3,GO AMINO ACID ACTIVATION,0.0038387,0.25083,0.24203,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.0041716,0.25013,0.19736,1,1
3,GO NCRNA PROCESSING,2.4346e-05,0.25012,0.28976,1,1
3,GO REGULATION OF LYASE ACTIVITY,0.00012512,0.25006,0.21597,1,1
3,GO LATERAL VENTRICLE DEVELOPMENT,0.0040578,0.2496,0.26919,1,1
3,GO MRNA METHYLATION,0.00047456,0.24908,0.26081,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,5.2139e-05,0.24816,0.30018,1,1
3,GO TRANSLATIONAL TERMINATION,9.389e-05,0.24753,0.30948,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0001165,0.24642,0.25393,1,1
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.001986,0.24464,0.23949,1,1
3,GO REPRODUCTIVE BEHAVIOR,0.013139,0.24426,0.19899,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,2.0033e-05,0.24352,0.25784,1,1
3,GO L SERINE METABOLIC PROCESS,0.029068,0.2424,0.26917,1,1
3,GO AEROBIC RESPIRATION,0.00022676,0.24054,0.21892,1,1
3,GO STRESS GRANULE ASSEMBLY,8.7323e-05,0.24006,0.20617,1,1
3,GO HISTONE SERINE PHOSPHORYLATION,0.0029794,0.23994,0.18481,1,1
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0013054,0.23922,0.18418,1,1
3,GO NEURON REMODELING,0.0028957,0.23903,0.2714,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00026003,0.23721,0.21392,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0030654,0.23662,0.19149,1,1
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.0066042,0.23485,0.36675,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0024367,0.23401,0.19118,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0087944,0.23216,0.185,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,2.0833e-05,0.23187,0.24768,1,1
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.00047456,0.23181,0.26376,1,1
3,GO CELLULAR RESPONSE TO PH,5.4121e-05,0.23124,0.2288,1,1
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0033369,0.2308,0.20321,1,1
3,GO NCRNA METABOLIC PROCESS,6.0504e-05,0.23025,0.2474,1,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.044685,0.22964,0.15744,1,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00042998,0.22875,0.20767,1,1
3,GO FIBROBLAST APOPTOTIC PROCESS,0.011326,0.22693,0.18548,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,1.7806e-05,0.22669,0.26374,1,1
3,GO AMP METABOLIC PROCESS,0.029719,0.2251,0.16922,1,1
3,GO NADH METABOLIC PROCESS,0.0007696,0.22498,0.22987,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.00084609,0.2226,0.17045,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00040247,0.22204,0.26714,1,1
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.001986,0.22115,0.21126,1,1
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.0018173,0.22081,0.17842,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00012512,0.22077,0.19732,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00084609,0.21987,0.18513,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.001986,0.21957,0.161,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.020205,0.21892,0.15312,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.00025131,0.21733,0.17642,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.019283,0.21696,0.14742,1,1
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0031536,0.21505,0.20453,1,1
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.00042998,0.21449,0.21563,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.030383,0.21117,0.15313,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.00012512,0.21083,0.22161,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,2.7343e-05,0.21048,0.31127,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,2.7343e-05,0.20975,0.1878,1,1
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0014738,0.20959,0.21568,1,1
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.0021689,0.20851,0.35715,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.027188,0.20638,0.16504,1,1
3,GO RNA METHYLATION,9.7346e-05,0.20608,0.21429,1,1
3,GO CELLULAR RESPIRATION,0.00055855,0.20466,0.20082,1,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0054795,0.2013,0.16895,1,1
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00084609,0.20001,0.17039,1,1
3,GO CARDIOLIPIN METABOLIC PROCESS,0.011612,0.19883,0.16015,1,1
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0079323,0.19813,0.17612,1,1
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.042857,0.19738,0.2132,1,1
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.047551,0.19694,0.1282,1,1
3,GO TRNA TRANSPORT,0.00074557,0.19685,0.19311,1,1
3,GO TELOMERIC LOOP DISASSEMBLY,0.0014299,0.1967,0.19765,1,1
3,GO RNA POLYADENYLATION,8.7323e-05,0.19661,0.16335,1,1
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.01282,0.19605,0.1674,1,1
3,GO RNA MODIFICATION,9.0551e-05,0.19588,0.20752,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.00055855,0.19512,0.18251,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.00034072,0.19488,0.16853,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.00063551,0.1948,0.18255,1,1
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.045624,0.19459,0.10704,1,1
3,GO TRICARBOXYLIC ACID CYCLE,0.00079435,0.19226,0.19157,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,7.013e-05,0.191,0.17125,1,1
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00050664,0.19092,0.22242,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.029719,0.1902,0.10359,1,1
3,GO GLUTAMINE METABOLIC PROCESS,0.00024286,0.18877,0.24166,1,1
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.00098941,0.18773,0.21328,1,1
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.025414,0.18693,0.14308,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00013917,0.18592,0.21921,1,1
3,GO CELLULAR RESPONSE TO HEAT,0.00023468,0.18574,0.14786,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00016023,0.18542,0.16356,1,1
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.0037331,0.18531,0.30413,1,1
3,GO ALDITOL METABOLIC PROCESS,0.0029794,0.18512,0.20195,1,1
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0013872,0.1845,0.18435,1,1
3,GO NCRNA EXPORT FROM NUCLEUS,0.001986,0.18321,0.18447,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.001191,0.18259,0.16225,1,1
3,GO L AMINO ACID TRANSPORT,6.7596e-05,0.18257,0.25269,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,8.1192e-05,0.18232,0.1896,1,1
3,GO NUCLEAR PORE ORGANIZATION,0.0034322,0.18041,0.18694,1,1
3,GO DNA REPLICATION INITIATION,0.00044439,0.1803,0.17175,1,1
3,GO NCRNA 3 END PROCESSING,0.0015653,0.1799,0.16386,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,9.7346e-05,0.17928,0.14631,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.0028141,0.17695,0.12956,1,1
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.016734,0.17618,0.12509,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00067758,0.17613,0.17633,1,1
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.019739,0.17482,0.15559,1,1
3,GO FEAR RESPONSE,0.040234,0.17401,0.14304,1,1
3,GO PEPTIDE METABOLIC PROCESS,0.0020453,0.17382,0.15312,1,1
3,GO RNA CATABOLIC PROCESS,0.0010528,0.17373,0.18606,1,1
3,GO PROTEIN TARGETING,0.0014299,0.17188,0.15307,1,1
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0050528,0.1712,0.15105,1,1
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0066042,0.17104,0.11742,1,1
3,GO RRNA 3 END PROCESSING,0.034637,0.17099,0.16181,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00055855,0.16987,0.16561,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.03939,0.16857,0.12819,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.009256,0.16719,0.14266,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE,0.00010845,0.16676,0.16848,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.02068,0.16455,0.17417,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0027346,0.16445,0.13019,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0056288,0.16343,0.16223,1,1
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0011199,0.16322,0.15465,1,1
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.033166,0.16174,0.13603,1,1
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.036948,0.16164,0.054186,1,1
3,GO PIGMENT METABOLIC PROCESS,0.0049174,0.15784,0.18293,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0015189,0.15639,0.18525,1,1
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.0087944,0.15523,0.11227,1,1
3,GO BASE EXCISION REPAIR,0.0025083,0.15485,0.1283,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0059384,0.15353,0.16122,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0049174,0.15252,0.19714,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.0029794,0.15153,0.13355,1,1
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.019283,0.15054,0.12565,1,1
3,GO PROTEIN DENEDDYLATION,0.033166,0.1458,0.13333,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0015653,0.14574,0.12856,1,1
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.0057817,0.14571,0.22388,1,1
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0066042,0.1451,0.16892,1,1
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.011047,0.14122,0.12256,1,1
3,GO REGULATION OF CELL CYCLE ARREST,0.0069616,0.14045,0.09516,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00092958,0.14039,0.15646,1,1
3,GO PEPTIDYL METHIONINE MODIFICATION,0.013798,0.14015,0.12367,1,1
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0050528,0.13944,0.15305,1,1
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.027188,0.1394,0.10495,1,1
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0062634,0.13934,0.14105,1,1
3,GO ATP METABOLIC PROCESS,0.00036427,0.13891,0.13733,1,1
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0015653,0.13878,0.12525,1,1
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.0032441,0.13858,0.15865,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.013139,0.13854,0.13794,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,0.0039469,0.1377,0.15345,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0017123,0.13645,0.12495,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.00021167,0.13509,0.13119,1,1
3,GO MRNA METABOLIC PROCESS,0.00010845,0.13445,0.15089,1,1
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.024846,0.13404,0.14161,1,1
3,GO TRNA 5 END PROCESSING,0.0067808,0.13388,0.21578,1,1
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.02268,0.13344,0.14731,1,1
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.01282,0.13252,0.1515,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0054795,0.13233,0.10657,1,1
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0075304,0.12987,0.12196,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0040578,0.12982,0.098093,1,1
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.02166,0.12856,0.14164,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0073363,0.12815,0.10145,1,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.029068,0.12728,0.13142,1,1
3,GO RNA 3 END PROCESSING,0.00044439,0.1272,0.12357,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.0050528,0.12566,0.083652,1,1
3,GO REGULATION OF MRNA PROCESSING,0.0032441,0.12523,0.093725,1,1
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.0023671,0.12477,0.14432,1,1
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0056288,0.1247,0.13827,1,1
3,GO MRNA 3 END PROCESSING,0.0015189,0.12438,0.10174,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.11945,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.015574,0.12358,0.11078,1,1
3,GO RNA CAPPING,0.0051916,0.12224,0.11244,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00023468,0.12069,0.12789,1,1
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.0059384,0.12048,0.1204,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.0046564,0.11946,0.12898,1,1
3,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.027803,0.11878,0.18356,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.010245,0.11848,0.15949,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.014841,0.11796,0.095721,1,1
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0037331,0.11663,0.14972,1,1
3,GO APOPTOTIC DNA FRAGMENTATION,0.047551,0.11629,0.068816,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.00010462,0.11569,0.17534,1,1
3,GO NCRNA TRANSCRIPTION,0.00021909,0.11512,0.1263,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.02068,0.1146,0.10974,1,1
3,GO MITOTIC DNA REPLICATION CHECKPOINT,0.027188,0.11392,0.13377,1,1
3,GO PROTEIN TETRAMERIZATION,0.0011199,0.11376,0.12733,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.0034322,0.11335,0.11355,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.011904,0.11264,0.084577,1,1
3,GO BLASTOCYST FORMATION,0.047551,0.11239,0.08888,1,1
3,GO REPLICATION FORK PROCESSING,0.013798,0.11194,0.11154,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.042857,0.11171,0.088376,1,1
3,GO RNA PROCESSING,1.8521e-05,0.11065,0.16722,1,1
3,GO TELOMERE ORGANIZATION,0.00032948,0.1101,0.13039,1,1
3,GO PROTEIN HETEROTETRAMERIZATION,0.00353,0.10828,0.13485,1,1
3,GO DNA REPLICATION CHECKPOINT,0.027803,0.10672,0.1064,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0010206,0.10638,0.11963,1,1
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.011326,0.10624,0.099335,1,1
3,GO RNA LOCALIZATION,0.00055855,0.1058,0.14285,1,1
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.023205,0.10424,0.082899,1,1
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.046579,0.10341,0.079547,1,1
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.019283,0.10313,0.10302,1,1
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0094949,0.1026,0.079982,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.013139,0.10156,0.097536,1,1
3,GO PROTEIN NEDDYLATION,0.02166,0.10136,0.1262,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0075304,0.10107,0.10394,1,1
3,GO NUCLEAR EXPORT,0.0014299,0.099419,0.10354,1,1
3,GO DNA DEPENDENT DNA REPLICATION,0.02166,0.099319,0.083646,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.011612,0.098656,0.094442,1,1
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0064317,0.098564,0.11973,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.025414,0.098278,0.1227,1,1
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.017969,0.098273,0.16477,1,1
3,GO MRNA EXPORT FROM NUCLEUS,0.0097392,0.096912,0.10888,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001191,0.095508,0.096131,1,1
3,GO METHYLATION,0.0019282,0.094303,0.087309,1,1
3,GO NUCLEOTIDE EXCISION REPAIR,0.013139,0.094189,0.076672,1,1
3,GO NUCLEAR TRANSPORT,0.0056288,0.093246,0.073385,1,1
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.009256,0.091452,0.093086,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.013139,0.090542,0.091484,1,1
3,GO CELLULAR RESPONSE TO UV,0.023741,0.089531,0.083355,1,1
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00079435,0.08906,0.11576,1,1
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.014486,0.088299,0.062428,1,1
3,GO MRNA PROCESSING,0.00054072,0.084613,0.10714,1,1
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.017549,0.083357,0.069036,1,1
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0042883,0.081822,0.091204,1,1
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.040234,0.079823,0.052653,1,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.02268,0.077697,0.075358,1,1
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.004408,0.07556,0.082134,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.026586,0.075138,0.04598,1,1
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.043763,0.07361,0.049126,1,1
3,GO RNA SPLICING,0.001986,0.072933,0.09655,1,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.010773,0.066106,0.069703,1,1
3,GO INTERSTRAND CROSS LINK REPAIR,0.0090226,0.063217,0.080227,1,1
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.013465,0.06315,0.08346,1,1
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.0059384,0.055239,0.086292,1,1
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.033894,0.052704,0.046358,1,1
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.043763,0.051406,0.065806,1,1
3,GO MITOCHONDRION ORGANIZATION,0.046579,0.049212,0.052838,1,1
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.036948,0.043057,0.0782,1,1
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.00026903,0.39258,0.45651,1,0
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0081404,0.37973,0.38323,1,0
3,GO ELASTIC FIBER ASSEMBLY,0.0024367,0.35596,0.41574,1,0
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0073363,0.3503,0.30711,1,0
3,GO BONE TRABECULA FORMATION,0.0064317,0.32979,0.37042,1,0
3,GO NUCLEOTIDE SALVAGE,0.009256,0.3254,0.29083,1,0
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.0073363,0.32156,0.31803,1,0
3,GO PHAGOCYTOSIS RECOGNITION,0.016734,0.30286,0.22475,1,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.037747,0.30237,0.21763,1,0
3,GO LEUKOCYTE AGGREGATION,0.044685,0.28668,0.15977,1,0
3,GO ALANINE TRANSPORT,0.0087944,0.27138,0.26509,1,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.04854,0.2569,0.15756,1,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.045624,0.24726,0.14968,1,0
3,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.0064317,0.24522,0.26465,1,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.026586,0.24392,0.20827,1,0
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.027188,0.24155,0.2339,1,0
3,GO BASIC AMINO ACID TRANSPORT,0.014841,0.23992,0.23958,1,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0057817,0.23891,0.21851,1,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.041967,0.23278,0.14914,1,0
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.045624,0.22828,0.27378,1,0
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0046564,0.21539,0.16425,1,0
3,GO FATTY ACID HOMEOSTASIS,0.030383,0.21499,0.22494,1,0
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.017137,0.21422,0.18197,1,0
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.029719,0.21174,0.15658,1,0
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.044685,0.2061,0.16618,1,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.013798,0.20505,0.17235,1,0
3,GO POLYOL TRANSPORT,0.018836,0.20181,0.16247,1,0
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0079323,0.20104,0.20086,1,0
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.01282,0.20044,0.18865,1,0
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0085714,0.19781,0.1853,1,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.036948,0.19486,0.15052,1,0
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.010506,0.19367,0.18348,1,0
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.01282,0.18631,0.14046,1,0
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0071468,0.17642,0.10987,1,0
3,GO COPPER ION TRANSPORT,0.017137,0.17485,0.15388,1,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.027188,0.17296,0.17076,1,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0034322,0.17193,0.17248,1,0
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0087944,0.17001,0.19472,1,0
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.017137,0.16453,0.16453,1,0
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.041093,0.16446,0.12343,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0081404,0.16185,0.11942,1,0
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.004408,0.1605,0.1309,1,0
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0027346,0.15925,0.1797,1,0
3,GO COPPER ION HOMEOSTASIS,0.019739,0.15663,0.14714,1,0
3,GO TRANSEPITHELIAL TRANSPORT,0.013139,0.1558,0.11652,1,0
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.041093,0.14298,0.13307,1,0
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.045624,0.14267,0.092204,1,0
3,GO BICARBONATE TRANSPORT,0.036948,0.14235,0.095248,1,0
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.036164,0.13919,0.14094,1,0
3,GO LIVER REGENERATION,0.026586,0.13541,0.1025,1,0
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.035393,0.13526,0.091965,1,0
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.020205,0.13464,0.18444,1,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.031059,0.13289,0.11038,1,0
3,GO IRON ION HOMEOSTASIS,0.020205,0.13287,0.10625,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.018836,0.13008,0.20406,1,0
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.019283,0.1298,0.14549,1,0
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.007729,0.12946,0.097881,1,0
3,GO TOXIN TRANSPORT,0.011326,0.12756,0.10998,1,0
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.031748,0.12374,0.091153,1,0
3,GO CELLULAR IRON ION HOMEOSTASIS,0.0021062,0.12231,0.14635,1,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.029719,0.11796,0.070651,1,0
3,GO RESPONSE TO HEAT,0.0071468,0.11603,0.094228,1,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.010245,0.11382,0.1319,1,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.020205,0.1138,0.16582,1,0
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0094949,0.11277,0.15922,1,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.023741,0.11196,0.090796,1,0
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.015574,0.11121,0.12535,1,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.014138,0.11022,0.11503,1,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.01282,0.10817,0.13567,1,0
3,GO PEPTIDYL ARGININE MODIFICATION,0.03939,0.10794,0.11053,1,0
3,GO REGULATION OF ATP METABOLIC PROCESS,0.013465,0.10653,0.091337,1,0
3,GO PROTEIN FOLDING,0.04854,0.10506,0.071475,1,0
3,GO SNRNA PROCESSING,0.016734,0.098457,0.049846,1,0
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0059384,0.097434,0.10635,1,0
3,GO EXCRETION,0.041093,0.096981,0.093838,1,0
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.045624,0.092219,0.10937,1,0
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0081404,0.084093,0.10753,1,0
3,GO PROTEASOME ASSEMBLY,0.031059,0.08244,0.15606,1,0
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0081404,0.081878,0.12484,1,0
3,GO NUCLEOSIDE METABOLIC PROCESS,0.022165,0.079204,0.08034,1,0
3,GO MRNA CLEAVAGE,0.029719,0.077722,0.083571,1,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.04854,0.074749,0.075303,1,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0087944,0.073428,0.10102,1,0
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.031748,0.072663,0.080695,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.034637,0.07083,0.071438,1,0
3,GO SNRNA METABOLIC PROCESS,0.027188,0.063685,0.057015,1,0
3,GO DNA GEOMETRIC CHANGE,0.046579,0.062978,0.061629,1,0
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.03245,0.060989,0.076835,1,0
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.026586,0.060199,0.10239,1,0
3,GO MRNA TRANSPORT,0.011326,0.05716,0.096608,1,0
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.041093,-0.034683,-0.064853,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.02843,-0.03767,-0.065732,1,0
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.02268,-0.040981,-0.045749,1,0
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.031748,-0.041207,-0.068413,1,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.022165,-0.041648,-0.062282,1,0
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.033894,-0.043272,-0.056447,1,0
3,GO CELL CYCLE,0.044685,-0.045233,-0.037469,1,0
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.029719,-0.045409,-0.06543,1,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.015953,-0.045526,-0.15863,1,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.046579,-0.048313,-0.063978,1,0
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.010245,-0.049521,-0.090886,1,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.045624,-0.04992,-0.086551,1,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.010773,-0.051587,-0.053613,1,0
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.037747,-0.051605,-0.060858,1,0
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.016734,-0.05181,-0.071412,1,0
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.02166,-0.052689,-0.070334,1,0
3,GO SINGLE FERTILIZATION,0.037747,-0.052812,-0.064119,1,0
3,GO REGULATION OF PHOSPHORYLATION,0.041967,-0.052881,-0.06667,1,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.038561,-0.053837,-0.070133,1,0
3,GO SULFATE TRANSPORT,0.04854,-0.054302,-0.070459,1,0
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.042857,-0.055128,-0.11814,1,0
3,GO CELLULAR RESPONSE TO PEPTIDE,0.02843,-0.055308,-0.065047,1,0
3,GO CYTOKINESIS,0.010245,-0.055317,-0.095031,1,0
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.019739,-0.056054,-0.077075,1,0
3,GO NUCLEUS ORGANIZATION,0.045624,-0.056319,-0.053083,1,0
3,GO CERAMIDE METABOLIC PROCESS,0.024288,-0.056616,-0.10256,1,0
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.0090226,-0.057277,-0.054285,1,0
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.040234,-0.057426,-0.056369,1,0
3,GO CELL CYCLE CHECKPOINT,0.033166,-0.057581,-0.059175,1,0
3,GO APOPTOTIC PROCESS,0.043763,-0.057694,-0.064353,1,0
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.023205,-0.057713,-0.10289,1,0
3,GO REGULATION OF CELL DEATH,0.026586,-0.057967,-0.071216,1,0
3,GO TISSUE MORPHOGENESIS,0.0090226,-0.058374,-0.10346,1,0
3,GO MACROAUTOPHAGY,0.0034322,-0.060409,-0.083526,1,0
3,GO HUMORAL IMMUNE RESPONSE,0.0037331,-0.060529,-0.12668,1,0
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.036948,-0.060569,-0.056096,1,0
3,GO GLYCOSYLATION,0.033894,-0.062103,-0.099527,1,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.0030654,-0.062239,-0.077328,1,0
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.036164,-0.062598,-0.088158,1,0
3,GO SPHINGOLIPID METABOLIC PROCESS,0.027803,-0.063161,-0.10052,1,0
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.019739,-0.063653,-0.06654,1,0
3,GO ORGANELLE FISSION,0.001872,-0.063817,-0.078898,1,0
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.018836,-0.064111,-0.074825,1,0
3,GO VESICLE LOCALIZATION,0.034637,-0.064322,-0.075288,1,0
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.025994,-0.064691,-0.074248,1,0
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.034637,-0.065186,-0.10153,1,0
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.043763,-0.065493,-0.075967,1,0
3,GO ANTIMICROBIAL HUMORAL RESPONSE,0.029719,-0.065646,-0.12487,1,0
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.015574,-0.065819,-0.083854,1,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.033166,-0.065947,-0.082162,1,0
3,GO HISTONE UBIQUITINATION,0.022165,-0.066014,-0.078085,1,0
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.02843,-0.066524,-0.072165,1,0
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.047551,-0.066742,-0.091726,1,0
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0042883,-0.066799,-0.1011,1,0
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0032441,-0.067027,-0.11417,1,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.046579,-0.06812,-0.11564,1,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.012203,-0.068322,-0.086597,1,0
3,GO LEUKOCYTE DIFFERENTIATION,0.0097392,-0.068341,-0.10918,1,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.02843,-0.068424,-0.065714,1,0
3,GO ERAD PATHWAY,0.03245,-0.068427,-0.09817,1,0
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0022992,-0.068543,-0.089772,1,0
3,GO VACUOLE ORGANIZATION,0.029719,-0.068789,-0.087836,1,0
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.027803,-0.068826,-0.094533,1,0
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.027188,-0.069297,-0.081506,1,0
3,GO GLYCEROLIPID METABOLIC PROCESS,0.012203,-0.069809,-0.080974,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.025994,-0.070229,-0.15907,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION,0.00098941,-0.07038,-0.087241,1,0
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.015203,-0.070479,-0.071089,1,0
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.029068,-0.070481,-0.17479,1,0
3,GO LIPID BIOSYNTHETIC PROCESS,0.02068,-0.070531,-0.080347,1,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.014841,-0.070785,-0.0927,1,0
3,GO NEGATIVE REGULATION OF CELL DEATH,0.019283,-0.070877,-0.085042,1,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.047551,-0.070899,-0.1135,1,0
3,GO HISTONE H3 ACETYLATION,0.036164,-0.071031,-0.060251,1,0
3,GO METAPHASE PLATE CONGRESSION,0.0057817,-0.071151,-0.1242,1,0
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.02268,-0.071201,-0.089913,1,0
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0069616,-0.071461,-0.084761,1,0
3,GO EPITHELIAL CELL PROLIFERATION,0.023205,-0.07325,-0.12538,1,0
3,GO RESPONSE TO NITROGEN COMPOUND,0.036948,-0.073316,-0.0567,1,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.001986,-0.073643,-0.096646,1,0
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.03245,-0.073759,-0.10594,1,0
3,GO REGULATION OF HYDROLASE ACTIVITY,0.001872,-0.074901,-0.096977,1,0
3,GO SECRETION,0.00090094,-0.075098,-0.10526,1,0
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.047551,-0.075238,-0.098128,1,0
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.014841,-0.075299,-0.14347,1,0
3,GO BIOLOGICAL ADHESION,0.013465,-0.075302,-0.10996,1,0
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.019739,-0.075627,-0.10064,1,0
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.044685,-0.075663,-0.07275,1,0
3,GO CYTOSKELETON ORGANIZATION,0.0010206,-0.075676,-0.094463,1,0
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.03939,-0.075791,-0.054132,1,0
3,GO CELL MOTILITY,0.0025083,-0.075895,-0.11303,1,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.035393,-0.075951,-0.065167,1,0
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.036164,-0.076403,-0.079509,1,0
3,GO REGULATION OF RESPONSE TO STRESS,0.0047853,-0.07655,-0.094917,1,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.02166,-0.077095,-0.07873,1,0
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.034637,-0.077357,-0.086557,1,0
3,GO REGULATION OF SECRETION,0.0049174,-0.077627,-0.093904,1,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.029719,-0.078264,-0.089062,1,0
3,GO NATURAL KILLER CELL ACTIVATION,0.017969,-0.078464,-0.14171,1,0
3,GO IMMUNE SYSTEM DEVELOPMENT,0.001228,-0.078868,-0.11117,1,0
3,GO FC RECEPTOR SIGNALING PATHWAY,0.043763,-0.079405,-0.087827,1,0
3,GO POSITIVE REGULATION OF SIGNALING,0.0021689,-0.079504,-0.088865,1,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.011904,-0.079693,-0.08748,1,0
3,GO GOLGI VESICLE TRANSPORT,0.02268,-0.080398,-0.078751,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.014486,-0.080942,-0.12717,1,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.0021062,-0.081003,-0.12564,1,0
3,GO DEMETHYLATION,0.037747,-0.081129,-0.064341,1,0
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0079323,-0.081379,-0.093064,1,0
3,GO HISTONE H3 K14 ACETYLATION,0.03245,-0.081424,-0.11095,1,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.030383,-0.081575,-0.078199,1,0
3,GO REGULATION OF VASOCONSTRICTION,0.033894,-0.081741,-0.12261,1,0
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0083534,-0.081892,-0.12579,1,0
3,GO REGULATION OF PROTEOLYSIS,0.011047,-0.081894,-0.10418,1,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.025414,-0.081906,-0.078005,1,0
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.010506,-0.081941,-0.082958,1,0
3,GO RENAL SYSTEM PROCESS,0.0081404,-0.082015,-0.1365,1,0
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.018398,-0.082158,-0.11135,1,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.02268,-0.082266,-0.12892,1,0
3,GO CELLULAR LIPID METABOLIC PROCESS,0.041093,-0.082295,-0.074639,1,0
3,GO VESICLE ORGANIZATION,0.0071468,-0.0827,-0.095652,1,0
3,GO REGULATION OF LIPID STORAGE,0.044685,-0.082949,-0.11337,1,0
3,GO REGULATION OF IMMUNE RESPONSE,0.0079323,-0.082975,-0.11408,1,0
3,GO PROTEOLYSIS,0.00090094,-0.083141,-0.10017,1,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.017969,-0.083422,-0.07602,1,0
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.017969,-0.08356,-0.15742,1,0
3,GO MACROPHAGE DIFFERENTIATION,0.041967,-0.084098,-0.13399,1,0
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0022332,-0.084106,-0.07251,1,0
3,GO PEPTIDYL SERINE MODIFICATION,0.036948,-0.084176,-0.061185,1,0
3,GO NEUTROPHIL CHEMOTAXIS,0.0073363,-0.084681,-0.11307,1,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.017549,-0.084889,-0.097481,1,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.045624,-0.084971,-0.15573,1,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.044685,-0.085697,-0.12252,1,0
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0073363,-0.085783,-0.093785,1,0
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.029719,-0.085865,-0.18157,1,0
3,GO ESTABLISHMENT OF CELL POLARITY,0.0060989,-0.086007,-0.1077,1,0
3,GO VIRAL RNA GENOME REPLICATION,0.023741,-0.086106,-0.14202,1,0
3,GO TUBE DEVELOPMENT,0.0059384,-0.086193,-0.11859,1,0
3,GO PROTEIN MONOUBIQUITINATION,0.00069957,-0.086207,-0.097028,1,0
3,GO ORGANELLE DISASSEMBLY,0.017137,-0.086248,-0.085021,1,0
3,GO REGULATION OF CELL DIVISION,0.021165,-0.086384,-0.071939,1,0
3,GO MUSCLE ADAPTATION,0.014486,-0.086399,-0.11137,1,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.017969,-0.086416,-0.098262,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.027188,-0.086674,-0.12629,1,0
3,GO REGULATION OF HEMOPOIESIS,0.010773,-0.086715,-0.10715,1,0
3,GO GOLGI TO VACUOLE TRANSPORT,0.02068,-0.086788,-0.12532,1,0
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.01282,-0.086839,-0.12441,1,0
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.013139,-0.08715,-0.09978,1,0
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.01282,-0.087158,-0.12453,1,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00095906,-0.087194,-0.12317,1,0
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0071468,-0.087272,-0.13007,1,0
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.04854,-0.087316,-0.090433,1,0
3,GO CENTRIOLE ASSEMBLY,0.031748,-0.087391,-0.10183,1,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.010773,-0.087982,-0.13079,1,0
3,GO IMMUNOGLOBULIN PRODUCTION,0.0066042,-0.088036,-0.11068,1,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.034637,-0.088237,-0.15137,1,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.040234,-0.088374,-0.13161,1,0
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0028957,-0.088835,-0.094187,1,0
3,GO ORGANELLE ASSEMBLY,0.00081984,-0.088985,-0.072738,1,0
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.014138,-0.089169,-0.083915,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0056288,-0.089289,-0.15354,1,0
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0067808,-0.089494,-0.087541,1,0
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.019739,-0.089649,-0.1693,1,0
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.022165,-0.089857,-0.075525,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.007729,-0.090052,-0.10345,1,0
3,GO LYMPHOCYTE ACTIVATION,0.0049174,-0.090234,-0.11481,1,0
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.035393,-0.090727,-0.13499,1,0
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.00040247,-0.091432,-0.11385,1,0
3,GO ANATOMICAL STRUCTURE MATURATION,0.007729,-0.091433,-0.088435,1,0
3,GO REGULATION OF PH,0.0026572,-0.091444,-0.10459,1,0
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.024288,-0.091662,-0.14891,1,0
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.010506,-0.092083,-0.083169,1,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0011549,-0.092301,-0.14096,1,0
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.02166,-0.092742,-0.13747,1,0
3,GO NEUTROPHIL MIGRATION,0.022165,-0.092829,-0.11915,1,0
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0049174,-0.092847,-0.11737,1,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.035393,-0.092847,-0.075345,1,0
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.043763,-0.093058,-0.12778,1,0
3,GO EXOCYTOSIS,0.0019282,-0.093408,-0.12009,1,0
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0021062,-0.093551,-0.12399,1,0
3,GO REGULATION OF BODY FLUID LEVELS,0.00055855,-0.093563,-0.15115,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.014841,-0.093579,-0.18858,1,0
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0051916,-0.0936,-0.13708,1,0
3,GO REGULATION OF T CELL DIFFERENTIATION,0.013465,-0.093643,-0.11262,1,0
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.027188,-0.093862,-0.11528,1,0
3,GO REGULATION OF CELLULAR PH,0.001872,-0.093869,-0.1088,1,0
3,GO LYMPHOCYTE DIFFERENTIATION,0.0013872,-0.094343,-0.12248,1,0
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0041716,-0.094344,-0.11336,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.013465,-0.094359,-0.11686,1,0
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.027803,-0.094394,-0.083161,1,0
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.011047,-0.094624,-0.11566,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.014486,-0.09467,-0.09185,1,0
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.02268,-0.094853,-0.12145,1,0
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.041093,-0.094857,-0.13368,1,0
3,GO VESICLE TARGETING,0.0020453,-0.094945,-0.15101,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0073363,-0.094963,-0.090468,1,0
3,GO ACTIVATION OF IMMUNE RESPONSE,0.0079323,-0.095186,-0.10866,1,0
3,GO DETECTION OF STIMULUS,0.00087311,-0.095561,-0.09654,1,0
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.017549,-0.095573,-0.10912,1,0
3,GO REGULATION OF HORMONE SECRETION,0.0033369,-0.095647,-0.12274,1,0
3,GO TUBE MORPHOGENESIS,0.0081404,-0.095813,-0.12217,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.033894,-0.095997,-0.12914,1,0
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.025414,-0.096058,-0.12707,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.030383,-0.096326,-0.16532,1,0
3,GO GOLGI VESICLE BUDDING,0.015953,-0.09639,-0.10843,1,0
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.00016023,-0.096773,-0.10163,1,0
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0075304,-0.096782,-0.11778,1,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0037331,-0.096875,-0.088977,1,0
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.02068,-0.096907,-0.17894,1,0
3,GO FAT CELL DIFFERENTIATION,0.00081984,-0.09705,-0.15547,1,0
3,GO COPII COATED VESICLE BUDDING,0.0094949,-0.097142,-0.10779,1,0
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.047551,-0.097503,-0.095248,1,0
3,GO POSTREPLICATION REPAIR,0.016734,-0.097532,-0.085486,1,0
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.044685,-0.097731,-0.10014,1,0
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0032441,-0.097931,-0.12872,1,0
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0047853,-0.098168,-0.1034,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00074557,-0.098255,-0.14094,1,0
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0017123,-0.09827,-0.12257,1,0
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0051916,-0.098468,-0.11435,1,0
3,GO RESPONSE TO ALCOHOL,0.0071468,-0.098516,-0.10258,1,0
3,GO CELL MATURATION,0.0047853,-0.09882,-0.10492,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.038561,-0.098867,-0.15723,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.045624,-0.099827,-0.1037,1,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.031059,-0.09984,-0.10317,1,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0029794,-0.099889,-0.14195,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.035393,-0.099988,-0.14257,1,0
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.033166,-0.099999,-0.11013,1,0
3,GO PROTEIN POLYUBIQUITINATION,0.00019753,-0.10004,-0.11932,1,0
3,GO ACTIN FILAMENT ORGANIZATION,0.00090094,-0.10047,-0.1292,1,0
3,GO LIPOPROTEIN METABOLIC PROCESS,0.046579,-0.10049,-0.084108,1,0
3,GO MYOBLAST DIFFERENTIATION,0.015953,-0.10055,-0.16242,1,0
3,GO MULTI ORGANISM PROCESS,0.00016023,-0.10055,-0.095058,1,0
3,GO ACTIVATION OF GTPASE ACTIVITY,0.0014738,-0.10118,-0.11805,1,0
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.031059,-0.10137,-0.15048,1,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.034637,-0.1014,-0.092643,1,0
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0071468,-0.1016,-0.1294,1,0
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.02843,-0.10164,-0.093213,1,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0025817,-0.10165,-0.10002,1,0
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.02843,-0.10181,-0.19452,1,0
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.010245,-0.10184,-0.24022,1,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0069616,-0.10192,-0.095238,1,0
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.011326,-0.10194,-0.17888,1,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0056288,-0.1022,-0.14484,1,0
3,GO TEMPERATURE HOMEOSTASIS,0.016339,-0.10222,-0.089812,1,0
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0060989,-0.10222,-0.10382,1,0
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0079323,-0.10232,-0.11995,1,0
3,GO PROTEIN MATURATION,0.019283,-0.10233,-0.098846,1,0
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.0016129,-0.10236,-0.12975,1,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.036948,-0.10246,-0.082976,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0051916,-0.10248,-0.14193,1,0
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.01282,-0.10249,-0.10025,1,0
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0032441,-0.10265,-0.10455,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.047551,-0.10342,-0.087202,1,0
3,GO PROTEIN AUTOUBIQUITINATION,0.0018173,-0.10347,-0.097761,1,0
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.029068,-0.10387,-0.093135,1,0
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.026586,-0.10408,-0.19481,1,0
3,GO CELL ACTIVATION,0.0018173,-0.10428,-0.1409,1,0
3,GO PH REDUCTION,0.0015189,-0.10437,-0.15083,1,0
3,GO CHROMOSOME LOCALIZATION,0.0007696,-0.10445,-0.14285,1,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.011612,-0.10464,-0.11779,1,0
3,GO GOLGI ORGANIZATION,0.0014738,-0.10471,-0.12541,1,0
3,GO CYTOKINE METABOLIC PROCESS,0.0079323,-0.10502,-0.16957,1,0
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0011199,-0.10502,-0.1169,1,0
3,GO B CELL PROLIFERATION,0.025414,-0.10547,-0.11874,1,0
3,GO RESPONSE TO BIOTIC STIMULUS,0.0034322,-0.10564,-0.13389,1,0
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,8.1192e-05,-0.10575,-0.14345,1,0
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.025994,-0.10592,-0.18998,1,0
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.00090094,-0.10597,-0.14108,1,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.035393,-0.10611,-0.089584,1,0
3,GO GLAND DEVELOPMENT,0.0025083,-0.10616,-0.12945,1,0
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.010245,-0.10616,-0.12643,1,0
3,GO SPROUTING ANGIOGENESIS,0.04854,-0.10648,-0.11492,1,0
3,GO INNATE IMMUNE RESPONSE,0.001872,-0.10665,-0.16272,1,0
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.036948,-0.10678,-0.10607,1,0
3,GO POSITIVE REGULATION OF SECRETION,0.00025131,-0.10679,-0.13298,1,0
3,GO REGULATION OF HORMONE LEVELS,0.0049174,-0.1071,-0.11379,1,0
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,7.2754e-05,-0.10718,-0.15212,1,0
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.031059,-0.10718,-0.089537,1,0
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0099891,-0.10724,-0.15904,1,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.011612,-0.1073,-0.1572,1,0
3,GO ACTIN FILAMENT BASED PROCESS,0.0020453,-0.1077,-0.10611,1,0
3,GO PEPTIDE HORMONE SECRETION,0.033166,-0.10775,-0.09058,1,0
3,GO REGULATION OF PEPTIDE TRANSPORT,0.00026903,-0.10788,-0.10535,1,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.0047853,-0.10839,-0.13442,1,0
3,GO NEGATIVE T CELL SELECTION,0.00054072,-0.10853,-0.17331,1,0
3,GO T CELL DIFFERENTIATION,0.0027346,-0.10858,-0.13202,1,0
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0030654,-0.10871,-0.17731,1,0
3,GO REGULATION OF MAP KINASE ACTIVITY,0.024846,-0.10874,-0.095725,1,0
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00052342,-0.10924,-0.11581,1,0
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.03939,-0.10963,-0.08978,1,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0040578,-0.11063,-0.18061,1,0
3,GO APOPTOTIC SIGNALING PATHWAY,0.0041716,-0.11074,-0.11128,1,0
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0083534,-0.11103,-0.13223,1,0
3,GO RESPONSE TO OSMOTIC STRESS,0.014138,-0.11133,-0.12568,1,0
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0022332,-0.11141,-0.11953,1,0
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00045924,-0.11158,-0.15372,1,0
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.038561,-0.1116,-0.12939,1,0
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0020453,-0.112,-0.11627,1,0
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0029794,-0.11222,-0.17521,1,0
3,GO AUTOPHAGY OF MITOCHONDRION,0.0087944,-0.11257,-0.1013,1,0
3,GO PROTEIN O LINKED GLYCOSYLATION,0.0040578,-0.11259,-0.16405,1,0
3,GO RESPONSE TO BACTERIUM,0.013139,-0.11265,-0.12656,1,0
3,GO HORMONE TRANSPORT,0.0057817,-0.11267,-0.117,1,0
3,GO MITOTIC CYTOKINESIS,0.0021689,-0.11286,-0.14786,1,0
3,GO CARBOHYDRATE TRANSPORT,0.00353,-0.11335,-0.11185,1,0
3,GO CYTOKINE SECRETION,0.0038387,-0.1136,-0.14055,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0013054,-0.11364,-0.14419,1,0
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.015203,-0.11384,-0.10581,1,0
3,GO REGULATION OF FATTY ACID TRANSPORT,0.045624,-0.11388,-0.14633,1,0
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00095906,-0.11407,-0.16242,1,0
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.023205,-0.11448,-0.097759,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.021165,-0.11467,-0.17207,1,0
3,GO PLATELET MORPHOGENESIS,0.016734,-0.11472,-0.19134,1,0
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.011904,-0.11494,-0.12624,1,0
3,GO LEUKOCYTE CELL CELL ADHESION,0.001872,-0.11545,-0.15281,1,0
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0032441,-0.11566,-0.13405,1,0
3,GO REGULATION OF CELL ACTIVATION,0.00092958,-0.11572,-0.1396,1,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.0012662,-0.11585,-0.16494,1,0
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0075304,-0.11648,-0.098854,1,0
3,GO TISSUE HOMEOSTASIS,2.3418e-05,-0.11649,-0.1758,1,0
3,GO KETONE CATABOLIC PROCESS,0.019739,-0.117,-0.22735,1,0
3,GO FEMALE GAMETE GENERATION,0.004408,-0.11713,-0.098935,1,0
3,GO LYMPHOCYTE CHEMOTAXIS,0.011326,-0.11733,-0.14367,1,0
3,GO PEPTIDE SECRETION,0.0013054,-0.1174,-0.11689,1,0
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.019283,-0.11741,-0.22768,1,0
3,GO VIRAL LIFE CYCLE,0.0053338,-0.11756,-0.16283,1,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.013139,-0.11772,-0.12534,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0075304,-0.1178,-0.1057,1,0
3,GO REGULATION OF CELL ADHESION,0.00024286,-0.11787,-0.18036,1,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.013798,-0.11792,-0.10876,1,0
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.018836,-0.11798,-0.11435,1,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.020205,-0.11812,-0.15413,1,0
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.013798,-0.11824,-0.21648,1,0
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.01282,-0.11829,-0.1642,1,0
3,GO CELL CELL ADHESION,0.00019079,-0.11839,-0.15699,1,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.007729,-0.11842,-0.12635,1,0
3,GO RESPONSE TO BMP,0.0090226,-0.11856,-0.1468,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0094949,-0.11862,-0.099291,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.010506,-0.11862,-0.12633,1,0
3,GO REGULATION OF SPINDLE ORGANIZATION,0.00095906,-0.11866,-0.14228,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0017123,-0.11887,-0.14557,1,0
3,GO REGULATION OF NUCLEAR DIVISION,0.0010859,-0.11895,-0.10036,1,0
3,GO RESPONSE TO INTERLEUKIN 15,0.036164,-0.11896,-0.15847,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00021909,-0.11925,-0.15725,1,0
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0083534,-0.1193,-0.12502,1,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.0094949,-0.11946,-0.14451,1,0
3,GO REGULATION OF PINOCYTOSIS,0.023205,-0.11957,-0.18237,1,0
3,GO REGULATION OF HISTONE DEACETYLATION,0.034637,-0.11977,-0.1291,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00010462,-0.11981,-0.1651,1,0
3,GO MYELOID CELL DIFFERENTIATION,0.00052342,-0.11983,-0.1339,1,0
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,2.7343e-05,-0.11986,-0.15455,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0017641,-0.11991,-0.1279,1,0
3,GO HEMOGLOBIN METABOLIC PROCESS,0.0054795,-0.11997,-0.17851,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.001662,-0.12008,-0.14253,1,0
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.015203,-0.12025,-0.14678,1,0
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.046579,-0.12026,-0.10495,1,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.04854,-0.12082,-0.16233,1,0
3,GO VESICLE BUDDING FROM MEMBRANE,0.0007696,-0.12086,-0.14923,1,0
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0038387,-0.12158,-0.155,1,0
3,GO REGULATION OF ENDOCRINE PROCESS,0.012508,-0.12181,-0.14934,1,0
3,GO T CELL ACTIVATION,0.00047456,-0.12195,-0.15996,1,0
3,GO MYELOID LEUKOCYTE ACTIVATION,0.0071468,-0.12206,-0.15388,1,0
3,GO REGULATION OF DEFENSE RESPONSE,0.00054072,-0.12208,-0.14666,1,0
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0042883,-0.12225,-0.18457,1,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.012508,-0.12235,-0.098879,1,0
3,GO REGULATION OF T CELL ACTIVATION,0.00037661,-0.12243,-0.15611,1,0
3,GO POLYAMINE METABOLIC PROCESS,0.04854,-0.12251,-0.11762,1,0
3,GO REGULATION OF ISOTYPE SWITCHING,0.012203,-0.12256,-0.17197,1,0
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.0024367,-0.1232,-0.11174,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.013798,-0.1233,-0.16293,1,0
3,GO AUTOPHAGOSOME ORGANIZATION,0.00026903,-0.12341,-0.15728,1,0
3,GO DIGESTIVE SYSTEM PROCESS,0.013139,-0.12359,-0.13826,1,0
3,GO CELL MATRIX ADHESION,0.014486,-0.12365,-0.14924,1,0
3,GO ACUTE INFLAMMATORY RESPONSE,0.0057817,-0.12391,-0.19975,1,0
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.014138,-0.12405,-0.14335,1,0
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,7.013e-05,-0.12431,-0.13159,1,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0034322,-0.12443,-0.1786,1,0
3,GO REGULATION OF PEPTIDE SECRETION,0.00036427,-0.1246,-0.13004,1,0
3,GO POSITIVE CHEMOTAXIS,0.016339,-0.12486,-0.17802,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.031059,-0.12505,-0.16069,1,0
3,GO REGULATION OF B CELL ACTIVATION,0.0013872,-0.12526,-0.15571,1,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.02166,-0.1253,-0.12307,1,0
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.041967,-0.1254,-0.13186,1,0
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0015189,-0.12582,-0.17967,1,0
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.046579,-0.12589,-0.10159,1,0
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.00031859,-0.12604,-0.14939,1,0
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.013798,-0.12609,-0.13432,1,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.012508,-0.12649,-0.15344,1,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.013798,-0.12669,-0.18439,1,0
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.001191,-0.12675,-0.14319,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.04854,-0.12678,-0.15384,1,0
3,GO DEFENSE RESPONSE,0.00065623,-0.12697,-0.15075,1,0
3,GO LIPID LOCALIZATION,0.0030654,-0.12701,-0.13003,1,0
3,GO ERBB SIGNALING PATHWAY,0.011612,-0.12708,-0.12368,1,0
3,GO LEUKOCYTE PROLIFERATION,0.00020448,-0.12732,-0.1701,1,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.03245,-0.12742,-0.1834,1,0
3,GO CARDIOCYTE DIFFERENTIATION,0.015574,-0.12743,-0.11816,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.035393,-0.12764,-0.18513,1,0
3,GO GOLGI TO ENDOSOME TRANSPORT,0.03245,-0.1277,-0.139,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.035393,-0.1278,-0.15284,1,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.022165,-0.12804,-0.23898,1,0
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.014138,-0.12832,-0.15406,1,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.031059,-0.12833,-0.18594,1,0
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.0014299,-0.12846,-0.17411,1,0
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.00044439,-0.12849,-0.1833,1,0
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.007729,-0.1286,-0.19003,1,0
3,GO LYMPHOCYTE COSTIMULATION,0.0090226,-0.1287,-0.13035,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0013457,-0.1291,-0.16697,1,0
3,GO NEURAL TUBE DEVELOPMENT,0.00037661,-0.12933,-0.15216,1,0
3,GO RESPONSE TO COLD,0.022165,-0.12939,-0.18753,1,0
3,GO RESPONSE TO PEPTIDOGLYCAN,0.0032441,-0.1294,-0.19542,1,0
3,GO INSULIN SECRETION,0.022165,-0.12951,-0.10085,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.013798,-0.12954,-0.19744,1,0
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.013798,-0.12974,-0.16339,1,0
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0050528,-0.1298,-0.17042,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.033166,-0.12985,-0.14,1,0
3,GO EPITHELIUM DEVELOPMENT,9.7801e-06,-0.12997,-0.17622,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.012508,-0.13016,-0.12247,1,0
3,GO ADAPTIVE THERMOGENESIS,0.0054795,-0.13017,-0.11052,1,0
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.0060989,-0.13058,-0.15416,1,0
3,GO RESPONSE TO CYTOKINE,0.0024367,-0.1309,-0.14724,1,0
3,GO COAGULATION,0.0020453,-0.13091,-0.1596,1,0
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00014418,-0.13135,-0.13943,1,0
3,GO CYTOKINE PRODUCTION,0.00041602,-0.13156,-0.1686,1,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.042857,-0.13159,-0.089382,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00092958,-0.13165,-0.16713,1,0
3,GO TISSUE MIGRATION,0.038561,-0.13168,-0.11595,1,0
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0025817,-0.13189,-0.17344,1,0
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0060989,-0.13192,-0.17204,1,0
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00019753,-0.13205,-0.20088,1,0
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00063551,-0.13205,-0.11843,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0020453,-0.13214,-0.17416,1,0
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.00026003,-0.13237,-0.19009,1,0
3,GO DENDRITIC CELL MIGRATION,0.041093,-0.13265,-0.17049,1,0
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00057693,-0.13269,-0.16647,1,0
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00067758,-0.13281,-0.1783,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00050664,-0.13288,-0.1625,1,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.018398,-0.1329,-0.12033,1,0
3,GO PEPTIDYL TYROSINE MODIFICATION,0.001228,-0.13324,-0.15078,1,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0059384,-0.13326,-0.16621,1,0
3,GO RESPONSE TO WOUNDING,0.0030654,-0.13374,-0.15742,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.027188,-0.1338,-0.17838,1,0
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.011047,-0.13387,-0.2028,1,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.015574,-0.13402,-0.1989,1,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.025994,-0.13403,-0.13305,1,0
3,GO LIPOPROTEIN LOCALIZATION,0.011612,-0.13434,-0.15444,1,0
3,GO ENDOCYTIC RECYCLING,4.6597e-05,-0.13455,-0.18029,1,0
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.0019282,-0.1346,-0.14841,1,0
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0028957,-0.13468,-0.11781,1,0
3,GO RESPONSE TO DSRNA,0.047551,-0.13481,-0.11362,1,0
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.015203,-0.13486,-0.12712,1,0
3,GO CELL KILLING,0.0045306,-0.13513,-0.15828,1,0
3,GO BLOOD VESSEL REMODELING,0.017969,-0.13523,-0.19849,1,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,4.4878e-05,-0.1353,-0.1802,1,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0014738,-0.13533,-0.11041,1,0
3,GO ENTRY INTO HOST,0.0025817,-0.1358,-0.23649,1,0
3,GO DNA DEALKYLATION,0.017969,-0.13593,-0.13876,1,0
3,GO DIOL BIOSYNTHETIC PROCESS,0.042857,-0.13599,-0.14101,1,0
3,GO TRANSLESION SYNTHESIS,0.0087944,-0.13611,-0.10936,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0041716,-0.13651,-0.15592,1,0
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0034322,-0.13696,-0.1562,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0016129,-0.1371,-0.18961,1,0
3,GO REGULATION OF T CELL CHEMOTAXIS,0.03939,-0.13717,-0.12099,1,0
3,GO WOUND HEALING,0.0022992,-0.1373,-0.1744,1,0
3,GO T CELL PROLIFERATION,0.0010528,-0.13742,-0.16569,1,0
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0010859,-0.13742,-0.16011,1,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.00084609,-0.13789,-0.15997,1,0
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.00021167,-0.1379,-0.15162,1,0
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00065623,-0.13867,-0.12699,1,0
3,GO B CELL ACTIVATION,5.6174e-05,-0.13878,-0.15951,1,0
3,GO OOCYTE DIFFERENTIATION,0.035393,-0.13927,-0.12582,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0066042,-0.13929,-0.18719,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00037661,-0.13965,-0.1913,1,0
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.02068,-0.1397,-0.098384,1,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.00045924,-0.1397,-0.16936,1,0
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,7.8282e-05,-0.13992,-0.15189,1,0
3,GO REGULATION OF MUSCLE ADAPTATION,0.0010859,-0.14002,-0.15772,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00063551,-0.14012,-0.18399,1,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0049174,-0.14203,-0.15638,1,0
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00067758,-0.14205,-0.16759,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0099891,-0.14206,-0.15961,1,0
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00041602,-0.14214,-0.22836,1,0
3,GO INTERACTION WITH HOST,0.001228,-0.14223,-0.18837,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0025083,-0.14224,-0.15303,1,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.03939,-0.14227,-0.35219,1,0
3,GO PROTEIN KINASE B SIGNALING,0.00065623,-0.14248,-0.16057,1,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.025414,-0.14252,-0.14783,1,0
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00019079,-0.14266,-0.16749,1,0
3,GO RESPONSE TO CADMIUM ION,0.031748,-0.14295,-0.17718,1,0
3,GO INFLAMMATORY RESPONSE,0.00069957,-0.14296,-0.15213,1,0
3,GO SPINDLE LOCALIZATION,0.00030804,-0.14322,-0.16657,1,0
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.001662,-0.14322,-0.1271,1,0
3,GO MAST CELL MEDIATED IMMUNITY,0.007729,-0.14332,-0.22238,1,0
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,7.013e-05,-0.14338,-0.21169,1,0
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.001986,-0.144,-0.16389,1,0
3,GO RESPONSE TO ETHER,0.0053338,-0.14445,-0.13482,1,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.03245,-0.14456,-0.16562,1,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00029782,-0.14493,-0.18444,1,0
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0094949,-0.14505,-0.21996,1,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.019283,-0.14512,-0.22085,1,0
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.040234,-0.14517,-0.17913,1,0
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0054795,-0.1452,-0.19984,1,0
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0012662,-0.14559,-0.18855,1,0
3,GO SECONDARY METABOLIC PROCESS,0.011904,-0.14566,-0.19,1,0
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00042998,-0.14566,-0.15322,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00069957,-0.14573,-0.20554,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.001872,-0.14576,-0.18327,1,0
3,GO REGULATION OF HAIR CYCLE,0.023205,-0.14609,-0.16988,1,0
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0060989,-0.14618,-0.15409,1,0
3,GO REGULATION OF B CELL PROLIFERATION,0.0060989,-0.14658,-0.165,1,0
3,GO CELLULAR RESPONSE TO IRON ION,0.015953,-0.14692,-0.27402,1,0
3,GO SECRETION BY TISSUE,0.02166,-0.14693,-0.15417,1,0
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0099891,-0.14703,-0.18024,1,0
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0050528,-0.14743,-0.12426,1,0
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0090226,-0.14746,-0.13084,1,0
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0047853,-0.14794,-0.13657,1,0
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.013465,-0.14815,-0.18178,1,0
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00021167,-0.1482,-0.20055,1,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00027832,-0.14837,-0.17643,1,0
3,GO HISTONE MONOUBIQUITINATION,3.7145e-05,-0.14881,-0.16284,1,0
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,9.8628e-07,-0.14883,-0.18047,1,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0049174,-0.14899,-0.17322,1,0
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0071468,-0.14901,-0.19004,1,0
3,GO IMMUNE EFFECTOR PROCESS,0.00037661,-0.14917,-0.18236,1,0
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.017549,-0.14954,-0.26092,1,0
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.029719,-0.14977,-0.15496,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0097392,-0.14989,-0.22412,1,0
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0075304,-0.15016,-0.19006,1,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0011199,-0.15026,-0.18673,1,0
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.001662,-0.15048,-0.26235,1,0
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0010206,-0.15078,-0.16317,1,0
3,GO GRANULOCYTE MIGRATION,0.00067758,-0.15079,-0.17211,1,0
3,GO FIBROBLAST MIGRATION,0.0034322,-0.15081,-0.1968,1,0
3,GO FOAM CELL DIFFERENTIATION,0.027188,-0.15103,-0.16387,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.007729,-0.15109,-0.18177,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.004408,-0.15109,-0.19016,1,0
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0071468,-0.15125,-0.1859,1,0
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.0039469,-0.15136,-0.14344,1,0
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.02166,-0.15173,-0.16829,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0027346,-0.15197,-0.16061,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0066042,-0.15227,-0.19074,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,3.4421e-05,-0.15257,-0.19344,1,0
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.0032441,-0.15274,-0.16436,1,0
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00049035,-0.15281,-0.20009,1,0
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.001662,-0.15284,-0.19331,1,0
3,GO CELLULAR RESPONSE TO ALCOHOL,0.00036427,-0.15329,-0.15351,1,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.00029782,-0.1536,-0.16887,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00084609,-0.15363,-0.17367,1,0
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0013054,-0.15369,-0.16206,1,0
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0045306,-0.15376,-0.16515,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00074557,-0.15386,-0.1957,1,0
3,GO ACTIN NUCLEATION,1.2962e-05,-0.15393,-0.1686,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0057817,-0.15394,-0.2178,1,0
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0007696,-0.15396,-0.16421,1,0
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00023468,-0.15411,-0.19422,1,0
3,GO B CELL APOPTOTIC PROCESS,0.011904,-0.15433,-0.19159,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.009256,-0.15442,-0.20318,1,0
3,GO DEFENSE RESPONSE TO BACTERIUM,3.5759e-05,-0.15451,-0.19397,1,0
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0010206,-0.15522,-0.17103,1,0
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.02166,-0.15539,-0.16244,1,0
3,GO LEUKOCYTE MIGRATION,0.00011241,-0.15541,-0.18764,1,0
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.027188,-0.15548,-0.16268,1,0
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0071468,-0.15595,-0.2045,1,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0049174,-0.15606,-0.13229,1,0
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00055855,-0.15662,-0.19096,1,0
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00014418,-0.15674,-0.18136,1,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.011047,-0.15688,-0.15735,1,0
3,GO RESPONSE TO IRON ION,0.00087311,-0.15741,-0.23484,1,0
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.023741,-0.15793,-0.3831,1,0
3,GO RIG I SIGNALING PATHWAY,0.0087944,-0.15801,-0.1629,1,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.011047,-0.15826,-0.26814,1,0
3,GO ENDOTHELIAL CELL MIGRATION,0.013139,-0.15873,-0.14658,1,0
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00081984,-0.15877,-0.21103,1,0
3,GO REGULATION OF CHEMOTAXIS,8.4205e-05,-0.15891,-0.1702,1,0
3,GO RESPONSE TO VIRUS,0.00016595,-0.159,-0.20655,1,0
3,GO REGULATION OF CELL SHAPE,0.0013872,-0.15903,-0.15343,1,0
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.012508,-0.15911,-0.14871,1,0
3,GO PROTEIN DEMANNOSYLATION,0.041967,-0.15935,-0.1625,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00081984,-0.15945,-0.17483,1,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0051916,-0.15951,-0.18234,1,0
3,GO LIPID DIGESTION,0.010245,-0.15971,-0.27841,1,0
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.027188,-0.15983,-0.13748,1,0
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0011199,-0.15995,-0.17216,1,0
3,GO GRANULOCYTE CHEMOTAXIS,0.00029782,-0.1605,-0.17355,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.02068,-0.16092,-0.23241,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0006154,-0.16127,-0.19795,1,0
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00065623,-0.16127,-0.2399,1,0
3,GO RESPIRATORY BURST,0.0039469,-0.16153,-0.23564,1,0
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,1.1493e-05,-0.16156,-0.1721,1,0
3,GO RESPONSE TO INTERFERON BETA,0.025994,-0.16245,-0.38112,1,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.036164,-0.16263,-0.1418,1,0
3,GO CELLULAR RESPONSE TO VIRUS,0.00032948,-0.16279,-0.19792,1,0
3,GO PHAGOSOME ACIDIFICATION,0.0017641,-0.16286,-0.20229,1,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.038561,-0.1629,-0.15008,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.001191,-0.16295,-0.17348,1,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.026586,-0.16311,-0.14762,1,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.009256,-0.16314,-0.17045,1,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00026903,-0.16323,-0.17013,1,0
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.010506,-0.16326,-0.1727,1,0
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00084609,-0.16348,-0.17906,1,0
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.029719,-0.16354,-0.18503,1,0
3,GO OLIGOPEPTIDE TRANSPORT,0.019283,-0.16385,-0.29524,1,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.041093,-0.16405,-0.11349,1,0
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.001191,-0.16411,-0.13304,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.036948,-0.16414,-0.16221,1,0
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.016339,-0.16431,-0.16759,1,0
3,GO MOVEMENT IN HOST ENVIRONMENT,0.00030804,-0.16441,-0.23835,1,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.040234,-0.16443,-0.13034,1,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.0094949,-0.16449,-0.13875,1,0
3,GO CYTOLYSIS,0.009256,-0.165,-0.21787,1,0
3,GO HISTONE H2A UBIQUITINATION,0.00072223,-0.1651,-0.14361,1,0
3,GO GENETIC IMPRINTING,0.0011199,-0.16511,-0.2005,1,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.025994,-0.16571,-0.19775,1,0
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.011326,-0.16573,-0.17743,1,0
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0018173,-0.16601,-0.21587,1,0
3,GO RESPONSE TO ISCHEMIA,0.0062634,-0.16624,-0.1478,1,0
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.016339,-0.16625,-0.21142,1,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.010245,-0.16653,-0.22173,1,0
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.03245,-0.16662,-0.213,1,0
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.0085714,-0.16677,-0.2186,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION,0.00052342,-0.1668,-0.18735,1,0
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.00012964,-0.16695,-0.16002,1,0
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0017123,-0.16701,-0.20683,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.014841,-0.16755,-0.19586,1,0
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.0031536,-0.16761,-0.15245,1,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00090094,-0.16774,-0.2548,1,0
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00095906,-0.16806,-0.20819,1,0
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0038387,-0.16891,-0.156,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00040247,-0.16897,-0.22176,1,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.043763,-0.16914,-0.13671,1,0
3,GO CELLULAR RESPONSE TO DSRNA,0.02068,-0.16917,-0.1803,1,0
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.02268,-0.16923,-0.32375,1,0
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.03245,-0.16928,-0.18367,1,0
3,GO RETINOL METABOLIC PROCESS,0.040234,-0.16944,-0.183,1,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.016339,-0.16997,-0.16166,1,0
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.02068,-0.16999,-0.15733,1,0
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.547e-05,-0.17,-0.20865,1,0
3,GO REGULATION OF FIBROBLAST MIGRATION,0.0010206,-0.17012,-0.22263,1,0
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.030383,-0.1717,-0.1684,1,0
3,GO IMMUNOGLOBULIN SECRETION,0.0017641,-0.17173,-0.28009,1,0
3,GO DIGESTION,0.00069957,-0.17194,-0.18199,1,0
3,GO DIOL METABOLIC PROCESS,0.023741,-0.17195,-0.15986,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00063551,-0.17214,-0.17725,1,0
3,GO ACUTE PHASE RESPONSE,0.0010206,-0.17217,-0.21569,1,0
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0037331,-0.17218,-0.18808,1,0
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0045306,-0.17218,-0.20026,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0073363,-0.17253,-0.2266,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00019079,-0.17267,-0.19742,1,0
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.011904,-0.17268,-0.18817,1,0
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,8.6584e-06,-0.17277,-0.25385,1,0
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,9.0551e-05,-0.17292,-0.15553,1,0
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0034322,-0.17298,-0.15539,1,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.036948,-0.17301,-0.19567,1,0
3,GO PHOSPHOLIPID TRANSPORT,0.00026903,-0.17331,-0.17209,1,0
3,GO PROTEIN PROCESSING,0.00035231,-0.1735,-0.17704,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0045306,-0.17442,-0.3037,1,0
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0025083,-0.17476,-0.17016,1,0
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.010773,-0.17477,-0.1784,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00041602,-0.17479,-0.19113,1,0
3,GO REGULATION OF CELL CELL ADHESION,2.7343e-05,-0.17479,-0.20571,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.018398,-0.17497,-0.18862,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0045306,-0.17511,-0.2066,1,0
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00084609,-0.17514,-0.23068,1,0
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00038934,-0.17532,-0.20336,1,0
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,7.547e-05,-0.17544,-0.20919,1,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.011326,-0.17552,-0.15768,1,0
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,1.8521e-05,-0.17559,-0.20004,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.010506,-0.17565,-0.15519,1,0
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.001662,-0.17588,-0.2011,1,0
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.017137,-0.17593,-0.22984,1,0
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.009256,-0.176,-0.19015,1,0
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0049174,-0.17603,-0.20618,1,0
3,GO DNA DEMETHYLATION,0.00041602,-0.17626,-0.19873,1,0
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0083534,-0.1763,-0.15215,1,0
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.041093,-0.1763,-0.24631,1,0
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0014299,-0.17648,-0.2406,1,0
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.011904,-0.17713,-0.19481,1,0
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0013054,-0.17729,-0.19351,1,0
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0018173,-0.17754,-0.23576,1,0
3,GO REGULATION OF MAST CELL ACTIVATION,0.0075304,-0.17786,-0.1893,1,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.007729,-0.17792,-0.20272,1,0
3,GO SENSORY PERCEPTION OF TASTE,5.0226e-05,-0.17801,-0.21687,1,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.017969,-0.17802,-0.22052,1,0
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0029794,-0.17814,-0.21348,1,0
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00016595,-0.17818,-0.22027,1,0
3,GO MAST CELL ACTIVATION,0.0030654,-0.1784,-0.214,1,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.035393,-0.17883,-0.23258,1,0
3,GO B CELL DIFFERENTIATION,5.0683e-06,-0.17886,-0.20775,1,0
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0087944,-0.17934,-0.27848,1,0
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00017796,-0.1794,-0.17246,1,0
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.021165,-0.17942,-0.24678,1,0
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00059588,-0.17945,-0.24184,1,0
3,GO EXECUTION PHASE OF APOPTOSIS,6.7728e-06,-0.17948,-0.16726,1,0
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0010206,-0.17959,-0.18112,1,0
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0069616,-0.18011,-0.21973,1,0
3,GO ADAPTIVE IMMUNE RESPONSE,0.00019753,-0.18028,-0.21932,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00020448,-0.18029,-0.24031,1,0
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0064317,-0.18031,-0.23746,1,0
3,GO NEGATIVE REGULATION OF BONE REMODELING,0.031748,-0.18036,-0.22801,1,0
3,GO INTESTINAL LIPID ABSORPTION,0.0067808,-0.18058,-0.28825,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00067758,-0.18083,-0.28436,1,0
3,GO HISTAMINE TRANSPORT,0.014841,-0.18089,-0.24686,1,0
3,GO CHEMOKINE PRODUCTION,0.00016023,-0.18113,-0.22972,1,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00087311,-0.18124,-0.28685,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00029782,-0.18138,-0.22226,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0083534,-0.18149,-0.25475,1,0
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00067758,-0.1816,-0.20892,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.004408,-0.18197,-0.16559,1,0
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0040578,-0.18208,-0.19688,1,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.010773,-0.18257,-0.17993,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00037661,-0.18271,-0.20361,1,0
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0020453,-0.183,-0.17933,1,0
3,GO MATURE B CELL DIFFERENTIATION,0.011612,-0.18363,-0.23318,1,0
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.6584e-06,-0.18368,-0.26101,1,0
3,GO T CELL CYTOKINE PRODUCTION,0.0027346,-0.18394,-0.19475,1,0
3,GO RESPONSE TO PROGESTERONE,0.00072223,-0.18408,-0.26844,1,0
3,GO MYELOID CELL HOMEOSTASIS,4.0073e-05,-0.18416,-0.19809,1,0
3,GO VIRAL GENOME REPLICATION,0.00040247,-0.18488,-0.23984,1,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0026572,-0.18595,-0.2616,1,0
3,GO RESPONSE TO INTERFERON GAMMA,0.0046564,-0.18616,-0.23618,1,0
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0016129,-0.18693,-0.23813,1,0
3,GO REGULATION OF SYMBIOTIC PROCESS,0.00019079,-0.18714,-0.21312,1,0
3,GO AMYLOID BETA CLEARANCE,0.0079323,-0.18738,-0.19228,1,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00019753,-0.18815,-0.20879,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,1.8521e-05,-0.18843,-0.23633,1,0
3,GO ENDOCRINE HORMONE SECRETION,0.00038934,-0.18852,-0.19053,1,0
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.02068,-0.18855,-0.27659,1,0
3,GO RESPONSE TO OXYGEN RADICAL,0.001662,-0.18911,-0.17616,1,0
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0056288,-0.18952,-0.23287,1,0
3,GO MYELOID CELL APOPTOTIC PROCESS,0.0079323,-0.18981,-0.20475,1,0
3,GO TYPE I INTERFERON PRODUCTION,0.00067758,-0.19007,-0.19751,1,0
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.001872,-0.19011,-0.21782,1,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.025414,-0.19032,-0.27129,1,0
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00055855,-0.19054,-0.17654,1,0
3,GO MYELOID LEUKOCYTE MIGRATION,8.1192e-05,-0.19108,-0.19761,1,0
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.0047853,-0.19122,-0.19504,1,0
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0018173,-0.19176,-0.21821,1,0
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,1.4039e-05,-0.19246,-0.26092,1,0
3,GO KERATINOCYTE PROLIFERATION,0.0079323,-0.19259,-0.22235,1,0
3,GO RESPONSE TO INTERLEUKIN 6,0.00012964,-0.19283,-0.25339,1,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,2.4346e-05,-0.1929,-0.19186,1,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.00016023,-0.19337,-0.17412,1,0
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.7806e-05,-0.1935,-0.2,1,0
3,GO ENDOSOME ORGANIZATION,9.8628e-07,-0.19357,-0.20514,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0021689,-0.19373,-0.18013,1,0
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.015574,-0.19428,-0.24205,1,0
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0036303,-0.19447,-0.18983,1,0
3,GO REGULATION OF TISSUE REMODELING,0.00063551,-0.19459,-0.22502,1,0
3,GO RESPONSE TO INTERLEUKIN 2,0.0017123,-0.19464,-0.21941,1,0
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.012508,-0.1948,-0.15333,1,0
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.2454e-05,-0.19526,-0.23285,1,0
3,GO B CELL MEDIATED IMMUNITY,0.00014935,-0.19528,-0.23777,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0064317,-0.19572,-0.21684,1,0
3,GO PLATELET ACTIVATION,8.3127e-06,-0.19632,-0.24082,1,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.0067808,-0.19645,-0.16941,1,0
3,GO LIPID EXPORT FROM CELL,0.019283,-0.19725,-0.14265,1,0
3,GO ALPHA BETA T CELL ACTIVATION,1.1493e-05,-0.19733,-0.23471,1,0
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0047853,-0.1974,-0.19987,1,0
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00054072,-0.19751,-0.19225,1,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.019739,-0.19764,-0.19564,1,0
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.042857,-0.19785,-0.19265,1,0
3,GO POSITIVE REGULATION OF CELL KILLING,0.0018173,-0.19809,-0.21233,1,0
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0018173,-0.19838,-0.23213,1,0
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,1.1964e-05,-0.19877,-0.20501,1,0
3,GO ERYTHROCYTE HOMEOSTASIS,4.6597e-05,-0.19903,-0.19283,1,0
3,GO CYTOPLASM ORGANIZATION,0.037747,-0.19904,-0.15245,1,0
3,GO MEGAKARYOCYTE DIFFERENTIATION,1.4044e-06,-0.19906,-0.20344,1,0
3,GO ZYMOGEN ACTIVATION,0.010506,-0.19935,-0.25501,1,0
3,GO ALPHA BETA T CELL DIFFERENTIATION,4.4712e-06,-0.19945,-0.25253,1,0
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.001986,-0.19959,-0.20691,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0013054,-0.20035,-0.26166,1,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.00012512,-0.20068,-0.23869,1,0
3,GO ERYTHROCYTE DEVELOPMENT,0.00035231,-0.201,-0.17775,1,0
3,GO CENTROSOME DUPLICATION,1.0184e-05,-0.20131,-0.22617,1,0
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.4121e-05,-0.20145,-0.25117,1,0
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.00090094,-0.20178,-0.18811,1,0
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.00095906,-0.20202,-0.21834,1,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0015189,-0.20228,-0.19653,1,0
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.011047,-0.20232,-0.20594,1,0
3,GO LIPID DROPLET ORGANIZATION,0.00013433,-0.20239,-0.25451,1,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00054072,-0.20256,-0.26312,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0059384,-0.20283,-0.27833,1,0
3,GO MONOCYTE CHEMOTAXIS,0.00079435,-0.20291,-0.25447,1,0
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.00023468,-0.20305,-0.23725,1,0
3,GO MACROPHAGE MIGRATION,0.0023671,-0.20323,-0.19232,1,0
3,GO REGULATION OF CELL KILLING,0.00032948,-0.20353,-0.2271,1,0
3,GO NEURAL TUBE FORMATION,8.6584e-06,-0.20371,-0.21032,1,0
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.015953,-0.20396,-0.20463,1,0
3,GO AUTOPHAGOSOME MATURATION,6.5149e-05,-0.20443,-0.22304,1,0
3,GO MULTI ORGANISM CELLULAR PROCESS,0.017137,-0.20448,-0.24266,1,0
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,7.2754e-05,-0.20457,-0.21012,1,0
3,GO T CELL MEDIATED IMMUNITY,0.0021689,-0.20466,-0.23984,1,0
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00087311,-0.2047,-0.21446,1,0
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0034322,-0.2048,-0.17526,1,0
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0054795,-0.20549,-0.22734,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00092958,-0.20549,-0.21748,1,0
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.02843,-0.20604,-0.15621,1,0
3,GO MONONUCLEAR CELL MIGRATION,0.00049035,-0.20635,-0.21886,1,0
3,GO CYTOKINETIC PROCESS,2.8418e-05,-0.20698,-0.24729,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,6.7728e-06,-0.20744,-0.21127,1,0
3,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.04854,-0.20753,-0.24805,1,0
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.030383,-0.20787,-0.12367,1,0
3,GO LIPID STORAGE,0.0007696,-0.20795,-0.20156,1,0
3,GO MALE GENITALIA DEVELOPMENT,0.013465,-0.20916,-0.18964,1,0
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0028957,-0.20965,-0.17608,1,0
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0039469,-0.21012,-0.19107,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.8379e-05,-0.21014,-0.21227,1,0
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00087311,-0.21018,-0.32228,1,0
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.042857,-0.21035,-0.18089,1,0
3,GO RESPONSE TO ANGIOTENSIN,0.0014738,-0.21049,-0.23147,1,0
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00016595,-0.21064,-0.20396,1,0
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00021167,-0.21076,-0.24402,1,0
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.036164,-0.21078,-0.16761,1,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,9.389e-05,-0.21082,-0.26993,1,0
3,GO PEPTIDYL THREONINE MODIFICATION,1.5201e-05,-0.21091,-0.17533,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.8077e-06,-0.21106,-0.2419,1,0
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00087311,-0.21109,-0.19185,1,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,9.3916e-06,-0.2111,-0.28417,1,0
3,GO REGULATION OF GASTRULATION,0.001191,-0.21117,-0.20849,1,0
3,GO DEFENSE RESPONSE TO VIRUS,1.8521e-05,-0.21172,-0.27648,1,0
3,GO BONE RESORPTION,0.00055855,-0.21182,-0.2302,1,0
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00031859,-0.21214,-0.1961,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00025131,-0.21218,-0.23847,1,0
3,GO O GLYCAN PROCESSING,0.00069957,-0.21272,-0.27482,1,0
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.0032441,-0.21293,-0.23387,1,0
3,GO LEUKOCYTE CHEMOTAXIS,1.2962e-05,-0.21436,-0.21294,1,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,3.9418e-06,-0.21458,-0.23302,1,0
3,GO POSITIVE REGULATION OF TISSUE REMODELING,9.389e-05,-0.21469,-0.27946,1,0
3,GO CELL FATE SPECIFICATION,0.00023468,-0.21516,-0.24125,1,0
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0010859,-0.21558,-0.26293,1,0
3,GO ETHANOL METABOLIC PROCESS,0.010245,-0.2156,-0.23614,1,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.010245,-0.2159,-0.26236,1,0
3,GO RESPONSE TO MECHANICAL STIMULUS,1.349e-05,-0.21658,-0.23097,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0025083,-0.21672,-0.20054,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00026003,-0.21678,-0.25223,1,0
3,GO POSITIVE REGULATION OF HORMONE SECRETION,4.6623e-06,-0.21722,-0.23079,1,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00036427,-0.21752,-0.25538,1,0
3,GO ACTIN CYTOSKELETON REORGANIZATION,3.0264e-07,-0.21779,-0.23031,1,0
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0010206,-0.21855,-0.20592,1,0
3,GO MACROPHAGE CHEMOTAXIS,0.0020453,-0.21865,-0.20442,1,0
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0060989,-0.21908,-0.22912,1,0
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.00012074,-0.21958,-0.22391,1,0
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0030654,-0.21972,-0.21361,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00031859,-0.22033,-0.22566,1,0
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00016023,-0.2204,-0.22611,1,0
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0030654,-0.22054,-0.17452,1,0
3,GO VIRION ASSEMBLY,7.3528e-06,-0.22068,-0.21016,1,0
3,GO SUPEROXIDE METABOLIC PROCESS,0.00041602,-0.22078,-0.20392,1,0
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0025083,-0.22129,-0.16697,1,0
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.011047,-0.22145,-0.20058,1,0
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,8.4205e-05,-0.22181,-0.30704,1,0
3,GO INTERLEUKIN 12 PRODUCTION,1.3441e-06,-0.22211,-0.30684,1,0
3,GO MICROVILLUS ASSEMBLY,0.007729,-0.22221,-0.26929,1,0
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00020448,-0.22266,-0.27385,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00010462,-0.22284,-0.27109,1,0
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00026903,-0.22284,-0.26395,1,0
3,GO ENDODERMAL CELL FATE COMMITMENT,0.00079435,-0.22377,-0.22575,1,0
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00049035,-0.22428,-0.27696,1,0
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00035231,-0.22442,-0.35451,1,0
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.4205e-05,-0.22518,-0.26122,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00095906,-0.22539,-0.21258,1,0
3,GO INTERFERON BETA PRODUCTION,0.00029782,-0.22547,-0.21631,1,0
3,GO REGULATION OF CENTROSOME DUPLICATION,3.7791e-06,-0.22561,-0.24038,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0064317,-0.22562,-0.23673,1,0
3,GO PIGMENT ACCUMULATION,0.0066042,-0.22624,-0.19904,1,0
3,GO VIRAL RELEASE FROM HOST CELL,6.7728e-06,-0.22666,-0.24765,1,0
3,GO ICOSANOID METABOLIC PROCESS,5.2837e-06,-0.22668,-0.29333,1,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.001191,-0.22732,-0.21878,1,0
3,GO INTERLEUKIN 8 PRODUCTION,0.00014935,-0.22744,-0.24563,1,0
3,GO ER OVERLOAD RESPONSE,0.03939,-0.22781,-0.19044,1,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0049174,-0.22796,-0.26295,1,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,2.6307e-05,-0.22827,-0.23195,1,0
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0059384,-0.22843,-0.33284,1,0
3,GO BONE REMODELING,0.0014738,-0.22909,-0.21743,1,0
3,GO POSITIVE REGULATION OF CELL SIZE,0.00079435,-0.22939,-0.29463,1,0
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00021909,-0.22999,-0.26012,1,0
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0025817,-0.23007,-0.22045,1,0
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,1.1964e-05,-0.23007,-0.26603,1,0
3,GO CELLULAR DEFENSE RESPONSE,1.3441e-06,-0.23038,-0.30179,1,0
3,GO REGULATION OF CENTROSOME CYCLE,2.1702e-06,-0.23056,-0.22776,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,4.6623e-06,-0.23059,-0.27267,1,0
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.4421e-05,-0.23098,-0.24859,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.2524e-05,-0.23112,-0.24668,1,0
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00065623,-0.23144,-0.18519,1,0
3,GO CELL CHEMOTAXIS,1.7118e-05,-0.23169,-0.22361,1,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,1.4039e-05,-0.23193,-0.25709,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0013054,-0.23215,-0.30545,1,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0025817,-0.2323,-0.23819,1,0
3,GO MICROVILLUS ORGANIZATION,0.00084609,-0.23239,-0.29665,1,0
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0006154,-0.23253,-0.24592,1,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,1.0604e-05,-0.23314,-0.25455,1,0
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.013798,-0.23357,-0.25284,1,0
3,GO REGULATORY T CELL DIFFERENTIATION,0.0014738,-0.23404,-0.26869,1,0
3,GO TISSUE REMODELING,0.00021909,-0.23431,-0.23409,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION,3.3287e-06,-0.23442,-0.24629,1,0
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.015574,-0.23449,-0.23391,1,0
3,GO ZYMOGEN INHIBITION,0.0033369,-0.2349,-0.33862,1,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.0067808,-0.23506,-0.31829,1,0
3,GO REGULATION OF ACTIN NUCLEATION,4.0073e-05,-0.23542,-0.25847,1,0
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0090226,-0.23612,-0.18619,1,0
3,GO HYPOTHALAMUS DEVELOPMENT,0.00090094,-0.23631,-0.27061,1,0
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.029068,-0.23633,-0.17743,1,0
3,GO HORMONE CATABOLIC PROCESS,0.0011199,-0.23689,-0.30106,1,0
3,GO LIVER MORPHOGENESIS,0.001228,-0.2369,-0.30395,1,0
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0012662,-0.23692,-0.31167,1,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.011047,-0.23693,-0.28264,1,0
3,GO REGULATION OF VIRAL LIFE CYCLE,4.4878e-05,-0.23722,-0.29182,1,0
3,GO BILE ACID METABOLIC PROCESS,0.00013917,-0.23739,-0.26,1,0
3,GO MULTIVESICULAR BODY ORGANIZATION,7.5427e-07,-0.23775,-0.24943,1,0
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.00020448,-0.23777,-0.29201,1,0
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.1493e-05,-0.23804,-0.24148,1,0
3,GO RUFFLE ORGANIZATION,3.7791e-06,-0.23837,-0.2376,1,0
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00025131,-0.2386,-0.23183,1,0
3,GO REGULATION OF B CELL DIFFERENTIATION,0.0013054,-0.23864,-0.22357,1,0
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.1493e-05,-0.23954,-0.26766,1,0
3,GO RESPONSE TO REDOX STATE,0.0013054,-0.23959,-0.23698,1,0
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.012203,-0.2398,-0.34938,1,0
3,GO REGULATION OF ICOSANOID SECRETION,0.0094949,-0.24019,-0.18147,1,0
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0056288,-0.24052,-0.23058,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,2.0033e-05,-0.24073,-0.29548,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.015574,-0.24132,-0.19733,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00095906,-0.24132,-0.23594,1,0
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00011241,-0.24162,-0.32128,1,0
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00014418,-0.24255,-0.23907,1,0
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.00026003,-0.24255,-0.19671,1,0
3,GO PLACENTA DEVELOPMENT,1.0311e-06,-0.24266,-0.27121,1,0
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00095906,-0.24298,-0.22192,1,0
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00025131,-0.24388,-0.24645,1,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0028141,-0.24439,-0.26948,1,0
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0057817,-0.24475,-0.27579,1,0
3,GO SPHINGOMYELIN METABOLIC PROCESS,0.0022992,-0.24505,-0.2461,1,0
3,GO SPERM CAPACITATION,6.5149e-05,-0.24579,-0.2285,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.7343e-05,-0.24678,-0.25379,1,0
3,GO POSITIVE REGULATION OF CHEMOTAXIS,9.8628e-07,-0.24848,-0.26405,1,0
3,GO ETHER METABOLIC PROCESS,0.0046564,-0.24862,-0.26408,1,0
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.0226e-05,-0.24879,-0.2547,1,0
3,GO ENDOCRINE PROCESS,0.00055855,-0.24889,-0.21744,1,0
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,8.6584e-06,-0.24894,-0.23333,1,0
3,GO SMOOTH MUSCLE CELL MIGRATION,4.1617e-05,-0.249,-0.32768,1,0
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0034322,-0.24907,-0.22582,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.753e-07,-0.24941,-0.30364,1,0
3,GO REGULATION OF MACROPHAGE MIGRATION,0.00037661,-0.24959,-0.22364,1,0
3,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0021689,-0.24975,-0.24919,1,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0025817,-0.24992,-0.2916,1,0
3,GO SKIN DEVELOPMENT,1.7806e-05,-0.25008,-0.25936,1,0
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00010462,-0.25195,-0.22452,1,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,9.7801e-06,-0.25223,-0.23955,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,8.4205e-05,-0.25228,-0.24272,1,0
3,GO PROGRAMMED NECROTIC CELL DEATH,0.0040578,-0.25258,-0.22948,1,0
3,GO RENAL ABSORPTION,0.021165,-0.25258,-0.28345,1,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00026003,-0.25312,-0.30329,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,3.3287e-06,-0.25363,-0.31411,1,0
3,GO REGULATION OF RESPIRATORY BURST,0.00074557,-0.25379,-0.24486,1,0
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,7.013e-05,-0.25418,-0.26495,1,0
3,GO REGULATION OF RECEPTOR BINDING,0.0057817,-0.25471,-0.2422,1,0
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,5.6174e-05,-0.25474,-0.2393,1,0
3,GO RETINAL METABOLIC PROCESS,0.04854,-0.25519,-0.24132,1,0
3,GO LEFT RIGHT AXIS SPECIFICATION,0.0021062,-0.25553,-0.28148,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0010206,-0.25555,-0.26462,1,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.00042998,-0.25643,-0.26198,1,0
3,GO TRANSCYTOSIS,0.0001547,-0.25655,-0.22486,1,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00010845,-0.25706,-0.27938,1,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00037661,-0.25738,-0.3068,1,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.004408,-0.25827,-0.21216,1,0
3,GO BROWN FAT CELL DIFFERENTIATION,7.6603e-06,-0.25842,-0.33674,1,0
3,GO EOSINOPHIL CHEMOTAXIS,0.0049174,-0.25844,-0.3645,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00074557,-0.25856,-0.29804,1,0
3,GO ERBB2 SIGNALING PATHWAY,1.9263e-05,-0.25862,-0.27334,1,0
3,GO REGULATION OF RESPONSE TO WOUNDING,1.0184e-05,-0.25881,-0.28862,1,0
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00038934,-0.25885,-0.23302,1,0
3,GO NECROTIC CELL DEATH,0.0034322,-0.26094,-0.21521,1,0
3,GO REGULATION OF COAGULATION,0.0001547,-0.26241,-0.30084,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.014138,-0.26244,-0.20034,1,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,7.013e-05,-0.26396,-0.28133,1,0
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.012203,-0.26472,-0.26045,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00026903,-0.26529,-0.24404,1,0
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.022165,-0.26611,-0.28973,1,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.014138,-0.26657,-0.34046,1,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0031536,-0.26741,-0.32595,1,0
3,GO REGULATION OF BONE REMODELING,0.00050664,-0.26877,-0.25577,1,0
3,GO REGULATION OF CELL MATRIX ADHESION,0.0001547,-0.26931,-0.25314,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00012074,-0.26984,-0.24857,1,0
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.6584e-06,-0.27,-0.27426,1,0
3,GO T CELL SELECTION,0.00017186,-0.27061,-0.2088,1,0
3,GO CARDIOBLAST DIFFERENTIATION,0.007729,-0.27079,-0.24529,1,0
3,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.011047,-0.27163,-0.31058,1,0
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.00098941,-0.27177,-0.27496,1,0
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,5.9841e-06,-0.27192,-0.28685,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00012964,-0.2721,-0.28043,1,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.013798,-0.27229,-0.28854,1,0
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.009256,-0.2729,-0.26896,1,0
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,2.2524e-05,-0.27307,-0.27164,1,0
3,GO INTESTINAL ABSORPTION,0.00035231,-0.27352,-0.29987,1,0
3,GO FRUCTOSE METABOLIC PROCESS,0.033166,-0.27427,-0.28687,1,0
3,GO SIGNAL PEPTIDE PROCESSING,0.00014935,-0.27455,-0.33645,1,0
3,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00047456,-0.27486,-0.33135,1,0
3,GO INTERLEUKIN 1 BETA PRODUCTION,2.5308e-05,-0.27491,-0.30028,1,0
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.04854,-0.27492,-0.20311,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,2.6307e-05,-0.27497,-0.27345,1,0
3,GO DENDRITIC CELL DIFFERENTIATION,5.8301e-05,-0.27599,-0.33815,1,0
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.001191,-0.27645,-0.28803,1,0
3,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00074557,-0.27772,-0.34096,1,0
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.010245,-0.27779,-0.34294,1,0
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,1.0311e-06,-0.27789,-0.31892,1,0
3,GO MYOBLAST MIGRATION,0.033166,-0.27815,-0.25342,1,0
3,GO INTERLEUKIN 1 PRODUCTION,1.5816e-05,-0.27874,-0.32131,1,0
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0060989,-0.2792,-0.26169,1,0
3,GO MAGNESIUM ION TRANSPORT,1.906e-06,-0.27978,-0.32078,1,0
3,GO EPIDERMIS DEVELOPMENT,7.3528e-06,-0.28059,-0.26428,1,0
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,8.2505e-07,-0.28071,-0.30962,1,0
3,GO MEMBRANE RAFT ORGANIZATION,0.007729,-0.28126,-0.32844,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0014738,-0.28173,-0.29782,1,0
3,GO TOLERANCE INDUCTION,0.0075304,-0.28373,-0.36324,1,0
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0018173,-0.28377,-0.31236,1,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00044439,-0.28391,-0.27431,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00353,-0.28519,-0.29456,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00021909,-0.28526,-0.32909,1,0
3,GO REGULATION OF WOUND HEALING,1.0184e-05,-0.2856,-0.32068,1,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.045624,-0.28581,-0.21081,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,7.013e-05,-0.28586,-0.33146,1,0
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0060989,-0.28602,-0.33941,1,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.004408,-0.28606,-0.30433,1,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.020205,-0.28626,-0.2434,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00010462,-0.28655,-0.2974,1,0
3,GO CELLULAR RESPONSE TO ALKALOID,1.4609e-05,-0.28743,-0.28582,1,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.0041716,-0.28786,-0.25205,1,0
3,GO NATURAL KILLER CELL PROLIFERATION,0.0018173,-0.28911,-0.29853,1,0
3,GO PLATELET AGGREGATION,1.1493e-05,-0.28918,-0.30348,1,0
3,GO MUSCLE CELL MIGRATION,3.3132e-05,-0.29007,-0.31531,1,0
3,GO REGULATION OF EXOSOMAL SECRETION,1.2862e-06,-0.29027,-0.32679,1,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0028957,-0.2904,-0.35372,1,0
3,GO EOSINOPHIL MIGRATION,0.00092958,-0.29151,-0.37225,1,0
3,GO WATER HOMEOSTASIS,0.00065623,-0.29157,-0.26119,1,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00012512,-0.29245,-0.30239,1,0
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0022992,-0.29307,-0.29346,1,0
3,GO MATERNAL PLACENTA DEVELOPMENT,0.0060989,-0.29324,-0.22321,1,0
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.011047,-0.2934,-0.28214,1,0
3,GO HOMOTYPIC CELL CELL ADHESION,3.4421e-05,-0.29375,-0.32081,1,0
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,3.6414e-07,-0.29383,-0.3348,1,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.007729,-0.29395,-0.25665,1,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.026586,-0.29467,-0.25638,1,0
3,GO ANOIKIS,4.4878e-05,-0.29516,-0.31439,1,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0001547,-0.29604,-0.27673,1,0
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,1.1964e-05,-0.29628,-0.28953,1,0
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.03245,-0.29721,-0.21933,1,0
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.0081404,-0.2974,-0.30018,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.2524e-05,-0.29932,-0.29405,1,0
3,GO SPLEEN DEVELOPMENT,4.5813e-07,-0.29966,-0.30501,1,0
3,GO GLOMERULUS DEVELOPMENT,0.00057693,-0.30136,-0.27543,1,0
3,GO ACTIN FILAMENT SEVERING,0.0013054,-0.30141,-0.39952,1,0
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,5.2139e-05,-0.30154,-0.33792,1,0
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0022992,-0.30182,-0.38399,1,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0049174,-0.30202,-0.36008,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,2.4692e-06,-0.30264,-0.30569,1,0
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.019283,-0.30267,-0.27804,1,0
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,4.0073e-05,-0.30305,-0.29299,1,0
3,GO REGULATION OF PLATELET ACTIVATION,6.2367e-06,-0.30324,-0.40132,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.018836,-0.30334,-0.31591,1,0
3,GO ALPHA BETA T CELL PROLIFERATION,2.0033e-05,-0.30343,-0.33706,1,0
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,9.7801e-06,-0.30351,-0.3767,1,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.00054072,-0.30382,-0.27702,1,0
3,GO RESPONSE TO COPPER ION,0.0025817,-0.30394,-0.32135,1,0
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,2.5774e-06,-0.30535,-0.28761,1,0
3,GO INTERLEUKIN 10 PRODUCTION,9.0179e-06,-0.30613,-0.29452,1,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.027803,-0.30713,-0.28669,1,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.024846,-0.30805,-0.19676,1,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.037747,-0.30852,-0.39807,1,0
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,6.7728e-06,-0.30895,-0.315,1,0
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0054795,-0.3093,-0.32295,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.01282,-0.31062,-0.26154,1,0
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.012508,-0.31249,-0.39312,1,0
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00044439,-0.31311,-0.37968,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00031859,-0.31341,-0.41209,1,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00012964,-0.31398,-0.37241,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,8.628e-07,-0.31415,-0.30886,1,0
3,GO REGULATION OF INTEGRIN ACTIVATION,5.0226e-05,-0.315,-0.33613,1,0
3,GO CELL CELL JUNCTION ORGANIZATION,4.7955e-07,-0.31541,-0.30645,1,0
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0022992,-0.31648,-0.31314,1,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00012512,-0.31665,-0.33851,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00010845,-0.31726,-0.40632,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.9301e-06,-0.31744,-0.3606,1,0
3,GO REGULATION OF NECROTIC CELL DEATH,0.00052342,-0.31763,-0.30615,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,2.3654e-06,-0.31765,-0.33963,1,0
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00016595,-0.31786,-0.34246,1,0
3,GO OSTEOBLAST PROLIFERATION,7.547e-05,-0.31976,-0.33165,1,0
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.00079435,-0.32042,-0.3548,1,0
3,GO RESPONSE TO INTERFERON ALPHA,0.0023671,-0.32232,-0.45431,1,0
3,GO CELL CELL JUNCTION ASSEMBLY,3.4772e-07,-0.32295,-0.31894,1,0
3,GO EXTRACELLULAR VESICLE BIOGENESIS,1.0311e-06,-0.32332,-0.32007,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,1.3441e-06,-0.32366,-0.30789,1,0
3,GO LEFT RIGHT PATTERN FORMATION,0.00035231,-0.32382,-0.28757,1,0
3,GO DNA DEAMINATION,0.010773,-0.32461,-0.30145,1,0
3,GO T HELPER CELL LINEAGE COMMITMENT,1.0311e-06,-0.32599,-0.32887,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.2139e-05,-0.32673,-0.35194,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,6.2985e-07,-0.32744,-0.35471,1,0
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.010506,-0.32802,-0.40073,1,0
3,GO HAIR CELL DIFFERENTIATION,0.00021909,-0.32804,-0.33599,1,0
3,GO DETECTION OF OTHER ORGANISM,0.00049035,-0.32871,-0.34603,1,0
3,GO ESTROUS CYCLE,0.00022676,-0.32975,-0.32994,1,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0037331,-0.3298,-0.23854,1,0
3,GO SUPEROXIDE ANION GENERATION,0.00019753,-0.33044,-0.32869,1,0
3,GO BILE ACID AND BILE SALT TRANSPORT,3.8583e-05,-0.33076,-0.36255,1,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00012964,-0.33353,-0.34913,1,0
3,GO POSITIVE REGULATION OF COAGULATION,2.2658e-06,-0.3338,-0.36697,1,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.02068,-0.33507,-0.22733,1,0
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,2.6307e-05,-0.33662,-0.29348,1,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.00036427,-0.33683,-0.39522,1,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.011326,-0.33707,-0.22085,1,0
3,GO PROSTANOID METABOLIC PROCESS,2.7343e-05,-0.33753,-0.42849,1,0
3,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0001165,-0.33769,-0.31733,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00027832,-0.3383,-0.34173,1,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.00037661,-0.33863,-0.30236,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00026903,-0.3402,-0.40128,1,0
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00019079,-0.34044,-0.35971,1,0
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00098941,-0.34256,-0.34758,1,0
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00063551,-0.34337,-0.39749,1,0
3,GO IMMUNOLOGICAL MEMORY PROCESS,5.6174e-05,-0.34512,-0.36251,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,1.1964e-05,-0.34525,-0.38635,1,0
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0028141,-0.34544,-0.29998,1,0
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0046564,-0.34558,-0.27772,1,0
3,GO INTERFERON ALPHA PRODUCTION,3.0576e-06,-0.34926,-0.35519,1,0
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.4039e-05,-0.34926,-0.33463,1,0
3,GO REGULATION OF ANOIKIS,0.00019753,-0.34973,-0.377,1,0
3,GO HISTAMINE SECRETION,0.0028141,-0.35224,-0.35679,1,0
3,GO BARBED END ACTIN FILAMENT CAPPING,3.0689e-05,-0.35289,-0.44771,1,0
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00023468,-0.35581,-0.43654,1,0
3,GO LIPID TRANSLOCATION,6.8936e-07,-0.35609,-0.33753,1,0
3,GO DECIDUALIZATION,0.00090094,-0.35635,-0.33185,1,0
3,GO T CELL LINEAGE COMMITMENT,5.0683e-06,-0.357,-0.32209,1,0
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,6.2786e-05,-0.35854,-0.4021,1,0
3,GO PROTEIN ADP RIBOSYLATION,3.0576e-06,-0.35936,-0.32976,1,0
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,2.4346e-05,-0.3597,-0.44339,1,0
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00019753,-0.35997,-0.38306,1,0
3,GO VIRAL BUDDING,2.7578e-07,-0.36018,-0.31951,1,0
3,GO PROGESTERONE METABOLIC PROCESS,0.00025131,-0.36121,-0.51242,1,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00029782,-0.36182,-0.28024,1,0
3,GO RESPONSE TO LEPTIN,0.0045306,-0.36305,-0.25145,1,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0026572,-0.36436,-0.37807,1,0
3,GO ENDOTHELIAL CELL CHEMOTAXIS,3.4421e-05,-0.36547,-0.42209,1,0
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,9.0221e-07,-0.36691,-0.36478,1,0
3,GO KERATINOCYTE DIFFERENTIATION,6.7728e-06,-0.36752,-0.35407,1,0
3,GO TRANSPOSITION,5.508e-06,-0.36827,-0.44093,1,0
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.010245,-0.36836,-0.41054,1,0
3,GO MITOTIC CYTOKINETIC PROCESS,4.0375e-08,-0.36848,-0.38634,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00024286,-0.3702,-0.35804,1,0
3,GO AMINE BIOSYNTHETIC PROCESS,0.00095906,-0.37062,-0.30665,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00032948,-0.37359,-0.45952,1,0
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0034322,-0.37386,-0.32627,1,0
3,GO EPIDERMAL CELL DIFFERENTIATION,5.0683e-06,-0.37415,-0.34559,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0010206,-0.37546,-0.32863,1,0
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.0010206,-0.37642,-0.34714,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,3.0689e-05,-0.38047,-0.34918,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,2.8418e-05,-0.3813,-0.36154,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00025131,-0.38141,-0.44084,1,0
3,GO VASCULAR TRANSPORT,0.0022992,-0.382,-0.38376,1,0
3,GO EMBRYONIC PLACENTA DEVELOPMENT,1.5691e-07,-0.38261,-0.41346,1,0
3,GO PARAXIAL MESODERM DEVELOPMENT,0.0017641,-0.38309,-0.30894,1,0
3,GO GONADOTROPIN SECRETION,1.2962e-05,-0.38427,-0.43075,1,0
3,GO RESPONSE TO TYPE I INTERFERON,0.00016595,-0.38612,-0.46326,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00045924,-0.38685,-0.35775,1,0
3,GO RESPONSE TO NITROSATIVE STRESS,4.0073e-05,-0.38739,-0.44042,1,0
3,GO GAP JUNCTION ASSEMBLY,2.6307e-05,-0.38808,-0.48419,1,0
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.071e-07,-0.38885,-0.40931,1,0
3,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.00092958,-0.38926,-0.32237,1,0
3,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.01282,-0.39258,-0.41599,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.8521e-05,-0.3966,-0.39583,1,0
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.725e-07,-0.39783,-0.47481,1,0
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0083534,-0.39797,-0.36067,1,0
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,1.4674e-06,-0.39968,-0.40163,1,0
3,GO REGULATION OF TOLERANCE INDUCTION,3.3132e-05,-0.39997,-0.46109,1,0
3,GO REGULATION OF TRANSPOSITION,1.5816e-05,-0.40073,-0.46673,1,0
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0099891,-0.40278,-0.37582,1,0
3,GO TOXIN METABOLIC PROCESS,0.00057693,-0.40603,-0.36559,1,0
3,GO POSITIVE REGULATION OF CELL MATURATION,2.3418e-05,-0.41063,-0.44936,1,0
3,GO HEPATOCYTE DIFFERENTIATION,0.00036427,-0.4138,-0.40771,1,0
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.4039e-05,-0.4171,-0.37596,1,0
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,9.4334e-07,-0.41803,-0.50144,1,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,1.725e-07,-0.41826,-0.38511,1,0
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.7806e-05,-0.42133,-0.44326,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,8.1192e-05,-0.42159,-0.48488,1,0
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.0015653,-0.42326,-0.51624,1,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0025817,-0.42889,-0.38599,1,0
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,1.4268e-07,-0.42915,-0.50799,1,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.5759e-05,-0.43125,-0.44395,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,2.4692e-06,-0.43326,-0.4649,1,0
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00050664,-0.43513,-0.57634,1,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00059588,-0.44239,-0.40888,1,0
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00040247,-0.44435,-0.36483,1,0
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,2.7343e-05,-0.44496,-0.49912,1,0
3,GO LEYDIG CELL DIFFERENTIATION,0.0021689,-0.44632,-0.40799,1,0
3,GO RESPONSE TO INTERLEUKIN 18,0.00018427,-0.44644,-0.50559,1,0
3,GO RESPONSE TO LITHIUM ION,9.0551e-05,-0.44912,-0.43617,1,0
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.00027832,-0.44913,-0.39132,1,0
3,GO KERATINIZATION,1.1964e-05,-0.4492,-0.39241,1,0
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.2454e-05,-0.45066,-0.41465,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,1.1237e-07,-0.45935,-0.48094,1,0
3,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,2.2524e-05,-0.45948,-0.43579,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,2.5122e-07,-0.45982,-0.47032,1,0
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.00014418,-0.46546,-0.40918,1,0
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0001547,-0.46555,-0.43733,1,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.9263e-05,-0.47602,-0.45052,1,0
3,GO POSITIVE REGULATION OF WOUND HEALING,2.5122e-07,-0.48106,-0.49064,1,0
3,GO GLIAL CELL APOPTOTIC PROCESS,5.8301e-05,-0.48513,-0.48688,1,0
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,3.5759e-05,-0.48977,-0.43053,1,0
3,GO CORNIFICATION,1.7806e-05,-0.49011,-0.44254,1,0
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00011241,-0.49218,-0.42004,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,1.906e-06,-0.49482,-0.48421,1,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00013917,-0.49931,-0.49525,1,0
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,1.349e-05,-0.50143,-0.55439,1,0
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,2.1831e-07,-0.50316,-0.45438,1,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,3.8583e-05,-0.50386,-0.42865,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00025131,-0.50602,-0.4146,1,0
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0056288,-0.50639,-0.34596,1,0
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,6.2786e-05,-0.50766,-0.44061,1,0
3,GO LABYRINTHINE LAYER DEVELOPMENT,3.17e-07,-0.50816,-0.47471,1,0
3,GO RESPONSE TO FORSKOLIN,7.0571e-06,-0.50997,-0.45477,1,0
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,1.7474e-06,-0.51331,-0.42925,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,8.6584e-06,-0.52175,-0.57593,1,0
3,GO MIDBODY ABSCISSION,1.0207e-07,-0.52521,-0.49576,1,0
3,GO CARDIOBLAST PROLIFERATION,0.014486,-0.53014,-0.3812,1,0
3,GO MUCUS SECRETION,0.0030654,-0.54433,-0.48076,1,0
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,4.1617e-05,-0.54534,-0.50744,1,0
3,GO APICAL JUNCTION ASSEMBLY,4.6826e-08,-0.54725,-0.527,1,0
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,1.4674e-06,-0.54782,-0.60649,1,0
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,7.9801e-06,-0.55036,-0.52945,1,0
3,GO CYTIDINE TO URIDINE EDITING,0.0013457,-0.55542,-0.55396,1,0
3,GO REGULATION OF PLATELET AGGREGATION,1.9904e-06,-0.55585,-0.57999,1,0
3,GO NEURON FATE SPECIFICATION,0.00047456,-0.55851,-0.45962,1,0
3,GO REGULATION OF WATER LOSS VIA SKIN,0.00027832,-0.57307,-0.48694,1,0
3,GO NEGATIVE REGULATION OF ANOIKIS,9.7801e-06,-0.57759,-0.5744,1,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,2.4346e-05,-0.58141,-0.50358,1,0
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,3.9926e-07,-0.58616,-0.54046,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.8077e-06,-0.58792,-0.6371,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,2.0784e-06,-0.60457,-0.60175,1,0
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.7578e-07,-0.60625,-0.63166,1,0
3,GO ENTRY OF BACTERIUM INTO HOST CELL,4.6623e-06,-0.60767,-0.63767,1,0
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.5816e-05,-0.61639,-0.66557,1,0
3,GO PSEUDOPODIUM ORGANIZATION,3.0689e-05,-0.62889,-0.51229,1,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.7801e-06,-0.66139,-0.59687,1,0
3,GO LIPID DROPLET FORMATION,3.0576e-06,-0.66758,-0.69903,1,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0001547,-0.67047,-0.67819,1,0
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.00010845,-0.67913,-0.73843,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00081984,-0.74631,-0.75141,1,0
3,GO EPITHELIAL CELL CELL ADHESION,3.479e-08,-0.7504,-0.83357,1,0
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,2.8418e-05,-0.76712,-0.63291,1,0
3,GO GAMMA DELTA T CELL DIFFERENTIATION,2.0033e-05,-0.79675,-0.6512,1,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,7.9801e-06,-0.83124,-0.69472,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0010859,-0.90011,-0.91252,1,0
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,2.2879e-07,-1.0038,-0.8649,1,0
3,GO LABYRINTHINE LAYER MORPHOGENESIS,7.6379e-08,-1.0438,-0.95519,1,0
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,2.2879e-07,-1.2144,-1.1,1,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.19095,0.33644,0.2567,0,1
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.057089,0.30952,0.22906,0,1
3,GO CARDIAC CHAMBER FORMATION,0.053746,0.27961,0.25441,0,1
3,GO TELENCEPHALON REGIONALIZATION,0.077957,0.25621,0.23496,0,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.1313,0.24322,0.096103,0,1
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.11636,0.2415,0.10275,0,1
3,GO RESPONSE TO PARATHYROID HORMONE,0.0695,0.23045,0.19538,0,1
3,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.063042,0.22817,0.2407,0,1
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.092194,0.22616,0.15761,0,1
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.088862,0.22333,0.15974,0,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.049546,0.2217,0.12492,0,1
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.055956,0.21101,0.12529,0,1
3,GO MESODERMAL CELL FATE SPECIFICATION,0.20309,0.20986,0.11736,0,1
3,GO MATING BEHAVIOR,0.1028,0.20895,0.13499,0,1
3,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.12908,0.2089,0.13581,0,1
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.085627,0.19294,0.18555,0,1
3,GO BONE TRABECULA MORPHOGENESIS,0.053746,0.19291,0.18045,0,1
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.097379,0.18856,0.1628,0,1
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.049546,0.18836,0.19111,0,1
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.25363,0.186,0.10083,0,1
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.15015,0.18249,0.072211,0,1
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.050569,0.18238,0.20825,0,1
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.25363,0.17195,0.073515,0,1
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.22235,0.16527,0.097275,0,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.14526,0.16521,0.13342,0,1
3,GO VITAMIN CATABOLIC PROCESS,0.11434,0.16512,0.21201,0,1
3,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.077957,0.16283,0.16226,0,1
3,GO REGULATION OF DNA METHYLATION,0.082489,0.15952,0.10355,0,1
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.092194,0.15838,0.14638,0,1
3,GO CHYLOMICRON ASSEMBLY,0.21579,0.1558,0.057557,0,1
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.16032,0.15444,0.075341,0,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.16294,0.14772,0.1197,0,1
3,GO BONE MORPHOGENESIS,0.27999,0.14458,0.047665,0,1
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.068167,0.14146,0.12308,0,1
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.17934,0.13797,0.071228,0,1
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.17374,0.13697,0.090013,0,1
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.087232,0.13664,0.093949,0,1
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.068167,0.13125,0.11331,0,1
3,GO RNA STABILIZATION,0.061812,0.12799,0.090294,0,1
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.17099,0.12658,0.050241,0,1
3,GO MULTI ORGANISM LOCALIZATION,0.059411,0.12597,0.061581,0,1
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.082489,0.12495,0.15722,0,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.084046,0.12448,0.074074,0,1
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.11636,0.12317,0.19673,0,1
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.050569,0.12215,0.088028,0,1
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.21579,0.12177,0.059596,0,1
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.049546,0.11861,0.087356,0,1
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.084046,0.11765,0.087643,0,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.052669,0.11571,0.095428,0,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0695,0.1128,0.066787,0,1
3,GO SEQUESTERING OF METAL ION,0.40843,0.10969,0.02378,0,1
3,GO ALDEHYDE CATABOLIC PROCESS,0.066855,0.10773,0.10141,0,1
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.34702,0.10388,0.038078,0,1
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.22235,0.10279,0.054223,0,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.22235,0.10117,0.060037,0,1
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.14526,0.10112,0.065739,0,1
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.4978,0.098467,0.028479,0,1
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.11636,0.096998,0.11805,0,1
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.092194,0.094406,0.086592,0,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.080955,0.093843,0.087863,0,1
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.055956,0.093631,0.093391,0,1
3,GO ARTERY DEVELOPMENT,0.15264,0.093115,0.033298,0,1
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.090515,0.092987,0.080894,0,1
3,GO PRENYLATION,0.11434,0.09269,0.1325,0,1
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.052669,0.08999,0.1324,0,1
3,GO ODONTOGENESIS,0.52025,0.08998,0.016904,0,1
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.15264,0.087074,0.080426,0,1
3,GO POSITIVE REGULATION OF RNA SPLICING,0.087232,0.085521,0.052467,0,1
3,GO HISTONE H3 K36 METHYLATION,0.43883,0.084625,0.038995,0,1
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.079444,0.083657,0.065693,0,1
3,GO PROTEIN HOMOTETRAMERIZATION,0.11636,0.08348,0.060179,0,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.073629,0.081249,0.061775,0,1
3,GO MITOTIC CHROMOSOME CONDENSATION,0.15773,0.078058,0.046049,0,1
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.27999,0.07687,0.057982,0,1
3,GO RECOMBINATIONAL REPAIR,0.10465,0.073986,0.046047,0,1
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.29586,0.072441,0.056058,0,1
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.43367,0.071882,0.015966,0,1
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.050569,0.069442,0.084844,0,1
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.35153,0.065583,0.039499,0,1
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.099158,0.062645,0.056768,0,1
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.25001,0.059879,0.054023,0,1
3,GO REGULATION OF HISTONE UBIQUITINATION,0.32077,0.05719,0.038572,0,1
3,GO NEGATIVE REGULATION OF DNA BINDING,0.30402,0.054714,0.05772,0,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.097379,0.054263,0.051187,0,1
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.057089,0.051638,0.065322,0,1
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.15773,0.043048,0.053935,0,1
3,GO SNRNA TRANSCRIPTION,0.10465,0.042408,0.047574,0,1
3,GO DNA CONFORMATION CHANGE,0.11636,0.041122,0.04401,0,1
3,GO RESPONSE TO UV,0.097379,0.039549,0.045907,0,1
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.2,0.033679,0.021998,0,1
3,GO DNA REPLICATION,0.28785,0.026462,0.028983,0,1
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,5.0683e-06,0.9205,0.91235,0,0
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0001547,0.67822,0.72094,0,0
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,4.1617e-05,0.61038,0.54245,0,0
3,GO SYNAPSE MATURATION,0.00042998,0.58389,0.55191,0,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0067808,0.4664,0.44545,0,0
3,GO NEURON CELLULAR HOMEOSTASIS,2.8077e-06,0.46541,0.47652,0,0
3,GO BRANCHING MORPHOGENESIS OF A NERVE,0.00016023,0.45571,0.56461,0,0
3,GO SECRETORY GRANULE LOCALIZATION,0.0025817,0.45138,0.4067,0,0
3,GO REGULATION OF SYNAPSE MATURATION,0.0034322,0.45113,0.40967,0,0
3,GO POSTSYNAPSE ASSEMBLY,0.00081984,0.4442,0.43576,0,0
3,GO SYNAPTIC MEMBRANE ADHESION,0.025414,0.4128,0.3198,0,0
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,6.5149e-05,0.37968,0.31929,0,0
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.097379,0.36435,0.22988,0,0
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.046579,0.35692,0.20046,0,0
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0017123,0.35626,0.39178,0,0
3,GO PROTEIN TRIMERIZATION,0.00041602,0.35306,0.33001,0,0
3,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0021062,0.34723,0.33736,0,0
3,GO FACIAL NERVE MORPHOGENESIS,0.1313,0.34332,0.20569,0,0
3,GO DENSE CORE GRANULE TRANSPORT,0.024846,0.34184,0.33166,0,0
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00013433,0.34111,0.34542,0,0
3,GO NEGATIVE CHEMOTAXIS,0.00059588,0.33031,0.2949,0,0
3,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.004408,0.32824,0.28235,0,0
3,GO ANATOMICAL STRUCTURE REGRESSION,0.036164,0.32691,0.21922,0,0
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.014138,0.32351,0.28252,0,0
3,GO PYRAMIDAL NEURON DIFFERENTIATION,0.0045306,0.32272,0.43871,0,0
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0079323,0.32231,0.33252,0,0
3,GO SYNAPTIC VESICLE CLUSTERING,0.045624,0.32228,0.27197,0,0
3,GO REGULATION OF VESICLE FUSION,0.0022992,0.32162,0.31981,0,0
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.19095,0.31034,0.14973,0,0
3,GO ADAPTATION OF SIGNALING PATHWAY,0.0020453,0.30837,0.2676,0,0
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.00021167,0.30824,0.31654,0,0
3,GO REGULATION OF HIPPO SIGNALING,0.13583,0.30357,0.14721,0,0
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.11235,0.30126,0.136,0,0
3,GO SIALYLATION,0.014138,0.30053,0.27725,0,0
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.012508,0.30005,0.25019,0,0
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.00011241,0.29877,0.32346,0,0
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.010506,0.29461,0.26407,0,0
3,GO DIVALENT METAL ION EXPORT,0.0022332,0.2928,0.36634,0,0
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.0833e-05,0.29263,0.33567,0,0
3,GO CARDIAC VENTRICLE FORMATION,0.072231,0.29066,0.24654,0,0
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.014138,0.28954,0.28542,0,0
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00025131,0.2877,0.32833,0,0
3,GO DENTATE GYRUS DEVELOPMENT,0.00072223,0.28453,0.43099,0,0
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0024367,0.28419,0.25027,0,0
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.10096,0.28377,0.17628,0,0
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.011047,0.28022,0.27242,0,0
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.093897,0.27345,0.17045,0,0
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.00353,0.27232,0.28126,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.0062634,0.27115,0.23012,0,0
3,GO NEUROTRANSMITTER REUPTAKE,0.001191,0.27093,0.26433,0,0
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.016339,0.2705,0.29899,0,0
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.3746,0.269,0.078263,0,0
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.017137,0.26785,0.23298,0,0
3,GO ADULT FEEDING BEHAVIOR,0.02068,0.26172,0.12264,0,0
3,GO GLUTAMATE SECRETION,0.0051916,0.26161,0.24051,0,0
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0011199,0.2595,0.25663,0,0
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.024846,0.25878,0.18147,0,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00092958,0.25825,0.34529,0,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.11434,0.25612,0.19477,0,0
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.014841,0.25444,0.26426,0,0
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0695,0.25422,0.16884,0,0
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0071468,0.24865,0.23727,0,0
3,GO PREPULSE INHIBITION,0.13583,0.24516,0.19399,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.060602,0.24473,0.1688,0,0
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.068167,0.24238,0.16395,0,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.16032,0.24222,0.1925,0,0
3,GO RELAXATION OF MUSCLE,0.024846,0.24158,0.16698,0,0
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0056288,0.24129,0.26117,0,0
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.00079435,0.23986,0.22,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.13814,0.23912,0.10162,0,0
3,GO RESPONSE TO HYPEROXIA,0.31232,0.23675,0.084246,0,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0094949,0.23455,0.2142,0,0
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0010206,0.23285,0.27033,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0695,0.23229,0.13285,0,0
3,GO COLLAGEN METABOLIC PROCESS,0.065563,0.2303,0.11424,0,0
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0075304,0.22768,0.19368,0,0
3,GO NEURON PROJECTION ORGANIZATION,0.00074557,0.22727,0.21785,0,0
3,GO SYNAPTIC TRANSMISSION GABAERGIC,0.001986,0.22472,0.21687,0,0
3,GO REGULATION OF NEURON MIGRATION,0.017137,0.22398,0.19341,0,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0050528,0.22167,0.22295,0,0
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0090226,0.22067,0.23243,0,0
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.012203,0.22039,0.16538,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.013139,0.21845,0.23131,0,0
3,GO PROTEIN LOCALIZATION TO AXON,0.066855,0.21807,0.31057,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0056288,0.21762,0.20945,0,0
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.25729,0.21575,0.029571,0,0
3,GO RESPONSE TO AMINE,0.0039469,0.21489,0.19535,0,0
3,GO PARENTAL BEHAVIOR,0.11636,0.21458,0.13339,0,0
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.042857,0.21383,0.28053,0,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.23937,0.21359,0.07005,0,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.19095,0.21028,0.12095,0,0
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.014841,0.20906,0.2444,0,0
3,GO ENAMEL MINERALIZATION,0.46512,0.2084,0.058723,0,0
3,GO CELL PROLIFERATION IN FOREBRAIN,0.076492,0.20738,0.15981,0,0
3,GO LONG TERM MEMORY,0.0031536,0.20666,0.20571,0,0
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.076492,0.20474,0.11575,0,0
3,GO NOREPINEPHRINE TRANSPORT,0.011047,0.20419,0.17,0,0
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.082489,0.20406,0.11046,0,0
3,GO CGMP METABOLIC PROCESS,0.012508,0.20313,0.23463,0,0
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.3746,0.20211,0.10426,0,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.015953,0.20135,0.28305,0,0
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.14769,0.20012,0.12549,0,0
3,GO ONE CARBON METABOLIC PROCESS,0.004408,0.19988,0.17253,0,0
3,GO DENDRITIC SPINE MORPHOGENESIS,0.0071468,0.19848,0.20601,0,0
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.017137,0.19747,0.21302,0,0
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.36064,0.19631,0.053091,0,0
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.013798,0.19484,0.18448,0,0
3,GO NEUROTRANSMITTER UPTAKE,0.0040578,0.19445,0.20916,0,0
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.02068,0.19368,0.19109,0,0
3,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0079323,0.1929,0.15211,0,0
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.035393,0.19288,0.1578,0,0
3,GO CELL JUNCTION DISASSEMBLY,0.017137,0.19244,0.17848,0,0
3,GO SYNAPTIC VESICLE DOCKING,0.12473,0.18957,0.19528,0,0
3,GO REGULATION OF CYCLASE ACTIVITY,0.0006154,0.18953,0.18551,0,0
3,GO LEARNING,0.0069616,0.18828,0.16978,0,0
3,GO PROTEIN NITROSYLATION,0.034637,0.18795,0.16837,0,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.040234,0.18785,0.12711,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.030383,0.18771,0.16601,0,0
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.059411,0.18674,0.088108,0,0
3,GO AXONAL FASCICULATION,0.15264,0.1867,0.1669,0,0
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0081404,0.1864,0.24206,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.080955,0.18553,0.25368,0,0
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0041716,0.18517,0.16423,0,0
3,GO CHEMOSENSORY BEHAVIOR,0.013798,0.18486,0.19397,0,0
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.027803,0.18383,0.16377,0,0
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.15015,0.18339,0.13284,0,0
3,GO MEMBRANE DISASSEMBLY,0.065563,0.18323,0.088868,0,0
3,GO RESPONSE TO CAFFEINE,0.027188,0.18275,0.17407,0,0
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0064317,0.18258,0.16641,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.14285,0.18197,0.097332,0,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.055956,0.18141,0.18713,0,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.059411,0.18052,0.10417,0,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.088862,0.1804,0.15001,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.28785,0.17986,0.076709,0,0
3,GO SYNAPSE ORGANIZATION,0.011047,0.1797,0.14312,0,0
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.05161,0.17898,0.16018,0,0
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.077957,0.17887,0.14599,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.12049,0.17778,0.13047,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0028957,0.17765,0.15905,0,0
3,GO TOOTH MINERALIZATION,0.43883,0.17727,0.052733,0,0
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.17099,0.17721,0.14101,0,0
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.14769,0.17674,0.16338,0,0
3,GO CAMP METABOLIC PROCESS,0.10654,0.17499,0.095835,0,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.05161,0.17495,0.13642,0,0
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.087232,0.17493,0.13264,0,0
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.15517,0.17456,0.097567,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.43883,0.17441,0.072465,0,0
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0034322,0.17417,0.18174,0,0
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.060602,0.17345,0.14804,0,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.097379,0.17331,0.12035,0,0
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.029068,0.17307,0.13903,0,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.021165,0.17307,0.15703,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.2839,0.17145,0.12858,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.11434,0.17097,0.1472,0,0
3,GO POSTSYNAPSE ORGANIZATION,0.0064317,0.17082,0.16044,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.30402,0.17061,0.084633,0,0
3,GO REGULATION OF TUBULIN DEACETYLATION,0.30402,0.17047,0.1036,0,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.19095,0.16959,0.10458,0,0
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.031748,0.16932,0.12568,0,0
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.32077,0.169,0.02665,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.066855,0.1685,0.13596,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0049174,0.16787,0.18131,0,0
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.43883,0.16786,0.033859,0,0
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.009256,0.16517,0.19815,0,0
3,GO CORONARY VASCULATURE DEVELOPMENT,0.053746,0.16469,0.10407,0,0
3,GO RESPONSE TO LIGHT INTENSITY,0.072231,0.16397,0.18903,0,0
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.42855,0.16362,0.0595,0,0
3,GO DENDRITIC SPINE DEVELOPMENT,0.018836,0.16346,0.14409,0,0
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.033894,0.16336,0.13585,0,0
3,GO ASSOCIATIVE LEARNING,0.0040578,0.16306,0.16534,0,0
3,GO LIPID IMPORT INTO CELL,0.27227,0.16238,0.051652,0,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.088862,0.16153,0.13288,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.51459,0.16108,0.055696,0,0
3,GO CGMP MEDIATED SIGNALING,0.076492,0.16063,0.102,0,0
3,GO RESPONSE TO PROTOZOAN,0.72313,0.15989,0.0090345,0,0
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.1028,0.15925,0.1367,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.21905,0.15887,0.09842,0,0
3,GO HEPARIN METABOLIC PROCESS,0.050569,0.15858,0.22671,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.20937,0.15848,0.1326,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.16559,0.15835,0.069868,0,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0042883,0.15712,0.21215,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.20621,0.15688,0.081098,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0085714,0.15651,0.13749,0,0
3,GO CELL PROLIFERATION IN HINDBRAIN,0.15264,0.15632,0.14022,0,0
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.012203,0.15608,0.1901,0,0
3,GO ONE CARBON COMPOUND TRANSPORT,0.042857,0.15577,0.11004,0,0
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.013798,0.15504,0.17427,0,0
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.30815,0.15403,0.069504,0,0
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.030383,0.15394,0.13708,0,0
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.019739,0.15387,0.11646,0,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.22235,0.15332,0.069031,0,0
3,GO REGULATION OF CELLULAR RESPIRATION,0.049546,0.15298,0.12988,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.019283,0.15293,0.13831,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.049546,0.15168,0.10325,0,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.55487,0.15101,0.097265,0,0
3,GO RESPONSE TO PROSTAGLANDIN E,0.10654,0.15027,0.073831,0,0
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0695,0.14997,0.18598,0,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.29586,0.14956,0.032744,0,0
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.32506,0.1491,0.080587,0,0
3,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.27227,0.14882,0.091175,0,0
3,GO SYNAPTIC VESICLE EXOCYTOSIS,0.0060989,0.14836,0.20435,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.063042,0.14788,0.14578,0,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.26098,0.14773,0.066702,0,0
3,GO MINERALOCORTICOID METABOLIC PROCESS,0.67776,0.14765,-0.012528,0,0
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.03939,0.1475,0.13272,0,0
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.11434,0.14694,0.14246,0,0
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.19095,0.14634,0.11353,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.082489,0.14607,0.10808,0,0
3,GO COLLATERAL SPROUTING,0.036164,0.14592,0.14537,0,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.3746,0.14582,0.05916,0,0
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.14048,0.14573,0.094029,0,0
3,GO LONG TERM SYNAPTIC DEPRESSION,0.13814,0.14568,0.12667,0,0
3,GO ACYLGLYCEROL HOMEOSTASIS,0.20309,0.14528,0.072542,0,0
3,GO FATTY ACYL COA METABOLIC PROCESS,0.02843,0.14525,0.14159,0,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.093897,0.14519,0.15664,0,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.17653,0.14481,0.084633,0,0
3,GO RESPONSE TO MANGANESE ION,0.22905,0.14426,0.07976,0,0
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.068167,0.14352,0.098187,0,0
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.090515,0.14293,0.12847,0,0
3,GO FOREBRAIN CELL MIGRATION,0.041093,0.14275,0.13448,0,0
3,GO CELLULAR ANION HOMEOSTASIS,0.087232,0.14255,0.12873,0,0
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.14526,0.14237,0.13758,0,0
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.10845,0.14222,0.071577,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.068167,0.14212,0.092423,0,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.025414,0.14158,0.1525,0,0
3,GO XENOBIOTIC TRANSPORT,0.43883,0.14139,0.012707,0,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0013872,0.14106,0.1409,0,0
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.31232,0.14089,0.051021,0,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.22235,0.14048,0.07954,0,0
3,GO CARBOHYDRATE PHOSPHORYLATION,0.03939,0.14046,0.11655,0,0
3,GO POSITIVE REGULATION OF HEART GROWTH,0.064293,0.14016,0.12175,0,0
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.052669,0.13973,0.1169,0,0
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.018398,0.13937,0.12625,0,0
3,GO ACIDIC AMINO ACID TRANSPORT,0.0059384,0.13895,0.15741,0,0
3,GO RESPONSE TO UV B,0.69061,0.13872,-0.079753,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.007729,0.13843,0.12591,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.05161,0.13833,0.15556,0,0
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.10654,0.13833,0.11949,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.085627,0.13831,0.11713,0,0
3,GO MITOCHONDRION LOCALIZATION,0.0039469,0.13788,0.15366,0,0
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.74288,0.13705,0.025909,0,0
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.14769,0.13599,0.14128,0,0
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.15015,0.13599,0.16894,0,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.30402,0.13562,0.11625,0,0
3,GO VOCALIZATION BEHAVIOR,0.47588,0.13544,0.1168,0,0
3,GO POST ANAL TAIL MORPHOGENESIS,0.188,0.13485,0.10361,0,0
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.24288,0.13444,0.075406,0,0
3,GO CELL AGGREGATION,0.18219,0.13444,0.08419,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.090515,0.13411,0.17985,0,0
3,GO IMPORT INTO CELL,0.0023671,0.1341,0.1388,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.055956,0.13337,0.12663,0,0
3,GO NEURON PROJECTION EXTENSION,0.037747,0.13322,0.10066,0,0
3,GO LIMB BUD FORMATION,0.15517,0.13315,0.23847,0,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.084046,0.13227,0.089646,0,0
3,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.034637,0.13143,0.20291,0,0
3,GO WALKING BEHAVIOR,0.004408,0.13133,0.19622,0,0
3,GO PROTEIN OXIDATION,0.11235,0.13088,0.080542,0,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.38888,0.13064,0.053212,0,0
3,GO AMINO ACID TRANSPORT,0.00044439,0.13035,0.15736,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.50337,0.12972,0.033652,0,0
3,GO EXPLORATION BEHAVIOR,0.034637,0.12965,0.21732,0,0
3,GO COCHLEA MORPHOGENESIS,0.14526,0.1296,0.097496,0,0
3,GO REGULATION OF STEROL TRANSPORT,0.23245,0.12951,0.061162,0,0
3,GO AORTIC VALVE DEVELOPMENT,0.17934,0.12903,0.089401,0,0
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.018836,0.12866,0.11834,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.080955,0.12829,0.1066,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.080955,0.12815,0.12364,0,0
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.05824,0.12776,0.091806,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.12259,0.12701,0.081328,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.041093,0.12698,0.1597,0,0
3,GO MOTOR NEURON AXON GUIDANCE,0.0695,0.12696,0.13367,0,0
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.019739,0.12678,0.15271,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.20621,0.12673,0.12583,0,0
3,GO IRON COORDINATION ENTITY TRANSPORT,0.037747,0.126,0.15547,0,0
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.20937,0.12576,0.058962,0,0
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.35607,0.12549,0.061764,0,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.47049,0.1252,0.072522,0,0
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.035393,0.12512,0.10574,0,0
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.14526,0.12509,0.14873,0,0
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.35153,0.12488,0.06732,0,0
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.017137,0.1248,0.14552,0,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.060602,0.12471,0.094129,0,0
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.077957,0.12469,0.096129,0,0
3,GO MEMBRANE REPOLARIZATION,0.042857,0.12457,0.10648,0,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.40349,0.12445,0.046151,0,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.20309,0.12342,0.080321,0,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.018836,0.12279,0.10552,0,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.011612,0.12247,0.2099,0,0
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.088862,0.12233,0.12343,0,0
3,GO TETRAPYRROLE METABOLIC PROCESS,0.12259,0.12231,0.076083,0,0
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0067808,0.12224,0.10223,0,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.23589,0.12222,0.054083,0,0
3,GO RESPIRATORY SYSTEM PROCESS,0.018398,0.12196,0.14031,0,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.59059,0.12169,0.032359,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.24643,0.12134,0.062544,0,0
3,GO RESPONSE TO VITAMIN A,0.32506,0.12124,0.075908,0,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.11235,0.1204,0.063789,0,0
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.041093,0.12031,0.16321,0,0
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.19095,0.12007,0.10429,0,0
3,GO LYMPH VESSEL DEVELOPMENT,0.15517,0.11937,0.085766,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.27611,0.11908,0.079164,0,0
3,GO LYMPHANGIOGENESIS,0.22905,0.11819,0.071714,0,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.049546,0.11807,0.23578,0,0
3,GO NEURON RECOGNITION,0.16559,0.11777,0.11537,0,0
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.02268,0.1172,0.15048,0,0
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.29992,0.11711,0.055216,0,0
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.14048,0.11693,0.070023,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.019739,0.11665,0.10302,0,0
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.05161,0.11664,0.058763,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.10654,0.11627,0.14979,0,0
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.075049,0.11625,0.12621,0,0
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.016339,0.11607,0.12433,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.20937,0.11581,0.072476,0,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.14769,0.1156,0.055692,0,0
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.053746,0.11541,0.086327,0,0
3,GO DEVELOPMENTAL CELL GROWTH,0.031059,0.11541,0.080884,0,0
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.32506,0.11532,0.040718,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.077957,0.1153,0.097395,0,0
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.023205,0.11436,0.1835,0,0
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.011904,0.11417,0.18134,0,0
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.2839,0.11409,0.047716,0,0
3,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.73628,0.11379,-0.01629,0,0
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.0024367,0.11376,0.13229,0,0
3,GO POSITIVE REGULATION OF HEART RATE,0.29992,0.11314,0.076811,0,0
3,GO DENDRITIC TRANSPORT,0.099158,0.11295,0.17168,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.075049,0.11246,0.092922,0,0
3,GO THYROID GLAND DEVELOPMENT,0.59664,0.11214,0.00054879,0,0
3,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.082489,0.11202,0.16327,0,0
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.37932,0.11173,0.018891,0,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,0.31653,0.11127,0.028716,0,0
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.21579,0.1112,0.071744,0,0
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0016129,0.11108,0.11605,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.063042,0.11064,0.092832,0,0
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.2,0.11043,0.046865,0,0
3,GO RESPONSE TO NITRIC OXIDE,0.046579,0.11007,0.072861,0,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.2839,0.10977,0.07557,0,0
3,GO FOREBRAIN NEURON DEVELOPMENT,0.51459,0.10937,0.048321,0,0
3,GO SNARE COMPLEX ASSEMBLY,0.63978,0.10912,0.016152,0,0
3,GO FIBRINOLYSIS,0.39371,0.1091,-0.032119,0,0
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.085627,0.10877,0.095568,0,0
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.19695,0.10872,0.059129,0,0
3,GO MICROTUBULE DEPOLYMERIZATION,0.33812,0.10818,0.053595,0,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.52025,0.10807,-0.00091439,0,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.4545,0.10801,0.0010731,0,0
3,GO NEUROTRANSMITTER TRANSPORT,0.05161,0.10788,0.14311,0,0
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.076492,0.10761,0.14464,0,0
3,GO UBIQUINONE METABOLIC PROCESS,0.19393,0.10748,0.038215,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.1313,0.10747,0.04758,0,0
3,GO ANION HOMEOSTASIS,0.188,0.10723,0.06613,0,0
3,GO PLASMINOGEN ACTIVATION,0.31653,0.10714,-0.0098727,0,0
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.86455,0.10668,-0.016079,0,0
3,GO COCHLEA DEVELOPMENT,0.031059,0.10644,0.10417,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.16294,0.10632,0.062211,0,0
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.52594,0.10619,0.12075,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.17934,0.10596,0.088282,0,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.04854,0.10545,0.08285,0,0
3,GO RESPONSE TO AMPHETAMINE,0.093897,0.10436,0.106,0,0
3,GO ENDODERM DEVELOPMENT,0.30402,0.10422,0.031694,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.092194,0.10401,0.078183,0,0
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.14769,0.10386,0.043506,0,0
3,GO SYNAPTIC SIGNALING,0.12049,0.10342,0.079031,0,0
3,GO INTERACTION WITH SYMBIONT,0.082489,0.10304,0.053206,0,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.1313,0.10301,0.084176,0,0
3,GO NUCLEUS LOCALIZATION,0.14769,0.1027,0.08124,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.24643,0.1025,0.082335,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.061812,0.10241,0.15582,0,0
3,GO AXON EXTENSION,0.073629,0.10202,0.087028,0,0
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.077957,0.10151,0.092805,0,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.67776,0.10136,-0.011073,0,0
3,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.22235,0.10126,0.080949,0,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.15773,0.10086,0.26238,0,0
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.42347,0.10069,0.059364,0,0
3,GO DRUG CATABOLIC PROCESS,0.10845,0.10059,0.08512,0,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.092194,0.10048,0.11907,0,0
3,GO DENDRITE DEVELOPMENT,0.055956,0.10037,0.099755,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.99651,0.10026,0.0040398,0,0
3,GO RESPONSE TO MUSCLE ACTIVITY,0.30815,0.09988,0.064178,0,0
3,GO PHAGOLYSOSOME ASSEMBLY,0.29184,0.099778,0.06338,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.59664,0.099585,0.044991,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.080955,0.099118,0.086423,0,0
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.13583,0.098657,0.071962,0,0
3,GO CELL PART MORPHOGENESIS,0.13355,0.098553,0.070974,0,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.16032,0.09845,0.1543,0,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.4978,0.098054,0.026652,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.15517,0.098044,0.14909,0,0
3,GO OSTEOCLAST DEVELOPMENT,0.26847,0.097986,0.071693,0,0
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.56075,0.097973,0.031506,0,0
3,GO SEROTONIN TRANSPORT,0.53167,0.097963,0.05305,0,0
3,GO REGULATION OF CARDIAC CONDUCTION,0.15773,0.097797,0.069859,0,0
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.11434,0.0976,0.081688,0,0
3,GO NEGATIVE REGULATION OF CELL AGING,0.72313,0.097442,0.0034879,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.26471,0.097188,0.11648,0,0
3,GO RESPONSE TO INTERLEUKIN 12,0.19695,0.097107,0.062915,0,0
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.28785,0.09703,0.071566,0,0
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.05161,0.097005,0.073418,0,0
3,GO LEUKOCYTE TETHERING OR ROLLING,0.0090226,0.096816,0.12352,0,0
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.32077,0.096687,0.036298,0,0
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.055956,0.096577,0.072692,0,0
3,GO NEUROTRANSMITTER SECRETION,0.095625,0.096572,0.13582,0,0
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.15264,0.096499,0.097708,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.11039,0.096406,0.096929,0,0
3,GO REVERSE CHOLESTEROL TRANSPORT,0.61497,0.096301,0.0014899,0,0
3,GO NADPH REGENERATION,0.34256,0.095991,0.069792,0,0
3,GO MECHANOSENSORY BEHAVIOR,0.54903,0.095948,0.12864,0,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.14048,0.09588,0.14063,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.99651,0.095811,-0.011277,0,0
3,GO PROSTATE GLAND GROWTH,0.4598,0.095745,0.0073899,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.18219,0.095479,0.080572,0,0
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0025817,0.09519,0.1562,0,0
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.22568,0.095157,0.097298,0,0
3,GO RNA EXPORT FROM NUCLEUS,0.0030654,0.095103,0.13263,0,0
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.18508,0.095044,0.055907,0,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.05161,0.094784,0.089898,0,0
3,GO PROTEIN DEMETHYLATION,0.092194,0.094641,0.088082,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.082489,0.094223,0.081947,0,0
3,GO DENDRITE MORPHOGENESIS,0.10845,0.094021,0.0845,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.74288,0.093815,-0.023357,0,0
3,GO REGULATION OF DOPAMINE SECRETION,0.46512,0.093777,0.12908,0,0
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.66501,0.093714,0.055442,0,0
3,GO STRIATUM DEVELOPMENT,0.15015,0.093587,0.10795,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.36064,0.093579,0.034636,0,0
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.097379,0.093475,0.26418,0,0
3,GO DENDRITIC SPINE MAINTENANCE,0.19695,0.093215,0.066815,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.057089,0.09309,0.10753,0,0
3,GO MRNA SPLICE SITE SELECTION,0.4598,0.093081,0.043412,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.35153,0.092981,0.040938,0,0
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.85768,0.092798,-0.055454,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.22905,0.092693,0.067967,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.46512,0.09254,0.087937,0,0
3,GO LAMELLIPODIUM MORPHOGENESIS,0.98953,0.09237,-0.036545,0,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.050569,0.092058,0.13486,0,0
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.10096,0.091974,0.10846,0,0
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.38888,0.091777,0.055422,0,0
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0695,0.091507,0.097623,0,0
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.23245,0.091206,0.048869,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.21905,0.091025,0.065,0,0
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.063042,0.090901,0.093147,0,0
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.25363,0.090771,0.061256,0,0
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.23589,0.09066,0.050148,0,0
3,GO MESODERMAL CELL FATE COMMITMENT,0.69707,0.090614,0.010966,0,0
3,GO RESPONSE TO SALT,0.36991,0.090608,0.040233,0,0
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.11434,0.090602,0.094843,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.94073,0.090507,-0.040552,0,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.29184,0.090475,0.025129,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.15773,0.089817,0.096498,0,0
3,GO NOREPINEPHRINE SECRETION,0.29586,0.089701,0.062268,0,0
3,GO GLIAL CELL MIGRATION,0.084046,0.089393,0.12232,0,0
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.11039,0.089094,0.13447,0,0
3,GO NEUROMUSCULAR PROCESS,0.073629,0.089066,0.099478,0,0
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.12049,0.088633,0.1304,0,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.087232,0.088449,0.088138,0,0
3,GO ELECTRON TRANSPORT CHAIN,0.16828,0.088351,0.065751,0,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.86455,0.088241,0.0011628,0,0
3,GO REGULATION OF MEMBRANE POTENTIAL,0.36064,0.088148,0.061831,0,0
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.18508,0.088075,0.055615,0,0
3,GO GROOMING BEHAVIOR,0.31232,0.088031,0.082043,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.33812,0.087918,0.061206,0,0
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.62113,0.087791,0.033367,0,0
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.15773,0.087682,0.067905,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.59664,0.087667,-0.013965,0,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.2,0.087421,0.097797,0,0
3,GO RESPONSE TO AMYLOID BETA,0.029719,0.087272,0.10585,0,0
3,GO REGULATION OF AXON GUIDANCE,0.38888,0.087091,0.037917,0,0
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.12259,0.087011,0.095042,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.14526,0.086793,0.078283,0,0
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.055956,0.086737,0.064002,0,0
3,GO THIOESTER METABOLIC PROCESS,0.12049,0.086727,0.069068,0,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.4978,0.086638,0.047485,0,0
3,GO NERVE DEVELOPMENT,0.47588,0.086516,0.038488,0,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.48131,0.086259,0.04187,0,0
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.4545,0.085799,0.042413,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.52594,0.08509,0.032059,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.99651,0.084925,-0.01442,0,0
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.39858,0.084712,0.053191,0,0
3,GO MUSCLE ORGAN MORPHOGENESIS,0.097379,0.084583,0.06531,0,0
3,GO HORMONE BIOSYNTHETIC PROCESS,0.23245,0.084391,0.059413,0,0
3,GO VITAMIN TRANSPORT,0.16032,0.084336,0.10655,0,0
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.11841,0.084324,0.052132,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.31232,0.084131,0.055431,0,0
3,GO RESPONSE TO ACIDIC PH,0.32938,0.083931,0.042928,0,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.71006,0.083643,0.0077632,0,0
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.42347,0.083425,0.048464,0,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.16559,0.083387,0.071155,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.33373,0.08331,0.042359,0,0
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.32077,0.083196,0.071397,0,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.092194,0.08316,0.064267,0,0
3,GO PHOSPHATE ION TRANSPORT,0.027803,0.08289,0.088009,0,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.72313,0.08277,-0.0022853,0,0
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.15264,0.082719,0.074747,0,0
3,GO ESTROGEN BIOSYNTHETIC PROCESS,0.4978,0.082659,0.042054,0,0
3,GO SKELETAL MUSCLE CONTRACTION,0.16559,0.082368,0.098367,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.42347,0.082227,0.026832,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.60883,0.082158,0.014452,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.87833,0.082149,-0.08118,0,0
3,GO NUCLEOSIDE SALVAGE,0.070855,0.0814,0.083625,0,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.18219,0.081316,0.067266,0,0
3,GO LACTATION,0.057089,0.081178,0.118,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.072231,0.081174,0.14192,0,0
3,GO METENCEPHALON DEVELOPMENT,0.16032,0.080965,0.082103,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.17934,0.080802,0.049863,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.05824,0.080665,0.075728,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.69061,0.080616,0.038374,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0057817,0.080156,0.095867,0,0
3,GO DENDRITE SELF AVOIDANCE,0.68418,0.079969,0.021757,0,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.23937,0.079852,0.073452,0,0
3,GO PIGMENT GRANULE MATURATION,0.41842,0.079675,0.012841,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.36991,0.079666,0.16523,0,0
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.099158,0.079538,0.081877,0,0
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.24288,0.079471,0.060483,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.20309,0.07942,0.11763,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.17374,0.079309,0.058289,0,0
3,GO SYNCYTIUM FORMATION,0.94769,0.079052,-0.008242,0,0
3,GO STARTLE RESPONSE,0.65866,0.078272,0.051064,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.059411,0.078189,0.097893,0,0
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.14048,0.07805,0.075981,0,0
3,GO PRESYNAPSE ORGANIZATION,0.12259,0.07784,0.1304,0,0
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.22568,0.0778,0.052027,0,0
3,GO ENDODERM FORMATION,0.23245,0.077599,0.045717,0,0
3,GO AMINO SUGAR METABOLIC PROCESS,0.25001,0.077403,0.041516,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.59059,0.077338,-0.035884,0,0
3,GO AXON DEVELOPMENT,0.17374,0.077112,0.075409,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.35607,0.076896,0.044506,0,0
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.33373,0.0768,0.058719,0,0
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.18508,0.076709,0.05182,0,0
3,GO SYNAPSE ASSEMBLY,0.19695,0.076673,0.089211,0,0
3,GO NEURAL CREST FORMATION,0.39371,0.076568,0.071006,0,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.15517,0.076529,0.096888,0,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.19695,0.076369,0.1255,0,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.075049,0.076111,0.066236,0,0
3,GO BLASTOCYST GROWTH,0.17374,0.07605,0.051061,0,0
3,GO PROTEIN ACTIVATION CASCADE,0.81668,0.076004,-0.032636,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.22568,0.075929,0.097483,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.62113,0.075897,0.0013476,0,0
3,GO PORE COMPLEX ASSEMBLY,0.34256,0.07578,0.0085206,0,0
3,GO TRNA 5 LEADER REMOVAL,0.084046,0.07577,0.15022,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.59664,0.075603,0.013714,0,0
3,GO REGULATION OF LIGASE ACTIVITY,0.65234,0.075567,0.023663,0,0
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.16294,0.07521,0.044295,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.065563,0.075199,0.088538,0,0
3,GO HISTONE DEUBIQUITINATION,0.073629,0.075153,0.073265,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.16294,0.075074,0.068963,0,0
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.26471,0.074999,0.10415,0,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.48678,0.074641,0.021074,0,0
3,GO MAINTENANCE OF CELL POLARITY,0.46512,0.074631,0.051033,0,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.34702,0.074464,0.044892,0,0
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.3746,0.074348,0.042074,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.94769,0.074271,-0.023354,0,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.89907,0.073448,0.018344,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.40349,0.073263,0.049686,0,0
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.10096,0.073209,0.04609,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.94073,0.072925,-0.01309,0,0
3,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.29992,0.072915,0.075386,0,0
3,GO RHYTHMIC BEHAVIOR,0.29992,0.072645,0.054643,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.30402,0.072552,0.057875,0,0
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.03245,0.072155,0.078427,0,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.40349,0.072126,0.039982,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.7495,0.071828,0.033529,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.18508,0.071803,0.078762,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.44402,0.071656,0.05549,0,0
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.95466,0.0715,-0.0031225,0,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.57857,0.071367,0.070847,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.15773,0.071253,0.080002,0,0
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.13583,0.070946,0.060371,0,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.13355,0.070835,0.056989,0,0
3,GO REGULATION OF EXCRETION,0.16294,0.070778,0.091762,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.32077,0.070769,0.064092,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.56075,0.070748,-0.010541,0,0
3,GO PROSTATIC BUD FORMATION,0.84397,0.070535,-0.053246,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.16559,0.070368,0.095496,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.13355,0.070001,0.11479,0,0
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.32077,0.069564,0.023769,0,0
3,GO CELL RECOGNITION,0.093897,0.069529,0.060574,0,0
3,GO CONVERGENT EXTENSION,0.22568,0.069473,0.087078,0,0
3,GO CELLULAR OXIDANT DETOXIFICATION,0.60883,0.069339,0.027863,0,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.32506,0.069006,0.038429,0,0
3,GO POSITIVE REGULATION OF FERTILIZATION,0.31653,0.068786,0.1074,0,0
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.34702,0.068671,0.025215,0,0
3,GO CERAMIDE TRANSPORT,0.052669,0.068442,0.070996,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.11636,0.068341,0.069082,0,0
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.060602,0.068316,0.12803,0,0
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.53167,0.068115,0.052675,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.34702,0.06808,0.041968,0,0
3,GO SYNAPTIC VESICLE RECYCLING,0.41341,0.06801,0.054923,0,0
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.4598,0.067988,0.025815,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.91293,0.067964,-0.063463,0,0
3,GO INTRACELLULAR LIPID TRANSPORT,0.44402,0.067907,0.035124,0,0
3,GO CELL CYCLE DNA REPLICATION,0.10096,0.067864,0.075561,0,0
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.033894,0.067726,0.13192,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.11841,0.067439,0.06872,0,0
3,GO TRABECULA FORMATION,0.19695,0.067389,0.089833,0,0
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.4545,0.067341,-0.0064355,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.74288,0.067285,-0.0045993,0,0
3,GO TELENCEPHALON DEVELOPMENT,0.10096,0.067265,0.065375,0,0
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.70355,0.067151,-0.014778,0,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.12473,0.067116,0.072375,0,0
3,GO CATECHOLAMINE UPTAKE,0.63354,0.067065,0.040436,0,0
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.16828,0.066987,0.051514,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.22905,0.066971,0.098623,0,0
3,GO MITOCHONDRIAL FISSION,0.25363,0.066962,0.052019,0,0
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.56666,0.066952,0.030064,0,0
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.015574,0.066896,0.0807,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.29184,0.066693,0.13801,0,0
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.16032,0.066608,0.052802,0,0
3,GO HEXOSE CATABOLIC PROCESS,0.50337,0.066554,0.020451,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.54903,0.066329,0.040659,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.47588,0.06629,0.0063202,0,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.67137,0.066188,0.031406,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.52025,0.066147,0.011429,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.95466,0.065844,-0.051774,0,0
3,GO CARDIAC CONDUCTION,0.1313,0.065475,0.093044,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.57857,0.065444,0.03223,0,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.32938,0.065308,0.073977,0,0
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.30815,0.064722,0.054001,0,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.22568,0.064689,0.068893,0,0
3,GO COENZYME A METABOLIC PROCESS,0.55487,0.064626,0.017659,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.12259,0.064443,0.068319,0,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.35607,0.064419,0.091987,0,0
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.47049,0.064416,0.064104,0,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.090515,0.064412,0.063097,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.12049,0.064203,0.080028,0,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.29586,0.06413,0.06809,0,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.057089,0.064081,0.065968,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.33812,0.063997,0.052847,0,0
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.52025,0.063665,0.03832,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.15517,0.063624,0.10096,0,0
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.38408,0.063594,0.022996,0,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.79636,0.063367,0.0079558,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.32938,0.063282,0.071844,0,0
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.59059,0.063136,0.017971,0,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.84397,0.063118,0.049202,0,0
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.27611,0.063027,0.088378,0,0
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.95466,0.063018,-0.029422,0,0
3,GO CHOLESTEROL EFFLUX,0.57857,0.062895,0.0072254,0,0
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.89215,0.062822,-0.026983,0,0
3,GO NEURON PROJECTION GUIDANCE,0.21905,0.062799,0.070639,0,0
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.61497,0.062764,0.024554,0,0
3,GO MEMORY,0.088862,0.062756,0.087837,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.27227,0.062729,0.039784,0,0
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.20937,0.062723,0.054297,0,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.63978,0.062687,0.0085889,0,0
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.13583,0.062556,0.069922,0,0
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.26098,0.062522,0.038157,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.54903,0.062207,0.068049,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.60272,0.0622,0.067214,0,0
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.32938,0.062074,0.031581,0,0
3,GO COLLAGEN CATABOLIC PROCESS,0.65234,0.062015,0.0040729,0,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.18508,0.061668,0.05576,0,0
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.98255,0.061656,-0.0036776,0,0
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.36526,0.061587,0.068694,0,0
3,GO REGULATION OF AXONOGENESIS,0.20621,0.061521,0.070157,0,0
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.3746,0.061509,0.038682,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.48131,0.061427,0.017464,0,0
3,GO NAD BIOSYNTHETIC PROCESS,0.91293,0.061303,-0.016784,0,0
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.69061,0.061271,0.012707,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.27999,0.061175,0.073177,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.49227,0.061165,0.0077329,0,0
3,GO CYCLOOXYGENASE PATHWAY,0.5726,0.061087,0.039498,0,0
3,GO HYPOTONIC RESPONSE,0.20937,0.060873,0.078223,0,0
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.14526,0.060548,0.11017,0,0
3,GO LATERAL MESODERM DEVELOPMENT,0.70355,0.060531,-0.069945,0,0
3,GO REGULATION OF GENE SILENCING,0.16828,0.060435,0.047147,0,0
3,GO TUBULIN DEACETYLATION,0.25363,0.060383,0.097862,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.80312,0.060279,-0.051433,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.36991,0.060128,0.027202,0,0
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.91293,0.059789,-0.041529,0,0
3,GO PROSTAGLANDIN SECRETION,0.4598,0.059545,0.044781,0,0
3,GO SYNAPTIC VESICLE LOCALIZATION,0.44402,0.05953,0.057459,0,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.40843,0.059469,0.038384,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.63354,0.059426,0.0029244,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.60272,0.059211,0.059267,0,0
3,GO PROTEIN HYDROXYLATION,0.65866,0.059074,0.039153,0,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.34702,0.05882,0.058338,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.26471,0.058732,0.092396,0,0
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.11636,0.058595,0.080541,0,0
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.11434,0.058519,0.13347,0,0
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.30402,0.058508,0.049542,0,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.2,0.058487,0.053573,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.35607,0.058445,0.028625,0,0
3,GO MATING,0.27999,0.058367,0.049701,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.2,0.058104,0.041441,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.12473,0.058008,0.056918,0,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.38408,0.057919,0.032613,0,0
3,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.2,0.057859,0.0693,0,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.50896,0.05759,0.017391,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.41341,0.057564,0.031179,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.085627,0.05756,0.097878,0,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.072231,0.057513,0.10861,0,0
3,GO PHOSPHOLIPID HOMEOSTASIS,0.64605,0.057347,-0.024619,0,0
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.54903,0.057012,0.041474,0,0
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.84397,0.056855,-0.0071487,0,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.52594,0.056844,0.018709,0,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.19695,0.056823,0.066719,0,0
3,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.76948,0.056775,0.0019162,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.76281,0.056664,0.012984,0,0
3,GO NEURAL CREST CELL MIGRATION,0.35607,0.056286,0.052701,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.58456,0.056176,0.054833,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.27611,0.05609,0.064462,0,0
3,GO CHROMOSOME CONDENSATION,0.12908,0.056019,0.058893,0,0
3,GO ACTIN MEDIATED CELL CONTRACTION,0.31653,0.055942,0.061977,0,0
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.36526,0.055756,0.042121,0,0
3,GO NADP METABOLIC PROCESS,0.26847,0.055751,0.029937,0,0
3,GO REGULATION OF CELL SIZE,0.26098,0.055687,0.03429,0,0
3,GO REGULATION OF SYSTEM PROCESS,0.24288,0.055557,0.041003,0,0
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.62732,0.055398,0.032633,0,0
3,GO NEUTRAL AMINO ACID TRANSPORT,0.17099,0.055362,0.097151,0,0
3,GO FOREBRAIN REGIONALIZATION,0.43883,0.055347,0.090658,0,0
3,GO PALLIUM DEVELOPMENT,0.32077,0.05503,0.051232,0,0
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.80312,0.054812,0.0048177,0,0
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.077957,0.054783,0.068158,0,0
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.91987,0.054772,-0.020843,0,0
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.60272,0.054627,0.00011078,0,0
3,GO VASCULOGENESIS,0.60883,0.054249,0.0046344,0,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.59059,0.054221,-0.024825,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.7495,0.054206,0.00048659,0,0
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.48678,0.054106,0.011747,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.4545,0.053982,0.037377,0,0
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.39858,0.05394,0.032654,0,0
3,GO PROTEIN STABILIZATION,0.21579,0.053869,0.037921,0,0
3,GO OSTEOBLAST DEVELOPMENT,0.99651,0.053807,-0.039613,0,0
3,GO REGULATION OF PROTEIN TARGETING,0.16294,0.053776,0.046344,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.23589,0.05371,0.079671,0,0
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.56666,0.053703,0.055375,0,0
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.68418,0.053501,0.013985,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.19095,0.053419,0.077466,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.21579,0.053381,0.070752,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.80312,0.053046,-0.017481,0,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.12908,0.052929,0.066832,0,0
3,GO REGULATION OF PROTON TRANSPORT,0.39371,0.052867,0.068415,0,0
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.22235,0.052634,0.064371,0,0
3,GO RESPONSE TO CALCIUM ION,0.26098,0.052607,0.054234,0,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.12049,0.052365,0.10055,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.79636,0.05231,-0.027232,0,0
3,GO PLASMA MEMBRANE TUBULATION,0.073629,0.052277,0.11976,0,0
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.22568,0.052199,0.10264,0,0
3,GO NUCLEOSOME ORGANIZATION,0.26847,0.052174,0.043323,0,0
3,GO RENAL SODIUM EXCRETION,0.19095,0.052167,0.05913,0,0
3,GO RNA INTERFERENCE,0.20937,0.052037,0.067167,0,0
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.8303,0.051913,-0.036679,0,0
3,GO HYALURONAN CATABOLIC PROCESS,0.95466,0.051599,-0.04667,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.53167,0.051515,0.13069,0,0
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.077957,0.051372,0.1305,0,0
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.87833,0.051146,-0.01793,0,0
3,GO MYOBLAST FUSION,0.75615,0.05105,-0.035335,0,0
3,GO REGULATION OF HEART RATE,0.31232,0.051025,0.057126,0,0
3,GO GRANULOCYTE DIFFERENTIATION,0.85768,0.050771,-0.041013,0,0
3,GO PROTEIN IMPORT,0.27227,0.050675,0.030545,0,0
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.54321,0.050528,0.031159,0,0
3,GO RESPONSE TO AMINO ACID STARVATION,0.25363,0.050524,0.075995,0,0
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.51459,0.050237,0.031634,0,0
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.31653,0.04991,0.01929,0,0
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.12908,0.049905,0.058743,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.94073,0.049895,-0.023426,0,0
3,GO DEFENSE RESPONSE TO FUNGUS,0.63978,0.049532,0.007549,0,0
3,GO BEHAVIOR,0.32938,0.049419,0.045134,0,0
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.41842,0.049364,0.033079,0,0
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.54903,0.049327,0.017995,0,0
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.17653,0.049301,0.077012,0,0
3,GO ANIMAL ORGAN REGENERATION,0.60883,0.049277,0.0036675,0,0
3,GO STRIATED MUSCLE CONTRACTION,0.22568,0.049242,0.058136,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.40843,0.049215,0.024378,0,0
3,GO SCHWANN CELL DEVELOPMENT,0.93377,0.048968,-0.0028933,0,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.48678,0.048913,0.052922,0,0
3,GO VESICLE CARGO LOADING,0.59059,0.04887,-0.0095624,0,0
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.10654,0.048806,0.13453,0,0
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.81668,0.04877,0.016703,0,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.12689,0.048685,0.076828,0,0
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.068167,0.048654,0.10533,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.35153,0.048612,0.043394,0,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.27999,0.048554,0.062978,0,0
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.1313,0.048522,0.06857,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.8303,0.048495,-0.0073822,0,0
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.65866,0.04843,0.00022936,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.62732,0.048407,0.030145,0,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.47049,0.048107,0.049886,0,0
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.30815,0.047971,0.033938,0,0
3,GO CHRONIC INFLAMMATORY RESPONSE,0.78289,0.047819,-0.092437,0,0
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.91293,0.047806,-0.0060566,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.43883,0.047698,0.01365,0,0
3,GO COGNITION,0.11235,0.04755,0.084171,0,0
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.32077,0.04754,0.040261,0,0
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.19095,0.047491,0.046053,0,0
3,GO T CELL HOMEOSTASIS,0.92682,0.047435,-0.0044166,0,0
3,GO SODIUM ION TRANSPORT,0.39371,0.047341,0.027893,0,0
3,GO GROWTH HORMONE SECRETION,0.63978,0.047294,0.039705,0,0
3,GO RESPONSE TO MISFOLDED PROTEIN,0.80989,0.047197,-0.0058946,0,0
3,GO MULTICELLULAR ORGANISM GROWTH,0.59059,0.046846,0.0083562,0,0
3,GO NEURON DEVELOPMENT,0.36526,0.046792,0.036874,0,0
3,GO RESPONSE TO LEAD ION,0.54321,0.046779,0.030356,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.26471,0.046672,0.030317,0,0
3,GO NEURON PROJECTION ARBORIZATION,1,0.046481,0.017364,0,0
3,GO CHROMATIN SILENCING AT TELOMERE,0.47588,0.046451,0.041914,0,0
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.63354,0.046339,0.05532,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.11636,0.046313,0.075296,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.15517,0.046174,0.060387,0,0
3,GO PRESYNAPTIC ENDOCYTOSIS,0.46512,0.046106,0.056425,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.76948,0.046074,0.018414,0,0
3,GO REGULATION OF CELL AGING,0.97557,0.046047,-0.024844,0,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.20621,0.04602,0.078893,0,0
3,GO SEQUESTERING OF CALCIUM ION,0.4545,0.04595,0.037995,0,0
3,GO MIRNA METABOLIC PROCESS,0.51459,0.045931,0.031144,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.63354,0.04592,0.024683,0,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.38888,0.045489,0.061204,0,0
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.24643,0.045469,0.041274,0,0
3,GO PROTEIN KINASE A SIGNALING,0.69707,0.045452,0.013731,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.54903,0.045331,0.010674,0,0
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.61497,0.045174,0.0020427,0,0
3,GO MUSCLE CELL FATE COMMITMENT,0.43883,0.045156,0.029573,0,0
3,GO REGULATION OF TELOMERASE ACTIVITY,0.43883,0.044986,0.037419,0,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.40349,0.044919,0.048793,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.87833,0.044749,0.028381,0,0
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.64605,0.044613,-0.057547,0,0
3,GO CATION TRANSMEMBRANE TRANSPORT,0.17374,0.044505,0.048619,0,0
3,GO OPTIC NERVE DEVELOPMENT,0.64605,0.044431,0.030338,0,0
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.65234,0.044184,0.028123,0,0
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.44402,0.04414,0.029821,0,0
3,GO PROTEIN HOMOOLIGOMERIZATION,0.03245,0.043942,0.07731,0,0
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.188,0.043851,0.065318,0,0
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.38408,0.043833,0.099113,0,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.35607,0.043818,0.032959,0,0
3,GO T CELL DIFFERENTIATION IN THYMUS,0.36526,0.043794,0.039256,0,0
3,GO IMMATURE T CELL PROLIFERATION,0.69707,0.04375,-0.016381,0,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.24643,0.04373,0.057075,0,0
3,GO MITOCHONDRIAL TRANSPORT,0.19095,0.043713,0.040525,0,0
3,GO MEMBRANE HYPERPOLARIZATION,0.76281,0.043604,-0.02257,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.75615,0.043547,0.017203,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.23937,0.043486,0.041946,0,0
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.11434,0.043476,0.031351,0,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.56666,0.043451,-0.033323,0,0
3,GO BEHAVIORAL RESPONSE TO PAIN,0.61497,0.043091,0.06159,0,0
3,GO DRUG METABOLIC PROCESS,0.33373,0.042753,0.025015,0,0
3,GO SPINDLE MIDZONE ASSEMBLY,0.8303,0.042623,-0.018627,0,0
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.15264,0.042566,0.061547,0,0
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.36991,0.042486,0.029874,0,0
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.58456,0.042241,0.073235,0,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.2,0.042199,0.086413,0,0
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.092194,0.042024,0.088716,0,0
3,GO LYMPH VESSEL MORPHOGENESIS,0.99651,0.041962,-0.035782,0,0
3,GO POLYOL METABOLIC PROCESS,0.22235,0.041906,0.036785,0,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.80312,0.041721,0.018267,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.60883,0.041597,-0.0084243,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.50896,0.041544,0.0055364,0,0
3,GO EPIBOLY,0.80989,0.041503,-0.071522,0,0
3,GO HYPEROSMOTIC RESPONSE,0.72313,0.041338,0.013402,0,0
3,GO CELLULAR RESPONSE TO RADIATION,0.36526,0.041311,0.021209,0,0
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.95466,0.040761,-0.0090058,0,0
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.54903,0.040725,0.028677,0,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.75615,0.040696,-0.071384,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.44402,0.040674,0.056266,0,0
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.25001,0.040627,0.082925,0,0
3,GO BONE DEVELOPMENT,0.65866,0.040599,0.0017683,0,0
3,GO ORGANIC CATION TRANSPORT,0.23589,0.040472,0.061168,0,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.63354,0.040459,0.015066,0,0
3,GO METAL ION TRANSPORT,0.29992,0.040395,0.030374,0,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.71006,0.040319,0.017854,0,0
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.50337,0.040308,0.03509,0,0
3,GO CAMP BIOSYNTHETIC PROCESS,0.88523,0.040248,-0.024108,0,0
3,GO RECEPTOR INTERNALIZATION,0.30815,0.040068,0.039294,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.24643,0.04004,0.090826,0,0
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.37932,0.039993,0.092903,0,0
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.38408,0.03982,0.058863,0,0
3,GO L PHENYLALANINE METABOLIC PROCESS,0.52594,0.039494,-0.14045,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.91293,0.039332,-0.02527,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.41842,0.039256,0.040367,0,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.76281,0.039221,0.08787,0,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.50896,0.039127,0.017755,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.18219,0.038768,0.036946,0,0
3,GO PHOSPHOLIPID EFFLUX,0.87144,0.038735,0.019209,0,0
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.21579,0.038422,0.070608,0,0
3,GO PENILE ERECTION,0.48131,0.038204,0.036943,0,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.55487,0.03817,-0.0042794,0,0
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.44402,0.038066,0.041048,0,0
3,GO DORSAL AORTA DEVELOPMENT,0.60883,0.037939,0.036337,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.48678,0.037931,0.032615,0,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.65234,0.037892,0.026167,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.40349,0.037864,0.080963,0,0
3,GO HIPPOCAMPUS DEVELOPMENT,0.12908,0.03782,0.10965,0,0
3,GO ADHESION OF SYMBIONT TO HOST,0.76948,0.037789,0.0080335,0,0
3,GO SMOOTH MUSCLE CONTRACTION,0.63978,0.037642,0.00083558,0,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.42855,0.037477,0.075228,0,0
3,GO ACETYL COA METABOLIC PROCESS,0.60883,0.037359,0.018824,0,0
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.30402,0.037326,0.047527,0,0
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.39371,0.037223,0.038079,0,0
3,GO NUCLEAR MIGRATION,0.30815,0.037209,0.061271,0,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.35153,0.036885,0.039156,0,0
3,GO CHROMATIN SILENCING,0.61497,0.036686,0.022562,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.64605,0.036493,0.030414,0,0
3,GO RECEPTOR CLUSTERING,0.60272,0.036482,0.025722,0,0
3,GO RESPONSE TO RETINOIC ACID,0.87833,0.036452,-0.019901,0,0
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.35153,0.03641,0.025479,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.41842,0.0364,0.018005,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.20621,0.036389,0.06787,0,0
3,GO MISMATCH REPAIR,0.36991,0.036133,0.032975,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.69707,0.035989,-0.032879,0,0
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.62732,0.035935,0.016937,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.69707,0.035896,0.011259,0,0
3,GO REGULATION OF NEURON DIFFERENTIATION,0.4545,0.035816,0.036691,0,0
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.54321,0.035797,0.032538,0,0
3,GO REGULATION OF ION TRANSPORT,0.7495,0.035697,0.013311,0,0
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.43883,0.035438,0.030966,0,0
3,GO RRNA CATABOLIC PROCESS,0.67137,0.035427,0.046648,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.76281,0.035425,0.0056431,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.47588,0.03537,0.0041544,0,0
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.17934,0.035289,0.068456,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.60272,0.03516,0.01245,0,0
3,GO DNA REPAIR,0.077957,0.035033,0.036105,0,0
3,GO REGULATION OF AMYLOID BETA FORMATION,1,0.034937,0.0029449,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.33812,0.03491,0.026854,0,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.61497,0.034779,-0.010475,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.76281,0.034774,0.050069,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.48131,0.034755,0.029145,0,0
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.21905,0.03474,0.044983,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.89215,0.034666,-0.075341,0,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.50896,0.034637,0.015918,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY,0.20621,0.034507,0.031985,0,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.14285,0.034342,0.051481,0,0
3,GO OXIDATION REDUCTION PROCESS,0.35607,0.034337,0.030534,0,0
3,GO NCRNA CATABOLIC PROCESS,0.36991,0.034235,0.05382,0,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.79636,0.034189,0.0054242,0,0
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.4978,0.034151,0.021057,0,0
3,GO HEART VALVE DEVELOPMENT,0.49227,0.034098,0.048784,0,0
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.66501,0.034072,0.022379,0,0
3,GO LIPID PHOSPHORYLATION,0.51459,0.033942,0.0095146,0,0
3,GO REGULATION OF FERTILIZATION,0.48131,0.033886,0.026939,0,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.32077,0.033839,0.074249,0,0
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.54903,0.033812,0.021047,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.79636,0.03368,-0.0015757,0,0
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.53167,0.03368,0.048965,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.21579,0.033596,0.063521,0,0
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.20937,0.03341,0.054265,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.36064,0.03335,0.052068,0,0
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.69061,0.033241,0.038114,0,0
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.26847,0.033143,0.064467,0,0
3,GO HISTONE METHYLATION,0.18219,0.03308,0.040619,0,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.77618,0.03304,-0.0582,0,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.53167,0.032961,0.074641,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.94769,0.03294,-0.0090511,0,0
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.59664,0.032793,0.072766,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.087232,0.032489,0.060161,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.76948,0.032437,0.033595,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.32938,0.032403,0.036732,0,0
3,GO CATECHOLAMINE SECRETION,0.62113,0.032322,0.10213,0,0
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.42855,0.032237,0.024513,0,0
3,GO LUNG ALVEOLUS DEVELOPMENT,0.88523,0.032095,-0.002892,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.79636,0.031964,-0.0064984,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.54903,0.031901,-0.0053086,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.23589,0.03158,0.12895,0,0
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.29184,0.03155,0.033042,0,0
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.27611,0.031474,0.030773,0,0
3,GO FORMATION OF PRIMARY GERM LAYER,0.52025,0.031384,0.0047172,0,0
3,GO TRANSITION METAL ION HOMEOSTASIS,0.48678,0.031333,0.02587,0,0
3,GO PROTEIN POLYGLUTAMYLATION,0.89215,0.031092,-0.032217,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.91293,0.03087,-0.029863,0,0
3,GO TRANSMEMBRANE TRANSPORT,0.33812,0.030732,0.024437,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.38888,0.030687,0.03172,0,0
3,GO RESPONSE TO IONIZING RADIATION,0.88523,0.030677,-0.026178,0,0
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.38408,0.030636,0.013652,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.96163,0.030632,0.0050266,0,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.30402,0.030525,0.015821,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.61497,0.030457,0.00019562,0,0
3,GO RESPONSE TO X RAY,0.86455,0.03039,-0.045833,0,0
3,GO COPII COATED VESICLE CARGO LOADING,0.88523,0.030032,-0.010829,0,0
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.9686,0.030016,-0.015321,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.4978,0.029952,0.039516,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.25729,0.029934,0.098383,0,0
3,GO G0 TO G1 TRANSITION,0.65234,0.029927,-0.020929,0,0
3,GO DNA PACKAGING,0.27999,0.029913,0.030213,0,0
3,GO QUINONE METABOLIC PROCESS,0.53167,0.029856,-0.13316,0,0
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.65234,0.029594,0.049879,0,0
3,GO TONGUE MORPHOGENESIS,0.98255,0.029586,0.044781,0,0
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.85768,0.029503,0.0085634,0,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.75615,0.029417,-0.033336,0,0
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.84397,0.029392,-0.03502,0,0
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.51459,0.029337,0.0054251,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.78962,0.029258,0.0071593,0,0
3,GO RESPONSE TO GONADOTROPIN,0.84397,0.029167,-0.040883,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.60272,0.029127,0.045646,0,0
3,GO PROTEIN SUMOYLATION,0.48131,0.029106,0.018182,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.73628,0.029071,-0.016728,0,0
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.47049,0.029057,0.012538,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.38888,0.028975,0.034065,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.27999,0.028501,0.053776,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.49227,0.028409,0.049331,0,0
3,GO TORC1 SIGNALING,0.12049,0.028336,0.073934,0,0
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.80989,0.028077,-0.003331,0,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.4978,0.027955,0.021365,0,0
3,GO REGULATION OF ACROSOME REACTION,0.54903,0.027939,0.047477,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.063042,0.027868,0.087762,0,0
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.46512,0.027821,0.028863,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.36991,0.027717,0.057797,0,0
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.33812,0.027681,0.036559,0,0
3,GO CELL CYCLE ARREST,0.27227,0.027653,0.034319,0,0
3,GO CELL GROWTH,0.3746,0.027333,0.019636,0,0
3,GO MICROTUBULE POLYMERIZATION,0.40843,0.027317,0.039006,0,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.69061,0.027175,0.012489,0,0
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.28785,0.027142,0.030651,0,0
3,GO ADULT BEHAVIOR,0.85082,0.026971,0.040552,0,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.62113,0.026963,0.031843,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.55487,0.026948,0.024027,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.85768,0.026772,0.0084521,0,0
3,GO MYELIN MAINTENANCE,0.98953,0.026715,-0.0032009,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.92682,0.02668,0.0015846,0,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.50896,0.026586,0.039486,0,0
3,GO HISTONE EXCHANGE,0.3746,0.026465,0.03506,0,0
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.4598,0.026407,0.043065,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.78962,0.026357,-0.022547,0,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.28785,0.026089,0.062741,0,0
3,GO SECRETORY GRANULE ORGANIZATION,0.73628,0.02599,-0.026778,0,0
3,GO RESPONSE TO PH,0.65866,0.025889,0.015487,0,0
3,GO SLEEP,0.67776,0.025875,0.028231,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.88523,0.025837,-0.012495,0,0
3,GO POTASSIUM ION TRANSPORT,0.33812,0.025805,0.062224,0,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.62732,0.02577,0.067826,0,0
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.19695,0.025723,0.03808,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.51459,0.02561,0.025859,0,0
3,GO SEGMENTATION,0.7495,0.025492,0.0025867,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.68418,0.025486,0.019446,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.85082,0.025311,0.0039837,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.98953,0.025299,-0.030076,0,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.36064,0.025262,0.013214,0,0
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.71006,0.0252,0.015693,0,0
3,GO MIDBRAIN DEVELOPMENT,0.48678,0.025187,-0.050898,0,0
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.83713,0.025146,-0.014073,0,0
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.50337,0.024687,0.022901,0,0
3,GO HIPPO SIGNALING,0.65234,0.024658,-0.019354,0,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.51459,0.024557,0.03107,0,0
3,GO DNA RECOMBINATION,0.60883,0.024551,0.010179,0,0
3,GO REGULATION OF METAL ION TRANSPORT,0.41341,0.024545,0.029546,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.76948,0.024522,-0.012866,0,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.93377,0.024522,-0.023996,0,0
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.90599,0.024393,-0.021215,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.62113,0.024347,0.016249,0,0
3,GO REGULATION OF DNA BINDING,0.89907,0.024312,0.0054037,0,0
3,GO NEURONAL ION CHANNEL CLUSTERING,0.73628,0.024305,0.064593,0,0
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.83713,0.02426,-0.023391,0,0
3,GO REGULATION OF FIBRINOLYSIS,0.60272,0.024101,-0.084205,0,0
3,GO CHROMOSOME SEPARATION,0.4598,0.024024,0.021754,0,0
3,GO METHIONINE METABOLIC PROCESS,0.73628,0.023918,-0.010175,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.36991,0.023848,0.072186,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.79636,0.023797,0.00084742,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.62732,0.023789,0.011728,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.72969,0.023757,0.0095575,0,0
3,GO LOCOMOTORY BEHAVIOR,0.57857,0.023743,0.051304,0,0
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.94073,0.023665,-0.016625,0,0
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.29992,0.023635,0.032052,0,0
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.98953,0.023618,0.0023302,0,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.49227,0.023542,0.027873,0,0
3,GO DNA METHYLATION,0.78289,0.023535,0.010426,0,0
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.94769,0.023328,0.0078824,0,0
3,GO REGULATION OF PROTEIN STABILITY,0.96163,0.023325,-0.0030844,0,0
3,GO INTRACELLULAR MRNA LOCALIZATION,0.72313,0.02307,0.00068536,0,0
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.53167,0.022556,0.088618,0,0
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.94073,0.022401,-0.013438,0,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.71006,0.022338,0.010647,0,0
3,GO MAINTENANCE OF LOCATION IN CELL,0.52025,0.022317,0.028919,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.89907,0.022217,-0.015316,0,0
3,GO ION TRANSMEMBRANE TRANSPORT,0.34702,0.022122,0.032997,0,0
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.56075,0.022082,0.023841,0,0
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.55487,0.02182,0.029509,0,0
3,GO INTERMEMBRANE LIPID TRANSFER,0.91293,0.021783,-0.0106,0,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.31232,0.021543,0.057307,0,0
3,GO CHROMATIN DISASSEMBLY,0.41842,0.021536,0.092908,0,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.40349,0.021458,0.04039,0,0
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.72313,0.02139,-0.033795,0,0
3,GO RESPONSE TO ACETYLCHOLINE,0.8303,0.021378,0.011747,0,0
3,GO TRACHEA DEVELOPMENT,0.82348,0.021152,0.020717,0,0
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.85768,0.021113,-0.034524,0,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.97557,0.021103,0.0034875,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.69707,0.021065,0.0086098,0,0
3,GO REGULATION OF SENSORY PERCEPTION,0.87833,0.021029,0.0083922,0,0
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.61497,0.020947,-0.0025913,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.8303,0.020862,0.018202,0,0
3,GO REGULATION OF HISTONE METHYLATION,0.4598,0.020853,0.028536,0,0
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.89215,0.020786,-0.029363,0,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.60883,0.020747,-0.043255,0,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.86455,0.02027,0.0016064,0,0
3,GO FOREGUT MORPHOGENESIS,0.98953,0.02027,-0.032546,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.63978,0.020259,-0.03435,0,0
3,GO REGULATION OF RNA SPLICING,0.34702,0.020254,0.022772,0,0
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.5726,0.020182,0.0073005,0,0
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.90599,0.020113,-0.027536,0,0
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.88523,0.020112,-0.020668,0,0
3,GO CHROMATIN REMODELING,0.21579,0.020082,0.03908,0,0
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.26098,0.020003,-0.072128,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.44924,0.019912,0.039754,0,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.85082,0.019871,0.003969,0,0
3,GO REGULATION OF GLUCONEOGENESIS,0.76281,0.019698,-0.024493,0,0
3,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.48131,0.019683,0.049025,0,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.87144,0.019617,-0.0014587,0,0
3,GO TRABECULA MORPHOGENESIS,0.80989,0.019545,0.00070848,0,0
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.51459,0.01932,-0.087211,0,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.88523,0.01919,-0.0058154,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.32506,0.01916,0.033914,0,0
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.5726,0.019033,0.0040963,0,0
3,GO DNA MODIFICATION,0.8303,0.018973,-0.019389,0,0
3,GO IRON ION TRANSPORT,0.89215,0.018931,-0.023157,0,0
3,GO LIMBIC SYSTEM DEVELOPMENT,0.53742,0.018856,0.033341,0,0
3,GO DNA METABOLIC PROCESS,0.25363,0.018838,0.022475,0,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.88523,0.018803,-0.032402,0,0
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.91293,0.0187,-0.012034,0,0
3,GO CYSTEINE METABOLIC PROCESS,0.96163,0.018663,-0.0087297,0,0
3,GO FEEDING BEHAVIOR,0.63978,0.018591,0.019777,0,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.44924,0.018591,0.028219,0,0
3,GO NEURON DIFFERENTIATION,0.56666,0.0182,0.024862,0,0
3,GO CARDIAC MUSCLE CONTRACTION,0.34256,0.018105,0.054424,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.80312,0.018072,-0.026003,0,0
3,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.72313,0.018001,0.068539,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.69707,0.017959,0.012655,0,0
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.25001,0.017792,0.042172,0,0
3,GO CATION TRANSPORT,0.44402,0.017726,0.023126,0,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.76948,0.017507,-0.033145,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.31232,0.017469,-0.089667,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.43883,0.017288,0.057686,0,0
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.56075,0.017216,0.025659,0,0
3,GO HAIR FOLLICLE MATURATION,0.4545,0.017204,-0.070184,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.72313,0.01717,0.010612,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.41341,0.017149,0.077076,0,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.89907,0.017129,-0.017776,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.89215,0.017069,-0.012464,0,0
3,GO CRANIAL NERVE MORPHOGENESIS,0.62113,0.016949,0.052903,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.84397,0.016916,-0.011414,0,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.53742,0.016798,0.018682,0,0
3,GO REGULATION OF OOGENESIS,0.37932,0.01662,-0.065966,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.72313,0.016593,0.020667,0,0
3,GO TERPENOID METABOLIC PROCESS,0.52025,0.01656,-0.051562,0,0
3,GO REGULATION OF NUCLEASE ACTIVITY,0.52025,0.016455,-0.068027,0,0
3,GO PROTON TRANSMEMBRANE TRANSPORT,1,0.016445,-0.016702,0,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.99651,0.016438,0.015797,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.55487,0.016183,0.021279,0,0
3,GO MITOTIC RECOMBINATION,0.25001,0.016148,0.06036,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.57857,0.016116,0.022603,0,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.25729,0.015983,0.024026,0,0
3,GO DETECTION OF VISIBLE LIGHT,0.71658,0.0159,0.12477,0,0
3,GO HEART PROCESS,0.40349,0.01581,0.03665,0,0
3,GO GLIAL CELL ACTIVATION,0.85082,0.015692,-0.021073,0,0
3,GO PROTEIN REFOLDING,0.75615,0.015667,-0.0036166,0,0
3,GO NODAL SIGNALING PATHWAY,0.69707,0.015654,-0.044847,0,0
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.54903,0.0155,-0.02951,0,0
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.82348,0.015492,-0.0039779,0,0
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.62113,0.015423,0.015762,0,0
3,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.60883,0.015396,-0.19237,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.46512,0.015387,0.02272,0,0
3,GO MICROTUBULE NUCLEATION,0.79636,0.015373,-0.015139,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.73628,0.015359,0.020463,0,0
3,GO LYTIC VACUOLE ORGANIZATION,0.88523,0.015242,-0.021361,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.2839,0.015223,0.029047,0,0
3,GO ETHER BIOSYNTHETIC PROCESS,0.72969,0.015138,-0.06517,0,0
3,GO PROTEIN METHYLATION,0.52594,0.015123,0.022369,0,0
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.26098,0.015072,0.066575,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.85768,0.014846,-0.0019504,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.93377,0.014691,-7.3125e-06,0,0
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.72969,0.014671,0.011829,0,0
3,GO HISTONE H3 K4 TRIMETHYLATION,0.98953,0.014647,-0.016821,0,0
3,GO RESPONSE TO ESTROGEN,0.63978,0.014535,0.0034202,0,0
3,GO NUCLEOSOME ASSEMBLY,0.67137,0.014344,0.017304,0,0
3,GO CELL REDOX HOMEOSTASIS,0.69061,0.014237,0.0067433,0,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.90599,0.014217,0.00062267,0,0
3,GO AMINOGLYCAN METABOLIC PROCESS,0.8303,0.014016,-0.0059792,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.27999,0.014008,0.032141,0,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.69707,0.014002,0.024872,0,0
3,GO DOPAMINE TRANSPORT,0.63978,0.013941,0.0081436,0,0
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.96163,0.013916,-0.0027562,0,0
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.50896,0.013743,-0.078707,0,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.91293,0.013729,0.016368,0,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.17374,0.013563,0.10865,0,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.78962,0.013462,-0.010087,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.78962,0.01329,0.0065545,0,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.50337,0.013279,0.047375,0,0
3,GO ASYMMETRIC CELL DIVISION,0.89215,0.01313,0.018242,0,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.85768,0.013113,-0.012716,0,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.82348,0.01311,-0.0019827,0,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.4545,0.013091,0.028869,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.54903,0.013075,-0.06024,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.92682,0.013012,-0.0021,0,0
3,GO THALAMUS DEVELOPMENT,0.95466,0.012996,0.018345,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.78962,0.012948,-0.040671,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.78962,0.012924,-0.0094753,0,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.82348,0.012757,0.010167,0,0
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.79636,0.012529,-0.014215,0,0
3,GO DEVELOPMENTAL GROWTH,0.65866,0.012239,0.009896,0,0
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.36064,0.01215,0.037324,0,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.98953,0.012018,0.0028355,0,0
3,GO REGULATION OF CELL PROJECTION SIZE,0.40349,0.012015,-0.082889,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.78962,0.011997,0.00062865,0,0
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.59059,0.01196,0.030528,0,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.82348,0.011832,-0.0020648,0,0
3,GO VASODILATION,0.50337,0.011816,0.027227,0,0
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.78289,0.011645,0.0093569,0,0
3,GO DOUBLE STRAND BREAK REPAIR,0.71006,0.011466,0.010936,0,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.65234,0.011304,0.016485,0,0
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.34702,0.011263,-0.059432,0,0
3,GO RESPONSE TO ATP,0.87144,0.011184,-0.0058987,0,0
3,GO ISOPRENOID METABOLIC PROCESS,0.40843,0.010938,-0.05225,0,0
3,GO CHLORIDE TRANSPORT,0.84397,0.010921,0.006621,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.86455,0.010641,0.0031363,0,0
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.55487,0.010495,0.019685,0,0
3,GO AXO DENDRITIC TRANSPORT,0.52594,0.01039,0.039747,0,0
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.94073,0.010296,-0.11377,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.79636,0.010126,-0.061248,0,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.88523,0.010095,-0.026856,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,0.48678,0.01004,-0.021597,0,0
3,GO ION TRANSPORT,0.78962,0.010002,0.006067,0,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.5726,0.0097964,0.025657,0,0
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.86455,0.0097503,-0.01235,0,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.92682,0.0096897,-0.03498,0,0
3,GO EMBRYONIC AXIS SPECIFICATION,0.62732,0.0096661,0.036619,0,0
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.40843,0.0095956,0.016675,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.75615,0.009539,0.023193,0,0
3,GO VAGINA DEVELOPMENT,0.99651,0.0095358,-0.027999,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.94769,0.0094821,-0.0094635,0,0
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.72313,0.0094599,-0.059727,0,0
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.93377,0.009458,-0.0098098,0,0
3,GO REGULATION OF ORGAN GROWTH,0.42347,0.0094019,0.035632,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.49227,0.0093866,0.083523,0,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.66501,0.0093786,0.016685,0,0
3,GO NEURON MIGRATION,0.62732,0.0093618,0.041358,0,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.52025,0.0093476,0.025773,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.67776,0.009331,0.041884,0,0
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.4978,0.0093146,-0.043656,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.53167,0.0091812,0.011205,0,0
3,GO HISTONE DEACETYLATION,0.71006,0.0091255,-0.014648,0,0
3,GO URETER DEVELOPMENT,0.65234,0.0091179,-0.069572,0,0
3,GO HEAD MORPHOGENESIS,0.56075,0.0090675,-0.067869,0,0
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.85768,0.0090481,0.01119,0,0
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.76948,0.0090431,-0.0177,0,0
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.63978,0.0089488,0.050667,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.71658,0.0088391,0.00644,0,0
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.32506,0.0088074,0.027689,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.90599,0.0087486,-0.063608,0,0
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.56075,0.0087226,0.034606,0,0
3,GO RESPONSE TO STEROL DEPLETION,0.65866,0.0087161,-0.05881,0,0
3,GO ANION TRANSMEMBRANE TRANSPORT,0.25001,0.0087116,0.044155,0,0
3,GO DE NOVO PROTEIN FOLDING,0.98255,0.0086814,0.0081141,0,0
3,GO SKIN MORPHOGENESIS,0.54321,0.0086685,-0.12337,0,0
3,GO REGULATION OF DNA REPLICATION,1,0.008577,-0.0023858,0,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.25363,0.0084888,0.13628,0,0
3,GO PROTEIN O LINKED MANNOSYLATION,0.9686,0.0084362,-0.015116,0,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.73628,0.0084304,-0.029921,0,0
3,GO REGULATION OF TORC1 SIGNALING,0.39858,0.0084052,0.040374,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.54321,0.0083696,-0.089803,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.85768,0.0083657,-0.018395,0,0
3,GO CELL CELL SIGNALING,0.94073,0.0083447,-0.0075046,0,0
3,GO CELLULAR RESPONSE TO X RAY,0.52025,0.0081692,0.067313,0,0
3,GO REGULATION OF MACROAUTOPHAGY,0.78962,0.0081344,-0.020532,0,0
3,GO FIBROBLAST ACTIVATION,0.92682,0.0081279,-0.033773,0,0
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.78962,0.0077524,0.027086,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.77618,0.0075588,0.0023202,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.54903,0.0074425,-0.065798,0,0
3,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.67137,0.007441,-0.033721,0,0
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.71658,0.00741,0.025162,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.89907,0.0073703,-0.0013593,0,0
3,GO MUSCLE SYSTEM PROCESS,0.50337,0.0072565,0.018812,0,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.43367,0.0072445,0.030145,0,0
3,GO CELLULAR RESPONSE TO SALT STRESS,0.78289,0.0072213,-0.0060799,0,0
3,GO OVULATION CYCLE PROCESS,0.99651,0.0071886,-0.009714,0,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.87144,0.0070766,0.016744,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.66501,0.0069479,0.046245,0,0
3,GO NERVOUS SYSTEM PROCESS,0.85082,0.0068036,0.001643,0,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.73628,0.0067746,0.019458,0,0
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.68418,0.0067294,0.0016549,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.52025,0.0064415,-0.032759,0,0
3,GO CELLULAR HOMEOSTASIS,0.60883,0.0064282,0.01402,0,0
3,GO REGULATION OF EXOCYTOSIS,0.87144,0.0064274,-0.0015096,0,0
3,GO MUSCLE ATROPHY,0.84397,0.0063985,-0.067493,0,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.49227,0.0063876,0.025251,0,0
3,GO MUSCLE CONTRACTION,0.35607,0.0062875,0.030956,0,0
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.34256,0.0061696,0.148,0,0
3,GO REGULATION OF MICROTUBULE BINDING,0.96163,0.0061449,0.0034374,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.92682,0.0061248,-0.0005327,0,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.8303,0.0060765,-0.055849,0,0
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.80312,0.0060164,-0.025969,0,0
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.80989,0.0059511,-0.028688,0,0
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.80989,0.0059008,-0.012625,0,0
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.67776,0.0058761,0.029919,0,0
3,GO PLASMA MEMBRANE ORGANIZATION,0.91293,0.0058114,0.0070859,0,0
3,GO NEUROBLAST PROLIFERATION,0.7495,0.0057582,0.02441,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.27227,0.0056825,-0.034736,0,0
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.65866,0.0056245,0.01767,0,0
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.86455,0.0055788,0.0082836,0,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.42855,0.0055685,-0.066139,0,0
3,GO STEROL TRANSPORT,0.72313,0.0055668,-0.032079,0,0
3,GO GROWTH,0.8303,0.0054979,-0.010889,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.61497,0.0054051,-0.035887,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.89907,0.0053581,-0.0098558,0,0
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.8303,0.0053579,-0.017075,0,0
3,GO REGULATION OF VACUOLE ORGANIZATION,0.4545,0.0052244,-0.04705,0,0
3,GO MIDGUT DEVELOPMENT,0.92682,0.0051445,-0.026747,0,0
3,GO CHONDROCYTE PROLIFERATION,0.9686,0.0051153,0.011029,0,0
3,GO CELLULAR RESPONSE TO ATP,0.54321,0.0050817,0.021362,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.24643,0.0050261,0.046692,0,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.94769,0.0049136,-0.034977,0,0
3,GO VITAMIN METABOLIC PROCESS,0.56075,0.0047384,0.023287,0,0
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.66501,0.0046862,-0.066217,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.56075,0.0046429,0.08052,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.71658,0.0044672,0.067106,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.65234,0.0043662,-0.010346,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.38408,0.0043337,-0.065101,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.53742,0.0041339,-0.026516,0,0
3,GO INORGANIC ANION TRANSPORT,0.61497,0.00411,0.0087962,0,0
3,GO RESPONSE TO MONOSACCHARIDE,0.9686,0.0041064,-0.0077657,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.47588,0.0039977,-0.063468,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.80312,0.0038876,-0.012936,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.53742,0.0038835,0.015973,0,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.59664,0.0038315,0.028845,0,0
3,GO ACTIN FILAMENT BASED MOVEMENT,0.70355,0.0037939,-0.017072,0,0
3,GO CARBOHYDRATE HOMEOSTASIS,0.93377,0.003226,-0.0030475,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,1,0.0031747,-0.0052759,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.99651,0.003172,-0.0010033,0,0
3,GO ENERGY RESERVE METABOLIC PROCESS,0.88523,0.0030698,-0.010122,0,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.9686,0.002901,0.0011308,0,0
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.96163,0.0028891,-0.0065969,0,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.84397,0.0028497,-0.022511,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.5726,0.0027846,0.0328,0,0
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.79636,0.0027822,-0.010546,0,0
3,GO REGULATION OF CELL DEVELOPMENT,0.9686,0.0027228,0.0035403,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.91293,0.0026831,-0.00025874,0,0
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.65234,0.0025736,-0.025734,0,0
3,GO PEPTIDYL LYSINE METHYLATION,0.8303,0.00256,0.001977,0,0
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.95466,0.0025581,-0.014493,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.188,0.0024897,0.090534,0,0
3,GO PROTEIN PALMITOYLATION,0.82348,0.002359,-0.0024836,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.70355,0.0020387,-0.022696,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.82348,0.0019705,0.0040525,0,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.82348,0.0018575,-0.058235,0,0
3,GO REGULATION OF CELLULAR LOCALIZATION,0.48131,0.0017483,-0.019832,0,0
3,GO NEUROGENESIS,0.81668,0.0015997,0.011781,0,0
3,GO RESPONSE TO INTERLEUKIN 4,0.80312,0.0015985,-0.022976,0,0
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.98953,0.0015939,-0.014932,0,0
3,GO MITOPHAGY,0.60272,0.0015386,-0.048309,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.19095,0.0014556,0.10511,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.72313,0.0014074,-0.04195,0,0
3,GO CELL CELL SIGNALING BY WNT,0.83713,0.0013252,-0.014714,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.35153,0.0012478,0.059052,0,0
3,GO REGULATION OF DNA REPAIR,0.94073,0.001238,0.00012882,0,0
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.94769,0.0012121,-0.0081496,0,0
3,GO METAL ION HOMEOSTASIS,0.65234,0.0011846,-0.015686,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.81668,0.0010392,-0.014179,0,0
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.89907,0.00091341,0.024427,0,0
3,GO ACROSOME REACTION,0.98953,0.00085977,-0.014995,0,0
3,GO MACROMOLECULE CATABOLIC PROCESS,0.40843,0.00084009,0.015677,0,0
3,GO REGULATION OF PROTEIN MATURATION,0.63978,0.00082385,-0.05123,0,0
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.95466,0.0008002,-0.010519,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.4978,0.00070797,-0.075628,0,0
3,GO ENERGY HOMEOSTASIS,0.91987,0.00056725,-0.030165,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.57857,0.00049936,-0.062279,0,0
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.95466,0.00029149,-0.023806,0,0
3,GO MODIFIED AMINO ACID TRANSPORT,0.95466,0.00018089,-0.035136,0,0
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.87144,0.00013264,-0.0077626,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.59664,0.00011039,0.027602,0,0
3,GO INTRACELLULAR TRANSPORT,0.9686,6.1787e-05,-0.00088566,0,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.68418,-4.8057e-05,-0.013414,0,0
3,GO MAINTENANCE OF LOCATION,0.96163,-6.148e-05,-0.0029357,0,0
3,GO REGULATION OF GROWTH,0.54321,-0.00011209,-0.02352,0,0
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.17934,-0.00015641,-0.11614,0,0
3,GO PROTEIN AUTOPROCESSING,0.98255,-0.00016379,-0.026687,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.74288,-0.00024798,-0.12216,0,0
3,GO ORGAN GROWTH,0.84397,-0.00033556,-0.014221,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.72969,-0.00036335,0.009503,0,0
3,GO PROSTAGLANDIN TRANSPORT,0.76948,-0.00041911,-0.044409,0,0
3,GO REGULATION OF ACTION POTENTIAL,0.82348,-0.00042039,-0.027014,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.93377,-0.00048452,-0.00098598,0,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.90599,-0.00051995,0.0031147,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.52594,-0.00055466,-0.040137,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.99651,-0.00069125,-0.043001,0,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.94073,-0.0007256,0.032787,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.91987,-0.00079317,-0.0043769,0,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.81668,-0.00086836,0.0056712,0,0
3,GO SELECTIVE AUTOPHAGY,0.8303,-0.0011154,-0.024351,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.58456,-0.0012086,-0.041752,0,0
3,GO MACROMOLECULE DEACYLATION,0.95466,-0.0013367,0.0044703,0,0
3,GO ION HOMEOSTASIS,0.98255,-0.001394,-7.1603e-05,0,0
3,GO BODY FLUID SECRETION,0.73628,-0.0014761,0.006648,0,0
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.65866,-0.0016885,0.0085588,0,0
3,GO HINDBRAIN DEVELOPMENT,0.5726,-0.0016954,-0.013696,0,0
3,GO MYELIN ASSEMBLY,0.91987,-0.0017178,-0.018606,0,0
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.98255,-0.0017264,-0.016728,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.82348,-0.0019049,-0.031035,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.5726,-0.0019744,-0.052833,0,0
3,GO LYMPH NODE DEVELOPMENT,0.44402,-0.0020119,-0.067006,0,0
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.70355,-0.0020953,-0.098388,0,0
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.5726,-0.0021447,0.015259,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.67137,-0.0022028,0.029028,0,0
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.98953,-0.0023323,-0.010961,0,0
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.94769,-0.0023419,-0.0066323,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.69061,-0.0023444,-0.011346,0,0
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.89907,-0.0026231,-0.016383,0,0
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.76281,-0.0026711,-0.039345,0,0
3,GO OTIC VESICLE MORPHOGENESIS,0.91987,-0.0028899,0.056691,0,0
3,GO REGULATION OF LIPASE ACTIVITY,0.96163,-0.0030686,-0.018943,0,0
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.7495,-0.0030703,-0.11066,0,0
3,GO CHROMOSOME ORGANIZATION,0.79636,-0.0030851,-0.0016489,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.20937,-0.0031091,-0.16413,0,0
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.49227,-0.0032129,-0.034651,0,0
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.90599,-0.0032702,0.0019008,0,0
3,GO CHROMATIN ORGANIZATION,0.49227,-0.0033144,-0.013141,0,0
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.7495,-0.0033782,-0.013571,0,0
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.81668,-0.003475,0.027432,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.60272,-0.0035346,-0.013534,0,0
3,GO FOREBRAIN MORPHOGENESIS,0.94073,-0.0035371,0.014534,0,0
3,GO CANONICAL WNT SIGNALING PATHWAY,0.72969,-0.0036787,-0.024135,0,0
3,GO RESPONSE TO LIGHT STIMULUS,0.62113,-0.0037699,0.032486,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.86455,-0.0038334,-0.014578,0,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.9686,-0.0038826,0.0066162,0,0
3,GO POLYOL BIOSYNTHETIC PROCESS,0.89215,-0.0039421,-0.0035969,0,0
3,GO CHEMICAL HOMEOSTASIS,0.57857,-0.003967,-0.022768,0,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.98953,-0.0039912,-0.0040776,0,0
3,GO ORGANIC ACID TRANSPORT,0.68418,-0.0042215,0.011331,0,0
3,GO REGULATION OF CATABOLIC PROCESS,0.84397,-0.004325,-0.00026285,0,0
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.59664,-0.0043483,0.013767,0,0
3,GO AMELOGENESIS,0.65866,-0.0046126,-0.04294,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.64605,-0.0046491,-0.017626,0,0
3,GO LYMPHOCYTE HOMEOSTASIS,0.65866,-0.0046824,-0.030989,0,0
3,GO ORGANIC ACID CATABOLIC PROCESS,0.98255,-0.0046847,-0.013614,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.44402,-0.0047296,-0.0278,0,0
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.41842,-0.0047526,-0.03567,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.72969,-0.0047639,-0.020234,0,0
3,GO RESPONSE TO SALT STRESS,0.53167,-0.004773,-0.0552,0,0
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.87833,-0.0048312,0.0029023,0,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.85082,-0.0048833,0.039438,0,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.98953,-0.0049002,0.001949,0,0
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.38888,-0.004938,-0.067462,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.98953,-0.0050262,0.0026497,0,0
3,GO REGULATION OF HEART GROWTH,0.55487,-0.0050349,0.033871,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.50896,-0.0050782,-0.072423,0,0
3,GO GENE SILENCING,0.61497,-0.0053529,-0.01459,0,0
3,GO HEART TRABECULA FORMATION,0.65866,-0.0056493,-0.040569,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.96163,-0.0056677,-0.052002,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.82348,-0.0056781,-0.057876,0,0
3,GO KERATAN SULFATE METABOLIC PROCESS,0.98953,-0.0057365,-0.012845,0,0
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.12473,-0.0057439,-0.068631,0,0
3,GO ORGANIC ACID METABOLIC PROCESS,0.72313,-0.0057545,0.0069834,0,0
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.78962,-0.0057762,-0.02125,0,0
3,GO TUMOR NECROSIS FACTOR SECRETION,0.27999,-0.0058258,-0.072027,0,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.88523,-0.0059802,0.011274,0,0
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.44402,-0.0061909,-0.080853,0,0
3,GO CELLULAR ION HOMEOSTASIS,0.58456,-0.0062059,-0.014933,0,0
3,GO SKELETAL SYSTEM DEVELOPMENT,0.48678,-0.006228,-0.037974,0,0
3,GO LIPID CATABOLIC PROCESS,0.51459,-0.0062484,-0.035188,0,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.83713,-0.0062948,-0.014332,0,0
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.34702,-0.0063962,-0.048257,0,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.51459,-0.0065651,-0.046456,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.80989,-0.0065955,0.029559,0,0
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.90599,-0.0066102,-0.040392,0,0
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.95466,-0.0066964,-0.028981,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.60272,-0.0067367,-0.021494,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.97557,-0.0068298,-0.0053473,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.62113,-0.0068908,-0.027022,0,0
3,GO BLASTODERM SEGMENTATION,0.44924,-0.0069007,0.11252,0,0
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.91293,-0.0069369,-0.012599,0,0
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.54903,-0.0071089,-0.071704,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.93377,-0.0071364,0.0082632,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.97557,-0.0071651,0.0031054,0,0
3,GO DNA STRAND ELONGATION,0.69061,-0.0072286,0.048575,0,0
3,GO PROTEIN N LINKED GLYCOSYLATION,0.66501,-0.0073873,-0.052326,0,0
3,GO MANNOSYLATION,0.62732,-0.0073983,-0.046152,0,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.76281,-0.0074564,-0.021703,0,0
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.8303,-0.0075437,-0.011513,0,0
3,GO ENGULFMENT OF APOPTOTIC CELL,0.56666,-0.0075787,-0.054973,0,0
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.47588,-0.0075877,0.035435,0,0
3,GO DEVELOPMENTAL MATURATION,0.80989,-0.0076031,0.00015207,0,0
3,GO CELL JUNCTION ORGANIZATION,0.93377,-0.0077046,-0.0096263,0,0
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.62732,-0.00779,-0.056412,0,0
3,GO ANION TRANSPORT,0.80989,-0.0078293,-0.0098897,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.66501,-0.0079039,0.040903,0,0
3,GO CELL CYCLE PROCESS,0.48131,-0.0079646,-0.015976,0,0
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.78289,-0.008001,-0.02364,0,0
3,GO SERTOLI CELL DEVELOPMENT,0.65866,-0.0080773,-0.037037,0,0
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.89907,-0.0081249,-0.016215,0,0
3,GO ACTIVATION OF MAPKK ACTIVITY,0.71006,-0.0081273,-0.022435,0,0
3,GO PROTEIN KINASE C SIGNALING,0.50896,-0.0081374,-0.05345,0,0
3,GO RESPONSE TO FATTY ACID,0.95466,-0.0081579,-0.024235,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.5726,-0.0081736,-0.052361,0,0
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.97557,-0.0082378,-0.016891,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.9686,-0.008254,-0.0064585,0,0
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.98255,-0.0083745,-0.0081423,0,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.62732,-0.0084986,-0.016232,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.56075,-0.0085146,-0.017871,0,0
3,GO REGULATION OF ENDOCYTOSIS,0.5726,-0.0085272,-0.020547,0,0
3,GO DNA INTEGRITY CHECKPOINT,0.24288,-0.0085516,-0.042615,0,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.76948,-0.0085715,-0.017124,0,0
3,GO COMPLEMENT ACTIVATION,0.72969,-0.0085819,-0.062362,0,0
3,GO REGULATION OF BINDING,0.32506,-0.0086176,-0.032591,0,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.26471,-0.0086256,-0.053964,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.39371,-0.0086369,-0.064321,0,0
3,GO GASTRULATION,0.79636,-0.0087489,-0.035426,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.34702,-0.0088168,-0.086386,0,0
3,GO CD40 SIGNALING PATHWAY,0.7495,-0.0088224,-0.037485,0,0
3,GO HISTONE H3 K4 METHYLATION,0.52025,-0.0088323,-0.016933,0,0
3,GO APOPTOTIC CELL CLEARANCE,0.79636,-0.0088617,-0.083523,0,0
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.52594,-0.008925,0.026741,0,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.49227,-0.0089429,0.12701,0,0
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.86455,-0.0090008,0.011689,0,0
3,GO ACTION POTENTIAL,0.92682,-0.0090027,0.0034161,0,0
3,GO DRINKING BEHAVIOR,0.89907,-0.0093318,-0.018493,0,0
3,GO HEART GROWTH,0.9686,-0.0094319,-0.001944,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.15517,-0.0095126,-0.16056,0,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.34256,-0.0096237,-0.10403,0,0
3,GO REGULATION OF URINE VOLUME,0.92682,-0.0096354,-0.0060355,0,0
3,GO TRANSITION METAL ION TRANSPORT,0.5726,-0.0097109,-0.032749,0,0
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.85768,-0.0097248,-0.044066,0,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.66501,-0.0098974,-0.048021,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.30402,-0.010054,-0.099511,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.3746,-0.010058,-0.013492,0,0
3,GO FOREBRAIN DEVELOPMENT,0.89907,-0.010115,-0.00046857,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.34256,-0.010146,-0.063363,0,0
3,GO PROSTATE GLAND DEVELOPMENT,0.92682,-0.010221,-0.051639,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.95466,-0.010257,-0.0080077,0,0
3,GO RESPONSE TO DRUG,0.72969,-0.010265,0.014816,0,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.72313,-0.010278,0.017348,0,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.88523,-0.010279,-0.0087314,0,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.54903,-0.010283,-0.079075,0,0
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.53167,-0.010351,-0.035353,0,0
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.61497,-0.010416,-0.040566,0,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.41341,-0.010519,-0.019388,0,0
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.98953,-0.010542,-0.0071721,0,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.63354,-0.010648,0.044099,0,0
3,GO CARTILAGE DEVELOPMENT,0.85768,-0.010679,-0.025141,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.85768,-0.010684,0.010589,0,0
3,GO ZINC ION TRANSPORT,0.98953,-0.010695,-0.0069211,0,0
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.47588,-0.0107,0.048582,0,0
3,GO HINDLIMB MORPHOGENESIS,0.47049,-0.010736,-0.076603,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.38408,-0.010749,-0.07337,0,0
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.83713,-0.010795,-0.0099395,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.65234,-0.010848,0.03164,0,0
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.3746,-0.010882,-0.040744,0,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.76948,-0.010928,-0.0019027,0,0
3,GO PEPTIDE CATABOLIC PROCESS,0.61497,-0.011032,-0.043179,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.87833,-0.011083,0.0029256,0,0
3,GO REGULATION OF CELL CYCLE PROCESS,0.62732,-0.011117,-0.012908,0,0
3,GO RESPONSE TO DEXAMETHASONE,0.94073,-0.011136,-0.012647,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.75615,-0.011149,-0.010389,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.66501,-0.011172,-0.020159,0,0
3,GO REGULATION OF BLOOD CIRCULATION,0.59059,-0.011192,0.024034,0,0
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.57857,-0.011435,-0.017905,0,0
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.95466,-0.01147,-0.0098085,0,0
3,GO RESPONSE TO CARBOHYDRATE,0.84397,-0.011613,-0.015076,0,0
3,GO RESPONSE TO ABIOTIC STIMULUS,0.53167,-0.011704,-0.023956,0,0
3,GO RESPONSE TO AXON INJURY,0.80989,-0.011778,-0.025051,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.77618,-0.01182,-0.029725,0,0
3,GO CALCIUM MEDIATED SIGNALING,0.48678,-0.012007,-0.025243,0,0
3,GO HETEROCHROMATIN ORGANIZATION,0.27227,-0.012087,-0.028963,0,0
3,GO DOSAGE COMPENSATION,0.56075,-0.012247,-0.030506,0,0
3,GO SOMITOGENESIS,0.54321,-0.012258,-0.027113,0,0
3,GO PROTEIN ACYLATION,0.97557,-0.0123,0.0038658,0,0
3,GO HISTONE H2A ACETYLATION,0.4545,-0.012413,-0.03872,0,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.97557,-0.012423,0.032022,0,0
3,GO MEMBRANE DEPOLARIZATION,0.98255,-0.01243,0.0091559,0,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.16559,-0.012499,-0.053006,0,0
3,GO I KAPPAB PHOSPHORYLATION,0.44924,-0.012837,-0.075719,0,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.42347,-0.012938,-0.040017,0,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.5726,-0.013012,-0.059886,0,0
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.63978,-0.013174,-0.03689,0,0
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.72313,-0.013207,-0.014088,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.43367,-0.013268,-0.064135,0,0
3,GO RESPONSE TO PROSTAGLANDIN,0.96163,-0.013277,-0.019998,0,0
3,GO STEM CELL DIFFERENTIATION,0.29992,-0.013323,-0.040141,0,0
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.53167,-0.013401,-0.046856,0,0
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.50337,-0.013427,-0.069423,0,0
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.89907,-0.01344,0.0042484,0,0
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.26471,-0.013641,-0.05889,0,0
3,GO PHOTOPERIODISM,0.89215,-0.013648,0.0065279,0,0
3,GO PROTEIN ACETYLATION,0.87144,-0.013668,0.00079514,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.94073,-0.013694,-0.024806,0,0
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,1,-0.01374,0.0037877,0,0
3,GO RESPONSE TO CAMP,0.52025,-0.013777,0.023376,0,0
3,GO SERTOLI CELL DIFFERENTIATION,0.79636,-0.013871,-0.029909,0,0
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.51459,-0.01388,-0.037434,0,0
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.85082,-0.013899,-0.028294,0,0
3,GO REGULATION OF FATTY ACID OXIDATION,0.86455,-0.013971,-0.033127,0,0
3,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.73628,-0.014084,-0.063765,0,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.76281,-0.014107,-0.04343,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.32938,-0.01413,-0.084645,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.47588,-0.014158,-0.050084,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.72313,-0.014279,-0.023583,0,0
3,GO POSITIVE REGULATION OF BINDING,0.87144,-0.014376,-0.0058185,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.68418,-0.014377,-0.02321,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.84397,-0.014378,0.007651,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.34702,-0.014577,-0.062028,0,0
3,GO VESICLE DOCKING,0.54321,-0.01464,-0.038461,0,0
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.79636,-0.014704,0.0075998,0,0
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.52594,-0.014717,-0.045035,0,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.52025,-0.014764,-0.073884,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS,0.63354,-0.014843,0.066964,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.79636,-0.01516,-0.024127,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.35153,-0.015162,-0.05905,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.73628,-0.015176,-0.10097,0,0
3,GO NEURON DEATH,0.24288,-0.015344,-0.043511,0,0
3,GO CARTILAGE MORPHOGENESIS,0.81668,-0.015541,0.039297,0,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.67137,-0.015547,-0.030673,0,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.39371,-0.015562,-0.040103,0,0
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.33812,-0.01557,-0.044927,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.90599,-0.015593,-0.0098546,0,0
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.42855,-0.015836,-0.11232,0,0
3,GO COVALENT CHROMATIN MODIFICATION,0.40349,-0.015933,-0.014181,0,0
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.95466,-0.015957,0.00096462,0,0
3,GO HEART MORPHOGENESIS,0.42855,-0.01599,-0.048024,0,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.98953,-0.015996,0.0080932,0,0
3,GO CELL CELL RECOGNITION,0.57857,-0.016113,-0.034156,0,0
3,GO SPINDLE ORGANIZATION,0.17934,-0.016137,-0.049248,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.36991,-0.016172,-0.068516,0,0
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.85768,-0.016205,0.021122,0,0
3,GO AXONAL TRANSPORT,0.71658,-0.0163,0.027905,0,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.67776,-0.016464,-0.035757,0,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.94073,-0.016578,0.0071474,0,0
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.24288,-0.016644,-0.084611,0,0
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.35607,-0.016728,-0.048925,0,0
3,GO ENSHEATHMENT OF NEURONS,0.54903,-0.016785,-0.026586,0,0
3,GO DENDRITE EXTENSION,0.93377,-0.016884,0.036903,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.26098,-0.016887,-0.14225,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.63354,-0.016939,-0.016331,0,0
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.21256,-0.016957,-0.052298,0,0
3,GO NEURON MATURATION,0.73628,-0.017017,0.069857,0,0
3,GO STORE OPERATED CALCIUM ENTRY,0.70355,-0.017037,0.0077113,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.80989,-0.017164,0.02887,0,0
3,GO RESPONSE TO GLUCAGON,0.92682,-0.017234,-0.015062,0,0
3,GO LOCOMOTOR RHYTHM,0.99651,-0.017274,-0.003731,0,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.61497,-0.017283,-0.026969,0,0
3,GO CIRCULATORY SYSTEM PROCESS,0.44402,-0.017502,-0.031552,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.14526,-0.017578,-0.030918,0,0
3,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.26471,-0.017581,-0.1367,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.23589,-0.017602,-0.047117,0,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.73628,-0.017635,-0.1012,0,0
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.33812,-0.01778,-0.034634,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.97557,-0.017809,0.00084395,0,0
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.5726,-0.017821,-0.063207,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.36991,-0.017831,-0.076728,0,0
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.84397,-0.01788,-0.028645,0,0
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.33812,-0.017974,-0.064064,0,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.087232,-0.018008,-0.039079,0,0
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.98255,-0.018184,0.0016751,0,0
3,GO CELL MORPHOGENESIS,0.94073,-0.018186,-0.0011297,0,0
3,GO HINDBRAIN MORPHOGENESIS,0.81668,-0.018208,-0.0053286,0,0
3,GO AMMONIUM ION METABOLIC PROCESS,0.3746,-0.01823,-0.096729,0,0
3,GO PIGMENT GRANULE ORGANIZATION,0.98953,-0.0183,0.0075626,0,0
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.46512,-0.018404,-0.051377,0,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.51459,-0.018726,-0.059434,0,0
3,GO FIBROBLAST PROLIFERATION,0.46512,-0.01873,0.046519,0,0
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.39858,-0.018763,0.11197,0,0
3,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.81668,-0.018783,0.0058164,0,0
3,GO EXOCYTIC PROCESS,0.43883,-0.018789,-0.020622,0,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.16294,-0.018833,-0.032442,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.71006,-0.018987,-0.023838,0,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.94769,-0.019045,-0.02421,0,0
3,GO PULMONARY VALVE DEVELOPMENT,0.78962,-0.019216,-0.051655,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.67776,-0.019219,-0.033512,0,0
3,GO LAMELLIPODIUM ORGANIZATION,0.24643,-0.019267,-0.06403,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.50337,-0.019319,-0.042099,0,0
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.58456,-0.01951,-0.032156,0,0
3,GO RECEPTOR METABOLIC PROCESS,0.50896,-0.019518,-0.022122,0,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.27227,-0.019559,-0.12909,0,0
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.41842,-0.019603,-0.057795,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.81668,-0.019705,0.11476,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.62113,-0.019797,-0.051516,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.20309,-0.019873,-0.11949,0,0
3,GO FATTY ACID BETA OXIDATION,0.94769,-0.019883,-0.015101,0,0
3,GO OXIDATIVE DEMETHYLATION,0.64605,-0.019906,0.031194,0,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.26471,-0.019909,-0.028882,0,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.57857,-0.019914,-0.017538,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.72313,-0.01993,-0.066221,0,0
3,GO REGULATION OF CELL DIFFERENTIATION,0.19695,-0.019984,-0.045597,0,0
3,GO KERATINOCYTE MIGRATION,0.98255,-0.01999,-0.010623,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.38408,-0.020471,-0.030784,0,0
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.25001,-0.020514,-0.02032,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.12908,-0.020664,-0.032859,0,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.67776,-0.020808,0.023687,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.84397,-0.020811,0.052348,0,0
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.36526,-0.020931,-0.11115,0,0
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.52025,-0.020985,-0.048475,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.84397,-0.021097,-0.0075382,0,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.59664,-0.021099,-0.035909,0,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.46512,-0.021117,-0.041799,0,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.35607,-0.021174,-0.031898,0,0
3,GO SISTER CHROMATID COHESION,0.69061,-0.0212,-0.011708,0,0
3,GO PIRNA METABOLIC PROCESS,0.20621,-0.02128,-0.13897,0,0
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.60883,-0.021369,-0.034647,0,0
3,GO ORGANIC ANION TRANSPORT,0.61497,-0.021437,-0.020446,0,0
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.35607,-0.021448,-0.047657,0,0
3,GO MUSCLE FILAMENT SLIDING,0.86455,-0.021468,0.019914,0,0
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.41842,-0.021583,-0.022336,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.3746,-0.021645,-0.062482,0,0
3,GO IMPORT INTO NUCLEUS,0.87833,-0.021777,0.0035539,0,0
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.67776,-0.022015,-0.019384,0,0
3,GO THYMOCYTE APOPTOTIC PROCESS,0.38888,-0.022046,-0.084483,0,0
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.54903,-0.022332,-0.088314,0,0
3,GO RESPONSE TO MUSCLE STRETCH,0.85082,-0.022374,-0.037333,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.23245,-0.022433,-0.053939,0,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.91293,-0.022502,0.0090184,0,0
3,GO MEMBRANE BIOGENESIS,0.26098,-0.02252,-0.10101,0,0
3,GO BIOMINERALIZATION,0.5726,-0.022669,-0.046066,0,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.36526,-0.022701,-0.059103,0,0
3,GO OVULATION CYCLE,0.76281,-0.022758,-0.023137,0,0
3,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.69061,-0.022768,0.026451,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.18508,-0.022817,-0.050058,0,0
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.55487,-0.022831,0.045491,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.65234,-0.022899,-0.017331,0,0
3,GO CELLULAR RESPONSE TO KETONE,0.39858,-0.022926,-0.059234,0,0
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.5726,-0.023078,-0.061545,0,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.38408,-0.023137,-0.051524,0,0
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.7495,-0.023149,0.0067949,0,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.40843,-0.023164,-0.036065,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.87833,-0.023186,-0.04591,0,0
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.71006,-0.023226,-0.054929,0,0
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.72969,-0.02328,-0.11843,0,0
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.17374,-0.023425,-0.093614,0,0
3,GO PEROXISOMAL TRANSPORT,0.82348,-0.023545,-0.0098166,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.39371,-0.023612,-0.065497,0,0
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.98255,-0.023621,-0.0051095,0,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.33373,-0.023813,-0.033691,0,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.15773,-0.024099,-0.049078,0,0
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.27611,-0.024186,-0.1074,0,0
3,GO ENDOCYTOSIS,0.82348,-0.02419,-0.013832,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.91987,-0.024193,-0.02623,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.40349,-0.024268,-0.036539,0,0
3,GO MACROMOLECULE DEPALMITOYLATION,0.81668,-0.024286,-0.0075644,0,0
3,GO CERAMIDE CATABOLIC PROCESS,0.47588,-0.024303,-0.10116,0,0
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.50896,-0.024315,-0.032417,0,0
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.36991,-0.024366,-0.094681,0,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.94073,-0.024372,-0.0035945,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.94769,-0.0244,0.0054902,0,0
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.20937,-0.024416,-0.067879,0,0
3,GO WATER TRANSPORT,0.67137,-0.02449,-0.027703,0,0
3,GO POST EMBRYONIC DEVELOPMENT,0.33373,-0.024511,-0.048179,0,0
3,GO REGULATION OF MYELINATION,0.79636,-0.024565,0.032511,0,0
3,GO ANIMAL ORGAN MORPHOGENESIS,0.23245,-0.024792,-0.054834,0,0
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.49227,-0.024799,-0.030472,0,0
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.86455,-0.024906,0.004121,0,0
3,GO NIK NF KAPPAB SIGNALING,0.44402,-0.02493,-0.064904,0,0
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.39371,-0.024937,-0.098317,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.33373,-0.024951,-0.029538,0,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.71006,-0.02503,0.028838,0,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.85768,-0.025123,0.053565,0,0
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.44924,-0.025158,-0.056021,0,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.34256,-0.025198,-0.060049,0,0
3,GO BLEB ASSEMBLY,0.54903,-0.025225,-0.18642,0,0
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.41341,-0.025437,-0.12396,0,0
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.84397,-0.025496,0.023726,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.86455,-0.025523,-0.008417,0,0
3,GO MEMBRANE INVAGINATION,0.26471,-0.025558,-0.069864,0,0
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.188,-0.025559,-0.063846,0,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.62732,-0.025639,-0.11756,0,0
3,GO CELLULAR KETONE METABOLIC PROCESS,0.44402,-0.02593,-0.055819,0,0
3,GO BLASTOCYST DEVELOPMENT,0.37932,-0.02599,-0.026524,0,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.34702,-0.02613,-0.093526,0,0
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.76281,-0.026156,-0.019476,0,0
3,GO RESPONSE TO RADIATION,0.63978,-0.02629,0.00094669,0,0
3,GO AGING,0.13583,-0.026317,-0.067224,0,0
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.14048,-0.026516,-0.068028,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.46512,-0.026536,-0.029421,0,0
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.30402,-0.026602,-0.12989,0,0
3,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.57857,-0.026697,-0.093093,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.11636,-0.026729,-0.12204,0,0
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.48678,-0.026793,-0.053459,0,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.41341,-0.026839,-0.043268,0,0
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.42855,-0.026861,-0.039921,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.79636,-0.026947,-0.023173,0,0
3,GO T CELL MIGRATION,0.50896,-0.02695,-0.06035,0,0
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.67137,-0.026957,-0.053332,0,0
3,GO AXIS SPECIFICATION,0.64605,-0.027023,-0.0042137,0,0
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.33812,-0.027051,-0.056853,0,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.84397,-0.027106,-0.00607,0,0
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.7495,-0.02729,-0.044215,0,0
3,GO POSITIVE REGULATION OF MYELINATION,0.98953,-0.02741,0.012985,0,0
3,GO ORGANELLE MEMBRANE FUSION,0.60883,-0.027553,-0.029932,0,0
3,GO TRANSPORT ALONG MICROTUBULE,0.24288,-0.027556,-0.02892,0,0
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.4545,-0.027617,-0.072215,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.80989,-0.027686,-0.03712,0,0
3,GO PEROXISOME ORGANIZATION,0.70355,-0.027716,-0.013043,0,0
3,GO PRE MIRNA PROCESSING,0.89907,-0.027795,-0.0026399,0,0
3,GO SENSORY PERCEPTION OF SMELL,0.17934,-0.027852,-0.051713,0,0
3,GO GLIAL CELL PROLIFERATION,0.21256,-0.027852,-0.10434,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.62732,-0.027862,0.083106,0,0
3,GO ORGANELLE FUSION,0.62732,-0.02792,-0.029113,0,0
3,GO MITOTIC CELL CYCLE,0.30815,-0.028051,-0.027433,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.16828,-0.028062,-0.092044,0,0
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.21256,-0.028103,-0.11231,0,0
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.4978,-0.028413,-0.048367,0,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1,-0.028467,0.046562,0,0
3,GO CELL PROJECTION ORGANIZATION,0.22568,-0.028482,-0.036686,0,0
3,GO SULFUR COMPOUND TRANSPORT,0.46512,-0.028483,-0.040672,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.78289,-0.028582,0.00054349,0,0
3,GO RHYTHMIC PROCESS,0.36064,-0.028612,-0.024784,0,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.68418,-0.028654,-0.01835,0,0
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.76948,-0.028764,-0.020582,0,0
3,GO SISTER CHROMATID SEGREGATION,0.39371,-0.02877,-0.029771,0,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.188,-0.028815,-0.053354,0,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.94769,-0.028846,-0.014004,0,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.52594,-0.029016,-0.03682,0,0
3,GO AMINE METABOLIC PROCESS,0.24643,-0.029063,-0.0662,0,0
3,GO PROTEIN TARGETING TO LYSOSOME,0.47049,-0.029082,-0.074006,0,0
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.11434,-0.029098,-0.071854,0,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.83713,-0.029106,-0.0071441,0,0
3,GO HOMEOSTATIC PROCESS,0.16032,-0.029135,-0.037144,0,0
3,GO EPIDERMIS MORPHOGENESIS,0.54903,-0.029194,-0.079968,0,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.070855,-0.029237,-0.047532,0,0
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.81668,-0.02927,-0.054692,0,0
3,GO RESPONSE TO CHEMOKINE,0.71006,-0.029408,-0.036359,0,0
3,GO ALCOHOL CATABOLIC PROCESS,0.47588,-0.029463,-0.067054,0,0
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.27999,-0.029479,-0.035877,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.19393,-0.029527,-0.029762,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.91987,-0.030004,0.01188,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.75615,-0.030062,0.022301,0,0
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.46512,-0.030152,-0.066167,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.38888,-0.030155,-0.039205,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.86455,-0.030173,0.010198,0,0
3,GO EMBRYONIC EYE MORPHOGENESIS,0.31653,-0.03025,-0.077487,0,0
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.2,-0.03029,-0.067251,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.11039,-0.03056,-0.096492,0,0
3,GO GMP METABOLIC PROCESS,0.95466,-0.030648,0.014685,0,0
3,GO GLUTATHIONE METABOLIC PROCESS,0.9686,-0.030648,-0.0092514,0,0
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.47588,-0.030721,-0.10073,0,0
3,GO STEM CELL DIVISION,0.92682,-0.030731,0.0046617,0,0
3,GO COLLECTING DUCT DEVELOPMENT,0.47588,-0.030807,-0.057795,0,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.19095,-0.030931,-0.20232,0,0
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.65866,-0.030998,-0.047412,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.92682,-0.031042,0.0082032,0,0
3,GO REGULATION OF CALCIUM ION IMPORT,0.60883,-0.031173,-0.04011,0,0
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.4598,-0.031382,-0.050868,0,0
3,GO NEPHRON TUBULE FORMATION,0.42855,-0.031387,-0.08693,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.44402,-0.031437,-0.030609,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.9686,-0.031444,0.00096786,0,0
3,GO POSITIVE REGULATION OF CELL AGING,0.53742,-0.031522,-0.049367,0,0
3,GO NEUROINFLAMMATORY RESPONSE,0.32506,-0.031553,-0.061697,0,0
3,GO LIPID MODIFICATION,0.093897,-0.031555,-0.070816,0,0
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.26847,-0.031622,-0.12248,0,0
3,GO MITOTIC DNA REPLICATION,0.65234,-0.031672,-0.03032,0,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.89215,-0.031684,-0.017589,0,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.54321,-0.031764,-0.054718,0,0
3,GO REGULATION OF DNA RECOMBINATION,0.57857,-0.031849,-0.026391,0,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.30402,-0.031898,-0.057754,0,0
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.22905,-0.031966,-0.064716,0,0
3,GO SOMITE DEVELOPMENT,0.84397,-0.031997,-0.012614,0,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.87833,-0.032022,0.017418,0,0
3,GO RESPONSE TO GAMMA RADIATION,0.32506,-0.032333,-0.049645,0,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.26847,-0.032341,-0.068536,0,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.046579,-0.032396,-0.182,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.26471,-0.03243,-0.03882,0,0
3,GO PIGMENT CELL DIFFERENTIATION,0.27999,-0.032529,-0.067154,0,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.56075,-0.032553,-0.046736,0,0
3,GO FEVER GENERATION,0.91987,-0.032576,-0.0069729,0,0
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.4978,-0.032754,-0.025883,0,0
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.35153,-0.032951,-0.034018,0,0
3,GO LAMELLIPODIUM ASSEMBLY,0.20621,-0.032959,-0.065869,0,0
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.36991,-0.032966,-0.046627,0,0
3,GO MACROPHAGE APOPTOTIC PROCESS,0.52594,-0.032969,-0.047886,0,0
3,GO FERTILIZATION,0.15015,-0.033035,-0.037722,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.04854,-0.033048,-0.053847,0,0
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.61497,-0.033101,-0.037486,0,0
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.41842,-0.033134,-0.037008,0,0
3,GO CARBOHYDRATE METABOLIC PROCESS,0.89215,-0.033535,-0.006314,0,0
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.78962,-0.03357,-0.018766,0,0
3,GO DNA LIGATION,0.48678,-0.03366,-0.046821,0,0
3,GO REGULATION OF AUTOPHAGY,0.36991,-0.0337,-0.034544,0,0
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.59664,-0.033767,-0.035888,0,0
3,GO CARDIAC SEPTUM DEVELOPMENT,0.85768,-0.033809,-0.0021785,0,0
3,GO LIPID HOMEOSTASIS,0.30815,-0.033866,-0.060614,0,0
3,GO RESPONSE TO OXYGEN LEVELS,0.67137,-0.033926,-0.026821,0,0
3,GO ALCOHOL METABOLIC PROCESS,0.52594,-0.033941,-0.03645,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.24643,-0.033994,-0.07,0,0
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.093897,-0.034014,-0.077295,0,0
3,GO FATTY ACID CATABOLIC PROCESS,0.31653,-0.034062,-0.063187,0,0
3,GO PROTEIN CATABOLIC PROCESS,0.11235,-0.034215,-0.050256,0,0
3,GO REGULATION OF GLIOGENESIS,0.40349,-0.034228,-0.046305,0,0
3,GO INTRACELLULAR STEROL TRANSPORT,0.48131,-0.034258,-0.056484,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.3746,-0.034357,-0.062707,0,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.63354,-0.034394,-0.075102,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.63354,-0.034462,0.024197,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.60272,-0.034574,-0.13755,0,0
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.24643,-0.034579,-0.042669,0,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.58456,-0.034617,-0.090478,0,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.48678,-0.034645,-0.030691,0,0
3,GO COBALAMIN METABOLIC PROCESS,0.43883,-0.034665,-0.068664,0,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.36526,-0.034719,-0.0534,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.56666,-0.034743,-0.045952,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.3746,-0.034804,-0.027706,0,0
3,GO REGULATION OF HISTONE MODIFICATION,0.22905,-0.034986,-0.035883,0,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.5726,-0.034993,-0.037353,0,0
3,GO FATTY ACID TRANSPORT,0.48678,-0.035113,-0.040554,0,0
3,GO NON RECOMBINATIONAL REPAIR,0.22905,-0.035115,-0.04093,0,0
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.58456,-0.035182,-0.068592,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.40349,-0.035215,-0.049638,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.54903,-0.035303,-0.043711,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.43883,-0.035455,-0.068054,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.78289,-0.035532,0.0025769,0,0
3,GO TOR SIGNALING,0.27227,-0.035613,-0.02999,0,0
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.22568,-0.035614,-0.037523,0,0
3,GO SYMBIOTIC PROCESS,0.40349,-0.035697,-0.042426,0,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.4978,-0.035733,-0.056237,0,0
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.188,-0.035782,-0.060344,0,0
3,GO GLYCOLIPID CATABOLIC PROCESS,0.59664,-0.035852,-0.11574,0,0
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.057089,-0.035916,-0.038824,0,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.30402,-0.036011,-0.059999,0,0
3,GO CELL DIVISION,0.15517,-0.036138,-0.040357,0,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.78289,-0.036344,0.034919,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.29992,-0.036366,-0.078546,0,0
3,GO RESPONSE TO HYDROPEROXIDE,0.94073,-0.03645,0.0035729,0,0
3,GO RESPONSE TO THYROID HORMONE,0.7495,-0.036511,-0.042405,0,0
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.072231,-0.036519,-0.042633,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.75615,-0.03652,0.02848,0,0
3,GO REGULATION OF CELL CYCLE,0.084046,-0.036546,-0.031547,0,0
3,GO AMINE CATABOLIC PROCESS,0.44402,-0.036591,-0.091412,0,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.10845,-0.036648,-0.039142,0,0
3,GO SEQUESTERING OF TRIGLYCERIDE,0.83713,-0.036686,0.016813,0,0
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.29992,-0.036878,-0.13291,0,0
3,GO NEGATIVE REGULATION OF SIGNALING,0.11636,-0.036968,-0.052007,0,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.74288,-0.036999,0.062547,0,0
3,GO LEUKOCYTE HOMEOSTASIS,0.15015,-0.037089,-0.088229,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.60883,-0.03717,-0.022477,0,0
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.54321,-0.037178,-0.032426,0,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.73628,-0.037201,0.040864,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.40349,-0.037225,-0.079752,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.76281,-0.037328,0.011244,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.27611,-0.037404,-0.02464,0,0
3,GO CELL AGING,0.43367,-0.037486,-0.040076,0,0
3,GO GLAND MORPHOGENESIS,0.17934,-0.037501,-0.13739,0,0
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.49227,-0.037615,-0.052011,0,0
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.36064,-0.037676,-0.089183,0,0
3,GO HEAD DEVELOPMENT,0.47049,-0.037735,-0.020868,0,0
3,GO REGULATION OF T CELL MIGRATION,0.26471,-0.037818,-0.06513,0,0
3,GO RESPONSE TO ETHANOL,0.34256,-0.037836,-0.038939,0,0
3,GO RESPONSE TO CATECHOLAMINE,0.51459,-0.038011,-0.028639,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.34702,-0.038061,-0.071979,0,0
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.65234,-0.038201,-0.041235,0,0
3,GO OSSIFICATION,0.23589,-0.038407,-0.065649,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.17653,-0.038424,-0.052394,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.35153,-0.038467,-0.11874,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.088862,-0.038479,-0.063256,0,0
3,GO MESENCHYME DEVELOPMENT,0.39858,-0.038687,-0.050435,0,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.16294,-0.038831,-0.035058,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.3746,-0.038884,-0.073504,0,0
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.63978,-0.038893,-0.072679,0,0
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.33812,-0.038902,-0.081704,0,0
3,GO DIET INDUCED THERMOGENESIS,0.89907,-0.038937,-0.001434,0,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.25363,-0.038955,-0.059144,0,0
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.32938,-0.038962,-0.063027,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.090515,-0.039026,-0.086355,0,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.36526,-0.039076,-0.077276,0,0
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.85768,-0.039266,-0.015094,0,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.15264,-0.039321,-0.075653,0,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.30815,-0.039355,-0.044383,0,0
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.2839,-0.039374,-0.063616,0,0
3,GO HYALURONAN METABOLIC PROCESS,0.76281,-0.039465,-0.037122,0,0
3,GO CALCIUM ION IMPORT,0.72969,-0.039576,-0.01284,0,0
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.98953,-0.039674,-0.0079965,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.31653,-0.039724,-0.093865,0,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.53167,-0.039815,-0.08422,0,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.095625,-0.039912,-0.066992,0,0
3,GO FLUID TRANSPORT,0.19393,-0.039947,-0.079175,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.88523,-0.039995,0.03141,0,0
3,GO RESPONSE TO MAGNESIUM ION,0.5726,-0.040085,-0.059015,0,0
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.49227,-0.040147,-0.023876,0,0
3,GO LIPID OXIDATION,0.55487,-0.040258,-0.039677,0,0
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.39858,-0.040292,-0.03813,0,0
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.68418,-0.04031,-0.023482,0,0
3,GO LYSINE METABOLIC PROCESS,0.35153,-0.040549,-0.11279,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.042857,-0.040677,-0.079576,0,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.87144,-0.040713,0.011125,0,0
3,GO REGULATION OF ODONTOGENESIS,0.67137,-0.040784,-0.057664,0,0
3,GO MOLTING CYCLE,0.29992,-0.040822,-0.077114,0,0
3,GO CHROMOSOME SEGREGATION,0.24643,-0.040884,-0.040777,0,0
3,GO STEROL BIOSYNTHETIC PROCESS,0.80989,-0.040917,-0.0086481,0,0
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.67776,-0.040924,-0.013887,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.35153,-0.040975,-0.04702,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.26847,-0.040978,-0.067581,0,0
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.76948,-0.04118,-0.022886,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.69061,-0.041295,-0.023351,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.34702,-0.041323,-0.045009,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.12689,-0.041396,-0.080716,0,0
3,GO MESODERM DEVELOPMENT,0.21905,-0.041464,-0.065698,0,0
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.62113,-0.041506,-0.07144,0,0
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.63978,-0.04151,-0.012513,0,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.49227,-0.041511,-0.05678,0,0
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.070855,-0.041536,-0.12112,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.69707,-0.041616,0.0042145,0,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.21256,-0.041616,-0.052012,0,0
3,GO CHOLESTEROL STORAGE,0.60883,-0.041642,-0.033408,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.22905,-0.041729,-0.05148,0,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.26847,-0.041744,-0.044162,0,0
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.080955,-0.041775,-0.092175,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.56666,-0.041792,-0.029111,0,0
3,GO STEROID BIOSYNTHETIC PROCESS,0.39371,-0.041792,-0.049755,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.11434,-0.041855,-0.045323,0,0
3,GO HEART DEVELOPMENT,0.15264,-0.041944,-0.06181,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.31232,-0.04199,-0.059456,0,0
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.60883,-0.04201,-0.052154,0,0
3,GO SPINDLE ASSEMBLY,0.076492,-0.042033,-0.060418,0,0
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.29184,-0.042078,-0.060694,0,0
3,GO AXIS ELONGATION,0.36064,-0.042082,-0.10353,0,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.11235,-0.042238,-0.091562,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.48131,-0.042368,-0.03911,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.48678,-0.042438,0.088799,0,0
3,GO POSITIVE REGULATION OF GROWTH,0.15517,-0.04248,-0.044718,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.097379,-0.04255,-0.058675,0,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.14526,-0.042576,-0.07894,0,0
3,GO REGULATION OF SODIUM ION TRANSPORT,0.98255,-0.042617,-0.0062961,0,0
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.40349,-0.042641,-0.026417,0,0
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.98255,-0.042662,-0.0058146,0,0
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.17374,-0.042679,-0.081484,0,0
3,GO STEROID ESTERIFICATION,0.63354,-0.042738,-0.083026,0,0
3,GO DNA METHYLATION OR DEMETHYLATION,0.13583,-0.042748,-0.053686,0,0
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.23589,-0.042886,-0.10911,0,0
3,GO REGULATION OF BONE DEVELOPMENT,0.43883,-0.042906,-0.054382,0,0
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.17099,-0.042932,-0.076899,0,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.3746,-0.04295,-0.028209,0,0
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.084046,-0.042964,-0.073557,0,0
3,GO INTERLEUKIN 2 PRODUCTION,0.62732,-0.043012,-0.054977,0,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.11636,-0.043505,-0.039491,0,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.67776,-0.043584,-0.013278,0,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.62113,-0.043596,-0.027811,0,0
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.093897,-0.043651,-0.085467,0,0
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.2839,-0.043805,-0.072877,0,0
3,GO POSITIVE REGULATION OF DNA REPAIR,0.32077,-0.04386,-0.034043,0,0
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.11235,-0.043934,-0.074635,0,0
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.41842,-0.043953,-0.06231,0,0
3,GO REGULATION OF MITOPHAGY,0.31653,-0.044058,-0.064312,0,0
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.25729,-0.044097,-0.086956,0,0
3,GO CELLULAR RESPONSE TO STARVATION,0.17653,-0.044108,-0.065873,0,0
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.17653,-0.044179,-0.094791,0,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.43883,-0.044233,-0.059793,0,0
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.16032,-0.044272,-0.040215,0,0
3,GO MACROPHAGE ACTIVATION,0.53742,-0.044395,-0.040427,0,0
3,GO PROTEIN AUTOPHOSPHORYLATION,0.16032,-0.044427,-0.050621,0,0
3,GO MAINTENANCE OF CELL NUMBER,0.076492,-0.044606,-0.078417,0,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.24643,-0.044662,-0.070866,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.44402,-0.044806,-0.064898,0,0
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.23245,-0.044884,-0.072974,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.32938,-0.044959,-0.065413,0,0
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.3746,-0.04497,-0.078786,0,0
3,GO CELL SUBSTRATE ADHESION,0.23245,-0.045022,-0.082612,0,0
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.32506,-0.045041,-0.037712,0,0
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.89215,-0.045191,-0.036489,0,0
3,GO FILOPODIUM ASSEMBLY,0.65866,-0.045235,-0.030373,0,0
3,GO PINOCYTOSIS,0.20937,-0.045298,-0.11567,0,0
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.073629,-0.045378,-0.079582,0,0
3,GO GLIOGENESIS,0.20309,-0.045407,-0.060505,0,0
3,GO ORGANELLE INHERITANCE,0.075049,-0.04542,-0.081011,0,0
3,GO VISUAL BEHAVIOR,0.63978,-0.045429,-0.025973,0,0
3,GO RECEPTOR CATABOLIC PROCESS,0.3746,-0.045482,-0.061906,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.67776,-0.045571,0.04929,0,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.29992,-0.045597,-0.035524,0,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.04854,-0.045668,-0.052658,0,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.070855,-0.045685,-0.063654,0,0
3,GO RECEPTOR RECYCLING,0.18508,-0.045795,-0.061201,0,0
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.15517,-0.045849,-0.072928,0,0
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.27611,-0.045903,-0.048596,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.11235,-0.045953,-0.07412,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.080955,-0.045975,-0.06306,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.96163,-0.045991,0.0057428,0,0
3,GO CHLORIDE ION HOMEOSTASIS,0.41842,-0.046056,-0.075258,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.088862,-0.046065,-0.078566,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.38408,-0.046175,-0.10924,0,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.27611,-0.04623,-0.11301,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.71006,-0.046243,-0.011201,0,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.066855,-0.046246,-0.051243,0,0
3,GO GANGLIOSIDE METABOLIC PROCESS,0.99651,-0.046382,0.01931,0,0
3,GO MUSCLE CELL PROLIFERATION,0.47049,-0.046403,-0.051427,0,0
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.44924,-0.046495,-0.027635,0,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.068167,-0.046565,-0.13006,0,0
3,GO DETOXIFICATION,0.60883,-0.046569,-0.033772,0,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.2,-0.046716,-0.13511,0,0
3,GO RESPONSE TO NUTRIENT,0.22568,-0.046753,-0.072972,0,0
3,GO ACTIVATION OF JNKK ACTIVITY,0.4545,-0.046845,-0.08167,0,0
3,GO MONOAMINE TRANSPORT,0.44402,-0.047135,0.0008588,0,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.81668,-0.047142,-0.0068613,0,0
3,GO RESPONSE TO FUNGUS,0.34702,-0.047162,-0.041554,0,0
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.060602,-0.047176,-0.05597,0,0
3,GO NOTOCHORD DEVELOPMENT,0.91293,-0.047265,-0.056994,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.42855,-0.0473,-0.11566,0,0
3,GO CELLULAR SENESCENCE,0.19393,-0.04733,-0.064177,0,0
3,GO ASTROCYTE DEVELOPMENT,0.21905,-0.047371,-0.10643,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.34702,-0.047449,-0.063988,0,0
3,GO RESPONSE TO PEPTIDE,0.085627,-0.047494,-0.052594,0,0
3,GO RETROGRADE AXONAL TRANSPORT,0.36991,-0.04752,-0.054313,0,0
3,GO MICROTUBULE BASED PROCESS,0.015953,-0.047563,-0.061614,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.22568,-0.047567,-0.071692,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.96163,-0.047713,-0.0023948,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.74288,-0.047945,0.074614,0,0
3,GO RESPONSE TO INSULIN,0.10654,-0.0481,-0.051335,0,0
3,GO REGULATION OF LIPID LOCALIZATION,0.20937,-0.048159,-0.063045,0,0
3,GO REGULATION OF PROTEIN BINDING,0.16828,-0.048185,-0.054485,0,0
3,GO CIRCADIAN RHYTHM,0.031059,-0.048237,-0.054546,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.53167,-0.048239,-0.027764,0,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.55487,-0.048619,-0.025415,0,0
3,GO VACUOLAR ACIDIFICATION,0.42855,-0.048637,-0.070704,0,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.52594,-0.048742,-0.035142,0,0
3,GO POLYOL CATABOLIC PROCESS,0.16559,-0.048766,-0.085078,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.73628,-0.048799,-0.036857,0,0
3,GO MANGANESE ION TRANSPORT,0.7495,-0.048862,-0.016189,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.71658,-0.048873,-0.040804,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE,0.036164,-0.048977,-0.044093,0,0
3,GO RESPONSE TO TUMOR CELL,0.57857,-0.049036,-0.03105,0,0
3,GO KETONE BIOSYNTHETIC PROCESS,0.55487,-0.049193,-0.073074,0,0
3,GO REGULATION OF BEHAVIOR,0.76948,-0.049283,-0.017503,0,0
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.47049,-0.049297,-0.053482,0,0
3,GO MUSCLE FIBER DEVELOPMENT,0.24643,-0.049386,-0.062292,0,0
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.2,-0.049522,-0.058376,0,0
3,GO MUSCLE HYPERTROPHY,0.30815,-0.049561,-0.060898,0,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.12049,-0.049577,-0.14349,0,0
3,GO INTEGRIN ACTIVATION,0.23589,-0.049632,-0.09538,0,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.35607,-0.049646,-0.099283,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.71658,-0.049736,-0.027795,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.15264,-0.049837,-0.056709,0,0
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.097379,-0.049882,-0.067081,0,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.64605,-0.049935,0.069685,0,0
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.41842,-0.049986,-0.058208,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.63978,-0.050077,-0.060554,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.27999,-0.050234,-0.047955,0,0
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.052669,-0.05025,-0.071365,0,0
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.097379,-0.050313,-0.067736,0,0
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.097379,-0.050324,-0.090782,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.095625,-0.050338,-0.058063,0,0
3,GO MICROTUBULE BASED MOVEMENT,0.014841,-0.050429,-0.075563,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.21256,-0.050456,-0.11768,0,0
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.22235,-0.050572,-0.10084,0,0
3,GO FOCAL ADHESION ASSEMBLY,0.17653,-0.050598,-0.089757,0,0
3,GO KINETOCHORE ORGANIZATION,0.23937,-0.050601,-0.094197,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.24643,-0.050639,-0.042706,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.79636,-0.050754,-0.013704,0,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.93377,-0.050779,0.00073953,0,0
3,GO REGULATION OF PHAGOCYTOSIS,0.11841,-0.050804,-0.10677,0,0
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.34702,-0.050847,-0.050739,0,0
3,GO SODIUM ION HOMEOSTASIS,0.16294,-0.050849,-0.057355,0,0
3,GO HISTONE PHOSPHORYLATION,0.32938,-0.050957,-0.052821,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.80989,-0.051057,0.081868,0,0
3,GO REGULATION OF LIPID TRANSPORT,0.26847,-0.051105,-0.061433,0,0
3,GO SENSORY PERCEPTION OF PAIN,0.15517,-0.051137,-0.068786,0,0
3,GO REGULATION OF TOR SIGNALING,0.32938,-0.0512,-0.039213,0,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.19695,-0.051313,-0.10876,0,0
3,GO HISTONE H3 K27 METHYLATION,0.89907,-0.051385,4.8425e-05,0,0
3,GO RESPONSE TO HORMONE,0.15517,-0.051493,-0.050102,0,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.10654,-0.05156,-0.052926,0,0
3,GO ATP TRANSPORT,0.7495,-0.051613,0.032104,0,0
3,GO SCHWANN CELL DIFFERENTIATION,0.21256,-0.051719,-0.065019,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.084046,-0.05181,-0.09201,0,0
3,GO ERK1 AND ERK2 CASCADE,0.25363,-0.051832,-0.069428,0,0
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.18219,-0.052106,-0.04448,0,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.12689,-0.052275,-0.095738,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.22905,-0.052287,-0.15009,0,0
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.043763,-0.052748,-0.096331,0,0
3,GO MEMBRANE ORGANIZATION,0.11235,-0.052761,-0.048579,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.42347,-0.052912,-0.057517,0,0
3,GO POSITIVE REGULATION OF CELL DEATH,0.1028,-0.052972,-0.055722,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.41341,-0.052989,-0.07429,0,0
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.44402,-0.053085,-0.066708,0,0
3,GO REGULATION OF TRANSPORT,0.061812,-0.053259,-0.05031,0,0
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.066855,-0.053438,-0.054731,0,0
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.39371,-0.053468,-0.054175,0,0
3,GO PHAGOCYTOSIS,0.21905,-0.053521,-0.074103,0,0
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.20937,-0.053522,-0.037842,0,0
3,GO PROTEIN POLYMERIZATION,0.059411,-0.053603,-0.061225,0,0
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.17099,-0.053653,-0.060509,0,0
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.62113,-0.05369,-0.060718,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.26471,-0.053698,-0.10607,0,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.029068,-0.0537,-0.11358,0,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.015574,-0.053701,-0.066891,0,0
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.67776,-0.053944,-0.048307,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.02843,-0.053954,-0.074541,0,0
3,GO PROTEIN TARGETING TO VACUOLE,0.17934,-0.05401,-0.076676,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.15264,-0.054016,-0.099988,0,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0031536,-0.054019,-0.070285,0,0
3,GO ESTROGEN METABOLIC PROCESS,0.24643,-0.054029,-0.076098,0,0
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.188,-0.054061,-0.17142,0,0
3,GO CYTOSOLIC TRANSPORT,0.054842,-0.054282,-0.05966,0,0
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.24288,-0.054326,-0.080185,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.093897,-0.054337,-0.070632,0,0
3,GO STRIATED MUSCLE ADAPTATION,0.71658,-0.054364,-0.016571,0,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.41842,-0.054375,-0.03948,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.78289,-0.05447,0.042681,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.26471,-0.054584,-0.045012,0,0
3,GO RESPONSE TO ACID CHEMICAL,0.55487,-0.054649,-0.030764,0,0
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.25729,-0.054699,-0.077667,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.041967,-0.054746,-0.052603,0,0
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.39858,-0.054815,-0.059298,0,0
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.27611,-0.05483,-0.090246,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.084046,-0.054868,-0.14983,0,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.29586,-0.054875,-0.061539,0,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.068167,-0.054914,-0.074397,0,0
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.56075,-0.054954,-0.031768,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.064293,-0.055053,-0.072127,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.053746,-0.055058,-0.10323,0,0
3,GO RESPONSE TO DOPAMINE,0.41341,-0.055282,-0.033488,0,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.090515,-0.055447,-0.077601,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.87144,-0.055476,-0.030581,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.76948,-0.055477,-0.030709,0,0
3,GO REGULATION OF CYTOKINESIS,0.063042,-0.055525,-0.069542,0,0
3,GO FACE DEVELOPMENT,0.095625,-0.055662,-0.11633,0,0
3,GO JNK CASCADE,0.070855,-0.055697,-0.060503,0,0
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.18508,-0.055725,-0.0553,0,0
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.097379,-0.055854,-0.07248,0,0
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.26098,-0.055975,-0.10712,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.50896,-0.056018,-0.048874,0,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.35153,-0.056021,-0.056578,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.17374,-0.05608,-0.068911,0,0
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.23245,-0.05609,-0.03737,0,0
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.17934,-0.056268,-0.1333,0,0
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.046579,-0.056274,-0.047511,0,0
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.4598,-0.056348,-0.068815,0,0
3,GO BODY MORPHOGENESIS,0.19095,-0.056392,-0.096971,0,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.0041716,-0.056423,-0.1041,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.15517,-0.056516,-0.089149,0,0
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.15773,-0.056629,-0.11057,0,0
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.10654,-0.056685,-0.12085,0,0
3,GO INTERFERON GAMMA PRODUCTION,0.14526,-0.056857,-0.074325,0,0
3,GO BLOOD VESSEL MORPHOGENESIS,0.073629,-0.056904,-0.098516,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.25729,-0.057168,-0.052367,0,0
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.19695,-0.057368,-0.096823,0,0
3,GO HISTONE H3 K9 METHYLATION,0.21579,-0.05747,-0.049916,0,0
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.56666,-0.05749,-0.026942,0,0
3,GO PROTEIN MANNOSYLATION,0.3746,-0.057564,-0.049612,0,0
3,GO NEURON APOPTOTIC PROCESS,0.10845,-0.057601,-0.051861,0,0
3,GO T CELL CHEMOTAXIS,0.25001,-0.057641,-0.059279,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0041716,-0.057719,-0.075917,0,0
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.12259,-0.057725,-0.055904,0,0
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.44402,-0.057819,-0.08193,0,0
3,GO RESPONSE TO GROWTH FACTOR,0.059411,-0.05796,-0.088711,0,0
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.082489,-0.058127,-0.08307,0,0
3,GO REGULATION OF AMINO ACID TRANSPORT,0.17653,-0.05821,-0.077314,0,0
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.044685,-0.058247,-0.11395,0,0
3,GO RESPONSE TO PEPTIDE HORMONE,0.061812,-0.058387,-0.054513,0,0
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.082489,-0.058403,-0.048418,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.86455,-0.058464,0.011388,0,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00353,-0.058474,-0.059746,0,0
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.32077,-0.058537,-0.071256,0,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.15517,-0.058829,-0.10346,0,0
3,GO RNA DESTABILIZATION,0.21256,-0.058831,-0.062354,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.35607,-0.058863,-0.07544,0,0
3,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.72313,-0.058891,-0.024969,0,0
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.077957,-0.058894,-0.090988,0,0
3,GO FATTY ACID METABOLIC PROCESS,0.050569,-0.05901,-0.09476,0,0
3,GO AMYLOID BETA FORMATION,0.66501,-0.059059,-0.029476,0,0
3,GO REGULATION OF DENDRITE EXTENSION,0.63354,-0.059078,-0.0006393,0,0
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.24643,-0.059096,-0.066814,0,0
3,GO REGENERATION,0.25001,-0.059097,-0.064219,0,0
3,GO INSEMINATION,0.53167,-0.059099,-0.071229,0,0
3,GO MYOTUBE DIFFERENTIATION,0.1028,-0.059202,-0.096107,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.52594,-0.059205,-0.044627,0,0
3,GO TONGUE DEVELOPMENT,0.15015,-0.059263,-0.16964,0,0
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.22235,-0.05931,-0.048459,0,0
3,GO RESPONSE TO INTERLEUKIN 1,0.097379,-0.059349,-0.094111,0,0
3,GO PIGMENTATION,0.076492,-0.059355,-0.076815,0,0
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.15264,-0.059504,-0.10324,0,0
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.090515,-0.059505,-0.066178,0,0
3,GO DNA CATABOLIC PROCESS,0.082489,-0.059539,-0.075325,0,0
3,GO PROTEIN DEGLYCOSYLATION,0.36526,-0.059617,-0.097804,0,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.17374,-0.059704,-0.10968,0,0
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.25363,-0.059774,-0.055793,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.4978,-0.059801,-0.092366,0,0
3,GO METANEPHROS DEVELOPMENT,0.097379,-0.059819,-0.10709,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.082489,-0.059831,-0.064951,0,0
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.31232,-0.059832,-0.1451,0,0
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.060602,-0.059905,-0.071601,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.093897,-0.059945,-0.096261,0,0
3,GO RESPONSE TO STARVATION,0.36526,-0.05998,-0.044047,0,0
3,GO STRESS FIBER ASSEMBLY,0.28785,-0.06015,-0.060972,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.045624,-0.060418,-0.066516,0,0
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.19095,-0.060454,-0.052906,0,0
3,GO VASCULATURE DEVELOPMENT,0.10654,-0.060488,-0.084804,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.12049,-0.060573,-0.12257,0,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.064293,-0.060598,-0.11053,0,0
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.2839,-0.060603,-0.074002,0,0
3,GO ORGANELLE LOCALIZATION,0.0013457,-0.060632,-0.078652,0,0
3,GO T CELL APOPTOTIC PROCESS,0.22235,-0.061098,-0.090661,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.14048,-0.061125,-0.05906,0,0
3,GO HEAT GENERATION,0.33812,-0.061151,-0.092862,0,0
3,GO OXALATE TRANSPORT,0.34702,-0.0613,-0.054455,0,0
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.22235,-0.061396,-0.062503,0,0
3,GO MUSCLE CELL DIFFERENTIATION,0.068167,-0.061518,-0.078479,0,0
3,GO RETINOIC ACID METABOLIC PROCESS,0.51459,-0.061542,-0.077373,0,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.54903,-0.061588,-0.036208,0,0
3,GO REGULATION OF GTPASE ACTIVITY,0.065563,-0.061611,-0.052762,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.27611,-0.061612,-0.13214,0,0
3,GO OSTEOCLAST DIFFERENTIATION,0.3746,-0.061676,-0.042545,0,0
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.019739,-0.061727,-0.096454,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.26098,-0.061759,-0.098831,0,0
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.090515,-0.062,-0.084036,0,0
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.52594,-0.062005,-0.032321,0,0
3,GO LYSOSOME LOCALIZATION,0.082489,-0.062045,-0.09981,0,0
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.25729,-0.062086,-0.11208,0,0
3,GO CELLULAR RESPONSE TO CAMP,0.77618,-0.062102,-0.0026104,0,0
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.040234,-0.0624,-0.14155,0,0
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.055956,-0.062711,-0.11316,0,0
3,GO NEURAL TUBE PATTERNING,0.34702,-0.06273,-0.061416,0,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.15773,-0.062742,-0.082798,0,0
3,GO HISTONE H3 K9 MODIFICATION,0.088862,-0.062807,-0.065386,0,0
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.19695,-0.062871,-0.041944,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.36064,-0.063109,-0.079876,0,0
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.25001,-0.063233,-0.064027,0,0
3,GO SINGLE STRAND BREAK REPAIR,0.16294,-0.063235,-0.079423,0,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.073629,-0.063268,-0.055925,0,0
3,GO GLIAL CELL DIFFERENTIATION,0.12049,-0.06328,-0.072397,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.076492,-0.063371,-0.057849,0,0
3,GO P BODY ASSEMBLY,0.05161,-0.063545,-0.06778,0,0
3,GO POSITIVE THYMIC T CELL SELECTION,0.17653,-0.063803,-0.1079,0,0
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.20309,-0.063832,-0.10996,0,0
3,GO HISTONE H4 ACETYLATION,0.066855,-0.063837,-0.051884,0,0
3,GO RESPONSE TO COCAINE,0.63354,-0.063852,-0.013833,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.065563,-0.063977,-0.17111,0,0
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.49227,-0.06399,-0.067242,0,0
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.073629,-0.06414,-0.056858,0,0
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.21579,-0.064153,-0.075007,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.62113,-0.064202,-0.017238,0,0
3,GO SMOOTHENED SIGNALING PATHWAY,0.11039,-0.06423,-0.072372,0,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.36526,-0.064486,-0.046196,0,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.32077,-0.064496,-0.091825,0,0
3,GO CELL FATE COMMITMENT,0.082489,-0.064547,-0.083285,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.2,-0.064578,-0.042436,0,0
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.20937,-0.064636,-0.076969,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.061812,-0.064737,-0.0654,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.077957,-0.064843,-0.080415,0,0
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.10465,-0.064846,-0.053925,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.71006,-0.064849,-0.034616,0,0
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.087232,-0.064912,-0.092745,0,0
3,GO ADIPOSE TISSUE DEVELOPMENT,0.27227,-0.065027,-0.08055,0,0
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.39371,-0.065128,-0.036197,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.38888,-0.065203,-0.078894,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.15517,-0.065207,-0.10701,0,0
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.059411,-0.065349,-0.1085,0,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.42855,-0.065459,-0.032397,0,0
3,GO POSITIVE REGULATION OF JNK CASCADE,0.087232,-0.065473,-0.070882,0,0
3,GO PRIMARY MIRNA PROCESSING,0.66501,-0.065474,-0.027828,0,0
3,GO RESPONSE TO ACTIVITY,0.12473,-0.065507,-0.084063,0,0
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.099158,-0.06561,-0.16705,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.65234,-0.065615,-0.039421,0,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.85082,-0.065715,0.018127,0,0
3,GO GLIAL CELL DEVELOPMENT,0.095625,-0.065787,-0.089819,0,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.4978,-0.066048,-0.10505,0,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.77618,-0.066107,-0.0046425,0,0
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.088862,-0.066134,-0.31085,0,0
3,GO RESPONSE TO OXIDATIVE STRESS,0.11039,-0.066179,-0.06782,0,0
3,GO REGULATION OF ANION TRANSPORT,0.05161,-0.066647,-0.094323,0,0
3,GO TAXIS,0.082489,-0.066771,-0.067506,0,0
3,GO ACROSOME ASSEMBLY,0.95466,-0.066773,0.042083,0,0
3,GO AUTOPHAGIC CELL DEATH,0.23937,-0.066855,-0.093267,0,0
3,GO REGULATION OF GTP BINDING,0.60272,-0.06694,-0.046248,0,0
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.43367,-0.066944,-0.081758,0,0
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.39858,-0.066951,-0.081626,0,0
3,GO RESPONSE TO LEUCINE,0.82348,-0.066961,0.039203,0,0
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.26471,-0.066961,-0.10851,0,0
3,GO REGULATION OF BLOOD PRESSURE,0.053746,-0.067023,-0.087946,0,0
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.97557,-0.067074,0.0041699,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.72969,-0.067076,-0.041855,0,0
3,GO PERICARDIUM DEVELOPMENT,0.21256,-0.067084,-0.10089,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.82348,-0.067147,0.039352,0,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.78289,-0.067173,-0.02288,0,0
3,GO DEVELOPMENTAL PIGMENTATION,0.11235,-0.067227,-0.080312,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.99651,-0.067271,-0.016423,0,0
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.25729,-0.067337,-0.056865,0,0
3,GO RESPONSE TO KETONE,0.087232,-0.067422,-0.084469,0,0
3,GO RESPONSE TO VITAMIN,0.20937,-0.06754,-0.090526,0,0
3,GO SPINAL CORD DEVELOPMENT,0.3746,-0.067596,-0.041247,0,0
3,GO NEGATIVE REGULATION OF TRANSPORT,0.072231,-0.067711,-0.050793,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.13583,-0.067847,-0.08824,0,0
3,GO MICROTUBULE ANCHORING,0.10096,-0.067977,-0.089345,0,0
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.15264,-0.068033,-0.1369,0,0
3,GO MICROTUBULE BASED TRANSPORT,0.0081404,-0.068283,-0.082948,0,0
3,GO REGULATION OF PROTEIN IMPORT,0.19393,-0.068329,-0.097615,0,0
3,GO OOCYTE MATURATION,0.23245,-0.068437,-0.060261,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.13355,-0.068515,-0.069911,0,0
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.25001,-0.068617,-0.059653,0,0
3,GO TROPHOBLAST CELL MIGRATION,0.41341,-0.068763,-0.12973,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.13355,-0.068766,-0.12527,0,0
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.12473,-0.06906,-0.075196,0,0
3,GO POSITIVE REGULATION OF CELL GROWTH,0.01282,-0.06915,-0.081101,0,0
3,GO DETECTION OF BIOTIC STIMULUS,0.51459,-0.069196,-0.077608,0,0
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.49227,-0.069307,-0.047559,0,0
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.10096,-0.069397,-0.08354,0,0
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0695,-0.069583,-0.083452,0,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.087232,-0.069586,-0.10243,0,0
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.61497,-0.069665,-0.033965,0,0
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.15773,-0.069718,-0.054633,0,0
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.17374,-0.069859,-0.065786,0,0
3,GO OOGENESIS,0.029068,-0.069865,-0.10662,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.12259,-0.07001,-0.058333,0,0
3,GO SIGNAL RELEASE,0.049546,-0.070023,-0.061967,0,0
3,GO RESPONSE TO EPINEPHRINE,0.61497,-0.070059,-0.058421,0,0
3,GO GPI ANCHOR METABOLIC PROCESS,0.15015,-0.070077,-0.073359,0,0
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.05824,-0.07011,-0.11331,0,0
3,GO LYSOSOMAL TRANSPORT,0.066855,-0.07017,-0.084047,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.20621,-0.070281,-0.088629,0,0
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.40349,-0.070396,-0.10426,0,0
3,GO RESPONSE TO PAIN,0.23589,-0.070426,-0.12425,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.12049,-0.070492,-0.086208,0,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.084046,-0.070659,-0.088597,0,0
3,GO EMBRYO DEVELOPMENT,0.0049174,-0.070686,-0.084697,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0046564,-0.070796,-0.077851,0,0
3,GO SPERM EGG RECOGNITION,0.4598,-0.070868,-0.024968,0,0
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.1313,-0.070931,-0.07796,0,0
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.068167,-0.071106,-0.070659,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.51459,-0.071361,-0.031288,0,0
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.23245,-0.07139,-0.073338,0,0
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.14769,-0.071459,-0.07648,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.27999,-0.07151,-0.073135,0,0
3,GO REGULATION OF RESPONSE TO FOOD,0.16294,-0.071569,-0.096806,0,0
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.14048,-0.071608,-0.071661,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0045306,-0.071646,-0.1055,0,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.097379,-0.071726,-0.24597,0,0
3,GO REGULATION OF APPETITE,0.057089,-0.071764,-0.10312,0,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.91987,-0.071896,-5.4763e-05,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.37932,-0.071948,-0.056765,0,0
3,GO BONE MINERALIZATION,0.39371,-0.072045,-0.046616,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.91987,-0.072046,0.037037,0,0
3,GO MESENCHYME MORPHOGENESIS,0.16828,-0.072191,-0.10966,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.093897,-0.072246,-0.13602,0,0
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.32938,-0.072254,-0.083643,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.018398,-0.072362,-0.063139,0,0
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.049546,-0.072652,-0.11029,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.30815,-0.072675,-0.080519,0,0
3,GO THYMIC T CELL SELECTION,0.079444,-0.072736,-0.082315,0,0
3,GO AORTA MORPHOGENESIS,0.21256,-0.072779,-0.10783,0,0
3,GO MAMMARY GLAND DEVELOPMENT,0.0695,-0.072838,-0.107,0,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.13583,-0.072968,-0.046813,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.15517,-0.072973,-0.11039,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.1028,-0.073032,-0.10003,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.16828,-0.073457,-0.085625,0,0
3,GO DISTAL TUBULE DEVELOPMENT,0.26098,-0.073574,-0.12451,0,0
3,GO LYMPHOCYTE MIGRATION,0.16032,-0.073594,-0.088625,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.58456,-0.073657,-0.010461,0,0
3,GO ACTIVATION OF MAPK ACTIVITY,0.060602,-0.073672,-0.076111,0,0
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.30402,-0.073724,-0.10915,0,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.98953,-0.073843,0.047009,0,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.22235,-0.074115,-0.092782,0,0
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.20309,-0.074133,-0.052459,0,0
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.064293,-0.074143,-0.06674,0,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.11039,-0.074236,-0.09204,0,0
3,GO POTASSIUM ION HOMEOSTASIS,0.14048,-0.074241,-0.094763,0,0
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.47588,-0.074303,-0.054088,0,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.30815,-0.074412,-0.14554,0,0
3,GO BRAIN MORPHOGENESIS,0.85768,-0.074434,0.01554,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.21579,-0.07468,-0.038843,0,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.33373,-0.074747,-0.089291,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.62113,-0.074804,-0.0055691,0,0
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.087232,-0.074807,-0.11852,0,0
3,GO MELANOCYTE DIFFERENTIATION,0.13583,-0.074819,-0.10049,0,0
3,GO REGULATION OF MYOBLAST FUSION,0.25363,-0.074983,-0.14828,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.26847,-0.075231,-0.124,0,0
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.088862,-0.075306,-0.13213,0,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.014486,-0.075331,-0.079797,0,0
3,GO REGULATION OF RECEPTOR RECYCLING,0.11434,-0.075348,-0.097783,0,0
3,GO GLUCOSE METABOLIC PROCESS,0.05824,-0.075647,-0.065325,0,0
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.29586,-0.075736,-0.13918,0,0
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.34702,-0.076096,-0.053005,0,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.0695,-0.076169,-0.098888,0,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.022165,-0.076208,-0.12031,0,0
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.05161,-0.076253,-0.076124,0,0
3,GO RNA DECAPPING,0.23245,-0.076507,-0.059446,0,0
3,GO STEROL METABOLIC PROCESS,0.30402,-0.076559,-0.059001,0,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.59664,-0.07666,-0.031419,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.054842,-0.07668,-0.058898,0,0
3,GO DENDRITIC CELL CHEMOTAXIS,0.10654,-0.076713,-0.13363,0,0
3,GO CELL VOLUME HOMEOSTASIS,0.024846,-0.076728,-0.11089,0,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.30815,-0.076791,-0.051452,0,0
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.19695,-0.076902,-0.080214,0,0
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.17099,-0.077036,-0.055192,0,0
3,GO SENSORY PERCEPTION,0.043763,-0.077147,-0.057397,0,0
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.13355,-0.077327,-0.043003,0,0
3,GO ACID SECRETION,0.11636,-0.077407,-0.075516,0,0
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.061812,-0.077452,-0.082246,0,0
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.05161,-0.077503,-0.071756,0,0
3,GO STEROL HOMEOSTASIS,0.34702,-0.077527,-0.077842,0,0
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.050569,-0.077556,-0.12926,0,0
3,GO REGULATION OF TUBE SIZE,0.068167,-0.077634,-0.093076,0,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.030383,-0.07769,-0.13851,0,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.50337,-0.077704,0.0039192,0,0
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.0064317,-0.077733,-0.10364,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.62732,-0.077814,-0.076809,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.025994,-0.077936,-0.05637,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.16294,-0.078241,-0.096357,0,0
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.060602,-0.078309,-0.10508,0,0
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.087232,-0.07853,-0.11667,0,0
3,GO RESPONSE TO TOXIC SUBSTANCE,0.15015,-0.078621,-0.062698,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.64605,-0.078727,-0.069228,0,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.037747,-0.078749,-0.082999,0,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.19393,-0.078803,-0.075781,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.030383,-0.078836,-0.12384,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.41842,-0.07887,-0.039316,0,0
3,GO NEPHRON MORPHOGENESIS,0.025414,-0.078905,-0.13492,0,0
3,GO SEX DIFFERENTIATION,0.011047,-0.079119,-0.080037,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.49227,-0.079125,-0.11642,0,0
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.025414,-0.079132,-0.063193,0,0
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.068167,-0.079335,-0.15847,0,0
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.085627,-0.07943,-0.098366,0,0
3,GO HISTONE H2B UBIQUITINATION,0.080955,-0.079461,-0.091907,0,0
3,GO ATP BIOSYNTHETIC PROCESS,0.11841,-0.079549,-0.083392,0,0
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.33812,-0.079661,-0.068327,0,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.009256,-0.079736,-0.12037,0,0
3,GO RESPONSE TO CORTICOSTERONE,0.53742,-0.079801,-0.052546,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.188,-0.079906,-0.079522,0,0
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.11841,-0.079932,-0.13652,0,0
3,GO REGULATION OF COLLATERAL SPROUTING,0.95466,-0.080056,-0.011602,0,0
3,GO REGULATION OF ERAD PATHWAY,0.063042,-0.080101,-0.062021,0,0
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.53167,-0.080185,-0.039844,0,0
3,GO GOLGI RIBBON FORMATION,0.080955,-0.080192,-0.13419,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.16559,-0.080256,-0.10911,0,0
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.015203,-0.080377,-0.071168,0,0
3,GO POSITIVE REGULATION OF TRANSPORT,0.0053338,-0.08042,-0.077277,0,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.053746,-0.080427,-0.067508,0,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.70355,-0.080457,-0.050176,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.17374,-0.080484,-0.087852,0,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.0028141,-0.080671,-0.1002,0,0
3,GO RESPONSE TO NICOTINE,0.18508,-0.080679,-0.10242,0,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.021165,-0.080948,-0.075353,0,0
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.070855,-0.08095,-0.10771,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.4978,-0.080976,-0.068134,0,0
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.15264,-0.081055,-0.10756,0,0
3,GO LIPID METABOLIC PROCESS,0.05824,-0.081135,-0.067387,0,0
3,GO RESPONSE TO STEROID HORMONE,0.075049,-0.081174,-0.087825,0,0
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.22905,-0.081216,-0.069857,0,0
3,GO B CELL HOMEOSTASIS,0.24643,-0.081433,-0.081096,0,0
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.10096,-0.081472,-0.1229,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.27611,-0.081499,-0.10315,0,0
3,GO REGULATION OF VASCULAR PERMEABILITY,0.15517,-0.08151,-0.095332,0,0
3,GO PODOSOME ASSEMBLY,0.26098,-0.081526,-0.1146,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.099158,-0.081665,-0.1036,0,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.44924,-0.081752,-0.024951,0,0
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.98953,-0.08209,-0.072906,0,0
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.188,-0.082365,-0.099116,0,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.13814,-0.082412,-0.12028,0,0
3,GO GERMINAL CENTER FORMATION,0.11039,-0.082418,-0.21271,0,0
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.44924,-0.082527,-0.042343,0,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.027188,-0.082792,-0.085107,0,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.29992,-0.082916,-0.076586,0,0
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.16294,-0.082949,-0.065038,0,0
3,GO ANIMAL ORGAN FORMATION,0.061812,-0.08319,-0.12136,0,0
3,GO RESPONSE TO POTASSIUM ION,0.48131,-0.083199,-0.059134,0,0
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.20309,-0.083661,-0.050408,0,0
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.11039,-0.083758,-0.076323,0,0
3,GO CARNITINE SHUTTLE,0.98953,-0.084,0.031336,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.23937,-0.084056,-0.10497,0,0
3,GO CELLULAR RESPONSE TO FATTY ACID,0.25001,-0.084056,-0.081484,0,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.77618,-0.084097,-0.0043927,0,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.65234,-0.084164,-0.02348,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.027803,-0.084293,-0.09182,0,0
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.85768,-0.084431,-0.024869,0,0
3,GO RESPONSE TO ALKALOID,0.063042,-0.084735,-0.083524,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.26471,-0.084735,-0.069893,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.32506,-0.084743,-0.078062,0,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.18219,-0.085001,-0.11008,0,0
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.063042,-0.085074,-0.11086,0,0
3,GO NEURON PROJECTION REGENERATION,0.23937,-0.085397,-0.06964,0,0
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.17653,-0.085406,-0.096762,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.090515,-0.08545,-0.08693,0,0
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.18508,-0.085496,-0.070095,0,0
3,GO RESPONSE TO ANTIBIOTIC,0.070855,-0.085625,-0.095728,0,0
3,GO RESPONSE TO METAL ION,0.05161,-0.08582,-0.078152,0,0
3,GO THYMUS DEVELOPMENT,0.21579,-0.085855,-0.065936,0,0
3,GO REGULATION OF GLUCOSE IMPORT,0.093897,-0.085944,-0.079866,0,0
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.11039,-0.086164,-0.069397,0,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.11039,-0.086166,-0.13256,0,0
3,GO INTERLEUKIN 17 PRODUCTION,0.26471,-0.086188,-0.086141,0,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0094949,-0.086325,-0.095408,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.15773,-0.086341,-0.094935,0,0
3,GO RESPONSE TO GROWTH HORMONE,0.30815,-0.086562,-0.080141,0,0
3,GO TISSUE REGENERATION,0.12049,-0.08681,-0.10762,0,0
3,GO INOSITOL METABOLIC PROCESS,0.068167,-0.086994,-0.1042,0,0
3,GO RESPONSE TO LIPID,0.068167,-0.087034,-0.076981,0,0
3,GO MEMBRANE DOCKING,0.0073363,-0.087122,-0.087706,0,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.11235,-0.087247,-0.083196,0,0
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.064293,-0.087477,-0.15411,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.10465,-0.087507,-0.14978,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.70355,-0.087581,-0.01482,0,0
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.21256,-0.08764,-0.097039,0,0
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.32938,-0.087814,-0.13053,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.2,-0.087926,-0.059513,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0037331,-0.08809,-0.099837,0,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.19695,-0.088184,-0.05926,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.14285,-0.088246,-0.1753,0,0
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.21905,-0.088588,-0.086455,0,0
3,GO POSITIVE REGULATION OF MITOPHAGY,0.16294,-0.088655,-0.096837,0,0
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.30402,-0.088678,-0.056621,0,0
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.043763,-0.088875,-0.10538,0,0
3,GO TRANSFERRIN TRANSPORT,0.064293,-0.088908,-0.1027,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.066855,-0.089014,-0.10395,0,0
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.097379,-0.089107,-0.18054,0,0
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.13355,-0.089212,-0.069993,0,0
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.81668,-0.08953,-0.020955,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.055956,-0.089568,-0.14038,0,0
3,GO CELL JUNCTION ASSEMBLY,0.033894,-0.089719,-0.10079,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.22905,-0.089725,-0.076947,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.44924,-0.090061,-0.049554,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.46512,-0.090256,-0.088024,0,0
3,GO ASTROCYTE ACTIVATION,0.059411,-0.090505,-0.15987,0,0
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.22235,-0.09056,-0.09773,0,0
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.0094949,-0.090688,-0.12733,0,0
3,GO REGULATION OF CIRCADIAN RHYTHM,0.0062634,-0.090699,-0.084632,0,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.2,-0.090781,-0.069704,0,0
3,GO NEGATIVE REGULATION OF SECRETION,0.031059,-0.090997,-0.074382,0,0
3,GO GOLGI LOCALIZATION,0.29184,-0.091096,-0.056653,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.38408,-0.091182,-0.11137,0,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.072231,-0.091195,-0.11632,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.090515,-0.091218,-0.12321,0,0
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0695,-0.091296,-0.11363,0,0
3,GO CELLULAR PIGMENTATION,0.0032441,-0.091369,-0.13615,0,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.00054072,-0.091464,-0.10275,0,0
3,GO NEGATIVE REGULATION OF GROWTH,0.025414,-0.091499,-0.080451,0,0
3,GO CELLULAR RESPONSE TO LIPID,0.099158,-0.091532,-0.077984,0,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.016734,-0.091532,-0.11105,0,0
3,GO REGULATION OF MAPK CASCADE,0.05161,-0.091538,-0.08029,0,0
3,GO GLUCOSE IMPORT,0.090515,-0.091548,-0.066186,0,0
3,GO VITAMIN D METABOLIC PROCESS,0.28785,-0.0916,-0.087379,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.27999,-0.091885,-0.084062,0,0
3,GO MACROPHAGE PROLIFERATION,0.33812,-0.091977,-0.13397,0,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0011199,-0.092034,-0.12303,0,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.29586,-0.092187,-0.14926,0,0
3,GO SECONDARY PALATE DEVELOPMENT,0.13814,-0.092249,-0.13968,0,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.47049,-0.092274,-0.050985,0,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.073629,-0.092371,-0.067996,0,0
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.066855,-0.092557,-0.18622,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.44402,-0.092615,-0.048731,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.12689,-0.092627,-0.12035,0,0
3,GO ORGAN INDUCTION,0.090515,-0.092809,-0.1289,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.010773,-0.092821,-0.089748,0,0
3,GO MITOCHONDRIAL FUSION,0.24288,-0.093065,-0.053896,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.25729,-0.093303,-0.062569,0,0
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.057089,-0.093336,-0.083795,0,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.12473,-0.093605,-0.085646,0,0
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.25001,-0.09375,-0.070137,0,0
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.4598,-0.093886,-0.072624,0,0
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.054842,-0.093985,-0.12474,0,0
3,GO TRACHEA MORPHOGENESIS,0.31653,-0.094076,-0.092515,0,0
3,GO DETECTION OF ABIOTIC STIMULUS,0.040234,-0.094137,-0.07028,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0031536,-0.094306,-0.11137,0,0
3,GO CEREBELLAR CORTEX FORMATION,0.39858,-0.094338,-0.065511,0,0
3,GO NEURAL RETINA DEVELOPMENT,0.4598,-0.094421,-0.034925,0,0
3,GO REGULATION OF PODOSOME ASSEMBLY,0.16294,-0.094489,-0.17814,0,0
3,GO REGULATION OF PROTEIN DEACETYLATION,0.22235,-0.094497,-0.065125,0,0
3,GO RESPONSE TO INACTIVITY,0.057089,-0.094531,-0.13226,0,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.10654,-0.094556,-0.061817,0,0
3,GO T CELL EXTRAVASATION,0.16032,-0.094581,-0.23119,0,0
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.25729,-0.094584,-0.062044,0,0
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.44924,-0.09462,-0.077814,0,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.29586,-0.094676,-0.07968,0,0
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.066855,-0.094678,-0.11499,0,0
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.20937,-0.094736,-0.14855,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.20309,-0.095,-0.14973,0,0
3,GO DEPHOSPHORYLATION,0.00037661,-0.095031,-0.093313,0,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.54903,-0.095058,-0.079478,0,0
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.38408,-0.095141,-0.095504,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.16032,-0.095184,-0.10131,0,0
3,GO STEROID METABOLIC PROCESS,0.049546,-0.095191,-0.09795,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.031748,-0.095246,-0.16132,0,0
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.065563,-0.095266,-0.15783,0,0
3,GO PATTERN SPECIFICATION PROCESS,0.030383,-0.095316,-0.081791,0,0
3,GO TRANSMISSION OF NERVE IMPULSE,0.17099,-0.095526,-0.079421,0,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.0056288,-0.095618,-0.10223,0,0
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.021165,-0.095633,-0.10852,0,0
3,GO HISTONE H4 DEACETYLATION,0.12259,-0.095672,-0.11659,0,0
3,GO GLUTAMATE METABOLIC PROCESS,0.12473,-0.095869,-0.098665,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.049546,-0.095925,-0.1924,0,0
3,GO AMINE TRANSPORT,0.23245,-0.096044,-0.034777,0,0
3,GO GENITALIA DEVELOPMENT,0.057089,-0.096223,-0.11216,0,0
3,GO CELLULAR EXTRAVASATION,0.10096,-0.09631,-0.079556,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.1313,-0.096392,-0.080015,0,0
3,GO PHAGOSOME MATURATION,0.068167,-0.096487,-0.10316,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.1028,-0.096559,-0.11828,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.099158,-0.096666,-0.16105,0,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.092194,-0.096694,-0.13743,0,0
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.50337,-0.09674,-0.087203,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,0.34702,-0.096773,-0.077536,0,0
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.084046,-0.096798,-0.10293,0,0
3,GO MEMBRANE FUSION,0.059411,-0.096959,-0.080456,0,0
3,GO OLIGODENDROCYTE DEVELOPMENT,0.080955,-0.097,-0.10486,0,0
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0039469,-0.097004,-0.10676,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.016734,-0.097052,-0.14361,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.52594,-0.097561,-0.048056,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00012964,-0.09769,-0.11114,0,0
3,GO RENAL WATER HOMEOSTASIS,0.088862,-0.097948,-0.099947,0,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.30815,-0.097988,-0.055967,0,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.16294,-0.09801,-0.10505,0,0
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.16294,-0.09806,-0.074078,0,0
3,GO HISTONE H3 DEACETYLATION,0.18219,-0.098169,-0.059008,0,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.061812,-0.098186,-0.10697,0,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.061812,-0.098392,-0.14317,0,0
3,GO AUTOPHAGY OF NUCLEUS,0.1028,-0.09864,-0.12055,0,0
3,GO MESODERM MORPHOGENESIS,0.1028,-0.098651,-0.11189,0,0
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.24288,-0.098717,-0.13181,0,0
3,GO NEUTROPHIL HOMEOSTASIS,0.32077,-0.098881,-0.16471,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.10096,-0.099038,-0.10868,0,0
3,GO RESPONSE TO MINERALOCORTICOID,0.11841,-0.099492,-0.092838,0,0
3,GO SENSORY ORGAN DEVELOPMENT,0.0054795,-0.099861,-0.09765,0,0
3,GO RESPONSE TO TESTOSTERONE,0.3746,-0.099893,-0.063626,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.46512,-0.10023,-0.061229,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.060602,-0.10041,-0.11929,0,0
3,GO ARTERY MORPHOGENESIS,0.011904,-0.10049,-0.14214,0,0
3,GO CARDIAC CELL DEVELOPMENT,0.070855,-0.10051,-0.091751,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.29184,-0.10053,-0.038156,0,0
3,GO CENTRIOLE CENTRIOLE COHESION,0.30815,-0.10054,-0.038067,0,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.099158,-0.10065,-0.092796,0,0
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0017123,-0.10067,-0.13917,0,0
3,GO ENDOSOMAL TRANSPORT,1.5816e-05,-0.10079,-0.12898,0,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.0021062,-0.10083,-0.14676,0,0
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.17374,-0.10086,-0.13222,0,0
3,GO HISTONE H3 K9 ACETYLATION,0.060602,-0.10097,-0.10408,0,0
3,GO LEUKOTRIENE METABOLIC PROCESS,0.14285,-0.10128,-0.10904,0,0
3,GO LUNG MORPHOGENESIS,0.025994,-0.10152,-0.17475,0,0
3,GO DETECTION OF LIGHT STIMULUS,0.16828,-0.10155,0.024053,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.014138,-0.10173,-0.1058,0,0
3,GO REGULATION OF JUN KINASE ACTIVITY,0.017969,-0.10175,-0.099588,0,0
3,GO ECTODERM DEVELOPMENT,0.015203,-0.10208,-0.10824,0,0
3,GO TUBE FORMATION,0.0053338,-0.10232,-0.11294,0,0
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.05824,-0.10237,-0.1338,0,0
3,GO MRNA TRANSCRIPTION,0.2,-0.10239,-0.082827,0,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.077957,-0.1024,-0.16175,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.17653,-0.1026,-0.087116,0,0
3,GO CRANIAL NERVE DEVELOPMENT,0.079444,-0.10272,-0.13581,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.12689,-0.10282,-0.13848,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.11039,-0.10298,-0.11997,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.54321,-0.10302,-0.050802,0,0
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.12259,-0.10315,-0.071554,0,0
3,GO RESPONSE TO STEROL,0.25001,-0.10319,-0.06284,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,3.3132e-05,-0.10334,-0.13251,0,0
3,GO AMINO SUGAR CATABOLIC PROCESS,0.12908,-0.10337,-0.096618,0,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.036948,-0.10338,-0.12137,0,0
3,GO ANDROGEN METABOLIC PROCESS,0.22235,-0.10338,-0.083534,0,0
3,GO APPENDAGE DEVELOPMENT,0.029068,-0.10352,-0.12221,0,0
3,GO REGULATION OF INSULIN SECRETION,0.11434,-0.10358,-0.064219,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.16032,-0.1037,-0.070162,0,0
3,GO MAST CELL MIGRATION,0.11841,-0.1038,-0.22667,0,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.001872,-0.10382,-0.13853,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.075049,-0.10387,-0.12986,0,0
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.43367,-0.10394,-0.089635,0,0
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.13355,-0.10399,-0.11072,0,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.03939,-0.10422,-0.16834,0,0
3,GO MALE SEX DIFFERENTIATION,0.0013872,-0.10436,-0.13802,0,0
3,GO COPULATION,0.099158,-0.10451,-0.10592,0,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.053746,-0.10453,-0.097235,0,0
3,GO VACUOLAR TRANSPORT,0.00065623,-0.10465,-0.12832,0,0
3,GO MITRAL VALVE DEVELOPMENT,0.27999,-0.10469,-0.11171,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.10096,-0.10473,-0.21687,0,0
3,GO OVULATION,0.072231,-0.10476,-0.14744,0,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.21905,-0.105,-0.08679,0,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0695,-0.10502,-0.087609,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.087232,-0.10505,-0.14323,0,0
3,GO KINETOCHORE ASSEMBLY,0.32506,-0.10537,-0.08621,0,0
3,GO P38MAPK CASCADE,0.095625,-0.10568,-0.11032,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.12259,-0.10591,-0.13173,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.14769,-0.10605,-0.11177,0,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.11841,-0.1063,-0.10681,0,0
3,GO MUSCLE CELL DEVELOPMENT,0.027188,-0.10634,-0.096793,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.26098,-0.10637,-0.068419,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.42347,-0.10672,-0.062838,0,0
3,GO REGIONALIZATION,0.033894,-0.10673,-0.085016,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.69061,-0.10673,-0.032999,0,0
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.20309,-0.10711,-0.19065,0,0
3,GO INCLUSION BODY ASSEMBLY,0.49227,-0.10722,-0.036569,0,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0034322,-0.10754,-0.15457,0,0
3,GO RELAXATION OF CARDIAC MUSCLE,0.31232,-0.10758,-0.10708,0,0
3,GO EAR DEVELOPMENT,0.0031536,-0.1077,-0.13942,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.059411,-0.10782,-0.12112,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.022165,-0.10799,-0.17006,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.30815,-0.10817,-0.15756,0,0
3,GO CALCINEURIN MEDIATED SIGNALING,0.076492,-0.10817,-0.073999,0,0
3,GO NEGATIVE REGULATION OF CELL SIZE,0.26847,-0.10821,-0.056631,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.092194,-0.10846,-0.10012,0,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.05161,-0.10857,-0.10003,0,0
3,GO SPERM MOTILITY,0.0010859,-0.10861,-0.1242,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.038561,-0.10863,-0.10341,0,0
3,GO MECHANORECEPTOR DIFFERENTIATION,0.022165,-0.10865,-0.16812,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.065563,-0.10876,-0.15407,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.19095,-0.10892,-0.098432,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.188,-0.10894,-0.089171,0,0
3,GO EMBRYONIC MORPHOGENESIS,0.00044439,-0.10896,-0.13812,0,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.049546,-0.10898,-0.15995,0,0
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.076492,-0.10915,-0.10817,0,0
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.065563,-0.10916,-0.13009,0,0
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.001228,-0.10943,-0.10161,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.029719,-0.10954,-0.08334,0,0
3,GO REGULATION OF CELL MATURATION,0.007729,-0.10966,-0.11939,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.34702,-0.10975,-0.083105,0,0
3,GO RESPONSE TO ZINC ION,0.15773,-0.10996,-0.13339,0,0
3,GO SEXUAL REPRODUCTION,2.5308e-05,-0.10996,-0.10176,0,0
3,GO UV DAMAGE EXCISION REPAIR,0.26471,-0.11013,-0.055491,0,0
3,GO GALACTOSE METABOLIC PROCESS,0.30815,-0.1103,-0.10569,0,0
3,GO RESPONSE TO CORTICOSTEROID,0.12473,-0.11086,-0.089485,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.18508,-0.11104,-0.10672,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.072231,-0.11109,-0.14573,0,0
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.010506,-0.11115,-0.21788,0,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.035393,-0.11126,-0.093231,0,0
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.066855,-0.11157,-0.09592,0,0
3,GO REPLACEMENT OSSIFICATION,0.054842,-0.11165,-0.14868,0,0
3,GO BONE MATURATION,0.10465,-0.11189,-0.11515,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.092194,-0.1125,-0.071696,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.099158,-0.11254,-0.12817,0,0
3,GO FUCOSYLATION,0.17374,-0.113,-0.098459,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.057089,-0.11307,-0.12814,0,0
3,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.14048,-0.11327,-0.072863,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.02166,-0.11331,-0.11484,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.049546,-0.11337,-0.11143,0,0
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0021689,-0.11339,-0.11311,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.19695,-0.11359,-0.1535,0,0
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.13355,-0.1136,-0.2992,0,0
3,GO NEURON CELL CELL ADHESION,0.30815,-0.11361,-0.14487,0,0
3,GO SPHINGOID METABOLIC PROCESS,0.22905,-0.11366,-0.089347,0,0
3,GO ACTIN FILAMENT NETWORK FORMATION,0.27999,-0.11388,-0.13842,0,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.29586,-0.11395,-0.14621,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.50896,-0.11419,-0.03391,0,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.064293,-0.11421,-0.092059,0,0
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00069957,-0.11424,-0.1806,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.81668,-0.1144,0.010012,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.11039,-0.11465,-0.099755,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0014299,-0.1148,-0.13539,0,0
3,GO VIRAL LATENCY,0.035393,-0.11506,-0.11359,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.02068,-0.11517,-0.20571,0,0
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.064293,-0.11533,-0.083904,0,0
3,GO NUCLEOTIDE TRANSPORT,0.1313,-0.11536,-0.06816,0,0
3,GO MEIOTIC CELL CYCLE,1.1493e-05,-0.11536,-0.13571,0,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.17099,-0.11559,-0.14714,0,0
3,GO RESPONSE TO VITAMIN D,0.27611,-0.11602,-0.058823,0,0
3,GO REPRODUCTION,1.349e-05,-0.11605,-0.11923,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.2839,-0.11622,-0.12501,0,0
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.077957,-0.11629,-0.1213,0,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.26471,-0.11631,-0.075292,0,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.068167,-0.11642,-0.08511,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.097379,-0.11665,-0.14668,0,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.001662,-0.11672,-0.16687,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.13583,-0.11697,-0.28446,0,0
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.14769,-0.11725,-0.12034,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.95466,-0.11734,0.017295,0,0
3,GO GERM CELL DEVELOPMENT,0.00019753,-0.11758,-0.12079,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.23589,-0.1177,-0.11718,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.040234,-0.11771,-0.10305,0,0
3,GO RESPONSE TO FOOD,0.010506,-0.11776,-0.13294,0,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.48678,-0.11788,-0.10558,0,0
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.077957,-0.11832,-0.17505,0,0
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.14769,-0.11851,-0.15191,0,0
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.21905,-0.11851,-0.12884,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.050569,-0.11853,-0.17286,0,0
3,GO INTERLEUKIN 4 PRODUCTION,0.0050528,-0.11883,-0.18191,0,0
3,GO MULTICELLULAR ORGANISM AGING,0.0064317,-0.11886,-0.14231,0,0
3,GO EMBRYO IMPLANTATION,0.19095,-0.11894,-0.11369,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.19695,-0.11897,-0.069075,0,0
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.060602,-0.11902,-0.14856,0,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.014841,-0.1191,-0.12599,0,0
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.033166,-0.11933,-0.17538,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.085627,-0.11935,-0.09228,0,0
3,GO STEROL IMPORT,0.30402,-0.11938,-0.058586,0,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.0049174,-0.11946,-0.14468,0,0
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0079323,-0.11962,-0.14434,0,0
3,GO ERYTHROCYTE MATURATION,0.05824,-0.11964,-0.11855,0,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.02068,-0.11975,-0.11686,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.041093,-0.12004,-0.099859,0,0
3,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.33373,-0.12007,-0.055147,0,0
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.28785,-0.12028,-0.16274,0,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.38408,-0.12034,-0.091617,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.14769,-0.12131,-0.19851,0,0
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.097379,-0.12177,-0.085118,0,0
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.38888,-0.12183,-0.12359,0,0
3,GO STEM CELL PROLIFERATION,0.0046564,-0.12184,-0.13878,0,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.049546,-0.12184,-0.11873,0,0
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0007696,-0.12187,-0.13489,0,0
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.188,-0.1222,-0.12997,0,0
3,GO PEPTIDE CROSS LINKING,0.065563,-0.12231,-0.18088,0,0
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.39858,-0.12237,-0.083199,0,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.2,-0.12249,-0.16106,0,0
3,GO LACTATE METABOLIC PROCESS,0.14285,-0.12257,-0.10014,0,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.12259,-0.12265,-0.093254,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.1028,-0.12321,-0.12123,0,0
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.079444,-0.12408,-0.12834,0,0
3,GO KIDNEY MORPHOGENESIS,0.0045306,-0.12427,-0.15462,0,0
3,GO PROTEIN DESTABILIZATION,0.0047853,-0.1245,-0.11798,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.053746,-0.12463,-0.17173,0,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.053746,-0.12499,-0.11435,0,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.78962,-0.12506,-0.028338,0,0
3,GO NUCLEAR BODY ORGANIZATION,0.42347,-0.12522,-0.032614,0,0
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.11841,-0.126,-0.13108,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.13814,-0.12602,-0.16372,0,0
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.050569,-0.12603,-0.1935,0,0
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0069616,-0.12604,-0.12417,0,0
3,GO WHITE FAT CELL DIFFERENTIATION,0.026586,-0.12605,-0.13645,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.03939,-0.12609,-0.18606,0,0
3,GO MULTICELLULAR ORGANISM REPRODUCTION,5.8301e-05,-0.12616,-0.10302,0,0
3,GO ACTIN CROSSLINK FORMATION,0.4598,-0.12617,-0.0095117,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.068167,-0.12632,-0.13451,0,0
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.00057693,-0.12635,-0.14434,0,0
3,GO RESPONSE TO FLUID SHEAR STRESS,0.068167,-0.12636,-0.14695,0,0
3,GO PANCREATIC JUICE SECRETION,0.12473,-0.12641,-0.087599,0,0
3,GO REGULATION OF PROTEIN SUMOYLATION,0.38888,-0.12688,-0.042439,0,0
3,GO REGULATION OF OSSIFICATION,0.05161,-0.1269,-0.11507,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.0090226,-0.12698,-0.11245,0,0
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.099158,-0.12713,-0.11111,0,0
3,GO T HELPER 2 CELL DIFFERENTIATION,0.26847,-0.12718,-0.20713,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.02068,-0.12737,-0.2265,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.00019753,-0.12748,-0.15541,0,0
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011904,-0.12749,-0.13521,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.053746,-0.12771,-0.13755,0,0
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.084046,-0.12818,-0.10113,0,0
3,GO DIENCEPHALON DEVELOPMENT,0.0081404,-0.12864,-0.17658,0,0
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,1.349e-05,-0.12874,-0.12438,0,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.36064,-0.12881,-0.091609,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.060602,-0.1291,-0.12526,0,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.046579,-0.12913,-0.22886,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.25001,-0.12913,-0.13492,0,0
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.046579,-0.1294,-0.096962,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.084046,-0.12952,-0.10184,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.082489,-0.1301,-0.1467,0,0
3,GO AMYLOID BETA METABOLIC PROCESS,0.11636,-0.13018,-0.083576,0,0
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.1028,-0.13055,-0.14676,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.14526,-0.13075,-0.17861,0,0
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0028957,-0.13079,-0.13731,0,0
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.19095,-0.1312,-0.11175,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.030383,-0.13162,-0.17976,0,0
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.057089,-0.13174,-0.17963,0,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.27999,-0.13175,-0.079716,0,0
3,GO ER NUCLEUS SIGNALING PATHWAY,0.022165,-0.13213,-0.14083,0,0
3,GO NEGATIVE REGULATION OF COAGULATION,0.19393,-0.13217,-0.16476,0,0
3,GO REGULATION OF CHLORIDE TRANSPORT,0.24288,-0.13226,-0.12687,0,0
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.052669,-0.13279,-0.10835,0,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.18508,-0.13283,-0.071515,0,0
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.087232,-0.13297,-0.26141,0,0
3,GO N GLYCAN PROCESSING,0.063042,-0.13327,-0.20635,0,0
3,GO GASTRIC ACID SECRETION,0.21256,-0.13338,-0.091894,0,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.011612,-0.13357,-0.13446,0,0
3,GO RESPONSE TO UV C,0.023741,-0.13366,-0.14422,0,0
3,GO ETHANOL CATABOLIC PROCESS,0.34702,-0.13368,-0.098197,0,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.11841,-0.13368,-0.1184,0,0
3,GO ARACHIDONIC ACID SECRETION,0.097379,-0.13378,-0.10887,0,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0024367,-0.13379,-0.17586,0,0
3,GO CATECHOLAMINE METABOLIC PROCESS,0.20621,-0.13401,-0.065992,0,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.11235,-0.13404,-0.089061,0,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.3746,-0.13427,-0.064095,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.088862,-0.13517,-0.12794,0,0
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.59059,-0.13543,-0.068249,0,0
3,GO CILIUM MOVEMENT,0.00011241,-0.13545,-0.15453,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.23589,-0.13598,-0.095176,0,0
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.009256,-0.13601,-0.11739,0,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.60883,-0.13612,-0.036371,0,0
3,GO RESPONSE TO ESTRADIOL,0.014486,-0.13638,-0.11169,0,0
3,GO EAR MORPHOGENESIS,0.00059588,-0.13652,-0.1629,0,0
3,GO CELLULAR RESPONSE TO STEROL,0.34256,-0.1366,-0.057806,0,0
3,GO RESPONSE TO INSECTICIDE,0.52025,-0.13684,-0.045413,0,0
3,GO PLASMA MEMBRANE FUSION,0.16828,-0.13697,-0.12144,0,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.15773,-0.13703,-0.19801,0,0
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.18508,-0.13707,-0.10473,0,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.17374,-0.13717,-0.1586,0,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.020205,-0.13723,-0.13316,0,0
3,GO DEVELOPMENTAL INDUCTION,0.027188,-0.13771,-0.15254,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.98953,-0.13772,0.042634,0,0
3,GO NEURONAL ACTION POTENTIAL,0.036948,-0.13786,-0.20975,0,0
3,GO APPENDAGE MORPHOGENESIS,0.040234,-0.13826,-0.1358,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.35607,-0.13834,-0.09294,0,0
3,GO RESPONSE TO HYDROXYUREA,0.047551,-0.13871,-0.14492,0,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.19695,-0.13938,-0.14743,0,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.018836,-0.13939,-0.16393,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.043763,-0.13943,-0.091912,0,0
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.34256,-0.13957,-0.062895,0,0
3,GO SENSORY ORGAN MORPHOGENESIS,2.5308e-05,-0.1398,-0.16499,0,0
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.061812,-0.14006,-0.13596,0,0
3,GO EPITHELIAL TUBE MORPHOGENESIS,1.0184e-05,-0.14014,-0.18263,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.077957,-0.14046,-0.20052,0,0
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.16294,-0.14048,-0.077058,0,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,2.9532e-05,-0.14055,-0.16047,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.077957,-0.14078,-0.11753,0,0
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.087232,-0.14087,-0.099143,0,0
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.099158,-0.14101,-0.15112,0,0
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.079444,-0.14102,-0.12027,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.092194,-0.14118,-0.12312,0,0
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.093897,-0.14148,-0.14801,0,0
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.00092958,-0.14174,-0.12992,0,0
3,GO T HELPER 1 CELL DIFFERENTIATION,0.11039,-0.14184,-0.25406,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.22235,-0.14184,-0.10196,0,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.23245,-0.1419,-0.14294,0,0
3,GO GAMETE GENERATION,7.6603e-06,-0.14201,-0.12081,0,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.12473,-0.14262,-0.034957,0,0
3,GO STEROID CATABOLIC PROCESS,0.25363,-0.14269,-0.093116,0,0
3,GO V D J RECOMBINATION,0.0099891,-0.14309,-0.19923,0,0
3,GO INNER EAR MORPHOGENESIS,0.0016129,-0.14314,-0.16408,0,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.012508,-0.14322,-0.16322,0,0
3,GO PURINE NUCLEOTIDE TRANSPORT,0.12259,-0.1433,-0.080648,0,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.088862,-0.14355,-0.15244,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0017641,-0.14373,-0.15211,0,0
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.076492,-0.14432,-0.16824,0,0
3,GO RENAL FILTRATION,0.12259,-0.14524,-0.16163,0,0
3,GO FAT CELL PROLIFERATION,0.099158,-0.14535,-0.13517,0,0
3,GO NOTCH SIGNALING PATHWAY,0.00040247,-0.14566,-0.16607,0,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.017549,-0.14571,-0.14396,0,0
3,GO CARNITINE METABOLIC PROCESS,0.31232,-0.14588,-0.076261,0,0
3,GO MYOTUBE CELL DEVELOPMENT,0.033894,-0.14607,-0.1366,0,0
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.14285,-0.14614,-0.1366,0,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.29184,-0.14619,-0.099609,0,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.055956,-0.14652,-0.18561,0,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.87144,-0.14725,0.0012881,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.060602,-0.14749,-0.16961,0,0
3,GO EATING BEHAVIOR,0.015203,-0.1475,-0.13187,0,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.066855,-0.14849,-0.22385,0,0
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.068167,-0.14855,-0.14665,0,0
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.060602,-0.14863,-0.09799,0,0
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.10845,-0.14863,-0.13022,0,0
3,GO LINOLEIC ACID METABOLIC PROCESS,0.073629,-0.14891,-0.17717,0,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.026586,-0.14949,-0.14702,0,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.063042,-0.15011,-0.19456,0,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.021165,-0.15017,-0.12832,0,0
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.1028,-0.15083,-0.12579,0,0
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.02268,-0.15088,-0.15799,0,0
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.055956,-0.15103,-0.16964,0,0
3,GO EPITHELIAL TUBE FORMATION,2.2524e-05,-0.15111,-0.17864,0,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.055956,-0.15147,-0.199,0,0
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,2.1702e-06,-0.15163,-0.14766,0,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.0085714,-0.15167,-0.1809,0,0
3,GO HORMONE METABOLIC PROCESS,0.057089,-0.15199,-0.11621,0,0
3,GO MALE GAMETE GENERATION,6.2786e-05,-0.15206,-0.11871,0,0
3,GO DISACCHARIDE METABOLIC PROCESS,0.0695,-0.15236,-0.16296,0,0
3,GO SPERMATID DIFFERENTIATION,0.00038934,-0.15284,-0.14413,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.12259,-0.1529,-0.1255,0,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.21905,-0.15303,-0.14766,0,0
3,GO DETERMINATION OF ADULT LIFESPAN,0.05824,-0.15348,-0.12845,0,0
3,GO CORTICOSTEROID HORMONE SECRETION,0.47049,-0.15397,-0.067465,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.02843,-0.1542,-0.13458,0,0
3,GO EPITHELIAL CELL FATE COMMITMENT,0.18219,-0.15469,-0.14201,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.1028,-0.15473,-0.21282,0,0
3,GO PROTEIN K48 LINKED UBIQUITINATION,9.7346e-05,-0.15501,-0.15735,0,0
3,GO AMYLOID FIBRIL FORMATION,0.21579,-0.15512,-0.1366,0,0
3,GO MEMBRANE RAFT ASSEMBLY,0.33812,-0.15612,-0.23734,0,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.0047853,-0.15651,-0.16465,0,0
3,GO TELOMERE CAPPING,0.0022332,-0.15682,-0.12925,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.00081984,-0.15691,-0.15467,0,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.001191,-0.15743,-0.16186,0,0
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.2839,-0.15763,-0.10098,0,0
3,GO SEX DETERMINATION,0.00353,-0.15844,-0.20516,0,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.00010845,-0.15924,-0.18482,0,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,7.9801e-06,-0.15944,-0.21772,0,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.2839,-0.15953,-0.12587,0,0
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.11841,-0.15953,-0.17202,0,0
3,GO BONE CELL DEVELOPMENT,0.0023671,-0.16065,-0.17857,0,0
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.00041602,-0.16147,-0.19522,0,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.46512,-0.16165,-0.067966,0,0
3,GO ZINC ION HOMEOSTASIS,0.10465,-0.16229,-0.18049,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.029719,-0.16247,-0.13272,0,0
3,GO POSITIVE REGULATION OF NEURON DEATH,0.0027346,-0.16262,-0.15415,0,0
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.16559,-0.16268,-0.1024,0,0
3,GO DEFINITIVE HEMOPOIESIS,0.03939,-0.1634,-0.15398,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.27611,-0.16381,-0.11286,0,0
3,GO REGULATION OF CILIUM MOVEMENT,0.0064317,-0.16395,-0.16107,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.29586,-0.16436,-0.1133,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.001191,-0.16466,-0.13372,0,0
3,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.10465,-0.16491,-0.15258,0,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.25001,-0.16514,-0.10907,0,0
3,GO EYE MORPHOGENESIS,7.013e-05,-0.16569,-0.17496,0,0
3,GO EXIT FROM MITOSIS,0.0090226,-0.16575,-0.1236,0,0
3,GO CELL PROJECTION ASSEMBLY,1.2862e-06,-0.16653,-0.16284,0,0
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.14769,-0.16653,-0.12855,0,0
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.012203,-0.16663,-0.16986,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.024288,-0.16705,-0.16302,0,0
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.19695,-0.16711,-0.11362,0,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.15264,-0.16786,-0.13977,0,0
3,GO REGULATION OF HEAT GENERATION,0.20621,-0.16787,-0.13194,0,0
3,GO PLATELET DEGRANULATION,0.080955,-0.1682,-0.13985,0,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.011326,-0.16825,-0.16152,0,0
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.099158,-0.16878,-0.17013,0,0
3,GO MEMBRANE FISSION,0.004408,-0.1691,-0.18504,0,0
3,GO PIGMENT GRANULE LOCALIZATION,0.004408,-0.16931,-0.18212,0,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.036164,-0.16934,-0.17693,0,0
3,GO REGULATION OF CHROMATIN BINDING,0.001228,-0.16935,-0.20702,0,0
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.10654,-0.16943,-0.16766,0,0
3,GO DOPAMINE METABOLIC PROCESS,0.33812,-0.16994,-0.062507,0,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.00019753,-0.16996,-0.15634,0,0
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.14285,-0.1703,-0.229,0,0
3,GO RETINA HOMEOSTASIS,0.0056288,-0.17096,-0.076124,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.11039,-0.17106,-0.1093,0,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.00030804,-0.17166,-0.16536,0,0
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.26471,-0.17274,-0.095693,0,0
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,9.7801e-06,-0.17277,-0.18053,0,0
3,GO TRNA CATABOLIC PROCESS,0.17934,-0.17279,-0.1565,0,0
3,GO SPECIFICATION OF SYMMETRY,0.00016023,-0.17306,-0.13723,0,0
3,GO HEART FORMATION,0.011904,-0.17336,-0.1964,0,0
3,GO TYPE 2 IMMUNE RESPONSE,0.065563,-0.17398,-0.19538,0,0
3,GO REGULATION OF RUFFLE ASSEMBLY,0.00098941,-0.17406,-0.18987,0,0
3,GO MYELOID CELL DEVELOPMENT,7.2754e-05,-0.17412,-0.18177,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.10654,-0.1742,-0.2261,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.053746,-0.17485,-0.12009,0,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.43367,-0.17523,-0.18516,0,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.019739,-0.1753,-0.14461,0,0
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0046564,-0.17556,-0.15513,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.079444,-0.17573,-0.13814,0,0
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.055956,-0.1758,-0.20707,0,0
3,GO SYNAPTIC VESICLE BUDDING,0.026586,-0.1761,-0.16918,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.26098,-0.17636,-0.11512,0,0
3,GO RESPONSE TO DIETARY EXCESS,0.18508,-0.17643,-0.13628,0,0
3,GO EPOXYGENASE P450 PATHWAY,0.088862,-0.17744,-0.15891,0,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.0016129,-0.17752,-0.14455,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.061812,-0.17753,-0.18963,0,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00045924,-0.17761,-0.21407,0,0
3,GO ENDOTHELIUM DEVELOPMENT,8.1192e-05,-0.17872,-0.21786,0,0
3,GO SPERM AXONEME ASSEMBLY,0.0083534,-0.17897,-0.1885,0,0
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.025994,-0.1794,-0.17445,0,0
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.014486,-0.17954,-0.15859,0,0
3,GO MESONEPHROS DEVELOPMENT,0.00057693,-0.17993,-0.20408,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.001191,-0.18009,-0.1982,0,0
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0075304,-0.1806,-0.16909,0,0
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00040247,-0.18063,-0.22508,0,0
3,GO T CELL MEDIATED CYTOTOXICITY,0.14769,-0.18194,-0.22307,0,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,5.4121e-05,-0.18257,-0.18266,0,0
3,GO RENAL TUBULE DEVELOPMENT,0.00034072,-0.18266,-0.2037,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.057089,-0.1827,-0.20406,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.15773,-0.18272,-0.1608,0,0
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0022332,-0.18297,-0.20308,0,0
3,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.24643,-0.18338,-0.2362,0,0
3,GO GENITALIA MORPHOGENESIS,0.15517,-0.18359,-0.14887,0,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.16032,-0.18476,-0.054028,0,0
3,GO FUCOSE METABOLIC PROCESS,0.14769,-0.18492,-0.12716,0,0
3,GO NEURON FATE COMMITMENT,0.04854,-0.18495,-0.19235,0,0
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.088862,-0.18518,-0.15627,0,0
3,GO REGULATION OF TELOMERE CAPPING,0.0025817,-0.18534,-0.15251,0,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0019282,-0.18568,-0.15161,0,0
3,GO PHOTOTRANSDUCTION,0.0067808,-0.18616,-0.054528,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00095906,-0.18621,-0.19103,0,0
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.18508,-0.18625,-0.13324,0,0
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.001986,-0.18764,-0.1923,0,0
3,GO NEPHRON DEVELOPMENT,7.547e-05,-0.18798,-0.21986,0,0
3,GO BIOLOGICAL PHASE,0.12689,-0.18805,-0.26158,0,0
3,GO UTERUS DEVELOPMENT,0.084046,-0.1882,-0.1383,0,0
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.03939,-0.18888,-0.1468,0,0
3,GO REGULATION OF NEURON MATURATION,0.10654,-0.18944,-0.12183,0,0
3,GO DETECTION OF MECHANICAL STIMULUS,0.0015189,-0.18946,-0.21302,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.093897,-0.1896,-0.17212,0,0
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00067758,-0.18982,-0.23308,0,0
3,GO REGULATION OF VASCULOGENESIS,0.05824,-0.19122,-0.1669,0,0
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,5.6174e-05,-0.19163,-0.20347,0,0
3,GO HEART INDUCTION,0.20937,-0.19214,-0.11296,0,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0010859,-0.19228,-0.18192,0,0
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.061812,-0.19235,-0.18598,0,0
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.05824,-0.19305,-0.17514,0,0
3,GO REPLICATIVE SENESCENCE,0.079444,-0.19326,-0.16119,0,0
3,GO MICROTUBULE SEVERING,0.009256,-0.19376,-0.17703,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00018427,-0.19378,-0.17459,0,0
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.059411,-0.19424,-0.21057,0,0
3,GO FEMALE GENITALIA DEVELOPMENT,0.0090226,-0.19429,-0.18804,0,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.10465,-0.19472,-0.29266,0,0
3,GO METANEPHROS MORPHOGENESIS,0.041093,-0.195,-0.14215,0,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.12049,-0.19535,-0.22533,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0013457,-0.19584,-0.20568,0,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00059588,-0.19612,-0.19508,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION,1.0604e-05,-0.19616,-0.20687,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00038934,-0.19631,-0.18162,0,0
3,GO EPITHELIAL CELL DEVELOPMENT,7.9801e-06,-0.19666,-0.25107,0,0
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0695,-0.19732,-0.2046,0,0
3,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.66501,-0.19732,-0.042896,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0030654,-0.19774,-0.20959,0,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.066855,-0.19826,-0.18614,0,0
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.066855,-0.19891,-0.24449,0,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.19695,-0.19901,-0.08678,0,0
3,GO FORELIMB MORPHOGENESIS,0.0087944,-0.19925,-0.20257,0,0
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.05824,-0.19946,-0.17278,0,0
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0033369,-0.20002,-0.15607,0,0
3,GO EPITHELIAL CELL MATURATION,0.031059,-0.20011,-0.17049,0,0
3,GO STEROID HORMONE SECRETION,0.12049,-0.20078,-0.12935,0,0
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.00014935,-0.20109,-0.21327,0,0
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0042883,-0.20122,-0.23754,0,0
3,GO OTIC VESICLE DEVELOPMENT,0.11039,-0.20156,-0.16677,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0028957,-0.20236,-0.16818,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.001986,-0.20239,-0.25784,0,0
3,GO MITOCHONDRIAL DEPOLARIZATION,0.070855,-0.20262,-0.13809,0,0
3,GO MICROTUBULE BUNDLE FORMATION,7.547e-05,-0.20279,-0.21222,0,0
3,GO CELL FATE DETERMINATION,0.0017123,-0.20344,-0.24805,0,0
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.12049,-0.2045,-0.17564,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.28785,-0.20519,-0.11838,0,0
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.00021909,-0.20544,-0.17126,0,0
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0013054,-0.20564,-0.19676,0,0
3,GO MALE MEIOSIS I,0.015953,-0.20576,-0.24224,0,0
3,GO CILIUM ORGANIZATION,2.0833e-05,-0.20674,-0.1752,0,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0094949,-0.20694,-0.17838,0,0
3,GO RESPONSE TO IMMOBILIZATION STRESS,0.0064317,-0.20696,-0.23164,0,0
3,GO CLATHRIN COAT ASSEMBLY,0.030383,-0.20747,-0.19476,0,0
3,GO ETHANOL OXIDATION,0.061812,-0.20771,-0.2852,0,0
3,GO REGULATION OF CILIUM BEAT FREQUENCY,0.0021689,-0.20794,-0.22138,0,0
3,GO RDNA HETEROCHROMATIN ASSEMBLY,6.0504e-05,-0.2084,-0.24097,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.2839,-0.20853,-0.029546,0,0
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.099158,-0.20855,-0.23413,0,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.0073363,-0.20866,-0.1602,0,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.090515,-0.20868,-0.25098,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.15015,-0.20926,-0.11171,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.013798,-0.21084,-0.22068,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0036303,-0.21283,-0.22582,0,0
3,GO SEROTONIN SECRETION,0.043763,-0.21289,-0.15027,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.038561,-0.21342,-0.14778,0,0
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.00021167,-0.21379,-0.21506,0,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.00040247,-0.21395,-0.19076,0,0
3,GO INTERLEUKIN 13 PRODUCTION,0.050569,-0.21516,-0.19624,0,0
3,GO ACTIVATED T CELL PROLIFERATION,0.00030804,-0.21613,-0.21341,0,0
3,GO AMMONIUM TRANSPORT,0.019283,-0.21704,-0.24995,0,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,1.5201e-05,-0.21713,-0.21551,0,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.00052342,-0.21769,-0.25544,0,0
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.00030804,-0.21843,-0.25758,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.090515,-0.21866,-0.12544,0,0
3,GO ADHERENS JUNCTION ORGANIZATION,0.0087944,-0.2205,-0.16156,0,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.21905,-0.22055,-0.07101,0,0
3,GO BRONCHUS DEVELOPMENT,0.053746,-0.22059,-0.26161,0,0
3,GO NEGATIVE REGULATION OF CELL ADHESION,1.6455e-05,-0.22152,-0.23283,0,0
3,GO PARTURITION,0.0071468,-0.22169,-0.23068,0,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,6.4994e-06,-0.22232,-0.23399,0,0
3,GO SULFATION,0.13355,-0.22253,-0.13816,0,0
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.066855,-0.22319,-0.19358,0,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.00021909,-0.22372,-0.19856,0,0
3,GO DORSAL VENTRAL PATTERN FORMATION,0.00042998,-0.22436,-0.18971,0,0
3,GO NEGATIVE REGULATION OF CELL KILLING,0.10654,-0.2257,-0.28662,0,0
3,GO POSITIVE T CELL SELECTION,0.00010092,-0.22775,-0.22145,0,0
3,GO CELL MIGRATION IN HINDBRAIN,0.015203,-0.22808,-0.22882,0,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0010859,-0.229,-0.18549,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.030383,-0.2297,-0.17393,0,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0056288,-0.22988,-0.26626,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.043763,-0.22994,-0.21823,0,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0087944,-0.23096,-0.24323,0,0
3,GO RUFFLE ASSEMBLY,6.2367e-06,-0.2315,-0.22726,0,0
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00047456,-0.23243,-0.25882,0,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.16559,-0.23403,-0.11337,0,0
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,3.5759e-05,-0.23472,-0.25905,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.0057817,-0.23492,-0.1788,0,0
3,GO SOMATIC STEM CELL DIVISION,0.23245,-0.23531,-0.1394,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.055956,-0.23556,-0.19538,0,0
3,GO SKELETAL MUSCLE ADAPTATION,0.070855,-0.23652,-0.12128,0,0
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.0014738,-0.23778,-0.2126,0,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.019739,-0.23779,-0.2056,0,0
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.049546,-0.23784,-0.15027,0,0
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00054072,-0.23866,-0.26904,0,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.05161,-0.23907,-0.25798,0,0
3,GO ANIMAL ORGAN MATURATION,0.013798,-0.23958,-0.16851,0,0
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0012662,-0.24015,-0.29799,0,0
3,GO GLYCOSIDE METABOLIC PROCESS,0.14769,-0.24069,-0.26831,0,0
3,GO REGULATION OF SPINDLE ASSEMBLY,3.4421e-05,-0.24113,-0.24241,0,0
3,GO SEGMENT SPECIFICATION,0.0021689,-0.24187,-0.29924,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,7.013e-05,-0.24199,-0.24975,0,0
3,GO APICAL PROTEIN LOCALIZATION,0.00069957,-0.24235,-0.20808,0,0
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.050569,-0.24299,-0.22469,0,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0015653,-0.24326,-0.21592,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0075304,-0.24473,-0.21428,0,0
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.095625,-0.24545,-0.35379,0,0
3,GO MALE SEX DETERMINATION,0.00044439,-0.24548,-0.31738,0,0
3,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.057089,-0.24592,-0.27799,0,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,1.7118e-05,-0.24598,-0.24192,0,0
3,GO RESPONSE TO MUSCLE INACTIVITY,0.00013433,-0.24689,-0.32974,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.015203,-0.24716,-0.18099,0,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00074557,-0.24811,-0.28743,0,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.099158,-0.24835,-0.27367,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0041716,-0.24887,-0.26335,0,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,7.8282e-05,-0.25096,-0.23025,0,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.013798,-0.25174,-0.26194,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.053746,-0.25322,-0.33231,0,0
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.001662,-0.25408,-0.25085,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.0050528,-0.25422,-0.22724,0,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.00022676,-0.25485,-0.26336,0,0
3,GO PANCREAS DEVELOPMENT,6.2786e-05,-0.25757,-0.27149,0,0
3,GO INTERLEUKIN 5 PRODUCTION,0.034637,-0.25795,-0.18066,0,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0011199,-0.25935,-0.27495,0,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.0090226,-0.25943,-0.22538,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,1.1964e-05,-0.25987,-0.26892,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.12689,-0.26031,-0.16797,0,0
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.060602,-0.26063,-0.21762,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0014299,-0.26184,-0.2448,0,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.026586,-0.26333,-0.20368,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.010773,-0.26549,-0.16122,0,0
3,GO MYOFIBRIL ASSEMBLY,0.00024286,-0.26621,-0.20109,0,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.013798,-0.26634,-0.24562,0,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.013139,-0.26737,-0.23631,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.021165,-0.26845,-0.23547,0,0
3,GO VASCULAR WOUND HEALING,0.0036303,-0.26848,-0.27024,0,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.00017796,-0.26886,-0.20927,0,0
3,GO INTERLEUKIN 6 PRODUCTION,1.0779e-06,-0.26931,-0.26279,0,0
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,1.8521e-05,-0.26993,-0.2581,0,0
3,GO CELL JUNCTION MAINTENANCE,0.0014738,-0.27055,-0.23655,0,0
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.00012964,-0.27075,-0.25705,0,0
3,GO CENTROSOME SEPARATION,0.00052342,-0.27154,-0.262,0,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.00024286,-0.27266,-0.255,0,0
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.0015653,-0.2748,-0.33305,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0026572,-0.2771,-0.30802,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.041093,-0.28084,-0.20928,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.010506,-0.28258,-0.27334,0,0
3,GO NEURAL NUCLEUS DEVELOPMENT,0.0013054,-0.28302,-0.23091,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0028141,-0.28382,-0.20832,0,0
3,GO INTRACILIARY TRANSPORT,0.00034072,-0.28456,-0.25001,0,0
3,GO PRO B CELL DIFFERENTIATION,0.0040578,-0.28668,-0.232,0,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.0023671,-0.28708,-0.22674,0,0
3,GO EMBRYONIC HEMOPOIESIS,4.3218e-05,-0.28764,-0.3095,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,2.0033e-05,-0.28875,-0.30811,0,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.0094949,-0.28972,-0.28694,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.00010092,-0.29485,-0.31295,0,0
3,GO OUTER DYNEIN ARM ASSEMBLY,3.4421e-05,-0.29668,-0.36244,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00038934,-0.2983,-0.33785,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.055956,-0.29961,-0.50009,0,0
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,3.0689e-05,-0.29966,-0.24362,0,0
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.010506,-0.2998,-0.29677,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.10465,-0.30212,-0.19418,0,0
3,GO LIPOXYGENASE PATHWAY,0.0031536,-0.30244,-0.3332,0,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00017186,-0.30279,-0.29762,0,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0015189,-0.30288,-0.29344,0,0
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.02166,-0.30349,-0.23258,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0021689,-0.3061,-0.27008,0,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0075304,-0.30756,-0.2403,0,0
3,GO SARCOMERE ORGANIZATION,0.00059588,-0.30791,-0.23518,0,0
3,GO DETECTION OF CALCIUM ION,0.011612,-0.30822,-0.2739,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.060602,-0.30914,-0.34625,0,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.011904,-0.3097,-0.2234,0,0
3,GO REGULATION OF CELL FATE COMMITMENT,0.00017796,-0.31247,-0.29432,0,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.00013917,-0.3131,-0.26044,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.0056288,-0.31342,-0.26275,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0090226,-0.314,-0.32337,0,0
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,2.5308e-05,-0.31444,-0.29226,0,0
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00057693,-0.3147,-0.26648,0,0
3,GO HETEROTYPIC CELL CELL ADHESION,2.0829e-07,-0.3189,-0.39039,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.00084609,-0.32116,-0.33522,0,0
3,GO EXTRACELLULAR TRANSPORT,1.6015e-06,-0.32295,-0.40046,0,0
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.033166,-0.32377,-0.30437,0,0
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0028957,-0.32505,-0.31941,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.00014935,-0.32512,-0.29447,0,0
3,GO HEART FIELD SPECIFICATION,0.0083534,-0.32516,-0.26176,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,3.1888e-05,-0.33766,-0.30821,0,0
3,GO MOTILE CILIUM ASSEMBLY,0.0028957,-0.34171,-0.27243,0,0
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00013433,-0.34307,-0.27113,0,0
3,GO AXONEME ASSEMBLY,8.3127e-06,-0.34641,-0.34911,0,0
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.0087944,-0.34698,-0.2929,0,0
3,GO SPINAL CORD PATTERNING,0.0013054,-0.34994,-0.32001,0,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.021165,-0.35147,-0.34631,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,7.5427e-07,-0.35314,-0.33908,0,0
3,GO CELLULAR RESPONSE TO COPPER ION,0.0014738,-0.35326,-0.4539,0,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00021167,-0.35422,-0.32364,0,0
3,GO ENDOCARDIUM DEVELOPMENT,0.00084609,-0.35464,-0.35318,0,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.00013917,-0.35511,-0.29926,0,0
3,GO GDP METABOLIC PROCESS,0.00029782,-0.35975,-0.3357,0,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.0040578,-0.35979,-0.30887,0,0
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.082489,-0.36194,-0.28507,0,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.023205,-0.36573,-0.38621,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,1.0779e-06,-0.36655,-0.37397,0,0
3,GO PITUITARY GLAND DEVELOPMENT,0.00017186,-0.36669,-0.33981,0,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.00026903,-0.36735,-0.34919,0,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,4.3218e-05,-0.36938,-0.34745,0,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0030654,-0.37116,-0.28291,0,0
3,GO IMMATURE B CELL DIFFERENTIATION,0.00095906,-0.37406,-0.26521,0,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0028141,-0.37409,-0.31493,0,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.001986,-0.37447,-0.39186,0,0
3,GO KERATINOCYTE DEVELOPMENT,0.0069616,-0.37542,-0.36861,0,0
3,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0020453,-0.37969,-0.40054,0,0
3,GO REFLEX,0.00034072,-0.38699,-0.40692,0,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.13355,-0.39392,-0.25513,0,0
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0071468,-0.3963,-0.31373,0,0
3,GO GANGLION DEVELOPMENT,0.021165,-0.39697,-0.28143,0,0
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.0025083,-0.39796,-0.29924,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.0060989,-0.40518,-0.31789,0,0
3,GO LUNG EPITHELIUM DEVELOPMENT,0.00035231,-0.40606,-0.3283,0,0
3,GO CELL CELL JUNCTION MAINTENANCE,0.0025817,-0.42002,-0.34013,0,0
3,GO ADRENAL GLAND DEVELOPMENT,9.7346e-05,-0.42035,-0.36018,0,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,9.4334e-07,-0.42384,-0.45862,0,0
3,GO ACTIN FILAMENT BASED TRANSPORT,0.00017186,-0.4258,-0.34175,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,5.6174e-05,-0.4273,-0.34413,0,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00098941,-0.42833,-0.3871,0,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,2.4346e-05,-0.4291,-0.46121,0,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,1.2454e-05,-0.43047,-0.44669,0,0
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.0026572,-0.43095,-0.46036,0,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,4.4878e-05,-0.43486,-0.44343,0,0
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,1.8521e-05,-0.44419,-0.43224,0,0
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,1.906e-06,-0.44912,-0.4746,0,0
3,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0006154,-0.45043,-0.55951,0,0
3,GO REGULATION OF CELL FATE SPECIFICATION,9.0551e-05,-0.45104,-0.40733,0,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.00081984,-0.46571,-0.41489,0,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.9301e-06,-0.47305,-0.51574,0,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00024286,-0.48435,-0.44772,0,0
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.00040247,-0.48751,-0.3629,0,0
3,GO RETINA LAYER FORMATION,0.00025131,-0.49361,-0.42195,0,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,3.4728e-06,-0.49691,-0.5218,0,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0015653,-0.51475,-0.45624,0,0
3,GO RESPONSE TO WATER,1.7118e-05,-0.52097,-0.47175,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,3.8583e-05,-0.52149,-0.45274,0,0
3,GO NOTCH RECEPTOR PROCESSING,5.7413e-06,-0.52724,-0.50548,0,0
3,GO SEROTONIN METABOLIC PROCESS,0.0014299,-0.53266,-0.39886,0,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,3.8583e-05,-0.53775,-0.5303,0,0
3,GO ADENOHYPOPHYSIS DEVELOPMENT,0.0062634,-0.54036,-0.3912,0,0
3,GO REGULATION OF RECEPTOR CLUSTERING,9.0179e-06,-0.54769,-0.56097,0,0
3,GO MEGAKARYOCYTE DEVELOPMENT,2.6307e-05,-0.55074,-0.46011,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,5.4121e-05,-0.5698,-0.56086,0,0
3,GO INNER DYNEIN ARM ASSEMBLY,1.0779e-06,-0.57102,-0.64526,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,1.7118e-05,-0.57186,-0.52272,0,0
3,GO EPITHELIAL CELL MORPHOGENESIS,1.1776e-06,-0.57676,-0.59968,0,0
3,GO GLIAL CELL FATE COMMITMENT,0.00087311,-0.58808,-0.45619,0,0
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,4.8612e-06,-0.58825,-0.52577,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.0051916,-0.62237,-0.44343,0,0
3,GO PROTEIN AUTO ADP RIBOSYLATION,7.3528e-06,-0.62299,-0.50544,0,0
3,GO PARAXIAL MESODERM MORPHOGENESIS,6.7596e-05,-0.63709,-0.54699,0,0
3,GO GAMMA DELTA T CELL ACTIVATION,5.7413e-06,-0.64565,-0.56313,0,0
3,GO LUNG CELL DIFFERENTIATION,2.7343e-05,-0.67843,-0.57055,0,0
3,GO CARDIAC CELL FATE COMMITMENT,5.2837e-06,-0.72322,-0.65418,0,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,2.2524e-05,-0.73332,-0.59099,0,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,2.9301e-06,-0.74682,-0.62777,0,0
3,GO NOSE DEVELOPMENT,0.00010462,-0.93158,-0.68796,0,0
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,5.986e-08,-0.95111,-0.89408,0,0
3,GO HEPATOCYTE APOPTOTIC PROCESS,1.0207e-07,-1.0909,-1.1088,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0040578,1.0353,0.91381,1,1
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.014138,0.99549,0.61131,1,1
4,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,4.4712e-06,0.97462,1.0214,1,1
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,2.5308e-05,0.88751,0.61766,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0049174,0.88692,0.72637,1,1
4,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00041602,0.8722,0.64801,1,1
4,GO GLYCOSIDE METABOLIC PROCESS,0.0013872,0.86553,0.8549,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,5.508e-06,0.84862,0.75607,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00010462,0.84853,0.58017,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.9926e-07,0.77046,0.73808,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,2.0833e-05,0.76592,0.78822,1,1
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00010092,0.74598,0.69495,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00010092,0.73643,0.62128,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0037331,0.72815,0.55926,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,5.6174e-05,0.71562,0.6318,1,1
4,GO HISTAMINE SECRETION,6.2985e-07,0.70834,0.69611,1,1
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0029794,0.69319,0.44862,1,1
4,GO PROGESTERONE METABOLIC PROCESS,7.2754e-05,0.68692,0.92235,1,1
4,GO TOLERANCE INDUCTION,0.0064317,0.68437,0.44712,1,1
4,GO DOPAMINE BIOSYNTHETIC PROCESS,1.2454e-05,0.67914,0.70678,1,1
4,GO GERMINAL CENTER FORMATION,0.00010092,0.67825,0.52145,1,1
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,1.4674e-06,0.67711,0.63039,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,5.8301e-05,0.67693,0.61165,1,1
4,GO MUCUS SECRETION,0.00026003,0.67366,0.61397,1,1
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0046564,0.66712,0.47712,1,1
4,GO QUINONE METABOLIC PROCESS,6.0504e-05,0.65692,0.66878,1,1
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00041602,0.65675,0.47396,1,1
4,GO RENAL ABSORPTION,2.1663e-05,0.65415,0.66074,1,1
4,GO LIPID DROPLET FORMATION,3.0576e-06,0.65137,0.68134,1,1
4,GO ACTIN FILAMENT NETWORK FORMATION,0.011904,0.641,0.32846,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.00021909,0.63787,0.55033,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00028792,0.63568,0.46561,1,1
4,GO CYTIDINE TO URIDINE EDITING,0.00036427,0.63072,0.61837,1,1
4,GO ACTIN FILAMENT SEVERING,0.00010462,0.62813,0.50593,1,1
4,GO HISTAMINE TRANSPORT,6.0198e-07,0.62544,0.66413,1,1
4,GO RESPONSE TO INTERFERON BETA,0.00072223,0.62376,0.45758,1,1
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0015653,0.6148,0.42716,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00016023,0.61244,0.49726,1,1
4,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,4.0073e-05,0.60248,0.52633,1,1
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.038561,0.60079,0.40259,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,9.4334e-07,0.5899,0.60056,1,1
4,GO RESPONSE TO TYPE I INTERFERON,6.2786e-05,0.58953,0.5358,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,1.7118e-05,0.58705,0.64636,1,1
4,GO INTESTINAL LIPID ABSORPTION,4.4712e-06,0.58025,0.68765,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,3.3132e-05,0.56344,0.52731,1,1
4,GO NEGATIVE REGULATION OF BONE REMODELING,4.6623e-06,0.5582,0.56422,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,8.4205e-05,0.55632,0.56875,1,1
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00052342,0.55423,0.38314,1,1
4,GO TOXIN METABOLIC PROCESS,1.1267e-06,0.55021,0.5504,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0064317,0.54712,0.5329,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.00019079,0.54565,0.57128,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,1.0184e-05,0.54156,0.49972,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.007729,0.54023,0.65633,1,1
4,GO KETONE CATABOLIC PROCESS,0.00098941,0.53833,0.43593,1,1
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00020448,0.53559,0.39458,1,1
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.013465,0.53226,0.36365,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,7.8282e-05,0.52905,0.50147,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00032948,0.52569,0.4757,1,1
4,GO ADHESION OF SYMBIONT TO HOST,0.009256,0.52551,0.33775,1,1
4,GO RETINAL METABOLIC PROCESS,0.0013457,0.5247,0.59356,1,1
4,GO GLYCOLIPID CATABOLIC PROCESS,6.2786e-05,0.52462,0.53033,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,0.00074557,0.52216,0.4344,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,0.0050528,0.52032,0.34569,1,1
4,GO CYSTEINE METABOLIC PROCESS,0.010773,0.5188,0.42217,1,1
4,GO LIPID DIGESTION,2.3418e-05,0.51795,0.60338,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00016023,0.51655,0.46322,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,4.6597e-05,0.51514,0.47593,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00018427,0.51385,0.48642,1,1
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,1.349e-05,0.51337,0.48787,1,1
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00090094,0.51266,0.46089,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,7.547e-05,0.51147,0.52983,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.0075304,0.51096,0.44183,1,1
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00030804,0.50852,0.5515,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.1112e-06,0.50785,0.51709,1,1
4,GO SUPEROXIDE ANION GENERATION,3.0689e-05,0.50745,0.48849,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,6.5149e-05,0.50529,0.47929,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00049035,0.50496,0.40235,1,1
4,GO CYCLOOXYGENASE PATHWAY,0.00098941,0.50453,0.52269,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,9.0221e-07,0.50437,0.51308,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00024286,0.49977,0.38759,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.0576e-06,0.49824,0.4741,1,1
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0050528,0.49719,0.31099,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0087944,0.49686,0.34768,1,1
4,GO RESPONSE TO PAIN,2.0784e-06,0.49302,0.47618,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00079435,0.49156,0.43467,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,0.00012964,0.49059,0.47958,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,3.4421e-05,0.4905,0.58024,1,1
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0017123,0.48935,0.3626,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,0.0066042,0.48928,0.3381,1,1
4,GO RESPONSE TO EPINEPHRINE,0.0094949,0.48914,0.32043,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0073363,0.48906,0.38471,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,2.3418e-05,0.4886,0.41949,1,1
4,GO GALACTOSE METABOLIC PROCESS,2.2524e-05,0.48813,0.59255,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00019753,0.48564,0.59695,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00059588,0.48518,0.38915,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,9.3916e-06,0.48403,0.47416,1,1
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.020205,0.48376,0.43335,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,0.0010859,0.48138,0.40154,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,3.3132e-05,0.47648,0.43503,1,1
4,GO METHIONINE BIOSYNTHETIC PROCESS,1.2454e-05,0.47569,0.45209,1,1
4,GO RESPONSE TO COLD,4.5813e-07,0.47522,0.4508,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.2658e-06,0.47377,0.40744,1,1
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,2.6307e-05,0.47307,0.40702,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00047456,0.4726,0.37064,1,1
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0040578,0.4723,0.4397,1,1
4,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00012074,0.47027,0.61289,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00016023,0.46977,0.41024,1,1
4,GO SECONDARY METABOLIC PROCESS,0.00019753,0.46942,0.42694,1,1
4,GO RESPONSE TO INTERFERON ALPHA,0.0042883,0.46663,0.30748,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,2.8418e-05,0.46623,0.47836,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.00016023,0.46621,0.39127,1,1
4,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0031536,0.46513,0.45567,1,1
4,GO T CELL EXTRAVASATION,0.0014738,0.46452,0.49626,1,1
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0062634,0.46377,0.31255,1,1
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,2.6307e-05,0.46365,0.38713,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,8.6584e-06,0.46333,0.45527,1,1
4,GO O GLYCAN PROCESSING,0.00016023,0.4633,0.39627,1,1
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0099891,0.46201,0.3576,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00012964,0.45912,0.48722,1,1
4,GO SIGNAL PEPTIDE PROCESSING,3.1904e-06,0.45727,0.47064,1,1
4,GO NADP METABOLIC PROCESS,0.00038934,0.45707,0.33894,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0019282,0.45608,0.31798,1,1
4,GO DETECTION OF OTHER ORGANISM,0.00044439,0.45538,0.43354,1,1
4,GO REGULATION OF FIBRINOLYSIS,0.00012512,0.45504,0.4655,1,1
4,GO VASCULAR TRANSPORT,0.0012662,0.45375,0.37519,1,1
4,GO RESPONSE TO DIETARY EXCESS,2.6307e-05,0.44852,0.44942,1,1
4,GO PROSTANOID METABOLIC PROCESS,0.0015653,0.44824,0.39708,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,3.1888e-05,0.4482,0.46602,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00030804,0.44752,0.43711,1,1
4,GO REGULATION OF NEURON MATURATION,0.00025131,0.44583,0.35655,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,5.0226e-05,0.44543,0.37517,1,1
4,GO LEYDIG CELL DIFFERENTIATION,0.00022676,0.44515,0.51508,1,1
4,GO MATURE B CELL DIFFERENTIATION,9.389e-05,0.44493,0.40029,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00037661,0.44437,0.36479,1,1
4,GO PROTEIN DEGLYCOSYLATION,1.1964e-05,0.44129,0.4349,1,1
4,GO REGULATION OF ANOIKIS,0.00010845,0.44121,0.41415,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00042998,0.44011,0.33216,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00030804,0.4388,0.36405,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,5.4121e-05,0.43705,0.40823,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,2.5308e-05,0.43678,0.47565,1,1
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.00019079,0.43647,0.40515,1,1
4,GO ZYMOGEN ACTIVATION,0.00025131,0.43405,0.3917,1,1
4,GO CERAMIDE CATABOLIC PROCESS,0.00031859,0.43274,0.43139,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,4.6597e-05,0.43137,0.54721,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00032948,0.4312,0.37754,1,1
4,GO STEROID ESTERIFICATION,0.00010092,0.43018,0.55875,1,1
4,GO INTESTINAL ABSORPTION,6.4994e-06,0.42998,0.58626,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.00095906,0.42834,0.4157,1,1
4,GO NEGATIVE REGULATION OF COAGULATION,0.0017123,0.42833,0.35596,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0047853,0.42818,0.35424,1,1
4,GO BASIC AMINO ACID TRANSPORT,0.0045306,0.42711,0.41423,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0027346,0.42564,0.33063,1,1
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.031059,0.42401,0.33055,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,6.5149e-05,0.42246,0.47442,1,1
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.00037661,0.42119,0.39408,1,1
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00020448,0.4207,0.34112,1,1
4,GO REGULATION OF INTEGRIN ACTIVATION,9.4334e-07,0.42049,0.49854,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00065623,0.42022,0.38488,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00054072,0.41991,0.40644,1,1
4,GO BONE RESORPTION,1.9904e-06,0.41918,0.42817,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.2367e-06,0.41896,0.43528,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00014418,0.41893,0.36257,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0037331,0.4177,0.29901,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00052342,0.41676,0.3428,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0018173,0.41639,0.38568,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,5.6174e-05,0.41635,0.51497,1,1
4,GO CELLULAR DEFENSE RESPONSE,4.2876e-06,0.41362,0.42398,1,1
4,GO LYSINE METABOLIC PROCESS,0.012508,0.41285,0.2663,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.1617e-05,0.41091,0.44459,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,1.5201e-05,0.41077,0.32851,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.00010462,0.41015,0.42927,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,2.5308e-05,0.4099,0.35232,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0016129,0.4093,0.36227,1,1
4,GO VACUOLAR ACIDIFICATION,1.2366e-07,0.40868,0.44048,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.00029782,0.40855,0.36355,1,1
4,GO KETONE BODY METABOLIC PROCESS,0.0025817,0.40625,0.33581,1,1
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00095906,0.40538,0.36851,1,1
4,GO EOSINOPHIL MIGRATION,0.001228,0.40498,0.3562,1,1
4,GO REGULATION OF BONE REMODELING,3.4728e-06,0.40409,0.43719,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00037661,0.40398,0.38875,1,1
4,GO VASODILATION,8.1192e-05,0.40384,0.53819,1,1
4,GO NADPH REGENERATION,0.024846,0.40375,0.21958,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00026903,0.40318,0.37035,1,1
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0016129,0.40163,0.34332,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,0.00024286,0.4011,0.34529,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.2876e-06,0.40096,0.41284,1,1
4,GO RESPONSE TO ACIDIC PH,0.0014738,0.40059,0.30607,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,3.1888e-05,0.40016,0.38135,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,5.4121e-05,0.40001,0.45979,1,1
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0022992,0.39982,0.31147,1,1
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.0054795,0.39827,0.36145,1,1
4,GO REGULATION OF PLATELET AGGREGATION,0.0071468,0.39786,0.29363,1,1
4,GO PHAGOSOME ACIDIFICATION,7.2756e-08,0.3964,0.43599,1,1
4,GO REGULATION OF PLATELET ACTIVATION,0.00079435,0.39636,0.3168,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.0090226,0.39532,0.35072,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.001662,0.39479,0.34277,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0030654,0.39441,0.42783,1,1
4,GO B CELL APOPTOTIC PROCESS,1.2962e-05,0.39426,0.35922,1,1
4,GO INSEMINATION,0.00025131,0.39426,0.35747,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,5.2139e-05,0.39393,0.30083,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0019282,0.39378,0.41772,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.0016129,0.39251,0.29674,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,3.0689e-05,0.39175,0.35454,1,1
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0062634,0.39113,0.42086,1,1
4,GO GAP JUNCTION ASSEMBLY,0.0099891,0.39086,0.28064,1,1
4,GO NUCLEOTIDE SALVAGE,0.00081984,0.39062,0.34564,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.0033e-05,0.3906,0.47339,1,1
4,GO HEPARIN METABOLIC PROCESS,0.033166,0.39058,0.21187,1,1
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00012964,0.38975,0.3766,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,0.00026903,0.38923,0.58641,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00026903,0.38859,0.38606,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,4.3218e-05,0.38755,0.41942,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,2.6307e-05,0.38602,0.3251,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00021909,0.38503,0.38008,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,1.3441e-06,0.38413,0.39382,1,1
4,GO L PHENYLALANINE METABOLIC PROCESS,0.00090094,0.3815,0.56335,1,1
4,GO EOSINOPHIL CHEMOTAXIS,0.0014299,0.3814,0.36408,1,1
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0094949,0.38071,0.3641,1,1
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.024846,0.38022,0.31924,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,4.4878e-05,0.38019,0.3188,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,1.2862e-06,0.37986,0.38623,1,1
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00036427,0.37976,0.32912,1,1
4,GO UBIQUINONE METABOLIC PROCESS,3.1904e-06,0.37784,0.35618,1,1
4,GO N GLYCAN PROCESSING,0.0026572,0.37707,0.28663,1,1
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0025083,0.37665,0.24707,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,0.00038934,0.37664,0.30893,1,1
4,GO PROTEIN DEMANNOSYLATION,3.4421e-05,0.37576,0.416,1,1
4,GO ACUTE PHASE RESPONSE,0.00019079,0.37529,0.3115,1,1
4,GO PLASMINOGEN ACTIVATION,0.0021062,0.37529,0.42612,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00084609,0.37525,0.30076,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.012203,0.37433,0.25468,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.018836,0.37357,0.28158,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00023468,0.37284,0.31712,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,0.0033369,0.37233,0.31446,1,1
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.00030804,0.37168,0.41095,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00012964,0.37151,0.3719,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00026903,0.37136,0.30858,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.012203,0.37056,0.22504,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.001662,0.37005,0.34702,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00044439,0.36978,0.4612,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,8.6584e-06,0.36967,0.34412,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0017641,0.3669,0.29132,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0087944,0.36682,0.30049,1,1
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0042883,0.36642,0.31232,1,1
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.035393,0.36631,0.24165,1,1
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.00044439,0.36618,0.31856,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00028792,0.3661,0.39917,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00017186,0.36492,0.41003,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.0022332,0.3649,0.28471,1,1
4,GO RESPONSE TO LITHIUM ION,3.3132e-05,0.36354,0.45494,1,1
4,GO REGULATION OF COAGULATION,0.00037661,0.36349,0.30854,1,1
4,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0027346,0.36335,0.39405,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00026003,0.36269,0.34791,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0018173,0.36231,0.26531,1,1
4,GO METHIONINE METABOLIC PROCESS,2.0833e-05,0.36227,0.34216,1,1
4,GO REGULATION OF TISSUE REMODELING,7.9801e-06,0.36148,0.37487,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0012662,0.36107,0.37549,1,1
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0025083,0.36107,0.3036,1,1
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0020453,0.36097,0.30627,1,1
4,GO THYMOCYTE APOPTOTIC PROCESS,0.0037331,0.36051,0.2652,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,2.2658e-06,0.35872,0.35666,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00038934,0.35821,0.33077,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.01282,0.35819,0.28876,1,1
4,GO REGULATION OF MYOBLAST FUSION,0.00016595,0.35753,0.33134,1,1
4,GO INTEGRIN ACTIVATION,5.508e-06,0.35733,0.37059,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.00014418,0.35593,0.32879,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0025817,0.35569,0.36671,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,2.0833e-05,0.3553,0.36421,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00059588,0.35485,0.37066,1,1
4,GO REGULATION OF ICOSANOID SECRETION,0.0001547,0.35459,0.32159,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,3.8583e-05,0.35208,0.30766,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,8.1192e-05,0.35193,0.31122,1,1
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.001662,0.35188,0.30994,1,1
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00026003,0.35187,0.35299,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.0013872,0.35001,0.23511,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00055855,0.34992,0.36339,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,6.0504e-05,0.34972,0.29205,1,1
4,GO ETHER METABOLIC PROCESS,0.0023671,0.34896,0.23392,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,3.8583e-05,0.34885,0.39422,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00019753,0.34882,0.35256,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0050528,0.34798,0.36587,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,6.2786e-05,0.34783,0.28906,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0006154,0.34714,0.31126,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00030804,0.34698,0.36363,1,1
4,GO SNARE COMPLEX ASSEMBLY,0.00019753,0.34616,0.28327,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,0.0006154,0.34594,0.26512,1,1
4,GO LYTIC VACUOLE ORGANIZATION,6.5896e-07,0.3459,0.34854,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0013457,0.34493,0.29459,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.0017123,0.34466,0.2709,1,1
4,GO PROTEIN AUTOPROCESSING,2.1663e-05,0.34438,0.38428,1,1
4,GO ANOIKIS,4.4878e-05,0.34435,0.29752,1,1
4,GO BILE ACID METABOLIC PROCESS,4.0073e-05,0.34373,0.36134,1,1
4,GO STEROID HORMONE SECRETION,0.0011199,0.34338,0.29335,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00079435,0.34301,0.34668,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00041602,0.34296,0.27672,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00047456,0.34212,0.33239,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0010528,0.34086,0.26307,1,1
4,GO ICOSANOID METABOLIC PROCESS,5.0226e-05,0.34061,0.3399,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.013e-05,0.34043,0.31022,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.019739,0.33975,0.31849,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.004408,0.33961,0.45905,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,8.1192e-05,0.33943,0.28575,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0015653,0.33916,0.3064,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.9263e-05,0.33902,0.35413,1,1
4,GO TISSUE REMODELING,5.4121e-05,0.33875,0.29149,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0038387,0.33761,0.32151,1,1
4,GO POSITIVE REGULATION OF CELL SIZE,2.6307e-05,0.33732,0.36143,1,1
4,GO MITOCHONDRIAL RNA PROCESSING,0.0024367,0.33718,0.26332,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0041716,0.33715,0.27789,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00019753,0.33635,0.30504,1,1
4,GO CELLULAR RESPONSE TO FATTY ACID,8.4205e-05,0.33626,0.34154,1,1
4,GO RESPONSE TO THYROID HORMONE,0.001662,0.33591,0.26629,1,1
4,GO IMMUNOGLOBULIN SECRETION,0.00087311,0.33585,0.25448,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,0.00029782,0.33577,0.30249,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,9.0551e-05,0.33538,0.32819,1,1
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00029782,0.33538,0.28571,1,1
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.013798,0.33533,0.26968,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00030804,0.33528,0.25469,1,1
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00049035,0.33522,0.276,1,1
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0016129,0.33413,0.33969,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.019739,0.33412,0.3841,1,1
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.00016023,0.33408,0.29169,1,1
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0010528,0.33386,0.28915,1,1
4,GO TRICARBOXYLIC ACID CYCLE,0.0037331,0.33322,0.25574,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00065623,0.33312,0.25212,1,1
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.0083534,0.333,0.31622,1,1
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.0037331,0.33297,0.26077,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,0.00040247,0.33275,0.31992,1,1
4,GO LIVER MORPHOGENESIS,0.0013054,0.33211,0.28853,1,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0024367,0.33191,0.35379,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,8.6584e-06,0.33164,0.31315,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.4346e-05,0.33039,0.2797,1,1
4,GO CARNITINE METABOLIC PROCESS,0.0012662,0.33037,0.28276,1,1
4,GO KERATAN SULFATE CATABOLIC PROCESS,0.00035231,0.33032,0.34232,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,0.00057693,0.32883,0.25565,1,1
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00049035,0.32861,0.25744,1,1
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.021165,0.32834,0.31057,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.00054072,0.32801,0.3787,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0045306,0.328,0.26689,1,1
4,GO DORSAL AORTA DEVELOPMENT,0.0094949,0.3276,0.22094,1,1
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.00012074,0.32664,0.30501,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,7.013e-05,0.32563,0.32903,1,1
4,GO DENDRITIC CELL APOPTOTIC PROCESS,0.016339,0.3256,0.26958,1,1
4,GO FATTY ACID CATABOLIC PROCESS,1.2862e-06,0.32552,0.3251,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.104e-05,0.32489,0.30706,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.00098941,0.32473,0.24243,1,1
4,GO BLOOD VESSEL REMODELING,0.00044439,0.32471,0.29259,1,1
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.022165,0.32469,0.18226,1,1
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0018173,0.32446,0.29134,1,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.018398,0.32368,0.26222,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.9263e-05,0.32365,0.28001,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.033894,0.32353,0.28879,1,1
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0015189,0.3234,0.34022,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0099891,0.32331,0.215,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00010845,0.32319,0.35819,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001191,0.32297,0.26934,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,4.1617e-05,0.32252,0.26871,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00025131,0.32219,0.28893,1,1
4,GO INTRACELLULAR STEROL TRANSPORT,0.0006154,0.32206,0.30877,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0021062,0.32144,0.25569,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0081404,0.32107,0.18329,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0013054,0.32062,0.28659,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0015189,0.32023,0.34478,1,1
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0022332,0.32007,0.29684,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,7.013e-05,0.32004,0.38951,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,1.2962e-05,0.32001,0.32374,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00092958,0.31981,0.22971,1,1
4,GO BONE REMODELING,2.5308e-05,0.31964,0.34277,1,1
4,GO EPITHELIAL CELL CELL ADHESION,0.011047,0.31961,0.34722,1,1
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0026572,0.3196,0.19337,1,1
4,GO PLATELET DEGRANULATION,0.00072223,0.31951,0.2569,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00019753,0.31933,0.27788,1,1
4,GO STEROID METABOLIC PROCESS,1.349e-05,0.31933,0.29674,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.001872,0.31874,0.26659,1,1
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.001872,0.3186,0.21269,1,1
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.5201e-05,0.31807,0.29468,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,1.349e-05,0.31782,0.27591,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,4.3218e-05,0.3178,0.33123,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.5816e-05,0.31768,0.33622,1,1
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0019282,0.31693,0.1978,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0001547,0.31686,0.2781,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00038934,0.31667,0.22806,1,1
4,GO DIGESTION,0.00010462,0.31611,0.29321,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.00029782,0.31542,0.28057,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0013457,0.31504,0.29487,1,1
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0038387,0.3139,0.24463,1,1
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0049174,0.31386,0.26686,1,1
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00055855,0.31343,0.29455,1,1
4,GO REGULATION OF CHLORIDE TRANSPORT,0.0023671,0.31314,0.35411,1,1
4,GO DEFENSE RESPONSE TO VIRUS,0.00057693,0.31303,0.22803,1,1
4,GO REGULATION OF CELL PROJECTION SIZE,0.013465,0.31296,0.26879,1,1
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.0046564,0.31288,0.22853,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.025994,0.31249,0.25174,1,1
4,GO FOAM CELL DIFFERENTIATION,0.00016023,0.31222,0.27021,1,1
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00057693,0.31219,0.33255,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.014841,0.31145,0.21875,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.4421e-05,0.31107,0.2639,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.0081404,0.3108,0.20861,1,1
4,GO PH REDUCTION,1.5331e-06,0.3106,0.29002,1,1
4,GO RESPONSE TO GROWTH HORMONE,3.3132e-05,0.31005,0.35136,1,1
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.014138,0.30989,0.23071,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,0.00065623,0.3096,0.28001,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00035231,0.30927,0.26918,1,1
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0067808,0.30921,0.1998,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0057817,0.30891,0.39838,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.036164,0.30821,0.20022,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,6.2786e-05,0.30665,0.23431,1,1
4,GO INOSITOL METABOLIC PROCESS,1.0184e-05,0.30602,0.33113,1,1
4,GO B CELL MEDIATED IMMUNITY,0.00044439,0.30538,0.23407,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,0.00010092,0.30517,0.28338,1,1
4,GO REGULATION OF B CELL DIFFERENTIATION,0.0001547,0.30513,0.28843,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,1.8251e-06,0.3051,0.30096,1,1
4,GO PHAGOSOME MATURATION,2.9301e-06,0.30491,0.3315,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0010528,0.30445,0.24222,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.6603e-06,0.3044,0.34405,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00059588,0.30402,0.28883,1,1
4,GO IMMUNE EFFECTOR PROCESS,9.389e-05,0.30383,0.22774,1,1
4,GO RESPONSE TO INTERFERON GAMMA,0.00090094,0.30338,0.26169,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.001872,0.30313,0.19516,1,1
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.0014738,0.303,0.21449,1,1
4,GO RESPONSE TO STEROL DEPLETION,0.00065623,0.30284,0.39355,1,1
4,GO MICROVILLUS ORGANIZATION,0.0085714,0.30268,0.28782,1,1
4,GO RESPONSE TO MINERALOCORTICOID,0.00054072,0.30248,0.26654,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0025083,0.30213,0.25921,1,1
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.041967,0.30209,0.18826,1,1
4,GO PHOSPHOLIPID EFFLUX,0.00098941,0.30176,0.35159,1,1
4,GO GLUTATHIONE METABOLIC PROCESS,0.0053338,0.30164,0.30259,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,0.031059,0.30051,0.33504,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0021062,0.30041,0.30005,1,1
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,5.7413e-06,0.29988,0.31504,1,1
4,GO TRANSCYTOSIS,6.7596e-05,0.29937,0.30395,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,0.00067758,0.29919,0.24604,1,1
4,GO PROTEIN HYDROXYLATION,0.0026572,0.29878,0.27369,1,1
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00074557,0.29875,0.19627,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.001662,0.2987,0.25804,1,1
4,GO RESPIRATORY BURST,0.00016595,0.29868,0.28292,1,1
4,GO ENTRY INTO HOST,0.0020453,0.29841,0.22126,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00037661,0.2984,0.27915,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.6174e-05,0.29828,0.24937,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.015953,0.2982,0.24607,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.023741,0.29815,0.22379,1,1
4,GO RESPONSE TO INTERLEUKIN 6,0.00047456,0.29805,0.28472,1,1
4,GO REGULATION OF B CELL PROLIFERATION,1.4609e-05,0.2979,0.28028,1,1
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.031748,0.29781,0.20368,1,1
4,GO MAST CELL ACTIVATION,2.3418e-05,0.29759,0.29178,1,1
4,GO ARACHIDONIC ACID SECRETION,0.00012512,0.29699,0.26294,1,1
4,GO OSTEOBLAST PROLIFERATION,0.0013457,0.29693,0.27359,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,5.4121e-05,0.2965,0.24976,1,1
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,4.2876e-06,0.29637,0.27738,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,7.8282e-05,0.29619,0.29395,1,1
4,GO ZYMOGEN INHIBITION,0.0053338,0.29614,0.22553,1,1
4,GO DIGESTIVE SYSTEM PROCESS,0.00035231,0.29564,0.25741,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.0028957,0.29513,0.2685,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,7.013e-05,0.29489,0.23424,1,1
4,GO VITAMIN D METABOLIC PROCESS,0.0047853,0.2948,0.26811,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,0.00087311,0.29471,0.27414,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00027832,0.29466,0.22049,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0053338,0.29452,0.19646,1,1
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0050528,0.29435,0.2032,1,1
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0021689,0.29401,0.21758,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0046564,0.29371,0.19663,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,3.0689e-05,0.29335,0.26052,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00031859,0.29309,0.2609,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00072223,0.29281,0.22028,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00010462,0.29239,0.2742,1,1
4,GO VIRAL GENOME REPLICATION,0.0020453,0.29216,0.1903,1,1
4,GO RESPONSE TO INTERLEUKIN 2,0.0015653,0.29214,0.23346,1,1
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0067808,0.29142,0.26493,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00010462,0.29116,0.2592,1,1
4,GO REGULATION OF WOUND HEALING,0.00040247,0.29114,0.26565,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,2.9301e-06,0.29102,0.25158,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00049035,0.29073,0.37375,1,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00017186,0.29067,0.36045,1,1
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.00040247,0.2903,0.24676,1,1
4,GO REGULATION OF RESPIRATORY BURST,0.00019079,0.29029,0.32414,1,1
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0041716,0.29028,0.2495,1,1
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0099891,0.29013,0.29447,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.00054072,0.28993,0.19837,1,1
4,GO CELL REDOX HOMEOSTASIS,0.00012964,0.28984,0.30175,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,0.00042998,0.28963,0.27052,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,0.0010206,0.28939,0.2304,1,1
4,GO ENDOCRINE PROCESS,0.00023468,0.28882,0.2591,1,1
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,5.6174e-05,0.28871,0.29471,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0032441,0.28867,0.3307,1,1
4,GO T CELL MEDIATED IMMUNITY,0.0090226,0.28867,0.21263,1,1
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0041716,0.28842,0.2333,1,1
4,GO POLYOL TRANSPORT,0.0025083,0.28821,0.30054,1,1
4,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.0073363,0.28756,0.30903,1,1
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.017137,0.28706,0.21499,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0028957,0.2869,0.22682,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0012662,0.28681,0.26146,1,1
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.004408,0.28654,0.27969,1,1
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.00044439,0.28649,0.28826,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.00041602,0.28593,0.26172,1,1
4,GO STEROL METABOLIC PROCESS,0.00026903,0.28578,0.24154,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0015653,0.28568,0.24734,1,1
4,GO CORNIFICATION,0.00057693,0.28567,0.27446,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.001191,0.28533,0.25014,1,1
4,GO HYALURONAN CATABOLIC PROCESS,0.010506,0.28521,0.16458,1,1
4,GO OPTIC NERVE DEVELOPMENT,0.00047456,0.28499,0.40531,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00065623,0.28467,0.22666,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00013433,0.28451,0.23234,1,1
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.001986,0.28429,0.28818,1,1
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0020453,0.28428,0.28801,1,1
4,GO AMYLOID BETA CLEARANCE,0.0028141,0.2837,0.1999,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0014299,0.28358,0.24018,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,2.6307e-05,0.28357,0.25133,1,1
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.010773,0.28297,0.21418,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00052342,0.28253,0.20437,1,1
4,GO MAST CELL MEDIATED IMMUNITY,6.7596e-05,0.28247,0.27768,1,1
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00037661,0.28236,0.3119,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.001662,0.28233,0.3482,1,1
4,GO NEUTROPHIL MIGRATION,4.8612e-06,0.28216,0.23798,1,1
4,GO ETHANOL METABOLIC PROCESS,0.0041716,0.28205,0.25936,1,1
4,GO AMINO ACID ACTIVATION,0.00353,0.28188,0.22072,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.010506,0.28187,0.22493,1,1
4,GO AMINE METABOLIC PROCESS,7.5427e-07,0.28177,0.3026,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0006154,0.2817,0.23192,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0021689,0.28169,0.21058,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,2.5308e-05,0.28169,0.28188,1,1
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.00042998,0.2813,0.31481,1,1
4,GO ANIMAL ORGAN REGENERATION,0.0023671,0.28121,0.17819,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0014738,0.28099,0.27803,1,1
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0014299,0.28072,0.26053,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.1617e-05,0.28051,0.28431,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,0.00041602,0.28032,0.25307,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0060989,0.28032,0.22501,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,3.7145e-05,0.27947,0.25379,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00081984,0.27944,0.20541,1,1
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00026003,0.27911,0.19306,1,1
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0057817,0.27901,0.30777,1,1
4,GO STEROL TRANSPORT,0.00021167,0.27898,0.25706,1,1
4,GO INNATE IMMUNE RESPONSE,9.0551e-05,0.27862,0.22074,1,1
4,GO CELL KILLING,3.8583e-05,0.27857,0.2356,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0037331,0.2785,0.23681,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00031859,0.27827,0.33483,1,1
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.041093,0.27823,0.1609,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,2.0033e-05,0.27789,0.27504,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0025083,0.27776,0.28332,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.001662,0.27733,0.2038,1,1
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00059588,0.27722,0.25368,1,1
4,GO LIPID DROPLET ORGANIZATION,2.7343e-05,0.27719,0.30015,1,1
4,GO AEROBIC RESPIRATION,0.00055855,0.27698,0.25023,1,1
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.03939,0.27664,0.21907,1,1
4,GO PHOSPHOLIPID TRANSPORT,9.7801e-06,0.27628,0.24174,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0015653,0.27626,0.28617,1,1
4,GO APICAL JUNCTION ASSEMBLY,0.001228,0.27577,0.28827,1,1
4,GO RESPONSE TO ANGIOTENSIN,0.0042883,0.27571,0.24978,1,1
4,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.036948,0.2757,0.2567,1,1
4,GO REGULATION OF CELL KILLING,0.00044439,0.27566,0.24209,1,1
4,GO OXALATE TRANSPORT,0.00040247,0.27491,0.23902,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,6.5149e-05,0.27488,0.27618,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,7.013e-05,0.27453,0.21558,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00065623,0.27445,0.2084,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.0081404,0.27439,0.17913,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,4.8379e-05,0.27432,0.24552,1,1
4,GO INTERLEUKIN 8 PRODUCTION,0.00019753,0.27402,0.25058,1,1
4,GO RESPONSE TO COPPER ION,0.013465,0.27347,0.29142,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00081984,0.27346,0.23646,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00090094,0.27317,0.23202,1,1
4,GO INTERLEUKIN 10 PRODUCTION,0.00020448,0.27291,0.21802,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00087311,0.27238,0.29621,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,1.7806e-05,0.27234,0.3085,1,1
4,GO HORMONE METABOLIC PROCESS,0.0001165,0.2723,0.29058,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0027346,0.27228,0.29999,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0062634,0.27199,0.25058,1,1
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0025083,0.2714,0.18538,1,1
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.010773,0.27138,0.28879,1,1
4,GO RESPONSE TO PROTOZOAN,0.00057693,0.2711,0.22455,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.00024286,0.27103,0.24156,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,7.8282e-05,0.27096,0.30718,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.022165,0.27089,0.22116,1,1
4,GO FUCOSE METABOLIC PROCESS,0.034637,0.27019,0.26171,1,1
4,GO BEHAVIORAL RESPONSE TO PAIN,0.027803,0.27011,0.20874,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,5.7413e-06,0.27007,0.24588,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.0012662,0.27002,0.24522,1,1
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.012203,0.26985,0.20846,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0018173,0.26971,0.31229,1,1
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.00050664,0.26941,0.28358,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0051916,0.26939,0.1964,1,1
4,GO RESPONSE TO FATTY ACID,0.00072223,0.26937,0.2193,1,1
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.010245,0.26926,0.38654,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.00029782,0.26925,0.30853,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00063551,0.26917,0.33439,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,1.9263e-05,0.26905,0.3006,1,1
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.0015653,0.26902,0.27915,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00353,0.26897,0.21287,1,1
4,GO CHYLOMICRON ASSEMBLY,0.02166,0.26892,0.27631,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0040578,0.26864,0.21881,1,1
4,GO RETINOL METABOLIC PROCESS,0.00084609,0.26806,0.3805,1,1
4,GO GRANULOCYTE MIGRATION,3.0689e-05,0.26786,0.22874,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0010528,0.2677,0.18434,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,2.7343e-05,0.26765,0.23115,1,1
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00019079,0.26714,0.28598,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00010845,0.26705,0.27127,1,1
4,GO CYTOKINE METABOLIC PROCESS,0.00045924,0.26685,0.19168,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0028141,0.26654,0.20086,1,1
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.021165,0.26636,0.23572,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.017969,0.26627,0.20244,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,2.0033e-05,0.26598,0.23643,1,1
4,GO DOPAMINE TRANSPORT,0.0021689,0.26585,0.31654,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,8.4205e-05,0.26582,0.21381,1,1
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.004408,0.26568,0.28836,1,1
4,GO RESPONSE TO PH,0.0010528,0.26537,0.20872,1,1
4,GO MAGNESIUM ION TRANSPORT,0.00072223,0.26502,0.2565,1,1
4,GO DEFENSE RESPONSE,6.5149e-05,0.26488,0.20549,1,1
4,GO STEROL HOMEOSTASIS,0.0019282,0.26476,0.2628,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.029068,0.26472,0.17337,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.0039469,0.26425,0.20492,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.001986,0.26381,0.1756,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00052342,0.26366,0.21405,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.00029782,0.2627,0.31385,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0014738,0.26226,0.25638,1,1
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00095906,0.26205,0.17464,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00031859,0.26175,0.26951,1,1
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.00042998,0.26156,0.25088,1,1
4,GO LIPID LOCALIZATION,5.0683e-06,0.26155,0.27163,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0001165,0.26145,0.23193,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.0001547,0.26104,0.26902,1,1
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.022165,0.26098,0.24675,1,1
4,GO POSITIVE REGULATION OF ANION TRANSPORT,9.7346e-05,0.26097,0.321,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,0.00065623,0.26028,0.21422,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0027346,0.26013,0.26404,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.001228,0.26011,0.23393,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.0056288,0.26006,0.1645,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0015189,0.25981,0.23382,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.0604e-05,0.25938,0.29973,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0066042,0.25911,0.18074,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0013054,0.25891,0.2309,1,1
4,GO LYMPHOCYTE MIGRATION,0.00052342,0.25889,0.18917,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0001165,0.25847,0.23556,1,1
4,GO SEQUESTERING OF TRIGLYCERIDE,0.010773,0.25844,0.22888,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,0.00069957,0.25843,0.24572,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.00021909,0.25791,0.24692,1,1
4,GO KERATINIZATION,0.00055855,0.25781,0.23318,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.001872,0.25764,0.20518,1,1
4,GO TRANSFERRIN TRANSPORT,1.7474e-06,0.25715,0.33978,1,1
4,GO FLUID TRANSPORT,6.0504e-05,0.25713,0.23442,1,1
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.017549,0.25707,0.14529,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00023468,0.25693,0.2784,1,1
4,GO SECRETION BY TISSUE,0.0014299,0.25686,0.22494,1,1
4,GO REGULATION OF B CELL ACTIVATION,2.8418e-05,0.25677,0.23076,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00069957,0.25645,0.26309,1,1
4,GO RESPONSE TO GONADOTROPIN,0.00074557,0.25639,0.25171,1,1
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0059384,0.25628,0.36157,1,1
4,GO WATER HOMEOSTASIS,0.00079435,0.25618,0.24022,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0067808,0.25605,0.18214,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0069616,0.25603,0.17705,1,1
4,GO LIPID TRANSLOCATION,0.00081984,0.25567,0.23754,1,1
4,GO ELECTRON TRANSPORT CHAIN,0.00017186,0.2555,0.25103,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.02268,0.25546,0.24661,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,2.9532e-05,0.25525,0.23874,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.0030654,0.25494,0.24869,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,4.0073e-05,0.25483,0.24051,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,0.0001547,0.25428,0.23799,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0046564,0.25418,0.17087,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,3.4421e-05,0.25353,0.30858,1,1
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.036948,0.25345,0.15403,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00020448,0.25304,0.23602,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.001872,0.25292,0.20818,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00052342,0.25277,0.20396,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00027832,0.25211,0.20216,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,3.7145e-05,0.25207,0.23506,1,1
4,GO B CELL PROLIFERATION,2.8418e-05,0.252,0.23122,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,9.389e-05,0.25184,0.33202,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00072223,0.25172,0.18883,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0018173,0.25169,0.24072,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.023741,0.25112,0.19119,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,0.0022992,0.25103,0.19977,1,1
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0014738,0.25085,0.28917,1,1
4,GO ER OVERLOAD RESPONSE,0.0025817,0.25063,0.26579,1,1
4,GO CERAMIDE TRANSPORT,0.0073363,0.25052,0.33431,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0047853,0.25041,0.18647,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00059588,0.25033,0.24166,1,1
4,GO GLYCOSYLATION,9.0551e-05,0.25032,0.25008,1,1
4,GO CD40 SIGNALING PATHWAY,0.0026572,0.25,0.17739,1,1
4,GO DOPAMINE METABOLIC PROCESS,0.00087311,0.24991,0.29757,1,1
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0081404,0.24988,0.2432,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.00010092,0.24974,0.30764,1,1
4,GO REGULATION OF CELLULAR PH,2.9301e-06,0.24968,0.23482,1,1
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,8.4205e-05,0.24935,0.23111,1,1
4,GO MACROPHAGE PROLIFERATION,0.035393,0.2488,0.2184,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0014299,0.24879,0.22877,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00028792,0.24878,0.27819,1,1
4,GO HEXOSE CATABOLIC PROCESS,0.00095906,0.24876,0.24996,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00050664,0.24866,0.16568,1,1
4,GO PEROXISOMAL TRANSPORT,4.0073e-05,0.24843,0.25232,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.018398,0.24835,0.19669,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.0013872,0.24828,0.21602,1,1
4,GO RESPONSE TO INSECTICIDE,0.0073363,0.24828,0.33947,1,1
4,GO DETECTION OF BIOTIC STIMULUS,0.0017641,0.24806,0.26518,1,1
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.041967,0.24802,0.18254,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.041093,0.24781,0.23366,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00055855,0.24766,0.26701,1,1
4,GO ORGANELLE MEMBRANE FUSION,0.0001547,0.24735,0.21782,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00010845,0.2468,0.21649,1,1
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00095906,0.24659,0.30988,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.035393,0.24658,0.13137,1,1
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.025994,0.24649,0.16743,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,0.00019753,0.24617,0.18194,1,1
4,GO GOLGI VESICLE BUDDING,0.00010092,0.24615,0.22903,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,8.1192e-05,0.24597,0.20758,1,1
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.03245,0.24579,0.17917,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,2.9532e-05,0.24575,0.22189,1,1
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0022992,0.24565,0.20964,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00023468,0.24553,0.24372,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00055855,0.24548,0.1931,1,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.021165,0.24484,0.13256,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0031536,0.24436,0.20457,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0026572,0.24427,0.23003,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.013465,0.24415,0.18541,1,1
4,GO COPII COATED VESICLE BUDDING,0.00019079,0.24364,0.22064,1,1
4,GO LIPID OXIDATION,6.0504e-05,0.24357,0.23518,1,1
4,GO XENOBIOTIC TRANSPORT,0.00024286,0.24348,0.33093,1,1
4,GO RESPONSE TO VIRUS,0.00052342,0.24335,0.19836,1,1
4,GO REGULATION OF CELLULAR RESPIRATION,0.013465,0.24316,0.22742,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.015203,0.24306,0.1861,1,1
4,GO RESPONSE TO PROGESTERONE,0.0049174,0.24299,0.19624,1,1
4,GO INTRACELLULAR LIPID TRANSPORT,0.00052342,0.2429,0.23655,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.0031536,0.24287,0.18866,1,1
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.0022992,0.24232,0.22834,1,1
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0087944,0.24221,0.22148,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00013917,0.24216,0.24635,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.024288,0.24203,0.17843,1,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.00084609,0.24172,0.23067,1,1
4,GO REGULATION OF ACTIN NUCLEATION,0.00054072,0.24146,0.28043,1,1
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0041716,0.24131,0.2197,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.015574,0.24119,0.20429,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,5.6174e-05,0.24103,0.21258,1,1
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.0062634,0.24052,0.23202,1,1
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,9.389e-05,0.24035,0.21959,1,1
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.015953,0.24022,0.16349,1,1
4,GO AMELOGENESIS,0.011047,0.24017,0.21911,1,1
4,GO REVERSE CHOLESTEROL TRANSPORT,0.010506,0.24016,0.34637,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00047456,0.23999,0.2445,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0013872,0.23932,0.18294,1,1
4,GO NUCLEOTIDE TRANSPORT,5.6174e-05,0.23923,0.23261,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,0.00090094,0.23895,0.22704,1,1
4,GO REGULATION OF PH,4.8612e-06,0.23879,0.22887,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.001872,0.23875,0.23861,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.031748,0.23861,0.20801,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,0.0006154,0.23844,0.23949,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.001872,0.2382,0.17995,1,1
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0012662,0.23809,0.27036,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00013917,0.23803,0.22611,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0033369,0.23798,0.17715,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00041602,0.23791,0.26104,1,1
4,GO HYALURONAN METABOLIC PROCESS,0.0010859,0.23783,0.17362,1,1
4,GO RESPONSE TO CYTOKINE,0.00019079,0.23767,0.18563,1,1
4,GO TYPE I INTERFERON PRODUCTION,0.00035231,0.23766,0.21007,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.020205,0.23756,0.17872,1,1
4,GO DIOL METABOLIC PROCESS,0.0053338,0.23728,0.27482,1,1
4,GO CHEMOKINE PRODUCTION,0.0042883,0.23715,0.16688,1,1
4,GO RESPONSE TO NUTRIENT,0.0050528,0.23701,0.16223,1,1
4,GO MITOCHONDRIAL TRNA PROCESSING,0.004408,0.23697,0.24434,1,1
4,GO MUSCLE HYPERTROPHY,0.00098941,0.23691,0.18313,1,1
4,GO ANDROGEN METABOLIC PROCESS,0.00019079,0.23656,0.36961,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.00028792,0.23647,0.19557,1,1
4,GO ALANINE TRANSPORT,0.0045306,0.2364,0.29334,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.011612,0.23635,0.17006,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0025817,0.23583,0.19735,1,1
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.011326,0.23575,0.17144,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0073363,0.23574,0.23717,1,1
4,GO INTERLEUKIN 12 PRODUCTION,6.5149e-05,0.23558,0.24324,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,1.2962e-05,0.23556,0.20561,1,1
4,GO GOLGI TO VACUOLE TRANSPORT,0.0057817,0.23542,0.17951,1,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.00098941,0.2354,0.28024,1,1
4,GO FATTY ACID BETA OXIDATION,2.9532e-05,0.23518,0.2745,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,8.1192e-05,0.23508,0.24717,1,1
4,GO CELL CHEMOTAXIS,0.00010092,0.23498,0.20016,1,1
4,GO LIPID EXPORT FROM CELL,0.0016129,0.23484,0.26248,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0026572,0.23461,0.19324,1,1
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0013457,0.23445,0.21676,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,1.0604e-05,0.23406,0.27192,1,1
4,GO MEMBRANE FUSION,0.0001547,0.23406,0.19994,1,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.014486,0.23388,0.17986,1,1
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0015653,0.23365,0.26651,1,1
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0059384,0.23362,0.24358,1,1
4,GO SPERM CAPACITATION,0.0017123,0.2336,0.22643,1,1
4,GO LEUKOCYTE MIGRATION,0.00036427,0.23358,0.18929,1,1
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.020205,0.23356,0.16415,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,5.4121e-05,0.2335,0.22203,1,1
4,GO RESPONSE TO ACTIVITY,0.0013457,0.23348,0.20778,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00047456,0.23342,0.22432,1,1
4,GO RESPONSE TO BACTERIUM,0.00034072,0.23322,0.18272,1,1
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00034072,0.23319,0.16312,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,0.00020448,0.23301,0.30784,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.023205,0.23295,0.15666,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.038561,0.23293,0.17141,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.012508,0.23249,0.25227,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0017123,0.23244,0.25325,1,1
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00072223,0.23202,0.23534,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.035393,0.23188,0.26982,1,1
4,GO RESPONSE TO CADMIUM ION,0.024846,0.23163,0.16648,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.010245,0.23134,0.17836,1,1
4,GO INFLAMMATORY RESPONSE,0.00010845,0.23132,0.19562,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0062634,0.23131,0.28925,1,1
4,GO VESICLE TARGETING,0.0018173,0.23129,0.20744,1,1
4,GO RENAL SYSTEM PROCESS,0.00052342,0.23124,0.20105,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,3.6228e-06,0.23109,0.31383,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00069957,0.23098,0.21189,1,1
4,GO EXOCYTOSIS,5.8301e-05,0.23088,0.1968,1,1
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.0097392,0.23085,0.14933,1,1
4,GO REGULATION OF FERTILIZATION,0.0023671,0.23082,0.28278,1,1
4,GO REGULATION OF PROSTAGLANDIN SECRETION,0.0030654,0.23051,0.2611,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0037331,0.23041,0.26753,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,8.7323e-05,0.23039,0.19628,1,1
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.036164,0.23034,0.18815,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,3.7145e-05,0.22999,0.23653,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.020205,0.22994,0.14847,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0049174,0.22985,0.21574,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0071468,0.22985,0.17109,1,1
4,GO ALCOHOL METABOLIC PROCESS,7.547e-05,0.22977,0.23213,1,1
4,GO CYTOKINE PRODUCTION,0.00028792,0.22913,0.18827,1,1
4,GO MANNOSYLATION,1.6455e-05,0.22889,0.26715,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.044685,0.22872,0.17805,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.023205,0.22866,0.23154,1,1
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.0033369,0.22864,0.18467,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,3.1888e-05,0.22861,0.22606,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00095906,0.22858,0.23896,1,1
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0001165,0.22852,0.22887,1,1
4,GO RESPONSE TO ISCHEMIA,0.00059588,0.2282,0.22884,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.0031536,0.22814,0.21145,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0013457,0.22777,0.19761,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.0057817,0.22774,0.25232,1,1
4,GO PROTEIN ACTIVATION CASCADE,0.033894,0.22731,0.24267,1,1
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0050528,0.22705,0.16234,1,1
4,GO FIBROBLAST PROLIFERATION,0.029068,0.22702,0.13047,1,1
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.036164,0.22696,0.1544,1,1
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00019753,0.22656,0.28994,1,1
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0019282,0.22655,0.17621,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0066042,0.2265,0.16417,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0099891,0.22649,0.17387,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0018173,0.22636,0.18278,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00074557,0.22607,0.17848,1,1
4,GO DENDRITIC CELL MIGRATION,0.011612,0.22602,0.15037,1,1
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0034322,0.22583,0.2678,1,1
4,GO COMPLEMENT ACTIVATION,0.0083534,0.2255,0.17941,1,1
4,GO LIPID STORAGE,0.0013457,0.22532,0.2231,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0049174,0.22509,0.16809,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00019753,0.22496,0.24208,1,1
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0079323,0.2249,0.20385,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0032441,0.2247,0.22143,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.0039469,0.22464,0.22356,1,1
4,GO SELECTIVE AUTOPHAGY,6.5149e-05,0.2246,0.23616,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00038934,0.22446,0.19789,1,1
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00022676,0.22423,0.1949,1,1
4,GO REGULATION OF PROTON TRANSPORT,0.025994,0.22394,0.17826,1,1
4,GO FUCOSYLATION,0.021165,0.22367,0.23115,1,1
4,GO INCLUSION BODY ASSEMBLY,0.0079323,0.22292,0.26184,1,1
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.012508,0.2227,0.29603,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.7806e-05,0.2227,0.24703,1,1
4,GO ESTROGEN BIOSYNTHETIC PROCESS,0.0049174,0.22267,0.27458,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0027346,0.22266,0.1658,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,7.547e-05,0.22246,0.18961,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0024367,0.22244,0.16681,1,1
4,GO MUSCLE CELL MIGRATION,0.013465,0.22236,0.17715,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.0023671,0.22235,0.21763,1,1
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.016734,0.22219,0.17892,1,1
4,GO CELLULAR RESPONSE TO STARVATION,1.2962e-05,0.22215,0.2354,1,1
4,GO MITOPHAGY,0.0040578,0.22204,0.18015,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.00069957,0.22199,0.17233,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,5.4121e-05,0.22162,0.2519,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00017796,0.22157,0.20458,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.0010206,0.22099,0.16046,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0025817,0.22098,0.14459,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0029794,0.22082,0.17069,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00045924,0.22066,0.19625,1,1
4,GO LOCOMOTOR RHYTHM,0.025994,0.22063,0.17758,1,1
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0007696,0.2204,0.27475,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.013798,0.22035,0.17597,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.043763,0.22002,0.14596,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,1.4039e-05,0.21996,0.22833,1,1
4,GO COAGULATION,0.0021062,0.21938,0.15592,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0021689,0.21929,0.20037,1,1
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.00079435,0.21919,0.25092,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.014841,0.21914,0.19687,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00032948,0.21876,0.19758,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00067758,0.21862,0.29631,1,1
4,GO VITAMIN TRANSPORT,0.0094949,0.21861,0.20829,1,1
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00067758,0.21856,0.22575,1,1
4,GO HAIR CELL DIFFERENTIATION,0.0038387,0.21801,0.19346,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0051916,0.21752,0.19038,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.035393,0.21748,0.20428,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,0.00038934,0.21737,0.25113,1,1
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0090226,0.2172,0.24103,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,5.9841e-06,0.21719,0.23337,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0010206,0.21714,0.22402,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.015953,0.21712,0.1458,1,1
4,GO INTERFERON ALPHA PRODUCTION,0.0022992,0.21708,0.19732,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,1.7474e-06,0.21669,0.24724,1,1
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0094949,0.21655,0.1929,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,4.1112e-06,0.21645,0.24424,1,1
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.044685,0.21638,0.13822,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0014738,0.21637,0.18582,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0028957,0.2163,0.19628,1,1
4,GO MYOBLAST FUSION,0.0041716,0.21617,0.19473,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.0029794,0.21614,0.31512,1,1
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0064317,0.21612,0.19739,1,1
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.011326,0.21603,0.15387,1,1
4,GO MANGANESE ION TRANSPORT,0.00054072,0.21582,0.22949,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,0.0025083,0.21576,0.19596,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00072223,0.21569,0.17913,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0037331,0.21562,0.19046,1,1
4,GO T CELL MIGRATION,0.0094949,0.21524,0.16416,1,1
4,GO ORGANELLE FUSION,0.00014418,0.21503,0.18682,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.001662,0.21473,0.19498,1,1
4,GO SPLEEN DEVELOPMENT,0.004408,0.21429,0.16453,1,1
4,GO PROTEIN TARGETING TO LYSOSOME,0.030383,0.21416,0.19885,1,1
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00067758,0.21412,0.24338,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0021062,0.21394,0.2215,1,1
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.017969,0.21373,0.13387,1,1
4,GO VIRION ASSEMBLY,0.00052342,0.21309,0.16293,1,1
4,GO CARNITINE SHUTTLE,0.0016129,0.21282,0.24374,1,1
4,GO LEUKOCYTE PROLIFERATION,0.00067758,0.21209,0.17376,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.0025083,0.21198,0.19367,1,1
4,GO WOUND HEALING,0.0083534,0.21192,0.13773,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00026003,0.21174,0.20035,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0036303,0.21173,0.17634,1,1
4,GO POSITIVE CHEMOTAXIS,0.0079323,0.21169,0.14815,1,1
4,GO HORMONE CATABOLIC PROCESS,0.0073363,0.21165,0.33642,1,1
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.0025083,0.21164,0.22083,1,1
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.038561,0.21161,0.12389,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,5.0226e-05,0.21133,0.23665,1,1
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0075304,0.21131,0.17605,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,0.00040247,0.21118,0.22084,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.015953,0.21087,0.22501,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0006154,0.21085,0.21555,1,1
4,GO ENERGY HOMEOSTASIS,0.011047,0.21066,0.18048,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0027346,0.21064,0.1526,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,0.00013433,0.21057,0.19578,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.03245,0.21051,0.17169,1,1
4,GO CATECHOLAMINE METABOLIC PROCESS,0.0021062,0.21044,0.25793,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00028792,0.21041,0.18142,1,1
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0042883,0.21034,0.14936,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.044685,0.20986,0.22441,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0022992,0.20985,0.20366,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.00020448,0.20972,0.17497,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,0.0014299,0.20961,0.19237,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.014138,0.20953,0.24386,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0053338,0.20935,0.1654,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0019282,0.20918,0.15868,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.013798,0.20913,0.14195,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00014418,0.2089,0.20083,1,1
4,GO MITOCHONDRIAL GENE EXPRESSION,0.012508,0.20886,0.15792,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0038387,0.20884,0.2059,1,1
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.010506,0.20858,0.13503,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0085714,0.20819,0.23013,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,5.4121e-05,0.20807,0.24091,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.0022992,0.20804,0.2149,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0032441,0.20803,0.15394,1,1
4,GO MITOCHONDRIAL TRANSCRIPTION,0.02268,0.20771,0.18171,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.00017796,0.20761,0.20726,1,1
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0081404,0.20754,0.18261,1,1
4,GO INTERLEUKIN 1 PRODUCTION,0.0042883,0.2075,0.17377,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00026003,0.20739,0.20036,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.8583e-05,0.20719,0.20009,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.024288,0.20712,0.2118,1,1
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00010845,0.20707,0.2242,1,1
4,GO KERATINOCYTE DIFFERENTIATION,0.001872,0.20706,0.1935,1,1
4,GO PIGMENTATION,0.00069957,0.20703,0.16037,1,1
4,GO CELLULAR RESPIRATION,0.00059588,0.207,0.21313,1,1
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.02068,0.20699,0.12412,1,1
4,GO AUTOPHAGOSOME MATURATION,0.00090094,0.20697,0.21502,1,1
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0028141,0.20672,0.17776,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0017123,0.20649,0.16093,1,1
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0013872,0.20561,0.1966,1,1
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.010506,0.20551,0.14161,1,1
4,GO LYMPHOCYTE HOMEOSTASIS,0.00040247,0.20514,0.17826,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,8.1192e-05,0.20509,0.27998,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.00032948,0.20506,0.22226,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00034072,0.20502,0.19557,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00063551,0.20489,0.1808,1,1
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.043763,0.20448,0.14172,1,1
4,GO RESPONSE TO CHEMOKINE,7.013e-05,0.20447,0.20566,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00084609,0.2044,0.1725,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,5.0226e-05,0.20427,0.19779,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0040578,0.20416,0.24293,1,1
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0022332,0.20385,0.24418,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.0051916,0.20347,0.14337,1,1
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.046579,0.20341,0.11939,1,1
4,GO LYMPHOCYTE COSTIMULATION,0.009256,0.20325,0.14019,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.01282,0.20324,0.17004,1,1
4,GO RESPONSE TO KETONE,0.0017641,0.20303,0.16838,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0045306,0.20301,0.15407,1,1
4,GO LEUKOCYTE CHEMOTAXIS,0.00010092,0.20292,0.19668,1,1
4,GO MONOCYTE CHEMOTAXIS,0.018398,0.20285,0.15107,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.0020453,0.20276,0.18831,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0036303,0.20257,0.20195,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.00021167,0.20252,0.21979,1,1
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.024846,0.20252,0.1907,1,1
4,GO PEROXISOME ORGANIZATION,4.4878e-05,0.20251,0.2357,1,1
4,GO OXIDATION REDUCTION PROCESS,3.1888e-05,0.20227,0.2178,1,1
4,GO RESPONSE TO INTERLEUKIN 1,0.00026903,0.20216,0.17528,1,1
4,GO AMYLOID BETA METABOLIC PROCESS,0.0041716,0.20202,0.18989,1,1
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0007696,0.20149,0.22395,1,1
4,GO CELL ACTIVATION,0.00034072,0.20107,0.17115,1,1
4,GO REGULATION OF ISOTYPE SWITCHING,0.011326,0.20079,0.11269,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0032441,0.20068,0.13701,1,1
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.015953,0.20056,0.19489,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,6.5149e-05,0.20052,0.22282,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.004408,0.2005,0.17177,1,1
4,GO PLATELET MORPHOGENESIS,0.0036303,0.2003,0.2127,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0041716,0.20006,0.1938,1,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00010462,0.19996,0.19731,1,1
4,GO DNA DEAMINATION,0.041967,0.19978,0.20084,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.010506,0.19948,0.25198,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0042883,0.19947,0.17895,1,1
4,GO TRNA 5 LEADER REMOVAL,0.0097392,0.19922,0.16857,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,0.0039469,0.19921,0.18778,1,1
4,GO RESPONSE TO TESTOSTERONE,0.015574,0.19909,0.14832,1,1
4,GO HEPATOCYTE DIFFERENTIATION,0.030383,0.19903,0.19504,1,1
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0079323,0.19876,0.15383,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.018398,0.19871,0.26355,1,1
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.018398,0.19857,0.32755,1,1
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0033369,0.19856,0.18845,1,1
4,GO TYPE 2 IMMUNE RESPONSE,0.020205,0.19832,0.15501,1,1
4,GO CELLULAR RESPONSE TO VIRUS,0.0017123,0.19821,0.18327,1,1
4,GO REGULATION OF DEFENSE RESPONSE,0.00012964,0.19813,0.18201,1,1
4,GO INSULIN SECRETION,0.00095906,0.1981,0.17045,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0059384,0.19802,0.21125,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.024288,0.19778,0.13284,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0037331,0.19774,0.16313,1,1
4,GO SYNCYTIUM FORMATION,0.0073363,0.1977,0.1468,1,1
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.00081984,0.19769,0.19282,1,1
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.026586,0.19768,0.14888,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,0.00045924,0.19765,0.31263,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00055855,0.19756,0.15384,1,1
4,GO ENDOCYTIC RECYCLING,0.0021062,0.19748,0.14226,1,1
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.036164,0.19747,0.18911,1,1
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0013872,0.19723,0.28419,1,1
4,GO NECROTIC CELL DEATH,0.0011549,0.19723,0.2131,1,1
4,GO MITOCHONDRIAL TRANSLATION,0.029719,0.19721,0.14608,1,1
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0050528,0.19701,0.17076,1,1
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.017969,0.19654,0.28828,1,1
4,GO CARDIOLIPIN METABOLIC PROCESS,0.042857,0.19647,0.10062,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0094949,0.19623,0.12704,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0059384,0.19616,0.19081,1,1
4,GO NIK NF KAPPAB SIGNALING,0.0006154,0.19602,0.15977,1,1
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.029719,0.19602,0.12797,1,1
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.03245,0.19584,0.10355,1,1
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.013139,0.19577,0.15287,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0028141,0.19575,0.12491,1,1
4,GO REGULATION OF PEPTIDE SECRETION,6.2786e-05,0.19557,0.17208,1,1
4,GO T CELL DIFFERENTIATION,0.00087311,0.19552,0.13457,1,1
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.0016129,0.19541,0.19491,1,1
4,GO FATTY ACID METABOLIC PROCESS,0.00012074,0.19533,0.2241,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00040247,0.1953,0.17683,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.00028792,0.19521,0.22318,1,1
4,GO ALPHA BETA T CELL ACTIVATION,0.00054072,0.1952,0.17765,1,1
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.035393,0.19508,0.15551,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,3.4421e-05,0.19491,0.22353,1,1
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.011326,0.19483,0.18413,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,0.00042998,0.1948,0.20106,1,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.011612,0.1948,0.17704,1,1
4,GO RESPONSE TO INTERLEUKIN 15,0.017549,0.19468,0.21209,1,1
4,GO DETERMINATION OF ADULT LIFESPAN,0.0025083,0.19449,0.24628,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.015203,0.19429,0.16398,1,1
4,GO DRUG METABOLIC PROCESS,0.0010528,0.19428,0.28771,1,1
4,GO COPULATION,0.0040578,0.19418,0.20722,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.00029782,0.19414,0.16942,1,1
4,GO PEPTIDE CATABOLIC PROCESS,0.0034322,0.19406,0.23257,1,1
4,GO REGULATION OF TUBE SIZE,0.00074557,0.19401,0.20137,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0097392,0.19382,0.15665,1,1
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00054072,0.19378,0.20961,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,5.6174e-05,0.19374,0.22499,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.014138,0.19339,0.13171,1,1
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.027188,0.19319,0.12149,1,1
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.00084609,0.1931,0.18406,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0017123,0.1929,0.15627,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00098941,0.19278,0.1535,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.001191,0.19269,0.14977,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0059384,0.19265,0.13427,1,1
4,GO REGULATION OF MITOPHAGY,0.0067808,0.19251,0.17008,1,1
4,GO DRINKING BEHAVIOR,0.019739,0.1925,0.1779,1,1
4,GO RESPONSE TO ALCOHOL,0.00067758,0.19249,0.15335,1,1
4,GO B CELL ACTIVATION,9.0551e-05,0.19246,0.18247,1,1
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.03245,0.19228,0.16368,1,1
4,GO B CELL DIFFERENTIATION,6.2786e-05,0.19222,0.19968,1,1
4,GO PEPTIDE SECRETION,4.3218e-05,0.19183,0.18087,1,1
4,GO NATURAL KILLER CELL ACTIVATION,0.0011199,0.1917,0.16471,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.0013457,0.19156,0.16058,1,1
4,GO SODIUM ION HOMEOSTASIS,0.010506,0.19146,0.15226,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0097392,0.19134,0.21569,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.00029782,0.19114,0.21706,1,1
4,GO REGULATION OF GLUCONEOGENESIS,0.00047456,0.19094,0.23652,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00013433,0.19091,0.19925,1,1
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.027803,0.19076,0.17028,1,1
4,GO REGULATION OF HORMONE LEVELS,2.9532e-05,0.19042,0.21113,1,1
4,GO FATTY ACID TRANSPORT,5.0226e-05,0.19038,0.22765,1,1
4,GO ERAD PATHWAY,0.0099891,0.19036,0.13697,1,1
4,GO T HELPER CELL LINEAGE COMMITMENT,0.011326,0.19028,0.15563,1,1
4,GO LYMPHOCYTE CHEMOTAXIS,0.042857,0.19021,0.090816,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0036303,0.19021,0.20947,1,1
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0032441,0.1902,0.17907,1,1
4,GO RESPONSE TO INTERLEUKIN 4,0.0011549,0.1902,0.17153,1,1
4,GO ADAPTIVE THERMOGENESIS,0.0001547,0.19012,0.17076,1,1
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0012662,0.18991,0.20591,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00055855,0.18954,0.19729,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.00018427,0.1895,0.17626,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.0028957,0.18943,0.28349,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.001662,0.1894,0.13775,1,1
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0028141,0.18933,0.20608,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0022992,0.18925,0.18595,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00038934,0.18917,0.17097,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.015203,0.18909,0.15851,1,1
4,GO SENSORY PERCEPTION OF SMELL,3.3132e-05,0.18898,0.19759,1,1
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.026586,0.18886,0.10772,1,1
4,GO PROTEIN KINASE B SIGNALING,0.0097392,0.18885,0.12508,1,1
4,GO TETRAPYRROLE METABOLIC PROCESS,0.0024367,0.18881,0.24974,1,1
4,GO VIRAL LIFE CYCLE,0.001191,0.1887,0.15114,1,1
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.018398,0.18865,0.12961,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,0.0090226,0.18854,0.17215,1,1
4,GO IRON ION TRANSPORT,0.00012512,0.18842,0.23147,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00095906,0.1884,0.18232,1,1
4,GO REGULATION OF BLOOD PRESSURE,4.8379e-05,0.18834,0.20297,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.001662,0.18826,0.1541,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.015953,0.18825,0.15731,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.010506,0.18787,0.18974,1,1
4,GO HUMORAL IMMUNE RESPONSE,6.0504e-05,0.18786,0.18729,1,1
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0099891,0.18773,0.11729,1,1
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.025414,0.18769,0.14941,1,1
4,GO CELLULAR RESPONSE TO DSRNA,0.016734,0.18731,0.14657,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.001872,0.18692,0.15478,1,1
4,GO NEUTROPHIL CHEMOTAXIS,6.7596e-05,0.18691,0.16992,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,0.00018427,0.1868,0.22079,1,1
4,GO TISSUE HOMEOSTASIS,0.0021689,0.18675,0.16703,1,1
4,GO REGULATION OF ANION TRANSPORT,0.00045924,0.1867,0.21777,1,1
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0037331,0.18664,0.16204,1,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.001986,0.18663,0.19281,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00016595,0.18656,0.17006,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0011199,0.18632,0.15645,1,1
4,GO PROTEIN REFOLDING,0.011047,0.18603,0.19993,1,1
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0053338,0.18603,0.17029,1,1
4,GO REGULATION OF IMMUNE RESPONSE,0.00081984,0.18602,0.15199,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,0.00024286,0.18595,0.17243,1,1
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.013465,0.1859,0.14009,1,1
4,GO PEPTIDYL PROLINE MODIFICATION,0.012203,0.18586,0.15905,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0042883,0.18584,0.18249,1,1
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.0069616,0.1858,0.27073,1,1
4,GO ESTROGEN METABOLIC PROCESS,0.0083534,0.1857,0.18513,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,5.2139e-05,0.18537,0.21367,1,1
4,GO POSITIVE REGULATION OF COAGULATION,0.0071468,0.18513,0.18686,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0039469,0.18504,0.11753,1,1
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0059384,0.18475,0.12769,1,1
4,GO RIG I SIGNALING PATHWAY,0.031059,0.18463,0.11216,1,1
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.017969,0.18438,0.14129,1,1
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0064317,0.18426,0.27498,1,1
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00044439,0.18409,0.2345,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.040234,0.18408,0.12617,1,1
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0034322,0.18395,0.22786,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.0071468,0.18393,0.15203,1,1
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0041716,0.18358,0.19478,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00045924,0.1831,0.20008,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00036427,0.18307,0.17094,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,0.00031859,0.18299,0.14774,1,1
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.021165,0.18298,0.20377,1,1
4,GO PLATELET ACTIVATION,0.0081404,0.18276,0.1367,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,0.0024367,0.18274,0.15834,1,1
4,GO ACETYL COA METABOLIC PROCESS,0.010245,0.1827,0.17055,1,1
4,GO RESPONSE TO WOUNDING,0.014841,0.1826,0.11376,1,1
4,GO REGULATION OF NECROTIC CELL DEATH,0.017969,0.18257,0.17099,1,1
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.001872,0.18246,0.19803,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00079435,0.18227,0.18133,1,1
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.02068,0.18221,0.17811,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.00069957,0.1821,0.18544,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.03939,0.18163,0.13369,1,1
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0032441,0.1814,0.18545,1,1
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0024367,0.18135,0.1267,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,0.0012662,0.1813,0.14986,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0042883,0.18106,0.1443,1,1
4,GO REGULATION OF CELL ACTIVATION,0.0028141,0.18101,0.12857,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0025817,0.18097,0.20918,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0006154,0.18058,0.17999,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0006154,0.1805,0.15208,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.013465,0.18019,0.12883,1,1
4,GO ATP BIOSYNTHETIC PROCESS,0.031059,0.18013,0.1591,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0025817,0.18,0.16941,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00034072,0.17994,0.15359,1,1
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00042998,0.17986,0.2155,1,1
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,5.8301e-05,0.17983,0.22781,1,1
4,GO LIPID CATABOLIC PROCESS,1.2962e-05,0.17976,0.23466,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00057693,0.17973,0.17876,1,1
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.023741,0.17971,0.25058,1,1
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.029068,0.17969,0.1429,1,1
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.014486,0.17965,0.14538,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.00074557,0.1796,0.18012,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,0.0001547,0.17957,0.18251,1,1
4,GO LYMPHOCYTE DIFFERENTIATION,0.001191,0.17936,0.1191,1,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0041716,0.17932,0.172,1,1
4,GO SKIN DEVELOPMENT,0.0056288,0.17906,0.1406,1,1
4,GO EPIDERMIS DEVELOPMENT,0.0049174,0.17902,0.14574,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0010528,0.17881,0.1741,1,1
4,GO VACUOLE ORGANIZATION,1.4609e-05,0.17877,0.22033,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0013872,0.17877,0.12618,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.00055855,0.17874,0.15082,1,1
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.029068,0.17868,0.16976,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,4.6597e-05,0.17864,0.23951,1,1
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.015574,0.17856,0.16192,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0016129,0.1785,0.17688,1,1
4,GO MUSCLE ADAPTATION,0.004408,0.17813,0.14432,1,1
4,GO REGULATION OF CELL CELL ADHESION,0.0051916,0.17805,0.14147,1,1
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0045306,0.17802,0.16116,1,1
4,GO HORMONE TRANSPORT,0.00027832,0.17802,0.17371,1,1
4,GO REGULATION OF SYMBIOTIC PROCESS,0.0025083,0.17784,0.15931,1,1
4,GO BROWN FAT CELL DIFFERENTIATION,0.0097392,0.17769,0.14713,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00074557,0.17766,0.18382,1,1
4,GO LIPID METABOLIC PROCESS,0.00017186,0.17747,0.17916,1,1
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.001872,0.17743,0.31558,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,0.00057693,0.17742,0.15311,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00040247,0.17733,0.18634,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,1.7118e-05,0.17709,0.24367,1,1
4,GO RESPONSE TO METAL ION,0.00050664,0.1769,0.17773,1,1
4,GO T CELL ACTIVATION,0.0023671,0.1769,0.13641,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0031536,0.17689,0.13291,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00055855,0.17684,0.16071,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.030383,0.17675,0.13997,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00029782,0.17673,0.16293,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,0.0029794,0.17666,0.13634,1,1
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.007729,0.17661,0.18183,1,1
4,GO CARBOHYDRATE TRANSPORT,0.00012964,0.1766,0.21459,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0050528,0.17651,0.15419,1,1
4,GO ORGANIC ANION TRANSPORT,1.9263e-05,0.17644,0.20698,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00079435,0.17636,0.17856,1,1
4,GO PROTEASOME ASSEMBLY,0.0040578,0.1763,0.18408,1,1
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.021165,0.1763,0.14024,1,1
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.0069616,0.17626,0.17856,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00074557,0.1762,0.20442,1,1
4,GO POSITIVE REGULATION OF HEART RATE,0.037747,0.17611,0.1708,1,1
4,GO DENDRITIC CELL CHEMOTAXIS,0.017137,0.17611,0.1446,1,1
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.014486,0.17598,0.17139,1,1
4,GO REGULATION OF NUCLEASE ACTIVITY,0.0025083,0.17595,0.17944,1,1
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.036948,0.17591,0.12398,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.0027346,0.1759,0.14965,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.0022332,0.17574,0.14006,1,1
4,GO LYMPHOCYTE ACTIVATION,0.0023671,0.17564,0.12002,1,1
4,GO VIRAL BUDDING,0.0012662,0.17564,0.16236,1,1
4,GO GLUCOSE METABOLIC PROCESS,3.9418e-06,0.1756,0.23073,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00019079,0.17553,0.20603,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.014841,0.17546,0.13424,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0034322,0.17509,0.11887,1,1
4,GO PEPTIDE HORMONE SECRETION,0.00067758,0.17505,0.16331,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0011549,0.17468,0.14984,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.001872,0.1745,0.15636,1,1
4,GO LIPID HOMEOSTASIS,0.0028141,0.17434,0.19529,1,1
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.025994,0.17433,0.19922,1,1
4,GO T CELL HOMEOSTASIS,0.0049174,0.17393,0.13601,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.0071468,0.17385,0.14469,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0023671,0.1738,0.12809,1,1
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0039469,0.17361,0.1648,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.01282,0.17348,0.13132,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00012512,0.17293,0.15908,1,1
4,GO INTERACTION WITH HOST,0.0037331,0.17293,0.15654,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00032948,0.17291,0.14935,1,1
4,GO AMYLOID BETA FORMATION,0.040234,0.17283,0.14051,1,1
4,GO METAL ION HOMEOSTASIS,0.0015653,0.17282,0.12348,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.0073e-05,0.17264,0.17917,1,1
4,GO POSITIVE REGULATION OF CELL AGING,0.04854,0.1725,0.16158,1,1
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.001872,0.17248,0.15505,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00013917,0.17224,0.21032,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.015203,0.17218,0.17673,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.016734,0.17187,0.14286,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.011904,0.17184,0.15691,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0034322,0.17181,0.18219,1,1
4,GO IMMUNOGLOBULIN PRODUCTION,0.00027832,0.17159,0.15421,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0006154,0.17154,0.18564,1,1
4,GO ACTIN NUCLEATION,0.0022332,0.17152,0.15951,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00031859,0.17136,0.15944,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.029719,0.17127,0.17319,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.00021909,0.17099,0.17684,1,1
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.01282,0.17075,0.15922,1,1
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.010773,0.17073,0.13082,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.016339,0.17064,0.15933,1,1
4,GO REGULATION OF HORMONE SECRETION,0.00049035,0.17049,0.16262,1,1
4,GO LIPID IMPORT INTO CELL,0.02843,0.17042,0.17874,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.009256,0.17031,0.13331,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0047853,0.17018,0.13187,1,1
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00074557,0.17,0.21464,1,1
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00353,0.16999,0.19473,1,1
4,GO POSITIVE REGULATION OF MITOPHAGY,0.013139,0.16994,0.18437,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.00027832,0.16955,0.18675,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0045306,0.16955,0.12676,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.023205,0.1692,0.15039,1,1
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0024367,0.16919,0.17659,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,0.012508,0.16913,0.16126,1,1
4,GO PROTEIN MATURATION,4.1617e-05,0.16908,0.21151,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0012662,0.16903,0.12957,1,1
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.01282,0.16891,0.22771,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0030654,0.16865,0.16254,1,1
4,GO REGULATION OF T CELL DIFFERENTIATION,0.0036303,0.16842,0.12095,1,1
4,GO MULTI ORGANISM CELLULAR PROCESS,0.025414,0.16841,0.13129,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0040578,0.16837,0.11211,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0013054,0.16823,0.219,1,1
4,GO PROTEIN PROCESSING,1.7806e-05,0.16812,0.2562,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.020205,0.16802,0.16776,1,1
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.010506,0.16797,0.21194,1,1
4,GO AMINE CATABOLIC PROCESS,0.004408,0.16778,0.28897,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.018836,0.16771,0.15062,1,1
4,GO HORMONE BIOSYNTHETIC PROCESS,0.025414,0.16766,0.1717,1,1
4,GO P38MAPK CASCADE,0.015953,0.1675,0.15148,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.010506,0.16734,0.14771,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.0051916,0.16695,0.18575,1,1
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.011326,0.16681,0.12922,1,1
4,GO RESPONSE TO ETHER,0.0085714,0.1668,0.16669,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00038934,0.16678,0.14893,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0028141,0.16677,0.20929,1,1
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0053338,0.16661,0.15358,1,1
4,GO REGULATION OF LIPID STORAGE,0.004408,0.1666,0.16978,1,1
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.0059384,0.16658,0.14604,1,1
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0090226,0.16638,0.16682,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,8.7323e-05,0.16633,0.19611,1,1
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00042998,0.16622,0.22379,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.5308e-05,0.16598,0.21192,1,1
4,GO ERK1 AND ERK2 CASCADE,0.024288,0.16591,0.11348,1,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.02843,0.1658,0.15352,1,1
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.026586,0.16579,0.12672,1,1
4,GO ACID SECRETION,0.0057817,0.1657,0.16505,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.010773,0.16559,0.11183,1,1
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0056288,0.16557,0.16031,1,1
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.019739,0.16521,0.14251,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0001547,0.16443,0.16169,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0034322,0.16428,0.17753,1,1
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.014841,0.16418,0.23668,1,1
4,GO COPPER ION TRANSPORT,0.018836,0.16378,0.16006,1,1
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0013457,0.16322,0.13454,1,1
4,GO RESPONSE TO FUNGUS,0.0025083,0.16283,0.13253,1,1
4,GO CHOLESTEROL STORAGE,0.045624,0.16267,0.13266,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0099891,0.16264,0.25414,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0067808,0.16248,0.15414,1,1
4,GO RENAL SODIUM EXCRETION,0.0079323,0.16237,0.18203,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.014841,0.16236,0.14719,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0010859,0.16236,0.15642,1,1
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0025083,0.16235,0.18359,1,1
4,GO RESPONSE TO STEROL,0.011047,0.16225,0.17476,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0010206,0.16206,0.16371,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00065623,0.16193,0.17729,1,1
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.016734,0.16187,0.16041,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.015203,0.16178,0.12826,1,1
4,GO OXIDATIVE PHOSPHORYLATION,0.0021689,0.16174,0.1972,1,1
4,GO CYTOKINE SECRETION,0.0020453,0.16171,0.16887,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0020453,0.16111,0.1465,1,1
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.0028141,0.1611,0.2019,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00090094,0.16093,0.15273,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00019079,0.16089,0.15032,1,1
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.021165,0.16088,0.10725,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00035231,0.16086,0.13028,1,1
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.018836,0.16045,0.18363,1,1
4,GO RESPONSE TO DSRNA,0.0017641,0.16043,0.1506,1,1
4,GO ATP TRANSPORT,0.029068,0.16036,0.10802,1,1
4,GO SULFUR COMPOUND TRANSPORT,0.00027832,0.16032,0.19641,1,1
4,GO ION HOMEOSTASIS,0.0011199,0.1603,0.13058,1,1
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.026586,0.15985,0.13951,1,1
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0026572,0.15981,0.12728,1,1
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0012662,0.15967,0.18455,1,1
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.011047,0.15963,0.1681,1,1
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0069616,0.1596,0.10407,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0040578,0.15933,0.14125,1,1
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.02068,0.15929,0.19796,1,1
4,GO TEMPERATURE HOMEOSTASIS,0.00087311,0.15927,0.14444,1,1
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0081404,0.1591,0.11526,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.00098941,0.15887,0.18091,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0017641,0.15841,0.12715,1,1
4,GO ENDOTHELIAL CELL MIGRATION,0.0073363,0.15829,0.14977,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00028792,0.15824,0.16221,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0017641,0.15822,0.12947,1,1
4,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0066042,0.15818,0.37617,1,1
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0014299,0.15808,0.17852,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0038387,0.15804,0.12652,1,1
4,GO SECRETION,0.00013433,0.1571,0.1632,1,1
4,GO REGULATION OF PROTEIN FOLDING,0.03939,0.15709,0.11005,1,1
4,GO PROTEIN FOLDING,0.0069616,0.15708,0.13895,1,1
4,GO CERAMIDE METABOLIC PROCESS,0.00052342,0.15681,0.20662,1,1
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0045306,0.15678,0.16707,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,0.00012964,0.15629,0.1563,1,1
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.027188,0.15626,0.11018,1,1
4,GO PROTEIN MANNOSYLATION,0.0025817,0.15617,0.18299,1,1
4,GO REGULATION OF LIPID LOCALIZATION,0.00090094,0.15607,0.19593,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.02843,0.1558,0.12989,1,1
4,GO REGULATION OF CELL ADHESION,0.0085714,0.15577,0.12348,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,5.0226e-05,0.15567,0.22735,1,1
4,GO CELLULAR ION HOMEOSTASIS,0.001872,0.15544,0.1228,1,1
4,GO LEUKOCYTE DIFFERENTIATION,0.0013872,0.15537,0.12658,1,1
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0054795,0.15532,0.14529,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0060989,0.15506,0.1173,1,1
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.030383,0.15484,0.12811,1,1
4,GO RESPONSE TO MECHANICAL STIMULUS,0.00049035,0.15481,0.16048,1,1
4,GO REGULATION OF PROTEOLYSIS,0.00081984,0.15467,0.14182,1,1
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0026572,0.15465,0.12218,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,6.5149e-05,0.15457,0.18883,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.010773,0.15457,0.11886,1,1
4,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.021165,0.15426,0.1745,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.0071468,0.15376,0.1519,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.00021909,0.15371,0.16137,1,1
4,GO REGULATION OF HEMOPOIESIS,0.001986,0.15367,0.11822,1,1
4,GO RESPONSE TO LIPID,0.0037331,0.15363,0.1208,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00081984,0.15361,0.1693,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.0021062,0.15356,0.14848,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0050528,0.15329,0.14649,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.0030654,0.15309,0.13452,1,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.041967,0.15277,0.15946,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0021062,0.15272,0.13354,1,1
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00050664,0.15264,0.21527,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00017796,0.15252,0.1814,1,1
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.010506,0.15235,0.13424,1,1
4,GO CHLORIDE TRANSPORT,0.0007696,0.15233,0.14687,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0025083,0.15227,0.1637,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.0057817,0.15223,0.15316,1,1
4,GO DE NOVO PROTEIN FOLDING,0.0047853,0.15189,0.16212,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,0.00029782,0.15184,0.18229,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.027803,0.15163,0.15643,1,1
4,GO PROTEIN TARGETING TO VACUOLE,0.0099891,0.15153,0.15154,1,1
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0021689,0.15122,0.2064,1,1
4,GO T CELL APOPTOTIC PROCESS,0.033166,0.15121,0.12173,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00034072,0.15116,0.16111,1,1
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.041093,0.15106,0.12861,1,1
4,GO INTERFERON BETA PRODUCTION,0.019739,0.15105,0.12656,1,1
4,GO AGING,0.00041602,0.15105,0.14103,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0017641,0.15096,0.23355,1,1
4,GO GOLGI ORGANIZATION,4.6597e-05,0.15093,0.18392,1,1
4,GO DEFENSE RESPONSE TO FUNGUS,0.0099891,0.15092,0.12099,1,1
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0017641,0.1508,0.25877,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0051916,0.15079,0.13987,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0021689,0.15075,0.14956,1,1
4,GO ALCOHOL CATABOLIC PROCESS,0.00074557,0.15052,0.19257,1,1
4,GO T CELL LINEAGE COMMITMENT,0.0017123,0.15045,0.17614,1,1
4,GO MACROPHAGE ACTIVATION,0.00084609,0.15041,0.15659,1,1
4,GO ANION TRANSPORT,4.3218e-05,0.1504,0.18272,1,1
4,GO LEUKOCYTE HOMEOSTASIS,0.0085714,0.15037,0.12744,1,1
4,GO SYMBIOTIC PROCESS,0.0033369,0.15024,0.108,1,1
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0056288,0.15001,0.14716,1,1
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.016734,0.14986,0.14372,1,1
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.042857,0.14965,0.10055,1,1
4,GO MITOCHONDRIAL FISSION,0.047551,0.14954,0.16036,1,1
4,GO TERPENOID METABOLIC PROCESS,0.038561,0.14937,0.14916,1,1
4,GO BICARBONATE TRANSPORT,0.007729,0.14928,0.17012,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,0.0057817,0.14874,0.13304,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0022992,0.14868,0.13188,1,1
4,GO CHEMICAL HOMEOSTASIS,0.00032948,0.14847,0.14551,1,1
4,GO CALCIUM ION IMPORT,0.043763,0.14838,0.082155,1,1
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.042857,0.14822,0.099986,1,1
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0064317,0.14822,0.1929,1,1
4,GO RESPONSE TO ANTIBIOTIC,0.023741,0.14808,0.11195,1,1
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00035231,0.14799,0.16302,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.00013917,0.14785,0.18924,1,1
4,GO RESPONSE TO DRUG,0.0039469,0.14765,0.13856,1,1
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0079323,0.14756,0.14925,1,1
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0025817,0.14753,0.21628,1,1
4,GO HEME METABOLIC PROCESS,0.013798,0.1475,0.26665,1,1
4,GO MACROPHAGE DIFFERENTIATION,0.029719,0.14745,0.15906,1,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.001986,0.14738,0.15985,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.040234,0.14728,0.15251,1,1
4,GO NCRNA CATABOLIC PROCESS,0.02068,0.14723,0.11529,1,1
4,GO TRANSITION METAL ION HOMEOSTASIS,0.031059,0.14701,0.11934,1,1
4,GO RESPONSE TO CALCIUM ION,0.0029794,0.14691,0.16965,1,1
4,GO TOXIN TRANSPORT,0.0056288,0.1469,0.18428,1,1
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.00021909,0.14676,0.16834,1,1
4,GO RESPONSE TO MISFOLDED PROTEIN,0.001872,0.14665,0.19484,1,1
4,GO ORGANELLE DISASSEMBLY,0.00038934,0.14649,0.16208,1,1
4,GO REGULATION OF LIPID TRANSPORT,0.0013054,0.14636,0.20425,1,1
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00098941,0.14623,0.18186,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0032441,0.14618,0.17622,1,1
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.023741,0.14599,0.17053,1,1
4,GO POSITIVE REGULATION OF SECRETION,0.0001547,0.14576,0.16116,1,1
4,GO OOCYTE DIFFERENTIATION,0.0059384,0.14568,0.12418,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.009256,0.14545,0.1467,1,1
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0013457,0.14535,0.18502,1,1
4,GO MYOTUBE DIFFERENTIATION,0.0015653,0.14469,0.14846,1,1
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00049035,0.14459,0.16464,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.00016023,0.14454,0.16532,1,1
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.026586,0.1444,0.12645,1,1
4,GO LYSOSOME LOCALIZATION,0.00079435,0.14364,0.15591,1,1
4,GO POLYAMINE METABOLIC PROCESS,0.020205,0.14352,0.15984,1,1
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.027803,0.14343,0.13728,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00010845,0.143,0.16742,1,1
4,GO ORGANIC ACID TRANSPORT,7.013e-05,0.14295,0.2025,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,0.0053338,0.1424,0.19539,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.01282,0.14237,0.11131,1,1
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.034637,0.14236,0.12826,1,1
4,GO RESPONSE TO TOXIC SUBSTANCE,0.010773,0.14219,0.16315,1,1
4,GO REGULATION OF INSULIN SECRETION,0.0025817,0.1419,0.14783,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.025994,0.14187,0.19797,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0097392,0.14182,0.18437,1,1
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.036164,0.14182,0.12359,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0036303,0.1417,0.13748,1,1
4,GO CELL CELL ADHESION,0.02268,0.14152,0.10283,1,1
4,GO REGULATION OF STEROL TRANSPORT,0.018398,0.14094,0.1435,1,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.01282,0.14094,0.14384,1,1
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.02843,0.14094,0.1415,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.038561,0.14072,0.12399,1,1
4,GO T CELL PROLIFERATION,0.0050528,0.14065,0.14366,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0010206,0.14048,0.15944,1,1
4,GO MYELOID CELL DIFFERENTIATION,0.0039469,0.14042,0.10779,1,1
4,GO RESPONSE TO STEROID HORMONE,0.0025817,0.14029,0.14619,1,1
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0047853,0.14028,0.16596,1,1
4,GO RESPONSE TO HORMONE,0.001662,0.13995,0.13151,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0017641,0.13984,0.12997,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0041716,0.13977,0.14971,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00034072,0.13959,0.15145,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.013139,0.13929,0.13657,1,1
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.031748,0.13928,0.12326,1,1
4,GO PROSTAGLANDIN SECRETION,0.02268,0.13926,0.1849,1,1
4,GO RESPONSE TO GAMMA RADIATION,0.020205,0.13926,0.10551,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.043763,0.13921,0.13966,1,1
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00092958,0.13905,0.12761,1,1
4,GO VITAMIN METABOLIC PROCESS,0.013139,0.1389,0.17894,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.011047,0.13865,0.13676,1,1
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.013465,0.13863,0.14723,1,1
4,GO GOLGI RIBBON FORMATION,0.02068,0.13862,0.15664,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0067808,0.13818,0.14965,1,1
4,GO PIGMENT CELL DIFFERENTIATION,0.042857,0.13805,0.10042,1,1
4,GO REGULATION OF PROTEIN BINDING,0.0071468,0.13785,0.1196,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00021167,0.13769,0.17541,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00079435,0.13752,0.12713,1,1
4,GO RESPONSE TO ETHANOL,0.016734,0.13718,0.10983,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0011549,0.13715,0.16005,1,1
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0056288,0.13667,0.14148,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00019753,0.13643,0.15463,1,1
4,GO EPITHELIUM DEVELOPMENT,0.0062634,0.13634,0.10237,1,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0028141,0.13632,0.17884,1,1
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.015574,0.13632,0.12462,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00098941,0.1363,0.14747,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0066042,0.13625,0.11745,1,1
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.026586,0.13613,0.11282,1,1
4,GO VESICLE ORGANIZATION,0.00087311,0.13599,0.1594,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00023468,0.13584,0.15261,1,1
4,GO EXCRETION,0.0028957,0.13548,0.16041,1,1
4,GO CHOLESTEROL EFFLUX,0.026586,0.13527,0.15417,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.02068,0.13518,0.10505,1,1
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.026586,0.13472,0.10209,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,0.0025817,0.13442,0.098261,1,1
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.00014935,0.13396,0.16649,1,1
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.04854,0.13386,0.11518,1,1
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.011326,0.13377,0.12745,1,1
4,GO LIPID MODIFICATION,0.00049035,0.13355,0.16341,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.00095906,0.13325,0.17678,1,1
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.014486,0.13292,0.13048,1,1
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.034637,0.13291,0.088714,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0010528,0.13281,0.14114,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0010206,0.13273,0.13552,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.043763,0.13271,0.069605,1,1
4,GO CELL MATURATION,0.0051916,0.13174,0.10393,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.0064317,0.1315,0.12182,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.0020453,0.13128,0.20347,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0013872,0.13123,0.12359,1,1
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.001228,0.13104,0.10521,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.012508,0.13057,0.16165,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.043763,0.13032,0.10606,1,1
4,GO DETECTION OF STIMULUS,0.00021909,0.12943,0.11678,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.036164,0.12939,0.12178,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.001191,0.12912,0.11961,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0026572,0.12893,0.137,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0046564,0.1282,0.10991,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.040234,0.12809,0.09661,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.009256,0.12791,0.12843,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.0047853,0.1279,0.19785,1,1
4,GO REGULATION OF VASOCONSTRICTION,0.0021062,0.12766,0.19281,1,1
4,GO PIGMENT METABOLIC PROCESS,0.019283,0.1275,0.16416,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.024846,0.12748,0.12098,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.016734,0.12741,0.096293,1,1
4,GO TISSUE MIGRATION,0.014841,0.12718,0.12442,1,1
4,GO INORGANIC ANION TRANSPORT,0.00045924,0.12715,0.13928,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.011047,0.12695,0.096411,1,1
4,GO BODY FLUID SECRETION,0.029068,0.12667,0.090429,1,1
4,GO ENDOCRINE HORMONE SECRETION,0.015203,0.12666,0.1184,1,1
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.0020453,0.12656,0.12759,1,1
4,GO RESPONSE TO IRON ION,0.019283,0.1265,0.16932,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,0.00017796,0.12632,0.1637,1,1
4,GO TRANSITION METAL ION TRANSPORT,0.00026003,0.12551,0.20883,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.0022332,0.12517,0.10747,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.0039469,0.12516,0.15477,1,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.025414,0.12481,0.14123,1,1
4,GO REGULATION OF CHEMOTAXIS,0.01282,0.12479,0.09712,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.014486,0.12454,0.11905,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0045306,0.12427,0.15278,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.01282,0.12427,0.11042,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.0013872,0.12425,0.15477,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.027188,0.12386,0.10273,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.03245,0.12375,0.10088,1,1
4,GO T CELL SELECTION,0.010245,0.12372,0.1029,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.036164,0.12369,0.1024,1,1
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.011904,0.12341,0.13153,1,1
4,GO PROTEOLYSIS,0.00026003,0.1234,0.13389,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,0.00027832,0.12338,0.12219,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,0.00022676,0.12326,0.15117,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00011241,0.12308,0.17837,1,1
4,GO REGULATION OF VACUOLE ORGANIZATION,0.0066042,0.12306,0.15714,1,1
4,GO CELLULAR RESPONSE TO LIPID,0.012508,0.12302,0.10697,1,1
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.0051916,0.123,0.14246,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0022332,0.12298,0.10638,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00026003,0.12289,0.15361,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0056288,0.12209,0.1505,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00055855,0.12185,0.12917,1,1
4,GO GLUCOSE IMPORT,0.042857,0.12153,0.11971,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.02068,0.12123,0.093596,1,1
4,GO MAINTENANCE OF LOCATION IN CELL,0.0050528,0.12119,0.11067,1,1
4,GO REGULATION OF CELL DEATH,0.0057817,0.12113,0.090647,1,1
4,GO REGULATION OF ION TRANSPORT,0.042857,0.12111,0.081788,1,1
4,GO STEROL IMPORT,0.02068,0.1209,0.22252,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.001662,0.12078,0.12139,1,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.027188,0.12008,0.11366,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0029794,0.11971,0.11006,1,1
4,GO BIOLOGICAL ADHESION,0.041093,0.11952,0.08425,1,1
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.023205,0.11937,0.11486,1,1
4,GO MAINTENANCE OF LOCATION,0.0081404,0.11925,0.10818,1,1
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0073363,0.11924,0.15949,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0059384,0.11906,0.098645,1,1
4,GO HOMEOSTATIC PROCESS,0.00029782,0.11897,0.12188,1,1
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.026586,0.11895,0.074004,1,1
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0034322,0.11851,0.11703,1,1
4,GO SINGLE FERTILIZATION,0.025414,0.11834,0.082837,1,1
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0022992,0.11824,0.12165,1,1
4,GO REGULATION OF SECRETION,0.00098941,0.1176,0.13141,1,1
4,GO RESPONSE TO INSULIN,0.0013457,0.11747,0.13992,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.012508,0.11744,0.13336,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.0081404,0.11738,0.10854,1,1
4,GO REGULATION OF GLUCOSE IMPORT,0.025994,0.11728,0.12409,1,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00079435,0.11709,0.12074,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.00057693,0.11668,0.15236,1,1
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.04854,0.11624,0.15401,1,1
4,GO CELL CELL RECOGNITION,0.03939,0.11621,0.12383,1,1
4,GO MITOCHONDRIAL TRANSPORT,0.0013872,0.11615,0.10367,1,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.010245,0.11614,0.11358,1,1
4,GO REGULATION OF RESPONSE TO STRESS,0.001872,0.11608,0.11356,1,1
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.046579,0.11599,0.12358,1,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.019283,0.11595,0.077585,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00010845,0.11574,0.1635,1,1
4,GO GLAND DEVELOPMENT,0.024288,0.11572,0.080118,1,1
4,GO CIRCULATORY SYSTEM PROCESS,0.0034322,0.11543,0.12009,1,1
4,GO TOR SIGNALING,0.0010528,0.11533,0.092004,1,1
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.027803,0.11504,0.09338,1,1
4,GO PYRUVATE METABOLIC PROCESS,0.033166,0.11464,0.10642,1,1
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.013798,0.11454,0.09667,1,1
4,GO THIOESTER METABOLIC PROCESS,0.0032441,0.11412,0.16932,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.041093,0.11409,0.080127,1,1
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.009256,0.11405,0.21688,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.011326,0.11389,0.1103,1,1
4,GO APOPTOTIC PROCESS,0.0053338,0.11327,0.091091,1,1
4,GO CATECHOLAMINE SECRETION,0.041093,0.11319,0.23199,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0017641,0.11315,0.12337,1,1
4,GO ATP METABOLIC PROCESS,0.0032441,0.11301,0.13594,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.013465,0.11278,0.12469,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,0.0050528,0.11238,0.12307,1,1
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0090226,0.11217,0.13115,1,1
4,GO SOMITOGENESIS,0.0073363,0.11188,0.11761,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.027188,0.11186,0.086644,1,1
4,GO REGULATION OF TOR SIGNALING,0.004408,0.1118,0.099662,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0097392,0.11179,0.10756,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.0028957,0.1111,0.11411,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.0075304,0.11066,0.081661,1,1
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0075304,0.11049,0.11861,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0066042,0.11019,0.11142,1,1
4,GO EXOCYTIC PROCESS,0.014841,0.10988,0.16802,1,1
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0014299,0.10976,0.1215,1,1
4,GO WATER TRANSPORT,0.042857,0.10952,0.085683,1,1
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.012203,0.10952,0.14833,1,1
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.012508,0.10948,0.11121,1,1
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0050528,0.10929,0.14418,1,1
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.01282,0.10927,0.10193,1,1
4,GO ERYTHROCYTE HOMEOSTASIS,0.0051916,0.10849,0.11488,1,1
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.035393,0.10835,0.16892,1,1
4,GO INTERFERON GAMMA PRODUCTION,0.02268,0.10812,0.10643,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0022992,0.10805,0.1339,1,1
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0037331,0.10803,0.15645,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.013139,0.10775,0.12367,1,1
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.0085714,0.1063,0.094009,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.0012662,0.10612,0.12962,1,1
4,GO RESPONSE TO PEPTIDE,0.0054795,0.10601,0.09639,1,1
4,GO TRANSMEMBRANE TRANSPORT,0.00054072,0.10589,0.1366,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.012203,0.10567,0.099175,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.014138,0.10562,0.080227,1,1
4,GO FEEDING BEHAVIOR,0.041093,0.1054,0.11211,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0067808,0.10525,0.10809,1,1
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.045624,0.10503,0.18161,1,1
4,GO REGULATION OF BLOOD CIRCULATION,0.03939,0.10495,0.097418,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0014738,0.10445,0.11539,1,1
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0069616,0.10435,0.10492,1,1
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.019739,0.10371,0.08958,1,1
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0079323,0.10321,0.11238,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0013872,0.10317,0.12602,1,1
4,GO POSITIVE REGULATION OF SIGNALING,0.0027346,0.1031,0.096319,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0025083,0.10287,0.1084,1,1
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.041967,0.10263,0.11864,1,1
4,GO STEROID CATABOLIC PROCESS,0.041967,0.10249,0.21942,1,1
4,GO MAMMARY GLAND DEVELOPMENT,0.041093,0.10216,0.090254,1,1
4,GO CELLULAR HOMEOSTASIS,0.0022992,0.10195,0.11459,1,1
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0085714,0.10182,0.094039,1,1
4,GO RESPONSE TO CAMP,0.040234,0.1017,0.12506,1,1
4,GO CELLULAR AMIDE METABOLIC PROCESS,0.012203,0.10164,0.10659,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.022165,0.10158,0.074507,1,1
4,GO REGULATION OF MAPK CASCADE,0.013798,0.1014,0.10035,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.0079323,0.10106,0.09814,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.03939,0.10089,0.071636,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.017549,0.10079,0.10395,1,1
4,GO BIOMINERALIZATION,0.041093,0.10063,0.094104,1,1
4,GO SPERM EGG RECOGNITION,0.015203,0.10027,0.116,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.015953,0.10006,0.10359,1,1
4,GO IRON ION HOMEOSTASIS,0.030383,0.099012,0.13166,1,1
4,GO NEGATIVE REGULATION OF CELL DEATH,0.011904,0.09875,0.087896,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.0085714,0.098437,0.083532,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.0029794,0.09811,0.099993,1,1
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.019739,0.098044,0.081646,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0081404,0.097842,0.089367,1,1
4,GO CALCIUM MEDIATED SIGNALING,0.0057817,0.097807,0.083627,1,1
4,GO REGULATION OF MACROPHAGE MIGRATION,0.043763,0.097524,0.10211,1,1
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.023205,0.097491,0.16682,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.037747,0.097377,0.11632,1,1
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.013139,0.096996,0.19734,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.0060989,0.096974,0.1121,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0085714,0.096524,0.10234,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0040578,0.096222,0.11764,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0032441,0.096139,0.1252,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0090226,0.095939,0.086167,1,1
4,GO PROTEIN STABILIZATION,0.021165,0.095842,0.086806,1,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.041967,0.095617,0.071063,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.0021689,0.09466,0.10893,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.017137,0.094041,0.091483,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0059384,0.094026,0.11716,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0039469,0.093467,0.13775,1,1
4,GO CYTOSOLIC TRANSPORT,0.001872,0.093246,0.11338,1,1
4,GO MACROMOLECULE CATABOLIC PROCESS,0.0083534,0.093034,0.070728,1,1
4,GO VESICLE LOCALIZATION,0.020205,0.092571,0.099445,1,1
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.04854,0.09178,0.08824,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.022165,0.091174,0.071233,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.042857,0.090807,0.068878,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0049174,0.090574,0.094822,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.022165,0.090371,0.07821,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0097392,0.089968,0.085164,1,1
4,GO PROTEIN CATABOLIC PROCESS,0.0027346,0.089758,0.095315,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.018398,0.089694,0.080419,1,1
4,GO REGULATION OF HISTONE DEACETYLATION,0.033894,0.089531,0.11516,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0087944,0.089201,0.10471,1,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0014738,0.088711,0.10019,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.017549,0.088533,0.085532,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.033894,0.088331,0.083727,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0057817,0.0882,0.12377,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.031059,0.087674,0.14349,1,1
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.011904,0.087444,0.066085,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.0013872,0.085808,0.097735,1,1
4,GO SIGNAL RELEASE,0.011904,0.085658,0.10416,1,1
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.02843,0.085215,0.084214,1,1
4,GO POLYOL METABOLIC PROCESS,0.026586,0.084901,0.10983,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY,0.01282,0.084021,0.081808,1,1
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.031748,0.083243,0.08609,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.02068,0.080492,0.077291,1,1
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.045624,0.080006,0.058645,1,1
4,GO JNK CASCADE,0.033166,0.079852,0.076137,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.013139,0.079799,0.081906,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.009256,0.079585,0.091402,1,1
4,GO RESPONSE TO MONOSACCHARIDE,0.0054795,0.077427,0.11938,1,1
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.029068,0.077215,0.084825,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.017969,0.077203,0.07407,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.041967,0.07713,0.070331,1,1
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.036164,0.0768,0.070414,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.045624,0.076613,0.087166,1,1
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.031748,0.076001,0.077896,1,1
4,GO MITOCHONDRION ORGANIZATION,0.0017641,0.075479,0.11437,1,1
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.025994,0.075103,0.09528,1,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.024846,0.074835,0.071649,1,1
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.01282,0.074406,0.14099,1,1
4,GO GOLGI VESICLE TRANSPORT,0.0087944,0.07412,0.10632,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.016734,0.072745,0.10169,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.022165,0.072717,0.075978,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.011047,0.072705,0.096373,1,1
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.029068,0.072536,0.05601,1,1
4,GO LYSOSOMAL TRANSPORT,0.013798,0.070567,0.13631,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.013465,0.070225,0.082022,1,1
4,GO INTRACELLULAR TRANSPORT,0.0024367,0.069899,0.076814,1,1
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.0075304,0.069456,0.061873,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.0087944,0.068224,0.11419,1,1
4,GO DNA CATABOLIC PROCESS,0.0083534,0.067745,0.09866,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.043763,0.066688,0.060887,1,1
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.030383,0.065299,0.052518,1,1
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.024288,0.061138,0.075727,1,1
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.036948,0.057576,0.067237,1,1
4,GO REGULATION OF AUTOPHAGY,0.0031536,0.056563,0.10819,1,1
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.016734,0.055271,0.077597,1,1
4,GO REGULATION OF CATABOLIC PROCESS,0.020205,0.054076,0.068903,1,1
4,GO MACROAUTOPHAGY,0.001228,0.05403,0.12383,1,1
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.022165,0.05313,0.079814,1,1
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.015574,0.051948,0.069725,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.016734,0.04982,0.053616,1,1
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.017549,0.047617,0.070807,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0094949,0.046732,0.071985,1,1
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.025414,0.045244,0.081049,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.044685,0.032504,0.044,1,1
4,GO REGULATION OF MACROAUTOPHAGY,0.02268,0.03143,0.092292,1,1
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.029719,0.37987,0.29614,1,0
4,GO ETHANOL OXIDATION,0.0032441,0.30934,0.45538,1,0
4,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.015953,0.30639,0.32501,1,0
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.0083534,0.30328,0.28826,1,0
4,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00025131,0.28946,0.30382,1,0
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0051916,0.28385,0.22909,1,0
4,GO RESPONSE TO HISTAMINE,0.02166,0.27986,0.33085,1,0
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0014738,0.26166,0.31177,1,0
4,GO REGULATION OF EXOSOMAL SECRETION,0.0085714,0.24914,0.17924,1,0
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.015203,0.24034,0.21105,1,0
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.041093,0.23048,0.29338,1,0
4,GO RESPONSE TO REDOX STATE,0.0045306,0.22599,0.25616,1,0
4,GO PLATELET AGGREGATION,0.017137,0.20799,0.14008,1,0
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0060989,0.20571,0.17106,1,0
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.014841,0.19844,0.1649,1,0
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.020205,0.19178,0.23073,1,0
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0038387,0.18893,0.13685,1,0
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.02843,0.18796,0.19395,1,0
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.041093,0.18436,0.24025,1,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00090094,0.17863,0.14539,1,0
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0071468,0.16952,0.13978,1,0
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.011326,0.16597,0.16913,1,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.044685,0.15994,0.16502,1,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.041967,0.15678,0.16167,1,0
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.011904,0.15515,0.19258,1,0
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0021689,0.15318,0.19672,1,0
4,GO PHAGOCYTOSIS,0.015574,0.15018,0.11398,1,0
4,GO ENDOSOME ORGANIZATION,0.0017123,0.1491,0.16313,1,0
4,GO ARGININE METABOLIC PROCESS,0.042857,0.14475,0.30139,1,0
4,GO REPLICATIVE SENESCENCE,0.011612,0.14421,0.21296,1,0
4,GO MIDBODY ABSCISSION,0.0062634,0.14386,0.20553,1,0
4,GO TRNA 5 END PROCESSING,0.034637,0.14297,0.12453,1,0
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.045624,0.13668,0.11136,1,0
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.004408,0.13623,0.13583,1,0
4,GO MONONUCLEAR CELL MIGRATION,0.025994,0.13547,0.10889,1,0
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0046564,0.13289,0.20294,1,0
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.031748,0.12677,0.11065,1,0
4,GO SENSORY PERCEPTION OF TASTE,0.007729,0.12491,0.13166,1,0
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.037747,0.12446,0.11743,1,0
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.027803,0.12434,0.19435,1,0
4,GO PEPTIDE METABOLIC PROCESS,0.046579,0.11972,0.086251,1,0
4,GO VIRAL RELEASE FROM HOST CELL,0.015953,0.11814,0.14065,1,0
4,GO RESPONSE TO OXYGEN RADICAL,0.019283,0.11677,0.15692,1,0
4,GO CYTOKINETIC PROCESS,0.038561,0.11501,0.096518,1,0
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.043763,0.11432,0.133,1,0
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.031748,0.11286,0.10062,1,0
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.044685,0.11025,0.080249,1,0
4,GO FC RECEPTOR SIGNALING PATHWAY,0.0046564,0.10858,0.11577,1,0
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.02068,0.10745,0.10956,1,0
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.023741,0.1035,0.16341,1,0
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.044685,0.10248,0.11547,1,0
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.029719,0.10243,0.099827,1,0
4,GO MYELOID CELL HOMEOSTASIS,0.014138,0.099687,0.10303,1,0
4,GO ORGANELLE INHERITANCE,0.021165,0.09665,0.11285,1,0
4,GO AUTOPHAGOSOME ORGANIZATION,0.0038387,0.096335,0.16051,1,0
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.026586,0.093086,0.094278,1,0
4,GO REGULATION OF CELL MATRIX ADHESION,0.042857,0.092658,0.1271,1,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0040578,0.091954,0.13648,1,0
4,GO MEMBRANE ORGANIZATION,0.0094949,0.091316,0.092909,1,0
4,GO FAT CELL DIFFERENTIATION,0.04854,0.089341,0.072076,1,0
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.024288,0.080528,0.096656,1,0
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0097392,0.075383,0.14015,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.042857,0.075189,0.071703,1,0
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.04854,0.071458,0.065494,1,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.027803,0.069679,0.064281,1,0
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.033894,0.063635,0.091207,1,0
4,GO URONIC ACID METABOLIC PROCESS,0.036164,0.06154,0.13418,1,0
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.035393,0.060543,0.089905,1,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.02068,0.059997,0.085588,1,0
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.035393,0.059364,0.071498,1,0
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00069957,0.057644,0.12417,1,0
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.022165,0.056118,0.072734,1,0
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.045624,0.05365,0.078688,1,0
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.044685,0.04613,0.065977,1,0
4,GO DNA REPAIR,0.033894,-0.039402,-0.047251,1,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.046579,-0.039541,-0.089835,1,0
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.030383,-0.049615,-0.05868,1,0
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.029719,-0.056832,-0.071295,1,0
4,GO CHROMOSOME ORGANIZATION,0.011904,-0.057137,-0.051121,1,0
4,GO REGULATION OF DNA METABOLIC PROCESS,0.0090226,-0.057225,-0.065348,1,0
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.027188,-0.058878,-0.10634,1,0
4,GO DOUBLE STRAND BREAK REPAIR,0.0079323,-0.061856,-0.076066,1,0
4,GO DNA GEOMETRIC CHANGE,0.044685,-0.06364,-0.072707,1,0
4,GO HISTONE UBIQUITINATION,0.036948,-0.064558,-0.078322,1,0
4,GO MRNA PROCESSING,0.0050528,-0.066946,-0.077033,1,0
4,GO MRNA EXPORT FROM NUCLEUS,0.017549,-0.067734,-0.093164,1,0
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.033894,-0.068353,-0.075696,1,0
4,GO DNA CONFORMATION CHANGE,0.0064317,-0.068783,-0.080396,1,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.017549,-0.070285,-0.11844,1,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.043763,-0.070807,-0.078787,1,0
4,GO ORGAN GROWTH,0.037747,-0.071005,-0.098314,1,0
4,GO CHROMOSOME SEPARATION,0.037747,-0.07144,-0.080396,1,0
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0059384,-0.071464,-0.10099,1,0
4,GO PROTEIN MONOUBIQUITINATION,0.029719,-0.071633,-0.066036,1,0
4,GO RNA SPLICING,0.0014299,-0.071689,-0.09306,1,0
4,GO REGULATION OF CYTOKINESIS,0.038561,-0.072113,-0.061367,1,0
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0023671,-0.074589,-0.093882,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.007729,-0.075538,-0.09093,1,0
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.0062634,-0.076157,-0.075411,1,0
4,GO MRNA 3 END PROCESSING,0.011904,-0.076842,-0.097516,1,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.0014299,-0.076946,-0.082879,1,0
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.040234,-0.081295,-0.14062,1,0
4,GO SPINDLE LOCALIZATION,0.02268,-0.082011,-0.092211,1,0
4,GO MAINTENANCE OF CELL NUMBER,0.010506,-0.082193,-0.11899,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.026586,-0.085342,-0.079861,1,0
4,GO DNA REPLICATION,0.0059384,-0.088233,-0.089514,1,0
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.042857,-0.089648,-0.095807,1,0
4,GO INTERSTRAND CROSS LINK REPAIR,0.03245,-0.089985,-0.072564,1,0
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0087944,-0.090256,-0.081249,1,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.013465,-0.091351,-0.092334,1,0
4,GO REGULATION OF CENTRIOLE REPLICATION,0.02166,-0.092297,-0.10629,1,0
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.017969,-0.092754,-0.10251,1,0
4,GO SPINDLE ORGANIZATION,0.00084609,-0.09461,-0.093686,1,0
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.023741,-0.09583,-0.090851,1,0
4,GO POSITIVE REGULATION OF HEART GROWTH,0.015574,-0.096314,-0.17523,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.046579,-0.097068,-0.1442,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.02843,-0.097187,-0.14145,1,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00038934,-0.097226,-0.11631,1,0
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.033166,-0.097275,-0.08653,1,0
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0053338,-0.098915,-0.16361,1,0
4,GO MITOTIC DNA REPLICATION CHECKPOINT,0.023205,-0.099002,-0.15155,1,0
4,GO MRNA TRANSPORT,0.018398,-0.10073,-0.093218,1,0
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0059384,-0.1019,-0.13013,1,0
4,GO LYMPH VESSEL DEVELOPMENT,0.038561,-0.10202,-0.15546,1,0
4,GO NEGATIVE REGULATION OF DNA BINDING,0.0023671,-0.10221,-0.15379,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.040234,-0.10229,-0.098728,1,0
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.024846,-0.10302,-0.07999,1,0
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.031748,-0.1037,-0.14254,1,0
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.012508,-0.10398,-0.11431,1,0
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0025817,-0.10458,-0.11459,1,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00042998,-0.10489,-0.1188,1,0
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.010773,-0.10497,-0.086394,1,0
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.024846,-0.10525,-0.071463,1,0
4,GO REGULATION OF MRNA POLYADENYLATION,0.025994,-0.10615,-0.11124,1,0
4,GO REGULATION OF DNA RECOMBINATION,0.010773,-0.10664,-0.097541,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.02166,-0.10768,-0.11681,1,0
4,GO CHROMOSOME SEGREGATION,0.0019282,-0.10855,-0.090204,1,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.014841,-0.10881,-0.095526,1,0
4,GO RNA STABILIZATION,0.0094949,-0.10886,-0.12705,1,0
4,GO ANIMAL ORGAN FORMATION,0.027188,-0.1089,-0.12903,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0015653,-0.11095,-0.11419,1,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.0016129,-0.1116,-0.10977,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.02166,-0.1117,-0.13568,1,0
4,GO DNA REPLICATION INITIATION,0.00067758,-0.11247,-0.16962,1,0
4,GO DNA REPLICATION CHECKPOINT,0.0099891,-0.11277,-0.15121,1,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.0030654,-0.11449,-0.090306,1,0
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.018836,-0.11583,-0.11608,1,0
4,GO BONE MORPHOGENESIS,0.023741,-0.11649,-0.14641,1,0
4,GO CELL DIVISION,0.0030654,-0.11661,-0.082564,1,0
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.045624,-0.11701,-0.11028,1,0
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.017969,-0.11709,-0.16186,1,0
4,GO CELLULAR RESPONSE TO X RAY,0.0057817,-0.11765,-0.20995,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.026586,-0.11772,-0.20567,1,0
4,GO SMOOTHENED SIGNALING PATHWAY,0.011326,-0.1182,-0.11422,1,0
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.041967,-0.11875,-0.13372,1,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0075304,-0.1195,-0.12384,1,0
4,GO DNA DEPENDENT DNA REPLICATION,0.0014299,-0.1204,-0.12313,1,0
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0034322,-0.12055,-0.23097,1,0
4,GO REGULATION OF LYASE ACTIVITY,0.033894,-0.12066,-0.13431,1,0
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.041967,-0.1209,-0.11452,1,0
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.02068,-0.12244,-0.11735,1,0
4,GO G2 DNA DAMAGE CHECKPOINT,0.025994,-0.12297,-0.12279,1,0
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.025414,-0.12308,-0.15821,1,0
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.043763,-0.12327,-0.088662,1,0
4,GO REPLICATION FORK PROCESSING,0.0029794,-0.12359,-0.16297,1,0
4,GO CHROMATIN REMODELING,0.00034072,-0.12494,-0.10902,1,0
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.00035231,-0.12514,-0.11552,1,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.017549,-0.12596,-0.12248,1,0
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.0038387,-0.12644,-0.18122,1,0
4,GO RETROGRADE AXONAL TRANSPORT,0.038561,-0.12691,-0.17756,1,0
4,GO HISTONE H4 DEACETYLATION,0.045624,-0.12703,-0.15819,1,0
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0014299,-0.12705,-0.14335,1,0
4,GO CHROMOSOME CONDENSATION,0.00081984,-0.12705,-0.15895,1,0
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00026903,-0.12757,-0.13063,1,0
4,GO SNORNA 3 END PROCESSING,0.029719,-0.12868,-0.17023,1,0
4,GO REGULATION OF ORGAN GROWTH,0.01282,-0.12999,-0.14003,1,0
4,GO REGULATION OF FIBROBLAST MIGRATION,0.03939,-0.132,-0.13307,1,0
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.027188,-0.13248,-0.13491,1,0
4,GO CENTRIOLE ASSEMBLY,0.0051916,-0.13431,-0.11629,1,0
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.045624,-0.13501,-0.10036,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0020453,-0.13725,-0.11781,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00072223,-0.13838,-0.13516,1,0
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0028957,-0.13839,-0.11382,1,0
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.00095906,-0.14021,-0.11566,1,0
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.019283,-0.14301,-0.17027,1,0
4,GO GTP METABOLIC PROCESS,0.035393,-0.14424,-0.17625,1,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.030383,-0.14455,-0.13713,1,0
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.017969,-0.14465,-0.27737,1,0
4,GO REGULATION OF MYELINATION,0.00057693,-0.14533,-0.17702,1,0
4,GO L GLUTAMATE IMPORT,0.0075304,-0.146,-0.19259,1,0
4,GO REGULATION OF DNA REPAIR,1.4039e-05,-0.14605,-0.13898,1,0
4,GO REGULATION OF MRNA PROCESSING,0.00017796,-0.14652,-0.12736,1,0
4,GO HISTONE H3 K9 ACETYLATION,0.016734,-0.14881,-0.11207,1,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.024288,-0.14895,-0.23217,1,0
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.012508,-0.14905,-0.19315,1,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.009256,-0.15063,-0.10515,1,0
4,GO MEIOTIC SPINDLE ORGANIZATION,0.0033369,-0.15107,-0.16091,1,0
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0001547,-0.15249,-0.16721,1,0
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.0013054,-0.15263,-0.18148,1,0
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.0016129,-0.15276,-0.15436,1,0
4,GO NEURAL CREST CELL MIGRATION,0.0079323,-0.15297,-0.21432,1,0
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.013465,-0.15507,-0.2248,1,0
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.013139,-0.15575,-0.10207,1,0
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0028957,-0.15755,-0.22246,1,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.016339,-0.15892,-0.17904,1,0
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.030383,-0.15943,-0.11625,1,0
4,GO REGULATION OF STEM CELL PROLIFERATION,0.0010206,-0.15991,-0.18484,1,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0023671,-0.16374,-0.19769,1,0
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,6.7596e-05,-0.16586,-0.1655,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.012203,-0.16646,-0.090342,1,0
4,GO PROSTATE GLAND GROWTH,0.045624,-0.16699,-0.20097,1,0
4,GO REGULATION OF HEART GROWTH,0.0010528,-0.1672,-0.18794,1,0
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.001872,-0.16732,-0.17669,1,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.036948,-0.16853,-0.12718,1,0
4,GO HISTONE H2A MONOUBIQUITINATION,0.0013457,-0.16971,-0.20296,1,0
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.047551,-0.17066,-0.21429,1,0
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.011047,-0.17116,-0.13445,1,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0031536,-0.17259,-0.20776,1,0
4,GO REGULATION OF SENSORY PERCEPTION,0.0025817,-0.1727,-0.17184,1,0
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0046564,-0.1742,-0.17841,1,0
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0011199,-0.17877,-0.22728,1,0
4,GO REGULATION OF SISTER CHROMATID COHESION,0.0032441,-0.17963,-0.16927,1,0
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.027188,-0.17992,-0.31185,1,0
4,GO AXIS ELONGATION,0.011904,-0.18005,-0.20687,1,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.041093,-0.18032,-0.11387,1,0
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.0024367,-0.18076,-0.21274,1,0
4,GO KINETOCHORE ORGANIZATION,0.007729,-0.18241,-0.18848,1,0
4,GO MITOCHONDRION DISTRIBUTION,0.030383,-0.18352,-0.12984,1,0
4,GO SYNAPTIC VESICLE LOCALIZATION,0.0039469,-0.18673,-0.18905,1,0
4,GO NUCLEAR PORE ORGANIZATION,0.019739,-0.18854,-0.13349,1,0
4,GO KINETOCHORE ASSEMBLY,0.024288,-0.18856,-0.16985,1,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.029719,-0.18857,-0.1441,1,0
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00081984,-0.18875,-0.25321,1,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0054795,-0.19048,-0.17233,1,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.0050528,-0.19098,-0.16653,1,0
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.034637,-0.19268,-0.20401,1,0
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00045924,-0.19387,-0.2093,1,0
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.041967,-0.19405,-0.17729,1,0
4,GO HISTONE H3 K9 DEMETHYLATION,0.0010859,-0.19409,-0.23985,1,0
4,GO REPLACEMENT OSSIFICATION,0.023741,-0.19451,-0.18058,1,0
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.016734,-0.19459,-0.15964,1,0
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0042883,-0.19552,-0.18308,1,0
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.024288,-0.19758,-0.17763,1,0
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00067758,-0.19822,-0.18544,1,0
4,GO LYMPHANGIOGENESIS,0.0013872,-0.20121,-0.24881,1,0
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.038561,-0.20279,-0.17278,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.044685,-0.2049,-0.18028,1,0
4,GO HISTONE H4 K16 ACETYLATION,0.009256,-0.20497,-0.17551,1,0
4,GO MUSCLE CELL FATE COMMITMENT,0.0060989,-0.20567,-0.25564,1,0
4,GO NEUROBLAST DIVISION,0.043763,-0.20582,-0.20956,1,0
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0027346,-0.20801,-0.23184,1,0
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0037331,-0.20934,-0.15459,1,0
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.045624,-0.21066,-0.21944,1,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.02843,-0.21503,-0.20122,1,0
4,GO GENETIC IMPRINTING,0.02166,-0.21699,-0.17586,1,0
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0018173,-0.21907,-0.17408,1,0
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.00028792,-0.22086,-0.24443,1,0
4,GO NEURAL TUBE PATTERNING,0.0017641,-0.22103,-0.19656,1,0
4,GO CARDIOBLAST DIFFERENTIATION,0.0012662,-0.22261,-0.32596,1,0
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.00074557,-0.22369,-0.23718,1,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0097392,-0.22423,-0.16034,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.00016595,-0.22846,-0.2221,1,0
4,GO NEURAL CREST FORMATION,0.014486,-0.22888,-0.2304,1,0
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.042857,-0.23035,-0.26999,1,0
4,GO MITRAL VALVE DEVELOPMENT,0.0038387,-0.23067,-0.3015,1,0
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0051916,-0.23218,-0.33547,1,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0056288,-0.23718,-0.23416,1,0
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.043763,-0.2394,-0.21793,1,0
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0036303,-0.24373,-0.17271,1,0
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0079323,-0.24472,-0.21215,1,0
4,GO HIPPO SIGNALING,0.00059588,-0.24735,-0.30673,1,0
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0036303,-0.25099,-0.37346,1,0
4,GO BONE GROWTH,0.00047456,-0.25157,-0.30905,1,0
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.018398,-0.25172,-0.26904,1,0
4,GO TONGUE DEVELOPMENT,0.011326,-0.25209,-0.25954,1,0
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.016734,-0.25349,-0.20349,1,0
4,GO ELASTIC FIBER ASSEMBLY,0.041967,-0.25485,-0.27971,1,0
4,GO CHROMATIN REMODELING AT CENTROMERE,0.00092958,-0.2573,-0.21385,1,0
4,GO MITOTIC SISTER CHROMATID COHESION,0.00067758,-0.2591,-0.19643,1,0
4,GO FOREBRAIN MORPHOGENESIS,0.0041716,-0.25917,-0.22024,1,0
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0071468,-0.26088,-0.17034,1,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.0033369,-0.26179,-0.27661,1,0
4,GO CARDIOBLAST PROLIFERATION,0.03245,-0.26743,-0.37238,1,0
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0033369,-0.26761,-0.17643,1,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0016129,-0.26919,-0.19573,1,0
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00037661,-0.26926,-0.27876,1,0
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0020453,-0.27017,-0.33894,1,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0015653,-0.27148,-0.24366,1,0
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.0081404,-0.27265,-0.28557,1,0
4,GO BONE TRABECULA FORMATION,0.035393,-0.27394,-0.33108,1,0
4,GO DNA LIGATION,0.0028957,-0.27433,-0.21226,1,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,1.2454e-05,-0.2753,-0.34459,1,0
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.043763,-0.2765,-0.28432,1,0
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00016595,-0.27714,-0.27171,1,0
4,GO MITOTIC CHROMOSOME CONDENSATION,0.00013917,-0.28041,-0.25095,1,0
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.016339,-0.28438,-0.32823,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0046564,-0.29117,-0.26055,1,0
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0050528,-0.29259,-0.21011,1,0
4,GO EMBRYONIC BRAIN DEVELOPMENT,2.9532e-05,-0.29542,-0.30594,1,0
4,GO DENDRITE SELF AVOIDANCE,0.013139,-0.29787,-0.2499,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.023741,-0.2981,-0.18175,1,0
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0049174,-0.30136,-0.28387,1,0
4,GO NEPHRON TUBULE FORMATION,0.0066042,-0.30669,-0.31113,1,0
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.00010092,-0.30991,-0.28219,1,0
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.00022676,-0.31726,-0.2884,1,0
4,GO RESPONSE TO L GLUTAMATE,0.0015189,-0.31788,-0.34245,1,0
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,3.5759e-05,-0.32422,-0.33192,1,0
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00012964,-0.32543,-0.35802,1,0
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0047853,-0.32642,-0.28384,1,0
4,GO CHROMATIN DISASSEMBLY,5.2837e-06,-0.33013,-0.33137,1,0
4,GO PHAGOCYTOSIS RECOGNITION,0.0010206,-0.34576,-0.32991,1,0
4,GO DENDRITIC TRANSPORT,0.00025131,-0.35104,-0.32118,1,0
4,GO EMBRYONIC EYE MORPHOGENESIS,2.0033e-05,-0.35143,-0.34011,1,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,6.7596e-05,-0.35464,-0.41239,1,0
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,4.1617e-05,-0.36107,-0.38415,1,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.015574,-0.36452,-0.24159,1,0
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,3.5759e-05,-0.36737,-0.35239,1,0
4,GO CENTRIOLE CENTRIOLE COHESION,4.6623e-06,-0.37393,-0.36765,1,0
4,GO HEART VALVE FORMATION,0.014841,-0.37628,-0.30082,1,0
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0041716,-0.38022,-0.27886,1,0
4,GO POSITIVE REGULATION OF NEURON MIGRATION,5.6174e-05,-0.38058,-0.36807,1,0
4,GO LATERAL MESODERM DEVELOPMENT,0.00044439,-0.38814,-0.40152,1,0
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00353,-0.39272,-0.34003,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0020453,-0.39291,-0.37653,1,0
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.00059588,-0.3947,-0.39753,1,0
4,GO MYOBLAST MIGRATION,0.0064317,-0.39584,-0.36061,1,0
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,2.8418e-05,-0.40684,-0.40149,1,0
4,GO TONGUE MORPHOGENESIS,0.016339,-0.4194,-0.31762,1,0
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.026586,-0.42004,-0.29535,1,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.6455e-05,-0.42347,-0.48177,1,0
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,7.8282e-05,-0.43029,-0.39435,1,0
4,GO SYNAPTIC VESICLE MATURATION,0.0079323,-0.43645,-0.27744,1,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,5.2139e-05,-0.43878,-0.4257,1,0
4,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00050664,-0.44487,-0.42504,1,0
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,5.4121e-05,-0.45785,-0.49194,1,0
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00049035,-0.46267,-0.53136,1,0
4,GO LIMB BUD FORMATION,0.01282,-0.47408,-0.33368,1,0
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,7.9801e-06,-0.47707,-0.5358,1,0
4,GO CORPUS CALLOSUM DEVELOPMENT,0.0001547,-0.49575,-0.39099,1,0
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.001228,-0.51041,-0.40071,1,0
4,GO EXCITATORY SYNAPSE ASSEMBLY,3.3132e-05,-0.52063,-0.53078,1,0
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.00044439,-0.55324,-0.42436,1,0
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,2.3418e-05,-0.57362,-0.57156,1,0
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,3.5759e-05,-0.6892,-0.60333,1,0
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.5759e-05,-0.74264,-0.75733,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.088862,0.47738,0.29694,0,1
4,GO NEGATIVE REGULATION OF CELL KILLING,0.097379,0.41757,0.2536,0,1
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.11434,0.38407,0.21057,0,1
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.055956,0.37694,0.20743,0,1
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.073629,0.34731,0.26106,0,1
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.073629,0.34032,0.16008,0,1
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.057089,0.30244,0.18525,0,1
4,GO NATURAL KILLER CELL PROLIFERATION,0.11235,0.29186,0.1415,0,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.053746,0.28978,0.19361,0,1
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.17099,0.28877,0.13875,0,1
4,GO PENTOSE METABOLIC PROCESS,0.049546,0.26853,0.17796,0,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.052669,0.26619,0.15619,0,1
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.53742,0.26422,0.066474,0,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.064293,0.26391,0.17736,0,1
4,GO RESPONSE TO MUSCLE ACTIVITY,0.052669,0.26334,0.18244,0,1
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.13583,0.26098,0.14432,0,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.064293,0.26013,0.16144,0,1
4,GO MEMBRANE RAFT ORGANIZATION,0.077957,0.25977,0.15688,0,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.082489,0.25729,0.18857,0,1
4,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.055956,0.25532,0.18658,0,1
4,GO PANCREATIC JUICE SECRETION,0.085627,0.24957,0.14267,0,1
4,GO FIBRINOLYSIS,0.10654,0.24902,0.25909,0,1
4,GO EPITHELIAL CELL FATE COMMITMENT,0.20309,0.24755,0.13767,0,1
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.055956,0.24704,0.15919,0,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.12259,0.24125,0.12336,0,1
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.049546,0.24039,0.15643,0,1
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.057089,0.23921,0.18581,0,1
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.1313,0.23907,0.14244,0,1
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.068167,0.2377,0.20973,0,1
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.088862,0.2367,0.13272,0,1
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.064293,0.23659,0.17873,0,1
4,GO EPOXYGENASE P450 PATHWAY,0.05161,0.23366,0.18795,0,1
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.099158,0.23225,0.14356,0,1
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.053746,0.22976,0.15454,0,1
4,GO CYTOPLASM ORGANIZATION,0.063042,0.22694,0.17751,0,1
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.10654,0.22578,0.10467,0,1
4,GO GLYCOPROTEIN CATABOLIC PROCESS,0.11235,0.22495,0.13209,0,1
4,GO REGULATION OF VASCULOGENESIS,0.093897,0.22417,0.13979,0,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.10845,0.22407,0.23219,0,1
4,GO ETHER BIOSYNTHETIC PROCESS,0.15517,0.22376,0.086929,0,1
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.057089,0.223,0.12226,0,1
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.15015,0.2227,0.10982,0,1
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.13583,0.2183,0.15975,0,1
4,GO ENAMEL MINERALIZATION,0.075049,0.21675,0.1717,0,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.18508,0.2167,0.13165,0,1
4,GO T HELPER 2 CELL DIFFERENTIATION,0.20937,0.21412,0.049911,0,1
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.1028,0.20909,0.090052,0,1
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.14285,0.20808,0.065003,0,1
4,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.17653,0.20693,0.14825,0,1
4,GO HEMOGLOBIN METABOLIC PROCESS,0.10654,0.20641,0.159,0,1
4,GO DETOXIFICATION,0.060602,0.20555,0.16028,0,1
4,GO OUTER DYNEIN ARM ASSEMBLY,0.092194,0.20451,0.12896,0,1
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.080955,0.20397,0.11522,0,1
4,GO REGULATION OF RECEPTOR BINDING,0.049546,0.20253,0.193,0,1
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.077957,0.20236,0.15294,0,1
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.060602,0.20227,0.12252,0,1
4,GO GLYCINE METABOLIC PROCESS,0.40349,0.20147,0.14098,0,1
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.087232,0.20126,0.14649,0,1
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.087232,0.1997,0.12098,0,1
4,GO NAD BIOSYNTHETIC PROCESS,0.05824,0.19886,0.15801,0,1
4,GO PODOSOME ASSEMBLY,0.38408,0.19871,0.032831,0,1
4,GO CELLULAR OXIDANT DETOXIFICATION,0.076492,0.19805,0.12599,0,1
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.12473,0.19788,0.15607,0,1
4,GO PSEUDOURIDINE SYNTHESIS,0.43883,0.19757,0.075309,0,1
4,GO LINOLEIC ACID METABOLIC PROCESS,0.12259,0.19739,0.17363,0,1
4,GO RESPONSE TO PROSTAGLANDIN,0.092194,0.19591,0.16833,0,1
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.076492,0.19548,0.076216,0,1
4,GO HEMIDESMOSOME ASSEMBLY,0.29586,0.19434,0.12494,0,1
4,GO AMYLOID FIBRIL FORMATION,0.079444,0.19106,0.14251,0,1
4,GO T CELL CYTOKINE PRODUCTION,0.068167,0.19018,0.14736,0,1
4,GO HETEROTYPIC CELL CELL ADHESION,0.0695,0.18995,0.13399,0,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.059411,0.18832,0.15703,0,1
4,GO INTERLEUKIN 13 PRODUCTION,0.0695,0.18719,0.15213,0,1
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.32077,0.18501,0.031402,0,1
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.077957,0.18496,0.1655,0,1
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.46512,0.18494,-0.00026961,0,1
4,GO MYELIN MAINTENANCE,0.077957,0.18319,0.18803,0,1
4,GO REGULATION OF T CELL MIGRATION,0.05824,0.18319,0.11948,0,1
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.080955,0.18258,0.14482,0,1
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.054842,0.18203,0.12675,0,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.2,0.18189,0.15174,0,1
4,GO CYTOLYSIS,0.099158,0.18154,0.1095,0,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.22905,0.17936,0.052335,0,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.14285,0.17804,0.084442,0,1
4,GO ENDODERM DEVELOPMENT,0.16828,0.17702,0.07587,0,1
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.05824,0.1767,0.13954,0,1
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.14526,0.17658,0.081744,0,1
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.12908,0.1762,0.081429,0,1
4,GO STORE OPERATED CALCIUM ENTRY,0.2,0.17599,0.12087,0,1
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.064293,0.17472,0.13556,0,1
4,GO PROTEIN ADP RIBOSYLATION,0.11434,0.17396,0.10623,0,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.10465,0.17291,0.1686,0,1
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.064293,0.17141,0.12469,0,1
4,GO RENAL WATER HOMEOSTASIS,0.12473,0.17079,0.072032,0,1
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.4545,0.17073,0.03986,0,1
4,GO TRNA METHYLATION,0.21579,0.17069,0.066798,0,1
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.67137,0.16997,-0.02313,0,1
4,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.15517,0.16967,0.12947,0,1
4,GO RECEPTOR CATABOLIC PROCESS,0.049546,0.16964,0.099591,0,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.068167,0.16681,0.099292,0,1
4,GO AMMONIUM TRANSPORT,0.097379,0.16649,0.1041,0,1
4,GO PARTURITION,0.082489,0.16537,0.14793,0,1
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.27227,0.16535,0.066368,0,1
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.060602,0.16471,0.10095,0,1
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.063042,0.16447,0.11268,0,1
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.061812,0.16437,0.11089,0,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.20309,0.16433,0.065074,0,1
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.13583,0.16365,0.13327,0,1
4,GO RNA 5 END PROCESSING,0.11235,0.16337,0.096749,0,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.065563,0.16327,0.15972,0,1
4,GO BONE CELL DEVELOPMENT,0.19095,0.1632,0.090861,0,1
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.097379,0.16293,0.10606,0,1
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.050569,0.16168,0.13627,0,1
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.072231,0.15991,0.11068,0,1
4,GO REGULATION OF EXCRETION,0.19695,0.15872,0.097657,0,1
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.070855,0.15864,0.094826,0,1
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.15015,0.15839,0.085381,0,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.068167,0.15744,0.11963,0,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.064293,0.15741,0.14175,0,1
4,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.14048,0.15617,0.16369,0,1
4,GO GLIAL CELL PROLIFERATION,0.15264,0.15591,0.10976,0,1
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.064293,0.15522,0.13351,0,1
4,GO FOLIC ACID METABOLIC PROCESS,0.40843,0.15516,0.011969,0,1
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.0695,0.15492,0.26629,0,1
4,GO NEGATIVE T CELL SELECTION,0.087232,0.15461,0.079058,0,1
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.10096,0.15402,0.075342,0,1
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.060602,0.15401,0.1339,0,1
4,GO IMMATURE T CELL PROLIFERATION,0.21905,0.15399,0.13978,0,1
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.059411,0.15381,0.14462,0,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.070855,0.15314,0.14002,0,1
4,GO SECRETORY GRANULE ORGANIZATION,0.065563,0.15242,0.11235,0,1
4,GO PIRNA METABOLIC PROCESS,0.057089,0.15089,0.21011,0,1
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.0695,0.14963,0.084851,0,1
4,GO AMINO ACID IMPORT,0.054842,0.14954,0.14161,0,1
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.2,0.14847,0.046878,0,1
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.11039,0.14834,0.11416,0,1
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.075049,0.14824,0.091756,0,1
4,GO NOREPINEPHRINE SECRETION,0.092194,0.14566,0.14928,0,1
4,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.077957,0.14554,0.15463,0,1
4,GO PINOCYTOSIS,0.11235,0.14552,0.058687,0,1
4,GO RESPONSE TO VITAMIN,0.25729,0.14511,0.055309,0,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.12473,0.14501,0.058799,0,1
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.079444,0.1447,0.073939,0,1
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.30815,0.14289,0.037286,0,1
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.076492,0.14248,0.11935,0,1
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.077957,0.14122,0.10524,0,1
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.05161,0.14023,0.20113,0,1
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.082489,0.13998,0.1192,0,1
4,GO RETINA HOMEOSTASIS,0.11841,0.13875,0.049394,0,1
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.0695,0.13868,0.082645,0,1
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.20309,0.13809,0.066693,0,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.31232,0.13778,0.17152,0,1
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.18508,0.13719,0.045361,0,1
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.44924,0.13681,-0.005103,0,1
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.36991,0.13654,0.093081,0,1
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.059411,0.13629,0.11067,0,1
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.11235,0.13622,0.078362,0,1
4,GO RESPONSE TO FLUID SHEAR STRESS,0.052669,0.13542,0.13434,0,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.095625,0.13473,0.090418,0,1
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.1028,0.13419,0.11799,0,1
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.10096,0.13354,0.17388,0,1
4,GO MUSCLE ATROPHY,0.15015,0.13347,0.14642,0,1
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.088862,0.13305,0.096874,0,1
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.082489,0.13257,0.088044,0,1
4,GO RESPONSE TO ESTROGEN,0.17934,0.13213,0.073056,0,1
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.24643,0.13203,0.05309,0,1
4,GO REGULATION OF APPETITE,0.057089,0.13186,0.083297,0,1
4,GO SYNAPTIC VESICLE BUDDING,0.095625,0.13179,0.14073,0,1
4,GO LIVER REGENERATION,0.29992,0.1313,0.072632,0,1
4,GO CELLULAR IRON ION HOMEOSTASIS,0.065563,0.13102,0.12198,0,1
4,GO REGENERATION,0.12908,0.1306,0.051999,0,1
4,GO RESPONSE TO UV C,0.072231,0.13043,0.10682,0,1
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.2839,0.13011,0.054908,0,1
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.25729,0.12866,0.047863,0,1
4,GO ERBB SIGNALING PATHWAY,0.13814,0.12863,0.086067,0,1
4,GO ACYLGLYCEROL HOMEOSTASIS,0.25001,0.12797,0.10694,0,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.072231,0.12725,0.10635,0,1
4,GO DRUG CATABOLIC PROCESS,0.05161,0.127,0.17535,0,1
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.32077,0.12692,0.041847,0,1
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.18508,0.12663,0.09734,0,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.29184,0.1265,0.051332,0,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.053746,0.12625,0.22656,0,1
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.10845,0.12564,0.071349,0,1
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.15015,0.12533,0.020735,0,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.060602,0.12525,0.07759,0,1
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.50896,0.12521,0.024606,0,1
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.085627,0.12495,0.078726,0,1
4,GO KERATINOCYTE MIGRATION,0.12908,0.12486,0.086954,0,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.14769,0.12354,0.082102,0,1
4,GO EPITHELIAL CELL PROLIFERATION,0.072231,0.12266,0.069245,0,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.10654,0.1225,0.049664,0,1
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.093897,0.12246,0.10064,0,1
4,GO EPITHELIAL CELL DEVELOPMENT,0.068167,0.12197,0.08169,0,1
4,GO MUSCLE CELL PROLIFERATION,0.090515,0.12193,0.063824,0,1
4,GO GLIAL CELL ACTIVATION,0.1028,0.12114,0.084223,0,1
4,GO ZINC ION TRANSPORT,0.061812,0.12088,0.14093,0,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.24643,0.12061,0.025467,0,1
4,GO I KAPPAB PHOSPHORYLATION,0.14526,0.11896,0.079852,0,1
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.061812,0.11888,0.15188,0,1
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.11039,0.11887,0.086996,0,1
4,GO MACROPHAGE MIGRATION,0.2,0.11855,0.0583,0,1
4,GO CELL MATRIX ADHESION,0.053746,0.11824,0.090133,0,1
4,GO REGULATION OF PODOSOME ASSEMBLY,0.60272,0.11722,0.0064853,0,1
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.054842,0.11702,0.089901,0,1
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.12259,0.11695,0.079798,0,1
4,GO RNA MODIFICATION,0.079444,0.11693,0.070384,0,1
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.16294,0.11685,0.069642,0,1
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.053746,0.11639,0.062166,0,1
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.10096,0.11625,0.10774,0,1
4,GO RESPONSE TO INTERLEUKIN 12,0.12473,0.11585,0.087813,0,1
4,GO MACROPHAGE CHEMOTAXIS,0.063042,0.11516,0.076855,0,1
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.28785,0.11402,0.046131,0,1
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.26471,0.11392,0.046986,0,1
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.30402,0.11384,0.064657,0,1
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.25729,0.11286,0.041918,0,1
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.057089,0.11259,0.094874,0,1
4,GO REGULATION OF PROTEIN IMPORT,0.095625,0.1124,0.081414,0,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.084046,0.11215,0.090741,0,1
4,GO IMMATURE B CELL DIFFERENTIATION,0.20937,0.11209,0.087557,0,1
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.059411,0.11111,0.1062,0,1
4,GO MITOCHONDRIAL FUSION,0.2,0.10966,0.094522,0,1
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.14285,0.10954,0.061347,0,1
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.21256,0.10914,0.040438,0,1
4,GO TRNA METABOLIC PROCESS,0.095625,0.109,0.075649,0,1
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.12908,0.10899,0.088598,0,1
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.066855,0.10869,0.14742,0,1
4,GO FEMALE SEX DIFFERENTIATION,0.1313,0.1085,0.05899,0,1
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.1313,0.10842,0.11115,0,1
4,GO MONONUCLEAR CELL DIFFERENTIATION,0.10845,0.10806,0.12452,0,1
4,GO AXONEME ASSEMBLY,0.25729,0.10775,0.064379,0,1
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.12049,0.10739,0.097615,0,1
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.13355,0.10657,0.091785,0,1
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.26098,0.10631,0.045692,0,1
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.12473,0.10584,0.059368,0,1
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.38888,0.10507,0.03709,0,1
4,GO CELLULAR EXTRAVASATION,0.11039,0.10469,0.07552,0,1
4,GO PROTEIN HOMOTETRAMERIZATION,0.087232,0.10465,0.072845,0,1
4,GO RESPONSE TO RETINOIC ACID,0.48131,0.10411,0.030396,0,1
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.16828,0.10408,0.083855,0,1
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.059411,0.10399,0.060518,0,1
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.2,0.10389,0.044734,0,1
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.20621,0.10328,0.059829,0,1
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.16828,0.10112,0.047094,0,1
4,GO CRISTAE FORMATION,0.19393,0.10094,0.088051,0,1
4,GO ENDOTHELIUM DEVELOPMENT,0.088862,0.10094,0.080174,0,1
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.53167,0.10083,0.0078704,0,1
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.42855,0.10082,0.035838,0,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.17374,0.10019,0.062044,0,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.080955,0.09922,0.10988,0,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.34702,0.09907,0.044936,0,1
4,GO REGULATION OF GTP BINDING,0.47588,0.098415,0.038684,0,1
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.20309,0.098278,0.069501,0,1
4,GO ASTROCYTE ACTIVATION,0.74288,0.098223,-0.023154,0,1
4,GO GLIAL CELL DEVELOPMENT,0.35153,0.097947,0.036202,0,1
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.36526,0.097338,0.081166,0,1
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.060602,0.097285,0.062794,0,1
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.52594,0.096687,-0.041241,0,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.066855,0.096324,0.074516,0,1
4,GO COENZYME A METABOLIC PROCESS,0.25363,0.096273,0.085567,0,1
4,GO MAMMARY GLAND MORPHOGENESIS,0.11039,0.094683,0.11005,0,1
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.064293,0.094408,0.070266,0,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.39371,0.093799,0.055379,0,1
4,GO CELL MOTILITY,0.052669,0.093749,0.069582,0,1
4,GO NEGATIVE REGULATION OF SECRETION,0.093897,0.093619,0.064404,0,1
4,GO HEAD MORPHOGENESIS,0.70355,0.092914,-0.0070455,0,1
4,GO T HELPER 1 CELL DIFFERENTIATION,0.87144,0.091929,-0.010707,0,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.34702,0.091736,0.059737,0,1
4,GO REGULATION OF RESPONSE TO FOOD,0.88523,0.091393,0.00080627,0,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.66501,0.090776,0.014068,0,1
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.099158,0.089653,0.11842,0,1
4,GO PROTEIN PALMITOYLATION,0.14285,0.089353,0.08782,0,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.18219,0.089125,0.046918,0,1
4,GO ENDODERMAL CELL FATE COMMITMENT,0.70355,0.089047,0.014277,0,1
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.14526,0.088519,0.08701,0,1
4,GO ETHANOL CATABOLIC PROCESS,0.31232,0.088215,0.05892,0,1
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.42347,0.087678,0.033491,0,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.11434,0.08756,0.053391,0,1
4,GO OVULATION CYCLE PROCESS,0.29184,0.087354,0.067707,0,1
4,GO APOPTOTIC CELL CLEARANCE,0.29992,0.086614,-0.0084085,0,1
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.087232,0.086522,0.085418,0,1
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.19095,0.085947,0.13551,0,1
4,GO BLASTOCYST FORMATION,0.053746,0.085827,0.11965,0,1
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.31232,0.085375,0.029226,0,1
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.064293,0.085227,0.12523,0,1
4,GO AMEBOIDAL TYPE CELL MIGRATION,0.093897,0.084961,0.068755,0,1
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.05824,0.084655,0.087057,0,1
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.073629,0.084621,0.095453,0,1
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.46512,0.084138,0.056189,0,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.34256,0.084047,0.052436,0,1
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.053746,0.083013,0.20269,0,1
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.20937,0.082962,0.073108,0,1
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.05824,0.082882,0.08554,0,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.064293,0.082256,0.091963,0,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.32506,0.082224,0.04414,0,1
4,GO MALE SEX DIFFERENTIATION,0.10465,0.081758,0.057252,0,1
4,GO OOCYTE MATURATION,0.44924,0.081327,0.036436,0,1
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.063042,0.081297,0.063528,0,1
4,GO NEUROINFLAMMATORY RESPONSE,0.15517,0.081064,0.070118,0,1
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.095625,0.080912,0.053413,0,1
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.37932,0.080495,0.024577,0,1
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.085627,0.080271,0.07044,0,1
4,GO ERYTHROCYTE DEVELOPMENT,0.26847,0.080256,0.046694,0,1
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.27611,0.07975,0.074406,0,1
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.15015,0.079043,0.058141,0,1
4,GO POSITIVE REGULATION OF BINDING,0.19393,0.07883,0.043933,0,1
4,GO RETINOIC ACID METABOLIC PROCESS,0.47049,0.07833,0.042716,0,1
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.15773,0.078252,0.057028,0,1
4,GO LAMELLIPODIUM ORGANIZATION,0.4545,0.078062,0.022256,0,1
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.36064,0.077202,0.023765,0,1
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.21905,0.07677,0.029173,0,1
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.19695,0.075246,0.030936,0,1
4,GO PROTEIN IMPORT,0.076492,0.074812,0.066988,0,1
4,GO FERTILIZATION,0.076492,0.07419,0.058746,0,1
4,GO LUNG MORPHOGENESIS,0.39858,0.074069,0.03368,0,1
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.19695,0.07401,0.058779,0,1
4,GO RNA INTERFERENCE,0.43367,0.072197,0.051852,0,1
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.29586,0.071274,0.038612,0,1
4,GO FATTY ACYL COA METABOLIC PROCESS,0.1313,0.071155,0.12488,0,1
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.12908,0.071133,0.056498,0,1
4,GO REGULATION OF EXOCYTOSIS,0.11841,0.071015,0.08508,0,1
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.23589,0.071002,0.030594,0,1
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.065563,0.070842,0.054911,0,1
4,GO T CELL DIFFERENTIATION IN THYMUS,0.25729,0.07081,0.048577,0,1
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.24288,0.070251,0.034858,0,1
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.20937,0.070011,0.034707,0,1
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.087232,0.069961,0.09633,0,1
4,GO POSITIVE REGULATION OF CELL GROWTH,0.15517,0.069776,0.054912,0,1
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.16828,0.068923,0.066106,0,1
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.12908,0.06828,0.064809,0,1
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.052669,0.068098,0.061349,0,1
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.22235,0.067694,0.092469,0,1
4,GO SULFATE TRANSPORT,0.11235,0.06741,0.068414,0,1
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.087232,0.067133,0.074012,0,1
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.188,0.067036,0.045011,0,1
4,GO TUBE MORPHOGENESIS,0.35607,0.066751,0.019986,0,1
4,GO BLOOD VESSEL MORPHOGENESIS,0.29586,0.066523,0.029176,0,1
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.52025,0.066301,0.035748,0,1
4,GO OVULATION CYCLE,0.33812,0.066084,0.048084,0,1
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.050569,0.066079,0.065608,0,1
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.10096,0.065892,0.072662,0,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.076492,0.065362,0.05727,0,1
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.13814,0.065328,0.061152,0,1
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.13583,0.065033,0.058449,0,1
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.25363,0.064633,0.055006,0,1
4,GO CELL AGING,0.10465,0.064539,0.060157,0,1
4,GO TISSUE REGENERATION,0.17374,0.064119,0.076031,0,1
4,GO PHOTOPERIODISM,0.40349,0.064091,0.039805,0,1
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.82348,0.063896,-0.0020978,0,1
4,GO REPRODUCTION,0.11235,0.06355,0.044499,0,1
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.2,0.063382,0.058964,0,1
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.39371,0.061896,0.021568,0,1
4,GO SOMITE DEVELOPMENT,0.14526,0.061716,0.058037,0,1
4,GO SENSORY PERCEPTION OF PAIN,0.26471,0.061522,0.062006,0,1
4,GO OSTEOCLAST DIFFERENTIATION,0.65866,0.061003,0.012255,0,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.068167,0.060991,0.078138,0,1
4,GO REGULATION OF OSSIFICATION,0.072231,0.060906,0.064452,0,1
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.48131,0.060866,0.013631,0,1
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.05161,0.060799,0.046378,0,1
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.084046,0.060525,0.088776,0,1
4,GO INTERACTION WITH SYMBIONT,0.22905,0.060316,0.028947,0,1
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.1313,0.060089,0.068538,0,1
4,GO TUBE DEVELOPMENT,0.25729,0.059573,0.032448,0,1
4,GO MYELOID CELL DEVELOPMENT,0.076492,0.058539,0.077449,0,1
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.25001,0.058371,0.035199,0,1
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.16559,0.058116,0.039819,0,1
4,GO ARTERY MORPHOGENESIS,0.29184,0.056274,0.017477,0,1
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.30815,0.055954,0.048146,0,1
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.1028,0.055904,0.02655,0,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.1313,0.0554,0.050208,0,1
4,GO TORC1 SIGNALING,0.10654,0.055278,0.058306,0,1
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.52025,0.054887,0.0026172,0,1
4,GO NEGATIVE REGULATION OF SIGNALING,0.20309,0.053821,0.040447,0,1
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.43883,0.053734,0.014153,0,1
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.22905,0.053598,0.017805,0,1
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.064293,0.053593,0.096072,0,1
4,GO RESPONSE TO IONIZING RADIATION,0.11039,0.05327,0.030364,0,1
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.05161,0.052553,0.042585,0,1
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.12049,0.052472,0.036513,0,1
4,GO TISSUE MORPHOGENESIS,0.23589,0.052415,0.025642,0,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.12908,0.052067,0.046709,0,1
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.21579,0.051677,0.048073,0,1
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.44402,0.051115,0.040889,0,1
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.10654,0.049753,0.080432,0,1
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.32938,0.049051,0.026707,0,1
4,GO SEX DIFFERENTIATION,0.36064,0.048219,0.025962,0,1
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.21579,0.046363,0.035897,0,1
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.077957,0.04512,0.047437,0,1
4,GO PROTEIN LOCALIZATION TO ORGANELLE,0.10845,0.045047,0.038145,0,1
4,GO MULTI ORGANISM PROCESS,0.11039,0.045006,0.046147,0,1
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.28785,0.044674,0.034801,0,1
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.43367,0.043856,0.016971,0,1
4,GO REGULATION OF BINDING,0.12689,0.042264,0.046615,0,1
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.43883,0.039867,0.031687,0,1
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.17934,0.036517,0.040416,0,1
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.32938,0.036202,0.028988,0,1
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.41842,0.035328,0.015032,0,1
4,GO PROTEIN HOMOOLIGOMERIZATION,0.1028,0.034985,0.050366,0,1
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.7495,0.034521,-0.030288,0,1
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.21905,0.032909,0.031317,0,1
4,GO METHYLATION,0.51459,0.03211,0.0021095,0,1
4,GO RESPONSE TO RADIATION,0.4978,0.031515,0.012339,0,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.14526,0.03085,0.0412,0,1
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.30815,0.030696,0.035737,0,1
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.55487,0.028988,0.004393,0,1
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.14285,0.026844,0.055437,0,1
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.69061,0.021885,0.0017878,0,1
4,GO RESPONSE TO GROWTH FACTOR,0.2839,0.021763,0.032492,0,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0049174,0.41814,0.3503,0,0
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.0010206,0.41729,0.3694,0,0
4,GO REFLEX,0.00092958,0.41425,0.38613,0,0
4,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.026586,0.40641,0.32411,0,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,8.4205e-05,0.39557,0.3786,0,0
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0028141,0.3768,0.3912,0,0
4,GO RESPONSE TO IMMOBILIZATION STRESS,0.0020453,0.35145,0.30432,0,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.022165,0.34362,0.24265,0,0
4,GO SEROTONIN METABOLIC PROCESS,0.00047456,0.33327,0.4218,0,0
4,GO LIPOXYGENASE PATHWAY,0.060602,0.32323,0.21217,0,0
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.0097392,0.30555,0.28192,0,0
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.11636,0.29729,0.1934,0,0
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0085714,0.29501,0.27991,0,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0017641,0.29489,0.36758,0,0
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0042883,0.29365,0.28912,0,0
4,GO DIET INDUCED THERMOGENESIS,0.031748,0.28641,0.18177,0,0
4,GO INTERLEUKIN 5 PRODUCTION,0.049546,0.28505,0.18519,0,0
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.011047,0.27887,0.21608,0,0
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.19695,0.27587,0.14513,0,0
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0011199,0.27495,0.26451,0,0
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.17653,0.27325,0.17098,0,0
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,5.2139e-05,0.27153,0.26223,0,0
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.023741,0.2652,0.22153,0,0
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00069957,0.26347,0.28998,0,0
4,GO RELAXATION OF CARDIAC MUSCLE,0.0034322,0.25955,0.28203,0,0
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.016734,0.25746,0.23252,0,0
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.30815,0.25738,0.1609,0,0
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.049546,0.2573,0.13864,0,0
4,GO RESPONSE TO MAGNESIUM ION,0.0097392,0.25637,0.30057,0,0
4,GO RESPONSE TO MUSCLE STRETCH,0.0059384,0.25145,0.27118,0,0
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.013798,0.25097,0.32304,0,0
4,GO EPITHELIAL CELL MORPHOGENESIS,0.014486,0.25038,0.25507,0,0
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.055956,0.24869,0.16672,0,0
4,GO CELLULAR RESPONSE TO COPPER ION,0.17374,0.24498,0.21569,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0085714,0.24495,0.22944,0,0
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.097379,0.24334,0.18397,0,0
4,GO B CELL HOMEOSTASIS,0.00065623,0.24011,0.21989,0,0
4,GO HEART INDUCTION,0.25001,0.23948,0.1311,0,0
4,GO DISACCHARIDE METABOLIC PROCESS,0.0049174,0.23783,0.34225,0,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.12259,0.23763,0.16354,0,0
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.080955,0.2359,0.14717,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.40843,0.23568,0.048986,0,0
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.024846,0.23553,0.24763,0,0
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0695,0.23389,0.23833,0,0
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.17374,0.23212,0.18617,0,0
4,GO LUNG CELL DIFFERENTIATION,0.035393,0.23038,0.29099,0,0
4,GO IMP METABOLIC PROCESS,0.65866,0.22626,0.042132,0,0
4,GO RESPONSE TO WATER,0.087232,0.22601,0.17545,0,0
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.070855,0.22565,0.13858,0,0
4,GO VASCULAR WOUND HEALING,0.0087944,0.22301,0.29568,0,0
4,GO REGULATION OF METANEPHROS DEVELOPMENT,0.11434,0.22296,0.10883,0,0
4,GO REGULATION OF DOPAMINE SECRETION,0.063042,0.22053,0.27648,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.041093,0.21983,0.15826,0,0
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.12689,0.21736,0.209,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.28785,0.21726,0.080631,0,0
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.11235,0.21648,0.14466,0,0
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0067808,0.2148,0.26151,0,0
4,GO NEURONAL ACTION POTENTIAL,0.0020453,0.21391,0.34297,0,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.066855,0.2131,0.17387,0,0
4,GO POSITIVE REGULATION OF HEART CONTRACTION,0.0036303,0.20849,0.19151,0,0
4,GO ADRENAL GLAND DEVELOPMENT,0.0085714,0.20559,0.24888,0,0
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.24643,0.20473,0.10857,0,0
4,GO REGULATION OF VESICLE FUSION,0.080955,0.20305,0.18193,0,0
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0028957,0.20175,0.25178,0,0
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.064293,0.20122,0.22932,0,0
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.052669,0.20108,0.16598,0,0
4,GO DETECTION OF CALCIUM ION,0.060602,0.19955,0.22687,0,0
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.053746,0.19934,0.14481,0,0
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0029794,0.19744,0.21247,0,0
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.17653,0.19741,0.15422,0,0
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.041967,0.19741,0.31422,0,0
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.079444,0.1968,0.16924,0,0
4,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.24288,0.19589,0.087557,0,0
4,GO CAMP METABOLIC PROCESS,0.076492,0.19558,0.14673,0,0
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0085714,0.19407,0.26877,0,0
4,GO MIDGUT DEVELOPMENT,0.057089,0.19175,0.21735,0,0
4,GO REGULATION OF AMINO ACID TRANSPORT,0.05824,0.19111,0.16269,0,0
4,GO OXYGEN TRANSPORT,0.48131,0.18992,0.056774,0,0
4,GO COLLAGEN BIOSYNTHETIC PROCESS,0.67776,0.18896,-0.0088818,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0011549,0.18826,0.19585,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.016339,0.18392,0.2327,0,0
4,GO PROTEIN OXIDATION,0.21579,0.18384,0.077082,0,0
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.25363,0.18322,0.11003,0,0
4,GO CATECHOLAMINE UPTAKE,0.029068,0.1829,0.22157,0,0
4,GO RESPONSE TO TUMOR CELL,0.11434,0.18269,0.18922,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0087944,0.18256,0.21377,0,0
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.31653,0.18225,0.15088,0,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.010245,0.18094,0.24399,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.39858,0.18059,0.077917,0,0
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0087944,0.18029,0.2053,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.0020453,0.1783,0.21507,0,0
4,GO CELL JUNCTION DISASSEMBLY,0.20937,0.17741,0.10249,0,0
4,GO ZINC ION HOMEOSTASIS,0.12259,0.17669,0.13728,0,0
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.05824,0.1765,0.25073,0,0
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.085627,0.17493,0.12217,0,0
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.029719,0.17435,0.12654,0,0
4,GO RESPONSE TO LEUCINE,0.11841,0.17432,0.1601,0,0
4,GO TRANSLATIONAL TERMINATION,0.064293,0.17372,0.11674,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.10096,0.17358,0.20145,0,0
4,GO MACROPHAGE APOPTOTIC PROCESS,0.060602,0.17307,0.16664,0,0
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.082489,0.17277,0.19986,0,0
4,GO RESPONSE TO STARVATION,4.1617e-05,0.17201,0.21639,0,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.4545,0.17181,0.060624,0,0
4,GO INFLAMMATORY RESPONSE TO WOUNDING,0.26471,0.17107,0.13828,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.11235,0.16957,0.11375,0,0
4,GO MEMBRANE DEPOLARIZATION,0.060602,0.16927,0.12501,0,0
4,GO CELLULAR PIGMENTATION,0.0020453,0.16927,0.15889,0,0
4,GO RIBOSOME ASSEMBLY,0.26471,0.16828,0.093509,0,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.11039,0.16817,0.10249,0,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.35607,0.16805,0.090855,0,0
4,GO CHLORIDE ION HOMEOSTASIS,0.04854,0.16771,0.13584,0,0
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.17653,0.16493,0.16444,0,0
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.077957,0.1646,0.17255,0,0
4,GO LUNG EPITHELIUM DEVELOPMENT,0.05161,0.16425,0.19168,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.27999,0.16414,0.13861,0,0
4,GO ADENOHYPOPHYSIS DEVELOPMENT,0.44924,0.16394,0.10084,0,0
4,GO MONOAMINE TRANSPORT,0.025414,0.163,0.20686,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.60272,0.16237,0.035672,0,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.188,0.16223,0.080292,0,0
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.14048,0.16219,0.1191,0,0
4,GO PLASMA MEMBRANE FUSION,0.12689,0.16199,0.13813,0,0
4,GO REGULATION OF ACROSOME REACTION,0.080955,0.16186,0.25664,0,0
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.11636,0.16099,0.14874,0,0
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.050569,0.16096,0.20883,0,0
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0046564,0.16089,0.18962,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.010773,0.16078,0.22984,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.03939,0.15997,0.12897,0,0
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.068167,0.1594,0.11889,0,0
4,GO MEGAKARYOCYTE DEVELOPMENT,0.02166,0.15938,0.22789,0,0
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.087232,0.15935,0.16809,0,0
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.24288,0.15891,0.014641,0,0
4,GO REGULATION OF BONE DEVELOPMENT,0.14285,0.15823,0.0933,0,0
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.04854,0.15755,0.20615,0,0
4,GO REGULATION OF HEART RATE,0.019283,0.15679,0.14537,0,0
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.084046,0.15678,0.21636,0,0
4,GO MALE MEIOSIS I,0.17934,0.15669,0.1535,0,0
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.052669,0.15662,0.14151,0,0
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.016734,0.1565,0.2247,0,0
4,GO REGULATION OF CARDIAC CONDUCTION,0.01282,0.15559,0.12741,0,0
4,GO RESPONSE TO HYPEROXIA,0.21905,0.15529,0.053153,0,0
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.26098,0.15521,0.1157,0,0
4,GO ENDODERMAL CELL DIFFERENTIATION,0.33373,0.15462,0.027276,0,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.4978,0.15457,0.057651,0,0
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.16828,0.15365,0.11294,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.02843,0.1531,0.24135,0,0
4,GO ENDODERM FORMATION,0.29586,0.15271,0.045532,0,0
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.043763,0.15216,0.15975,0,0
4,GO WHITE FAT CELL DIFFERENTIATION,0.087232,0.15214,0.089014,0,0
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.32938,0.15189,0.071042,0,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.23245,0.15175,0.095744,0,0
4,GO PROTEIN KINASE C SIGNALING,0.15773,0.15109,0.089532,0,0
4,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.18508,0.15107,0.13639,0,0
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.42855,0.151,0.063562,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.48131,0.15065,0.052516,0,0
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.11039,0.15056,0.11509,0,0
4,GO INTERLEUKIN 6 PRODUCTION,0.0013872,0.15055,0.18138,0,0
4,GO RESPONSE TO LIGHT INTENSITY,0.088862,0.15037,0.10248,0,0
4,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.44924,0.14972,0.044572,0,0
4,GO CHAPERONE MEDIATED AUTOPHAGY,0.56075,0.14954,0.051869,0,0
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.188,0.14927,0.10203,0,0
4,GO RESPONSE TO FORSKOLIN,0.30402,0.14925,0.1074,0,0
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.39858,0.14859,0.015911,0,0
4,GO RESPONSE TO CAFFEINE,0.093897,0.14811,0.13264,0,0
4,GO ER NUCLEUS SIGNALING PATHWAY,0.0056288,0.14803,0.23044,0,0
4,GO L SERINE METABOLIC PROCESS,0.74288,0.14774,0.02384,0,0
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.18508,0.14745,0.058015,0,0
4,GO TRANSPOSITION,0.065563,0.14724,0.16744,0,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.67137,0.14707,0.012154,0,0
4,GO SPHINGOID METABOLIC PROCESS,0.041093,0.14675,0.19258,0,0
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.11235,0.14628,0.12573,0,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.52594,0.14553,-0.005494,0,0
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.059411,0.14465,0.093404,0,0
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.30815,0.14389,0.12858,0,0
4,GO CHEMOSENSORY BEHAVIOR,0.13583,0.14324,0.068485,0,0
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.05161,0.1431,0.16942,0,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.070855,0.14298,0.1674,0,0
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.090515,0.14265,0.1226,0,0
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.05161,0.14219,0.18638,0,0
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.52594,0.14198,0.04044,0,0
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0075304,0.14155,0.14758,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.12908,0.14072,0.10535,0,0
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.090515,0.14038,0.13721,0,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.18508,0.14037,0.12429,0,0
4,GO STRIATED MUSCLE ADAPTATION,0.090515,0.13962,0.10701,0,0
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.14526,0.13931,0.090204,0,0
4,GO MECHANORECEPTOR DIFFERENTIATION,0.03245,0.1393,0.095571,0,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.32506,0.13909,-0.014079,0,0
4,GO NOREPINEPHRINE TRANSPORT,0.057089,0.13899,0.14472,0,0
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.53742,0.13856,0.075955,0,0
4,GO SKIN MORPHOGENESIS,0.76948,0.13795,-0.090832,0,0
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.084046,0.13786,0.15202,0,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.60272,0.13765,0.005615,0,0
4,GO TRANSMISSION OF NERVE IMPULSE,0.036164,0.13755,0.17272,0,0
4,GO REGULATION OF CELL MATURATION,0.02166,0.13751,0.14156,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.046579,0.13731,0.15011,0,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.65234,0.13634,0.032266,0,0
4,GO CARDIAC CELL DEVELOPMENT,0.041093,0.13618,0.1019,0,0
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.37932,0.13614,0.062685,0,0
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.36064,0.13592,0.047443,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.18219,0.13568,0.098045,0,0
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0062634,0.13557,0.13246,0,0
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.30815,0.13531,0.057063,0,0
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00090094,0.13505,0.13972,0,0
4,GO MAINTENANCE OF CELL POLARITY,0.36526,0.13504,0.078212,0,0
4,GO LAMELLIPODIUM MORPHOGENESIS,0.10845,0.13466,0.15608,0,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.054842,0.13441,0.18264,0,0
4,GO NOTCH SIGNALING PATHWAY,0.0042883,0.13418,0.13645,0,0
4,GO AMINE TRANSPORT,0.034637,0.13412,0.18612,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.33812,0.13359,0.14123,0,0
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.031748,0.13342,0.13922,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.34702,0.13299,0.087965,0,0
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.085627,0.13281,0.1151,0,0
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.11039,0.13254,0.075362,0,0
4,GO MEMBRANE FISSION,0.21579,0.13252,0.11976,0,0
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0073363,0.13241,0.16588,0,0
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.73628,0.1314,0.01642,0,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.075049,0.13132,0.14295,0,0
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.057089,0.13117,0.17536,0,0
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.015574,0.13105,0.23654,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.14526,0.13102,0.10535,0,0
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.64605,0.1308,0.024921,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.024288,0.13039,0.13688,0,0
4,GO MITOTIC CYTOKINETIC PROCESS,0.23245,0.1301,0.074407,0,0
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.36991,0.12999,0.091838,0,0
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.36991,0.12982,0.098238,0,0
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.024288,0.12979,0.10724,0,0
4,GO PIGMENT GRANULE LOCALIZATION,0.0099891,0.1297,0.14261,0,0
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.13814,0.12963,0.10912,0,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.54903,0.12953,-0.025759,0,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.30815,0.1293,0.087318,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.14048,0.12877,0.041604,0,0
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.10654,0.12872,0.20644,0,0
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.050569,0.12846,0.14806,0,0
4,GO GLYCINE TRANSPORT,0.49227,0.1284,0.065164,0,0
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.49227,0.12839,0.035983,0,0
4,GO ENERGY RESERVE METABOLIC PROCESS,0.013139,0.12816,0.124,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.25363,0.12746,0.12328,0,0
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.10654,0.12731,0.090902,0,0
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.36526,0.12728,0.036326,0,0
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.18508,0.12707,0.06652,0,0
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0054795,0.12647,0.14517,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.21905,0.12617,0.2516,0,0
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.16294,0.12583,0.091549,0,0
4,GO FAT CELL PROLIFERATION,0.60272,0.1258,0.053557,0,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.009256,0.12567,0.13729,0,0
4,GO NEURON REMODELING,0.23245,0.12551,0.07222,0,0
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.059411,0.12537,0.10564,0,0
4,GO CELLULAR RESPONSE TO IRON ION,0.20937,0.12497,0.081061,0,0
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.22568,0.12481,0.16526,0,0
4,GO PENILE ERECTION,0.54903,0.12476,0.057558,0,0
4,GO REGULATION OF TRANSPOSITION,0.10654,0.12457,0.15751,0,0
4,GO REGULATION OF DENDRITE EXTENSION,0.079444,0.12452,0.20824,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.27227,0.12403,0.048125,0,0
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.15264,0.12382,0.092148,0,0
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0042883,0.12378,0.128,0,0
4,GO CAMP BIOSYNTHETIC PROCESS,0.11636,0.12352,0.14427,0,0
4,GO GRANULOCYTE DIFFERENTIATION,0.26471,0.12336,0.11772,0,0
4,GO CELLULAR RESPONSE TO ZINC ION,0.30402,0.12324,0.14188,0,0
4,GO COLLAGEN CATABOLIC PROCESS,0.14048,0.12263,0.069091,0,0
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.085627,0.12243,0.13412,0,0
4,GO GAMMA DELTA T CELL ACTIVATION,0.30815,0.12235,0.11056,0,0
4,GO GLUCOSE CATABOLIC PROCESS,0.12259,0.12211,0.13259,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.077957,0.12182,0.18553,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.017137,0.12168,0.11081,0,0
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.34256,0.12147,0.048901,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.012508,0.1211,0.18439,0,0
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.35153,0.12089,0.071531,0,0
4,GO ALDEHYDE CATABOLIC PROCESS,0.20937,0.12076,0.1151,0,0
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.69707,0.12064,-0.020369,0,0
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.011047,0.12062,0.16094,0,0
4,GO OSTEOBLAST DEVELOPMENT,0.075049,0.12027,0.065746,0,0
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.43883,0.12003,0.079323,0,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.32506,0.11944,0.082717,0,0
4,GO GANGLIOSIDE METABOLIC PROCESS,0.11841,0.11868,0.12864,0,0
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.27611,0.11853,0.081199,0,0
4,GO RESPONSE TO ALKALOID,0.0695,0.11853,0.079048,0,0
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.60272,0.11829,0.035692,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.60272,0.11829,0.070518,0,0
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.16559,0.1175,0.11059,0,0
4,GO INACTIVATION OF MAPK ACTIVITY,0.12049,0.1175,0.15088,0,0
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.046579,0.11732,0.11246,0,0
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.016734,0.11729,0.13857,0,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.011047,0.11728,0.22316,0,0
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.082489,0.11594,0.26058,0,0
4,GO PROTEIN DESTABILIZATION,0.011326,0.11572,0.10713,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.9686,0.11567,-0.015649,0,0
4,GO LYMPH NODE DEVELOPMENT,0.012508,0.11534,0.1747,0,0
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.65234,0.11523,0.056312,0,0
4,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.39371,0.11517,0.096562,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.049546,0.11517,0.14098,0,0
4,GO GLOMERULUS DEVELOPMENT,0.075049,0.11491,0.117,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.054842,0.11482,0.11294,0,0
4,GO SODIUM ION TRANSPORT,0.043763,0.11482,0.092752,0,0
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.25363,0.11457,0.058134,0,0
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.095625,0.11453,0.12917,0,0
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.10654,0.11429,0.14805,0,0
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.24288,0.11371,0.082642,0,0
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.011612,0.11338,0.22061,0,0
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.011904,0.11327,0.11134,0,0
4,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.48131,0.11316,0.037377,0,0
4,GO GROOMING BEHAVIOR,0.11039,0.11288,0.14497,0,0
4,GO VIRAL RNA GENOME REPLICATION,0.088862,0.11281,0.067682,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0012662,0.11269,0.11208,0,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.25001,0.11226,0.25003,0,0
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.037747,0.11114,0.14687,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.022165,0.1111,0.079529,0,0
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0064317,0.11053,0.10878,0,0
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.52025,0.11039,0.044088,0,0
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.30402,0.11036,0.04135,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.32506,0.11031,0.04124,0,0
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.064293,0.11012,0.15626,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.034637,0.10962,0.12287,0,0
4,GO ANION HOMEOSTASIS,0.17099,0.10925,0.10387,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.025994,0.109,0.1111,0,0
4,GO RESPONSE TO SALT,0.16294,0.10882,0.072097,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.075049,0.10879,0.096694,0,0
4,GO MELANOCYTE DIFFERENTIATION,0.029719,0.10875,0.12778,0,0
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.097379,0.10797,0.073526,0,0
4,GO TRNA MODIFICATION,0.31653,0.10797,0.04241,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.12049,0.10783,0.11542,0,0
4,GO COPPER ION HOMEOSTASIS,0.17934,0.10731,0.085749,0,0
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.16828,0.10726,0.076593,0,0
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.26847,0.10665,0.073104,0,0
4,GO NUCLEOSIDE SALVAGE,0.17653,0.10634,0.057125,0,0
4,GO RENAL TUBULE DEVELOPMENT,0.17099,0.10608,0.053013,0,0
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.73628,0.10572,0.010449,0,0
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0031536,0.10571,0.14013,0,0
4,GO ANIMAL ORGAN MATURATION,0.14769,0.10568,0.078264,0,0
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.34702,0.10545,0.040731,0,0
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.040234,0.10518,0.095421,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.38408,0.10516,0.040703,0,0
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.26847,0.10495,0.073848,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0014299,0.10476,0.10497,0,0
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.19695,0.10471,0.10972,0,0
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.099158,0.1045,0.10327,0,0
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.22235,0.1042,0.096583,0,0
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.42855,0.10417,0.083644,0,0
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.30402,0.10403,0.067153,0,0
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.016339,0.10372,0.10846,0,0
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.14526,0.10344,0.1299,0,0
4,GO ENDOSOMAL TRANSPORT,0.00055855,0.1029,0.10328,0,0
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.034637,0.10274,0.15968,0,0
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.090515,0.10241,0.12649,0,0
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.57857,0.10229,0.038838,0,0
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.061812,0.10198,0.067342,0,0
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.2839,0.10191,0.093722,0,0
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.31653,0.1019,0.036779,0,0
4,GO COLLAGEN METABOLIC PROCESS,0.64605,0.10166,-0.00038833,0,0
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.085627,0.10156,0.10257,0,0
4,GO XENOBIOTIC CATABOLIC PROCESS,0.7495,0.10149,0.078838,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.52594,0.10114,0.024558,0,0
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.080955,0.10105,0.14426,0,0
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.093897,0.10101,0.17393,0,0
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.11636,0.10099,0.18648,0,0
4,GO ACTIN FILAMENT BASED TRANSPORT,0.050569,0.10061,0.17036,0,0
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.092194,0.10052,0.15559,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.22905,0.10027,0.029912,0,0
4,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.60883,0.10025,0.035538,0,0
4,GO INTERLEUKIN 4 PRODUCTION,0.17099,0.10025,0.098702,0,0
4,GO ACTIVATED T CELL PROLIFERATION,0.023741,0.10009,0.12317,0,0
4,GO ION TRANSPORT,0.00084609,0.10004,0.13566,0,0
4,GO RESPONSE TO ESTRADIOL,0.064293,0.099803,0.072504,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS,0.32077,0.099476,0.095398,0,0
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.11235,0.099088,0.078675,0,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.31653,0.099043,0.041358,0,0
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.027803,0.098799,0.11755,0,0
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.14769,0.098726,0.068317,0,0
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.22235,0.098672,0.081375,0,0
4,GO PROTEIN TARGETING TO MEMBRANE,0.60883,0.09856,0.020302,0,0
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.075049,0.098362,0.15447,0,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,0.2,0.098339,0.08085,0,0
4,GO PEPTIDYL HISTIDINE MODIFICATION,0.28785,0.098232,0.061784,0,0
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.087232,0.098195,0.11326,0,0
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.2,0.097958,0.090798,0,0
4,GO ION TRANSMEMBRANE TRANSPORT,0.0041716,0.097352,0.1142,0,0
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.30815,0.097305,0.080175,0,0
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.21256,0.097228,0.10948,0,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.62113,0.096876,0.0040906,0,0
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.13814,0.096857,0.066261,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.82348,0.09664,0.0063188,0,0
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.64605,0.096619,0.018449,0,0
4,GO VACUOLAR TRANSPORT,0.0017641,0.096403,0.14802,0,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.38888,0.096384,0.069769,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.34256,0.096044,0.14501,0,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.095625,0.096026,0.05454,0,0
4,GO L AMINO ACID TRANSPORT,0.14048,0.095975,0.11369,0,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.20621,0.095969,0.099369,0,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.29992,0.095768,0.064438,0,0
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.38408,0.095569,0.076585,0,0
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.75615,0.095485,-0.00021436,0,0
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.57857,0.095445,0.038616,0,0
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.13583,0.094957,0.16883,0,0
4,GO LACTATE METABOLIC PROCESS,0.20621,0.09489,0.074728,0,0
4,GO POTASSIUM ION HOMEOSTASIS,0.2839,0.094751,0.060707,0,0
4,GO TONIC SMOOTH MUSCLE CONTRACTION,0.44924,0.094749,0.088991,0,0
4,GO TRNA PROCESSING,0.32938,0.094264,0.037335,0,0
4,GO URETER DEVELOPMENT,0.38408,0.093933,0.021609,0,0
4,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.11039,0.093806,0.21514,0,0
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.17099,0.093704,0.075397,0,0
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.188,0.093685,0.063264,0,0
4,GO EMBRYONIC BODY MORPHOGENESIS,0.47049,0.0936,0.012133,0,0
4,GO FORMATION OF PRIMARY GERM LAYER,0.21256,0.093316,0.060547,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.14285,0.093145,0.12021,0,0
4,GO ORGANIC CATION TRANSPORT,0.090515,0.093108,0.1077,0,0
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.027803,0.09294,0.14804,0,0
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.24288,0.092699,0.18371,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.56075,0.092512,-0.028827,0,0
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.10845,0.09242,0.084946,0,0
4,GO KERATINOCYTE PROLIFERATION,0.20937,0.09215,0.0507,0,0
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.03939,0.091951,0.08782,0,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.65234,0.091895,0.013815,0,0
4,GO AMIDE BIOSYNTHETIC PROCESS,0.1028,0.091644,0.064657,0,0
4,GO PANCREAS DEVELOPMENT,0.12473,0.091369,0.10202,0,0
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.12259,0.091094,0.069068,0,0
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.068167,0.091064,0.16137,0,0
4,GO NAD METABOLIC PROCESS,0.26098,0.090888,0.090445,0,0
4,GO METAL ION TRANSPORT,0.020205,0.090733,0.093425,0,0
4,GO PROTEIN DENEDDYLATION,0.59664,0.090683,0.035175,0,0
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.98255,0.090466,-0.033565,0,0
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.035393,0.090164,0.097319,0,0
4,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.89907,0.090152,-0.053668,0,0
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.079444,0.089935,0.091216,0,0
4,GO MATURATION OF 5 8S RRNA,0.63354,0.08968,0.018463,0,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.40349,0.089436,0.049869,0,0
4,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.49227,0.089353,0.051142,0,0
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.014841,0.089218,0.15994,0,0
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.14526,0.089214,0.067209,0,0
4,GO MULTICELLULAR ORGANISM AGING,0.031748,0.089021,0.091188,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.23245,0.088945,0.040951,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.24643,0.088913,0.12302,0,0
4,GO NCRNA METABOLIC PROCESS,0.17934,0.088833,0.054315,0,0
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.38888,0.088724,0.045613,0,0
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.093897,0.088591,0.11282,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.44924,0.088577,0.040643,0,0
4,GO ESTROUS CYCLE,0.78289,0.088544,0.027306,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.23937,0.088537,0.1167,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.17374,0.088419,0.07092,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.015953,0.088391,0.17214,0,0
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.18508,0.088346,0.13703,0,0
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.48678,0.088254,0.053891,0,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.83713,0.088212,-0.02952,0,0
4,GO ADAPTATION OF SIGNALING PATHWAY,0.39858,0.08808,0.044522,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.14769,0.087768,0.077985,0,0
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.12908,0.087761,0.085619,0,0
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.43883,0.087718,0.056207,0,0
4,GO CIRCADIAN RHYTHM,0.026586,0.087399,0.05894,0,0
4,GO CARDIAC CONDUCTION,0.31653,0.087326,0.049649,0,0
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.54903,0.087063,0.073662,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.63354,0.087057,-0.053401,0,0
4,GO VESICLE DOCKING,0.10654,0.08679,0.11058,0,0
4,GO RESPONSE TO NICOTINE,0.37932,0.08676,0.054751,0,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.13583,0.086598,0.069394,0,0
4,GO PROTEIN TARGETING,0.0695,0.08636,0.073986,0,0
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.055956,0.086216,0.092749,0,0
4,GO BASEMENT MEMBRANE ORGANIZATION,0.25729,0.08607,0.11608,0,0
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.066855,0.085882,0.15685,0,0
4,GO ENDOCYTOSIS,0.15517,0.085587,0.06154,0,0
4,GO THYROID HORMONE METABOLIC PROCESS,0.14769,0.084984,0.076024,0,0
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.24288,0.084918,0.053231,0,0
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.4978,0.084748,0.038613,0,0
4,GO CATION TRANSPORT,0.009256,0.084517,0.10532,0,0
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.080955,0.084301,0.085808,0,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.39858,0.084101,0.10203,0,0
4,GO CATION TRANSMEMBRANE TRANSPORT,0.023741,0.084089,0.092217,0,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.32938,0.084042,0.040435,0,0
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.12473,0.083886,0.058771,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.12473,0.08383,0.11211,0,0
4,GO CARBOHYDRATE PHOSPHORYLATION,0.36064,0.083731,0.054174,0,0
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.68418,0.08368,0.025331,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.035393,0.083621,0.10566,0,0
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.25363,0.0836,0.090436,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.24288,0.083491,0.044437,0,0
4,GO NUCLEOTIDE PHOSPHORYLATION,0.10845,0.083428,0.075105,0,0
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.13355,0.083052,0.08093,0,0
4,GO REGULATION OF CALCIUM ION IMPORT,0.19095,0.082984,0.092129,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.38888,0.08291,0.096164,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.53167,0.08271,0.027094,0,0
4,GO PIGMENT GRANULE MATURATION,0.38408,0.08265,0.034774,0,0
4,GO PARAXIAL MESODERM DEVELOPMENT,0.79636,0.081998,0.021995,0,0
4,GO RESPONSE TO INACTIVITY,0.16294,0.081965,0.14399,0,0
4,GO POSITIVE REGULATION OF JNK CASCADE,0.013798,0.081867,0.094295,0,0
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.36526,0.081495,0.062014,0,0
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.59059,0.08148,0.031558,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.53167,0.081378,0.037348,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.064293,0.080916,0.05308,0,0
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.16559,0.080891,0.076417,0,0
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.32077,0.080878,0.095657,0,0
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.14769,0.080844,0.083534,0,0
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.02166,0.080818,0.11235,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.80989,0.08048,0.0083654,0,0
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.12049,0.080474,0.2263,0,0
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.066855,0.080451,0.15524,0,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,0.29992,0.080427,0.04103,0,0
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.62113,0.080385,0.045212,0,0
4,GO RESPONSE TO LEPTIN,0.16828,0.080318,0.11053,0,0
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.50337,0.080309,0.011004,0,0
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.3746,0.080116,0.040267,0,0
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033894,0.080051,0.11866,0,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.14769,0.079994,0.088202,0,0
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.22235,0.079945,0.077652,0,0
4,GO INTERLEUKIN 17 PRODUCTION,0.1313,0.079856,0.09649,0,0
4,GO SENSORY PERCEPTION,0.025994,0.079775,0.066646,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.090515,0.079588,0.19965,0,0
4,GO ONE CARBON METABOLIC PROCESS,0.20309,0.079234,0.078676,0,0
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.33373,0.079176,0.099982,0,0
4,GO INNER DYNEIN ARM ASSEMBLY,0.51459,0.079027,0.03919,0,0
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.050569,0.079017,0.088477,0,0
4,GO RNA CATABOLIC PROCESS,0.49227,0.078903,0.018585,0,0
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.15773,0.078491,0.073554,0,0
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.012508,0.07845,0.10523,0,0
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.061812,0.077961,0.11773,0,0
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.44402,0.077603,0.045943,0,0
4,GO PEPTIDYL TYROSINE MODIFICATION,0.057089,0.077522,0.079076,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.94769,0.077277,0.065594,0,0
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.78289,0.077159,-0.0081262,0,0
4,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.27999,0.077148,0.15602,0,0
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.94073,0.077098,-0.017208,0,0
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.10096,0.076846,0.073769,0,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.18219,0.076831,0.077612,0,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.15517,0.076815,0.048236,0,0
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.32506,0.076643,0.0642,0,0
4,GO ANATOMICAL STRUCTURE REGRESSION,0.53742,0.076638,0.010575,0,0
4,GO RESPONSE TO GLUCAGON,0.26098,0.076484,0.07748,0,0
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.66501,0.076354,-0.071739,0,0
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.061812,0.07635,0.075121,0,0
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.068167,0.076209,0.10406,0,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.67137,0.075966,-0.0052016,0,0
4,GO INTERMEMBRANE LIPID TRANSFER,0.024846,0.075907,0.12831,0,0
4,GO RESPONSE TO INTERLEUKIN 7,0.077957,0.075447,0.088813,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.038561,0.075349,0.079022,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.56666,0.075329,0.020901,0,0
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.30402,0.075228,0.031627,0,0
4,GO RRNA CATABOLIC PROCESS,0.22905,0.075209,0.069817,0,0
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.17653,0.075186,0.057484,0,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.43883,0.075066,0.073002,0,0
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.35153,0.075003,0.018322,0,0
4,GO HYPEROSMOTIC RESPONSE,0.54903,0.074612,0.048039,0,0
4,GO RUFFLE ORGANIZATION,0.070855,0.074558,0.11968,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.92682,0.074556,-0.017834,0,0
4,GO PSEUDOPODIUM ORGANIZATION,0.18508,0.074535,0.15664,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.72313,0.074497,0.034178,0,0
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.097379,0.074484,0.080406,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.14048,0.074464,0.05173,0,0
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.15773,0.074431,0.044388,0,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.56075,0.073832,-0.043826,0,0
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.43883,0.073623,0.0491,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.072231,0.07348,0.074626,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.48678,0.073401,0.063247,0,0
4,GO CELLULAR ANION HOMEOSTASIS,0.62113,0.07339,-0.0049118,0,0
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.019739,0.073263,0.088762,0,0
4,GO MYOFIBRIL ASSEMBLY,0.02843,0.073237,0.09854,0,0
4,GO NUCLEUS LOCALIZATION,0.99651,0.073105,-0.02157,0,0
4,GO REGULATION OF SODIUM ION TRANSPORT,0.41842,0.072879,0.033921,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.21905,0.07277,0.069075,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.080955,0.072679,0.079269,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.52594,0.072647,0.057707,0,0
4,GO GLIAL CELL MIGRATION,0.96163,0.072391,-0.024098,0,0
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.35607,0.072298,0.034601,0,0
4,GO COBALAMIN METABOLIC PROCESS,0.12259,0.072207,0.12171,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.50337,0.072194,0.025249,0,0
4,GO REGULATION OF PHAGOCYTOSIS,0.14526,0.07218,0.067414,0,0
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.39858,0.072141,0.036995,0,0
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.52025,0.072086,0.019862,0,0
4,GO POLYOL CATABOLIC PROCESS,0.037747,0.071965,0.12192,0,0
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.068167,0.071881,0.066862,0,0
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.18219,0.071874,0.11205,0,0
4,GO SARCOMERE ORGANIZATION,0.11434,0.071582,0.093388,0,0
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.12689,0.071446,0.070617,0,0
4,GO PLACENTA DEVELOPMENT,0.36526,0.071397,0.047231,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.17099,0.071007,0.086248,0,0
4,GO ERBB2 SIGNALING PATHWAY,0.87833,0.070978,0.024003,0,0
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.17653,0.07074,0.10024,0,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.36064,0.070731,0.051859,0,0
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.037747,0.070636,0.13171,0,0
4,GO REGULATION OF MRNA BINDING,0.50896,0.070395,0.011325,0,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.1313,0.070241,0.07234,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.1313,0.070085,0.084764,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.31232,0.070075,0.069771,0,0
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.61497,0.070045,0.035668,0,0
4,GO EATING BEHAVIOR,0.047551,0.069665,0.10918,0,0
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.1028,0.069567,0.12096,0,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.56075,0.06951,0.039447,0,0
4,GO NCRNA PROCESSING,0.40843,0.069379,0.031687,0,0
4,GO GLAND MORPHOGENESIS,0.21256,0.069372,0.054068,0,0
4,GO PROTEIN HETEROOLIGOMERIZATION,0.33812,0.069361,0.023352,0,0
4,GO SERTOLI CELL DIFFERENTIATION,0.41341,0.069307,0.033709,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.56666,0.069233,0.040434,0,0
4,GO RESPONSE TO AMINE,0.74288,0.069208,0.017259,0,0
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.3746,0.069153,0.053243,0,0
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.39858,0.06904,0.025269,0,0
4,GO AMINO SUGAR METABOLIC PROCESS,0.53167,0.068976,0.041978,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.20621,0.068956,0.077399,0,0
4,GO DNA DEMETHYLATION,0.43883,0.068732,0.03138,0,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.94073,0.068696,0.024423,0,0
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.13814,0.068352,0.051761,0,0
4,GO SNRNA PROCESSING,0.16559,0.068334,0.031355,0,0
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.54321,0.068207,0.040064,0,0
4,GO EPIDERMIS MORPHOGENESIS,0.30402,0.068185,0.045504,0,0
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.48131,0.067965,0.033663,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.15264,0.067932,0.092477,0,0
4,GO PHOTOTRANSDUCTION,0.18219,0.06793,0.029339,0,0
4,GO AORTA MORPHOGENESIS,0.68418,0.067731,0.020112,0,0
4,GO ACTIN FILAMENT BASED MOVEMENT,0.43883,0.067719,0.031946,0,0
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.56666,0.067558,0.016425,0,0
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.65866,0.067439,-0.0036284,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.98255,0.067355,-0.021137,0,0
4,GO RESPONSE TO MANGANESE ION,0.16294,0.067323,0.115,0,0
4,GO REGULATION OF DNA METHYLATION,0.54903,0.067283,0.025051,0,0
4,GO NADH METABOLIC PROCESS,0.27611,0.067102,0.10599,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.2839,0.067094,0.03919,0,0
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.2839,0.067078,0.091803,0,0
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.084046,0.067058,0.1029,0,0
4,GO EPIBOLY,0.56075,0.067004,-0.025227,0,0
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.5726,0.067003,0.019629,0,0
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.41341,0.066777,0.014435,0,0
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.32938,0.066677,0.082057,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.23245,0.066585,0.073462,0,0
4,GO REGULATION OF GOLGI ORGANIZATION,0.28785,0.066563,0.077044,0,0
4,GO REGULATION OF PROTEIN MATURATION,0.19393,0.066379,0.058411,0,0
4,GO STRESS FIBER ASSEMBLY,0.76281,0.066364,-0.00071868,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.15264,0.066341,0.052479,0,0
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.079444,0.066132,0.10194,0,0
4,GO MUSCLE SYSTEM PROCESS,0.087232,0.066017,0.069813,0,0
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.21579,0.065858,0.042859,0,0
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.38888,0.065711,0.027029,0,0
4,GO AUTOPHAGIC CELL DEATH,0.1313,0.065604,0.092849,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.23589,0.065517,0.068196,0,0
4,GO POSITIVE T CELL SELECTION,0.097379,0.065152,0.071024,0,0
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.68418,0.065105,0.077652,0,0
4,GO NEGATIVE REGULATION OF TRANSPORT,0.092194,0.06479,0.063511,0,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.53167,0.064639,0.013726,0,0
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.86455,0.064316,0.0046885,0,0
4,GO SPROUTING ANGIOGENESIS,0.70355,0.064279,0.00044201,0,0
4,GO PROTEIN TETRAMERIZATION,0.19393,0.064066,0.055175,0,0
4,GO MESONEPHROS DEVELOPMENT,0.31653,0.063986,0.03791,0,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.65866,0.063948,0.015493,0,0
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.042857,0.063884,0.067515,0,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.37932,0.063838,0.060101,0,0
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.8303,0.06376,-0.0065521,0,0
4,GO FEAR RESPONSE,0.31232,0.063349,0.058428,0,0
4,GO ALDITOL METABOLIC PROCESS,0.40349,0.063249,0.04805,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.48131,0.063066,-0.12802,0,0
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.15015,0.062931,0.081668,0,0
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.91987,0.062831,-0.0096028,0,0
4,GO TRNA CATABOLIC PROCESS,0.29992,0.06281,0.11808,0,0
4,GO RIBOSOME BIOGENESIS,0.44402,0.062731,0.04033,0,0
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.088862,0.062716,0.094738,0,0
4,GO RNA METHYLATION,0.39858,0.06265,0.03245,0,0
4,GO AMP METABOLIC PROCESS,0.26847,0.062494,0.11795,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.60272,0.062389,0.03324,0,0
4,GO RRNA METABOLIC PROCESS,0.44402,0.062069,0.03853,0,0
4,GO CELLULAR SENESCENCE,0.072231,0.06206,0.065489,0,0
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.55487,0.061951,0.066081,0,0
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.59059,0.061943,0.032575,0,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.89907,0.061889,-0.0042324,0,0
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.3746,0.0617,0.044169,0,0
4,GO TUMOR NECROSIS FACTOR SECRETION,0.85082,0.061611,-0.0025175,0,0
4,GO GASTRULATION,0.28785,0.061538,0.046065,0,0
4,GO TRANSLATIONAL ELONGATION,0.19393,0.061438,0.069233,0,0
4,GO ACTION POTENTIAL,0.15517,0.06143,0.09057,0,0
4,GO STRIATED MUSCLE CONTRACTION,0.32938,0.061342,0.060533,0,0
4,GO POSTREPLICATION REPAIR,0.27611,0.060742,0.030158,0,0
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.092194,0.060734,0.094788,0,0
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.37932,0.060709,0.085432,0,0
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.50337,0.060673,0.046891,0,0
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.35607,0.06061,0.019332,0,0
4,GO MEMBRANE INVAGINATION,0.13814,0.06052,0.072273,0,0
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.32938,0.060517,0.041091,0,0
4,GO RESPONSE TO MUSCLE INACTIVITY,0.15264,0.060478,0.1685,0,0
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.35607,0.060357,0.15949,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.22905,0.060273,0.060747,0,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.12049,0.060117,0.25029,0,0
4,GO DENDRITIC SPINE MAINTENANCE,0.86455,0.06011,0.015225,0,0
4,GO PULMONARY VALVE MORPHOGENESIS,0.23937,0.060036,0.10368,0,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.91293,0.059856,-0.077385,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.39858,0.059785,0.049592,0,0
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.21905,0.059566,0.062076,0,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.76948,0.059423,0.11835,0,0
4,GO PROTEIN AUTOPHOSPHORYLATION,0.30402,0.059115,0.03229,0,0
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.15015,0.059107,0.043269,0,0
4,GO MUSCLE CELL DEVELOPMENT,0.047551,0.059026,0.080328,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.48678,0.058963,0.049006,0,0
4,GO MRNA MODIFICATION,0.56075,0.058905,0.019169,0,0
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.053746,0.05889,0.085632,0,0
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.097379,0.058636,0.067594,0,0
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.12689,0.058204,0.18741,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.099158,0.058073,0.063149,0,0
4,GO REGULATION OF HAIR CYCLE,0.23589,0.058056,0.094402,0,0
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.61497,0.058001,0.079987,0,0
4,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.50337,0.057926,0.062029,0,0
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.20937,0.057713,0.044557,0,0
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.30402,0.057635,0.039739,0,0
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.25729,0.05747,0.068884,0,0
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.26098,0.057387,0.071851,0,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.11039,0.057127,0.061427,0,0
4,GO HEART PROCESS,0.188,0.057098,0.057858,0,0
4,GO PIGMENT GRANULE ORGANIZATION,0.2839,0.057078,0.055508,0,0
4,GO MESODERM MORPHOGENESIS,0.47588,0.057064,0.020084,0,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.32938,0.057064,0.04969,0,0
4,GO VESICLE CARGO LOADING,0.50896,0.057016,0.070209,0,0
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.22905,0.056945,0.044061,0,0
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.31232,0.056944,0.02738,0,0
4,GO RESPONSE TO SALT STRESS,0.81668,0.056827,-0.024586,0,0
4,GO POSITIVE REGULATION OF TRANSPORT,0.019283,0.056822,0.079732,0,0
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.18508,0.056591,0.034332,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.23245,0.056481,0.099183,0,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.070855,0.056129,0.070228,0,0
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.16828,0.056055,0.061496,0,0
4,GO MYELIN ASSEMBLY,0.55487,0.056032,0.037416,0,0
4,GO CELL SUBSTRATE ADHESION,0.24288,0.056006,0.037365,0,0
4,GO REGULATION OF ERAD PATHWAY,0.52025,0.055932,0.028482,0,0
4,GO OSSIFICATION,0.12049,0.055873,0.049213,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.36064,0.055651,0.050257,0,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.91987,0.055412,-0.011211,0,0
4,GO NCRNA 3 END PROCESSING,0.35153,0.055362,0.01035,0,0
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.62732,0.055339,0.048474,0,0
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.94073,0.055321,0.11384,0,0
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.020205,0.055313,0.07072,0,0
4,GO DETECTION OF MECHANICAL STIMULUS,0.38888,0.055265,0.056486,0,0
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.19695,0.055225,0.054066,0,0
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.91293,0.055215,-0.0052797,0,0
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.38408,0.055178,0.040303,0,0
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.025414,0.055066,0.11252,0,0
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.16032,0.055003,0.098905,0,0
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,1,0.05499,-0.021798,0,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.68418,0.054604,0.030302,0,0
4,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.53167,0.054594,0.018204,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.087232,0.054463,0.048715,0,0
4,GO RESPONSE TO AMPHETAMINE,0.94073,0.054283,-0.0066569,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.56075,0.054225,0.015833,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.39371,0.054084,0.036545,0,0
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.31653,0.054003,0.038227,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.53742,0.053658,0.042513,0,0
4,GO SEGMENT SPECIFICATION,0.63978,0.05363,-0.070317,0,0
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.64605,0.053563,-0.0037355,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.46512,0.053556,0.020379,0,0
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.12259,0.053438,0.086898,0,0
4,GO REPRODUCTIVE BEHAVIOR,0.72969,0.05335,0.016648,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.23937,0.05331,0.027665,0,0
4,GO REGULATION OF TRANSPORT,0.011904,0.053307,0.077588,0,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.60272,0.053284,0.040144,0,0
4,GO PRESYNAPTIC ENDOCYTOSIS,0.88523,0.053153,0.011321,0,0
4,GO POSITIVE REGULATION OF NEURON DEATH,0.0695,0.053099,0.090282,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.36991,0.053089,0.034534,0,0
4,GO BLASTOCYST DEVELOPMENT,0.02166,0.053001,0.083112,0,0
4,GO RESPONSE TO UV B,0.7495,0.052904,-0.013039,0,0
4,GO BASEMENT MEMBRANE ASSEMBLY,0.93377,0.052802,-0.034607,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.56666,0.052537,0.01671,0,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.095625,0.052495,0.053623,0,0
4,GO PROTEIN LOCALIZATION TO AXON,0.98255,0.052378,0.012099,0,0
4,GO DECIDUALIZATION,0.84397,0.052145,-0.030831,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.34702,0.052145,0.035158,0,0
4,GO EXTRACELLULAR TRANSPORT,0.28785,0.052048,0.072001,0,0
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.01282,0.052021,0.16612,0,0
4,GO PLASMA MEMBRANE TUBULATION,0.85768,0.051907,0.00020451,0,0
4,GO NEPHRON DEVELOPMENT,0.26098,0.051774,0.037649,0,0
4,GO ENDOTHELIAL CELL PROLIFERATION,0.073629,0.051756,0.078327,0,0
4,GO ONE CARBON COMPOUND TRANSPORT,0.31653,0.051649,0.071838,0,0
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.59664,0.051403,0.045086,0,0
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.69707,0.051342,-0.0093795,0,0
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.50896,0.051096,0.023985,0,0
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.85082,0.051045,0.035753,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.40843,0.050914,0.036658,0,0
4,GO REGULATION OF LIPASE ACTIVITY,0.4598,0.050838,0.015744,0,0
4,GO DNA DEALKYLATION,0.84397,0.050825,-0.0061254,0,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.81668,0.050812,-0.030395,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.093897,0.050751,0.070866,0,0
4,GO GAS TRANSPORT,0.74288,0.050679,-0.009579,0,0
4,GO OSTEOCLAST DEVELOPMENT,0.91293,0.050639,-0.030942,0,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.96163,0.050519,-0.027965,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.89907,0.050504,-0.048505,0,0
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.32077,0.05031,0.084929,0,0
4,GO THYMIC T CELL SELECTION,0.32077,0.050283,0.036764,0,0
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.69061,0.050255,0.075971,0,0
4,GO VASCULATURE DEVELOPMENT,0.4598,0.050166,0.013224,0,0
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.1028,0.050092,0.060462,0,0
4,GO SEGMENTATION,0.41842,0.05002,0.040122,0,0
4,GO PRENYLATION,0.36991,0.05002,0.034899,0,0
4,GO NERVE DEVELOPMENT,0.5726,0.049863,0.032712,0,0
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.16294,0.049829,0.055649,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.061812,0.049726,0.086578,0,0
4,GO PIGMENT ACCUMULATION,0.36991,0.04968,0.049535,0,0
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.26098,0.049495,0.05535,0,0
4,GO SNRNA METABOLIC PROCESS,0.188,0.049449,0.034893,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.21579,0.049426,0.055121,0,0
4,GO DEPHOSPHORYLATION,0.20309,0.04916,0.034033,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.085627,0.04915,0.1315,0,0
4,GO RELAXATION OF MUSCLE,0.35607,0.049109,0.064518,0,0
4,GO RESPONSE TO ATP,0.52594,0.048789,0.037866,0,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.32077,0.048716,0.046127,0,0
4,GO VIRAL GENE EXPRESSION,0.7495,0.048694,0.0080468,0,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.079444,0.048369,0.080226,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.94073,0.048367,0.0024598,0,0
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.16559,0.048285,0.11518,0,0
4,GO PRIMARY MIRNA PROCESSING,0.69707,0.048283,0.0022441,0,0
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.19695,0.048134,0.070147,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.84397,0.048094,-0.0076526,0,0
4,GO REGULATION OF SYSTEM PROCESS,0.31232,0.04797,0.036911,0,0
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.65234,0.047539,-0.075406,0,0
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.28785,0.04753,0.13809,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.54321,0.047419,0.018023,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.87144,0.047278,-0.00757,0,0
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.70355,0.047077,0.011707,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.15264,0.046817,0.073627,0,0
4,GO NUCLEOBASE METABOLIC PROCESS,0.33373,0.0468,0.04887,0,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.69061,0.046598,0.019435,0,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.82348,0.046491,-0.010855,0,0
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.37932,0.046487,0.019007,0,0
4,GO CYTOPLASMIC TRANSLATION,0.87144,0.046467,-0.0057376,0,0
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.19095,0.046332,0.13553,0,0
4,GO REGULATION OF PROTEIN DEACETYLATION,0.29992,0.046237,0.057654,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.91293,0.045915,-0.008735,0,0
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.054842,0.045851,0.061707,0,0
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.29184,0.045843,0.073646,0,0
4,GO MULTI ORGANISM LOCALIZATION,0.62113,0.045784,-0.0072909,0,0
4,GO ADHERENS JUNCTION ORGANIZATION,0.42347,0.045754,0.050537,0,0
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.084046,0.045646,0.051662,0,0
4,GO TRANSEPITHELIAL TRANSPORT,0.14048,0.045511,0.10408,0,0
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.59664,0.045388,0.026969,0,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,0.24643,0.045263,0.021663,0,0
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.84397,0.045186,0.022264,0,0
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.05824,0.045168,0.11083,0,0
4,GO PRO B CELL DIFFERENTIATION,0.24288,0.045148,0.089609,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.50896,0.04514,0.13309,0,0
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.084046,0.045045,0.059918,0,0
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.99651,0.045008,-0.012851,0,0
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.34702,0.044959,0.021285,0,0
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.64605,0.04492,0.0284,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.72969,0.044907,-0.0072467,0,0
4,GO EMBRYO IMPLANTATION,0.5726,0.044889,0.043434,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.49227,0.04483,0.039074,0,0
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.14769,0.044759,0.072294,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.22235,0.044741,0.043117,0,0
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.60272,0.044652,0.074512,0,0
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.59059,0.044639,0.061977,0,0
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.2,0.044526,0.039483,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.32938,0.044319,0.025233,0,0
4,GO AMINO ACID TRANSPORT,0.12049,0.044217,0.11523,0,0
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.054842,0.044207,0.066269,0,0
4,GO ESCRT COMPLEX DISASSEMBLY,0.99651,0.044111,0.0063716,0,0
4,GO SMOOTH MUSCLE CONTRACTION,0.25363,0.044007,0.040362,0,0
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.24288,0.043954,0.039198,0,0
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.72313,0.043664,0.0092233,0,0
4,GO REGULATION OF GASTRULATION,0.96163,0.043568,-0.027921,0,0
4,GO MEMBRANE REPOLARIZATION,0.38888,0.043421,0.030542,0,0
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.81668,0.043402,-0.002032,0,0
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.15264,0.043373,0.045131,0,0
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.24288,0.043324,0.072212,0,0
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.16032,0.043288,0.037215,0,0
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.30815,0.043214,0.068533,0,0
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.98255,0.042896,-0.039109,0,0
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.36526,0.042852,0.026828,0,0
4,GO REGULATION OF PINOCYTOSIS,0.65866,0.04282,-0.035473,0,0
4,GO CELLULAR RESPONSE TO CAMP,0.35153,0.042796,0.05514,0,0
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.33812,0.042784,0.051821,0,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.24643,0.042438,0.038607,0,0
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.27999,0.042384,0.045939,0,0
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.42855,0.042262,0.01944,0,0
4,GO NEURON MATURATION,0.31653,0.042201,0.092231,0,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.32938,0.04189,0.035043,0,0
4,GO NUCLEOSIDE METABOLIC PROCESS,0.42347,0.041799,0.016765,0,0
4,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.89907,0.041732,-0.0041447,0,0
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.188,0.04166,0.045536,0,0
4,GO TRANSLATIONAL INITIATION,0.91293,0.04157,-0.0060766,0,0
4,GO REGULATION OF PROTEIN SUMOYLATION,0.31653,0.04157,0.053609,0,0
4,GO BONE MINERALIZATION,0.24643,0.041468,0.047559,0,0
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.71006,0.041376,0.0054662,0,0
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.20309,0.041356,0.045627,0,0
4,GO MYOBLAST DIFFERENTIATION,0.87833,0.041219,-0.017302,0,0
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.34702,0.041208,0.073147,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.93377,0.041173,-0.029747,0,0
4,GO POSITIVE REGULATION OF OSSIFICATION,0.40843,0.041124,0.025261,0,0
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.2839,0.040956,0.040431,0,0
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.87833,0.040408,0.0083213,0,0
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.13814,0.040405,0.10788,0,0
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.31232,0.040124,0.055055,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.43367,0.039974,0.020043,0,0
4,GO REGULATION OF VIRAL TRANSCRIPTION,0.42347,0.039809,0.0041384,0,0
4,GO OSTEOBLAST DIFFERENTIATION,0.59664,0.039771,0.015782,0,0
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.072231,0.039763,0.045926,0,0
4,GO MUSCLE CONTRACTION,0.15264,0.039582,0.057699,0,0
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.61497,0.039562,0.018386,0,0
4,GO RESPONSE TO ZINC ION,0.59059,0.039464,0.044049,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.33812,0.039351,0.050402,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.28785,0.039229,0.04218,0,0
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.32938,0.039036,0.037812,0,0
4,GO PORE COMPLEX ASSEMBLY,0.98953,0.038711,0.0018578,0,0
4,GO CHRONIC INFLAMMATORY RESPONSE,0.40843,0.038624,0.013667,0,0
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.11235,0.038607,0.070456,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.49227,0.038513,0.028597,0,0
4,GO REGULATION OF JUN KINASE ACTIVITY,0.34702,0.038374,0.030097,0,0
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.13814,0.038364,0.078336,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.99651,0.038325,-0.026312,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.36526,0.038271,0.047829,0,0
4,GO CRANIAL NERVE DEVELOPMENT,0.7495,0.038207,0.02048,0,0
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.16828,0.038039,0.061072,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.20309,0.037978,0.059301,0,0
4,GO CELL CELL JUNCTION MAINTENANCE,0.78289,0.037819,0.011059,0,0
4,GO POSITIVE REGULATION OF MYELINATION,0.69061,0.037409,0.0098488,0,0
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.80312,0.037374,0.0033202,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.15517,0.037077,0.058848,0,0
4,GO MUSCLE CELL DIFFERENTIATION,0.26098,0.036983,0.035103,0,0
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.68418,0.036954,0.0085294,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.56075,0.0369,0.0074241,0,0
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.27999,0.036741,0.035183,0,0
4,GO LAMELLIPODIUM ASSEMBLY,0.98255,0.03673,-0.0097159,0,0
4,GO PEPTIDYL METHIONINE MODIFICATION,0.44402,0.036714,0.12003,0,0
4,GO ASSOCIATIVE LEARNING,0.44924,0.036401,0.039514,0,0
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.18219,0.036365,0.079763,0,0
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.23589,0.036146,0.025343,0,0
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.29586,0.035825,0.028076,0,0
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.63354,0.035641,0.026313,0,0
4,GO CARDIAC MUSCLE CONTRACTION,0.42347,0.03547,0.046434,0,0
4,GO TRANSLESION SYNTHESIS,0.12689,0.03534,0.05485,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.21256,0.035168,0.05486,0,0
4,GO GONADOTROPIN SECRETION,0.50337,0.035162,0.053543,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.59059,0.035146,0.012076,0,0
4,GO KERATINOCYTE DEVELOPMENT,0.28785,0.034995,0.12961,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.39858,0.034825,0.056897,0,0
4,GO CILIUM MOVEMENT,0.27999,0.03478,0.021433,0,0
4,GO REGULATION OF ODONTOGENESIS,0.89907,0.034721,-0.049152,0,0
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.63978,0.034513,0.041625,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.65234,0.034494,0.010989,0,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.62732,0.034476,-0.010609,0,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.89215,0.034322,-0.01311,0,0
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.42347,0.034262,0.032827,0,0
4,GO MOLTING CYCLE,0.38408,0.034224,0.025366,0,0
4,GO RESPONSE TO HYDROXYUREA,0.47588,0.033952,0.043163,0,0
4,GO TOOTH MINERALIZATION,0.98255,0.033911,-0.0083749,0,0
4,GO PEPTIDE CROSS LINKING,0.4545,0.033795,0.022178,0,0
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.090515,0.03371,0.075551,0,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.37932,0.033669,0.017212,0,0
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.57857,0.03336,0.011448,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.48678,0.033146,0.095733,0,0
4,GO MITOTIC CELL CYCLE ARREST,0.17653,0.033145,0.14392,0,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.92682,0.033141,0.0027796,0,0
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.16559,0.033123,0.047953,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.39371,0.033115,0.059321,0,0
4,GO REGULATION OF GTPASE ACTIVITY,0.17099,0.033062,0.045549,0,0
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.4598,0.032985,0.069402,0,0
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.48678,0.032939,0.022951,0,0
4,GO MATING,0.12259,0.032926,0.073953,0,0
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.29586,0.032776,0.0305,0,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.63354,0.032668,0.019948,0,0
4,GO RHYTHMIC PROCESS,0.24288,0.032664,0.031338,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.32938,0.032595,0.039847,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.38408,0.032556,0.028402,0,0
4,GO REGULATION OF ENDOCYTOSIS,0.24288,0.032516,0.045189,0,0
4,GO POTASSIUM ION TRANSPORT,0.5726,0.032465,0.037132,0,0
4,GO HISTONE DEACETYLATION,0.78289,0.032323,0.0028649,0,0
4,GO REGULATION OF METAL ION TRANSPORT,0.34702,0.032277,0.03786,0,0
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.51459,0.032257,0.02998,0,0
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.62113,0.032224,0.023276,0,0
4,GO REGULATION OF CELLULAR LOCALIZATION,0.16559,0.032099,0.037542,0,0
4,GO MALE GAMETE GENERATION,0.43367,0.032065,0.018361,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.48678,0.031841,0.059827,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.9686,0.031778,-0.061774,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.19695,0.031521,0.12593,0,0
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.55487,0.031445,0.093932,0,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.8303,0.031333,-0.022499,0,0
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.80312,0.031234,0.0088868,0,0
4,GO REGULATION OF MUSCLE CONTRACTION,0.14048,0.031184,0.068761,0,0
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.30402,0.030951,0.065626,0,0
4,GO RESPONSE TO HEAT,0.095625,0.030897,0.085665,0,0
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.74288,0.030676,-0.0059143,0,0
4,GO REGULATION OF CELL FATE SPECIFICATION,0.72969,0.030666,-0.13619,0,0
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.5726,0.030646,0.0029999,0,0
4,GO DEVELOPMENTAL MATURATION,0.39858,0.030569,0.041318,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.38888,0.030385,0.025962,0,0
4,GO CELL JUNCTION ASSEMBLY,0.43367,0.030335,0.032197,0,0
4,GO RRNA TRANSCRIPTION,0.94073,0.03019,-0.007836,0,0
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.85082,0.030074,-0.030982,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.36526,0.030041,0.046716,0,0
4,GO FACE DEVELOPMENT,0.92682,0.030001,-0.0037193,0,0
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.28785,0.029927,0.036516,0,0
4,GO FATTY ACID HOMEOSTASIS,0.3746,0.029899,0.10174,0,0
4,GO MEIOTIC CELL CYCLE,0.21579,0.029775,0.025874,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.42347,0.029768,0.061545,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.48131,0.029767,0.051354,0,0
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.40349,0.02975,0.08295,0,0
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.8303,0.029686,0.0059335,0,0
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.59059,0.029474,0.0069262,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.26471,0.029433,0.092056,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.57857,0.029401,0.035389,0,0
4,GO ORGAN INDUCTION,0.8303,0.029367,-0.017148,0,0
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.82348,0.029261,-0.030046,0,0
4,GO ACTIN FILAMENT ORGANIZATION,0.27611,0.029255,0.033426,0,0
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.89215,0.029214,0.029598,0,0
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.57857,0.029206,0.015009,0,0
4,GO RESPONSE TO LIGHT STIMULUS,0.96163,0.029,-0.0064933,0,0
4,GO POSITIVE REGULATION OF TRANSLATION,0.96163,0.028923,-0.025209,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.65234,0.028659,0.00661,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.30402,0.028458,0.072634,0,0
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.70355,0.028329,0.024279,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.7495,0.028311,-0.016075,0,0
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.84397,0.028195,0.0048237,0,0
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.28785,0.02814,0.068292,0,0
4,GO SEXUAL REPRODUCTION,0.29992,0.028047,0.025224,0,0
4,GO LACTATION,0.62732,0.027991,0.034362,0,0
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.38408,0.027969,0.040902,0,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,1,0.027805,-0.011745,0,0
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.49227,0.02773,0.21012,0,0
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.14526,0.027678,0.052877,0,0
4,GO PITUITARY GLAND DEVELOPMENT,0.70355,0.027616,0.057768,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.43367,0.02748,0.014478,0,0
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.81668,0.027391,0.011443,0,0
4,GO REGULATION OF GLOMERULAR FILTRATION,0.97557,0.027346,0.013779,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.59664,0.027255,0.043644,0,0
4,GO BODY MORPHOGENESIS,0.97557,0.027249,-0.011317,0,0
4,GO MATURATION OF SSU RRNA,0.72969,0.027005,0.012161,0,0
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.44402,0.026994,0.031757,0,0
4,GO IMPORT INTO NUCLEUS,0.29586,0.02698,0.034376,0,0
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.97557,0.02694,-0.0086602,0,0
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.27999,0.026918,0.13527,0,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.92682,0.026885,-0.0036484,0,0
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.64605,0.026787,0.0052927,0,0
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.60883,0.026564,0.017919,0,0
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.96163,0.026476,-0.052602,0,0
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.44402,0.026418,0.038272,0,0
4,GO REGULATION OF GLIAL CELL MIGRATION,0.31232,0.026403,0.048858,0,0
4,GO HISTONE H2B UBIQUITINATION,0.33812,0.026375,0.042764,0,0
4,GO MALE GENITALIA DEVELOPMENT,0.40349,0.02596,0.067477,0,0
4,GO VISUAL BEHAVIOR,0.43367,0.025936,0.057536,0,0
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.72313,0.025881,0.016885,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.91293,0.025784,-0.025964,0,0
4,GO PROTEIN TRIMERIZATION,0.52594,0.025605,0.034479,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.52025,0.025573,0.03269,0,0
4,GO RESPONSE TO NITRIC OXIDE,0.52594,0.025505,0.023035,0,0
4,GO CELLULAR RESPONSE TO ATP,0.36526,0.025225,0.067249,0,0
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.49227,0.024829,0.037453,0,0
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.48131,0.024827,0.023414,0,0
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.85082,0.024658,0.005027,0,0
4,GO ORGANELLE LOCALIZATION,0.39371,0.024548,0.018612,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.30815,0.024534,0.045636,0,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.95466,0.024408,-0.020933,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.52025,0.024047,0.036127,0,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.63354,0.023984,0.019924,0,0
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.44924,0.023959,0.066475,0,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.58456,0.023748,0.047972,0,0
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.087232,0.023684,0.091439,0,0
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.91987,0.023469,-0.0054784,0,0
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.12908,0.023392,0.14499,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.25001,0.023262,0.074981,0,0
4,GO DNA BIOSYNTHETIC PROCESS,0.98255,0.023242,-0.0054807,0,0
4,GO REGULATION OF RECEPTOR RECYCLING,0.98953,0.023043,-0.0034233,0,0
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.72313,0.023037,0.016206,0,0
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.55487,0.022985,0.11942,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.60272,0.022956,-0.070545,0,0
4,GO REGULATION OF RUFFLE ASSEMBLY,0.26098,0.022835,0.086276,0,0
4,GO SEX DETERMINATION,0.77618,0.022775,0.010728,0,0
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.97557,0.022674,-0.044509,0,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.74288,0.022622,0.042124,0,0
4,GO LEUKOCYTE TETHERING OR ROLLING,0.34256,0.022583,0.03871,0,0
4,GO FEMALE GENITALIA DEVELOPMENT,0.85768,0.022562,-0.031488,0,0
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.21579,0.022515,0.05265,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.71658,0.022487,0.013707,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.94073,0.02247,-0.014003,0,0
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.20621,0.022469,0.1072,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.44402,0.022392,0.010248,0,0
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.4545,0.022345,0.02513,0,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.19393,0.022272,0.02898,0,0
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.70355,0.022223,0.017175,0,0
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.60272,0.022086,-0.00295,0,0
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.79636,0.021989,0.0056294,0,0
4,GO MEIOTIC CELL CYCLE PROCESS,0.67137,0.021794,0.0050836,0,0
4,GO ADULT LOCOMOTORY BEHAVIOR,0.51459,0.02179,0.057005,0,0
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.35153,0.021547,0.051558,0,0
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.91293,0.021391,-0.030776,0,0
4,GO DETECTION OF ABIOTIC STIMULUS,0.52594,0.021292,0.0243,0,0
4,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.50896,0.021196,0.11377,0,0
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.5726,0.021179,0.032902,0,0
4,GO BLASTODERM SEGMENTATION,0.86455,0.021177,-0.0063267,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,1,0.020762,-0.013499,0,0
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.89907,0.020715,-0.028051,0,0
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.48131,0.020694,0.027957,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.87833,0.020693,-0.026573,0,0
4,GO NEUROTRANSMITTER REUPTAKE,0.63978,0.020591,0.042408,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.74288,0.020581,0.0096612,0,0
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.30815,0.020525,0.058557,0,0
4,GO TROPHOBLAST CELL MIGRATION,0.74288,0.019978,-0.0232,0,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.89215,0.01981,-0.013166,0,0
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.48131,0.019586,0.028922,0,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.33373,0.019542,0.034202,0,0
4,GO GLUTAMINE METABOLIC PROCESS,0.76281,0.01947,-0.042009,0,0
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.89215,0.019445,-0.0057983,0,0
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.98953,0.019251,-0.023476,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.62732,0.019204,0.046239,0,0
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.86455,0.019053,0.014884,0,0
4,GO GERM CELL DEVELOPMENT,0.7495,0.019029,0.010496,0,0
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.68418,0.018955,0.0073541,0,0
4,GO POSITIVE REGULATION OF CELL DIVISION,0.80989,0.018955,-0.0031958,0,0
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.39371,0.01895,0.031574,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.40843,0.018888,-0.057733,0,0
4,GO REGULATION OF EXIT FROM MITOSIS,0.75615,0.018843,0.017072,0,0
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.71006,0.018743,0.013801,0,0
4,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.74288,0.018735,-0.032,0,0
4,GO ACTIN MEDIATED CELL CONTRACTION,0.73628,0.018719,0.020947,0,0
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.54903,0.018641,0.020561,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.97557,0.018585,0.018615,0,0
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.80312,0.018415,0.019282,0,0
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.60883,0.01833,0.025923,0,0
4,GO PRE MIRNA PROCESSING,0.92682,0.018313,-0.015554,0,0
4,GO CELL FATE DETERMINATION,0.74288,0.018261,0.02614,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.7495,0.018212,-0.022132,0,0
4,GO DEVELOPMENTAL INDUCTION,0.50337,0.017966,0.027265,0,0
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.56666,0.017907,0.023387,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.40843,0.017767,0.026496,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.91293,0.017669,-0.037555,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.80312,0.017653,0.005307,0,0
4,GO FEVER GENERATION,0.93377,0.017636,-0.012363,0,0
4,GO GAMETE GENERATION,0.54903,0.017276,0.014191,0,0
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.95466,0.017271,-0.011079,0,0
4,GO RESPONSE TO BMP,0.71658,0.016908,-0.0056296,0,0
4,GO COPII COATED VESICLE CARGO LOADING,0.89907,0.016838,0.023078,0,0
4,GO HISTONE ARGININE METHYLATION,0.38888,0.016804,0.045694,0,0
4,GO UV DAMAGE EXCISION REPAIR,0.95466,0.016792,0.0041899,0,0
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.59059,0.016745,0.039931,0,0
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.73628,0.016701,0.0012179,0,0
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.55487,0.016564,0.013919,0,0
4,GO POSITIVE REGULATION OF ERAD PATHWAY,0.71006,0.016513,0.019794,0,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.46512,0.016483,0.11813,0,0
4,GO MITOTIC DNA REPLICATION,0.94769,0.016393,-0.0028629,0,0
4,GO PHOSPHATE ION TRANSPORT,0.63978,0.015636,0.016509,0,0
4,GO MEMBRANE RAFT ASSEMBLY,0.4598,0.015503,0.061501,0,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.15517,0.015413,0.11802,0,0
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.87833,0.015179,0.0037482,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.67137,0.015178,0.01816,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.91987,0.015161,0.026599,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.56075,0.01516,-0.047307,0,0
4,GO RRNA PSEUDOURIDINE SYNTHESIS,0.91293,0.015107,-0.0013584,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.34702,0.014969,0.05218,0,0
4,GO POSITIVE REGULATION OF GROWTH,0.58456,0.014916,0.013454,0,0
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.78962,0.014916,-0.027666,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.58456,0.014901,0.052224,0,0
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.35607,0.014859,0.039718,0,0
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,1,0.014714,0.02393,0,0
4,GO REGULATION OF NUCLEAR DIVISION,0.59664,0.014662,0.015342,0,0
4,GO SKELETAL MUSCLE CONTRACTION,0.80312,0.014655,-0.016389,0,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.79636,0.014599,0.0091853,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.94769,0.014568,0.0092327,0,0
4,GO REGULATION OF GROWTH,0.55487,0.014547,0.016239,0,0
4,GO SKIN EPIDERMIS DEVELOPMENT,0.71658,0.014524,0.0096262,0,0
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.42347,0.014497,0.094194,0,0
4,GO EPITHELIAL TUBE FORMATION,0.43883,0.014419,-0.060639,0,0
4,GO MACROMOLECULE DEACYLATION,0.39858,0.014309,0.023903,0,0
4,GO REGULATION OF GASTRIC ACID SECRETION,0.62113,0.014218,0.031101,0,0
4,GO HISTONE H3 ACETYLATION,0.87144,0.014106,-0.013281,0,0
4,GO REGULATION OF URINE VOLUME,0.65234,0.014058,-0.034145,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.10654,0.014036,0.04123,0,0
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.13814,0.013914,0.053667,0,0
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.47588,0.013914,0.036484,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.78289,0.013908,0.00165,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.50896,0.013899,-0.079361,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.75615,0.013783,0.030701,0,0
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.85768,0.013783,0.027153,0,0
4,GO DNA MODIFICATION,0.4978,0.013748,0.020689,0,0
4,GO REGULATION OF CELL DIFFERENTIATION,0.87833,0.013689,-0.0097188,0,0
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.47049,0.013613,0.040536,0,0
4,GO CELL CYCLE ARREST,0.83713,0.013531,0.0057513,0,0
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.31232,0.013414,0.041896,0,0
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.81668,0.013355,-0.023453,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.90599,0.013338,-0.0079963,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.76281,0.013198,-0.0032626,0,0
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.68418,0.013122,0.0039593,0,0
4,GO REGULATION OF BIOMINERALIZATION,0.54321,0.012468,0.018761,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.29184,0.012438,0.044281,0,0
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.54321,0.012388,0.019013,0,0
4,GO RECEPTOR METABOLIC PROCESS,0.75615,0.012241,-0.017324,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.73628,0.012239,-0.049514,0,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.51459,0.011958,0.06331,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.81668,0.01191,0.0071861,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,0.4545,0.011682,0.025248,0,0
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.36064,0.011558,0.026496,0,0
4,GO T CELL CHEMOTAXIS,0.58456,0.011522,0.032542,0,0
4,GO MODIFIED AMINO ACID TRANSPORT,0.37932,0.011315,0.064961,0,0
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.88523,0.011071,-0.018143,0,0
4,GO GENITALIA DEVELOPMENT,0.76948,0.011042,0.011336,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.42855,0.010752,0.12666,0,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.59664,0.010607,0.0061229,0,0
4,GO NEURON DEATH,0.2,0.010589,0.037062,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.53167,0.010573,0.031962,0,0
4,GO TAXIS,0.67776,0.01056,-0.019598,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.85768,0.010398,0.021188,0,0
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.82348,0.0099877,-0.032226,0,0
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.85082,0.0099717,-0.032721,0,0
4,GO KIDNEY MORPHOGENESIS,0.87833,0.0099393,-0.026834,0,0
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.43367,0.0098537,0.035027,0,0
4,GO NEGATIVE REGULATION OF BINDING,0.56075,0.0098277,0.024477,0,0
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.88523,0.0097054,0.0063216,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.77618,0.0096578,0.0069306,0,0
4,GO MALE SEX DETERMINATION,0.36991,0.0096116,0.085004,0,0
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.29586,0.009492,0.11939,0,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.79636,0.0093923,-0.0032711,0,0
4,GO MINERALOCORTICOID METABOLIC PROCESS,0.80312,0.0093804,0.028385,0,0
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.62113,0.0092559,0.02975,0,0
4,GO GLIOGENESIS,0.80312,0.0091959,-0.012362,0,0
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.71658,0.0090643,-0.022326,0,0
4,GO PROTEIN DEPHOSPHORYLATION,0.78289,0.0089976,-0.01328,0,0
4,GO MYELOID CELL APOPTOTIC PROCESS,0.48131,0.0089904,0.029359,0,0
4,GO INNERVATION,0.89907,0.0089203,0.060244,0,0
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.82348,0.0088613,0.043714,0,0
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.82348,0.0088082,-0.0093001,0,0
4,GO ASTROCYTE DEVELOPMENT,0.85768,0.0088028,-0.017675,0,0
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.60272,0.0087945,0.020676,0,0
4,GO REGULATION OF CENTROSOME DUPLICATION,0.56666,0.0087602,0.033778,0,0
4,GO NEGATIVE REGULATION OF CELL SIZE,0.88523,0.0087214,-0.022218,0,0
4,GO PROTEIN NITROSYLATION,0.85082,0.0086565,-0.051979,0,0
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.63354,0.0085937,0.022684,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.53167,0.0084857,-0.10265,0,0
4,GO ACTIN FILAMENT BASED PROCESS,0.4598,0.0084755,0.019521,0,0
4,GO MITOCHONDRION MORPHOGENESIS,0.68418,0.0084548,-0.032634,0,0
4,GO CLATHRIN COAT ASSEMBLY,0.7495,0.0084058,0.034391,0,0
4,GO NOTOCHORD DEVELOPMENT,0.50896,0.0083182,-0.14059,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.56075,0.0083163,-0.078472,0,0
4,GO CARTILAGE DEVELOPMENT,0.65866,0.0082319,-0.042506,0,0
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.41341,0.008067,-0.057742,0,0
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.95466,0.0077803,0.11204,0,0
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.50896,0.0077102,-0.11703,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.72969,0.0076733,-0.019868,0,0
4,GO RESPONSE TO MURAMYL DIPEPTIDE,1,0.0076632,-0.022302,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.53742,0.0074703,0.018598,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.67776,0.0074367,0.010561,0,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.85768,0.0073974,-0.010053,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.8303,0.0073588,-0.0014356,0,0
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.36064,0.0071054,0.032008,0,0
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.56666,0.0070854,0.02392,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.68418,0.006985,-0.091953,0,0
4,GO REGULATION OF TORC1 SIGNALING,0.53742,0.0069714,0.044414,0,0
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.89215,0.0069291,0.0025459,0,0
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.2839,0.006909,0.058665,0,0
4,GO ANIMAL ORGAN MORPHOGENESIS,0.90599,0.0068524,-0.015983,0,0
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.56075,0.0068301,0.018467,0,0
4,GO REGULATION OF T CELL CHEMOTAXIS,0.26098,0.0068155,0.078191,0,0
4,GO REGULATION OF HISTONE UBIQUITINATION,0.94769,0.0067618,0.0022109,0,0
4,GO SPERMATID DIFFERENTIATION,0.85082,0.0067397,0.0060651,0,0
4,GO METANEPHROS DEVELOPMENT,0.79636,0.0066448,-0.024047,0,0
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.82348,0.0065842,-0.026999,0,0
4,GO OOGENESIS,0.78289,0.0065595,0.016872,0,0
4,GO MUSCLE TISSUE DEVELOPMENT,0.85082,0.0064815,0.003393,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.85082,0.0063606,-0.012416,0,0
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.54903,0.0061552,-0.01989,0,0
4,GO GLIAL CELL DIFFERENTIATION,0.57857,0.0061545,-0.028401,0,0
4,GO CHONDROCYTE DIFFERENTIATION,0.87833,0.0061428,-0.0050923,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.9686,0.0060192,-0.0006798,0,0
4,GO NEGATIVE REGULATION OF GROWTH,0.47049,0.0060093,0.034314,0,0
4,GO REGULATION OF DEPHOSPHORYLATION,0.89907,0.0059025,-0.0025271,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.90599,0.0056751,-0.0021465,0,0
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.72313,0.0053731,0.0038078,0,0
4,GO NEURONAL ION CHANNEL CLUSTERING,0.98953,0.0050705,0.0094038,0,0
4,GO CELL GROWTH,0.85768,0.0050246,-0.005301,0,0
4,GO PROTEIN NEDDYLATION,0.84397,0.0049875,-0.014054,0,0
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.54321,0.0049476,0.036765,0,0
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.25363,0.0047622,0.098414,0,0
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.80989,0.0046825,0.011331,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.95466,0.0043722,0.0096085,0,0
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.89907,0.0043363,0.00024493,0,0
4,GO CANONICAL WNT SIGNALING PATHWAY,0.41341,0.0041961,-0.044218,0,0
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.85768,0.0040359,0.00032864,0,0
4,GO TRABECULA MORPHOGENESIS,0.61497,0.0038282,-0.045869,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.76948,0.0037871,-0.024226,0,0
4,GO DIENCEPHALON DEVELOPMENT,0.94073,0.0036023,0.017221,0,0
4,GO ORGANELLE FISSION,0.80989,0.0032523,-0.0065636,0,0
4,GO AXIS SPECIFICATION,0.91987,0.0032499,0.0019372,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.59664,0.0031868,0.019498,0,0
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.59664,0.0030511,0.0074936,0,0
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.36526,0.0029988,0.034529,0,0
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.5726,0.002882,0.016086,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.55487,0.0028438,-0.048992,0,0
4,GO PULMONARY VALVE DEVELOPMENT,0.41341,0.0028385,0.078733,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.76948,0.0026787,0.0057441,0,0
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.73628,0.0025997,-0.015524,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.69707,0.0025368,0.032492,0,0
4,GO MICROTUBULE BUNDLE FORMATION,0.84397,0.0024886,0.008113,0,0
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.5726,0.0023919,-0.085879,0,0
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.32938,0.0023741,0.098172,0,0
4,GO NCRNA TRANSCRIPTION,0.81668,0.0022379,-0.024531,0,0
4,GO RNA DECAPPING,0.47588,0.0022265,-0.035929,0,0
4,GO REGULATION OF CILIUM BEAT FREQUENCY,0.91987,0.0022233,-0.021279,0,0
4,GO MRNA TRANSCRIPTION,0.93377,0.0021508,-0.0060929,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.70355,0.0020556,-0.0022224,0,0
4,GO VIRAL TRANSLATION,0.60272,0.0019262,-0.064406,0,0
4,GO RESPONSE TO VITAMIN A,0.5726,0.001889,-0.053464,0,0
4,GO EAR DEVELOPMENT,0.87833,0.0015968,-0.01896,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.49227,0.0015459,-0.028068,0,0
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.90599,0.0013996,-0.0041174,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.90599,0.0013511,0.0016196,0,0
4,GO REGULATION OF CELL CYCLE ARREST,0.9686,0.0011459,0.00087477,0,0
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.87833,0.0010698,-0.01082,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.4978,0.0010561,-0.045263,0,0
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.69061,0.00086246,0.017742,0,0
4,GO RENAL VESICLE DEVELOPMENT,0.81668,0.00064562,-0.056814,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.64605,0.00054871,0.014139,0,0
4,GO REGULATION OF CELL SHAPE,0.40349,0.00034061,0.01898,0,0
4,GO HEART TRABECULA FORMATION,0.67137,0.0003164,0.053352,0,0
4,GO IMPORT INTO CELL,0.25729,0.00030582,0.06257,0,0
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.89215,0.00026066,-0.038308,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.41341,0.00025865,0.009208,0,0
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.91293,0.00021749,-0.000886,0,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.97557,0.00010629,-0.0028182,0,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.98953,3.5005e-05,0.00055104,0,0
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.67137,-5.2752e-05,0.11573,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.78289,-0.0001431,0.004655,0,0
4,GO SYNAPTIC VESICLE RECYCLING,0.99651,-0.00023073,0.0072708,0,0
4,GO NEPHRON MORPHOGENESIS,0.79636,-0.00026506,-0.022616,0,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.76281,-0.00039608,0.0043134,0,0
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.64605,-0.00049884,0.017688,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.98953,-0.00059937,-0.0078135,0,0
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.72313,-0.00083823,0.00578,0,0
4,GO LOCOMOTORY BEHAVIOR,0.98255,-0.0011554,0.026111,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.60883,-0.0012455,0.046168,0,0
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.97557,-0.0012782,0.0213,0,0
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.85082,-0.0013098,0.012361,0,0
4,GO NON RECOMBINATIONAL REPAIR,0.96163,-0.0013225,-0.0073332,0,0
4,GO DETECTION OF LIGHT STIMULUS,0.81668,-0.0013878,-0.039214,0,0
4,GO SULFATION,0.71006,-0.0014007,0.015592,0,0
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.53167,-0.0014374,-0.040279,0,0
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.65866,-0.0015384,0.0029111,0,0
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.76281,-0.0017073,0.047788,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.41842,-0.0018082,0.027142,0,0
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.86455,-0.0018616,-0.01604,0,0
4,GO REGULATION OF CILIUM MOVEMENT,0.89907,-0.0018792,-0.017818,0,0
4,GO ORGANELLE ASSEMBLY,0.8303,-0.0020721,-0.0077285,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.80989,-0.0021942,0.0024665,0,0
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.39858,-0.0022044,0.044785,0,0
4,GO P BODY ASSEMBLY,0.87144,-0.0022418,-0.014046,0,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.76281,-0.0023768,-0.016368,0,0
4,GO SUBPALLIUM DEVELOPMENT,0.60272,-0.0024308,0.081783,0,0
4,GO EMBRYONIC MORPHOGENESIS,0.60272,-0.0024903,-0.026011,0,0
4,GO STRIATUM DEVELOPMENT,0.57857,-0.0027939,0.058143,0,0
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.34256,-0.0027974,0.047664,0,0
4,GO PEPTIDYL ARGININE N METHYLATION,0.76948,-0.0030699,-0.029816,0,0
4,GO PARENTAL BEHAVIOR,0.42347,-0.0030838,0.09594,0,0
4,GO PEPTIDYL SERINE MODIFICATION,0.26471,-0.00315,0.034458,0,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.62732,-0.0033367,-0.047704,0,0
4,GO REGULATION OF HISTONE MODIFICATION,0.90599,-0.0033842,-0.0065054,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.98953,-0.0033955,-0.021092,0,0
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.97557,-0.0034189,-0.0031729,0,0
4,GO MESENCHYMAL CELL DIFFERENTIATION,1,-0.0036472,-0.011885,0,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.83713,-0.0037216,-0.016715,0,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.71006,-0.0037767,-0.039257,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.67137,-0.0039177,-0.061792,0,0
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.91293,-0.0039395,-0.022594,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.71658,-0.0040207,0.017882,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.38888,-0.0041873,0.026904,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.54903,-0.0042473,0.030594,0,0
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.91293,-0.0043654,-0.030368,0,0
4,GO SNRNA TRANSCRIPTION,0.40349,-0.004593,-0.035909,0,0
4,GO METANEPHROS MORPHOGENESIS,0.9686,-0.0047559,-0.0059469,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.98255,-0.0048199,0.0011356,0,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.87144,-0.0048623,0.0015552,0,0
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.84397,-0.0049153,-0.011431,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.72969,-0.0049578,-0.013509,0,0
4,GO MITOTIC CYTOKINESIS,0.50337,-0.004985,-0.029703,0,0
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.37932,-0.0050746,-0.028486,0,0
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.38888,-0.0050866,-0.057619,0,0
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.89215,-0.0051216,-0.0069313,0,0
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.91987,-0.0051557,-0.0060597,0,0
4,GO OVULATION,0.69707,-0.0052538,0.045607,0,0
4,GO PROTEIN KINASE A SIGNALING,0.87144,-0.0053306,-0.023679,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.65866,-0.0055749,-0.033382,0,0
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.89215,-0.0056127,-0.0094845,0,0
4,GO CELLULAR RESPONSE TO DRUG,0.97557,-0.0056467,0.0054228,0,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.38888,-0.0057638,-0.046227,0,0
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.94073,-0.0058936,0.028969,0,0
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.73628,-0.0060714,0.04361,0,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.56075,-0.0061337,0.023338,0,0
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.80989,-0.0063163,-0.067839,0,0
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.36064,-0.0064352,-0.032454,0,0
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.89907,-0.0065192,0.0071467,0,0
4,GO PEPTIDYL ARGININE MODIFICATION,0.81668,-0.006579,-0.017077,0,0
4,GO RNA PROCESSING,0.72969,-0.0065808,-0.023299,0,0
4,GO DNA METHYLATION OR DEMETHYLATION,0.97557,-0.0066936,-0.0022471,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.97557,-0.0067107,-0.01187,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE,0.58456,-0.0067547,0.017664,0,0
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.35607,-0.0068238,-0.044658,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.94073,-0.0068262,0.010147,0,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.40349,-0.0068274,-0.046737,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.58456,-0.0069023,-0.043425,0,0
4,GO HEART TRABECULA MORPHOGENESIS,0.7495,-0.0069089,0.022148,0,0
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.55487,-0.0070545,0.057857,0,0
4,GO GROWTH,0.60883,-0.0077548,-0.022516,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.84397,-0.0077853,-0.0075254,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.70355,-0.0078163,-0.013086,0,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.80989,-0.0078195,-0.0023004,0,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.4978,-0.0079734,-0.065741,0,0
4,GO MESENCHYME DEVELOPMENT,0.41842,-0.0080495,-0.059795,0,0
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.55487,-0.0082221,-0.066263,0,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.80312,-0.0082929,0.017918,0,0
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.63978,-0.0083082,-0.054259,0,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.64605,-0.0084644,-0.050775,0,0
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.70355,-0.0086075,-0.011047,0,0
4,GO EMBRYO DEVELOPMENT,0.59059,-0.0086607,-0.02216,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.9686,-0.0087586,-0.014827,0,0
4,GO TELOMERE ORGANIZATION,0.71658,-0.0089091,-0.023903,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.75615,-0.0089108,0.044206,0,0
4,GO DOSAGE COMPENSATION,0.44924,-0.008928,-0.043062,0,0
4,GO MATERNAL PLACENTA DEVELOPMENT,0.36064,-0.009062,-0.089923,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.4545,-0.0090851,0.053203,0,0
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.75615,-0.009238,-0.042664,0,0
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.95466,-0.0092445,-0.019801,0,0
4,GO HETEROCHROMATIN ORGANIZATION,0.19095,-0.0093427,-0.06553,0,0
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.51459,-0.0093749,-0.018896,0,0
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.9686,-0.00952,-0.00037533,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.9686,-0.0096833,0.0045627,0,0
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.92682,-0.0098141,-0.0055242,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.97557,-0.010131,-0.013539,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.70355,-0.010209,-0.012319,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.4545,-0.010214,-0.059146,0,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,0.8303,-0.01032,-0.010641,0,0
4,GO RNA POLYADENYLATION,0.29992,-0.010402,-0.052224,0,0
4,GO REGULATION OF ATPASE ACTIVITY,0.35153,-0.010415,-0.03165,0,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.24643,-0.010478,0.065713,0,0
4,GO AORTA DEVELOPMENT,0.27227,-0.010619,-0.098401,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.85082,-0.010666,-0.01861,0,0
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.43367,-0.010744,-0.043953,0,0
4,GO ENSHEATHMENT OF NEURONS,0.85768,-0.010746,-0.011115,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.61497,-0.010765,0.06755,0,0
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.89907,-0.010784,0.014067,0,0
4,GO ODONTOGENESIS,0.46512,-0.01082,-0.068934,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.88523,-0.01082,0.017016,0,0
4,GO NUCLEUS ORGANIZATION,0.9686,-0.01086,0.011352,0,0
4,GO DEFINITIVE HEMOPOIESIS,0.65866,-0.010894,-0.060969,0,0
4,GO REGULATION OF CELL AGING,0.80312,-0.011049,-0.020294,0,0
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.71006,-0.011124,0.030195,0,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.36064,-0.011363,-0.076273,0,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.36991,-0.011444,-0.024544,0,0
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.67776,-0.011466,-0.013738,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION,0.71658,-0.011608,-0.02248,0,0
4,GO NOTCH RECEPTOR PROCESSING,0.50896,-0.01169,0.08958,0,0
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.65866,-0.011722,-0.049206,0,0
4,GO INTERLEUKIN 2 PRODUCTION,0.91293,-0.011818,-0.028652,0,0
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.62732,-0.011972,-0.016249,0,0
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.77618,-0.01211,-0.0044256,0,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.88523,-0.012266,0.016089,0,0
4,GO RECEPTOR RECYCLING,0.93377,-0.012315,0.016969,0,0
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.90599,-0.012342,-0.010916,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.8303,-0.012416,0.046821,0,0
4,GO ACTIN CROSSLINK FORMATION,0.24643,-0.012591,-0.095614,0,0
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.48678,-0.012714,0.020669,0,0
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.53167,-0.012729,-0.02855,0,0
4,GO TRNA WOBBLE BASE MODIFICATION,0.60272,-0.012788,-0.035334,0,0
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.8303,-0.012949,0.021512,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.96163,-0.013024,0.01184,0,0
4,GO ENDOCARDIUM DEVELOPMENT,0.8303,-0.013032,0.02229,0,0
4,GO SERTOLI CELL DEVELOPMENT,0.61497,-0.013185,-0.095365,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.48678,-0.013205,-0.070037,0,0
4,GO MIRNA METABOLIC PROCESS,0.71006,-0.013207,-0.021117,0,0
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.91987,-0.013237,-0.01309,0,0
4,GO CELL JUNCTION ORGANIZATION,0.78289,-0.013254,-0.013876,0,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.36064,-0.01331,-0.044546,0,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.87833,-0.013347,-0.011871,0,0
4,GO REGULATION OF PROTEIN TARGETING,0.98255,-0.013363,0.010078,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.5726,-0.013522,-0.036067,0,0
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.9686,-0.013639,-0.002109,0,0
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.63354,-0.013701,-0.047051,0,0
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.69061,-0.013769,-0.068513,0,0
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.77618,-0.013829,0.0077984,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.83713,-0.014189,-0.014733,0,0
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.36064,-0.014269,-0.071273,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.72313,-0.014319,0.016484,0,0
4,GO DISTAL TUBULE DEVELOPMENT,0.62732,-0.014338,-0.062439,0,0
4,GO CELL CELL SIGNALING,0.88523,-0.014346,-0.0037655,0,0
4,GO CYTOKINESIS,0.23937,-0.014461,-0.039332,0,0
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.72969,-0.014539,0.029516,0,0
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.3746,-0.014559,-0.031945,0,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.97557,-0.014639,0.011157,0,0
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.65234,-0.014678,0.013826,0,0
4,GO SPERM AXONEME ASSEMBLY,0.37932,-0.014703,-0.048171,0,0
4,GO CELL FATE COMMITMENT,0.36064,-0.014725,-0.034042,0,0
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.69707,-0.014859,0.048216,0,0
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.68418,-0.014868,-0.011691,0,0
4,GO GENE SILENCING,0.71006,-0.01489,-0.022362,0,0
4,GO RRNA METHYLATION,0.91987,-0.014975,0.011314,0,0
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.62113,-0.015621,-0.024648,0,0
4,GO REGULATION OF GENE SILENCING,0.96163,-0.015886,-0.017769,0,0
4,GO MISMATCH REPAIR,0.47588,-0.016267,-0.029596,0,0
4,GO CARDIOCYTE DIFFERENTIATION,0.81668,-0.016523,0.0067395,0,0
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.44924,-0.01658,-0.026998,0,0
4,GO NEURAL TUBE FORMATION,0.31232,-0.016696,-0.068417,0,0
4,GO MATING BEHAVIOR,0.9686,-0.016791,-0.0091188,0,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.4598,-0.016855,-0.027833,0,0
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.71658,-0.016872,0.054203,0,0
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.48678,-0.016941,0.030912,0,0
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.28785,-0.016966,-0.081349,0,0
4,GO ERYTHROCYTE MATURATION,0.75615,-0.016997,-0.051241,0,0
4,GO REGULATION OF CIRCADIAN RHYTHM,0.92682,-0.017108,0.0063881,0,0
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.92682,-0.017132,0.039037,0,0
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.23245,-0.017329,-0.043169,0,0
4,GO POST EMBRYONIC DEVELOPMENT,0.29184,-0.017421,-0.047902,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.86455,-0.017424,0.013982,0,0
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.91987,-0.017457,-0.022997,0,0
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.73628,-0.017735,-0.042747,0,0
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.83713,-0.01776,-0.0099893,0,0
4,GO GOLGI LOCALIZATION,0.7495,-0.017768,-0.022178,0,0
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.94769,-0.017848,0.004856,0,0
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.12689,-0.017918,-0.072262,0,0
4,GO DNA METHYLATION,0.54321,-0.017981,-0.024263,0,0
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,1,-0.018636,0.009505,0,0
4,GO POSITIVE REGULATION OF URINE VOLUME,0.52594,-0.018674,-0.055037,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.54321,-0.018747,-0.01441,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.65866,-0.018782,0.01945,0,0
4,GO DENDRITE EXTENSION,0.65866,-0.018793,-0.0057101,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.13583,-0.018833,-0.064439,0,0
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.99651,-0.018888,0.0085654,0,0
4,GO RESPONSE TO X RAY,0.30815,-0.018992,-0.10035,0,0
4,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.50896,-0.019011,-0.027225,0,0
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.62732,-0.019063,-0.020838,0,0
4,GO NUCLEAR TRANSPORT,0.98953,-0.019068,-0.0082062,0,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.40843,-0.019272,-0.06495,0,0
4,GO PERICARDIUM DEVELOPMENT,0.89215,-0.019304,-0.040474,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.40843,-0.019368,-0.031181,0,0
4,GO MEMBRANE HYPERPOLARIZATION,0.75615,-0.019426,0.020029,0,0
4,GO RESPONSE TO AMINO ACID STARVATION,0.59664,-0.019568,0.035853,0,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.9686,-0.019782,-0.0068372,0,0
4,GO MESENCHYME MORPHOGENESIS,0.84397,-0.019782,-0.042747,0,0
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.32506,-0.019798,-0.034848,0,0
4,GO RHYTHMIC BEHAVIOR,0.69707,-0.020152,-0.010922,0,0
4,GO CHROMOSOME LOCALIZATION,0.3746,-0.020239,-0.035355,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.3746,-0.02024,-0.038032,0,0
4,GO ACROSOME REACTION,0.32506,-0.020284,0.1039,0,0
4,GO GROWTH HORMONE SECRETION,0.85768,-0.020351,0.026375,0,0
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.80312,-0.020628,0.018842,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.70355,-0.020641,0.069018,0,0
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.95466,-0.020799,0.0085421,0,0
4,GO AORTIC VALVE DEVELOPMENT,0.79636,-0.020918,-0.045722,0,0
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.23937,-0.020929,-0.080958,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.48131,-0.020999,-0.034304,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.87833,-0.021024,0.032203,0,0
4,GO HISTONE MONOUBIQUITINATION,0.11434,-0.021165,-0.076917,0,0
4,GO METAPHASE PLATE CONGRESSION,0.4978,-0.021231,-0.022476,0,0
4,GO CELL CELL SIGNALING BY WNT,0.21905,-0.021332,-0.047481,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.64605,-0.021381,0.057145,0,0
4,GO FOCAL ADHESION ASSEMBLY,0.93377,-0.021547,-0.020712,0,0
4,GO MULTICELLULAR ORGANISM GROWTH,0.60883,-0.021608,-0.01592,0,0
4,GO SKELETAL SYSTEM DEVELOPMENT,0.61497,-0.021625,-0.03322,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.31232,-0.021702,-0.089195,0,0
4,GO REGULATION OF MITOTIC CELL CYCLE,0.78289,-0.02175,-0.0049764,0,0
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.32506,-0.021802,-0.038908,0,0
4,GO MESODERM DEVELOPMENT,0.26471,-0.021905,-0.062714,0,0
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.67776,-0.022024,-0.024572,0,0
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.30815,-0.022025,-0.028223,0,0
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.80989,-0.022122,-0.012745,0,0
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.87144,-0.022235,0.019703,0,0
4,GO BRONCHUS DEVELOPMENT,0.98953,-0.022403,0.017371,0,0
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.83713,-0.022428,0.027901,0,0
4,GO POSITIVE REGULATION OF RNA SPLICING,0.72969,-0.022461,0.045907,0,0
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.85082,-0.022514,-0.0024827,0,0
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.62113,-0.02253,-0.036014,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.61497,-0.022542,-0.01615,0,0
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.99651,-0.022554,-0.02477,0,0
4,GO GLIAL CELL APOPTOTIC PROCESS,0.81668,-0.022642,0.032754,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.40843,-0.022932,-0.11439,0,0
4,GO SPERM MOTILITY,0.60883,-0.023002,-0.016267,0,0
4,GO RNA SURVEILLANCE,0.89907,-0.023094,-0.0029302,0,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.36991,-0.023164,-0.029164,0,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.92682,-0.023164,0.0056343,0,0
4,GO PEPTIDYL THREONINE MODIFICATION,0.87144,-0.023293,0.0017823,0,0
4,GO DNA METABOLIC PROCESS,0.23937,-0.023371,-0.026934,0,0
4,GO NUCLEAR EXPORT,0.44924,-0.023452,-0.04113,0,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.77618,-0.02351,-0.030955,0,0
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.76948,-0.023553,-0.033893,0,0
4,GO RRNA MODIFICATION,0.80312,-0.023728,0.0015028,0,0
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.58456,-0.023737,-0.054337,0,0
4,GO REGULATION OF PROTEIN ACETYLATION,0.60883,-0.023778,-0.0071318,0,0
4,GO TUBE FORMATION,0.2839,-0.023794,-0.070413,0,0
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.30402,-0.023871,-0.088373,0,0
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.80989,-0.023939,-0.019248,0,0
4,GO OXIDATIVE DEMETHYLATION,0.48131,-0.023947,-0.024177,0,0
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.21579,-0.023958,-0.1161,0,0
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.4545,-0.023989,-0.092098,0,0
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.8303,-0.02399,-0.018465,0,0
4,GO CELLULAR RESPONSE TO HEAT,0.87833,-0.024105,-0.011129,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.87144,-0.02412,0.0060137,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.60883,-0.024253,-0.017473,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.36991,-0.024296,-0.060888,0,0
4,GO MIDDLE EAR MORPHOGENESIS,0.2839,-0.024307,-0.11146,0,0
4,GO SENSORY ORGAN MORPHOGENESIS,0.20309,-0.024459,-0.060794,0,0
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.77618,-0.024489,0.072403,0,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.21905,-0.024685,-0.076841,0,0
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.72969,-0.024782,-0.065349,0,0
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.35153,-0.024861,-0.02268,0,0
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.53167,-0.024943,-0.02131,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.30815,-0.025042,-0.057101,0,0
4,GO CELL CYCLE CHECKPOINT,0.30815,-0.025048,-0.027358,0,0
4,GO SENSORY ORGAN DEVELOPMENT,0.25001,-0.025157,-0.046353,0,0
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.18219,-0.025316,-0.041065,0,0
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.20621,-0.025402,-0.040229,0,0
4,GO HEART DEVELOPMENT,0.41341,-0.02577,-0.037887,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.91293,-0.025879,0.022638,0,0
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.53742,-0.025932,-0.021298,0,0
4,GO VIRAL LATENCY,0.21256,-0.025943,-0.11195,0,0
4,GO PROTEIN ACYLATION,0.14769,-0.026014,-0.024344,0,0
4,GO RNA LOCALIZATION,0.14048,-0.026196,-0.069921,0,0
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.4598,-0.026569,-0.040726,0,0
4,GO RESPONSE TO COCAINE,0.38888,-0.026744,-0.050803,0,0
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.43367,-0.02685,-0.030328,0,0
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.4598,-0.026887,-0.076368,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.080955,-0.026987,-0.13218,0,0
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.69061,-0.026988,-0.015702,0,0
4,GO FEMALE GAMETE GENERATION,0.97557,-0.027092,0.0025248,0,0
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.63354,-0.027155,-0.036619,0,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.50896,-0.027483,-0.045021,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.27999,-0.02763,-0.046043,0,0
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.94769,-0.027651,-0.0089584,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.79636,-0.027772,0.0059209,0,0
4,GO REGULATION OF CHROMATIN BINDING,0.58456,-0.027799,-0.032385,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.8303,-0.028133,0.046361,0,0
4,GO RECEPTOR INTERNALIZATION,0.34702,-0.028176,-0.062997,0,0
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.61497,-0.028237,-0.051001,0,0
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.24643,-0.028263,-0.07402,0,0
4,GO NEUROTRANSMITTER UPTAKE,0.77618,-0.028385,0.025355,0,0
4,GO REGULATION OF CELL CYCLE,0.65866,-0.028388,-0.0085316,0,0
4,GO DICARBOXYLIC ACID TRANSPORT,0.86455,-0.028551,0.01245,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.86455,-0.028562,0.016342,0,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.94769,-0.028729,-0.0044815,0,0
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.65234,-0.028796,-0.014631,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.84397,-0.02907,-0.0061436,0,0
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.32938,-0.02917,-0.026808,0,0
4,GO NEURON APOPTOTIC PROCESS,0.62113,-0.029175,-0.0099149,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.89907,-0.02933,0.011063,0,0
4,GO NEPHRIC DUCT DEVELOPMENT,0.80989,-0.029635,0.0061025,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.44924,-0.029641,-0.043496,0,0
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.54903,-0.029675,-0.032955,0,0
4,GO PROTEIN SUMOYLATION,0.21905,-0.029728,-0.034965,0,0
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.48131,-0.029875,-0.02606,0,0
4,GO CELL PROJECTION ASSEMBLY,0.21256,-0.029898,-0.037684,0,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.35607,-0.030334,-0.019378,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.15264,-0.030354,-0.029776,0,0
4,GO MRNA CLEAVAGE,0.36526,-0.030407,-0.036256,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.7495,-0.030445,-0.010493,0,0
4,GO THYMUS DEVELOPMENT,0.50896,-0.030483,-0.043342,0,0
4,GO NERVOUS SYSTEM PROCESS,0.76281,-0.030493,0.013777,0,0
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.1028,-0.030525,-0.046337,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.40349,-0.030682,-0.11253,0,0
4,GO AROMATIC AMINO ACID TRANSPORT,0.73628,-0.030696,0.051766,0,0
4,GO STARTLE RESPONSE,0.60883,-0.030845,-0.048604,0,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.72969,-0.030935,-0.037592,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.56666,-0.031,-0.037167,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.48131,-0.031066,-0.060487,0,0
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.65234,-0.031074,0.030549,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.69707,-0.031207,-0.041947,0,0
4,GO SECONDARY PALATE DEVELOPMENT,0.72969,-0.031283,-0.027779,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.34256,-0.031351,-0.034235,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.59664,-0.031471,-0.01686,0,0
4,GO WALKING BEHAVIOR,0.50896,-0.031478,-0.060867,0,0
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.29992,-0.031553,-0.046925,0,0
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.56666,-0.031879,-0.059309,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.14285,-0.031905,-0.05955,0,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.98255,-0.031959,0.00069805,0,0
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.14526,-0.032161,-0.1207,0,0
4,GO HISTONE PHOSPHORYLATION,0.61497,-0.032292,-0.01875,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.67776,-0.032356,-0.018975,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.67776,-0.032373,0.041239,0,0
4,GO PROTEIN POLYMERIZATION,0.83713,-0.032465,-0.010814,0,0
4,GO CELLULAR RESPONSE TO ETHANOL,0.47049,-0.032536,0.073889,0,0
4,GO CAMERA TYPE EYE DEVELOPMENT,0.18508,-0.03254,-0.058006,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.33812,-0.032719,-0.15698,0,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,0.96163,-0.032844,0.0096591,0,0
4,GO CYTOSKELETON ORGANIZATION,0.48131,-0.03286,-0.023579,0,0
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.89215,-0.032991,-0.0054246,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.84397,-0.033013,0.016973,0,0
4,GO MRNA METABOLIC PROCESS,0.38888,-0.033394,-0.036203,0,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.91293,-0.033896,0.03726,0,0
4,GO APOPTOTIC DNA FRAGMENTATION,0.32077,-0.034044,-0.035079,0,0
4,GO MICROVILLUS ASSEMBLY,0.91987,-0.034062,-0.030439,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.17934,-0.034068,-0.066053,0,0
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.25363,-0.034168,-0.027992,0,0
4,GO GDP METABOLIC PROCESS,0.94769,-0.034296,0.0057954,0,0
4,GO NEUTROPHIL HOMEOSTASIS,0.94073,-0.03452,-0.057501,0,0
4,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.78962,-0.03457,0.083304,0,0
4,GO SCHWANN CELL DEVELOPMENT,0.56666,-0.034699,-0.030266,0,0
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.96163,-0.034716,-0.0089014,0,0
4,GO CELLULAR RESPONSE TO PH,0.25729,-0.03474,-0.072858,0,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.78289,-0.034807,-0.0035091,0,0
4,GO MRNA METHYLATION,0.26847,-0.034825,-0.074517,0,0
4,GO REGULATION OF RNA BINDING,0.46512,-0.034835,-0.063076,0,0
4,GO PROTEIN DEPOLYMERIZATION,0.69061,-0.034901,-0.0080934,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.39858,-0.035032,-0.080687,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.88523,-0.035048,-0.012319,0,0
4,GO CHROMATIN SILENCING AT TELOMERE,0.31653,-0.035063,-0.066148,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.79636,-0.035225,0.012809,0,0
4,GO HISTONE H4 ACETYLATION,0.18508,-0.03528,-0.043945,0,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.78962,-0.035304,-0.025139,0,0
4,GO HEART FIELD SPECIFICATION,0.43883,-0.035363,-0.077503,0,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.12908,-0.035373,-0.12884,0,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.56666,-0.035385,-0.097965,0,0
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.78289,-0.035505,-0.039751,0,0
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.54321,-0.035636,-0.020688,0,0
4,GO RESPONSE TO FOOD,0.98953,-0.035637,-0.00062683,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.26847,-0.036062,-0.058699,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.34702,-0.036173,-0.018705,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.67137,-0.036399,-0.040012,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.17099,-0.036579,-0.042393,0,0
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.74288,-0.036625,-0.017598,0,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,0.72313,-0.036632,-0.015805,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.71006,-0.036667,-0.02739,0,0
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.59664,-0.036688,-0.016099,0,0
4,GO EXIT FROM MITOSIS,0.52025,-0.03679,-0.023715,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.49227,-0.036889,-0.050579,0,0
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.54321,-0.036898,-0.017995,0,0
4,GO NEURAL NUCLEUS DEVELOPMENT,0.76281,-0.036901,0.013089,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.39371,-0.036972,-0.044565,0,0
4,GO BONE DEVELOPMENT,0.17653,-0.036974,-0.075654,0,0
4,GO CGMP MEDIATED SIGNALING,0.80989,-0.037154,-0.0062934,0,0
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.036164,-0.037163,-0.050569,0,0
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.095625,-0.037279,-0.047057,0,0
4,GO ENDOCARDIAL CUSHION FORMATION,0.60272,-0.03729,-0.047812,0,0
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.71658,-0.037602,-0.013615,0,0
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.67776,-0.037846,0.0075793,0,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,0.85768,-0.038042,-0.026683,0,0
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.44402,-0.038231,-0.085637,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.93377,-0.038449,-0.0013456,0,0
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.70355,-0.038624,-0.029603,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.67776,-0.038931,0.0012616,0,0
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.18219,-0.038952,-0.063229,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.97557,-0.038972,0.0075557,0,0
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.34702,-0.039134,-0.1597,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.92682,-0.03942,-0.00014555,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.43367,-0.039504,-0.045716,0,0
4,GO LENS FIBER CELL DEVELOPMENT,0.29992,-0.039687,-0.12707,0,0
4,GO CELLULAR RESPONSE TO NUTRIENT,0.47588,-0.039896,-0.05723,0,0
4,GO CELL CYCLE,0.36064,-0.039932,-0.019632,0,0
4,GO CELLULAR COMPONENT MAINTENANCE,0.78962,-0.040226,0.0002868,0,0
4,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.78289,-0.040288,-0.017369,0,0
4,GO COVALENT CHROMATIN MODIFICATION,0.013139,-0.040385,-0.06846,0,0
4,GO SKELETAL MUSCLE ADAPTATION,0.91987,-0.04044,0.018025,0,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.26098,-0.040479,-0.057036,0,0
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.36526,-0.04072,-0.064434,0,0
4,GO RESPONSE TO UV,0.20309,-0.040753,-0.046685,0,0
4,GO MESENCHYMAL CELL PROLIFERATION,0.65234,-0.040801,-0.073438,0,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.56666,-0.040909,-0.05198,0,0
4,GO ACTIVATION OF MAPKK ACTIVITY,0.48678,-0.040921,-0.038072,0,0
4,GO DNA INTEGRITY CHECKPOINT,0.16559,-0.041161,-0.039172,0,0
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.23245,-0.041198,-0.093985,0,0
4,GO REGULATION OF MRNA 3 END PROCESSING,0.16294,-0.041224,-0.076148,0,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.27999,-0.041527,-0.042313,0,0
4,GO POSITIVE THYMIC T CELL SELECTION,0.72313,-0.04173,-0.025386,0,0
4,GO CELL CYCLE PHASE TRANSITION,0.14526,-0.041832,-0.033273,0,0
4,GO HOMOLOGOUS RECOMBINATION,0.2839,-0.041869,-0.046569,0,0
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.78962,-0.041936,-0.023341,0,0
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.093897,-0.042187,-0.081274,0,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.60272,-0.04247,-0.029408,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.42855,-0.042543,-0.047795,0,0
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.44924,-0.042688,-0.051646,0,0
4,GO REGULATION OF GLIOGENESIS,0.53742,-0.042736,-0.02749,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.4598,-0.042954,-0.077599,0,0
4,GO LIPOPROTEIN LOCALIZATION,0.17653,-0.043138,-0.10309,0,0
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.49227,-0.043198,-0.0087923,0,0
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.35607,-0.043328,-0.070971,0,0
4,GO NEPHRIC DUCT MORPHOGENESIS,0.78289,-0.043345,-0.066773,0,0
4,GO NCRNA EXPORT FROM NUCLEUS,0.58456,-0.043523,-0.038087,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.30815,-0.043714,-0.056729,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.85768,-0.043761,0.016123,0,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.25729,-0.043765,-0.12423,0,0
4,GO PEPTIDYL ARGININE METHYLATION,0.96163,-0.044066,-0.0025391,0,0
4,GO BEHAVIOR,0.76281,-0.044172,-0.0062679,0,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.32938,-0.044345,-0.043052,0,0
4,GO RETINAL CONE CELL DIFFERENTIATION,0.47049,-0.044538,-0.092218,0,0
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.36526,-0.044618,-0.040606,0,0
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.40843,-0.044639,-0.052099,0,0
4,GO FOREGUT MORPHOGENESIS,0.19095,-0.044675,-0.11901,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.25729,-0.044712,-0.12258,0,0
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.057089,-0.044776,-0.10343,0,0
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.188,-0.044836,-0.058106,0,0
4,GO MOTILE CILIUM ASSEMBLY,0.47588,-0.044846,-0.058247,0,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.34702,-0.045406,-0.063632,0,0
4,GO ADULT HEART DEVELOPMENT,0.35153,-0.045446,-0.11004,0,0
4,GO SYNAPTIC VESICLE DOCKING,0.99651,-0.045545,0.063257,0,0
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.69707,-0.045588,-0.034686,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.63354,-0.045672,-0.033663,0,0
4,GO CELLULAR RESPONSE TO RADIATION,0.16559,-0.045743,-0.045086,0,0
4,GO FIBROBLAST MIGRATION,0.54321,-0.045862,-0.048766,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.80312,-0.045903,-0.033667,0,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.83713,-0.046175,-0.061309,0,0
4,GO MUSCLE FIBER DEVELOPMENT,0.40843,-0.046184,-0.036927,0,0
4,GO TRNA TRANSPORT,0.44924,-0.046353,-0.047662,0,0
4,GO EMBRYONIC PATTERN SPECIFICATION,0.49227,-0.046673,-0.041299,0,0
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.072231,-0.046719,-0.096053,0,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.54321,-0.04685,-0.054599,0,0
4,GO EAR MORPHOGENESIS,0.23245,-0.046932,-0.066992,0,0
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.67137,-0.046982,-0.012367,0,0
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.1028,-0.047041,-0.035688,0,0
4,GO DEMETHYLATION,0.48678,-0.047104,-0.033356,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.20937,-0.04725,-0.039684,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.35153,-0.047287,-0.028909,0,0
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.34702,-0.047407,-0.044735,0,0
4,GO PEPTIDYL LYSINE MODIFICATION,0.010245,-0.047426,-0.054021,0,0
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.47049,-0.047444,-0.041071,0,0
4,GO RESPONSE TO PROSTAGLANDIN E,0.90599,-0.047509,-0.013825,0,0
4,GO ACTIVATION OF JNKK ACTIVITY,0.47049,-0.047572,-0.074637,0,0
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.29184,-0.047642,-0.075445,0,0
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.63354,-0.047698,-0.030363,0,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.53742,-0.0477,-0.019104,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.41341,-0.048081,-0.053251,0,0
4,GO MIDBRAIN DEVELOPMENT,0.14769,-0.048133,-0.056705,0,0
4,GO REGULATION OF OOGENESIS,0.99651,-0.048139,0.036773,0,0
4,GO CEREBELLAR CORTEX FORMATION,0.33373,-0.04814,-0.053358,0,0
4,GO RNA CAPPING,0.54903,-0.04816,-0.026851,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.8303,-0.04818,0.047335,0,0
4,GO SALIVARY GLAND DEVELOPMENT,0.57857,-0.048219,0.020294,0,0
4,GO REGULATION OF HELICASE ACTIVITY,0.63354,-0.048406,-0.019112,0,0
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.44402,-0.048442,-0.039295,0,0
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.58456,-0.048559,-0.050952,0,0
4,GO NOSE DEVELOPMENT,0.72969,-0.048631,0.073528,0,0
4,GO PROSTATE GLAND DEVELOPMENT,0.099158,-0.048891,-0.18462,0,0
4,GO REGULATION OF BONE MINERALIZATION,0.95466,-0.049023,-0.011028,0,0
4,GO REGULATION OF CELL DIVISION,0.32938,-0.049048,-0.032599,0,0
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.56666,-0.049464,0.019289,0,0
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.14048,-0.049471,-0.07793,0,0
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.26471,-0.049546,-0.074377,0,0
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.045624,-0.049801,-0.090878,0,0
4,GO NEURAL TUBE DEVELOPMENT,0.24288,-0.049922,-0.067959,0,0
4,GO RNA EXPORT FROM NUCLEUS,0.059411,-0.050385,-0.07909,0,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.48678,-0.0504,-0.044957,0,0
4,GO FIBROBLAST APOPTOTIC PROCESS,0.7495,-0.050482,-0.039998,0,0
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.38888,-0.050679,-0.11267,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.92682,-0.050716,0.0033539,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.96163,-0.050834,-0.016534,0,0
4,GO HINDBRAIN MORPHOGENESIS,0.13355,-0.050881,-0.084583,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.49227,-0.050899,-0.0521,0,0
4,GO RNA 3 END PROCESSING,0.14526,-0.050914,-0.065747,0,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.14285,-0.051096,-0.063889,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.44924,-0.051285,-0.056567,0,0
4,GO EPITHELIAL CELL MATURATION,0.92682,-0.051311,0.037607,0,0
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.27999,-0.05159,-0.038929,0,0
4,GO IRON COORDINATION ENTITY TRANSPORT,0.87144,-0.051673,0.016401,0,0
4,GO SPINDLE ASSEMBLY,0.050569,-0.051935,-0.052662,0,0
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.065563,-0.052319,-0.10732,0,0
4,GO REGULATION OF HEAT GENERATION,0.63354,-0.052398,-0.019615,0,0
4,GO SENSORY SYSTEM DEVELOPMENT,0.15517,-0.052401,-0.055121,0,0
4,GO MUSCLE ORGAN MORPHOGENESIS,0.3746,-0.05242,-0.053637,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.56666,-0.05248,-0.060874,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.9686,-0.052516,-0.010086,0,0
4,GO CELL VOLUME HOMEOSTASIS,0.67776,-0.052698,0.0027413,0,0
4,GO REGULATION OF GONAD DEVELOPMENT,0.30402,-0.052709,-0.085727,0,0
4,GO REGULATION OF SPINDLE CHECKPOINT,0.23937,-0.052992,-0.076264,0,0
4,GO MICROTUBULE BASED MOVEMENT,0.05824,-0.05316,-0.058477,0,0
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.26098,-0.05332,-0.084516,0,0
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.40843,-0.053426,-0.047536,0,0
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.68418,-0.053537,-0.022421,0,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.093897,-0.05359,-0.081013,0,0
4,GO PROTEIN METHYLATION,0.082489,-0.053617,-0.04435,0,0
4,GO GLIAL CELL FATE COMMITMENT,0.94073,-0.053714,0.025282,0,0
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.25729,-0.053803,-0.074379,0,0
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.12259,-0.05403,-0.16778,0,0
4,GO MITOTIC CELL CYCLE,0.15517,-0.054213,-0.032534,0,0
4,GO STEM CELL DIFFERENTIATION,0.34702,-0.0544,-0.036365,0,0
4,GO RESPONSE TO AMYLOID BETA,0.36991,-0.054479,-0.038777,0,0
4,GO REGULATION OF RNA SPLICING,0.0099891,-0.054545,-0.075393,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.11235,-0.054598,-0.071353,0,0
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.89907,-0.054611,-0.0091086,0,0
4,GO FIBROBLAST ACTIVATION,0.61497,-0.054627,-0.040924,0,0
4,GO REGULATION OF CHROMOSOME SEPARATION,0.12908,-0.054635,-0.065757,0,0
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.60272,-0.054832,-0.049915,0,0
4,GO RUFFLE ASSEMBLY,0.98255,-0.054946,0.0123,0,0
4,GO MITOTIC NUCLEAR DIVISION,0.11235,-0.055343,-0.046036,0,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.29184,-0.055416,-0.098575,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.17653,-0.055536,-0.22684,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.71006,-0.05555,0.082847,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.63978,-0.055671,-0.064118,0,0
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.4545,-0.055915,-0.080123,0,0
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.38888,-0.055994,-0.068492,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.20309,-0.056041,-0.065791,0,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.65234,-0.056049,0.026571,0,0
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.59059,-0.056151,-0.002628,0,0
4,GO EYE MORPHOGENESIS,0.16559,-0.056271,-0.066126,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.40349,-0.056316,-0.060441,0,0
4,GO MEMBRANE DOCKING,0.34256,-0.056372,-0.025087,0,0
4,GO ARTERY DEVELOPMENT,0.35153,-0.056376,-0.071295,0,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.088862,-0.056451,-0.14718,0,0
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.15264,-0.056465,-0.087675,0,0
4,GO LIPID PHOSPHORYLATION,0.98953,-0.056625,0.028188,0,0
4,GO MYOTUBE CELL DEVELOPMENT,0.59664,-0.056968,-0.014139,0,0
4,GO ESTABLISHMENT OF CELL POLARITY,0.19695,-0.057001,-0.052144,0,0
4,GO HEART VALVE DEVELOPMENT,0.52025,-0.057149,-0.050653,0,0
4,GO BASE EXCISION REPAIR,0.12908,-0.057227,-0.073122,0,0
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.65866,-0.05731,-0.04199,0,0
4,GO CELL CYCLE PROCESS,0.0695,-0.057386,-0.035437,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.60272,-0.057418,-0.034723,0,0
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.35607,-0.057899,-0.036352,0,0
4,GO LEFT RIGHT AXIS SPECIFICATION,0.98255,-0.057917,-0.021581,0,0
4,GO REGULATION OF RECEPTOR CLUSTERING,0.41341,-0.058024,-0.10369,0,0
4,GO RENAL FILTRATION,0.65866,-0.05813,-0.023228,0,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.36526,-0.058136,-0.12389,0,0
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.088862,-0.058502,-0.099398,0,0
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.7495,-0.058518,-0.012243,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.65866,-0.05852,-0.038418,0,0
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.22905,-0.058521,-0.049754,0,0
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.59664,-0.058609,-0.029364,0,0
4,GO RESPONSE TO CATECHOLAMINE,0.88523,-0.059138,0.015749,0,0
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.94073,-0.059221,-0.022381,0,0
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.22235,-0.05971,-0.082767,0,0
4,GO HISTONE H3 K14 ACETYLATION,0.30815,-0.059842,-0.03406,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.57857,-0.060002,-0.045093,0,0
4,GO AXONAL FASCICULATION,0.093897,-0.060097,-0.19666,0,0
4,GO GANGLION DEVELOPMENT,0.87144,-0.060432,0.050613,0,0
4,GO HISTONE H3 DEACETYLATION,0.38888,-0.060534,-0.049164,0,0
4,GO LENS FIBER CELL DIFFERENTIATION,0.22905,-0.060737,-0.081555,0,0
4,GO VAGINA DEVELOPMENT,0.91293,-0.060756,-0.038135,0,0
4,GO REGULATION OF DNA BINDING,0.064293,-0.061013,-0.059228,0,0
4,GO MATURATION OF LSU RRNA,0.92682,-0.061092,-0.0077824,0,0
4,GO RETINA LAYER FORMATION,0.29184,-0.061236,-0.069805,0,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.44402,-0.06124,-0.05727,0,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.88523,-0.06132,-0.022894,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.14048,-0.061353,-0.057919,0,0
4,GO REGULATION OF CELL CYCLE PROCESS,0.092194,-0.061576,-0.037245,0,0
4,GO REGULATION OF SYNAPSE MATURATION,0.34702,-0.062172,-0.15815,0,0
4,GO HISTONE H2A ACETYLATION,0.42347,-0.062311,-0.060057,0,0
4,GO SHORT TERM MEMORY,0.36991,-0.062439,-0.11463,0,0
4,GO HYPOTONIC RESPONSE,0.19695,-0.062669,-0.12719,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.25001,-0.06293,-0.052229,0,0
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.15773,-0.062994,-0.09954,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.88523,-0.063017,-0.0271,0,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.11235,-0.063075,-0.078638,0,0
4,GO GASTRIC ACID SECRETION,0.74288,-0.06316,0.019682,0,0
4,GO EMBRYONIC AXIS SPECIFICATION,0.71006,-0.063553,-0.028173,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.21905,-0.063633,-0.083364,0,0
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.37932,-0.063873,-0.065108,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.16828,-0.063924,-0.10558,0,0
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.42855,-0.064168,-0.138,0,0
4,GO HISTONE METHYLATION,0.0064317,-0.064254,-0.08551,0,0
4,GO LYMPH VESSEL MORPHOGENESIS,0.19095,-0.064302,-0.0967,0,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.090515,-0.064564,-0.086039,0,0
4,GO SEQUESTERING OF METAL ION,0.71658,-0.064592,-0.041031,0,0
4,GO CILIUM ORGANIZATION,0.052669,-0.064798,-0.072372,0,0
4,GO PROTEIN ACETYLATION,0.016339,-0.064907,-0.045796,0,0
4,GO DNA RECOMBINATION,0.046579,-0.064925,-0.049426,0,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.39371,-0.064926,-0.085539,0,0
4,GO TELOMERASE RNA LOCALIZATION,0.55487,-0.065273,-0.051463,0,0
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.21579,-0.065303,-0.07069,0,0
4,GO REGULATION OF MEMBRANE POTENTIAL,0.76281,-0.065431,-0.0037911,0,0
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.30402,-0.065447,-0.067109,0,0
4,GO CARDIAC CHAMBER DEVELOPMENT,0.19695,-0.06546,-0.065128,0,0
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.14769,-0.065566,-0.12151,0,0
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.36526,-0.065671,-0.046152,0,0
4,GO CHROMATIN ORGANIZATION,0.0060989,-0.065785,-0.066821,0,0
4,GO VASCULOGENESIS,0.27611,-0.065787,-0.11566,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.15773,-0.065861,-0.067232,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.1028,-0.065911,-0.1039,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.29184,-0.066148,-0.1107,0,0
4,GO REGULATION OF TELOMERE MAINTENANCE,0.16032,-0.066179,-0.059156,0,0
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.25001,-0.066412,-0.12479,0,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.19393,-0.06678,-0.06018,0,0
4,GO SPECIFICATION OF SYMMETRY,0.079444,-0.0668,-0.07709,0,0
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.21256,-0.066912,-0.11682,0,0
4,GO POSITIVE REGULATION OF DNA BINDING,0.049546,-0.067175,-0.087114,0,0
4,GO DEVELOPMENTAL GROWTH,0.090515,-0.067364,-0.070262,0,0
4,GO V D J RECOMBINATION,0.4545,-0.067572,-0.076906,0,0
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.27999,-0.067591,-0.078746,0,0
4,GO PROSTATIC BUD FORMATION,0.14048,-0.067595,-0.22228,0,0
4,GO RNA DESTABILIZATION,0.17099,-0.0679,-0.079784,0,0
4,GO NUCLEAR MIGRATION,0.33373,-0.067975,-0.081845,0,0
4,GO INNER EAR MORPHOGENESIS,0.14526,-0.06799,-0.076232,0,0
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.063042,-0.068014,-0.055883,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.42347,-0.06802,-0.027905,0,0
4,GO NEUROMUSCULAR PROCESS,0.27999,-0.068103,-0.051998,0,0
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.052669,-0.06831,-0.09413,0,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.3746,-0.068623,-0.042289,0,0
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.32938,-0.068657,-0.044987,0,0
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.28785,-0.068802,-0.067998,0,0
4,GO HISTONE H3 K4 TRIMETHYLATION,0.0695,-0.068884,-0.088366,0,0
4,GO CENTROSOME SEPARATION,0.3746,-0.069028,-0.024822,0,0
4,GO GMP METABOLIC PROCESS,0.5726,-0.069245,-0.049557,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.064293,-0.069345,-0.16187,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.62113,-0.069422,-0.044743,0,0
4,GO MUSCLE ORGAN DEVELOPMENT,0.088862,-0.069504,-0.051638,0,0
4,GO HEART MORPHOGENESIS,0.17099,-0.069578,-0.066448,0,0
4,GO ADULT BEHAVIOR,0.52025,-0.069915,4.9131e-05,0,0
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.21905,-0.069936,-0.060483,0,0
4,GO FACIAL NERVE MORPHOGENESIS,0.41842,-0.070252,-0.12863,0,0
4,GO MICROTUBULE BASED PROCESS,0.0021062,-0.070434,-0.075842,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.46512,-0.070539,-0.059459,0,0
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.44924,-0.070728,-0.10807,0,0
4,GO MICROTUBULE ANCHORING,0.14285,-0.070942,-0.063223,0,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.05824,-0.071047,-0.075655,0,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.62732,-0.071436,-0.032458,0,0
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.40349,-0.07158,-0.0062953,0,0
4,GO CELL RECOGNITION,0.32506,-0.071583,-0.061832,0,0
4,GO REGULATION OF GLUTAMATE SECRETION,0.74288,-0.071631,-0.00020882,0,0
4,GO REGULATION OF CENTROSOME CYCLE,0.17653,-0.071634,-0.03493,0,0
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.03245,-0.071651,-0.1449,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.21905,-0.072149,-0.097545,0,0
4,GO MYOBLAST PROLIFERATION,0.64605,-0.072386,-0.03524,0,0
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.043763,-0.072469,-0.094534,0,0
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.2,-0.072502,-0.093574,0,0
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.23245,-0.072563,-0.048114,0,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.24643,-0.072891,-0.1335,0,0
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.090515,-0.072976,-0.085359,0,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.70355,-0.073092,-0.11254,0,0
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.027188,-0.073102,-0.071811,0,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.15773,-0.07314,-0.12397,0,0
4,GO PEPTIDYL LYSINE ACETYLATION,0.0087944,-0.073258,-0.06611,0,0
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.59664,-0.073412,-0.011097,0,0
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.26471,-0.073614,-0.11672,0,0
4,GO HEAT GENERATION,0.63978,-0.073644,-0.016686,0,0
4,GO RESPONSE TO POTASSIUM ION,0.56075,-0.073694,-0.047366,0,0
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.53167,-0.073735,-0.032451,0,0
4,GO RESPONSE TO AXON INJURY,0.30402,-0.074214,-0.050737,0,0
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0071468,-0.074447,-0.108,0,0
4,GO CALCINEURIN MEDIATED SIGNALING,0.33812,-0.074571,-0.041165,0,0
4,GO LATERAL VENTRICLE DEVELOPMENT,0.12049,-0.074597,-0.22692,0,0
4,GO CARDIAC ATRIUM DEVELOPMENT,0.73628,-0.074635,-0.022899,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.057089,-0.074776,-0.086495,0,0
4,GO MOTOR NEURON AXON GUIDANCE,0.0695,-0.074804,-0.14593,0,0
4,GO SLEEP,0.43883,-0.074841,-0.04366,0,0
4,GO HISTONE H3 K4 METHYLATION,0.031748,-0.074953,-0.089246,0,0
4,GO HINDBRAIN DEVELOPMENT,0.43367,-0.075077,-0.033726,0,0
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.15015,-0.075191,-0.10024,0,0
4,GO SNORNA METABOLIC PROCESS,0.088862,-0.075645,-0.13089,0,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.10465,-0.075656,-0.073455,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.43883,-0.075677,-0.11524,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.4598,-0.075758,-0.05589,0,0
4,GO PEPTIDYL LYSINE METHYLATION,0.0087944,-0.075935,-0.092584,0,0
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.065563,-0.076033,-0.062429,0,0
4,GO SCHWANN CELL DIFFERENTIATION,0.35607,-0.076061,-0.053645,0,0
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.14048,-0.076064,-0.063369,0,0
4,GO REGULATION OF MEMBRANE INVAGINATION,0.89215,-0.076066,0.022374,0,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.16828,-0.076211,-0.043895,0,0
4,GO BONE MATURATION,0.18219,-0.076261,-0.11723,0,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.46512,-0.076507,-0.069503,0,0
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.27999,-0.076631,-0.084477,0,0
4,GO NEURON CELLULAR HOMEOSTASIS,0.1313,-0.077388,-0.16187,0,0
4,GO RESPONSE TO DOPAMINE,0.47049,-0.077659,-0.031061,0,0
4,GO MEIOTIC CHROMOSOME SEPARATION,0.024846,-0.077833,-0.12538,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.16294,-0.077933,-0.12342,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.031748,-0.078113,-0.073347,0,0
4,GO THYROID GLAND DEVELOPMENT,0.076492,-0.078135,-0.17723,0,0
4,GO PROSTATE GLAND MORPHOGENESIS,0.077957,-0.078193,-0.28372,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.86455,-0.07832,-0.0018274,0,0
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.44402,-0.078606,-0.049745,0,0
4,GO ASYMMETRIC CELL DIVISION,0.27999,-0.078832,-0.099649,0,0
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.099158,-0.07893,-0.12426,0,0
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.41842,-0.079398,-0.067663,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.14526,-0.079439,-0.067587,0,0
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.74288,-0.079617,-0.019254,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.4978,-0.079735,-0.062827,0,0
4,GO ASTROCYTE DIFFERENTIATION,0.49227,-0.079905,-0.028713,0,0
4,GO SISTER CHROMATID SEGREGATION,0.011904,-0.080132,-0.079064,0,0
4,GO DENSE CORE GRANULE TRANSPORT,0.90599,-0.080317,0.062169,0,0
4,GO SYNAPTIC VESICLE TRANSPORT,0.35153,-0.080493,-0.053572,0,0
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.017137,-0.080518,-0.095912,0,0
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.56666,-0.080835,-0.032652,0,0
4,GO MEMORY,0.32938,-0.080862,-0.044278,0,0
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.54321,-0.081018,-0.026184,0,0
4,GO ECTODERM DEVELOPMENT,0.17934,-0.081053,-0.088258,0,0
4,GO NUCLEAR BODY ORGANIZATION,0.3746,-0.081064,-0.017782,0,0
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.26847,-0.081334,-0.086645,0,0
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.68418,-0.081336,-0.044706,0,0
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.070855,-0.081593,-0.081226,0,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.39371,-0.081935,-0.06314,0,0
4,GO RESPONSE TO VITAMIN D,0.39858,-0.081946,-0.078359,0,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.48678,-0.081967,-0.075672,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.11434,-0.082035,-0.15504,0,0
4,GO REGULATION OF TELOMERE CAPPING,0.093897,-0.082302,-0.074201,0,0
4,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.22905,-0.082311,-0.13504,0,0
4,GO MUSCLE FILAMENT SLIDING,0.065563,-0.08238,-0.16626,0,0
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.5726,-0.08246,-0.050185,0,0
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.016339,-0.083149,-0.10472,0,0
4,GO BLEB ASSEMBLY,0.74288,-0.083387,-0.18124,0,0
4,GO CELL MIGRATION IN HINDBRAIN,0.36064,-0.083439,-0.10481,0,0
4,GO HAIR FOLLICLE MATURATION,0.34702,-0.083492,-0.081458,0,0
4,GO NODAL SIGNALING PATHWAY,0.13583,-0.083677,-0.11017,0,0
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.019283,-0.08396,-0.12993,0,0
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.076492,-0.084604,-0.13022,0,0
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.40843,-0.084632,-0.039975,0,0
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.1313,-0.08466,-0.057506,0,0
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.024846,-0.084822,-0.10355,0,0
4,GO LEFT RIGHT PATTERN FORMATION,0.72969,-0.084991,-0.022288,0,0
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.059411,-0.085027,-0.088014,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.057089,-0.085407,-0.079518,0,0
4,GO APICAL PROTEIN LOCALIZATION,0.35153,-0.085989,-0.066888,0,0
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.02843,-0.086213,-0.079539,0,0
4,GO GENITALIA MORPHOGENESIS,0.19393,-0.086316,-0.13984,0,0
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.30402,-0.086624,-0.059381,0,0
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.15015,-0.086684,-0.076823,0,0
4,GO CELL PROJECTION ORGANIZATION,0.023205,-0.086806,-0.079166,0,0
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.56075,-0.08686,-0.060055,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.29992,-0.086974,-0.048516,0,0
4,GO VITAMIN CATABOLIC PROCESS,0.36526,-0.087343,0.16091,0,0
4,GO CHROMATIN SILENCING,0.016734,-0.087528,-0.11832,0,0
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.13814,-0.087585,-0.089751,0,0
4,GO PATTERN SPECIFICATION PROCESS,0.15264,-0.087843,-0.051312,0,0
4,GO HEART GROWTH,0.068167,-0.087875,-0.08787,0,0
4,GO SECRETORY GRANULE LOCALIZATION,0.54903,-0.088014,-0.051787,0,0
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.78289,-0.088076,-0.038652,0,0
4,GO CELLULAR RESPONSE TO VITAMIN D,0.19095,-0.088156,-0.12083,0,0
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.24643,-0.088169,-0.059876,0,0
4,GO SEROTONIN SECRETION,0.36526,-0.088197,-0.04992,0,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.18219,-0.08827,-0.095827,0,0
4,GO MAST CELL MIGRATION,0.53742,-0.088381,-0.077525,0,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.00038934,-0.088445,-0.10266,0,0
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.1028,-0.088459,-0.069922,0,0
4,GO REGULATION OF HISTONE METHYLATION,0.018836,-0.088613,-0.09666,0,0
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.085627,-0.088835,-0.068127,0,0
4,GO REGIONALIZATION,0.30402,-0.088851,-0.037339,0,0
4,GO STRESS GRANULE ASSEMBLY,0.064293,-0.088883,-0.10876,0,0
4,GO CENTROSOME DUPLICATION,0.16032,-0.089342,-0.057873,0,0
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.11434,-0.089653,-0.093646,0,0
4,GO RRNA 3 END PROCESSING,0.82348,-0.089865,-0.0056671,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.54321,-0.090059,-0.049453,0,0
4,GO CORONARY VASCULATURE DEVELOPMENT,0.053746,-0.090152,-0.13496,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.38408,-0.090202,-0.065133,0,0
4,GO MICROTUBULE NUCLEATION,0.031748,-0.090472,-0.087065,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.18508,-0.090645,-0.10336,0,0
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.25001,-0.09068,-0.076093,0,0
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.69061,-0.090986,-0.046012,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.87833,-0.090986,-0.049721,0,0
4,GO MICROTUBULE BASED TRANSPORT,0.010773,-0.091049,-0.10395,0,0
4,GO REGULATION OF CELL SIZE,0.066855,-0.091341,-0.089721,0,0
4,GO BLASTOCYST GROWTH,0.43367,-0.091378,-0.02612,0,0
4,GO CELL MORPHOGENESIS,0.026586,-0.091498,-0.096443,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.21905,-0.091506,-0.1292,0,0
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.22568,-0.09155,-0.085511,0,0
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.13355,-0.091825,-0.1475,0,0
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.10654,-0.091841,-0.16624,0,0
4,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.27227,-0.092047,-0.098683,0,0
4,GO HEAD DEVELOPMENT,0.015953,-0.092123,-0.081166,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.11039,-0.092158,-0.097215,0,0
4,GO REGULATION OF BEHAVIOR,0.043763,-0.092251,-0.11403,0,0
4,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.42855,-0.09227,-0.077442,0,0
4,GO NEURAL CREST CELL DIFFERENTIATION,0.066855,-0.092846,-0.12705,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.8303,-0.093138,-0.051901,0,0
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.007729,-0.093518,-0.13092,0,0
4,GO TRANSPORT ALONG MICROTUBULE,0.00044439,-0.0936,-0.12642,0,0
4,GO HINDLIMB MORPHOGENESIS,0.054842,-0.093906,-0.15422,0,0
4,GO EMBRYONIC HEMOPOIESIS,0.042857,-0.095155,-0.14393,0,0
4,GO MEMBRANE DISASSEMBLY,0.1313,-0.095571,-0.10847,0,0
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.44402,-0.095592,-0.047874,0,0
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.17374,-0.095748,-0.070818,0,0
4,GO HISTONE H4 K5 ACETYLATION,0.11636,-0.095822,-0.10068,0,0
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.26098,-0.096071,-0.059254,0,0
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.25363,-0.096331,-0.08045,0,0
4,GO TELOMERE CAPPING,0.15773,-0.096386,-0.046429,0,0
4,GO REGULATION OF DNA REPLICATION,0.15015,-0.096523,-0.052869,0,0
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0099891,-0.096581,-0.11201,0,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.17099,-0.096667,-0.078583,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.2,-0.097002,-0.085851,0,0
4,GO LONG TERM MEMORY,0.10654,-0.097218,-0.12145,0,0
4,GO ANTEROGRADE AXONAL TRANSPORT,0.044685,-0.09726,-0.096548,0,0
4,GO HISTONE DEUBIQUITINATION,0.085627,-0.097267,-0.059866,0,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.32938,-0.097334,-0.092496,0,0
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.12049,-0.097545,-0.066934,0,0
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.1313,-0.098244,-0.091066,0,0
4,GO CELLULAR RESPONSE TO UV,0.084046,-0.098278,-0.070312,0,0
4,GO CELLULAR RESPONSE TO SALT STRESS,0.068167,-0.098418,-0.23516,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.13814,-0.098625,-0.088597,0,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.075049,-0.098736,-0.080338,0,0
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.17374,-0.098907,-0.11789,0,0
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.1313,-0.099249,-0.07454,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.0066042,-0.099541,-0.10964,0,0
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.1028,-0.099842,-0.087447,0,0
4,GO RECOMBINATIONAL REPAIR,0.0015189,-0.099849,-0.10972,0,0
4,GO REGULATION OF FEEDING BEHAVIOR,0.15517,-0.099873,-0.09525,0,0
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.023205,-0.099922,-0.11483,0,0
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.25363,-0.10001,-0.069308,0,0
4,GO CELL JUNCTION MAINTENANCE,0.47588,-0.10002,-0.033722,0,0
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.11235,-0.1005,-0.17873,0,0
4,GO RESPONSE TO PARATHYROID HORMONE,0.14769,-0.1008,-0.13823,0,0
4,GO CELL CYCLE DNA REPLICATION,0.001228,-0.10094,-0.14025,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.98255,-0.10095,0.01162,0,0
4,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.10845,-0.10106,-0.17833,0,0
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.44402,-0.10109,-0.10168,0,0
4,GO DETECTION OF VISIBLE LIGHT,0.0026572,-0.10144,-0.14602,0,0
4,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.47049,-0.10163,-0.10973,0,0
4,GO REGULATION OF CELL DEVELOPMENT,0.027803,-0.10178,-0.081232,0,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.4978,-0.10202,-0.11183,0,0
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.24643,-0.10216,-0.11529,0,0
4,GO AXO DENDRITIC TRANSPORT,0.02068,-0.10225,-0.11816,0,0
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.10654,-0.10226,-0.13657,0,0
4,GO COLLAGEN FIBRIL ORGANIZATION,0.068167,-0.10273,-0.19069,0,0
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.17099,-0.10275,-0.10329,0,0
4,GO MITOTIC RECOMBINATION,0.082489,-0.10319,-0.095432,0,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.35153,-0.10361,-0.057068,0,0
4,GO NEUROGENESIS,0.014138,-0.10384,-0.092356,0,0
4,GO HISTONE H2A UBIQUITINATION,0.063042,-0.10419,-0.11192,0,0
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.91293,-0.10468,0.0018969,0,0
4,GO MESODERMAL CELL DIFFERENTIATION,0.084046,-0.10478,-0.13076,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.079444,-0.10519,-0.076973,0,0
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.054842,-0.10535,-0.13185,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.072231,-0.10569,-0.066295,0,0
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.66501,-0.10578,-0.028191,0,0
4,GO SEROTONIN TRANSPORT,0.26847,-0.1064,-0.086687,0,0
4,GO TELOMERIC LOOP DISASSEMBLY,0.14769,-0.10642,-0.078081,0,0
4,GO DNA STRAND ELONGATION,0.031059,-0.1065,-0.11287,0,0
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.00019079,-0.10654,-0.11725,0,0
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.32938,-0.10672,-0.077551,0,0
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.12689,-0.10673,-0.064245,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.16032,-0.10705,-0.09929,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.14769,-0.10706,-0.11863,0,0
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.44924,-0.10759,-0.025041,0,0
4,GO POST ANAL TAIL MORPHOGENESIS,0.052669,-0.10784,-0.13454,0,0
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.024288,-0.10813,-0.14359,0,0
4,GO REGULATION OF CILIUM ASSEMBLY,0.0021689,-0.10814,-0.12614,0,0
4,GO REGULATION OF CELL MORPHOGENESIS,0.024846,-0.10828,-0.093824,0,0
4,GO ACIDIC AMINO ACID TRANSPORT,0.16828,-0.10841,-0.05433,0,0
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.00031859,-0.10852,-0.18477,0,0
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.017137,-0.1088,-0.15215,0,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.22568,-0.10881,-0.083201,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.19695,-0.10917,-0.097752,0,0
4,GO NEUROTRANSMITTER TRANSPORT,0.21579,-0.10938,-0.033578,0,0
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.1028,-0.10942,-0.13197,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.4598,-0.11018,-0.072733,0,0
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.16032,-0.11027,-0.090618,0,0
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.32938,-0.11055,-0.061765,0,0
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.059411,-0.11075,-0.069438,0,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.0051916,-0.11144,-0.12873,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.34256,-0.11165,-0.10194,0,0
4,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.71658,-0.11312,-0.026632,0,0
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.20621,-0.11322,-0.10649,0,0
4,GO LONG TERM SYNAPTIC POTENTIATION,0.073629,-0.11357,-0.10797,0,0
4,GO OTIC VESICLE MORPHOGENESIS,0.12908,-0.1138,-0.18343,0,0
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.11235,-0.11382,-0.11199,0,0
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.43367,-0.11383,-0.079907,0,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.11841,-0.11518,-0.11112,0,0
4,GO CARDIAC SEPTUM DEVELOPMENT,0.1028,-0.1153,-0.10937,0,0
4,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.072231,-0.11532,-0.19277,0,0
4,GO LIMBIC SYSTEM DEVELOPMENT,0.013465,-0.11545,-0.12179,0,0
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.10654,-0.11553,-0.17181,0,0
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.16032,-0.11578,-0.11069,0,0
4,GO AXONAL TRANSPORT,0.013139,-0.11626,-0.13069,0,0
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.17099,-0.11629,-0.076558,0,0
4,GO SINGLE STRAND BREAK REPAIR,0.036164,-0.11646,-0.11863,0,0
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.26098,-0.11687,-0.054123,0,0
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.012203,-0.11743,-0.23701,0,0
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.04854,-0.1177,-0.11121,0,0
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.055956,-0.11788,-0.089135,0,0
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.11235,-0.11799,-0.03381,0,0
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.47588,-0.1181,-0.035819,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.26471,-0.11812,-0.11688,0,0
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.060602,-0.11817,-0.082095,0,0
4,GO COLLATERAL SPROUTING,0.082489,-0.11856,-0.14727,0,0
4,GO TRABECULA FORMATION,0.28785,-0.11912,-0.10079,0,0
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.027803,-0.11937,-0.12068,0,0
4,GO DORSAL VENTRAL PATTERN FORMATION,0.024846,-0.11959,-0.095736,0,0
4,GO COGNITION,0.055956,-0.11985,-0.087329,0,0
4,GO NEURON DEVELOPMENT,0.0094949,-0.1199,-0.1104,0,0
4,GO MITOCHONDRION LOCALIZATION,0.0079323,-0.11991,-0.11144,0,0
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.25729,-0.12006,-0.15398,0,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.041967,-0.12019,-0.089169,0,0
4,GO UV PROTECTION,0.27227,-0.12043,-0.11842,0,0
4,GO HISTONE H3 K9 MODIFICATION,0.015203,-0.12058,-0.12182,0,0
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.063042,-0.12147,-0.12318,0,0
4,GO RESPONSE TO LEAD ION,0.077957,-0.12149,-0.088032,0,0
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.036948,-0.12156,-0.098179,0,0
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.15773,-0.1217,-0.12392,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.27227,-0.12245,-0.066225,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.35607,-0.12245,-0.020551,0,0
4,GO REGULATION OF MICROTUBULE BINDING,0.041093,-0.12283,-0.15853,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.027188,-0.12292,-0.14953,0,0
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.21256,-0.12323,-0.11008,0,0
4,GO INTRACELLULAR MRNA LOCALIZATION,0.4978,-0.12337,-0.068454,0,0
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.034637,-0.12352,-0.19939,0,0
4,GO TUBULIN DEACETYLATION,0.076492,-0.1249,-0.10251,0,0
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.087232,-0.12503,-0.066041,0,0
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.015203,-0.1253,-0.10504,0,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.075049,-0.12548,-0.14086,0,0
4,GO REGULATION OF AXON GUIDANCE,0.088862,-0.12617,-0.12985,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.11636,-0.12704,-0.13256,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.03939,-0.12746,-0.12779,0,0
4,GO NUCLEOSOME ORGANIZATION,0.00067758,-0.12764,-0.13345,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.20937,-0.12804,-0.082788,0,0
4,GO CHONDROCYTE DEVELOPMENT,0.16828,-0.12809,-0.12419,0,0
4,GO NEURON DIFFERENTIATION,0.0069616,-0.12848,-0.11261,0,0
4,GO ADULT FEEDING BEHAVIOR,0.17099,-0.12863,-0.11081,0,0
4,GO POSITIVE REGULATION OF BEHAVIOR,0.10654,-0.12871,-0.153,0,0
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0039469,-0.12879,-0.15385,0,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.14285,-0.12879,-0.11013,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0051916,-0.12909,-0.16597,0,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.0033369,-0.12961,-0.15036,0,0
4,GO HISTONE EXCHANGE,0.015203,-0.12979,-0.11512,0,0
4,GO DEVELOPMENTAL CELL GROWTH,0.034637,-0.13048,-0.10453,0,0
4,GO RESPONSE TO AUDITORY STIMULUS,0.17374,-0.13049,-0.11242,0,0
4,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.16294,-0.13052,-0.10421,0,0
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.054842,-0.13056,-0.1504,0,0
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.23937,-0.13056,-0.080018,0,0
4,GO SEQUESTERING OF ACTIN MONOMERS,0.22235,-0.13084,-0.2233,0,0
4,GO METENCEPHALON DEVELOPMENT,0.19393,-0.13105,-0.044012,0,0
4,GO HISTONE H3 K9 METHYLATION,0.015203,-0.13139,-0.14359,0,0
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.05161,-0.13151,-0.16759,0,0
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.041967,-0.13181,-0.11513,0,0
4,GO PROTEIN LOCALIZATION TO CILIUM,0.0032441,-0.13183,-0.16345,0,0
4,GO CEREBRAL CORTEX DEVELOPMENT,0.004408,-0.13207,-0.11086,0,0
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.4598,-0.13231,-0.056184,0,0
4,GO DIVALENT METAL ION EXPORT,0.10654,-0.13245,-0.1779,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.12908,-0.13268,-0.11181,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.10465,-0.13293,-0.095874,0,0
4,GO SUCKLING BEHAVIOR,0.20621,-0.13319,-0.11619,0,0
4,GO SPINDLE MIDZONE ASSEMBLY,0.14769,-0.13319,-0.096401,0,0
4,GO BONE TRABECULA MORPHOGENESIS,0.15773,-0.13356,-0.19483,0,0
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.010773,-0.13388,-0.19311,0,0
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.19095,-0.13389,-0.063026,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.050569,-0.13421,-0.20208,0,0
4,GO OUTFLOW TRACT MORPHOGENESIS,0.084046,-0.13479,-0.12458,0,0
4,GO REGULATION OF TUBULIN DEACETYLATION,0.17374,-0.13494,-0.089284,0,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.1028,-0.13575,-0.13014,0,0
4,GO REGULATION OF CYCLASE ACTIVITY,0.0050528,-0.13722,-0.19206,0,0
4,GO CHONDROCYTE PROLIFERATION,0.13814,-0.13745,-0.1619,0,0
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.080955,-0.13752,-0.086517,0,0
4,GO STEM CELL PROLIFERATION,0.045624,-0.13752,-0.0962,0,0
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.26847,-0.13766,-0.0878,0,0
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0010528,-0.1377,-0.17423,0,0
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.025994,-0.13801,-0.12448,0,0
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.2,-0.13805,-0.095136,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.075049,-0.13813,-0.10255,0,0
4,GO ACROSOME ASSEMBLY,0.076492,-0.13866,-0.12224,0,0
4,GO FILOPODIUM ASSEMBLY,0.053746,-0.13873,-0.12386,0,0
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.049546,-0.13918,-0.10438,0,0
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.0032441,-0.13927,-0.14209,0,0
4,GO NEURAL RETINA DEVELOPMENT,0.014841,-0.13958,-0.13023,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.12259,-0.14005,-0.13594,0,0
4,GO THALAMUS DEVELOPMENT,0.17653,-0.14022,-0.11398,0,0
4,GO SYNAPSE MATURATION,0.17099,-0.1405,-0.17694,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.072231,-0.14056,-0.097447,0,0
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.84397,-0.1406,-0.021296,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.11434,-0.1409,-0.15284,0,0
4,GO OTIC VESICLE DEVELOPMENT,0.21256,-0.14136,-0.16438,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.097379,-0.14166,-0.12169,0,0
4,GO CELL FATE SPECIFICATION,0.076492,-0.14174,-0.093375,0,0
4,GO CELL PROLIFERATION IN HINDBRAIN,0.080955,-0.14175,-0.14978,0,0
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.0026572,-0.14176,-0.16409,0,0
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.17934,-0.14177,-0.088263,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.13355,-0.14193,-0.1228,0,0
4,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.34256,-0.14218,-0.15689,0,0
4,GO NEGATIVE REGULATION OF CELL AGING,0.11434,-0.14235,-0.14854,0,0
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0054795,-0.14302,-0.20863,0,0
4,GO REGULATION OF HEART MORPHOGENESIS,0.087232,-0.14345,-0.14599,0,0
4,GO POSITIVE REGULATION OF DNA REPAIR,6.2786e-05,-0.14351,-0.14674,0,0
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.052669,-0.14368,-0.07762,0,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.061812,-0.14378,-0.10854,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.47049,-0.14382,-0.066027,0,0
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.088862,-0.14403,-0.16345,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0079323,-0.14406,-0.14535,0,0
4,GO INTRACILIARY TRANSPORT,0.0031536,-0.14417,-0.19532,0,0
4,GO DNA PACKAGING,0.00034072,-0.14421,-0.10987,0,0
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.049546,-0.14468,-0.11287,0,0
4,GO G0 TO G1 TRANSITION,0.001662,-0.14592,-0.16389,0,0
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.40843,-0.14628,-0.11078,0,0
4,GO REGULATION OF COLLATERAL SPROUTING,0.12473,-0.14636,-0.15704,0,0
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0056288,-0.14655,-0.1601,0,0
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.10465,-0.14674,-0.13628,0,0
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.11841,-0.14692,-0.14657,0,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.2839,-0.14703,-0.10086,0,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.077957,-0.14706,-0.21728,0,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.035393,-0.14742,-0.09356,0,0
4,GO COLLECTING DUCT DEVELOPMENT,0.03939,-0.14798,-0.18568,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.22235,-0.14834,-0.071732,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0032441,-0.14989,-0.1437,0,0
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,1.6455e-05,-0.14994,-0.1393,0,0
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.02068,-0.15,-0.12056,0,0
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.010506,-0.15005,-0.12285,0,0
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0014299,-0.1501,-0.17689,0,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.079444,-0.15044,-0.31295,0,0
4,GO FOREBRAIN DEVELOPMENT,0.0011549,-0.15064,-0.13415,0,0
4,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.26098,-0.15111,-0.17504,0,0
4,GO APPENDAGE DEVELOPMENT,0.014486,-0.1515,-0.12895,0,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.0087944,-0.15191,-0.115,0,0
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.046579,-0.1525,-0.14336,0,0
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.077957,-0.15256,-0.16249,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.016734,-0.15377,-0.15089,0,0
4,GO SYNAPTIC VESICLE PRIMING,0.88523,-0.1541,0.055357,0,0
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0067808,-0.15418,-0.15843,0,0
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.00054072,-0.15457,-0.15494,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0028957,-0.15476,-0.14808,0,0
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.27227,-0.15481,-0.078479,0,0
4,GO PROTEIN LOCALIZATION TO CHROMATIN,4.4878e-05,-0.15496,-0.17285,0,0
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.041967,-0.15501,-0.14009,0,0
4,GO ADHERENS JUNCTION ASSEMBLY,0.073629,-0.15519,-0.1129,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.015953,-0.15548,-0.30324,0,0
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0006154,-0.15555,-0.14202,0,0
4,GO LEARNING,0.027188,-0.15592,-0.13364,0,0
4,GO GLUTAMATE SECRETION,0.077957,-0.156,-0.10224,0,0
4,GO PROTEIN POLYGLUTAMYLATION,0.0090226,-0.15624,-0.13906,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.3746,-0.1569,-0.11335,0,0
4,GO NEUROTRANSMITTER SECRETION,0.079444,-0.15727,-0.058741,0,0
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.0085714,-0.15756,-0.17397,0,0
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.085627,-0.1576,-0.12408,0,0
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.040234,-0.15789,-0.13558,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.15015,-0.15832,-0.12029,0,0
4,GO CRANIAL NERVE MORPHOGENESIS,0.17934,-0.1585,-0.11855,0,0
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0018173,-0.15863,-0.20471,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.049546,-0.15915,-0.22371,0,0
4,GO REGULATION OF AXONOGENESIS,0.0040578,-0.15918,-0.20824,0,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.2,-0.15937,-0.082279,0,0
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.30815,-0.15951,-0.092419,0,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.11235,-0.16073,-0.16819,0,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.32077,-0.16124,-0.091695,0,0
4,GO REGULATION OF NEURON DIFFERENTIATION,0.011326,-0.1613,-0.11717,0,0
4,GO MICROTUBULE POLYMERIZATION,0.00098941,-0.16152,-0.16234,0,0
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.00081984,-0.16162,-0.156,0,0
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.034637,-0.16185,-0.1183,0,0
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0056288,-0.1621,-0.1868,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.033166,-0.1622,-0.20896,0,0
4,GO REGULATION OF HIPPO SIGNALING,0.15773,-0.16243,-0.1445,0,0
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.010506,-0.16254,-0.15394,0,0
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.055956,-0.16257,-0.098038,0,0
4,GO NEURON PROJECTION ARBORIZATION,0.036164,-0.16264,-0.16763,0,0
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.025414,-0.16347,-0.092314,0,0
4,GO CELL PART MORPHOGENESIS,0.00081984,-0.16385,-0.17302,0,0
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.012203,-0.16393,-0.22573,0,0
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.097379,-0.16403,-0.13006,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0040578,-0.16487,-0.17553,0,0
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.049546,-0.16577,-0.16894,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0059384,-0.1659,-0.15364,0,0
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.027803,-0.16727,-0.19621,0,0
4,GO PALLIUM DEVELOPMENT,0.00027832,-0.16735,-0.15524,0,0
4,GO NON MOTILE CILIUM ASSEMBLY,0.001662,-0.16738,-0.17279,0,0
4,GO BIOLOGICAL PHASE,0.77618,-0.16768,-0.0075302,0,0
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0029794,-0.16816,-0.15807,0,0
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,8.1192e-05,-0.16874,-0.15767,0,0
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.017549,-0.16932,-0.14373,0,0
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.19695,-0.1695,-0.087781,0,0
4,GO SYNAPSE ORGANIZATION,0.023741,-0.16979,-0.13317,0,0
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0047853,-0.16997,-0.19091,0,0
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.011326,-0.17047,-0.16546,0,0
4,GO PREPULSE INHIBITION,0.33373,-0.17048,-0.11312,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.34702,-0.1707,-0.062777,0,0
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.12473,-0.17076,-0.18352,0,0
4,GO FOREBRAIN GENERATION OF NEURONS,0.11636,-0.17087,-0.085288,0,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.038561,-0.17092,-0.16664,0,0
4,GO SYNAPTIC SIGNALING,0.095625,-0.17097,-0.085012,0,0
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.03939,-0.1712,-0.11307,0,0
4,GO TELENCEPHALON DEVELOPMENT,0.00037661,-0.17172,-0.15965,0,0
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00024286,-0.17261,-0.13485,0,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.2,-0.17288,-0.088155,0,0
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0022332,-0.17289,-0.16805,0,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0094949,-0.17337,-0.22011,0,0
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.23589,-0.17369,-0.12779,0,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.093897,-0.17479,-0.17517,0,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.0695,-0.17482,-0.16586,0,0
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.027803,-0.17508,-0.14598,0,0
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00072223,-0.17532,-0.1542,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.015953,-0.17543,-0.17536,0,0
4,GO FORELIMB MORPHOGENESIS,0.0090226,-0.17578,-0.22432,0,0
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.023741,-0.17653,-0.24186,0,0
4,GO HISTONE H3 K9 TRIMETHYLATION,0.0010528,-0.17662,-0.15941,0,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.072231,-0.17713,-0.15295,0,0
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.2,-0.17757,-0.13067,0,0
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.17099,-0.17761,-0.094034,0,0
4,GO REGULATION OF STEM CELL DIVISION,0.013798,-0.17765,-0.2054,0,0
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.16032,-0.17798,-0.12969,0,0
4,GO MAGNESIUM ION HOMEOSTASIS,0.023205,-0.17835,-0.20223,0,0
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0051916,-0.17845,-0.14553,0,0
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.0019282,-0.17909,-0.15682,0,0
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.17653,-0.17943,-0.12297,0,0
4,GO NEURON PROJECTION REGENERATION,0.0099891,-0.17968,-0.15996,0,0
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.97557,-0.18005,-0.0077936,0,0
4,GO ATRIAL SEPTUM DEVELOPMENT,0.20309,-0.18022,-0.10523,0,0
4,GO ROOF OF MOUTH DEVELOPMENT,0.021165,-0.18071,-0.15173,0,0
4,GO EXPLORATION BEHAVIOR,0.060602,-0.18076,-0.19238,0,0
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.12049,-0.18099,-0.12924,0,0
4,GO SOMATIC STEM CELL DIVISION,0.030383,-0.18101,-0.37996,0,0
4,GO TRACHEA DEVELOPMENT,0.05161,-0.18161,-0.16734,0,0
4,GO NUCLEOSOME ASSEMBLY,0.0034322,-0.18191,-0.14328,0,0
4,GO MEMBRANE BIOGENESIS,0.054842,-0.18209,-0.15614,0,0
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.004408,-0.18264,-0.2001,0,0
4,GO FOREBRAIN CELL MIGRATION,0.001872,-0.18268,-0.19749,0,0
4,GO TRACHEA MORPHOGENESIS,0.1313,-0.18293,-0.11997,0,0
4,GO SYNAPSE ASSEMBLY,0.11636,-0.18385,-0.098529,0,0
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.036948,-0.18398,-0.11886,0,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.11434,-0.18442,-0.094535,0,0
4,GO NEGATIVE CHEMOTAXIS,0.085627,-0.18456,-0.17918,0,0
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0067808,-0.18533,-0.21238,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.061812,-0.18559,-0.15107,0,0
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.0041716,-0.18564,-0.2074,0,0
4,GO STEM CELL DIVISION,0.024288,-0.18567,-0.16114,0,0
4,GO NEURON PROJECTION EXTENSION,0.017969,-0.18668,-0.15118,0,0
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.0038387,-0.18704,-0.16237,0,0
4,GO CELL AGGREGATION,0.042857,-0.18745,-0.15831,0,0
4,GO HISTONE H3 K27 METHYLATION,0.0013054,-0.18751,-0.19207,0,0
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.10845,-0.18757,-0.08,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.02166,-0.18777,-0.15821,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00054072,-0.18819,-0.20084,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.020205,-0.18955,-0.15983,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0050528,-0.19093,-0.19854,0,0
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.49227,-0.19158,-0.064057,0,0
4,GO AXON EXTENSION,0.0025817,-0.19167,-0.20861,0,0
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.17099,-0.19273,-0.12018,0,0
4,GO HEART FORMATION,0.080955,-0.19327,-0.13126,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.084046,-0.194,-0.14897,0,0
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0012662,-0.19535,-0.17292,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,9.7346e-05,-0.19545,-0.18573,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.00059588,-0.19545,-0.20319,0,0
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.25363,-0.19621,-0.068919,0,0
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.016734,-0.19661,-0.16581,0,0
4,GO SPINAL CORD DEVELOPMENT,0.0040578,-0.1969,-0.17855,0,0
4,GO SISTER CHROMATID COHESION,0.00047456,-0.19695,-0.14983,0,0
4,GO APPENDAGE MORPHOGENESIS,0.0054795,-0.19721,-0.16447,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0029794,-0.19762,-0.17699,0,0
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00028792,-0.19797,-0.21941,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.026586,-0.1981,-0.17288,0,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0062634,-0.19837,-0.2308,0,0
4,GO NEURON FATE COMMITMENT,0.073629,-0.19868,-0.14229,0,0
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0069616,-0.19906,-0.1685,0,0
4,GO POSTSYNAPSE ORGANIZATION,0.0010528,-0.2001,-0.21639,0,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.013798,-0.20042,-0.21419,0,0
4,GO DENDRITE DEVELOPMENT,0.0010528,-0.20114,-0.16516,0,0
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00034072,-0.20231,-0.17066,0,0
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.37932,-0.20333,-0.088038,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.031748,-0.20338,-0.15595,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.025994,-0.20386,-0.17533,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.022165,-0.204,-0.14858,0,0
4,GO CEREBRAL CORTEX CELL MIGRATION,0.0019282,-0.20417,-0.1977,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0021062,-0.20438,-0.16217,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.83713,-0.20548,-0.021637,0,0
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0085714,-0.20758,-0.18604,0,0
4,GO MICROTUBULE SEVERING,0.019283,-0.20758,-0.16339,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.11235,-0.20827,-0.14514,0,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.066855,-0.20834,-0.22533,0,0
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.029719,-0.20911,-0.16596,0,0
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.085627,-0.20957,-0.12922,0,0
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.031059,-0.21007,-0.1217,0,0
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.095625,-0.21067,-0.14957,0,0
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.42855,-0.21141,-0.094131,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.041967,-0.21214,-0.20043,0,0
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.011904,-0.21344,-0.16762,0,0
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.017969,-0.21366,-0.16307,0,0
4,GO AXON DEVELOPMENT,0.00079435,-0.21444,-0.21209,0,0
4,GO SIALYLATION,0.15015,-0.21479,-0.14927,0,0
4,GO RESPIRATORY SYSTEM PROCESS,0.0014299,-0.21594,-0.21737,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.10096,-0.21669,-0.13841,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0011549,-0.21699,-0.19119,0,0
4,GO LOCALIZATION WITHIN MEMBRANE,0.00011241,-0.2177,-0.22057,0,0
4,GO HIPPOCAMPUS DEVELOPMENT,0.00013917,-0.21801,-0.22088,0,0
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.017137,-0.21872,-0.20185,0,0
4,GO PROTEIN DEMETHYLATION,0.00010845,-0.21874,-0.22012,0,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.013798,-0.21877,-0.19146,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.76281,-0.22002,0.065952,0,0
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.00054072,-0.22126,-0.19678,0,0
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.16032,-0.2213,-0.11924,0,0
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.087232,-0.22194,-0.14658,0,0
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,9.7346e-05,-0.22317,-0.21377,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.011326,-0.22443,-0.17437,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.018398,-0.22659,-0.19155,0,0
4,GO NEURON PROJECTION GUIDANCE,0.00025131,-0.22715,-0.24257,0,0
4,GO NEURON PROJECTION ORGANIZATION,0.00098941,-0.22715,-0.21644,0,0
4,GO UTERUS DEVELOPMENT,0.066855,-0.22727,-0.19407,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,0.27227,-0.22858,-0.11652,0,0
4,GO DENDRITIC SPINE DEVELOPMENT,0.00047456,-0.22867,-0.22195,0,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.041093,-0.22954,-0.19424,0,0
4,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.19695,-0.22988,-0.22171,0,0
4,GO RESPONSE TO ACETYLCHOLINE,0.011326,-0.23,-0.2498,0,0
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0015653,-0.23033,-0.16034,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.27227,-0.23041,-0.13628,0,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.011612,-0.23121,-0.18757,0,0
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.00353,-0.2316,-0.24999,0,0
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.020205,-0.23208,-0.12179,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.066855,-0.23242,-0.16471,0,0
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0014738,-0.23273,-0.29097,0,0
4,GO CGMP METABOLIC PROCESS,0.0695,-0.23535,-0.1561,0,0
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.0042883,-0.23572,-0.18498,0,0
4,GO NEURON MIGRATION,0.001872,-0.23626,-0.21487,0,0
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0001165,-0.23632,-0.2915,0,0
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.023205,-0.23634,-0.20793,0,0
4,GO CONVERGENT EXTENSION,0.027803,-0.23658,-0.1958,0,0
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.012508,-0.23659,-0.21681,0,0
4,GO COCHLEA MORPHOGENESIS,0.00057693,-0.23704,-0.30468,0,0
4,GO NEUROBLAST PROLIFERATION,0.00067758,-0.23801,-0.22492,0,0
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00018427,-0.23823,-0.20591,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0030654,-0.23831,-0.21608,0,0
4,GO LEUKOCYTE AGGREGATION,0.054842,-0.23928,-0.27701,0,0
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.027803,-0.23963,-0.23468,0,0
4,GO HISTONE H3 K36 METHYLATION,0.015953,-0.23982,-0.15655,0,0
4,GO NEURON CELL CELL ADHESION,0.36991,-0.24015,-0.082536,0,0
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.049546,-0.24086,-0.18245,0,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00011241,-0.24113,-0.25924,0,0
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00049035,-0.24285,-0.22247,0,0
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0010859,-0.24299,-0.30974,0,0
4,GO SPINAL CORD PATTERNING,0.13814,-0.2438,-0.12412,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.0011199,-0.24603,-0.24655,0,0
4,GO PYRAMIDAL NEURON DIFFERENTIATION,0.013798,-0.24636,-0.26922,0,0
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.00029782,-0.24713,-0.25516,0,0
4,GO MRNA SPLICE SITE SELECTION,0.00035231,-0.24813,-0.22596,0,0
4,GO OLFACTORY LOBE DEVELOPMENT,0.0079323,-0.2482,-0.25627,0,0
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.011904,-0.24917,-0.21684,0,0
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.025994,-0.25338,-0.22427,0,0
4,GO REGULATION OF NEURON MIGRATION,9.7346e-05,-0.25411,-0.30757,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.012203,-0.25476,-0.19796,0,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.11636,-0.25563,-0.11425,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.043763,-0.2572,-0.13745,0,0
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.0053338,-0.25832,-0.25451,0,0
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.00026903,-0.2589,-0.22692,0,0
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0020453,-0.25899,-0.2348,0,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.0081404,-0.25911,-0.23507,0,0
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0028141,-0.25916,-0.2371,0,0
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00038934,-0.25939,-0.24815,0,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.03939,-0.25963,-0.20314,0,0
4,GO BRAIN MORPHOGENESIS,0.00020448,-0.25977,-0.21631,0,0
4,GO TELENCEPHALON GLIAL CELL MIGRATION,3.5759e-05,-0.26014,-0.31369,0,0
4,GO CENTROMERE COMPLEX ASSEMBLY,0.00041602,-0.26036,-0.22204,0,0
4,GO DENDRITE MORPHOGENESIS,0.00024286,-0.2604,-0.21809,0,0
4,GO PLASMA MEMBRANE REPAIR,0.092194,-0.26061,-0.17164,0,0
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.001986,-0.26142,-0.2322,0,0
4,GO RECEPTOR CLUSTERING,0.00028792,-0.26316,-0.2529,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.010245,-0.26762,-0.27321,0,0
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,8.1192e-05,-0.26766,-0.28597,0,0
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.69707,-0.27071,-0.044444,0,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.092194,-0.27091,-0.22125,0,0
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0059384,-0.27197,-0.23322,0,0
4,GO MICROTUBULE DEPOLYMERIZATION,0.00084609,-0.27251,-0.24775,0,0
4,GO PRESYNAPSE ORGANIZATION,0.038561,-0.27256,-0.17431,0,0
4,GO CELL PROLIFERATION IN FOREBRAIN,7.013e-05,-0.27432,-0.28741,0,0
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0067808,-0.27442,-0.32836,0,0
4,GO NEURON RECOGNITION,0.012203,-0.27591,-0.24084,0,0
4,GO FOREBRAIN NEURON DEVELOPMENT,0.023741,-0.27637,-0.19676,0,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.0036303,-0.27799,-0.23718,0,0
4,GO COCHLEA DEVELOPMENT,0.0015189,-0.2786,-0.23318,0,0
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0097392,-0.27976,-0.19286,0,0
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0038387,-0.28118,-0.33231,0,0
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.00049035,-0.28206,-0.42244,0,0
4,GO RETINAL ROD CELL DIFFERENTIATION,0.013798,-0.28574,-0.26255,0,0
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.001662,-0.28802,-0.21292,0,0
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.00034072,-0.28908,-0.2702,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0023671,-0.2897,-0.26414,0,0
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.025414,-0.29002,-0.20939,0,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.009256,-0.29136,-0.23389,0,0
4,GO FOREBRAIN NEURON FATE COMMITMENT,0.15264,-0.29147,-0.16463,0,0
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,6.5149e-05,-0.29375,-0.29117,0,0
4,GO MECHANOSENSORY BEHAVIOR,0.32506,-0.29485,-0.14946,0,0
4,GO DENTATE GYRUS DEVELOPMENT,0.016734,-0.29618,-0.21931,0,0
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.00010092,-0.29725,-0.33611,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00027832,-0.30161,-0.25991,0,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.017969,-0.30493,-0.21291,0,0
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0018173,-0.30607,-0.23578,0,0
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.015203,-0.30783,-0.28219,0,0
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00057693,-0.30896,-0.29838,0,0
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00016023,-0.309,-0.28249,0,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00090094,-0.30904,-0.32727,0,0
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.035393,-0.30906,-0.29234,0,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0094949,-0.30965,-0.31042,0,0
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00011241,-0.30967,-0.27291,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0032441,-0.31018,-0.23327,0,0
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0027346,-0.31224,-0.20424,0,0
4,GO REGULATION OF NEUROBLAST PROLIFERATION,2.7343e-05,-0.31527,-0.34402,0,0
4,GO CARTILAGE MORPHOGENESIS,0.019283,-0.32189,-0.30643,0,0
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00029782,-0.32445,-0.36598,0,0
4,GO FOREBRAIN REGIONALIZATION,0.00353,-0.3282,-0.26702,0,0
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,8.1192e-05,-0.32894,-0.38243,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.00022676,-0.33338,-0.3368,0,0
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00098941,-0.33451,-0.2728,0,0
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,5.7413e-06,-0.34084,-0.3233,0,0
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.00087311,-0.34179,-0.29595,0,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,5.8301e-05,-0.34194,-0.37916,0,0
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0013054,-0.34421,-0.2828,0,0
4,GO DENDRITIC SPINE MORPHOGENESIS,7.8282e-05,-0.34591,-0.30679,0,0
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0097392,-0.34682,-0.3668,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0011549,-0.3479,-0.274,0,0
4,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00098941,-0.35291,-0.45968,0,0
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0001547,-0.35368,-0.3265,0,0
4,GO NEURON FATE SPECIFICATION,0.30402,-0.35671,-0.086927,0,0
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.015203,-0.35977,-0.23936,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.077957,-0.36114,-0.32422,0,0
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.016734,-0.36258,-0.24478,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.1313,-0.36268,-0.13026,0,0
4,GO SYNAPTIC MEMBRANE ADHESION,0.0099891,-0.36603,-0.31974,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0046564,-0.36625,-0.32715,0,0
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.00027832,-0.36817,-0.29888,0,0
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00035231,-0.37868,-0.32486,0,0
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00050664,-0.38674,-0.36155,0,0
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.009256,-0.38749,-0.34864,0,0
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.007729,-0.38797,-0.3959,0,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.03939,-0.38939,-0.27714,0,0
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00050664,-0.39831,-0.4172,0,0
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.0015653,-0.40623,-0.31549,0,0
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0028957,-0.40803,-0.41805,0,0
4,GO LONG TERM SYNAPTIC DEPRESSION,8.7323e-05,-0.42408,-0.35007,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.0066042,-0.45388,-0.34697,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.007729,-0.45431,-0.3824,0,0
4,GO TELENCEPHALON REGIONALIZATION,0.0036303,-0.47015,-0.40388,0,0
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0001165,-0.48285,-0.54944,0,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,0.00011241,-0.48436,-0.48258,0,0
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.085627,-0.49139,-0.2541,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,3.4421e-05,-0.49591,-0.48987,0,0
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00030804,-0.50777,-0.45685,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.6307e-05,-0.52005,-0.61195,0,0
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,2.4346e-05,-0.52893,-0.51789,0,0
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.00041602,-0.54181,-0.45683,0,0
4,GO CARDIAC CHAMBER FORMATION,0.00037661,-0.56311,-0.50971,0,0
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,4.1617e-05,-0.57459,-0.60126,0,0
4,GO VOCALIZATION BEHAVIOR,0.00055855,-0.57882,-0.52442,0,0
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,5.2139e-05,-0.58407,-0.49297,0,0
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00031859,-0.58818,-0.68909,0,0
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,5.9841e-06,-0.5934,-0.64448,0,0
4,GO CARDIAC VENTRICLE FORMATION,0.00059588,-0.59349,-0.5346,0,0
4,GO POSTSYNAPSE ASSEMBLY,0.00018427,-0.6104,-0.5423,0,0
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00012964,-0.62244,-0.51543,0,0
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0056288,-0.66315,-0.4665,0,0
4,GO SYNAPTIC VESICLE CLUSTERING,0.00011241,-0.73562,-0.63242,0,0
5,GO FOREBRAIN NEURON FATE COMMITMENT,0.00029782,0.63972,0.72353,1,1
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.001872,0.59075,0.49246,1,1
5,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.001191,0.52831,0.41554,1,1
5,GO CARDIOBLAST PROLIFERATION,0.013139,0.48758,0.39833,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0049174,0.46479,0.41436,1,1
5,GO NEURON FATE SPECIFICATION,0.0013457,0.44934,0.43382,1,1
5,GO ATRIAL SEPTUM MORPHOGENESIS,0.0059384,0.44781,0.33487,1,1
5,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.02268,0.38267,0.28982,1,1
5,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00023468,0.36551,0.4253,1,1
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0054795,0.34681,0.25477,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0012662,0.32464,0.32441,1,1
5,GO RESPONSE TO FORSKOLIN,0.015953,0.31071,0.25346,1,1
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0069616,0.30015,0.26851,1,1
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.0033369,0.29878,0.40974,1,1
5,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,5.8301e-05,0.29214,0.47913,1,1
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0059384,0.29212,0.29368,1,1
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.024288,0.28486,0.30399,1,1
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.012203,0.27135,0.19788,1,1
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0021062,0.26909,0.22949,1,1
5,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00028792,0.26842,0.35946,1,1
5,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.0017123,0.2588,0.26159,1,1
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.036948,0.25419,0.26388,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0069616,0.25035,0.31857,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.019739,0.24802,0.16689,1,1
5,GO DENDRITE SELF AVOIDANCE,0.014486,0.24466,0.19709,1,1
5,GO GAMMA DELTA T CELL DIFFERENTIATION,0.010506,0.23542,0.36471,1,1
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.00065623,0.23254,0.19127,1,1
5,GO CELL FATE SPECIFICATION,0.0025083,0.22738,0.19452,1,1
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0066042,0.22172,0.16914,1,1
5,GO ESTROUS CYCLE,0.016339,0.22046,0.20727,1,1
5,GO DNA DEMETHYLATION,0.0067808,0.21511,0.14664,1,1
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.021165,0.20781,0.12937,1,1
5,GO REGULATION OF SISTER CHROMATID COHESION,0.0062634,0.20264,0.14578,1,1
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0014738,0.19545,0.21862,1,1
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.025414,0.19484,0.16678,1,1
5,GO MITOTIC SISTER CHROMATID COHESION,0.0017123,0.19186,0.19797,1,1
5,GO NEGATIVE REGULATION OF GLIOGENESIS,0.02166,0.19088,0.14301,1,1
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.014486,0.18229,0.184,1,1
5,GO KINETOCHORE ORGANIZATION,0.033166,0.18131,0.12841,1,1
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.013465,0.18096,0.34992,1,1
5,GO DENDRITIC TRANSPORT,0.04854,0.1809,0.16223,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.02068,0.17772,0.18498,1,1
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0034322,0.17095,0.18824,1,1
5,GO GENETIC IMPRINTING,0.01282,0.16805,0.16445,1,1
5,GO COPULATION,0.041967,0.16469,0.13843,1,1
5,GO HISTONE H2A MONOUBIQUITINATION,0.001228,0.16297,0.19019,1,1
5,GO ACROSOME ASSEMBLY,0.016734,0.16188,0.14107,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.025994,0.15909,0.13094,1,1
5,GO DOSAGE COMPENSATION,0.0024367,0.15508,0.13231,1,1
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.0015189,0.15453,0.14521,1,1
5,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0047853,0.15219,0.23593,1,1
5,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.012508,0.1514,0.1997,1,1
5,GO DNA DEALKYLATION,0.047551,0.14866,0.090425,1,1
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0059384,0.14669,0.13595,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING,0.023741,0.14386,0.109,1,1
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.01282,0.14369,0.1184,1,1
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.016734,0.14185,0.16698,1,1
5,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.03939,0.13992,0.097637,1,1
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.021165,0.13967,0.16339,1,1
5,GO ASTRAL MICROTUBULE ORGANIZATION,0.0090226,0.13521,0.15376,1,1
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.015953,0.13463,0.12212,1,1
5,GO HISTONE H2A UBIQUITINATION,0.0099891,0.1331,0.12152,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0079323,0.13153,0.1494,1,1
5,GO HISTONE H2A ACETYLATION,0.011612,0.13087,0.13462,1,1
5,GO HISTONE H4 K16 ACETYLATION,0.0026572,0.12732,0.16261,1,1
5,GO MITOTIC CHROMOSOME CONDENSATION,0.0047853,0.12707,0.14285,1,1
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0023671,0.12356,0.12344,1,1
5,GO CENTROSOME DUPLICATION,0.0057817,0.12346,0.12194,1,1
5,GO MEIOTIC SPINDLE ORGANIZATION,0.019283,0.11981,0.10804,1,1
5,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0041716,0.11603,0.11345,1,1
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.04854,0.11293,0.071084,1,1
5,GO RETROGRADE AXONAL TRANSPORT,0.044685,0.10968,0.14007,1,1
5,GO HISTONE MONOUBIQUITINATION,0.0039469,0.10776,0.11149,1,1
5,GO CHROMATIN REMODELING AT CENTROMERE,0.029719,0.10501,0.12465,1,1
5,GO HISTONE UBIQUITINATION,0.017969,0.10044,0.074395,1,1
5,GO SYNAPTIC VESICLE LOCALIZATION,0.036164,0.098571,0.16326,1,1
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.034637,0.094694,0.075117,1,1
5,GO MITOTIC SPINDLE ORGANIZATION,0.036164,0.093783,0.063565,1,1
5,GO DEMETHYLATION,0.016734,0.083583,0.072182,1,1
5,GO HISTONE H4 ACETYLATION,0.0071468,0.081818,0.096623,1,1
5,GO RESPONSE TO NERVE GROWTH FACTOR,0.018836,0.072224,0.11331,1,1
5,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.026586,0.071678,0.066401,1,1
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.034637,0.070893,0.052678,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.0067808,0.070258,0.094585,1,1
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.03939,0.067949,0.062674,1,1
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.041093,0.066251,0.088991,1,1
5,GO SPINDLE ORGANIZATION,0.041967,0.061988,0.049083,1,1
5,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0042883,0.32971,0.33496,1,0
5,GO TRANSPOSITION,0.026586,0.20668,0.17616,1,0
5,GO CARDIOBLAST DIFFERENTIATION,0.015203,0.20167,0.21415,1,0
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.021165,0.19252,0.29312,1,0
5,GO INSEMINATION,0.027803,0.13643,0.16051,1,0
5,GO REGULATION OF STEM CELL PROLIFERATION,0.027803,0.099715,0.099927,1,0
5,GO CHROMOSOME LOCALIZATION,0.033166,0.088539,0.067535,1,0
5,GO REGULATION OF CENTROSOME CYCLE,0.027188,0.069246,0.091227,1,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.041093,0.063299,0.056721,1,0
5,GO NUCLEAR CHROMOSOME SEGREGATION,0.038561,0.05044,0.044221,1,0
5,GO CERAMIDE METABOLIC PROCESS,0.036948,-0.028811,-0.099236,1,0
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.042857,-0.03554,-0.11335,1,0
5,GO METHYLATION,0.020205,-0.035669,-0.051164,1,0
5,GO PEPTIDYL AMINO ACID MODIFICATION,0.011612,-0.038756,-0.057583,1,0
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.027803,-0.038912,-0.079863,1,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.017137,-0.039594,-0.057603,1,0
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.047551,-0.041752,-0.049426,1,0
5,GO REGULATION OF CELLULAR PH,0.04854,-0.042472,-0.074103,1,0
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.037747,-0.043056,-0.066165,1,0
5,GO HEART DEVELOPMENT,0.044685,-0.044496,-0.078283,1,0
5,GO ESTABLISHMENT OF RNA LOCALIZATION,0.04854,-0.046619,-0.077483,1,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.033166,-0.047401,-0.06105,1,0
5,GO POSITIVE REGULATION OF SIGNALING,0.033894,-0.047819,-0.067117,1,0
5,GO LEUKOCYTE DIFFERENTIATION,0.027803,-0.04827,-0.092688,1,0
5,GO MYELOID CELL DIFFERENTIATION,0.042857,-0.049547,-0.080786,1,0
5,GO SENSORY PERCEPTION OF SMELL,0.0081404,-0.049582,-0.11323,1,0
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.036164,-0.049821,-0.072308,1,0
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.026586,-0.050723,-0.10073,1,0
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.047551,-0.052018,-0.077556,1,0
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0075304,-0.052432,-0.074377,1,0
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.025414,-0.053334,-0.09814,1,0
5,GO NUCLEAR TRANSPORT,0.017549,-0.053534,-0.070626,1,0
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.031748,-0.053647,-0.088015,1,0
5,GO GRANULOCYTE MIGRATION,0.047551,-0.054573,-0.11987,1,0
5,GO GLYCOSYLATION,0.019283,-0.056097,-0.111,1,0
5,GO REGULATION OF BLOOD PRESSURE,0.02268,-0.056375,-0.10321,1,0
5,GO CYTOKINE METABOLIC PROCESS,0.033166,-0.057261,-0.14971,1,0
5,GO REGULATION OF TRANSFERASE ACTIVITY,0.0051916,-0.057372,-0.081871,1,0
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.040234,-0.057803,-0.10577,1,0
5,GO IMPORT INTO NUCLEUS,0.047551,-0.058216,-0.073686,1,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.033894,-0.058239,-0.069755,1,0
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.044685,-0.058309,-0.079395,1,0
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0067808,-0.058348,-0.090623,1,0
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.044685,-0.05858,-0.076735,1,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0022332,-0.058828,-0.061947,1,0
5,GO HUMORAL IMMUNE RESPONSE,0.0051916,-0.058865,-0.12406,1,0
5,GO REGULATION OF BODY FLUID LEVELS,0.033894,-0.058916,-0.10156,1,0
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.025414,-0.05909,-0.068366,1,0
5,GO PROTEIN AUTOUBIQUITINATION,0.047551,-0.059222,-0.06014,1,0
5,GO MUSCLE ADAPTATION,0.026586,-0.059267,-0.12073,1,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.02843,-0.059488,-0.076677,1,0
5,GO REGULATION OF ACTIN FILAMENT LENGTH,0.019283,-0.05977,-0.08484,1,0
5,GO VESICLE ORGANIZATION,0.0087944,-0.060712,-0.091447,1,0
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.035393,-0.060743,-0.10356,1,0
5,GO PROTEIN KINASE A SIGNALING,0.015574,-0.061048,-0.1107,1,0
5,GO MUSCLE STRUCTURE DEVELOPMENT,0.047551,-0.061166,-0.07431,1,0
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.036948,-0.061778,-0.1051,1,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0014738,-0.062335,-0.064734,1,0
5,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.010245,-0.062431,-0.073285,1,0
5,GO PROTEOLYSIS,0.0025083,-0.062904,-0.091778,1,0
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0040578,-0.063115,-0.088714,1,0
5,GO CARDIAC CHAMBER DEVELOPMENT,0.013139,-0.063456,-0.12967,1,0
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.02068,-0.063657,-0.077281,1,0
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.044685,-0.0641,-0.11662,1,0
5,GO PROTEIN K63 LINKED UBIQUITINATION,0.0083534,-0.064485,-0.084722,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.018398,-0.064562,-0.12153,1,0
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0047853,-0.064735,-0.078533,1,0
5,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.033166,-0.064911,-0.11463,1,0
5,GO PIGMENTATION,0.02843,-0.065103,-0.095294,1,0
5,GO RNA LOCALIZATION,0.029719,-0.065603,-0.087162,1,0
5,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.018398,-0.065818,-0.085658,1,0
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.018836,-0.06582,-0.084967,1,0
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.040234,-0.066715,-0.077133,1,0
5,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.001986,-0.067325,-0.084836,1,0
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.010245,-0.067353,-0.073932,1,0
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.02068,-0.067932,-0.097873,1,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.04854,-0.068148,-0.074694,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.0023671,-0.068163,-0.082474,1,0
5,GO PEPTIDYL ASPARAGINE MODIFICATION,0.036164,-0.068279,-0.12918,1,0
5,GO REGULATION OF GENE SILENCING,0.0049174,-0.068364,-0.11115,1,0
5,GO SECRETION,0.0022992,-0.068364,-0.1024,1,0
5,GO REGULATION OF RESPONSE TO STRESS,0.0071468,-0.068398,-0.094133,1,0
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0057817,-0.068805,-0.11309,1,0
5,GO LEUKOCYTE CELL CELL ADHESION,0.037747,-0.068813,-0.11973,1,0
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.036164,-0.068919,-0.12613,1,0
5,GO HOMEOSTATIC PROCESS,0.00028792,-0.068953,-0.094971,1,0
5,GO RESPONSE TO IONIZING RADIATION,0.03245,-0.069362,-0.082356,1,0
5,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0041716,-0.069464,-0.11968,1,0
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.010245,-0.069491,-0.083234,1,0
5,GO RESPONSE TO CARBOHYDRATE,0.0028141,-0.069504,-0.10015,1,0
5,GO CIRCULATORY SYSTEM DEVELOPMENT,0.031748,-0.069844,-0.097565,1,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.022165,-0.069927,-0.11247,1,0
5,GO REGULATION OF VIRAL TRANSCRIPTION,0.017137,-0.070235,-0.10141,1,0
5,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.03245,-0.070424,-0.082721,1,0
5,GO CELLULAR RESPONSE TO KETONE,0.042857,-0.070684,-0.10699,1,0
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.044685,-0.070729,-0.094641,1,0
5,GO DEFENSE RESPONSE TO BACTERIUM,0.023205,-0.070738,-0.12045,1,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.009256,-0.070821,-0.081143,1,0
5,GO REGULATION OF B CELL PROLIFERATION,0.042857,-0.070849,-0.13653,1,0
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.042857,-0.070854,-0.16418,1,0
5,GO MYELOID LEUKOCYTE MIGRATION,0.036948,-0.070967,-0.1154,1,0
5,GO CARBOHYDRATE TRANSPORT,0.010506,-0.07097,-0.10119,1,0
5,GO NEGATIVE REGULATION OF SIGNALING,0.0071468,-0.071025,-0.079475,1,0
5,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0014738,-0.071418,-0.072277,1,0
5,GO ENDOTHELIAL CELL DEVELOPMENT,0.040234,-0.071436,-0.13854,1,0
5,GO REGULATION OF HYDROLASE ACTIVITY,0.01282,-0.071451,-0.085566,1,0
5,GO PROTEIN TARGETING TO VACUOLE,0.045624,-0.071716,-0.11186,1,0
5,GO REGULATION OF CARTILAGE DEVELOPMENT,0.042857,-0.071736,-0.11421,1,0
5,GO PROTEIN CATABOLIC PROCESS,0.00014935,-0.071836,-0.092413,1,0
5,GO CELLULAR DEFENSE RESPONSE,0.041093,-0.071898,-0.16732,1,0
5,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00055855,-0.071988,-0.085298,1,0
5,GO APOPTOTIC PROCESS,0.0029794,-0.072234,-0.087907,1,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.01282,-0.072334,-0.079377,1,0
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0031536,-0.072504,-0.096786,1,0
5,GO TUBE MORPHOGENESIS,0.030383,-0.072572,-0.10538,1,0
5,GO ACTIN NUCLEATION,0.0054795,-0.072612,-0.10588,1,0
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.019739,-0.072854,-0.11123,1,0
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.037747,-0.073156,-0.1025,1,0
5,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.046579,-0.073274,-0.11929,1,0
5,GO TELOMERE ORGANIZATION,0.03939,-0.073387,-0.071115,1,0
5,GO MUSCLE ORGAN MORPHOGENESIS,0.038561,-0.073895,-0.11354,1,0
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.029068,-0.074118,-0.097011,1,0
5,GO PROTEIN NEDDYLATION,0.031059,-0.074251,-0.11476,1,0
5,GO REGULATION OF REPRODUCTIVE PROCESS,0.014486,-0.074533,-0.077849,1,0
5,GO REGULATION OF URINE VOLUME,0.045624,-0.074572,-0.10536,1,0
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.012508,-0.074695,-0.11532,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0022992,-0.074873,-0.085846,1,0
5,GO REGULATION OF BLOOD CIRCULATION,0.041967,-0.074879,-0.092326,1,0
5,GO PROTEIN AUTOPHOSPHORYLATION,0.016339,-0.075134,-0.083217,1,0
5,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.013798,-0.075263,-0.070368,1,0
5,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.011612,-0.075327,-0.10834,1,0
5,GO NEGATIVE REGULATION OF TRANSPORT,0.001191,-0.075347,-0.095911,1,0
5,GO ANTIMICROBIAL HUMORAL RESPONSE,0.016339,-0.075578,-0.12171,1,0
5,GO REGULATION OF PEPTIDASE ACTIVITY,0.037747,-0.07563,-0.11343,1,0
5,GO RESPONSE TO MONOSACCHARIDE,0.0050528,-0.075697,-0.096548,1,0
5,GO POSITIVE REGULATION OF CELL DEATH,0.0059384,-0.075846,-0.089514,1,0
5,GO RESPONSE TO XENOBIOTIC STIMULUS,0.04854,-0.075904,-0.12692,1,0
5,GO CELLULAR RESPONSE TO PEPTIDE,0.0032441,-0.075929,-0.097409,1,0
5,GO ACTIVATION OF MAPK ACTIVITY,0.046579,-0.075941,-0.07821,1,0
5,GO PROTEIN STABILIZATION,0.00054072,-0.076032,-0.11457,1,0
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0085714,-0.076087,-0.09964,1,0
5,GO GOLGI ORGANIZATION,0.0030654,-0.076158,-0.10303,1,0
5,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.004408,-0.076179,-0.076667,1,0
5,GO SPHINGOLIPID METABOLIC PROCESS,0.02068,-0.076249,-0.11768,1,0
5,GO RESPONSE TO GROWTH FACTOR,0.020205,-0.076305,-0.08813,1,0
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0053338,-0.076528,-0.078484,1,0
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0041716,-0.07669,-0.08534,1,0
5,GO PROTEIN AUTOPROCESSING,0.04854,-0.077182,-0.14717,1,0
5,GO I KAPPAB PHOSPHORYLATION,0.03245,-0.077326,-0.15021,1,0
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.01282,-0.07744,-0.086222,1,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00047456,-0.077524,-0.069907,1,0
5,GO AGING,0.001228,-0.077758,-0.12077,1,0
5,GO SULFUR COMPOUND TRANSPORT,0.027188,-0.077825,-0.10469,1,0
5,GO REGULATION OF DNA METHYLATION,0.047551,-0.07822,-0.11738,1,0
5,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0013872,-0.07833,-0.09351,1,0
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0050528,-0.078657,-0.086685,1,0
5,GO REGULATION OF PROTEIN MATURATION,0.047551,-0.078706,-0.12256,1,0
5,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.02068,-0.078739,-0.13604,1,0
5,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0006154,-0.079197,-0.080531,1,0
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0019282,-0.079294,-0.082466,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.012508,-0.079606,-0.11905,1,0
5,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.02068,-0.079843,-0.13292,1,0
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0079323,-0.080004,-0.081481,1,0
5,GO REGULATION OF CELL DEATH,0.0021689,-0.080095,-0.091476,1,0
5,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.034637,-0.080144,-0.1058,1,0
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.015953,-0.08035,-0.099601,1,0
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.011612,-0.080383,-0.085978,1,0
5,GO BIOLOGICAL ADHESION,0.014841,-0.080521,-0.10676,1,0
5,GO SINGLE FERTILIZATION,0.024288,-0.080654,-0.087146,1,0
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0040578,-0.080814,-0.081348,1,0
5,GO INFLAMMATORY RESPONSE,0.018836,-0.080836,-0.12437,1,0
5,GO COAGULATION,0.016339,-0.081054,-0.12797,1,0
5,GO REGULATION OF BINDING,0.02068,-0.081147,-0.074221,1,0
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.036164,-0.081154,-0.087957,1,0
5,GO LEUKOCYTE PROLIFERATION,0.018398,-0.081307,-0.12702,1,0
5,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.02166,-0.081677,-0.079495,1,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.044685,-0.081827,-0.10222,1,0
5,GO ALCOHOL CATABOLIC PROCESS,0.0079323,-0.081885,-0.10401,1,0
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.041967,-0.081993,-0.093373,1,0
5,GO JNK CASCADE,0.004408,-0.082002,-0.10157,1,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0064317,-0.082109,-0.08325,1,0
5,GO GLUCOSE IMPORT,0.047551,-0.082208,-0.075482,1,0
5,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.026586,-0.082389,-0.080669,1,0
5,GO REGULATION OF PHOSPHORYLATION,0.0017123,-0.082412,-0.095428,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION,0.02843,-0.082477,-0.15824,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.022165,-0.082564,-0.13908,1,0
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.046579,-0.082574,-0.12032,1,0
5,GO CIRCULATORY SYSTEM PROCESS,0.0046564,-0.082916,-0.10317,1,0
5,GO METHIONINE METABOLIC PROCESS,0.0060989,-0.082962,-0.14581,1,0
5,GO REGULATION OF INFLAMMATORY RESPONSE,0.010245,-0.083001,-0.12732,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.041093,-0.083179,-0.11381,1,0
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00072223,-0.083285,-0.10832,1,0
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.013139,-0.083461,-0.11525,1,0
5,GO PROTEIN N LINKED GLYCOSYLATION,0.010773,-0.08348,-0.13037,1,0
5,GO PROTEIN MATURATION,0.0097392,-0.083679,-0.11139,1,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.043763,-0.083749,-0.089996,1,0
5,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.041093,-0.083976,-0.1286,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.029068,-0.083988,-0.13409,1,0
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.031748,-0.084136,-0.10815,1,0
5,GO APOPTOTIC SIGNALING PATHWAY,0.010245,-0.084205,-0.097703,1,0
5,GO T CELL RECEPTOR SIGNALING PATHWAY,0.010773,-0.084242,-0.12774,1,0
5,GO CHEMICAL HOMEOSTASIS,0.00042998,-0.084244,-0.10591,1,0
5,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.030383,-0.084357,-0.16136,1,0
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.001662,-0.084408,-0.091713,1,0
5,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0023671,-0.084569,-0.089722,1,0
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.025414,-0.084776,-0.10069,1,0
5,GO LIPID BIOSYNTHETIC PROCESS,0.00063551,-0.08488,-0.11993,1,0
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0040578,-0.084963,-0.088952,1,0
5,GO LIPID HOMEOSTASIS,0.011047,-0.085083,-0.11399,1,0
5,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.009256,-0.085127,-0.15325,1,0
5,GO CELL ACTIVATION,0.010773,-0.085133,-0.12379,1,0
5,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0081404,-0.085351,-0.18726,1,0
5,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0087944,-0.085561,-0.093465,1,0
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0066042,-0.086017,-0.092773,1,0
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.046579,-0.086081,-0.12796,1,0
5,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.034637,-0.086095,-0.10325,1,0
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0041716,-0.086198,-0.1074,1,0
5,GO HEART TRABECULA MORPHOGENESIS,0.041967,-0.086352,-0.17103,1,0
5,GO REGULATION OF TOR SIGNALING,0.033166,-0.086357,-0.065851,1,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.031748,-0.086422,-0.14143,1,0
5,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.031748,-0.086555,-0.16026,1,0
5,GO REGULATION OF ERBB SIGNALING PATHWAY,0.03245,-0.086579,-0.11705,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.022165,-0.086584,-0.10808,1,0
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.0097392,-0.086615,-0.15989,1,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.00092958,-0.086716,-0.11048,1,0
5,GO CARDIAC SEPTUM DEVELOPMENT,0.040234,-0.086861,-0.13146,1,0
5,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0022332,-0.086944,-0.081637,1,0
5,GO ACTIN FILAMENT BASED MOVEMENT,0.018398,-0.087029,-0.11985,1,0
5,GO PROTEIN IMPORT,0.0026572,-0.08706,-0.11099,1,0
5,GO RESPONSE TO ABIOTIC STIMULUS,0.00055855,-0.087079,-0.10159,1,0
5,GO ORGANELLE MEMBRANE FUSION,0.025994,-0.087094,-0.11189,1,0
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00074557,-0.087358,-0.11341,1,0
5,GO CELL AGING,0.0099891,-0.087399,-0.094847,1,0
5,GO WOUND HEALING,0.04854,-0.087625,-0.12657,1,0
5,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0023671,-0.087644,-0.086227,1,0
5,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.010245,-0.087769,-0.077283,1,0
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.036948,-0.087771,-0.10542,1,0
5,GO REGULATION OF INNATE IMMUNE RESPONSE,0.033894,-0.087982,-0.11036,1,0
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0022332,-0.088029,-0.12003,1,0
5,GO MAMMARY GLAND DEVELOPMENT,0.031748,-0.088107,-0.10245,1,0
5,GO PROTEIN PROCESSING,0.012508,-0.088111,-0.12198,1,0
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,6.0504e-05,-0.088292,-0.095944,1,0
5,GO POSITIVE REGULATION OF BINDING,0.0067808,-0.088636,-0.097069,1,0
5,GO RECEPTOR METABOLIC PROCESS,0.016734,-0.088861,-0.086183,1,0
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.026586,-0.088876,-0.12406,1,0
5,GO FATTY ACID DERIVATIVE TRANSPORT,0.047551,-0.088885,-0.10169,1,0
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.029068,-0.088956,-0.07706,1,0
5,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0036303,-0.088958,-0.1033,1,0
5,GO STEROID BIOSYNTHETIC PROCESS,0.0014738,-0.088988,-0.15371,1,0
5,GO REGULATION OF LIPID KINASE ACTIVITY,0.0079323,-0.088999,-0.12007,1,0
5,GO MEMBRANE FUSION,0.017969,-0.08902,-0.10131,1,0
5,GO INNATE IMMUNE RESPONSE,0.019283,-0.089425,-0.13503,1,0
5,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0049174,-0.089521,-0.17886,1,0
5,GO OXALATE TRANSPORT,0.014841,-0.089682,-0.1534,1,0
5,GO REGULATION OF ION TRANSPORT,0.033894,-0.089743,-0.08919,1,0
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.046579,-0.089929,-0.092697,1,0
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.034637,-0.090007,-0.088073,1,0
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0051916,-0.090188,-0.096111,1,0
5,GO VESICLE TARGETING,0.0021062,-0.090226,-0.1415,1,0
5,GO GLYCEROLIPID METABOLIC PROCESS,0.00021167,-0.090236,-0.11766,1,0
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.026586,-0.090251,-0.10777,1,0
5,GO NEGATIVE REGULATION OF CELL DEATH,0.0049174,-0.090477,-0.095381,1,0
5,GO RESPONSE TO OSMOTIC STRESS,0.04854,-0.09054,-0.098941,1,0
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0039469,-0.090741,-0.11946,1,0
5,GO REGULATION OF PROTEIN STABILITY,0.00028792,-0.090805,-0.10588,1,0
5,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,2.6307e-05,-0.090861,-0.092334,1,0
5,GO MITOCHONDRIAL FISSION,0.029068,-0.09101,-0.10627,1,0
5,GO METAL ION HOMEOSTASIS,0.00021909,-0.091061,-0.11282,1,0
5,GO ORGANELLE DISASSEMBLY,0.0039469,-0.09109,-0.10644,1,0
5,GO PHOSPHOLIPID TRANSPORT,0.015203,-0.091385,-0.11677,1,0
5,GO GASTRULATION,0.0079323,-0.091695,-0.16437,1,0
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0014299,-0.091909,-0.10326,1,0
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00023468,-0.09193,-0.092305,1,0
5,GO RESPONSE TO PEPTIDE,0.00037661,-0.092049,-0.11141,1,0
5,GO REGULATION OF LYMPHOCYTE MIGRATION,0.046579,-0.092176,-0.12791,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.041967,-0.092187,-0.13021,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.004408,-0.092282,-0.097143,1,0
5,GO VASCULATURE DEVELOPMENT,0.018398,-0.092335,-0.12604,1,0
5,GO TRANSMEMBRANE TRANSPORT,0.00050664,-0.092366,-0.1047,1,0
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0064317,-0.092512,-0.11766,1,0
5,GO POSITIVE REGULATION OF CELL ADHESION,0.023741,-0.092601,-0.13759,1,0
5,GO RESPONSE TO ALCOHOL,0.017549,-0.093135,-0.097009,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0046564,-0.093166,-0.11611,1,0
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0030654,-0.093247,-0.11047,1,0
5,GO CARTILAGE DEVELOPMENT,0.034637,-0.093309,-0.11003,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.022165,-0.093316,-0.096763,1,0
5,GO RESPONSE TO METAL ION,0.0060989,-0.093347,-0.11106,1,0
5,GO RNA POLYADENYLATION,0.017137,-0.093411,-0.099235,1,0
5,GO BLOOD VESSEL MORPHOGENESIS,0.021165,-0.093563,-0.1324,1,0
5,GO RESPONSE TO NITROGEN COMPOUND,0.00034072,-0.093637,-0.099599,1,0
5,GO AUTOPHAGY OF MITOCHONDRION,0.0017641,-0.093728,-0.12288,1,0
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.02068,-0.093981,-0.11903,1,0
5,GO TRNA WOBBLE URIDINE MODIFICATION,0.036164,-0.094096,-0.13167,1,0
5,GO VIRAL LIFE CYCLE,0.025994,-0.094139,-0.1348,1,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0012662,-0.094155,-0.13784,1,0
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00025131,-0.094373,-0.11753,1,0
5,GO RESPONSE TO INORGANIC SUBSTANCE,0.0017641,-0.094413,-0.11844,1,0
5,GO REGULATION OF PROTEOLYSIS,0.0021062,-0.094594,-0.11804,1,0
5,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.031748,-0.094615,-0.12779,1,0
5,GO GOLGI TO ENDOSOME TRANSPORT,0.031748,-0.094729,-0.13388,1,0
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.038561,-0.094739,-0.11485,1,0
5,GO TOR SIGNALING,0.0054795,-0.094844,-0.07412,1,0
5,GO INOSITOL LIPID MEDIATED SIGNALING,0.017549,-0.094921,-0.093982,1,0
5,GO ANION TRANSPORT,0.00059588,-0.094969,-0.11021,1,0
5,GO SNRNA METABOLIC PROCESS,0.013465,-0.094988,-0.13591,1,0
5,GO CELLULAR RESPONSE TO RETINOIC ACID,0.017969,-0.095183,-0.14208,1,0
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.024846,-0.095242,-0.14816,1,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.011904,-0.095457,-0.10765,1,0
5,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00063551,-0.09548,-0.12508,1,0
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.027188,-0.095594,-0.11996,1,0
5,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.036948,-0.095726,-0.074115,1,0
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.019283,-0.095826,-0.11439,1,0
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.015574,-0.095854,-0.15515,1,0
5,GO COPII COATED VESICLE BUDDING,0.00036427,-0.096153,-0.15226,1,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.011612,-0.096298,-0.2745,1,0
5,GO IRON ION TRANSPORT,0.0029794,-0.09632,-0.10821,1,0
5,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.024846,-0.096498,-0.18531,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.025414,-0.096596,-0.16746,1,0
5,GO TRANSFERRIN TRANSPORT,0.033166,-0.096633,-0.11207,1,0
5,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0033369,-0.096765,-0.11576,1,0
5,GO REGULATION OF MULTI ORGANISM PROCESS,0.0073363,-0.096824,-0.13695,1,0
5,GO PEPTIDYL TYROSINE MODIFICATION,0.013798,-0.096848,-0.11174,1,0
5,GO LIVER REGENERATION,0.0064317,-0.09696,-0.20244,1,0
5,GO MACROMOLECULE DEACYLATION,0.014486,-0.096974,-0.062588,1,0
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.00054072,-0.097003,-0.13102,1,0
5,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.029068,-0.097045,-0.10699,1,0
5,GO LYMPHOCYTE MEDIATED IMMUNITY,0.034637,-0.097204,-0.14744,1,0
5,GO RNA PROCESSING,0.0045306,-0.097405,-0.099596,1,0
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.013798,-0.097493,-0.12444,1,0
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0013872,-0.097703,-0.10087,1,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.02843,-0.097717,-0.080627,1,0
5,GO TEMPERATURE HOMEOSTASIS,0.014486,-0.097851,-0.093379,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.045624,-0.097854,-0.24897,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.031059,-0.097935,-0.084491,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.011904,-0.097979,-0.13828,1,0
5,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.02166,-0.098271,-0.094639,1,0
5,GO POSITIVE REGULATION OF CELL AGING,0.012203,-0.098532,-0.13095,1,0
5,GO PHOSPHOLIPID METABOLIC PROCESS,0.00017796,-0.098794,-0.11697,1,0
5,GO REGULATION OF DEFENSE RESPONSE,0.012203,-0.098852,-0.11056,1,0
5,GO REGULATION OF LEUKOCYTE MIGRATION,0.023741,-0.099094,-0.12283,1,0
5,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0039469,-0.099134,-0.085158,1,0
5,GO GLYCOPROTEIN METABOLIC PROCESS,0.0010528,-0.099145,-0.1316,1,0
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.011326,-0.099264,-0.10397,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0085714,-0.099279,-0.13369,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0085714,-0.099356,-0.13056,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION,0.0071468,-0.099387,-0.11253,1,0
5,GO MACROAUTOPHAGY,0.00074557,-0.099609,-0.098887,1,0
5,GO RESPONSE TO TEMPERATURE STIMULUS,0.0031536,-0.099817,-0.11014,1,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0085714,-0.099819,-0.12073,1,0
5,GO REGENERATION,0.014486,-0.10009,-0.13966,1,0
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.025994,-0.1003,-0.11693,1,0
5,GO VESICLE BUDDING FROM MEMBRANE,0.0059384,-0.10035,-0.12245,1,0
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00024286,-0.1004,-0.10809,1,0
5,GO MRNA METABOLIC PROCESS,0.0030654,-0.10045,-0.096096,1,0
5,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0050528,-0.10064,-0.10234,1,0
5,GO ORGANIC ANION TRANSPORT,0.00074557,-0.10067,-0.1179,1,0
5,GO VESICLE CARGO LOADING,0.0056288,-0.10069,-0.1648,1,0
5,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.017549,-0.10071,-0.1313,1,0
5,GO TRNA TRANSPORT,0.019283,-0.10071,-0.11181,1,0
5,GO MIRNA METABOLIC PROCESS,0.0016129,-0.10079,-0.12488,1,0
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0066042,-0.10082,-0.14028,1,0
5,GO TRANSITION METAL ION TRANSPORT,0.00045924,-0.10095,-0.11766,1,0
5,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0047853,-0.10104,-0.12935,1,0
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.027188,-0.10105,-0.13326,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.01282,-0.10107,-0.15354,1,0
5,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00047456,-0.10119,-0.091082,1,0
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.013139,-0.10119,-0.10877,1,0
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0011549,-0.1012,-0.1116,1,0
5,GO CELLULAR ION HOMEOSTASIS,0.00014935,-0.10138,-0.11113,1,0
5,GO HORMONE METABOLIC PROCESS,0.0087944,-0.10148,-0.12345,1,0
5,GO ORGANIC ACID TRANSPORT,0.00095906,-0.10148,-0.11674,1,0
5,GO ACUTE PHASE RESPONSE,0.02843,-0.10157,-0.13765,1,0
5,GO POLYSACCHARIDE METABOLIC PROCESS,0.00098941,-0.10161,-0.14383,1,0
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.041093,-0.10193,-0.16607,1,0
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0027346,-0.10202,-0.10159,1,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.017969,-0.10218,-0.12499,1,0
5,GO EXOCYTOSIS,0.001986,-0.1022,-0.12961,1,0
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.018398,-0.10234,-0.099294,1,0
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0090226,-0.10259,-0.099055,1,0
5,GO MITOCHONDRIAL DNA REPLICATION,0.030383,-0.10261,-0.11698,1,0
5,GO CYTOKINE PRODUCTION,0.013798,-0.10278,-0.12874,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.024846,-0.10286,-0.14485,1,0
5,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.027803,-0.10297,-0.11105,1,0
5,GO CELLULAR KETONE METABOLIC PROCESS,0.0037331,-0.10309,-0.14031,1,0
5,GO HOMOTYPIC CELL CELL ADHESION,0.041093,-0.10315,-0.14571,1,0
5,GO REGULATION OF KERATINOCYTE MIGRATION,0.02268,-0.10326,-0.13965,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.031059,-0.10336,-0.11297,1,0
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.014138,-0.10348,-0.15564,1,0
5,GO REGULATION OF FERTILIZATION,0.037747,-0.10368,-0.1537,1,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.041967,-0.10379,-0.14999,1,0
5,GO RESPONSE TO ACTIVITY,0.0062634,-0.10391,-0.11204,1,0
5,GO AMEBOIDAL TYPE CELL MIGRATION,0.015203,-0.10407,-0.13072,1,0
5,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0017123,-0.10417,-0.093846,1,0
5,GO CELLULAR HORMONE METABOLIC PROCESS,0.020205,-0.10418,-0.13334,1,0
5,GO RESPONSE TO ISCHEMIA,0.035393,-0.10445,-0.11486,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.011047,-0.10445,-0.11697,1,0
5,GO OSSIFICATION,0.0039469,-0.10458,-0.13488,1,0
5,GO ORGANELLE FUSION,0.019283,-0.10489,-0.096102,1,0
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.034637,-0.10508,-0.12794,1,0
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00024286,-0.10522,-0.12319,1,0
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0067808,-0.10524,-0.14708,1,0
5,GO DEFENSE RESPONSE,0.0087944,-0.10526,-0.12577,1,0
5,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.011904,-0.1054,-0.15991,1,0
5,GO GOLGI VESICLE TRANSPORT,0.0018173,-0.10549,-0.098655,1,0
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00092958,-0.10563,-0.12257,1,0
5,GO ION HOMEOSTASIS,8.1192e-05,-0.10579,-0.12199,1,0
5,GO MRNA CLEAVAGE,0.016339,-0.10583,-0.087425,1,0
5,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.044685,-0.10586,-0.11231,1,0
5,GO MEMBRANE ORGANIZATION,0.0012662,-0.10593,-0.097213,1,0
5,GO RIG I SIGNALING PATHWAY,0.020205,-0.10629,-0.15105,1,0
5,GO ACTIVATION OF IMMUNE RESPONSE,0.014841,-0.10649,-0.1129,1,0
5,GO INTRACELLULAR TRANSPORT,8.7323e-05,-0.10656,-0.089166,1,0
5,GO ENDOTHELIAL CELL PROLIFERATION,0.0026572,-0.1066,-0.15621,1,0
5,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.038561,-0.10681,-0.079178,1,0
5,GO CELLULAR LIPID METABOLIC PROCESS,0.00022676,-0.10689,-0.13086,1,0
5,GO LIPID MODIFICATION,0.00052342,-0.10695,-0.12893,1,0
5,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0085714,-0.10699,-0.15475,1,0
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.02268,-0.10705,-0.10359,1,0
5,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.011326,-0.10718,-0.14957,1,0
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.019283,-0.10718,-0.1215,1,0
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0031536,-0.10722,-0.11201,1,0
5,GO PEPTIDE CROSS LINKING,0.035393,-0.10733,-0.20761,1,0
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00041602,-0.10738,-0.10798,1,0
5,GO REGULATION OF MRNA CATABOLIC PROCESS,0.0050528,-0.10744,-0.12054,1,0
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0067808,-0.10744,-0.11886,1,0
5,GO RESPONSE TO PEPTIDE HORMONE,0.00028792,-0.10755,-0.11409,1,0
5,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.015953,-0.10757,-0.14609,1,0
5,GO LIPID METABOLIC PROCESS,0.00020448,-0.10772,-0.12722,1,0
5,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.026586,-0.10799,-0.087172,1,0
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.012203,-0.10801,-0.15358,1,0
5,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00052342,-0.10802,-0.11361,1,0
5,GO STEROID METABOLIC PROCESS,0.0017123,-0.10805,-0.14565,1,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.020205,-0.10812,-0.14235,1,0
5,GO CELLULAR RESPONSE TO HEAT,0.02268,-0.10818,-0.095389,1,0
5,GO CELL KILLING,0.018398,-0.10819,-0.12285,1,0
5,GO MUSCLE HYPERTROPHY,0.017969,-0.10831,-0.13027,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.041967,-0.10833,-0.15107,1,0
5,GO REGULATION OF MACROAUTOPHAGY,0.00098941,-0.10848,-0.10007,1,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.02068,-0.1088,-0.15588,1,0
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.040234,-0.1088,-0.16267,1,0
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.011612,-0.10881,-0.1345,1,0
5,GO NEGATIVE REGULATION OF MAPK CASCADE,0.013139,-0.10886,-0.11743,1,0
5,GO MUSCLE CELL APOPTOTIC PROCESS,0.0020453,-0.10893,-0.15699,1,0
5,GO REGULATION OF ENDOCRINE PROCESS,0.02268,-0.10895,-0.11983,1,0
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0062634,-0.10896,-0.099427,1,0
5,GO RESPONSE TO RETINOIC ACID,0.022165,-0.10903,-0.10843,1,0
5,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0079323,-0.10924,-0.12653,1,0
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0069616,-0.10937,-0.17482,1,0
5,GO REGULATION OF TRANSLATIONAL INITIATION,0.00059588,-0.10938,-0.13605,1,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.00079435,-0.10948,-0.094215,1,0
5,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,3.5759e-05,-0.10949,-0.11741,1,0
5,GO RECEPTOR CATABOLIC PROCESS,0.020205,-0.10953,-0.15685,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.0094949,-0.1096,-0.12275,1,0
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.012508,-0.10963,-0.16473,1,0
5,GO MACROPHAGE ACTIVATION,0.0023671,-0.10977,-0.15172,1,0
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0039469,-0.11004,-0.11252,1,0
5,GO ESTROGEN METABOLIC PROCESS,0.023205,-0.11009,-0.11809,1,0
5,GO ADAPTIVE IMMUNE RESPONSE,0.02166,-0.11018,-0.14893,1,0
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00022676,-0.11031,-0.11531,1,0
5,GO MUSCLE FILAMENT SLIDING,0.030383,-0.11031,-0.15402,1,0
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.036164,-0.11037,-0.11976,1,0
5,GO RESPONSE TO INSULIN,5.0226e-05,-0.11037,-0.12665,1,0
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.047551,-0.1104,-0.085726,1,0
5,GO REGULATION OF CATABOLIC PROCESS,3.7145e-05,-0.11061,-0.11538,1,0
5,GO LYSOSOMAL TRANSPORT,0.0067808,-0.11062,-0.11488,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.027188,-0.11066,-0.14105,1,0
5,GO ADAPTIVE THERMOGENESIS,0.015203,-0.11084,-0.096793,1,0
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0038387,-0.11087,-0.1159,1,0
5,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00050664,-0.11096,-0.13218,1,0
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.027803,-0.11111,-0.1014,1,0
5,GO MITOCHONDRION ORGANIZATION,0.00047456,-0.1112,-0.1015,1,0
5,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.0081404,-0.11131,-0.14414,1,0
5,GO RESPONSE TO LEPTIN,0.015203,-0.11152,-0.16095,1,0
5,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0015189,-0.11158,-0.13217,1,0
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.00081984,-0.11163,-0.11364,1,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0051916,-0.11173,-0.10411,1,0
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0012662,-0.11189,-0.16866,1,0
5,GO METHIONINE BIOSYNTHETIC PROCESS,0.0073363,-0.11189,-0.18415,1,0
5,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0021062,-0.11191,-0.10206,1,0
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0066042,-0.11199,-0.12193,1,0
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.009256,-0.11203,-0.15198,1,0
5,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.011612,-0.11207,-0.1002,1,0
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.029719,-0.11215,-0.095407,1,0
5,GO OSTEOBLAST DIFFERENTIATION,0.0037331,-0.11223,-0.15207,1,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.017969,-0.11224,-0.13367,1,0
5,GO CELLULAR HOMEOSTASIS,2.7343e-05,-0.11226,-0.12024,1,0
5,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,2.5774e-06,-0.11237,-0.12188,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.045624,-0.11248,-0.15913,1,0
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0081404,-0.11256,-0.12993,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.024288,-0.11279,-0.17506,1,0
5,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0030654,-0.1129,-0.16907,1,0
5,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.029719,-0.11297,-0.15946,1,0
5,GO ENDOCYTOSIS,0.0015653,-0.11308,-0.11531,1,0
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.017549,-0.11318,-0.13225,1,0
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.015574,-0.1134,-0.13928,1,0
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0054795,-0.11345,-0.14623,1,0
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0075304,-0.11351,-0.088425,1,0
5,GO CELL SUBSTRATE ADHESION,0.026586,-0.1136,-0.14219,1,0
5,GO AUTOPHAGOSOME ORGANIZATION,0.0081404,-0.11407,-0.1271,1,0
5,GO DIVALENT INORGANIC CATION TRANSPORT,0.00090094,-0.1141,-0.11405,1,0
5,GO COMPLEMENT ACTIVATION,0.0011549,-0.1141,-0.1959,1,0
5,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0038387,-0.11423,-0.15024,1,0
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0046564,-0.11428,-0.13703,1,0
5,GO ESTABLISHMENT OF TISSUE POLARITY,0.01282,-0.11432,-0.10436,1,0
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.001228,-0.11444,-0.11387,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.014486,-0.11444,-0.18607,1,0
5,GO SCHWANN CELL DEVELOPMENT,0.0079323,-0.11462,-0.11014,1,0
5,GO ERAD PATHWAY,0.00063551,-0.11513,-0.14655,1,0
5,GO HISTONE SERINE PHOSPHORYLATION,0.0071468,-0.11518,-0.21696,1,0
5,GO REGULATION OF CELL AGING,0.0010859,-0.1152,-0.15098,1,0
5,GO T CELL CYTOKINE PRODUCTION,0.030383,-0.11529,-0.15631,1,0
5,GO B CELL PROLIFERATION,0.0081404,-0.11536,-0.14831,1,0
5,GO CELLULAR RESPONSE TO STARVATION,0.010773,-0.11543,-0.103,1,0
5,GO LYMPHOCYTE CHEMOTAXIS,0.017969,-0.11548,-0.13358,1,0
5,GO ANDROGEN METABOLIC PROCESS,0.023741,-0.11549,-0.16511,1,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.00041602,-0.11549,-0.12044,1,0
5,GO RESPONSE TO LIPID,0.00072223,-0.11552,-0.1349,1,0
5,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.027188,-0.11555,-0.13484,1,0
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00023468,-0.11569,-0.11481,1,0
5,GO LYMPHOCYTE MIGRATION,0.0026572,-0.11573,-0.15266,1,0
5,GO INTRACELLULAR PROTEIN TRANSPORT,6.0504e-05,-0.11574,-0.097114,1,0
5,GO MUSCLE CELL PROLIFERATION,0.030383,-0.11601,-0.11777,1,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.017137,-0.11603,-0.17299,1,0
5,GO MULTI ORGANISM LOCALIZATION,0.0017123,-0.11611,-0.14837,1,0
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00035231,-0.11615,-0.12371,1,0
5,GO REGULATION OF IMMUNE RESPONSE,0.0059384,-0.11615,-0.12221,1,0
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.041093,-0.11627,-0.1019,1,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0050528,-0.11634,-0.10454,1,0
5,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.04854,-0.11641,-0.14774,1,0
5,GO MACROMOLECULE CATABOLIC PROCESS,3.6228e-06,-0.11643,-0.12428,1,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.045624,-0.11644,-0.10263,1,0
5,GO FORMATION OF PRIMARY GERM LAYER,0.0049174,-0.11655,-0.20597,1,0
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0066042,-0.11659,-0.18543,1,0
5,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0039469,-0.11662,-0.12705,1,0
5,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.0053338,-0.11664,-0.22923,1,0
5,GO POST TRANSLATIONAL PROTEIN MODIFICATION,3.1888e-05,-0.11666,-0.15568,1,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.033166,-0.11668,-0.27444,1,0
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00019753,-0.11671,-0.12922,1,0
5,GO PROTEIN LOCALIZATION TO ORGANELLE,6.2786e-05,-0.11678,-0.096352,1,0
5,GO RESPONSE TO BIOTIC STIMULUS,0.0045306,-0.1168,-0.13458,1,0
5,GO INORGANIC ANION TRANSPORT,0.00041602,-0.11683,-0.11531,1,0
5,GO SMOOTH MUSCLE CELL PROLIFERATION,0.019739,-0.11687,-0.14863,1,0
5,GO TRIGLYCERIDE METABOLIC PROCESS,0.00074557,-0.11688,-0.15361,1,0
5,GO GOLGI VESICLE BUDDING,8.7323e-05,-0.11719,-0.16102,1,0
5,GO RESPONSE TO HORMONE,0.00022676,-0.1172,-0.12547,1,0
5,GO RESPONSE TO KETONE,0.0049174,-0.11733,-0.12276,1,0
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,2.2524e-05,-0.11734,-0.14741,1,0
5,GO RESPONSE TO INTERLEUKIN 1,0.0017123,-0.11755,-0.15873,1,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00353,-0.11762,-0.19729,1,0
5,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0066042,-0.11774,-0.13811,1,0
5,GO NCRNA EXPORT FROM NUCLEUS,0.02068,-0.11778,-0.1186,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.01282,-0.11782,-0.10672,1,0
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.020205,-0.118,-0.14494,1,0
5,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.033894,-0.11801,-0.14092,1,0
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.001191,-0.11807,-0.19097,1,0
5,GO LAMELLIPODIUM ORGANIZATION,0.0039469,-0.11808,-0.13769,1,0
5,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0037331,-0.11848,-0.13357,1,0
5,GO T CELL PROLIFERATION,0.017969,-0.1186,-0.12991,1,0
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0062634,-0.11867,-0.16247,1,0
5,GO RESPONSE TO TOXIC SUBSTANCE,0.0059384,-0.11868,-0.11548,1,0
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00050664,-0.11874,-0.12362,1,0
5,GO ENDOSOME TO LYSOSOME TRANSPORT,0.015953,-0.11879,-0.099865,1,0
5,GO AORTA DEVELOPMENT,0.031059,-0.11879,-0.14703,1,0
5,GO REGULATION OF OSSIFICATION,0.022165,-0.1188,-0.12584,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.011612,-0.11885,-0.15359,1,0
5,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0050528,-0.11894,-0.21462,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.031059,-0.11916,-0.092233,1,0
5,GO POLYOL TRANSPORT,0.0099891,-0.11922,-0.22384,1,0
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0064317,-0.11933,-0.15267,1,0
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0010528,-0.11955,-0.15031,1,0
5,GO RNA SURVEILLANCE,0.019283,-0.11965,-0.13088,1,0
5,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.018836,-0.11994,-0.13917,1,0
5,GO REGULATION OF STEROL TRANSPORT,0.0064317,-0.12008,-0.18024,1,0
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0015189,-0.12035,-0.11701,1,0
5,GO PEPTIDE CATABOLIC PROCESS,0.030383,-0.12066,-0.14291,1,0
5,GO NEUTRAL LIPID METABOLIC PROCESS,0.0006154,-0.12088,-0.13905,1,0
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.018398,-0.12101,-0.16844,1,0
5,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.00013917,-0.12105,-0.12431,1,0
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00047456,-0.12106,-0.13387,1,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.026586,-0.12106,-0.15348,1,0
5,GO CRISTAE FORMATION,0.0087944,-0.1212,-0.19564,1,0
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0037331,-0.12129,-0.15087,1,0
5,GO INTERLEUKIN 8 PRODUCTION,0.03939,-0.1213,-0.15789,1,0
5,GO TRANSCRIPTION BY RNA POLYMERASE I,0.012508,-0.1213,-0.12071,1,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00067758,-0.12133,-0.14262,1,0
5,GO PROSTANOID BIOSYNTHETIC PROCESS,0.044685,-0.12135,-0.21024,1,0
5,GO TISSUE MIGRATION,0.0099891,-0.12137,-0.15176,1,0
5,GO NIK NF KAPPAB SIGNALING,0.019283,-0.12142,-0.14141,1,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010245,-0.12151,-0.12556,1,0
5,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00079435,-0.12153,-0.16447,1,0
5,GO REGULATION OF VASCULATURE DEVELOPMENT,0.016734,-0.12157,-0.13727,1,0
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.5308e-05,-0.12159,-0.14123,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0094949,-0.12179,-0.15377,1,0
5,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0027346,-0.12182,-0.20967,1,0
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.011904,-0.12185,-0.15422,1,0
5,GO RESPONSE TO OXIDATIVE STRESS,0.00079435,-0.12227,-0.13735,1,0
5,GO MITOCHONDRIAL TRANSPORT,0.0014299,-0.12291,-0.10047,1,0
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.026586,-0.12322,-0.14236,1,0
5,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0006154,-0.12324,-0.10234,1,0
5,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.001191,-0.1233,-0.17806,1,0
5,GO RESPONSE TO CALCIUM ION,0.010506,-0.12337,-0.1228,1,0
5,GO REGULATION OF PROTEIN BINDING,0.00067758,-0.12337,-0.13639,1,0
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.029719,-0.12338,-0.16481,1,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.014138,-0.12342,-0.1068,1,0
5,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.013465,-0.1236,-0.12514,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.023741,-0.12366,-0.15054,1,0
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.020205,-0.12391,-0.17354,1,0
5,GO COLLAGEN FIBRIL ORGANIZATION,0.031748,-0.12394,-0.2213,1,0
5,GO MYOTUBE DIFFERENTIATION,0.0094949,-0.12398,-0.13177,1,0
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,9.0551e-05,-0.12403,-0.14308,1,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.040234,-0.12423,-0.15742,1,0
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.014486,-0.12425,-0.15556,1,0
5,GO REGULATION OF AUTOPHAGY,5.2139e-05,-0.12429,-0.12293,1,0
5,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0023671,-0.12431,-0.14569,1,0
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.023741,-0.12436,-0.13088,1,0
5,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.00063551,-0.12451,-0.159,1,0
5,GO CHLORIDE TRANSPORT,0.015953,-0.12451,-0.10185,1,0
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0032441,-0.12455,-0.15116,1,0
5,GO PROTEIN HETEROOLIGOMERIZATION,0.013139,-0.12457,-0.1233,1,0
5,GO ANION TRANSMEMBRANE TRANSPORT,0.00041602,-0.12464,-0.11997,1,0
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.00024286,-0.12469,-0.13151,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.019283,-0.12475,-0.16924,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.047551,-0.12477,-0.21572,1,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0097392,-0.12477,-0.15846,1,0
5,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0079323,-0.12482,-0.12553,1,0
5,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.02268,-0.12496,-0.17353,1,0
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.02843,-0.12522,-0.13649,1,0
5,GO RESPONSE TO CYTOKINE,0.0045306,-0.12544,-0.14791,1,0
5,GO LIPID LOCALIZATION,0.00079435,-0.12553,-0.14497,1,0
5,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.026586,-0.12562,-0.21009,1,0
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.01282,-0.12562,-0.10018,1,0
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0051916,-0.12566,-0.10914,1,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0032441,-0.12584,-0.18327,1,0
5,GO CARBOHYDRATE HOMEOSTASIS,0.001191,-0.12592,-0.13273,1,0
5,GO STEROL METABOLIC PROCESS,0.0064317,-0.12596,-0.14129,1,0
5,GO EXCRETION,0.0067808,-0.12596,-0.13078,1,0
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.0071468,-0.12614,-0.15153,1,0
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0026572,-0.12618,-0.16187,1,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.023741,-0.12625,-0.19495,1,0
5,GO RESPONSE TO STEROID HORMONE,0.0013872,-0.12627,-0.14365,1,0
5,GO FEAR RESPONSE,0.0069616,-0.12627,-0.13981,1,0
5,GO RESPONSE TO PEPTIDOGLYCAN,0.0039469,-0.12629,-0.24098,1,0
5,GO MACROPHAGE MIGRATION,0.036948,-0.12647,-0.12845,1,0
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0054795,-0.1266,-0.16087,1,0
5,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.001986,-0.12666,-0.16382,1,0
5,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.012508,-0.12672,-0.1738,1,0
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.036164,-0.12689,-0.10977,1,0
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00025131,-0.12702,-0.17393,1,0
5,GO RESPONSE TO HYDROGEN PEROXIDE,0.0032441,-0.12732,-0.16974,1,0
5,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00021909,-0.12738,-0.13852,1,0
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.018836,-0.12746,-0.13732,1,0
5,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.041093,-0.12747,-0.14944,1,0
5,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0054795,-0.12753,-0.21839,1,0
5,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.02166,-0.12762,-0.14552,1,0
5,GO T CELL MIGRATION,0.0066042,-0.12812,-0.17653,1,0
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.015574,-0.12828,-0.18495,1,0
5,GO RESPONSE TO INTERLEUKIN 4,0.015203,-0.12828,-0.12999,1,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.03939,-0.12834,-0.24357,1,0
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.018398,-0.12836,-0.13,1,0
5,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0028957,-0.12839,-0.13275,1,0
5,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.013139,-0.12843,-0.16717,1,0
5,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.031748,-0.12854,-0.1615,1,0
5,GO CELLULAR RESPONSE TO LIPID,0.00069957,-0.12866,-0.1363,1,0
5,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0079323,-0.12867,-0.19094,1,0
5,GO ERK1 AND ERK2 CASCADE,0.0050528,-0.12868,-0.14437,1,0
5,GO PRE MIRNA PROCESSING,0.040234,-0.12871,-0.13884,1,0
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0025083,-0.12872,-0.17123,1,0
5,GO ALCOHOL METABOLIC PROCESS,0.00029782,-0.12882,-0.14909,1,0
5,GO AMYLOID BETA CLEARANCE,0.045624,-0.12889,-0.15913,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.018398,-0.12893,-0.15057,1,0
5,GO NEGATIVE REGULATION OF LIPID STORAGE,0.033894,-0.12904,-0.15171,1,0
5,GO REGULATION OF CELLULAR CATABOLIC PROCESS,8.6584e-06,-0.1291,-0.13432,1,0
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00014935,-0.12913,-0.13873,1,0
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.010245,-0.12916,-0.14176,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0021689,-0.12917,-0.16528,1,0
5,GO STEROL TRANSPORT,0.0020453,-0.12919,-0.17737,1,0
5,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,3.7145e-05,-0.12955,-0.11973,1,0
5,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.007729,-0.12982,-0.16725,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0011199,-0.13006,-0.11332,1,0
5,GO GLIAL CELL MIGRATION,0.02166,-0.13028,-0.15848,1,0
5,GO RESPONSE TO DRUG,0.00017186,-0.1303,-0.15989,1,0
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.013798,-0.13039,-0.10636,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0060989,-0.1304,-0.14414,1,0
5,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.0042883,-0.13041,-0.18464,1,0
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.00055855,-0.13085,-0.12332,1,0
5,GO REGULATION OF MAPK CASCADE,0.0021062,-0.13112,-0.12714,1,0
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00011241,-0.13119,-0.14047,1,0
5,GO INTERLEUKIN 2 PRODUCTION,0.014841,-0.13133,-0.13477,1,0
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.038561,-0.13139,-0.1169,1,0
5,GO REGULATION OF CALCIUM ION IMPORT,0.0067808,-0.13139,-0.15836,1,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.013139,-0.13141,-0.1569,1,0
5,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.011047,-0.13149,-0.18468,1,0
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.010245,-0.13157,-0.12331,1,0
5,GO FLUID TRANSPORT,0.012203,-0.13165,-0.13442,1,0
5,GO RESPONSE TO NUTRIENT,0.012508,-0.13174,-0.13007,1,0
5,GO STEROL HOMEOSTASIS,0.023205,-0.13181,-0.13877,1,0
5,GO RESPONSE TO OXYGEN LEVELS,6.0504e-05,-0.13186,-0.16561,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.025994,-0.13187,-0.15451,1,0
5,GO REGULATION OF LIPID TRANSPORT,0.0028141,-0.13189,-0.14374,1,0
5,GO MONOCARBOXYLIC ACID TRANSPORT,0.00092958,-0.13197,-0.13645,1,0
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0085714,-0.13207,-0.18708,1,0
5,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0085714,-0.13225,-0.16369,1,0
5,GO P38MAPK CASCADE,0.021165,-0.13231,-0.14901,1,0
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.001986,-0.13232,-0.12328,1,0
5,GO HISTONE ARGININE METHYLATION,0.0053338,-0.13261,-0.1289,1,0
5,GO REGULATION OF LIPASE ACTIVITY,0.00026003,-0.13271,-0.16129,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.013465,-0.13291,-0.16889,1,0
5,GO REGULATION OF MAP KINASE ACTIVITY,0.0073363,-0.13318,-0.11525,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.037747,-0.13324,-0.12249,1,0
5,GO VACUOLAR ACIDIFICATION,0.0022992,-0.13337,-0.17575,1,0
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,6.0504e-05,-0.13341,-0.15712,1,0
5,GO TROPHOBLAST CELL MIGRATION,0.042857,-0.13343,-0.2494,1,0
5,GO L AMINO ACID TRANSPORT,0.0033369,-0.13353,-0.15859,1,0
5,GO REGULATION OF STEROID METABOLIC PROCESS,0.0011199,-0.13364,-0.19966,1,0
5,GO SYMBIOTIC PROCESS,0.00017186,-0.13364,-0.14457,1,0
5,GO IMMUNE EFFECTOR PROCESS,0.0085714,-0.1337,-0.14335,1,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0081404,-0.1338,-0.13019,1,0
5,GO RESPONSE TO HEAT,0.0039469,-0.13381,-0.11861,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.023741,-0.134,-0.17383,1,0
5,GO PEROXISOMAL MEMBRANE TRANSPORT,0.001986,-0.13426,-0.15016,1,0
5,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00011241,-0.13433,-0.16372,1,0
5,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,6.4994e-06,-0.13436,-0.1452,1,0
5,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.030383,-0.13438,-0.17263,1,0
5,GO REGULATION OF LIPID METABOLIC PROCESS,0.0001547,-0.1344,-0.15054,1,0
5,GO AORTIC VALVE DEVELOPMENT,0.041967,-0.13465,-0.22151,1,0
5,GO RESPONSE TO COLD,0.017549,-0.13478,-0.19339,1,0
5,GO GLUCOSE METABOLIC PROCESS,4.3218e-05,-0.13482,-0.14746,1,0
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00040247,-0.13493,-0.1479,1,0
5,GO L GLUTAMATE IMPORT,0.04854,-0.13509,-0.1482,1,0
5,GO LEUKOCYTE MEDIATED IMMUNITY,0.004408,-0.13515,-0.15848,1,0
5,GO DRUG METABOLIC PROCESS,0.0097392,-0.13515,-0.16953,1,0
5,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.004408,-0.13521,-0.20899,1,0
5,GO RESPONSE TO FLUID SHEAR STRESS,0.041967,-0.1353,-0.15277,1,0
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.001662,-0.13538,-0.1234,1,0
5,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00014418,-0.13538,-0.16281,1,0
5,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0025083,-0.13552,-0.15978,1,0
5,GO NCRNA 3 END PROCESSING,0.0037331,-0.13557,-0.16216,1,0
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0046564,-0.13567,-0.14521,1,0
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0033369,-0.13576,-0.1489,1,0
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00022676,-0.13576,-0.14418,1,0
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00031859,-0.13604,-0.18261,1,0
5,GO RESPONSE TO ETHANOL,0.0054795,-0.1361,-0.12551,1,0
5,GO PEPTIDYL ARGININE MODIFICATION,0.00018427,-0.13612,-0.15957,1,0
5,GO ARTERY DEVELOPMENT,0.024288,-0.13618,-0.12755,1,0
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.027188,-0.13633,-0.089323,1,0
5,GO NEUTRAL AMINO ACID TRANSPORT,0.011326,-0.13657,-0.17296,1,0
5,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00057693,-0.13669,-0.16413,1,0
5,GO CELLULAR IRON ION HOMEOSTASIS,0.001986,-0.13679,-0.14284,1,0
5,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0011549,-0.13679,-0.14212,1,0
5,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0013457,-0.13691,-0.15126,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.00057693,-0.13695,-0.14914,1,0
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.011326,-0.13706,-0.16613,1,0
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00050664,-0.13713,-0.18645,1,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.009256,-0.13716,-0.2199,1,0
5,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.0097392,-0.13722,-0.17605,1,0
5,GO MAINTENANCE OF LOCATION,0.0001165,-0.13743,-0.14647,1,0
5,GO DENDRITIC CELL DIFFERENTIATION,0.037747,-0.13745,-0.19612,1,0
5,GO RNA MODIFICATION,0.00026003,-0.13751,-0.15599,1,0
5,GO MEMBRANE INVAGINATION,0.0036303,-0.13756,-0.1692,1,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.010245,-0.13771,-0.21084,1,0
5,GO IMMUNOGLOBULIN SECRETION,0.0051916,-0.13772,-0.2058,1,0
5,GO TYPE 2 IMMUNE RESPONSE,0.020205,-0.13774,-0.22037,1,0
5,GO CELLULAR COMPONENT DISASSEMBLY,2.5308e-05,-0.13774,-0.1337,1,0
5,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0014738,-0.13774,-0.17247,1,0
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0036303,-0.13777,-0.15454,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,6.7596e-05,-0.13785,-0.16697,1,0
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00031859,-0.13802,-0.15158,1,0
5,GO POLYOL BIOSYNTHETIC PROCESS,0.00072223,-0.1381,-0.14348,1,0
5,GO GLIAL CELL ACTIVATION,0.01282,-0.13833,-0.154,1,0
5,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00049035,-0.13842,-0.13792,1,0
5,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0018173,-0.13843,-0.15597,1,0
5,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0010859,-0.13886,-0.14405,1,0
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00098941,-0.13896,-0.13774,1,0
5,GO POSITIVE REGULATION OF AUTOPHAGY,0.00019753,-0.1392,-0.15861,1,0
5,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.045624,-0.13924,-0.19508,1,0
5,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.004408,-0.13926,-0.23514,1,0
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.013465,-0.13949,-0.14347,1,0
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.015574,-0.1395,-0.11396,1,0
5,GO PLASMA MEMBRANE ORGANIZATION,0.0020453,-0.13957,-0.14623,1,0
5,GO PROTEIN TRANSMEMBRANE TRANSPORT,8.6584e-06,-0.13971,-0.17,1,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.033166,-0.13972,-0.15123,1,0
5,GO RESPONSE TO BACTERIUM,0.00081984,-0.13997,-0.16322,1,0
5,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00092958,-0.14024,-0.14668,1,0
5,GO RESPONSE TO CORTICOSTERONE,0.045624,-0.14031,-0.18755,1,0
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0045306,-0.14053,-0.17132,1,0
5,GO AMYLOID BETA METABOLIC PROCESS,0.017137,-0.14054,-0.17184,1,0
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0081404,-0.1406,-0.17499,1,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.011904,-0.14064,-0.15185,1,0
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0030654,-0.14086,-0.22747,1,0
5,GO INTERFERON GAMMA PRODUCTION,0.0032441,-0.14088,-0.14489,1,0
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.017549,-0.14092,-0.19583,1,0
5,GO PROTEIN TARGETING TO MITOCHONDRION,0.00012074,-0.14094,-0.15797,1,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.02843,-0.14094,-0.13517,1,0
5,GO CORONARY VASCULATURE DEVELOPMENT,0.0022992,-0.14098,-0.19247,1,0
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.01282,-0.14099,-0.2151,1,0
5,GO MYOBLAST PROLIFERATION,0.034637,-0.14099,-0.15085,1,0
5,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.00045924,-0.14103,-0.1841,1,0
5,GO CHYLOMICRON ASSEMBLY,0.0042883,-0.14111,-0.1826,1,0
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0013457,-0.14116,-0.13018,1,0
5,GO HYALURONAN METABOLIC PROCESS,0.0012662,-0.14124,-0.19545,1,0
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00042998,-0.14129,-0.15482,1,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.025414,-0.14134,-0.17889,1,0
5,GO RESPONSE TO PAIN,0.023205,-0.14134,-0.22813,1,0
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.0033369,-0.1414,-0.16753,1,0
5,GO VITAMIN METABOLIC PROCESS,0.0028141,-0.14146,-0.13984,1,0
5,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0040578,-0.14147,-0.13898,1,0
5,GO IMMATURE T CELL PROLIFERATION,0.017137,-0.14165,-0.18714,1,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.020205,-0.14176,-0.1543,1,0
5,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0015653,-0.14187,-0.19472,1,0
5,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0031536,-0.14192,-0.1205,1,0
5,GO VACUOLE ORGANIZATION,7.013e-05,-0.14208,-0.15318,1,0
5,GO INTRACELLULAR LIPID TRANSPORT,0.017549,-0.14213,-0.1403,1,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0011549,-0.14244,-0.12612,1,0
5,GO SNRNA PROCESSING,0.0060989,-0.14254,-0.17749,1,0
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.00013917,-0.14255,-0.16255,1,0
5,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0066042,-0.14258,-0.12146,1,0
5,GO NCRNA CATABOLIC PROCESS,0.0014738,-0.14283,-0.17912,1,0
5,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0017641,-0.14313,-0.18666,1,0
5,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.001228,-0.14317,-0.16048,1,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.012203,-0.14323,-0.1756,1,0
5,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.010245,-0.14344,-0.13315,1,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0060989,-0.14346,-0.1983,1,0
5,GO PROTEIN DEMANNOSYLATION,0.0051916,-0.14347,-0.22965,1,0
5,GO DETOXIFICATION,0.0079323,-0.14351,-0.15494,1,0
5,GO CELLULAR EXTRAVASATION,0.0014299,-0.14359,-0.16083,1,0
5,GO POSITIVE REGULATION OF MAPK CASCADE,0.00090094,-0.14362,-0.13975,1,0
5,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0014738,-0.14362,-0.16702,1,0
5,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00092958,-0.14401,-0.14547,1,0
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.013798,-0.14407,-0.13339,1,0
5,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.0069616,-0.1442,-0.11895,1,0
5,GO MRNA MODIFICATION,0.027803,-0.14437,-0.13838,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.036948,-0.14439,-0.19188,1,0
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.011047,-0.1444,-0.15802,1,0
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.013465,-0.1444,-0.14727,1,0
5,GO MYELOID LEUKOCYTE ACTIVATION,0.0015653,-0.14463,-0.16988,1,0
5,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.015574,-0.14471,-0.16085,1,0
5,GO AUTOPHAGOSOME MATURATION,0.017969,-0.14473,-0.13107,1,0
5,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.00018427,-0.14475,-0.15915,1,0
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00024286,-0.14476,-0.18835,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0016129,-0.14478,-0.23822,1,0
5,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.025414,-0.14498,-0.16259,1,0
5,GO RNA METHYLATION,0.00024286,-0.1451,-0.16357,1,0
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00012512,-0.1451,-0.15661,1,0
5,GO BONE GROWTH,0.042857,-0.14513,-0.20095,1,0
5,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.0011549,-0.14546,-0.15542,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.0071468,-0.14547,-0.16891,1,0
5,GO FIBROBLAST PROLIFERATION,0.0032441,-0.1456,-0.21022,1,0
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0037331,-0.14568,-0.1991,1,0
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.018398,-0.14586,-0.15984,1,0
5,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00019079,-0.14602,-0.17207,1,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.021165,-0.1461,-0.11962,1,0
5,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0069616,-0.14646,-0.16047,1,0
5,GO URONIC ACID METABOLIC PROCESS,0.0012662,-0.14662,-0.16885,1,0
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.00016023,-0.14668,-0.14833,1,0
5,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.033894,-0.14688,-0.1375,1,0
5,GO MAINTENANCE OF LOCATION IN CELL,0.00019079,-0.14701,-0.15091,1,0
5,GO NON CANONICAL WNT SIGNALING PATHWAY,0.01282,-0.14709,-0.10677,1,0
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0060989,-0.14747,-0.12691,1,0
5,GO REGULATION OF ENDOCYTOSIS,0.00087311,-0.14752,-0.12583,1,0
5,GO POSITIVE REGULATION OF TRANSLATION,0.00010092,-0.14755,-0.18228,1,0
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.001986,-0.14759,-0.15599,1,0
5,GO ENDOCRINE PROCESS,0.021165,-0.14775,-0.13076,1,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0024367,-0.14775,-0.18701,1,0
5,GO CERAMIDE CATABOLIC PROCESS,0.0079323,-0.14779,-0.24863,1,0
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.015203,-0.14876,-0.1629,1,0
5,GO HYPOTONIC RESPONSE,0.011326,-0.14876,-0.19384,1,0
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,6.5149e-05,-0.14882,-0.15337,1,0
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.016339,-0.14935,-0.15393,1,0
5,GO ENDOTHELIAL CELL MIGRATION,0.007729,-0.14948,-0.16824,1,0
5,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,9.7346e-05,-0.14966,-0.17549,1,0
5,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.025414,-0.14966,-0.13641,1,0
5,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.025414,-0.14978,-0.204,1,0
5,GO CARBOHYDRATE METABOLIC PROCESS,2.3654e-06,-0.15004,-0.1689,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0097392,-0.15008,-0.14374,1,0
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.014841,-0.15009,-0.20539,1,0
5,GO INTERACTION WITH HOST,0.0021689,-0.15035,-0.17578,1,0
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0021689,-0.15051,-0.16311,1,0
5,GO CELLULAR RESPONSE TO PH,0.0085714,-0.15052,-0.15937,1,0
5,GO CHOLESTEROL EFFLUX,0.0042883,-0.15061,-0.15506,1,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0071468,-0.15068,-0.19068,1,0
5,GO AMINOGLYCAN CATABOLIC PROCESS,0.0038387,-0.15088,-0.23911,1,0
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00074557,-0.15118,-0.1786,1,0
5,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00087311,-0.15121,-0.13433,1,0
5,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.00022676,-0.15133,-0.17086,1,0
5,GO REGULATION OF VASCULAR PERMEABILITY,0.010506,-0.15135,-0.15415,1,0
5,GO SPROUTING ANGIOGENESIS,0.0056288,-0.15159,-0.16626,1,0
5,GO RESPONSE TO ACID CHEMICAL,0.0012662,-0.15197,-0.13643,1,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00084609,-0.15201,-0.11157,1,0
5,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.0010206,-0.15201,-0.17201,1,0
5,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0038387,-0.15228,-0.20616,1,0
5,GO LAMELLIPODIUM ASSEMBLY,0.0064317,-0.15233,-0.12375,1,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00035231,-0.15241,-0.1873,1,0
5,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0049174,-0.15265,-0.15996,1,0
5,GO TRNA WOBBLE BASE MODIFICATION,0.001662,-0.1528,-0.19088,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.019739,-0.15315,-0.24429,1,0
5,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0022992,-0.15324,-0.16675,1,0
5,GO FIBROBLAST APOPTOTIC PROCESS,0.04854,-0.15332,-0.15979,1,0
5,GO PROTEASOME ASSEMBLY,0.036164,-0.15346,-0.13467,1,0
5,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00022676,-0.15364,-0.19756,1,0
5,GO POLYOL METABOLIC PROCESS,1.349e-05,-0.15376,-0.16203,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.007729,-0.15381,-0.15313,1,0
5,GO BLOOD VESSEL REMODELING,0.0073363,-0.15388,-0.2176,1,0
5,GO REGULATION OF KIDNEY DEVELOPMENT,0.0059384,-0.15401,-0.18307,1,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0062634,-0.15403,-0.14348,1,0
5,GO TRANSEPITHELIAL TRANSPORT,0.00026003,-0.15427,-0.19671,1,0
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.011612,-0.15444,-0.15809,1,0
5,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.014138,-0.15448,-0.20213,1,0
5,GO RESPONSE TO STEROL,0.0034322,-0.1545,-0.19269,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0040578,-0.15467,-0.13686,1,0
5,GO RNA INTERFERENCE,0.014841,-0.15475,-0.14714,1,0
5,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.009256,-0.15485,-0.22448,1,0
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0060989,-0.15486,-0.16146,1,0
5,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.004408,-0.15488,-0.16022,1,0
5,GO PHAGOCYTOSIS,0.00063551,-0.15518,-0.18387,1,0
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.019739,-0.15519,-0.16564,1,0
5,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.00019753,-0.15526,-0.1955,1,0
5,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,6.4994e-06,-0.15534,-0.1342,1,0
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0066042,-0.15538,-0.19361,1,0
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0026572,-0.15541,-0.18796,1,0
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0022332,-0.15554,-0.17871,1,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.031748,-0.15565,-0.18494,1,0
5,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.011612,-0.15566,-0.14436,1,0
5,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.017137,-0.15586,-0.21989,1,0
5,GO REGULATION OF PHAGOCYTOSIS,0.0033369,-0.15607,-0.17423,1,0
5,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.019283,-0.15612,-0.14969,1,0
5,GO RESPONSE TO INTERLEUKIN 15,0.0042883,-0.15616,-0.236,1,0
5,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.0073363,-0.15633,-0.25279,1,0
5,GO RESPONSE TO PH,0.001191,-0.15633,-0.21336,1,0
5,GO AMINO SUGAR CATABOLIC PROCESS,0.0060989,-0.15635,-0.20234,1,0
5,GO T CELL MEDIATED IMMUNITY,0.0054795,-0.15638,-0.23142,1,0
5,GO RESPONSE TO CAMP,0.00059588,-0.15647,-0.16027,1,0
5,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.0042883,-0.15656,-0.177,1,0
5,GO REGULATION OF TRANSLATIONAL TERMINATION,0.014841,-0.15672,-0.18204,1,0
5,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.011047,-0.15699,-0.14468,1,0
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0034322,-0.15712,-0.18466,1,0
5,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.029068,-0.15717,-0.13282,1,0
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,7.3528e-06,-0.15731,-0.14491,1,0
5,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.02843,-0.15732,-0.19819,1,0
5,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0015653,-0.15738,-0.21568,1,0
5,GO FATTY ACID METABOLIC PROCESS,0.00024286,-0.1577,-0.16577,1,0
5,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.036164,-0.15776,-0.14827,1,0
5,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.026586,-0.15778,-0.19875,1,0
5,GO REGULATION OF LIPID LOCALIZATION,0.00055855,-0.15798,-0.16466,1,0
5,GO SECRETION BY TISSUE,0.037747,-0.15808,-0.15032,1,0
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0057817,-0.15817,-0.22853,1,0
5,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.022165,-0.15822,-0.15832,1,0
5,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.017549,-0.15827,-0.22565,1,0
5,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0051916,-0.15831,-0.18872,1,0
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.00057693,-0.15837,-0.22945,1,0
5,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00012074,-0.15839,-0.16009,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,5.0226e-05,-0.15843,-0.21419,1,0
5,GO FUCOSYLATION,0.012508,-0.15875,-0.17436,1,0
5,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.00020448,-0.15882,-0.17174,1,0
5,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0054795,-0.15883,-0.18476,1,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.011047,-0.15887,-0.20402,1,0
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,2.5308e-05,-0.15891,-0.1473,1,0
5,GO AMYLOID BETA FORMATION,0.0053338,-0.15903,-0.21331,1,0
5,GO CELLULAR HYPEROSMOTIC RESPONSE,0.041093,-0.15933,-0.21026,1,0
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0033369,-0.15937,-0.26409,1,0
5,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.038561,-0.15951,-0.18522,1,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0013054,-0.15963,-0.17422,1,0
5,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.024288,-0.15969,-0.21107,1,0
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0045306,-0.15977,-0.16609,1,0
5,GO LEUKOCYTE APOPTOTIC PROCESS,0.017137,-0.16,-0.15114,1,0
5,GO REGULATION OF ATP METABOLIC PROCESS,0.00021167,-0.16009,-0.15126,1,0
5,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0028957,-0.16046,-0.23689,1,0
5,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0028957,-0.16054,-0.13879,1,0
5,GO REGULATION OF MYOBLAST FUSION,0.044685,-0.16057,-0.21876,1,0
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.001228,-0.16065,-0.19241,1,0
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0017641,-0.16067,-0.21278,1,0
5,GO PHOSPHOLIPID EFFLUX,0.015574,-0.16075,-0.21967,1,0
5,GO OSTEOBLAST DEVELOPMENT,0.033166,-0.16085,-0.16148,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0075304,-0.16085,-0.24812,1,0
5,GO RESPONSE TO CORTICOSTEROID,0.0012662,-0.16092,-0.18547,1,0
5,GO BODY FLUID SECRETION,7.547e-05,-0.1612,-0.19602,1,0
5,GO MOVEMENT IN HOST ENVIRONMENT,0.0025083,-0.16123,-0.20241,1,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0028957,-0.16124,-0.24527,1,0
5,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,9.7346e-05,-0.16138,-0.21801,1,0
5,GO CELLULAR RESPONSE TO CHOLESTEROL,0.010506,-0.16176,-0.21343,1,0
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,6.7728e-06,-0.16188,-0.16867,1,0
5,GO ACUTE INFLAMMATORY RESPONSE,0.0015653,-0.162,-0.21912,1,0
5,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0067808,-0.16208,-0.21421,1,0
5,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0013457,-0.16212,-0.18077,1,0
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.017969,-0.1625,-0.12931,1,0
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.029068,-0.1626,-0.15506,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,2.4346e-05,-0.16263,-0.15081,1,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00014935,-0.1627,-0.17352,1,0
5,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.009256,-0.1628,-0.15595,1,0
5,GO LIPID CATABOLIC PROCESS,0.00017796,-0.16321,-0.16047,1,0
5,GO PROTEIN FOLDING,4.6597e-05,-0.16329,-0.1707,1,0
5,GO MONOSACCHARIDE METABOLIC PROCESS,5.508e-06,-0.16335,-0.18117,1,0
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.014841,-0.16339,-0.17417,1,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0045306,-0.16348,-0.14366,1,0
5,GO MEMBRANE LIPID CATABOLIC PROCESS,0.012508,-0.16353,-0.19021,1,0
5,GO RESPONSE TO DSRNA,0.0033369,-0.1637,-0.16393,1,0
5,GO PROTEIN HOMOTETRAMERIZATION,0.0010859,-0.16389,-0.12825,1,0
5,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00041602,-0.16391,-0.18049,1,0
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0049174,-0.16411,-0.18163,1,0
5,GO COENZYME A METABOLIC PROCESS,0.03939,-0.16417,-0.12816,1,0
5,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.00013917,-0.16417,-0.20233,1,0
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0019282,-0.16421,-0.16789,1,0
5,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.0015189,-0.1644,-0.21209,1,0
5,GO AMINO ACID IMPORT,0.0047853,-0.16445,-0.18887,1,0
5,GO MACROPHAGE APOPTOTIC PROCESS,0.02268,-0.16463,-0.18124,1,0
5,GO RESPONSE TO ORGANOPHOSPHORUS,0.00042998,-0.16486,-0.15068,1,0
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0071468,-0.16502,-0.24262,1,0
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.00045924,-0.16514,-0.16952,1,0
5,GO REGULATION OF MACROPHAGE ACTIVATION,0.0014738,-0.16535,-0.1917,1,0
5,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0040578,-0.16555,-0.16549,1,0
5,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.004408,-0.16569,-0.22614,1,0
5,GO MACROPHAGE CYTOKINE PRODUCTION,0.010773,-0.16575,-0.24809,1,0
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.0075304,-0.16583,-0.18335,1,0
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0019282,-0.16596,-0.14324,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00084609,-0.16599,-0.19657,1,0
5,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0069616,-0.16604,-0.15647,1,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.010506,-0.16605,-0.1784,1,0
5,GO PROTEIN ACTIVATION CASCADE,0.0059384,-0.16607,-0.21895,1,0
5,GO CELLULAR RESPONSE TO STEROL,0.018836,-0.16634,-0.18002,1,0
5,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0060989,-0.1667,-0.19706,1,0
5,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.0030654,-0.167,-0.14668,1,0
5,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0069616,-0.16702,-0.16171,1,0
5,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.0020453,-0.16702,-0.19198,1,0
5,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0020453,-0.16715,-0.17348,1,0
5,GO MONONUCLEAR CELL MIGRATION,0.0079323,-0.16716,-0.17847,1,0
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.017137,-0.16748,-0.16661,1,0
5,GO VITAMIN TRANSPORT,0.00025131,-0.16808,-0.20887,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.043763,-0.16822,-0.17299,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0025083,-0.16825,-0.19906,1,0
5,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.0069616,-0.16857,-0.25972,1,0
5,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0025083,-0.16859,-0.18557,1,0
5,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.00063551,-0.16866,-0.13888,1,0
5,GO TOXIN TRANSPORT,0.0017641,-0.16875,-0.15025,1,0
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00065623,-0.16891,-0.15845,1,0
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.014486,-0.16939,-0.18445,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.023741,-0.1694,-0.16561,1,0
5,GO ETHER BIOSYNTHETIC PROCESS,0.0029794,-0.16943,-0.33814,1,0
5,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0031536,-0.1696,-0.15676,1,0
5,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00072223,-0.16968,-0.15089,1,0
5,GO NUCLEOSIDE METABOLIC PROCESS,0.00063551,-0.16974,-0.14437,1,0
5,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.0014738,-0.16981,-0.23998,1,0
5,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0038387,-0.16988,-0.20804,1,0
5,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00010092,-0.16997,-0.19098,1,0
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0032441,-0.17003,-0.19433,1,0
5,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00050664,-0.1703,-0.20116,1,0
5,GO STEROL IMPORT,0.0067808,-0.17063,-0.23493,1,0
5,GO FATTY ACID TRANSPORT,0.00019079,-0.17073,-0.1613,1,0
5,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00044439,-0.17074,-0.19092,1,0
5,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.027803,-0.17108,-0.2445,1,0
5,GO REVERSE CHOLESTEROL TRANSPORT,0.014841,-0.17113,-0.23346,1,0
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0011199,-0.17123,-0.22937,1,0
5,GO ORGANIC ACID METABOLIC PROCESS,1.8521e-05,-0.17124,-0.16632,1,0
5,GO ELECTRON TRANSPORT CHAIN,0.00074557,-0.17127,-0.17357,1,0
5,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.038561,-0.17136,-0.26477,1,0
5,GO NECROTIC CELL DEATH,0.0016129,-0.17147,-0.2264,1,0
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.033894,-0.17184,-0.20059,1,0
5,GO RIBOSE PHOSPHATE METABOLIC PROCESS,6.2367e-06,-0.17184,-0.17498,1,0
5,GO ACETYL COA METABOLIC PROCESS,0.0056288,-0.17209,-0.16355,1,0
5,GO MULTI ORGANISM CELLULAR PROCESS,0.0087944,-0.17215,-0.29598,1,0
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00013917,-0.17218,-0.1512,1,0
5,GO LYTIC VACUOLE ORGANIZATION,0.00024286,-0.1722,-0.19651,1,0
5,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0071468,-0.17225,-0.18586,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.031748,-0.17225,-0.25663,1,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0073363,-0.17234,-0.23268,1,0
5,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.00012964,-0.17235,-0.15386,1,0
5,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.014138,-0.1724,-0.1464,1,0
5,GO GERMINAL CENTER FORMATION,0.033166,-0.17266,-0.2735,1,0
5,GO ATP METABOLIC PROCESS,2.1663e-05,-0.17286,-0.16947,1,0
5,GO RESPONSE TO DEXAMETHASONE,0.001662,-0.1729,-0.24492,1,0
5,GO PEPTIDYL METHIONINE MODIFICATION,0.0014738,-0.17301,-0.20768,1,0
5,GO RESPONSE TO MINERALOCORTICOID,0.0064317,-0.17312,-0.1969,1,0
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00050664,-0.17338,-0.17298,1,0
5,GO IRON ION TRANSMEMBRANE TRANSPORT,0.0071468,-0.17341,-0.18072,1,0
5,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,2.4346e-05,-0.17341,-0.17618,1,0
5,GO CELL CELL RECOGNITION,1.1964e-05,-0.17366,-0.21545,1,0
5,GO OXIDATIVE PHOSPHORYLATION,0.00084609,-0.17385,-0.20139,1,0
5,GO IRON ION HOMEOSTASIS,0.0013872,-0.17388,-0.1679,1,0
5,GO APOPTOTIC CELL CLEARANCE,0.0011549,-0.17411,-0.26587,1,0
5,GO ZYMOGEN ACTIVATION,0.009256,-0.17423,-0.26098,1,0
5,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0050528,-0.17436,-0.16125,1,0
5,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0001165,-0.17444,-0.22145,1,0
5,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.016734,-0.17448,-0.20663,1,0
5,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0073363,-0.17454,-0.2078,1,0
5,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.044685,-0.17468,-0.11975,1,0
5,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.013465,-0.17483,-0.19318,1,0
5,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0015653,-0.17486,-0.16307,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00016595,-0.17499,-0.17418,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0038387,-0.17502,-0.20658,1,0
5,GO PROTEIN TETRAMERIZATION,0.0006154,-0.17507,-0.13157,1,0
5,GO KERATINOCYTE MIGRATION,0.0054795,-0.1751,-0.17568,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0057817,-0.17534,-0.23336,1,0
5,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,4.8379e-05,-0.17547,-0.1866,1,0
5,GO REGULATION OF FATTY ACID BETA OXIDATION,0.015574,-0.17554,-0.15437,1,0
5,GO POSITIVE CHEMOTAXIS,0.0031536,-0.17565,-0.17751,1,0
5,GO PYRUVATE METABOLIC PROCESS,1.0184e-05,-0.17569,-0.19638,1,0
5,GO PEPTIDYL ARGININE METHYLATION,0.0013872,-0.1759,-0.16871,1,0
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.027188,-0.1761,-0.18587,1,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0069616,-0.17613,-0.131,1,0
5,GO PROGRAMMED NECROTIC CELL DEATH,0.0047853,-0.17613,-0.20676,1,0
5,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0010206,-0.17614,-0.16386,1,0
5,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,8.3127e-06,-0.17618,-0.17329,1,0
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0014299,-0.17628,-0.17611,1,0
5,GO SELECTIVE AUTOPHAGY,0.00022676,-0.17632,-0.18409,1,0
5,GO MYOBLAST FUSION,0.0025083,-0.1765,-0.24152,1,0
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.004408,-0.17657,-0.23085,1,0
5,GO REGULATION OF GLUCONEOGENESIS,0.00049035,-0.1766,-0.15252,1,0
5,GO REGULATION OF NUCLEASE ACTIVITY,0.0020453,-0.17682,-0.1893,1,0
5,GO RESPONSE TO HYPEROXIA,0.019739,-0.17683,-0.23017,1,0
5,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00353,-0.17685,-0.20857,1,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.010773,-0.17685,-0.17495,1,0
5,GO TRANSITION METAL ION HOMEOSTASIS,9.389e-05,-0.17699,-0.18628,1,0
5,GO RESPONSE TO CADMIUM ION,0.021165,-0.17705,-0.17472,1,0
5,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0001547,-0.17707,-0.1831,1,0
5,GO NEGATIVE REGULATION OF WOUND HEALING,0.016339,-0.17751,-0.21283,1,0
5,GO RESPONSE TO INTERLEUKIN 7,0.0010206,-0.17752,-0.17642,1,0
5,GO INTERACTION WITH SYMBIONT,0.0001165,-0.17753,-0.17501,1,0
5,GO RRNA TRANSCRIPTION,0.0040578,-0.17769,-0.1678,1,0
5,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.00041602,-0.17773,-0.20781,1,0
5,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.014486,-0.17787,-0.26971,1,0
5,GO SYNCYTIUM FORMATION,0.0038387,-0.17795,-0.20506,1,0
5,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.5816e-05,-0.17801,-0.18712,1,0
5,GO GLUTATHIONE METABOLIC PROCESS,0.0040578,-0.17809,-0.19702,1,0
5,GO LIPID STORAGE,0.0026572,-0.17821,-0.17712,1,0
5,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00017796,-0.17848,-0.17512,1,0
5,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00014418,-0.1786,-0.19234,1,0
5,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0071468,-0.17883,-0.20969,1,0
5,GO TRNA PROCESSING,0.00019753,-0.17912,-0.17503,1,0
5,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.0075304,-0.17934,-0.28862,1,0
5,GO PROSTAGLANDIN SECRETION,0.0099891,-0.17961,-0.17568,1,0
5,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0059384,-0.17963,-0.21572,1,0
5,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.044685,-0.17977,-0.19914,1,0
5,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.037747,-0.1799,-0.16591,1,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.012508,-0.1799,-0.13677,1,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0097392,-0.18006,-0.17398,1,0
5,GO MATURE B CELL DIFFERENTIATION,0.014486,-0.18027,-0.24318,1,0
5,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.00010845,-0.18027,-0.16302,1,0
5,GO AMINO SUGAR METABOLIC PROCESS,0.0014299,-0.18027,-0.18091,1,0
5,GO NUCLEOTIDE PHOSPHORYLATION,1.6455e-05,-0.18055,-0.1977,1,0
5,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.012203,-0.18062,-0.18035,1,0
5,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00014935,-0.18104,-0.18815,1,0
5,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.0028141,-0.18129,-0.15895,1,0
5,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.038561,-0.18146,-0.15537,1,0
5,GO ENDODERMAL CELL DIFFERENTIATION,0.00020448,-0.18167,-0.34542,1,0
5,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0031536,-0.18211,-0.19374,1,0
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0085714,-0.18224,-0.17504,1,0
5,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0066042,-0.18228,-0.14755,1,0
5,GO ALPHA AMINO ACID METABOLIC PROCESS,4.8379e-05,-0.18242,-0.19743,1,0
5,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.0011549,-0.18257,-0.19875,1,0
5,GO MONOCYTE CHEMOTAXIS,0.013139,-0.18288,-0.18927,1,0
5,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.00014418,-0.18304,-0.19105,1,0
5,GO RESPONSE TO PROTOZOAN,0.0027346,-0.18305,-0.20257,1,0
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,2.6307e-05,-0.18315,-0.15966,1,0
5,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00090094,-0.18326,-0.17648,1,0
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0016129,-0.18333,-0.20147,1,0
5,GO LONG CHAIN FATTY ACID TRANSPORT,0.00012074,-0.18341,-0.1715,1,0
5,GO OXIDATION REDUCTION PROCESS,1.7118e-05,-0.18358,-0.17864,1,0
5,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0007696,-0.18358,-0.21679,1,0
5,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0090226,-0.18387,-0.24741,1,0
5,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.045624,-0.184,-0.19941,1,0
5,GO MACROMOLECULE DEPALMITOYLATION,0.00041602,-0.18417,-0.2294,1,0
5,GO DIOL METABOLIC PROCESS,0.03245,-0.18446,-0.14441,1,0
5,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.00040247,-0.18465,-0.17393,1,0
5,GO RESPONSE TO ESTROGEN,0.00055855,-0.1847,-0.2035,1,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.038561,-0.18471,-0.155,1,0
5,GO BIOMINERALIZATION,0.00087311,-0.1848,-0.17736,1,0
5,GO NEURAL CREST CELL MIGRATION,0.036164,-0.18511,-0.16523,1,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.046579,-0.18534,-0.20086,1,0
5,GO FIBRINOLYSIS,0.0031536,-0.18539,-0.32506,1,0
5,GO INTERLEUKIN 13 PRODUCTION,0.018836,-0.18586,-0.22738,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.025994,-0.18597,-0.1707,1,0
5,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00021909,-0.18644,-0.17573,1,0
5,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0059384,-0.18648,-0.18572,1,0
5,GO RESPONSE TO ANGIOTENSIN,0.0066042,-0.18658,-0.20154,1,0
5,GO T CELL APOPTOTIC PROCESS,0.0029794,-0.1867,-0.18213,1,0
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.019739,-0.18691,-0.20471,1,0
5,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,3.6228e-06,-0.18693,-0.16721,1,0
5,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,7.2754e-05,-0.18695,-0.21031,1,0
5,GO SMALL MOLECULE CATABOLIC PROCESS,2.7343e-05,-0.18713,-0.17739,1,0
5,GO TRNA METHYLATION,0.00026903,-0.18721,-0.19726,1,0
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00049035,-0.18729,-0.24795,1,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0087944,-0.18731,-0.25087,1,0
5,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.040234,-0.18761,-0.1564,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0067808,-0.18766,-0.21637,1,0
5,GO RESPONSE TO CHEMOKINE,0.00021167,-0.18781,-0.16574,1,0
5,GO EXOCRINE SYSTEM DEVELOPMENT,0.02268,-0.18844,-0.19866,1,0
5,GO LIPID OXIDATION,0.00028792,-0.18858,-0.19623,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00026003,-0.18879,-0.23245,1,0
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0071468,-0.18901,-0.15418,1,0
5,GO PROTEIN TARGETING,1.7806e-05,-0.18904,-0.1957,1,0
5,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,3.9418e-06,-0.18906,-0.19598,1,0
5,GO C21 STEROID HORMONE METABOLIC PROCESS,0.017137,-0.18907,-0.21694,1,0
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.013465,-0.18924,-0.18796,1,0
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0050528,-0.18933,-0.23746,1,0
5,GO GLOMERULUS DEVELOPMENT,0.017969,-0.18959,-0.18136,1,0
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.02843,-0.18967,-0.21598,1,0
5,GO CARBOHYDRATE CATABOLIC PROCESS,4.2876e-06,-0.18974,-0.19675,1,0
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00037661,-0.18991,-0.24208,1,0
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.0030654,-0.18991,-0.30644,1,0
5,GO FATTY ACID BETA OXIDATION,0.00045924,-0.19007,-0.19443,1,0
5,GO NEGATIVE REGULATION OF GENE SILENCING,4.0073e-05,-0.1902,-0.23436,1,0
5,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.044685,-0.19026,-0.15741,1,0
5,GO CERAMIDE TRANSPORT,0.015953,-0.19033,-0.1862,1,0
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.041093,-0.1906,-0.1389,1,0
5,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.00010092,-0.19099,-0.20191,1,0
5,GO INTERLEUKIN 17 PRODUCTION,0.0001547,-0.19104,-0.22718,1,0
5,GO FOAM CELL DIFFERENTIATION,0.0071468,-0.19104,-0.1958,1,0
5,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.017549,-0.19109,-0.23309,1,0
5,GO ORGANIC ACID CATABOLIC PROCESS,2.3418e-05,-0.19111,-0.20641,1,0
5,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.044685,-0.19117,-0.30641,1,0
5,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0069616,-0.19117,-0.22833,1,0
5,GO INTEGRIN ACTIVATION,0.01282,-0.19124,-0.1723,1,0
5,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.0033369,-0.19124,-0.19572,1,0
5,GO ENTRY INTO HOST,0.0014299,-0.19136,-0.23979,1,0
5,GO STORE OPERATED CALCIUM ENTRY,0.00353,-0.19168,-0.22299,1,0
5,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0017641,-0.19175,-0.22032,1,0
5,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0050528,-0.19185,-0.17059,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,1.2454e-05,-0.19187,-0.16344,1,0
5,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0047853,-0.19188,-0.17256,1,0
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,6.5149e-05,-0.19192,-0.16734,1,0
5,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0020453,-0.19203,-0.24403,1,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,2.1663e-05,-0.19207,-0.19841,1,0
5,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,2.6902e-06,-0.1921,-0.1849,1,0
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0013054,-0.19215,-0.21618,1,0
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0038387,-0.19222,-0.19255,1,0
5,GO REGULATION OF MRNA BINDING,0.011612,-0.19244,-0.19999,1,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.019283,-0.19245,-0.17925,1,0
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.015574,-0.1926,-0.2448,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0039469,-0.19262,-0.21115,1,0
5,GO RRNA METHYLATION,0.0017641,-0.19304,-0.20754,1,0
5,GO PURINE NUCLEOSIDE METABOLIC PROCESS,6.4994e-06,-0.1932,-0.19504,1,0
5,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00067758,-0.19324,-0.23113,1,0
5,GO ETHER METABOLIC PROCESS,0.001662,-0.19329,-0.24907,1,0
5,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.001228,-0.19332,-0.18601,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0011549,-0.19345,-0.23279,1,0
5,GO NUCLEOSIDE SALVAGE,0.017969,-0.19347,-0.18302,1,0
5,GO TRNA 5 LEADER REMOVAL,0.001228,-0.19364,-0.22046,1,0
5,GO NEGATIVE REGULATION OF AUTOPHAGY,3.5759e-05,-0.19384,-0.19803,1,0
5,GO STEROID HORMONE SECRETION,0.026586,-0.19422,-0.18731,1,0
5,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0081404,-0.19429,-0.36513,1,0
5,GO TRANSLATIONAL TERMINATION,0.00095906,-0.19429,-0.21673,1,0
5,GO REGULATION OF SPROUTING ANGIOGENESIS,0.0021689,-0.19466,-0.18279,1,0
5,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.021165,-0.19515,-0.12405,1,0
5,GO IRON SULFUR CLUSTER ASSEMBLY,0.0045306,-0.19523,-0.21113,1,0
5,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.001662,-0.19553,-0.2735,1,0
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0083534,-0.19564,-0.19623,1,0
5,GO AMINOGLYCAN METABOLIC PROCESS,0.0010859,-0.19581,-0.18896,1,0
5,GO CELLULAR LIPID CATABOLIC PROCESS,9.0551e-05,-0.19586,-0.1849,1,0
5,GO GLYCEROL ETHER METABOLIC PROCESS,0.0062634,-0.19588,-0.20243,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.036948,-0.19608,-0.24146,1,0
5,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,9.3916e-06,-0.19612,-0.20034,1,0
5,GO TRNA METABOLIC PROCESS,8.4205e-05,-0.19623,-0.18937,1,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0038387,-0.19637,-0.18197,1,0
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.011047,-0.19644,-0.23066,1,0
5,GO RESPONSE TO INTERFERON GAMMA,0.001872,-0.19646,-0.26938,1,0
5,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.0011549,-0.19658,-0.24591,1,0
5,GO PENTOSE METABOLIC PROCESS,0.00067758,-0.19667,-0.27186,1,0
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00026903,-0.19675,-0.19224,1,0
5,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0012662,-0.19686,-0.22094,1,0
5,GO SEQUESTERING OF CALCIUM ION,0.00036427,-0.19717,-0.17777,1,0
5,GO NADP METABOLIC PROCESS,0.00024286,-0.19727,-0.25135,1,0
5,GO SPHINGOMYELIN METABOLIC PROCESS,0.015203,-0.19753,-0.20793,1,0
5,GO RETINOL METABOLIC PROCESS,0.0025817,-0.19759,-0.22135,1,0
5,GO RNA CATABOLIC PROCESS,7.013e-05,-0.19759,-0.19204,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0033369,-0.19781,-0.17201,1,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.011612,-0.19794,-0.18271,1,0
5,GO REGULATION OF LIPID STORAGE,0.00029782,-0.19832,-0.20101,1,0
5,GO FATTY ACID CATABOLIC PROCESS,0.0001165,-0.19838,-0.20131,1,0
5,GO CELLULAR RESPIRATION,0.00012512,-0.19847,-0.21066,1,0
5,GO LATERAL VENTRICLE DEVELOPMENT,0.014841,-0.19876,-0.22145,1,0
5,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00092958,-0.19884,-0.23435,1,0
5,GO RESPONSE TO MISFOLDED PROTEIN,0.001872,-0.19884,-0.18263,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00027832,-0.19914,-0.27513,1,0
5,GO OVULATION,0.02068,-0.19914,-0.17751,1,0
5,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00081984,-0.19919,-0.17155,1,0
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.02268,-0.19921,-0.20869,1,0
5,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.018836,-0.19926,-0.21199,1,0
5,GO RRNA 3 END PROCESSING,0.0059384,-0.19976,-0.17306,1,0
5,GO MITOCHONDRIAL DEPOLARIZATION,0.011326,-0.1998,-0.20435,1,0
5,GO SPERM EGG RECOGNITION,1.2454e-05,-0.19991,-0.20742,1,0
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0046564,-0.20001,-0.19713,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0030654,-0.20006,-0.23418,1,0
5,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.00041602,-0.20025,-0.23327,1,0
5,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.001662,-0.20053,-0.22473,1,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0011549,-0.20058,-0.18924,1,0
5,GO REGULATION OF CHLORIDE TRANSPORT,0.010506,-0.20067,-0.23395,1,0
5,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.01282,-0.20077,-0.16989,1,0
5,GO ANIMAL ORGAN REGENERATION,0.00057693,-0.20077,-0.22668,1,0
5,GO NEGATIVE REGULATION OF COAGULATION,0.0060989,-0.20089,-0.27866,1,0
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.00020448,-0.20126,-0.18944,1,0
5,GO TRNA MODIFICATION,0.0001547,-0.20139,-0.19593,1,0
5,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00020448,-0.20157,-0.23781,1,0
5,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0013054,-0.2018,-0.19097,1,0
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.009256,-0.20183,-0.21033,1,0
5,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.017969,-0.20192,-0.17641,1,0
5,GO XENOBIOTIC TRANSPORT,0.00035231,-0.20196,-0.23428,1,0
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0024367,-0.20203,-0.24178,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00057693,-0.20248,-0.20304,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.033166,-0.2027,-0.19114,1,0
5,GO PLATELET DEGRANULATION,0.0011199,-0.20283,-0.23697,1,0
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0015189,-0.20289,-0.20594,1,0
5,GO SULFUR COMPOUND METABOLIC PROCESS,1.7118e-05,-0.20321,-0.19687,1,0
5,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0053338,-0.20351,-0.20915,1,0
5,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.0099891,-0.20355,-0.24201,1,0
5,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00072223,-0.20365,-0.1686,1,0
5,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00069957,-0.2037,-0.25033,1,0
5,GO RESPONSE TO THYROID HORMONE,0.0019282,-0.20395,-0.26221,1,0
5,GO KETONE BIOSYNTHETIC PROCESS,0.0019282,-0.20421,-0.20865,1,0
5,GO CELLULAR RESPONSE TO DRUG,5.0226e-05,-0.20422,-0.18476,1,0
5,GO MODULATION BY HOST OF VIRAL PROCESS,0.0001165,-0.20439,-0.24673,1,0
5,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,4.4878e-05,-0.20449,-0.22675,1,0
5,GO NUCLEOBASE METABOLIC PROCESS,0.00084609,-0.20522,-0.22615,1,0
5,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,2.9532e-05,-0.20532,-0.19787,1,0
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.045624,-0.2054,-0.15217,1,0
5,GO EXTRACELLULAR MATRIX ASSEMBLY,0.007729,-0.20578,-0.24606,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.0039469,-0.20612,-0.2194,1,0
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.019283,-0.20616,-0.27382,1,0
5,GO REGULATION OF RIBOSOME BIOGENESIS,8.1192e-05,-0.20664,-0.30688,1,0
5,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00067758,-0.20684,-0.20238,1,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.00041602,-0.20694,-0.28551,1,0
5,GO REGULATION OF AMYLOID BETA CLEARANCE,0.017137,-0.20712,-0.23581,1,0
5,GO PRIMARY MIRNA PROCESSING,0.00057693,-0.20724,-0.21516,1,0
5,GO HISTAMINE TRANSPORT,0.024288,-0.20736,-0.25002,1,0
5,GO TETRAHYDROFOLATE INTERCONVERSION,0.0050528,-0.20765,-0.22038,1,0
5,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0034322,-0.2078,-0.28813,1,0
5,GO PLATELET MORPHOGENESIS,0.00013917,-0.20798,-0.20811,1,0
5,GO CAMP METABOLIC PROCESS,0.0087944,-0.20839,-0.19309,1,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.001662,-0.20941,-0.24721,1,0
5,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.0090226,-0.20965,-0.23277,1,0
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0047853,-0.20996,-0.2415,1,0
5,GO AUTOPHAGY OF NUCLEUS,0.0012662,-0.21012,-0.21399,1,0
5,GO CELLULAR AMINO ACID METABOLIC PROCESS,7.547e-05,-0.21058,-0.19016,1,0
5,GO REGULATION OF VACUOLE ORGANIZATION,4.0073e-05,-0.21082,-0.21259,1,0
5,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00045924,-0.21082,-0.25437,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00047456,-0.2109,-0.28512,1,0
5,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.011612,-0.21122,-0.17928,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.010245,-0.21124,-0.25911,1,0
5,GO GLYCOLIPID CATABOLIC PROCESS,0.0032441,-0.2114,-0.31346,1,0
5,GO CELLULAR RESPONSE TO INTERFERON BETA,0.041967,-0.21153,-0.22178,1,0
5,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.015953,-0.21159,-0.17627,1,0
5,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,1.5816e-05,-0.2116,-0.22928,1,0
5,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,3.7145e-05,-0.21183,-0.26565,1,0
5,GO TRNA 5 END PROCESSING,0.0039469,-0.21194,-0.18866,1,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0038387,-0.21235,-0.17137,1,0
5,GO RESPONSE TO GROWTH HORMONE,0.011612,-0.21255,-0.17775,1,0
5,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0023671,-0.21259,-0.22382,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.017969,-0.21306,-0.28578,1,0
5,GO NCRNA METABOLIC PROCESS,7.8282e-05,-0.21316,-0.20747,1,0
5,GO MITOCHONDRIAL TRANSLATION,0.00031859,-0.21335,-0.23517,1,0
5,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.040234,-0.21358,-0.24525,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00087311,-0.21406,-0.23362,1,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.001191,-0.21415,-0.25712,1,0
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00095906,-0.21446,-0.21548,1,0
5,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0014738,-0.21447,-0.24371,1,0
5,GO STEROID ESTERIFICATION,0.0071468,-0.21457,-0.27939,1,0
5,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.011047,-0.21466,-0.29594,1,0
5,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.019739,-0.21467,-0.2717,1,0
5,GO THIOESTER METABOLIC PROCESS,0.00013917,-0.21509,-0.20931,1,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00034072,-0.21523,-0.20539,1,0
5,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.017549,-0.21557,-0.28691,1,0
5,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0031536,-0.21571,-0.19925,1,0
5,GO RESPONSE TO ACIDIC PH,0.0011199,-0.21575,-0.28399,1,0
5,GO NEGATIVE REGULATION OF CELL AGING,0.02268,-0.21619,-0.19567,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00079435,-0.21623,-0.22178,1,0
5,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00030804,-0.21632,-0.31147,1,0
5,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.02068,-0.2165,-0.18249,1,0
5,GO CELLULAR AMIDE METABOLIC PROCESS,4.6623e-06,-0.21701,-0.18945,1,0
5,GO PEPTIDE METABOLIC PROCESS,7.3528e-06,-0.21728,-0.20049,1,0
5,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0037331,-0.21728,-0.33481,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0046564,-0.2177,-0.27732,1,0
5,GO DE NOVO PROTEIN FOLDING,0.00090094,-0.21775,-0.1858,1,0
5,GO HYALURONAN CATABOLIC PROCESS,0.0020453,-0.21792,-0.35097,1,0
5,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0006154,-0.21796,-0.17275,1,0
5,GO CHOLESTEROL STORAGE,0.0087944,-0.21812,-0.17445,1,0
5,GO BLASTOCYST FORMATION,0.0010206,-0.21838,-0.18192,1,0
5,GO RESPONSE TO REDOX STATE,0.0083534,-0.21843,-0.2113,1,0
5,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0021689,-0.21846,-0.18476,1,0
5,GO RNA 5 END PROCESSING,0.00065623,-0.21863,-0.21756,1,0
5,GO REGULATION OF FATTY ACID OXIDATION,0.0018173,-0.21878,-0.20892,1,0
5,GO RESPONSE TO STEROL DEPLETION,0.009256,-0.21893,-0.21007,1,0
5,GO CD40 SIGNALING PATHWAY,7.547e-05,-0.21936,-0.30789,1,0
5,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,4.6597e-05,-0.21953,-0.23301,1,0
5,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0025817,-0.21958,-0.25686,1,0
5,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.00072223,-0.21992,-0.24739,1,0
5,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.004408,-0.22049,-0.28416,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.0083534,-0.22082,-0.34787,1,0
5,GO COLLAGEN CATABOLIC PROCESS,9.0551e-05,-0.22101,-0.28402,1,0
5,GO NEUROBLAST DIVISION,0.0099891,-0.22102,-0.24353,1,0
5,GO RRNA MODIFICATION,0.00055855,-0.22102,-0.23578,1,0
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00041602,-0.22192,-0.26463,1,0
5,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.023205,-0.22221,-0.28264,1,0
5,GO POSITIVE REGULATION OF VASCULOGENESIS,0.027803,-0.22235,-0.26581,1,0
5,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0023671,-0.22249,-0.23139,1,0
5,GO TRICARBOXYLIC ACID CYCLE,4.3218e-05,-0.22277,-0.25205,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,8.4205e-05,-0.22316,-0.19423,1,0
5,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0006154,-0.2236,-0.3888,1,0
5,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0040578,-0.22382,-0.26851,1,0
5,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00092958,-0.22388,-0.22889,1,0
5,GO UV PROTECTION,0.027803,-0.22419,-0.1922,1,0
5,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.022165,-0.22453,-0.15054,1,0
5,GO PROTEIN TARGETING TO MEMBRANE,0.00014935,-0.2248,-0.25563,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0042883,-0.22517,-0.24246,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00353,-0.22523,-0.22474,1,0
5,GO FOLIC ACID METABOLIC PROCESS,0.0019282,-0.22533,-0.21596,1,0
5,GO TRANSLATIONAL ELONGATION,0.00026003,-0.22553,-0.2248,1,0
5,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0015653,-0.2263,-0.19354,1,0
5,GO NCRNA PROCESSING,0.00019079,-0.22647,-0.21789,1,0
5,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.017137,-0.22648,-0.20041,1,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00059588,-0.2272,-0.28871,1,0
5,GO GLYCINE METABOLIC PROCESS,0.001191,-0.22735,-0.32056,1,0
5,GO TETRAPYRROLE METABOLIC PROCESS,5.4121e-05,-0.22741,-0.24679,1,0
5,GO GENITALIA MORPHOGENESIS,0.040234,-0.22746,-0.20137,1,0
5,GO HORMONE BIOSYNTHETIC PROCESS,5.2139e-05,-0.22758,-0.25226,1,0
5,GO RESPONSE TO INTERFERON BETA,0.040234,-0.22792,-0.34715,1,0
5,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.013798,-0.22839,-0.21512,1,0
5,GO DETECTION OF BIOTIC STIMULUS,0.00012964,-0.22873,-0.32705,1,0
5,GO GLUCOCORTICOID METABOLIC PROCESS,0.0019282,-0.22928,-0.2289,1,0
5,GO PEPTIDE BIOSYNTHETIC PROCESS,3.5759e-05,-0.22996,-0.20683,1,0
5,GO AMIDE BIOSYNTHETIC PROCESS,1.1964e-05,-0.23001,-0.19965,1,0
5,GO RESPONSE TO INTERLEUKIN 12,0.00092958,-0.23001,-0.22407,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.00095906,-0.23015,-0.24982,1,0
5,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.014486,-0.23032,-0.17464,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00023468,-0.23065,-0.26074,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0090226,-0.2307,-0.24166,1,0
5,GO ENDODERM DEVELOPMENT,0.0013872,-0.23094,-0.26396,1,0
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.015203,-0.23113,-0.21311,1,0
5,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.00353,-0.23121,-0.20956,1,0
5,GO POSITIVE REGULATION OF HEART RATE,0.015203,-0.23133,-0.2024,1,0
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0036303,-0.23144,-0.24825,1,0
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00084609,-0.2318,-0.22806,1,0
5,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0056288,-0.232,-0.26341,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.031748,-0.23209,-0.22232,1,0
5,GO PEROXISOME ORGANIZATION,1.5201e-05,-0.23235,-0.23157,1,0
5,GO PULMONARY VALVE MORPHOGENESIS,0.041967,-0.23238,-0.30024,1,0
5,GO BLOOD COAGULATION INTRINSIC PATHWAY,3.0689e-05,-0.23243,-0.25104,1,0
5,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.014841,-0.23301,-0.26339,1,0
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00092958,-0.23344,-0.25967,1,0
5,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,6.2786e-05,-0.23366,-0.30183,1,0
5,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00055855,-0.23371,-0.21929,1,0
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.015574,-0.23372,-0.31247,1,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00090094,-0.23441,-0.23178,1,0
5,GO REGULATION OF AMYLOID BETA FORMATION,0.00074557,-0.23471,-0.28012,1,0
5,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0059384,-0.23495,-0.29409,1,0
5,GO BEHAVIORAL RESPONSE TO PAIN,0.001986,-0.23501,-0.36774,1,0
5,GO MITOCHONDRIAL RNA PROCESSING,0.0013054,-0.23504,-0.26346,1,0
5,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.041093,-0.23507,-0.21903,1,0
5,GO MITOCHONDRIAL TRNA PROCESSING,0.0046564,-0.23553,-0.24294,1,0
5,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00020448,-0.23563,-0.20678,1,0
5,GO POLYSACCHARIDE CATABOLIC PROCESS,0.00010462,-0.23583,-0.23297,1,0
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0090226,-0.23593,-0.31068,1,0
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00014418,-0.23637,-0.33976,1,0
5,GO PROTEIN OXIDATION,0.0013054,-0.23646,-0.30812,1,0
5,GO PEPTIDYL ARGININE N METHYLATION,0.0018173,-0.23671,-0.21715,1,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00028792,-0.23675,-0.22213,1,0
5,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.023741,-0.23707,-0.1655,1,0
5,GO RESPONSE TO MANGANESE ION,0.0011199,-0.23714,-0.2316,1,0
5,GO THIOESTER BIOSYNTHETIC PROCESS,0.00040247,-0.23725,-0.22607,1,0
5,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0094949,-0.23782,-0.34564,1,0
5,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00041602,-0.23843,-0.24243,1,0
5,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.011612,-0.23878,-0.20805,1,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00022676,-0.23891,-0.26234,1,0
5,GO RESPONSE TO GONADOTROPIN,7.547e-05,-0.23924,-0.28277,1,0
5,GO CORTICOSTEROID HORMONE SECRETION,0.010773,-0.23962,-0.24833,1,0
5,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.0094949,-0.23964,-0.19272,1,0
5,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00013917,-0.23988,-0.22202,1,0
5,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0090226,-0.23997,-0.35585,1,0
5,GO ALDITOL METABOLIC PROCESS,8.1192e-05,-0.24064,-0.2679,1,0
5,GO PIGMENT BIOSYNTHETIC PROCESS,5.8301e-05,-0.24071,-0.24116,1,0
5,GO GLUTAMINE METABOLIC PROCESS,0.00052342,-0.2411,-0.20003,1,0
5,GO LACTATION,2.0033e-05,-0.24113,-0.25431,1,0
5,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,9.3916e-06,-0.24128,-0.23438,1,0
5,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.00016023,-0.24129,-0.27978,1,0
5,GO CARDIOLIPIN METABOLIC PROCESS,4.4878e-05,-0.2413,-0.28006,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0012662,-0.24159,-0.24441,1,0
5,GO MALE GENITALIA DEVELOPMENT,0.00067758,-0.2421,-0.24485,1,0
5,GO REGULATION OF FIBRINOLYSIS,4.8379e-05,-0.24286,-0.37345,1,0
5,GO VASODILATION,0.0037331,-0.24392,-0.24622,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,1.4039e-05,-0.24401,-0.31827,1,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS,0.00023468,-0.24401,-0.28095,1,0
5,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0006154,-0.24547,-0.25978,1,0
5,GO REGULATION OF CYTOPLASMIC TRANSLATION,2.0033e-05,-0.24554,-0.27492,1,0
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0025817,-0.24555,-0.3059,1,0
5,GO REGULATION OF TRANSLATIONAL FIDELITY,0.00012512,-0.24555,-0.27074,1,0
5,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0031536,-0.24615,-0.18905,1,0
5,GO SEQUESTERING OF TRIGLYCERIDE,0.0032441,-0.24658,-0.27738,1,0
5,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.00021909,-0.24702,-0.27222,1,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.034637,-0.24706,-0.22892,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00092958,-0.24731,-0.32258,1,0
5,GO RESPONSE TO TESTOSTERONE,0.00081984,-0.24756,-0.21804,1,0
5,GO MUSCLE ATROPHY,0.010506,-0.24786,-0.21263,1,0
5,GO EOSINOPHIL CHEMOTAXIS,0.018836,-0.24793,-0.29425,1,0
5,GO T CELL MEDIATED CYTOTOXICITY,0.0039469,-0.24819,-0.34995,1,0
5,GO REGULATION OF TOLERANCE INDUCTION,0.0066042,-0.24822,-0.31293,1,0
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0015653,-0.24823,-0.25233,1,0
5,GO EOSINOPHIL MIGRATION,0.01282,-0.24834,-0.29261,1,0
5,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0017641,-0.24863,-0.21422,1,0
5,GO DETECTION OF OTHER ORGANISM,0.0090226,-0.24864,-0.27612,1,0
5,GO BICARBONATE TRANSPORT,0.00079435,-0.24882,-0.19173,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.017549,-0.2489,-0.30423,1,0
5,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0014299,-0.24907,-0.30858,1,0
5,GO RESPONSE TO COPPER ION,0.0059384,-0.24933,-0.29524,1,0
5,GO AEROBIC RESPIRATION,9.3916e-06,-0.24941,-0.25597,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,3.8583e-05,-0.24956,-0.22947,1,0
5,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.036164,-0.24959,-0.21188,1,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00021909,-0.25007,-0.28658,1,0
5,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.037747,-0.25024,-0.28199,1,0
5,GO MITOCHONDRIAL GENE EXPRESSION,0.00010845,-0.25052,-0.24601,1,0
5,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0049174,-0.25076,-0.31096,1,0
5,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.017969,-0.25087,-0.2084,1,0
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00014935,-0.25164,-0.25187,1,0
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0015189,-0.25179,-0.29315,1,0
5,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,2.0033e-05,-0.25251,-0.26458,1,0
5,GO RRNA METABOLIC PROCESS,0.00021167,-0.253,-0.24471,1,0
5,GO PEROXISOMAL TRANSPORT,2.1663e-05,-0.25308,-0.24222,1,0
5,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.00017186,-0.25313,-0.24333,1,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00013433,-0.25329,-0.22224,1,0
5,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00013433,-0.25365,-0.22665,1,0
5,GO PEPTIDYL PROLINE MODIFICATION,1.5816e-05,-0.25385,-0.29549,1,0
5,GO ENDODERM FORMATION,0.00032948,-0.25386,-0.32417,1,0
5,GO SIGNAL PEPTIDE PROCESSING,0.0081404,-0.25414,-0.20218,1,0
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0097392,-0.25442,-0.29793,1,0
5,GO ESTROGEN BIOSYNTHETIC PROCESS,0.0046564,-0.25547,-0.23056,1,0
5,GO COLLAGEN METABOLIC PROCESS,0.001986,-0.25568,-0.25715,1,0
5,GO CARNITINE SHUTTLE,0.015203,-0.25569,-0.19181,1,0
5,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00019753,-0.25574,-0.2395,1,0
5,GO HEXOSE CATABOLIC PROCESS,5.6174e-05,-0.25653,-0.27028,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0021062,-0.25667,-0.21667,1,0
5,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0057817,-0.25704,-0.3557,1,0
5,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,1.2454e-05,-0.25734,-0.27357,1,0
5,GO PROTEIN DEGLYCOSYLATION,0.00030804,-0.25819,-0.28149,1,0
5,GO KETONE BODY METABOLIC PROCESS,0.0071468,-0.25853,-0.23094,1,0
5,GO SKELETAL MUSCLE TISSUE REGENERATION,0.0006154,-0.25874,-0.24528,1,0
5,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00010845,-0.25885,-0.28576,1,0
5,GO STEROID HORMONE BIOSYNTHETIC PROCESS,7.013e-05,-0.25919,-0.29487,1,0
5,GO REGULATION OF NECROTIC CELL DEATH,0.0053338,-0.25921,-0.25197,1,0
5,GO KERATAN SULFATE CATABOLIC PROCESS,9.389e-05,-0.25944,-0.33303,1,0
5,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.001872,-0.25992,-0.25661,1,0
5,GO TELOMERASE RNA LOCALIZATION,0.011904,-0.25992,-0.21251,1,0
5,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.021165,-0.26002,-0.3099,1,0
5,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00041602,-0.26032,-0.31355,1,0
5,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.00013917,-0.26052,-0.27464,1,0
5,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.00038934,-0.26067,-0.28901,1,0
5,GO MONOSACCHARIDE CATABOLIC PROCESS,2.4346e-05,-0.26074,-0.25837,1,0
5,GO ELASTIC FIBER ASSEMBLY,0.0079323,-0.26159,-0.34328,1,0
5,GO LIPID IMPORT INTO CELL,0.00037661,-0.2621,-0.25689,1,0
5,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.0001165,-0.26216,-0.25272,1,0
5,GO PROTEIN HYDROXYLATION,0.00013433,-0.26277,-0.36445,1,0
5,GO SULFUR COMPOUND CATABOLIC PROCESS,5.2837e-06,-0.263,-0.28255,1,0
5,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0041716,-0.26378,-0.38531,1,0
5,GO HOMOCYSTEINE METABOLIC PROCESS,0.00030804,-0.26383,-0.37231,1,0
5,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.00045924,-0.26408,-0.21589,1,0
5,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0012662,-0.2642,-0.30749,1,0
5,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,6.7596e-05,-0.26462,-0.27016,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00035231,-0.26529,-0.25203,1,0
5,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00081984,-0.26553,-0.26869,1,0
5,GO RIBOSOME BIOGENESIS,0.00019753,-0.26637,-0.26252,1,0
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.014138,-0.26712,-0.30795,1,0
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0090226,-0.26719,-0.24071,1,0
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00040247,-0.26737,-0.31312,1,0
5,GO PEPTIDYL HISTIDINE MODIFICATION,0.00026903,-0.26761,-0.23938,1,0
5,GO PROTEIN REFOLDING,0.007729,-0.2682,-0.18949,1,0
5,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.0029794,-0.26838,-0.32691,1,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0042883,-0.26872,-0.29522,1,0
5,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00019753,-0.2689,-0.33316,1,0
5,GO FATTY ACID HOMEOSTASIS,0.00026903,-0.26894,-0.33201,1,0
5,GO SULFUR AMINO ACID METABOLIC PROCESS,2.3418e-05,-0.2692,-0.26481,1,0
5,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00059588,-0.26973,-0.26164,1,0
5,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0028957,-0.27028,-0.22475,1,0
5,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0053338,-0.27069,-0.25731,1,0
5,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,9.7346e-05,-0.27124,-0.36176,1,0
5,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.023741,-0.27139,-0.26757,1,0
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.3132e-05,-0.27248,-0.28844,1,0
5,GO COPPER ION TRANSPORT,0.00026903,-0.27269,-0.27242,1,0
5,GO RESPONSE TO TUMOR CELL,0.00014418,-0.27308,-0.31506,1,0
5,GO MATURATION OF 5 8S RRNA,0.00081984,-0.27392,-0.25976,1,0
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,7.6603e-06,-0.27408,-0.30394,1,0
5,GO CELL REDOX HOMEOSTASIS,0.0001547,-0.27414,-0.24918,1,0
5,GO L PHENYLALANINE METABOLIC PROCESS,0.0071468,-0.27464,-0.25783,1,0
5,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,2.1663e-05,-0.27509,-0.30782,1,0
5,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00065623,-0.27733,-0.31833,1,0
5,GO THYMOCYTE APOPTOTIC PROCESS,0.0028957,-0.27828,-0.27,1,0
5,GO CYTOCHROME COMPLEX ASSEMBLY,0.0007696,-0.27953,-0.23155,1,0
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.040234,-0.28029,-0.40708,1,0
5,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.0011199,-0.28034,-0.26997,1,0
5,GO PSEUDOURIDINE SYNTHESIS,0.00017186,-0.28116,-0.3096,1,0
5,GO COLLAGEN BIOSYNTHETIC PROCESS,0.019283,-0.28171,-0.27524,1,0
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.00079435,-0.28185,-0.28934,1,0
5,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00084609,-0.28326,-0.42037,1,0
5,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00016023,-0.28384,-0.26794,1,0
5,GO COPPER ION HOMEOSTASIS,0.00024286,-0.28511,-0.27328,1,0
5,GO PIGMENT METABOLIC PROCESS,7.2754e-05,-0.28644,-0.25747,1,0
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.017137,-0.2871,-0.24718,1,0
5,GO KERATAN SULFATE METABOLIC PROCESS,2.9301e-06,-0.28724,-0.33338,1,0
5,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.00044439,-0.28741,-0.25236,1,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.0038387,-0.28745,-0.29598,1,0
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0025817,-0.28763,-0.30962,1,0
5,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.0029794,-0.28802,-0.34973,1,0
5,GO ENAMEL MINERALIZATION,0.024846,-0.28825,-0.21139,1,0
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.00041602,-0.28855,-0.26836,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0083534,-0.28895,-0.29808,1,0
5,GO NADPH REGENERATION,0.0057817,-0.28906,-0.22875,1,0
5,GO CYCLOOXYGENASE PATHWAY,0.0010859,-0.2907,-0.43431,1,0
5,GO VIRAL TRANSLATION,0.00065623,-0.29089,-0.30462,1,0
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00057693,-0.29113,-0.30524,1,0
5,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.00353,-0.29117,-0.32282,1,0
5,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,1.104e-05,-0.29133,-0.32553,1,0
5,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.00019079,-0.29186,-0.30639,1,0
5,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,9.7346e-05,-0.29286,-0.32946,1,0
5,GO ADHESION OF SYMBIONT TO HOST,0.00090094,-0.29395,-0.31542,1,0
5,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0025817,-0.29448,-0.2933,1,0
5,GO VIRAL GENE EXPRESSION,0.00012074,-0.29693,-0.30962,1,0
5,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00010845,-0.29723,-0.29152,1,0
5,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0067808,-0.2973,-0.29789,1,0
5,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.004408,-0.29747,-0.2429,1,0
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00065623,-0.29833,-0.33128,1,0
5,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.00016595,-0.29883,-0.31525,1,0
5,GO PODOSOME ASSEMBLY,0.0034322,-0.29936,-0.22308,1,0
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00027832,-0.30102,-0.29775,1,0
5,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,1.349e-05,-0.30142,-0.32743,1,0
5,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00027832,-0.30156,-0.32108,1,0
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,1.2962e-05,-0.30166,-0.33063,1,0
5,GO SALIVARY GLAND DEVELOPMENT,0.0030654,-0.30183,-0.27374,1,0
5,GO NEURON REMODELING,0.0064317,-0.30202,-0.23505,1,0
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.016734,-0.30206,-0.25407,1,0
5,GO RIBOSOME ASSEMBLY,0.00021909,-0.30295,-0.34273,1,0
5,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0013054,-0.30387,-0.39128,1,0
5,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0069616,-0.30391,-0.3055,1,0
5,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.0067808,-0.30427,-0.31082,1,0
5,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0015653,-0.3055,-0.31174,1,0
5,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00028792,-0.30558,-0.34709,1,0
5,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00022676,-0.30561,-0.35756,1,0
5,GO MATURATION OF SSU RRNA,0.00024286,-0.30631,-0.31031,1,0
5,GO PHAGOCYTOSIS RECOGNITION,0.0028957,-0.30645,-0.28725,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,9.7346e-05,-0.30652,-0.37893,1,0
5,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00049035,-0.3073,-0.35075,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0018173,-0.30819,-0.37564,1,0
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.014486,-0.30834,-0.26337,1,0
5,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00012512,-0.30904,-0.33289,1,0
5,GO MEMBRANE RAFT ORGANIZATION,0.040234,-0.31008,-0.28401,1,0
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0027346,-0.31033,-0.30222,1,0
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.00010462,-0.31081,-0.33432,1,0
5,GO REGULATION OF CELLULAR EXTRAVASATION,0.00010462,-0.31092,-0.30943,1,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0013872,-0.31132,-0.31608,1,0
5,GO RESPONSE TO EPINEPHRINE,0.0056288,-0.31282,-0.33354,1,0
5,GO SNARE COMPLEX ASSEMBLY,0.0022332,-0.31322,-0.23549,1,0
5,GO POSITIVE REGULATION OF LIPID STORAGE,7.0571e-06,-0.31377,-0.34962,1,0
5,GO CYSTEINE METABOLIC PROCESS,0.00028792,-0.31475,-0.43836,1,0
5,GO GAS TRANSPORT,0.013139,-0.31512,-0.27075,1,0
5,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0014738,-0.31518,-0.30225,1,0
5,GO BASEMENT MEMBRANE ORGANIZATION,0.0036303,-0.31558,-0.30701,1,0
5,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.00012512,-0.31602,-0.31994,1,0
5,GO CELLULAR COPPER ION HOMEOSTASIS,0.00026903,-0.31643,-0.29755,1,0
5,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.0025083,-0.31705,-0.28943,1,0
5,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00032948,-0.31811,-0.36839,1,0
5,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.00019753,-0.31863,-0.29967,1,0
5,GO REGULATION OF CELLULAR RESPIRATION,3.8583e-05,-0.31878,-0.31598,1,0
5,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00081984,-0.31893,-0.30626,1,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.0094949,-0.31951,-0.31016,1,0
5,GO AMINO ACID ACTIVATION,0.00013917,-0.31954,-0.27095,1,0
5,GO ARGININE METABOLIC PROCESS,0.015953,-0.32076,-0.26613,1,0
5,GO NEGATIVE REGULATION OF CELL KILLING,0.0034322,-0.32089,-0.4408,1,0
5,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.00049035,-0.32183,-0.31372,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0085714,-0.3223,-0.33176,1,0
5,GO NOTOCHORD DEVELOPMENT,0.019283,-0.32234,-0.25853,1,0
5,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0006154,-0.32269,-0.33973,1,0
5,GO BIOLOGICAL PHASE,0.027188,-0.3229,-0.30471,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0053338,-0.32322,-0.45593,1,0
5,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00050664,-0.32396,-0.27646,1,0
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.015953,-0.32418,-0.21107,1,0
5,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.0007696,-0.3242,-0.35186,1,0
5,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,3.0689e-05,-0.32429,-0.36175,1,0
5,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0015189,-0.32474,-0.32026,1,0
5,GO EXTRACELLULAR MATRIX DISASSEMBLY,3.3132e-05,-0.32614,-0.32305,1,0
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00072223,-0.32615,-0.3664,1,0
5,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0024367,-0.32653,-0.29408,1,0
5,GO HEME METABOLIC PROCESS,7.547e-05,-0.32693,-0.37108,1,0
5,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00011241,-0.32745,-0.33479,1,0
5,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0016129,-0.32763,-0.30157,1,0
5,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.011047,-0.32804,-0.26776,1,0
5,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00024286,-0.3281,-0.35152,1,0
5,GO T CELL EXTRAVASATION,0.0034322,-0.32832,-0.36938,1,0
5,GO DENDRITIC CELL APOPTOTIC PROCESS,0.00041602,-0.3287,-0.37459,1,0
5,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00035231,-0.32892,-0.33978,1,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.010245,-0.32933,-0.27757,1,0
5,GO GLUCOSE CATABOLIC PROCESS,4.6597e-05,-0.3301,-0.32978,1,0
5,GO MATURATION OF LSU RRNA,0.0017641,-0.33029,-0.30166,1,0
5,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.00069957,-0.3331,-0.28014,1,0
5,GO TRANSLATIONAL INITIATION,8.7323e-05,-0.33318,-0.34066,1,0
5,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.00010092,-0.33423,-0.28079,1,0
5,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,8.4205e-05,-0.33478,-0.32937,1,0
5,GO CELLULAR RESPONSE TO ETHANOL,0.0047853,-0.33521,-0.2424,1,0
5,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.001986,-0.33585,-0.33003,1,0
5,GO IMMUNE RESPONSE TO TUMOR CELL,0.00049035,-0.33735,-0.37703,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.01282,-0.33747,-0.44942,1,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0056288,-0.33918,-0.37418,1,0
5,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.00032948,-0.3405,-0.35805,1,0
5,GO NAD METABOLIC PROCESS,3.1888e-05,-0.34063,-0.34447,1,0
5,GO MITOCHONDRIAL RNA METABOLIC PROCESS,7.0571e-06,-0.34173,-0.33704,1,0
5,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,2.9301e-06,-0.34174,-0.35875,1,0
5,GO CYTOPLASMIC TRANSLATION,0.00010462,-0.34247,-0.35738,1,0
5,GO REGULATION OF HORMONE METABOLIC PROCESS,7.8282e-05,-0.34281,-0.37287,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00092958,-0.34598,-0.39207,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.014841,-0.34721,-0.22418,1,0
5,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0030654,-0.34726,-0.28715,1,0
5,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,1.5201e-05,-0.34738,-0.30662,1,0
5,GO MONONUCLEAR CELL DIFFERENTIATION,8.4205e-05,-0.34927,-0.32719,1,0
5,GO PURINE CONTAINING COMPOUND SALVAGE,0.00019753,-0.34946,-0.33675,1,0
5,GO MUSCLE CELL CELLULAR HOMEOSTASIS,7.3528e-06,-0.35202,-0.42811,1,0
5,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.043763,-0.35291,-0.25714,1,0
5,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.013465,-0.35423,-0.24942,1,0
5,GO PLASMINOGEN ACTIVATION,0.00079435,-0.3559,-0.35078,1,0
5,GO GLYCOPROTEIN CATABOLIC PROCESS,5.0226e-05,-0.35742,-0.4661,1,0
5,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.0040578,-0.35752,-0.33233,1,0
5,GO TOLERANCE INDUCTION,0.00040247,-0.35789,-0.4517,1,0
5,GO L ASCORBIC ACID METABOLIC PROCESS,0.0067808,-0.35936,-0.31269,1,0
5,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0062634,-0.3594,-0.30332,1,0
5,GO HEMIDESMOSOME ASSEMBLY,0.0014738,-0.36219,-0.47951,1,0
5,GO NADH METABOLIC PROCESS,2.9532e-05,-0.36474,-0.33113,1,0
5,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00065623,-0.36489,-0.39603,1,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.014138,-0.36675,-0.3517,1,0
5,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00047456,-0.36691,-0.34892,1,0
5,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.00059588,-0.36735,-0.38898,1,0
5,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00035231,-0.36887,-0.27429,1,0
5,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0071468,-0.37032,-0.35011,1,0
5,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0057817,-0.37189,-0.3445,1,0
5,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00019753,-0.37291,-0.36884,1,0
5,GO REGULATION OF METANEPHROS DEVELOPMENT,5.8301e-05,-0.37345,-0.4581,1,0
5,GO GALACTOSE METABOLIC PROCESS,0.00010462,-0.37418,-0.40274,1,0
5,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.00084609,-0.37518,-0.34916,1,0
5,GO MITOCHONDRIAL TRANSCRIPTION,3.7791e-06,-0.37681,-0.38659,1,0
5,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00016595,-0.3785,-0.37416,1,0
5,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00047456,-0.37867,-0.43023,1,0
5,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0024367,-0.37891,-0.34518,1,0
5,GO REGULATION OF PODOSOME ASSEMBLY,0.0025083,-0.38062,-0.27319,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.03939,-0.38154,-0.5237,1,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00040247,-0.38249,-0.37753,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00010092,-0.38265,-0.38701,1,0
5,GO HEPARIN METABOLIC PROCESS,0.00026903,-0.3827,-0.39268,1,0
5,GO AMP METABOLIC PROCESS,2.0033e-05,-0.38299,-0.41224,1,0
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0057817,-0.38324,-0.4981,1,0
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00072223,-0.38494,-0.33248,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00044439,-0.38591,-0.38007,1,0
5,GO INFLAMMATORY RESPONSE TO WOUNDING,0.011904,-0.3875,-0.37017,1,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,8.1192e-05,-0.38968,-0.36024,1,0
5,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.00021167,-0.39076,-0.42321,1,0
5,GO RESPONSE TO INTERLEUKIN 18,0.0097392,-0.39257,-0.38962,1,0
5,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00010462,-0.39397,-0.40364,1,0
5,GO CHAPERONE MEDIATED AUTOPHAGY,0.00020448,-0.39713,-0.42948,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0015653,-0.39874,-0.27349,1,0
5,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.001662,-0.3999,-0.34175,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,1.349e-05,-0.4009,-0.40559,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00016023,-0.40567,-0.43101,1,0
5,GO IMP METABOLIC PROCESS,0.00032948,-0.40915,-0.39127,1,0
5,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,2.3418e-05,-0.41009,-0.52284,1,0
5,GO GTP METABOLIC PROCESS,1.8251e-06,-0.41094,-0.39422,1,0
5,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00092958,-0.41498,-0.48337,1,0
5,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.0025083,-0.41547,-0.39332,1,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00010845,-0.42787,-0.40315,1,0
5,GO ACTIN FILAMENT NETWORK FORMATION,0.0064317,-0.43141,-0.31132,1,0
5,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,1.5816e-05,-0.43346,-0.45264,1,0
5,GO NUCLEOTIDE SALVAGE,5.2139e-05,-0.45031,-0.46088,1,0
5,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00029782,-0.45436,-0.46687,1,0
5,GO MUCUS SECRETION,0.015574,-0.46498,-0.43424,1,0
5,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.0049174,-0.48123,-0.50098,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.027803,-0.48135,-0.68322,1,0
5,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00079435,-0.48464,-0.40041,1,0
5,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00054072,-0.48634,-0.49898,1,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,3.6228e-06,-0.51438,-0.55938,1,0
5,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0014738,-0.51625,-0.4443,1,0
5,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.00011241,-0.54617,-0.54297,1,0
5,GO PEPTIDYL PROLINE HYDROXYLATION,5.2139e-05,-0.54661,-0.48499,1,0
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,8.4205e-05,-0.54861,-0.54181,1,0
5,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.0046564,-0.55252,-0.38796,1,0
5,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00021167,-0.55395,-0.51914,1,0
5,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0034322,-0.57773,-0.3599,1,0
5,GO CAMP BIOSYNTHETIC PROCESS,0.23589,0.25617,0.11348,0,1
5,GO HORMONE CATABOLIC PROCESS,0.32506,0.23353,0.098587,0,1
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.092194,0.22398,0.14624,0,1
5,GO ATRIAL SEPTUM DEVELOPMENT,0.10845,0.2157,0.15752,0,1
5,GO REGULATION OF RECEPTOR CLUSTERING,0.54903,0.19506,0.044377,0,1
5,GO CARDIAC ATRIUM MORPHOGENESIS,0.1028,0.1897,0.12182,0,1
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.093897,0.18503,0.1031,0,1
5,GO GAMMA DELTA T CELL ACTIVATION,0.072231,0.17644,0.17893,0,1
5,GO EMBRYONIC HEMOPOIESIS,0.049546,0.1764,0.13764,0,1
5,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.12259,0.16901,0.11612,0,1
5,GO RESPONSE TO ACETYLCHOLINE,0.066855,0.16189,0.15257,0,1
5,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.4598,0.15715,0.068504,0,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.10096,0.15507,0.094669,0,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.087232,0.15212,0.093276,0,1
5,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.14285,0.15197,0.11476,0,1
5,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.12049,0.14487,0.13567,0,1
5,GO PARENTAL BEHAVIOR,0.11636,0.13147,0.24246,0,1
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.26098,0.12818,0.052355,0,1
5,GO BONE MATURATION,0.38408,0.12652,0.047794,0,1
5,GO CENTRIOLE ASSEMBLY,0.057089,0.12118,0.076386,0,1
5,GO NEURON PROJECTION ARBORIZATION,0.15015,0.11846,0.11555,0,1
5,GO REGULATION OF GLIOGENESIS,0.1028,0.11633,0.060542,0,1
5,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.080955,0.11421,0.086114,0,1
5,GO REGULATION OF ENDOCYTIC RECYCLING,0.34256,0.11124,0.052614,0,1
5,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.080955,0.10976,0.096671,0,1
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.12689,0.10695,0.10347,0,1
5,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.25001,0.10661,0.080227,0,1
5,GO REGULATION OF HISTONE H4 ACETYLATION,0.17653,0.1063,0.073406,0,1
5,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.10845,0.10234,0.093798,0,1
5,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.084046,0.097154,0.096557,0,1
5,GO REGULATION OF EXIT FROM MITOSIS,0.48131,0.095449,0.031097,0,1
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.066855,0.094145,0.088829,0,1
5,GO MITOTIC DNA REPLICATION CHECKPOINT,0.34256,0.091843,0.058347,0,1
5,GO EXIT FROM MITOSIS,0.2,0.091271,0.044612,0,1
5,GO POST EMBRYONIC DEVELOPMENT,0.15773,0.091221,0.060981,0,1
5,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.15015,0.083841,0.08743,0,1
5,GO ERYTHROCYTE DEVELOPMENT,0.18219,0.081974,0.046358,0,1
5,GO CHROMOSOME CONDENSATION,0.068167,0.072319,0.07196,0,1
5,GO REGULATION OF PROTEIN ACETYLATION,0.12689,0.070073,0.051285,0,1
5,GO REGULATION OF CELL CYCLE CHECKPOINT,0.25729,0.062979,0.028908,0,1
5,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.093897,0.062972,0.089715,0,1
5,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.092194,0.062067,0.076024,0,1
5,GO MICROTUBULE BASED PROCESS,0.10465,0.052988,0.037987,0,1
5,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.51459,0.049261,0.024579,0,1
5,GO PROTEIN MONOUBIQUITINATION,0.18219,0.048425,0.043638,0,1
5,GO SPINDLE ASSEMBLY,0.20309,0.046098,0.031364,0,1
5,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.47588,0.041302,0.017447,0,1
5,GO CYTOKINESIS,0.51459,0.039657,0.0087367,0,1
5,GO G2 DNA DAMAGE CHECKPOINT,0.16828,0.037971,0.055508,0,1
5,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.36991,0.033313,0.020263,0,1
5,GO DNA INTEGRITY CHECKPOINT,0.33373,0.014153,0.02201,0,1
5,GO TRIGEMINAL NERVE DEVELOPMENT,0.0017641,0.56509,0.39329,0,0
5,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0032441,0.4034,0.50129,0,0
5,GO CARDIAC CELL FATE COMMITMENT,0.0007696,0.37705,0.4258,0,0
5,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.00069957,0.36995,0.43845,0,0
5,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.033894,0.3683,0.26611,0,0
5,GO NEURON FATE COMMITMENT,0.00024286,0.36407,0.35917,0,0
5,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0028141,0.32785,0.33325,0,0
5,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0032441,0.32398,0.4015,0,0
5,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0083534,0.31378,0.36663,0,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.075049,0.30235,0.25891,0,0
5,GO GANGLION DEVELOPMENT,0.018836,0.29579,0.31666,0,0
5,GO NOSE DEVELOPMENT,0.0011199,0.29508,0.48764,0,0
5,GO ADENOHYPOPHYSIS DEVELOPMENT,0.11636,0.27662,0.23212,0,0
5,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.12908,0.27423,0.12782,0,0
5,GO GDP METABOLIC PROCESS,0.0019282,0.24993,0.28554,0,0
5,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.027803,0.24704,0.28339,0,0
5,GO CELL DIFFERENTIATION IN SPINAL CORD,9.7346e-05,0.247,0.24281,0,0
5,GO RETINAL GANGLION CELL AXON GUIDANCE,0.050569,0.24247,0.28771,0,0
5,GO MYOBLAST MIGRATION,0.28785,0.24064,0.056291,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00090094,0.23917,0.2542,0,0
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.29586,0.23902,0.082841,0,0
5,GO POSITIVE REGULATION OF BEHAVIOR,0.050569,0.23749,0.17189,0,0
5,GO DNA DEAMINATION,0.17374,0.23578,0.10179,0,0
5,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0090226,0.23374,0.20845,0,0
5,GO SPINAL CORD PATTERNING,0.0041716,0.23342,0.29891,0,0
5,GO REGULATION OF GROWTH HORMONE SECRETION,0.014841,0.23303,0.29273,0,0
5,GO PITUITARY GLAND DEVELOPMENT,0.066855,0.23103,0.15001,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.075049,0.22842,0.23761,0,0
5,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.33373,0.22824,0.062115,0,0
5,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.099158,0.22229,0.13961,0,0
5,GO CYTIDINE TO URIDINE EDITING,0.4598,0.22116,0.080599,0,0
5,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.001872,0.22092,0.27809,0,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.031748,0.21972,0.19344,0,0
5,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.012203,0.21508,0.21656,0,0
5,GO GABAERGIC NEURON DIFFERENTIATION,0.099158,0.21413,0.32672,0,0
5,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0012662,0.21081,0.32137,0,0
5,GO VOCALIZATION BEHAVIOR,0.17653,0.20997,0.20903,0,0
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.50337,0.20935,0.034988,0,0
5,GO THALAMUS DEVELOPMENT,0.097379,0.20749,0.18023,0,0
5,GO PRO B CELL DIFFERENTIATION,0.27999,0.20568,0.085646,0,0
5,GO FOREBRAIN REGIONALIZATION,0.0051916,0.20179,0.21858,0,0
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.27227,0.20102,0.1524,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.018398,0.20053,0.23142,0,0
5,GO ECTODERMAL PLACODE DEVELOPMENT,0.12473,0.19968,0.17192,0,0
5,GO FORELIMB MORPHOGENESIS,0.019739,0.19903,0.18199,0,0
5,GO MICROTUBULE DEPOLYMERIZATION,0.035393,0.19877,0.16317,0,0
5,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.015953,0.19782,0.26827,0,0
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.18508,0.19556,0.16503,0,0
5,GO LONG TERM SYNAPTIC DEPRESSION,0.023205,0.19498,0.17027,0,0
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.014138,0.19402,0.17731,0,0
5,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.1028,0.19174,0.20522,0,0
5,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.27611,0.19147,0.12022,0,0
5,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.075049,0.18767,0.1864,0,0
5,GO RETINAL ROD CELL DIFFERENTIATION,0.029719,0.18766,0.23239,0,0
5,GO REGULATION OF TRANSPOSITION,0.072231,0.18666,0.14369,0,0
5,GO KERATINOCYTE DEVELOPMENT,0.097379,0.18628,0.20096,0,0
5,GO CARDIAC VENTRICLE FORMATION,0.044685,0.18533,0.31571,0,0
5,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.4598,0.18447,0.077829,0,0
5,GO LIMB BUD FORMATION,0.055956,0.18176,0.18681,0,0
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.23589,0.18145,0.19432,0,0
5,GO CARDIAC CHAMBER FORMATION,0.1028,0.17832,0.22583,0,0
5,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.57857,0.17482,0.057554,0,0
5,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.079444,0.17418,0.20289,0,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.044685,0.17366,0.20855,0,0
5,GO KINETOCHORE ASSEMBLY,0.10096,0.17329,0.092666,0,0
5,GO VENTRAL SPINAL CORD DEVELOPMENT,0.027803,0.16926,0.14734,0,0
5,GO LATERAL MESODERM DEVELOPMENT,0.36991,0.16915,0.032181,0,0
5,GO MRNA SPLICE SITE SELECTION,0.004408,0.16901,0.1797,0,0
5,GO THYROID GLAND DEVELOPMENT,0.69061,0.16871,0.029687,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.18219,0.16784,0.1118,0,0
5,GO CEREBELLAR CORTEX DEVELOPMENT,0.012203,0.16713,0.16278,0,0
5,GO DORSAL SPINAL CORD DEVELOPMENT,0.023205,0.16625,0.2201,0,0
5,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.12908,0.1658,0.16805,0,0
5,GO REGULATION OF MESODERM DEVELOPMENT,0.16559,0.16572,0.094918,0,0
5,GO CEREBELLAR CORTEX MORPHOGENESIS,0.010773,0.16541,0.16495,0,0
5,GO DECIDUALIZATION,0.47049,0.16516,0.042433,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.085627,0.16443,0.12447,0,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.56075,0.16428,0.038846,0,0
5,GO NEURAL NUCLEUS DEVELOPMENT,0.045624,0.1635,0.16018,0,0
5,GO RESPONSE TO UV B,0.42347,0.16204,0.072767,0,0
5,GO CELL MIGRATION IN HINDBRAIN,0.13814,0.1617,0.12166,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.015953,0.16162,0.19362,0,0
5,GO FOREBRAIN NEURON DIFFERENTIATION,0.053746,0.16153,0.19812,0,0
5,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.092194,0.1611,0.1233,0,0
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.066855,0.16104,0.12109,0,0
5,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.16559,0.15995,0.10648,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.068167,0.1585,0.18868,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.030383,0.15837,0.22942,0,0
5,GO AXO DENDRITIC PROTEIN TRANSPORT,0.4598,0.15816,0.059166,0,0
5,GO PYRAMIDAL NEURON DIFFERENTIATION,0.20937,0.15777,0.12062,0,0
5,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.13583,0.15348,0.12294,0,0
5,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.024846,0.1522,0.17525,0,0
5,GO DORSAL VENTRAL PATTERN FORMATION,0.0030654,0.15134,0.15216,0,0
5,GO PROXIMAL DISTAL PATTERN FORMATION,0.24288,0.1504,0.11744,0,0
5,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.188,0.15039,0.11849,0,0
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.42855,0.14978,0.17625,0,0
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.041093,0.14967,0.19187,0,0
5,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.17374,0.14921,0.088356,0,0
5,GO REGULATION OF CHROMATIN BINDING,0.05161,0.14821,0.10152,0,0
5,GO CELL FATE DETERMINATION,0.25729,0.14813,0.083833,0,0
5,GO FOREBRAIN GENERATION OF NEURONS,0.057089,0.1475,0.1572,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.012203,0.14511,0.1409,0,0
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.02843,0.14421,0.24918,0,0
5,GO SYNAPTIC VESICLE CLUSTERING,0.12473,0.14364,0.28017,0,0
5,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.90599,0.14356,0.011063,0,0
5,GO OLFACTORY LOBE DEVELOPMENT,0.073629,0.14334,0.1645,0,0
5,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.26847,0.14205,0.13813,0,0
5,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.60272,0.14193,0.039655,0,0
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.34256,0.14162,0.11174,0,0
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.12908,0.14142,0.11015,0,0
5,GO MEGAKARYOCYTE DEVELOPMENT,0.082489,0.1405,0.16833,0,0
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.80989,0.14048,-0.01322,0,0
5,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.027188,0.14045,0.15697,0,0
5,GO SPINAL CORD DEVELOPMENT,0.012203,0.14033,0.13399,0,0
5,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.37932,0.13804,0.031519,0,0
5,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.19095,0.13793,0.11771,0,0
5,GO LUNG CELL DIFFERENTIATION,0.30402,0.13759,0.1784,0,0
5,GO CELL PROLIFERATION IN HINDBRAIN,0.27999,0.13715,0.088473,0,0
5,GO CEREBELLAR CORTEX FORMATION,0.029719,0.13685,0.18427,0,0
5,GO ENDOCARDIUM DEVELOPMENT,0.13355,0.13653,0.1635,0,0
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.13583,0.13563,0.10275,0,0
5,GO HISTONE H4 K5 ACETYLATION,0.00353,0.13458,0.17538,0,0
5,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.082489,0.13435,0.14268,0,0
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.061812,0.13428,0.10157,0,0
5,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.064293,0.13411,0.50273,0,0
5,GO SPERM AXONEME ASSEMBLY,0.12049,0.13389,0.12811,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.25363,0.13372,0.077914,0,0
5,GO CELLULAR RESPONSE TO LITHIUM ION,0.17653,0.13025,0.13169,0,0
5,GO RETINA LAYER FORMATION,0.025994,0.12943,0.2511,0,0
5,GO MITRAL VALVE DEVELOPMENT,0.33373,0.12826,0.071601,0,0
5,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.085627,0.12811,0.13184,0,0
5,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.011047,0.12695,0.11452,0,0
5,GO RESPONSE TO FOOD,0.037747,0.1265,0.087328,0,0
5,GO NEURAL TUBE PATTERNING,0.40843,0.12649,0.04383,0,0
5,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.67776,0.12643,0.038595,0,0
5,GO GLIAL CELL FATE COMMITMENT,0.041967,0.12569,0.3048,0,0
5,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.063042,0.12518,0.10248,0,0
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.40349,0.1249,0.086341,0,0
5,GO HEART FORMATION,0.50896,0.12436,0.053048,0,0
5,GO ACTIN FILAMENT BASED TRANSPORT,0.13583,0.12427,0.10956,0,0
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.25363,0.12411,0.075124,0,0
5,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.22568,0.12378,0.061396,0,0
5,GO COLLECTING DUCT DEVELOPMENT,0.027188,0.12372,0.1617,0,0
5,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.040234,0.12329,0.10478,0,0
5,GO PROGESTERONE METABOLIC PROCESS,0.62732,0.12269,-0.026904,0,0
5,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.26098,0.12203,0.085146,0,0
5,GO SECONDARY HEART FIELD SPECIFICATION,0.14769,0.12175,0.16463,0,0
5,GO REGULATION OF CELL PROJECTION SIZE,0.63354,0.12086,0.033029,0,0
5,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.3746,0.12063,0.066372,0,0
5,GO TELENCEPHALON REGIONALIZATION,0.16294,0.12056,0.16289,0,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.36064,0.12049,0.084666,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.02268,0.1198,0.12906,0,0
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.23937,0.11977,0.099476,0,0
5,GO COMMISSURAL NEURON AXON GUIDANCE,0.099158,0.11925,0.16514,0,0
5,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.27611,0.11914,0.11557,0,0
5,GO NEURON RECOGNITION,0.21256,0.11911,0.10888,0,0
5,GO DOPAMINE BIOSYNTHETIC PROCESS,0.85082,0.11909,0.038525,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.4545,0.11816,0.038921,0,0
5,GO HISTONE H3 K9 TRIMETHYLATION,0.0073363,0.11794,0.1373,0,0
5,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.013139,0.11776,0.12158,0,0
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.13583,0.11719,0.16809,0,0
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.29586,0.11647,0.11227,0,0
5,GO RESPONSE TO LITHIUM ION,0.055956,0.11546,0.21726,0,0
5,GO RDNA HETEROCHROMATIN ASSEMBLY,0.033894,0.11514,0.12846,0,0
5,GO RESPONSE TO DOPAMINE,0.079444,0.11408,0.083425,0,0
5,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.0695,0.11273,0.15585,0,0
5,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.063042,0.11252,0.11598,0,0
5,GO V D J RECOMBINATION,0.029068,0.11196,0.17426,0,0
5,GO CELL JUNCTION MAINTENANCE,0.042857,0.11155,0.1458,0,0
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.15264,0.11142,0.099924,0,0
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.39371,0.11071,0.028253,0,0
5,GO NEURAL RETINA DEVELOPMENT,0.10845,0.11036,0.10668,0,0
5,GO CELL DIFFERENTIATION IN HINDBRAIN,0.085627,0.10963,0.12538,0,0
5,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.087232,0.10944,0.20613,0,0
5,GO PROTEIN LOCALIZATION TO CHROMATIN,0.03245,0.10927,0.087781,0,0
5,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.16828,0.10922,0.15154,0,0
5,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.38408,0.10845,0.14209,0,0
5,GO NATURAL KILLER CELL DIFFERENTIATION,0.14769,0.1083,0.085153,0,0
5,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.2839,0.10813,0.056845,0,0
5,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.12049,0.10665,0.1033,0,0
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.017549,0.10654,0.11177,0,0
5,GO REGULATION OF MICROTUBULE BINDING,0.026586,0.10645,0.16428,0,0
5,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.034637,0.1064,0.11026,0,0
5,GO HEART FIELD SPECIFICATION,0.50896,0.10622,0.068965,0,0
5,GO NEPHRON TUBULE FORMATION,0.56075,0.10607,0.053947,0,0
5,GO APICAL PROTEIN LOCALIZATION,0.060602,0.1058,0.11984,0,0
5,GO NEURONAL ACTION POTENTIAL,0.54903,0.10505,0.068183,0,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.088862,0.10459,0.10493,0,0
5,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.22905,0.10455,0.0614,0,0
5,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.43367,0.10393,0.03659,0,0
5,GO TONGUE DEVELOPMENT,0.65866,0.10382,0.01908,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.073629,0.10331,0.077929,0,0
5,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.15517,0.10265,0.14316,0,0
5,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.16559,0.10261,0.055656,0,0
5,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.38408,0.10261,0.1705,0,0
5,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.54903,0.10247,0.070008,0,0
5,GO HISTONE H3 K27 METHYLATION,0.033894,0.1023,0.098405,0,0
5,GO CARDIAC ATRIUM DEVELOPMENT,0.33812,0.10206,0.065542,0,0
5,GO DIENCEPHALON DEVELOPMENT,0.188,0.10162,0.092734,0,0
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0033369,0.10148,0.10938,0,0
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.16294,0.10114,0.096595,0,0
5,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.065563,0.10111,0.10577,0,0
5,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.037747,0.10104,0.13536,0,0
5,GO CENTROMERE COMPLEX ASSEMBLY,0.021165,0.10047,0.11984,0,0
5,GO EPITHELIAL CELL MATURATION,0.24643,0.1001,0.10855,0,0
5,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.15264,0.099634,0.2083,0,0
5,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.61497,0.099547,0.048064,0,0
5,GO REGULATION OF STEM CELL DIVISION,0.10654,0.099449,0.10826,0,0
5,GO FILOPODIUM ASSEMBLY,0.73628,0.099259,0.023031,0,0
5,GO OLIGODENDROCYTE DIFFERENTIATION,0.15773,0.098975,0.075352,0,0
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.031748,0.098961,0.15486,0,0
5,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.022165,0.098742,0.10632,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.86455,0.0985,-0.022683,0,0
5,GO NEURON CELL CELL ADHESION,0.33812,0.098451,0.16605,0,0
5,GO SOMATIC STEM CELL DIVISION,0.088862,0.098352,0.24068,0,0
5,GO DENSE CORE GRANULE TRANSPORT,0.47049,0.097673,0.12717,0,0
5,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.30402,0.097574,0.053854,0,0
5,GO INNER DYNEIN ARM ASSEMBLY,0.50337,0.097571,0.095514,0,0
5,GO RENAL WATER HOMEOSTASIS,0.10845,0.097509,0.092382,0,0
5,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.13814,0.097399,0.10193,0,0
5,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.20309,0.096793,0.095964,0,0
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.31232,0.096703,0.056288,0,0
5,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.29992,0.096695,0.091507,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.26471,0.096543,0.076134,0,0
5,GO ENDOCRINE SYSTEM DEVELOPMENT,0.30815,0.095968,0.044953,0,0
5,GO SPERM CAPACITATION,0.29184,0.095955,0.04841,0,0
5,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.13814,0.095817,0.060407,0,0
5,GO POST ANAL TAIL MORPHOGENESIS,0.15773,0.095537,0.076648,0,0
5,GO INTRACILIARY TRANSPORT,0.15264,0.095312,0.11918,0,0
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.15517,0.094981,0.16754,0,0
5,GO SINGLE STRAND BREAK REPAIR,0.38888,0.094599,0.046712,0,0
5,GO G0 TO G1 TRANSITION,0.05161,0.094578,0.092278,0,0
5,GO LIPID DROPLET FORMATION,0.69707,0.094474,0.02504,0,0
5,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.20309,0.093708,0.098435,0,0
5,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.073629,0.093373,0.10223,0,0
5,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.25729,0.093253,0.060671,0,0
5,GO IMMUNOLOGICAL MEMORY PROCESS,0.16032,0.093104,0.10733,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.188,0.092742,0.082434,0,0
5,GO REGULATION OF CENTRIOLE REPLICATION,0.076492,0.092563,0.062574,0,0
5,GO HISTONE H3 K9 METHYLATION,0.037747,0.09193,0.10474,0,0
5,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.69061,0.09167,0.045738,0,0
5,GO SEROTONIN SECRETION,0.16032,0.091401,0.13902,0,0
5,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.47588,0.091177,0.070758,0,0
5,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.14526,0.090648,0.1186,0,0
5,GO SISTER CHROMATID COHESION,0.0087944,0.090618,0.11434,0,0
5,GO VIRAL RNA GENOME REPLICATION,0.65234,0.090388,0.0015023,0,0
5,GO REGULATION OF NEUROBLAST PROLIFERATION,0.13814,0.089954,0.098647,0,0
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.36526,0.089924,0.09946,0,0
5,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.13355,0.089306,0.12565,0,0
5,GO KERATINIZATION,0.25363,0.08922,0.081615,0,0
5,GO EMBRYONIC BODY MORPHOGENESIS,0.27611,0.089118,0.050679,0,0
5,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.26098,0.089028,0.043159,0,0
5,GO REGULATION OF AMINO ACID TRANSPORT,0.32077,0.088742,0.060298,0,0
5,GO SUBPALLIUM DEVELOPMENT,0.38888,0.088409,0.095487,0,0
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.80312,0.08837,-0.012065,0,0
5,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.19393,0.088327,0.15162,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.37932,0.08773,0.099056,0,0
5,GO EMBRYONIC BRAIN DEVELOPMENT,0.52025,0.087672,0.038831,0,0
5,GO APPENDAGE MORPHOGENESIS,0.11039,0.087633,0.060656,0,0
5,GO ASTROCYTE ACTIVATION,0.35607,0.087558,0.038667,0,0
5,GO SUBSTANTIA NIGRA DEVELOPMENT,0.42347,0.087294,0.040885,0,0
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.87833,0.087148,-0.051027,0,0
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.11434,0.087095,0.0943,0,0
5,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.36991,0.086625,0.078859,0,0
5,GO EPIDERMIS MORPHOGENESIS,0.32938,0.086091,0.056349,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.017549,0.086063,0.085762,0,0
5,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.12908,0.085533,0.067001,0,0
5,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.99651,0.085512,-0.019278,0,0
5,GO CENTROSOME SEPARATION,0.029068,0.085417,0.14555,0,0
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.27999,0.085025,0.065384,0,0
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.30815,0.084986,0.095192,0,0
5,GO VIRAL LATENCY,0.1028,0.084945,0.11929,0,0
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.32506,0.084582,0.029243,0,0
5,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.11039,0.084418,0.080833,0,0
5,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.029068,0.083709,0.075371,0,0
5,GO PEPTIDYL LYSINE TRIMETHYLATION,0.045624,0.0833,0.079927,0,0
5,GO ADHERENS JUNCTION ASSEMBLY,0.50337,0.083293,0.049718,0,0
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.43883,0.083249,0.1003,0,0
5,GO UTERUS DEVELOPMENT,0.41341,0.083249,0.070014,0,0
5,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.10096,0.08302,0.10164,0,0
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.44402,0.081876,0.051192,0,0
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.39371,0.081752,0.048941,0,0
5,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.11841,0.081477,0.094163,0,0
5,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.78289,0.080314,0.0011003,0,0
5,GO PROTEIN DEMETHYLATION,0.38888,0.080292,0.039614,0,0
5,GO ERYTHROCYTE MATURATION,0.9686,0.080061,-0.011968,0,0
5,GO NOREPINEPHRINE METABOLIC PROCESS,0.14048,0.080032,0.16147,0,0
5,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.93377,0.079545,-0.006224,0,0
5,GO AMINE BIOSYNTHETIC PROCESS,0.36064,0.079503,0.074087,0,0
5,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.83713,0.079403,0.020175,0,0
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.95466,0.079225,-0.066317,0,0
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.52025,0.078498,0.021616,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.34702,0.078485,0.067583,0,0
5,GO MALE SEX DETERMINATION,0.3746,0.078077,0.089464,0,0
5,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.58456,0.077969,0.066357,0,0
5,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.46512,0.077684,0.034052,0,0
5,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.32938,0.077656,0.094141,0,0
5,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.53742,0.077156,0.032612,0,0
5,GO IMMATURE B CELL DIFFERENTIATION,0.18219,0.076947,0.083262,0,0
5,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.43367,0.076319,0.037463,0,0
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.4978,0.075921,-0.084168,0,0
5,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.25001,0.075533,0.059134,0,0
5,GO MITOTIC SPINDLE ASSEMBLY,0.066855,0.075513,0.078426,0,0
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.93377,0.075489,-0.022053,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.092194,0.07532,0.089329,0,0
5,GO CELLULAR RESPONSE TO VITAMIN,0.93377,0.075222,-0.049955,0,0
5,GO SECRETORY GRANULE LOCALIZATION,0.76948,0.074619,0.027244,0,0
5,GO LUNG EPITHELIUM DEVELOPMENT,0.32938,0.074449,0.10614,0,0
5,GO METAPHASE PLATE CONGRESSION,0.072231,0.074429,0.057418,0,0
5,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.043763,0.074252,0.058646,0,0
5,GO RESPONSE TO HYDROXYUREA,0.024846,0.074003,0.154,0,0
5,GO SKELETAL MUSCLE ADAPTATION,0.71658,0.073979,0.033603,0,0
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.16828,0.073786,0.065873,0,0
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.58456,0.073731,0.038164,0,0
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.89907,0.073456,0.011338,0,0
5,GO RENAL FILTRATION,0.30402,0.073399,0.11965,0,0
5,GO ERROR PRONE TRANSLESION SYNTHESIS,0.30815,0.073306,0.039251,0,0
5,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.188,0.073184,0.093715,0,0
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.69707,0.073106,0.018675,0,0
5,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.83713,0.072665,-0.0077206,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.50896,0.07263,0.057725,0,0
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.63354,0.07245,-0.012349,0,0
5,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.11039,0.072222,0.069496,0,0
5,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.093897,0.072191,0.072562,0,0
5,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.91293,0.072111,-0.0066691,0,0
5,GO SYNAPTIC VESICLE TRANSPORT,0.064293,0.072033,0.12299,0,0
5,GO SYNAPTIC MEMBRANE ADHESION,0.56075,0.072005,0.055849,0,0
5,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.67137,0.071711,0.10165,0,0
5,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.66501,0.071623,0.059674,0,0
5,GO LONG TERM SYNAPTIC POTENTIATION,0.9686,0.071532,-0.0040714,0,0
5,GO MICROTUBULE SEVERING,0.36526,0.071434,0.072313,0,0
5,GO PROTEIN DEPOLYMERIZATION,0.38408,0.071429,0.032415,0,0
5,GO CRANIAL NERVE DEVELOPMENT,0.58456,0.07126,0.027547,0,0
5,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.66501,0.071173,-0.10363,0,0
5,GO HEPATOCYTE DIFFERENTIATION,0.88523,0.070865,0.010343,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.7495,0.070836,0.046687,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.70355,0.070376,0.0083071,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.60272,0.070217,0.040953,0,0
5,GO HINDBRAIN MORPHOGENESIS,0.05161,0.069807,0.080761,0,0
5,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.4598,0.069785,0.038685,0,0
5,GO COCHLEA DEVELOPMENT,0.4978,0.069629,0.040373,0,0
5,GO AXONAL FASCICULATION,0.75615,0.06954,0.010563,0,0
5,GO EPITHELIAL CELL MORPHOGENESIS,0.62113,0.069432,0.059705,0,0
5,GO CELLULAR RESPONSE TO VITAMIN D,0.80989,0.069272,-0.045062,0,0
5,GO POSITIVE REGULATION OF DNA REPLICATION,0.15773,0.068875,0.05008,0,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.47588,0.068736,0.046072,0,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.71006,0.068465,0.02946,0,0
5,GO REGULATION OF DNA BINDING,0.20309,0.068389,0.041551,0,0
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.89907,0.06787,-0.030379,0,0
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.36064,0.067691,0.12001,0,0
5,GO MEIOTIC CHROMOSOME SEPARATION,0.4978,0.067233,0.025844,0,0
5,GO TRIPARTITE REGIONAL SUBDIVISION,0.74288,0.067228,0.024192,0,0
5,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.12473,0.067099,0.049277,0,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.22568,0.06638,0.062734,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.59059,0.066143,0.034898,0,0
5,GO CHROMOSOME SEGREGATION,0.061812,0.066098,0.04267,0,0
5,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.12259,0.065888,0.07094,0,0
5,GO MITOCHONDRION DISTRIBUTION,0.50337,0.065651,0.046082,0,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.39371,0.065329,0.049844,0,0
5,GO DETECTION OF TEMPERATURE STIMULUS,0.35153,0.065319,0.11026,0,0
5,GO REGULATION OF GLUTAMATE SECRETION,0.15015,0.064673,0.17261,0,0
5,GO NON RECOMBINATIONAL REPAIR,0.17653,0.064368,0.040045,0,0
5,GO CELLULAR RESPONSE TO NUTRIENT,0.98255,0.064327,-0.038672,0,0
5,GO ANTEROGRADE AXONAL TRANSPORT,0.27611,0.063987,0.051547,0,0
5,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.061812,0.063695,0.1116,0,0
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.50896,0.063494,0.020071,0,0
5,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.17653,0.06332,0.078012,0,0
5,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.77618,0.062786,0.00033807,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.070855,0.062784,0.077293,0,0
5,GO RESPONSE TO ETHER,0.25363,0.062768,0.0563,0,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.70355,0.062695,0.018927,0,0
5,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.8303,0.062549,0.017722,0,0
5,GO NUCLEOSOME ASSEMBLY,0.10654,0.062313,0.081371,0,0
5,GO HISTONE H3 K9 MODIFICATION,0.045624,0.06223,0.089908,0,0
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.54903,0.062221,0.018414,0,0
5,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.12473,0.062082,0.086843,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.70355,0.062006,0.0073706,0,0
5,GO T HELPER CELL LINEAGE COMMITMENT,0.34256,0.061977,0.046245,0,0
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.16032,0.061825,0.10484,0,0
5,GO REGULATION OF TELOMERE CAPPING,0.31653,0.061773,0.033822,0,0
5,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.81668,0.061769,-0.046353,0,0
5,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.021165,0.061286,0.080524,0,0
5,GO REGULATION OF MICROTUBULE BASED PROCESS,0.11039,0.060905,0.043255,0,0
5,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.89907,0.060877,-0.010038,0,0
5,GO SPERMATID NUCLEUS DIFFERENTIATION,0.35153,0.060841,0.055335,0,0
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.69061,0.060554,0.01102,0,0
5,GO GROWTH HORMONE SECRETION,0.26098,0.060266,0.12011,0,0
5,GO SISTER CHROMATID SEGREGATION,0.030383,0.060237,0.060724,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.34256,0.06019,0.097723,0,0
5,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.065563,0.060045,0.076506,0,0
5,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.47049,0.06004,0.04588,0,0
5,GO CEREBRAL CORTEX DEVELOPMENT,0.18508,0.059816,0.05524,0,0
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.95466,0.059623,-0.012771,0,0
5,GO AXONAL TRANSPORT,0.22235,0.059516,0.065564,0,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.67137,0.059238,-0.0020043,0,0
5,GO ACTIVATION OF JUN KINASE ACTIVITY,0.46512,0.059086,0.025015,0,0
5,GO REGULATION OF TORC1 SIGNALING,0.12908,0.059065,0.050725,0,0
5,GO O GLYCAN PROCESSING,0.86455,0.058982,-0.081883,0,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.44924,0.05891,0.029639,0,0
5,GO PEPTIDYL LYSINE ACETYLATION,0.0051916,0.058904,0.072317,0,0
5,GO AUTOPHAGIC CELL DEATH,0.74288,0.058873,0.0094198,0,0
5,GO MICROTUBULE ANCHORING AT CENTROSOME,0.16559,0.058828,0.092001,0,0
5,GO CYTOPLASM ORGANIZATION,0.62113,0.058764,0.022774,0,0
5,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.39858,0.058656,0.044871,0,0
5,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.188,0.058593,0.078678,0,0
5,GO NUCLEAR MIGRATION,0.32506,0.058527,0.033695,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.12259,0.058505,0.12518,0,0
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.51459,0.058448,0.02089,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.30815,0.058249,0.040868,0,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.36526,0.058186,0.05545,0,0
5,GO MESODERMAL CELL FATE COMMITMENT,0.80989,0.058185,0.015844,0,0
5,GO REGULATION OF CILIUM ASSEMBLY,0.12908,0.057973,0.071239,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.62113,0.057921,0.011529,0,0
5,GO HISTONE H3 K4 TRIMETHYLATION,0.21579,0.057853,0.085815,0,0
5,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.33373,0.057645,0.038032,0,0
5,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.21256,0.057391,0.17894,0,0
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.52025,0.057386,0.027353,0,0
5,GO AXO DENDRITIC TRANSPORT,0.37932,0.057371,0.045076,0,0
5,GO ATP DEPENDENT CHROMATIN REMODELING,0.025414,0.057042,0.079123,0,0
5,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.46512,0.056835,0.032727,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.36064,0.056779,0.061641,0,0
5,GO HINDBRAIN DEVELOPMENT,0.13583,0.056218,0.075608,0,0
5,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.31232,0.055894,0.046925,0,0
5,GO PALLIUM DEVELOPMENT,0.33812,0.055807,0.040337,0,0
5,GO LABYRINTHINE LAYER MORPHOGENESIS,0.78962,0.055796,0.081605,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.61497,0.055745,0.0030061,0,0
5,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.41842,0.055584,0.025345,0,0
5,GO NEGATIVE REGULATION OF RNA SPLICING,0.11841,0.055401,0.072439,0,0
5,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.82348,0.055354,-0.034961,0,0
5,GO NEURONAL ION CHANNEL CLUSTERING,0.76948,0.055305,0.013946,0,0
5,GO MAINTENANCE OF ORGANELLE LOCATION,0.18219,0.055233,0.04508,0,0
5,GO MITOTIC DNA REPLICATION,0.79636,0.055119,0.00114,0,0
5,GO TRACHEA MORPHOGENESIS,0.94769,0.055005,-0.021243,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.52594,0.054986,0.026408,0,0
5,GO DNA STRAND ELONGATION,0.48678,0.0549,0.028423,0,0
5,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.23589,0.054867,0.070674,0,0
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.51459,0.054656,0.0015199,0,0
5,GO CELL FATE COMMITMENT,0.17653,0.054526,0.041201,0,0
5,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.46512,0.054515,0.080524,0,0
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.32077,0.054095,0.061749,0,0
5,GO POSITIVE REGULATION OF CELL MATURATION,0.82348,0.054086,-0.059021,0,0
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.58456,0.054026,0.060833,0,0
5,GO MATERNAL PLACENTA DEVELOPMENT,0.68418,0.053983,0.011608,0,0
5,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.3746,0.053976,0.05379,0,0
5,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.43883,0.053944,0.038183,0,0
5,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.30402,0.053875,0.11799,0,0
5,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.10465,0.053815,0.057343,0,0
5,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.67776,0.053093,0.033698,0,0
5,GO TRANSCYTOSIS,0.65866,0.052983,0.014151,0,0
5,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.32077,0.052979,0.032109,0,0
5,GO METENCEPHALON DEVELOPMENT,0.2,0.052974,0.080036,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.44402,0.052927,0.03966,0,0
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.18508,0.052819,0.07989,0,0
5,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.50337,0.052791,0.059618,0,0
5,GO HEART INDUCTION,0.22568,0.052784,-0.16552,0,0
5,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.81668,0.052623,-0.081885,0,0
5,GO CALCIUM ION IMPORT INTO CYTOSOL,0.94769,0.052599,0.0037829,0,0
5,GO POSITIVE REGULATION OF AXON EXTENSION,0.56075,0.052542,0.02714,0,0
5,GO DNA DOUBLE STRAND BREAK PROCESSING,0.27999,0.052516,0.042749,0,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.077957,0.052298,0.086612,0,0
5,GO REGULATORY T CELL DIFFERENTIATION,0.90599,0.052138,-0.0096683,0,0
5,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.59664,0.051934,0.019288,0,0
5,GO MICROTUBULE BASED MOVEMENT,0.43883,0.051415,0.02721,0,0
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.83713,0.050683,0.0014227,0,0
5,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.56666,0.050415,0.052186,0,0
5,GO NOREPINEPHRINE SECRETION,0.60272,0.050219,0.038878,0,0
5,GO REGULATION OF VIRAL GENOME REPLICATION,0.63978,0.050213,-0.085531,0,0
5,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.51459,0.050103,0.053796,0,0
5,GO REGULATION OF ANIMAL ORGAN FORMATION,0.89907,0.049634,-0.030023,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.80312,0.04956,-0.018962,0,0
5,GO MICROTUBULE POLYMERIZATION,0.47588,0.049526,0.030168,0,0
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.53167,0.049473,-0.05189,0,0
5,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.14048,0.049137,0.11653,0,0
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.20309,0.048985,0.053489,0,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION,0.25001,0.048765,0.048055,0,0
5,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.19095,0.048743,0.10158,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.3746,0.048733,0.031948,0,0
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.98255,0.048637,-0.016972,0,0
5,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.29586,0.04861,0.032607,0,0
5,GO CORNIFICATION,0.47049,0.048599,0.052116,0,0
5,GO PROTEIN ACETYLATION,0.023205,0.048256,0.051321,0,0
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.96163,0.048225,0.015088,0,0
5,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.67776,0.048207,0.035026,0,0
5,GO POSITIVE REGULATION OF DNA REPAIR,0.03939,0.048206,0.062894,0,0
5,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.84397,0.048148,0.012167,0,0
5,GO RESPONSE TO INTERLEUKIN 2,0.98255,0.048082,-0.0028341,0,0
5,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.32506,0.047907,0.10453,0,0
5,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.10845,0.047711,0.069381,0,0
5,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.20621,0.047705,0.037667,0,0
5,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.3746,0.047532,0.044908,0,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.72969,0.047505,0.0073223,0,0
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.56666,0.047319,0.0074959,0,0
5,GO AXONAL TRANSPORT OF MITOCHONDRION,0.81668,0.04717,-0.013314,0,0
5,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.4978,0.04709,-0.064999,0,0
5,GO ENDOCYTIC RECYCLING,0.88523,0.047046,0.0016165,0,0
5,GO ACTIN CROSSLINK FORMATION,0.71006,0.047018,0.013014,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.15264,0.046921,0.14483,0,0
5,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.94073,0.046918,-0.0025425,0,0
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.43367,0.046846,0.10391,0,0
5,GO EMBRYONIC AXIS SPECIFICATION,0.34702,0.046815,0.055169,0,0
5,GO REGULATION OF CYTOKINESIS,0.21579,0.046721,0.026201,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.62113,0.046583,0.040706,0,0
5,GO HISTONE EXCHANGE,0.24288,0.046508,0.046652,0,0
5,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.85768,0.046405,-0.051662,0,0
5,GO HEAD DEVELOPMENT,0.22235,0.046318,0.038521,0,0
5,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.16828,0.046313,0.053933,0,0
5,GO HISTONE H3 K4 METHYLATION,0.087232,0.046059,0.096798,0,0
5,GO REPRODUCTIVE BEHAVIOR,0.87144,0.045826,-0.018378,0,0
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.65866,0.04576,0.0057251,0,0
5,GO STEM CELL PROLIFERATION,0.066855,0.045733,0.080762,0,0
5,GO EMBRYONIC PLACENTA DEVELOPMENT,0.57857,0.045727,0.034263,0,0
5,GO HISTONE H3 K36 METHYLATION,0.25363,0.04553,0.063655,0,0
5,GO PROTEIN LOCALIZATION TO SYNAPSE,0.32077,0.045427,0.081929,0,0
5,GO INTERLEUKIN 10 PRODUCTION,0.90599,0.04542,-0.02616,0,0
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.69061,0.045401,-0.045377,0,0
5,GO TELENCEPHALON DEVELOPMENT,0.39371,0.045201,0.031432,0,0
5,GO SMOOTHENED SIGNALING PATHWAY,0.62113,0.04507,0.014731,0,0
5,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.60272,0.044974,0.026621,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.16294,0.044808,0.05921,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.21256,0.044798,0.055607,0,0
5,GO OTIC VESICLE DEVELOPMENT,0.48678,0.044759,0.07044,0,0
5,GO REGULATION OF BEHAVIOR,0.95466,0.044741,-0.022354,0,0
5,GO RECOMBINATIONAL REPAIR,0.14526,0.044622,0.040014,0,0
5,GO NATURAL KILLER CELL PROLIFERATION,0.87833,0.044618,-0.018515,0,0
5,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.89215,0.044546,-0.023933,0,0
5,GO REGULATION OF MRNA PROCESSING,0.47049,0.044495,0.025887,0,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.24643,0.044384,0.046718,0,0
5,GO COCHLEA MORPHOGENESIS,0.43883,0.0443,-0.087648,0,0
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.90599,0.044128,-0.019168,0,0
5,GO T CELL HOMEOSTASIS,0.42855,0.044074,0.026787,0,0
5,GO REGULATION OF FIBROBLAST MIGRATION,0.63978,0.043866,-0.0025741,0,0
5,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.52025,0.043846,0.018576,0,0
5,GO DNA DEPENDENT DNA REPLICATION,0.99651,0.043803,0.0094821,0,0
5,GO CILIUM ORGANIZATION,0.26098,0.043719,0.054154,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.91987,0.043718,0.0015966,0,0
5,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.15517,0.043608,0.059439,0,0
5,GO HISTONE H3 K9 ACETYLATION,0.19393,0.043305,0.049325,0,0
5,GO CELL PROLIFERATION IN FOREBRAIN,0.56075,0.043303,0.013343,0,0
5,GO FOREBRAIN DEVELOPMENT,0.090515,0.04328,0.061473,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.88523,0.04327,-0.016817,0,0
5,GO ECTODERM DEVELOPMENT,0.10654,0.043265,0.080515,0,0
5,GO POSITIVE REGULATION OF AXONOGENESIS,0.34702,0.043259,0.056376,0,0
5,GO PSEUDOPODIUM ORGANIZATION,0.91987,0.04324,0.0014752,0,0
5,GO HETEROCHROMATIN ORGANIZATION,0.088862,0.043233,0.060705,0,0
5,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.2839,0.042758,0.057034,0,0
5,GO REGULATION OF FILOPODIUM ASSEMBLY,0.87833,0.042718,0.012766,0,0
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.38888,0.042518,0.077036,0,0
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.98953,0.042487,-0.026443,0,0
5,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.81668,0.042186,-0.026079,0,0
5,GO SARCOMERE ORGANIZATION,0.9686,0.041878,-0.004207,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.69061,0.041872,0.016037,0,0
5,GO NEURON PROJECTION REGENERATION,0.96163,0.041727,-0.0039813,0,0
5,GO REGULATION OF CHROMOSOME SEGREGATION,0.32506,0.041674,0.031828,0,0
5,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.36064,0.041604,0.029107,0,0
5,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.39858,0.041546,0.036995,0,0
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.28785,0.041438,0.1218,0,0
5,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.29992,0.041365,0.033995,0,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.43883,0.041328,0.031559,0,0
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.5726,0.041176,0.012173,0,0
5,GO MITOTIC METAPHASE PLATE CONGRESSION,0.17374,0.041163,0.055471,0,0
5,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.71006,0.041049,0.08777,0,0
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.36526,0.040947,0.052069,0,0
5,GO ER OVERLOAD RESPONSE,0.81668,0.040911,0.020319,0,0
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.89907,0.040682,-0.030802,0,0
5,GO ADRENAL GLAND DEVELOPMENT,0.97557,0.040142,-0.02081,0,0
5,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.10465,0.040136,0.061477,0,0
5,GO CELLULAR COMPONENT MAINTENANCE,0.25729,0.04008,0.054256,0,0
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.81668,0.040012,0.011049,0,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.98953,0.039924,0.0089747,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.83713,0.039736,-0.029622,0,0
5,GO LABYRINTHINE LAYER DEVELOPMENT,0.79636,0.039622,0.033426,0,0
5,GO GMP METABOLIC PROCESS,0.34256,0.039611,0.070784,0,0
5,GO RESPONSE TO NITROSATIVE STRESS,0.91987,0.039402,-0.069093,0,0
5,GO REGULATION OF ISOTYPE SWITCHING,0.42855,0.039341,-0.024218,0,0
5,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.33373,0.039245,0.051995,0,0
5,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.69061,0.039212,0.03631,0,0
5,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.48131,0.039189,0.034208,0,0
5,GO T CELL SELECTION,0.22568,0.039123,0.047849,0,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.71006,0.038894,0.017188,0,0
5,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.66501,0.038789,0.012202,0,0
5,GO 3 UTR MEDIATED MRNA STABILIZATION,0.74288,0.038712,0.020881,0,0
5,GO POSITIVE T CELL SELECTION,0.34256,0.038691,0.035651,0,0
5,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.25729,0.03864,0.060949,0,0
5,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.32506,0.038637,0.046345,0,0
5,GO TELOMERE CAPPING,0.093897,0.038423,0.053229,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.97557,0.038292,-0.010502,0,0
5,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.20937,0.038291,0.079174,0,0
5,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.54321,0.038248,0.18076,0,0
5,GO GONADOTROPIN SECRETION,0.3746,0.038023,0.096977,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.53742,0.037965,0.03672,0,0
5,GO NON MOTILE CILIUM ASSEMBLY,0.21579,0.037869,0.079639,0,0
5,GO MITOTIC CELL CYCLE CHECKPOINT,0.24288,0.037813,0.026506,0,0
5,GO MYELOID CELL DEVELOPMENT,0.21905,0.037809,0.048561,0,0
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.85768,0.037703,0.018828,0,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.44402,0.037515,0.028891,0,0
5,GO TRANSPORT ALONG MICROTUBULE,0.21256,0.037508,0.04032,0,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.68418,0.037404,-0.010783,0,0
5,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.53742,0.037392,0.026354,0,0
5,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.088862,0.037312,0.092341,0,0
5,GO MICROTUBULE BASED TRANSPORT,0.41842,0.037067,0.021689,0,0
5,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.67137,0.037009,0.022677,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.4978,0.036838,0.011793,0,0
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.73628,0.036818,0.0094388,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.8303,0.036721,-0.019078,0,0
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.71006,0.03667,-0.093281,0,0
5,GO MICROTUBULE NUCLEATION,0.47049,0.036664,0.038433,0,0
5,GO CHROMATIN REMODELING,0.13583,0.036652,0.042239,0,0
5,GO POSITIVE REGULATION OF CELL GROWTH,0.87144,0.036634,-0.0024964,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.26847,0.036611,0.1078,0,0
5,GO PHOTORECEPTOR CELL MAINTENANCE,0.76281,0.036282,0.0049616,0,0
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.94073,0.036178,0.0064469,0,0
5,GO REGULATION OF ORGANIC ACID TRANSPORT,0.64605,0.035866,-0.0028684,0,0
5,GO PROTEIN K11 LINKED UBIQUITINATION,0.97557,0.035843,-0.013225,0,0
5,GO RESPONSE TO CATECHOLAMINE,0.73628,0.035832,0.016914,0,0
5,GO AMMONIUM TRANSPORT,0.44402,0.035817,0.069616,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.34256,0.035624,0.026178,0,0
5,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.91293,0.035553,-0.0052489,0,0
5,GO REGULATION OF MEIOTIC CELL CYCLE,0.50337,0.035017,0.029013,0,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.99651,0.034905,-0.021218,0,0
5,GO MITOTIC NUCLEAR DIVISION,0.14526,0.034891,0.039565,0,0
5,GO REGULATION OF HISTONE METHYLATION,0.17934,0.034886,0.060576,0,0
5,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.86455,0.034853,-0.015217,0,0
5,GO CLATHRIN COAT ASSEMBLY,0.99651,0.03476,-0.0010597,0,0
5,GO POSITIVE REGULATION OF HORMONE SECRETION,0.26098,0.034736,0.044271,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.53167,0.034711,0.011294,0,0
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.9686,0.034616,-0.040492,0,0
5,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.095625,0.034558,0.044002,0,0
5,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.50337,0.034252,-0.065065,0,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.91293,0.034141,-0.05335,0,0
5,GO PATTERN SPECIFICATION PROCESS,0.53167,0.034111,0.015063,0,0
5,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.40843,0.034034,0.029004,0,0
5,GO PHOTORECEPTOR CELL DEVELOPMENT,0.68418,0.033881,0.020965,0,0
5,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.60883,0.033676,0.027725,0,0
5,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.58456,0.033327,0.036472,0,0
5,GO VIRAL BUDDING,0.78289,0.033281,0.028647,0,0
5,GO REGULATION OF RESPIRATORY BURST,0.93377,0.033235,-0.0063309,0,0
5,GO CHONDROCYTE DEVELOPMENT,0.66501,0.032923,-0.004926,0,0
5,GO SEQUESTERING OF ACTIN MONOMERS,0.29184,0.032768,0.19738,0,0
5,GO VESICLE CYTOSKELETAL TRAFFICKING,0.21256,0.032754,0.048154,0,0
5,GO HINDLIMB MORPHOGENESIS,0.64605,0.03271,0.02968,0,0
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.56666,0.032593,0.017447,0,0
5,GO CHROMATIN ORGANIZATION,0.072231,0.032585,0.036598,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.38888,0.032499,-0.099387,0,0
5,GO DNA PACKAGING,0.077957,0.032447,0.058046,0,0
5,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.67137,0.03241,0.034269,0,0
5,GO MAGNESIUM ION HOMEOSTASIS,0.80312,0.03237,0.023989,0,0
5,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.53742,0.032234,0.022532,0,0
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.94073,0.032187,0.00055534,0,0
5,GO REGULATION OF SPINDLE ORGANIZATION,0.52594,0.032155,0.021723,0,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.79636,0.032129,0.082923,0,0
5,GO RESPONSE TO PARATHYROID HORMONE,0.53167,0.031982,0.0018776,0,0
5,GO REGULATION OF CELL FATE COMMITMENT,0.36526,0.031901,0.049401,0,0
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.47588,0.031871,0.02017,0,0
5,GO DENDRITE MORPHOGENESIS,0.4545,0.031832,0.057336,0,0
5,GO CAMERA TYPE EYE MORPHOGENESIS,0.24643,0.031762,0.041725,0,0
5,GO REGULATION OF NEURON MIGRATION,0.87833,0.031724,-0.0049609,0,0
5,GO PANCREAS DEVELOPMENT,0.63978,0.031689,0.025807,0,0
5,GO NEURAL CREST FORMATION,0.19095,0.03165,0.11396,0,0
5,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.85082,0.031525,-0.018878,0,0
5,GO DNA REPLICATION CHECKPOINT,0.67137,0.031501,0.033324,0,0
5,GO PROTEIN ACYLATION,0.15773,0.031433,0.034282,0,0
5,GO MITOCHONDRION LOCALIZATION,0.54321,0.031343,0.029856,0,0
5,GO DETECTION OF MECHANICAL STIMULUS,0.22905,0.031115,0.073382,0,0
5,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.34256,0.03105,0.03836,0,0
5,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.32938,0.030846,0.045879,0,0
5,GO REGULATION OF CIRCADIAN RHYTHM,0.20309,0.03077,0.036035,0,0
5,GO REGULATION OF RECEPTOR INTERNALIZATION,0.75615,0.030741,-0.0062905,0,0
5,GO REGULATION OF GASTRIC ACID SECRETION,0.79636,0.030402,-0.015579,0,0
5,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.67776,0.030205,0.0094346,0,0
5,GO LEFT RIGHT PATTERN FORMATION,0.96163,0.030164,-0.0045768,0,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.27227,0.030148,0.032555,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.94073,0.030148,-0.048154,0,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.41341,0.030137,0.02871,0,0
5,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.22905,0.030099,0.10298,0,0
5,GO NOTCH RECEPTOR PROCESSING,0.36991,0.030053,0.077984,0,0
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,1,0.029961,0.00056056,0,0
5,GO REGULATION OF CENTROSOME DUPLICATION,0.29586,0.02995,0.048496,0,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.50896,0.029831,-0.075693,0,0
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.30402,0.029822,0.093229,0,0
5,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.80989,0.029636,0.031522,0,0
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.4598,0.029566,0.03062,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.72969,0.029437,0.037453,0,0
5,GO REGULATION OF CELL DIVISION,0.69707,0.029407,0.0032396,0,0
5,GO SPINDLE LOCALIZATION,0.26471,0.029315,0.052555,0,0
5,GO WATER HOMEOSTASIS,0.29184,0.029248,0.056906,0,0
5,GO CELL CYCLE CHECKPOINT,0.14285,0.029151,0.033976,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.18508,0.028719,-0.1189,0,0
5,GO OOGENESIS,0.36991,0.028668,0.029392,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.63354,0.028602,0.009277,0,0
5,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.88523,0.028597,-0.0079156,0,0
5,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.88523,0.028398,-0.028449,0,0
5,GO MITOTIC CYTOKINETIC PROCESS,0.52025,0.028381,0.045379,0,0
5,GO DORSAL AORTA DEVELOPMENT,0.91293,0.028346,-0.014005,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.72313,0.028056,-0.010279,0,0
5,GO RETINAL CONE CELL DIFFERENTIATION,0.62113,0.028039,-0.070084,0,0
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.65234,0.02783,0.037535,0,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.80989,0.027802,-0.00047186,0,0
5,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.60272,0.027732,0.042771,0,0
5,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.47049,0.027729,0.040302,0,0
5,GO APPENDAGE DEVELOPMENT,0.65234,0.027497,0.0050513,0,0
5,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.62113,0.027477,0.089813,0,0
5,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.47588,0.027477,0.051409,0,0
5,GO REGULATION OF NUCLEAR DIVISION,0.88523,0.027408,0.0015995,0,0
5,GO MEMBRANE FISSION,0.188,0.027307,0.10516,0,0
5,GO DETECTION OF ABIOTIC STIMULUS,0.30815,0.027135,0.041506,0,0
5,GO PROTEIN INSERTION INTO MEMBRANE,0.080955,0.027096,0.068698,0,0
5,GO VIRAL GENOME REPLICATION,0.4598,0.026958,-0.089381,0,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.53167,0.026957,0.13808,0,0
5,GO SENSORY SYSTEM DEVELOPMENT,0.95466,0.026812,-0.0063871,0,0
5,GO MULTIVESICULAR BODY ORGANIZATION,0.95466,0.026788,0.0019995,0,0
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.74288,0.026658,0.024731,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.63354,0.026523,0.019473,0,0
5,GO RESPONSE TO POTASSIUM ION,0.53167,0.026272,0.071077,0,0
5,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.65234,0.026241,0.044024,0,0
5,GO DENDRITE DEVELOPMENT,0.54903,0.025925,0.037888,0,0
5,GO NEURON PROJECTION GUIDANCE,0.54321,0.025778,0.024401,0,0
5,GO REGULATION OF HELICASE ACTIVITY,0.62113,0.025703,0.071899,0,0
5,GO LYSOSOME LOCALIZATION,0.80312,0.025663,0.014586,0,0
5,GO DNA CATABOLIC PROCESS,0.53167,0.025653,0.020545,0,0
5,GO INTERSTRAND CROSS LINK REPAIR,0.25729,0.025651,0.037702,0,0
5,GO RESPONSE TO INSECTICIDE,0.50896,0.025614,0.066558,0,0
5,GO POSITIVE REGULATION OF MITOPHAGY,0.9686,0.025573,-0.025876,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.72313,0.025409,0.0010132,0,0
5,GO NEGATIVE REGULATION OF TOR SIGNALING,0.87144,0.025401,-0.0071491,0,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.98953,0.025279,-0.019347,0,0
5,GO COVALENT CHROMATIN MODIFICATION,0.18508,0.025276,0.02841,0,0
5,GO REGULATION OF CELL FATE SPECIFICATION,0.4545,0.025248,0.064382,0,0
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.80312,0.025186,0.016565,0,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.188,0.025166,0.037789,0,0
5,GO REGULATION OF HISTONE MODIFICATION,0.36526,0.025074,0.018029,0,0
5,GO NUCLEAR BODY ORGANIZATION,0.53167,0.02499,0.023036,0,0
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.43367,0.024975,0.023853,0,0
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.88523,0.024599,-0.023797,0,0
5,GO MESODERMAL CELL FATE SPECIFICATION,0.54903,0.024569,0.054498,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.63354,0.024443,-0.039216,0,0
5,GO DIGESTIVE SYSTEM DEVELOPMENT,0.79636,0.024241,-0.015685,0,0
5,GO HISTONE H3 K9 DEMETHYLATION,0.78289,0.02411,0.017398,0,0
5,GO PEPTIDYL LYSINE METHYLATION,0.14526,0.024012,0.059725,0,0
5,GO T CELL LINEAGE COMMITMENT,0.65234,0.023941,0.024201,0,0
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.71658,0.023915,-0.055046,0,0
5,GO CELLULAR RESPONSE TO MANGANESE ION,0.98953,0.023801,-0.010785,0,0
5,GO TUMOR NECROSIS FACTOR SECRETION,0.94073,0.023793,-0.0055906,0,0
5,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.89215,0.023785,-0.039046,0,0
5,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.60883,0.023714,0.018523,0,0
5,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.78289,0.023629,-0.04254,0,0
5,GO SPLEEN DEVELOPMENT,0.89215,0.023427,-0.0049844,0,0
5,GO CELL PROJECTION ASSEMBLY,0.84397,0.023332,-0.0033148,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.58456,0.023273,0.0032044,0,0
5,GO PROTEIN LOCALIZATION TO CILIUM,0.96163,0.023205,0.0099212,0,0
5,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.2,0.023133,0.034885,0,0
5,GO SIALYLATION,0.71658,0.023121,0.035059,0,0
5,GO PENILE ERECTION,0.40843,0.022798,0.11005,0,0
5,GO REGULATION OF RNA SPLICING,0.52594,0.022739,0.018256,0,0
5,GO PROTEIN METHYLATION,0.40843,0.022604,0.031435,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.56666,0.022564,0.039811,0,0
5,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.53742,0.022469,0.017317,0,0
5,GO DETECTION OF CALCIUM ION,0.62113,0.022413,0.057159,0,0
5,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.96163,0.022403,-0.02509,0,0
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.68418,0.022248,0.026075,0,0
5,GO REGIONALIZATION,0.53742,0.022244,0.014861,0,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.60883,0.022218,0.030654,0,0
5,GO TOXIN METABOLIC PROCESS,0.72969,0.021792,0.03259,0,0
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.55487,0.021668,0.0065404,0,0
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.93377,0.021624,0.0078902,0,0
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.60883,0.02151,0.027258,0,0
5,GO POSITIVE REGULATION OF NEURON DEATH,0.33812,0.021472,0.038173,0,0
5,GO DNA CONFORMATION CHANGE,0.57857,0.021407,0.014676,0,0
5,GO SPERM MOTILITY,0.67137,0.02132,0.015337,0,0
5,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.91293,0.021131,0.011681,0,0
5,GO ATP TRANSPORT,0.76281,0.020991,-0.019699,0,0
5,GO ANIMAL ORGAN MATURATION,0.91987,0.020948,-0.011181,0,0
5,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.77618,0.020577,-0.045043,0,0
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.63978,0.020568,0.016577,0,0
5,GO POSITIVE REGULATION OF DNA BINDING,0.60272,0.020491,0.018965,0,0
5,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.70355,0.020454,-0.034797,0,0
5,GO CELL MATURATION,0.83713,0.020379,0.0074027,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.64605,0.020345,0.007592,0,0
5,GO POLYAMINE BIOSYNTHETIC PROCESS,0.44924,0.020339,0.047819,0,0
5,GO REGULATION OF AXONOGENESIS,0.54903,0.020295,0.028167,0,0
5,GO SENSORY ORGAN MORPHOGENESIS,0.9686,0.020283,-0.0064443,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.93377,0.020271,-0.02117,0,0
5,GO REGULATION OF OOGENESIS,0.97557,0.020177,-0.0044895,0,0
5,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.82348,0.020107,0.037529,0,0
5,GO NEURAL TUBE DEVELOPMENT,0.92682,0.019837,-0.016288,0,0
5,GO REGULATION OF CHROMOSOME SEPARATION,0.85082,0.019784,0.0011347,0,0
5,GO LEFT RIGHT AXIS SPECIFICATION,0.92682,0.019762,-0.029075,0,0
5,GO ACTIVATED T CELL PROLIFERATION,0.77618,0.019756,-0.030192,0,0
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.60883,0.01975,-0.063022,0,0
5,GO MICROTUBULE BUNDLE FORMATION,0.23245,0.019743,0.076599,0,0
5,GO REGULATION OF HISTONE PHOSPHORYLATION,0.88523,0.019731,-0.034881,0,0
5,GO METANEPHROS MORPHOGENESIS,0.46512,0.019672,0.071769,0,0
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.98255,0.019642,-0.023956,0,0
5,GO CHROMOSOME ORGANIZATION,0.44924,0.019598,0.012228,0,0
5,GO MULTICELLULAR ORGANISM AGING,0.88523,0.01945,0.0016256,0,0
5,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.9686,0.019428,0.0010548,0,0
5,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.89215,0.019136,0.025124,0,0
5,GO REGULATION OF MEMBRANE PERMEABILITY,0.97557,0.018963,0.0033118,0,0
5,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.98255,0.018957,-0.016688,0,0
5,GO RETINOIC ACID METABOLIC PROCESS,0.31232,0.018908,0.075001,0,0
5,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.70355,0.01883,0.059102,0,0
5,GO HISTONE H4 DEACETYLATION,0.98255,0.018721,-0.010666,0,0
5,GO REGULATION OF PLATELET AGGREGATION,0.91293,0.018703,0.0033087,0,0
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.54903,0.0186,0.040171,0,0
5,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.38408,0.018496,0.025595,0,0
5,GO NUCLEOSOME ORGANIZATION,0.29184,0.018492,0.044519,0,0
5,GO SEX DETERMINATION,0.69707,0.018443,0.02313,0,0
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.55487,0.018406,0.02055,0,0
5,GO MEMBRANE DOCKING,0.36526,0.018388,0.022875,0,0
5,GO DNA REPLICATION,0.38888,0.018274,0.024022,0,0
5,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.65234,0.018269,-0.0087499,0,0
5,GO RUFFLE ORGANIZATION,0.91987,0.018224,-0.0037949,0,0
5,GO RESPONSE TO COCAINE,0.81668,0.01813,0.02676,0,0
5,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.62732,0.01808,-0.12621,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.63978,0.018071,0.023302,0,0
5,GO LYMPHOCYTE COSTIMULATION,0.56666,0.018026,0.020142,0,0
5,GO CELL CYCLE DNA REPLICATION,0.43367,0.017947,0.028608,0,0
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.80312,0.017858,-0.024999,0,0
5,GO PHOTOTRANSDUCTION,0.79636,0.017819,-0.013188,0,0
5,GO APOPTOTIC DNA FRAGMENTATION,0.81668,0.017749,-0.0089534,0,0
5,GO EPIDERMAL CELL DIFFERENTIATION,0.78289,0.017614,0.014177,0,0
5,GO INTESTINAL LIPID ABSORPTION,0.90599,0.017585,-0.051053,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.81668,0.017354,0.0046716,0,0
5,GO REGULATION OF MEMBRANE INVAGINATION,0.23245,0.017318,-0.14043,0,0
5,GO TELENCEPHALON GLIAL CELL MIGRATION,0.99651,0.01723,-0.03089,0,0
5,GO AXIS SPECIFICATION,0.89907,0.017103,-0.0019349,0,0
5,GO EXOCYTIC PROCESS,0.84397,0.017067,0.0091304,0,0
5,GO REGULATION OF EXTENT OF CELL GROWTH,0.74288,0.017042,0.010949,0,0
5,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.96163,0.016952,-0.009602,0,0
5,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.68418,0.016952,0.023168,0,0
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.59664,0.016907,0.02605,0,0
5,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.32938,0.016801,0.050964,0,0
5,GO SYNAPSE MATURATION,0.94769,0.016788,-0.0028672,0,0
5,GO DNA METHYLATION OR DEMETHYLATION,0.47588,0.016719,0.01837,0,0
5,GO MITOCHONDRIAL GENOME MAINTENANCE,0.91293,0.016678,-0.0063797,0,0
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.81668,0.016628,0.0062368,0,0
5,GO ANATOMICAL STRUCTURE MATURATION,0.86455,0.016619,0.0036536,0,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.89907,0.016427,-0.014937,0,0
5,GO DOUBLE STRAND BREAK REPAIR,0.41341,0.01637,0.019327,0,0
5,GO TONGUE MORPHOGENESIS,0.91987,0.016364,0.019269,0,0
5,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.50896,0.016252,0.0261,0,0
5,GO BRONCHUS DEVELOPMENT,0.56075,0.016032,0.053242,0,0
5,GO DETECTION OF LIGHT STIMULUS,0.69061,0.015865,-0.0051047,0,0
5,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.84397,0.015818,0.061288,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.94073,0.015715,-0.011236,0,0
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.90599,0.015605,0.011031,0,0
5,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.91293,0.015582,-0.0065391,0,0
5,GO ORGANELLE LOCALIZATION,0.34702,0.015522,0.017296,0,0
5,GO POTASSIUM ION HOMEOSTASIS,0.41341,0.015414,0.054587,0,0
5,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.81668,0.015151,-0.0076634,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.2839,0.015126,0.067428,0,0
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.85082,0.015046,-0.030588,0,0
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.97557,0.015038,0.00042195,0,0
5,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.69707,0.014981,0.048533,0,0
5,GO SYNAPTIC VESICLE MATURATION,0.73628,0.014911,0.071308,0,0
5,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.51459,0.014766,0.060285,0,0
5,GO NEGATIVE REGULATION OF NEURON DEATH,0.78289,0.014747,-0.0086974,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.56075,0.014721,-0.077218,0,0
5,GO DETECTION OF VISIBLE LIGHT,0.54321,0.014627,0.005712,0,0
5,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.85768,0.014559,-0.010325,0,0
5,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.71658,0.014413,-0.0054472,0,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.58456,0.014291,0.02847,0,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.69061,0.014267,0.043969,0,0
5,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.88523,0.014253,0.00015086,0,0
5,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.99651,0.014235,0.016488,0,0
5,GO NEURON APOPTOTIC PROCESS,0.4598,0.014207,0.018696,0,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.60883,0.014077,0.0099401,0,0
5,GO ACTIVATION OF MAPKK ACTIVITY,0.84397,0.014052,-0.030584,0,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.22235,0.013935,-0.10133,0,0
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.71658,0.013922,0.0022249,0,0
5,GO NEURON MIGRATION,0.36526,0.013922,0.082755,0,0
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.88523,0.013887,0.010574,0,0
5,GO POSITIVE REGULATION OF GLIOGENESIS,0.51459,0.013884,0.031408,0,0
5,GO CHLORIDE ION HOMEOSTASIS,0.75615,0.013876,-0.024936,0,0
5,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.60272,0.01386,0.025052,0,0
5,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.93377,0.0137,0.004221,0,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.56666,0.013698,0.083622,0,0
5,GO GLIAL CELL DIFFERENTIATION,0.92682,0.01368,-0.016777,0,0
5,GO PEPTIDYL LYSINE MODIFICATION,0.17653,0.013677,0.029747,0,0
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.94073,0.013616,-0.014898,0,0
5,GO REGULATION OF DNA REPAIR,0.44924,0.013448,0.018011,0,0
5,GO CHROMATIN SILENCING AT TELOMERE,0.71006,0.013406,0.01688,0,0
5,GO HISTONE METHYLATION,0.41341,0.013361,0.035799,0,0
5,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.94073,0.013345,-0.00163,0,0
5,GO EYE MORPHOGENESIS,0.49227,0.013241,0.01798,0,0
5,GO PROTEIN LOCALIZATION TO ENDOSOME,0.69061,0.013226,-0.034614,0,0
5,GO CELL DIVISION,0.50337,0.013214,0.0092232,0,0
5,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.39371,0.013161,-0.079956,0,0
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.40843,0.013023,0.040163,0,0
5,GO REPLICATION FORK PROCESSING,0.58456,0.012986,0.018779,0,0
5,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.53742,0.012935,0.026914,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.72969,0.012923,0.010417,0,0
5,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.96163,0.012885,0.070106,0,0
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.4545,0.012851,-0.088686,0,0
5,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.16294,0.012724,-0.13662,0,0
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.63978,0.012692,0.029609,0,0
5,GO POSITIVE REGULATION OF MRNA PROCESSING,0.94073,0.012444,-0.00044117,0,0
5,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.53742,0.012266,-0.069543,0,0
5,GO MALE GAMETE GENERATION,0.97557,0.012255,-0.0037429,0,0
5,GO REGULATION OF CILIUM BEAT FREQUENCY,0.5726,0.012076,0.023951,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.47588,0.011987,-0.073968,0,0
5,GO MEIOTIC CELL CYCLE,0.61497,0.011915,0.0051286,0,0
5,GO SECRETORY GRANULE ORGANIZATION,0.72969,0.011873,0.018419,0,0
5,GO CARDIAC SEPTUM MORPHOGENESIS,0.37932,0.01168,-0.092347,0,0
5,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.50337,0.011675,0.028801,0,0
5,GO MAST CELL MEDIATED IMMUNITY,0.67776,0.011447,0.024527,0,0
5,GO NEGATIVE REGULATION OF CELL DIVISION,0.87144,0.011444,0.0045447,0,0
5,GO REGULATION OF MITOTIC CELL CYCLE,0.88523,0.011308,-0.0090006,0,0
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.70355,0.011307,-0.035137,0,0
5,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.82348,0.011297,0.012013,0,0
5,GO ACIDIC AMINO ACID TRANSPORT,0.81668,0.011286,0.00078362,0,0
5,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.44402,0.011266,-0.10166,0,0
5,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.77618,0.01098,-0.016072,0,0
5,GO GAMETE GENERATION,0.79636,0.010948,0.0010167,0,0
5,GO NEUROTROPHIN SIGNALING PATHWAY,0.76948,0.010944,0.015632,0,0
5,GO CELL PART MORPHOGENESIS,0.67137,0.010943,0.019387,0,0
5,GO ALPHA BETA T CELL DIFFERENTIATION,0.4978,0.010792,-0.058088,0,0
5,GO SPINDLE MIDZONE ASSEMBLY,0.70355,0.010747,0.0071416,0,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.94769,0.01072,-0.007795,0,0
5,GO MITOTIC CYTOKINESIS,0.66501,0.010692,0.011692,0,0
5,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.97557,0.010644,0.009052,0,0
5,GO REGULATION OF PROTON TRANSPORT,0.67137,0.010477,0.038488,0,0
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.63354,0.010455,0.019809,0,0
5,GO TORC1 SIGNALING,0.62732,0.010449,0.0042396,0,0
5,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.91987,0.010369,-0.003234,0,0
5,GO ROOF OF MOUTH DEVELOPMENT,0.65866,0.010328,0.021431,0,0
5,GO RUFFLE ASSEMBLY,0.64605,0.010227,0.01092,0,0
5,GO POSITIVE REGULATION OF EXOCYTOSIS,0.80989,0.010204,-0.015528,0,0
5,GO REGULATION OF DENDRITE MORPHOGENESIS,0.69061,0.010087,0.026938,0,0
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.89907,0.01002,-0.013077,0,0
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.87144,0.0099406,-0.0056818,0,0
5,GO BASE EXCISION REPAIR,0.78289,0.0099161,-0.034152,0,0
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.35607,0.0099073,0.064456,0,0
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.63354,0.0098531,-0.067471,0,0
5,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.77618,0.009807,0.0051341,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.79636,0.0097277,-0.022482,0,0
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.84397,0.009633,0.0074285,0,0
5,GO CAMERA TYPE EYE DEVELOPMENT,0.87833,0.0096215,-0.01098,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.92682,0.0095627,-0.031592,0,0
5,GO REGULATION OF DNA RECOMBINATION,0.81668,0.0095305,-0.00095018,0,0
5,GO DEFINITIVE HEMOPOIESIS,0.95466,0.0095169,-0.028183,0,0
5,GO CALCINEURIN MEDIATED SIGNALING,0.69061,0.0094961,0.00019344,0,0
5,GO BONE CELL DEVELOPMENT,0.48131,0.009479,0.032816,0,0
5,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.94073,0.0092789,-0.029789,0,0
5,GO DNA REPLICATION INITIATION,0.88523,0.0091928,0.0066517,0,0
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.69061,0.0091453,0.023712,0,0
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.34702,0.0091293,-0.11818,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE,0.89907,0.0088991,-0.00097517,0,0
5,GO MEIOTIC CHROMOSOME SEGREGATION,0.74288,0.0088953,0.004003,0,0
5,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.85768,0.0088947,-0.038209,0,0
5,GO P BODY ASSEMBLY,0.82348,0.0087897,0.0090657,0,0
5,GO DETERMINATION OF ADULT LIFESPAN,0.72969,0.0087243,-0.036217,0,0
5,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.97557,0.0087114,-0.0012327,0,0
5,GO MYOBLAST DIFFERENTIATION,0.93377,0.0087004,-0.015158,0,0
5,GO MIDBODY ABSCISSION,0.66501,0.0086171,0.054502,0,0
5,GO MICROTUBULE ANCHORING,0.54903,0.0086105,0.021885,0,0
5,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.56075,0.0085628,0.044971,0,0
5,GO CEREBRAL CORTEX CELL MIGRATION,0.8303,0.0085109,-0.014574,0,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.80312,0.0084536,0.0034842,0,0
5,GO HYPEROSMOTIC SALINITY RESPONSE,0.97557,0.0083551,0.034692,0,0
5,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.87144,0.008326,-0.043638,0,0
5,GO MAST CELL ACTIVATION,0.90599,0.0082967,-0.0084951,0,0
5,GO CIRCADIAN RHYTHM,0.96163,0.0082685,-0.0063072,0,0
5,GO AXON EXTENSION,0.91293,0.0081289,-0.010001,0,0
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.8303,0.0080929,0.0056991,0,0
5,GO NEUROBLAST PROLIFERATION,0.15773,0.0079825,0.083924,0,0
5,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.84397,0.0078869,0.020505,0,0
5,GO REGULATION OF DENDRITE DEVELOPMENT,0.88523,0.0078563,0.011476,0,0
5,GO MAST CELL MIGRATION,0.27611,0.007807,0.15768,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.99651,0.0076855,-0.022143,0,0
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.76281,0.0075502,-0.072723,0,0
5,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.98953,0.0074672,-0.01468,0,0
5,GO SPERMATID DIFFERENTIATION,0.64605,0.0074189,0.025815,0,0
5,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.90599,0.0073922,-0.0051676,0,0
5,GO GERM CELL DEVELOPMENT,0.50337,0.0072977,0.020747,0,0
5,GO CYTOSKELETON ORGANIZATION,0.90599,0.0070704,-0.013157,0,0
5,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.76281,0.0069627,-0.017367,0,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.34256,0.0069279,-0.050583,0,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.62732,0.0068228,0.022112,0,0
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.80989,0.0068032,-0.048028,0,0
5,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.44924,0.0067602,0.061755,0,0
5,GO SEROTONIN METABOLIC PROCESS,0.94073,0.0067599,0.040618,0,0
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.41842,0.0066721,-0.052371,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.91987,0.0065822,-0.017314,0,0
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.9686,0.006566,0.023102,0,0
5,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.9686,0.0065284,0.0031682,0,0
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.62732,0.0064913,-0.03021,0,0
5,GO REGULATION OF NEURON DIFFERENTIATION,0.89907,0.0064745,0.010196,0,0
5,GO HIPPOCAMPUS DEVELOPMENT,0.67137,0.0064656,0.022246,0,0
5,GO RESPONSE TO LEUCINE,0.91987,0.006408,0.037345,0,0
5,GO RESPONSE TO ELECTRICAL STIMULUS,0.72313,0.0063875,0.017649,0,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS,0.39858,0.0063623,-0.0058288,0,0
5,GO POSITIVE REGULATION OF SECRETION,0.69707,0.0063372,-0.02503,0,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.9686,0.0062986,-0.015852,0,0
5,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.72969,0.006248,0.037756,0,0
5,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.39371,0.0062188,-0.076639,0,0
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.75615,0.0061709,0.02173,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.93377,0.006109,-0.019384,0,0
5,GO REGULATION OF CELL CYCLE PROCESS,0.82348,0.0060875,-0.010657,0,0
5,GO REGULATION OF GOLGI ORGANIZATION,0.78962,0.0059992,0.015366,0,0
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.76948,0.0057883,-0.043929,0,0
5,GO GLIAL CELL APOPTOTIC PROCESS,0.87833,0.0055675,-0.026866,0,0
5,GO MISMATCH REPAIR,0.65234,0.0054893,-0.022608,0,0
5,GO MALE MEIOSIS I,0.79636,0.0053461,-0.039914,0,0
5,GO FOREBRAIN NEURON DEVELOPMENT,0.63978,0.0052821,0.059976,0,0
5,GO MULTICELLULAR ORGANISM GROWTH,0.76281,0.0052788,-0.013006,0,0
5,GO REGULATION OF CILIUM MOVEMENT,0.61497,0.0052263,0.031318,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.52025,0.0052049,-0.044625,0,0
5,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.94769,0.0051776,-0.0076232,0,0
5,GO PROTEIN LOCALIZATION TO AXON,0.84397,0.0051502,0.051962,0,0
5,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.53742,0.005098,0.077015,0,0
5,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.58456,0.005072,0.03862,0,0
5,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.92682,0.0050364,0.0072093,0,0
5,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.91987,0.0049366,-0.0029641,0,0
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.94769,0.0049166,-0.0015573,0,0
5,GO DEVELOPMENTAL MATURATION,0.97557,0.004859,0.0052103,0,0
5,GO CHROMATIN DISASSEMBLY,0.84397,0.0047607,-0.0094845,0,0
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.8303,0.0047423,-0.015829,0,0
5,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.88523,0.0046828,-0.0022953,0,0
5,GO NUCLEUS LOCALIZATION,0.91293,0.0045209,-0.0099943,0,0
5,GO NEURON DIFFERENTIATION,0.77618,0.0044651,0.020922,0,0
5,GO REGULATION OF GLIAL CELL MIGRATION,0.96163,0.0044526,-0.0012022,0,0
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.81668,0.0044139,-0.0089191,0,0
5,GO LIPOSACCHARIDE METABOLIC PROCESS,0.36991,0.0043497,-0.069375,0,0
5,GO CHROMATIN SILENCING,0.22905,0.0042663,0.04773,0,0
5,GO REGULATION OF SYNAPTIC PLASTICITY,0.73628,0.0042655,0.027408,0,0
5,GO REGULATION OF DNA METABOLIC PROCESS,0.96163,0.0042211,-0.0040197,0,0
5,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.97557,0.0040725,-0.0098833,0,0
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.91293,0.0038861,-0.0059997,0,0
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.90599,0.0038468,-0.0056715,0,0
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.37932,0.0038004,-0.08444,0,0
5,GO ADULT FEEDING BEHAVIOR,0.9686,0.0037931,-0.037734,0,0
5,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.68418,0.0037162,-0.027284,0,0
5,GO EPITHELIAL CELL CELL ADHESION,0.59059,0.0036539,0.063922,0,0
5,GO NEUTROPHIL CHEMOTAXIS,0.68418,0.0036521,-0.046486,0,0
5,GO PIGMENT ACCUMULATION,0.54321,0.0036252,-0.058343,0,0
5,GO LIPID TRANSLOCATION,0.43367,0.003413,-0.060763,0,0
5,GO CHROMOSOME SEPARATION,0.75615,0.0033442,0.0087067,0,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.59664,0.0032549,-0.077717,0,0
5,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.89215,0.0031713,-0.039128,0,0
5,GO REGULATION OF ODONTOGENESIS,0.71658,0.0031693,-0.054297,0,0
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.83713,0.0031318,-0.017456,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.4545,0.0030866,0.061387,0,0
5,GO SULFATION,0.76281,0.003065,-0.035398,0,0
5,GO SENSORY ORGAN DEVELOPMENT,0.99651,0.0030114,-0.0076608,0,0
5,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.89215,0.0029329,0.012642,0,0
5,GO CELLULAR COMPONENT MORPHOGENESIS,0.87833,0.0028991,0.011403,0,0
5,GO NUCLEOTIDE TRANSPORT,0.70355,0.0028529,-0.02613,0,0
5,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.76281,0.0025757,-0.021986,0,0
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.80989,0.0024457,0.0035114,0,0
5,GO PROSTATE GLAND MORPHOGENESIS,0.5726,0.0024154,0.037742,0,0
5,GO REGULATION OF HEART MORPHOGENESIS,0.77618,0.0023797,-0.042246,0,0
5,GO HISTONE H3 ACETYLATION,0.56075,0.0023714,-0.01792,0,0
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.69061,0.0023564,-0.015723,0,0
5,GO NEURON DEVELOPMENT,0.93377,0.0023214,0.0091265,0,0
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.74288,0.0023013,0.017956,0,0
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.62113,0.0020514,-0.039999,0,0
5,GO EMBRYONIC MORPHOGENESIS,0.47588,0.0019869,-0.046232,0,0
5,GO GOLGI LOCALIZATION,0.91987,0.0018963,-0.017294,0,0
5,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.89907,0.0018025,-0.0097828,0,0
5,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.70355,0.001567,0.051502,0,0
5,GO GLIOGENESIS,0.49227,0.0015387,-0.039322,0,0
5,GO REGULATION OF CHROMATIN ASSEMBLY,0.65234,0.0014976,0.028813,0,0
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.76281,0.0014805,0.011143,0,0
5,GO REGULATION OF CHROMATIN ORGANIZATION,0.57857,0.0013444,0.01111,0,0
5,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.71658,0.0011785,-0.038276,0,0
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.31232,0.0011777,-0.08936,0,0
5,GO NEURON DEATH,0.62732,0.0010639,-0.018291,0,0
5,GO ORGANELLE INHERITANCE,0.79636,0.0010328,-0.018649,0,0
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.71006,0.0010035,0.0031098,0,0
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.54903,0.00074929,-0.021137,0,0
5,GO CELL PROJECTION ORGANIZATION,0.86455,0.00066289,-0.0017448,0,0
5,GO AMINE TRANSPORT,0.95466,0.00064282,0.046502,0,0
5,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.78289,0.00063966,-0.0024537,0,0
5,GO POSITIVE REGULATION OF RNA SPLICING,0.85082,0.00061302,0.00087342,0,0
5,GO PURINE NUCLEOTIDE TRANSPORT,0.80312,0.00060932,-0.022142,0,0
5,GO NEUROGENESIS,0.89215,0.00047096,0.011452,0,0
5,GO LIPID DIGESTION,0.94073,0.00045546,-0.050632,0,0
5,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.83713,0.0004338,0.034226,0,0
5,GO DNA MODIFICATION,0.66501,0.00016456,-0.012448,0,0
5,GO VIRION ASSEMBLY,0.4545,8.871e-05,-0.039174,0,0
5,GO EMBRYONIC EYE MORPHOGENESIS,0.96163,1.0086e-05,-0.0095376,0,0
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.78289,-0.00014024,-0.029551,0,0
5,GO SERTOLI CELL DEVELOPMENT,0.54903,-0.00018117,-0.073379,0,0
5,GO REGULATION OF SPINDLE CHECKPOINT,0.80989,-0.0002997,-0.0059554,0,0
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.96163,-0.00033912,-0.014459,0,0
5,GO ERROR FREE TRANSLESION SYNTHESIS,0.36064,-0.00035595,-0.034368,0,0
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.89907,-0.00038811,-0.02524,0,0
5,GO REGULATION OF LIGASE ACTIVITY,0.82348,-0.00051099,-0.038199,0,0
5,GO TRANSMISSION OF NERVE IMPULSE,0.74288,-0.00059212,-0.0061513,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.72969,-0.00060093,-0.020995,0,0
5,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.67137,-0.00066773,0.013355,0,0
5,GO OXIDATIVE DEMETHYLATION,0.91293,-0.00069202,-0.0053378,0,0
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.75615,-0.00081739,-0.0088688,0,0
5,GO KERATINOCYTE DIFFERENTIATION,0.95466,-0.00088994,0.00098238,0,0
5,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.30815,-0.0009878,-0.073671,0,0
5,GO VENTRICULAR SEPTUM DEVELOPMENT,0.26847,-0.0010541,-0.096594,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.85768,-0.0010773,0.0072185,0,0
5,GO MEMBRANE HYPERPOLARIZATION,0.76948,-0.0011084,-0.014556,0,0
5,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.89215,-0.0014143,-0.002782,0,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.7495,-0.0014644,0.0066649,0,0
5,GO REGULATION OF CELL SHAPE,0.85768,-0.0015384,-0.025982,0,0
5,GO REGULATION OF APPETITE,0.87144,-0.0015758,-0.021614,0,0
5,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.85082,-0.0016505,-0.018386,0,0
5,GO FEMALE GAMETE GENERATION,0.67776,-0.0017822,-0.017916,0,0
5,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.54903,-0.0018075,-0.036135,0,0
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.77618,-0.0018728,0.0041087,0,0
5,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.17653,-0.0020264,-0.1427,0,0
5,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.47049,-0.0020352,-0.054629,0,0
5,GO AXONEME ASSEMBLY,0.42347,-0.0020976,0.078208,0,0
5,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.40843,-0.0021821,-0.061042,0,0
5,GO MEIOTIC CELL CYCLE PROCESS,0.98255,-0.0021872,-0.0060259,0,0
5,GO REGULATION OF CELL MATURATION,0.85082,-0.0022383,-0.0087185,0,0
5,GO SOMITE DEVELOPMENT,0.71658,-0.0023697,-0.026283,0,0
5,GO MRNA EXPORT FROM NUCLEUS,0.80312,-0.0023728,-0.0078529,0,0
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.42347,-0.0023994,-0.0398,0,0
5,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.78289,-0.0024272,-0.017759,0,0
5,GO NEGATIVE T CELL SELECTION,0.63978,-0.0024328,-0.068612,0,0
5,GO AXON DEVELOPMENT,0.98255,-0.002461,0.0051158,0,0
5,GO CARDIAC VENTRICLE MORPHOGENESIS,0.32506,-0.0027365,-0.068697,0,0
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.62113,-0.0028035,-0.026248,0,0
5,GO MITOTIC CELL CYCLE,0.94073,-0.0028162,-0.010662,0,0
5,GO POSITIVE REGULATION OF TISSUE REMODELING,0.73628,-0.0028978,-0.032922,0,0
5,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.70355,-0.0029003,-0.036738,0,0
5,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.99651,-0.0029125,-0.0086657,0,0
5,GO PROTEIN PALMITOYLATION,0.89215,-0.002916,0.0054782,0,0
5,GO REGULATION OF CHROMOSOME ORGANIZATION,0.94073,-0.0029474,0.0038976,0,0
5,GO DNA RECOMBINATION,0.56075,-0.0029586,0.012298,0,0
5,GO EPIDERMIS DEVELOPMENT,0.91987,-0.0030151,-0.021057,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.58456,-0.0030805,-0.041516,0,0
5,GO POLYAMINE METABOLIC PROCESS,0.69707,-0.0031521,0.027255,0,0
5,GO REGULATION OF COLLATERAL SPROUTING,0.8303,-0.0033918,-0.02287,0,0
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.55487,-0.0034468,-0.038782,0,0
5,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.93377,-0.0036443,0.0012039,0,0
5,GO EXTRACELLULAR VESICLE BIOGENESIS,0.98953,-0.0036454,-0.014451,0,0
5,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.94073,-0.0037057,0.0021887,0,0
5,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.92682,-0.0038114,-0.012791,0,0
5,GO GASTRIC ACID SECRETION,0.72969,-0.0038498,-0.02692,0,0
5,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.71658,-0.0040159,0.027396,0,0
5,GO REGULATION OF DNA REPLICATION,0.80312,-0.0040813,0.0006627,0,0
5,GO ASTROCYTE DIFFERENTIATION,0.52594,-0.0041079,-0.053337,0,0
5,GO PROTEIN O LINKED GLYCOSYLATION,0.42855,-0.0041739,-0.08686,0,0
5,GO REGULATION OF B CELL DIFFERENTIATION,0.98953,-0.0041953,-0.014642,0,0
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.76948,-0.0043594,-0.045345,0,0
5,GO REGULATION OF CELL MORPHOGENESIS,0.87833,-0.0045177,-0.011681,0,0
5,GO MALE SEX DIFFERENTIATION,0.3746,-0.0045385,-0.050633,0,0
5,GO REPRODUCTION,0.31232,-0.0046123,-0.032345,0,0
5,GO OVARIAN FOLLICLE DEVELOPMENT,0.7495,-0.0046626,-0.015727,0,0
5,GO DENDRITIC SPINE MORPHOGENESIS,0.74288,-0.0046797,0.01644,0,0
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.49227,-0.0047654,-0.025581,0,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.48131,-0.0047679,0.022089,0,0
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.89907,-0.0047699,-0.0077065,0,0
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.88523,-0.0047889,-0.017898,0,0
5,GO REGULATION OF WNT SIGNALING PATHWAY,0.54321,-0.0048567,-0.03273,0,0
5,GO SYNAPSE ASSEMBLY,0.98255,-0.0048703,0.030877,0,0
5,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.63354,-0.0049012,-0.027526,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.60272,-0.0049346,-0.019392,0,0
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.65234,-0.0050125,-0.05352,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.80312,-0.0051406,0.020244,0,0
5,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.59664,-0.0052355,-0.0082405,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.63354,-0.0052475,-0.01831,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.52594,-0.005318,0.014505,0,0
5,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.67137,-0.0053995,0.02593,0,0
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.50896,-0.0054142,-0.03833,0,0
5,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.64605,-0.005536,-0.055518,0,0
5,GO RESPONSE TO UV,0.93377,-0.0055707,-0.0079906,0,0
5,GO CELLULAR RESPONSE TO RADIATION,0.56075,-0.0056981,-0.026732,0,0
5,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.67776,-0.0057025,0.0086337,0,0
5,GO RESPONSE TO AUDITORY STIMULUS,0.67137,-0.0057075,0.093702,0,0
5,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.71658,-0.0057208,-0.038928,0,0
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.64605,-0.0058609,-0.017012,0,0
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.87144,-0.0058777,-0.012219,0,0
5,GO SEX DIFFERENTIATION,0.17374,-0.0059705,-0.050714,0,0
5,GO REGULATION OF VASOCONSTRICTION,0.97557,-0.0060798,-0.020254,0,0
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.48678,-0.006232,0.011647,0,0
5,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.64605,-0.0062587,0.027278,0,0
5,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.98953,-0.0065623,-0.042975,0,0
5,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.72313,-0.006575,-0.0054796,0,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.17374,-0.0066155,-0.13602,0,0
5,GO ADULT BEHAVIOR,0.87833,-0.0066557,0.034914,0,0
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.65234,-0.006723,0.022732,0,0
5,GO POSITIVE REGULATION OF GROWTH,0.44924,-0.0067708,-0.026853,0,0
5,GO REGULATION OF NEURON PROJECTION REGENERATION,0.89215,-0.0068563,0.011166,0,0
5,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.96163,-0.0068813,0.0044724,0,0
5,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.46512,-0.0069052,-0.055321,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.67776,-0.0069783,-0.016631,0,0
5,GO REGULATION OF CELL CYCLE,0.59664,-0.0069784,-0.018713,0,0
5,GO SEROTONIN TRANSPORT,0.95466,-0.0070028,-0.016794,0,0
5,GO CELLULAR RESPONSE TO UV,0.96163,-0.0071328,-0.00070637,0,0
5,GO SEXUAL REPRODUCTION,0.54903,-0.0072691,-0.018389,0,0
5,GO SYNAPTIC VESICLE EXOCYTOSIS,0.7495,-0.0073843,0.043631,0,0
5,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.48678,-0.0073917,-0.068206,0,0
5,GO PEPTIDYL SERINE MODIFICATION,0.19393,-0.007508,-0.037199,0,0
5,GO POSITIVE REGULATION OF CELL DIVISION,1,-0.0075494,-0.015245,0,0
5,GO RESPONSE TO FUNGUS,0.83713,-0.0075565,-0.012576,0,0
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.52594,-0.0075631,-0.027041,0,0
5,GO EMBRYONIC DIGIT MORPHOGENESIS,0.8303,-0.0075736,-0.018789,0,0
5,GO ADHERENS JUNCTION ORGANIZATION,0.56666,-0.0075843,-0.027621,0,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.98255,-0.0076081,-0.020071,0,0
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.5726,-0.0077685,-0.023515,0,0
5,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.43883,-0.0078555,-0.034064,0,0
5,GO ACTIN CYTOSKELETON REORGANIZATION,0.69707,-0.007906,-0.038827,0,0
5,GO REGULATION OF JUN KINASE ACTIVITY,0.4545,-0.0080108,-0.04502,0,0
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.64605,-0.0080623,-0.082866,0,0
5,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.89907,-0.0080793,-0.0026673,0,0
5,GO CGMP METABOLIC PROCESS,0.94769,-0.008135,-0.00043274,0,0
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.67137,-0.0081459,-0.054462,0,0
5,GO MYOTUBE CELL DEVELOPMENT,0.78289,-0.0081481,-0.024406,0,0
5,GO HOMEOSTASIS OF NUMBER OF CELLS,0.25729,-0.0081599,-0.050272,0,0
5,GO RESPONSE TO ANTIBIOTIC,0.67776,-0.0081851,-0.025555,0,0
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.89215,-0.0083325,-0.042918,0,0
5,GO CELL CYCLE G2 M PHASE TRANSITION,0.98953,-0.0084021,0.0035562,0,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.19695,-0.0085025,-0.047469,0,0
5,GO RESPONSE TO VITAMIN D,0.5726,-0.0088059,-0.066695,0,0
5,GO CELL CELL SIGNALING,0.48131,-0.0088475,-0.020195,0,0
5,GO DENDRITIC SPINE DEVELOPMENT,0.97557,-0.0091383,-0.0073718,0,0
5,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.99651,-0.0091408,0.0020594,0,0
5,GO VESICLE LOCALIZATION,0.51459,-0.0091511,-0.024527,0,0
5,GO SYNAPTIC VESICLE DOCKING,0.66501,-0.0092919,0.006111,0,0
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.82348,-0.0093456,-0.02475,0,0
5,GO BONE TRABECULA MORPHOGENESIS,0.89215,-0.0093502,-0.06433,0,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.47049,-0.0093571,0.02902,0,0
5,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.92682,-0.0093801,-1.4393e-05,0,0
5,GO RESPONSE TO PROSTAGLANDIN,0.63354,-0.0093804,-0.053205,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.48131,-0.0094165,-0.027909,0,0
5,GO EPITHELIUM DEVELOPMENT,0.43883,-0.0094193,-0.045108,0,0
5,GO REGULATION OF HEART GROWTH,0.59059,-0.009475,-0.029408,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.52025,-0.0094991,-0.025253,0,0
5,GO PARTURITION,0.56075,-0.0096448,0.01975,0,0
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.88523,-0.0096734,-0.0049506,0,0
5,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.94073,-0.0096825,-0.00088974,0,0
5,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.89215,-0.0097016,-0.028843,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.55487,-0.0097031,-0.084206,0,0
5,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.67137,-0.0097617,-0.002601,0,0
5,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.64605,-0.0099822,0.019239,0,0
5,GO THYMUS DEVELOPMENT,0.87144,-0.01005,0.010843,0,0
5,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.86455,-0.010072,-0.010419,0,0
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.94769,-0.010122,-0.016586,0,0
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.52594,-0.010122,-0.079139,0,0
5,GO DORSAL VENTRAL AXIS SPECIFICATION,0.9686,-0.010181,-0.016339,0,0
5,GO REGULATION OF PROTEIN SUMOYLATION,0.87833,-0.010186,-0.0063118,0,0
5,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.9686,-0.010199,-0.0053844,0,0
5,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.77618,-0.010252,-0.00094415,0,0
5,GO FOREBRAIN CELL MIGRATION,0.55487,-0.010287,-0.028292,0,0
5,GO QUINONE METABOLIC PROCESS,0.61497,-0.010312,-0.07812,0,0
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.99651,-0.010348,0.0027598,0,0
5,GO LIVER MORPHOGENESIS,0.75615,-0.010352,-0.053157,0,0
5,GO DNA LIGATION,0.71006,-0.010354,0.02898,0,0
5,GO CENTRIOLE CENTRIOLE COHESION,0.29184,-0.010374,0.084644,0,0
5,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.99651,-0.010422,-0.014453,0,0
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.74288,-0.010453,-0.053475,0,0
5,GO EMBRYO DEVELOPMENT,0.57857,-0.010493,-0.03014,0,0
5,GO REGULATION OF CELL DEVELOPMENT,0.92682,-0.010523,-0.0051668,0,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.60272,-0.010636,-0.032499,0,0
5,GO SIGNAL RELEASE,0.60272,-0.010695,-0.0022415,0,0
5,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.47588,-0.010796,-0.026033,0,0
5,GO NEURON PROJECTION EXTENSION,0.98255,-0.010831,-0.0013687,0,0
5,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.71658,-0.010883,-0.10561,0,0
5,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.89907,-0.010936,0.014367,0,0
5,GO RNA SPLICING,0.91293,-0.011012,0.0030749,0,0
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.27611,-0.011018,-0.075968,0,0
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.48131,-0.011222,-0.030973,0,0
5,GO DNA REPAIR,0.86455,-0.011308,0.00033508,0,0
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.50337,-0.011411,-0.056914,0,0
5,GO INOSITOL METABOLIC PROCESS,0.71006,-0.011518,0.03185,0,0
5,GO CELL CYCLE PHASE TRANSITION,0.62113,-0.01152,-0.018037,0,0
5,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.188,-0.01163,-0.20225,0,0
5,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.17099,-0.011666,-0.099406,0,0
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.90599,-0.011694,-0.0037478,0,0
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.13814,-0.011728,-0.090595,0,0
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.80989,-0.011789,-0.031192,0,0
5,GO CELL CYCLE,0.62113,-0.011988,-0.01476,0,0
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.41341,-0.011997,-0.06733,0,0
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.90599,-0.01211,-0.0033698,0,0
5,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.62113,-0.012381,-0.068777,0,0
5,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.79636,-0.012423,-0.025997,0,0
5,GO RESPONSE TO GLUCAGON,0.79636,-0.012543,-0.010505,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.76281,-0.012563,-0.010398,0,0
5,GO UV DAMAGE EXCISION REPAIR,0.66501,-0.012653,-0.013196,0,0
5,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.89907,-0.012788,0.059572,0,0
5,GO PEPTIDE HORMONE SECRETION,0.80312,-0.01287,-0.0055543,0,0
5,GO SULFATE TRANSPORT,0.57857,-0.012886,-0.052724,0,0
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.70355,-0.01289,-0.0077727,0,0
5,GO ESCRT COMPLEX DISASSEMBLY,0.62732,-0.01295,0.030715,0,0
5,GO PROTEIN K48 LINKED UBIQUITINATION,0.87833,-0.012999,0.0015266,0,0
5,GO DIVALENT METAL ION EXPORT,0.59059,-0.013084,-0.049065,0,0
5,GO INTERLEUKIN 12 PRODUCTION,0.47588,-0.013106,-0.047304,0,0
5,GO SYNAPTIC SIGNALING,0.94073,-0.013117,0.025479,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.79636,-0.013138,-0.0027742,0,0
5,GO WATER TRANSPORT,0.4978,-0.013383,-0.0086807,0,0
5,GO NEGATIVE REGULATION OF JNK CASCADE,0.39371,-0.01348,-0.044614,0,0
5,GO IN UTERO EMBRYONIC DEVELOPMENT,0.52594,-0.01353,-0.026725,0,0
5,GO RESPONSE TO INTERLEUKIN 6,0.85768,-0.013568,-0.025749,0,0
5,GO PLACENTA DEVELOPMENT,0.96163,-0.013585,-0.013542,0,0
5,GO VASCULAR WOUND HEALING,0.60883,-0.013618,-0.036876,0,0
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,1,-0.013623,0.0047976,0,0
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.43883,-0.013623,-0.047225,0,0
5,GO HISTONE H3 DEACETYLATION,0.80989,-0.013703,-0.0061433,0,0
5,GO BRANCHING MORPHOGENESIS OF A NERVE,0.70355,-0.013733,-0.042867,0,0
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.84397,-0.013745,0.01255,0,0
5,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.66501,-0.01386,-0.019098,0,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.4545,-0.013923,-0.024628,0,0
5,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.43883,-0.013956,-0.016541,0,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.67137,-0.01397,-0.11384,0,0
5,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.87833,-0.013976,0.027365,0,0
5,GO SLEEP,0.48678,-0.013981,-0.051928,0,0
5,GO SODIUM ION HOMEOSTASIS,0.76948,-0.014026,0.015874,0,0
5,GO INTRACELLULAR MRNA LOCALIZATION,0.40843,-0.014096,-0.062149,0,0
5,GO REGULATION OF HORMONE SECRETION,0.75615,-0.014326,-0.013497,0,0
5,GO INNER EAR MORPHOGENESIS,0.67137,-0.014349,-0.024988,0,0
5,GO PROTEIN SUMOYLATION,0.4978,-0.014418,-0.020901,0,0
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.86455,-0.014437,0.0096104,0,0
5,GO C4 DICARBOXYLATE TRANSPORT,0.15015,-0.01452,-0.097541,0,0
5,GO PIGMENT GRANULE LOCALIZATION,0.98953,-0.014606,-0.0053278,0,0
5,GO HISTONE DEUBIQUITINATION,0.41341,-0.014634,-0.036955,0,0
5,GO REGULATION OF PROTEIN POLYMERIZATION,0.38408,-0.014639,-0.031125,0,0
5,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.4598,-0.014709,-0.081705,0,0
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.98953,-0.014729,0.0034694,0,0
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.72313,-0.014778,0.027601,0,0
5,GO BLASTOCYST DEVELOPMENT,0.21256,-0.014806,-0.047127,0,0
5,GO LAYER FORMATION IN CEREBRAL CORTEX,0.80989,-0.014842,-0.010592,0,0
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.9686,-0.014926,0.0094956,0,0
5,GO REGULATION OF BONE REMODELING,0.36991,-0.014946,-0.095763,0,0
5,GO HOMOLOGOUS RECOMBINATION,0.51459,-0.015009,-0.031122,0,0
5,GO SNRNA TRANSCRIPTION,0.52594,-0.015025,-0.017449,0,0
5,GO FAT CELL PROLIFERATION,0.63354,-0.015067,0.049977,0,0
5,GO LIPID PHOSPHORYLATION,0.30815,-0.01507,-0.034222,0,0
5,GO RESPONSE TO AXON INJURY,0.44402,-0.015081,-0.050509,0,0
5,GO CELL JUNCTION ASSEMBLY,0.32506,-0.015246,-0.047389,0,0
5,GO MYOFIBRIL ASSEMBLY,0.40349,-0.015407,-0.04166,0,0
5,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.8303,-0.015425,0.019359,0,0
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.37932,-0.015459,-0.062516,0,0
5,GO COGNITION,0.89215,-0.015672,0.008939,0,0
5,GO ALDEHYDE CATABOLIC PROCESS,0.54903,-0.015747,-0.0534,0,0
5,GO REGULATION OF MITOPHAGY,0.89215,-0.015825,-0.011481,0,0
5,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.87833,-0.015869,-0.02025,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.64605,-0.015893,-0.014497,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.48131,-0.016089,-0.033517,0,0
5,GO CELL MORPHOGENESIS,0.67776,-0.016121,-0.015379,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.62732,-0.016171,-0.047914,0,0
5,GO REGULATION OF GASTRULATION,0.52594,-0.016189,-0.05561,0,0
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.31232,-0.016194,-0.081153,0,0
5,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.55487,-0.016195,-0.018395,0,0
5,GO NEURAL TUBE FORMATION,0.71006,-0.016267,-0.029663,0,0
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.54903,-0.01627,0.024569,0,0
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.62113,-0.01629,-0.020455,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.38888,-0.016361,-0.07553,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.44924,-0.016386,-0.058991,0,0
5,GO SKELETAL MUSCLE CELL PROLIFERATION,0.78962,-0.016436,-0.040108,0,0
5,GO MULTICELLULAR ORGANISM REPRODUCTION,0.60883,-0.016471,-0.015351,0,0
5,GO ORGANELLE FISSION,0.63978,-0.016499,0.0050024,0,0
5,GO MUSCLE CELL MIGRATION,0.42347,-0.016671,-0.080112,0,0
5,GO DIGESTIVE TRACT MORPHOGENESIS,0.91293,-0.016679,-0.01899,0,0
5,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.94073,-0.016737,0.026714,0,0
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.96163,-0.016739,0.0048778,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.89215,-0.01679,-0.016392,0,0
5,GO MESODERMAL CELL DIFFERENTIATION,0.65234,-0.016858,-0.062632,0,0
5,GO EXECUTION PHASE OF APOPTOSIS,0.63978,-0.016902,-0.018257,0,0
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.56666,-0.016962,0.14202,0,0
5,GO CELL CYCLE PROCESS,0.41341,-0.01697,-0.022615,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.23937,-0.01703,-0.079656,0,0
5,GO INHIBITORY SYNAPSE ASSEMBLY,0.9686,-0.017206,0.033861,0,0
5,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.80989,-0.01736,-0.019789,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.85768,-0.017404,-0.018484,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.85082,-0.017535,-0.021342,0,0
5,GO CARDIAC VENTRICLE DEVELOPMENT,0.15015,-0.017601,-0.093935,0,0
5,GO ACTIVATION OF GTPASE ACTIVITY,0.26098,-0.017627,-0.049371,0,0
5,GO RNA DECAPPING,0.41842,-0.017796,-0.05244,0,0
5,GO MRNA TRANSPORT,0.23937,-0.017923,-0.042267,0,0
5,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.60883,-0.017937,-0.016401,0,0
5,GO CELLULAR RESPONSE TO ALCOHOL,0.77618,-0.017967,-0.034371,0,0
5,GO OPTIC NERVE DEVELOPMENT,0.7495,-0.017975,0.017729,0,0
5,GO EAR DEVELOPMENT,0.71006,-0.018158,-0.01845,0,0
5,GO REGULATION OF MYELINATION,0.89215,-0.018247,0.0036967,0,0
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.80312,-0.018266,-0.028273,0,0
5,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.39371,-0.018283,-0.060428,0,0
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.56075,-0.018401,-0.07804,0,0
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.11636,-0.018407,-0.10163,0,0
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.73628,-0.018436,-0.025225,0,0
5,GO SYNAPTIC VESICLE RECYCLING,0.76281,-0.018446,0.00081809,0,0
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.54903,-0.018449,-0.025226,0,0
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.26098,-0.018519,-0.047583,0,0
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.16828,-0.018546,-0.09014,0,0
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.56075,-0.018547,-0.021866,0,0
5,GO REGULATION OF DEVELOPMENTAL GROWTH,0.53742,-0.01856,-0.024715,0,0
5,GO NEUROTRANSMITTER SECRETION,0.84397,-0.01856,0.041342,0,0
5,GO ETHANOL CATABOLIC PROCESS,0.72313,-0.018599,-0.039219,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.32077,-0.01862,-0.041035,0,0
5,GO POSTSYNAPSE ORGANIZATION,0.70355,-0.01865,-0.017429,0,0
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.36991,-0.018849,-0.085631,0,0
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.16828,-0.018888,-0.058001,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.94073,-0.018924,-0.018652,0,0
5,GO REGULATION OF CELL DIFFERENTIATION,0.35153,-0.018947,-0.036857,0,0
5,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.15264,-0.019115,-0.21561,0,0
5,GO TRIGLYCERIDE CATABOLIC PROCESS,0.39858,-0.019159,-0.052377,0,0
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.42855,-0.019173,-0.035835,0,0
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.29586,-0.019471,-0.047419,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION,0.13355,-0.019484,-0.044376,0,0
5,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.24288,-0.01952,-0.081792,0,0
5,GO REGULATION OF SECRETION,0.38408,-0.01953,-0.032616,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.40349,-0.019656,-0.025248,0,0
5,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.63354,-0.019682,-0.018515,0,0
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.98255,-0.019728,0.0048099,0,0
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.20621,-0.019733,-0.056259,0,0
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.28785,-0.019788,-0.060421,0,0
5,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.78962,-0.019794,-0.0096554,0,0
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.53167,-0.019915,-0.083115,0,0
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.52025,-0.019971,-0.041552,0,0
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.80312,-0.01999,-0.0048698,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE,0.14048,-0.020006,-0.039352,0,0
5,GO REGULATION OF SPINDLE ASSEMBLY,0.98953,-0.020062,-0.0039072,0,0
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.46512,-0.020079,-0.019632,0,0
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.71006,-0.020108,-0.024443,0,0
5,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.63354,-0.020188,-0.013754,0,0
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.43883,-0.020216,-0.066739,0,0
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.99651,-0.020218,0.025021,0,0
5,GO RESPIRATORY SYSTEM PROCESS,0.92682,-0.020341,0.0042222,0,0
5,GO RESPONSE TO LIGHT STIMULUS,0.28785,-0.020356,-0.024401,0,0
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.48678,-0.020368,-0.041672,0,0
5,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.48678,-0.020382,-0.10644,0,0
5,GO GRANULOCYTE CHEMOTAXIS,0.26098,-0.020453,-0.081889,0,0
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.28785,-0.020663,-0.086913,0,0
5,GO MYELOID DENDRITIC CELL ACTIVATION,0.74288,-0.020688,-0.04478,0,0
5,GO NUCLEUS ORGANIZATION,0.21905,-0.020836,-0.043382,0,0
5,GO FIBROBLAST MIGRATION,0.93377,-0.020837,-0.0097399,0,0
5,GO PEPTIDYL THREONINE MODIFICATION,0.32077,-0.020852,-0.035799,0,0
5,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.079444,-0.020882,-0.033864,0,0
5,GO DENDRITE EXTENSION,0.95466,-0.020905,0.087829,0,0
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.29992,-0.020907,-0.054985,0,0
5,GO INTESTINAL ABSORPTION,0.80312,-0.02091,-0.042639,0,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.7495,-0.020951,-0.01109,0,0
5,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.69707,-0.02125,-0.029751,0,0
5,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.87833,-0.021333,0.019656,0,0
5,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.98255,-0.021353,-0.041847,0,0
5,GO RENAL ABSORPTION,0.53167,-0.021649,-0.11955,0,0
5,GO EPITHELIAL CELL DIFFERENTIATION,0.78289,-0.021662,-0.021485,0,0
5,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.51459,-0.021692,-0.028497,0,0
5,GO PEPTIDYL CYSTEINE MODIFICATION,0.66501,-0.021778,-0.011442,0,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.71006,-0.021803,-0.019007,0,0
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.72969,-0.021861,-0.016338,0,0
5,GO MEMORY,0.83713,-0.021898,-0.0083825,0,0
5,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.52594,-0.021906,-0.079891,0,0
5,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.99651,-0.021942,-0.0095124,0,0
5,GO VITAMIN D METABOLIC PROCESS,0.32938,-0.021956,-0.092069,0,0
5,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.95466,-0.022109,-0.013996,0,0
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.26098,-0.022132,-0.034361,0,0
5,GO MRNA 3 END PROCESSING,0.60272,-0.022183,-0.01428,0,0
5,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.27999,-0.022244,-0.079031,0,0
5,GO COENZYME A BIOSYNTHETIC PROCESS,0.4545,-0.022266,-0.036438,0,0
5,GO MITOCHONDRION MORPHOGENESIS,0.31232,-0.022476,-0.048346,0,0
5,GO REGULATION OF VASCULOGENESIS,0.27999,-0.022512,-0.18314,0,0
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.44402,-0.022516,-0.035777,0,0
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.95466,-0.022605,-0.027242,0,0
5,GO NEURON PROJECTION ORGANIZATION,0.96163,-0.022615,-0.018301,0,0
5,GO REGULATION OF TELOMERASE ACTIVITY,0.42855,-0.022636,-0.044063,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.31653,-0.022711,-0.076523,0,0
5,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.49227,-0.022721,-0.036137,0,0
5,GO DNA METABOLIC PROCESS,0.5726,-0.022745,-0.012466,0,0
5,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.96163,-0.022748,-0.02242,0,0
5,GO NEGATIVE REGULATION OF DNA REPAIR,0.50896,-0.022824,-0.045615,0,0
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.2839,-0.022836,-0.030582,0,0
5,GO SEGMENT SPECIFICATION,0.87833,-0.022867,0.020152,0,0
5,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.85768,-0.02287,0.0020129,0,0
5,GO HIPPO SIGNALING,0.69061,-0.023011,-0.084056,0,0
5,GO N GLYCAN PROCESSING,0.67776,-0.023022,-0.033064,0,0
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.80312,-0.023049,-0.00047829,0,0
5,GO CARDIAC MUSCLE CELL PROLIFERATION,0.70355,-0.023086,-0.026586,0,0
5,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.40349,-0.023178,-0.13151,0,0
5,GO CELL VOLUME HOMEOSTASIS,0.65866,-0.02322,-0.020941,0,0
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.51459,-0.023225,-0.023203,0,0
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.42855,-0.023309,-0.039105,0,0
5,GO REGULATION OF CELL CYCLE ARREST,0.44924,-0.023332,-0.02287,0,0
5,GO HEMOGLOBIN METABOLIC PROCESS,0.19695,-0.023375,-0.11511,0,0
5,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.14769,-0.023477,-0.060292,0,0
5,GO REGULATION OF EXCRETION,0.46512,-0.023518,-0.066386,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.34702,-0.023533,-0.11595,0,0
5,GO REGULATION OF VIRAL LIFE CYCLE,0.41842,-0.023616,-0.112,0,0
5,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.79636,-0.023645,-0.0039793,0,0
5,GO ESTABLISHMENT OF CELL POLARITY,0.66501,-0.02381,-0.016342,0,0
5,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.41842,-0.023941,-0.046881,0,0
5,GO ANOIKIS,0.51459,-0.023949,-0.063467,0,0
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.57857,-0.024048,-0.08821,0,0
5,GO EMBRYONIC ORGAN DEVELOPMENT,0.64605,-0.024113,-0.025664,0,0
5,GO SKIN DEVELOPMENT,0.84397,-0.024214,-0.025733,0,0
5,GO REGULATION OF POSITIVE CHEMOTAXIS,0.87144,-0.024237,-0.011513,0,0
5,GO POSITIVE REGULATION OF CELL ACTIVATION,0.24288,-0.024373,-0.07632,0,0
5,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.23245,-0.024395,-0.14808,0,0
5,GO HORMONE TRANSPORT,0.76281,-0.024524,-0.01378,0,0
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.51459,-0.024683,-0.035866,0,0
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.31653,-0.024688,-0.041993,0,0
5,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.67776,-0.02471,0.045784,0,0
5,GO ORGANELLE ASSEMBLY,0.21256,-0.024722,-0.030636,0,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.92682,-0.024724,-0.015876,0,0
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.72969,-0.02475,-0.014632,0,0
5,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.90599,-0.024842,0.0046756,0,0
5,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.89907,-0.024915,0.0040684,0,0
5,GO OOCYTE MATURATION,0.79636,-0.024975,-0.0056379,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.89907,-0.025019,0.022229,0,0
5,GO RESPONSE TO BMP,0.43367,-0.025019,-0.048005,0,0
5,GO LEUKOCYTE HOMEOSTASIS,0.26471,-0.025116,-0.062588,0,0
5,GO GANGLIOSIDE METABOLIC PROCESS,0.80989,-0.025119,-0.033919,0,0
5,GO HETEROTYPIC CELL CELL ADHESION,0.44924,-0.025122,-0.051371,0,0
5,GO THYMIC T CELL SELECTION,0.97557,-0.025175,0.010561,0,0
5,GO CELL GROWTH,0.25363,-0.025178,-0.043442,0,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.98255,-0.025267,-0.031115,0,0
5,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.91987,-0.025295,-0.011751,0,0
5,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.17099,-0.025341,-0.058694,0,0
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.54321,-0.025354,-0.077847,0,0
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.14285,-0.025422,-0.11327,0,0
5,GO CELLULAR PIGMENTATION,0.21579,-0.025504,-0.068799,0,0
5,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.71006,-0.025599,0.020407,0,0
5,GO B CELL ACTIVATION,0.070855,-0.025711,-0.089222,0,0
5,GO CELLULAR ANION HOMEOSTASIS,0.98953,-0.025728,0.0080499,0,0
5,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.54903,-0.025755,-0.031137,0,0
5,GO CELL CYCLE G1 S PHASE TRANSITION,0.2,-0.025825,-0.041122,0,0
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.41341,-0.025848,-0.068415,0,0
5,GO LIMBIC SYSTEM DEVELOPMENT,0.91987,-0.02588,-0.0056387,0,0
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.30815,-0.025938,-0.065374,0,0
5,GO PHOTOPERIODISM,0.47588,-0.025994,-0.039664,0,0
5,GO ERBB2 SIGNALING PATHWAY,0.43883,-0.02605,-0.061566,0,0
5,GO CELL CELL SIGNALING BY WNT,0.35153,-0.02608,-0.039462,0,0
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.097379,-0.026101,-0.11255,0,0
5,GO COBALAMIN METABOLIC PROCESS,0.33812,-0.026268,-0.086056,0,0
5,GO POSITIVE THYMIC T CELL SELECTION,0.91293,-0.026294,0.019851,0,0
5,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.46512,-0.026304,-0.059577,0,0
5,GO EMBRYONIC PATTERN SPECIFICATION,0.58456,-0.026308,-0.025293,0,0
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.33373,-0.026365,-0.1065,0,0
5,GO B CELL DIFFERENTIATION,0.19695,-0.026749,-0.068523,0,0
5,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.83713,-0.02682,0.017503,0,0
5,GO MAINTENANCE OF CELL NUMBER,0.78962,-0.02682,-0.017972,0,0
5,GO LYMPHANGIOGENESIS,0.27227,-0.026908,-0.10759,0,0
5,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.39858,-0.026933,-0.02907,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.98953,-0.02694,0.034444,0,0
5,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.88523,-0.026953,0.0079883,0,0
5,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.62732,-0.026972,-0.041626,0,0
5,GO REGULATION OF DNA CATABOLIC PROCESS,0.46512,-0.026973,-0.030679,0,0
5,GO RESPONSE TO ALKALOID,0.31232,-0.027045,-0.048505,0,0
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.41842,-0.027084,-0.042723,0,0
5,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.91987,-0.02712,0.003764,0,0
5,GO CILIUM MOVEMENT,0.74288,-0.027276,-0.0035691,0,0
5,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.65234,-0.027278,-0.022643,0,0
5,GO CELLULAR RESPONSE TO ALKALOID,0.90599,-0.027297,0.0017388,0,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.81668,-0.027372,0.017357,0,0
5,GO COPII COATED VESICLE CARGO LOADING,0.18219,-0.027384,-0.090982,0,0
5,GO DNA GEOMETRIC CHANGE,0.70355,-0.027552,-0.012823,0,0
5,GO NOTCH SIGNALING PATHWAY,0.32506,-0.027701,-0.050285,0,0
5,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.12473,-0.027814,-0.074405,0,0
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.85768,-0.027815,0.024237,0,0
5,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.093897,-0.027829,-0.16778,0,0
5,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.95466,-0.027853,0.001471,0,0
5,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.59059,-0.027859,-0.004712,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.27999,-0.027926,-0.10069,0,0
5,GO ALPHA BETA T CELL ACTIVATION,0.188,-0.027956,-0.088406,0,0
5,GO EATING BEHAVIOR,0.60883,-0.028115,-0.021036,0,0
5,GO MRNA PROCESSING,0.72969,-0.028224,-0.007534,0,0
5,GO EMBRYONIC ORGAN MORPHOGENESIS,0.59664,-0.028373,-0.031247,0,0
5,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.69061,-0.0284,-0.021881,0,0
5,GO CELL CELL JUNCTION MAINTENANCE,0.98953,-0.028446,-0.00035212,0,0
5,GO GRANULOCYTE DIFFERENTIATION,0.079444,-0.028605,-0.128,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.40349,-0.028645,-0.065857,0,0
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.32938,-0.028708,-0.082538,0,0
5,GO EPITHELIAL TUBE MORPHOGENESIS,0.17099,-0.028754,-0.067297,0,0
5,GO ACTIN FILAMENT ORGANIZATION,0.1028,-0.028789,-0.07307,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.63978,-0.028878,-0.034546,0,0
5,GO ENDOSOMAL TRANSPORT,0.22235,-0.028883,-0.034578,0,0
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.072231,-0.028969,-0.039815,0,0
5,GO SPECIFICATION OF SYMMETRY,0.4545,-0.02912,-0.018415,0,0
5,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.78962,-0.029125,-0.025083,0,0
5,GO DEVELOPMENTAL CELL GROWTH,0.54321,-0.029141,-0.023237,0,0
5,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.42855,-0.029144,-0.085293,0,0
5,GO RESPONSE TO AMINO ACID STARVATION,0.46512,-0.029335,-0.040951,0,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.42855,-0.029385,-0.005438,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.50896,-0.029408,-0.055003,0,0
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.95466,-0.029444,0.0040622,0,0
5,GO POSTSYNAPSE ASSEMBLY,0.93377,-0.029456,0.011097,0,0
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.31232,-0.029467,-0.061251,0,0
5,GO MEIOSIS I CELL CYCLE PROCESS,0.66501,-0.029498,-0.01883,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEUS,0.090515,-0.029524,-0.059861,0,0
5,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.54321,-0.029612,-0.0098872,0,0
5,GO COLLATERAL SPROUTING,0.42347,-0.029632,-0.046786,0,0
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.36064,-0.029647,-0.061325,0,0
5,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.188,-0.029659,-0.086615,0,0
5,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.63354,-0.02967,-0.036436,0,0
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.38408,-0.029706,-0.04277,0,0
5,GO IRON COORDINATION ENTITY TRANSPORT,0.65866,-0.029797,-0.033496,0,0
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.10654,-0.029821,-0.057676,0,0
5,GO SECOND MESSENGER MEDIATED SIGNALING,0.072231,-0.029826,-0.062188,0,0
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.39858,-0.029907,-0.049328,0,0
5,GO NEGATIVE REGULATION OF BINDING,0.11841,-0.02992,-0.04356,0,0
5,GO VENTRICULAR SYSTEM DEVELOPMENT,0.66501,-0.030035,-0.025867,0,0
5,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.66501,-0.030339,-0.033124,0,0
5,GO SKELETAL SYSTEM MORPHOGENESIS,0.39371,-0.030462,-0.051407,0,0
5,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.77618,-0.030524,-0.0067761,0,0
5,GO RNA EXPORT FROM NUCLEUS,0.23589,-0.030695,-0.042791,0,0
5,GO ENDOTHELIUM DEVELOPMENT,0.3746,-0.030763,-0.057154,0,0
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.092194,-0.030882,-0.098384,0,0
5,GO OUTER DYNEIN ARM ASSEMBLY,0.60272,-0.030883,-0.024166,0,0
5,GO SYNAPTIC VESICLE BUDDING,0.64605,-0.03094,-0.046192,0,0
5,GO RESPONSE TO RADIATION,0.093897,-0.030976,-0.035926,0,0
5,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.68418,-0.031,-0.030126,0,0
5,GO PEPTIDYL LYSINE DIMETHYLATION,0.89907,-0.031004,0.015132,0,0
5,GO ENDOCRINE PANCREAS DEVELOPMENT,0.60883,-0.031018,-0.032421,0,0
5,GO CELL CELL JUNCTION ASSEMBLY,0.37932,-0.031094,-0.052736,0,0
5,GO VESICLE DOCKING,0.25729,-0.031109,-0.047548,0,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.59059,-0.031131,-0.014708,0,0
5,GO KIDNEY MORPHOGENESIS,0.58456,-0.031156,-0.03495,0,0
5,GO REGULATION OF TUBE SIZE,0.23937,-0.031159,-0.062961,0,0
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.9686,-0.031311,-0.003236,0,0
5,GO MESODERM DEVELOPMENT,0.33373,-0.031435,-0.050099,0,0
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.17374,-0.031442,-0.081277,0,0
5,GO SECONDARY PALATE DEVELOPMENT,0.63978,-0.031505,-0.045634,0,0
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.13355,-0.031519,-0.077785,0,0
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.66501,-0.031568,-0.025896,0,0
5,GO RESPONSE TO MURAMYL DIPEPTIDE,0.23589,-0.031667,-0.1828,0,0
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.41341,-0.0318,-0.052028,0,0
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.76948,-0.031816,-0.040492,0,0
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.74288,-0.031915,0.053466,0,0
5,GO EPITHELIAL CELL DEVELOPMENT,0.35153,-0.031945,-0.064338,0,0
5,GO MUSCLE ORGAN DEVELOPMENT,0.068167,-0.032065,-0.064816,0,0
5,GO MIDBRAIN DEVELOPMENT,0.76281,-0.032167,-0.014376,0,0
5,GO T CELL DIFFERENTIATION,0.47588,-0.032212,-0.052823,0,0
5,GO FOREGUT MORPHOGENESIS,0.75615,-0.032265,-0.043489,0,0
5,GO REGULATION OF EXOCYTOSIS,0.40349,-0.032294,-0.010284,0,0
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.47588,-0.032402,-0.024529,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.21905,-0.032501,-0.078949,0,0
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.11039,-0.032755,-0.077285,0,0
5,GO KILLING OF CELLS OF OTHER ORGANISM,0.86455,-0.032773,0.011848,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.77618,-0.032779,0.014995,0,0
5,GO CATECHOLAMINE METABOLIC PROCESS,0.94073,-0.03284,0.028706,0,0
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.83713,-0.032901,-0.0046174,0,0
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.47588,-0.033,-0.082499,0,0
5,GO HYPOTHALAMUS DEVELOPMENT,0.33812,-0.033039,-0.078659,0,0
5,GO RESPONSE TO IMMOBILIZATION STRESS,0.48131,-0.033055,-0.10313,0,0
5,GO REGULATION OF T CELL ACTIVATION,0.24288,-0.033093,-0.073299,0,0
5,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.4978,-0.033225,-0.089589,0,0
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.17934,-0.033239,-0.039226,0,0
5,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.29184,-0.03329,-0.15542,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.29184,-0.033323,-0.079145,0,0
5,GO LEARNING,0.80312,-0.033377,-0.00324,0,0
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.29586,-0.033529,-0.058686,0,0
5,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.16828,-0.033587,-0.10463,0,0
5,GO REGULATION OF DEACETYLASE ACTIVITY,0.58456,-0.033587,-0.03286,0,0
5,GO PROTEIN DESTABILIZATION,0.33373,-0.033639,-0.043551,0,0
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.18508,-0.033726,-0.055046,0,0
5,GO GLUTAMATE SECRETION,0.98255,-0.03376,0.014044,0,0
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.61497,-0.033765,-0.079633,0,0
5,GO RESPIRATORY SYSTEM DEVELOPMENT,0.50896,-0.033767,-0.036348,0,0
5,GO ACTIN FILAMENT BASED PROCESS,0.14048,-0.033769,-0.062942,0,0
5,GO GOLGI RIBBON FORMATION,0.29586,-0.033791,-0.071413,0,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.34702,-0.033793,-0.048842,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.48131,-0.033837,-0.029647,0,0
5,GO REGULATION OF GLUCOSE IMPORT,0.23937,-0.033869,-0.051234,0,0
5,GO SENSORY PERCEPTION OF PAIN,0.72313,-0.03387,-0.0053876,0,0
5,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.30402,-0.033943,-0.15169,0,0
5,GO REGULATION OF RENAL SYSTEM PROCESS,0.79636,-0.033965,-0.023733,0,0
5,GO UROGENITAL SYSTEM DEVELOPMENT,0.25001,-0.034082,-0.068248,0,0
5,GO DEVELOPMENTAL PIGMENTATION,0.25729,-0.034093,-0.062893,0,0
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.27999,-0.03421,-0.069099,0,0
5,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.36064,-0.0343,-0.12829,0,0
5,GO PEPTIDE SECRETION,0.24288,-0.034324,-0.054547,0,0
5,GO IMMUNE SYSTEM DEVELOPMENT,0.11636,-0.034424,-0.063198,0,0
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.52025,-0.034486,-0.065801,0,0
5,GO REGULATION OF ORGANELLE ORGANIZATION,0.05824,-0.034509,-0.038684,0,0
5,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.51459,-0.034599,-0.071776,0,0
5,GO CELL AGGREGATION,0.92682,-0.034634,-0.014782,0,0
5,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.69707,-0.034705,0.010888,0,0
5,GO CELL JUNCTION ORGANIZATION,0.21905,-0.034773,-0.05389,0,0
5,GO NEUROTRANSMITTER TRANSPORT,0.56075,-0.034779,0.0072368,0,0
5,GO RESPONSE TO NICOTINE,0.94769,-0.034815,0.016638,0,0
5,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.64605,-0.034875,-0.04046,0,0
5,GO LOCALIZATION WITHIN MEMBRANE,0.60883,-0.035001,-0.029761,0,0
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.1313,-0.035113,-0.073181,0,0
5,GO EXCITATORY SYNAPSE ASSEMBLY,0.96163,-0.035123,-0.0063734,0,0
5,GO REGULATION OF T CELL DIFFERENTIATION,0.30402,-0.035175,-0.058899,0,0
5,GO HISTONE H3 K14 ACETYLATION,0.86455,-0.035222,-0.0060346,0,0
5,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.67776,-0.035316,-0.011289,0,0
5,GO ACTIVATION OF JNKK ACTIVITY,0.49227,-0.035346,-0.04413,0,0
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.22905,-0.035379,-0.052867,0,0
5,GO DISTAL TUBULE DEVELOPMENT,0.94073,-0.035467,-0.018612,0,0
5,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.23937,-0.035471,-0.068906,0,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.12049,-0.035525,-0.050378,0,0
5,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.65866,-0.035578,-0.025583,0,0
5,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.33812,-0.035579,-0.087074,0,0
5,GO RESPONSE TO WATER,0.75615,-0.035626,-0.024704,0,0
5,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.78962,-0.035715,-0.055536,0,0
5,GO DENDRITIC SPINE MAINTENANCE,0.26847,-0.035763,-0.098718,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.53167,-0.035845,-0.03346,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.26471,-0.035858,-0.06573,0,0
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.30815,-0.035878,-0.046373,0,0
5,GO REGULATION OF PROTEIN IMPORT,0.11841,-0.036004,-0.11582,0,0
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.20937,-0.036049,-0.11773,0,0
5,GO SKIN EPIDERMIS DEVELOPMENT,0.48678,-0.036243,-0.062524,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.4545,-0.036255,-0.036037,0,0
5,GO HEART GROWTH,0.20937,-0.036287,-0.061441,0,0
5,GO RECEPTOR CLUSTERING,0.65866,-0.03631,-0.032749,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.93377,-0.036362,-0.019057,0,0
5,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.16828,-0.036364,-0.078345,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.78962,-0.036632,0.014995,0,0
5,GO THYROID HORMONE METABOLIC PROCESS,0.77618,-0.036674,-0.0076546,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.51459,-0.036697,-0.049164,0,0
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.16032,-0.036703,-0.066689,0,0
5,GO BODY MORPHOGENESIS,0.41341,-0.036713,-0.052959,0,0
5,GO NEGATIVE REGULATION OF CELL ADHESION,0.32506,-0.036748,-0.069866,0,0
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.36526,-0.036933,-0.053936,0,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.21905,-0.037019,-0.05411,0,0
5,GO PHAGOSOME ACIDIFICATION,0.56075,-0.037074,-0.054869,0,0
5,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.72313,-0.037131,0.021332,0,0
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.13814,-0.037138,-0.080997,0,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.87833,-0.037166,-0.0034143,0,0
5,GO DOPAMINE METABOLIC PROCESS,0.93377,-0.037293,0.029075,0,0
5,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.76948,-0.037323,-0.00094683,0,0
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.19393,-0.037326,-0.05951,0,0
5,GO NEUTROPHIL MIGRATION,0.10845,-0.037351,-0.096017,0,0
5,GO REGULATION OF RESPONSE TO FOOD,0.32077,-0.037372,-0.077414,0,0
5,GO FAT CELL DIFFERENTIATION,0.064293,-0.037386,-0.095107,0,0
5,GO LYMPHOCYTE HOMEOSTASIS,0.26471,-0.037399,-0.049665,0,0
5,GO HAIR CELL DIFFERENTIATION,0.81668,-0.037424,-0.011888,0,0
5,GO PH REDUCTION,0.38408,-0.037453,-0.042769,0,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.080955,-0.037469,-0.062069,0,0
5,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.23937,-0.037635,-0.065834,0,0
5,GO INTERLEUKIN 6 PRODUCTION,0.44402,-0.037645,-0.051594,0,0
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.35153,-0.037707,-0.032866,0,0
5,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.092194,-0.037797,-0.16494,0,0
5,GO DEVELOPMENTAL GROWTH,0.16828,-0.037827,-0.046168,0,0
5,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.59664,-0.037841,-0.032925,0,0
5,GO INTERLEUKIN 1 BETA PRODUCTION,0.16032,-0.038019,-0.12207,0,0
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.91987,-0.038098,0.02558,0,0
5,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.21579,-0.038126,-0.094209,0,0
5,GO CANONICAL WNT SIGNALING PATHWAY,0.21579,-0.038195,-0.053861,0,0
5,GO TAXIS,0.15264,-0.038234,-0.05467,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.26471,-0.038289,-0.028938,0,0
5,GO GLAND DEVELOPMENT,0.099158,-0.038317,-0.070165,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.26471,-0.038364,-0.064335,0,0
5,GO B CELL RECEPTOR SIGNALING PATHWAY,0.35607,-0.03842,-0.059011,0,0
5,GO REGULATION OF INTRACELLULAR TRANSPORT,0.27227,-0.038505,-0.032136,0,0
5,GO REGULATION OF RECEPTOR RECYCLING,0.5726,-0.038542,-0.03996,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.41842,-0.038629,-0.028953,0,0
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.77618,-0.038637,-0.01747,0,0
5,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.23589,-0.038676,-0.072928,0,0
5,GO REGULATION OF PEPTIDE SECRETION,0.22235,-0.038704,-0.049915,0,0
5,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.81668,-0.038828,-0.00032478,0,0
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.5726,-0.038843,-0.084978,0,0
5,GO ANIMAL ORGAN FORMATION,0.10654,-0.038874,-0.10549,0,0
5,GO REGULATION OF HAIR CYCLE,0.47588,-0.038889,-0.062724,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.73628,-0.038914,-0.026649,0,0
5,GO HEART MORPHOGENESIS,0.093897,-0.03907,-0.087414,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.23937,-0.039113,-0.034688,0,0
5,GO VISUAL BEHAVIOR,0.31232,-0.039122,-0.041073,0,0
5,GO MESENCHYMAL CELL PROLIFERATION,0.42347,-0.039197,-0.082601,0,0
5,GO BRAIN MORPHOGENESIS,0.80312,-0.039276,-0.01551,0,0
5,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.85082,-0.039304,0.01663,0,0
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.11235,-0.039341,-0.062299,0,0
5,GO MULTI ORGANISM PROCESS,0.079444,-0.039401,-0.044803,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.05161,-0.039436,-0.086217,0,0
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.059411,-0.039477,-0.055364,0,0
5,GO REGULATION OF NEUTROPHIL MIGRATION,0.30815,-0.039557,-0.079724,0,0
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.2,-0.039706,-0.085767,0,0
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.14048,-0.039737,-0.05898,0,0
5,GO CALCIUM MEDIATED SIGNALING,0.15773,-0.03979,-0.046812,0,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.41842,-0.039859,-0.07975,0,0
5,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.32938,-0.039935,-0.051843,0,0
5,GO PROTEIN POLYMERIZATION,0.19695,-0.039938,-0.045135,0,0
5,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.99651,-0.040185,-0.010261,0,0
5,GO REGULATION OF SENSORY PERCEPTION,0.26847,-0.040249,-0.077983,0,0
5,GO CYTOSOLIC TRANSPORT,0.11434,-0.0403,-0.053763,0,0
5,GO TISSUE HOMEOSTASIS,0.20937,-0.040316,-0.063321,0,0
5,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.12689,-0.040459,-0.052086,0,0
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.30402,-0.040492,-0.079411,0,0
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.084046,-0.04053,-0.081897,0,0
5,GO SMOOTH MUSCLE CELL MIGRATION,0.33812,-0.040552,-0.10739,0,0
5,GO INTERMEDIATE FILAMENT BASED PROCESS,0.29184,-0.040576,-0.090072,0,0
5,GO NERVE DEVELOPMENT,0.59664,-0.040604,-0.030641,0,0
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.17099,-0.040709,-0.057584,0,0
5,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.32506,-0.04072,-0.05299,0,0
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.13355,-0.040757,-0.076022,0,0
5,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.17099,-0.040798,-0.041731,0,0
5,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.4545,-0.040875,-0.075897,0,0
5,GO PROTEIN POLYGLUTAMYLATION,0.63978,-0.040948,-0.025657,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.44924,-0.040961,-0.063457,0,0
5,GO CHONDROCYTE DIFFERENTIATION,0.15517,-0.040974,-0.088187,0,0
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.25729,-0.040992,-0.045209,0,0
5,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.80989,-0.04107,-0.04015,0,0
5,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.69707,-0.041107,-0.068765,0,0
5,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.17653,-0.041127,-0.035041,0,0
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23937,-0.041169,-0.074314,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.35607,-0.041296,-0.068166,0,0
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.56075,-0.041303,-0.04757,0,0
5,GO EAR MORPHOGENESIS,0.48131,-0.041303,-0.038203,0,0
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.11434,-0.041426,-0.059833,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.19095,-0.041461,-0.041856,0,0
5,GO REGULATION OF MUSCLE HYPERTROPHY,0.15015,-0.04148,-0.09397,0,0
5,GO ADIPOSE TISSUE DEVELOPMENT,0.2839,-0.041516,-0.055057,0,0
5,GO NUCLEAR ENVELOPE ORGANIZATION,0.13814,-0.041557,-0.064796,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.39371,-0.041591,-0.040118,0,0
5,GO REGULATION OF CELL ACTIVATION,0.12908,-0.041699,-0.086751,0,0
5,GO DEFENSE RESPONSE TO FUNGUS,0.31232,-0.041734,-0.058154,0,0
5,GO EPITHELIAL TUBE FORMATION,0.71006,-0.04181,-0.030392,0,0
5,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.80989,-0.04189,-0.064041,0,0
5,GO AMYLOID FIBRIL FORMATION,0.67137,-0.041891,-0.049449,0,0
5,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.011904,-0.041915,-0.080383,0,0
5,GO NEURON MATURATION,0.48131,-0.041953,-0.027725,0,0
5,GO STABILIZATION OF MEMBRANE POTENTIAL,0.90599,-0.042006,-0.01363,0,0
5,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.38888,-0.042048,-0.049955,0,0
5,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.41341,-0.042099,-0.072899,0,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.78962,-0.042116,-0.062728,0,0
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.87144,-0.042189,-0.012171,0,0
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.1028,-0.042288,-0.063397,0,0
5,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.14048,-0.042311,-0.082415,0,0
5,GO GAP JUNCTION ASSEMBLY,0.43883,-0.042313,-0.1116,0,0
5,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.21905,-0.042339,-0.039262,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.2,-0.042346,-0.09819,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.81668,-0.042401,-0.01071,0,0
5,GO ARTERY MORPHOGENESIS,0.40349,-0.042475,-0.060371,0,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.61497,-0.042484,-0.036366,0,0
5,GO CHEMOKINE PRODUCTION,0.24288,-0.042545,-0.10705,0,0
5,GO REGULATION OF T CELL MIGRATION,0.19095,-0.042569,-0.092004,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.36991,-0.042576,-0.0691,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.19393,-0.042595,-0.093367,0,0
5,GO REGULATION OF MRNA METABOLIC PROCESS,0.059411,-0.042605,-0.059101,0,0
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.42855,-0.04268,-0.093904,0,0
5,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.33373,-0.042688,-0.045065,0,0
5,GO ENGULFMENT OF APOPTOTIC CELL,0.11039,-0.042789,-0.12517,0,0
5,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.48678,-0.042814,-0.019972,0,0
5,GO CELL MOTILITY,0.075049,-0.042906,-0.078163,0,0
5,GO REGULATION OF ANION TRANSPORT,0.36064,-0.042949,-0.053679,0,0
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.47588,-0.043131,-0.061481,0,0
5,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.15517,-0.043187,-0.052047,0,0
5,GO CARDIAC CHAMBER MORPHOGENESIS,0.080955,-0.043192,-0.12096,0,0
5,GO REGULATION OF B CELL ACTIVATION,0.14769,-0.04322,-0.090571,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.22905,-0.04333,-0.029047,0,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.34256,-0.043349,-0.070092,0,0
5,GO AORTA MORPHOGENESIS,0.75615,-0.043419,-0.02656,0,0
5,GO POSTREPLICATION REPAIR,0.81668,-0.043452,-0.0027313,0,0
5,GO LYMPHOCYTE DIFFERENTIATION,0.23245,-0.043463,-0.060625,0,0
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.44924,-0.043486,-0.062231,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.13814,-0.043588,-0.046144,0,0
5,GO REGULATION OF PEPTIDE TRANSPORT,0.15264,-0.043711,-0.042236,0,0
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.69707,-0.043715,-0.047723,0,0
5,GO OVULATION CYCLE,0.17099,-0.043796,-0.071612,0,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.40349,-0.0438,-0.090652,0,0
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.4978,-0.043809,-0.032756,0,0
5,GO RESPONSE TO PROGESTERONE,0.50337,-0.043891,-0.059894,0,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.033894,-0.043896,-0.057592,0,0
5,GO RENAL SYSTEM PROCESS,0.4545,-0.043929,-0.038021,0,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.079444,-0.04417,-0.13215,0,0
5,GO FACE DEVELOPMENT,0.36991,-0.044172,-0.056282,0,0
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.2839,-0.044216,-0.090355,0,0
5,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.29586,-0.0443,-0.037651,0,0
5,GO RHYTHMIC BEHAVIOR,0.11841,-0.044362,-0.064646,0,0
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.24288,-0.044372,-0.090098,0,0
5,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.43883,-0.044389,-0.019331,0,0
5,GO BONE TRABECULA FORMATION,0.43883,-0.044401,-0.17483,0,0
5,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.40843,-0.044423,-0.052422,0,0
5,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.50896,-0.044428,-0.028718,0,0
5,GO VESICLE FUSION TO PLASMA MEMBRANE,0.35607,-0.044566,-0.015561,0,0
5,GO GENE SILENCING,0.05161,-0.044567,-0.049557,0,0
5,GO POSITIVE REGULATION OF CHEMOTAXIS,0.30402,-0.044629,-0.066212,0,0
5,GO OLIGODENDROCYTE DEVELOPMENT,0.34702,-0.044705,-0.054218,0,0
5,GO GLYCOSIDE METABOLIC PROCESS,0.52025,-0.044721,-0.13423,0,0
5,GO HEART VALVE DEVELOPMENT,0.30402,-0.04479,-0.093001,0,0
5,GO MOLTING CYCLE,0.26847,-0.044993,-0.068748,0,0
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.36991,-0.045109,-0.08293,0,0
5,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.62732,-0.045231,-0.032066,0,0
5,GO RESPONSE TO L GLUTAMATE,0.69707,-0.045257,-0.037352,0,0
5,GO MORPHOGENESIS OF AN EPITHELIUM,0.15773,-0.045293,-0.073447,0,0
5,GO MEMBRANE LIPID METABOLIC PROCESS,0.05161,-0.045348,-0.10196,0,0
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.78289,-0.045368,-0.0098722,0,0
5,GO HISTONE PHOSPHORYLATION,0.16294,-0.045443,-0.073953,0,0
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.25363,-0.045476,-0.068437,0,0
5,GO NUCLEOSIDE CATABOLIC PROCESS,0.48678,-0.045571,-0.072515,0,0
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.1028,-0.045605,-0.097188,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.068167,-0.045677,-0.05062,0,0
5,GO CELLULAR RESPONSE TO VIRUS,0.15517,-0.045686,-0.091155,0,0
5,GO T CELL ACTIVATION,0.17653,-0.04569,-0.086843,0,0
5,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.80312,-0.045708,-0.013851,0,0
5,GO TRABECULA MORPHOGENESIS,0.11235,-0.045744,-0.12535,0,0
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.42855,-0.04579,-0.087761,0,0
5,GO REGULATION OF GROWTH,0.065563,-0.045857,-0.057143,0,0
5,GO ENDODERMAL CELL FATE COMMITMENT,0.78962,-0.045978,-0.018802,0,0
5,GO RHYTHMIC PROCESS,0.32506,-0.045998,-0.026532,0,0
5,GO LENS FIBER CELL DIFFERENTIATION,0.24288,-0.046038,-0.095026,0,0
5,GO REGULATION OF HORMONE LEVELS,0.27999,-0.046183,-0.048376,0,0
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.17653,-0.046297,-0.050028,0,0
5,GO REGULATION OF PH,0.061812,-0.046315,-0.06931,0,0
5,GO MUSCLE TISSUE DEVELOPMENT,0.099158,-0.046364,-0.060038,0,0
5,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.55487,-0.046466,-0.089593,0,0
5,GO REGULATION OF CYCLASE ACTIVITY,0.34702,-0.046469,-0.049686,0,0
5,GO REGULATION OF RUFFLE ASSEMBLY,0.41341,-0.046504,-0.060514,0,0
5,GO NEUTRAL LIPID CATABOLIC PROCESS,0.25001,-0.046663,-0.073314,0,0
5,GO BONE RESORPTION,0.095625,-0.04679,-0.12185,0,0
5,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.36991,-0.046838,-0.077056,0,0
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.188,-0.046852,-0.086076,0,0
5,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.40349,-0.046881,-0.0035889,0,0
5,GO HEART VALVE FORMATION,0.79636,-0.046922,-0.038696,0,0
5,GO LIPID DROPLET ORGANIZATION,0.32938,-0.046959,-0.073367,0,0
5,GO RESPONSE TO LEAD ION,0.60272,-0.047058,-0.032491,0,0
5,GO NEGATIVE REGULATION OF DNA REPLICATION,0.62113,-0.04716,-0.044392,0,0
5,GO RNA CAPPING,0.11434,-0.047161,-0.064157,0,0
5,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.16828,-0.047211,-0.068447,0,0
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.17653,-0.047281,-0.115,0,0
5,GO ONE CARBON COMPOUND TRANSPORT,0.14526,-0.047303,-0.12731,0,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.15773,-0.047327,-0.1088,0,0
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.21905,-0.04743,-0.075889,0,0
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.38408,-0.047441,-0.07262,0,0
5,GO LIPOPROTEIN METABOLIC PROCESS,0.05824,-0.047447,-0.080703,0,0
5,GO SOMITOGENESIS,0.16032,-0.04755,-0.063667,0,0
5,GO AROMATIC AMINO ACID TRANSPORT,0.30815,-0.047562,-0.13366,0,0
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.10654,-0.047721,-0.07321,0,0
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.092194,-0.047759,-0.052784,0,0
5,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.46512,-0.047764,-0.035524,0,0
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.44924,-0.047771,-0.069464,0,0
5,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.98953,-0.047927,-0.025844,0,0
5,GO CELL CELL JUNCTION ORGANIZATION,0.49227,-0.047987,-0.042657,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.22235,-0.048069,-0.086874,0,0
5,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.12689,-0.048497,-0.12332,0,0
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.12473,-0.048525,-0.061833,0,0
5,GO MUSCLE CELL DIFFERENTIATION,0.090515,-0.048592,-0.067665,0,0
5,GO RADIAL GLIAL CELL DIFFERENTIATION,0.39371,-0.048607,-0.10414,0,0
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.13355,-0.048635,-0.057229,0,0
5,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.12908,-0.048793,-0.092093,0,0
5,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.34256,-0.04889,-0.043969,0,0
5,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.40843,-0.048896,-0.045121,0,0
5,GO ARACHIDONIC ACID SECRETION,0.077957,-0.048907,-0.10123,0,0
5,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.4978,-0.048974,-0.041506,0,0
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.33812,-0.048993,-0.06808,0,0
5,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.25363,-0.049061,-0.041109,0,0
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.188,-0.049084,-0.058989,0,0
5,GO APICAL JUNCTION ASSEMBLY,0.61497,-0.049116,-0.023004,0,0
5,GO REGULATION OF ICOSANOID SECRETION,0.77618,-0.049124,-0.014903,0,0
5,GO CELL CELL ADHESION,0.075049,-0.049131,-0.084828,0,0
5,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.097379,-0.049206,-0.21412,0,0
5,GO FEMALE GENITALIA DEVELOPMENT,0.8303,-0.049229,-0.010824,0,0
5,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.25729,-0.049243,-0.081249,0,0
5,GO PROSTATE GLAND DEVELOPMENT,0.4598,-0.049305,-0.076878,0,0
5,GO TRACHEA DEVELOPMENT,0.44924,-0.049305,-0.091369,0,0
5,GO NERVOUS SYSTEM PROCESS,0.22568,-0.049451,-0.030987,0,0
5,GO PANCREATIC JUICE SECRETION,0.2839,-0.049517,-0.081635,0,0
5,GO REGULATION OF PROTEIN DEACETYLATION,0.53742,-0.049519,-0.022995,0,0
5,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.21579,-0.049532,-0.12479,0,0
5,GO LYMPH VESSEL DEVELOPMENT,0.14769,-0.049569,-0.12513,0,0
5,GO CYTOKINETIC PROCESS,0.50337,-0.049704,-0.041628,0,0
5,GO PROTEIN AUTO ADP RIBOSYLATION,0.99651,-0.049727,0.02812,0,0
5,GO SEGMENTATION,0.2,-0.049757,-0.061996,0,0
5,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.19695,-0.049855,-0.045018,0,0
5,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.066855,-0.049872,-0.066383,0,0
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.21579,-0.049879,-0.074544,0,0
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.3746,-0.049891,-0.083216,0,0
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.27999,-0.049901,-0.063387,0,0
5,GO CORPUS CALLOSUM DEVELOPMENT,0.29992,-0.049919,-0.085722,0,0
5,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.12259,-0.049946,-0.051888,0,0
5,GO DEFENSE RESPONSE TO VIRUS,0.36064,-0.049949,-0.10103,0,0
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.22568,-0.049969,-0.1452,0,0
5,GO RESPONSE TO VITAMIN A,0.99651,-0.050028,-0.00010856,0,0
5,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.35153,-0.050059,-0.045387,0,0
5,GO TRANSLESION SYNTHESIS,0.63354,-0.050172,-0.016407,0,0
5,GO OOCYTE DIFFERENTIATION,0.48678,-0.050218,-0.030541,0,0
5,GO STEM CELL DIFFERENTIATION,0.085627,-0.050245,-0.059619,0,0
5,GO REGULATION OF HEAT GENERATION,0.93377,-0.050338,0.042982,0,0
5,GO POSITIVE REGULATION OF TRANSPORT,0.025414,-0.0504,-0.066174,0,0
5,GO ORGANIC CATION TRANSPORT,0.18508,-0.05041,-0.075913,0,0
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.19393,-0.0508,-0.057029,0,0
5,GO REGULATION OF POTASSIUM ION TRANSPORT,0.29586,-0.050805,-0.059676,0,0
5,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.38408,-0.050814,-0.10858,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE,0.83713,-0.050897,-0.018741,0,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.023205,-0.050919,-0.055283,0,0
5,GO REGULATION OF SYMBIOTIC PROCESS,0.188,-0.050971,-0.10472,0,0
5,GO UBIQUINONE METABOLIC PROCESS,0.18219,-0.051115,-0.081896,0,0
5,GO STRESS GRANULE ASSEMBLY,0.093897,-0.051122,-0.088249,0,0
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.25001,-0.051133,-0.10712,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.25001,-0.051177,-0.072796,0,0
5,GO REGULATION OF DENDRITE EXTENSION,0.36064,-0.051269,0.015295,0,0
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.0695,-0.051321,-0.076829,0,0
5,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.52594,-0.051448,-0.079291,0,0
5,GO POLYOL CATABOLIC PROCESS,0.44924,-0.051451,-0.024267,0,0
5,GO NUCLEAR EXPORT,0.049546,-0.051499,-0.066598,0,0
5,GO REGULATION OF MUSCLE ADAPTATION,0.18508,-0.05156,-0.074087,0,0
5,GO OSTEOCLAST DIFFERENTIATION,0.11434,-0.051586,-0.070038,0,0
5,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.69707,-0.051676,-0.028375,0,0
5,GO PROTEIN LOCALIZATION TO VACUOLE,0.11039,-0.051699,-0.089012,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.41341,-0.051706,-0.038101,0,0
5,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.53167,-0.051841,-0.024629,0,0
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.19393,-0.051867,-0.07429,0,0
5,GO TISSUE MORPHOGENESIS,0.084046,-0.051918,-0.07909,0,0
5,GO LYMPHOCYTE ACTIVATION,0.065563,-0.051927,-0.089894,0,0
5,GO REGULATION OF FAT CELL DIFFERENTIATION,0.066855,-0.051938,-0.10683,0,0
5,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.23937,-0.051946,-0.17825,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.12908,-0.051948,-0.095231,0,0
5,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.26847,-0.05196,-0.093908,0,0
5,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.21579,-0.052047,-0.11555,0,0
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.11841,-0.052106,-0.075683,0,0
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.1028,-0.052137,-0.08507,0,0
5,GO GPI ANCHOR METABOLIC PROCESS,0.19695,-0.052159,-0.066269,0,0
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.50896,-0.052168,-0.025873,0,0
5,GO PIGMENT CELL DIFFERENTIATION,0.31653,-0.052239,-0.065132,0,0
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.19393,-0.052253,-0.092552,0,0
5,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.38888,-0.052261,-0.12269,0,0
5,GO REGULATION OF FEEDING BEHAVIOR,0.19095,-0.052341,-0.10932,0,0
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.21256,-0.052352,-0.064407,0,0
5,GO REGULATION OF CELL POPULATION PROLIFERATION,0.055956,-0.052476,-0.072039,0,0
5,GO DETECTION OF STIMULUS,0.082489,-0.052481,-0.043937,0,0
5,GO POSITIVE REGULATION OF ERAD PATHWAY,0.40349,-0.052575,-0.07202,0,0
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.53742,-0.052575,-0.021943,0,0
5,GO MATING,0.33373,-0.052596,-0.042418,0,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.29586,-0.052616,-0.063936,0,0
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.79636,-0.05267,-0.0079088,0,0
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.097379,-0.052734,-0.11862,0,0
5,GO DEVELOPMENTAL INDUCTION,0.42347,-0.052848,-0.045311,0,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.24643,-0.052884,-0.11049,0,0
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.054842,-0.052939,-0.084439,0,0
5,GO MAINTENANCE OF CELL POLARITY,0.63354,-0.052993,-0.035758,0,0
5,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.29586,-0.053056,-0.096561,0,0
5,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.088862,-0.053177,-0.071743,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.17934,-0.053296,-0.063801,0,0
5,GO REGULATION OF TELOMERE MAINTENANCE,0.23937,-0.053302,-0.049784,0,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.14769,-0.053313,-0.062924,0,0
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.05161,-0.053313,-0.17105,0,0
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.14048,-0.053318,-0.12973,0,0
5,GO RESPONSE TO UV C,0.47588,-0.05377,-0.042007,0,0
5,GO PREPULSE INHIBITION,0.62113,-0.053947,-0.074672,0,0
5,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.39371,-0.053967,-0.09093,0,0
5,GO REGULATION OF CELLULAR COMPONENT SIZE,0.1313,-0.054021,-0.048363,0,0
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.80989,-0.054084,-0.021843,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.079444,-0.0541,-0.10867,0,0
5,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.14285,-0.054113,-0.089047,0,0
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.065563,-0.054153,-0.097385,0,0
5,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.82348,-0.054291,0.021408,0,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.087232,-0.054441,-0.22957,0,0
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.21905,-0.054474,-0.089815,0,0
5,GO REGULATION OF WATER LOSS VIA SKIN,0.85768,-0.054533,-0.011918,0,0
5,GO BEHAVIOR,0.56075,-0.054547,-0.017664,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.34702,-0.054562,-0.047853,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.22568,-0.054635,-0.047625,0,0
5,GO PROTEIN NITROSYLATION,0.69707,-0.054769,-0.035811,0,0
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.10096,-0.054777,-0.065411,0,0
5,GO INSULIN SECRETION,0.48678,-0.054781,-0.025107,0,0
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.34256,-0.054869,-0.03968,0,0
5,GO MONOAMINE TRANSPORT,0.36526,-0.054925,0.0021886,0,0
5,GO REGULATION OF EXOSOMAL SECRETION,0.55487,-0.05498,-0.073792,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.1313,-0.055,-0.057279,0,0
5,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.62732,-0.055037,-0.040081,0,0
5,GO CELL RECOGNITION,0.076492,-0.055042,-0.084046,0,0
5,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.58456,-0.055126,-0.046427,0,0
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.12908,-0.055281,-0.069355,0,0
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.13583,-0.055283,-0.074155,0,0
5,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.090515,-0.0553,-0.11193,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.23937,-0.055422,-0.077146,0,0
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.16559,-0.05544,-0.10626,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.3746,-0.055463,-0.064067,0,0
5,GO REGULATION OF CHEMOTAXIS,0.12259,-0.055551,-0.081849,0,0
5,GO REGULATION OF ACTIN NUCLEATION,0.10096,-0.055719,-0.10263,0,0
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.26847,-0.055727,-0.032113,0,0
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.065563,-0.055732,-0.072907,0,0
5,GO FEMALE SEX DIFFERENTIATION,0.20937,-0.055827,-0.063579,0,0
5,GO DNA METHYLATION,0.25001,-0.055851,-0.028134,0,0
5,GO ANIMAL ORGAN MORPHOGENESIS,0.093897,-0.055855,-0.065198,0,0
5,GO NEGATIVE REGULATION OF ION TRANSPORT,0.10465,-0.055871,-0.053,0,0
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.26098,-0.055889,-0.038927,0,0
5,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.4978,-0.055894,-0.051539,0,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.090515,-0.055916,-0.097757,0,0
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.3746,-0.055952,-0.06686,0,0
5,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.63978,-0.055973,-0.022546,0,0
5,GO GROWTH,0.061812,-0.056027,-0.055335,0,0
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.64605,-0.056261,-0.02323,0,0
5,GO SKELETAL MUSCLE CONTRACTION,0.40843,-0.056304,-0.050745,0,0
5,GO INTERFERON ALPHA PRODUCTION,0.60883,-0.056359,-0.051626,0,0
5,GO FOREBRAIN MORPHOGENESIS,0.64605,-0.056452,-0.059426,0,0
5,GO PRESYNAPTIC ENDOCYTOSIS,0.63354,-0.056454,-0.0049874,0,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.94769,-0.056464,0.025459,0,0
5,GO STRESS FIBER ASSEMBLY,0.23245,-0.05648,-0.076477,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.10465,-0.056565,-0.089973,0,0
5,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.27227,-0.056679,-0.088523,0,0
5,GO REGULATION OF CELLULAR LOCALIZATION,0.061812,-0.056706,-0.049259,0,0
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.97557,-0.056728,-0.028644,0,0
5,GO MACROPHAGE DIFFERENTIATION,0.054842,-0.056742,-0.13076,0,0
5,GO BASE EXCISION REPAIR AP SITE FORMATION,0.32938,-0.056827,-0.079051,0,0
5,GO ICOSANOID METABOLIC PROCESS,0.063042,-0.056854,-0.12393,0,0
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.10465,-0.056875,-0.087139,0,0
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.17374,-0.056954,-0.062501,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.066855,-0.057055,-0.10466,0,0
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.057089,-0.057125,-0.11003,0,0
5,GO REGULATION OF TRANSPORT,0.019739,-0.05716,-0.067958,0,0
5,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.26098,-0.057253,-0.060189,0,0
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.65234,-0.05731,-0.093994,0,0
5,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.38408,-0.057388,-0.094936,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.095625,-0.057417,-0.1118,0,0
5,GO OTIC VESICLE MORPHOGENESIS,0.79636,-0.057569,-0.019506,0,0
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.15015,-0.057584,-0.053003,0,0
5,GO RECEPTOR RECYCLING,0.26098,-0.057669,-0.050823,0,0
5,GO RESPONSE TO HYDROPEROXIDE,0.7495,-0.057761,-0.053145,0,0
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.064293,-0.057762,-0.082875,0,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.20937,-0.057772,-0.047456,0,0
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20937,-0.05778,-0.073113,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.76281,-0.057781,0.0077146,0,0
5,GO RESPONSE TO IRON ION,0.097379,-0.057807,-0.086313,0,0
5,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.50337,-0.05782,-0.039103,0,0
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.053746,-0.057891,-0.061603,0,0
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.17653,-0.057909,-0.10362,0,0
5,GO REGULATION OF HEMOPOIESIS,0.050569,-0.058042,-0.087676,0,0
5,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.65866,-0.058049,-0.035217,0,0
5,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.46512,-0.058113,-0.042316,0,0
5,GO NCRNA TRANSCRIPTION,0.061812,-0.058285,-0.051921,0,0
5,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.58456,-0.058303,-0.034012,0,0
5,GO REGULATION OF ATPASE ACTIVITY,0.065563,-0.058321,-0.06467,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.13355,-0.058411,-0.078198,0,0
5,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.33373,-0.058439,-0.058937,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.70355,-0.058454,-0.036942,0,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.32077,-0.058481,-0.058121,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.18508,-0.058491,-0.056196,0,0
5,GO LYSINE METABOLIC PROCESS,0.54321,-0.058528,-0.086495,0,0
5,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.48131,-0.058548,-0.056225,0,0
5,GO NEGATIVE REGULATION OF CELL GROWTH,0.19393,-0.058623,-0.049255,0,0
5,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.21905,-0.058637,-0.064299,0,0
5,GO CELLULAR RESPONSE TO FATTY ACID,0.19393,-0.058729,-0.096584,0,0
5,GO LEUKOCYTE CHEMOTAXIS,0.18219,-0.058823,-0.080448,0,0
5,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.33812,-0.058825,-0.03024,0,0
5,GO ENDOSOME ORGANIZATION,0.11235,-0.058835,-0.066432,0,0
5,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.34702,-0.058876,-0.048675,0,0
5,GO PROTEIN POLYUBIQUITINATION,0.065563,-0.058889,-0.054953,0,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.14526,-0.059003,-0.053046,0,0
5,GO OLIGOPEPTIDE TRANSPORT,0.16828,-0.059066,-0.1762,0,0
5,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.64605,-0.059121,-0.051441,0,0
5,GO CELLULAR RESPONSE TO ATP,0.075049,-0.05913,-0.10532,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.13814,-0.059146,-0.093152,0,0
5,GO CORTICAL CYTOSKELETON ORGANIZATION,0.58456,-0.059155,-0.047278,0,0
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.052669,-0.059162,-0.12147,0,0
5,GO REGULATION OF CELL SIZE,0.22568,-0.059204,-0.038321,0,0
5,GO REGULATION OF SYSTEM PROCESS,0.05161,-0.059225,-0.072587,0,0
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.72969,-0.05923,-0.03511,0,0
5,GO RESPONSE TO MECHANICAL STIMULUS,0.22905,-0.059268,-0.066132,0,0
5,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.69707,-0.059272,-0.022897,0,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.12049,-0.059311,-0.06051,0,0
5,GO NEPHRON EPITHELIUM DEVELOPMENT,0.24288,-0.059319,-0.069659,0,0
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.21905,-0.059497,-0.05664,0,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.087232,-0.059508,-0.07627,0,0
5,GO NATURAL KILLER CELL ACTIVATION,0.29992,-0.059549,-0.066062,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.9686,-0.059689,-0.0080002,0,0
5,GO INTERLEUKIN 1 PRODUCTION,0.17099,-0.059743,-0.12372,0,0
5,GO LEUKOCYTE MIGRATION,0.05824,-0.059988,-0.10956,0,0
5,GO PROTON TRANSMEMBRANE TRANSPORT,0.080955,-0.060106,-0.073904,0,0
5,GO RETINA HOMEOSTASIS,0.1313,-0.06013,-0.064847,0,0
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.41842,-0.060279,-0.11452,0,0
5,GO REGULATION OF BMP SIGNALING PATHWAY,0.51459,-0.06032,-0.048179,0,0
5,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.34256,-0.060348,-0.063569,0,0
5,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.14769,-0.060358,-0.043381,0,0
5,GO PRESYNAPSE ORGANIZATION,0.43883,-0.060439,-0.034771,0,0
5,GO TUBE DEVELOPMENT,0.057089,-0.060498,-0.088312,0,0
5,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.30402,-0.060501,-0.084458,0,0
5,GO RNA DESTABILIZATION,0.10654,-0.060526,-0.083619,0,0
5,GO MIDDLE EAR MORPHOGENESIS,0.35153,-0.060551,-0.075062,0,0
5,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.41842,-0.060551,-0.023303,0,0
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.188,-0.060632,-0.10509,0,0
5,GO MESENCHYME MORPHOGENESIS,0.19393,-0.060681,-0.11396,0,0
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.69707,-0.060695,-0.011506,0,0
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.052669,-0.060716,-0.070827,0,0
5,GO BONE DEVELOPMENT,0.093897,-0.060901,-0.078807,0,0
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.1313,-0.060951,-0.058586,0,0
5,GO POSITIVE REGULATION OF URINE VOLUME,0.14526,-0.060989,-0.10199,0,0
5,GO REGULATION OF GTPASE ACTIVITY,0.053746,-0.061033,-0.069817,0,0
5,GO DNA BIOSYNTHETIC PROCESS,0.064293,-0.061039,-0.046291,0,0
5,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.19393,-0.061167,-0.071471,0,0
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.12473,-0.061167,-0.12052,0,0
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.92682,-0.061178,-0.0080616,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.29992,-0.061343,-0.04598,0,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.78962,-0.061393,-0.031383,0,0
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.44402,-0.0614,-0.056403,0,0
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.052669,-0.061421,-0.085764,0,0
5,GO NEGATIVE REGULATION OF AXON EXTENSION,0.67137,-0.061465,-0.037723,0,0
5,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.81668,-0.061531,-0.0062821,0,0
5,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.188,-0.061733,-0.1117,0,0
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.17653,-0.061746,-0.064962,0,0
5,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.40349,-0.061814,-0.084082,0,0
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.0090226,-0.062048,-0.078345,0,0
5,GO RNA STABILIZATION,0.34256,-0.062053,-0.05134,0,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.26471,-0.062094,-0.07295,0,0
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.25729,-0.062128,-0.063851,0,0
5,GO CELLULAR SENESCENCE,0.097379,-0.062151,-0.062136,0,0
5,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.98953,-0.062176,0.0051664,0,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.13583,-0.06238,-0.099964,0,0
5,GO PROTEIN KINASE B SIGNALING,0.17653,-0.062391,-0.073859,0,0
5,GO SENSORY PERCEPTION,0.025414,-0.062495,-0.063963,0,0
5,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.17374,-0.062496,-0.039944,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.11039,-0.062565,-0.099533,0,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.35607,-0.062616,-0.072085,0,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.063042,-0.062713,-0.069478,0,0
5,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.17653,-0.062719,-0.060022,0,0
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.53167,-0.062765,-0.041711,0,0
5,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.090515,-0.06279,-0.06472,0,0
5,GO MAGNESIUM ION TRANSPORT,0.89907,-0.062819,0.01318,0,0
5,GO SODIUM ION TRANSPORT,0.05824,-0.062876,-0.088216,0,0
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.29184,-0.06288,-0.084619,0,0
5,GO REGULATION OF SYNAPSE ASSEMBLY,0.34702,-0.062882,-0.060035,0,0
5,GO OVULATION CYCLE PROCESS,0.060602,-0.06289,-0.11193,0,0
5,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.25363,-0.063095,-0.15131,0,0
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.35607,-0.063153,-0.071514,0,0
5,GO AMINO ACID TRANSPORT,0.068167,-0.063188,-0.066778,0,0
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.30402,-0.063251,-0.081742,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.20621,-0.06326,-0.13268,0,0
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.24288,-0.063263,-0.092727,0,0
5,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.25729,-0.063416,-0.15314,0,0
5,GO SECONDARY METABOLIC PROCESS,0.41842,-0.063423,-0.068404,0,0
5,GO REGULATION OF MEMBRANE POTENTIAL,0.31232,-0.063424,-0.034109,0,0
5,GO STRIATUM DEVELOPMENT,0.18219,-0.063455,-0.099051,0,0
5,GO WALKING BEHAVIOR,0.25363,-0.063475,-0.06206,0,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.18508,-0.063644,-0.098637,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.14769,-0.063656,-0.063292,0,0
5,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.35153,-0.063666,-0.05148,0,0
5,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.30402,-0.063671,-0.069945,0,0
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.40349,-0.063782,-0.066556,0,0
5,GO PLATELET ACTIVATION,0.084046,-0.063783,-0.096297,0,0
5,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.63978,-0.063865,-0.041505,0,0
5,GO REGULATION OF SULFUR METABOLIC PROCESS,0.15517,-0.063879,-0.12509,0,0
5,GO CYTOKINE SECRETION,0.31232,-0.063921,-0.063742,0,0
5,GO DENTATE GYRUS DEVELOPMENT,0.49227,-0.064176,-0.071546,0,0
5,GO OSTEOCLAST DEVELOPMENT,0.33373,-0.064249,-0.087637,0,0
5,GO NUCLEOTIDE EXCISION REPAIR,0.090515,-0.064391,-0.047379,0,0
5,GO WHITE FAT CELL DIFFERENTIATION,0.24288,-0.064423,-0.079518,0,0
5,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.23937,-0.064465,-0.10693,0,0
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.13583,-0.064484,-0.081459,0,0
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.24643,-0.064532,-0.096883,0,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.18219,-0.064595,-0.20424,0,0
5,GO HEAT GENERATION,0.56075,-0.064635,-0.010679,0,0
5,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.35153,-0.064673,-0.045896,0,0
5,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.052669,-0.064772,-0.063596,0,0
5,GO SCHWANN CELL DIFFERENTIATION,0.18219,-0.064845,-0.062217,0,0
5,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.29992,-0.064854,-0.095541,0,0
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.13583,-0.064903,-0.12415,0,0
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.068167,-0.064982,-0.095444,0,0
5,GO RESPONSE TO VIRUS,0.17653,-0.064983,-0.10853,0,0
5,GO REGULATION OF HISTONE DEACETYLATION,0.68418,-0.064998,-0.024154,0,0
5,GO BILE ACID METABOLIC PROCESS,0.4545,-0.065021,-0.0634,0,0
5,GO MESENCHYME DEVELOPMENT,0.075049,-0.065041,-0.086209,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.10845,-0.065118,-0.082653,0,0
5,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.21579,-0.065128,-0.073189,0,0
5,GO RESPONSE TO SALT,0.14769,-0.065141,-0.071881,0,0
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.25363,-0.065156,-0.11706,0,0
5,GO PROSTATE GLAND GROWTH,0.37932,-0.06516,-0.12214,0,0
5,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.15015,-0.065194,-0.055987,0,0
5,GO REGULATION OF INSULIN SECRETION,0.35153,-0.065239,-0.034354,0,0
5,GO METANEPHRIC NEPHRON DEVELOPMENT,0.32938,-0.065305,-0.068889,0,0
5,GO HISTONE DEACETYLATION,0.26471,-0.065341,-0.034648,0,0
5,GO ADULT LOCOMOTORY BEHAVIOR,0.71006,-0.065365,-0.00052314,0,0
5,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.097379,-0.065369,-0.26492,0,0
5,GO TERPENOID METABOLIC PROCESS,0.15773,-0.065387,-0.082923,0,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.30402,-0.065395,-0.10469,0,0
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.39371,-0.065397,-0.034958,0,0
5,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.15773,-0.065407,-0.097492,0,0
5,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.40349,-0.065427,-0.053354,0,0
5,GO REGULATION OF PROTEIN FOLDING,0.068167,-0.065488,-0.095434,0,0
5,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.15517,-0.065511,-0.04959,0,0
5,GO REGULATION OF CELL ADHESION,0.072231,-0.06555,-0.10673,0,0
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.075049,-0.065556,-0.091296,0,0
5,GO REGULATION OF CELL SUBSTRATE ADHESION,0.095625,-0.065638,-0.12305,0,0
5,GO INNER CELL MASS CELL PROLIFERATION,0.2839,-0.065773,-0.093822,0,0
5,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.19095,-0.065935,-0.1445,0,0
5,GO NUCLEAR PORE ORGANIZATION,0.21905,-0.065941,-0.087204,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.14769,-0.065951,-0.079497,0,0
5,GO ORGAN GROWTH,0.054842,-0.06598,-0.081913,0,0
5,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.37932,-0.065988,-0.053359,0,0
5,GO LOCOMOTORY BEHAVIOR,0.59059,-0.066064,-0.0039891,0,0
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.2,-0.0661,-0.071716,0,0
5,GO REGULATION OF HISTONE UBIQUITINATION,0.066855,-0.066131,-0.068661,0,0
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.32077,-0.066146,-0.10568,0,0
5,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.29184,-0.066148,-0.11368,0,0
5,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.54903,-0.066289,-0.093401,0,0
5,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.26471,-0.066345,-0.24879,0,0
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.40349,-0.066464,-0.048165,0,0
5,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.25729,-0.066489,-0.070772,0,0
5,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.35607,-0.066619,-0.051799,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.15773,-0.066698,-0.11947,0,0
5,GO PROTEIN LOCALIZATION TO LYSOSOME,0.15517,-0.066732,-0.092019,0,0
5,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.15773,-0.066808,-0.087818,0,0
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.11636,-0.066843,-0.1366,0,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.18508,-0.06685,-0.12707,0,0
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0695,-0.066875,-0.10027,0,0
5,GO NEGATIVE REGULATION OF BEHAVIOR,0.32938,-0.066878,-0.073315,0,0
5,GO SYNAPSE ORGANIZATION,0.49227,-0.066916,-0.018518,0,0
5,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.15773,-0.067008,-0.11407,0,0
5,GO GOLGI TO VACUOLE TRANSPORT,0.14285,-0.067037,-0.095065,0,0
5,GO TISSUE REMODELING,0.084046,-0.067053,-0.12583,0,0
5,GO CONNECTIVE TISSUE DEVELOPMENT,0.05161,-0.067114,-0.092193,0,0
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.072231,-0.067176,-0.075292,0,0
5,GO REGULATION OF DEPHOSPHORYLATION,0.066855,-0.067628,-0.043951,0,0
5,GO EPITHELIAL CELL PROLIFERATION,0.049546,-0.067635,-0.10286,0,0
5,GO MYELOID CELL HOMEOSTASIS,0.11235,-0.067648,-0.075877,0,0
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.35153,-0.067866,-0.074473,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.11039,-0.06788,-0.11716,0,0
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.021165,-0.067929,-0.077601,0,0
5,GO DIGESTION,0.39371,-0.067949,-0.044106,0,0
5,GO SYNAPTIC VESICLE PRIMING,0.60272,-0.068159,0.02203,0,0
5,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.5726,-0.068244,-0.050982,0,0
5,GO DICARBOXYLIC ACID TRANSPORT,0.19095,-0.06827,-0.034852,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.44924,-0.068326,-0.083549,0,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.22905,-0.068334,-0.078462,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.40349,-0.068355,-0.055654,0,0
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.10654,-0.068427,-0.07705,0,0
5,GO AMINE METABOLIC PROCESS,0.093897,-0.068453,-0.09211,0,0
5,GO IMMUNOGLOBULIN PRODUCTION,0.057089,-0.068466,-0.092536,0,0
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.4598,-0.06847,-0.073992,0,0
5,GO TUBULIN DEACETYLATION,0.63354,-0.068493,-0.019749,0,0
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.25729,-0.068494,-0.10175,0,0
5,GO CERAMIDE BIOSYNTHETIC PROCESS,0.063042,-0.068624,-0.1018,0,0
5,GO NEUROINFLAMMATORY RESPONSE,0.16032,-0.06868,-0.090352,0,0
5,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.21579,-0.068688,-0.23989,0,0
5,GO INDOLALKYLAMINE METABOLIC PROCESS,0.60883,-0.068748,-0.051609,0,0
5,GO ACTIN FILAMENT DEPOLYMERIZATION,0.26847,-0.068748,-0.062558,0,0
5,GO PLATELET AGGREGATION,0.1028,-0.06875,-0.12856,0,0
5,GO SKELETAL SYSTEM DEVELOPMENT,0.068167,-0.068762,-0.073078,0,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.58456,-0.068844,-0.042202,0,0
5,GO POSITIVE REGULATION OF HEMOPOIESIS,0.092194,-0.068855,-0.089119,0,0
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.099158,-0.068909,-0.088037,0,0
5,GO REGULATION OF FATTY ACID TRANSPORT,0.31232,-0.068917,-0.072139,0,0
5,GO LEYDIG CELL DIFFERENTIATION,0.56666,-0.069007,-0.071619,0,0
5,GO INTERFERON BETA PRODUCTION,0.20309,-0.069044,-0.090716,0,0
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.13814,-0.06908,-0.10247,0,0
5,GO PROTEIN DEPHOSPHORYLATION,0.025994,-0.069143,-0.059225,0,0
5,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.099158,-0.069145,-0.16481,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.25001,-0.06918,-0.13825,0,0
5,GO PINOCYTOSIS,0.10845,-0.069217,-0.13814,0,0
5,GO METANEPHROS DEVELOPMENT,0.16294,-0.069282,-0.080604,0,0
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.11235,-0.069344,-0.057696,0,0
5,GO CARTILAGE MORPHOGENESIS,0.98953,-0.069412,-0.0022168,0,0
5,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.31232,-0.069415,-0.052985,0,0
5,GO INTERLEUKIN 4 PRODUCTION,0.12473,-0.069453,-0.083963,0,0
5,GO DIGESTIVE SYSTEM PROCESS,0.44402,-0.069516,-0.041107,0,0
5,GO REGULATION OF BONE DEVELOPMENT,0.059411,-0.069576,-0.13473,0,0
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0038387,-0.069739,-0.081926,0,0
5,GO REGULATION OF PHOSPHATASE ACTIVITY,0.059411,-0.069769,-0.051526,0,0
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.053746,-0.069861,-0.14081,0,0
5,GO PROTEIN MANNOSYLATION,0.15517,-0.069934,-0.075529,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.69707,-0.07013,-0.051844,0,0
5,GO REPLACEMENT OSSIFICATION,0.36064,-0.070156,-0.089267,0,0
5,GO FC RECEPTOR SIGNALING PATHWAY,0.0695,-0.070189,-0.077582,0,0
5,GO CELLULAR SODIUM ION HOMEOSTASIS,0.4545,-0.070209,-0.065048,0,0
5,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.43367,-0.070245,-0.0822,0,0
5,GO MANNOSYLATION,0.05161,-0.070283,-0.10458,0,0
5,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.27227,-0.07035,-0.049658,0,0
5,GO DEPHOSPHORYLATION,0.036164,-0.070473,-0.057502,0,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.25729,-0.070559,-0.099463,0,0
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.060602,-0.070586,-0.067453,0,0
5,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.34256,-0.070658,-0.10294,0,0
5,GO CONVERGENT EXTENSION,0.71006,-0.070742,-0.025234,0,0
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.1028,-0.070767,-0.11467,0,0
5,GO POSITIVE REGULATION OF CELL KILLING,0.16294,-0.070851,-0.12235,0,0
5,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.86455,-0.070883,-0.069009,0,0
5,GO REGULATION OF RECEPTOR BINDING,0.23245,-0.070996,-0.13647,0,0
5,GO ASTROCYTE DEVELOPMENT,0.084046,-0.071005,-0.13656,0,0
5,GO T CELL DIFFERENTIATION IN THYMUS,0.17374,-0.071043,-0.070732,0,0
5,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.20621,-0.071057,-0.11274,0,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.066855,-0.071355,-0.11101,0,0
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.10654,-0.071438,-0.13225,0,0
5,GO HYPEROSMOTIC RESPONSE,0.36991,-0.07147,-0.074919,0,0
5,GO ACTION POTENTIAL,0.10654,-0.071495,-0.087782,0,0
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.28785,-0.071496,-0.10271,0,0
5,GO T HELPER 1 CELL DIFFERENTIATION,0.33373,-0.071519,-0.1682,0,0
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.15015,-0.071547,-0.11698,0,0
5,GO REGULATION OF LYASE ACTIVITY,0.12049,-0.07161,-0.082864,0,0
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.041967,-0.071703,-0.075636,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.095625,-0.071797,-0.11285,0,0
5,GO ERYTHROCYTE HOMEOSTASIS,0.063042,-0.071814,-0.081295,0,0
5,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.37932,-0.071918,-0.047277,0,0
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.24288,-0.071922,-0.07799,0,0
5,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.29586,-0.071923,-0.063347,0,0
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.070855,-0.071973,-0.10032,0,0
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.05824,-0.072,-0.085493,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.027803,-0.072025,-0.11975,0,0
5,GO MOTILE CILIUM ASSEMBLY,0.56666,-0.072066,-0.019991,0,0
5,GO MESODERM MORPHOGENESIS,0.17374,-0.07212,-0.098907,0,0
5,GO KIDNEY EPITHELIUM DEVELOPMENT,0.11039,-0.072194,-0.093262,0,0
5,GO HEAD MORPHOGENESIS,0.28785,-0.072252,-0.058112,0,0
5,GO CELLULAR RESPONSE TO IRON ION,0.29184,-0.072316,-0.095941,0,0
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.057089,-0.072318,-0.10446,0,0
5,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.30815,-0.072576,-0.097133,0,0
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.36991,-0.072706,-0.080768,0,0
5,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.27999,-0.072897,-0.048261,0,0
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.042857,-0.073015,-0.1111,0,0
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.9686,-0.073021,0.073514,0,0
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.12049,-0.073051,-0.11419,0,0
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.093897,-0.073111,-0.1131,0,0
5,GO LIPOPROTEIN LOCALIZATION,0.0695,-0.073183,-0.11072,0,0
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.12473,-0.073227,-0.10303,0,0
5,GO RESPONSE TO PROSTAGLANDIN E,0.20309,-0.073298,-0.064916,0,0
5,GO RESPONSE TO X RAY,0.15015,-0.073384,-0.11971,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.12689,-0.073548,-0.096188,0,0
5,GO MITOCHONDRIAL FUSION,0.44924,-0.073552,-0.020989,0,0
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.13355,-0.073647,-0.085232,0,0
5,GO ACID SECRETION,0.20937,-0.073687,-0.05282,0,0
5,GO MONOVALENT INORGANIC CATION TRANSPORT,0.061812,-0.073706,-0.071378,0,0
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.5726,-0.073747,-0.046122,0,0
5,GO RENAL TUBULE DEVELOPMENT,0.11636,-0.073821,-0.091795,0,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.12259,-0.073831,-0.092049,0,0
5,GO REGULATION OF CGMP MEDIATED SIGNALING,0.21579,-0.073874,-0.15369,0,0
5,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.011326,-0.07389,-0.074989,0,0
5,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.084046,-0.074004,-0.096729,0,0
5,GO BLASTOCYST GROWTH,0.11636,-0.074195,-0.094998,0,0
5,GO NEUTROPHIL HOMEOSTASIS,0.2839,-0.074247,-0.18778,0,0
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.12049,-0.074249,-0.12324,0,0
5,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.25363,-0.074253,-0.044449,0,0
5,GO REGULATION OF MRNA POLYADENYLATION,0.11841,-0.074282,-0.062491,0,0
5,GO ENDOCRINE HORMONE SECRETION,0.32938,-0.074314,-0.062916,0,0
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.1028,-0.074426,-0.10812,0,0
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.41842,-0.074498,-0.06907,0,0
5,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.10096,-0.074527,-0.21803,0,0
5,GO REGULATION OF PROTEIN TARGETING,0.036948,-0.074542,-0.071349,0,0
5,GO MIDGUT DEVELOPMENT,0.30402,-0.07465,-0.10051,0,0
5,GO REGULATION OF ERAD PATHWAY,0.070855,-0.074689,-0.06218,0,0
5,GO REGULATION OF ORGANELLE ASSEMBLY,0.02843,-0.074709,-0.057635,0,0
5,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.32077,-0.074748,-0.042585,0,0
5,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.59059,-0.074756,-0.037395,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.22235,-0.074781,-0.070559,0,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.41341,-0.074823,-0.10021,0,0
5,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.11235,-0.07483,-0.097672,0,0
5,GO STRIATED MUSCLE CELL PROLIFERATION,0.59059,-0.075013,-0.030201,0,0
5,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.63354,-0.075016,-0.0094317,0,0
5,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.099158,-0.075106,-0.097929,0,0
5,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.48678,-0.075322,-0.080028,0,0
5,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.17374,-0.075346,-0.064675,0,0
5,GO SUPEROXIDE METABOLIC PROCESS,0.10465,-0.075349,-0.09805,0,0
5,GO POSITIVE REGULATION OF HEAT GENERATION,0.47049,-0.075447,-0.0061768,0,0
5,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.070855,-0.075507,-0.12972,0,0
5,GO MALE MEIOTIC NUCLEAR DIVISION,0.36991,-0.0756,-0.067448,0,0
5,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.085627,-0.075614,-0.12172,0,0
5,GO FOCAL ADHESION ASSEMBLY,0.26847,-0.075676,-0.10076,0,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.35607,-0.075716,-0.070502,0,0
5,GO VACUOLAR TRANSPORT,0.057089,-0.075752,-0.080825,0,0
5,GO AMMONIUM ION METABOLIC PROCESS,0.52594,-0.075934,-0.055359,0,0
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.055956,-0.07609,-0.10617,0,0
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.12259,-0.076124,-0.12797,0,0
5,GO POSITIVE REGULATION OF ANION TRANSPORT,0.20309,-0.076186,-0.079842,0,0
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.10654,-0.076244,-0.12973,0,0
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.37932,-0.07638,-0.12055,0,0
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.25001,-0.076416,-0.083512,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.097379,-0.076578,-0.14864,0,0
5,GO REGULATION OF ORGAN GROWTH,0.16559,-0.076658,-0.068991,0,0
5,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0695,-0.076859,-0.17197,0,0
5,GO ER NUCLEUS SIGNALING PATHWAY,0.11636,-0.076875,-0.094808,0,0
5,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.12259,-0.076912,-0.073258,0,0
5,GO PROTEIN TARGETING TO LYSOSOME,0.095625,-0.076944,-0.1427,0,0
5,GO NEGATIVE REGULATION OF GROWTH,0.023741,-0.076947,-0.088136,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.16559,-0.077003,-0.082691,0,0
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.40349,-0.077015,-0.10933,0,0
5,GO REGULATION OF CELL CELL ADHESION,0.065563,-0.077024,-0.10725,0,0
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.0067808,-0.077068,-0.1076,0,0
5,GO CELLULAR MACROMOLECULE LOCALIZATION,0.00079435,-0.077082,-0.069881,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.17934,-0.077083,-0.11988,0,0
5,GO ISOPRENOID METABOLIC PROCESS,0.11636,-0.077103,-0.089587,0,0
5,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.12689,-0.077126,-0.11375,0,0
5,GO REGULATION OF CELL KILLING,0.090515,-0.077257,-0.12602,0,0
5,GO RNA 3 END PROCESSING,0.084046,-0.077261,-0.06929,0,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.11039,-0.077323,-0.1456,0,0
5,GO REGULATION OF AXON GUIDANCE,0.3746,-0.07739,-0.052599,0,0
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.47588,-0.077516,-0.052957,0,0
5,GO PARAXIAL MESODERM DEVELOPMENT,0.31653,-0.077538,-0.10771,0,0
5,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.46512,-0.077654,-0.12424,0,0
5,GO CALCIUM ION IMPORT,0.052669,-0.077725,-0.078709,0,0
5,GO PHAGOLYSOSOME ASSEMBLY,0.26098,-0.077745,-0.12907,0,0
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.35607,-0.077772,-0.068497,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.59059,-0.077852,-0.019565,0,0
5,GO RESPONSE TO ESTRADIOL,0.040234,-0.078078,-0.085246,0,0
5,GO PIRNA METABOLIC PROCESS,0.1313,-0.078226,-0.13809,0,0
5,GO TONIC SMOOTH MUSCLE CONTRACTION,0.56075,-0.07823,-0.085232,0,0
5,GO ACTIVATION OF MAPKKK ACTIVITY,0.34702,-0.078261,-0.088937,0,0
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0087944,-0.07831,-0.1413,0,0
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.1313,-0.078346,-0.10192,0,0
5,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.055956,-0.078358,-0.071233,0,0
5,GO NEGATIVE REGULATION OF OSSIFICATION,0.32938,-0.078448,-0.066157,0,0
5,GO REGULATION OF MAST CELL ACTIVATION,0.30402,-0.078513,-0.062099,0,0
5,GO MODULATION BY VIRUS OF HOST PROCESS,0.052669,-0.078617,-0.10457,0,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.055956,-0.078731,-0.10358,0,0
5,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.21905,-0.078767,-0.088644,0,0
5,GO CELLULAR RESPONSE TO AMYLOID BETA,0.14048,-0.078826,-0.095801,0,0
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.087232,-0.078862,-0.091841,0,0
5,GO MODIFIED AMINO ACID TRANSPORT,0.04854,-0.078891,-0.1256,0,0
5,GO TYPE I INTERFERON PRODUCTION,0.12049,-0.078962,-0.10955,0,0
5,GO PORE COMPLEX ASSEMBLY,0.15264,-0.079008,-0.071011,0,0
5,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.68418,-0.079019,-0.024293,0,0
5,GO INTRACELLULAR STEROL TRANSPORT,0.14285,-0.079026,-0.11823,0,0
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.060602,-0.079176,-0.095263,0,0
5,GO TUBE FORMATION,0.43883,-0.07928,-0.039837,0,0
5,GO CELLULAR RESPONSE TO X RAY,0.48131,-0.079294,-0.060301,0,0
5,GO RESPONSE TO WOUNDING,0.063042,-0.079549,-0.11468,0,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.30402,-0.079688,-0.10849,0,0
5,GO SNORNA 3 END PROCESSING,0.188,-0.079814,-0.078849,0,0
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.060602,-0.079817,-0.17651,0,0
5,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.076492,-0.079842,-0.10649,0,0
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.017137,-0.080161,-0.081491,0,0
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.26471,-0.080239,-0.022801,0,0
5,GO CELL CHEMOTAXIS,0.054842,-0.080242,-0.10972,0,0
5,GO MATING BEHAVIOR,0.25001,-0.080329,-0.08267,0,0
5,GO REGULATION OF PINOCYTOSIS,0.061812,-0.080642,-0.16277,0,0
5,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.12259,-0.080742,-0.063593,0,0
5,GO PLASMA MEMBRANE REPAIR,0.38888,-0.080926,-0.071682,0,0
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.58456,-0.081046,-0.045509,0,0
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0071468,-0.081339,-0.091671,0,0
5,GO BILE ACID BIOSYNTHETIC PROCESS,0.049546,-0.081399,-0.12379,0,0
5,GO KETONE CATABOLIC PROCESS,0.34702,-0.081457,-0.13329,0,0
5,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.092194,-0.081458,-0.097039,0,0
5,GO HISTONE MRNA METABOLIC PROCESS,0.11636,-0.081689,-0.065968,0,0
5,GO STRIATED MUSCLE ADAPTATION,0.1313,-0.081701,-0.084756,0,0
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.053746,-0.081729,-0.092849,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.44924,-0.08175,-0.06043,0,0
5,GO STEM CELL DIVISION,0.27611,-0.081924,-0.071542,0,0
5,GO HISTONE H2B UBIQUITINATION,0.42855,-0.081939,-0.043782,0,0
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.99651,-0.082019,-0.013329,0,0
5,GO BONE REMODELING,0.099158,-0.082153,-0.12135,0,0
5,GO MOTOR NEURON AXON GUIDANCE,0.25001,-0.082352,-0.062601,0,0
5,GO RESPONSE TO OXYGEN RADICAL,0.28785,-0.082383,-0.059934,0,0
5,GO LIPOXYGENASE PATHWAY,0.23589,-0.082567,-0.1559,0,0
5,GO RESPONSE TO GAMMA RADIATION,0.076492,-0.082608,-0.077742,0,0
5,GO EMBRYO IMPLANTATION,0.1028,-0.082613,-0.13342,0,0
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.16559,-0.082676,-0.11541,0,0
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.063042,-0.082816,-0.14443,0,0
5,GO PROTEIN ADP RIBOSYLATION,0.34702,-0.082986,-0.037726,0,0
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.076492,-0.082994,-0.085109,0,0
5,GO REGULATION OF MACROPHAGE MIGRATION,0.11039,-0.083025,-0.088657,0,0
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.11841,-0.08306,-0.1105,0,0
5,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.11434,-0.083196,-0.11912,0,0
5,GO ION TRANSMEMBRANE TRANSPORT,0.0066042,-0.083345,-0.089833,0,0
5,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.58456,-0.083346,-0.039222,0,0
5,GO BARBED END ACTIN FILAMENT CAPPING,0.78289,-0.083424,-0.043793,0,0
5,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.009256,-0.083506,-0.11947,0,0
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.017137,-0.083568,-0.084279,0,0
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.073629,-0.083672,-0.11557,0,0
5,GO RESPONSE TO AMPHETAMINE,0.23245,-0.083692,-0.12593,0,0
5,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.15015,-0.08374,-0.12797,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.076492,-0.083838,-0.084858,0,0
5,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.44402,-0.083987,-0.080735,0,0
5,GO REGULATION OF GLOMERULAR FILTRATION,0.49227,-0.08402,0.11472,0,0
5,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.17099,-0.08408,-0.088463,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.32077,-0.084145,-0.068206,0,0
5,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.023741,-0.084256,-0.080478,0,0
5,GO SEQUESTERING OF METAL ION,0.095625,-0.084412,-0.13374,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.050569,-0.084429,-0.111,0,0
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.10845,-0.084577,-0.084531,0,0
5,GO ALANINE TRANSPORT,0.17374,-0.084621,-0.11922,0,0
5,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.16828,-0.084687,-0.076304,0,0
5,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.075049,-0.084833,-0.07123,0,0
5,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.079444,-0.084857,-0.17318,0,0
5,GO RESPONSE TO AMYLOID BETA,0.13583,-0.084862,-0.0904,0,0
5,GO RRNA CATABOLIC PROCESS,0.21256,-0.085005,-0.075975,0,0
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0032441,-0.08502,-0.1167,0,0
5,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.35153,-0.085064,-0.14979,0,0
5,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.40843,-0.08508,-0.095259,0,0
5,GO MESONEPHROS DEVELOPMENT,0.11636,-0.085261,-0.098517,0,0
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.11636,-0.085275,-0.1155,0,0
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.11636,-0.08531,-0.074241,0,0
5,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.15264,-0.085396,-0.081238,0,0
5,GO POTASSIUM ION TRANSPORT,0.12689,-0.085526,-0.05858,0,0
5,GO NEPHRON DEVELOPMENT,0.10654,-0.085687,-0.086587,0,0
5,GO SERTOLI CELL DIFFERENTIATION,0.12689,-0.085742,-0.14201,0,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.60272,-0.085845,-0.11004,0,0
5,GO LINOLEIC ACID METABOLIC PROCESS,0.23589,-0.085861,-0.12068,0,0
5,GO INTRA S DNA DAMAGE CHECKPOINT,0.085627,-0.085872,-0.070324,0,0
5,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.52025,-0.085875,-0.042089,0,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.02166,-0.085896,-0.09867,0,0
5,GO NEPHRON MORPHOGENESIS,0.10845,-0.08598,-0.079293,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.063042,-0.086098,-0.12629,0,0
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.10096,-0.086108,-0.093055,0,0
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.23245,-0.086143,-0.078131,0,0
5,GO REGULATION OF STEM CELL DIFFERENTIATION,0.10096,-0.086166,-0.10585,0,0
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.059411,-0.086357,-0.14484,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.064293,-0.086584,-0.25649,0,0
5,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.27611,-0.086639,-0.15436,0,0
5,GO POSITIVE REGULATION OF TOR SIGNALING,0.010773,-0.087033,-0.095042,0,0
5,GO REGULATION OF TISSUE REMODELING,0.065563,-0.087066,-0.13512,0,0
5,GO REGULATION OF MITOCHONDRIAL FUSION,0.33373,-0.087107,-0.043466,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.027188,-0.087312,-0.10809,0,0
5,GO TYPE B PANCREATIC CELL PROLIFERATION,0.48678,-0.087349,-0.093047,0,0
5,GO CGMP MEDIATED SIGNALING,0.041093,-0.087349,-0.13063,0,0
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.070855,-0.087376,-0.089713,0,0
5,GO ATP BIOSYNTHETIC PROCESS,0.12259,-0.087404,-0.097357,0,0
5,GO SENSORY PERCEPTION OF TASTE,0.22235,-0.087476,-0.078511,0,0
5,GO PHOSPHOLIPID HOMEOSTASIS,0.29586,-0.087528,-0.10195,0,0
5,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.059411,-0.087592,-0.16705,0,0
5,GO RESPONSE TO INTERFERON ALPHA,0.26847,-0.087636,-0.25286,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.079444,-0.087679,-0.15793,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.093897,-0.087712,-0.14902,0,0
5,GO EXPLORATION BEHAVIOR,0.23245,-0.087729,-0.10553,0,0
5,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.3746,-0.087779,-0.03854,0,0
5,GO PROTEIN HETEROTETRAMERIZATION,0.064293,-0.087804,-0.094008,0,0
5,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.16559,-0.08784,-0.10605,0,0
5,GO CELL CYCLE ARREST,0.0085714,-0.087873,-0.072966,0,0
5,GO MYELIN MAINTENANCE,0.30815,-0.087966,-0.087509,0,0
5,GO HEART PROCESS,0.022165,-0.08798,-0.104,0,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.25001,-0.088075,-0.07805,0,0
5,GO URETER DEVELOPMENT,0.10654,-0.088094,-0.15355,0,0
5,GO RESPONSE TO VITAMIN,0.1313,-0.088181,-0.097207,0,0
5,GO CELL MATRIX ADHESION,0.05824,-0.088199,-0.1305,0,0
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.23589,-0.088211,-0.066421,0,0
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.065563,-0.088229,-0.1164,0,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.059411,-0.088334,-0.18062,0,0
5,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.2,-0.088363,-0.11216,0,0
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.090515,-0.088463,-0.10468,0,0
5,GO MRNA TRANSCRIPTION,0.65234,-0.088615,-0.035387,0,0
5,GO ENSHEATHMENT OF NEURONS,0.082489,-0.088723,-0.069774,0,0
5,GO REGULATION OF MRNA 3 END PROCESSING,0.11636,-0.088802,-0.070115,0,0
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.21256,-0.088895,-0.13876,0,0
5,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.17374,-0.089079,-0.17415,0,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.24643,-0.089093,-0.12418,0,0
5,GO MUSCLE CELL DEVELOPMENT,0.025994,-0.089136,-0.098767,0,0
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.023205,-0.089199,-0.078498,0,0
5,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.082489,-0.089265,-0.10483,0,0
5,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.1313,-0.089277,-0.1645,0,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.69061,-0.089374,-0.025389,0,0
5,GO MESENCHYMAL CELL DIFFERENTIATION,0.090515,-0.089377,-0.095646,0,0
5,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.33373,-0.089502,-0.058005,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.34256,-0.08958,-0.066133,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.11039,-0.089777,-0.11901,0,0
5,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.42347,-0.089828,-0.048834,0,0
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.33373,-0.090001,-0.074289,0,0
5,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.087232,-0.090043,-0.080569,0,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.061812,-0.090108,-0.14173,0,0
5,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.16032,-0.090141,-0.09375,0,0
5,GO CRANIAL NERVE MORPHOGENESIS,0.68418,-0.090184,-0.048972,0,0
5,GO MELANOCYTE DIFFERENTIATION,0.5726,-0.090242,-0.026626,0,0
5,GO REGULATION OF MEMBRANE REPOLARIZATION,0.053746,-0.090243,-0.12373,0,0
5,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.18219,-0.090482,-0.12906,0,0
5,GO MITOTIC CELL CYCLE ARREST,0.89215,-0.090545,-0.00075161,0,0
5,GO GLYCINE TRANSPORT,0.10096,-0.09062,-0.22216,0,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.22235,-0.09077,-0.14648,0,0
5,GO BILE ACID AND BILE SALT TRANSPORT,0.33812,-0.090939,-0.11595,0,0
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.10845,-0.09096,-0.096476,0,0
5,GO NEGATIVE REGULATION OF CELL SIZE,0.099158,-0.091026,-0.11254,0,0
5,GO ETHANOL METABOLIC PROCESS,0.2839,-0.091042,-0.11052,0,0
5,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.10654,-0.091142,-0.11651,0,0
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.12473,-0.091186,-0.16195,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.061812,-0.091226,-0.08088,0,0
5,GO POSITIVE REGULATION OF HEART GROWTH,0.093897,-0.091352,-0.098279,0,0
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.16294,-0.091446,-0.13094,0,0
5,GO LEUKOTRIENE METABOLIC PROCESS,0.079444,-0.091474,-0.14037,0,0
5,GO NAD BIOSYNTHETIC PROCESS,0.1313,-0.091702,-0.10645,0,0
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.082489,-0.091735,-0.11899,0,0
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.075049,-0.091761,-0.079292,0,0
5,GO PROSTANOID METABOLIC PROCESS,0.15517,-0.09181,-0.17667,0,0
5,GO RESPIRATORY BURST,0.11434,-0.091916,-0.13505,0,0
5,GO RESPONSE TO SALT STRESS,0.31653,-0.091937,-0.061813,0,0
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.22905,-0.091984,-0.079045,0,0
5,GO MEMBRANE DEPOLARIZATION,0.36991,-0.092154,-0.05672,0,0
5,GO MITOTIC RECOMBINATION,0.44924,-0.092176,-0.034391,0,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.11434,-0.092576,-0.1821,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.10465,-0.092895,-0.14754,0,0
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.32938,-0.092937,-0.13438,0,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.35607,-0.092951,-0.12462,0,0
5,GO RESPONSE TO FATTY ACID,0.05824,-0.093187,-0.11094,0,0
5,GO KERATINOCYTE PROLIFERATION,0.72313,-0.093254,-0.047981,0,0
5,GO MUSCLE FIBER DEVELOPMENT,0.033166,-0.093433,-0.10348,0,0
5,GO INTRACILIARY RETROGRADE TRANSPORT,0.32938,-0.093524,-0.048127,0,0
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.12049,-0.093534,-0.10244,0,0
5,GO PIGMENT GRANULE MATURATION,0.10096,-0.093681,-0.15755,0,0
5,GO POSITIVE REGULATION OF WOUND HEALING,0.17934,-0.093725,-0.090973,0,0
5,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.23937,-0.093754,-0.070055,0,0
5,GO ION TRANSPORT,0.0032441,-0.09385,-0.096992,0,0
5,GO MRNA METHYLATION,0.18219,-0.093967,-0.077585,0,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.15015,-0.093978,-0.089637,0,0
5,GO CATION TRANSPORT,0.011326,-0.093992,-0.086621,0,0
5,GO AMELOGENESIS,0.097379,-0.094092,-0.12427,0,0
5,GO LOCOMOTOR RHYTHM,0.39858,-0.094129,-0.050661,0,0
5,GO LYMPH VESSEL MORPHOGENESIS,0.090515,-0.094244,-0.13739,0,0
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.022165,-0.094259,-0.092064,0,0
5,GO LIPID EXPORT FROM CELL,0.059411,-0.094455,-0.12056,0,0
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.026586,-0.094456,-0.12044,0,0
5,GO VIRAL RELEASE FROM HOST CELL,0.12473,-0.09448,-0.083852,0,0
5,GO PROSTAGLANDIN TRANSPORT,0.084046,-0.094495,-0.11198,0,0
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.050569,-0.094503,-0.11261,0,0
5,GO TELOMERIC LOOP DISASSEMBLY,0.32506,-0.094543,-0.048787,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.188,-0.0946,-0.09998,0,0
5,GO PHAGOSOME MATURATION,0.082489,-0.094667,-0.099461,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.10654,-0.094727,-0.13311,0,0
5,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.5726,-0.094777,-0.059437,0,0
5,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.061812,-0.094825,-0.13274,0,0
5,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.095625,-0.094845,-0.15175,0,0
5,GO NEGATIVE REGULATION OF SECRETION,0.0045306,-0.094994,-0.095042,0,0
5,GO FERTILIZATION,0.0051916,-0.095075,-0.09523,0,0
5,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.05824,-0.095119,-0.12199,0,0
5,GO MUSCLE CELL FATE COMMITMENT,0.14526,-0.09518,-0.13364,0,0
5,GO MITOPHAGY,0.065563,-0.095302,-0.089937,0,0
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.25729,-0.095422,-0.079694,0,0
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.19095,-0.095468,-0.072208,0,0
5,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.068167,-0.095482,-0.094071,0,0
5,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.23589,-0.095718,-0.080844,0,0
5,GO ENERGY HOMEOSTASIS,0.12689,-0.095729,-0.10075,0,0
5,GO GENITALIA DEVELOPMENT,0.0073363,-0.095769,-0.13405,0,0
5,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.17934,-0.095791,-0.07754,0,0
5,GO MANGANESE ION TRANSPORT,0.057089,-0.096004,-0.11045,0,0
5,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.42855,-0.096172,-0.094978,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.15015,-0.09657,-0.11482,0,0
5,GO MEMBRANE DISASSEMBLY,0.21256,-0.096573,-0.088461,0,0
5,GO RENAL VESICLE DEVELOPMENT,0.47049,-0.096586,-0.052927,0,0
5,GO CATION TRANSMEMBRANE TRANSPORT,0.013465,-0.09659,-0.089731,0,0
5,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.14285,-0.096592,-0.074062,0,0
5,GO AMINE CATABOLIC PROCESS,0.22905,-0.096676,-0.12026,0,0
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.16559,-0.096784,-0.091957,0,0
5,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.21905,-0.096915,-0.12966,0,0
5,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.10465,-0.09703,-0.11882,0,0
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.093897,-0.097077,-0.10766,0,0
5,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.27611,-0.097082,-0.14559,0,0
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.080955,-0.097104,-0.19273,0,0
5,GO SNORNA METABOLIC PROCESS,0.13814,-0.097162,-0.095804,0,0
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0695,-0.097193,-0.09963,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.12908,-0.097228,-0.14889,0,0
5,GO METAL ION TRANSPORT,0.0071468,-0.097322,-0.094331,0,0
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.023741,-0.097481,-0.08942,0,0
5,GO T CELL CHEMOTAXIS,0.080955,-0.097513,-0.10977,0,0
5,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.057089,-0.097539,-0.090496,0,0
5,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.28785,-0.097757,-0.074738,0,0
5,GO ERBB SIGNALING PATHWAY,0.10845,-0.097893,-0.088236,0,0
5,GO RECEPTOR INTERNALIZATION,0.031748,-0.098113,-0.084199,0,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.066855,-0.098204,-0.085874,0,0
5,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.066855,-0.098279,-0.16911,0,0
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.017969,-0.098459,-0.10083,0,0
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.088862,-0.098627,-0.099998,0,0
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.068167,-0.099038,-0.11381,0,0
5,GO ETHANOL OXIDATION,0.22235,-0.099197,-0.22763,0,0
5,GO GLIAL CELL DEVELOPMENT,0.093897,-0.099265,-0.086878,0,0
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.2,-0.099292,-0.13264,0,0
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.22568,-0.099305,-0.10371,0,0
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0695,-0.099366,-0.14707,0,0
5,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.054842,-0.09958,-0.13657,0,0
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.031748,-0.099645,-0.08428,0,0
5,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.23937,-0.09965,-0.11222,0,0
5,GO MAMMARY GLAND MORPHOGENESIS,0.27999,-0.099676,-0.097406,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.22568,-0.099895,-0.09467,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.064293,-0.099939,-0.13295,0,0
5,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.14769,-0.099948,-0.21366,0,0
5,GO LACTATE METABOLIC PROCESS,0.63978,-0.10016,-0.0078574,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.065563,-0.10019,-0.13745,0,0
5,GO GLUTAMATE METABOLIC PROCESS,0.14285,-0.10068,-0.077229,0,0
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.01282,-0.10072,-0.084384,0,0
5,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.14048,-0.10092,-0.080145,0,0
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.079444,-0.10125,-0.13538,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.059411,-0.10137,-0.079093,0,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.19695,-0.10139,-0.04242,0,0
5,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.30815,-0.10149,-0.070662,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.061812,-0.10151,-0.12938,0,0
5,GO LENS FIBER CELL DEVELOPMENT,0.16294,-0.10152,-0.13578,0,0
5,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.55487,-0.10163,-0.074719,0,0
5,GO ODONTOGENESIS,0.093897,-0.10178,-0.11106,0,0
5,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.26471,-0.10192,-0.075111,0,0
5,GO REGULATION OF GLIAL CELL PROLIFERATION,0.42347,-0.10193,-0.0385,0,0
5,GO OSTEOBLAST PROLIFERATION,0.16294,-0.1021,-0.12935,0,0
5,GO LUNG MORPHOGENESIS,0.25729,-0.10219,-0.073553,0,0
5,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.4978,-0.10234,-0.053284,0,0
5,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.092194,-0.10257,-0.080604,0,0
5,GO DIET INDUCED THERMOGENESIS,0.072231,-0.1028,-0.14127,0,0
5,GO CATECHOLAMINE SECRETION,0.29992,-0.10295,0.0090809,0,0
5,GO NEGATIVE REGULATION OF AXONOGENESIS,0.35153,-0.10297,-0.054467,0,0
5,GO BASIC AMINO ACID TRANSPORT,0.093897,-0.10304,-0.17704,0,0
5,GO PROTEIN O LINKED MANNOSYLATION,0.097379,-0.10312,-0.094281,0,0
5,GO RESPONSE TO NITRIC OXIDE,0.057089,-0.10316,-0.07642,0,0
5,GO REGULATION OF COAGULATION,0.05161,-0.10326,-0.17521,0,0
5,GO DRINKING BEHAVIOR,0.14526,-0.10348,-0.15647,0,0
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.018836,-0.10358,-0.11911,0,0
5,GO REGULATION OF TRANSPORTER ACTIVITY,0.033894,-0.10389,-0.10092,0,0
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.0695,-0.10392,-0.1067,0,0
5,GO REGULATION OF METAL ION TRANSPORT,0.0010859,-0.10398,-0.12289,0,0
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.24643,-0.104,-0.074799,0,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.91293,-0.10403,-0.013796,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.16294,-0.10405,-0.038315,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.088862,-0.10407,-0.083359,0,0
5,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.10465,-0.10423,-0.1458,0,0
5,GO POSITIVE REGULATION OF JNK CASCADE,0.009256,-0.10427,-0.10551,0,0
5,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.16032,-0.10427,-0.12731,0,0
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.11841,-0.10448,-0.13969,0,0
5,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.27611,-0.10451,-0.1003,0,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.14769,-0.10453,-0.14877,0,0
5,GO REGULATION OF SODIUM ION TRANSPORT,0.079444,-0.10462,-0.10831,0,0
5,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.67776,-0.10465,-0.072009,0,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.12049,-0.10477,-0.11545,0,0
5,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.077957,-0.10486,-0.12491,0,0
5,GO REPLICATIVE SENESCENCE,0.32077,-0.1049,-0.10605,0,0
5,GO MYELOID CELL APOPTOTIC PROCESS,0.084046,-0.10494,-0.1345,0,0
5,GO EPITHELIAL CELL FATE COMMITMENT,0.42855,-0.10534,-0.060948,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.17099,-0.10537,-0.070215,0,0
5,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.12689,-0.1054,-0.10259,0,0
5,GO PROTEIN CONTAINING COMPLEX REMODELING,0.05161,-0.10554,-0.12979,0,0
5,GO CELLULAR OXIDANT DETOXIFICATION,0.093897,-0.10557,-0.098836,0,0
5,GO MECHANORECEPTOR DIFFERENTIATION,0.39371,-0.10563,-0.061047,0,0
5,GO CARNITINE METABOLIC PROCESS,0.26471,-0.10578,-0.076632,0,0
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.11636,-0.10586,-0.16034,0,0
5,GO FEEDING BEHAVIOR,0.05824,-0.10588,-0.076364,0,0
5,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.36526,-0.10589,-0.1376,0,0
5,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.48131,-0.10593,-0.064394,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.29586,-0.10615,-0.069628,0,0
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.055956,-0.10624,-0.17252,0,0
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0075304,-0.10636,-0.086427,0,0
5,GO CELLULAR RESPONSE TO DSRNA,0.11039,-0.10638,-0.13605,0,0
5,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.077957,-0.10657,-0.11442,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.060602,-0.10703,-0.14836,0,0
5,GO SMOOTH MUSCLE CONTRACTION,0.0060989,-0.10707,-0.11558,0,0
5,GO DRUG CATABOLIC PROCESS,0.0025083,-0.10714,-0.16257,0,0
5,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.10845,-0.10722,-0.092466,0,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.10654,-0.10749,-0.11134,0,0
5,GO CARDIOCYTE DIFFERENTIATION,0.099158,-0.10758,-0.083801,0,0
5,GO PRENYLATION,0.23245,-0.1079,-0.054278,0,0
5,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.23589,-0.10794,-0.071157,0,0
5,GO NUCLEAR ENVELOPE REASSEMBLY,0.32938,-0.10796,-0.054877,0,0
5,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.2,-0.10803,-0.068889,0,0
5,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.11841,-0.10815,-0.14548,0,0
5,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.24643,-0.10822,-0.10309,0,0
5,GO PHOSPHATE ION TRANSPORT,0.044685,-0.10825,-0.077985,0,0
5,GO REGULATION OF CHOLESTEROL EFFLUX,0.0695,-0.10827,-0.10015,0,0
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0056288,-0.10829,-0.15085,0,0
5,GO SHORT TERM MEMORY,0.32077,-0.10849,-0.11145,0,0
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.19695,-0.10851,-0.10616,0,0
5,GO REGULATION OF PLATELET ACTIVATION,0.10465,-0.10855,-0.15424,0,0
5,GO CELLULAR RESPONSE TO CAMP,0.046579,-0.10862,-0.095832,0,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.17374,-0.10871,-0.15734,0,0
5,GO REGULATION OF MITOCHONDRIAL FISSION,0.045624,-0.10894,-0.10268,0,0
5,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.13355,-0.10901,-0.10174,0,0
5,GO GLAND MORPHOGENESIS,0.32506,-0.1094,-0.098484,0,0
5,GO VITAMIN D BIOSYNTHETIC PROCESS,0.56075,-0.10955,-0.054574,0,0
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.03939,-0.10971,-0.11159,0,0
5,GO MUSCLE SYSTEM PROCESS,0.0001547,-0.10979,-0.13348,0,0
5,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.15773,-0.10982,-0.10438,0,0
5,GO LYMPH NODE DEVELOPMENT,0.077957,-0.10995,-0.1027,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.054842,-0.11003,-0.141,0,0
5,GO RESPONSE TO ATP,0.0066042,-0.11015,-0.12678,0,0
5,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.063042,-0.11037,-0.15334,0,0
5,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.15264,-0.11037,-0.12792,0,0
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.097379,-0.11043,-0.084357,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.1313,-0.11069,-0.12249,0,0
5,GO LEUKOCYTE AGGREGATION,0.19695,-0.11086,-0.19118,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.17934,-0.11093,-0.085035,0,0
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0083534,-0.11117,-0.11348,0,0
5,GO NEURON CELLULAR HOMEOSTASIS,0.36064,-0.1112,-0.097146,0,0
5,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.20309,-0.11128,-0.12651,0,0
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.02166,-0.11128,-0.10102,0,0
5,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.030383,-0.11129,-0.15513,0,0
5,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.4598,-0.11153,-0.10858,0,0
5,GO NEURAL CREST CELL DIFFERENTIATION,0.063042,-0.11157,-0.11444,0,0
5,GO ICOSANOID BIOSYNTHETIC PROCESS,0.080955,-0.11158,-0.11803,0,0
5,GO MULTICELLULAR ORGANISMAL SIGNALING,0.12259,-0.1116,-0.08155,0,0
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.077957,-0.11163,-0.14599,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.085627,-0.11192,-0.15504,0,0
5,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.095625,-0.11199,-0.099614,0,0
5,GO RENAL SODIUM EXCRETION,0.11039,-0.1123,-0.099043,0,0
5,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.14769,-0.11265,-0.13128,0,0
5,GO VASCULOGENESIS,0.072231,-0.11281,-0.179,0,0
5,GO OUTFLOW TRACT MORPHOGENESIS,0.065563,-0.11287,-0.14355,0,0
5,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.085627,-0.11291,-0.20807,0,0
5,GO REGULATION OF RESPONSE TO WOUNDING,0.25001,-0.11293,-0.088367,0,0
5,GO POSITIVE REGULATION OF COAGULATION,0.060602,-0.11299,-0.14472,0,0
5,GO REGULATION OF ACTION POTENTIAL,0.064293,-0.11317,-0.12084,0,0
5,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.22568,-0.11333,-0.076569,0,0
5,GO CELLULAR RESPONSE TO CALCIUM ION,0.13355,-0.11335,-0.097558,0,0
5,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.11235,-0.11363,-0.09796,0,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.17374,-0.11365,-0.13584,0,0
5,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.32938,-0.11372,-0.062869,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.085627,-0.11378,-0.10677,0,0
5,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.075049,-0.11399,-0.10696,0,0
5,GO HAIR FOLLICLE MATURATION,0.079444,-0.11433,-0.18651,0,0
5,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0024367,-0.11434,-0.11526,0,0
5,GO POSITIVE REGULATION OF CELL SIZE,0.1313,-0.11439,-0.11864,0,0
5,GO NOREPINEPHRINE TRANSPORT,0.17653,-0.11474,-0.090314,0,0
5,GO RESPONSE TO INACTIVITY,0.021165,-0.11476,-0.18728,0,0
5,GO PLASMA MEMBRANE TUBULATION,0.082489,-0.11477,-0.12163,0,0
5,GO CYTOLYSIS,0.12259,-0.11481,-0.14743,0,0
5,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.068167,-0.1149,-0.16852,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.087232,-0.11509,-0.10089,0,0
5,GO CELLULAR RESPONSE TO SALT STRESS,0.087232,-0.11512,-0.16348,0,0
5,GO AMINO ACID BETAINE METABOLIC PROCESS,0.077957,-0.11534,-0.15524,0,0
5,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.077957,-0.11557,-0.14469,0,0
5,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.049546,-0.1157,-0.14393,0,0
5,GO INTERMEDIATE FILAMENT ORGANIZATION,0.088862,-0.11574,-0.14621,0,0
5,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.099158,-0.11576,-0.081501,0,0
5,GO INACTIVATION OF MAPK ACTIVITY,0.23589,-0.11611,-0.08966,0,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.093897,-0.11622,-0.11859,0,0
5,GO FIBROBLAST ACTIVATION,0.068167,-0.11625,-0.13782,0,0
5,GO CHONDROCYTE PROLIFERATION,0.47049,-0.11654,-0.091838,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.055956,-0.11667,-0.12382,0,0
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.090515,-0.11668,-0.12345,0,0
5,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.017137,-0.11669,-0.14689,0,0
5,GO LUNG ALVEOLUS DEVELOPMENT,0.14048,-0.11676,-0.086938,0,0
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.060602,-0.11706,-0.090071,0,0
5,GO LEUKOCYTE TETHERING OR ROLLING,0.0013054,-0.11715,-0.13513,0,0
5,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.14769,-0.11719,-0.10502,0,0
5,GO POSITIVE REGULATION OF ORGAN GROWTH,0.064293,-0.11732,-0.12503,0,0
5,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.073629,-0.11754,-0.14228,0,0
5,GO REGULATION OF INTEGRIN ACTIVATION,0.29586,-0.11778,-0.10568,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.27611,-0.11782,-0.083848,0,0
5,GO STRIATED MUSCLE CONTRACTION,0.0064317,-0.11791,-0.1315,0,0
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0040578,-0.11803,-0.11925,0,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.17374,-0.11808,-0.16442,0,0
5,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.11636,-0.1182,-0.13733,0,0
5,GO B CELL MEDIATED IMMUNITY,0.057089,-0.11833,-0.1445,0,0
5,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.12908,-0.11833,-0.079172,0,0
5,GO SEMI LUNAR VALVE DEVELOPMENT,0.097379,-0.11833,-0.19549,0,0
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.049546,-0.1184,-0.13921,0,0
5,GO TISSUE REGENERATION,0.075049,-0.11855,-0.13042,0,0
5,GO DIACYLGLYCEROL METABOLIC PROCESS,0.099158,-0.11863,-0.09949,0,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.073629,-0.11866,-0.15205,0,0
5,GO REGULATION OF RNA BINDING,0.05824,-0.11881,-0.12854,0,0
5,GO POSITIVE REGULATION OF MYELINATION,0.053746,-0.11894,-0.11545,0,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.22568,-0.11895,-0.04958,0,0
5,GO DENDRITIC CELL MIGRATION,0.084046,-0.11904,-0.14549,0,0
5,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.70355,-0.11933,-0.015121,0,0
5,GO STEROID CATABOLIC PROCESS,0.070855,-0.11941,-0.11948,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.057089,-0.1195,-0.127,0,0
5,GO LAMELLIPODIUM MORPHOGENESIS,0.13583,-0.11955,-0.14065,0,0
5,GO PROTEIN HOMOOLIGOMERIZATION,0.00010462,-0.11961,-0.12767,0,0
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.059411,-0.11964,-0.14106,0,0
5,GO REGULATION OF WOUND HEALING,0.11039,-0.11981,-0.12028,0,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.054842,-0.11989,-0.14173,0,0
5,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.16032,-0.11993,-0.12064,0,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.14048,-0.12053,-0.12006,0,0
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.019739,-0.12055,-0.12444,0,0
5,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.31232,-0.12095,-0.073332,0,0
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.16032,-0.12096,-0.075626,0,0
5,GO HYALURONAN BIOSYNTHETIC PROCESS,0.015574,-0.12156,-0.1614,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.15773,-0.12159,-0.089998,0,0
5,GO MUSCLE CONTRACTION,0.00020448,-0.12191,-0.13409,0,0
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.29586,-0.12195,-0.078154,0,0
5,GO LONG TERM MEMORY,0.19095,-0.12201,-0.075268,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.19095,-0.12202,-0.12185,0,0
5,GO ANTIBACTERIAL HUMORAL RESPONSE,0.049546,-0.12221,-0.15597,0,0
5,GO TOOTH MINERALIZATION,0.075049,-0.12229,-0.14213,0,0
5,GO TRABECULA FORMATION,0.050569,-0.12265,-0.18775,0,0
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.085627,-0.12275,-0.13763,0,0
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.061812,-0.12314,-0.15538,0,0
5,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.15264,-0.12373,-0.13784,0,0
5,GO EPIBOLY,0.072231,-0.12404,-0.21937,0,0
5,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.15264,-0.12416,-0.11345,0,0
5,GO STEROL BIOSYNTHETIC PROCESS,0.090515,-0.12423,-0.10404,0,0
5,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.22905,-0.12462,-0.17432,0,0
5,GO MEMBRANE BIOGENESIS,0.20937,-0.12473,-0.075223,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.063042,-0.12499,-0.10257,0,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.26471,-0.12557,-0.11887,0,0
5,GO RESPONSE TO HISTAMINE,0.27999,-0.12557,-0.17002,0,0
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.17653,-0.12574,-0.11112,0,0
5,GO MACROPHAGE CHEMOTAXIS,0.11235,-0.12591,-0.11786,0,0
5,GO REGULATION OF CATION CHANNEL ACTIVITY,0.05824,-0.12604,-0.10519,0,0
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.91987,-0.12625,0.0025187,0,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0083534,-0.1263,-0.13083,0,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.075049,-0.12648,-0.17333,0,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.052669,-0.1266,-0.13973,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.28785,-0.12669,-0.093379,0,0
5,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.11841,-0.12671,-0.19602,0,0
5,GO BRANCH ELONGATION OF AN EPITHELIUM,0.10654,-0.12725,-0.22562,0,0
5,GO ALPHA BETA T CELL PROLIFERATION,0.090515,-0.12761,-0.13459,0,0
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.12049,-0.12789,-0.11309,0,0
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.14769,-0.12794,-0.12365,0,0
5,GO CARDIAC MUSCLE CONTRACTION,0.0053338,-0.12812,-0.14169,0,0
5,GO DERMATAN SULFATE METABOLIC PROCESS,0.1313,-0.12847,-0.19398,0,0
5,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.34256,-0.12855,-0.05854,0,0
5,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.41842,-0.1286,-0.089222,0,0
5,GO ANION HOMEOSTASIS,0.022165,-0.12893,-0.13343,0,0
5,GO BLASTODERM SEGMENTATION,0.32506,-0.12904,-0.10933,0,0
5,GO CARDIAC CELL DEVELOPMENT,0.0056288,-0.1291,-0.14254,0,0
5,GO B CELL APOPTOTIC PROCESS,0.11434,-0.12919,-0.12221,0,0
5,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0047853,-0.12933,-0.19549,0,0
5,GO NEUROPEPTIDE SIGNALING PATHWAY,0.16559,-0.12972,-0.081913,0,0
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.054842,-0.12981,-0.12886,0,0
5,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.34702,-0.12985,-0.08439,0,0
5,GO POSITIVE REGULATION OF FERTILIZATION,0.070855,-0.12999,-0.18031,0,0
5,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.0069616,-0.13002,-0.11423,0,0
5,GO REGULATION OF T CELL CHEMOTAXIS,0.11039,-0.13032,-0.11663,0,0
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.092194,-0.13038,-0.10868,0,0
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,2.8418e-05,-0.13045,-0.10806,0,0
5,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.085627,-0.13052,-0.17347,0,0
5,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.11039,-0.13063,-0.12002,0,0
5,GO PROTEOGLYCAN METABOLIC PROCESS,0.064293,-0.13076,-0.10274,0,0
5,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.41842,-0.13087,-0.085749,0,0
5,GO CARDIAC MYOFIBRIL ASSEMBLY,0.48678,-0.13104,-0.049242,0,0
5,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.02268,-0.1314,-0.15775,0,0
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.022165,-0.13155,-0.11935,0,0
5,GO RESPONSE TO MUSCLE INACTIVITY,0.27999,-0.13158,-0.081415,0,0
5,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.060602,-0.13161,-0.21605,0,0
5,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.093897,-0.13163,-0.11744,0,0
5,GO REGULATION OF CELL MATRIX ADHESION,0.15517,-0.13174,-0.11657,0,0
5,GO ASSOCIATIVE LEARNING,0.047551,-0.13181,-0.091142,0,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.26847,-0.13205,-0.090611,0,0
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.053746,-0.13225,-0.16649,0,0
5,GO CORONARY VASCULATURE MORPHOGENESIS,0.13355,-0.13306,-0.14241,0,0
5,GO REGULATION OF ANOIKIS,0.15517,-0.13332,-0.16393,0,0
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0010206,-0.13339,-0.15387,0,0
5,GO VITAMIN BIOSYNTHETIC PROCESS,0.10845,-0.13342,-0.10916,0,0
5,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.11636,-0.13357,-0.17973,0,0
5,GO GLIAL CELL PROLIFERATION,0.10845,-0.13359,-0.094902,0,0
5,GO POSITIVE REGULATION OF ION TRANSPORT,0.0067808,-0.13362,-0.10541,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.038561,-0.13393,-0.11156,0,0
5,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.20309,-0.13401,-0.11466,0,0
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.087232,-0.13407,-0.14459,0,0
5,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.16032,-0.13418,-0.18527,0,0
5,GO GROOMING BEHAVIOR,0.30815,-0.13419,-0.06352,0,0
5,GO REGULATION OF HIPPO SIGNALING,0.050569,-0.13425,-0.20502,0,0
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.066855,-0.1346,-0.16694,0,0
5,GO DENDRITIC CELL CHEMOTAXIS,0.097379,-0.13463,-0.126,0,0
5,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.44924,-0.13488,-0.095023,0,0
5,GO INTERMEMBRANE LIPID TRANSFER,0.00353,-0.13519,-0.12924,0,0
5,GO FEVER GENERATION,0.045624,-0.13534,-0.15397,0,0
5,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.20621,-0.13544,-0.15938,0,0
5,GO NEGATIVE REGULATION OF ANOIKIS,0.25363,-0.13551,-0.15943,0,0
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.11636,-0.13568,-0.16964,0,0
5,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.17374,-0.13593,-0.085123,0,0
5,GO PULMONARY VALVE DEVELOPMENT,0.060602,-0.13622,-0.23007,0,0
5,GO PLASMA MEMBRANE FUSION,0.044685,-0.13623,-0.20776,0,0
5,GO PROTEIN DENEDDYLATION,0.14048,-0.13668,-0.084842,0,0
5,GO PERICARDIUM DEVELOPMENT,0.13814,-0.13691,-0.13893,0,0
5,GO PROTEIN COMPLEX OLIGOMERIZATION,4.8379e-05,-0.1373,-0.14094,0,0
5,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.18219,-0.13734,-0.079665,0,0
5,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.097379,-0.13778,-0.19424,0,0
5,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.23589,-0.13796,-0.13573,0,0
5,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.12689,-0.13804,-0.13146,0,0
5,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.11636,-0.13826,-0.091843,0,0
5,GO NEPHRIC DUCT MORPHOGENESIS,0.087232,-0.13848,-0.22312,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.32077,-0.13853,-0.090722,0,0
5,GO BONE MORPHOGENESIS,0.05161,-0.13866,-0.11778,0,0
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.060602,-0.13879,-0.12102,0,0
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.018836,-0.13887,-0.15152,0,0
5,GO BROWN FAT CELL DIFFERENTIATION,0.05824,-0.13933,-0.11816,0,0
5,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.013139,-0.13943,-0.18008,0,0
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.19695,-0.13954,-0.14285,0,0
5,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.15264,-0.13976,-0.11362,0,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.041093,-0.13979,-0.15423,0,0
5,GO NODAL SIGNALING PATHWAY,0.036164,-0.14018,-0.14774,0,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.10465,-0.1402,-0.16122,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.1028,-0.14036,-0.21779,0,0
5,GO KIDNEY MESENCHYME DEVELOPMENT,0.1313,-0.14069,-0.13922,0,0
5,GO DIOL BIOSYNTHETIC PROCESS,0.057089,-0.14079,-0.1335,0,0
5,GO POSITIVE REGULATION OF HAIR CYCLE,0.26847,-0.14085,-0.13609,0,0
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.23589,-0.1418,-0.16373,0,0
5,GO ACROSOME REACTION,0.05824,-0.14183,-0.13502,0,0
5,GO ENDOTHELIAL CELL CHEMOTAXIS,0.097379,-0.14192,-0.15536,0,0
5,GO MEMBRANE REPOLARIZATION,0.0054795,-0.14212,-0.17993,0,0
5,GO RESPONSE TO STARVATION,0.0016129,-0.14232,-0.12879,0,0
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.17099,-0.14274,-0.098825,0,0
5,GO REGULATION OF TUBULIN DEACETYLATION,0.35153,-0.14284,-0.065642,0,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.064293,-0.14304,-0.18282,0,0
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.21905,-0.14352,-0.11089,0,0
5,GO MYELIN ASSEMBLY,0.099158,-0.14382,-0.11327,0,0
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.014841,-0.14407,-0.18728,0,0
5,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.30402,-0.14451,-0.093769,0,0
5,GO POSITIVE REGULATION OF NEURON MIGRATION,0.25001,-0.1448,-0.11707,0,0
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0031536,-0.14492,-0.1513,0,0
5,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0021689,-0.14597,-0.15724,0,0
5,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.055956,-0.14604,-0.13008,0,0
5,GO SUCKLING BEHAVIOR,0.16294,-0.14605,-0.11561,0,0
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.085627,-0.14616,-0.13552,0,0
5,GO PIGMENT GRANULE ORGANIZATION,0.097379,-0.14654,-0.10266,0,0
5,GO CHRONIC INFLAMMATORY RESPONSE,0.073629,-0.14671,-0.18818,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.14769,-0.14741,-0.13649,0,0
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.022165,-0.14741,-0.18309,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.042857,-0.14749,-0.20816,0,0
5,GO POSITIVE REGULATION OF OSSIFICATION,0.02166,-0.14761,-0.15344,0,0
5,GO T HELPER 2 CELL DIFFERENTIATION,0.055956,-0.14772,-0.29678,0,0
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.066855,-0.14782,-0.13367,0,0
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.85768,-0.14809,0.094273,0,0
5,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.17653,-0.14857,-0.18729,0,0
5,GO NEUROMUSCULAR PROCESS,0.016339,-0.14858,-0.10377,0,0
5,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.43367,-0.14882,-0.065,0,0
5,GO BEHAVIORAL RESPONSE TO COCAINE,0.51459,-0.14894,-0.039549,0,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.019283,-0.14908,-0.18794,0,0
5,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.16559,-0.14949,-0.19099,0,0
5,GO RESPONSE TO MUSCLE STRETCH,0.079444,-0.14973,-0.18438,0,0
5,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.0695,-0.14985,-0.1598,0,0
5,GO REGULATION OF CARDIAC CONDUCTION,0.00353,-0.15035,-0.16059,0,0
5,GO ORGAN INDUCTION,0.019283,-0.15038,-0.15442,0,0
5,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.031059,-0.15046,-0.16097,0,0
5,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.080955,-0.15063,-0.14065,0,0
5,GO IMPORT INTO CELL,0.0028957,-0.15078,-0.13701,0,0
5,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.14048,-0.15111,-0.15564,0,0
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.11841,-0.15125,-0.16182,0,0
5,GO ENDOTHELIAL CELL MORPHOGENESIS,0.16294,-0.15132,-0.15898,0,0
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.016339,-0.15149,-0.1718,0,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.024288,-0.15215,-0.11943,0,0
5,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.13583,-0.15248,-0.10284,0,0
5,GO SYNAPTIC TRANSMISSION GABAERGIC,0.012203,-0.15252,-0.1388,0,0
5,GO INTERLEUKIN 5 PRODUCTION,0.068167,-0.15255,-0.18199,0,0
5,GO RETINAL METABOLIC PROCESS,0.3746,-0.15279,-0.14605,0,0
5,GO IMPORT ACROSS PLASMA MEMBRANE,0.0011549,-0.15295,-0.14419,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.11841,-0.15311,-0.20672,0,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.84397,-0.15339,0.041242,0,0
5,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.088862,-0.15376,-0.11941,0,0
5,GO REGULATION OF MUSCLE CONTRACTION,0.001986,-0.15376,-0.12481,0,0
5,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.031748,-0.15396,-0.1416,0,0
5,GO ENERGY RESERVE METABOLIC PROCESS,0.00016595,-0.15402,-0.16504,0,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.023741,-0.15432,-0.12365,0,0
5,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.018836,-0.15438,-0.18346,0,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.2,-0.15532,-0.068459,0,0
5,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.16294,-0.15553,-0.21866,0,0
5,GO RESPONSE TO AMINE,0.0073363,-0.15568,-0.19436,0,0
5,GO REGULATION OF GONAD DEVELOPMENT,0.11434,-0.15593,-0.12526,0,0
5,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.022165,-0.15602,-0.17812,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.035393,-0.15666,-0.11938,0,0
5,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.097379,-0.15678,-0.22566,0,0
5,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0081404,-0.15711,-0.15108,0,0
5,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.066855,-0.15728,-0.13589,0,0
5,GO FACIAL NERVE MORPHOGENESIS,0.44402,-0.1574,-0.059886,0,0
5,GO MECHANOSENSORY BEHAVIOR,0.39858,-0.15776,-0.060495,0,0
5,GO REGULATION OF BONE MINERALIZATION,0.0050528,-0.15777,-0.17631,0,0
5,GO REGULATION OF VESICLE FUSION,0.068167,-0.15793,-0.18784,0,0
5,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.099158,-0.15817,-0.19253,0,0
5,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.16559,-0.15824,-0.14033,0,0
5,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.059411,-0.15831,-0.147,0,0
5,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.025414,-0.15908,-0.12371,0,0
5,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.029068,-0.15913,-0.21988,0,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.12908,-0.15986,-0.14884,0,0
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.015953,-0.15995,-0.14958,0,0
5,GO RESPONSE TO LIGHT INTENSITY,0.030383,-0.15998,-0.16739,0,0
5,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.15773,-0.16021,-0.14526,0,0
5,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.29992,-0.16128,-0.15296,0,0
5,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.092194,-0.16148,-0.2005,0,0
5,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,1.2962e-05,-0.16161,-0.1659,0,0
5,GO ASYMMETRIC CELL DIVISION,0.031059,-0.16165,-0.17225,0,0
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.40843,-0.16188,-0.077718,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0695,-0.16241,-0.11006,0,0
5,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.073629,-0.1628,-0.13962,0,0
5,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.15517,-0.16292,-0.085427,0,0
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.25363,-0.16316,-0.072875,0,0
5,GO VITAMIN CATABOLIC PROCESS,0.097379,-0.16319,-0.17165,0,0
5,GO DISACCHARIDE METABOLIC PROCESS,0.14285,-0.16365,-0.12285,0,0
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.080955,-0.16448,-0.16369,0,0
5,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.068167,-0.1646,-0.2086,0,0
5,GO PROTEIN KINASE C SIGNALING,0.05161,-0.16477,-0.1161,0,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.25001,-0.16488,-0.13223,0,0
5,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.017549,-0.16497,-0.13803,0,0
5,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.35607,-0.16518,-0.072495,0,0
5,GO POSITIVE REGULATION OF HEART CONTRACTION,0.041093,-0.16544,-0.13371,0,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.023741,-0.16655,-0.16293,0,0
5,GO REGULATION OF CALCIUM ION TRANSPORT,0.00019079,-0.16675,-0.15073,0,0
5,GO NEGATIVE CHEMOTAXIS,0.0099891,-0.16688,-0.21649,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.1313,-0.1673,-0.13385,0,0
5,GO BONE MINERALIZATION,0.001228,-0.16732,-0.18705,0,0
5,GO MICROVILLUS ASSEMBLY,0.15264,-0.16767,-0.15241,0,0
5,GO RESPONSE TO TYPE I INTERFERON,0.12689,-0.16831,-0.23432,0,0
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.23245,-0.16876,-0.1121,0,0
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.17653,-0.16932,-0.1825,0,0
5,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.13583,-0.16959,-0.13679,0,0
5,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.072231,-0.16966,-0.1824,0,0
5,GO PARAXIAL MESODERM MORPHOGENESIS,0.12473,-0.16978,-0.15865,0,0
5,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.29184,-0.17045,-0.041537,0,0
5,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.20621,-0.17051,-0.13862,0,0
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0695,-0.17135,-0.19992,0,0
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.11841,-0.17165,-0.082708,0,0
5,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.15015,-0.17171,-0.19827,0,0
5,GO ACYLGLYCEROL HOMEOSTASIS,0.0013457,-0.17203,-0.18323,0,0
5,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.080955,-0.17253,-0.16878,0,0
5,GO ADULT HEART DEVELOPMENT,0.36991,-0.1727,-0.078975,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.055956,-0.1733,-0.18803,0,0
5,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.23245,-0.17338,-0.14013,0,0
5,GO REFLEX,0.23937,-0.17339,-0.12353,0,0
5,GO INNERVATION,0.25001,-0.17389,-0.086821,0,0
5,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.19393,-0.17397,-0.18274,0,0
5,GO RESPONSE TO DIETARY EXCESS,0.12689,-0.17408,-0.14573,0,0
5,GO DOPAMINE TRANSPORT,0.14285,-0.17421,-0.065935,0,0
5,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.23245,-0.17437,-0.18334,0,0
5,GO ACTIN MEDIATED CELL CONTRACTION,0.0017641,-0.17441,-0.18211,0,0
5,GO ANATOMICAL STRUCTURE REGRESSION,0.03245,-0.17444,-0.19385,0,0
5,GO CELLULAR RESPONSE TO ZINC ION,0.014841,-0.17486,-0.38384,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.079444,-0.1749,-0.1284,0,0
5,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.2839,-0.17501,-0.11786,0,0
5,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.095625,-0.17531,-0.13811,0,0
5,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,5.0226e-05,-0.17595,-0.17536,0,0
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.084046,-0.17611,-0.15904,0,0
5,GO CARDIAC CONDUCTION,0.030383,-0.17706,-0.13114,0,0
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.29184,-0.17749,-0.080941,0,0
5,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.42347,-0.17778,-0.071393,0,0
5,GO STARTLE RESPONSE,0.17099,-0.17816,-0.14562,0,0
5,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.12259,-0.17824,-0.12567,0,0
5,GO SUPEROXIDE ANION GENERATION,0.099158,-0.17828,-0.18841,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.007729,-0.17849,-0.13682,0,0
5,GO REGULATION OF BIOMINERALIZATION,0.0046564,-0.17861,-0.1618,0,0
5,GO EXTRACELLULAR TRANSPORT,0.14285,-0.17882,-0.086851,0,0
5,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.12259,-0.17898,-0.17846,0,0
5,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.066855,-0.17933,-0.12156,0,0
5,GO REGULATION OF GTP BINDING,0.016734,-0.17956,-0.21315,0,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.009256,-0.1797,-0.12473,0,0
5,GO REGULATION OF HEART RATE,0.018398,-0.18044,-0.14377,0,0
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.51459,-0.18053,-0.065702,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.17653,-0.18115,-0.10938,0,0
5,GO EXPORT ACROSS PLASMA MEMBRANE,0.023205,-0.18149,-0.14235,0,0
5,GO PROSTATIC BUD FORMATION,0.14769,-0.18296,-0.20093,0,0
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.13583,-0.18323,-0.14159,0,0
5,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.3746,-0.18417,-0.08839,0,0
5,GO VAGINA DEVELOPMENT,0.057089,-0.18447,-0.19015,0,0
5,GO ENDOCARDIAL CUSHION FORMATION,0.18219,-0.18504,-0.13754,0,0
5,GO REGULATION OF SYNAPSE MATURATION,0.25001,-0.18525,-0.14432,0,0
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00014418,-0.18597,-0.19774,0,0
5,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,5.0226e-05,-0.18598,-0.18954,0,0
5,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.095625,-0.18648,-0.19153,0,0
5,GO REGULATION OF PROSTAGLANDIN SECRETION,0.11235,-0.18694,-0.10355,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.10096,-0.18725,-0.24438,0,0
5,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.076492,-0.18789,-0.20433,0,0
5,GO ACTIN FILAMENT SEVERING,0.22568,-0.18789,-0.13748,0,0
5,GO INCLUSION BODY ASSEMBLY,0.14769,-0.18822,-0.1214,0,0
5,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.011326,-0.18888,-0.16147,0,0
5,GO FUCOSE METABOLIC PROCESS,0.049546,-0.18891,-0.16968,0,0
5,GO ZYMOGEN INHIBITION,0.053746,-0.18912,-0.21529,0,0
5,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.17934,-0.18913,-0.14208,0,0
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.12259,-0.18931,-0.16791,0,0
5,GO REGULATION OF NEURON MATURATION,0.12049,-0.18999,-0.11117,0,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.079444,-0.1904,-0.18343,0,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.014486,-0.1905,-0.19503,0,0
5,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.14048,-0.19129,-0.13054,0,0
5,GO B CELL HOMEOSTASIS,0.0057817,-0.19164,-0.16217,0,0
5,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.065563,-0.19182,-0.20126,0,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.029719,-0.19226,-0.16515,0,0
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.1313,-0.19228,-0.1369,0,0
5,GO CHEMOSENSORY BEHAVIOR,0.00014935,-0.19258,-0.23402,0,0
5,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.076492,-0.19328,-0.13329,0,0
5,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.061812,-0.19381,-0.17594,0,0
5,GO ENTRY OF BACTERIUM INTO HOST CELL,0.085627,-0.19425,-0.2238,0,0
5,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.010506,-0.1946,-0.21044,0,0
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0021062,-0.19468,-0.17014,0,0
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.17653,-0.19489,-0.21141,0,0
5,GO SPHINGOID METABOLIC PROCESS,0.0015189,-0.19493,-0.19847,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0081404,-0.19518,-0.2224,0,0
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.15517,-0.19536,-0.12804,0,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.11434,-0.19602,-0.13232,0,0
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.060602,-0.197,-0.17094,0,0
5,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.070855,-0.19725,-0.18366,0,0
5,GO TRNA CATABOLIC PROCESS,0.13583,-0.19734,-0.17404,0,0
5,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00090094,-0.19759,-0.25846,0,0
5,GO BLEB ASSEMBLY,0.10845,-0.19768,-0.34446,0,0
5,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.052669,-0.19946,-0.18862,0,0
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.076492,-0.19988,-0.15343,0,0
5,GO REGULATION OF DOPAMINE SECRETION,0.18219,-0.20015,-0.052422,0,0
5,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00054072,-0.20045,-0.16272,0,0
5,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.12473,-0.20053,-0.23823,0,0
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.063042,-0.20103,-0.18211,0,0
5,GO CATECHOLAMINE UPTAKE,0.0059384,-0.20159,-0.22934,0,0
5,GO MACROPHAGE PROLIFERATION,0.055956,-0.20178,-0.22301,0,0
5,GO CELLULAR RESPONSE TO CADMIUM ION,0.088862,-0.20334,-0.1996,0,0
5,GO ADAPTATION OF SIGNALING PATHWAY,0.007729,-0.20347,-0.19419,0,0
5,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.0054795,-0.20453,-0.18984,0,0
5,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.19393,-0.20454,-0.11751,0,0
5,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.00059588,-0.20474,-0.21712,0,0
5,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.013465,-0.20621,-0.16592,0,0
5,GO HISTAMINE SECRETION,0.072231,-0.20662,-0.22113,0,0
5,GO REGULATION OF ACROSOME REACTION,0.050569,-0.20775,-0.19791,0,0
5,GO RESPONSE TO ZINC ION,0.012203,-0.20842,-0.21239,0,0
5,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.023205,-0.20872,-0.20651,0,0
5,GO ZINC ION TRANSPORT,0.00057693,-0.21173,-0.1983,0,0
5,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.56666,-0.21217,-0.054229,0,0
5,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.11235,-0.21368,-0.1631,0,0
5,GO RESPONSE TO MUSCLE ACTIVITY,0.0039469,-0.21463,-0.23653,0,0
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.0066042,-0.21566,-0.21328,0,0
5,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.036164,-0.21731,-0.19218,0,0
5,GO CARBOHYDRATE PHOSPHORYLATION,0.001872,-0.21813,-0.20536,0,0
5,GO CARDIAC MUSCLE CELL CONTRACTION,0.0028141,-0.21837,-0.18624,0,0
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.00013433,-0.21851,-0.24312,0,0
5,GO ONE CARBON METABOLIC PROCESS,2.1663e-05,-0.21967,-0.24174,0,0
5,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0013054,-0.21985,-0.17029,0,0
5,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.2,-0.2204,-0.22001,0,0
5,GO MICROVILLUS ORGANIZATION,0.12049,-0.22085,-0.14658,0,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.023205,-0.22085,-0.17197,0,0
5,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.088862,-0.22146,-0.21023,0,0
5,GO POSITIVE REGULATION OF VESICLE FUSION,0.087232,-0.22249,-0.26327,0,0
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.014138,-0.22355,-0.17786,0,0
5,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.0007696,-0.22398,-0.2621,0,0
5,GO AXIS ELONGATION,0.13814,-0.22614,-0.12777,0,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.011612,-0.22732,-0.22579,0,0
5,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0695,-0.22754,-0.16557,0,0
5,GO BASEMENT MEMBRANE ASSEMBLY,0.05161,-0.22842,-0.23964,0,0
5,GO VASCULAR TRANSPORT,0.05161,-0.23099,-0.24602,0,0
5,GO NEUROTRANSMITTER UPTAKE,0.013798,-0.23138,-0.17324,0,0
5,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0022332,-0.23353,-0.22118,0,0
5,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.11434,-0.23427,-0.18836,0,0
5,GO ZINC ION HOMEOSTASIS,0.014486,-0.23429,-0.24073,0,0
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0050528,-0.2343,-0.25554,0,0
5,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.097379,-0.23536,-0.16932,0,0
5,GO NEPHRIC DUCT DEVELOPMENT,0.0034322,-0.2358,-0.27887,0,0
5,GO NEGATIVE REGULATION OF BONE REMODELING,0.095625,-0.23588,-0.17211,0,0
5,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.017969,-0.23701,-0.25902,0,0
5,GO HEART TRABECULA FORMATION,0.025994,-0.23772,-0.25383,0,0
5,GO RELAXATION OF MUSCLE,0.009256,-0.23777,-0.20453,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00092958,-0.23796,-0.27309,0,0
5,GO XENOBIOTIC CATABOLIC PROCESS,0.082489,-0.238,-0.24524,0,0
5,GO CELL JUNCTION DISASSEMBLY,0.0014299,-0.24107,-0.24308,0,0
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0022992,-0.24394,-0.26414,0,0
5,GO SKIN MORPHOGENESIS,0.080955,-0.24438,-0.23876,0,0
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.0039469,-0.24735,-0.27785,0,0
5,GO CELLULAR RESPONSE TO COPPER ION,0.033166,-0.24788,-0.29789,0,0
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.066855,-0.24935,-0.23282,0,0
5,GO RESPONSE TO MAGNESIUM ION,0.00353,-0.24946,-0.30202,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.023741,-0.25167,-0.17079,0,0
5,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.014841,-0.25281,-0.2422,0,0
5,GO FRUCTOSE METABOLIC PROCESS,0.097379,-0.25408,-0.22619,0,0
5,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.088862,-0.25539,-0.23189,0,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00095906,-0.26054,-0.20826,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.14048,-0.26485,-0.15812,0,0
5,GO RELAXATION OF CARDIAC MUSCLE,0.066855,-0.26586,-0.18093,0,0
5,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.011904,-0.27013,-0.26068,0,0
5,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.1313,-0.27015,-0.19395,0,0
5,GO NEUROTRANSMITTER REUPTAKE,0.018836,-0.27125,-0.20436,0,0
5,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.052669,-0.27448,-0.16545,0,0
5,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00044439,-0.2803,-0.26236,0,0
5,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.05824,-0.284,-0.25158,0,0
5,GO L SERINE METABOLIC PROCESS,0.064293,-0.28429,-0.18934,0,0
5,GO RESPONSE TO CAFFEINE,0.00072223,-0.28459,-0.26219,0,0
5,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.050569,-0.28783,-0.21509,0,0
5,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0029794,-0.2881,-0.28321,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.05824,-0.28883,-0.16261,0,0
5,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0011549,-0.291,-0.22292,0,0
5,GO FATTY ACYL COA METABOLIC PROCESS,0.00084609,-0.29193,-0.21736,0,0
5,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0695,-0.29501,-0.26385,0,0
5,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.1028,-0.29651,-0.26368,0,0
5,GO EPOXYGENASE P450 PATHWAY,0.0057817,-0.30331,-0.23963,0,0
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.11434,-0.30617,-0.3303,0,0
5,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.036164,-0.30665,-0.22491,0,0
5,GO DETOXIFICATION OF INORGANIC COMPOUND,0.097379,-0.30947,-0.42175,0,0
5,GO MINERALOCORTICOID METABOLIC PROCESS,0.0023671,-0.3097,-0.33487,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0057817,-0.31178,-0.26466,0,0
5,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.001872,-0.3127,-0.22632,0,0
5,GO MEMBRANE RAFT ASSEMBLY,0.21579,-0.31785,-0.28925,0,0
5,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.046579,-0.32664,-0.24618,0,0
5,GO OXYGEN TRANSPORT,0.052669,-0.33071,-0.29866,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.017969,-0.34978,-0.20364,0,0
5,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0059384,-0.35026,-0.3491,0,0
5,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.00017186,-0.35564,-0.32819,0,0
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0028141,-0.35934,-0.28662,0,0
5,GO ALDEHYDE BIOSYNTHETIC PROCESS,8.1192e-05,-0.40841,-0.41053,0,0
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00052342,-0.4279,-0.35283,0,0
5,GO PROTEIN TRIMERIZATION,1.6452e-07,-0.42941,-0.47886,0,0
5,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.00026903,-0.43872,-0.40328,0,0
5,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,1.9904e-06,-0.51942,-0.54879,0,0
